data_2kxf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kxf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 C--O 1.231 0.108 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -61.48 -41.75 97.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.787 0.327 . . . . 0.0 110.791 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.51 -32.82 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.977 0.418 . . . . 0.0 110.075 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.542 HD22 ' SD ' ' A' ' 111' ' ' MET . 83.8 mt -63.25 -34.29 77.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.642 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.47 66.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.167 0.508 . . . . 0.0 110.813 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.0 mt -83.39 -36.83 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.883 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.625 ' SD ' HG12 ' A' ' 198' ' ' ILE . 87.2 mtp -72.22 -22.37 61.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.626 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 76.1 m -74.75 -9.78 58.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.88 0.371 . . . . 0.0 111.021 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -105.46 142.25 35.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.589 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.493 HG13 ' HB ' ' A' ' 158' ' ' VAL . 8.7 p -123.93 127.71 73.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.446 0.641 . . . . 0.0 109.826 170.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -80.54 106.8 12.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.829 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.465 HG12 ' CZ ' ' A' ' 132' ' ' PHE . 19.0 m -99.09 115.31 39.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.423 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.38 149.92 17.53 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.719 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.9 m 76.35 -66.69 0.25 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.872 0.869 . . . . 0.0 111.436 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 120' ' ' TYR . 78.6 mt 61.88 -91.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 O-C-N 123.383 0.427 . . . . 0.0 110.697 -176.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.501 ' HB2' ' O ' ' A' ' 119' ' ' ILE . 23.3 t80 165.94 140.01 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -175.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -79.07 75.35 5.59 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.378 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -174.53 -51.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.991 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 178' ' ' LEU . 78.8 mt -58.81 128.21 36.07 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.717 -173.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.99 -177.6 37.82 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.605 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -67.96 -43.59 78.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.412 . . . . 0.0 111.024 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 16.9 t70 -68.28 -42.42 79.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.087 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.0 m -67.0 -37.96 85.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.125 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.452 HD11 ' HA ' ' A' ' 128' ' ' ILE . 17.2 mm -61.98 -40.86 88.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.62 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.532 ' HA ' HD12 ' A' ' 138' ' ' ILE . 38.0 ttp-105 -59.06 -39.76 83.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 110.178 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 72.6 mt-30 -68.59 -34.2 75.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.337 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.09 -21.32 36.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.6 ' HB2' HD13 ' A' ' 138' ' ' ILE . 31.6 m-85 -100.93 -15.29 17.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.956 0.408 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.631 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -54.13 -40.56 82.89 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 5.9 Cg_exo -42.76 -38.18 6.41 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.289 2.66 . . . . 0.0 114.013 174.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.538 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 60.3 m-85 -81.49 -46.89 13.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.881 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.73 165.57 38.51 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.073 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.438 ' HG2' ' CE1' ' A' ' 252' ' ' TYR . 24.9 Cg_exo -65.05 120.16 7.33 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.722 2.282 . . . . 0.0 111.408 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.6 HD13 ' HB2' ' A' ' 132' ' ' PHE . 41.2 mt -79.62 129.54 37.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.356 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -96.62 -29.82 13.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.832 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.0 t -158.65 141.5 14.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.593 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.426 ' CG1' HG21 ' A' ' 138' ' ' ILE . 72.1 mt -131.5 122.65 50.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.657 0.265 . . . . 0.0 110.943 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 33.1 t70 -98.14 100.06 11.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.416 ' CE ' HG13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -104.93 139.62 39.38 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.833 -171.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.339 177.257 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 48.3 p90 . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.54 0.209 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.9 152.78 33.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.319 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 46.8 m-85 -109.56 109.95 20.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.785 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.493 ' HB ' HG13 ' A' ' 114' ' ' VAL . 97.4 t -95.33 108.81 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.801 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -106.42 115.7 30.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.354 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -89.21 178.83 6.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.218 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.49 -45.64 30.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.082 0.468 . . . . 0.0 109.796 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.64 141.86 24.21 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.452 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.9 Cg_endo -69.5 -21.33 34.87 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.256 2.637 . . . . 0.0 112.518 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.616 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 6.5 mp0 -55.2 -51.43 66.57 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.883 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.12 -23.85 66.79 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 120.954 0.407 . . . . 0.0 111.921 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.22 -48.53 12.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.753 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.594 ' HG3' HG13 ' A' ' 286' ' ' VAL . 32.2 mm-40 -64.6 -36.53 84.52 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.699 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.538 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 11.8 tp -66.51 -46.81 75.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.734 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.148 0.499 . . . . 0.0 109.931 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.498 ' HG ' HG22 ' A' ' 185' ' ' VAL . 6.7 tt -69.79 -46.1 66.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.574 173.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 16.4 mm-40 -56.75 -56.83 16.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.25 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -86.51 -39.42 16.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 27.2 ttp -104.63 30.17 5.61 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.588 -165.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -89.11 44.38 1.21 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.884 0.849 . . . . 0.0 109.673 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 19.6 m -115.59 -73.87 0.63 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.416 173.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.24 169.34 5.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.712 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.587 ' HB2' HD13 ' A' ' 183' ' ' ILE . 25.0 tpp -145.45 78.98 1.56 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.951 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.592 ' HB2' HD12 ' A' ' 123' ' ' LEU . 75.6 mt 63.84 162.15 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.527 174.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.29 -65.07 1.65 Allowed Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.008 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.6 62.81 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.203 -0.522 . . . . 0.0 111.861 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -143.53 129.54 19.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.772 0.32 . . . . 0.0 111.242 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 175' ' ' SER . 8.9 t30 -71.5 103.69 3.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.373 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.5 pt -85.62 159.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.211 0.529 . . . . 0.0 111.884 -173.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -110.51 114.95 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.804 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.498 HG22 ' HG ' ' A' ' 170' ' ' LEU . 5.3 m -103.64 108.33 24.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.422 0.63 . . . . 0.0 110.787 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.88 177.37 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.441 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 43.8 tt0 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 121.081 0.467 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.483 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -75.05 -28.8 60.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.067 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.707 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 27.2 mm-40 -54.32 -53.76 55.66 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.812 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.707 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 52.6 Cg_exo -55.08 -36.12 92.11 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.196 1.931 . . . . 0.0 112.851 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 72.6 mt -70.98 -46.09 69.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.339 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.625 HG12 ' SD ' ' A' ' 111' ' ' MET . 73.9 mt -57.15 -45.76 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.924 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.7 -39.9 95.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.244 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -63.08 -49.94 72.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.868 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 68.1 mt -67.88 -31.91 72.04 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.34 -47.86 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.65 -36.57 81.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.826 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.434 ' O ' ' HD2' ' A' ' 208' ' ' PHE . 39.2 mt-10 -68.37 -37.14 80.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.255 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -67.96 -32.24 72.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.83 0.348 . . . . 0.0 110.423 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.9 mtp180 -63.02 -37.98 89.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.317 175.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.58 -27.86 67.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.507 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.434 ' HD2' ' O ' ' A' ' 204' ' ' GLU . 75.0 m-85 -94.73 -16.48 23.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.45 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 60.71 41.65 14.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.987 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.488 ' HD2' ' OE1' ' A' ' 256' ' ' GLU . 16.5 ttt180 -101.42 145.15 29.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.279 0.561 . . . . 0.0 112.285 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 47.9 pt -129.05 167.56 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.4 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.49 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 27.0 t80 -117.65 138.03 52.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.461 HG12 ' CZ ' ' A' ' 229' ' ' PHE . 28.9 m -128.21 131.63 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.395 0.617 . . . . 0.0 110.915 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.38 173.05 7.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.588 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.8 t 58.51 31.5 21.09 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.742 0.782 . . . . 0.0 109.619 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.51 114.23 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.828 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.621 ' HA ' ' OE1' ' A' ' 278' ' ' GLN . 25.0 t-80 -54.05 130.39 37.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.442 0.639 . . . . 0.0 111.726 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -48.58 -33.13 9.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.186 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -85.09 -23.1 28.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.964 0.411 . . . . 0.0 111.835 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.407 HD11 ' HG ' ' A' ' 275' ' ' LEU . 69.5 mt -77.74 128.55 34.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.421 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 21.6 m -92.24 173.29 7.9 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.468 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -49.29 -50.28 39.83 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.842 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.24 -33.87 75.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.506 -174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.84 -38.1 73.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.629 0.252 . . . . 0.0 110.586 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.779 HG23 HD13 ' A' ' 255' ' ' ILE . 29.2 mm -67.01 -41.84 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 83.9 tttt -57.67 -45.45 85.53 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.389 173.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 39.6 t -54.19 -47.75 71.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.45 -39.58 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.347 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.528 ' CB ' HD11 ' A' ' 235' ' ' ILE . 24.0 m-85 -68.31 -29.78 68.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.019 0.438 . . . . 0.0 110.603 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.12 -26.24 68.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.946 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.66 -16.31 62.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.407 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -111.56 -40.12 4.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.437 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -138.31 161.8 25.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.325 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -81.02 104.23 11.37 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.181 0.515 . . . . 0.0 110.694 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.528 HD11 ' CB ' ' A' ' 229' ' ' PHE . 27.3 mt -82.83 151.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.702 0.763 . . . . 0.0 111.759 -175.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.602 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 45.4 tttm -107.26 -40.13 5.49 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.044 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 53.1 m -158.62 152.92 24.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.816 0.341 . . . . 0.0 110.545 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 9.3 p -133.37 125.67 29.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.746 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 12.0 m -140.37 100.9 4.0 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.717 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.481 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 44.4 mt -84.23 148.04 26.93 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.3 91.75 1.35 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 16.4 ttp85 -109.06 138.08 45.96 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.428 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 9.4 t70 -118.95 126.59 27.01 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.643 -172.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 11.6 Cg_exo -67.37 -21.03 47.88 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.994 2.462 . . . . 0.0 113.258 -176.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 35.2 p -100.97 13.57 34.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 0.0 111.238 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.409 ' HG1' ' HB3' ' A' ' 243' ' ' ASP . 63.8 p -115.23 -29.65 6.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.251 0.548 . . . . 0.0 110.078 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 93.59 1.44 66.09 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.015 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -154.56 -165.87 2.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 7.9 p80 -98.6 154.0 18.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.301 0.572 . . . . 0.0 109.764 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -71.22 -15.34 62.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.864 -168.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 120.39 -6.19 11.78 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.281 -0.962 . . . . 0.0 113.035 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.438 ' CE1' ' HG2' ' A' ' 137' ' ' PRO . 0.5 OUTLIER -134.61 158.62 43.57 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.481 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -162.79 177.62 38.82 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.407 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.616 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 52.9 m-85 -132.28 149.19 52.42 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.779 HD13 HG23 ' A' ' 225' ' ' ILE . 82.5 mt -134.08 142.59 40.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.488 ' OE1' ' HD2' ' A' ' 210' ' ' ARG . 30.7 tt0 -128.16 134.54 49.09 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -170.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.581 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 10.4 m-85 -111.0 165.52 11.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.142 0.496 . . . . 0.0 111.534 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.602 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 13.6 mt-10 -88.22 -12.0 45.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.156 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -134.93 124.78 25.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.886 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -65.44 -22.09 66.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.45 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -75.17 -47.08 30.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.4 m -65.09 -33.35 75.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.831 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.581 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 90.2 p -67.74 -31.88 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 75.4 mt-30 -75.25 -24.65 57.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -63.98 -49.19 73.46 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.471 ' HB1' ' CD2' ' A' ' 229' ' ' PHE . . . -58.5 -40.16 82.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.259 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.546 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 97.5 t -57.1 -39.33 65.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.976 0.417 . . . . 0.0 111.045 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.6 t -81.66 -40.52 22.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.285 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.5 m -80.48 -40.35 26.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.404 ' HB2' HG22 ' A' ' 282' ' ' VAL . 89.5 mmm -89.69 -5.01 57.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.856 -170.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 267' ' ' VAL . 63.5 t30 -71.09 122.05 19.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 98.3 mt 70.09 23.06 5.42 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.886 0.741 . . . . 0.0 111.015 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.35 125.77 30.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.09 101.57 9.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.063 0.459 . . . . 0.0 110.185 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.407 ' HG ' HD11 ' A' ' 220' ' ' LEU . 36.5 tp -121.25 99.55 6.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.983 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.73 25.8 37.25 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.285 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 77.19 33.78 43.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.206 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.621 ' OE1' ' HA ' ' A' ' 217' ' ' HIS . 2.1 tt0 -152.43 139.99 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -91.45 103.15 15.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.665 0.269 . . . . 0.0 111.079 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 34.8 mt -58.36 116.97 3.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.806 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -93.46 114.6 27.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 267' ' ' VAL . 17.1 t -112.35 140.05 34.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.858 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -153.92 170.58 32.56 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.625 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -75.9 128.98 36.23 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.505 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -74.05 128.76 36.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.594 HG13 ' HG3' ' A' ' 167' ' ' GLN . 20.1 m -93.77 -19.67 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.478 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.511 HG22 HD23 ' A' ' 108' ' ' LEU . 4.3 t -147.82 138.86 13.31 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.144 175.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 CA--C 1.531 0.342 0 C-N-CA 123.346 2.697 . . . . 0.0 112.924 -179.093 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HB3' HD12 ' A' ' 108' ' ' LEU . 69.1 mt-30 . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -65.62 -42.09 91.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.821 -172.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.85 -33.07 74.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.035 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.481 HD23 ' SD ' ' A' ' 111' ' ' MET . 57.3 mt -63.47 -32.13 73.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.467 -176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.13 -28.63 69.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.189 0.519 . . . . 0.0 110.575 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.5 mt -88.52 -35.92 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.207 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.522 ' SD ' HG12 ' A' ' 198' ' ' ILE . 94.0 mtp -67.06 -18.94 65.57 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.083 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.663 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 85.3 m -81.94 -10.68 59.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 110.592 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.433 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 98.4 mtt180 -109.7 143.4 39.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.229 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.4 p -120.37 121.7 66.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 168.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -76.09 129.16 36.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.721 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 15.0 m -123.83 122.16 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.497 0.665 . . . . 0.0 111.128 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.63 174.97 19.22 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.416 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 66.0 m 64.46 36.9 8.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.295 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.3 mt -85.0 105.84 14.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.42 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -52.85 146.49 10.59 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.341 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -71.4 76.13 0.76 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 122.029 0.919 . . . . 0.0 111.314 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -165.67 -43.34 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.196 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.468 HD23 HD13 ' A' ' 178' ' ' LEU . 36.2 mt -75.11 103.34 5.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.114 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.64 174.32 54.1 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.208 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.32 -39.97 94.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.69 -42.03 92.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.208 0.528 . . . . 0.0 110.371 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.3 m -68.9 -39.93 79.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.46 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.844 HG13 ' HE2' ' A' ' 143' ' ' MET . 35.5 mm -64.09 -44.2 97.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.512 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -57.28 -46.68 82.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.543 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.34 -33.25 74.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.582 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.494 ' HB2' ' HE2' ' A' ' 177' ' ' MET . . . -78.28 -31.98 49.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.453 ' HD1' ' O ' ' A' ' 128' ' ' ILE . 50.1 m-85 -93.43 -17.08 23.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.776 0.322 . . . . 0.0 111.454 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.03 -44.11 91.22 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -47.52 -33.17 17.09 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.783 2.322 . . . . 0.0 114.389 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.563 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 70.1 m-85 -79.69 -53.47 6.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.4 -171.04 25.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 119.637 -1.268 . . . . 0.0 113.361 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.46 112.82 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.921 2.414 . . . . 0.0 111.736 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.635 HD12 HD13 ' A' ' 141' ' ' ILE . 68.7 mt -76.6 127.27 37.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.428 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -84.81 -45.81 11.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.568 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -166.22 131.65 2.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.803 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.635 HD13 HD12 ' A' ' 138' ' ' ILE . 67.6 mt -109.36 114.11 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 171.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -94.09 100.46 12.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.044 0.45 . . . . 0.0 110.554 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.844 ' HE2' HG13 ' A' ' 128' ' ' ILE . 36.5 ttm -143.14 124.65 14.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.929 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.581 177.723 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.66 164.74 37.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.965 0.412 . . . . 0.0 111.305 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.83 111.86 18.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.422 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 78.7 t -97.45 106.49 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.98 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.433 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 39.4 tt0 -107.57 128.57 54.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.76 0.314 . . . . 0.0 110.615 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -95.17 179.82 5.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.976 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.94 -14.9 28.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.851 0.358 . . . . 0.0 110.16 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.53 135.09 26.86 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.234 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 46.0 Cg_endo -67.57 -21.11 46.45 Favored 'Trans proline' 0 N--CA 1.474 0.35 0 C-N-CA 123.311 2.674 . . . . 0.0 112.585 -176.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.937 ' HG3' ' HE1' ' A' ' 254' ' ' PHE . 5.7 mm-40 -61.01 -52.08 66.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.872 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -66.86 -17.88 65.11 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.02 -47.21 18.94 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.425 ' HG3' HG12 ' A' ' 286' ' ' VAL . 29.6 mm-40 -69.49 -34.88 74.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.461 174.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.591 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 13.6 tp -61.77 -48.1 82.18 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.581 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.98 72.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.97 0.414 . . . . 0.0 110.229 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.65 -52.13 41.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.589 173.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.54 -38.85 60.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.669 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . 0.417 HE21 ' HE1' ' A' ' 135' ' ' PHE . 22.7 mt-30 -99.76 -49.22 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 34.4 ttp -104.87 29.63 6.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -165.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.96 -20.78 60.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.929 0.395 . . . . 0.0 110.708 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.9 p -72.32 -73.58 0.19 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.6 m -134.07 151.98 33.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.033 0.444 . . . . 0.0 111.422 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.966 ' HE1' ' HG ' ' A' ' 178' ' ' LEU . 1.7 tpt -125.55 97.14 5.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.809 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.966 ' HG ' ' HE1' ' A' ' 177' ' ' MET . 85.9 mt 67.56 127.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.93 0.769 . . . . 0.0 112.377 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 72.17 -80.17 0.61 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.385 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.43 36.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.07 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -100.4 122.42 43.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.687 0.279 . . . . 0.0 110.808 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.6 126.44 30.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.546 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.8 pt -120.26 176.91 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.396 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.663 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 74.0 mmtt -103.24 107.27 18.03 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 27.6 t -113.36 106.87 21.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.13 0.269 . . . . 0.0 110.696 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 C-N-CA 119.855 -1.164 . . . . 0.0 114.24 172.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 120.849 0.357 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -88.45 -12.37 43.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.653 0.263 . . . . 0.0 111.362 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.56 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 33.8 mm-40 -59.08 -49.88 90.79 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 75.4 Cg_exo -52.97 -35.29 70.76 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.288 1.992 . . . . 0.0 112.847 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.6 mt -69.94 -46.64 72.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.129 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.522 HG12 ' SD ' ' A' ' 111' ' ' MET . 57.6 mt -57.41 -43.27 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.239 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.19 -44.38 88.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.043 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -68.8 -45.44 71.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.911 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 19.4 mt -64.73 -33.53 76.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.783 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.651 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.02 -51.77 60.61 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -60.18 -38.29 82.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.272 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 52.5 mt-10 -60.54 -45.98 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.106 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.02 87.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.882 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.651 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 53.3 mtp180 -64.89 -33.93 77.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.791 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.42 -30.03 66.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.814 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.69 -4.47 47.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.035 0.445 . . . . 0.0 110.68 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.2 m120 62.89 44.03 6.48 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.055 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -99.93 142.78 30.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.188 0.518 . . . . 0.0 111.382 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.5 pt -127.76 166.35 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.175 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.554 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 86.3 t80 -119.18 128.79 54.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.156 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.611 HG12 HG23 ' A' ' 282' ' ' VAL . 32.2 m -121.77 131.28 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.183 0.516 . . . . 0.0 110.641 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -124.8 174.19 8.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.17 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.2 t 60.78 30.94 20.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.887 0.851 . . . . 0.0 109.223 -174.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 36.1 t -79.91 116.06 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.581 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.588 ' HD2' ' HG3' ' A' ' 278' ' ' GLN . 7.6 t-80 -56.4 135.25 54.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.471 0.653 . . . . 0.0 111.677 -169.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -49.29 -38.19 26.48 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -171.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -89.94 -10.02 46.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.754 0.311 . . . . 0.0 111.145 -174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 220' ' ' LEU . 10.7 tp -83.44 124.59 30.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.257 -174.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.9 t -87.59 169.17 12.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.817 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.08 -36.8 71.0 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.791 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.41 -45.56 72.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.706 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -74.01 -40.95 62.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.059 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.668 HG21 HD13 ' A' ' 255' ' ' ILE . 31.4 mm -63.38 -47.73 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 238' ' ' CYS . 66.1 tttm -58.16 -46.57 85.46 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.052 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.5 t -54.5 -43.57 71.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.07 -41.98 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.41 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.535 ' CB ' HD11 ' A' ' 235' ' ' ILE . 20.6 m-85 -67.44 -28.22 67.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.207 0.527 . . . . 0.0 110.537 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.7 -24.54 64.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.151 0.981 . . . . 0.0 110.467 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.95 -15.84 60.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.205 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -111.3 -23.23 10.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.99 0.424 . . . . 0.0 110.658 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.518 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -165.66 156.31 28.17 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.81 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 23.4 mmtp -74.08 122.52 22.81 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.546 0.688 . . . . 0.0 110.861 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.535 HD11 ' CB ' ' A' ' 229' ' ' PHE . 57.1 mt -92.91 150.43 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.144 -172.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.424 ' HE2' ' CB ' ' A' ' 256' ' ' GLU . 31.8 ttpt -110.5 -28.57 8.46 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.221 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 16.8 m -152.43 146.58 25.42 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.458 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 226' ' ' LYS . 47.2 t -152.78 107.33 3.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.521 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.7 m -140.52 109.27 5.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.133 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.547 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 51.4 mt -77.31 143.61 38.69 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.479 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.08 113.12 4.25 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 29.3 ttp180 -149.89 139.49 21.62 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.147 -169.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.29 128.45 86.04 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -44.49 -46.0 12.41 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.897 3.065 . . . . 0.0 114.394 -163.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 3.7 t -133.89 76.58 1.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.705 0.764 . . . . 0.0 110.579 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 6.6 p -125.75 1.33 7.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.289 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.18 12.75 69.31 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.043 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 22.5 pttp -163.35 179.66 7.2 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -131.0 152.02 50.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -48.32 -61.53 1.95 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.976 0.798 . . . . 0.0 112.573 -172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 160.97 12.33 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.616 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -152.05 -179.69 7.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -170.61 177.76 43.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.357 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.937 ' HE1' ' HG3' ' A' ' 164' ' ' GLU . 83.3 m-85 -128.96 143.57 50.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.971 0.415 . . . . 0.0 110.917 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.668 HD13 HG21 ' A' ' 225' ' ' ILE . 89.7 mt -140.45 140.75 33.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.004 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.424 ' CB ' ' HE2' ' A' ' 236' ' ' LYS . 45.2 mt-10 -120.67 147.6 45.04 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.632 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 20.2 m-85 -111.75 164.2 13.32 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.654 0.264 . . . . 0.0 110.312 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.84 -5.23 59.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.323 0.582 . . . . 0.0 109.433 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -127.87 128.63 45.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.848 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.51 68.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.206 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -74.86 -52.69 10.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.519 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.518 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 28.3 m -60.14 -31.49 70.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.456 -172.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 48.7 p -64.63 -48.62 74.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.997 0.427 . . . . 0.0 109.988 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -72.53 -18.92 61.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.189 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -69.15 -40.9 77.92 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.045 0.45 . . . . 0.0 110.044 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.62 75.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.949 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 271' ' ' ASN . 88.2 t -59.25 -31.58 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.164 0.507 . . . . 0.0 110.64 174.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.5 t -83.93 -46.6 11.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.898 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.7 m -78.31 -43.24 28.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.481 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 80.0 mmm -83.87 1.21 44.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.161 0.505 . . . . 0.0 110.752 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.549 ' HA ' HG12 ' A' ' 282' ' ' VAL . 18.7 t-20 -71.81 114.22 9.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.157 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 86.0 mt 67.31 36.86 3.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.195 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.42 121.78 33.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.326 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.54 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 26.7 t70 -75.76 106.35 7.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.72 0.295 . . . . 0.0 110.271 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 41.1 tp -131.04 110.03 10.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.028 0.442 . . . . 0.0 110.506 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.82 5.02 74.73 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.185 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.12 -5.16 31.89 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.337 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.588 ' HG3' ' HD2' ' A' ' 217' ' ' HIS . 28.5 mt-30 -125.19 143.52 50.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.828 0.346 . . . . 0.0 110.526 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.54 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 57.4 m-85 -78.07 113.22 15.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.089 173.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.37 130.37 44.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.05 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -98.35 114.58 26.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.611 HG23 HG12 ' A' ' 213' ' ' VAL . 7.5 p -118.39 143.91 27.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.878 -174.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -157.59 173.81 35.0 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.394 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -75.83 135.01 40.22 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -71.99 144.93 48.67 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.425 HG12 ' HG3' ' A' ' 167' ' ' GLN . 20.3 m -109.3 -4.77 10.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.329 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.9 p -129.58 146.75 62.43 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.49 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.462 -0.351 0 C-N-CA 122.553 2.169 . . . . 0.0 111.013 173.247 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.466 0.65 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -64.03 -30.2 71.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.753 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.1 -44.05 60.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.39 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.489 HD23 ' SD ' ' A' ' 111' ' ' MET . 60.3 mt -61.02 -36.07 78.54 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.47 -36.74 71.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.5 mt -78.73 -40.86 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.215 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.549 ' SD ' HG12 ' A' ' 198' ' ' ILE . 90.6 mtp -62.09 -28.2 69.45 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.588 -176.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 67.0 m -74.97 -14.69 60.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.815 0.341 . . . . 0.0 111.109 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.58 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 42.8 mtp180 -101.53 140.31 35.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.851 HG11 ' HB ' ' A' ' 158' ' ' VAL . 9.6 p -110.0 121.82 63.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -82.23 100.98 10.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.008 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 35.3 m -108.21 141.32 23.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.145 0.498 . . . . 0.0 110.969 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.806 ' HA3' ' HD1' ' A' ' 155' ' ' PHE . . . -155.59 170.97 33.59 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.277 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.4 t 62.49 37.83 13.08 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.795 0.807 . . . . 0.0 109.683 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.5 mt -73.29 -14.99 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.543 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.9 t80 74.55 140.88 0.06 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.822 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -72.11 78.25 0.95 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.427 0.632 . . . . 0.0 110.995 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -159.58 -54.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.256 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.8 mt -68.54 119.58 13.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.753 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.63 -173.48 44.34 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.073 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.59 -39.32 94.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.632 0.373 . . . . 0.0 111.316 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.85 -41.19 99.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.38 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.2 m -68.7 -40.13 80.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.453 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.791 HG13 ' HE2' ' A' ' 143' ' ' MET . 31.2 mm -62.73 -50.82 78.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.061 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -60.05 -42.28 94.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.169 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -67.63 -33.29 74.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.498 ' HB1' ' HE3' ' A' ' 177' ' ' MET . . . -82.39 -33.5 28.69 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.562 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 51.2 m-85 -87.89 -20.54 25.85 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.86 -43.93 97.28 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -41.68 -40.93 5.67 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.069 2.512 . . . . 0.0 114.221 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.681 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 57.0 m-85 -75.45 -46.64 31.42 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.544 0.211 . . . . 0.0 111.295 -174.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -165.25 173.21 41.02 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.612 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.49 119.89 6.79 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.672 2.248 . . . . 0.0 111.688 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.6 mt -83.39 121.97 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.623 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -80.78 -52.49 7.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.695 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.5 t -152.17 152.12 31.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.097 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -124.69 108.98 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.066 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.767 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 18.4 m-20 -81.46 98.76 8.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.791 ' HE2' HG13 ' A' ' 128' ' ' ILE . 51.5 ttm -136.76 137.65 40.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.025 0.441 . . . . 0.0 111.014 -176.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.792 175.289 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.806 ' HD1' ' HA3' ' A' ' 117' ' ' GLY . 41.4 m-85 . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 120.88 0.372 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.25 151.53 37.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.886 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.767 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 81.7 m-85 -114.87 109.44 18.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.952 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.851 ' HB ' HG11 ' A' ' 114' ' ' VAL . 87.8 t -91.71 105.63 16.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.58 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 50.5 tt0 -99.53 115.6 29.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.717 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -91.55 178.46 5.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.93 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -77.54 -37.18 51.35 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.258 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.77 146.14 37.04 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.078 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.9 Cg_endo -70.17 -18.99 34.75 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.358 2.705 . . . . 0.0 112.056 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.594 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 9.1 mp0 -55.92 -53.84 51.91 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.807 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.08 -21.37 64.9 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.09 -45.46 15.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.75 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.629 ' HG3' HG11 ' A' ' 286' ' ' VAL . 16.0 mm100 -69.0 -31.83 70.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.787 173.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.681 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 14.2 tp -70.23 -47.19 62.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.522 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.34 71.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.091 0.472 . . . . 0.0 109.85 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.606 ' HG ' HG22 ' A' ' 185' ' ' VAL . 4.0 tt -67.64 -51.81 45.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 172.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -52.53 -43.47 65.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.853 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -95.6 -46.41 6.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.7 ttp -104.28 31.08 4.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.089 0.471 . . . . 0.0 112.123 -166.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 9.0 p30 -76.59 7.06 4.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.582 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 15.3 m -102.49 -73.49 0.66 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.554 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 24.5 m -133.04 156.11 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 0.0 111.365 -173.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.949 ' HB2' HD11 ' A' ' 183' ' ' ILE . 2.1 tpt -122.95 104.06 9.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.376 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.99 61.04 2.48 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.181 172.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 122.75 -153.56 16.94 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.489 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.58 72.33 0.79 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.253 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 176' ' ' VAL . 21.8 tpt180 -143.57 118.95 10.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 175' ' ' SER . 42.2 m-80 -78.47 119.28 21.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.209 176.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.949 HD11 ' HB2' ' A' ' 177' ' ' MET . 45.4 pt -111.81 166.72 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.237 -176.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.732 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 27.4 mtpp -103.48 134.65 46.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 172.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 116' ' ' VAL . 26.4 m -134.18 152.73 34.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.937 0.399 . . . . 0.0 110.305 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.596 ' HA3' HD13 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.83 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.003 173.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 N--CA 1.46 0.055 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -79.27 -32.46 43.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.487 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 51.4 tp60 -54.08 -53.31 59.99 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.0 Cg_endo -53.2 -39.38 80.73 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.542 2.162 . . . . 0.0 112.674 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.97 -45.21 55.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.549 HG12 ' SD ' ' A' ' 111' ' ' MET . 51.8 mt -59.33 -47.48 90.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.162 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.46 -39.5 94.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.777 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -63.35 -47.42 82.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.008 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 39.8 mt -67.18 -32.94 74.35 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.629 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.629 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.74 -45.23 74.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.991 0.424 . . . . 0.0 109.914 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -68.47 -34.95 76.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.066 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 35.5 mt-10 -66.69 -31.57 72.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.275 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.98 -29.24 64.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.164 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 74.9 mtp180 -72.36 -15.29 61.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.602 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -90.73 -2.53 57.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.92 169.06 16.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.987 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.571 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 36.3 m-20 -108.7 35.13 3.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.382 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.455 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 24.2 ttm180 -95.11 137.42 34.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.121 0.486 . . . . 0.0 111.595 -173.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 34.0 pt -128.95 167.07 25.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.987 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.484 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 73.5 t80 -122.34 126.81 48.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.618 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.516 HG12 ' CZ ' ' A' ' 229' ' ' PHE . 35.7 m -122.4 132.96 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.998 0.428 . . . . 0.0 110.461 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.15 174.54 7.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.685 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 54.5 m 60.8 31.13 20.05 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.499 0.666 . . . . 0.0 109.955 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.55 127.64 36.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.031 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.528 ' HD2' ' HG3' ' A' ' 278' ' ' GLN . 19.0 t-80 -56.91 135.16 55.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.593 0.235 . . . . 0.0 111.191 -173.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -47.5 -53.75 13.45 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.26 22.61 5.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.413 HD22 ' HG ' ' A' ' 275' ' ' LEU . 15.1 tp -101.5 131.36 47.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.7 p -93.94 171.61 8.75 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.287 0.476 . . . . 0.0 112.287 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.62 -32.13 73.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.856 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.33 -34.5 76.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.475 0.655 . . . . 0.0 109.844 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.4 ' O ' HG21 ' A' ' 228' ' ' VAL . 62.7 m-20 -73.56 -43.68 59.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.702 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.69 HG21 HD13 ' A' ' 255' ' ' ILE . 32.6 mm -64.38 -44.12 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 65.5 tttm -57.16 -49.8 74.83 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.607 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 67.3 m -56.84 -37.7 71.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 224' ' ' ASP . 25.1 t -75.95 -44.23 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 122.122 -0.361 . . . . 0.0 111.559 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.568 ' HB2' HD12 ' A' ' 235' ' ' ILE . 32.6 m-85 -69.77 -28.79 66.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.455 0.645 . . . . 0.0 110.188 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 8.7 tp10 -59.51 -25.12 64.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.796 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.42 -9.93 59.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.182 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -109.61 -45.29 3.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.666 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -144.55 165.19 27.59 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.096 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -70.96 115.83 10.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.233 0.539 . . . . 0.0 110.783 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 229' ' ' PHE . 27.6 mt -87.8 150.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.756 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -112.49 -23.08 10.49 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.26 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 22.6 t -172.24 145.37 1.72 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.321 . . . . 0.0 110.859 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.42 ' HG ' HD13 ' A' ' 255' ' ' ILE . 52.5 t -141.69 128.26 20.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.8 m -142.38 110.78 6.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.985 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.604 HD23 HG13 ' A' ' 225' ' ' ILE . 46.0 mt -83.98 133.55 34.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.18 119.31 14.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.839 0.352 . . . . 0.0 110.544 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.519 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 18.0 mtm180 -122.94 145.9 48.07 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.706 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.778 ' HB2' ' HG1' ' A' ' 246' ' ' THR . 10.6 m-20 -79.55 140.11 55.4 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.441 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.46 -25.6 14.53 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 124.04 3.16 . . . . 0.0 114.769 -171.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.1 t -157.78 48.16 0.39 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.517 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.778 ' HG1' ' HB2' ' A' ' 243' ' ' ASP . 17.2 p -102.89 -28.81 11.82 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.73 -0.606 . . . . 0.0 111.879 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.54 59.09 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.702 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.27 174.23 14.56 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.519 ' HB3' ' HG2' ' A' ' 242' ' ' ARG . 28.0 p80 -109.24 146.72 33.76 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.586 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -48.2 -50.48 29.05 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.812 0.695 . . . . 0.0 111.718 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 152.6 -11.73 0.63 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.821 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.484 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 46.2 p90 -124.95 171.03 10.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.818 0.342 . . . . 0.0 110.605 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -162.32 167.76 37.03 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.499 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.594 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 98.6 m-85 -123.66 146.66 48.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.004 0.43 . . . . 0.0 110.983 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.69 HD13 HG21 ' A' ' 225' ' ' ILE . 87.4 mt -139.8 136.1 38.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.209 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 46.1 mt-10 -119.17 136.33 54.23 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.524 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 6.8 m-85 -98.63 176.04 5.79 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -80.5 -21.79 41.6 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.341 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -131.19 137.48 48.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.063 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -69.5 -31.78 70.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.661 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -66.47 -35.6 80.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.976 0.417 . . . . 0.0 110.369 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.8 m -70.82 -42.38 70.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.327 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 40.7 p -66.89 -40.02 87.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.443 . . . . 0.0 110.694 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -70.92 -22.67 62.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.077 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.5 -37.24 71.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.63 84.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.71 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.471 ' HA ' ' CG2' ' A' ' 282' ' ' VAL . 61.9 t -61.77 -27.32 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.498 0.666 . . . . 0.0 110.568 174.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.0 t -87.21 -34.12 19.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.788 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.9 m -94.07 -31.35 14.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.525 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 91.1 mmm -92.32 7.1 44.34 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -170.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.468 ' HA ' HG12 ' A' ' 282' ' ' VAL . 52.9 t30 -72.69 121.66 20.18 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.377 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 86.8 mt 65.95 27.71 10.75 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.06 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -81.92 122.76 28.16 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.92 114.24 15.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.009 0.433 . . . . 0.0 110.06 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.413 ' HG ' HD22 ' A' ' 220' ' ' LEU . 26.4 tp -127.03 91.94 3.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.373 0.606 . . . . 0.0 110.09 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 94.07 11.36 57.65 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.547 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.9 6.66 39.83 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.688 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.528 ' HG3' ' HD2' ' A' ' 217' ' ' HIS . 29.2 mt-30 -133.59 144.45 49.3 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -89.31 114.81 26.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.783 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 62.8 mt -63.49 124.37 21.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.271 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -94.0 115.12 27.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' A' ' 267' ' ' VAL . 13.9 p -114.6 140.1 37.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.33 0.586 . . . . 0.0 111.139 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.28 174.69 33.4 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.578 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -84.86 122.94 29.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -61.27 127.38 31.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.172 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.629 HG11 ' HG3' ' A' ' 167' ' ' GLN . 35.5 m -91.45 -12.91 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.811 0.338 . . . . 0.0 111.443 -173.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 288' ' ' PRO . 36.4 p -111.97 119.52 44.12 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-O 121.264 0.554 . . . . 0.0 111.058 175.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.498 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 43.9 Cg_endo . . . . . 0 CA--C 1.53 0.29 0 C-N-CA 123.102 2.535 . . . . 0.0 111.909 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.584 ' HB2' HD13 ' A' ' 108' ' ' LEU . 29.8 pt20 . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 121.066 0.46 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -60.58 -28.4 68.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.911 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 110' ' ' ILE . . . -74.86 -22.0 58.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.737 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.584 HD13 ' HB2' ' A' ' 105' ' ' GLN . 57.2 mt -62.56 -33.3 74.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.693 0.282 . . . . 0.0 110.594 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.02 -25.67 65.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.794 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 107' ' ' ALA . 3.6 mp -87.75 -36.82 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.61 ' SD ' HG23 ' A' ' 198' ' ' ILE . 42.5 mtm -74.7 -22.28 58.94 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.44 -11.74 60.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.958 0.408 . . . . 0.0 110.46 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -106.55 140.95 38.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.713 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.53 HG11 ' HB ' ' A' ' 158' ' ' VAL . 2.9 p -121.59 128.79 75.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.404 0.621 . . . . 0.0 110.225 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -81.25 109.89 16.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.778 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 119' ' ' ILE . 39.3 t -108.02 120.05 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.104 0.478 . . . . 0.0 111.253 -174.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -135.21 174.07 21.36 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.442 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.759 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 25.9 m 66.59 35.35 5.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.069 0.547 . . . . 0.0 111.37 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.442 HD12 HG11 ' A' ' 116' ' ' VAL . 46.0 mt -85.22 114.72 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.558 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -52.29 134.41 33.79 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.435 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -71.42 76.66 0.76 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 122.162 0.982 . . . . 0.0 111.474 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.46 -37.75 0.06 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.931 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.448 ' CD1' ' HG3' ' A' ' 177' ' ' MET . 59.8 mt -75.16 110.64 9.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.825 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.55 169.58 49.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.869 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.09 -36.91 84.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.935 0.397 . . . . 0.0 110.275 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.53 -35.01 76.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.547 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.6 m -64.54 -42.81 95.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 110.142 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.513 HG13 ' HE2' ' A' ' 143' ' ' MET . 33.7 mm -63.2 -41.58 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.488 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 43.3 ttp-105 -59.04 -41.36 87.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.548 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.24 -34.13 77.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.525 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.68 -32.21 28.22 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -88.35 -21.42 24.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.773 0.32 . . . . 0.0 111.383 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.62 98.32 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.66 -32.4 5.84 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 122.998 2.465 . . . . 0.0 114.252 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.596 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 74.0 m-85 -83.01 -44.14 15.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.485 0.183 . . . . 0.0 111.367 -176.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.41 167.41 40.24 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.367 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.35 134.41 35.99 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.697 2.265 . . . . 0.0 111.338 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.444 HG22 ' CG1' ' A' ' 141' ' ' ILE . 50.3 mt -100.14 132.84 44.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.409 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 21.4 ttmm -98.7 -29.58 12.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.551 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.7 t -156.82 135.17 11.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.83 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.444 ' CG1' HG22 ' A' ' 138' ' ' ILE . 63.4 mt -128.69 116.57 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -114.22 99.53 7.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.973 0.416 . . . . 0.0 110.327 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.513 ' HE2' HG13 ' A' ' 128' ' ' ILE . 49.2 ttm -103.05 140.72 36.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.694 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 121.39 0.614 . . . . 0.0 110.119 176.283 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.231 0.08 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 143' ' ' MET . . . -127.09 139.53 52.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.006 0.431 . . . . 0.0 110.716 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -114.52 118.72 34.55 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.091 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.53 ' HB ' HG11 ' A' ' 114' ' ' VAL . 96.5 t -104.87 112.1 37.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -105.02 115.42 30.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -88.29 165.19 15.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.564 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 23.0 mt-10 -83.04 -12.02 57.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.222 175.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.9 m -136.66 134.43 19.5 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.969 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.08 -22.37 47.63 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.896 2.397 . . . . 0.0 112.475 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.753 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 13.7 mp0 -55.26 -54.2 46.48 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.389 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.03 -19.59 63.04 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.49 -52.1 9.65 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.63 ' HG3' HG12 ' A' ' 286' ' ' VAL . 14.9 mm100 -69.94 -27.17 64.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 175.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.596 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 12.9 tp -70.02 -50.57 40.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.415 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.63 -33.87 76.58 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.484 HD11 ' HA3' ' A' ' 186' ' ' GLY . 8.2 tt -61.25 -46.5 90.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.993 173.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 284' ' ' LYS . 4.7 mt-10 -65.64 -44.2 87.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.675 -175.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -86.93 -37.92 17.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.4 mtm -101.6 30.25 4.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.958 0.409 . . . . 0.0 111.324 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -68.33 -11.08 58.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.128 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 20.3 m -101.31 -72.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.2 m -138.21 166.06 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.08 0.467 . . . . 0.0 111.855 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.448 ' HG3' ' CD1' ' A' ' 123' ' ' LEU . 18.3 tpp -134.87 99.21 4.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.877 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.433 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 89.7 mt 53.49 41.28 32.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.607 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.62 -144.52 16.45 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.993 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.64 -123.02 15.2 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.255 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -143.95 179.0 7.46 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 175' ' ' SER . 9.2 t30 -51.27 111.56 0.59 Allowed 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.628 0.58 . . . . 0.0 110.694 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.759 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 47.6 pt -89.29 160.8 2.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.474 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 52.2 tttp -107.25 116.22 31.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.5 t -120.31 106.2 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.484 ' HA3' HD11 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.422 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.25 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 . . . . . 0 C--O 1.23 0.027 0 CA-C-O 120.796 0.332 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.88 -38.52 27.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.456 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.521 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 56.4 tp60 -58.22 -49.77 91.75 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.9 Cg_endo -52.9 -39.08 79.47 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.332 2.021 . . . . 0.0 112.458 177.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 56.9 mt -72.61 -39.39 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.819 0.342 . . . . 0.0 110.438 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.61 HG23 ' SD ' ' A' ' 111' ' ' MET . 69.9 mt -59.35 -50.07 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.602 176.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.64 -30.96 68.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.55 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.68 -52.09 62.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.453 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.584 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 27.5 mt -67.56 -33.55 75.26 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.921 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.688 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.28 -51.12 60.32 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 173.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -65.71 -30.91 71.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.308 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 40.3 mt-10 -67.2 -34.75 78.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.068 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.79 -36.69 65.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.712 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 71.5 mtp180 -66.48 -24.24 66.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.125 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.17 -13.92 60.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.241 0.543 . . . . 0.0 110.66 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -113.74 -179.28 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.365 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 46.2 m-20 -116.46 40.87 2.79 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -93.95 135.62 35.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.704 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.1 pt -135.18 167.18 26.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.566 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.565 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 27.0 t80 -121.65 130.57 53.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.776 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 225' ' ' ILE . 28.1 m -121.42 131.92 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.099 0.476 . . . . 0.0 110.145 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.07 176.58 6.59 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.915 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.6 m 62.27 32.52 17.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.906 0.86 . . . . 0.0 109.339 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.436 HG11 HD12 ' A' ' 225' ' ' ILE . 16.4 t -77.76 112.74 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.505 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -60.13 139.57 57.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.232 0.539 . . . . 0.0 111.341 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -51.05 -35.99 37.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.78 -17.72 30.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.134 0.492 . . . . 0.0 111.051 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.719 HD21 ' HG ' ' A' ' 275' ' ' LEU . 0.9 OUTLIER -74.1 132.55 42.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.061 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.2 m -103.25 179.71 4.19 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.303 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -55.63 -46.46 77.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.602 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -67.47 -27.34 66.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.613 -173.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -66.91 -54.05 25.92 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.467 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.686 HG21 HD12 ' A' ' 255' ' ' ILE . 42.7 mm -63.5 -43.2 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.73 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.444 ' O ' HD13 ' A' ' 235' ' ' ILE . 83.9 tttt -56.85 -49.44 75.46 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.577 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 35.3 t -55.51 -41.09 72.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.541 HG13 ' HE3' ' A' ' 270' ' ' MET . 14.1 t -74.75 -40.93 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.235 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.7 ' HB2' HD11 ' A' ' 235' ' ' ILE . 24.4 m-85 -69.12 -35.74 76.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.467 0.651 . . . . 0.0 110.35 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 34.9 tp10 -59.2 -24.89 63.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.695 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.47 -19.76 64.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.002 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -111.51 -34.36 6.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -145.15 153.93 25.59 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.561 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 66.0 mmtt -73.76 113.3 10.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 111.941 -177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.7 HD11 ' HB2' ' A' ' 229' ' ' PHE . 51.4 mt -92.47 151.09 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.878 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -109.66 -36.31 5.97 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.562 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 19.0 m -147.94 146.04 28.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.705 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.44 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 53.3 t -153.9 118.26 4.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.758 174.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.9 t -141.26 119.22 11.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.205 0.526 . . . . 0.0 111.51 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.652 HD21 ' HA3' ' A' ' 253' ' ' GLY . 40.8 mt -91.94 132.61 36.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.033 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.64 124.44 23.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.55 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.581 ' HB3' ' CB ' ' A' ' 249' ' ' HIS . 14.7 ptt-85 -144.59 169.89 17.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.478 -173.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -104.56 100.92 25.04 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.728 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.25 -22.24 64.01 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.513 2.142 . . . . 0.0 112.368 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.8 p -75.65 -17.94 59.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.48 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 49.3 p -108.84 -42.22 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.997 0.427 . . . . 0.0 110.369 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 114.54 -16.92 18.96 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.748 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -107.19 160.69 15.39 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.608 -0.348 . . . . 0.0 110.493 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.581 ' CB ' ' HB3' ' A' ' 242' ' ' ARG . 26.9 p80 -100.76 162.56 12.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.539 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -75.03 -69.93 0.44 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.213 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 170.19 25.99 0.02 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.095 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.474 ' HB2' ' CE1' ' A' ' 212' ' ' TYR . 3.1 p90 -153.77 154.07 33.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.652 ' HA3' HD21 ' A' ' 240' ' ' LEU . . . -157.78 173.22 35.1 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.137 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.753 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 81.4 m-85 -127.09 146.06 50.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.981 0.419 . . . . 0.0 110.626 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.686 HD12 HG21 ' A' ' 225' ' ' ILE . 74.5 mt -135.02 138.78 48.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.284 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 45.6 mt-10 -121.63 142.46 50.1 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.638 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 6.3 m-85 -105.85 163.69 12.53 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.05 0.452 . . . . 0.0 111.458 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.31 -36.75 20.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.526 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -100.41 114.94 28.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.571 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -50.83 -59.46 4.09 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.547 0.53 . . . . 0.0 112.375 -168.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.43 -36.54 64.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.257 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.2 t -67.94 -21.14 65.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.638 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 89.6 p -66.55 -49.93 64.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.218 0.533 . . . . 0.0 110.4 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -75.56 -15.9 60.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.67 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.48 -40.84 73.4 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.29 83.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 95.9 t -57.44 -30.58 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.236 0.541 . . . . 0.0 111.177 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.8 m -87.34 -29.45 21.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.342 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 13.3 m -93.54 -40.47 10.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.989 0.423 . . . . 0.0 112.03 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.541 ' HE3' HG13 ' A' ' 228' ' ' VAL . 87.6 mmm -85.08 -2.88 58.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.951 -171.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -69.1 129.66 40.52 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.371 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.7 mt 66.31 27.69 10.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.808 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -90.34 117.96 29.47 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.655 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 4.0 p-10 -76.03 122.38 24.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.371 0.605 . . . . 0.0 110.289 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.719 ' HG ' HD21 ' A' ' 220' ' ' LEU . 26.5 tp -134.24 95.21 3.36 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.635 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 93.36 18.65 38.17 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.699 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.89 -36.75 4.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.68 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -93.82 147.95 22.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.767 0.317 . . . . 0.0 110.746 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.655 ' CE1' ' HB3' ' A' ' 274' ' ' ASP . 54.2 m-85 -87.44 115.9 25.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.743 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.4 mt -57.13 116.6 3.35 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.797 0.685 . . . . 0.0 111.122 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -93.69 115.0 27.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 13.7 p -121.41 147.63 25.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.173 0.511 . . . . 0.0 111.12 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.38 179.7 37.53 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 171' ' ' GLU . 2.0 mppt? -84.74 134.96 34.32 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.579 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -68.85 137.15 53.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.63 HG12 ' HG3' ' A' ' 167' ' ' GLN . 33.1 m -97.96 -11.96 8.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.479 . . . . 0.0 110.917 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 38.3 p -108.6 135.06 20.08 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.004 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 CA--C 1.53 0.312 0 C-N-CA 122.847 2.364 . . . . 0.0 111.478 174.273 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 120.988 0.423 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -55.51 -28.2 53.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.281 -174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.407 ' HB2' ' HB ' ' A' ' 197' ' ' ILE . . . -68.37 -35.04 77.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.036 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.465 HD23 HG22 ' A' ' 287' ' ' THR . 40.8 mt -66.71 -31.8 72.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.041 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.42 69.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.339 0.59 . . . . 0.0 110.36 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.4 mt -88.05 -36.96 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.348 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.479 ' SD ' HG12 ' A' ' 198' ' ' ILE . 90.4 mtp -69.88 -19.27 63.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.44 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 86.3 m -85.71 -1.89 57.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.1 0.476 . . . . 0.0 110.99 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -118.33 142.13 47.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.211 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.683 HG12 ' HB ' ' A' ' 158' ' ' VAL . 8.8 p -115.24 119.79 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.631 0.729 . . . . 0.0 109.761 172.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 41.7 t80 -67.87 119.99 13.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.192 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.563 HG23 ' HB3' ' A' ' 156' ' ' ALA . 17.0 m -119.48 117.51 54.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.59 0.709 . . . . 0.0 111.69 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.46 170.86 23.15 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.056 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.663 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 10.5 t 64.15 36.76 9.37 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.645 0.735 . . . . 0.0 109.604 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 84.7 mt -78.76 -15.51 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.854 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 75.5 t80 76.04 139.28 0.06 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.664 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -74.89 77.64 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.581 0.705 . . . . 0.0 110.892 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -163.59 -35.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.396 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 178' ' ' LEU . 72.8 mt -85.64 128.92 34.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.206 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.27 176.85 39.08 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.893 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.72 -39.9 93.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 0.0 110.549 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 16.1 t70 -65.03 -41.96 94.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.279 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 m -61.15 -40.56 94.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.938 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.571 HG13 ' HE3' ' A' ' 143' ' ' MET . 29.3 mm -66.09 -38.69 82.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.789 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.403 ' O ' ' HB1' ' A' ' 133' ' ' ALA . 33.2 ttp-105 -61.52 -39.02 89.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.993 0.425 . . . . 0.0 109.946 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 78.0 mt-30 -63.94 -37.78 88.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.335 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.56 -36.66 37.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.264 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.544 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 56.9 m-85 -92.29 -7.85 46.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.978 0.418 . . . . 0.0 111.777 -177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.601 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -53.4 -45.58 98.42 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 6.8 Cg_endo -51.21 -27.66 23.47 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.854 2.369 . . . . 0.0 114.534 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.616 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 58.5 m-85 -83.88 -42.95 15.82 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.408 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.8 -179.49 40.49 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.849 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.93 110.92 3.13 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.763 2.309 . . . . 0.0 111.799 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 63.1 mt -79.57 113.02 18.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.353 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -78.58 -41.48 31.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.845 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -162.1 156.75 22.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.523 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.1 mt -134.76 116.18 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.732 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 12.8 m-20 -88.31 98.92 11.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.571 ' HE3' HG13 ' A' ' 128' ' ' ILE . 50.1 ttm -120.61 133.37 55.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.885 0.374 . . . . 0.0 111.228 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.44 172.639 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 37.9 p90 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.563 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -138.15 158.46 44.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.064 0.459 . . . . 0.0 111.662 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -117.84 115.8 25.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.338 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.683 ' HB ' HG12 ' A' ' 114' ' ' VAL . 99.4 t -91.52 109.93 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.936 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -98.03 116.22 29.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.431 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.544 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 95.9 m-85 -92.86 176.47 6.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.657 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -95.76 -1.52 49.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.045 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.9 m -145.76 137.31 12.92 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.22 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 43.5 Cg_endo -68.54 -20.34 41.39 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.039 2.493 . . . . 0.0 112.164 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.473 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 79.6 mm-40 -58.09 -56.34 23.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.79 -20.35 34.83 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.27 -51.82 7.54 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -63.31 -34.68 78.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.769 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.616 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.6 tp -68.67 -48.92 62.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.601 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.49 83.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 110.155 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 174' ' ' ASN . 6.7 tt -63.06 -51.16 67.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.532 174.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -57.72 -47.93 81.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.014 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -85.7 -33.37 21.53 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.9 mtm -108.15 30.09 6.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 24.2 p-10 -79.81 23.26 0.44 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.828 0.347 . . . . 0.0 111.584 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.8 t -114.59 -73.35 0.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.853 0.358 . . . . 0.0 110.625 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.581 HG13 ' H ' ' A' ' 182' ' ' ASN . 20.8 m -139.73 169.04 17.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.217 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.815 ' HB2' HD12 ' A' ' 183' ' ' ILE . 1.1 tpt -141.59 94.36 2.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.72 ' HG ' ' HE1' ' A' ' 177' ' ' MET . 89.0 mt 60.13 -83.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.579 0.752 . . . . 0.0 112.279 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -108.99 -12.8 19.67 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.336 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.32 115.03 4.32 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.246 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -82.94 127.06 33.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.581 ' H ' HG13 ' A' ' 176' ' ' VAL . 20.4 t-20 61.54 76.43 0.37 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.773 0.671 . . . . 0.0 110.258 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.815 HD12 ' HB2' ' A' ' 177' ' ' MET . 49.6 pt -88.36 160.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.724 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 67.0 mttm -105.65 106.91 17.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.528 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 6.2 m -109.27 116.4 51.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.317 0.58 . . . . 0.0 110.217 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.411 ' HA3' HD13 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.443 -0.853 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.595 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.014 0.435 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -70.52 -32.04 69.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.437 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 29.1 mm-40 -57.36 -56.19 36.52 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -173.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.2 Cg_endo -53.68 -37.51 83.9 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.219 1.946 . . . . 0.0 112.748 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 107' ' ' ALA . 54.7 mt -75.96 -43.09 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.774 0.321 . . . . 0.0 111.15 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.479 HG12 ' SD ' ' A' ' 111' ' ' MET . 72.8 mt -61.72 -46.49 96.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.05 0.452 . . . . 0.0 109.975 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.57 -36.98 85.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.352 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -58.32 -53.95 52.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.118 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 58.1 mt -68.8 -33.7 74.31 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.904 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.694 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.03 -48.96 69.95 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.6 ' OE1' ' HD3' ' A' ' 206' ' ' ARG . 6.6 mm-40 -62.89 -35.99 81.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.084 176.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 40.7 mt-10 -63.92 -36.25 83.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.356 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.09 -34.01 63.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.83 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.694 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 72.2 mtp180 -69.09 -20.63 64.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.937 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.53 -18.13 59.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.149 0.5 . . . . 0.0 110.554 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -109.14 -169.96 1.58 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.052 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.478 ' CB ' ' HA ' ' A' ' 260' ' ' ALA . 27.2 p-10 -139.5 58.75 1.61 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.835 0.826 . . . . 0.0 109.656 178.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.529 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 18.6 ttm180 -111.05 139.13 46.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.173 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.537 HG21 ' HB2' ' A' ' 263' ' ' SER . 47.1 pt -119.57 163.15 17.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.668 0.271 . . . . 0.0 110.597 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -113.9 127.0 55.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.152 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 28.3 m -114.8 128.01 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.359 0.599 . . . . 0.0 110.154 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -120.27 167.53 12.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.097 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.3 t 59.67 40.03 20.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.975 0.893 . . . . 0.0 109.095 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 225' ' ' ILE . 39.4 t -77.4 120.99 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.473 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 40.2 t-80 -52.57 133.01 36.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.257 0.551 . . . . 0.0 111.05 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -49.27 -37.68 24.42 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -171.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -96.41 -6.1 38.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.126 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.644 HD23 HD11 ' A' ' 275' ' ' LEU . 10.7 tp -88.7 112.41 23.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.5 t -96.93 -178.67 4.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.854 0.359 . . . . 0.0 111.734 -170.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -53.36 -38.51 63.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.544 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.45 -37.55 87.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.391 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.401 ' HB2' ' HG ' ' A' ' 220' ' ' LEU . 15.7 m-20 -73.86 -42.68 60.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.992 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.531 HG21 HD11 ' A' ' 255' ' ' ILE . 34.6 mm -64.21 -42.14 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.09 -48.77 80.14 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.001 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 13.2 p -60.16 -38.17 82.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.44 HG21 HD22 ' A' ' 275' ' ' LEU . 49.1 t -76.56 -40.29 33.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.766 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.545 ' CB ' HD13 ' A' ' 235' ' ' ILE . 6.1 m-85 -69.19 -32.49 71.81 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.133 0.492 . . . . 0.0 110.993 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 7.2 tm-20 -63.35 -24.39 67.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.051 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.2 -23.82 64.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.731 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -101.41 -34.21 9.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.341 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -152.16 149.25 20.9 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.539 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 29.6 mmtp -71.19 120.52 16.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.567 0.698 . . . . 0.0 111.105 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.545 HD13 ' CB ' ' A' ' 229' ' ' PHE . 28.2 mt -91.38 151.2 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.919 -172.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.48 ' HE3' ' O ' ' A' ' 257' ' ' TYR . 17.0 ttmt -103.7 -30.28 10.53 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.202 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 28.2 t -170.34 141.91 2.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.325 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 40.4 t -142.61 127.1 17.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.744 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.9 t -141.31 133.48 27.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.823 0.344 . . . . 0.0 110.304 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 27.7 mt -109.84 136.18 49.56 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.86 126.44 29.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.221 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.402 ' HG2' ' CB ' ' A' ' 249' ' ' HIS . 73.5 mtp180 -122.83 152.45 40.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.831 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.823 ' HB2' ' HG1' ' A' ' 246' ' ' THR . 17.9 m-20 -70.5 145.85 93.29 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.74 -19.98 56.37 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 123.197 2.598 . . . . 0.0 114.159 -171.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.3 t -162.93 62.2 0.19 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.295 0.569 . . . . 0.0 111.996 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.823 ' HG1' ' HB2' ' A' ' 243' ' ' ASP . 58.7 p -127.93 -18.46 4.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.095 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.07 -46.3 1.72 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.101 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.34 177.89 6.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.848 0.356 . . . . 0.0 110.711 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.402 ' CB ' ' HG2' ' A' ' 242' ' ' ARG . 30.8 p80 -96.15 170.7 9.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.293 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -77.06 -80.6 0.1 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.938 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -179.8 18.12 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.029 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -154.89 163.9 39.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -168.66 -179.24 40.77 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.228 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.473 ' CZ ' ' HG3' ' A' ' 164' ' ' GLU . 91.1 m-85 -134.44 145.37 48.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.625 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.531 HD11 HG21 ' A' ' 225' ' ' ILE . 88.5 mt -138.04 132.06 42.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.036 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.529 ' HG2' ' HB2' ' A' ' 210' ' ' ARG . 81.6 mt-10 -110.02 146.16 35.79 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.526 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 8.2 m-85 -106.94 179.24 4.32 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.164 176.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -70.24 -50.63 37.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.924 0.868 . . . . 0.0 108.905 171.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -103.48 139.56 38.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.968 -1.469 . . . . 0.0 109.227 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.478 ' HA ' ' CB ' ' A' ' 209' ' ' ASN . . . -65.56 -28.79 69.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.705 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -72.82 -33.45 66.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.844 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.8 m -67.07 -37.18 83.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.053 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.537 ' HB2' HG21 ' A' ' 211' ' ' ILE . 21.6 p -68.23 -38.63 82.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 0.0 110.04 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -71.6 -25.96 62.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.33 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -65.39 -41.94 93.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.028 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -63.83 -41.68 97.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.468 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.17 -32.98 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.231 0.539 . . . . 0.0 111.001 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.9 t -75.37 -33.83 61.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.132 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.8 t -94.29 -40.17 10.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 112.041 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 75.2 mmm -83.33 -4.41 58.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -168.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.469 ' HA ' HG13 ' A' ' 282' ' ' VAL . 57.8 t30 -69.2 112.81 6.03 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.159 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 281' ' ' ARG . 94.1 mt 67.77 36.36 3.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.778 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -91.17 132.97 35.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.244 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -82.04 109.57 16.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.305 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.668 HD12 HD11 ' A' ' 280' ' ' LEU . 0.6 OUTLIER -117.38 91.38 3.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.137 0.494 . . . . 0.0 109.851 176.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.9 34.1 28.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.756 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 91.03 -0.29 75.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.969 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 217' ' ' HIS . 34.6 tt0 -126.57 141.17 51.95 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 120.773 0.32 . . . . 0.0 110.342 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -92.58 123.25 35.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.87 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.668 HD11 HD12 ' A' ' 275' ' ' LEU . 48.2 mt -77.73 127.6 32.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.135 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.443 ' CZ ' HD23 ' A' ' 272' ' ' LEU . 37.4 mmt180 -95.1 114.78 26.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 271' ' ' ASN . 10.7 p -117.34 147.65 20.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.157 -173.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -159.47 175.47 36.36 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.382 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -82.06 126.41 31.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -61.68 126.81 28.68 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.309 0.381 . . . . 0.0 110.585 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.59 -24.94 5.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.359 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.465 HG22 HD23 ' A' ' 108' ' ' LEU . 16.1 p -132.57 133.16 23.21 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.732 0.301 . . . . 0.0 111.269 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.534 0.495 0 C-N-CA 122.616 2.211 . . . . 0.0 112.077 175.317 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.192 0.52 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -52.8 -48.23 67.05 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.908 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.0 -35.83 69.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.704 0.288 . . . . 0.0 111.081 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 108' ' ' LEU . 34.7 mt -66.59 -32.35 73.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.203 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.8 85.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.192 0.52 . . . . 0.0 110.136 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.97 -36.48 57.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.219 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.425 ' SD ' HG12 ' A' ' 198' ' ' ILE . 89.9 mtp -72.14 -17.01 62.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.915 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 80.2 m -89.01 -17.78 28.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.91 0.386 . . . . 0.0 110.597 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -99.08 141.53 31.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.144 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.686 HG13 ' HB ' ' A' ' 158' ' ' VAL . 2.5 p -128.05 131.58 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 121.773 0.796 . . . . 0.0 110.145 174.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.436 ' H ' ' HA2' ' A' ' 186' ' ' GLY . 39.1 t80 -94.71 104.48 16.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.222 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 17.4 m -99.38 116.52 42.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.607 0.717 . . . . 0.0 111.352 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.479 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -116.36 165.32 12.27 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.638 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.7 m 63.45 44.42 5.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.347 0.594 . . . . 0.0 110.861 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -72.91 142.93 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.234 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.447 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 37.8 t80 -54.81 127.26 27.65 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.598 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -74.47 76.71 1.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.024 0.44 . . . . 0.0 110.135 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 178.54 -36.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.111 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 93.8 mt -61.44 132.41 53.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.965 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -98.59 168.23 22.65 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.791 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -55.41 -39.51 70.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.935 0.397 . . . . 0.0 111.183 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -64.55 -39.51 93.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.076 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -71.57 -38.25 70.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.49 HG13 ' HE1' ' A' ' 143' ' ' MET . 34.4 mm -64.41 -40.24 88.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.145 176.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -59.16 -43.35 92.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.58 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.37 -34.45 73.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.297 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.11 -33.44 26.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.489 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 40.7 m-85 -91.77 -16.81 26.3 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -54.88 -43.72 98.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 42.0 Cg_exo -40.58 -38.95 2.74 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.245 2.63 . . . . 0.0 115.062 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.71 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 61.5 m-85 -77.48 -37.17 51.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -173.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -179.01 -177.71 47.76 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.867 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.06 135.43 18.97 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.772 2.314 . . . . 0.0 112.258 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.499 HD12 HD12 ' A' ' 141' ' ' ILE . 68.9 mt -102.1 130.97 51.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.564 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.456 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 29.5 ttpp -94.48 -31.75 13.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -168.79 145.91 3.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.6 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.499 HD12 HD12 ' A' ' 138' ' ' ILE . 69.5 mt -130.81 131.16 64.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -122.29 101.49 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.49 ' HE1' HG13 ' A' ' 128' ' ' ILE . 43.5 ttm -111.97 138.28 48.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.747 0.308 . . . . 0.0 110.931 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.8 m . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.295 173.609 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.479 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 29.5 m-85 . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.2 139.52 51.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.954 0.407 . . . . 0.0 110.647 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -105.34 109.33 21.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.824 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.686 ' HB ' HG13 ' A' ' 114' ' ' VAL . 62.9 t -94.57 105.72 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -102.87 115.15 30.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.409 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -88.94 172.38 9.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.628 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 47.8 mt-10 -89.95 -24.29 21.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.845 172.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.82 137.35 29.37 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.303 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.3 Cg_endo -69.43 -17.46 39.05 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.169 2.579 . . . . 0.0 112.362 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 71.3 mm-40 -57.99 -54.91 41.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.011 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -59.33 -21.5 59.86 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.68 -52.39 8.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -63.95 -32.33 73.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.841 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.71 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.1 tp -68.52 -50.04 55.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.584 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.42 74.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.756 0.313 . . . . 0.0 110.374 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.578 HD11 ' O ' ' A' ' 185' ' ' VAL . 24.4 tp -68.76 -40.77 79.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.125 0.488 . . . . 0.0 110.651 173.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.84 -33.95 75.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.253 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -100.13 -51.19 3.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.429 ' C ' ' H ' ' A' ' 175' ' ' SER . 13.6 mtm -103.11 29.3 5.59 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -165.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.414 ' HB2' HD12 ' A' ' 170' ' ' LEU . 64.4 t30 -83.61 32.5 0.46 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.575 0.702 . . . . 0.0 109.941 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 48.6 m -114.87 -74.08 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.369 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.07 163.84 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.395 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.878 ' HB2' HD11 ' A' ' 183' ' ' ILE . 0.8 OUTLIER -134.03 103.25 5.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.568 177.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.811 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 84.0 mt 54.7 77.75 0.19 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.931 0.77 . . . . 0.0 111.995 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 131.72 -139.56 11.05 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.167 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -133.7 62.67 0.63 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.322 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -142.22 124.19 15.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 175' ' ' SER . 95.3 m-20 -68.27 124.12 22.62 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 123.307 0.38 . . . . 0.0 110.439 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.878 HD11 ' HB2' ' A' ' 177' ' ' MET . 47.3 pt -106.49 155.56 7.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.043 0.449 . . . . 0.0 110.77 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.1 tppp? -105.42 116.01 31.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.578 ' O ' HD11 ' A' ' 170' ' ' LEU . 21.7 t -100.06 102.19 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.405 0.621 . . . . 0.0 109.806 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.436 ' HA2' ' H ' ' A' ' 115' ' ' TYR . . . . . . . . 0 N--CA 1.445 -0.711 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.805 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.26 -13.2 50.52 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.485 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 12.0 tm0? -64.04 -52.87 52.89 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.82 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 77.7 Cg_exo -53.23 -38.52 81.65 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.485 2.123 . . . . 0.0 113.094 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 52.4 mt -67.36 -46.47 83.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.318 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.425 HG12 ' SD ' ' A' ' 111' ' ' MET . 66.5 mt -60.95 -45.56 98.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.317 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.32 -39.95 95.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.534 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -65.38 -47.31 76.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.557 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 49.9 mt -67.43 -33.11 74.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.092 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.592 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.6 -45.19 66.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.379 0.609 . . . . 0.0 109.53 173.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -70.44 -33.02 70.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.29 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 32.3 mt-10 -68.38 -25.6 65.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.812 0.339 . . . . 0.0 111.534 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.22 58.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 78.6 mtp180 -70.65 -10.69 59.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.193 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.34 -27.17 67.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.196 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -128.37 124.27 35.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.144 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -74.87 70.35 1.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.855 0.836 . . . . 0.0 110.277 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.858 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 3.3 ptp180 -113.46 155.37 25.44 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.725 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.6 pt -122.84 164.4 20.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.745 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -112.45 129.14 56.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.315 0.384 . . . . 0.0 110.204 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.572 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.7 m -124.08 132.91 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.192 0.52 . . . . 0.0 110.506 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . . . -126.23 177.42 6.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.649 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.9 m 61.38 30.24 18.89 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.718 0.771 . . . . 0.0 109.792 -173.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.483 ' O ' ' HA2' ' A' ' 251' ' ' GLY . 30.8 t -85.42 115.48 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.432 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.655 ' HB3' HD23 ' A' ' 220' ' ' LEU . 23.3 t-80 -57.66 139.96 52.4 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.057 0.456 . . . . 0.0 110.661 -176.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.544 ' HB2' ' HD2' ' A' ' 248' ' ' LYS . 6.0 pt20 -46.38 -41.74 14.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 218' ' ' GLN . 0.7 OUTLIER -98.16 13.91 29.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -167.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.655 HD23 ' HB3' ' A' ' 217' ' ' HIS . 3.6 mm? -86.72 121.89 29.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 25.0 m -78.11 171.61 14.77 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.609 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.49 -41.25 76.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.078 0.466 . . . . 0.0 110.101 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -69.49 -24.24 63.74 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.02 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.437 ' HB3' HD11 ' A' ' 220' ' ' LEU . 7.6 m-20 -69.75 -45.64 67.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 110.258 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.682 HG23 HD12 ' A' ' 255' ' ' ILE . 14.5 mm -68.58 -38.08 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -60.53 -53.68 54.59 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.946 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 11.2 p -55.12 -38.63 68.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.458 HG11 ' HE2' ' A' ' 270' ' ' MET . 32.3 t -73.42 -46.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.541 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.641 ' HB2' HD13 ' A' ' 235' ' ' ILE . 17.3 m-85 -67.24 -29.99 69.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.39 0.614 . . . . 0.0 110.63 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.53 -24.15 63.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.902 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.53 -13.27 60.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.771 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -111.43 -30.92 7.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.799 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -157.34 166.8 33.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.974 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -80.18 110.69 15.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.509 0.671 . . . . 0.0 111.036 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 229' ' ' PHE . 37.5 mt -83.17 151.21 4.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.604 -176.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -106.02 -34.94 7.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.448 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.4 p -173.37 156.24 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.537 ' HG ' HG22 ' A' ' 255' ' ' ILE . 74.1 m -142.46 138.88 31.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.252 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 31.9 m -141.14 103.0 4.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.676 HD23 HG13 ' A' ' 225' ' ' ILE . 81.2 mt -83.94 149.53 26.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.705 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -84.85 104.37 14.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.756 0.313 . . . . 0.0 110.356 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.716 ' HG3' ' HB3' ' A' ' 249' ' ' HIS . 0.2 OUTLIER -97.53 152.67 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.53 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.614 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 8.8 m-20 -77.84 148.72 76.26 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.95 -8.13 13.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.972 2.448 . . . . 0.0 114.422 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -166.62 38.82 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.614 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 25.4 p -108.21 -16.45 14.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.347 -0.846 . . . . 0.0 112.02 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.4 77.17 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.696 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.544 ' HD2' ' HB2' ' A' ' 218' ' ' GLN . 46.4 pttt -168.22 -168.56 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.716 ' HB3' ' HG3' ' A' ' 242' ' ' ARG . 33.9 p80 -118.79 165.16 14.37 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.239 -177.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -64.76 -68.98 0.32 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.211 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 216' ' ' VAL . . . 170.5 24.91 0.02 OUTLIER Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.431 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -152.4 160.51 43.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.543 ' HA3' HD21 ' A' ' 240' ' ' LEU . . . -174.21 178.83 45.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.532 -176.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.576 ' CZ ' ' HG3' ' A' ' 164' ' ' GLU . 81.2 m-85 -131.92 153.05 50.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.774 0.321 . . . . 0.0 111.119 -176.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.682 HD12 HG23 ' A' ' 225' ' ' ILE . 84.1 mt -142.19 131.29 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.074 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.858 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 45.6 mt-10 -105.7 146.65 29.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.482 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 9.7 m-85 -110.77 160.61 16.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.723 0.297 . . . . 0.0 110.795 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.28 -23.77 51.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.372 0.606 . . . . 0.0 110.066 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -130.53 124.61 32.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.018 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.79 68.79 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.543 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 262' ' ' SER . 7.8 pt20 -59.6 -42.88 93.59 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.102 0.251 . . . . 0.0 111.03 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.429 ' N ' ' HG3' ' A' ' 261' ' ' GLN . 20.1 m -71.14 -32.83 69.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.826 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -43.06 97.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.017 0.437 . . . . 0.0 111.039 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -74.73 -23.12 58.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.49 -35.75 65.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.053 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.61 84.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.923 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.436 ' HA ' ' CG2' ' A' ' 282' ' ' VAL . 77.3 t -58.76 -27.01 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.225 0.535 . . . . 0.0 110.646 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.8 t -86.15 -30.6 22.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.9 m -93.95 -41.15 9.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.581 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 88.3 mmm -84.11 4.9 28.22 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -169.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.442 ' HA ' HG12 ' A' ' 282' ' ' VAL . 11.0 t30 -71.58 118.11 13.98 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.382 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 93.1 mt 66.83 34.13 5.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.601 -178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -88.33 122.85 32.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 16.3 t70 -73.28 119.24 17.25 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.727 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 44.8 tp -137.01 91.91 2.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.292 0.568 . . . . 0.0 110.111 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 96.65 22.77 17.6 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.464 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.91 -1.93 68.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.623 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -127.2 147.26 50.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.474 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 84.6 m-85 -89.39 116.1 27.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.217 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 69.6 mt -58.04 127.85 34.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.857 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 17.1 mmt180 -93.45 115.39 27.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 271' ' ' ASN . 13.9 p -115.82 135.98 54.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.178 0.513 . . . . 0.0 111.143 -173.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -154.94 -179.53 30.2 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.537 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -84.16 130.2 34.86 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.56 120.63 12.11 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.528 0.518 . . . . 0.0 109.821 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.68 -26.89 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 28.3 p -134.86 145.11 53.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.654 0.264 . . . . 0.0 110.783 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.459 -0.523 0 C-N-CA 122.366 2.044 . . . . 0.0 112.199 177.022 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.434 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -65.54 -32.2 73.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.835 0.35 . . . . 0.0 111.283 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.22 -30.84 66.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.153 0.502 . . . . 0.0 110.438 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.681 HD23 HD11 ' A' ' 201' ' ' LEU . 56.9 mt -71.71 -33.08 68.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.325 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.9 73.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.265 0.555 . . . . 0.0 110.028 175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.7 mt -73.31 -38.49 53.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.116 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.445 ' SD ' HG23 ' A' ' 198' ' ' ILE . 31.7 mtm -74.29 -2.22 24.11 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.541 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 73.8 m -82.68 -8.58 59.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.098 0.475 . . . . 0.0 110.018 175.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.937 ' HG2' ' HG2' ' A' ' 159' ' ' GLU . 58.3 mtt180 -113.33 141.87 46.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.15 -177.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.564 HG13 ' HB ' ' A' ' 158' ' ' VAL . 9.9 p -121.51 130.32 74.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.273 0.558 . . . . 0.0 109.749 171.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -83.64 114.91 21.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.079 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 21.4 m -112.24 121.23 64.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.616 0.722 . . . . 0.0 110.935 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.478 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -127.47 173.09 18.69 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.981 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 58.7 m 60.75 31.47 20.11 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.408 0.283 . . . . 0.0 111.176 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.545 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 71.1 mt -61.39 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.485 -176.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.517 ' HB2' ' O ' ' A' ' 119' ' ' ILE . 2.3 t80 164.6 149.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -174.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -88.26 73.14 8.94 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -176.84 -58.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.226 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.8 mt -58.84 99.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.273 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.32 171.32 54.76 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.032 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -57.05 -39.9 75.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.874 0.368 . . . . 0.0 110.656 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.35 -49.46 77.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.79 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.7 m -63.3 -44.18 95.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.087 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.537 HG13 ' HE1' ' A' ' 143' ' ' MET . 33.8 mm -60.74 -40.46 85.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.532 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -61.2 -38.67 87.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.337 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -70.88 -34.04 71.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.495 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.02 32.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.231 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.499 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 46.3 m-85 -94.33 -14.86 24.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.829 0.347 . . . . 0.0 111.569 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.416 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.99 -41.97 88.3 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 55.1 Cg_exo -42.48 -35.72 4.04 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.016 2.477 . . . . 0.0 114.488 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.514 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 51.3 m-85 -82.49 -49.34 10.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 121.141 -0.223 . . . . 0.0 111.202 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.01 172.39 39.84 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.918 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.94 121.64 8.29 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.617 2.211 . . . . 0.0 111.705 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.2 mt -84.53 116.7 28.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.945 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -74.76 -43.75 53.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.917 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.3 t -161.96 152.78 17.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.358 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -130.45 126.12 60.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.616 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 13.3 t70 -96.28 99.77 11.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.537 ' HE1' HG13 ' A' ' 128' ' ' ILE . 46.9 ttm -136.21 126.88 27.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.204 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 C--N 1.322 -0.613 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.008 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.478 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 67.2 m-85 . . . . . 0 C--O 1.233 0.237 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 142' ' ' ASP . . . -137.29 140.95 41.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.089 0.471 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -109.98 109.75 20.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.597 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.564 ' HB ' HG13 ' A' ' 114' ' ' VAL . 47.7 t -91.06 110.36 22.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.337 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.937 ' HG2' ' HG2' ' A' ' 113' ' ' ARG . 47.3 mt-10 -99.72 123.08 43.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.532 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.444 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 95.8 m-85 -100.98 171.67 7.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.033 0.444 . . . . 0.0 110.085 176.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -86.1 -5.36 59.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.271 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 5.2 m -142.23 143.98 29.59 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.191 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 12.6 Cg_exo -69.69 -26.54 27.82 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.384 2.723 . . . . 0.0 112.038 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.687 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 8.1 mp0 -55.73 -57.05 13.62 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.954 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.81 -19.73 52.51 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.85 -51.15 8.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -68.07 -31.55 71.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.757 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.514 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 18.2 tp -67.03 -46.47 74.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.673 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.81 -34.73 73.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.072 0.463 . . . . 0.0 110.168 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 185' ' ' VAL . 2.9 tp -67.6 -51.98 43.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.556 172.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -54.83 -34.44 62.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.745 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -100.56 -51.54 3.58 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.409 ' C ' ' H ' ' A' ' 175' ' ' SER . 29.1 ttp -107.78 29.33 7.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -165.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 31.9 p-10 -78.72 25.21 0.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.911 0.386 . . . . 0.0 111.302 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 173' ' ' MET . 4.1 m -113.33 -72.91 0.68 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.867 0.365 . . . . 0.0 111.069 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 30.9 m -134.29 164.04 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.002 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.747 ' HE1' ' HG ' ' A' ' 178' ' ' LEU . 1.9 tpt -139.51 91.9 2.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.793 0.33 . . . . 0.0 110.734 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.747 ' HG ' ' HE1' ' A' ' 177' ' ' MET . 94.6 mt 61.56 -177.79 0.12 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.429 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.69 -113.14 1.06 Allowed Glycine 0 C--N 1.337 0.587 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.185 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.6 45.84 0.59 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 119' ' ' ILE . 12.5 tpt180 -127.2 135.84 51.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.899 -173.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 4.1 p-10 -91.85 142.53 27.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' ' 177' ' ' MET . 42.8 pt -129.66 168.19 23.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.792 0.33 . . . . 0.0 110.568 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 55.5 tptt -109.25 106.01 15.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.772 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.491 ' O ' HD11 ' A' ' 170' ' ' LEU . 43.3 t -103.03 104.29 16.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.698 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.1 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.459 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 59.5 tt0 . . . . . 0 C--O 1.236 0.368 0 CA-C-O 120.855 0.36 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -74.43 -23.2 58.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.203 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.68 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 23.1 tm0? -58.93 -52.92 71.38 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.497 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 54.2 Cg_exo -56.61 -35.17 96.97 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.286 1.99 . . . . 0.0 112.65 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.3 mt -67.99 -43.73 85.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 109.92 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.445 HG23 ' SD ' ' A' ' 111' ' ' MET . 84.9 mt -59.6 -48.71 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.052 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.25 -45.53 90.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.91 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -62.02 -53.03 61.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.681 HD11 HD23 ' A' ' 108' ' ' LEU . 30.8 mt -65.83 -33.11 75.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.262 -178.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.648 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.28 -42.84 70.48 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -71.44 -34.47 70.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.907 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 31.3 mt-10 -65.09 -36.51 84.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.67 -26.73 64.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.686 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.5 mtp180 -72.29 -14.12 61.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.59 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -88.39 0.8 55.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.351 0.596 . . . . 0.0 110.273 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -131.42 177.18 7.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.926 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 3.1 m-80 -118.95 43.35 2.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.13 -174.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -99.8 137.24 38.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.98 -173.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.1 pt -133.08 166.57 29.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.559 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.623 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 84.6 t80 -120.81 131.89 54.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.363 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.405 HG13 ' CZ ' ' A' ' 229' ' ' PHE . 33.6 m -125.91 137.42 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.156 0.503 . . . . 0.0 110.677 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -133.29 -178.55 5.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.715 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 28.2 t 62.73 26.58 15.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.756 0.789 . . . . 0.0 109.444 -171.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.428 HG13 HD11 ' A' ' 225' ' ' ILE . 9.4 t -79.68 115.86 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.093 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -60.88 145.5 49.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.551 -171.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -48.42 -54.54 13.7 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -85.68 36.91 0.67 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.992 0.425 . . . . 0.0 111.537 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 9.1 tp -121.01 118.01 28.74 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 19.7 m -99.3 177.45 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.388 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -64.42 -26.75 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 110.412 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.46 -40.25 92.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.348 0.594 . . . . 0.0 109.909 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.64 -50.0 68.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.799 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.599 HG22 HD11 ' A' ' 255' ' ' ILE . 26.0 mm -68.17 -44.81 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.435 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 64.0 tttm -57.61 -46.56 83.93 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.44 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.2 t -52.76 -48.47 66.75 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.68 -43.32 61.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.343 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.579 ' CB ' HD13 ' A' ' 235' ' ' ILE . 11.2 m-85 -67.39 -30.01 69.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.232 0.539 . . . . 0.0 110.744 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.554 ' OE1' ' HB ' ' A' ' 235' ' ' ILE . 9.0 tp10 -63.16 -24.45 67.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.843 177.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.56 -11.63 59.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.874 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -111.2 -40.2 4.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.515 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -142.81 166.51 26.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.767 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -77.97 106.84 10.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.078 0.466 . . . . 0.0 110.521 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.579 HD13 ' CB ' ' A' ' 229' ' ' PHE . 21.5 mt -83.29 148.37 5.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.636 0.731 . . . . 0.0 111.579 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -106.9 -36.15 6.72 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.097 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.1 m -154.7 146.5 23.4 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -171.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.405 ' HG ' HD11 ' A' ' 255' ' ' ILE . 49.7 t -141.83 119.45 11.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 171.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.6 m -140.48 103.13 4.48 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.301 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.575 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 48.1 mt -75.96 129.23 36.59 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.445 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.21 116.5 6.64 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.475 0.485 . . . . 0.0 110.195 -175.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 31.0 ttp180 -136.43 142.21 43.63 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.783 -174.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.574 ' HB2' ' HG1' ' A' ' 246' ' ' THR . 9.2 m-20 -75.97 115.18 44.21 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.69 -27.33 25.92 Favored 'Trans proline' 0 CA--C 1.527 0.175 0 C-N-CA 123.679 2.919 . . . . 0.0 114.138 -171.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 t -97.44 -14.21 21.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.574 ' HG1' ' HB2' ' A' ' 243' ' ' ASP . 71.0 p -92.37 -39.32 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.843 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.77 -0.47 70.14 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.3 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 62.6 pttt -117.56 138.18 52.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -82.63 144.55 30.22 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.503 ' HB2' ' CE1' ' A' ' 252' ' ' TYR . 23.8 mtpp -78.29 10.96 2.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -167.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.64 38.43 Favored Glycine 0 CA--C 1.508 -0.388 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.264 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.503 ' CE1' ' HB2' ' A' ' 250' ' ' LYS . 28.9 p90 -142.15 177.78 8.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.687 0.28 . . . . 0.0 110.488 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -167.63 174.41 42.68 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.158 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.687 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 86.1 m-85 -126.38 149.67 49.08 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.599 HD11 HG22 ' A' ' 225' ' ' ILE . 74.9 mt -140.29 142.73 30.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.454 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 51.0 mt-10 -117.75 147.52 42.9 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.549 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 11.6 m-85 -114.38 171.0 7.89 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 171.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -86.99 -9.75 54.85 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.46 0.648 . . . . 0.0 109.569 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -136.12 122.63 20.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.273 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.71 72.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.141 0.496 . . . . 0.0 111.079 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -63.44 -36.47 83.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.882 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.5 m -71.64 -40.82 69.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.33 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 43.1 p -67.17 -36.79 82.55 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -67.68 -30.86 70.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.3 -35.49 76.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.115 0.483 . . . . 0.0 110.256 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.24 85.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.086 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.441 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 95.7 t -58.25 -34.12 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 121.443 0.639 . . . . 0.0 110.126 173.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 43.1 t -73.06 -44.59 60.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.362 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.8 m -90.37 -35.36 15.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.446 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 82.7 mmm -87.17 -7.79 57.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -170.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -73.24 122.09 21.39 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.165 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 97.4 mt 64.25 31.27 13.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.437 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -86.59 133.85 33.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.022 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -80.09 105.6 11.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.951 0.405 . . . . 0.0 110.607 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 56.1 tp -126.11 95.65 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.244 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.12 21.99 47.07 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.502 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 90.05 9.26 65.89 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.607 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -129.92 155.3 46.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.535 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 73.5 m-85 -100.39 109.35 21.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 74.9 mt -59.55 133.95 56.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.639 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 14.8 mmt180 -99.58 116.18 31.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 267' ' ' VAL . 12.4 p -123.68 144.41 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.65 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.45 173.06 38.68 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.691 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -71.95 128.1 34.66 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.23 113.25 6.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.25 -24.14 23.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.867 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 50.2 p -100.67 133.09 21.43 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.983 0.42 . . . . 0.0 110.403 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 N--CA 1.463 -0.292 0 C-N-CA 122.594 2.196 . . . . 0.0 111.603 176.271 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.751 0.31 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.28 -48.85 80.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.468 ' HB3' HD12 ' A' ' 197' ' ' ILE . . . -69.75 -22.8 63.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.489 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.91 -32.12 73.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.092 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.71 -28.37 68.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.341 0.591 . . . . 0.0 110.401 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.0 mt -87.91 -40.44 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.343 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.527 ' SD ' HG12 ' A' ' 198' ' ' ILE . 92.2 mtp -69.08 -29.9 68.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.018 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 92.9 m -73.94 -12.02 60.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.593 0.235 . . . . 0.0 111.01 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 159' ' ' GLU . 47.1 mtt180 -106.51 141.39 37.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.08 0.467 . . . . 0.0 110.894 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.54 122.43 69.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.461 0.648 . . . . 0.0 109.407 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -74.86 119.88 19.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.108 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 15.3 m -114.22 114.74 47.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.405 0.621 . . . . 0.0 109.959 175.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.06 171.36 13.78 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.249 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.9 m 58.67 35.08 24.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 111.102 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.502 HD13 HG21 ' A' ' 116' ' ' VAL . 58.3 mt -68.99 126.36 28.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.213 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.62 140.28 58.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.165 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.37 77.3 1.02 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 122.133 0.968 . . . . 0.0 111.19 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -170.93 -26.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.732 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.1 mt -93.4 110.02 21.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.253 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.26 -174.99 45.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.962 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.65 -40.55 97.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 110.117 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 36.0 t70 -62.89 -48.77 77.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.688 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -61.12 -43.65 98.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.177 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.42 HG13 ' HE3' ' A' ' 143' ' ' MET . 28.1 mm -63.66 -43.18 98.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -57.91 -41.37 82.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.486 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 97.8 mt-30 -60.29 -46.31 90.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.495 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.87 -26.98 36.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -171.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.515 ' CZ ' HG12 ' A' ' 116' ' ' VAL . 32.1 m-85 -90.17 -16.4 29.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.705 0.288 . . . . 0.0 111.542 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -56.9 -42.48 96.57 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 6.9 Cg_endo -51.31 -27.92 25.09 Favored 'Trans proline' 0 C--N 1.361 1.184 0 C-N-CA 122.507 2.138 . . . . 0.0 114.197 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.751 ' HD2' ' HG ' ' A' ' 168' ' ' LEU . 64.6 m-85 -80.99 -46.04 15.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.635 0.255 . . . . 0.0 110.988 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.31 -178.53 39.09 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.476 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.412 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 62.3 Cg_endo -75.43 117.45 4.82 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.559 2.173 . . . . 0.0 111.65 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.8 mt -83.49 114.24 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.897 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.614 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 74.3 tttt -88.38 -33.17 18.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.78 -173.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.7 t -157.94 147.91 20.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.389 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.9 mt -133.67 113.24 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -96.63 100.02 11.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.51 ' HG3' ' HB2' ' A' ' 156' ' ' ALA . 52.4 ttm -126.92 137.85 53.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 177.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 38.5 p90 . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.172 0.511 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.51 ' HB2' ' HG3' ' A' ' 143' ' ' MET . . . -152.08 154.5 36.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.377 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -111.93 109.85 19.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.185 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 62.1 t -91.91 112.16 25.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.756 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.46 ' HA ' ' HG2' ' A' ' 113' ' ' ARG . 39.0 tt0 -100.08 120.49 39.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.972 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -98.23 170.0 9.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.685 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.614 ' HG2' ' HD2' ' A' ' 139' ' ' LYS . 35.6 mt-10 -80.34 -38.67 30.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 171.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.2 m -109.64 135.81 20.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.365 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 56.2 Cg_endo -69.44 -21.15 35.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.127 2.551 . . . . 0.0 112.597 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.705 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 10.7 mp0 -57.59 -50.65 72.41 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.129 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.04 -21.76 65.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.46 -51.72 8.99 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.022 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 164' ' ' GLU . 5.0 pp0? -63.85 -30.23 71.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.556 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.751 ' HG ' ' HD2' ' A' ' 135' ' ' PHE . 14.2 tp -73.79 -45.83 49.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.6 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.4 72.17 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.532 ' O ' ' HB3' ' A' ' 174' ' ' ASN . 6.8 tt -66.44 -50.0 64.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.27 172.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 10.6 mm-40 -52.72 -50.87 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.554 -178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -89.72 -32.98 16.76 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 22.8 mtm -106.71 30.79 5.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.479 . . . . 0.0 111.744 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 33.4 p-10 -74.92 -3.59 33.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.412 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.6 m -95.13 -73.38 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 110.841 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.9 m -140.69 164.73 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.082 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.675 ' HA ' ' HE1' ' A' ' 177' ' ' MET . 1.4 tpt -124.43 95.03 4.38 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.549 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.452 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 91.7 mt 71.95 -50.53 0.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.971 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 161.1 -177.29 37.52 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.638 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 94.72 -87.78 1.1 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.604 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -127.55 142.54 51.35 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -70.68 108.4 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.629 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.3 pt -72.47 156.35 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.776 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 83.2 tttt -106.2 116.77 32.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.258 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.53 HG12 HG11 ' A' ' 116' ' ' VAL . 5.4 m -100.27 114.39 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 172.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.478 179.004 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 . . . . . 0 N--CA 1.464 0.271 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.423 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -78.04 -22.2 49.53 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.521 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 71.9 mm-40 -52.32 -54.02 46.4 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -175.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 53.2 Cg_exo -56.21 -34.54 93.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.021 1.814 . . . . 0.0 112.684 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.468 HD12 ' HB3' ' A' ' 107' ' ' ALA . 51.3 mt -75.98 -45.98 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.327 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.527 HG12 ' SD ' ' A' ' 111' ' ' MET . 69.1 mt -60.85 -43.34 95.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.292 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.08 -38.73 89.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.857 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -61.63 -52.47 64.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.855 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.472 HD11 HG23 ' A' ' 287' ' ' THR . 25.5 mt -67.54 -32.69 73.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.608 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.667 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.63 -47.84 66.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 171.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.507 ' OE1' ' HD3' ' A' ' 206' ' ' ARG . 5.8 mm-40 -63.24 -35.24 79.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.213 175.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.62 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 47.6 mt-10 -66.41 -33.45 75.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -77.64 -29.28 51.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.969 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.667 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 59.4 mtp180 -72.62 -25.35 61.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 110.408 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.65 -39.93 18.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.342 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -105.57 79.53 1.46 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 0.1 OUTLIER -52.4 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.427 1.079 . . . . 0.0 111.403 -173.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.463 ' HB2' ' HG3' ' A' ' 256' ' ' GLU . 44.8 ttm105 -134.09 146.12 50.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.995 0.426 . . . . 0.0 111.59 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.595 HG23 ' HB2' ' A' ' 263' ' ' SER . 49.3 pt -123.78 166.46 18.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.17 174.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.475 ' CG ' ' HB3' ' A' ' 164' ' ' GLU . 85.4 t80 -118.14 129.51 55.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.46 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.469 HG13 ' CZ ' ' A' ' 229' ' ' PHE . 29.3 m -121.1 128.56 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.335 0.588 . . . . 0.0 110.237 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -119.57 176.2 5.48 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.464 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.4 m 60.26 32.59 20.83 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.415 0.626 . . . . 0.0 109.972 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.49 114.67 20.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.353 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -55.57 137.65 48.44 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.456 0.472 . . . . 0.0 111.744 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -49.99 -52.37 34.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -82.23 20.38 1.05 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.91 0.386 . . . . 0.0 111.722 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.637 HD23 ' HG ' ' A' ' 275' ' ' LEU . 15.0 tp -105.41 126.53 52.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.0 m -90.85 163.96 14.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.832 0.349 . . . . 0.0 111.746 -173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.444 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 6.0 p-10 -65.11 -27.29 68.65 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.27 0.557 . . . . 0.0 110.313 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.34 -31.61 71.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.751 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -74.33 -39.85 62.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.694 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.734 HG13 HD21 ' A' ' 240' ' ' LEU . 24.8 mm -65.74 -46.7 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -58.61 -51.56 69.41 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.955 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.4 p -58.94 -38.92 80.11 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 51.1 t -76.53 -41.99 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.196 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.537 ' CB ' HD11 ' A' ' 235' ' ' ILE . 25.0 m-85 -65.43 -28.67 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.217 -0.302 . . . . 0.0 110.736 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.18 -25.02 67.54 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.522 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.88 -17.49 55.51 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.064 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -111.52 -31.36 7.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.924 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.551 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -146.93 160.25 28.21 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.377 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.421 ' HA ' ' HE3' ' A' ' 234' ' ' LYS . 0.7 OUTLIER -84.71 107.63 17.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.492 0.663 . . . . 0.0 110.993 -177.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.537 HD11 ' CB ' ' A' ' 229' ' ' PHE . 37.3 mt -86.03 151.4 3.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.928 -173.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -106.23 -27.49 11.01 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.921 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.446 ' N ' HG21 ' A' ' 235' ' ' ILE . 3.0 p -176.87 152.1 0.92 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.575 0.226 . . . . 0.0 110.677 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 36.5 t -137.59 129.5 28.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.282 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.1 t -141.05 104.16 4.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.411 0.624 . . . . 0.0 111.599 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.734 HD21 HG13 ' A' ' 225' ' ' ILE . 30.9 mt -75.95 133.57 40.43 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.406 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.44 114.35 4.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.162 0.506 . . . . 0.0 110.257 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 13.7 mtp180 -112.21 164.89 12.68 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.438 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.85 ' HB3' ' HG1' ' A' ' 246' ' ' THR . 0.6 OUTLIER -79.28 141.4 57.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 175.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -43.75 -45.04 11.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.518 2.812 . . . . 0.0 113.905 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.9 t -155.61 86.21 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.722 0.773 . . . . 0.0 111.21 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.85 ' HG1' ' HB3' ' A' ' 243' ' ' ASP . 20.3 p -135.28 -42.84 0.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.728 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 121.92 -24.04 7.19 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.463 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -107.65 166.5 10.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.969 0.414 . . . . 0.0 110.471 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 9.7 p80 -96.63 165.35 12.19 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -73.39 -82.15 0.06 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.402 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -167.4 7.52 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.615 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.412 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 28.7 p90 -150.49 175.76 11.57 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -165.16 174.98 41.09 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.44 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.705 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 78.8 m-85 -129.54 150.95 50.66 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.703 HD13 HG22 ' A' ' 225' ' ' ILE . 81.9 mt -142.49 133.04 23.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.473 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 4.8 mp0 -106.51 146.97 29.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.639 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 8.8 m-85 -118.68 165.15 14.33 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.83 -37.57 86.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.755 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -118.22 140.12 50.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.434 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.76 -25.73 68.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.224 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -74.21 -43.45 57.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.234 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.6 m -66.32 -33.0 74.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.982 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.639 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 79.9 p -66.29 -37.82 86.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -71.39 -27.94 63.67 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.473 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.44 -44.08 92.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.077 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.05 92.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.386 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.65 -40.31 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.573 . . . . 0.0 110.665 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 20.7 m -70.35 -30.98 68.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.533 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.0 m -94.37 -42.99 8.6 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.474 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.3 mmm -82.66 6.45 17.81 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -169.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.45 ' HA ' HG12 ' A' ' 282' ' ' VAL . 65.2 t30 -72.13 120.57 17.92 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.277 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 93.4 mt 64.21 31.25 13.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.418 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -78.91 128.93 33.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.386 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.42 ' HB2' ' HE1' ' A' ' 279' ' ' TYR . 36.6 t70 -74.47 102.92 4.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.637 ' HG ' HD23 ' A' ' 220' ' ' LEU . 34.2 tp -136.8 109.93 7.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.752 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.07 56.69 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.408 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 83.11 4.46 89.83 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.654 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -130.47 156.15 45.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.42 ' HE1' ' HB2' ' A' ' 274' ' ' ASP . 45.7 m-85 -97.18 111.76 23.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.506 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 45.6 mt -59.68 127.17 30.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.5 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 30.6 mmt180 -92.71 114.37 26.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 171.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 271' ' ' ASN . 11.0 p -118.5 151.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.487 -171.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -169.58 174.86 43.9 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -72.68 141.96 48.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -82.36 129.35 34.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 167' ' ' GLN . 19.9 m -92.05 -23.05 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.723 0.297 . . . . 0.0 110.739 -175.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.472 HG23 HD11 ' A' ' 201' ' ' LEU . 38.0 p -128.81 156.5 77.63 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 121.136 0.493 . . . . 0.0 111.373 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.62 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 66.4 Cg_endo . . . . . 0 N--CA 1.447 -1.242 0 C-N-CA 123.252 2.635 . . . . 0.0 112.662 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.516 0.198 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -57.12 -42.47 80.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.08 0.467 . . . . 0.0 110.991 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.63 -31.4 65.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.769 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.44 ' CD2' HG22 ' A' ' 287' ' ' THR . 45.7 mt -70.7 -32.93 70.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.14 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.36 -33.86 73.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.347 0.594 . . . . 0.0 109.801 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.4 mt -75.71 -37.07 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.381 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.549 ' CG ' HD12 ' A' ' 198' ' ' ILE . 86.6 mtp -69.26 -20.78 63.93 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.021 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 82.1 m -74.5 -11.72 60.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -99.5 142.38 31.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.805 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.6 p -123.52 122.74 65.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 89.5 t80 -65.56 126.62 28.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.741 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.99 115.41 48.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -124.3 163.2 18.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.139 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.0 m 60.76 47.12 8.27 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 122.661 0.385 . . . . 0.0 111.233 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.478 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 49.2 mt -74.05 -28.28 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.353 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.478 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 35.7 t80 72.43 135.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.619 0.575 . . . . 0.0 109.528 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -77.16 77.22 3.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.193 0.997 . . . . 0.0 111.047 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -151.67 -49.45 0.11 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.566 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 178' ' ' LEU . 57.0 mt -68.04 137.64 55.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.59 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -98.72 173.67 27.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.409 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.82 -51.25 70.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 110.88 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.98 -27.83 63.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.876 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -64.55 -43.53 93.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.188 0.518 . . . . 0.0 109.762 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.53 HG13 ' HE2' ' A' ' 143' ' ' MET . 36.5 mm -64.44 -41.35 92.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.151 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 129' ' ' ARG . 20.7 ttt180 -55.73 -49.18 73.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.777 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.87 -33.29 73.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.759 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.408 ' HB3' ' HE2' ' A' ' 177' ' ' MET . . . -83.17 -35.51 25.45 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.23 -17.2 33.14 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.55 96.38 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -44.35 -36.2 9.15 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.714 2.276 . . . . 0.0 114.277 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.512 ' CD1' ' HA ' ' A' ' 169' ' ' ALA . 60.7 m-85 -77.9 -39.01 44.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.666 0.269 . . . . 0.0 110.717 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . -173.8 167.6 40.2 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.738 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.46 114.52 2.56 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.578 2.186 . . . . 0.0 111.865 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.549 HD13 HD12 ' A' ' 141' ' ' ILE . 65.2 mt -74.05 130.71 35.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.635 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 139' ' ' LYS . 36.8 ttpt -93.06 -33.99 13.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.393 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 t -174.05 128.38 0.38 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.949 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.549 HD12 HD13 ' A' ' 138' ' ' ILE . 68.9 mt -104.42 119.12 52.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -88.23 100.67 13.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.53 ' HE2' HG13 ' A' ' 128' ' ' ILE . 43.7 ttm -143.41 101.28 3.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.93 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 C--N 1.324 -0.529 0 CA-C-O 120.841 0.353 . . . . 0.0 110.924 -178.061 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.9 p90 . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.93 169.33 24.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.316 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.463 ' CE2' ' HD1' ' A' ' 115' ' ' TYR . 95.6 m-85 -124.18 112.82 17.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.164 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.1 t -91.85 108.5 20.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -105.06 118.99 37.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.11 0.481 . . . . 0.0 110.036 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -88.66 -176.11 5.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.966 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -83.35 -35.52 25.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.4 m -117.41 140.91 27.94 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.405 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 51.0 Cg_endo -66.84 -19.7 52.54 Favored 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 123.52 2.814 . . . . 0.0 112.609 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.649 ' HG3' ' CE1' ' A' ' 254' ' ' PHE . 80.6 mm-40 -58.33 -55.04 40.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.752 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.68 -21.03 62.4 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.984 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.92 -48.68 15.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.692 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.478 ' HG3' HG13 ' A' ' 286' ' ' VAL . 30.5 mm-40 -69.19 -33.18 72.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.503 174.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 13.7 tp -65.65 -47.07 76.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.656 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . . . -59.79 -37.71 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.08 0.467 . . . . 0.0 110.13 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.589 ' HA ' HG23 ' A' ' 185' ' ' VAL . 6.8 tt -65.38 -43.52 90.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.806 174.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.34 -34.44 76.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.99 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -100.61 -47.25 4.92 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.433 ' C ' ' H ' ' A' ' 175' ' ' SER . 29.7 ttp -102.91 31.04 4.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.363 0.602 . . . . 0.0 111.708 -166.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 4.8 p-10 -74.68 16.66 0.26 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.551 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 173' ' ' MET . 5.4 m -106.35 -74.01 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.675 0.274 . . . . 0.0 111.47 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 18.6 m -144.34 169.56 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.876 ' HE1' ' HG ' ' A' ' 178' ' ' LEU . 1.9 tpt -129.62 101.1 5.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 110.673 177.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.876 ' HG ' ' HE1' ' A' ' 177' ' ' MET . 94.6 mt 63.66 32.45 13.82 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.016 173.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.63 -31.63 1.92 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.087 -0.578 . . . . 0.0 114.32 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.75 -64.71 3.99 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.647 -0.311 . . . . 0.0 113.293 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -144.41 150.91 38.49 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.563 -0.375 . . . . 0.0 110.679 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 8.4 p30 -72.44 118.8 15.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.74 HD13 ' HB2' ' A' ' 177' ' ' MET . 43.6 pt -96.46 157.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.497 -174.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -105.14 110.99 23.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.408 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 170' ' ' LEU . 9.7 m -99.76 122.82 52.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.067 0.461 . . . . 0.0 109.922 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.955 -178.022 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 . . . . . 0 N--CA 1.46 0.052 0 CA-C-O 121.058 0.456 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -97.52 11.81 35.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.777 -175.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.569 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 25.2 tm0? -53.57 -47.16 97.42 Favored Pre-proline 0 N--CA 1.47 0.551 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 6.9 Cg_endo -52.76 -36.19 72.21 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.355 2.036 . . . . 0.0 112.884 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 78.2 mt -74.18 -38.58 48.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.19 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.549 HD12 ' CG ' ' A' ' 111' ' ' MET . 12.7 mm -57.66 -50.19 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.179 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 30.5 t70 -69.98 -32.56 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.854 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.37 -50.64 72.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.03 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.432 HD12 HD22 ' A' ' 108' ' ' LEU . 44.6 mt -68.86 -33.47 73.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.645 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.577 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -55.54 -42.55 74.77 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 52.3 mt-10 -63.26 -33.73 76.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.732 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.68 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 26.4 mt-10 -65.37 -36.23 83.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.915 0.388 . . . . 0.0 110.84 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.5 -39.13 62.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.705 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.577 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 60.0 mtp180 -61.02 -22.3 64.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.485 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.96 -27.36 65.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.039 0.447 . . . . 0.0 110.71 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -105.8 169.73 8.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.224 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 0.9 OUTLIER -103.75 51.27 0.79 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.473 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 39.3 ttm180 -105.18 139.13 40.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.023 -167.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 263' ' ' SER . 47.4 pt -127.97 166.22 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.879 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.473 ' HE1' ' HB2' ' A' ' 252' ' ' TYR . 25.0 t80 -118.24 135.81 54.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.019 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.492 HG13 ' CZ ' ' A' ' 229' ' ' PHE . 27.5 m -130.01 136.45 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 110.991 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -131.3 -179.17 5.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.553 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 69.6 m 62.44 27.37 16.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.869 0.842 . . . . 0.0 109.72 -171.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 225' ' ' ILE . 21.7 t -79.22 116.56 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.538 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -56.0 140.7 42.46 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.253 0.549 . . . . 0.0 111.476 -174.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -58.52 -29.31 66.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.972 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.45 6.14 42.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.868 0.842 . . . . 0.0 110.067 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.555 HD22 ' HG ' ' A' ' 275' ' ' LEU . 7.3 tp -112.59 122.77 48.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.079 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.4 t -107.25 -178.69 3.71 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.074 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -60.63 -37.52 81.73 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.99 -24.62 64.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 0.0 110.452 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -72.6 -52.74 14.2 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.865 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.482 HD11 HG12 ' A' ' 216' ' ' VAL . 31.4 mm -61.76 -42.04 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.063 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 85.5 tttt -56.31 -50.23 72.02 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.708 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 m -56.09 -37.78 69.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 20.8 t -76.65 -44.28 33.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.555 ' HB2' HD11 ' A' ' 235' ' ' ILE . 7.4 m-85 -67.94 -31.34 71.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.591 0.71 . . . . 0.0 110.522 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -60.62 -24.46 65.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.94 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.29 -15.45 62.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.922 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.49 -33.76 6.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.348 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -152.03 163.7 30.21 Favored Glycine 0 CA--C 1.517 0.159 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.704 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.93 110.62 6.55 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.147 0.498 . . . . 0.0 111.581 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 229' ' ' PHE . 23.3 mt -88.33 150.44 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.017 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -106.16 -31.9 8.47 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.191 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 20.4 p -166.45 156.46 11.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.012 0.434 . . . . 0.0 111.423 -172.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 9.2 p -141.15 124.52 16.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.831 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.0 t -141.49 115.07 8.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.255 0.55 . . . . 0.0 110.973 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.463 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 28.9 mt -91.99 137.13 32.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.43 98.47 0.85 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.978 0.418 . . . . 0.0 110.08 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.627 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 25.5 ttt180 -104.68 131.69 51.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.523 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.544 ' HB2' ' HD2' ' A' ' 250' ' ' LYS . 4.7 t70 -97.28 126.52 41.58 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.317 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 10.5 Cg_exo -69.54 -20.45 35.85 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.457 2.772 . . . . 0.0 113.799 -173.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 43.3 p -87.24 -30.31 21.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.883 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.419 HG21 ' HG2' ' A' ' 248' ' ' LYS . 8.8 t -97.04 -22.84 16.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.295 0.569 . . . . 0.0 110.301 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 77.12 25.67 63.57 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.423 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.502 ' C ' ' HG3' ' A' ' 242' ' ' ARG . 64.2 pttt -142.72 154.65 44.48 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.6 OUTLIER -76.3 131.42 39.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . 0.544 ' HD2' ' HB2' ' A' ' 243' ' ' ASP . 50.0 mtpt -74.55 3.41 7.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -164.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 102.5 2.67 50.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.368 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.473 ' HB2' ' HE1' ' A' ' 212' ' ' TYR . 32.9 p90 -141.88 165.21 28.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -169.25 178.46 42.41 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.021 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.649 ' CE1' ' HG3' ' A' ' 164' ' ' GLU . 88.2 m-85 -129.78 148.85 51.7 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.018 0.437 . . . . 0.0 110.594 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 225' ' ' ILE . 95.2 mt -136.08 133.21 50.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.255 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 49.0 mt-10 -113.21 135.14 54.15 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.492 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 6.2 m-85 -95.4 179.61 5.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -82.3 -17.97 43.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.467 0.651 . . . . 0.0 109.378 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -129.32 130.14 45.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.535 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.448 ' HA ' ' HB3' ' A' ' 209' ' ' ASN . . . -68.87 -25.01 64.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.164 0.507 . . . . 0.0 111.232 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -75.09 -42.06 57.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.244 176.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.492 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 19.9 m -67.76 -29.44 68.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.733 -175.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.42 ' HB2' HG22 ' A' ' 211' ' ' ILE . 48.3 p -69.05 -32.58 72.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.195 0.521 . . . . 0.0 109.687 177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -74.67 -25.89 59.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.469 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.492 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 61.1 m-20 -64.02 -41.12 97.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.262 0.553 . . . . 0.0 109.836 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -61.96 -41.27 97.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.409 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.2 -40.13 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.187 0.517 . . . . 0.0 110.71 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 48.0 t -69.31 -30.9 69.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.5 m -94.53 -43.87 8.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 78.5 mmm -84.48 1.73 44.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.914 -169.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.49 ' HA ' HG13 ' A' ' 282' ' ' VAL . 45.7 t30 -69.45 117.07 10.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.603 0.24 . . . . 0.0 110.423 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 91.6 mt 63.68 36.78 10.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.38 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -90.25 124.55 34.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.254 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.468 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 18.2 t70 -74.81 108.96 7.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.65 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.555 ' HG ' HD22 ' A' ' 220' ' ' LEU . 46.3 tp -141.31 106.77 5.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.969 0.414 . . . . 0.0 109.997 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 94.08 24.64 19.11 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.552 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 78.52 11.85 84.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.654 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -142.68 150.47 40.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.682 0.277 . . . . 0.0 110.432 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.468 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 83.0 m-85 -87.16 114.18 23.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.392 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.4 131.68 51.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.636 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -96.39 116.44 29.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.49 HG13 ' HA ' ' A' ' 271' ' ' ASN . 9.4 p -120.66 144.68 28.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.617 -175.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.15 174.22 38.56 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.615 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -75.76 126.28 30.7 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.77 126.22 27.79 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.433 0.458 . . . . 0.0 109.862 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.478 HG13 ' HG3' ' A' ' 167' ' ' GLN . 34.4 m -94.29 -26.75 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -172.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.44 HG22 ' CD2' ' A' ' 108' ' ' LEU . 19.0 p -132.51 156.23 80.33 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.018 0.437 . . . . 0.0 111.687 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.68 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 86.6 Cg_endo . . . . . 0 N--CA 1.45 -1.04 0 C-N-CA 122.898 2.399 . . . . 0.0 112.572 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 . . . . . 0 C--O 1.227 -0.129 0 CA-C-O 120.97 0.414 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -61.86 -32.77 73.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.043 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -45.75 87.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.219 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.498 HD23 ' SD ' ' A' ' 111' ' ' MET . 87.0 mt -63.9 -31.84 73.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.807 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.76 67.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.835 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.6 mt -84.94 -33.61 8.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.21 0.528 . . . . 0.0 109.719 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.546 ' HE2' HG23 ' A' ' 198' ' ' ILE . 89.4 mtp -72.98 -21.68 60.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.016 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.963 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 31.6 p -82.59 3.55 28.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.095 0.474 . . . . 0.0 110.7 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.53 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 15.0 mtm180 -113.84 141.7 47.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.462 HG13 ' HB ' ' A' ' 158' ' ' VAL . 4.2 p -124.98 122.67 63.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.551 0.691 . . . . 0.0 109.684 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -77.66 128.88 34.81 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 14.0 m -123.79 116.29 47.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.506 0.669 . . . . 0.0 110.241 175.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -125.11 174.84 17.33 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.582 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.5 m 61.77 34.35 17.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.961 0.41 . . . . 0.0 110.817 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.9 mt -78.17 119.27 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.047 0.451 . . . . 0.0 110.889 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -53.25 144.86 15.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.442 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -70.8 80.61 0.62 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.771 0.796 . . . . 0.0 111.114 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -169.24 -29.69 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.552 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.0 mt -97.6 105.45 17.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.787 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.88 173.36 54.67 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.219 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.8 -35.42 74.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.257 0.551 . . . . 0.0 109.638 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.3 -51.38 67.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.878 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -61.99 -39.92 93.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.161 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.859 HG13 ' HE2' ' A' ' 143' ' ' MET . 22.2 mm -64.46 -39.73 86.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -56.6 -41.43 76.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.079 0.466 . . . . 0.0 110.116 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -72.24 -33.78 67.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.731 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.466 ' HB3' ' SD ' ' A' ' 177' ' ' MET . . . -85.6 -29.4 24.13 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.456 ' CD1' HG22 ' A' ' 128' ' ' ILE . 28.0 m-85 -94.98 -20.74 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.491 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -51.53 -41.9 79.65 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 29.2 Cg_exo -38.08 -41.98 1.4 Allowed 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 123.235 2.623 . . . . 0.0 114.625 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.485 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 67.0 m-85 -76.13 -44.59 37.7 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 121.299 -0.161 . . . . 0.0 111.156 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -170.22 166.83 40.02 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.571 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.408 ' HG2' ' CE1' ' A' ' 252' ' ' TYR . 35.1 Cg_exo -62.16 117.98 4.85 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.846 2.364 . . . . 0.0 111.773 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.819 HD13 HD11 ' A' ' 141' ' ' ILE . 57.2 mt -77.84 130.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.565 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -99.83 -27.36 13.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.44 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.2 t -165.16 131.46 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.043 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.819 HD11 HD13 ' A' ' 138' ' ' ILE . 59.9 mt -130.54 128.81 63.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -120.98 106.77 11.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.965 0.412 . . . . 0.0 110.173 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.859 ' HE2' HG13 ' A' ' 128' ' ' ILE . 46.3 ttm -114.69 138.27 50.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.634 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.285 177.202 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 46.9 p90 . . . . . 0 C--O 1.235 0.317 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.443 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -155.63 148.09 23.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.702 176.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 81.0 m-85 -110.6 113.02 25.31 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.181 175.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.462 ' HB ' HG13 ' A' ' 114' ' ' VAL . 58.9 t -102.74 105.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.53 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 46.6 tt0 -108.44 126.8 53.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.58 177.56 5.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -76.86 -35.15 57.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.059 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.72 142.2 31.29 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.794 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.963 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 37.8 Cg_endo -66.52 -18.28 54.17 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.3 2.667 . . . . 0.0 112.584 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.534 ' HG3' ' HE2' ' A' ' 254' ' ' PHE . 17.0 mm-40 -56.56 -57.36 12.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.827 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.427 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.55 -21.92 65.94 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.26 -49.13 15.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.237 0.541 . . . . 0.0 109.672 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.64 ' HB2' HG12 ' A' ' 286' ' ' VAL . 31.8 mm-40 -67.29 -38.79 85.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.505 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.485 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 11.9 tp -60.61 -46.56 89.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.98 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.48 74.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 110.291 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.603 HD12 ' HA3' ' A' ' 186' ' ' GLY . 7.0 tp -70.11 -41.99 73.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.856 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 8.1 mm-40 -59.21 -39.03 81.4 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.311 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -101.02 -50.67 3.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 28.4 ttp -102.86 31.37 4.21 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -162.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.43 13.98 1.76 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.1 m -105.28 -73.52 0.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.573 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.6 m -144.79 144.14 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.199 0.524 . . . . 0.0 111.42 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.66 ' HE2' ' HA ' ' A' ' 177' ' ' MET . 3.1 tpt -113.4 108.22 16.92 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.567 HD21 ' HE3' ' A' ' 177' ' ' MET . 4.3 mm? 72.1 -55.38 0.67 Allowed 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.878 0.736 . . . . 0.0 110.658 -173.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 145.26 -167.11 27.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.393 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 92.3 -51.58 2.76 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.174 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -143.75 139.56 29.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.574 0.187 . . . . 0.0 110.858 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -64.87 112.24 3.18 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.862 172.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.468 HD12 ' HB2' ' A' ' 177' ' ' MET . 47.6 pt -88.49 152.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.503 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 71.5 mmtt -103.66 105.19 15.35 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.439 HG22 HG13 ' A' ' 116' ' ' VAL . 43.1 t -111.23 135.93 48.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.227 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.603 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.597 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.717 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.434 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -76.82 -23.48 52.79 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.012 -0.43 . . . . 0.0 112.079 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.55 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 29.3 mm-40 -63.98 -49.61 73.91 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -172.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 8.9 Cg_endo -52.86 -38.43 78.55 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.665 2.243 . . . . 0.0 113.098 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.6 mt -71.83 -45.25 66.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.773 0.32 . . . . 0.0 110.485 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.546 HG23 ' HE2' ' A' ' 111' ' ' MET . 56.2 mt -60.78 -48.34 89.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.14 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.75 -42.3 95.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.344 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 6.4 tp-100 -60.44 -51.94 67.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.735 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.638 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 64.5 mt -67.5 -33.51 75.24 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.576 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.604 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -55.92 -42.96 76.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.304 0.573 . . . . 0.0 109.664 175.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -73.94 -32.71 63.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.943 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.638 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 29.5 mt-10 -69.69 -30.47 68.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.697 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.54 -29.04 65.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.993 0.425 . . . . 0.0 110.069 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 71.6 mtp180 -71.16 -21.76 62.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.361 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -81.41 6.16 15.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.47 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -132.58 -175.62 3.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.92 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -126.08 46.28 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.904 -174.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -105.58 137.66 43.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.15 -176.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 263' ' ' SER . 49.2 pt -129.15 166.82 25.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.01 0.433 . . . . 0.0 110.735 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.608 ' HD1' ' CE2' ' A' ' 254' ' ' PHE . 85.2 t80 -122.47 129.72 52.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.421 -174.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.542 HG12 HG21 ' A' ' 282' ' ' VAL . 35.1 m -126.63 135.84 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.046 0.45 . . . . 0.0 110.307 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -132.95 -179.49 5.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.861 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.7 t 63.43 27.56 15.23 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.894 0.854 . . . . 0.0 109.056 -172.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.93 121.31 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.256 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 40.8 t-80 -55.21 133.88 49.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.173 0.511 . . . . 0.0 111.283 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -57.79 -28.63 64.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.291 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.72 3.71 50.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.724 0.297 . . . . 0.0 111.304 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 217' ' ' HIS . 14.1 tp -87.06 134.32 33.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 63.2 p -86.41 156.35 20.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.054 -171.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.94 -42.45 68.85 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.577 0.703 . . . . 0.0 109.474 172.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.46 -40.38 74.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.833 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -71.7 -38.58 70.54 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.1 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 255' ' ' ILE . 27.0 mm -65.77 -46.24 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 86.8 tttt -57.7 -42.4 83.65 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.439 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.6 t -55.52 -47.75 75.77 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.641 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.33 -40.91 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 111.444 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.475 ' HD1' ' O ' ' A' ' 225' ' ' ILE . 26.4 m-85 -66.74 -29.07 68.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.884 0.373 . . . . 0.0 110.992 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.4 mm-40 -63.9 -24.66 67.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.419 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.85 -20.14 60.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.27 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.64 -37.2 6.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.917 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.428 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -147.18 168.92 28.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.801 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.485 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 35.2 mmtt -88.01 116.03 25.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.761 0.791 . . . . 0.0 111.231 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.452 HD12 ' CB ' ' A' ' 229' ' ' PHE . 52.6 mt -86.8 150.95 3.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.641 -173.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -110.8 -22.38 11.59 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.759 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.428 ' H ' HG23 ' A' ' 235' ' ' ILE . 43.1 t -172.56 143.28 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.707 0.289 . . . . 0.0 110.379 -175.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.0 t -140.49 105.13 4.9 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.8 m -129.21 110.13 11.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.256 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.535 HD21 HG13 ' A' ' 225' ' ' ILE . 60.9 mt -78.71 131.55 36.65 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.498 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -70.53 122.52 19.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.09 0.471 . . . . 0.0 109.834 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.729 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 76.4 mtt180 -111.05 166.49 11.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.29 -171.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.06 135.24 33.58 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.38 -46.25 11.94 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.861 3.041 . . . . 0.0 114.707 -166.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.3 t -159.73 65.42 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.844 0.831 . . . . 0.0 111.607 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 21.8 p -133.15 6.56 3.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.919 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.01 71.74 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.945 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 248' ' ' LYS . 41.3 mtmt -147.33 159.37 43.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.729 ' HB3' ' HG2' ' A' ' 242' ' ' ARG . 19.8 p80 -107.32 147.36 30.39 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.506 170.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -63.44 -7.5 6.87 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -164.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 108.61 5.43 31.67 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.443 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.408 ' CE1' ' HG2' ' A' ' 137' ' ' PRO . 12.8 p90 -141.43 174.09 10.88 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -164.49 172.34 40.23 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.767 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.608 ' CE2' ' HD1' ' A' ' 212' ' ' TYR . 92.4 m-85 -127.31 143.51 51.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.011 0.434 . . . . 0.0 110.687 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.56 HD13 HG21 ' A' ' 225' ' ' ILE . 83.5 mt -136.61 136.89 48.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.094 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -116.72 146.73 42.59 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 8.6 m-85 -111.28 175.27 5.49 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -83.79 -13.45 53.79 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.222 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -135.48 133.46 38.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.979 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.4 -24.93 67.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.017 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -73.43 -35.4 65.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.873 175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.443 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 8.2 t -70.69 -37.64 73.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.678 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.518 ' HB2' HG22 ' A' ' 211' ' ' ILE . 62.3 p -66.41 -32.79 74.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.068 0.461 . . . . 0.0 110.115 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.49 -27.02 62.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.83 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 53.5 m-20 -62.92 -45.3 93.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.208 0.528 . . . . 0.0 109.626 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -62.33 -43.53 98.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.018 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 263' ' ' SER . 86.5 t -55.38 -37.16 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.297 0.57 . . . . 0.0 111.206 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.6 m -75.83 -24.19 55.81 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.246 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 18.3 m -95.08 -41.83 8.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 78.5 mmm -88.07 1.95 53.06 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -167.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.483 ' HA ' HG12 ' A' ' 282' ' ' VAL . 66.7 t30 -72.36 115.42 11.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.213 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.2 mt 65.18 38.35 6.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.346 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -94.39 123.56 37.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.105 174.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.519 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 32.2 t70 -71.94 108.4 5.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -177.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 25.5 tp -141.8 111.19 6.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 90.94 16.34 54.57 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.051 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 97.35 -6.31 63.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.593 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.7 152.08 51.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 74.7 m-85 -81.06 113.13 19.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.215 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.94 134.63 57.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.388 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -100.49 115.7 30.71 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 213' ' ' VAL . 10.0 p -115.53 151.01 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.506 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.14 175.17 42.36 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.962 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -76.88 126.85 31.66 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.67 129.24 39.07 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.64 HG12 ' HB2' ' A' ' 167' ' ' GLN . 29.1 m -89.26 -11.43 10.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.783 0.325 . . . . 0.0 111.578 -170.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.509 HG22 HG21 ' A' ' 286' ' ' VAL . 68.3 p -120.87 133.39 24.1 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.27 0.557 . . . . 0.0 111.094 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 C--O 1.232 0.206 0 C-N-CA 123.099 2.533 . . . . 0.0 111.995 176.805 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -57.57 -47.85 80.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.75 92.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.118 0.485 . . . . 0.0 111.04 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 201' ' ' LEU . 60.0 mt -71.95 -35.57 69.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.43 -37.11 77.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.412 . . . . 0.0 110.505 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.3 mt -67.02 -42.8 89.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.308 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 1.8 ttm -68.53 -14.65 63.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.831 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.3 m -77.13 -15.78 59.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.454 177.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.497 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 18.4 mtp180 -101.09 141.7 33.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.622 HG12 ' HB ' ' A' ' 158' ' ' VAL . 1.0 OUTLIER -123.33 127.76 74.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 78.6 t80 -82.93 115.37 21.76 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 8.6 m -115.87 116.46 52.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.59 0.71 . . . . 0.0 110.787 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 155' ' ' PHE . . . -119.95 -175.0 15.6 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.898 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.841 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 20.9 m 67.12 21.46 10.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.928 0.491 . . . . 0.0 111.279 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.6 mt -84.88 102.81 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.388 . . . . 0.0 110.619 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 122' ' ' GLU . 79.3 t80 -53.75 144.25 18.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.633 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -72.3 76.62 1.0 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.172 0.987 . . . . 0.0 111.196 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 120' ' ' TYR . 31.0 tt0 -148.35 -47.47 0.16 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.756 174.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.3 mt -66.95 128.28 35.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.501 176.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.48 174.98 35.52 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.007 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.31 -36.51 71.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.339 0.59 . . . . 0.0 109.874 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -68.8 -43.44 75.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.132 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 m -59.59 -46.2 89.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.125 0.488 . . . . 0.0 110.454 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.723 HG13 ' HE1' ' A' ' 143' ' ' MET . 41.8 mm -62.22 -47.65 92.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.617 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 133' ' ' ALA . 74.3 ttt180 -60.26 -41.1 92.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.863 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -63.14 -34.4 77.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.492 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.79 -34.48 22.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.445 ' HD1' ' O ' ' A' ' 128' ' ' ILE . 69.8 m-85 -91.47 -18.41 24.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.453 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -55.41 -42.02 93.81 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 42.5 Cg_exo -40.39 -43.03 3.96 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 123.017 2.478 . . . . 0.0 113.925 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.669 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 50.1 m-85 -74.91 -51.78 12.94 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.645 0.26 . . . . 0.0 111.142 -175.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.37 170.54 36.41 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.023 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.3 118.71 5.74 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.87 2.38 . . . . 0.0 110.896 175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.437 HG22 ' CG1' ' A' ' 141' ' ' ILE . 53.3 mt -82.78 120.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.374 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -88.88 -33.6 17.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.341 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.3 t -153.58 136.79 15.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.968 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.437 ' CG1' HG22 ' A' ' 138' ' ' ILE . 71.7 mt -120.49 107.46 20.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 169.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.733 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -84.75 98.66 10.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.355 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.723 ' HE1' HG13 ' A' ' 128' ' ' ILE . 57.0 ttm -149.45 134.34 17.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.784 0.325 . . . . 0.0 110.377 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.633 177.912 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.414 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 47.9 p90 . . . . . 0 C--O 1.237 0.401 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -146.2 156.15 43.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.733 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 93.8 m-85 -113.75 109.55 18.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.775 175.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.622 ' HB ' HG12 ' A' ' 114' ' ' VAL . 59.8 t -97.31 106.34 18.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.497 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 72.8 tt0 -108.46 122.84 47.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.539 -177.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -96.37 178.89 5.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -82.43 -17.87 43.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.555 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 m -133.38 143.66 49.05 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.673 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 57.9 Cg_endo -71.95 -22.85 22.65 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.199 2.599 . . . . 0.0 112.785 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.59 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 16.3 mp0 -55.16 -58.72 6.52 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.684 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.67 -22.47 23.27 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.75 -48.13 12.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.968 0.413 . . . . 0.0 110.316 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -73.34 -26.66 61.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.302 0.572 . . . . 0.0 109.699 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.669 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 16.3 tp -70.47 -47.27 61.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.233 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.0 -34.72 78.15 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 18.6 tp -65.24 -46.08 82.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.714 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.37 -47.71 72.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.673 -174.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -90.45 -43.84 10.01 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.411 ' C ' ' H ' ' A' ' 175' ' ' SER . 12.4 mtm -94.46 30.3 2.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -170.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 170' ' ' LEU . 3.5 t-20 -75.98 12.97 0.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.168 0.508 . . . . 0.0 110.806 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 22.2 m -113.72 -73.38 0.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.523 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.9 m -142.28 162.04 19.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 111.373 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.646 ' HB2' HD13 ' A' ' 183' ' ' ILE . 17.2 tpp -128.53 84.39 2.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.494 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.452 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 89.0 mt 70.16 -56.25 0.59 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.305 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -73.59 168.87 53.79 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.461 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.63 53.75 4.07 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.722 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 118' ' ' SER . 43.3 ttm180 -143.77 137.64 28.21 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 175' ' ' SER . 0.9 OUTLIER -72.09 112.07 7.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.192 0.52 . . . . 0.0 110.382 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.841 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 45.3 pt -81.38 158.41 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.139 -176.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.717 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 24.8 ttmm -103.4 116.4 32.34 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.051 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.3 t -122.7 148.84 26.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.602 ' H ' HG23 ' A' ' 114' ' ' VAL . . . . . . . . 0 N--CA 1.446 -0.68 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.005 175.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 N--CA 1.46 0.064 0 CA-C-O 120.857 0.36 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -84.84 -19.6 32.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.489 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 25.3 tp60 -57.36 -47.47 98.96 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -176.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 73.1 Cg_exo -52.5 -38.88 75.46 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.08 1.853 . . . . 0.0 112.678 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.0 mt -75.67 -43.9 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.438 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 194' ' ' ALA . 79.9 mt -58.23 -46.88 88.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.784 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.04 -39.74 93.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.705 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -59.54 -52.81 63.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.98 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.531 HD11 HD21 ' A' ' 108' ' ' LEU . 42.0 mt -68.14 -32.91 73.51 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.191 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.591 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.59 -48.24 72.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -65.53 -33.7 76.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.855 175.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 30.7 mt-10 -66.11 -33.71 76.39 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.17 0.51 . . . . 0.0 111.155 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -72.75 -24.85 61.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.656 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 68.6 mtp180 -79.87 -28.12 39.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.372 174.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.8 -38.41 76.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.151 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -88.72 173.6 8.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.481 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 14.1 m120 -116.58 34.71 4.91 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.797 -174.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -98.73 138.13 36.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.373 0.606 . . . . 0.0 111.507 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.452 ' HA ' ' H ' ' A' ' 285' ' ' ALA . 47.7 pt -124.0 167.11 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.954 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.448 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 83.5 t80 -117.06 128.04 54.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.53 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.441 HG13 HG21 ' A' ' 282' ' ' VAL . 34.6 m -117.7 132.56 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.251 0.548 . . . . 0.0 110.112 177.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' A' ' 281' ' ' ARG . . . -126.95 169.68 13.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.894 -174.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.3 t 62.37 32.29 16.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.87 0.843 . . . . 0.0 109.312 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.45 108.28 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.091 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -54.98 133.38 48.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.911 0.386 . . . . 0.0 110.725 -174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -55.8 -24.22 34.76 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.24 -21.1 29.23 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.23 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.62 124.39 22.23 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.3 t -81.38 164.12 22.35 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.199 0.523 . . . . 0.0 111.329 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -53.47 -38.88 64.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.126 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.55 -35.56 77.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.661 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.33 -44.59 94.47 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.671 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.733 HG23 HD13 ' A' ' 255' ' ' ILE . 38.0 mm -67.04 -41.17 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.021 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.643 ' HD2' ' SG ' ' A' ' 238' ' ' CYS . 87.4 tttt -59.8 -45.07 93.48 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.633 174.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.1 m -54.96 -44.96 74.85 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.407 HG11 ' HE3' ' A' ' 270' ' ' MET . 21.0 t -76.32 -38.22 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.719 0.295 . . . . 0.0 111.485 -176.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.563 ' HB3' ' OH ' ' A' ' 257' ' ' TYR . 15.7 m-85 -72.51 -33.43 66.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 110.996 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -61.17 -24.61 66.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.027 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.56 -12.78 61.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.245 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -111.43 -45.51 3.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.896 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -134.02 177.12 19.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.044 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 234' ' ' LYS . 39.4 tptt -91.74 106.44 18.48 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.11 0.481 . . . . 0.0 110.424 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 229' ' ' PHE . 22.5 mt -75.94 142.71 14.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.843 0.83 . . . . 0.0 112.325 -175.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.453 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 54.4 tttt -101.69 -37.3 8.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.42 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 20.4 m -156.04 142.0 18.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.318 -172.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.643 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 26.6 p -130.05 121.58 26.72 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 168.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 29.0 m -142.05 102.31 4.1 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.943 0.401 . . . . 0.0 110.536 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.475 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 70.3 mt -76.4 131.0 38.85 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.443 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.21 115.32 5.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 14.7 ptt-85 -139.78 168.83 18.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -171.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.683 ' HB2' ' HG1' ' A' ' 246' ' ' THR . 16.6 m-20 -112.71 123.64 33.46 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.972 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 11.9 Cg_endo -58.51 -22.92 61.89 Favored 'Trans proline' 0 CA--C 1.526 0.117 0 C-N-CA 123.077 2.518 . . . . 0.0 111.999 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 p -91.32 -4.81 55.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.662 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.683 ' HG1' ' HB2' ' A' ' 243' ' ' ASP . 47.8 p -114.22 -34.48 5.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.493 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.7 6.33 80.25 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.267 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -138.31 160.0 40.6 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 6.5 p80 -87.19 151.22 23.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.563 . . . . 0.0 110.448 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.01 -25.34 68.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.384 -170.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 135.99 -12.12 4.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.874 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.416 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 44.3 p90 -130.87 174.52 9.89 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -165.86 175.53 41.45 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.329 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.59 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 96.6 m-85 -129.52 142.37 50.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.971 0.415 . . . . 0.0 110.448 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.733 HD13 HG23 ' A' ' 225' ' ' ILE . 90.4 mt -136.07 142.66 38.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.132 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 41.7 mt-10 -120.76 148.76 43.54 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.636 ' HB2' ' OG ' ' A' ' 263' ' ' SER . 25.5 m-85 -118.97 153.5 34.55 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 123.396 0.435 . . . . 0.0 109.888 175.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 25.0 mt-10 -75.95 -9.05 58.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.49 0.662 . . . . 0.0 110.036 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -130.66 122.56 27.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.392 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -59.36 -32.24 69.94 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.872 -171.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -67.86 -39.17 83.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.027 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.7 m -67.54 -33.34 74.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.747 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.636 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 3.3 m -58.38 -50.66 72.88 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.573 0.701 . . . . 0.0 109.701 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . 0.401 ' HG2' ' HD3' ' A' ' 284' ' ' LYS . 24.6 mt-30 -76.75 -14.66 59.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.146 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.84 -45.96 63.57 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.74 78.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.875 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.497 HG11 ' HA2' ' A' ' 283' ' ' GLY . 88.6 t -56.12 -31.62 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.195 0.521 . . . . 0.0 111.073 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.5 t -87.37 -39.18 15.53 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.079 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.6 m -80.99 -41.49 22.66 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.541 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 77.4 mmm -83.16 -0.23 48.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 111.059 -172.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.519 ' HA ' HG12 ' A' ' 282' ' ' VAL . 26.7 t-20 -71.37 111.18 6.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.308 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.9 mt 70.36 34.66 2.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.37 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -88.23 129.76 35.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.761 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.32 113.43 13.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.387 0.613 . . . . 0.0 111.242 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 33.9 tp -142.05 121.24 13.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.09 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 68.72 28.76 72.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.198 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 86.34 -13.5 57.53 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.97 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -114.81 150.75 34.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.634 -0.333 . . . . 0.0 110.257 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -89.28 116.68 27.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.802 0.334 . . . . 0.0 110.139 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.39 126.09 26.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.109 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.463 ' HB2' ' HB1' ' A' ' 214' ' ' ALA . 5.5 mmt180 -99.69 114.75 28.05 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 271' ' ' ASN . 8.4 p -121.62 150.85 24.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.528 -170.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.497 ' HA2' HG11 ' A' ' 267' ' ' VAL . . . -169.88 174.59 44.08 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.522 ' HB3' ' HZ3' ' A' ' 284' ' ' LYS . 4.2 mmmp? -73.21 125.69 28.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.153 0.477 . . . . 0.0 110.287 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.452 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -58.4 130.95 49.15 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.9 m -85.08 -17.56 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.926 0.393 . . . . 0.0 110.769 -173.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 66.4 p -109.73 142.88 26.72 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.101 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.531 0.348 0 C-N-CA 122.682 2.255 . . . . 0.0 111.343 172.625 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.678 ' HG3' HD13 ' A' ' 108' ' ' LEU . 35.2 tt0 . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 121.171 0.51 . . . . 0.0 111.677 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -65.97 -34.18 77.52 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.93 -24.78 58.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.678 HD13 ' HG3' ' A' ' 105' ' ' GLN . 39.4 mt -67.64 -33.9 75.88 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.957 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.29 -24.06 40.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.095 0.474 . . . . 0.0 111.006 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.3 -52.49 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.731 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.405 ' HE2' HG21 ' A' ' 198' ' ' ILE . 0.7 OUTLIER -66.9 -22.47 65.96 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -175.151 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 72.3 m -74.06 -10.5 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.206 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.531 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 78.0 mtt180 -102.71 139.96 37.61 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.174 175.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.28 119.89 60.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 170.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 84.8 t80 -80.65 129.54 34.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.758 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.51 HG12 HG11 ' A' ' 185' ' ' VAL . 9.6 m -108.65 115.97 50.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.316 0.579 . . . . 0.0 110.198 175.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.11 135.31 12.07 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.819 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.9 t 60.35 79.28 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.327 0.651 . . . . 0.0 111.442 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.478 HD11 ' CG2' ' A' ' 116' ' ' VAL . 59.5 mt -93.82 127.12 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.434 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.479 ' HB2' ' HB2' ' A' ' 181' ' ' ARG . 29.0 t80 -60.16 127.71 33.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -65.37 77.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.149 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -169.66 -37.93 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.061 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.2 mt -74.73 114.36 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.089 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.68 165.32 54.75 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.481 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -60.98 -40.65 94.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -60.6 -38.72 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.99 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.0 m -66.24 -42.92 87.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.563 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.658 HG13 ' HE3' ' A' ' 143' ' ' MET . 37.5 mm -65.86 -40.91 88.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.496 0.665 . . . . 0.0 109.9 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 133' ' ' ALA . 52.6 ttt180 -55.88 -44.17 77.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.829 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -72.21 -33.59 67.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.948 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.14 -37.35 46.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -91.16 -15.48 29.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 129' ' ' ARG . . . -53.24 -45.63 98.26 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -40.83 -40.79 3.72 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 123.247 2.631 . . . . 0.0 114.986 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.641 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 68.4 m-85 -72.66 -46.74 52.37 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -170.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.2 -164.93 20.53 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.561 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 161' ' ' GLU . 87.0 Cg_endo -79.83 107.73 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.071 2.514 . . . . 0.0 111.854 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.573 HD11 HD12 ' A' ' 141' ' ' ILE . 56.9 mt -66.71 113.74 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.316 0.579 . . . . 0.0 110.577 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -93.31 -40.58 10.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.047 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.2 t -155.54 128.62 8.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.466 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 138' ' ' ILE . 67.0 mt -111.06 108.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 171.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -100.43 98.65 9.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.805 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.658 ' HE3' HG13 ' A' ' 128' ' ' ILE . 52.7 ttm -131.34 127.51 37.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.948 0.404 . . . . 0.0 110.446 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.892 178.927 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 39.6 p90 . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.61 0.243 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.42 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -161.41 153.7 19.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.489 176.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -123.66 123.03 39.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.236 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.6 t -104.65 105.97 19.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.531 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 35.5 tt0 -97.21 131.71 43.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.001 -176.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -109.52 162.35 14.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.489 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 137' ' ' PRO . 44.4 mt-10 -79.13 -9.15 59.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 0.0 110.668 174.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.69 133.58 19.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.878 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 43.1 Cg_endo -66.79 -20.41 52.21 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.135 2.556 . . . . 0.0 112.358 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.645 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 17.6 mp0 -55.74 -52.86 62.47 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.956 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.55 -20.61 65.77 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.18 -48.58 12.92 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.615 ' HG3' HG12 ' A' ' 286' ' ' VAL . 15.6 mm100 -66.77 -34.11 77.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.044 174.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.641 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 13.0 tp -68.87 -46.61 68.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.672 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 135' ' ' PHE . . . -60.46 -31.21 70.23 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.595 HD12 ' HA3' ' A' ' 186' ' ' GLY . 5.3 tt -67.43 -55.9 11.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.014 172.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 167' ' ' GLN . 23.1 mt-10 -53.94 -30.14 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.058 -175.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -98.07 -51.22 4.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.9 mtm -106.62 29.33 7.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -167.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.547 ' HA ' HG22 ' A' ' 185' ' ' VAL . 65.1 t30 -86.09 26.08 1.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.632 0.729 . . . . 0.0 110.308 177.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.2 t -114.23 -70.29 0.81 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.97 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 m -140.1 155.46 24.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.617 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.817 ' HE1' ' HG ' ' A' ' 178' ' ' LEU . 0.9 OUTLIER -126.81 100.99 6.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.414 175.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.817 ' HG ' ' HE1' ' A' ' 177' ' ' MET . 94.9 mt 66.2 26.91 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.679 172.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 123.84 -112.26 1.81 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.954 -1.117 . . . . 0.0 114.594 171.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.81 38.51 3.04 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 114.451 0.541 . . . . 0.0 114.451 -165.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.479 ' HB2' ' HB2' ' A' ' 120' ' ' TYR . 8.5 tpp180 -145.53 120.09 9.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 117.209 0.505 . . . . 0.0 111.09 173.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -87.49 83.18 7.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.432 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.6 pt -70.22 147.69 11.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.086 0.47 . . . . 0.0 110.938 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -103.55 107.02 17.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.36 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.5 m -99.69 137.41 27.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.359 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.595 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.679 0 C-N-CA 120.655 -0.784 . . . . 0.0 111.447 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.006 0.431 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.69 -19.17 26.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.433 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.493 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 84.0 mm-40 -56.94 -48.87 96.68 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 54.5 Cg_exo -53.93 -39.29 85.36 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.152 1.902 . . . . 0.0 112.539 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.46 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 41.7 mm -67.61 -46.89 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 110.084 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.405 HG21 ' HE2' ' A' ' 111' ' ' MET . 87.1 mt -57.9 -48.45 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.531 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 29.7 t70 -67.53 -40.99 85.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.164 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -62.7 -44.99 94.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.115 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 76.0 mt -67.58 -32.84 73.87 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.55 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.472 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -58.21 -38.31 76.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.188 0.518 . . . . 0.0 109.72 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 40.1 mt-10 -73.73 -31.53 63.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.945 175.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 57.7 mt-10 -67.26 -24.16 65.77 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.184 0.516 . . . . 0.0 110.984 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.85 -33.39 62.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.137 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 18.0 mtm180 -73.35 -13.78 61.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.786 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.32 -22.2 60.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.329 0.585 . . . . 0.0 110.171 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.99 166.99 18.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.305 -0.862 . . . . 0.0 108.997 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 65.2 m-20 -95.26 48.67 1.17 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.615 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 7.8 ptp180 -91.44 149.5 21.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.398 0.618 . . . . 0.0 111.206 -173.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 263' ' ' SER . 44.1 pt -134.55 166.91 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.254 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -113.14 122.19 46.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.606 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.426 HG13 HG22 ' A' ' 282' ' ' VAL . 34.3 m -117.59 131.92 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.004 0.431 . . . . 0.0 110.227 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . . . -126.13 172.12 10.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.159 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.7 m 62.68 27.56 16.19 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.922 0.868 . . . . 0.0 109.863 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.61 112.27 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.83 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -58.58 138.86 56.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.253 -171.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -52.67 -30.95 34.64 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -88.6 -22.81 23.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.497 0.189 . . . . 0.0 111.489 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.29 120.72 12.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.548 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.6 m -82.04 166.6 19.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.274 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -53.91 -45.4 71.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.511 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.98 -32.38 73.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.652 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.443 ' O ' HG21 ' A' ' 228' ' ' VAL . 8.3 t70 -68.7 -45.81 70.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.637 HG22 HD12 ' A' ' 255' ' ' ILE . 39.8 mm -66.29 -36.78 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.58 -52.72 63.96 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.28 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 89.7 p -55.74 -34.4 65.15 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 224' ' ' ASP . 24.5 t -73.55 -47.66 44.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.314 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.719 ' HB2' HD12 ' A' ' 235' ' ' ILE . 16.2 m-85 -68.39 -31.64 71.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.411 0.624 . . . . 0.0 110.526 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 29.5 tp10 -60.08 -24.35 64.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.367 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.91 -8.33 58.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.644 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -112.79 -45.21 3.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.562 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.496 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -140.82 171.71 23.96 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 64.8 mmtt -90.03 111.7 22.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.894 0.854 . . . . 0.0 111.697 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.719 HD12 ' HB2' ' A' ' 229' ' ' PHE . 52.9 mt -87.16 151.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.682 -174.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -103.52 -40.33 6.38 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.786 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 50.8 m -156.88 151.01 24.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.411 -170.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.1 t -143.76 104.66 4.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.764 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.5 m -121.09 103.13 8.79 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.353 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.574 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 69.0 mt -80.46 144.52 32.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.818 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -66.55 105.05 1.4 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 41.0 ttt180 -129.16 142.09 50.97 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.065 -170.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.463 ' O ' HG21 ' A' ' 246' ' ' THR . 30.1 m-20 -93.61 115.16 64.7 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.032 176.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.42 -37.13 98.35 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.529 2.82 . . . . 0.0 113.769 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 82.8 p -92.75 10.22 31.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 243' ' ' ASP . 11.6 t -123.06 -9.78 8.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.045 -0.41 . . . . 0.0 111.196 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.09 -49.77 4.29 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.426 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -77.32 172.97 12.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.174 0.511 . . . . 0.0 110.685 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 20.2 p80 -116.1 167.67 10.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.508 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -65.26 -80.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 O-C-N 123.485 0.49 . . . . 0.0 111.69 -173.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -175.99 17.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.232 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.442 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 31.3 p90 -157.03 176.71 12.39 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.0 178.06 45.17 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.041 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.645 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 89.4 m-85 -125.67 143.85 50.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.917 0.389 . . . . 0.0 110.19 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.637 HD12 HG22 ' A' ' 225' ' ' ILE . 87.0 mt -134.68 128.44 50.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.462 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 47.8 mt-10 -109.98 131.95 54.59 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.635 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 6.8 m-85 -97.07 176.97 5.75 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 123.155 0.285 . . . . 0.0 110.294 176.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.12 -22.85 35.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -121.15 121.94 38.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.361 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.67 -22.56 67.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.075 0.464 . . . . 0.0 110.939 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -72.0 -49.33 37.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.719 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.9 m -66.67 -32.43 73.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.012 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.635 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 59.8 p -66.56 -42.54 86.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 110.057 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -74.51 -21.62 59.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.522 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.98 -37.19 72.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -63.78 -39.98 95.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 172.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.11 -33.67 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 121.33 0.586 . . . . 0.0 110.628 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.5 m -73.71 -39.61 64.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.133 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.5 m -89.37 -39.17 13.61 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.557 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 85.9 mmm -81.66 -1.56 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -171.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.525 ' HA ' HG12 ' A' ' 282' ' ' VAL . 22.9 t-20 -71.5 117.51 13.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 97.7 mt 70.01 32.75 2.95 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.44 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -91.23 121.19 32.78 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.449 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 12.4 t70 -74.38 118.55 17.47 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.333 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.7 tp -131.94 91.83 3.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.901 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 92.4 26.81 16.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 92.7 2.36 67.32 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.632 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -131.8 140.81 49.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 72.4 m-85 -85.37 112.61 20.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.6 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 71.7 mt -58.03 121.27 10.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.495 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 8.2 mmm180 -93.53 114.75 27.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 174.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 271' ' ' ASN . 11.4 p -119.87 143.85 30.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.745 -173.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -158.56 -171.84 24.93 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.505 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.62 128.92 36.76 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.773 0.32 . . . . 0.0 110.344 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -66.52 128.17 35.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.615 HG12 ' HG3' ' A' ' 167' ' ' GLN . 29.4 m -97.32 -25.02 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -171.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 35.5 p -131.39 168.13 18.76 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 120.844 0.354 . . . . 0.0 111.569 -178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.458 -0.56 0 C-N-CA 123.191 2.594 . . . . 0.0 110.989 169.31 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.211 0.529 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -62.03 -33.81 75.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.7 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.55 80.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 0.0 110.884 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.495 HD21 HD12 ' A' ' 201' ' ' LEU . 61.7 mt -68.91 -31.28 70.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.598 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.68 -28.41 69.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.256 0.551 . . . . 0.0 110.384 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.84 -36.47 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.858 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.511 ' SD ' HG12 ' A' ' 198' ' ' ILE . 87.9 mtp -73.31 -21.81 60.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.2 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.833 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 30.4 p -79.72 -3.71 48.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -110.7 141.09 44.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.678 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' A' ' 158' ' ' VAL . 6.0 p -121.56 131.93 71.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.177 0.513 . . . . 0.0 110.051 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -79.11 121.03 24.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.07 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 25.7 m -118.18 129.26 74.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.5 0.667 . . . . 0.0 111.383 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.46 176.26 21.51 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.62 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.549 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 22.7 m 60.29 39.11 19.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.236 0.541 . . . . 0.0 110.576 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 57.5 mt -81.02 -15.74 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.373 -176.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 44.7 t80 71.21 153.62 0.13 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.204 -176.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -83.54 76.24 9.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.453 0.644 . . . . 0.0 111.052 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -163.43 -50.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.021 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.82 104.55 1.71 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.081 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.87 172.77 55.33 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.935 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.468 ' OE2' ' HB ' ' A' ' 141' ' ' ILE . 61.2 tt0 -64.17 -32.31 73.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.849 0.324 . . . . 0.0 110.67 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -54.85 -48.87 72.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.355 0.598 . . . . 0.0 109.958 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.2 m -70.69 -41.67 71.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.961 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.651 HG13 ' HE1' ' A' ' 143' ' ' MET . 32.0 mm -61.41 -46.34 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.479 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -63.71 -37.31 86.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.034 0.445 . . . . 0.0 110.196 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -65.63 -32.38 73.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.969 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.428 ' HB3' HD11 ' A' ' 178' ' ' LEU . . . -79.44 -35.82 39.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.515 ' HB2' HD13 ' A' ' 138' ' ' ILE . 71.3 m-85 -90.66 -13.86 33.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 0.0 111.531 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.17 -43.18 89.71 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -43.83 -41.51 11.84 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.95 2.433 . . . . 0.0 114.564 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.452 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 51.4 m-85 -77.08 -50.94 11.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.536 0.208 . . . . 0.0 111.386 -174.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -158.36 171.0 35.14 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.884 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.64 117.63 5.01 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 111.218 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.515 HD13 ' HB2' ' A' ' 132' ' ' PHE . 58.5 mt -78.82 116.31 22.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.105 0.479 . . . . 0.0 110.535 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.494 ' HE3' ' OE1' ' A' ' 159' ' ' GLU . 34.9 ttpt -88.42 -27.42 21.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.542 -177.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.2 t -163.83 145.48 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.753 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.48 HD13 HD11 ' A' ' 138' ' ' ILE . 61.7 mt -133.02 121.43 43.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.85 100.66 10.46 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.799 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.651 ' HE1' HG13 ' A' ' 128' ' ' ILE . 46.8 ttm -128.48 131.95 48.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.378 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 120.962 0.411 . . . . 0.0 109.942 175.95 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.1 p90 . . . . . 0 C--O 1.237 0.407 0 CA-C-O 120.821 0.344 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.97 167.14 31.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.305 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -125.46 121.38 33.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.664 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' A' ' 114' ' ' VAL . 90.2 t -100.15 116.65 43.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.102 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.494 ' OE1' ' HE3' ' A' ' 139' ' ' LYS . 41.5 tt0 -107.48 126.97 53.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.615 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.98 175.48 5.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.858 0.361 . . . . 0.0 110.964 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.46 ' OE1' ' HD3' ' A' ' 139' ' ' LYS . 5.5 mm-40 -71.98 -37.26 69.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.199 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.04 143.39 45.38 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.466 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.833 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 38.1 Cg_endo -66.26 -14.57 44.84 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.416 2.744 . . . . 0.0 112.219 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.919 ' HG3' ' HE2' ' A' ' 254' ' ' PHE . 15.4 mm-40 -62.33 -53.19 58.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.335 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.97 -18.98 60.37 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.66 -54.11 6.76 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.625 ' HG3' HG12 ' A' ' 286' ' ' VAL . 19.1 mm-40 -64.05 -36.29 83.51 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.967 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 12.9 tp -61.05 -48.41 81.88 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.643 177.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.6 -31.91 69.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.837 0.351 . . . . 0.0 110.079 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.631 HD11 ' O ' ' A' ' 185' ' ' VAL . 16.3 tp -72.58 -46.76 52.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 172.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 14.3 mm-40 -52.47 -41.84 63.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.321 0.648 . . . . 0.0 111.701 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -100.72 -51.35 3.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.0 ttp -95.65 30.16 2.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -164.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.445 ' HB3' HD12 ' A' ' 170' ' ' LEU . 10.0 p30 -79.36 21.08 0.5 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.16 -0.337 . . . . 0.0 111.151 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.5 m -100.79 -74.11 0.62 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.071 0.462 . . . . 0.0 110.822 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.3 m -144.02 170.33 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.025 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.985 ' HB2' HD11 ' A' ' 183' ' ' ILE . 2.4 tpt -118.64 94.08 4.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.254 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.918 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 73.7 mt 56.13 45.36 23.58 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.788 0.68 . . . . 0.0 110.221 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.18 -135.39 12.96 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -172.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 66.98 -112.09 4.61 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.687 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -144.01 177.86 8.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.391 0.138 . . . . 0.0 110.796 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -63.9 112.62 3.0 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.985 HD11 ' HB2' ' A' ' 177' ' ' MET . 45.2 pt -97.54 168.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.292 0.568 . . . . 0.0 111.58 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 93.4 mttt -103.12 115.21 30.15 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.195 175.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.631 ' O ' HD11 ' A' ' 170' ' ' LEU . 18.3 t -113.01 102.85 14.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 171.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.883 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -175.506 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.155 0.502 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.518 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -90.24 -5.41 56.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.452 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.555 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 15.6 mm100 -54.01 -47.11 98.12 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.1 Cg_endo -52.76 -40.74 73.43 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.987 1.791 . . . . 0.0 112.354 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 70.7 mt -73.27 -45.69 52.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.534 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 194' ' ' ALA . 57.7 mt -58.26 -47.17 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.805 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.82 -39.78 91.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.915 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -67.11 -46.34 74.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.626 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.592 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 69.0 mt -66.95 -32.84 74.36 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.02 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.569 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.64 -46.03 70.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.484 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 18.2 mt-10 -68.5 -31.75 71.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.883 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 47.1 mt-10 -67.49 -30.27 69.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.4 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -76.98 -39.22 51.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.968 0.414 . . . . 0.0 110.046 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 58.5 mtp180 -57.76 -30.11 65.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.891 176.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.22 -19.9 62.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.994 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -110.94 0.12 16.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.799 0.333 . . . . 0.0 111.404 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 56.66 38.12 29.32 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.583 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -87.9 138.38 31.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.937 -173.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.482 ' HA ' ' H ' ' A' ' 285' ' ' ALA . 48.7 pt -129.99 166.19 28.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.088 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.498 ' HD1' ' CE2' ' A' ' 254' ' ' PHE . 84.4 t80 -120.97 129.58 53.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.339 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.601 HG12 HG22 ' A' ' 282' ' ' VAL . 31.5 m -121.23 133.35 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.231 0.538 . . . . 0.0 110.33 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.97 175.09 9.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.193 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 61.1 m 60.71 35.14 19.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.213 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.03 124.24 36.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.293 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 25.9 t-80 -54.31 134.31 45.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.575 0.702 . . . . 0.0 111.245 -175.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.403 ' H ' ' HG2' ' A' ' 218' ' ' GLN . 2.2 pt20 -49.12 -35.48 16.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.268 -1.333 . . . . 0.0 114.181 -174.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -105.63 24.55 12.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.835 0.826 . . . . 0.0 110.789 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 217' ' ' HIS . 15.6 tp -105.3 133.46 50.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 21.0 t -98.76 167.17 10.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.044 0.45 . . . . 0.0 111.18 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -66.23 -22.56 66.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.02 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.54 -39.2 93.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.156 177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 228' ' ' VAL . 33.6 m-20 -71.04 -47.2 59.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.837 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.686 HG13 HD22 ' A' ' 240' ' ' LEU . 8.3 mm -63.16 -47.2 93.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 47.8 tttm -56.77 -45.51 82.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.226 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 77.6 p -60.87 -37.59 82.67 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -174.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 224' ' ' ASP . 4.8 t -76.35 -45.45 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.676 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.589 ' CB ' HD11 ' A' ' 235' ' ' ILE . 38.0 m-85 -62.74 -34.9 78.16 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.1 mm-40 -62.0 -24.37 67.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.731 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.05 -10.25 59.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.275 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.96 -43.65 4.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.083 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -145.73 -175.94 19.22 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.331 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -87.01 111.47 20.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.895 0.379 . . . . 0.0 110.346 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.589 HD11 ' CB ' ' A' ' 229' ' ' PHE . 14.3 mt -81.25 146.52 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.861 0.839 . . . . 0.0 111.962 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -109.58 -32.83 6.98 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.799 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 55.4 m -157.52 146.24 19.54 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -173.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 43.2 t -153.9 99.53 2.28 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.488 0.493 . . . . 0.0 109.766 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.9 m -130.0 115.95 17.87 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.646 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.686 HD22 HG13 ' A' ' 225' ' ' ILE . 57.6 mt -84.59 135.82 34.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.63 112.95 1.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.659 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 27.0 ttp180 -133.57 141.78 47.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.56 ' HB2' ' HG1' ' A' ' 246' ' ' THR . 9.7 m-20 -83.93 112.42 40.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.712 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.97 -36.79 81.19 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.211 2.607 . . . . 0.0 113.305 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.9 t -93.99 13.39 23.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.768 0.318 . . . . 0.0 111.663 -172.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.56 ' HG1' ' HB2' ' A' ' 243' ' ' ASP . 80.3 p -125.2 -39.89 2.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.802 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 98.01 9.83 53.27 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.232 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -118.37 146.8 44.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.659 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 4.1 p80 -95.07 143.63 26.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -64.21 -65.36 0.69 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -168.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 177.99 -3.4 0.03 OUTLIER Glycine 0 CA--C 1.519 0.304 0 C-N-CA 119.871 -1.156 . . . . 0.0 113.751 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -140.26 172.37 12.84 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.342 -0.505 . . . . 0.0 110.472 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.56 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -160.22 174.98 37.04 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.919 ' HE2' ' HG3' ' A' ' 164' ' ' GLU . 85.1 m-85 -129.19 143.25 50.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.664 0.268 . . . . 0.0 110.874 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.494 HD11 HG22 ' A' ' 225' ' ' ILE . 92.3 mt -137.56 140.73 41.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.222 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 237' ' ' SER . 43.3 mt-10 -122.88 148.18 45.73 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 20.9 m-85 -116.98 158.05 24.76 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.007 0.432 . . . . 0.0 110.487 176.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.11 -3.91 58.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.757 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -135.67 134.03 38.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.095 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.74 -32.82 74.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.581 -171.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -70.48 -39.13 74.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.931 0.395 . . . . 0.0 110.437 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.8 m -64.97 -37.59 88.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.736 -174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 43.5 p -68.49 -45.13 73.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.167 0.508 . . . . 0.0 110.649 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -72.19 -22.16 61.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.944 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.52 -40.03 62.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 110.549 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.31 -33.4 75.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.474 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 263' ' ' SER . 97.7 t -56.16 -26.91 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.994 0.426 . . . . 0.0 111.137 173.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.2 t -85.72 -46.8 10.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.018 -0.427 . . . . 0.0 110.639 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.4 m -69.83 -38.2 76.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.54 ' HE1' ' CD1' ' A' ' 229' ' ' PHE . 89.5 mmm -91.81 -2.61 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.76 0.314 . . . . 0.0 111.543 -173.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.437 ' HA ' HG12 ' A' ' 282' ' ' VAL . 39.7 t30 -72.12 124.53 25.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.306 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.2 mt 63.48 25.9 14.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.326 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -83.11 118.04 23.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.774 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.82 121.45 21.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.2 tp -141.62 91.82 2.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.025 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 95.28 25.7 13.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.935 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 89.25 1.22 79.15 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.784 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -126.14 148.53 49.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.642 0.258 . . . . 0.0 110.541 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -89.83 117.67 28.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.404 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.21 120.56 14.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.791 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -93.8 115.75 28.18 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 174.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.601 HG22 HG12 ' A' ' 213' ' ' VAL . 14.2 p -121.08 143.76 32.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.053 0.454 . . . . 0.0 110.851 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -156.61 -179.69 31.78 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.684 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -80.25 133.74 36.02 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -76.3 146.26 39.01 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.625 HG12 ' HG3' ' A' ' 167' ' ' GLN . 30.8 m -112.66 -3.65 10.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.717 0.294 . . . . 0.0 111.516 -174.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 41.5 p -123.07 139.37 31.42 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.902 0.382 . . . . 0.0 111.015 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.463 -0.285 0 C-N-CA 122.834 2.356 . . . . 0.0 111.196 173.872 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.407 ' HB2' HD12 ' A' ' 108' ' ' LEU . 16.0 mm-40 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -64.67 -28.43 69.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.18 -30.09 70.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HA ' ' HB2' ' A' ' 111' ' ' MET . 26.0 mt -70.81 -30.84 67.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.23 -25.24 66.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.362 0.601 . . . . 0.0 110.094 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.0 mt -84.08 -40.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.786 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.546 ' HB2' ' HA ' ' A' ' 108' ' ' LEU . 60.2 mmm -61.12 -29.97 70.09 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.543 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 73.5 m -73.87 -13.64 60.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.441 0.162 . . . . 0.0 111.237 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.652 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 29.8 mtp85 -108.96 139.89 43.21 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.25 135.51 63.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.165 0.507 . . . . 0.0 110.349 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -77.91 119.26 21.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.817 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 13.5 m -121.15 116.05 48.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.221 0.534 . . . . 0.0 110.348 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 155' ' ' PHE . . . -117.8 170.17 13.51 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.193 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 20.9 t 72.09 51.18 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.608 0.718 . . . . 0.0 110.391 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.0 mt -103.06 127.43 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.651 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -72.11 147.15 46.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.876 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -72.37 75.59 1.02 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.855 0.836 . . . . 0.0 111.005 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -154.63 -45.55 0.09 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.845 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.418 HD11 ' HG3' ' A' ' 177' ' ' MET . 22.0 mt -77.29 91.37 3.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.03 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.25 -179.85 44.57 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.979 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -55.51 -46.4 76.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.117 0.484 . . . . 0.0 111.227 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.5 -46.57 89.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.103 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.3 m -67.27 -42.16 84.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.988 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.522 HG13 ' HE1' ' A' ' 143' ' ' MET . 18.1 mm -61.41 -45.27 98.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.084 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.508 ' HG3' HD11 ' A' ' 138' ' ' ILE . 59.0 ttt180 -62.4 -37.39 85.6 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.509 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -69.81 -33.4 72.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.068 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.47 -33.33 54.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.612 ' HB2' HD12 ' A' ' 138' ' ' ILE . 52.2 m-85 -90.1 -13.65 35.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.818 0.342 . . . . 0.0 111.068 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.417 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.89 -41.28 84.19 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 44.9 Cg_exo -40.97 -40.36 3.71 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.035 2.49 . . . . 0.0 114.26 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.493 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 43.6 m-85 -79.25 -47.93 15.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.685 0.279 . . . . 0.0 111.21 -176.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.31 170.04 41.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.702 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.2 122.69 9.76 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.755 2.303 . . . . 0.0 111.629 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 132' ' ' PHE . 75.1 mt -81.84 132.09 32.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.132 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -89.84 -43.6 10.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.307 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 97.4 p -157.7 155.24 29.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.139 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.435 HG23 ' HG2' ' A' ' 143' ' ' MET . 62.7 mt -133.52 127.01 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.65 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.745 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 28.9 m-20 -91.85 106.16 18.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.072 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.522 ' HE1' HG13 ' A' ' 128' ' ' ILE . 17.4 mmt -111.5 118.24 35.2 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.734 0.302 . . . . 0.0 111.062 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.795 0.807 . . . . 0.0 110.495 174.752 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.438 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 52.0 p90 . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 111.334 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.37 163.56 39.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.673 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.745 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 96.2 m-85 -123.06 120.33 32.98 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.1 t -104.71 112.19 37.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.644 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.652 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 40.5 tt0 -102.88 131.07 50.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.5 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 81.3 m-85 -104.93 179.48 4.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.625 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -67.31 -38.53 85.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.165 0.507 . . . . 0.0 110.092 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.63 149.78 69.13 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.37 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 56.9 Cg_endo -70.02 -14.01 34.73 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.356 2.704 . . . . 0.0 112.237 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.584 ' HG3' ' CE1' ' A' ' 254' ' ' PHE . 75.5 mm-40 -60.82 -53.03 62.38 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.544 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -63.38 -14.34 49.16 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.973 0.416 . . . . 0.0 111.898 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.5 -54.2 5.37 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.564 ' HG3' HG23 ' A' ' 286' ' ' VAL . 15.9 mm100 -65.57 -34.0 77.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.968 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.493 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 25.6 tp -65.41 -43.58 90.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.238 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.76 -28.26 69.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.037 0.446 . . . . 0.0 110.08 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.66 -50.9 31.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.406 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -54.35 -35.36 62.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.37 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -100.61 -52.3 3.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 34.5 ttp -106.56 31.26 5.36 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -163.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -77.1 17.01 0.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.338 -0.226 . . . . 0.0 111.567 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.1 m -110.04 -73.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.57 0.224 . . . . 0.0 111.483 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.4 m -135.54 159.53 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.535 0.207 . . . . 0.0 110.938 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.97 ' HB2' HD12 ' A' ' 183' ' ' ILE . 3.5 tpt -123.88 96.61 5.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.892 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 24.0 tp 50.61 61.53 3.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.671 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.56 -179.28 18.94 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.306 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.76 57.71 5.04 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.093 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -134.21 119.0 18.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -75.55 136.38 40.56 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.902 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.97 HD12 ' HB2' ' A' ' 177' ' ' MET . 42.0 pt -124.32 158.42 31.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.678 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 22.7 tptm -111.3 106.41 15.36 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.37 110.1 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.938 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.722 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.212 178.326 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.443 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 22.0 tp60 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.12 0.486 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.543 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -75.87 -19.49 58.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.603 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 27.9 mm-40 -58.83 -51.45 81.75 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.288 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 64.2 Cg_exo -53.63 -38.36 84.18 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.208 1.939 . . . . 0.0 112.764 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.82 -39.31 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.511 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 194' ' ' ALA . 72.3 mt -60.32 -45.98 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 175.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.585 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 26.0 t70 -61.54 -41.97 98.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.431 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.26 -51.38 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.256 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 44.8 mt -68.29 -32.77 73.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.85 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.47 -41.78 77.1 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 32.5 mt-10 -67.67 -33.91 75.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.544 174.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -63.68 -37.36 87.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.937 0.399 . . . . 0.0 110.653 175.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.57 -37.33 73.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.505 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 29.5 mtp180 -59.29 -26.02 64.61 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.357 176.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -76.91 -11.29 59.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -111.37 179.28 4.07 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 62.0 m-20 -126.25 38.76 4.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.952 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 10.3 ptp180 -108.28 158.06 17.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.646 0.736 . . . . 0.0 112.603 -170.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.599 HG22 ' HB2' ' A' ' 263' ' ' SER . 41.3 pt -135.39 166.63 27.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.623 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.445 ' CD2' HD23 ' A' ' 168' ' ' LEU . 57.1 t80 -112.62 124.03 51.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.377 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 229' ' ' PHE . 26.8 m -115.01 131.3 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.382 0.61 . . . . 0.0 110.453 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 281' ' ' ARG . . . -122.66 172.0 8.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.873 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 24.3 m 63.79 22.23 12.98 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.506 0.67 . . . . 0.0 110.461 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 38.2 t -79.7 109.02 13.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.806 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -56.04 142.8 34.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.285 0.564 . . . . 0.0 111.033 -171.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -59.13 -22.5 60.98 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -168.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -92.51 -13.28 30.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 93.6 mt -81.84 133.81 35.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 19.0 m -96.69 171.71 8.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.604 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.519 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 9.8 p-10 -61.02 -42.17 97.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.581 0.229 . . . . 0.0 111.552 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.25 -27.1 69.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.366 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.58 -48.28 33.97 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.896 0.379 . . . . 0.0 110.086 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.521 HG22 HD11 ' A' ' 255' ' ' ILE . 34.2 mm -61.93 -38.54 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.475 ' HG3' HG21 ' A' ' 235' ' ' ILE . 63.0 tttm -56.26 -52.57 63.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.114 175.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 88.3 p -58.55 -34.43 71.01 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.83 -50.01 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 121.129 -0.229 . . . . 0.0 111.279 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.695 ' HB2' HD13 ' A' ' 235' ' ' ILE . 20.8 m-85 -64.31 -34.18 77.55 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.207 0.527 . . . . 0.0 111.074 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -63.63 -23.6 67.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.429 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.23 -11.57 60.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.76 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -112.04 -37.95 4.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.724 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.504 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -140.29 167.63 25.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.499 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -78.64 99.72 6.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.845 0.355 . . . . 0.0 111.053 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.695 HD13 ' HB2' ' A' ' 229' ' ' PHE . 8.3 mt -77.05 146.19 9.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.615 0.721 . . . . 0.0 111.453 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -110.49 -37.19 5.56 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.664 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 25.8 m -154.5 151.36 28.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -172.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 255' ' ' ILE . 52.9 t -153.7 116.14 4.4 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 61.9 m -141.23 111.28 6.67 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.676 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.553 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 34.8 mt -81.8 137.75 35.25 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -62.05 113.51 2.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 70.3 ttt180 -137.74 141.34 40.98 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.68 -167.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -105.02 117.64 58.12 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.179 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.77 -28.41 81.94 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 123.573 2.848 . . . . 0.0 112.952 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.2 t -79.82 -13.27 59.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.072 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 37.0 p -106.01 -36.93 6.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.956 0.408 . . . . 0.0 111.241 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.76 -35.12 4.19 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.822 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 63.5 pttt -87.43 -179.77 6.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 241' ' ' ALA . 6.2 p80 -120.35 163.77 17.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.883 0.373 . . . . 0.0 110.174 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -71.09 -3.93 22.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.389 -167.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 111.71 -11.02 27.81 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.176 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.421 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 51.5 p90 -135.23 173.54 11.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.707 0.289 . . . . 0.0 111.062 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -165.36 175.03 41.22 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.065 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.584 ' CE1' ' HG3' ' A' ' 164' ' ' GLU . 94.0 m-85 -128.88 142.9 50.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.766 0.317 . . . . 0.0 110.767 -178.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.521 HD11 HG22 ' A' ' 225' ' ' ILE . 83.9 mt -136.3 132.21 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.451 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.952 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 18.6 mt-10 -109.24 147.95 31.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.504 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 12.5 m-85 -112.18 150.26 31.09 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 123.164 0.29 . . . . 0.0 110.66 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.22 -55.35 29.31 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -73.65 117.13 15.06 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.536 171.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -52.99 -38.41 62.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.211 -175.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -75.08 -30.63 61.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.64 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.54 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 69.0 m -64.52 -19.76 65.8 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.599 ' HB2' HG22 ' A' ' 211' ' ' ILE . 78.1 p -57.69 -46.08 84.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.206 0.527 . . . . 0.0 109.929 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -76.68 -13.87 60.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.107 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 2.6 m-20 -64.69 -47.92 76.61 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 173.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.431 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . . . -64.96 -35.75 82.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.214 176.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 263' ' ' SER . 89.0 t -56.82 -31.89 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.273 0.559 . . . . 0.0 110.787 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 20.2 m -80.64 -38.38 29.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.499 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 24.7 t -93.91 -34.02 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.477 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 91.1 mmm -84.74 -4.64 59.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 -174.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.479 ' HA ' HG12 ' A' ' 282' ' ' VAL . 50.8 t30 -68.9 117.03 10.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.864 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 95.4 mt 67.95 40.13 2.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.316 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -96.73 121.78 38.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.683 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.18 111.37 10.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.586 0.708 . . . . 0.0 111.17 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.4 tp -140.69 110.35 6.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.432 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 91.77 25.28 23.19 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.435 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 74.97 10.69 84.02 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.517 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -138.26 144.51 40.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -76.44 116.32 17.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.648 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.95 128.84 38.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.908 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.446 ' HB2' ' HB1' ' A' ' 214' ' ' ALA . 9.4 mmt85 -98.5 115.31 28.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 271' ' ' ASN . 14.3 p -116.25 144.0 24.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.788 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.63 178.47 32.21 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.608 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -77.09 132.73 39.03 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.35 114.42 7.58 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.564 HG23 ' HG3' ' A' ' 167' ' ' GLN . 28.6 m -87.29 -27.6 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.808 -171.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 22.2 p -136.35 162.74 54.6 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.442 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.444 -1.432 0 C-N-CA 122.489 2.126 . . . . 0.0 112.162 175.317 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 106' ' ' ARG . 9.9 mmt180 -60.44 -37.46 81.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.509 -174.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.07 -32.18 72.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.258 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.492 HD23 ' SD ' ' A' ' 111' ' ' MET . 25.1 mt -67.75 -32.47 73.1 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.962 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.31 -29.64 70.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.262 0.553 . . . . 0.0 109.907 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.7 mt -82.34 -38.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.28 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.492 ' SD ' HD23 ' A' ' 108' ' ' LEU . 91.4 mtp -67.41 -30.07 69.73 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.727 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.6 m -74.18 -21.63 59.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.852 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.607 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 96.6 mtt180 -97.32 139.68 32.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 p -126.15 132.02 70.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.16 0.505 . . . . 0.0 110.319 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.493 ' HD1' ' CE2' ' A' ' 157' ' ' PHE . 91.3 t80 -76.58 117.1 17.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.426 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 41.2 t -115.89 114.96 47.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.811 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.7 169.13 18.68 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.026 -176.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.733 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 12.2 t 68.64 33.98 3.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.359 0.599 . . . . 0.0 110.871 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.9 mt -80.56 -13.19 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.049 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 65.9 t80 72.69 147.18 0.08 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.901 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -77.34 76.22 3.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.38 0.609 . . . . 0.0 111.372 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.87 -65.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.23 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.8 mt -54.86 108.38 0.39 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.577 0.548 . . . . 0.0 111.503 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.21 -173.0 40.97 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.892 -174.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.14 -46.72 88.7 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.295 -0.452 . . . . 0.0 111.781 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 1.1 m-20 -60.41 -45.0 95.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.627 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.6 m -59.73 -43.7 94.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.874 0.368 . . . . 0.0 110.836 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.8 mm -63.98 -45.65 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.408 0.623 . . . . 0.0 110.226 177.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -56.58 -45.78 81.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.269 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 58.9 mt-30 -63.82 -34.12 77.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.526 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.56 -29.4 30.35 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -93.15 -20.18 20.74 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.442 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -50.2 -42.3 71.57 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 73.6 Cg_exo -42.3 -42.79 7.75 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 123.168 2.579 . . . . 0.0 114.786 174.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -78.38 -36.64 45.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -169.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 165' ' ' ALA . . . -177.87 -172.67 42.59 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.132 175.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.548 ' HG3' ' CE1' ' A' ' 252' ' ' TYR . 73.0 Cg_endo -76.28 129.15 10.99 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.955 2.436 . . . . 0.0 112.123 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.2 mt -90.11 128.6 41.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.29 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.544 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 24.5 ttmm -91.98 -37.23 12.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.711 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.3 p -169.71 157.04 6.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.381 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.6 mt -126.64 108.3 18.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.46 99.53 11.72 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.766 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 57.4 ttm -119.7 127.47 52.9 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.089 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.233 0.197 0 O-C-N 123.573 0.546 . . . . 0.0 110.426 178.445 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 36.3 p90 . . . . . 0 C--O 1.236 0.369 0 CA-C-O 121.416 0.627 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.72 156.25 31.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.269 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.493 ' CE2' ' HD1' ' A' ' 115' ' ' TYR . 76.8 m-85 -113.04 126.18 55.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.12 114.01 41.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.607 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 38.6 tt0 -101.47 122.27 43.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.577 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -97.56 172.61 7.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.024 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 23.6 mt-10 -93.5 -7.43 44.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.963 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.1 m -140.22 135.43 16.18 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.809 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.26 -25.75 36.34 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.195 2.597 . . . . 0.0 113.036 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 18.4 mp0 -55.81 -45.06 78.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.483 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . . . -55.62 -40.28 71.9 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.937 0.398 . . . . 0.0 111.352 175.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.5 -35.02 78.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.904 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.748 ' HG3' HG11 ' A' ' 286' ' ' VAL . 16.6 mm-40 -68.38 -48.13 65.54 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.671 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.574 HD13 ' HD2' ' A' ' 212' ' ' TYR . 64.0 mt -60.38 -43.68 96.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.177 0.513 . . . . 0.0 111.113 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.61 -37.24 80.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.563 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.586 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 8.2 tt -72.41 -48.51 40.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.092 174.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -53.36 -43.24 67.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.264 -177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -100.23 -49.22 4.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.589 ' HG2' ' O ' ' A' ' 176' ' ' VAL . 16.1 ttp -107.91 29.97 6.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.685 -166.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.586 ' HB2' ' O ' ' A' ' 170' ' ' LEU . 27.4 t-20 -54.63 -51.13 66.36 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -174.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 19.2 m -113.61 16.48 18.67 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -169.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.589 ' O ' ' HG2' ' A' ' 173' ' ' MET . 10.7 m -140.02 135.89 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.832 0.287 . . . . 0.0 110.98 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.975 ' HB2' HD13 ' A' ' 183' ' ' ILE . 27.7 tpp -126.68 102.09 6.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.911 0.386 . . . . 0.0 110.932 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 21.0 tp 71.13 -68.41 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.149 172.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -114.15 -143.34 8.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.094 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.56 65.73 3.91 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.204 -0.522 . . . . 0.0 111.875 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -131.73 120.09 22.24 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 175' ' ' SER . 6.2 p30 -77.84 128.64 34.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.975 HD13 ' HB2' ' A' ' 177' ' ' MET . 37.0 pt -135.78 -175.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.245 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 68.2 mmtt -134.15 106.67 7.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.037 174.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 54.9 t -99.49 101.53 12.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.921 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -174.956 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . 0.43 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 27.0 tt0 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.982 0.42 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -69.36 -34.99 75.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.855 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.647 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 15.6 tm0? -57.97 -53.33 66.94 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.222 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.647 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 74.7 Cg_exo -53.46 -36.04 78.21 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.588 2.192 . . . . 0.0 112.905 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.41 -42.0 73.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.777 0.322 . . . . 0.0 110.243 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 194' ' ' ALA . 81.5 mt -61.14 -47.88 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.287 0.565 . . . . 0.0 109.973 176.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.15 -37.47 87.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.836 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -58.95 -52.89 63.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.918 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 67.7 mt -68.04 -33.14 74.02 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.987 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.648 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.95 -46.03 71.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.4 -36.79 83.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.962 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 39.4 mt-10 -67.77 -27.39 66.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.975 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.13 -27.83 59.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.028 0.442 . . . . 0.0 110.326 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 72.4 mtp180 -74.39 -15.59 60.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.503 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.88 -11.01 60.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.511 0.672 . . . . 0.0 109.992 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -115.87 -178.74 3.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.388 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 9.6 m-80 -123.92 46.06 2.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -102.61 139.18 38.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.284 -166.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.446 HG21 ' HB2' ' A' ' 263' ' ' SER . 37.6 pt -125.17 166.55 20.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.798 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.624 ' HD1' ' HE1' ' A' ' 254' ' ' PHE . 49.0 t80 -117.65 130.07 56.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.697 -175.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.1 132.89 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.004 0.431 . . . . 0.0 110.256 176.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.02 176.46 7.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.6 t 64.41 22.71 12.81 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 123.93 0.768 . . . . 0.0 109.204 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 15.4 t -67.87 121.82 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.761 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -62.66 143.05 57.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.454 0.169 . . . . 0.0 110.687 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . 0.599 ' HA ' ' CE1' ' A' ' 249' ' ' HIS . 28.6 pt20 -61.05 -16.82 48.01 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -166.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -105.4 -5.52 20.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.046 0.451 . . . . 0.0 110.846 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.537 HD21 ' HG ' ' A' ' 275' ' ' LEU . 2.9 tp -83.55 130.3 35.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' SER . . . . . 0.543 ' O ' HG12 ' A' ' 225' ' ' ILE . 29.7 p -102.37 167.84 9.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.377 -174.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -37.98 83.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.282 0.563 . . . . 0.0 109.958 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -54.65 -40.03 68.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.997 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.7 -47.24 41.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.68 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.646 HG23 HD11 ' A' ' 255' ' ' ILE . 34.0 mm -60.41 -42.5 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.486 ' HG3' HG21 ' A' ' 235' ' ' ILE . 86.2 tttt -57.36 -48.78 78.12 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.04 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 88.0 p -60.83 -35.34 76.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -173.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.58 -43.67 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.633 0.254 . . . . 0.0 111.232 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.578 ' CB ' HD11 ' A' ' 235' ' ' ILE . 10.3 m-85 -68.26 -29.41 68.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.297 0.57 . . . . 0.0 110.802 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.87 -24.77 67.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.054 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.0 -17.84 62.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.889 -175.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.21 -44.73 3.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.02 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.627 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -124.55 170.17 16.61 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.098 -175.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -86.4 99.07 11.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.578 HD11 ' CB ' ' A' ' 229' ' ' PHE . 12.8 mt -84.59 150.82 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.332 0.587 . . . . 0.0 111.458 -175.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -117.04 -27.86 6.41 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.471 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.0 t -167.94 149.41 5.32 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.726 -173.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.57 ' SG ' HG12 ' A' ' 255' ' ' ILE . 50.3 t -148.2 126.3 12.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.257 175.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 99.0 m -142.52 121.33 12.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.787 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.438 ' CD2' ' HA3' ' A' ' 253' ' ' GLY . 31.1 mt -82.7 141.04 32.74 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.31 114.86 6.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 80.3 mtm180 -127.79 163.16 24.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.328 0.585 . . . . 0.0 112.365 -172.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 244' ' ' PRO . 9.6 m-20 -104.69 104.95 48.47 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.458 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 9.6 Cg_endo -50.03 -45.74 31.45 Favored 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 123.86 3.04 . . . . 0.0 114.934 -167.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.8 p -93.21 9.58 35.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 248' ' ' LYS . 72.3 p -114.5 -38.7 3.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.971 0.415 . . . . 0.0 110.469 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.15 2.54 56.89 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.34 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.428 ' HG2' ' OG1' ' A' ' 246' ' ' THR . 19.8 ptmt -99.27 158.33 15.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.887 0.375 . . . . 0.0 110.532 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.599 ' CE1' ' HA ' ' A' ' 218' ' ' GLN . 22.4 p80 -105.63 152.32 23.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -80.18 -1.29 39.8 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.832 -170.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 113.05 -6.98 25.38 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.375 172.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.548 ' CE1' ' HG3' ' A' ' 137' ' ' PRO . 24.3 p90 -138.2 161.86 35.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.664 0.269 . . . . 0.0 110.541 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' A' ' 240' ' ' LEU . . . -154.12 172.49 32.74 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.889 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.624 ' HE1' ' HD1' ' A' ' 212' ' ' TYR . 29.9 m-85 -129.0 144.07 51.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.811 0.339 . . . . 0.0 110.464 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.646 HD11 HG23 ' A' ' 225' ' ' ILE . 77.5 mt -136.09 133.2 50.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.297 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 33.4 mt-10 -113.78 143.72 44.17 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.627 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 6.6 m-85 -110.6 170.12 8.3 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.095 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.579 ' HB2' ' HD2' ' A' ' 259' ' ' LYS . 34.4 mt-10 -72.78 -43.56 62.66 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.709 0.766 . . . . 0.0 109.008 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . 0.579 ' HD2' ' HB2' ' A' ' 258' ' ' GLU . 11.0 mptt -105.81 130.09 53.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.058 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.79 -25.72 68.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.32 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -75.43 -31.92 60.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.776 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 46.7 m -70.12 -34.91 73.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.355 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.446 ' HB2' HG21 ' A' ' 211' ' ' ILE . 55.2 p -66.29 -34.61 78.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.339 0.59 . . . . 0.0 109.751 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -71.63 -25.93 62.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.556 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -68.45 -42.41 78.85 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.367 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.74 88.09 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.498 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.432 HG12 ' HA2' ' A' ' 283' ' ' GLY . 80.3 t -52.79 -48.71 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.985 0.422 . . . . 0.0 111.406 175.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.3 m -71.36 -23.47 61.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.1 m -94.34 -43.44 8.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' MET . . . . . . . . . . . . . 84.8 mmm -89.84 -4.4 57.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.022 -169.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -76.96 122.51 24.98 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.992 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.585 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 96.7 mt 70.79 27.97 3.46 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.182 -175.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -89.71 124.36 34.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.094 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -77.56 107.45 10.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.974 0.416 . . . . 0.0 110.961 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.537 ' HG ' HD21 ' A' ' 220' ' ' LEU . 31.2 tp -134.13 98.85 4.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.059 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 101.56 2.67 53.27 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.151 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.13 -0.15 41.12 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.319 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -131.68 142.44 49.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.804 0.335 . . . . 0.0 110.557 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.585 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 21.7 m-85 -74.0 111.22 8.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.592 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.44 128.16 35.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.884 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -98.95 116.23 30.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 212' ' ' TYR . 10.2 p -125.7 141.92 44.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.838 -176.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.432 ' HA2' HG12 ' A' ' 267' ' ' VAL . . . -160.8 173.41 37.29 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.397 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -71.1 125.99 28.37 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.85 124.05 21.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.748 HG11 ' HG3' ' A' ' 167' ' ' GLN . 34.0 m -88.79 -19.23 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 111.385 -172.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.413 ' OG1' ' HD2' ' A' ' 288' ' ' PRO . 5.4 t -147.36 147.98 30.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 173.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.413 ' HD2' ' OG1' ' A' ' 287' ' ' THR . 60.7 Cg_endo . . . . . 0 CA--C 1.533 0.469 0 C-N-CA 122.78 2.32 . . . . 0.0 112.717 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 CA--C 1.532 0.28 0 CA-C-O 120.761 0.315 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -57.25 -37.34 72.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.139 0.495 . . . . 0.0 109.931 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.22 88.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.236 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.434 HD22 ' SD ' ' A' ' 111' ' ' MET . 66.7 mt -61.87 -35.26 77.78 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.999 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.66 -26.51 68.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.346 0.593 . . . . 0.0 110.818 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.77 -37.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.778 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.493 ' SD ' HG12 ' A' ' 198' ' ' ILE . 88.1 mtp -70.57 -29.68 66.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.741 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.1 m -70.64 -17.71 62.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 110.875 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -98.5 140.81 32.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.855 0.36 . . . . 0.0 110.146 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.761 HG13 ' HB ' ' A' ' 158' ' ' VAL . 3.7 p -120.47 126.88 75.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.672 0.749 . . . . 0.0 109.994 176.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -83.69 101.25 11.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.053 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.726 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 25.1 m -108.35 143.15 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.033 0.445 . . . . 0.0 111.243 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.772 ' HA3' ' HD1' ' A' ' 155' ' ' PHE . . . -152.4 177.68 30.02 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.36 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 23.2 t 65.01 50.09 1.95 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.672 0.749 . . . . 0.0 109.294 -175.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.14 116.45 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.936 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -61.21 147.89 42.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.638 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -74.07 76.29 1.73 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.027 0.918 . . . . 0.0 111.047 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -163.55 -38.24 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.8 mt -76.53 92.6 3.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.453 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.56 -169.49 44.93 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.583 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 129' ' ' ARG . 20.8 tt0 -54.33 -46.51 72.89 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -64.11 -44.93 90.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.564 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -63.89 -45.17 90.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.945 HG13 ' HE2' ' A' ' 143' ' ' MET . 26.8 mm -69.17 -35.46 68.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.122 0.487 . . . . 0.0 110.427 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 27.9 ttt180 -59.37 -45.48 91.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.802 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.2 -33.45 71.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.838 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.19 -38.73 30.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.483 ' CD1' HG23 ' A' ' 128' ' ' ILE . 24.6 m-85 -89.33 -22.43 22.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.38 -42.97 90.16 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -44.96 -31.95 5.93 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.991 2.46 . . . . 0.0 114.53 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.684 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 74.6 m-85 -82.06 -37.2 26.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.48 -175.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.502 ' HA3' ' HB1' ' A' ' 165' ' ' ALA . . . -178.49 173.62 45.97 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.798 174.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.1 126.19 15.38 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.985 2.457 . . . . 0.0 111.956 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.611 HD11 HD12 ' A' ' 141' ' ' ILE . 61.9 mt -89.06 139.27 17.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.635 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.587 ' HD2' ' OE2' ' A' ' 159' ' ' GLU . 22.1 ttmm -98.84 -43.86 6.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.099 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.8 t -159.63 142.53 13.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.096 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.611 HD12 HD11 ' A' ' 138' ' ' ILE . 70.0 mt -126.17 110.42 23.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.87 0.366 . . . . 0.0 110.089 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 25.9 t70 -91.45 100.82 13.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.185 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.945 ' HE2' HG13 ' A' ' 128' ' ' ILE . 51.3 ttm -138.86 111.3 7.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.023 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 59.4 m . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.128 0.489 . . . . 0.0 111.377 178.904 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.772 ' HD1' ' HA3' ' A' ' 117' ' ' GLY . 67.8 m-85 . . . . . 0 C--O 1.236 0.381 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.96 153.8 41.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.81 0.338 . . . . 0.0 110.755 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.479 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 88.9 m-85 -114.85 110.82 20.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.588 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.761 ' HB ' HG13 ' A' ' 114' ' ' VAL . 58.2 t -97.49 108.72 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.902 177.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.587 ' OE2' ' HD2' ' A' ' 139' ' ' LYS . 33.3 tt0 -102.35 119.8 39.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.124 -178.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.45 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 90.2 m-85 -97.4 -177.72 3.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.001 0.429 . . . . 0.0 111.342 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -80.18 -58.79 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.646 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.7 m -103.7 143.16 26.09 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.626 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 40.9 Cg_endo -67.52 -18.8 49.08 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.147 2.565 . . . . 0.0 112.798 -176.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.698 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 15.7 mp0 -55.81 -57.17 13.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.459 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.502 ' HB1' ' HA3' ' A' ' 136' ' ' GLY . . . -52.98 -26.85 16.54 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 177.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.18 -47.26 13.68 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.404 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.568 ' HG2' HG11 ' A' ' 286' ' ' VAL . 2.6 pp0? -66.72 -31.57 72.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.684 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 10.7 tp -73.23 -45.81 53.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.53 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.86 71.92 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.595 HD11 ' HA3' ' A' ' 186' ' ' GLY . 8.5 tt -66.63 -50.28 63.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.473 172.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -54.19 -49.72 68.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.351 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -86.48 -38.92 16.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -173.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 30.9 mtm -106.8 21.93 16.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -171.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 32.1 p30 -72.14 0.16 10.37 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.324 0.583 . . . . 0.0 110.23 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.9 m -95.5 -73.72 0.58 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.506 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.5 m -139.16 161.82 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.729 0.299 . . . . 0.0 111.167 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.648 ' HA ' ' HE3' ' A' ' 177' ' ' MET . 1.6 tpt -150.63 72.47 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.494 ' HG ' ' HE1' ' A' ' 177' ' ' MET . 74.1 mt 57.16 -166.43 0.14 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.765 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.19 -17.76 1.73 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.798 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 178' ' ' LEU . . . 85.45 21.67 53.48 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.443 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -143.78 176.63 9.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.058 0.456 . . . . 0.0 111.332 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -95.04 144.08 25.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.692 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.522 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 22.3 pt -116.71 171.26 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.834 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.726 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 34.8 mmtp -103.8 131.6 50.85 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 6.1 t -129.94 110.22 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.8 0.333 . . . . 0.0 110.487 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.595 ' HA3' HD11 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.788 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.565 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.752 0.31 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -82.1 -28.49 32.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.483 -178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.575 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 11.5 mm100 -55.57 -49.81 90.51 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 75.7 Cg_exo -53.23 -33.89 67.1 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.249 1.966 . . . . 0.0 112.846 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 63.4 mt -75.25 -48.14 32.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.877 0.37 . . . . 0.0 110.227 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.493 HG12 ' SD ' ' A' ' 111' ' ' MET . 68.7 mt -57.5 -48.08 83.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.924 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -69.43 -34.12 73.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.115 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -71.58 -37.94 70.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.671 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 60.8 mt -67.74 -33.22 74.44 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.198 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -58.72 -37.27 75.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 109.772 173.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.49 -30.35 64.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.356 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -68.42 -33.8 74.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.993 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.9 -24.62 62.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.262 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.575 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 65.6 mtp180 -72.62 -24.23 61.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.17 173.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.67 -39.63 19.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.277 0.56 . . . . 0.0 110.047 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -109.36 80.19 1.29 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.77 85.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.773 0.67 . . . . 0.0 110.916 -175.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 256' ' ' GLU . 9.1 ttt180 -128.09 143.31 51.06 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.537 -171.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.418 HG22 ' HB2' ' A' ' 263' ' ' SER . 39.7 pt -118.21 166.76 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.564 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.517 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 73.9 t80 -121.91 126.36 48.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.388 -173.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.508 HG12 ' CZ ' ' A' ' 229' ' ' PHE . 27.7 m -121.32 131.27 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.985 0.422 . . . . 0.0 110.358 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.87 175.27 7.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.451 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.6 t 59.96 31.53 20.72 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.867 0.841 . . . . 0.0 109.206 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 44.9 t -73.02 123.06 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.224 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -50.3 128.91 20.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.391 0.615 . . . . 0.0 110.968 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -55.74 -33.1 63.96 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.159 -173.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -99.07 37.0 1.6 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.477 0.656 . . . . 0.0 110.386 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 220' ' ' LEU . 11.2 tp -124.69 133.01 53.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.7 m -95.84 170.09 9.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.849 -174.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -67.46 -36.33 80.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.756 0.312 . . . . 0.0 110.819 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.9 -30.78 70.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.642 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.5 -45.26 47.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.361 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.729 HG13 HD21 ' A' ' 240' ' ' LEU . 27.1 mm -59.85 -42.42 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.692 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.444 ' HB2' ' CB ' ' A' ' 238' ' ' CYS . 86.8 tttt -56.46 -52.52 64.38 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.868 176.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 79.6 p -56.31 -37.83 70.46 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -173.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.4 -45.48 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.677 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.554 ' HB2' HD12 ' A' ' 235' ' ' ILE . 26.3 m-85 -67.95 -27.75 66.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.292 0.568 . . . . 0.0 110.394 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.09 -26.51 67.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.142 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.19 -18.73 61.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.236 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -107.07 -31.33 8.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -153.28 159.37 28.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.875 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -75.45 111.2 10.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.505 0.669 . . . . 0.0 111.645 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 229' ' ' PHE . 40.0 mt -84.03 148.98 4.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.4 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.618 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 77.8 tttt -108.35 -35.85 6.41 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.861 176.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 256' ' ' GLU . 17.0 m -153.44 136.05 15.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -170.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.444 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 52.4 t -138.68 114.75 10.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.883 0.373 . . . . 0.0 110.103 175.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 31.3 m -141.99 116.01 9.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.57 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.729 HD21 HG13 ' A' ' 225' ' ' ILE . 66.3 mt -77.98 138.58 38.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.63 3.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 34.6 mtm180 -122.41 143.17 49.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.775 -176.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -83.96 109.92 22.16 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.47 -16.47 55.32 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.477 2.118 . . . . 0.0 111.992 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.7 p -73.29 -29.18 62.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.595 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.536 HG23 ' HG2' ' A' ' 248' ' ' LYS . 4.1 t -120.55 -26.68 5.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.796 0.331 . . . . 0.0 111.762 -178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.56 37.06 8.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.201 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HG2' HG23 ' A' ' 246' ' ' THR . 19.2 ptpt -140.43 150.05 43.35 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 18.1 p80 -80.59 132.36 35.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.332 0.586 . . . . 0.0 110.465 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -64.06 -21.04 66.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.112 -171.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 133.73 -15.3 4.64 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.273 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.517 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 33.8 p90 -128.36 169.86 13.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.692 0.282 . . . . 0.0 110.592 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.424 ' HA3' HD22 ' A' ' 240' ' ' LEU . . . -158.38 170.82 35.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.051 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.698 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 97.4 m-85 -130.86 138.92 50.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.068 0.461 . . . . 0.0 111.309 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.709 HD12 HG23 ' A' ' 225' ' ' ILE . 89.2 mt -133.95 128.53 53.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.699 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 210' ' ' ARG . 57.2 tt0 -109.85 145.89 36.02 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 16.8 m-85 -116.2 148.01 40.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.002 0.429 . . . . 0.0 111.262 -175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 26.3 mt-10 -72.54 -21.95 61.09 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.081 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -116.91 126.33 52.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.725 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -50.73 -58.11 6.69 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -171.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -62.44 -29.07 70.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.226 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' SER . . . . . 0.409 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 49.9 m -64.97 -29.22 70.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 111.556 -175.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.46 ' HA ' ' CD1' ' A' ' 257' ' ' TYR . 87.5 p -63.19 -39.93 96.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.323 0.582 . . . . 0.0 109.712 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -78.28 -19.32 53.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.136 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 85.9 m-20 -63.03 -43.05 99.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.65 84.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.683 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 263' ' ' SER . 97.4 t -56.06 -37.23 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 111.226 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.7 t -77.75 -35.69 51.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.0 m -94.83 -36.55 11.62 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -171.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.439 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.4 mmm -83.4 -0.52 50.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -169.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -73.53 125.99 29.22 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.487 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.522 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 91.1 mt 66.04 25.17 10.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.53 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -88.13 118.27 27.59 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 172.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.515 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 6.7 p-10 -74.69 115.71 14.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.458 0.647 . . . . 0.0 110.439 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 31.6 tp -123.75 97.83 5.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.14 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.5 26.63 35.2 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -175.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.5 -43.74 1.85 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.697 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -88.25 142.46 27.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.044 0.449 . . . . 0.0 111.203 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 68.2 m-85 -81.63 123.59 28.82 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.916 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.68 123.01 21.62 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.711 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -93.6 115.23 27.7 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 14.3 p -118.06 142.68 31.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.244 0.545 . . . . 0.0 111.428 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.483 ' HA3' HD13 ' A' ' 168' ' ' LEU . . . -157.95 -176.94 30.58 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.8 mppt? -85.98 147.73 26.08 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.323 0.561 . . . . 0.0 110.43 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.589 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -86.52 130.96 34.31 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.568 HG11 ' HG2' ' A' ' 167' ' ' GLN . 12.0 m -93.54 -19.46 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.834 0.349 . . . . 0.0 110.877 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 42.9 p -130.43 129.01 22.73 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.29 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 CA--C 1.531 0.364 0 C-N-CA 122.425 2.084 . . . . 0.0 111.045 173.368 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -50.86 -28.4 9.43 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.422 -173.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.06 71.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 111.363 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.53 HD21 ' SD ' ' A' ' 111' ' ' MET . 58.4 mt -68.55 -31.97 71.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.064 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.04 -27.87 68.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.213 0.53 . . . . 0.0 110.425 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.0 mt -85.86 -34.64 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.096 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.536 ' SD ' HG12 ' A' ' 198' ' ' ILE . 91.7 mtp -70.84 -16.43 62.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.042 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 71.2 m -84.39 -6.29 59.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.716 0.293 . . . . 0.0 111.188 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.504 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 51.8 mtt180 -116.78 141.88 47.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.757 0.313 . . . . 0.0 110.548 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.589 HG12 ' HB ' ' A' ' 158' ' ' VAL . 4.0 p -120.63 128.47 76.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.408 0.623 . . . . 0.0 109.752 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -83.11 115.56 21.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.016 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 17.2 m -108.33 124.87 65.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.518 0.675 . . . . 0.0 111.124 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.61 174.83 18.01 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.375 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 71.8 m 61.0 38.33 17.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.272 0.558 . . . . 0.0 110.517 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 57.5 mt -74.34 -21.81 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.563 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.423 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 84.0 t80 70.01 163.94 0.25 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.37 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -89.83 76.77 7.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.589 0.709 . . . . 0.0 110.704 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -164.1 -50.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.342 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.695 HD13 ' HG3' ' A' ' 177' ' ' MET . 73.3 mt -65.23 112.74 3.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.919 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.451 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -80.14 159.11 42.97 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.751 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -65.22 -37.32 86.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.207 0.527 . . . . 0.0 109.93 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.12 -41.12 97.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.606 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.4 m -64.76 -41.4 95.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.954 0.407 . . . . 0.0 110.292 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.722 HG13 ' HE1' ' A' ' 143' ' ' MET . 33.4 mm -59.2 -44.94 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.876 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.423 ' HA ' HD12 ' A' ' 138' ' ' ILE . 25.1 ttt180 -59.24 -40.48 86.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.223 0.535 . . . . 0.0 110.338 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -71.56 -33.89 69.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.583 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.95 -24.19 28.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.476 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 34.8 m-85 -95.15 -16.68 22.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.72 -42.03 92.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -44.73 -32.29 5.86 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 123.092 2.528 . . . . 0.0 114.888 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.758 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 78.5 m-85 -85.4 -42.78 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.769 0.319 . . . . 0.0 110.752 -177.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.61 157.22 29.46 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.969 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.45 117.92 4.65 Favored 'Trans proline' 0 C--O 1.241 0.649 0 C-N-CA 122.71 2.273 . . . . 0.0 111.722 175.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.431 HD13 ' HB2' ' A' ' 132' ' ' PHE . 54.9 mt -72.53 132.55 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.242 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -96.7 -43.05 7.72 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.228 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.7 m -152.76 140.41 19.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.3 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.8 mt -122.76 124.86 71.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.951 0.405 . . . . 0.0 110.139 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 8.0 m-20 -112.71 98.8 7.46 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 174.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.722 ' HE1' HG13 ' A' ' 128' ' ' ILE . 54.4 ttm -124.26 137.72 54.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.899 178.146 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 47.4 p90 . . . . . 0 C--O 1.236 0.343 0 CA-C-O 120.436 0.16 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 142' ' ' ASP . . . -148.84 140.93 23.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.913 0.387 . . . . 0.0 111.613 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -110.45 116.57 31.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.92 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.589 ' HB ' HG12 ' A' ' 114' ' ' VAL . 88.3 t -95.71 108.27 20.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.045 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.504 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 38.5 tt0 -96.41 128.89 43.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.217 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -103.57 165.97 10.71 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.77 -13.94 60.31 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.66 173.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.7 m -138.65 139.64 25.03 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 45.0 Cg_endo -67.83 -19.28 47.0 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.314 2.676 . . . . 0.0 112.486 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.691 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 7.5 mp0 -59.44 -48.21 82.5 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.966 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.24 -22.23 66.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.871 0.367 . . . . 0.0 111.853 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.08 -49.61 10.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.927 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 164' ' ' GLU . 5.0 pp0? -64.3 -30.78 71.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.758 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.8 tp -71.22 -50.54 31.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.431 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.31 -33.39 75.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.392 . . . . 0.0 110.296 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.553 HD11 ' HA3' ' A' ' 186' ' ' GLY . 8.8 tt -71.74 -38.06 70.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.2 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.64 -52.12 64.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.183 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -100.04 -30.43 11.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -172.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 27.8 ttp -106.87 28.19 8.21 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.483 -170.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -74.62 -8.62 56.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.089 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.6 m -72.7 -73.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.17 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.543 HG13 ' HA ' ' A' ' 182' ' ' ASN . 27.1 m -144.69 167.59 10.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.949 0.404 . . . . 0.0 111.42 -173.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.718 ' HB2' HD11 ' A' ' 183' ' ' ILE . 11.7 tpp -132.4 74.47 1.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 172.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 60.6 mt 59.5 -174.3 0.1 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.28 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.2 -63.63 3.57 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.889 173.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 129.56 34.99 0.47 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -144.04 136.59 26.92 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.543 ' HA ' HG13 ' A' ' 176' ' ' VAL . 2.1 p-10 -71.59 141.49 50.01 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.983 0.42 . . . . 0.0 109.998 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 177' ' ' MET . 45.3 pt -112.55 178.89 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.859 -176.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.628 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 18.6 tptm -112.87 112.64 24.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.603 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.0 t -109.7 109.45 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.049 0.452 . . . . 0.0 110.792 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.553 ' HA3' HD11 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.476 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.744 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 121.274 0.559 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.528 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -76.76 -22.49 53.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.369 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.472 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 31.7 mm-40 -60.59 -53.46 64.23 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.2 Cg_endo -53.24 -34.56 70.26 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.489 2.126 . . . . 0.0 112.995 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 65.9 mt -74.63 -38.85 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.543 0.211 . . . . 0.0 110.691 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.536 HG12 ' SD ' ' A' ' 111' ' ' MET . 70.2 mt -58.07 -49.07 82.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.225 0.536 . . . . 0.0 109.732 174.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.9 -37.49 87.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.888 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . 0.473 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 24.7 tp60 -60.2 -51.66 68.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.877 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 31.6 mt -67.52 -33.27 74.74 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.936 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.87 -37.71 66.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.48 -36.66 63.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.922 174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 200' ' ' GLN . 26.7 mt-10 -71.72 -24.0 61.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.819 0.342 . . . . 0.0 111.778 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.19 -26.55 61.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.394 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 37.2 mtm180 -69.71 -17.95 63.5 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.451 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.01 -15.25 62.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.097 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -119.89 -172.76 2.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.601 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 68.4 m-20 -130.29 41.72 3.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.453 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 32.1 ttp180 -101.13 138.01 38.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.3 0.571 . . . . 0.0 112.044 -172.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.435 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.5 pt -124.71 167.76 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.233 175.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.436 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 77.6 t80 -121.47 129.07 52.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.707 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.453 HG13 ' CZ ' ' A' ' 229' ' ' PHE . 33.7 m -124.28 134.9 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.014 0.435 . . . . 0.0 110.445 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -130.8 178.27 6.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.944 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 28.5 t 59.44 36.16 23.08 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.626 0.727 . . . . 0.0 109.413 -173.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.594 HG12 HD13 ' A' ' 225' ' ' ILE . 10.5 t -73.61 120.47 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.687 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.465 ' HD2' ' NE2' ' A' ' 278' ' ' GLN . 25.9 t-80 -54.11 146.89 13.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.297 -174.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -48.58 -53.37 18.63 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -93.03 37.4 1.03 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.155 0.502 . . . . 0.0 111.368 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.431 HD21 HD23 ' A' ' 275' ' ' LEU . 12.2 tp -117.69 109.49 16.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 96.8 p -93.91 -179.36 4.95 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.065 -175.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.46 -32.18 73.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.658 0.266 . . . . 0.0 110.571 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.84 -35.75 79.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.026 0.441 . . . . 0.0 110.173 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.26 -48.52 72.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.294 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 255' ' ' ILE . 33.4 mm -62.89 -46.73 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.43 ' HG3' HG21 ' A' ' 235' ' ' ILE . 54.2 tttm -54.33 -52.42 61.61 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.26 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 62.0 p -55.99 -39.6 72.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -174.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.1 t -76.48 -45.97 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.456 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.73 ' HB2' HD13 ' A' ' 235' ' ' ILE . 9.0 m-85 -64.72 -32.51 74.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.521 0.677 . . . . 0.0 110.557 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.63 -25.32 68.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.523 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.26 -25.81 63.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.765 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -101.59 -33.61 9.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.553 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -145.11 164.56 27.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.607 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -77.51 99.41 5.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.853 0.359 . . . . 0.0 110.746 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.73 HD13 ' HB2' ' A' ' 229' ' ' PHE . 13.3 mt -74.6 146.57 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.353 0.596 . . . . 0.0 111.393 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -110.31 -34.41 6.36 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.882 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 50.7 m -162.2 131.07 4.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.372 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.43 ' SG ' HG12 ' A' ' 255' ' ' ILE . 52.5 t -131.59 117.06 18.21 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 26.2 m -138.6 113.76 9.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.845 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.568 HD23 ' HA3' ' A' ' 253' ' ' GLY . 33.3 mt -82.46 139.93 33.68 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.39 115.56 7.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -128.62 136.75 51.11 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.172 -172.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -69.42 109.35 4.36 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.65 -45.35 41.7 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.199 3.266 . . . . 0.0 114.611 -168.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.51 HG22 HG22 ' A' ' 246' ' ' THR . 8.7 t -82.71 -11.86 58.01 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -170.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.51 HG22 HG22 ' A' ' 245' ' ' THR . 23.0 p -114.94 -21.51 10.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.114 0.483 . . . . 0.0 112.237 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 77.57 39.3 25.96 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.464 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -126.04 130.7 51.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.897 0.38 . . . . 0.0 110.36 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.43 ' HE1' ' O ' ' A' ' 216' ' ' VAL . 23.9 p80 -76.85 128.86 35.36 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 173.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -62.21 -20.64 64.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.274 -173.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 130.78 -5.02 5.79 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.274 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.436 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 46.3 p90 -140.65 167.96 20.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.745 0.307 . . . . 0.0 110.607 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.568 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -158.56 172.09 35.42 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.084 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.691 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 97.9 m-85 -128.05 142.52 51.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.894 0.378 . . . . 0.0 110.852 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.598 HD11 HG23 ' A' ' 225' ' ' ILE . 77.8 mt -136.8 131.79 47.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.767 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 16.5 mt-10 -112.44 146.57 38.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.875 175.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.553 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 9.2 m-85 -108.89 161.2 15.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.807 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.54 -22.33 59.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.509 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.8 141.58 48.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.035 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . 0.577 ' HA ' ' OD1' ' A' ' 209' ' ' ASN . . . -57.99 -60.21 4.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -169.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -74.51 -20.61 59.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 -171.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.9 m -62.1 -25.8 67.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.431 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.435 ' HB2' HG23 ' A' ' 211' ' ' ILE . 87.8 p -68.94 -39.61 79.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.372 0.606 . . . . 0.0 109.697 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -75.08 -23.16 57.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.897 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.28 -41.27 98.98 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.71 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.497 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -65.54 -42.22 92.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.37 175.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.556 ' HA ' HG21 ' A' ' 282' ' ' VAL . 96.4 t -54.14 -34.32 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.193 0.52 . . . . 0.0 110.822 177.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 26.1 t -73.11 -35.29 66.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.29 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.6 t -92.74 -35.08 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 111.832 -173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 73.2 mmm -88.64 5.65 42.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.785 0.326 . . . . 0.0 111.245 -171.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.476 ' HA ' HG11 ' A' ' 282' ' ' VAL . 25.1 t-20 -66.5 109.77 2.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.348 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.4 mt 63.47 40.91 7.89 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.549 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . 0.474 ' HD2' ' HB2' ' A' ' 275' ' ' LEU . 49.4 t80 -79.69 126.84 31.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.137 174.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -80.17 71.34 6.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.629 0.728 . . . . 0.0 111.444 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 30.8 tp -95.37 103.48 15.34 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.109 0.48 . . . . 0.0 110.245 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 90.14 21.45 38.65 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.494 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 88.91 -9.27 77.26 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.695 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.465 ' NE2' ' HD2' ' A' ' 217' ' ' HIS . 79.2 mt-30 -116.66 144.17 44.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.866 0.365 . . . . 0.0 110.697 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -80.2 115.45 19.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.577 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 64.6 mt -64.53 126.64 28.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.437 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 281' ' ' ARG . 2.5 mmt180 -93.57 115.1 27.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 176.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 267' ' ' VAL . 8.3 p -112.83 147.16 16.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.155 -173.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.93 169.92 38.27 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -84.15 134.26 34.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.07 107.78 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.018 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 15.9 m -68.19 -27.6 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.541 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 69.9 p -98.52 124.5 46.29 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-O 121.246 0.546 . . . . 0.0 110.845 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 N--CA 1.46 -0.454 0 C-N-CA 122.755 2.303 . . . . 0.0 111.23 172.885 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.936 0.398 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.0 mtp-105 -56.57 -40.12 74.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.279 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.86 -30.81 71.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.697 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 287' ' ' THR . 24.2 mt -69.37 -41.25 76.78 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.495 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.73 70.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 110.516 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 194' ' ' ALA . 69.4 mt -79.84 -46.25 22.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.872 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 30.9 mtm -65.22 -37.07 86.14 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.6 m -63.2 -19.21 64.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.738 0.304 . . . . 0.0 111.223 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -104.68 140.54 37.9 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.623 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.0 p -129.24 128.09 66.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.66 0.743 . . . . 0.0 110.371 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -85.13 113.59 21.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.332 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 29.6 m -111.41 116.44 52.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.306 0.574 . . . . 0.0 110.314 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -113.78 106.33 1.73 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.76 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' SER . . . . . 0.849 ' HB3' HG21 ' A' ' 183' ' ' ILE . 27.7 t 154.6 -90.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.894 1.278 . . . . 0.0 109.106 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.732 ' H ' HG21 ' A' ' 183' ' ' ILE . 13.6 mt 60.01 31.31 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.371 0.668 . . . . 0.0 111.497 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.646 ' HA ' ' HD3' ' A' ' 181' ' ' ARG . 27.8 t80 60.3 -164.06 0.23 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -124.14 75.44 1.38 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.792 1.282 . . . . 0.0 109.426 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 123' ' ' LEU . 5.8 tt0 -178.42 -144.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.81 -1.995 . . . . 0.0 106.64 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.538 HD22 HG21 ' A' ' 127' ' ' THR . 92.1 mt 57.6 -174.36 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.784 0.678 . . . . 0.0 112.187 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.79 -179.63 36.58 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.5 -45.72 90.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.821 0.343 . . . . 0.0 110.42 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.428 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 4.4 m-20 -56.87 -49.39 75.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.444 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.538 HG21 HD22 ' A' ' 123' ' ' LEU . 5.0 m -61.7 -43.1 99.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.034 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 21.5 mm -66.55 -39.84 84.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.54 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.445 ' O ' ' HB1' ' A' ' 133' ' ' ALA . 43.2 ttp180 -60.7 -38.65 85.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.999 177.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 78.0 mt-30 -71.53 -33.26 69.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.211 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.05 -33.76 50.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -92.73 -16.19 25.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.601 0.238 . . . . 0.0 111.495 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.605 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -51.01 -44.66 87.37 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 5.1 Cg_exo -43.24 -49.07 7.61 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.981 2.454 . . . . 0.0 113.976 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.504 ' HD2' ' HG ' ' A' ' 168' ' ' LEU . 72.7 m-85 -65.28 -48.49 72.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -170.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.3 -171.66 29.82 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.449 -1.358 . . . . 0.0 113.271 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 161' ' ' GLU . 71.7 Cg_endo -78.79 121.61 5.11 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.752 2.302 . . . . 0.0 111.737 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.48 HD11 HD13 ' A' ' 141' ' ' ILE . 57.6 mt -80.8 119.69 30.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.367 0.603 . . . . 0.0 110.662 -177.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.656 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 28.1 tptp -89.26 -34.13 16.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.847 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.9 t -174.53 162.14 3.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.857 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.48 HD13 HD11 ' A' ' 138' ' ' ILE . 70.1 mt -141.22 122.37 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.745 0.307 . . . . 0.0 110.307 175.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 12.0 m-20 -95.01 104.01 15.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.387 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 3.9 mmt -94.98 126.18 40.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.737 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.417 0.627 . . . . 0.0 109.75 174.495 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.96 140.95 28.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.154 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.672 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 92.7 m-85 -109.99 109.17 19.67 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.623 ' HB ' HG12 ' A' ' 114' ' ' VAL . 43.3 t -92.04 115.02 30.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.23 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.656 ' HG2' ' HB3' ' A' ' 139' ' ' LYS . 36.6 tt0 -105.26 125.46 51.01 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.414 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.18 174.44 5.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.373 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.488 ' HB2' ' HG2' ' A' ' 137' ' ' PRO . 46.3 mt-10 -89.46 -16.32 31.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.086 172.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.428 HG21 ' HD2' ' A' ' 137' ' ' PRO . 28.1 m -130.67 137.64 31.25 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.109 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.434 ' HG3' HD21 ' A' ' 108' ' ' LEU . 60.1 Cg_endo -73.1 -20.76 21.29 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.785 2.323 . . . . 0.0 112.647 -176.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.562 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 13.6 mp0 -54.24 -59.08 5.14 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.132 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.16 -26.66 17.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.17 -51.83 8.01 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.216 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.439 ' HG3' HG12 ' A' ' 286' ' ' VAL . 10.6 mm100 -67.52 -27.43 66.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.984 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.504 ' HG ' ' HD2' ' A' ' 135' ' ' PHE . 14.2 tp -72.13 -47.61 49.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.105 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.28 73.48 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 185' ' ' VAL . 6.6 tt -65.06 -51.95 58.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.656 172.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -56.09 -33.68 65.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.833 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -100.68 -48.85 4.37 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.9 mtm -95.73 28.83 2.87 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -167.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -85.5 30.69 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.996 0.903 . . . . 0.0 109.847 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 16.6 m -113.93 -74.32 0.63 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.323 176.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.4 m -145.59 170.86 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.467 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.609 ' HB2' HD11 ' A' ' 183' ' ' ILE . 22.5 tpp -143.4 91.33 2.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.604 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.511 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 75.7 mt 54.49 45.34 27.21 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.035 172.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 170.85 163.06 24.25 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.962 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.13 53.25 4.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.152 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . 0.646 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 25.4 mtp180 -143.46 125.78 15.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.096 0.474 . . . . 0.0 110.49 174.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 175' ' ' SER . 14.1 m120 -71.81 128.43 35.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.954 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.849 HG21 ' HB3' ' A' ' 118' ' ' SER . 43.9 pt -103.21 143.51 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.781 -177.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 50.4 mttp -103.0 118.29 36.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.7 t -110.67 111.77 37.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 123.591 0.557 . . . . 0.0 111.479 -172.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.262 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.552 170.059 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 121.012 0.434 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.448 ' HB2' HD12 ' A' ' 110' ' ' ILE . . . -87.34 -17.64 31.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.738 -175.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.549 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 11.8 tm0? -57.7 -50.58 87.34 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.886 -174.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.0 Cg_endo -53.16 -37.3 79.73 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.604 2.203 . . . . 0.0 113.1 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.5 mt -74.59 -41.33 48.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.297 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.6 mt -59.73 -48.85 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.096 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.535 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 14.7 t70 -59.19 -43.27 92.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.46 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -59.38 -50.93 72.05 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.471 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.6 -33.0 73.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.681 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.41 -39.49 73.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.663 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 44.3 mt-10 -66.75 -33.82 76.46 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.755 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.51 -37.02 84.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.349 . . . . 0.0 110.568 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.35 -33.76 76.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.095 0.474 . . . . 0.0 110.27 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.663 ' HD3' ' HA ' ' A' ' 203' ' ' GLU . 66.9 mtp180 -70.36 -13.77 62.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.158 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.73 -38.37 19.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.052 0.453 . . . . 0.0 110.783 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.47 -19.88 23.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.114 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 61.64 46.92 6.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.16 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.414 ' HE ' ' HB3' ' A' ' 254' ' ' PHE . 22.5 ttt180 -103.32 137.14 41.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.72 -171.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 263' ' ' SER . 42.2 pt -118.96 167.25 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.346 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 81.3 t80 -119.53 128.04 53.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.619 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.98 135.04 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.217 0.532 . . . . 0.0 110.105 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . . . -121.92 173.86 7.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.642 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.426 ' OG ' ' HG2' ' A' ' 281' ' ' ARG . 2.0 p 43.7 42.35 4.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.946 0.879 . . . . 0.0 111.202 -174.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 24.1 t -84.77 108.64 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.27 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -54.88 135.72 47.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.559 0.695 . . . . 0.0 111.369 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -51.72 -27.29 11.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.701 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -85.59 -9.84 56.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.918 0.389 . . . . 0.0 111.113 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 72.1 mt -86.52 136.39 33.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.214 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 49.3 m -97.26 169.44 9.77 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.496 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -62.29 -29.64 70.57 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.304 -0.247 . . . . 0.0 111.073 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -66.24 -35.18 79.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.172 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -61.04 -54.21 47.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.979 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.522 HG13 HD21 ' A' ' 240' ' ' LEU . 24.9 mm -63.52 -43.52 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.995 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.672 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 54.6 tttm -58.29 -49.63 76.46 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.318 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 97.8 p -56.04 -43.92 78.3 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 17.4 t -75.03 -41.62 45.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.609 0.242 . . . . 0.0 111.109 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.561 ' CB ' HD12 ' A' ' 235' ' ' ILE . 4.6 m-85 -65.75 -34.31 77.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.179 0.514 . . . . 0.0 110.912 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.3 tm-20 -66.33 -24.84 66.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.746 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.25 -16.45 61.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.648 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -111.74 -44.5 3.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.628 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . 0.564 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -124.57 173.49 16.99 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.525 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -94.96 99.28 11.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.393 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.561 HD12 ' CB ' ' A' ' 229' ' ' PHE . 17.9 mt -79.12 146.09 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.424 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -111.22 -33.14 6.53 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.126 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 18.8 m -152.84 125.55 8.33 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.485 -170.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 26.8 p -108.05 114.22 27.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.042 0.449 . . . . 0.0 109.907 170.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 27.5 m -141.71 102.06 4.09 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.286 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.522 HD21 HG13 ' A' ' 225' ' ' ILE . 64.6 mt -83.8 131.82 34.87 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.426 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -62.92 110.99 1.95 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.52 ' HD2' ' O ' ' A' ' 247' ' ' GLY . 16.1 ttp180 -123.98 144.88 49.55 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.798 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.54 113.66 41.4 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 172.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.19 -25.71 47.72 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.707 2.938 . . . . 0.0 115.162 -167.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.7 t -110.09 3.75 20.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 8.2 t -103.83 -13.57 16.36 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.934 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . 0.52 ' O ' ' HD2' ' A' ' 242' ' ' ARG . . . 91.83 -48.13 2.76 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.977 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 16.2 pttp -94.85 156.17 16.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.756 0.278 . . . . 0.0 110.451 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 4.4 p80 -80.07 161.88 25.11 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.743 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.15 -58.72 6.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.161 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 163.32 -17.18 0.13 Allowed Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.178 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.421 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 9.5 p90 -120.61 173.75 6.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.426 ' HA2' ' H ' ' A' ' 241' ' ' ALA . . . -163.84 172.89 39.82 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.959 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.562 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 76.4 m-85 -135.3 143.01 45.97 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 122.598 0.359 . . . . 0.0 110.072 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.2 mt -139.78 133.23 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.976 0.417 . . . . 0.0 110.705 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -105.68 147.79 28.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 13.2 m-85 -117.45 151.57 36.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.915 0.388 . . . . 0.0 110.269 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -72.4 -16.28 61.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.844 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -131.41 132.33 44.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.904 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -56.35 -33.95 66.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.332 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.37 -33.39 61.04 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.032 0.444 . . . . 0.0 110.864 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 4.7 t -66.56 -36.11 81.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.186 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.687 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 71.9 p -65.94 -36.69 84.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.207 0.527 . . . . 0.0 109.963 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -72.79 -24.12 60.88 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.82 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.63 -44.91 76.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.0 0.428 . . . . 0.0 110.398 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -64.28 -38.17 90.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.49 HG12 ' HA2' ' A' ' 283' ' ' GLY . 72.0 t -53.85 -38.94 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 120.966 0.413 . . . . 0.0 111.457 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 m -82.02 -19.8 39.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.81 0.338 . . . . 0.0 111.596 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 17.8 m -95.24 -49.26 5.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 58.4 mmm -81.57 -9.19 59.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -168.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -69.24 128.43 36.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.359 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 93.2 mt 66.99 31.69 6.83 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.852 0.72 . . . . 0.0 110.508 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -100.63 116.4 32.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.982 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.65 116.37 6.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.006 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 31.7 tp -143.02 118.67 10.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.766 173.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.57 6.48 87.34 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.028 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.44 -0.17 46.64 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.282 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -134.1 151.15 51.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -84.35 116.2 22.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.714 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.97 115.02 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.603 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . 0.554 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 14.1 mmt180 -93.89 114.95 27.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.33 140.82 40.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 119.711 -0.795 . . . . 0.0 111.202 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . 0.49 ' HA2' HG12 ' A' ' 267' ' ' VAL . . . -153.97 -169.98 19.46 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -89.95 137.94 31.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 117.334 0.567 . . . . 0.0 109.59 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -71.06 121.9 19.07 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.439 HG12 ' HG3' ' A' ' 167' ' ' GLN . 28.2 m -79.48 -25.66 12.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.794 0.33 . . . . 0.0 110.987 -175.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.714 HG21 HD22 ' A' ' 108' ' ' LEU . 73.2 p -133.18 145.54 57.24 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 N--CA 1.462 -0.345 0 C-N-CA 122.492 2.128 . . . . 0.0 111.185 173.189 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 121.498 0.666 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -67.99 -27.77 66.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.367 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 197' ' ' ILE . . . -65.89 -30.53 71.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.343 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.454 HD21 HG22 ' A' ' 287' ' ' THR . 42.9 mt -60.93 -31.52 71.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.361 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.7 -24.96 67.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.132 0.491 . . . . 0.0 110.757 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.1 mt -87.83 -34.46 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.142 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.511 ' SD ' HG12 ' A' ' 198' ' ' ILE . 88.0 mtp -74.99 -15.5 60.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.093 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 97.7 m -79.61 -1.26 37.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.538 0.209 . . . . 0.0 111.378 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.885 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 32.7 mtt180 -110.81 142.43 42.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.765 0.317 . . . . 0.0 111.235 -174.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.545 HG23 HD11 ' A' ' 170' ' ' LEU . 8.9 p -128.4 129.79 69.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.408 0.623 . . . . 0.0 109.817 169.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -85.01 118.32 24.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.819 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.603 HG11 HG13 ' A' ' 185' ' ' VAL . 15.5 m -112.59 126.68 70.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.286 0.565 . . . . 0.0 111.372 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -131.31 175.36 19.61 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.543 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.7 m 62.1 31.87 17.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 122.934 0.493 . . . . 0.0 111.455 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.5 mt -77.22 112.83 15.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.067 0.46 . . . . 0.0 110.513 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -61.38 153.55 26.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.628 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -78.01 76.29 4.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.086 0.946 . . . . 0.0 110.949 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -165.21 -39.95 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.095 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.405 ' HB3' HD13 ' A' ' 128' ' ' ILE . 66.3 mt -74.93 85.96 2.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.969 174.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.48 172.33 55.22 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.924 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -55.1 -40.03 69.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 0.0 110.942 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.28 -53.49 54.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.58 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 m -59.0 -43.07 91.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.978 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.813 HG13 ' HE1' ' A' ' 143' ' ' MET . 28.4 mm -63.19 -45.32 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.738 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -57.39 -43.85 84.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.43 . . . . 0.0 110.248 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -68.73 -33.79 74.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.939 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.61 -27.03 25.73 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.502 ' HB2' HD12 ' A' ' 138' ' ' ILE . 4.9 m-85 -87.52 -26.01 23.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.78 0.324 . . . . 0.0 111.06 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.437 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -50.76 -42.19 76.09 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 26.1 Cg_exo -39.12 -45.96 2.88 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.168 2.579 . . . . 0.0 114.559 173.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.496 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 54.2 m-85 -76.1 -37.12 58.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.877 0.37 . . . . 0.0 110.597 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -176.04 153.49 14.81 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.45 124.31 15.94 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.718 2.279 . . . . 0.0 111.755 175.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.502 HD12 ' HB2' ' A' ' 132' ' ' PHE . 21.0 mt -83.13 136.51 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.073 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -110.96 -20.32 12.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.175 0.512 . . . . 0.0 110.751 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.873 ' HB3' ' HB2' ' A' ' 159' ' ' GLU . 29.5 t -151.84 131.16 12.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.444 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.8 mt -130.28 129.67 65.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -117.48 99.45 7.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.813 ' HE1' HG13 ' A' ' 128' ' ' ILE . 52.1 ttm -141.33 112.0 7.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.828 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.768 178.731 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.12 167.62 27.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.995 0.426 . . . . 0.0 111.299 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -126.84 134.66 50.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.393 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.428 ' HB ' HG12 ' A' ' 114' ' ' VAL . 89.4 t -121.07 113.0 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.644 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.885 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 4.8 mp0 -105.54 119.62 39.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.554 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.14 179.87 5.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.793 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.36 -63.15 1.17 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.832 169.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.3 m -99.08 144.79 28.86 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.951 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 22.9 Cg_exo -65.71 -19.82 59.45 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.469 2.779 . . . . 0.0 112.535 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.479 ' OE2' ' HB3' ' A' ' 212' ' ' TYR . 0.6 OUTLIER -58.53 -54.91 41.75 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.836 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.16 -25.82 14.9 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.5 -53.01 7.29 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.384 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' A' ' 286' ' ' VAL . 83.7 mm-40 -64.47 -43.33 94.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.751 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.496 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 10.5 tp -59.64 -46.44 89.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.436 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.673 ' HB3' ' SD ' ' A' ' 173' ' ' MET . . . -61.68 -53.09 60.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.55 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.2 tt -54.45 -36.13 63.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.467 0.651 . . . . 0.0 110.234 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.01 -46.48 71.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.73 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -100.87 -21.13 15.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -173.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.673 ' SD ' ' HB3' ' A' ' 169' ' ' ALA . 4.6 ptm -99.74 18.55 17.88 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.925 -0.484 . . . . 0.0 110.792 -176.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -72.78 -2.92 22.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.1 m -101.56 -74.22 0.63 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.472 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.88 157.17 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.232 0.539 . . . . 0.0 111.675 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.537 ' HB2' HD12 ' A' ' 183' ' ' ILE . 23.9 tpp -121.78 97.27 5.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.693 175.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 75.3 mt 61.49 35.91 17.35 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.249 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.34 -130.37 9.73 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.112 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 67.1 -94.26 0.25 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.574 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -144.33 153.69 42.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -68.89 100.43 1.19 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 177' ' ' MET . 47.9 pt -74.84 149.6 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.369 -175.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.682 ' HE2' ' HA ' ' A' ' 184' ' ' LYS . 9.3 mmpt? -103.45 107.3 18.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.161 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.603 HG13 HG11 ' A' ' 116' ' ' VAL . 5.9 m -104.62 109.41 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.222 0.534 . . . . 0.0 111.135 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.55 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.409 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.486 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 CA--C 1.524 -0.036 0 CA-C-O 121.302 0.572 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -87.96 10.18 19.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.476 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.697 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 25.3 tp60 -49.25 -53.13 42.45 Favored Pre-proline 0 N--CA 1.469 0.488 0 O-C-N 123.296 0.373 . . . . 0.0 111.89 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 40.0 Cg_exo -59.06 -37.47 92.71 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.198 1.932 . . . . 0.0 112.701 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.484 HD11 ' HB1' ' A' ' 107' ' ' ALA . 74.8 mt -75.3 -43.26 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.065 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.511 HG12 ' SD ' ' A' ' 111' ' ' MET . 73.7 mt -58.16 -45.9 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.149 0.5 . . . . 0.0 110.158 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 36.0 t70 -66.8 -39.01 87.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.765 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.43 -48.4 75.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.869 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.578 ' HA ' ' HG3' ' A' ' 204' ' ' GLU . 54.3 mt -68.14 -33.12 73.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.649 0.261 . . . . 0.0 111.032 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.569 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.15 -42.96 77.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 51.5 mt-10 -64.7 -36.36 84.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.901 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 201' ' ' LEU . 5.8 mm-40 -53.66 -46.03 70.44 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.059 0.457 . . . . 0.0 110.891 175.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 285' ' ' ALA . . . -63.73 -37.01 85.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.784 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 76.3 mtp180 -72.47 -16.75 61.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.164 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -99.38 -38.21 8.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.458 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -86.72 -12.46 48.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.126 0.489 . . . . 0.0 111.1 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 61.02 48.48 6.47 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.18 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.863 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 12.8 ptm180 -122.11 158.02 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.989 0.424 . . . . 0.0 111.718 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 pt -136.36 168.59 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.578 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.518 ' HB2' ' CE2' ' A' ' 254' ' ' PHE . 14.1 t80 -122.89 138.63 54.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.611 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.572 HG12 ' CZ ' ' A' ' 229' ' ' PHE . 35.5 m -127.42 133.83 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 110.757 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.78 -178.52 4.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.309 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.4 t 61.27 30.24 19.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.902 0.858 . . . . 0.0 109.082 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.0 119.17 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.236 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -57.45 142.27 44.6 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.974 0.416 . . . . 0.0 111.062 -173.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -49.04 -36.18 17.49 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -168.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -91.03 -5.83 54.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -171.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.81 131.87 36.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.117 0.484 . . . . 0.0 111.14 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.2 p -100.6 173.58 6.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.192 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.467 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 6.1 p-10 -61.62 -35.46 77.94 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.722 0.296 . . . . 0.0 110.415 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.48 -39.08 82.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.258 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.36 -44.23 68.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.597 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.589 HG22 HD11 ' A' ' 255' ' ' ILE . 29.6 mm -66.37 -40.73 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.459 ' HB2' ' CB ' ' A' ' 238' ' ' CYS . 88.2 tttt -60.82 -43.33 98.35 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.479 176.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 51.1 m -59.36 -39.09 82.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.76 -45.5 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.625 0.25 . . . . 0.0 111.304 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.599 ' CB ' HD12 ' A' ' 235' ' ' ILE . 15.5 m-85 -65.91 -30.39 70.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.225 0.536 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 7.6 tp10 -61.0 -24.21 65.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.946 176.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.65 -13.16 59.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.883 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -111.06 -34.39 6.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.692 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.97 166.74 29.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.332 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -78.56 103.19 8.34 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.253 0.549 . . . . 0.0 111.336 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.599 HD12 ' CB ' ' A' ' 229' ' ' PHE . 22.3 mt -78.6 150.94 5.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.103 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.04 -28.66 8.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.794 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 256' ' ' GLU . 3.3 p -172.04 153.1 3.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.671 0.272 . . . . 0.0 111.136 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . 0.459 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 41.6 t -143.5 127.79 17.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.16 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.2 t -141.53 108.48 5.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.067 0.461 . . . . 0.0 111.311 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.525 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 36.5 mt -79.32 130.58 35.58 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . 0.571 ' HB3' ' CD1' ' A' ' 252' ' ' TYR . . . -75.03 118.68 18.26 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.522 ' CB ' ' HA ' ' A' ' 249' ' ' HIS . 35.9 ptt180 -139.56 169.04 18.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.95 -170.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -106.17 108.48 61.79 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 173.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.41 -37.61 94.1 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.305 2.67 . . . . 0.0 113.161 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -35.04 79.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.949 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 41.0 p -97.78 -18.67 18.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 111.537 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 73.77 44.82 30.14 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.05 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -150.95 139.64 20.7 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . 0.522 ' HA ' ' CB ' ' A' ' 242' ' ' ARG . 6.2 p80 -83.68 140.23 32.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -81.26 30.06 0.34 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -169.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 92.97 -6.06 76.27 Favored Glycine 0 CA--C 1.505 -0.578 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.429 171.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.571 ' CD1' ' HB3' ' A' ' 241' ' ' ALA . 0.2 OUTLIER -140.42 173.87 11.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -176.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -169.77 174.7 44.02 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.413 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 212' ' ' TYR . 59.7 m-85 -129.51 146.92 51.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.169 0.484 . . . . 0.0 110.512 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.589 HD11 HG22 ' A' ' 225' ' ' ILE . 84.9 mt -136.03 147.76 28.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.008 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.863 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 34.7 mt-10 -127.65 146.81 50.43 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.639 ' HB2' ' OG ' ' A' ' 263' ' ' SER . 18.7 m-85 -119.66 159.18 24.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.825 0.345 . . . . 0.0 110.915 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.16 -36.42 69.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.211 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -107.1 131.67 53.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -58.23 -34.26 70.23 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.655 -173.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . 0.428 HE21 ' HB2' ' A' ' 261' ' ' GLN . 0.0 OUTLIER -64.81 -44.48 89.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.2 176.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.0 m -65.02 -30.58 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.296 -169.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.639 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 1.6 m -60.96 -47.6 85.69 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.389 0.614 . . . . 0.0 109.646 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -73.69 -26.84 60.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.325 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -74.29 -32.99 63.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.418 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -66.78 -40.07 88.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.418 HG23 HG22 ' A' ' 282' ' ' VAL . 64.5 t -55.13 -45.56 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.433 0.635 . . . . 0.0 109.882 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 53.0 m -63.26 -30.01 71.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.699 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.9 m -95.61 -37.26 10.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.475 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 90.5 mmm -92.77 -3.52 54.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -166.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 272' ' ' LEU . 15.9 t30 -72.95 124.77 26.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.22 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 99.1 mt 72.37 26.17 2.67 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.901 0.75 . . . . 0.0 110.643 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -87.33 120.75 28.94 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.538 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 10.2 p-10 -78.21 101.23 6.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.467 0.651 . . . . 0.0 110.871 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.536 HD11 HD12 ' A' ' 280' ' ' LEU . 0.9 OUTLIER -113.37 107.7 16.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.03 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 73.58 22.32 78.56 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.838 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.27 -38.5 3.26 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.775 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -87.87 148.68 24.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.857 0.328 . . . . 0.0 110.979 -176.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 274' ' ' ASP . 81.4 m-85 -90.55 113.33 25.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.088 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.536 HD12 HD11 ' A' ' 275' ' ' LEU . 69.9 mt -60.18 133.27 55.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.479 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -107.1 116.35 31.77 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 172.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.418 HG22 HG23 ' A' ' 267' ' ' VAL . 7.8 p -118.1 140.55 41.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.184 0.516 . . . . 0.0 111.36 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -132.47 174.78 20.24 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.018 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -100.33 45.43 0.98 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.597 0.713 . . . . 0.0 110.957 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.517 ' O ' ' HB1' ' A' ' 205' ' ' ALA . . . 33.09 69.89 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 112.9 -1.955 . . . . 0.0 113.709 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.403 HG23 ' HG3' ' A' ' 167' ' ' GLN . 35.1 m -54.8 -26.29 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.926 0.393 . . . . 0.0 111.159 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' THR . . . . . 0.466 ' HA ' ' HD2' ' A' ' 288' ' ' PRO . 25.7 p -134.04 107.14 11.44 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.611 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 287' ' ' THR . 21.8 Cg_endo . . . . . 0 N--CA 1.462 -0.38 0 C-N-CA 122.857 2.372 . . . . 0.0 111.363 172.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.042 0.448 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -53.64 -49.26 68.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.494 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.7 -48.02 61.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.08 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.99 -34.66 78.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.947 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.96 -32.49 72.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.145 0.498 . . . . 0.0 110.584 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.8 mt -80.67 -34.59 14.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.158 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.455 ' SD ' HG12 ' A' ' 198' ' ' ILE . 84.8 mtp -71.42 -23.48 61.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.83 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.7 m -84.11 -1.74 55.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.842 0.353 . . . . 0.0 110.77 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.609 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 98.5 mtt180 -122.03 141.09 51.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.129 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.25 133.12 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.159 0.505 . . . . 0.0 110.022 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -83.5 121.1 26.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.617 HG12 ' HZ ' ' A' ' 132' ' ' PHE . 15.7 m -117.46 116.56 52.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.066 0.46 . . . . 0.0 110.097 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.462 ' O ' ' HB ' ' A' ' 183' ' ' ILE . . . -122.23 171.39 15.32 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.03 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 m 67.38 25.98 8.52 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.785 0.434 . . . . 0.0 111.196 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.3 mt -66.81 115.56 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -53.32 143.26 19.16 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.924 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -69.5 80.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.447 0.642 . . . . 0.0 110.206 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -164.3 -44.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.974 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.421 ' CD1' ' HG3' ' A' ' 177' ' ' MET . 48.1 mt -83.33 124.27 30.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.187 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -97.74 -169.86 32.63 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.4 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -65.28 -33.04 75.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.019 0.438 . . . . 0.0 110.225 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 9.8 m-20 -71.91 -50.59 27.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.535 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -41.86 86.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.503 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.905 HG13 ' HE3' ' A' ' 143' ' ' MET . 17.1 mm -63.95 -42.91 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.812 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.2 ttt85 -59.15 -38.74 80.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.982 0.42 . . . . 0.0 110.307 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 23.4 mt-30 -66.37 -33.78 76.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.338 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.62 -23.69 29.45 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.617 ' HZ ' HG12 ' A' ' 116' ' ' VAL . 28.3 m-85 -94.25 -21.8 18.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.765 0.317 . . . . 0.0 111.479 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.611 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.21 -42.58 87.16 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 1.1 Cg_endo -47.54 -39.12 29.12 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.86 2.374 . . . . 0.0 114.325 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.599 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 62.9 m-85 -78.39 -38.04 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -172.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.69 172.61 45.11 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.197 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.56 117.56 5.21 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.638 2.226 . . . . 0.0 111.469 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.736 HD12 HD12 ' A' ' 141' ' ' ILE . 80.9 mt -72.63 131.95 34.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.705 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -111.09 -21.02 12.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.352 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 t -165.36 142.28 5.68 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.963 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.736 HD12 HD12 ' A' ' 138' ' ' ILE . 54.0 mt -142.0 114.44 3.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.277 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 157' ' ' PHE . 7.9 p-10 -110.28 108.15 18.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.496 0.665 . . . . 0.0 109.426 172.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.905 ' HE3' HG13 ' A' ' 128' ' ' ILE . 45.5 ttm -109.68 146.37 34.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.265 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.742 178.193 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 51.6 p90 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.611 0.244 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.62 159.04 29.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.442 ' HB2' ' OD1' ' A' ' 142' ' ' ASP . 51.8 m-85 -112.33 112.74 24.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.846 172.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.445 HG12 ' CD2' ' A' ' 132' ' ' PHE . 59.3 t -98.7 117.46 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.177 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.609 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 37.0 tt0 -109.33 138.85 45.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -115.32 -175.97 2.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.229 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.36 -34.35 61.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.815 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.5 m -125.98 150.78 70.19 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.043 0.449 . . . . 0.0 111.365 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 58.0 Cg_endo -70.1 -14.1 34.62 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.369 2.713 . . . . 0.0 111.938 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.447 ' HG3' ' HE1' ' A' ' 254' ' ' PHE . 70.5 mm-40 -59.12 -59.59 5.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.985 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.73 -19.21 10.23 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.52 -53.32 6.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.798 0.332 . . . . 0.0 110.111 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.57 -36.78 84.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.828 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.599 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 18.5 tp -66.23 -46.96 75.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.29 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.54 -44.17 96.39 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.585 ' HG ' HG12 ' A' ' 185' ' ' VAL . 6.1 tt -55.43 -44.34 76.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.247 0.546 . . . . 0.0 109.789 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.16 -39.84 79.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.127 -0.942 . . . . 0.0 113.204 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -100.59 -7.34 24.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' MET . . . . . 0.871 ' HE2' ' HE2' ' A' ' 177' ' ' MET . 32.5 ttm -97.46 -16.46 20.15 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -78.59 27.39 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 111.414 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.473 ' O ' HG11 ' A' ' 176' ' ' VAL . 41.5 t -113.6 -58.77 2.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.359 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -164.3 167.47 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 124.042 0.839 . . . . 0.0 109.167 177.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' MET . . . . . 0.871 ' HE2' ' HE2' ' A' ' 173' ' ' MET . 15.1 tpp -134.05 88.16 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.423 0.63 . . . . 0.0 110.805 172.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.439 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 90.1 mt 58.96 -79.83 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.597 174.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -79.02 54.93 4.27 Favored Glycine 0 CA--C 1.518 0.219 0 N-CA-C 114.278 0.471 . . . . 0.0 114.278 -168.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.87 -52.42 3.6 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 114.078 0.391 . . . . 0.0 114.078 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -76.27 133.96 39.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.091 0.472 . . . . 0.0 111.631 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 43.8 t30 -80.12 134.59 36.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.096 171.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ILE . . . . . 0.641 HD12 ' SD ' ' A' ' 173' ' ' MET . 40.8 pt -105.0 173.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.951 0.405 . . . . 0.0 110.624 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 87.7 mttt -102.62 106.1 16.71 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.585 HG12 ' HG ' ' A' ' 170' ' ' LEU . 12.0 p -102.78 120.39 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.605 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.766 178.164 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.775 0.322 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -103.89 5.62 35.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.023 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLN . . . . . 0.583 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 19.3 tm0? -53.36 -46.64 97.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.146 -177.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 6.8 Cg_endo -51.85 -44.6 43.88 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.298 1.999 . . . . 0.0 112.75 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.427 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 70.5 mt -69.43 -41.43 80.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 0.0 110.386 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.455 HG12 ' SD ' ' A' ' 111' ' ' MET . 74.2 mt -57.8 -48.3 84.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.461 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.52 -38.75 90.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.078 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -63.84 -48.36 77.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.13 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 42.3 mt -67.48 -33.5 75.23 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.559 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.665 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.31 -47.87 68.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.55 -31.63 70.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.131 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.21 -37.95 89.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.008 0.432 . . . . 0.0 110.741 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -77.13 -26.19 52.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.181 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 81.1 mtp180 -70.95 -24.67 62.48 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.018 176.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.97 -24.15 63.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.293 0.568 . . . . 0.0 110.405 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.89 169.24 8.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.674 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 46.1 m-20 -105.31 38.59 1.92 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ARG . . . . . 0.446 ' CA ' ' HG2' ' A' ' 256' ' ' GLU . 20.7 ttm180 -95.36 138.25 33.31 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.033 -170.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.685 HG22 ' HD2' ' A' ' 284' ' ' LYS . 44.9 pt -122.75 167.02 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.074 175.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' TYR . . . . . 0.48 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 66.0 t80 -119.18 129.36 54.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.199 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . 0.554 HG13 ' CZ ' ' A' ' 229' ' ' PHE . 35.1 m -123.53 134.92 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -126.06 175.66 7.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.846 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.12 27.17 10.54 Favored 'General case' 0 CA--C 1.527 0.059 0 O-C-N 124.158 0.911 . . . . 0.0 109.629 -176.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' VAL . . . . . 0.434 HG12 HD11 ' A' ' 225' ' ' ILE . 22.2 t -77.13 112.46 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' HIS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 42.6 t-80 -53.3 136.95 36.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.058 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -55.08 -34.77 63.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.186 -173.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.13 7.13 47.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.727 0.775 . . . . 0.0 110.639 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.54 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.3 tp -92.0 124.5 36.15 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.7 t -89.65 168.43 12.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.986 0.422 . . . . 0.0 111.219 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.17 -22.85 63.89 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -65.48 -33.91 77.04 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.923 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -72.16 -46.44 56.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.423 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.71 HG13 HD21 ' A' ' 240' ' ' LEU . 21.8 mm -63.11 -50.82 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.67 -44.39 81.35 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.967 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 30.3 t -58.09 -43.68 87.19 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 19.1 t -76.82 -44.02 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.5 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' PHE . . . . . 0.622 ' HB2' HD12 ' A' ' 235' ' ' ILE . 55.3 m-85 -64.1 -33.41 75.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.098 0.475 . . . . 0.0 110.71 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -61.01 -24.96 66.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.457 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.48 -11.93 60.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.153 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.87 -33.89 6.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -156.85 158.39 28.76 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.904 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -69.44 116.05 9.42 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.268 0.556 . . . . 0.0 111.101 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.622 HD12 ' HB2' ' A' ' 229' ' ' PHE . 47.0 mt -86.19 151.58 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.733 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -119.32 -15.41 9.13 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.418 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 256' ' ' GLU . 47.6 t -165.77 143.88 5.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -174.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 54.1 t -153.87 117.78 4.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 10.5 t -140.26 139.39 35.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.234 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' LEU . . . . . 0.71 HD21 HG13 ' A' ' 225' ' ' ILE . 77.8 mt -105.43 130.94 53.41 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.81 121.28 15.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.033 0.444 . . . . 0.0 110.376 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 51.6 ttp180 -134.65 152.02 51.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.111 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 5.7 m-20 -74.11 148.47 86.6 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -45.94 -45.12 17.91 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.04 2.493 . . . . 0.0 113.377 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.2 t -154.66 75.11 0.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.707 0.765 . . . . 0.0 110.881 -176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 18.1 p -125.01 -11.19 7.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.138 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 72.45 20.3 79.33 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.389 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 21.6 ptmt -156.69 141.78 17.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -94.14 140.99 29.06 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.093 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -44.1 -55.97 4.37 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.235 0.959 . . . . 0.0 113.046 -172.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 145.95 11.04 0.24 Allowed Glycine 0 CA--C 1.511 -0.19 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.054 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' TYR . . . . . 0.48 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 44.4 p90 -144.37 167.23 22.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.08 173.81 32.62 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.26 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.447 ' HE1' ' HG3' ' A' ' 164' ' ' GLU . 81.0 m-85 -133.59 143.99 49.01 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.533 HD12 HG21 ' A' ' 225' ' ' ILE . 67.6 mt -140.12 135.74 37.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.501 -176.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 25.4 mt-10 -112.83 142.23 45.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 7.0 m-85 -102.18 167.35 10.06 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -73.3 -13.99 61.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.96 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -134.76 124.93 25.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.551 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -58.97 -44.14 91.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.203 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -62.89 -33.98 76.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.826 0.346 . . . . 0.0 110.802 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 53.3 m -70.48 -27.87 64.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.55 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 267' ' ' VAL . 83.9 p -72.81 -31.3 64.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -72.68 -30.62 64.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.946 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.05 -38.68 92.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.248 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ALA . . . . . 0.415 ' HB2' ' CD2' ' A' ' 229' ' ' PHE . . . -66.05 -42.37 89.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.131 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 263' ' ' SER . 82.4 t -53.03 -45.82 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.863 0.363 . . . . 0.0 111.345 176.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.6 m -65.54 -32.13 73.56 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 32.0 t -94.12 -33.64 13.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' MET . . . . . 0.514 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.3 mmm -91.75 0.55 57.48 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -169.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -74.29 118.39 17.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.7 mt 68.62 31.35 4.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.451 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -89.75 123.18 33.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.28 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.1 t70 -69.78 120.21 15.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.875 0.369 . . . . 0.0 110.892 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.54 ' HG ' HD21 ' A' ' 220' ' ' LEU . 38.8 tp -138.41 94.41 2.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.614 173.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.39 25.49 39.39 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.902 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 84.9 3.87 87.57 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.811 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLN . . . . . 0.436 ' HG3' ' HB2' ' A' ' 217' ' ' HIS . 16.8 mm100 -109.64 139.67 44.38 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.55 -178.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.6 103.27 15.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.886 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.6 124.5 21.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.635 -175.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -93.92 116.61 29.07 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 171.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.403 HG23 HG12 ' A' ' 213' ' ' VAL . 14.5 p -124.44 148.37 28.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.103 0.478 . . . . 0.0 111.346 -171.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.19 177.76 41.64 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LYS . . . . . 0.685 ' HD2' HG22 ' A' ' 211' ' ' ILE . 4.6 mmmp? -80.32 123.26 27.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.286 0.543 . . . . 0.0 109.942 175.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -52.47 127.48 22.69 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.96 0.787 . . . . 0.0 110.347 177.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.56 -25.6 5.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 123.466 0.479 . . . . 0.0 111.052 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 21.7 p -127.5 153.33 77.41 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 C-N-CA 122.793 2.329 . . . . 0.0 112.031 178.836 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.87 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 73.37 -62.82 0.45 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.534 0.734 . . . . 0.0 111.953 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 58.15 48.7 12.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.276 0.56 . . . . 0.0 110.73 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.44 108.69 21.47 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -78.45 114.25 17.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.417 0.627 . . . . 0.0 112.224 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -111.66 -6.2 14.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.25 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -66.67 -25.0 66.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.656 -171.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -61.48 -41.75 97.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.787 0.327 . . . . 0.0 110.791 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.51 -32.82 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.977 0.418 . . . . 0.0 110.075 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.542 HD22 ' SD ' ' A' ' 111' ' ' MET . 83.8 mt -63.25 -34.29 77.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.642 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.47 66.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.167 0.508 . . . . 0.0 110.813 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.0 mt -83.39 -36.83 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.883 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.625 ' SD ' HG12 ' A' ' 198' ' ' ILE . 87.2 mtp -72.22 -22.37 61.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.626 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.685 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 76.1 m -74.75 -9.78 58.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.88 0.371 . . . . 0.0 111.021 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -105.46 142.25 35.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.589 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.493 HG13 ' HB ' ' A' ' 158' ' ' VAL . 8.7 p -123.93 127.71 73.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.446 0.641 . . . . 0.0 109.826 170.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -80.54 106.8 12.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.829 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.465 HG12 ' CZ ' ' A' ' 132' ' ' PHE . 19.0 m -99.09 115.31 39.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.423 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.38 149.92 17.53 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.719 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.9 m 76.35 -66.69 0.25 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.872 0.869 . . . . 0.0 111.436 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.501 ' O ' ' HB2' ' A' ' 120' ' ' TYR . 78.6 mt 61.88 -91.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 O-C-N 123.383 0.427 . . . . 0.0 110.697 -176.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.501 ' HB2' ' O ' ' A' ' 119' ' ' ILE . 23.3 t80 165.94 140.01 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -175.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -79.07 75.35 5.59 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.378 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -174.53 -51.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.991 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.592 HD12 ' HB2' ' A' ' 178' ' ' LEU . 78.8 mt -58.81 128.21 36.07 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.717 -173.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.99 -177.6 37.82 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.605 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -67.96 -43.59 78.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.412 . . . . 0.0 111.024 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.447 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 16.9 t70 -68.28 -42.42 79.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.087 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.0 m -67.0 -37.96 85.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.125 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.452 HD11 ' HA ' ' A' ' 128' ' ' ILE . 17.2 mm -61.98 -40.86 88.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.62 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.532 ' HA ' HD12 ' A' ' 138' ' ' ILE . 38.0 ttp-105 -59.06 -39.76 83.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 110.178 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 72.6 mt-30 -68.59 -34.2 75.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.337 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.09 -21.32 36.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.6 ' HB2' HD13 ' A' ' 138' ' ' ILE . 31.6 m-85 -100.93 -15.29 17.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.956 0.408 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.631 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -54.13 -40.56 82.89 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 177.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 5.9 Cg_exo -42.76 -38.18 6.41 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.289 2.66 . . . . 0.0 114.013 174.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.538 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 60.3 m-85 -81.49 -46.89 13.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.881 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.73 165.57 38.51 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.073 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.438 ' HG2' ' CE1' ' A' ' 252' ' ' TYR . 24.9 Cg_exo -65.05 120.16 7.33 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.722 2.282 . . . . 0.0 111.408 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.6 HD13 ' HB2' ' A' ' 132' ' ' PHE . 41.2 mt -79.62 129.54 37.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.356 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -96.62 -29.82 13.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.832 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.0 t -158.65 141.5 14.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.593 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.426 ' CG1' HG21 ' A' ' 138' ' ' ILE . 72.1 mt -131.5 122.65 50.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.657 0.265 . . . . 0.0 110.943 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 33.1 t70 -98.14 100.06 11.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.424 ' HE2' ' HE1' ' A' ' 152' ' ' HIS . 0.0 OUTLIER -104.93 139.62 39.38 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.833 -171.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 p -80.43 122.37 26.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.339 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -142.33 122.66 13.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.827 0.346 . . . . 0.0 110.359 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.28 120.74 40.38 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.9 m -83.64 -11.63 57.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -170.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 22.3 m -95.61 -25.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.304 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.3 p -106.09 -19.27 13.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.786 0.327 . . . . 0.0 111.434 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 47.6 mtm 66.63 27.91 9.34 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.245 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -148.6 174.88 11.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.424 ' HE1' ' HE2' ' A' ' 143' ' ' MET . 3.7 p80 -156.17 130.23 8.62 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.79 -176.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -125.22 86.2 2.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.15 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -156.06 -114.44 0.47 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.509 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -151.58 176.45 11.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.54 0.209 . . . . 0.0 110.552 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.9 152.78 33.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.319 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.474 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 46.8 m-85 -109.56 109.95 20.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.785 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.493 ' HB ' HG13 ' A' ' 114' ' ' VAL . 97.4 t -95.33 108.81 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.801 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -106.42 115.7 30.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.354 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -89.21 178.83 6.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.218 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.49 -45.64 30.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.082 0.468 . . . . 0.0 109.796 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.64 141.86 24.21 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.452 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.685 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.9 Cg_endo -69.5 -21.33 34.87 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.256 2.637 . . . . 0.0 112.518 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.616 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 6.5 mp0 -55.2 -51.43 66.57 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.883 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.12 -23.85 66.79 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 120.954 0.407 . . . . 0.0 111.921 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.22 -48.53 12.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.753 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.594 ' HG3' HG13 ' A' ' 286' ' ' VAL . 32.2 mm-40 -64.6 -36.53 84.52 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.699 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.538 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 11.8 tp -66.51 -46.81 75.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.734 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.148 0.499 . . . . 0.0 109.931 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.498 ' HG ' HG22 ' A' ' 185' ' ' VAL . 6.7 tt -69.79 -46.1 66.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.574 173.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 16.4 mm-40 -56.75 -56.83 16.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.25 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -86.51 -39.42 16.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 27.2 ttp -104.63 30.17 5.61 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.588 -165.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -89.11 44.38 1.21 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.884 0.849 . . . . 0.0 109.673 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 19.6 m -115.59 -73.87 0.63 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.416 173.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.24 169.34 5.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.712 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.587 ' HB2' HD13 ' A' ' 183' ' ' ILE . 25.0 tpp -145.45 78.98 1.56 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.951 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.592 ' HB2' HD12 ' A' ' 123' ' ' LEU . 75.6 mt 63.84 162.15 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.527 174.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.29 -65.07 1.65 Allowed Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.008 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.6 62.81 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.203 -0.522 . . . . 0.0 111.861 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -143.53 129.54 19.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.772 0.32 . . . . 0.0 111.242 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 175' ' ' SER . 8.9 t30 -71.5 103.69 3.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.373 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.587 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.5 pt -85.62 159.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.211 0.529 . . . . 0.0 111.884 -173.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -110.51 114.95 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.804 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.498 HG22 ' HG ' ' A' ' 170' ' ' LEU . 5.3 m -103.64 108.33 24.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.422 0.63 . . . . 0.0 110.787 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.71 158.39 24.46 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.88 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.48 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 77.7 mtm180 -136.41 60.27 31.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.736 0.303 . . . . 0.0 110.189 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 9.3 Cg_endo -90.45 71.05 1.41 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.1 2.534 . . . . 0.0 111.493 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.461 ' O ' HG12 ' A' ' 191' ' ' ILE . 16.5 m -77.2 39.82 0.25 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.02 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 188' ' ' PRO . 3.3 p-10 45.2 28.09 0.39 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.507 1.123 . . . . 0.0 113.364 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 189' ' ' SER . 46.8 mm -126.95 118.44 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 148.66 176.67 22.25 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.052 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.441 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 43.8 tt0 -81.32 -28.07 34.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.081 0.467 . . . . 0.0 110.629 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.483 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -75.05 -28.8 60.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.067 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.707 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 27.2 mm-40 -54.32 -53.76 55.66 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.812 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.707 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 52.6 Cg_exo -55.08 -36.12 92.11 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.196 1.931 . . . . 0.0 112.851 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 72.6 mt -70.98 -46.09 69.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.339 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.625 HG12 ' SD ' ' A' ' 111' ' ' MET . 73.9 mt -57.15 -45.76 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.924 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.7 -39.9 95.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.244 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -63.08 -49.94 72.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.868 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.41 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 68.1 mt -67.88 -31.91 72.04 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.34 -47.86 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.65 -36.57 81.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.826 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.434 ' O ' ' HD2' ' A' ' 208' ' ' PHE . 39.2 mt-10 -68.37 -37.14 80.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.255 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -67.96 -32.24 72.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.83 0.348 . . . . 0.0 110.423 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.597 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.9 mtp180 -63.02 -37.98 89.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.317 175.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.58 -27.86 67.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.507 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.434 ' HD2' ' O ' ' A' ' 204' ' ' GLU . 75.0 m-85 -94.73 -16.48 23.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.45 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 60.71 41.65 14.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.987 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.488 ' HD2' ' OE1' ' A' ' 256' ' ' GLU . 16.5 ttt180 -101.42 145.15 29.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.279 0.561 . . . . 0.0 112.285 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 47.9 pt -129.05 167.56 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.4 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.49 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 27.0 t80 -117.65 138.03 52.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.461 HG12 ' CZ ' ' A' ' 229' ' ' PHE . 28.9 m -128.21 131.63 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.395 0.617 . . . . 0.0 110.915 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.38 173.05 7.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.588 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.8 t 58.51 31.5 21.09 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.742 0.782 . . . . 0.0 109.619 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.51 114.23 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.828 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.621 ' HA ' ' OE1' ' A' ' 278' ' ' GLN . 25.0 t-80 -54.05 130.39 37.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.442 0.639 . . . . 0.0 111.726 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -48.58 -33.13 9.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.186 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -85.09 -23.1 28.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.964 0.411 . . . . 0.0 111.835 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.407 HD11 ' HG ' ' A' ' 275' ' ' LEU . 69.5 mt -77.74 128.55 34.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.421 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 21.6 m -92.24 173.29 7.9 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.468 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -49.29 -50.28 39.83 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.842 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.24 -33.87 75.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.506 -174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.84 -38.1 73.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.629 0.252 . . . . 0.0 110.586 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.779 HG23 HD13 ' A' ' 255' ' ' ILE . 29.2 mm -67.01 -41.84 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 83.9 tttt -57.67 -45.45 85.53 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.389 173.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 39.6 t -54.19 -47.75 71.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.45 -39.58 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.347 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.528 ' CB ' HD11 ' A' ' 235' ' ' ILE . 24.0 m-85 -68.31 -29.78 68.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.019 0.438 . . . . 0.0 110.603 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.12 -26.24 68.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.946 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.66 -16.31 62.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.407 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -111.56 -40.12 4.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.437 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -138.31 161.8 25.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.325 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -81.02 104.23 11.37 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.181 0.515 . . . . 0.0 110.694 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.528 HD11 ' CB ' ' A' ' 229' ' ' PHE . 27.3 mt -82.83 151.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.702 0.763 . . . . 0.0 111.759 -175.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.602 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 45.4 tttm -107.26 -40.13 5.49 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.044 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 53.1 m -158.62 152.92 24.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.816 0.341 . . . . 0.0 110.545 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 9.3 p -133.37 125.67 29.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.746 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 12.0 m -140.37 100.9 4.0 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.717 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.481 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 44.4 mt -84.23 148.04 26.93 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.3 91.75 1.35 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 16.4 ttp85 -109.06 138.08 45.96 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.428 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 9.4 t70 -118.95 126.59 27.01 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.643 -172.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 11.6 Cg_exo -67.37 -21.03 47.88 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.994 2.462 . . . . 0.0 113.258 -176.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 35.2 p -100.97 13.57 34.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 0.0 111.238 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.409 ' HG1' ' HB3' ' A' ' 243' ' ' ASP . 63.8 p -115.23 -29.65 6.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.251 0.548 . . . . 0.0 110.078 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 93.59 1.44 66.09 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.015 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -154.56 -165.87 2.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 7.9 p80 -98.6 154.0 18.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.301 0.572 . . . . 0.0 109.764 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -71.22 -15.34 62.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.864 -168.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 120.39 -6.19 11.78 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.281 -0.962 . . . . 0.0 113.035 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.438 ' CE1' ' HG2' ' A' ' 137' ' ' PRO . 0.5 OUTLIER -134.61 158.62 43.57 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.481 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -162.79 177.62 38.82 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.407 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.616 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 52.9 m-85 -132.28 149.19 52.42 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.779 HD13 HG23 ' A' ' 225' ' ' ILE . 82.5 mt -134.08 142.59 40.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.488 ' OE1' ' HD2' ' A' ' 210' ' ' ARG . 30.7 tt0 -128.16 134.54 49.09 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -170.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.581 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 10.4 m-85 -111.0 165.52 11.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.142 0.496 . . . . 0.0 111.534 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.602 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 13.6 mt-10 -88.22 -12.0 45.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.156 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -134.93 124.78 25.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.886 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.415 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -65.44 -22.09 66.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.45 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -75.17 -47.08 30.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.4 m -65.09 -33.35 75.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.831 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.581 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 90.2 p -67.74 -31.88 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 75.4 mt-30 -75.25 -24.65 57.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -63.98 -49.19 73.46 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.471 ' HB1' ' CD2' ' A' ' 229' ' ' PHE . . . -58.5 -40.16 82.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.259 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.546 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 97.5 t -57.1 -39.33 65.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.976 0.417 . . . . 0.0 111.045 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.6 t -81.66 -40.52 22.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.285 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.5 m -80.48 -40.35 26.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.404 ' HB2' HG22 ' A' ' 282' ' ' VAL . 89.5 mmm -89.69 -5.01 57.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.856 -170.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 267' ' ' VAL . 63.5 t30 -71.09 122.05 19.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 98.3 mt 70.09 23.06 5.42 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.886 0.741 . . . . 0.0 111.015 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.35 125.77 30.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.09 101.57 9.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.063 0.459 . . . . 0.0 110.185 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.407 ' HG ' HD11 ' A' ' 220' ' ' LEU . 36.5 tp -121.25 99.55 6.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.983 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.73 25.8 37.25 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.285 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 77.19 33.78 43.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.206 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.621 ' OE1' ' HA ' ' A' ' 217' ' ' HIS . 2.1 tt0 -152.43 139.99 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -91.45 103.15 15.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.665 0.269 . . . . 0.0 111.079 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 34.8 mt -58.36 116.97 3.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.806 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.3 mmm-85 -93.46 114.6 27.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.546 ' CG1' ' HA ' ' A' ' 267' ' ' VAL . 17.1 t -112.35 140.05 34.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.858 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -153.92 170.58 32.56 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.625 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -75.9 128.98 36.23 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.505 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -74.05 128.76 36.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.594 HG13 ' HG3' ' A' ' 167' ' ' GLN . 20.1 m -93.77 -19.67 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.478 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.511 HG22 HD23 ' A' ' 108' ' ' LEU . 4.3 t -147.82 138.86 13.31 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.144 175.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.85 109.22 1.04 Allowed 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 123.346 2.697 . . . . 0.0 112.924 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.407 ' HD2' ' HD3' ' A' ' 210' ' ' ARG . 3.8 Cg_exo -76.2 99.67 1.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.097 2.531 . . . . 0.0 110.977 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 59.7 mtt -79.78 110.99 17.87 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.8 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.572 ' HB2' HD23 ' A' ' 292' ' ' LEU . 6.2 Cg_exo -74.43 -38.25 2.04 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.887 2.391 . . . . 0.0 111.98 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.572 HD23 ' HB2' ' A' ' 291' ' ' PRO . 3.2 mm? -119.2 95.79 4.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.252 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 34.3 tp -88.21 60.79 5.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.491 0.662 . . . . 0.0 109.667 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 19.8 p -115.52 92.73 34.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.542 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.04 24.31 0.75 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.109 2.539 . . . . 0.0 113.316 -174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -141.81 24.12 2.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.57 . . . . 0.0 110.504 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.07 -179.424 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.996 -0.441 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.17 -37.28 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.725 0.298 . . . . 0.0 110.81 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 25.5 mmt -89.91 -47.25 7.99 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.51 85.56 6.48 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -81.14 60.52 4.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.575 0.703 . . . . 0.0 112.169 -171.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.409 ' HG2' ' HG3' ' A' ' 105' ' ' GLN . 40.2 ttm180 -130.6 150.59 51.73 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 171.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.432 ' HB3' HD12 ' A' ' 108' ' ' LEU . 69.1 mt-30 63.67 35.96 11.12 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -65.62 -42.09 91.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.821 -172.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.85 -33.07 74.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.035 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.481 HD23 ' SD ' ' A' ' 111' ' ' MET . 57.3 mt -63.47 -32.13 73.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.467 -176.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.13 -28.63 69.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.189 0.519 . . . . 0.0 110.575 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.5 mt -88.52 -35.92 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.207 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.522 ' SD ' HG12 ' A' ' 198' ' ' ILE . 94.0 mtp -67.06 -18.94 65.57 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.083 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.663 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 85.3 m -81.94 -10.68 59.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 110.592 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.433 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 98.4 mtt180 -109.7 143.4 39.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.229 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.4 p -120.37 121.7 66.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 168.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -76.09 129.16 36.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.721 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.663 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 15.0 m -123.83 122.16 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.497 0.665 . . . . 0.0 111.128 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.63 174.97 19.22 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.416 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 66.0 m 64.46 36.9 8.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.295 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.3 mt -85.0 105.84 14.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.42 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -52.85 146.49 10.59 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.341 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.414 ' HA ' ' CE1' ' A' ' 152' ' ' HIS . 14.1 p90 -71.4 76.13 0.76 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 122.029 0.919 . . . . 0.0 111.314 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -165.67 -43.34 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.196 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.468 HD23 HD13 ' A' ' 178' ' ' LEU . 36.2 mt -75.11 103.34 5.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.114 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.64 174.32 54.1 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.208 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.32 -39.97 94.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.69 -42.03 92.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.208 0.528 . . . . 0.0 110.371 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.3 m -68.9 -39.93 79.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.46 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.844 HG13 ' HE2' ' A' ' 143' ' ' MET . 35.5 mm -64.09 -44.2 97.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.512 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -57.28 -46.68 82.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.543 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.34 -33.25 74.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.582 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.494 ' HB2' ' HE2' ' A' ' 177' ' ' MET . . . -78.28 -31.98 49.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.453 ' HD1' ' O ' ' A' ' 128' ' ' ILE . 50.1 m-85 -93.43 -17.08 23.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.776 0.322 . . . . 0.0 111.454 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.03 -44.11 91.22 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -47.52 -33.17 17.09 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.783 2.322 . . . . 0.0 114.389 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.563 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 70.1 m-85 -79.69 -53.47 6.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.4 -171.04 25.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 119.637 -1.268 . . . . 0.0 113.361 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.46 112.82 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.921 2.414 . . . . 0.0 111.736 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.635 HD12 HD13 ' A' ' 141' ' ' ILE . 68.7 mt -76.6 127.27 37.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.428 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -84.81 -45.81 11.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.568 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -166.22 131.65 2.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.803 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.635 HD13 HD12 ' A' ' 138' ' ' ILE . 67.6 mt -109.36 114.11 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 171.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -94.09 100.46 12.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.044 0.45 . . . . 0.0 110.554 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.844 ' HE2' HG13 ' A' ' 128' ' ' ILE . 36.5 ttm -143.14 124.65 14.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.929 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.5 m -87.41 107.63 18.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.581 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -84.18 83.53 7.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.552 0.691 . . . . 0.0 109.192 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.95 103.27 11.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.84 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.1 t -90.93 28.25 1.62 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.89 -174.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.0 t -71.71 -44.63 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.089 0.471 . . . . 0.0 109.894 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 150' ' ' MET . 33.0 p -119.62 12.78 12.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.629 175.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.498 ' HB2' ' O ' ' A' ' 149' ' ' THR . 42.2 mtp 74.19 -22.86 0.24 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.852 0.72 . . . . 0.0 110.984 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 149' ' ' THR . 49.7 mtmt -84.86 131.32 34.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.414 ' CE1' ' HA ' ' A' ' 121' ' ' TYR . 22.9 p-80 -96.91 -170.85 2.11 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.544 -174.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -54.36 -44.99 72.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.895 0.379 . . . . 0.0 111.039 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 108.99 -31.37 7.77 Favored Glycine 0 CA--C 1.508 -0.349 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.87 176.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -116.39 153.86 31.29 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.66 164.74 37.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.965 0.412 . . . . 0.0 111.305 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.83 111.86 18.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.422 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 78.7 t -97.45 106.49 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.98 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.433 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 39.4 tt0 -107.57 128.57 54.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.76 0.314 . . . . 0.0 110.615 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -95.17 179.82 5.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.976 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.94 -14.9 28.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.851 0.358 . . . . 0.0 110.16 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.53 135.09 26.86 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.234 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 46.0 Cg_endo -67.57 -21.11 46.45 Favored 'Trans proline' 0 N--CA 1.474 0.35 0 C-N-CA 123.311 2.674 . . . . 0.0 112.585 -176.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.937 ' HG3' ' HE1' ' A' ' 254' ' ' PHE . 5.7 mm-40 -61.01 -52.08 66.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.872 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -66.86 -17.88 65.11 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.02 -47.21 18.94 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.425 ' HG3' HG12 ' A' ' 286' ' ' VAL . 29.6 mm-40 -69.49 -34.88 74.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.461 174.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.591 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 13.6 tp -61.77 -48.1 82.18 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.581 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.98 72.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.97 0.414 . . . . 0.0 110.229 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.65 -52.13 41.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.589 173.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.54 -38.85 60.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.669 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . 0.417 HE21 ' HE1' ' A' ' 135' ' ' PHE . 22.7 mt-30 -99.76 -49.22 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 34.4 ttp -104.87 29.63 6.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -165.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.96 -20.78 60.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.929 0.395 . . . . 0.0 110.708 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.9 p -72.32 -73.58 0.19 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.6 m -134.07 151.98 33.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.033 0.444 . . . . 0.0 111.422 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.966 ' HE1' ' HG ' ' A' ' 178' ' ' LEU . 1.7 tpt -125.55 97.14 5.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.809 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.966 ' HG ' ' HE1' ' A' ' 177' ' ' MET . 85.9 mt 67.56 127.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.93 0.769 . . . . 0.0 112.377 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 72.17 -80.17 0.61 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.385 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.43 36.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.07 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -100.4 122.42 43.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.687 0.279 . . . . 0.0 110.808 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.6 126.44 30.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.546 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.8 pt -120.26 176.91 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.396 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.663 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 74.0 mmtt -103.24 107.27 18.03 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 27.6 t -113.36 106.87 21.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.13 0.269 . . . . 0.0 110.696 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 141.96 -97.87 0.21 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 119.855 -1.164 . . . . 0.0 114.24 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 189' ' ' SER . 87.5 mtt180 -78.25 127.16 82.0 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.665 0.269 . . . . 0.0 111.702 -170.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -77.91 -9.46 16.84 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.967 2.445 . . . . 0.0 111.178 172.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 187' ' ' ARG . 35.3 p -157.29 156.68 32.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.449 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -48.55 -61.45 2.01 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.619 0.574 . . . . 0.0 112.214 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.497 HD12 ' HG3' ' A' ' 195' ' ' GLN . 10.6 tp -138.22 152.02 25.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -144.31 166.02 27.3 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.202 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -71.25 -15.77 62.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.849 0.357 . . . . 0.0 111.795 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.468 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -88.45 -12.37 43.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.653 0.263 . . . . 0.0 111.362 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.56 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 33.8 mm-40 -59.08 -49.88 90.79 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.56 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 75.4 Cg_exo -52.97 -35.29 70.76 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.288 1.992 . . . . 0.0 112.847 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 60.6 mt -69.94 -46.64 72.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.129 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.522 HG12 ' SD ' ' A' ' 111' ' ' MET . 57.6 mt -57.41 -43.27 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.239 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.19 -44.38 88.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.043 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -68.8 -45.44 71.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.911 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 19.4 mt -64.73 -33.53 76.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.783 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.651 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.02 -51.77 60.61 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -60.18 -38.29 82.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.272 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 52.5 mt-10 -60.54 -45.98 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.106 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.02 87.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.882 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.651 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 53.3 mtp180 -64.89 -33.93 77.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.791 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.42 -30.03 66.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.814 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.69 -4.47 47.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.035 0.445 . . . . 0.0 110.68 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.2 m120 62.89 44.03 6.48 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.055 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -99.93 142.78 30.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.188 0.518 . . . . 0.0 111.382 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.5 pt -127.76 166.35 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.175 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.554 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 86.3 t80 -119.18 128.79 54.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.156 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.611 HG12 HG23 ' A' ' 282' ' ' VAL . 32.2 m -121.77 131.28 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.183 0.516 . . . . 0.0 110.641 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -124.8 174.19 8.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.17 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.2 t 60.78 30.94 20.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.887 0.851 . . . . 0.0 109.223 -174.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 36.1 t -79.91 116.06 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.581 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.588 ' HD2' ' HG3' ' A' ' 278' ' ' GLN . 7.6 t-80 -56.4 135.25 54.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.471 0.653 . . . . 0.0 111.677 -169.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -49.29 -38.19 26.48 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -171.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -89.94 -10.02 46.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.754 0.311 . . . . 0.0 111.145 -174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 220' ' ' LEU . 10.7 tp -83.44 124.59 30.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.257 -174.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.9 t -87.59 169.17 12.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.817 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.08 -36.8 71.0 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.791 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.41 -45.56 72.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.706 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -74.01 -40.95 62.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.059 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.668 HG21 HD13 ' A' ' 255' ' ' ILE . 31.4 mm -63.38 -47.73 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 238' ' ' CYS . 66.1 tttm -58.16 -46.57 85.46 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.052 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.5 t -54.5 -43.57 71.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.07 -41.98 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.41 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.535 ' CB ' HD11 ' A' ' 235' ' ' ILE . 20.6 m-85 -67.44 -28.22 67.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.207 0.527 . . . . 0.0 110.537 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.7 -24.54 64.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.151 0.981 . . . . 0.0 110.467 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.95 -15.84 60.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.205 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -111.3 -23.23 10.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.99 0.424 . . . . 0.0 110.658 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.518 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -165.66 156.31 28.17 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.81 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 23.4 mmtp -74.08 122.52 22.81 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.546 0.688 . . . . 0.0 110.861 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.535 HD11 ' CB ' ' A' ' 229' ' ' PHE . 57.1 mt -92.91 150.43 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.144 -172.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.424 ' HE2' ' CB ' ' A' ' 256' ' ' GLU . 31.8 ttpt -110.5 -28.57 8.46 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.221 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 16.8 m -152.43 146.58 25.42 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.458 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 226' ' ' LYS . 47.2 t -152.78 107.33 3.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.521 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.7 m -140.52 109.27 5.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.133 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.547 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 51.4 mt -77.31 143.61 38.69 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.479 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.08 113.12 4.25 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 29.3 ttp180 -149.89 139.49 21.62 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.147 -169.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.29 128.45 86.04 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -44.49 -46.0 12.41 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.897 3.065 . . . . 0.0 114.394 -163.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 3.7 t -133.89 76.58 1.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.705 0.764 . . . . 0.0 110.579 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 6.6 p -125.75 1.33 7.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.289 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.18 12.75 69.31 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.043 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 22.5 pttp -163.35 179.66 7.2 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -131.0 152.02 50.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -48.32 -61.53 1.95 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.976 0.798 . . . . 0.0 112.573 -172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 160.97 12.33 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.616 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -152.05 -179.69 7.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.547 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -170.61 177.76 43.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.357 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.937 ' HE1' ' HG3' ' A' ' 164' ' ' GLU . 83.3 m-85 -128.96 143.57 50.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.971 0.415 . . . . 0.0 110.917 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.668 HD13 HG21 ' A' ' 225' ' ' ILE . 89.7 mt -140.45 140.75 33.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.004 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.424 ' CB ' ' HE2' ' A' ' 236' ' ' LYS . 45.2 mt-10 -120.67 147.6 45.04 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.632 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 20.2 m-85 -111.75 164.2 13.32 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.654 0.264 . . . . 0.0 110.312 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.84 -5.23 59.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.323 0.582 . . . . 0.0 109.433 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -127.87 128.63 45.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.848 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.51 68.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.206 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -74.86 -52.69 10.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.519 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.518 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 28.3 m -60.14 -31.49 70.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.456 -172.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.632 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 48.7 p -64.63 -48.62 74.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.997 0.427 . . . . 0.0 109.988 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -72.53 -18.92 61.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.189 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -69.15 -40.9 77.92 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.045 0.45 . . . . 0.0 110.044 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.62 75.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.949 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 271' ' ' ASN . 88.2 t -59.25 -31.58 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.164 0.507 . . . . 0.0 110.64 174.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.5 t -83.93 -46.6 11.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.898 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.7 m -78.31 -43.24 28.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.481 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 80.0 mmm -83.87 1.21 44.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.161 0.505 . . . . 0.0 110.752 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.549 ' HA ' HG12 ' A' ' 282' ' ' VAL . 18.7 t-20 -71.81 114.22 9.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.157 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 86.0 mt 67.31 36.86 3.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.195 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.42 121.78 33.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.326 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.54 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 26.7 t70 -75.76 106.35 7.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.72 0.295 . . . . 0.0 110.271 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 41.1 tp -131.04 110.03 10.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.028 0.442 . . . . 0.0 110.506 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.82 5.02 74.73 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.185 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.12 -5.16 31.89 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.337 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.588 ' HG3' ' HD2' ' A' ' 217' ' ' HIS . 28.5 mt-30 -125.19 143.52 50.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.828 0.346 . . . . 0.0 110.526 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.54 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 57.4 m-85 -78.07 113.22 15.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.089 173.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.37 130.37 44.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.05 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -98.35 114.58 26.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.611 HG23 HG12 ' A' ' 213' ' ' VAL . 7.5 p -118.39 143.91 27.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.878 -174.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -157.59 173.81 35.0 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.394 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -75.83 135.01 40.22 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -71.99 144.93 48.67 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.425 HG12 ' HG3' ' A' ' 167' ' ' GLN . 20.3 m -109.3 -4.77 10.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.329 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.9 p -129.58 146.75 62.43 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.49 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.65 170.84 19.13 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.553 2.169 . . . . 0.0 111.013 173.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -44.89 -49.81 9.28 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.666 2.244 . . . . 0.0 112.11 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 24.4 mmt -133.58 111.92 12.69 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.394 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_exo -72.51 61.52 3.54 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.584 2.856 . . . . 0.0 112.554 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.7 pp -169.42 13.09 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.945 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 38.0 tp -97.54 64.53 1.83 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.425 0.631 . . . . 0.0 110.497 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 3.0 p -123.78 108.55 30.65 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.504 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.52 -37.52 97.2 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.816 2.344 . . . . 0.0 111.219 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -147.23 -69.83 0.24 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.123 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 84.0 m . . . . . 0 C--O 1.245 0.84 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.539 171.693 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.365 -0.294 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.98 -62.27 1.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.945 0.402 . . . . 0.0 111.422 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.9 mtm -86.81 -4.32 59.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 110.206 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.18 -37.09 54.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.851 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -82.75 64.17 7.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.263 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -99.18 20.15 14.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.816 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -86.44 28.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.466 0.65 . . . . 0.0 109.657 176.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -64.03 -30.2 71.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.753 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.1 -44.05 60.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.39 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.489 HD23 ' SD ' ' A' ' 111' ' ' MET . 60.3 mt -61.02 -36.07 78.54 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.47 -36.74 71.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.5 mt -78.73 -40.86 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.215 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.549 ' SD ' HG12 ' A' ' 198' ' ' ILE . 90.6 mtp -62.09 -28.2 69.45 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.588 -176.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.672 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 67.0 m -74.97 -14.69 60.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.815 0.341 . . . . 0.0 111.109 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.58 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 42.8 mtp180 -101.53 140.31 35.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.851 HG11 ' HB ' ' A' ' 158' ' ' VAL . 9.6 p -110.0 121.82 63.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -82.23 100.98 10.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.008 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.732 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 35.3 m -108.21 141.32 23.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.145 0.498 . . . . 0.0 110.969 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.806 ' HA3' ' HD1' ' A' ' 155' ' ' PHE . . . -155.59 170.97 33.59 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.277 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.4 t 62.49 37.83 13.08 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.795 0.807 . . . . 0.0 109.683 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.5 mt -73.29 -14.99 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.543 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.9 t80 74.55 140.88 0.06 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.822 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.7 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 6.6 p90 -72.11 78.25 0.95 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.427 0.632 . . . . 0.0 110.995 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -159.58 -54.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.256 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.8 mt -68.54 119.58 13.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.753 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.63 -173.48 44.34 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.073 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.59 -39.32 94.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.632 0.373 . . . . 0.0 111.316 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.85 -41.19 99.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.38 -176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.2 m -68.7 -40.13 80.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.453 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.791 HG13 ' HE2' ' A' ' 143' ' ' MET . 31.2 mm -62.73 -50.82 78.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.061 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -60.05 -42.28 94.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.169 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -67.63 -33.29 74.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.498 ' HB1' ' HE3' ' A' ' 177' ' ' MET . . . -82.39 -33.5 28.69 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -176.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.562 ' CZ ' HG13 ' A' ' 116' ' ' VAL . 51.2 m-85 -87.89 -20.54 25.85 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.86 -43.93 97.28 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -41.68 -40.93 5.67 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.069 2.512 . . . . 0.0 114.221 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.681 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 57.0 m-85 -75.45 -46.64 31.42 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.544 0.211 . . . . 0.0 111.295 -174.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -165.25 173.21 41.02 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.612 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.49 119.89 6.79 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.672 2.248 . . . . 0.0 111.688 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.6 mt -83.39 121.97 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.623 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -80.78 -52.49 7.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.695 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.5 t -152.17 152.12 31.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.097 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -124.69 108.98 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.066 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.767 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 18.4 m-20 -81.46 98.76 8.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.791 ' HE2' HG13 ' A' ' 128' ' ' ILE . 51.5 ttm -136.76 137.65 40.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.025 0.441 . . . . 0.0 111.014 -176.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 m -79.02 137.84 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.792 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.581 ' CZ2' ' HB2' ' A' ' 150' ' ' MET . 36.7 t-105 -119.02 124.01 45.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.531 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 46.6 m-20 -125.38 135.23 52.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.1 m 68.17 166.37 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 163.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 86.0 t -67.8 -31.4 52.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.896 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 150' ' ' MET . 3.3 p -71.92 2.52 5.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.736 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.581 ' HB2' ' CZ2' ' A' ' 145' ' ' TRP . 21.3 ptp 51.41 25.83 2.81 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.436 1.094 . . . . 0.0 111.869 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.7 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 99.8 mttt -100.8 130.28 46.8 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.531 ' HA ' ' HB2' ' A' ' 146' ' ' ASP . 24.4 p80 -124.88 151.99 44.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.873 0.368 . . . . 0.0 111.419 -169.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -101.18 171.98 7.28 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.944 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 89.21 -142.82 17.03 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.278 168.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.806 ' HD1' ' HA3' ' A' ' 117' ' ' GLY . 41.4 m-85 -128.36 177.96 6.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.069 -0.566 . . . . 0.0 110.394 -171.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.25 151.53 37.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.886 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.767 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 81.7 m-85 -114.87 109.44 18.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.952 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.851 ' HB ' HG11 ' A' ' 114' ' ' VAL . 87.8 t -91.71 105.63 16.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.58 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 50.5 tt0 -99.53 115.6 29.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.717 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -91.55 178.46 5.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.93 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -77.54 -37.18 51.35 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.258 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.77 146.14 37.04 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.078 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.672 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.9 Cg_endo -70.17 -18.99 34.75 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.358 2.705 . . . . 0.0 112.056 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.594 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 9.1 mp0 -55.92 -53.84 51.91 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.807 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.08 -21.37 64.9 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.09 -45.46 15.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.75 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.629 ' HG3' HG11 ' A' ' 286' ' ' VAL . 16.0 mm100 -69.0 -31.83 70.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.787 173.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.681 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 14.2 tp -70.23 -47.19 62.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.522 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.34 71.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.091 0.472 . . . . 0.0 109.85 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.606 ' HG ' HG22 ' A' ' 185' ' ' VAL . 4.0 tt -67.64 -51.81 45.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 172.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -52.53 -43.47 65.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.853 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -95.6 -46.41 6.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.7 ttp -104.28 31.08 4.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.089 0.471 . . . . 0.0 112.123 -166.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.418 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 9.0 p30 -76.59 7.06 4.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.582 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 15.3 m -102.49 -73.49 0.66 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.554 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 24.5 m -133.04 156.11 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 0.0 111.365 -173.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.949 ' HB2' HD11 ' A' ' 183' ' ' ILE . 2.1 tpt -122.95 104.06 9.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.376 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.99 61.04 2.48 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.181 172.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 122.75 -153.56 16.94 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.489 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.58 72.33 0.79 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.253 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 176' ' ' VAL . 21.8 tpt180 -143.57 118.95 10.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 175' ' ' SER . 42.2 m-80 -78.47 119.28 21.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.209 176.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.949 HD11 ' HB2' ' A' ' 177' ' ' MET . 45.4 pt -111.81 166.72 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.237 -176.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.732 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 27.4 mtpp -103.48 134.65 46.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 172.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.606 HG12 HG12 ' A' ' 116' ' ' VAL . 26.4 m -134.18 152.73 34.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.937 0.399 . . . . 0.0 110.305 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.596 ' HA3' HD13 ' A' ' 170' ' ' LEU . . . 86.72 -95.2 2.03 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.003 173.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 4.4 ptp85 -178.07 134.6 0.34 Allowed Pre-proline 0 C--N 1.328 -0.355 0 O-C-N 123.753 0.325 . . . . 0.0 110.562 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 37.5 Cg_exo -61.75 131.95 37.8 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.684 2.256 . . . . 0.0 111.137 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.2 m -62.9 109.14 1.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.961 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -149.44 155.38 40.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.1 tp -89.15 135.84 24.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.865 0.364 . . . . 0.0 110.159 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -168.38 -150.44 6.62 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.869 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -80.71 -39.75 26.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.549 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -79.27 -32.46 43.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.487 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 51.4 tp60 -54.08 -53.31 59.99 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.0 Cg_endo -53.2 -39.38 80.73 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.542 2.162 . . . . 0.0 112.674 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.97 -45.21 55.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.549 HG12 ' SD ' ' A' ' 111' ' ' MET . 51.8 mt -59.33 -47.48 90.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.162 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.46 -39.5 94.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.777 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -63.35 -47.42 82.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.008 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.561 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 39.8 mt -67.18 -32.94 74.35 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.629 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.629 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.74 -45.23 74.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.991 0.424 . . . . 0.0 109.914 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -68.47 -34.95 76.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.066 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 35.5 mt-10 -66.69 -31.57 72.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.275 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.98 -29.24 64.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.164 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.629 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 74.9 mtp180 -72.36 -15.29 61.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.602 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -90.73 -2.53 57.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.92 169.06 16.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.987 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.571 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 36.3 m-20 -108.7 35.13 3.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.382 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.455 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 24.2 ttm180 -95.11 137.42 34.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.121 0.486 . . . . 0.0 111.595 -173.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 34.0 pt -128.95 167.07 25.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.987 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.484 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 73.5 t80 -122.34 126.81 48.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.618 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.516 HG12 ' CZ ' ' A' ' 229' ' ' PHE . 35.7 m -122.4 132.96 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.998 0.428 . . . . 0.0 110.461 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.15 174.54 7.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.685 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 54.5 m 60.8 31.13 20.05 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.499 0.666 . . . . 0.0 109.955 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.55 127.64 36.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.031 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.528 ' HD2' ' HG3' ' A' ' 278' ' ' GLN . 19.0 t-80 -56.91 135.16 55.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.593 0.235 . . . . 0.0 111.191 -173.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -47.5 -53.75 13.45 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.26 22.61 5.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.413 HD22 ' HG ' ' A' ' 275' ' ' LEU . 15.1 tp -101.5 131.36 47.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.7 p -93.94 171.61 8.75 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.287 0.476 . . . . 0.0 112.287 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.62 -32.13 73.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.856 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.33 -34.5 76.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.475 0.655 . . . . 0.0 109.844 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.4 ' O ' HG21 ' A' ' 228' ' ' VAL . 62.7 m-20 -73.56 -43.68 59.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.702 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.69 HG21 HD13 ' A' ' 255' ' ' ILE . 32.6 mm -64.38 -44.12 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 65.5 tttm -57.16 -49.8 74.83 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.607 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 67.3 m -56.84 -37.7 71.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 224' ' ' ASP . 25.1 t -75.95 -44.23 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 122.122 -0.361 . . . . 0.0 111.559 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.568 ' HB2' HD12 ' A' ' 235' ' ' ILE . 32.6 m-85 -69.77 -28.79 66.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.455 0.645 . . . . 0.0 110.188 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 8.7 tp10 -59.51 -25.12 64.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.796 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.42 -9.93 59.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.182 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -109.61 -45.29 3.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.666 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -144.55 165.19 27.59 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.096 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -70.96 115.83 10.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.233 0.539 . . . . 0.0 110.783 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 229' ' ' PHE . 27.6 mt -87.8 150.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.756 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -112.49 -23.08 10.49 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.26 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 22.6 t -172.24 145.37 1.72 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.321 . . . . 0.0 110.859 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.42 ' HG ' HD13 ' A' ' 255' ' ' ILE . 52.5 t -141.69 128.26 20.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.8 m -142.38 110.78 6.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.985 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.604 HD23 HG13 ' A' ' 225' ' ' ILE . 46.0 mt -83.98 133.55 34.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.18 119.31 14.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.839 0.352 . . . . 0.0 110.544 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.519 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 18.0 mtm180 -122.94 145.9 48.07 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.706 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.778 ' HB2' ' HG1' ' A' ' 246' ' ' THR . 10.6 m-20 -79.55 140.11 55.4 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.441 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.46 -25.6 14.53 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 124.04 3.16 . . . . 0.0 114.769 -171.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.1 t -157.78 48.16 0.39 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.517 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.778 ' HG1' ' HB2' ' A' ' 243' ' ' ASP . 17.2 p -102.89 -28.81 11.82 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.73 -0.606 . . . . 0.0 111.879 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.54 59.09 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.702 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.27 174.23 14.56 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.519 ' HB3' ' HG2' ' A' ' 242' ' ' ARG . 28.0 p80 -109.24 146.72 33.76 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.586 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -48.2 -50.48 29.05 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.812 0.695 . . . . 0.0 111.718 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 152.6 -11.73 0.63 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.821 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.484 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 46.2 p90 -124.95 171.03 10.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.818 0.342 . . . . 0.0 110.605 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -162.32 167.76 37.03 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.499 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.594 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 98.6 m-85 -123.66 146.66 48.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.004 0.43 . . . . 0.0 110.983 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.69 HD13 HG21 ' A' ' 225' ' ' ILE . 87.4 mt -139.8 136.1 38.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.209 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 46.1 mt-10 -119.17 136.33 54.23 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.524 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 6.8 m-85 -98.63 176.04 5.79 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -80.5 -21.79 41.6 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.341 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -131.19 137.48 48.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.063 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -69.5 -31.78 70.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.661 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -66.47 -35.6 80.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.976 0.417 . . . . 0.0 110.369 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.8 m -70.82 -42.38 70.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.327 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 40.7 p -66.89 -40.02 87.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.443 . . . . 0.0 110.694 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -70.92 -22.67 62.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.077 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.5 -37.24 71.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.63 84.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.71 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.471 ' HA ' ' CG2' ' A' ' 282' ' ' VAL . 61.9 t -61.77 -27.32 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.498 0.666 . . . . 0.0 110.568 174.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.0 t -87.21 -34.12 19.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.788 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.9 m -94.07 -31.35 14.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.525 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 91.1 mmm -92.32 7.1 44.34 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -170.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.468 ' HA ' HG12 ' A' ' 282' ' ' VAL . 52.9 t30 -72.69 121.66 20.18 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.377 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 86.8 mt 65.95 27.71 10.75 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.06 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -81.92 122.76 28.16 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.92 114.24 15.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.009 0.433 . . . . 0.0 110.06 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.413 ' HG ' HD22 ' A' ' 220' ' ' LEU . 26.4 tp -127.03 91.94 3.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.373 0.606 . . . . 0.0 110.09 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 94.07 11.36 57.65 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.547 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.9 6.66 39.83 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.688 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.528 ' HG3' ' HD2' ' A' ' 217' ' ' HIS . 29.2 mt-30 -133.59 144.45 49.3 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -89.31 114.81 26.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.783 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 62.8 mt -63.49 124.37 21.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.271 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -94.0 115.12 27.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.471 ' CG2' ' HA ' ' A' ' 267' ' ' VAL . 13.9 p -114.6 140.1 37.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.33 0.586 . . . . 0.0 111.139 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.28 174.69 33.4 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.578 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -84.86 122.94 29.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -61.27 127.38 31.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.172 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.629 HG11 ' HG3' ' A' ' 167' ' ' GLN . 35.5 m -91.45 -12.91 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.811 0.338 . . . . 0.0 111.443 -173.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.432 ' HA ' ' HD2' ' A' ' 288' ' ' PRO . 36.4 p -111.97 119.52 44.12 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-O 121.264 0.554 . . . . 0.0 111.058 175.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.498 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 43.9 Cg_endo -66.84 162.07 39.35 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.102 2.535 . . . . 0.0 111.909 176.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -68.39 76.05 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.297 2.665 . . . . 0.0 112.934 -178.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.452 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 49.1 ttm -81.04 118.01 70.55 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 175.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 6.6 Cg_exo -74.73 59.48 4.98 Favored 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 123.235 2.623 . . . . 0.0 112.69 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.8 tp -118.2 37.08 4.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.423 0.63 . . . . 0.0 109.998 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.14 131.32 46.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 91.8 m 61.85 76.88 0.37 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 121.411 0.624 . . . . 0.0 109.609 -170.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.87 143.12 90.96 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.806 2.337 . . . . 0.0 112.171 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 59.64 42.48 17.1 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.444 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 C--O 1.251 1.15 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.535 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 112.266 -0.333 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.31 102.46 7.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.3 mtm -82.03 65.83 7.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.164 0.507 . . . . 0.0 110.688 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -89.8 124.05 34.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -99.21 77.4 2.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.404 0.621 . . . . 0.0 110.127 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.43 ' C ' ' H ' ' A' ' 106' ' ' ARG . 23.6 mmt180 -101.66 -0.99 33.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.044 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.584 ' HB2' HD13 ' A' ' 108' ' ' LEU . 29.8 pt20 -78.82 28.94 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.096 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 104' ' ' ARG . 90.2 mtm180 -60.58 -28.4 68.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.911 -173.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 110' ' ' ILE . . . -74.86 -22.0 58.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.737 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.584 HD13 ' HB2' ' A' ' 105' ' ' GLN . 57.2 mt -62.56 -33.3 74.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.693 0.282 . . . . 0.0 110.594 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.02 -25.67 65.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.794 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.438 ' CD1' ' HA ' ' A' ' 107' ' ' ALA . 3.6 mp -87.75 -36.82 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.61 ' SD ' HG23 ' A' ' 198' ' ' ILE . 42.5 mtm -74.7 -22.28 58.94 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.44 -11.74 60.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.958 0.408 . . . . 0.0 110.46 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -106.55 140.95 38.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.713 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.53 HG11 ' HB ' ' A' ' 158' ' ' VAL . 2.9 p -121.59 128.79 75.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.404 0.621 . . . . 0.0 110.225 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -81.25 109.89 16.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.778 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.442 HG11 HD12 ' A' ' 119' ' ' ILE . 39.3 t -108.02 120.05 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.104 0.478 . . . . 0.0 111.253 -174.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -135.21 174.07 21.36 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.442 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.759 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 25.9 m 66.59 35.35 5.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.069 0.547 . . . . 0.0 111.37 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.442 HD12 HG11 ' A' ' 116' ' ' VAL . 46.0 mt -85.22 114.72 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.558 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -52.29 134.41 33.79 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.435 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -71.42 76.66 0.76 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 122.162 0.982 . . . . 0.0 111.474 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.46 -37.75 0.06 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.931 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.448 ' CD1' ' HG3' ' A' ' 177' ' ' MET . 59.8 mt -75.16 110.64 9.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.825 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.55 169.58 49.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.869 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.09 -36.91 84.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.935 0.397 . . . . 0.0 110.275 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.53 -35.01 76.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.547 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.6 m -64.54 -42.81 95.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 110.142 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.513 HG13 ' HE2' ' A' ' 143' ' ' MET . 33.7 mm -63.2 -41.58 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.488 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 43.3 ttp-105 -59.04 -41.36 87.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.548 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.24 -34.13 77.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.525 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.68 -32.21 28.22 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -88.35 -21.42 24.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.773 0.32 . . . . 0.0 111.383 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.62 98.32 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.66 -32.4 5.84 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 122.998 2.465 . . . . 0.0 114.252 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.596 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 74.0 m-85 -83.01 -44.14 15.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.485 0.183 . . . . 0.0 111.367 -176.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.41 167.41 40.24 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.367 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.35 134.41 35.99 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.697 2.265 . . . . 0.0 111.338 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.444 HG22 ' CG1' ' A' ' 141' ' ' ILE . 50.3 mt -100.14 132.84 44.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.409 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 21.4 ttmm -98.7 -29.58 12.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.551 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.7 t -156.82 135.17 11.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.83 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.444 ' CG1' HG22 ' A' ' 138' ' ' ILE . 63.4 mt -128.69 116.57 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -114.22 99.53 7.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.973 0.416 . . . . 0.0 110.327 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.513 ' HE2' HG13 ' A' ' 128' ' ' ILE . 49.2 ttm -103.05 140.72 36.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.694 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.2 m -76.18 69.81 2.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.39 0.614 . . . . 0.0 110.119 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -97.81 90.59 5.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.399 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -138.02 77.91 1.66 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.498 -179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 88.7 p -172.71 156.13 3.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.967 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.4 m -89.62 -19.27 7.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.325 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.9 p -91.12 8.85 33.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.759 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.8 mtm 66.27 31.8 8.26 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.962 0.505 . . . . 0.0 111.643 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -92.76 144.39 25.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.14 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -86.13 100.02 11.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.436 0.636 . . . . 0.0 110.273 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -82.57 54.6 2.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.313 -176.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 143.14 -133.49 5.5 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.078 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -132.64 178.59 6.73 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 143' ' ' MET . . . -127.09 139.53 52.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.006 0.431 . . . . 0.0 110.716 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -114.52 118.72 34.55 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.091 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.53 ' HB ' HG11 ' A' ' 114' ' ' VAL . 96.5 t -104.87 112.1 37.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -105.02 115.42 30.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -88.29 165.19 15.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.564 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 23.0 mt-10 -83.04 -12.02 57.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.222 175.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.9 m -136.66 134.43 19.5 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.969 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.08 -22.37 47.63 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.896 2.397 . . . . 0.0 112.475 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.753 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 13.7 mp0 -55.26 -54.2 46.48 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.389 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.03 -19.59 63.04 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.49 -52.1 9.65 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.63 ' HG3' HG12 ' A' ' 286' ' ' VAL . 14.9 mm100 -69.94 -27.17 64.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 175.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.596 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 12.9 tp -70.02 -50.57 40.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.415 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.63 -33.87 76.58 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.484 HD11 ' HA3' ' A' ' 186' ' ' GLY . 8.2 tt -61.25 -46.5 90.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.993 173.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 284' ' ' LYS . 4.7 mt-10 -65.64 -44.2 87.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.675 -175.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -86.93 -37.92 17.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.4 mtm -101.6 30.25 4.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.958 0.409 . . . . 0.0 111.324 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -68.33 -11.08 58.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.128 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 20.3 m -101.31 -72.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.2 m -138.21 166.06 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.08 0.467 . . . . 0.0 111.855 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.448 ' HG3' ' CD1' ' A' ' 123' ' ' LEU . 18.3 tpp -134.87 99.21 4.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.877 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.433 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 89.7 mt 53.49 41.28 32.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.607 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.62 -144.52 16.45 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.993 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.64 -123.02 15.2 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.255 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -143.95 179.0 7.46 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 175' ' ' SER . 9.2 t30 -51.27 111.56 0.59 Allowed 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.628 0.58 . . . . 0.0 110.694 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.759 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 47.6 pt -89.29 160.8 2.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.474 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 52.2 tttp -107.25 116.22 31.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.5 t -120.31 106.2 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.484 ' HA3' HD11 ' A' ' 170' ' ' LEU . . . 101.61 163.53 27.15 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.25 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.492 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 30.1 ptt180 -139.14 58.6 13.09 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.872 0.367 . . . . 0.0 111.709 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 9.3 Cg_endo -88.33 11.47 3.08 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.795 2.33 . . . . 0.0 111.89 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 42.2 m -104.52 9.83 35.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.355 0.597 . . . . 0.0 110.633 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -94.31 155.08 17.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.907 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.5 tp -115.81 140.5 37.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.086 0.47 . . . . 0.0 110.436 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 175.5 -160.76 29.42 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -82.12 -11.44 58.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.584 0.692 . . . . 0.0 110.806 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.88 -38.52 27.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.456 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.521 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 56.4 tp60 -58.22 -49.77 91.75 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.9 Cg_endo -52.9 -39.08 79.47 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.332 2.021 . . . . 0.0 112.458 177.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 56.9 mt -72.61 -39.39 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.819 0.342 . . . . 0.0 110.438 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.61 HG23 ' SD ' ' A' ' 111' ' ' MET . 69.9 mt -59.35 -50.07 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.602 176.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.64 -30.96 68.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.55 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.68 -52.09 62.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.453 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.584 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 27.5 mt -67.56 -33.55 75.26 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.921 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.688 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.28 -51.12 60.32 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 173.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -65.71 -30.91 71.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.308 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 40.3 mt-10 -67.2 -34.75 78.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.068 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.79 -36.69 65.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.712 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.688 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 71.5 mtp180 -66.48 -24.24 66.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.125 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.17 -13.92 60.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.241 0.543 . . . . 0.0 110.66 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -113.74 -179.28 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.365 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 46.2 m-20 -116.46 40.87 2.79 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.43 ' HD2' ' HG3' ' A' ' 289' ' ' PRO . 28.1 ttt180 -93.95 135.62 35.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.704 -173.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.1 pt -135.18 167.18 26.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.566 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.565 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 27.0 t80 -121.65 130.57 53.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.776 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 225' ' ' ILE . 28.1 m -121.42 131.92 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.099 0.476 . . . . 0.0 110.145 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.07 176.58 6.59 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.915 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.6 m 62.27 32.52 17.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.906 0.86 . . . . 0.0 109.339 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.436 HG11 HD12 ' A' ' 225' ' ' ILE . 16.4 t -77.76 112.74 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.505 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -60.13 139.57 57.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.232 0.539 . . . . 0.0 111.341 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -51.05 -35.99 37.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.78 -17.72 30.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.134 0.492 . . . . 0.0 111.051 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.719 HD21 ' HG ' ' A' ' 275' ' ' LEU . 0.9 OUTLIER -74.1 132.55 42.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.061 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.2 m -103.25 179.71 4.19 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.303 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -55.63 -46.46 77.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.602 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -67.47 -27.34 66.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.613 -173.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -66.91 -54.05 25.92 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.467 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.686 HG21 HD12 ' A' ' 255' ' ' ILE . 42.7 mm -63.5 -43.2 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.73 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.444 ' O ' HD13 ' A' ' 235' ' ' ILE . 83.9 tttt -56.85 -49.44 75.46 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.577 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 35.3 t -55.51 -41.09 72.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.541 HG13 ' HE3' ' A' ' 270' ' ' MET . 14.1 t -74.75 -40.93 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.235 -176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.7 ' HB2' HD11 ' A' ' 235' ' ' ILE . 24.4 m-85 -69.12 -35.74 76.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.467 0.651 . . . . 0.0 110.35 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 34.9 tp10 -59.2 -24.89 63.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.695 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.47 -19.76 64.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.002 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -111.51 -34.36 6.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -145.15 153.93 25.59 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.561 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.465 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 66.0 mmtt -73.76 113.3 10.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 111.941 -177.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.7 HD11 ' HB2' ' A' ' 229' ' ' PHE . 51.4 mt -92.47 151.09 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.878 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -109.66 -36.31 5.97 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.562 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.521 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 19.0 m -147.94 146.04 28.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.705 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.44 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 53.3 t -153.9 118.26 4.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.758 174.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.9 t -141.26 119.22 11.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.205 0.526 . . . . 0.0 111.51 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.652 HD21 ' HA3' ' A' ' 253' ' ' GLY . 40.8 mt -91.94 132.61 36.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.033 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.64 124.44 23.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.55 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.581 ' HB3' ' CB ' ' A' ' 249' ' ' HIS . 14.7 ptt-85 -144.59 169.89 17.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.478 -173.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -104.56 100.92 25.04 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.728 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.25 -22.24 64.01 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.513 2.142 . . . . 0.0 112.368 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.8 p -75.65 -17.94 59.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.48 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 49.3 p -108.84 -42.22 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.997 0.427 . . . . 0.0 110.369 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 114.54 -16.92 18.96 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.748 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -107.19 160.69 15.39 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.608 -0.348 . . . . 0.0 110.493 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.581 ' CB ' ' HB3' ' A' ' 242' ' ' ARG . 26.9 p80 -100.76 162.56 12.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.539 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -75.03 -69.93 0.44 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.213 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 170.19 25.99 0.02 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.095 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.474 ' HB2' ' CE1' ' A' ' 212' ' ' TYR . 3.1 p90 -153.77 154.07 33.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.652 ' HA3' HD21 ' A' ' 240' ' ' LEU . . . -157.78 173.22 35.1 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.137 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.753 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 81.4 m-85 -127.09 146.06 50.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.981 0.419 . . . . 0.0 110.626 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.686 HD12 HG21 ' A' ' 225' ' ' ILE . 74.5 mt -135.02 138.78 48.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.284 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 45.6 mt-10 -121.63 142.46 50.1 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.638 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 6.3 m-85 -105.85 163.69 12.53 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.05 0.452 . . . . 0.0 111.458 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.31 -36.75 20.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.526 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -100.41 114.94 28.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.571 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -50.83 -59.46 4.09 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.547 0.53 . . . . 0.0 112.375 -168.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.43 -36.54 64.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.257 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.2 t -67.94 -21.14 65.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.638 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 89.6 p -66.55 -49.93 64.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.218 0.533 . . . . 0.0 110.4 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -75.56 -15.9 60.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.67 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.48 -40.84 73.4 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.29 83.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 95.9 t -57.44 -30.58 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.236 0.541 . . . . 0.0 111.177 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.8 m -87.34 -29.45 21.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.342 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 13.3 m -93.54 -40.47 10.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.989 0.423 . . . . 0.0 112.03 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.541 ' HE3' HG13 ' A' ' 228' ' ' VAL . 87.6 mmm -85.08 -2.88 58.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.951 -171.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -69.1 129.66 40.52 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.371 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.7 mt 66.31 27.69 10.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.808 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -90.34 117.96 29.47 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.655 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 4.0 p-10 -76.03 122.38 24.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.371 0.605 . . . . 0.0 110.289 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.719 ' HG ' HD21 ' A' ' 220' ' ' LEU . 26.5 tp -134.24 95.21 3.36 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.635 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 93.36 18.65 38.17 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.699 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.89 -36.75 4.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.68 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -93.82 147.95 22.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.767 0.317 . . . . 0.0 110.746 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.655 ' CE1' ' HB3' ' A' ' 274' ' ' ASP . 54.2 m-85 -87.44 115.9 25.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.743 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.4 mt -57.13 116.6 3.35 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.797 0.685 . . . . 0.0 111.122 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -93.69 115.0 27.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 13.7 p -121.41 147.63 25.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.173 0.511 . . . . 0.0 111.12 -173.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.38 179.7 37.53 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 171' ' ' GLU . 2.0 mppt? -84.74 134.96 34.32 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.579 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -68.85 137.15 53.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.63 HG12 ' HG3' ' A' ' 167' ' ' GLN . 33.1 m -97.96 -11.96 8.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.479 . . . . 0.0 110.917 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 38.3 p -108.6 135.06 20.08 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.004 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.29 147.82 42.6 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.847 2.364 . . . . 0.0 111.478 174.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.43 ' HG3' ' HD2' ' A' ' 210' ' ' ARG . 52.4 Cg_exo -54.18 143.19 64.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.866 2.377 . . . . 0.0 112.035 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 49.3 ttp -111.81 93.64 21.34 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.555 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.467 ' HD2' HD23 ' A' ' 292' ' ' LEU . 96.6 Cg_endo -84.92 -5.32 9.72 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.447 2.098 . . . . 0.0 111.267 171.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.467 HD23 ' HD2' ' A' ' 291' ' ' PRO . 3.3 mm? -63.29 107.38 1.06 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.932 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 92.8 mt 64.58 9.51 5.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.406 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 18.5 m -145.01 86.21 7.81 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.426 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.92 58.83 6.67 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.612 2.208 . . . . 0.0 111.351 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 60.12 -99.04 0.09 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.633 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 59.5 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.213 176.554 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 121.43 30.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.724 0.297 . . . . 0.0 110.518 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 49.5 tpp -131.1 -32.41 1.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.018 0.437 . . . . 0.0 110.718 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -120.71 163.55 17.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.369 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 56.77 58.66 3.95 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.403 0.621 . . . . 0.0 110.659 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -114.73 76.16 0.98 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.04 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 54.35 82.39 0.09 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.711 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -55.51 -28.2 53.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.281 -174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.407 ' HB2' ' HB ' ' A' ' 197' ' ' ILE . . . -68.37 -35.04 77.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.036 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.465 HD23 HG22 ' A' ' 287' ' ' THR . 40.8 mt -66.71 -31.8 72.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.041 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.42 69.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.339 0.59 . . . . 0.0 110.36 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.4 mt -88.05 -36.96 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.348 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.479 ' SD ' HG12 ' A' ' 198' ' ' ILE . 90.4 mtp -69.88 -19.27 63.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.44 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 86.3 m -85.71 -1.89 57.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.1 0.476 . . . . 0.0 110.99 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -118.33 142.13 47.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.211 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.683 HG12 ' HB ' ' A' ' 158' ' ' VAL . 8.8 p -115.24 119.79 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.631 0.729 . . . . 0.0 109.761 172.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 41.7 t80 -67.87 119.99 13.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.192 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.563 HG23 ' HB3' ' A' ' 156' ' ' ALA . 17.0 m -119.48 117.51 54.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.59 0.709 . . . . 0.0 111.69 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.46 170.86 23.15 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.056 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.663 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 10.5 t 64.15 36.76 9.37 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.645 0.735 . . . . 0.0 109.604 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.433 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 84.7 mt -78.76 -15.51 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.854 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 75.5 t80 76.04 139.28 0.06 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.664 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.583 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 26.0 p90 -74.89 77.64 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.581 0.705 . . . . 0.0 110.892 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -163.59 -35.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.396 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 ' HB2' ' A' ' 178' ' ' LEU . 72.8 mt -85.64 128.92 34.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.206 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.27 176.85 39.08 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.893 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.72 -39.9 93.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 0.0 110.549 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.4 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 16.1 t70 -65.03 -41.96 94.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.279 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 m -61.15 -40.56 94.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.938 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.571 HG13 ' HE3' ' A' ' 143' ' ' MET . 29.3 mm -66.09 -38.69 82.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.789 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.403 ' O ' ' HB1' ' A' ' 133' ' ' ALA . 33.2 ttp-105 -61.52 -39.02 89.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.993 0.425 . . . . 0.0 109.946 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 78.0 mt-30 -63.94 -37.78 88.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.335 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.56 -36.66 37.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.264 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.544 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 56.9 m-85 -92.29 -7.85 46.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.978 0.418 . . . . 0.0 111.777 -177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.601 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -53.4 -45.58 98.42 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 6.8 Cg_endo -51.21 -27.66 23.47 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.854 2.369 . . . . 0.0 114.534 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.616 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 58.5 m-85 -83.88 -42.95 15.82 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.408 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.8 -179.49 40.49 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.849 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.93 110.92 3.13 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.763 2.309 . . . . 0.0 111.799 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 63.1 mt -79.57 113.02 18.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.353 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -78.58 -41.48 31.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.845 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -162.1 156.75 22.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.523 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.1 mt -134.76 116.18 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.732 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 12.8 m-20 -88.31 98.92 11.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.571 ' HE3' HG13 ' A' ' 128' ' ' ILE . 50.1 ttm -120.61 133.37 55.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.885 0.374 . . . . 0.0 111.228 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 16.3 m -77.67 99.05 5.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.44 172.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.596 ' HA ' ' HB2' ' A' ' 152' ' ' HIS . 12.7 t-105 -124.63 112.22 16.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.502 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -172.16 104.56 0.18 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.21 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.5 m -157.62 140.36 14.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 32.0 m -62.33 -21.03 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.144 -173.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.51 ' OG1' ' HD2' ' A' ' 151' ' ' LYS . 15.3 p -99.67 27.7 5.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.312 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.464 ' HB2' ' HE3' ' A' ' 150' ' ' MET . 2.4 mpp? 55.12 60.16 3.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.45 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 40.2 mttp -143.12 176.51 9.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.685 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.623 ' HB2' ' O ' ' A' ' 144' ' ' SER . 14.6 p80 -153.35 158.22 41.21 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.127 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -112.62 -169.14 1.42 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.381 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 66.84 -147.05 49.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.496 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -140.86 178.44 7.35 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.563 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -138.15 158.46 44.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.064 0.459 . . . . 0.0 111.662 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -117.84 115.8 25.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.338 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.683 ' HB ' HG12 ' A' ' 114' ' ' VAL . 99.4 t -91.52 109.93 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.936 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -98.03 116.22 29.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.431 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.544 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 95.9 m-85 -92.86 176.47 6.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.657 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -95.76 -1.52 49.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.045 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.9 m -145.76 137.31 12.92 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.22 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.625 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 43.5 Cg_endo -68.54 -20.34 41.39 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.039 2.493 . . . . 0.0 112.164 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.473 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 79.6 mm-40 -58.09 -56.34 23.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.79 -20.35 34.83 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.27 -51.82 7.54 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -63.31 -34.68 78.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.769 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.616 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.6 tp -68.67 -48.92 62.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.601 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.49 83.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 110.155 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 174' ' ' ASN . 6.7 tt -63.06 -51.16 67.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.532 174.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -57.72 -47.93 81.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.014 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -85.7 -33.37 21.53 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.9 mtm -108.15 30.09 6.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.49 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 24.2 p-10 -79.81 23.26 0.44 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.828 0.347 . . . . 0.0 111.584 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.8 t -114.59 -73.35 0.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.853 0.358 . . . . 0.0 110.625 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.581 HG13 ' H ' ' A' ' 182' ' ' ASN . 20.8 m -139.73 169.04 17.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.217 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.815 ' HB2' HD12 ' A' ' 183' ' ' ILE . 1.1 tpt -141.59 94.36 2.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.72 ' HG ' ' HE1' ' A' ' 177' ' ' MET . 89.0 mt 60.13 -83.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.579 0.752 . . . . 0.0 112.279 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -108.99 -12.8 19.67 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.336 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.32 115.03 4.32 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.246 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -82.94 127.06 33.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.581 ' H ' HG13 ' A' ' 176' ' ' VAL . 20.4 t-20 61.54 76.43 0.37 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.773 0.671 . . . . 0.0 110.258 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.815 HD12 ' HB2' ' A' ' 177' ' ' MET . 49.6 pt -88.36 160.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.724 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 67.0 mttm -105.65 106.91 17.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.528 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 6.2 m -109.27 116.4 51.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.317 0.58 . . . . 0.0 110.217 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.411 ' HA3' HD13 ' A' ' 170' ' ' LEU . . . 72.87 -171.73 50.09 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.595 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.698 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 19.9 mmt180 -132.69 81.24 59.54 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 174.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.15 -37.61 96.22 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.124 2.549 . . . . 0.0 113.284 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.4 m -115.37 40.45 2.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.198 0.523 . . . . 0.0 111.461 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.698 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 29.4 t-20 -81.0 83.03 6.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.443 0.64 . . . . 0.0 109.295 173.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.539 ' HA ' ' HG3' ' A' ' 195' ' ' GLN . 10.0 tp -65.88 140.18 20.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.718 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 160.82 -161.28 32.67 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -64.32 -28.01 69.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.014 0.435 . . . . 0.0 111.454 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -70.52 -32.04 69.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.539 ' HG3' ' HA ' ' A' ' 191' ' ' ILE . 29.1 mm-40 -57.36 -56.19 36.52 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -173.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.2 Cg_endo -53.68 -37.51 83.9 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.219 1.946 . . . . 0.0 112.748 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 107' ' ' ALA . 54.7 mt -75.96 -43.09 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.774 0.321 . . . . 0.0 111.15 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.479 HG12 ' SD ' ' A' ' 111' ' ' MET . 72.8 mt -61.72 -46.49 96.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.05 0.452 . . . . 0.0 109.975 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.57 -36.98 85.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.352 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -58.32 -53.95 52.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.118 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.463 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 58.1 mt -68.8 -33.7 74.31 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.904 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.694 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.03 -48.96 69.95 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.6 ' OE1' ' HD3' ' A' ' 206' ' ' ARG . 6.6 mm-40 -62.89 -35.99 81.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.084 176.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 40.7 mt-10 -63.92 -36.25 83.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.356 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.09 -34.01 63.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.83 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.694 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 72.2 mtp180 -69.09 -20.63 64.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.937 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.53 -18.13 59.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.149 0.5 . . . . 0.0 110.554 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -109.14 -169.96 1.58 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.052 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.478 ' CB ' ' HA ' ' A' ' 260' ' ' ALA . 27.2 p-10 -139.5 58.75 1.61 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.835 0.826 . . . . 0.0 109.656 178.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.529 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 18.6 ttm180 -111.05 139.13 46.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.173 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.537 HG21 ' HB2' ' A' ' 263' ' ' SER . 47.1 pt -119.57 163.15 17.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.668 0.271 . . . . 0.0 110.597 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -113.9 127.0 55.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.152 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 28.3 m -114.8 128.01 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.359 0.599 . . . . 0.0 110.154 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -120.27 167.53 12.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.097 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.3 t 59.67 40.03 20.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.975 0.893 . . . . 0.0 109.095 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 225' ' ' ILE . 39.4 t -77.4 120.99 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.473 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.522 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 40.2 t-80 -52.57 133.01 36.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.257 0.551 . . . . 0.0 111.05 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -49.27 -37.68 24.42 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -171.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -96.41 -6.1 38.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.126 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.644 HD23 HD11 ' A' ' 275' ' ' LEU . 10.7 tp -88.7 112.41 23.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.5 t -96.93 -178.67 4.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.854 0.359 . . . . 0.0 111.734 -170.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -53.36 -38.51 63.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.544 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.45 -37.55 87.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.391 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.401 ' HB2' ' HG ' ' A' ' 220' ' ' LEU . 15.7 m-20 -73.86 -42.68 60.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.992 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.531 HG21 HD11 ' A' ' 255' ' ' ILE . 34.6 mm -64.21 -42.14 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -61.09 -48.77 80.14 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.001 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 13.2 p -60.16 -38.17 82.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.44 HG21 HD22 ' A' ' 275' ' ' LEU . 49.1 t -76.56 -40.29 33.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.766 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.545 ' CB ' HD13 ' A' ' 235' ' ' ILE . 6.1 m-85 -69.19 -32.49 71.81 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.133 0.492 . . . . 0.0 110.993 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 7.2 tm-20 -63.35 -24.39 67.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.051 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.2 -23.82 64.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.731 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -101.41 -34.21 9.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.341 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -152.16 149.25 20.9 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.539 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 29.6 mmtp -71.19 120.52 16.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.567 0.698 . . . . 0.0 111.105 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.545 HD13 ' CB ' ' A' ' 229' ' ' PHE . 28.2 mt -91.38 151.2 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.919 -172.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.48 ' HE3' ' O ' ' A' ' 257' ' ' TYR . 17.0 ttmt -103.7 -30.28 10.53 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.202 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 28.2 t -170.34 141.91 2.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.325 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 40.4 t -142.61 127.1 17.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.744 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.9 t -141.31 133.48 27.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.823 0.344 . . . . 0.0 110.304 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 27.7 mt -109.84 136.18 49.56 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.86 126.44 29.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.221 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.402 ' HG2' ' CB ' ' A' ' 249' ' ' HIS . 73.5 mtp180 -122.83 152.45 40.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.831 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.823 ' HB2' ' HG1' ' A' ' 246' ' ' THR . 17.9 m-20 -70.5 145.85 93.29 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.74 -19.98 56.37 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 123.197 2.598 . . . . 0.0 114.159 -171.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.3 t -162.93 62.2 0.19 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.295 0.569 . . . . 0.0 111.996 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.823 ' HG1' ' HB2' ' A' ' 243' ' ' ASP . 58.7 p -127.93 -18.46 4.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.095 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.07 -46.3 1.72 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.101 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.34 177.89 6.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.848 0.356 . . . . 0.0 110.711 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.402 ' CB ' ' HG2' ' A' ' 242' ' ' ARG . 30.8 p80 -96.15 170.7 9.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.293 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -77.06 -80.6 0.1 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.938 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -179.8 18.12 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.029 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -154.89 163.9 39.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -168.66 -179.24 40.77 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.228 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.473 ' CZ ' ' HG3' ' A' ' 164' ' ' GLU . 91.1 m-85 -134.44 145.37 48.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.625 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.531 HD11 HG21 ' A' ' 225' ' ' ILE . 88.5 mt -138.04 132.06 42.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.036 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.529 ' HG2' ' HB2' ' A' ' 210' ' ' ARG . 81.6 mt-10 -110.02 146.16 35.79 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.526 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 8.2 m-85 -106.94 179.24 4.32 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.164 176.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -70.24 -50.63 37.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.924 0.868 . . . . 0.0 108.905 171.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -103.48 139.56 38.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.968 -1.469 . . . . 0.0 109.227 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.478 ' HA ' ' CB ' ' A' ' 209' ' ' ASN . . . -65.56 -28.79 69.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.705 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -72.82 -33.45 66.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.844 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.8 m -67.07 -37.18 83.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.053 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.537 ' HB2' HG21 ' A' ' 211' ' ' ILE . 21.6 p -68.23 -38.63 82.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 0.0 110.04 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -71.6 -25.96 62.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.33 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -65.39 -41.94 93.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.028 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -63.83 -41.68 97.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.468 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.17 -32.98 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.231 0.539 . . . . 0.0 111.001 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.9 t -75.37 -33.83 61.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.132 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.8 t -94.29 -40.17 10.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 112.041 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 75.2 mmm -83.33 -4.41 58.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -168.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.469 ' HA ' HG13 ' A' ' 282' ' ' VAL . 57.8 t30 -69.2 112.81 6.03 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.159 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 281' ' ' ARG . 94.1 mt 67.77 36.36 3.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.778 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -91.17 132.97 35.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.244 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -82.04 109.57 16.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.305 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.668 HD12 HD11 ' A' ' 280' ' ' LEU . 0.6 OUTLIER -117.38 91.38 3.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.137 0.494 . . . . 0.0 109.851 176.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.9 34.1 28.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.756 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 91.03 -0.29 75.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.969 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 217' ' ' HIS . 34.6 tt0 -126.57 141.17 51.95 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 120.773 0.32 . . . . 0.0 110.342 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -92.58 123.25 35.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.87 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.668 HD11 HD12 ' A' ' 275' ' ' LEU . 48.2 mt -77.73 127.6 32.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.135 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.443 ' CZ ' HD23 ' A' ' 272' ' ' LEU . 37.4 mmt180 -95.1 114.78 26.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 271' ' ' ASN . 10.7 p -117.34 147.65 20.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.157 -173.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -159.47 175.47 36.36 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.382 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -82.06 126.41 31.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -61.68 126.81 28.68 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.309 0.381 . . . . 0.0 110.585 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.59 -24.94 5.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.359 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.602 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 16.1 p -132.57 133.16 23.21 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.732 0.301 . . . . 0.0 111.269 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.32 103.71 1.44 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.616 2.211 . . . . 0.0 112.077 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 287' ' ' THR . 90.9 Cg_endo -89.38 139.16 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.688 2.259 . . . . 0.0 113.187 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 64.1 mtt -108.11 109.51 61.91 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.803 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.33 113.19 3.63 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.488 2.125 . . . . 0.0 112.562 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 94.3 mt -83.23 51.77 2.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.352 0.596 . . . . 0.0 110.35 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 87.8 mt -89.92 105.53 17.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.092 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 2.7 p -90.14 114.43 60.9 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.508 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.35 76.01 2.79 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.101 2.534 . . . . 0.0 112.238 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -85.15 64.24 8.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.332 0.587 . . . . 0.0 110.294 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 28.8 m . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.776 179.632 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.285 -0.326 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 59.49 39.98 21.14 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 174.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 55.7 ttp -108.35 -38.54 5.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.948 0.404 . . . . 0.0 110.637 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.68 -71.24 0.75 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.734 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.429 ' HB3' ' H ' ' A' ' 104' ' ' ARG . 47.8 mt-30 -137.91 -161.15 1.14 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.713 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.429 ' H ' ' HB3' ' A' ' 103' ' ' GLN . 24.8 ttt180 64.75 -84.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.846 0.716 . . . . 0.0 111.353 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -86.71 -7.58 58.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.192 0.52 . . . . 0.0 110.157 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -52.8 -48.23 67.05 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.908 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.0 -35.83 69.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.704 0.288 . . . . 0.0 111.081 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 108' ' ' LEU . 34.7 mt -66.59 -32.35 73.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.203 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.8 85.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.192 0.52 . . . . 0.0 110.136 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.97 -36.48 57.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.219 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.425 ' SD ' HG12 ' A' ' 198' ' ' ILE . 89.9 mtp -72.14 -17.01 62.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.915 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 80.2 m -89.01 -17.78 28.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.91 0.386 . . . . 0.0 110.597 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -99.08 141.53 31.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.144 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.686 HG13 ' HB ' ' A' ' 158' ' ' VAL . 2.5 p -128.05 131.58 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 121.773 0.796 . . . . 0.0 110.145 174.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.436 ' H ' ' HA2' ' A' ' 186' ' ' GLY . 39.1 t80 -94.71 104.48 16.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.222 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 17.4 m -99.38 116.52 42.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.607 0.717 . . . . 0.0 111.352 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.479 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -116.36 165.32 12.27 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.638 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.7 m 63.45 44.42 5.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.347 0.594 . . . . 0.0 110.861 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -72.91 142.93 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.234 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.447 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 37.8 t80 -54.81 127.26 27.65 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.598 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.502 ' OH ' ' HA ' ' A' ' 151' ' ' LYS . 36.4 t80 -74.47 76.71 1.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.024 0.44 . . . . 0.0 110.135 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 178.54 -36.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.111 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' A' ' 120' ' ' TYR . 93.8 mt -61.44 132.41 53.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.965 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -98.59 168.23 22.65 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.791 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -55.41 -39.51 70.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.935 0.397 . . . . 0.0 111.183 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -64.55 -39.51 93.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.076 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -71.57 -38.25 70.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.49 HG13 ' HE1' ' A' ' 143' ' ' MET . 34.4 mm -64.41 -40.24 88.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.145 176.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -59.16 -43.35 92.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.58 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.37 -34.45 73.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.297 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.11 -33.44 26.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.489 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 40.7 m-85 -91.77 -16.81 26.3 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -54.88 -43.72 98.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 42.0 Cg_exo -40.58 -38.95 2.74 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.245 2.63 . . . . 0.0 115.062 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.71 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 61.5 m-85 -77.48 -37.17 51.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -173.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -179.01 -177.71 47.76 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.867 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.06 135.43 18.97 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.772 2.314 . . . . 0.0 112.258 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.499 HD12 HD12 ' A' ' 141' ' ' ILE . 68.9 mt -102.1 130.97 51.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.564 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.456 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 29.5 ttpp -94.48 -31.75 13.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -168.79 145.91 3.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.6 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.499 HD12 HD12 ' A' ' 138' ' ' ILE . 69.5 mt -130.81 131.16 64.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -122.29 101.49 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.49 ' HE1' HG13 ' A' ' 128' ' ' ILE . 43.5 ttm -111.97 138.28 48.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.747 0.308 . . . . 0.0 110.931 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.8 m -75.25 116.39 15.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.295 173.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.421 ' CD1' ' HD2' ' A' ' 152' ' ' HIS . 0.9 OUTLIER -149.23 98.27 2.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.28 114.2 4.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.034 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.8 m -87.14 3.73 45.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.503 HG12 HG22 ' A' ' 149' ' ' THR . 8.8 p -110.06 -40.51 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.368 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.503 HG22 HG12 ' A' ' 148' ' ' VAL . 36.8 p -104.71 -0.34 27.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.889 0.376 . . . . 0.0 111.521 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 53.8 mtm 63.28 33.63 13.94 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.309 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.502 ' HA ' ' OH ' ' A' ' 121' ' ' TYR . 28.3 mmmt -97.91 131.92 43.95 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.421 ' HD2' ' CD1' ' A' ' 145' ' ' TRP . 14.4 t-80 -78.0 -61.37 2.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.0 tttm 36.98 62.12 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.502 1.126 . . . . 0.0 112.33 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 165.26 -173.95 41.08 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.658 -177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.479 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 29.5 m-85 -118.96 179.13 4.25 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.2 139.52 51.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.954 0.407 . . . . 0.0 110.647 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -105.34 109.33 21.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.824 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.686 ' HB ' HG13 ' A' ' 114' ' ' VAL . 62.9 t -94.57 105.72 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -102.87 115.15 30.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.409 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -88.94 172.38 9.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.628 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 47.8 mt-10 -89.95 -24.29 21.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.845 172.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.82 137.35 29.37 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.303 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.3 Cg_endo -69.43 -17.46 39.05 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.169 2.579 . . . . 0.0 112.362 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 71.3 mm-40 -57.99 -54.91 41.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.011 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -59.33 -21.5 59.86 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.68 -52.39 8.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -63.95 -32.33 73.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.841 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.71 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.1 tp -68.52 -50.04 55.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.584 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.42 74.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.756 0.313 . . . . 0.0 110.374 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.578 HD11 ' O ' ' A' ' 185' ' ' VAL . 24.4 tp -68.76 -40.77 79.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.125 0.488 . . . . 0.0 110.651 173.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.84 -33.95 75.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.253 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -100.13 -51.19 3.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.429 ' C ' ' H ' ' A' ' 175' ' ' SER . 13.6 mtm -103.11 29.3 5.59 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -165.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.414 ' HB2' HD12 ' A' ' 170' ' ' LEU . 64.4 t30 -83.61 32.5 0.46 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.575 0.702 . . . . 0.0 109.941 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 48.6 m -114.87 -74.08 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.369 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.07 163.84 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.395 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.878 ' HB2' HD11 ' A' ' 183' ' ' ILE . 0.8 OUTLIER -134.03 103.25 5.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.568 177.71 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.811 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 84.0 mt 54.7 77.75 0.19 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.931 0.77 . . . . 0.0 111.995 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 131.72 -139.56 11.05 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.167 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -133.7 62.67 0.63 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.322 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -142.22 124.19 15.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 175' ' ' SER . 95.3 m-20 -68.27 124.12 22.62 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 123.307 0.38 . . . . 0.0 110.439 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.878 HD11 ' HB2' ' A' ' 177' ' ' MET . 47.3 pt -106.49 155.56 7.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.043 0.449 . . . . 0.0 110.77 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.1 tppp? -105.42 116.01 31.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.578 ' O ' HD11 ' A' ' 170' ' ' LEU . 21.7 t -100.06 102.19 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.405 0.621 . . . . 0.0 109.806 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.436 ' HA2' ' H ' ' A' ' 115' ' ' TYR . . . 92.15 -174.41 37.05 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.805 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -116.52 86.09 17.7 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.93 66.59 5.0 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.511 2.807 . . . . 0.0 112.372 -176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.3 t -137.54 170.82 15.43 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.304 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -76.88 91.04 3.52 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.6 tp -64.06 -21.35 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.453 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.98 -100.09 2.28 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.044 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -54.24 -40.33 67.62 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.26 -13.2 50.52 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.485 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 12.0 tm0? -64.04 -52.87 52.89 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.82 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 77.7 Cg_exo -53.23 -38.52 81.65 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.485 2.123 . . . . 0.0 113.094 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 52.4 mt -67.36 -46.47 83.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.318 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.425 HG12 ' SD ' ' A' ' 111' ' ' MET . 66.5 mt -60.95 -45.56 98.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.317 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.32 -39.95 95.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.534 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -65.38 -47.31 76.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.557 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 49.9 mt -67.43 -33.11 74.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.092 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.592 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.6 -45.19 66.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.379 0.609 . . . . 0.0 109.53 173.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -70.44 -33.02 70.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.29 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 32.3 mt-10 -68.38 -25.6 65.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.812 0.339 . . . . 0.0 111.534 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.22 58.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.592 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 78.6 mtp180 -70.65 -10.69 59.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.193 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.34 -27.17 67.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.196 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -128.37 124.27 35.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.144 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -74.87 70.35 1.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.855 0.836 . . . . 0.0 110.277 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.858 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 3.3 ptp180 -113.46 155.37 25.44 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.725 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.6 pt -122.84 164.4 20.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.745 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -112.45 129.14 56.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.315 0.384 . . . . 0.0 110.204 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.572 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.7 m -124.08 132.91 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.192 0.52 . . . . 0.0 110.506 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . . . -126.23 177.42 6.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.649 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.9 m 61.38 30.24 18.89 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.718 0.771 . . . . 0.0 109.792 -173.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.483 ' O ' ' HA2' ' A' ' 251' ' ' GLY . 30.8 t -85.42 115.48 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.432 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.655 ' HB3' HD23 ' A' ' 220' ' ' LEU . 23.3 t-80 -57.66 139.96 52.4 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.057 0.456 . . . . 0.0 110.661 -176.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.544 ' HB2' ' HD2' ' A' ' 248' ' ' LYS . 6.0 pt20 -46.38 -41.74 14.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . 0.427 ' N ' ' HG3' ' A' ' 218' ' ' GLN . 0.7 OUTLIER -98.16 13.91 29.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -167.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.655 HD23 ' HB3' ' A' ' 217' ' ' HIS . 3.6 mm? -86.72 121.89 29.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 25.0 m -78.11 171.61 14.77 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.609 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.49 -41.25 76.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.078 0.466 . . . . 0.0 110.101 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -69.49 -24.24 63.74 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.02 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.437 ' HB3' HD11 ' A' ' 220' ' ' LEU . 7.6 m-20 -69.75 -45.64 67.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 110.258 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.682 HG23 HD12 ' A' ' 255' ' ' ILE . 14.5 mm -68.58 -38.08 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -60.53 -53.68 54.59 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.946 175.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 11.2 p -55.12 -38.63 68.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.458 HG11 ' HE2' ' A' ' 270' ' ' MET . 32.3 t -73.42 -46.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.541 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.641 ' HB2' HD13 ' A' ' 235' ' ' ILE . 17.3 m-85 -67.24 -29.99 69.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.39 0.614 . . . . 0.0 110.63 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.53 -24.15 63.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.902 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.53 -13.27 60.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.771 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -111.43 -30.92 7.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.799 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -157.34 166.8 33.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.974 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -80.18 110.69 15.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.509 0.671 . . . . 0.0 111.036 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.641 HD13 ' HB2' ' A' ' 229' ' ' PHE . 37.5 mt -83.17 151.21 4.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.604 -176.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.429 ' HG3' ' CG2' ' A' ' 297' ' ' THR . 29.2 ttpp -106.02 -34.94 7.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.448 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.4 p -173.37 156.24 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.537 ' HG ' HG22 ' A' ' 255' ' ' ILE . 74.1 m -142.46 138.88 31.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.252 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 31.9 m -141.14 103.0 4.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.676 HD23 HG13 ' A' ' 225' ' ' ILE . 81.2 mt -83.94 149.53 26.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.705 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -84.85 104.37 14.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.756 0.313 . . . . 0.0 110.356 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.716 ' HG3' ' HB3' ' A' ' 249' ' ' HIS . 0.2 OUTLIER -97.53 152.67 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.53 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.614 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 8.8 m-20 -77.84 148.72 76.26 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.95 -8.13 13.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.972 2.448 . . . . 0.0 114.422 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -166.62 38.82 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.614 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 25.4 p -108.21 -16.45 14.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.347 -0.846 . . . . 0.0 112.02 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.4 77.17 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.696 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.544 ' HD2' ' HB2' ' A' ' 218' ' ' GLN . 46.4 pttt -168.22 -168.56 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.716 ' HB3' ' HG3' ' A' ' 242' ' ' ARG . 33.9 p80 -118.79 165.16 14.37 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.239 -177.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -64.76 -68.98 0.32 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.211 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 216' ' ' VAL . . . 170.5 24.91 0.02 OUTLIER Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.431 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -152.4 160.51 43.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.543 ' HA3' HD21 ' A' ' 240' ' ' LEU . . . -174.21 178.83 45.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.532 -176.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.576 ' CZ ' ' HG3' ' A' ' 164' ' ' GLU . 81.2 m-85 -131.92 153.05 50.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.774 0.321 . . . . 0.0 111.119 -176.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.682 HD12 HG23 ' A' ' 225' ' ' ILE . 84.1 mt -142.19 131.29 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.074 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.858 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 45.6 mt-10 -105.7 146.65 29.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.482 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 9.7 m-85 -110.77 160.61 16.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.723 0.297 . . . . 0.0 110.795 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.28 -23.77 51.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.372 0.606 . . . . 0.0 110.066 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -130.53 124.61 32.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.018 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.79 68.79 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.543 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 262' ' ' SER . 7.8 pt20 -59.6 -42.88 93.59 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.102 0.251 . . . . 0.0 111.03 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.429 ' N ' ' HG3' ' A' ' 261' ' ' GLN . 20.1 m -71.14 -32.83 69.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.826 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -43.06 97.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.017 0.437 . . . . 0.0 111.039 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -74.73 -23.12 58.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.49 -35.75 65.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.053 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.61 84.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.923 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.436 ' HA ' ' CG2' ' A' ' 282' ' ' VAL . 77.3 t -58.76 -27.01 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.225 0.535 . . . . 0.0 110.646 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.8 t -86.15 -30.6 22.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.9 m -93.95 -41.15 9.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.581 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 88.3 mmm -84.11 4.9 28.22 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -169.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.442 ' HA ' HG12 ' A' ' 282' ' ' VAL . 11.0 t30 -71.58 118.11 13.98 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.382 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.474 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 93.1 mt 66.83 34.13 5.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.601 -178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -88.33 122.85 32.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.434 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 16.3 t70 -73.28 119.24 17.25 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.727 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 44.8 tp -137.01 91.91 2.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.292 0.568 . . . . 0.0 110.111 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 96.65 22.77 17.6 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.464 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.91 -1.93 68.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.623 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -127.2 147.26 50.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.474 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 84.6 m-85 -89.39 116.1 27.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.217 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 69.6 mt -58.04 127.85 34.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.857 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.477 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 17.1 mmt180 -93.45 115.39 27.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 271' ' ' ASN . 13.9 p -115.82 135.98 54.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.178 0.513 . . . . 0.0 111.143 -173.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -154.94 -179.53 30.2 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.537 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -84.16 130.2 34.86 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.56 120.63 12.11 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.528 0.518 . . . . 0.0 109.821 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.68 -26.89 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -173.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.506 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 28.3 p -134.86 145.11 53.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.654 0.264 . . . . 0.0 110.783 177.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.2 108.05 2.59 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.366 2.044 . . . . 0.0 112.199 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 287' ' ' THR . 25.0 Cg_exo -63.17 -38.72 43.16 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.845 2.363 . . . . 0.0 111.444 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.45 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 27.9 ttt -138.45 108.64 7.97 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.796 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 12.1 Cg_exo -71.57 -21.85 25.21 Favored 'Trans proline' 0 CA--C 1.526 0.124 0 C-N-CA 123.303 2.669 . . . . 0.0 113.227 -176.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 49.6 tp -116.11 88.58 2.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.991 0.424 . . . . 0.0 111.374 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.522 HD12 ' NH2' ' A' ' 210' ' ' ARG . 43.7 mt -110.74 139.15 46.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.952 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 1.8 t -59.13 109.99 2.33 Favored Pre-proline 0 C--O 1.237 0.408 0 O-C-N 123.868 0.73 . . . . 0.0 111.729 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 8.3 Cg_endo -87.67 111.33 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.665 2.91 . . . . 0.0 112.546 -176.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.72 -29.14 4.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.361 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' THR . . . . . 0.429 ' CG2' ' HG3' ' A' ' 236' ' ' LYS . 93.8 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.06 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.811 -0.515 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.433 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . . . -122.85 -52.39 1.89 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.668 0.271 . . . . 0.0 111.041 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.0 mtm -83.25 -40.83 19.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.986 0.422 . . . . 0.0 110.827 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.9 40.26 1.05 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.483 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.469 ' HG3' ' HB3' ' A' ' 105' ' ' GLN . 6.4 tp-100 -163.75 134.54 4.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.455 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -100.88 67.62 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.767 0.794 . . . . 0.0 109.121 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.469 ' HB3' ' HG3' ' A' ' 103' ' ' GLN . 0.0 OUTLIER -95.3 -7.03 39.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.164 -168.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -65.54 -32.2 73.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.835 0.35 . . . . 0.0 111.283 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.22 -30.84 66.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.153 0.502 . . . . 0.0 110.438 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.681 HD23 HD11 ' A' ' 201' ' ' LEU . 56.9 mt -71.71 -33.08 68.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.325 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.9 73.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.265 0.555 . . . . 0.0 110.028 175.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.7 mt -73.31 -38.49 53.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.116 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.445 ' SD ' HG23 ' A' ' 198' ' ' ILE . 31.7 mtm -74.29 -2.22 24.11 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.541 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 73.8 m -82.68 -8.58 59.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.098 0.475 . . . . 0.0 110.018 175.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.937 ' HG2' ' HG2' ' A' ' 159' ' ' GLU . 58.3 mtt180 -113.33 141.87 46.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.15 -177.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.564 HG13 ' HB ' ' A' ' 158' ' ' VAL . 9.9 p -121.51 130.32 74.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.273 0.558 . . . . 0.0 109.749 171.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -83.64 114.91 21.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.079 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 21.4 m -112.24 121.23 64.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.616 0.722 . . . . 0.0 110.935 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.478 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -127.47 173.09 18.69 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.981 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 58.7 m 60.75 31.47 20.11 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.408 0.283 . . . . 0.0 111.176 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.545 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 71.1 mt -61.39 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.485 -176.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.517 ' HB2' ' O ' ' A' ' 119' ' ' ILE . 2.3 t80 164.6 149.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -174.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.47 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 5.0 p90 -88.26 73.14 8.94 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -176.84 -58.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.226 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.8 mt -58.84 99.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.273 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.32 171.32 54.76 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.032 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -57.05 -39.9 75.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.874 0.368 . . . . 0.0 110.656 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.35 -49.46 77.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.79 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.7 m -63.3 -44.18 95.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.087 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.537 HG13 ' HE1' ' A' ' 143' ' ' MET . 33.8 mm -60.74 -40.46 85.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.532 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -61.2 -38.67 87.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.337 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -70.88 -34.04 71.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.495 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.07 -29.02 32.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.231 -174.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.499 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 46.3 m-85 -94.33 -14.86 24.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.829 0.347 . . . . 0.0 111.569 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.416 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.99 -41.97 88.3 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 55.1 Cg_exo -42.48 -35.72 4.04 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.016 2.477 . . . . 0.0 114.488 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.514 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 51.3 m-85 -82.49 -49.34 10.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 121.141 -0.223 . . . . 0.0 111.202 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.01 172.39 39.84 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.918 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.94 121.64 8.29 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.617 2.211 . . . . 0.0 111.705 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.2 mt -84.53 116.7 28.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.945 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -74.76 -43.75 53.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.917 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.3 t -161.96 152.78 17.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.358 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -130.45 126.12 60.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.616 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 13.3 t70 -96.28 99.77 11.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.537 ' HE1' HG13 ' A' ' 128' ' ' ILE . 46.9 ttm -136.21 126.88 27.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.204 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 11.2 m -69.44 99.87 1.3 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -110.7 136.4 49.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -174.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.559 ' O ' ' HA ' ' A' ' 150' ' ' MET . 7.6 t70 -107.97 141.27 39.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.686 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.2 m -115.21 -1.95 12.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.331 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.0 t -77.12 -50.86 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.136 0.493 . . . . 0.0 109.859 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.6 p -113.35 -15.64 12.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.21 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 146' ' ' ASP . 60.8 mtm 70.98 14.09 6.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.841 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 59.0 mtmt -110.95 130.9 55.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 144' ' ' SER . 56.8 p-80 -127.13 140.0 52.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.064 0.459 . . . . 0.0 111.542 -169.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -110.53 117.34 33.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.809 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 153.85 -164.74 31.37 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.99 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.478 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 67.2 m-85 -125.12 177.81 5.89 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.616 ' HA ' ' O ' ' A' ' 142' ' ' ASP . . . -137.29 140.95 41.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.089 0.471 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -109.98 109.75 20.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.597 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.564 ' HB ' HG13 ' A' ' 114' ' ' VAL . 47.7 t -91.06 110.36 22.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.337 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.937 ' HG2' ' HG2' ' A' ' 113' ' ' ARG . 47.3 mt-10 -99.72 123.08 43.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.532 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.444 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 95.8 m-85 -100.98 171.67 7.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.033 0.444 . . . . 0.0 110.085 176.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -86.1 -5.36 59.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.271 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 5.2 m -142.23 143.98 29.59 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.191 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 12.6 Cg_exo -69.69 -26.54 27.82 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.384 2.723 . . . . 0.0 112.038 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.687 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 8.1 mp0 -55.73 -57.05 13.62 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.954 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -59.81 -19.73 52.51 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.85 -51.15 8.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -68.07 -31.55 71.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.757 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.514 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 18.2 tp -67.03 -46.47 74.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.673 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.81 -34.73 73.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.072 0.463 . . . . 0.0 110.168 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.491 HD11 ' O ' ' A' ' 185' ' ' VAL . 2.9 tp -67.6 -51.98 43.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.556 172.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -54.83 -34.44 62.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.745 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -100.56 -51.54 3.58 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.409 ' C ' ' H ' ' A' ' 175' ' ' SER . 29.1 ttp -107.78 29.33 7.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -165.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 31.9 p-10 -78.72 25.21 0.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.911 0.386 . . . . 0.0 111.302 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 173' ' ' MET . 4.1 m -113.33 -72.91 0.68 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.867 0.365 . . . . 0.0 111.069 -176.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 30.9 m -134.29 164.04 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.002 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.747 ' HE1' ' HG ' ' A' ' 178' ' ' LEU . 1.9 tpt -139.51 91.9 2.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.793 0.33 . . . . 0.0 110.734 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.747 ' HG ' ' HE1' ' A' ' 177' ' ' MET . 94.6 mt 61.56 -177.79 0.12 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.429 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.69 -113.14 1.06 Allowed Glycine 0 C--N 1.337 0.587 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.185 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.6 45.84 0.59 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.545 ' HG2' ' O ' ' A' ' 119' ' ' ILE . 12.5 tpt180 -127.2 135.84 51.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.899 -173.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 4.1 p-10 -91.85 142.53 27.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.593 HD13 ' HB2' ' A' ' 177' ' ' MET . 42.8 pt -129.66 168.19 23.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.792 0.33 . . . . 0.0 110.568 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.567 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 55.5 tptt -109.25 106.01 15.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.772 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.491 ' O ' HD11 ' A' ' 170' ' ' LEU . 43.3 t -103.03 104.29 16.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 188' ' ' PRO . . . 94.74 125.8 4.53 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.1 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -105.15 101.62 31.56 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 186' ' ' GLY . 18.4 Cg_exo -66.94 -21.1 50.46 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.813 2.342 . . . . 0.0 112.056 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 42.8 m -79.64 46.27 0.75 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.39 0.614 . . . . 0.0 111.367 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -76.6 -66.47 0.81 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.216 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.3 mm 52.01 41.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.651 0.739 . . . . 0.0 111.217 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.27 -155.21 19.73 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.484 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.459 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 59.5 tt0 -73.98 -30.8 62.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.855 0.36 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -74.43 -23.2 58.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.203 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.68 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 23.1 tm0? -58.93 -52.92 71.38 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.497 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.68 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 54.2 Cg_exo -56.61 -35.17 96.97 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.286 1.99 . . . . 0.0 112.65 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.3 mt -67.99 -43.73 85.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 109.92 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.445 HG23 ' SD ' ' A' ' 111' ' ' MET . 84.9 mt -59.6 -48.71 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.052 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.25 -45.53 90.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.91 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -62.02 -53.03 61.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.681 HD11 HD23 ' A' ' 108' ' ' LEU . 30.8 mt -65.83 -33.11 75.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.262 -178.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.648 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.28 -42.84 70.48 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -71.44 -34.47 70.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.907 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.526 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 31.3 mt-10 -65.09 -36.51 84.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.67 -26.73 64.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.686 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.5 mtp180 -72.29 -14.12 61.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.59 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -88.39 0.8 55.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.351 0.596 . . . . 0.0 110.273 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -131.42 177.18 7.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.926 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.534 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 3.1 m-80 -118.95 43.35 2.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.13 -174.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 36.7 ttt180 -99.8 137.24 38.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.98 -173.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.1 pt -133.08 166.57 29.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.559 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.623 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 84.6 t80 -120.81 131.89 54.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.363 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.405 HG13 ' CZ ' ' A' ' 229' ' ' PHE . 33.6 m -125.91 137.42 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.156 0.503 . . . . 0.0 110.677 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -133.29 -178.55 5.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.715 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 28.2 t 62.73 26.58 15.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.756 0.789 . . . . 0.0 109.444 -171.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.428 HG13 HD11 ' A' ' 225' ' ' ILE . 9.4 t -79.68 115.86 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.093 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -60.88 145.5 49.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.551 -171.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -48.42 -54.54 13.7 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -85.68 36.91 0.67 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.992 0.425 . . . . 0.0 111.537 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 9.1 tp -121.01 118.01 28.74 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 19.7 m -99.3 177.45 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.388 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -64.42 -26.75 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 110.412 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.46 -40.25 92.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.348 0.594 . . . . 0.0 109.909 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.64 -50.0 68.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.799 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.599 HG22 HD11 ' A' ' 255' ' ' ILE . 26.0 mm -68.17 -44.81 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.435 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.427 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 64.0 tttm -57.61 -46.56 83.93 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.44 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.2 t -52.76 -48.47 66.75 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.68 -43.32 61.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.343 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.579 ' CB ' HD13 ' A' ' 235' ' ' ILE . 11.2 m-85 -67.39 -30.01 69.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.232 0.539 . . . . 0.0 110.744 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.554 ' OE1' ' HB ' ' A' ' 235' ' ' ILE . 9.0 tp10 -63.16 -24.45 67.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.843 177.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.56 -11.63 59.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.874 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -111.2 -40.2 4.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.515 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -142.81 166.51 26.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.767 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -77.97 106.84 10.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.078 0.466 . . . . 0.0 110.521 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.579 HD13 ' CB ' ' A' ' 229' ' ' PHE . 21.5 mt -83.29 148.37 5.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.636 0.731 . . . . 0.0 111.579 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -106.9 -36.15 6.72 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.097 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.1 m -154.7 146.5 23.4 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -171.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.405 ' HG ' HD11 ' A' ' 255' ' ' ILE . 49.7 t -141.83 119.45 11.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 171.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.6 m -140.48 103.13 4.48 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.301 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.575 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 48.1 mt -75.96 129.23 36.59 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.445 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.21 116.5 6.64 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.475 0.485 . . . . 0.0 110.195 -175.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 31.0 ttp180 -136.43 142.21 43.63 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.783 -174.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.574 ' HB2' ' HG1' ' A' ' 246' ' ' THR . 9.2 m-20 -75.97 115.18 44.21 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.69 -27.33 25.92 Favored 'Trans proline' 0 CA--C 1.527 0.175 0 C-N-CA 123.679 2.919 . . . . 0.0 114.138 -171.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 t -97.44 -14.21 21.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.574 ' HG1' ' HB2' ' A' ' 243' ' ' ASP . 71.0 p -92.37 -39.32 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.843 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.77 -0.47 70.14 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.3 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 62.6 pttt -117.56 138.18 52.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -82.63 144.55 30.22 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.503 ' HB2' ' CE1' ' A' ' 252' ' ' TYR . 23.8 mtpp -78.29 10.96 2.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -167.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.64 38.43 Favored Glycine 0 CA--C 1.508 -0.388 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.264 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.503 ' CE1' ' HB2' ' A' ' 250' ' ' LYS . 28.9 p90 -142.15 177.78 8.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.687 0.28 . . . . 0.0 110.488 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.575 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -167.63 174.41 42.68 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.158 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.687 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 86.1 m-85 -126.38 149.67 49.08 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.599 HD11 HG22 ' A' ' 225' ' ' ILE . 74.9 mt -140.29 142.73 30.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.454 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 51.0 mt-10 -117.75 147.52 42.9 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.549 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 11.6 m-85 -114.38 171.0 7.89 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 171.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -86.99 -9.75 54.85 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.46 0.648 . . . . 0.0 109.569 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -136.12 122.63 20.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.273 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.71 72.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.141 0.496 . . . . 0.0 111.079 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -63.44 -36.47 83.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.882 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.5 m -71.64 -40.82 69.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.33 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 43.1 p -67.17 -36.79 82.55 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -67.68 -30.86 70.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.3 -35.49 76.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.115 0.483 . . . . 0.0 110.256 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.24 85.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.086 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.441 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 95.7 t -58.25 -34.12 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 121.443 0.639 . . . . 0.0 110.126 173.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 43.1 t -73.06 -44.59 60.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.362 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.8 m -90.37 -35.36 15.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.446 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 82.7 mmm -87.17 -7.79 57.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -170.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -73.24 122.09 21.39 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.165 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.535 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 97.4 mt 64.25 31.27 13.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.437 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -86.59 133.85 33.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.022 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -80.09 105.6 11.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.951 0.405 . . . . 0.0 110.607 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 56.1 tp -126.11 95.65 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.244 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.12 21.99 47.07 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.502 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 90.05 9.26 65.89 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.607 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -129.92 155.3 46.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.535 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 73.5 m-85 -100.39 109.35 21.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 74.9 mt -59.55 133.95 56.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.639 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.401 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 14.8 mmt180 -99.58 116.18 31.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 267' ' ' VAL . 12.4 p -123.68 144.41 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.65 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.45 173.06 38.68 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.691 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -71.95 128.1 34.66 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.23 113.25 6.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.25 -24.14 23.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.867 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 50.2 p -100.67 133.09 21.43 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.983 0.42 . . . . 0.0 110.403 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.01 143.71 73.34 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.594 2.196 . . . . 0.0 111.603 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.76 93.94 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.6 2.2 . . . . 0.0 111.926 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 65.1 mtt -78.13 121.98 84.69 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.205 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.39 101.88 1.41 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.486 2.124 . . . . 0.0 111.529 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.34 20.83 3.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.283 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 92.9 mt 72.85 124.47 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.227 0.955 . . . . 0.0 112.105 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 1.3 p -98.54 103.8 20.59 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.302 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.82 122.36 8.11 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.09 2.527 . . . . 0.0 112.443 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -110.76 133.45 53.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.488 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 62.8 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.422 -177.936 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 112.366 -0.293 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.91 41.59 2.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.079 0.466 . . . . 0.0 110.128 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.629 ' HB3' HH21 ' A' ' 106' ' ' ARG . 2.0 tmt? -75.78 82.7 2.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.718 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.621 ' O ' ' HG3' ' A' ' 106' ' ' ARG . . . 49.92 48.19 22.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.294 174.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -36.16 79.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.426 -175.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -81.65 -17.41 48.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 110.951 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 102' ' ' ALA . 62.5 tt0 -91.06 -21.93 21.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.236 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.629 HH21 ' HB3' ' A' ' 101' ' ' MET . 82.6 mtt180 -59.28 -48.85 80.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.468 ' HB3' HD12 ' A' ' 197' ' ' ILE . . . -69.75 -22.8 63.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.489 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.91 -32.12 73.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.092 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.71 -28.37 68.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.341 0.591 . . . . 0.0 110.401 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.0 mt -87.91 -40.44 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.343 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.527 ' SD ' HG12 ' A' ' 198' ' ' ILE . 92.2 mtp -69.08 -29.9 68.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.018 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.704 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 92.9 m -73.94 -12.02 60.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.593 0.235 . . . . 0.0 111.01 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.46 ' HG2' ' HA ' ' A' ' 159' ' ' GLU . 47.1 mtt180 -106.51 141.39 37.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.08 0.467 . . . . 0.0 110.894 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.54 122.43 69.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.461 0.648 . . . . 0.0 109.407 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -74.86 119.88 19.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.108 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 15.3 m -114.22 114.74 47.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.405 0.621 . . . . 0.0 109.959 175.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.06 171.36 13.78 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.249 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.9 m 58.67 35.08 24.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 111.102 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.502 HD13 HG21 ' A' ' 116' ' ' VAL . 58.3 mt -68.99 126.36 28.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.213 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.62 140.28 58.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.165 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.631 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 0.0 OUTLIER -72.37 77.3 1.02 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 122.133 0.968 . . . . 0.0 111.19 -179.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -170.93 -26.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.732 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 40.1 mt -93.4 110.02 21.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.253 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.26 -174.99 45.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.962 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.65 -40.55 97.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 110.117 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 36.0 t70 -62.89 -48.77 77.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.688 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -61.12 -43.65 98.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.177 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.42 HG13 ' HE3' ' A' ' 143' ' ' MET . 28.1 mm -63.66 -43.18 98.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 177.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -57.91 -41.37 82.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.486 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 97.8 mt-30 -60.29 -46.31 90.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.495 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.87 -26.98 36.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -171.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.515 ' CZ ' HG12 ' A' ' 116' ' ' VAL . 32.1 m-85 -90.17 -16.4 29.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.705 0.288 . . . . 0.0 111.542 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -56.9 -42.48 96.57 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 6.9 Cg_endo -51.31 -27.92 25.09 Favored 'Trans proline' 0 C--N 1.361 1.184 0 C-N-CA 122.507 2.138 . . . . 0.0 114.197 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.751 ' HD2' ' HG ' ' A' ' 168' ' ' LEU . 64.6 m-85 -80.99 -46.04 15.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.635 0.255 . . . . 0.0 110.988 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.31 -178.53 39.09 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.476 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.412 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 62.3 Cg_endo -75.43 117.45 4.82 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.559 2.173 . . . . 0.0 111.65 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.8 mt -83.49 114.24 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.897 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.614 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 74.3 tttt -88.38 -33.17 18.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.78 -173.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.7 t -157.94 147.91 20.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.389 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.9 mt -133.67 113.24 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -96.63 100.02 11.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.51 ' HG3' ' HB2' ' A' ' 156' ' ' ALA . 52.4 ttm -126.92 137.85 53.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.6 m -93.42 123.56 36.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.64 ' HD1' ' HD2' ' A' ' 152' ' ' HIS . 22.2 t90 -113.85 130.02 56.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.54 74.28 3.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.666 -176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.57 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 69.0 m -60.49 -23.57 64.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.877 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.491 HG23 HG23 ' A' ' 149' ' ' THR . 28.0 m -74.54 -25.08 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.706 -178.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 148' ' ' VAL . 34.4 p -125.73 3.36 7.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.991 0.424 . . . . 0.0 111.426 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.456 ' HA ' ' CH2' ' A' ' 145' ' ' TRP . 48.3 mtm 56.3 42.1 28.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.359 -177.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -127.21 176.51 7.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.557 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.64 ' HD2' ' HD1' ' A' ' 145' ' ' TRP . 63.8 t-80 -135.98 82.41 1.94 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.851 0.357 . . . . 0.0 110.795 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.46 ' HG2' ' N ' ' A' ' 154' ' ' GLY . 67.1 tttt -109.78 151.65 26.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.46 ' N ' ' HG2' ' A' ' 153' ' ' LYS . . . 112.97 -135.53 12.73 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.332 172.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -140.04 177.93 7.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.172 0.511 . . . . 0.0 111.642 -171.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.51 ' HB2' ' HG3' ' A' ' 143' ' ' MET . . . -152.08 154.5 36.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.377 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -111.93 109.85 19.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.185 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 62.1 t -91.91 112.16 25.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.756 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.46 ' HA ' ' HG2' ' A' ' 113' ' ' ARG . 39.0 tt0 -100.08 120.49 39.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.972 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -98.23 170.0 9.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.685 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.614 ' HG2' ' HD2' ' A' ' 139' ' ' LYS . 35.6 mt-10 -80.34 -38.67 30.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 171.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.2 m -109.64 135.81 20.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.365 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 56.2 Cg_endo -69.44 -21.15 35.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.127 2.551 . . . . 0.0 112.597 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.705 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 10.7 mp0 -57.59 -50.65 72.41 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.129 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.04 -21.76 65.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.46 -51.72 8.99 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.022 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.549 ' HG3' ' O ' ' A' ' 164' ' ' GLU . 5.0 pp0? -63.85 -30.23 71.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.556 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.751 ' HG ' ' HD2' ' A' ' 135' ' ' PHE . 14.2 tp -73.79 -45.83 49.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.6 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.4 72.17 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.532 ' O ' ' HB3' ' A' ' 174' ' ' ASN . 6.8 tt -66.44 -50.0 64.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.27 172.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 10.6 mm-40 -52.72 -50.87 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.554 -178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -89.72 -32.98 16.76 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 22.8 mtm -106.71 30.79 5.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.479 . . . . 0.0 111.744 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 33.4 p-10 -74.92 -3.59 33.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.412 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.6 m -95.13 -73.38 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 110.841 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.9 m -140.69 164.73 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.082 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.675 ' HA ' ' HE1' ' A' ' 177' ' ' MET . 1.4 tpt -124.43 95.03 4.38 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.549 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.452 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 91.7 mt 71.95 -50.53 0.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.971 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 161.1 -177.29 37.52 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.638 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 94.72 -87.78 1.1 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.604 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -127.55 142.54 51.35 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -70.68 108.4 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.629 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.3 pt -72.47 156.35 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.776 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.627 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 83.2 tttt -106.2 116.77 32.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.258 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.53 HG12 HG11 ' A' ' 116' ' ' VAL . 5.4 m -100.27 114.39 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 172.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 147.02 129.73 2.0 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.478 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 188' ' ' PRO . 26.7 tpt180 -104.58 -48.19 0.14 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.521 ' HD2' ' H ' ' A' ' 187' ' ' ARG . 59.2 Cg_endo -72.49 59.32 3.24 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.838 1.692 . . . . 0.0 113.106 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 m -78.77 -52.07 8.89 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -85.93 161.33 19.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.364 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.5 tp -61.21 115.44 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.36 0.6 . . . . 0.0 111.704 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -120.66 157.7 15.79 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.826 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -68.29 -7.95 35.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.423 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -78.04 -22.2 49.53 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.521 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 71.9 mm-40 -52.32 -54.02 46.4 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -175.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 53.2 Cg_exo -56.21 -34.54 93.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.021 1.814 . . . . 0.0 112.684 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.468 HD12 ' HB3' ' A' ' 107' ' ' ALA . 51.3 mt -75.98 -45.98 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.327 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.527 HG12 ' SD ' ' A' ' 111' ' ' MET . 69.1 mt -60.85 -43.34 95.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.292 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.08 -38.73 89.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.857 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -61.63 -52.47 64.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.855 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.472 HD11 HG23 ' A' ' 287' ' ' THR . 25.5 mt -67.54 -32.69 73.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.608 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.667 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.63 -47.84 66.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 171.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.507 ' OE1' ' HD3' ' A' ' 206' ' ' ARG . 5.8 mm-40 -63.24 -35.24 79.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.213 175.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.62 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 47.6 mt-10 -66.41 -33.45 75.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -77.64 -29.28 51.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.969 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.667 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 59.4 mtp180 -72.62 -25.35 61.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 110.408 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.65 -39.93 18.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.342 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -105.57 79.53 1.46 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 0.1 OUTLIER -52.4 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.427 1.079 . . . . 0.0 111.403 -173.198 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.463 ' HB2' ' HG3' ' A' ' 256' ' ' GLU . 44.8 ttm105 -134.09 146.12 50.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.995 0.426 . . . . 0.0 111.59 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.595 HG23 ' HB2' ' A' ' 263' ' ' SER . 49.3 pt -123.78 166.46 18.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.17 174.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.475 ' CG ' ' HB3' ' A' ' 164' ' ' GLU . 85.4 t80 -118.14 129.51 55.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.46 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.469 HG13 ' CZ ' ' A' ' 229' ' ' PHE . 29.3 m -121.1 128.56 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.335 0.588 . . . . 0.0 110.237 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -119.57 176.2 5.48 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.464 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.4 m 60.26 32.59 20.83 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.415 0.626 . . . . 0.0 109.972 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.49 114.67 20.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.353 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 32.4 t-80 -55.57 137.65 48.44 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.456 0.472 . . . . 0.0 111.744 -172.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -49.99 -52.37 34.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -82.23 20.38 1.05 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.91 0.386 . . . . 0.0 111.722 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.637 HD23 ' HG ' ' A' ' 275' ' ' LEU . 15.0 tp -105.41 126.53 52.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.0 m -90.85 163.96 14.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.832 0.349 . . . . 0.0 111.746 -173.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.444 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 6.0 p-10 -65.11 -27.29 68.65 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.27 0.557 . . . . 0.0 110.313 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.34 -31.61 71.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.751 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -74.33 -39.85 62.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.694 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.734 HG13 HD21 ' A' ' 240' ' ' LEU . 24.8 mm -65.74 -46.7 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -58.61 -51.56 69.41 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.955 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.4 p -58.94 -38.92 80.11 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 51.1 t -76.53 -41.99 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.196 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.537 ' CB ' HD11 ' A' ' 235' ' ' ILE . 25.0 m-85 -65.43 -28.67 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.217 -0.302 . . . . 0.0 110.736 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.18 -25.02 67.54 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.522 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.88 -17.49 55.51 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.064 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -111.52 -31.36 7.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.924 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.551 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -146.93 160.25 28.21 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.377 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.421 ' HA ' ' HE3' ' A' ' 234' ' ' LYS . 0.7 OUTLIER -84.71 107.63 17.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.492 0.663 . . . . 0.0 110.993 -177.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.537 HD11 ' CB ' ' A' ' 229' ' ' PHE . 37.3 mt -86.03 151.4 3.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.928 -173.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -106.23 -27.49 11.01 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.921 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.446 ' N ' HG21 ' A' ' 235' ' ' ILE . 3.0 p -176.87 152.1 0.92 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.575 0.226 . . . . 0.0 110.677 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 36.5 t -137.59 129.5 28.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.282 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.1 t -141.05 104.16 4.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.411 0.624 . . . . 0.0 111.599 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.734 HD21 HG13 ' A' ' 225' ' ' ILE . 30.9 mt -75.95 133.57 40.43 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.406 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.44 114.35 4.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.162 0.506 . . . . 0.0 110.257 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.568 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 13.7 mtp180 -112.21 164.89 12.68 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.438 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.85 ' HB3' ' HG1' ' A' ' 246' ' ' THR . 0.6 OUTLIER -79.28 141.4 57.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 175.173 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -43.75 -45.04 11.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.518 2.812 . . . . 0.0 113.905 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.9 t -155.61 86.21 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.722 0.773 . . . . 0.0 111.21 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.85 ' HG1' ' HB3' ' A' ' 243' ' ' ASP . 20.3 p -135.28 -42.84 0.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.728 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 121.92 -24.04 7.19 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.463 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -107.65 166.5 10.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.969 0.414 . . . . 0.0 110.471 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 9.7 p80 -96.63 165.35 12.19 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -73.39 -82.15 0.06 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.402 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -167.4 7.52 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.615 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.412 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 28.7 p90 -150.49 175.76 11.57 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -165.16 174.98 41.09 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.44 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.705 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 78.8 m-85 -129.54 150.95 50.66 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.703 HD13 HG22 ' A' ' 225' ' ' ILE . 81.9 mt -142.49 133.04 23.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.473 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 4.8 mp0 -106.51 146.97 29.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.639 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 8.8 m-85 -118.68 165.15 14.33 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.83 -37.57 86.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.755 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -118.22 140.12 50.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.434 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.76 -25.73 68.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.224 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -74.21 -43.45 57.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.234 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.6 m -66.32 -33.0 74.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.982 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.639 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 79.9 p -66.29 -37.82 86.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -71.39 -27.94 63.67 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.473 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.44 -44.08 92.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.077 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.05 92.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.386 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.65 -40.31 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.573 . . . . 0.0 110.665 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 20.7 m -70.35 -30.98 68.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.533 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.0 m -94.37 -42.99 8.6 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.474 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.3 mmm -82.66 6.45 17.81 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -169.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.45 ' HA ' HG12 ' A' ' 282' ' ' VAL . 65.2 t30 -72.13 120.57 17.92 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.277 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 93.4 mt 64.21 31.25 13.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.418 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -78.91 128.93 33.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.386 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.42 ' HB2' ' HE1' ' A' ' 279' ' ' TYR . 36.6 t70 -74.47 102.92 4.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.637 ' HG ' HD23 ' A' ' 220' ' ' LEU . 34.2 tp -136.8 109.93 7.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.752 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.07 56.69 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.408 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 83.11 4.46 89.83 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.654 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -130.47 156.15 45.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.42 ' HE1' ' HB2' ' A' ' 274' ' ' ASP . 45.7 m-85 -97.18 111.76 23.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.506 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 45.6 mt -59.68 127.17 30.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.5 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.516 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 30.6 mmt180 -92.71 114.37 26.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 171.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 271' ' ' ASN . 11.0 p -118.5 151.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.487 -171.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -169.58 174.86 43.9 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -72.68 141.96 48.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -82.36 129.35 34.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.427 ' CG1' ' HG2' ' A' ' 167' ' ' GLN . 19.9 m -92.05 -23.05 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.723 0.297 . . . . 0.0 110.739 -175.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.472 HG23 HD11 ' A' ' 201' ' ' LEU . 38.0 p -128.81 156.5 77.63 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 121.136 0.493 . . . . 0.0 111.373 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.62 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 66.4 Cg_endo -97.05 103.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 123.252 2.635 . . . . 0.0 112.662 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 288' ' ' PRO . 27.5 Cg_endo -64.4 135.07 44.5 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.273 1.982 . . . . 0.0 111.186 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 26.4 mmt -83.67 119.15 73.24 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.916 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 97.07 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.64 2.226 . . . . 0.0 111.975 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.542 HD22 ' H ' ' A' ' 292' ' ' LEU . 2.5 pt? -65.8 -26.87 67.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.053 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 89.7 mt -137.12 119.02 15.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.617 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 3.0 p -82.75 141.69 44.73 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.613 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 12.1 Cg_exo -70.32 97.53 0.69 Allowed 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.646 2.231 . . . . 0.0 111.111 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 62.4 -161.73 0.29 Allowed 'General case' 0 C--O 1.234 0.262 0 O-C-N 123.73 0.644 . . . . 0.0 110.724 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.752 179.263 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 55.38 55.46 7.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.266 0.555 . . . . 0.0 111.3 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.3 tpt -136.31 74.43 1.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -103.73 -171.75 1.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.891 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 59.12 40.33 22.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -92.14 -1.16 57.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.203 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -75.53 3.65 9.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.424 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -57.12 -42.47 80.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.08 0.467 . . . . 0.0 110.991 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.63 -31.4 65.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.769 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' CD2' HG22 ' A' ' 287' ' ' THR . 45.7 mt -70.7 -32.93 70.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.14 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.36 -33.86 73.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.347 0.594 . . . . 0.0 109.801 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.4 mt -75.71 -37.07 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.381 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.549 ' CG ' HD12 ' A' ' 198' ' ' ILE . 86.6 mtp -69.26 -20.78 63.93 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.021 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.618 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 82.1 m -74.5 -11.72 60.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -99.5 142.38 31.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.805 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.6 p -123.52 122.74 65.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 89.5 t80 -65.56 126.62 28.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.741 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.99 115.41 48.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -124.3 163.2 18.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.139 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.0 m 60.76 47.12 8.27 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 122.661 0.385 . . . . 0.0 111.233 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.478 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 49.2 mt -74.05 -28.28 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.353 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.478 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 35.7 t80 72.43 135.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.619 0.575 . . . . 0.0 109.528 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.491 ' HA ' ' CE1' ' A' ' 152' ' ' HIS . 21.2 p90 -77.16 77.22 3.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.193 0.997 . . . . 0.0 111.047 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -151.67 -49.45 0.11 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.566 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.463 HD22 HD12 ' A' ' 178' ' ' LEU . 57.0 mt -68.04 137.64 55.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.59 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -98.72 173.67 27.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.409 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.82 -51.25 70.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 110.88 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.98 -27.83 63.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.876 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -64.55 -43.53 93.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.188 0.518 . . . . 0.0 109.762 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.53 HG13 ' HE2' ' A' ' 143' ' ' MET . 36.5 mm -64.44 -41.35 92.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.151 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 129' ' ' ARG . 20.7 ttt180 -55.73 -49.18 73.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.777 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.87 -33.29 73.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.759 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.408 ' HB3' ' HE2' ' A' ' 177' ' ' MET . . . -83.17 -35.51 25.45 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.23 -17.2 33.14 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.55 96.38 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -44.35 -36.2 9.15 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.714 2.276 . . . . 0.0 114.277 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.512 ' CD1' ' HA ' ' A' ' 169' ' ' ALA . 60.7 m-85 -77.9 -39.01 44.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.666 0.269 . . . . 0.0 110.717 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . -173.8 167.6 40.2 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.738 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.46 114.52 2.56 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.578 2.186 . . . . 0.0 111.865 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.549 HD13 HD12 ' A' ' 141' ' ' ILE . 65.2 mt -74.05 130.71 35.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.635 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 139' ' ' LYS . 36.8 ttpt -93.06 -33.99 13.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.393 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 t -174.05 128.38 0.38 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.949 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.549 HD12 HD13 ' A' ' 138' ' ' ILE . 68.9 mt -104.42 119.12 52.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -88.23 100.67 13.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.53 ' HE2' HG13 ' A' ' 128' ' ' ILE . 43.7 ttm -143.41 101.28 3.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.93 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.691 ' HB2' ' HE2' ' A' ' 153' ' ' LYS . 18.4 m -74.59 104.68 5.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.841 0.353 . . . . 0.0 110.924 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -76.79 111.88 12.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.108 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.871 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 25.3 m-20 -76.81 83.02 3.4 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.4 m -52.09 -34.6 44.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.9 m -63.17 -27.59 43.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -130.09 12.07 5.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 111.515 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 47.1 mtm 55.83 32.4 19.52 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.656 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.871 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 91.9 mttt -89.21 175.6 7.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.082 0.468 . . . . 0.0 109.925 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.491 ' CE1' ' HA ' ' A' ' 121' ' ' TYR . 17.3 p-80 -153.03 46.11 0.68 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 170.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.691 ' HE2' ' HB2' ' A' ' 144' ' ' SER . 64.6 mmtt 65.45 -71.95 0.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.03 -174.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.34 -25.2 1.55 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -123.99 165.2 17.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.748 -0.726 . . . . 0.0 109.401 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.93 169.33 24.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.316 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.463 ' CE2' ' HD1' ' A' ' 115' ' ' TYR . 95.6 m-85 -124.18 112.82 17.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.164 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.1 t -91.85 108.5 20.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -105.06 118.99 37.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.11 0.481 . . . . 0.0 110.036 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -88.66 -176.11 5.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.966 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -83.35 -35.52 25.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.4 m -117.41 140.91 27.94 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.405 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.618 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 51.0 Cg_endo -66.84 -19.7 52.54 Favored 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 123.52 2.814 . . . . 0.0 112.609 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.649 ' HG3' ' CE1' ' A' ' 254' ' ' PHE . 80.6 mm-40 -58.33 -55.04 40.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.752 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.458 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.68 -21.03 62.4 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.984 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.92 -48.68 15.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.692 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.478 ' HG3' HG13 ' A' ' 286' ' ' VAL . 30.5 mm-40 -69.19 -33.18 72.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.503 174.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 13.7 tp -65.65 -47.07 76.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.656 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.512 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . . . -59.79 -37.71 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.08 0.467 . . . . 0.0 110.13 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.589 ' HA ' HG23 ' A' ' 185' ' ' VAL . 6.8 tt -65.38 -43.52 90.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.806 174.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.34 -34.44 76.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.99 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -100.61 -47.25 4.92 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.433 ' C ' ' H ' ' A' ' 175' ' ' SER . 29.7 ttp -102.91 31.04 4.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.363 0.602 . . . . 0.0 111.708 -166.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 4.8 p-10 -74.68 16.66 0.26 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.551 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 173' ' ' MET . 5.4 m -106.35 -74.01 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.675 0.274 . . . . 0.0 111.47 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 18.6 m -144.34 169.56 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.876 ' HE1' ' HG ' ' A' ' 178' ' ' LEU . 1.9 tpt -129.62 101.1 5.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 110.673 177.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.876 ' HG ' ' HE1' ' A' ' 177' ' ' MET . 94.6 mt 63.66 32.45 13.82 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.016 173.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.63 -31.63 1.92 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.087 -0.578 . . . . 0.0 114.32 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.75 -64.71 3.99 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.647 -0.311 . . . . 0.0 113.293 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -144.41 150.91 38.49 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.563 -0.375 . . . . 0.0 110.679 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 8.4 p30 -72.44 118.8 15.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.74 HD13 ' HB2' ' A' ' 177' ' ' MET . 43.6 pt -96.46 157.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.497 -174.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -105.14 110.99 23.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.408 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 170' ' ' LEU . 9.7 m -99.76 122.82 52.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.067 0.461 . . . . 0.0 109.922 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 87.05 143.8 8.19 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.955 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -142.43 73.09 20.96 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.0 57.23 6.4 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.175 2.583 . . . . 0.0 113.31 -171.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.8 t -154.88 -54.19 0.09 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -69.79 109.86 4.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.569 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 34.4 mm 61.64 69.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.464 0.65 . . . . 0.0 110.886 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -103.73 47.4 1.1 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -61.93 -37.59 85.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.058 0.456 . . . . 0.0 111.365 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.477 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -97.52 11.81 35.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.777 -175.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.569 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 25.2 tm0? -53.57 -47.16 97.42 Favored Pre-proline 0 N--CA 1.47 0.551 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 6.9 Cg_endo -52.76 -36.19 72.21 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.355 2.036 . . . . 0.0 112.884 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 78.2 mt -74.18 -38.58 48.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.19 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.549 HD12 ' CG ' ' A' ' 111' ' ' MET . 12.7 mm -57.66 -50.19 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.179 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 30.5 t70 -69.98 -32.56 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.854 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.37 -50.64 72.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.03 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.432 HD12 HD22 ' A' ' 108' ' ' LEU . 44.6 mt -68.86 -33.47 73.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.645 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.577 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -55.54 -42.55 74.77 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 52.3 mt-10 -63.26 -33.73 76.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.732 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.68 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 26.4 mt-10 -65.37 -36.23 83.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.915 0.388 . . . . 0.0 110.84 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.5 -39.13 62.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.705 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.577 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 60.0 mtp180 -61.02 -22.3 64.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.485 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.96 -27.36 65.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.039 0.447 . . . . 0.0 110.71 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -105.8 169.73 8.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.224 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 0.9 OUTLIER -103.75 51.27 0.79 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.473 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 39.3 ttm180 -105.18 139.13 40.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.023 -167.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.42 HG22 ' HB2' ' A' ' 263' ' ' SER . 47.4 pt -127.97 166.22 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.879 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.473 ' HE1' ' HB2' ' A' ' 252' ' ' TYR . 25.0 t80 -118.24 135.81 54.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.019 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.492 HG13 ' CZ ' ' A' ' 229' ' ' PHE . 27.5 m -130.01 136.45 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 110.991 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -131.3 -179.17 5.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.553 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 69.6 m 62.44 27.37 16.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.869 0.842 . . . . 0.0 109.72 -171.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.482 HG12 HD11 ' A' ' 225' ' ' ILE . 21.7 t -79.22 116.56 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.538 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -56.0 140.7 42.46 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.253 0.549 . . . . 0.0 111.476 -174.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -58.52 -29.31 66.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.972 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.45 6.14 42.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.868 0.842 . . . . 0.0 110.067 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.555 HD22 ' HG ' ' A' ' 275' ' ' LEU . 7.3 tp -112.59 122.77 48.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.079 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.4 t -107.25 -178.69 3.71 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.074 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -60.63 -37.52 81.73 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.99 -24.62 64.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 0.0 110.452 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -72.6 -52.74 14.2 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.865 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.482 HD11 HG12 ' A' ' 216' ' ' VAL . 31.4 mm -61.76 -42.04 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.063 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 85.5 tttt -56.31 -50.23 72.02 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.708 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 m -56.09 -37.78 69.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 20.8 t -76.65 -44.28 33.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.555 ' HB2' HD11 ' A' ' 235' ' ' ILE . 7.4 m-85 -67.94 -31.34 71.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.591 0.71 . . . . 0.0 110.522 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -60.62 -24.46 65.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.94 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.29 -15.45 62.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.922 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.49 -33.76 6.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.348 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -152.03 163.7 30.21 Favored Glycine 0 CA--C 1.517 0.159 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.704 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.93 110.62 6.55 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.147 0.498 . . . . 0.0 111.581 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 229' ' ' PHE . 23.3 mt -88.33 150.44 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.017 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -106.16 -31.9 8.47 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.191 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 20.4 p -166.45 156.46 11.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.012 0.434 . . . . 0.0 111.423 -172.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.488 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 9.2 p -141.15 124.52 16.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.831 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.0 t -141.49 115.07 8.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.255 0.55 . . . . 0.0 110.973 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.463 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 28.9 mt -91.99 137.13 32.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.43 98.47 0.85 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.978 0.418 . . . . 0.0 110.08 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.627 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 25.5 ttt180 -104.68 131.69 51.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.523 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.544 ' HB2' ' HD2' ' A' ' 250' ' ' LYS . 4.7 t70 -97.28 126.52 41.58 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.317 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 10.5 Cg_exo -69.54 -20.45 35.85 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.457 2.772 . . . . 0.0 113.799 -173.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 43.3 p -87.24 -30.31 21.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.883 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.419 HG21 ' HG2' ' A' ' 248' ' ' LYS . 8.8 t -97.04 -22.84 16.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.295 0.569 . . . . 0.0 110.301 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 77.12 25.67 63.57 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.423 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.502 ' C ' ' HG3' ' A' ' 242' ' ' ARG . 64.2 pttt -142.72 154.65 44.48 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.627 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.6 OUTLIER -76.3 131.42 39.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.069 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.544 ' HD2' ' HB2' ' A' ' 243' ' ' ASP . 50.0 mtpt -74.55 3.41 7.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -164.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 102.5 2.67 50.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.368 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.473 ' HB2' ' HE1' ' A' ' 212' ' ' TYR . 32.9 p90 -141.88 165.21 28.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -169.25 178.46 42.41 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.021 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.649 ' CE1' ' HG3' ' A' ' 164' ' ' GLU . 88.2 m-85 -129.78 148.85 51.7 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.018 0.437 . . . . 0.0 110.594 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 225' ' ' ILE . 95.2 mt -136.08 133.21 50.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.255 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 49.0 mt-10 -113.21 135.14 54.15 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.492 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 6.2 m-85 -95.4 179.61 5.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -82.3 -17.97 43.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.467 0.651 . . . . 0.0 109.378 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -129.32 130.14 45.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.535 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.448 ' HA ' ' HB3' ' A' ' 209' ' ' ASN . . . -68.87 -25.01 64.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.164 0.507 . . . . 0.0 111.232 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -75.09 -42.06 57.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.244 176.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.492 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 19.9 m -67.76 -29.44 68.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.733 -175.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.42 ' HB2' HG22 ' A' ' 211' ' ' ILE . 48.3 p -69.05 -32.58 72.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.195 0.521 . . . . 0.0 109.687 177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -74.67 -25.89 59.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.469 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.492 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 61.1 m-20 -64.02 -41.12 97.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.262 0.553 . . . . 0.0 109.836 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -61.96 -41.27 97.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.409 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.2 -40.13 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.187 0.517 . . . . 0.0 110.71 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 48.0 t -69.31 -30.9 69.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.5 m -94.53 -43.87 8.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 78.5 mmm -84.48 1.73 44.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.914 -169.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.49 ' HA ' HG13 ' A' ' 282' ' ' VAL . 45.7 t30 -69.45 117.07 10.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.603 0.24 . . . . 0.0 110.423 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 91.6 mt 63.68 36.78 10.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.38 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -90.25 124.55 34.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.254 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.468 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 18.2 t70 -74.81 108.96 7.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.65 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.555 ' HG ' HD22 ' A' ' 220' ' ' LEU . 46.3 tp -141.31 106.77 5.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.969 0.414 . . . . 0.0 109.997 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 94.08 24.64 19.11 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.552 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 78.52 11.85 84.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.654 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -142.68 150.47 40.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.682 0.277 . . . . 0.0 110.432 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.468 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 83.0 m-85 -87.16 114.18 23.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.392 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.4 131.68 51.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.636 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -96.39 116.44 29.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.49 HG13 ' HA ' ' A' ' 271' ' ' ASN . 9.4 p -120.66 144.68 28.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.617 -175.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.15 174.22 38.56 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.615 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -75.76 126.28 30.7 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.77 126.22 27.79 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.433 0.458 . . . . 0.0 109.862 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.478 HG13 ' HG3' ' A' ' 167' ' ' GLN . 34.4 m -94.29 -26.75 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -172.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.44 HG22 ' CD2' ' A' ' 108' ' ' LEU . 19.0 p -132.51 156.23 80.33 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.018 0.437 . . . . 0.0 111.687 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.68 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 86.6 Cg_endo -92.9 103.4 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.898 2.399 . . . . 0.0 112.572 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 287' ' ' THR . 74.3 Cg_endo -78.3 149.76 25.05 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.2 1.933 . . . . 0.0 111.159 175.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.731 ' HG3' ' HG ' ' A' ' 292' ' ' LEU . 46.9 tpp -91.62 108.4 29.12 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.39 55.19 5.32 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.844 2.363 . . . . 0.0 113.302 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.731 ' HG ' ' HG3' ' A' ' 290' ' ' MET . 96.4 mt -78.97 -74.59 0.27 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 93.2 mt 54.17 51.3 14.73 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.346 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 26.2 m -90.77 112.89 55.82 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.886 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.62 145.34 91.41 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.029 2.486 . . . . 0.0 112.108 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -93.11 58.88 3.0 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.246 0.546 . . . . 0.0 110.782 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.564 178.508 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.67 61.44 4.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.136 0.493 . . . . 0.0 110.346 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.3 mtm -112.29 83.17 1.76 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.033 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.18 -48.06 83.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.626 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -165.49 -60.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.977 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 64.56 54.87 1.39 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.597 0.561 . . . . 0.0 110.929 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -134.44 -53.37 0.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.893 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -61.86 -32.77 73.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.043 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -45.75 87.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.219 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.498 HD23 ' SD ' ' A' ' 111' ' ' MET . 87.0 mt -63.9 -31.84 73.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.807 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.76 67.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.835 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.6 mt -84.94 -33.61 8.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.21 0.528 . . . . 0.0 109.719 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.546 ' HE2' HG23 ' A' ' 198' ' ' ILE . 89.4 mtp -72.98 -21.68 60.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.016 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.963 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 31.6 p -82.59 3.55 28.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.095 0.474 . . . . 0.0 110.7 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.53 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 15.0 mtm180 -113.84 141.7 47.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.462 HG13 ' HB ' ' A' ' 158' ' ' VAL . 4.2 p -124.98 122.67 63.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.551 0.691 . . . . 0.0 109.684 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.435 ' CD2' ' HB3' ' A' ' 187' ' ' ARG . 48.7 t80 -77.66 128.88 34.81 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.645 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 14.0 m -123.79 116.29 47.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.506 0.669 . . . . 0.0 110.241 175.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -125.11 174.84 17.33 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.582 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.5 m 61.77 34.35 17.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.961 0.41 . . . . 0.0 110.817 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.9 mt -78.17 119.27 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.047 0.451 . . . . 0.0 110.889 -176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -53.25 144.86 15.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.442 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.955 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 10.4 p90 -70.8 80.61 0.62 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.771 0.796 . . . . 0.0 111.114 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -169.24 -29.69 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.552 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 35.0 mt -97.6 105.45 17.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.787 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.88 173.36 54.67 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.219 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.8 -35.42 74.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.257 0.551 . . . . 0.0 109.638 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.3 -51.38 67.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.878 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -61.99 -39.92 93.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.161 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.859 HG13 ' HE2' ' A' ' 143' ' ' MET . 22.2 mm -64.46 -39.73 86.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -56.6 -41.43 76.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.079 0.466 . . . . 0.0 110.116 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -72.24 -33.78 67.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.731 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.466 ' HB3' ' SD ' ' A' ' 177' ' ' MET . . . -85.6 -29.4 24.13 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.456 ' CD1' HG22 ' A' ' 128' ' ' ILE . 28.0 m-85 -94.98 -20.74 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.491 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -51.53 -41.9 79.65 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 29.2 Cg_exo -38.08 -41.98 1.4 Allowed 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 123.235 2.623 . . . . 0.0 114.625 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.485 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 67.0 m-85 -76.13 -44.59 37.7 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 121.299 -0.161 . . . . 0.0 111.156 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -170.22 166.83 40.02 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.571 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.408 ' HG2' ' CE1' ' A' ' 252' ' ' TYR . 35.1 Cg_exo -62.16 117.98 4.85 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.846 2.364 . . . . 0.0 111.773 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.819 HD13 HD11 ' A' ' 141' ' ' ILE . 57.2 mt -77.84 130.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.565 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -99.83 -27.36 13.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.44 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.2 t -165.16 131.46 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.043 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.819 HD11 HD13 ' A' ' 138' ' ' ILE . 59.9 mt -130.54 128.81 63.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -120.98 106.77 11.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.965 0.412 . . . . 0.0 110.173 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.859 ' HE2' HG13 ' A' ' 128' ' ' ILE . 46.3 ttm -114.69 138.27 50.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.634 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.6 m -80.33 89.2 5.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.285 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -106.57 119.28 38.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.944 0.402 . . . . 0.0 110.651 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -92.46 85.68 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.092 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.9 m -60.66 -25.67 66.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.043 -173.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.2 m -77.63 -25.57 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -173.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 69.5 p -111.94 -18.09 12.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.035 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 42.5 mtm 67.08 16.23 10.25 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.078 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -85.17 143.72 28.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.955 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 50.7 t-80 -129.92 88.76 2.71 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.333 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -135.86 96.71 3.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.302 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.06 -154.58 11.74 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.359 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -124.93 175.76 7.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.443 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -155.63 148.09 23.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.702 176.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 81.0 m-85 -110.6 113.02 25.31 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.181 175.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.462 ' HB ' HG13 ' A' ' 114' ' ' VAL . 58.9 t -102.74 105.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.53 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 46.6 tt0 -108.44 126.8 53.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.58 177.56 5.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -76.86 -35.15 57.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.059 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.72 142.2 31.29 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.794 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.963 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 37.8 Cg_endo -66.52 -18.28 54.17 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.3 2.667 . . . . 0.0 112.584 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.534 ' HG3' ' HE2' ' A' ' 254' ' ' PHE . 17.0 mm-40 -56.56 -57.36 12.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.827 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.427 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.55 -21.92 65.94 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.26 -49.13 15.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.237 0.541 . . . . 0.0 109.672 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.64 ' HB2' HG12 ' A' ' 286' ' ' VAL . 31.8 mm-40 -67.29 -38.79 85.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.505 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.485 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 11.9 tp -60.61 -46.56 89.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.98 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.48 74.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 110.291 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.603 HD12 ' HA3' ' A' ' 186' ' ' GLY . 7.0 tp -70.11 -41.99 73.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.856 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 8.1 mm-40 -59.21 -39.03 81.4 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.311 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -101.02 -50.67 3.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 28.4 ttp -102.86 31.37 4.21 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -162.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.43 13.98 1.76 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.1 m -105.28 -73.52 0.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.573 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.6 m -144.79 144.14 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.199 0.524 . . . . 0.0 111.42 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.66 ' HE2' ' HA ' ' A' ' 177' ' ' MET . 3.1 tpt -113.4 108.22 16.92 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.567 HD21 ' HE3' ' A' ' 177' ' ' MET . 4.3 mm? 72.1 -55.38 0.67 Allowed 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.878 0.736 . . . . 0.0 110.658 -173.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 145.26 -167.11 27.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.393 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 92.3 -51.58 2.76 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.174 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -143.75 139.56 29.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.574 0.187 . . . . 0.0 110.858 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -64.87 112.24 3.18 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.862 172.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.468 HD12 ' HB2' ' A' ' 177' ' ' MET . 47.6 pt -88.49 152.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.503 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.645 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 71.5 mmtt -103.66 105.19 15.35 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.439 HG22 HG13 ' A' ' 116' ' ' VAL . 43.1 t -111.23 135.93 48.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.227 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.603 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 87.04 48.49 4.36 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.717 173.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.435 ' HB3' ' CD2' ' A' ' 115' ' ' TYR . 8.4 tpt180 -118.34 79.81 15.5 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.39 -54.19 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.437 2.092 . . . . 0.0 111.774 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.2 p -179.27 159.52 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.013 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -132.24 32.41 3.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.565 0.697 . . . . 0.0 109.684 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.4 mm -95.01 27.83 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.359 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 77.16 -72.54 2.09 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 115.64 -0.709 . . . . 0.0 114.286 172.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -53.74 -39.47 65.34 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -164.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.434 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -76.82 -23.48 52.79 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.012 -0.43 . . . . 0.0 112.079 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.55 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 29.3 mm-40 -63.98 -49.61 73.91 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -172.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 8.9 Cg_endo -52.86 -38.43 78.55 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.665 2.243 . . . . 0.0 113.098 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.6 mt -71.83 -45.25 66.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.773 0.32 . . . . 0.0 110.485 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.546 HG23 ' HE2' ' A' ' 111' ' ' MET . 56.2 mt -60.78 -48.34 89.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.14 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.75 -42.3 95.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.344 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 6.4 tp-100 -60.44 -51.94 67.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.735 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.638 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 64.5 mt -67.5 -33.51 75.24 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.576 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.604 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -55.92 -42.96 76.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.304 0.573 . . . . 0.0 109.664 175.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -73.94 -32.71 63.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.943 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.638 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 29.5 mt-10 -69.69 -30.47 68.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.697 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.54 -29.04 65.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.993 0.425 . . . . 0.0 110.069 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 71.6 mtp180 -71.16 -21.76 62.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.361 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -81.41 6.16 15.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.47 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -132.58 -175.62 3.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.92 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -126.08 46.28 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.904 -174.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.798 ' HD2' ' HG3' ' A' ' 289' ' ' PRO . 39.7 ttt180 -105.58 137.66 43.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.15 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 263' ' ' SER . 49.2 pt -129.15 166.82 25.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.01 0.433 . . . . 0.0 110.735 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.608 ' HD1' ' CE2' ' A' ' 254' ' ' PHE . 85.2 t80 -122.47 129.72 52.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.421 -174.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.542 HG12 HG21 ' A' ' 282' ' ' VAL . 35.1 m -126.63 135.84 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.046 0.45 . . . . 0.0 110.307 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -132.95 -179.49 5.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.861 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.7 t 63.43 27.56 15.23 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.894 0.854 . . . . 0.0 109.056 -172.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.93 121.31 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.256 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 40.8 t-80 -55.21 133.88 49.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.173 0.511 . . . . 0.0 111.283 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -57.79 -28.63 64.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.291 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.72 3.71 50.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.724 0.297 . . . . 0.0 111.304 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 217' ' ' HIS . 14.1 tp -87.06 134.32 33.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 63.2 p -86.41 156.35 20.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.054 -171.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.94 -42.45 68.85 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.577 0.703 . . . . 0.0 109.474 172.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.46 -40.38 74.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.833 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -71.7 -38.58 70.54 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.1 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.56 HG21 HD13 ' A' ' 255' ' ' ILE . 27.0 mm -65.77 -46.24 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 86.8 tttt -57.7 -42.4 83.65 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.439 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.6 t -55.52 -47.75 75.77 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.641 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.33 -40.91 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 111.444 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.475 ' HD1' ' O ' ' A' ' 225' ' ' ILE . 26.4 m-85 -66.74 -29.07 68.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.884 0.373 . . . . 0.0 110.992 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.4 mm-40 -63.9 -24.66 67.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.419 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.85 -20.14 60.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.27 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.64 -37.2 6.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.917 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.428 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -147.18 168.92 28.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.801 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.485 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 35.2 mmtt -88.01 116.03 25.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.761 0.791 . . . . 0.0 111.231 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.452 HD12 ' CB ' ' A' ' 229' ' ' PHE . 52.6 mt -86.8 150.95 3.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.641 -173.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -110.8 -22.38 11.59 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.759 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.428 ' H ' HG23 ' A' ' 235' ' ' ILE . 43.1 t -172.56 143.28 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.707 0.289 . . . . 0.0 110.379 -175.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.0 t -140.49 105.13 4.9 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.8 m -129.21 110.13 11.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.256 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.535 HD21 HG13 ' A' ' 225' ' ' ILE . 60.9 mt -78.71 131.55 36.65 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.498 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -70.53 122.52 19.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.09 0.471 . . . . 0.0 109.834 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.729 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 76.4 mtt180 -111.05 166.49 11.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.29 -171.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.06 135.24 33.58 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.38 -46.25 11.94 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.861 3.041 . . . . 0.0 114.707 -166.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.3 t -159.73 65.42 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.844 0.831 . . . . 0.0 111.607 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 21.8 p -133.15 6.56 3.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.919 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.01 71.74 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.945 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 248' ' ' LYS . 41.3 mtmt -147.33 159.37 43.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.729 ' HB3' ' HG2' ' A' ' 242' ' ' ARG . 19.8 p80 -107.32 147.36 30.39 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.506 170.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -63.44 -7.5 6.87 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -164.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 108.61 5.43 31.67 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.443 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.408 ' CE1' ' HG2' ' A' ' 137' ' ' PRO . 12.8 p90 -141.43 174.09 10.88 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.513 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -164.49 172.34 40.23 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.767 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.608 ' CE2' ' HD1' ' A' ' 212' ' ' TYR . 92.4 m-85 -127.31 143.51 51.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.011 0.434 . . . . 0.0 110.687 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.56 HD13 HG21 ' A' ' 225' ' ' ILE . 83.5 mt -136.61 136.89 48.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.094 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -116.72 146.73 42.59 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.468 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 8.6 m-85 -111.28 175.27 5.49 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -83.79 -13.45 53.79 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.222 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -135.48 133.46 38.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.979 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.4 -24.93 67.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.017 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -73.43 -35.4 65.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.873 175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.443 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 8.2 t -70.69 -37.64 73.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.678 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.518 ' HB2' HG22 ' A' ' 211' ' ' ILE . 62.3 p -66.41 -32.79 74.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.068 0.461 . . . . 0.0 110.115 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.49 -27.02 62.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.83 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.443 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 53.5 m-20 -62.92 -45.3 93.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.208 0.528 . . . . 0.0 109.626 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -62.33 -43.53 98.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.018 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 263' ' ' SER . 86.5 t -55.38 -37.16 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.297 0.57 . . . . 0.0 111.206 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.6 m -75.83 -24.19 55.81 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.246 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 18.3 m -95.08 -41.83 8.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 78.5 mmm -88.07 1.95 53.06 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -167.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.483 ' HA ' HG12 ' A' ' 282' ' ' VAL . 66.7 t30 -72.36 115.42 11.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.213 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.2 mt 65.18 38.35 6.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.346 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -94.39 123.56 37.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.105 174.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.519 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 32.2 t70 -71.94 108.4 5.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -177.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 25.5 tp -141.8 111.19 6.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 90.94 16.34 54.57 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.051 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 97.35 -6.31 63.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.593 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.7 152.08 51.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 74.7 m-85 -81.06 113.13 19.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.215 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.94 134.63 57.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.388 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -100.49 115.7 30.71 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.542 HG21 HG12 ' A' ' 213' ' ' VAL . 10.0 p -115.53 151.01 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.506 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.14 175.17 42.36 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.962 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -76.88 126.85 31.66 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.67 129.24 39.07 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.64 HG12 ' HB2' ' A' ' 167' ' ' GLN . 29.1 m -89.26 -11.43 10.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.783 0.325 . . . . 0.0 111.578 -170.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.509 HG22 HG21 ' A' ' 286' ' ' VAL . 68.3 p -120.87 133.39 24.1 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.27 0.557 . . . . 0.0 111.094 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 38.8 Cg_endo -67.09 146.34 76.41 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.099 2.533 . . . . 0.0 111.995 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.798 ' HG3' ' HD2' ' A' ' 210' ' ' ARG . 14.3 Cg_exo -69.55 -16.7 38.57 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.04 2.493 . . . . 0.0 112.632 -177.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 54.2 ttp -148.05 92.03 4.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.3 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.72 72.08 6.24 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.977 2.452 . . . . 0.0 112.05 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 6.7 mp 52.16 57.61 6.29 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.284 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 45.4 tp -66.5 109.63 2.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.07 0.462 . . . . 0.0 110.16 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.75 ' HB ' ' HD3' ' A' ' 295' ' ' PRO . 39.7 m -105.87 -56.29 0.07 OUTLIER Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.847 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.75 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 39.5 Cg_exo -61.96 111.4 1.21 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.105 1.87 . . . . 0.0 112.427 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -158.58 -69.91 0.09 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.912 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 37.1 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.228 178.159 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.91 89.59 2.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.197 0.522 . . . . 0.0 110.737 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -94.07 62.76 3.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.356 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 59.79 30.12 19.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.013 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.436 ' O ' ' HB3' ' A' ' 104' ' ' ARG . 10.8 pt20 -95.99 165.15 12.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.968 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.436 ' HB3' ' O ' ' A' ' 103' ' ' GLN . 25.4 tpt180 72.1 138.61 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.11 0.881 . . . . 0.0 111.352 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 75.0 2.91 4.08 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.757 172.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -57.57 -47.85 80.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.75 92.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.118 0.485 . . . . 0.0 111.04 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 201' ' ' LEU . 60.0 mt -71.95 -35.57 69.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.43 -37.11 77.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.412 . . . . 0.0 110.505 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.3 mt -67.02 -42.8 89.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.308 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 1.8 ttm -68.53 -14.65 63.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.831 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.586 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.3 m -77.13 -15.78 59.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.454 177.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.497 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 18.4 mtp180 -101.09 141.7 33.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.622 HG12 ' HB ' ' A' ' 158' ' ' VAL . 1.0 OUTLIER -123.33 127.76 74.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 78.6 t80 -82.93 115.37 21.76 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 8.6 m -115.87 116.46 52.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.59 0.71 . . . . 0.0 110.787 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 155' ' ' PHE . . . -119.95 -175.0 15.6 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.898 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.841 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 20.9 m 67.12 21.46 10.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.928 0.491 . . . . 0.0 111.279 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.6 mt -84.88 102.81 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.388 . . . . 0.0 110.619 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 122' ' ' GLU . 79.3 t80 -53.75 144.25 18.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.633 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.5 ' HA ' ' CE1' ' A' ' 152' ' ' HIS . 20.1 p90 -72.3 76.62 1.0 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.172 0.987 . . . . 0.0 111.196 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 120' ' ' TYR . 31.0 tt0 -148.35 -47.47 0.16 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.756 174.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.3 mt -66.95 128.28 35.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.501 176.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.48 174.98 35.52 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.007 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.31 -36.51 71.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.339 0.59 . . . . 0.0 109.874 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -68.8 -43.44 75.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.132 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 m -59.59 -46.2 89.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.125 0.488 . . . . 0.0 110.454 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.723 HG13 ' HE1' ' A' ' 143' ' ' MET . 41.8 mm -62.22 -47.65 92.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.617 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 133' ' ' ALA . 74.3 ttt180 -60.26 -41.1 92.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.863 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -63.14 -34.4 77.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.492 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.79 -34.48 22.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.445 ' HD1' ' O ' ' A' ' 128' ' ' ILE . 69.8 m-85 -91.47 -18.41 24.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.453 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -55.41 -42.02 93.81 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 42.5 Cg_exo -40.39 -43.03 3.96 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 123.017 2.478 . . . . 0.0 113.925 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.669 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 50.1 m-85 -74.91 -51.78 12.94 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.645 0.26 . . . . 0.0 111.142 -175.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.37 170.54 36.41 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.023 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.3 118.71 5.74 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.87 2.38 . . . . 0.0 110.896 175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.437 HG22 ' CG1' ' A' ' 141' ' ' ILE . 53.3 mt -82.78 120.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.374 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -88.88 -33.6 17.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.341 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.3 t -153.58 136.79 15.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.968 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.437 ' CG1' HG22 ' A' ' 138' ' ' ILE . 71.7 mt -120.49 107.46 20.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 169.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.733 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -84.75 98.66 10.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.355 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.723 ' HE1' HG13 ' A' ' 128' ' ' ILE . 57.0 ttm -149.45 134.34 17.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.784 0.325 . . . . 0.0 110.377 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 p -74.2 56.98 0.65 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.633 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -99.7 93.2 5.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.002 0.43 . . . . 0.0 111.259 -177.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -173.05 88.35 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.597 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.2 p -163.54 140.55 7.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.594 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 50.5 t -65.38 -21.77 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.309 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.2 p -88.03 1.16 54.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.949 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 62.5 mtm 59.66 40.19 20.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -108.04 140.76 40.74 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.265 0.555 . . . . 0.0 111.83 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 121' ' ' TYR . 2.4 p-80 -145.95 162.03 38.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 170.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -54.62 -64.85 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.699 0.285 . . . . 0.0 111.476 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.78 -22.3 1.16 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.9 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.414 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 47.9 p90 -108.78 151.38 26.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -146.2 156.15 43.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.733 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 93.8 m-85 -113.75 109.55 18.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.775 175.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.622 ' HB ' HG12 ' A' ' 114' ' ' VAL . 59.8 t -97.31 106.34 18.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.497 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 72.8 tt0 -108.46 122.84 47.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.539 -177.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -96.37 178.89 5.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -82.43 -17.87 43.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.555 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 m -133.38 143.66 49.05 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.673 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 57.9 Cg_endo -71.95 -22.85 22.65 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.199 2.599 . . . . 0.0 112.785 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.59 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 16.3 mp0 -55.16 -58.72 6.52 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.684 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.67 -22.47 23.27 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.75 -48.13 12.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.968 0.413 . . . . 0.0 110.316 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -73.34 -26.66 61.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.302 0.572 . . . . 0.0 109.699 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.669 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 16.3 tp -70.47 -47.27 61.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.233 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.0 -34.72 78.15 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 18.6 tp -65.24 -46.08 82.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.714 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.37 -47.71 72.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.673 -174.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -90.45 -43.84 10.01 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.411 ' C ' ' H ' ' A' ' 175' ' ' SER . 12.4 mtm -94.46 30.3 2.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -170.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 170' ' ' LEU . 3.5 t-20 -75.98 12.97 0.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.168 0.508 . . . . 0.0 110.806 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 22.2 m -113.72 -73.38 0.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.523 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.9 m -142.28 162.04 19.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 111.373 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.646 ' HB2' HD13 ' A' ' 183' ' ' ILE . 17.2 tpp -128.53 84.39 2.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.494 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.452 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 89.0 mt 70.16 -56.25 0.59 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.305 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -73.59 168.87 53.79 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.461 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.63 53.75 4.07 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.722 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 118' ' ' SER . 43.3 ttm180 -143.77 137.64 28.21 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 175' ' ' SER . 0.9 OUTLIER -72.09 112.07 7.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.192 0.52 . . . . 0.0 110.382 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.841 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 45.3 pt -81.38 158.41 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.139 -176.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.717 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 24.8 ttmm -103.4 116.4 32.34 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.051 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.3 t -122.7 148.84 26.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.602 ' H ' HG23 ' A' ' 114' ' ' VAL . . . 107.24 -118.74 5.65 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.005 175.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 187' ' ' ARG . 0.0 OUTLIER -145.11 121.46 6.05 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.796 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.9 -35.89 53.16 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.498 2.132 . . . . 0.0 110.855 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.4 m -83.24 76.07 9.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.272 173.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -63.67 -57.16 10.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.106 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.08 72.52 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.608 0.718 . . . . 0.0 109.989 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -101.94 -178.09 27.95 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.978 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -70.35 -16.99 63.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.133 0.466 . . . . 0.0 111.091 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -84.84 -19.6 32.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.489 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 25.3 tp60 -57.36 -47.47 98.96 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -176.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 73.1 Cg_exo -52.5 -38.88 75.46 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.08 1.853 . . . . 0.0 112.678 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.0 mt -75.67 -43.9 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.438 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 194' ' ' ALA . 79.9 mt -58.23 -46.88 88.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.784 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.04 -39.74 93.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.705 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -59.54 -52.81 63.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.98 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.531 HD11 HD21 ' A' ' 108' ' ' LEU . 42.0 mt -68.14 -32.91 73.51 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.191 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.591 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.59 -48.24 72.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -65.53 -33.7 76.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.855 175.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.504 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 30.7 mt-10 -66.11 -33.71 76.39 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.17 0.51 . . . . 0.0 111.155 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -72.75 -24.85 61.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.656 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.591 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 68.6 mtp180 -79.87 -28.12 39.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.372 174.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.8 -38.41 76.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.151 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -88.72 173.6 8.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.481 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 14.1 m120 -116.58 34.71 4.91 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.797 -174.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.687 ' HD3' ' HG3' ' A' ' 289' ' ' PRO . 17.0 ttp180 -98.73 138.13 36.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.373 0.606 . . . . 0.0 111.507 -174.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.452 ' HA ' ' H ' ' A' ' 285' ' ' ALA . 47.7 pt -124.0 167.11 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.954 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.448 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 83.5 t80 -117.06 128.04 54.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.53 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.441 HG13 HG21 ' A' ' 282' ' ' VAL . 34.6 m -117.7 132.56 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.251 0.548 . . . . 0.0 110.112 177.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.463 ' HB1' ' HB2' ' A' ' 281' ' ' ARG . . . -126.95 169.68 13.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.894 -174.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.3 t 62.37 32.29 16.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.87 0.843 . . . . 0.0 109.312 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.45 108.28 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.091 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -54.98 133.38 48.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.911 0.386 . . . . 0.0 110.725 -174.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -55.8 -24.22 34.76 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.24 -21.1 29.23 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.23 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.62 124.39 22.23 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.3 t -81.38 164.12 22.35 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.199 0.523 . . . . 0.0 111.329 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -53.47 -38.88 64.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.126 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.55 -35.56 77.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.661 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.33 -44.59 94.47 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.671 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.733 HG23 HD13 ' A' ' 255' ' ' ILE . 38.0 mm -67.04 -41.17 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.021 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.643 ' HD2' ' SG ' ' A' ' 238' ' ' CYS . 87.4 tttt -59.8 -45.07 93.48 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.633 174.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.1 m -54.96 -44.96 74.85 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.407 HG11 ' HE3' ' A' ' 270' ' ' MET . 21.0 t -76.32 -38.22 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.719 0.295 . . . . 0.0 111.485 -176.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.563 ' HB3' ' OH ' ' A' ' 257' ' ' TYR . 15.7 m-85 -72.51 -33.43 66.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 110.996 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -61.17 -24.61 66.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.027 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.56 -12.78 61.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.245 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -111.43 -45.51 3.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.896 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -134.02 177.12 19.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.044 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 234' ' ' LYS . 39.4 tptt -91.74 106.44 18.48 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.11 0.481 . . . . 0.0 110.424 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.537 HD11 ' HB2' ' A' ' 229' ' ' PHE . 22.5 mt -75.94 142.71 14.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.843 0.83 . . . . 0.0 112.325 -175.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.453 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 54.4 tttt -101.69 -37.3 8.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.42 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.46 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 20.4 m -156.04 142.0 18.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.318 -172.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.643 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 26.6 p -130.05 121.58 26.72 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 168.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 29.0 m -142.05 102.31 4.1 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.943 0.401 . . . . 0.0 110.536 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.475 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 70.3 mt -76.4 131.0 38.85 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.443 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.21 115.32 5.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 14.7 ptt-85 -139.78 168.83 18.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -171.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.683 ' HB2' ' HG1' ' A' ' 246' ' ' THR . 16.6 m-20 -112.71 123.64 33.46 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.972 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 11.9 Cg_endo -58.51 -22.92 61.89 Favored 'Trans proline' 0 CA--C 1.526 0.117 0 C-N-CA 123.077 2.518 . . . . 0.0 111.999 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 p -91.32 -4.81 55.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.662 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.683 ' HG1' ' HB2' ' A' ' 243' ' ' ASP . 47.8 p -114.22 -34.48 5.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.493 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.7 6.33 80.25 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.267 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -138.31 160.0 40.6 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 6.5 p80 -87.19 151.22 23.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.563 . . . . 0.0 110.448 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.01 -25.34 68.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.384 -170.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 135.99 -12.12 4.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.874 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.416 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 44.3 p90 -130.87 174.52 9.89 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.475 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -165.86 175.53 41.45 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.329 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.59 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 96.6 m-85 -129.52 142.37 50.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.971 0.415 . . . . 0.0 110.448 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.733 HD13 HG23 ' A' ' 225' ' ' ILE . 90.4 mt -136.07 142.66 38.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.132 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.586 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 41.7 mt-10 -120.76 148.76 43.54 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.636 ' HB2' ' OG ' ' A' ' 263' ' ' SER . 25.5 m-85 -118.97 153.5 34.55 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 123.396 0.435 . . . . 0.0 109.888 175.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 25.0 mt-10 -75.95 -9.05 58.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.49 0.662 . . . . 0.0 110.036 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -130.66 122.56 27.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.392 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -59.36 -32.24 69.94 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.872 -171.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -67.86 -39.17 83.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.027 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.7 m -67.54 -33.34 74.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.747 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.636 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 3.3 m -58.38 -50.66 72.88 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.573 0.701 . . . . 0.0 109.701 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . 0.401 ' HG2' ' HD3' ' A' ' 284' ' ' LYS . 24.6 mt-30 -76.75 -14.66 59.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.146 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.84 -45.96 63.57 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.74 78.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.875 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.497 HG11 ' HA2' ' A' ' 283' ' ' GLY . 88.6 t -56.12 -31.62 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.195 0.521 . . . . 0.0 111.073 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.5 t -87.37 -39.18 15.53 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.079 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.6 m -80.99 -41.49 22.66 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.541 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 77.4 mmm -83.16 -0.23 48.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 111.059 -172.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.519 ' HA ' HG12 ' A' ' 282' ' ' VAL . 26.7 t-20 -71.37 111.18 6.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.308 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.9 mt 70.36 34.66 2.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.37 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -88.23 129.76 35.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.761 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.32 113.43 13.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.387 0.613 . . . . 0.0 111.242 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 33.9 tp -142.05 121.24 13.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.09 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 68.72 28.76 72.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.198 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 86.34 -13.5 57.53 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.97 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -114.81 150.75 34.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.634 -0.333 . . . . 0.0 110.257 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -89.28 116.68 27.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.802 0.334 . . . . 0.0 110.139 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.39 126.09 26.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.109 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.463 ' HB2' ' HB1' ' A' ' 214' ' ' ALA . 5.5 mmt180 -99.69 114.75 28.05 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 271' ' ' ASN . 8.4 p -121.62 150.85 24.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.528 -170.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.497 ' HA2' HG11 ' A' ' 267' ' ' VAL . . . -169.88 174.59 44.08 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.522 ' HB3' ' HZ3' ' A' ' 284' ' ' LYS . 4.2 mmmp? -73.21 125.69 28.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.153 0.477 . . . . 0.0 110.287 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.452 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -58.4 130.95 49.15 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.9 m -85.08 -17.56 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.926 0.393 . . . . 0.0 110.769 -173.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 66.4 p -109.73 142.88 26.72 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.101 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.05 156.65 51.75 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.682 2.255 . . . . 0.0 111.343 172.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.687 ' HG3' ' HD3' ' A' ' 210' ' ' ARG . 34.7 Cg_exo -58.36 92.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.909 2.406 . . . . 0.0 112.777 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 49.8 ttm -103.08 128.82 26.82 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.488 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.427 ' HB3' ' HB ' ' A' ' 294' ' ' THR . 69.1 Cg_exo -51.32 115.77 2.27 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.159 2.573 . . . . 0.0 113.084 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 93.1 mt -91.12 94.74 9.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.917 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 90.6 mt 56.13 56.19 6.1 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.644 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 291' ' ' PRO . 9.7 t -63.12 140.18 97.63 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.6 -178.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 16.5 Cg_exo -68.08 73.98 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.232 2.621 . . . . 0.0 112.621 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -97.99 104.23 16.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.343 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.572 179.159 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 62.82 176.84 0.15 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.403 0.62 . . . . 0.0 112.297 176.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 68.0 mtt -122.03 116.35 24.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.009 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 104' ' ' ARG . . . -129.31 174.34 9.7 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.828 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 102' ' ' ALA . 34.6 tt0 74.79 -38.77 0.39 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.324 0.65 . . . . 0.0 111.328 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' A' ' 102' ' ' ALA . 23.8 tpt180 -53.35 109.77 0.48 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.29 0.636 . . . . 0.0 111.35 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.678 ' HG3' HD13 ' A' ' 108' ' ' LEU . 35.2 tt0 68.62 11.88 8.5 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.576 0.547 . . . . 0.0 111.677 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -65.97 -34.18 77.52 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.93 -24.78 58.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.678 HD13 ' HG3' ' A' ' 105' ' ' GLN . 39.4 mt -67.64 -33.9 75.88 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.957 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.29 -24.06 40.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.095 0.474 . . . . 0.0 111.006 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.3 -52.49 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.731 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.405 ' HE2' HG21 ' A' ' 198' ' ' ILE . 0.7 OUTLIER -66.9 -22.47 65.96 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -175.151 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 72.3 m -74.06 -10.5 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.206 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.531 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 78.0 mtt180 -102.71 139.96 37.61 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.174 175.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.28 119.89 60.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 170.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.551 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 84.8 t80 -80.65 129.54 34.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.758 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.51 HG12 HG11 ' A' ' 185' ' ' VAL . 9.6 m -108.65 115.97 50.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.316 0.579 . . . . 0.0 110.198 175.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.11 135.31 12.07 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.819 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.9 t 60.35 79.28 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.327 0.651 . . . . 0.0 111.442 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.478 HD11 ' CG2' ' A' ' 116' ' ' VAL . 59.5 mt -93.82 127.12 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.434 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.479 ' HB2' ' HB2' ' A' ' 181' ' ' ARG . 29.0 t80 -60.16 127.71 33.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -65.37 77.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.149 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -169.66 -37.93 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.061 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.2 mt -74.73 114.36 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.089 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.418 ' HA2' ' HZ3' ' A' ' 145' ' ' TRP . . . -74.68 165.32 54.75 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.481 176.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -60.98 -40.65 94.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -60.6 -38.72 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.99 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.0 m -66.24 -42.92 87.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.563 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.658 HG13 ' HE3' ' A' ' 143' ' ' MET . 37.5 mm -65.86 -40.91 88.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.496 0.665 . . . . 0.0 109.9 176.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.41 ' O ' ' HB3' ' A' ' 133' ' ' ALA . 52.6 ttt180 -55.88 -44.17 77.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.829 176.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -72.21 -33.59 67.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.948 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.14 -37.35 46.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -91.16 -15.48 29.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 129' ' ' ARG . . . -53.24 -45.63 98.26 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -40.83 -40.79 3.72 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 123.247 2.631 . . . . 0.0 114.986 177.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.641 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 68.4 m-85 -72.66 -46.74 52.37 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -170.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.2 -164.93 20.53 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.561 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 161' ' ' GLU . 87.0 Cg_endo -79.83 107.73 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.071 2.514 . . . . 0.0 111.854 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.573 HD11 HD12 ' A' ' 141' ' ' ILE . 56.9 mt -66.71 113.74 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.316 0.579 . . . . 0.0 110.577 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -93.31 -40.58 10.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.047 -177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.2 t -155.54 128.62 8.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.466 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.573 HD12 HD11 ' A' ' 138' ' ' ILE . 67.0 mt -111.06 108.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 171.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -100.43 98.65 9.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.805 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.658 ' HE3' HG13 ' A' ' 128' ' ' ILE . 52.7 ttm -131.34 127.51 37.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.948 0.404 . . . . 0.0 110.446 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.6 p -80.53 124.69 29.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.892 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.418 ' HZ3' ' HA2' ' A' ' 124' ' ' GLY . 46.3 t-105 -103.95 122.58 45.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -132.11 173.37 11.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.626 0.25 . . . . 0.0 110.947 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.9 m 70.61 141.37 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 O-C-N 124.313 1.008 . . . . 0.0 112.434 171.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.43 -20.4 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.677 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.5 p -91.69 10.56 27.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.542 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 68.1 mtm 69.39 11.3 8.05 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.941 0.496 . . . . 0.0 112.21 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -87.33 130.3 34.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.958 0.409 . . . . 0.0 110.626 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -123.92 121.85 36.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.955 0.407 . . . . 0.0 110.371 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -116.8 73.44 0.86 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.839 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -154.08 -146.99 4.53 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.563 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -111.9 177.5 4.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.61 0.243 . . . . 0.0 110.605 -175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.42 ' HB2' ' CG2' ' A' ' 116' ' ' VAL . . . -161.41 153.7 19.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.489 176.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -123.66 123.03 39.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.236 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.6 t -104.65 105.97 19.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.531 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 35.5 tt0 -97.21 131.71 43.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.001 -176.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -109.52 162.35 14.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.489 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 137' ' ' PRO . 44.4 mt-10 -79.13 -9.15 59.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 0.0 110.668 174.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.69 133.58 19.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.878 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 43.1 Cg_endo -66.79 -20.41 52.21 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.135 2.556 . . . . 0.0 112.358 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.645 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 17.6 mp0 -55.74 -52.86 62.47 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.956 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.55 -20.61 65.77 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.18 -48.58 12.92 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.615 ' HG3' HG12 ' A' ' 286' ' ' VAL . 15.6 mm100 -66.77 -34.11 77.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.044 174.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.641 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 13.0 tp -68.87 -46.61 68.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.672 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.436 ' HA ' ' CE1' ' A' ' 135' ' ' PHE . . . -60.46 -31.21 70.23 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.595 HD12 ' HA3' ' A' ' 186' ' ' GLY . 5.3 tt -67.43 -55.9 11.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.014 172.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 167' ' ' GLN . 23.1 mt-10 -53.94 -30.14 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.058 -175.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -98.07 -51.22 4.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.9 mtm -106.62 29.33 7.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -167.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.547 ' HA ' HG22 ' A' ' 185' ' ' VAL . 65.1 t30 -86.09 26.08 1.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.632 0.729 . . . . 0.0 110.308 177.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.2 t -114.23 -70.29 0.81 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.97 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 m -140.1 155.46 24.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.617 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.817 ' HE1' ' HG ' ' A' ' 178' ' ' LEU . 0.9 OUTLIER -126.81 100.99 6.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.414 175.927 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.817 ' HG ' ' HE1' ' A' ' 177' ' ' MET . 94.9 mt 66.2 26.91 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.679 172.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 123.84 -112.26 1.81 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.954 -1.117 . . . . 0.0 114.594 171.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.81 38.51 3.04 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 114.451 0.541 . . . . 0.0 114.451 -165.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.479 ' HB2' ' HB2' ' A' ' 120' ' ' TYR . 8.5 tpp180 -145.53 120.09 9.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 117.209 0.505 . . . . 0.0 111.09 173.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -87.49 83.18 7.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.432 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.6 pt -70.22 147.69 11.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.086 0.47 . . . . 0.0 110.938 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -103.55 107.02 17.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.36 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.5 m -99.69 137.41 27.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.359 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.595 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 82.52 90.71 0.64 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.655 -0.784 . . . . 0.0 111.447 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.437 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 68.5 ttt180 -65.43 123.25 83.86 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.752 0.311 . . . . 0.0 110.76 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 3.5 Cg_exo -75.42 50.59 2.69 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 123.366 2.711 . . . . 0.0 112.217 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.6 p -87.92 62.9 7.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.434 0.635 . . . . 0.0 110.425 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.5 65.93 7.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.96 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 48.9 mm -63.72 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.396 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 118.32 -4.03 15.77 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.708 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -83.06 -56.89 3.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.006 0.431 . . . . 0.0 111.059 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.69 -19.17 26.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.433 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.493 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 84.0 mm-40 -56.94 -48.87 96.68 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 54.5 Cg_exo -53.93 -39.29 85.36 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.152 1.902 . . . . 0.0 112.539 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.46 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 41.7 mm -67.61 -46.89 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 110.084 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.405 HG21 ' HE2' ' A' ' 111' ' ' MET . 87.1 mt -57.9 -48.45 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.531 178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 29.7 t70 -67.53 -40.99 85.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.164 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -62.7 -44.99 94.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.115 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 76.0 mt -67.58 -32.84 73.87 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.55 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.472 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -58.21 -38.31 76.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.188 0.518 . . . . 0.0 109.72 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 40.1 mt-10 -73.73 -31.53 63.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.945 175.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 57.7 mt-10 -67.26 -24.16 65.77 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.184 0.516 . . . . 0.0 110.984 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.85 -33.39 62.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.137 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 18.0 mtm180 -73.35 -13.78 61.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.786 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.32 -22.2 60.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.329 0.585 . . . . 0.0 110.171 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.99 166.99 18.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.305 -0.862 . . . . 0.0 108.997 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.565 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 65.2 m-20 -95.26 48.67 1.17 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.615 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 7.8 ptp180 -91.44 149.5 21.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.398 0.618 . . . . 0.0 111.206 -173.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.428 HG21 ' HB2' ' A' ' 263' ' ' SER . 44.1 pt -134.55 166.91 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.254 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -113.14 122.19 46.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.606 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.426 HG13 HG22 ' A' ' 282' ' ' VAL . 34.3 m -117.59 131.92 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.004 0.431 . . . . 0.0 110.227 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.495 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . . . -126.13 172.12 10.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.159 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.7 m 62.68 27.56 16.19 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.922 0.868 . . . . 0.0 109.863 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.61 112.27 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.83 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -58.58 138.86 56.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.253 -171.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -52.67 -30.95 34.64 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -88.6 -22.81 23.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.497 0.189 . . . . 0.0 111.489 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.29 120.72 12.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.548 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.6 m -82.04 166.6 19.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.274 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -53.91 -45.4 71.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.511 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.98 -32.38 73.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.652 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.443 ' O ' HG21 ' A' ' 228' ' ' VAL . 8.3 t70 -68.7 -45.81 70.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.637 HG22 HD12 ' A' ' 255' ' ' ILE . 39.8 mm -66.29 -36.78 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.58 -52.72 63.96 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.28 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 89.7 p -55.74 -34.4 65.15 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 224' ' ' ASP . 24.5 t -73.55 -47.66 44.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.314 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.719 ' HB2' HD12 ' A' ' 235' ' ' ILE . 16.2 m-85 -68.39 -31.64 71.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.411 0.624 . . . . 0.0 110.526 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 29.5 tp10 -60.08 -24.35 64.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.367 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.91 -8.33 58.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.644 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -112.79 -45.21 3.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.562 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.496 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -140.82 171.71 23.96 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 64.8 mmtt -90.03 111.7 22.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.894 0.854 . . . . 0.0 111.697 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.719 HD12 ' HB2' ' A' ' 229' ' ' PHE . 52.9 mt -87.16 151.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.682 -174.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -103.52 -40.33 6.38 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.786 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 50.8 m -156.88 151.01 24.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.411 -170.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.1 t -143.76 104.66 4.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.764 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.5 m -121.09 103.13 8.79 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.353 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.574 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 69.0 mt -80.46 144.52 32.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.818 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -66.55 105.05 1.4 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 41.0 ttt180 -129.16 142.09 50.97 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.065 -170.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.463 ' O ' HG21 ' A' ' 246' ' ' THR . 30.1 m-20 -93.61 115.16 64.7 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.032 176.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.42 -37.13 98.35 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.529 2.82 . . . . 0.0 113.769 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 82.8 p -92.75 10.22 31.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.463 HG21 ' O ' ' A' ' 243' ' ' ASP . 11.6 t -123.06 -9.78 8.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.045 -0.41 . . . . 0.0 111.196 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.09 -49.77 4.29 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.426 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -77.32 172.97 12.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.174 0.511 . . . . 0.0 110.685 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 20.2 p80 -116.1 167.67 10.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.508 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -65.26 -80.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 O-C-N 123.485 0.49 . . . . 0.0 111.69 -173.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -175.99 17.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.232 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.442 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 31.3 p90 -157.03 176.71 12.39 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.0 178.06 45.17 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.041 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.645 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 89.4 m-85 -125.67 143.85 50.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.917 0.389 . . . . 0.0 110.19 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.637 HD12 HG22 ' A' ' 225' ' ' ILE . 87.0 mt -134.68 128.44 50.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.462 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.615 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 47.8 mt-10 -109.98 131.95 54.59 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.635 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 6.8 m-85 -97.07 176.97 5.75 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 123.155 0.285 . . . . 0.0 110.294 176.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.12 -22.85 35.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -121.15 121.94 38.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.361 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.67 -22.56 67.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.075 0.464 . . . . 0.0 110.939 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -72.0 -49.33 37.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.719 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 44.9 m -66.67 -32.43 73.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.012 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.635 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 59.8 p -66.56 -42.54 86.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 110.057 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -74.51 -21.62 59.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.522 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.98 -37.19 72.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -63.78 -39.98 95.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 172.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.11 -33.67 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 121.33 0.586 . . . . 0.0 110.628 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.5 m -73.71 -39.61 64.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.133 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.5 m -89.37 -39.17 13.61 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.557 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 85.9 mmm -81.66 -1.56 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -171.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.525 ' HA ' HG12 ' A' ' 282' ' ' VAL . 22.9 t-20 -71.5 117.51 13.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 97.7 mt 70.01 32.75 2.95 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.44 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -91.23 121.19 32.78 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.449 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 12.4 t70 -74.38 118.55 17.47 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.333 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.7 tp -131.94 91.83 3.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.901 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 92.4 26.81 16.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 92.7 2.36 67.32 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.632 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -131.8 140.81 49.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 72.4 m-85 -85.37 112.61 20.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.6 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 71.7 mt -58.03 121.27 10.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.495 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 8.2 mmm180 -93.53 114.75 27.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 174.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.525 HG12 ' HA ' ' A' ' 271' ' ' ASN . 11.4 p -119.87 143.85 30.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.745 -173.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -158.56 -171.84 24.93 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.505 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.62 128.92 36.76 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.773 0.32 . . . . 0.0 110.344 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -66.52 128.17 35.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.615 HG12 ' HG3' ' A' ' 167' ' ' GLN . 29.4 m -97.32 -25.02 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -171.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.461 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 35.5 p -131.39 168.13 18.76 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 120.844 0.354 . . . . 0.0 111.569 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.05 103.52 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.191 2.594 . . . . 0.0 110.989 169.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 287' ' ' THR . 20.4 Cg_exo -64.99 146.63 87.98 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.006 2.471 . . . . 0.0 112.682 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.419 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 88.3 mtp -100.15 110.29 59.21 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.121 177.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 1.5 Cg_endo -83.89 93.89 0.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.082 2.522 . . . . 0.0 111.596 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.14 63.17 1.8 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.212 0.529 . . . . 0.0 111.158 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.42 -2.52 58.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.925 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 11.0 m -53.97 126.41 51.2 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.048 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 7.7 Cg_exo -73.7 61.18 4.48 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.337 2.691 . . . . 0.0 112.503 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -107.2 16.66 23.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.24 0.543 . . . . 0.0 109.865 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.375 -178.224 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.039 0 N-CA-C 112.645 -0.182 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.0 81.0 8.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.901 0.381 . . . . 0.0 110.79 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 94.1 mmm -81.18 60.6 4.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.522 0.677 . . . . 0.0 110.624 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -122.81 74.67 1.22 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.95 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -97.71 156.48 16.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.709 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.42 72.37 1.38 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.637 0.732 . . . . 0.0 110.629 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -88.96 9.82 23.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.824 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -62.03 -33.81 75.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.7 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.55 80.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 0.0 110.884 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.495 HD21 HD12 ' A' ' 201' ' ' LEU . 61.7 mt -68.91 -31.28 70.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.598 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.68 -28.41 69.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.256 0.551 . . . . 0.0 110.384 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.84 -36.47 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.858 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.511 ' SD ' HG12 ' A' ' 198' ' ' ILE . 87.9 mtp -73.31 -21.81 60.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.2 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.833 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 30.4 p -79.72 -3.71 48.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -110.7 141.09 44.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.678 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.579 HG12 ' HB ' ' A' ' 158' ' ' VAL . 6.0 p -121.56 131.93 71.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.177 0.513 . . . . 0.0 110.051 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -79.11 121.03 24.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.07 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 25.7 m -118.18 129.26 74.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.5 0.667 . . . . 0.0 111.383 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.46 176.26 21.51 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.62 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.549 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 22.7 m 60.29 39.11 19.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.236 0.541 . . . . 0.0 110.576 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.403 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 57.5 mt -81.02 -15.74 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.373 -176.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.403 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 44.7 t80 71.21 153.62 0.13 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.204 -176.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -83.54 76.24 9.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.453 0.644 . . . . 0.0 111.052 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -163.43 -50.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.021 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.82 104.55 1.71 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.081 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.87 172.77 55.33 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.935 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.468 ' OE2' ' HB ' ' A' ' 141' ' ' ILE . 61.2 tt0 -64.17 -32.31 73.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.849 0.324 . . . . 0.0 110.67 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -54.85 -48.87 72.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.355 0.598 . . . . 0.0 109.958 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.2 m -70.69 -41.67 71.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.961 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.651 HG13 ' HE1' ' A' ' 143' ' ' MET . 32.0 mm -61.41 -46.34 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.479 -179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -63.71 -37.31 86.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.034 0.445 . . . . 0.0 110.196 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -65.63 -32.38 73.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.969 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.428 ' HB3' HD11 ' A' ' 178' ' ' LEU . . . -79.44 -35.82 39.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.515 ' HB2' HD13 ' A' ' 138' ' ' ILE . 71.3 m-85 -90.66 -13.86 33.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 0.0 111.531 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.17 -43.18 89.71 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -43.83 -41.51 11.84 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.95 2.433 . . . . 0.0 114.564 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.452 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 51.4 m-85 -77.08 -50.94 11.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.536 0.208 . . . . 0.0 111.386 -174.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -158.36 171.0 35.14 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.884 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.64 117.63 5.01 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 111.218 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.515 HD13 ' HB2' ' A' ' 132' ' ' PHE . 58.5 mt -78.82 116.31 22.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.105 0.479 . . . . 0.0 110.535 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.494 ' HE3' ' OE1' ' A' ' 159' ' ' GLU . 34.9 ttpt -88.42 -27.42 21.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.542 -177.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.2 t -163.83 145.48 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.753 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.48 HD13 HD11 ' A' ' 138' ' ' ILE . 61.7 mt -133.02 121.43 43.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.85 100.66 10.46 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.799 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.651 ' HE1' HG13 ' A' ' 128' ' ' ILE . 46.8 ttm -128.48 131.95 48.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.378 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.6 t -78.56 76.49 5.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.962 0.411 . . . . 0.0 109.942 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.573 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 38.1 t90 -89.23 95.14 10.18 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 175.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.63 110.39 4.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.667 -176.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.433 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 5.5 p -71.47 -25.52 62.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.149 -174.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.86 -50.44 80.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.386 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.0 p -91.46 -5.25 54.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.222 0.534 . . . . 0.0 111.324 179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 57.6 mtm 57.56 42.88 23.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.69 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -162.24 175.1 12.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.597 178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.573 ' HB3' ' HA ' ' A' ' 145' ' ' TRP . 9.9 p80 -142.13 135.62 29.24 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.991 0.425 . . . . 0.0 110.211 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -129.98 88.73 2.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.714 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 168.12 -130.46 2.1 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.635 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -124.54 177.86 5.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.821 0.344 . . . . 0.0 111.395 -172.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.97 167.14 31.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.305 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -125.46 121.38 33.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.664 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.579 ' HB ' HG12 ' A' ' 114' ' ' VAL . 90.2 t -100.15 116.65 43.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.102 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.494 ' OE1' ' HE3' ' A' ' 139' ' ' LYS . 41.5 tt0 -107.48 126.97 53.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.615 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.98 175.48 5.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.858 0.361 . . . . 0.0 110.964 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.46 ' OE1' ' HD3' ' A' ' 139' ' ' LYS . 5.5 mm-40 -71.98 -37.26 69.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.199 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.04 143.39 45.38 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.466 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.833 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 38.1 Cg_endo -66.26 -14.57 44.84 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.416 2.744 . . . . 0.0 112.219 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.919 ' HG3' ' HE2' ' A' ' 254' ' ' PHE . 15.4 mm-40 -62.33 -53.19 58.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.335 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.97 -18.98 60.37 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.66 -54.11 6.76 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.625 ' HG3' HG12 ' A' ' 286' ' ' VAL . 19.1 mm-40 -64.05 -36.29 83.51 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.967 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.497 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 12.9 tp -61.05 -48.41 81.88 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.643 177.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.6 -31.91 69.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.837 0.351 . . . . 0.0 110.079 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.631 HD11 ' O ' ' A' ' 185' ' ' VAL . 16.3 tp -72.58 -46.76 52.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 172.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 14.3 mm-40 -52.47 -41.84 63.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.321 0.648 . . . . 0.0 111.701 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -100.72 -51.35 3.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.0 ttp -95.65 30.16 2.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -164.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.445 ' HB3' HD12 ' A' ' 170' ' ' LEU . 10.0 p30 -79.36 21.08 0.5 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.16 -0.337 . . . . 0.0 111.151 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.5 m -100.79 -74.11 0.62 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.071 0.462 . . . . 0.0 110.822 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.3 m -144.02 170.33 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.025 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.985 ' HB2' HD11 ' A' ' 183' ' ' ILE . 2.4 tpt -118.64 94.08 4.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.254 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.918 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 73.7 mt 56.13 45.36 23.58 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.788 0.68 . . . . 0.0 110.221 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.18 -135.39 12.96 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -172.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 66.98 -112.09 4.61 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.687 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -144.01 177.86 8.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.391 0.138 . . . . 0.0 110.796 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 49.2 t-20 -63.9 112.62 3.0 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.985 HD11 ' HB2' ' A' ' 177' ' ' MET . 45.2 pt -97.54 168.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.292 0.568 . . . . 0.0 111.58 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.685 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 93.4 mttt -103.12 115.21 30.15 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.195 175.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.631 ' O ' HD11 ' A' ' 170' ' ' LEU . 18.3 t -113.01 102.85 14.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 171.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.02 -130.74 10.67 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 48.7 64.48 8.58 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-O 120.763 0.316 . . . . 0.0 111.493 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 190' ' ' ASN . 22.0 Cg_exo -64.57 -49.02 3.6 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.464 2.109 . . . . 0.0 112.251 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.4 t 70.65 -30.97 0.21 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.599 0.76 . . . . 0.0 112.034 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 188' ' ' PRO . 6.5 t30 -72.61 93.97 1.67 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.631 0.372 . . . . 0.0 110.741 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 50.4 mm 71.5 -69.11 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.502 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 74.58 60.14 3.56 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.119 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -72.8 -26.74 61.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.155 0.502 . . . . 0.0 110.693 -176.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.518 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -90.24 -5.41 56.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.452 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.555 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 15.6 mm100 -54.01 -47.11 98.12 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.1 Cg_endo -52.76 -40.74 73.43 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.987 1.791 . . . . 0.0 112.354 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 70.7 mt -73.27 -45.69 52.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.534 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 194' ' ' ALA . 57.7 mt -58.26 -47.17 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.805 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.82 -39.78 91.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.915 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -67.11 -46.34 74.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.626 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.592 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 69.0 mt -66.95 -32.84 74.36 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.02 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.569 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.64 -46.03 70.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.484 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 18.2 mt-10 -68.5 -31.75 71.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.883 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.592 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 47.1 mt-10 -67.49 -30.27 69.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.4 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -76.98 -39.22 51.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.968 0.414 . . . . 0.0 110.046 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 58.5 mtp180 -57.76 -30.11 65.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.891 176.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.22 -19.9 62.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.994 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -110.94 0.12 16.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.799 0.333 . . . . 0.0 111.404 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 56.66 38.12 29.32 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.583 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.848 ' HD2' ' HD3' ' A' ' 289' ' ' PRO . 43.9 ttt180 -87.9 138.38 31.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.937 -173.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.482 ' HA ' ' H ' ' A' ' 285' ' ' ALA . 48.7 pt -129.99 166.19 28.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.088 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.498 ' HD1' ' CE2' ' A' ' 254' ' ' PHE . 84.4 t80 -120.97 129.58 53.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.339 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.601 HG12 HG22 ' A' ' 282' ' ' VAL . 31.5 m -121.23 133.35 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.231 0.538 . . . . 0.0 110.33 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.97 175.09 9.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.193 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 61.1 m 60.71 35.14 19.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.213 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.03 124.24 36.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.293 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.482 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 25.9 t-80 -54.31 134.31 45.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.575 0.702 . . . . 0.0 111.245 -175.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.403 ' H ' ' HG2' ' A' ' 218' ' ' GLN . 2.2 pt20 -49.12 -35.48 16.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.268 -1.333 . . . . 0.0 114.181 -174.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -105.63 24.55 12.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.835 0.826 . . . . 0.0 110.789 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 217' ' ' HIS . 15.6 tp -105.3 133.46 50.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 21.0 t -98.76 167.17 10.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.044 0.45 . . . . 0.0 111.18 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -66.23 -22.56 66.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.02 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.54 -39.2 93.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.156 177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . 0.407 ' O ' HG23 ' A' ' 228' ' ' VAL . 33.6 m-20 -71.04 -47.2 59.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.837 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.686 HG13 HD22 ' A' ' 240' ' ' LEU . 8.3 mm -63.16 -47.2 93.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 47.8 tttm -56.77 -45.51 82.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.226 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 77.6 p -60.87 -37.59 82.67 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -174.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 224' ' ' ASP . 4.8 t -76.35 -45.45 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.676 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.589 ' CB ' HD11 ' A' ' 235' ' ' ILE . 38.0 m-85 -62.74 -34.9 78.16 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.1 mm-40 -62.0 -24.37 67.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.731 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.05 -10.25 59.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.275 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.96 -43.65 4.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.083 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -145.73 -175.94 19.22 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.331 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -87.01 111.47 20.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.895 0.379 . . . . 0.0 110.346 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.589 HD11 ' CB ' ' A' ' 229' ' ' PHE . 14.3 mt -81.25 146.52 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.861 0.839 . . . . 0.0 111.962 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -109.58 -32.83 6.98 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.799 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 55.4 m -157.52 146.24 19.54 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -173.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 43.2 t -153.9 99.53 2.28 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.488 0.493 . . . . 0.0 109.766 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.9 m -130.0 115.95 17.87 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.646 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.686 HD22 HG13 ' A' ' 225' ' ' ILE . 57.6 mt -84.59 135.82 34.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.63 112.95 1.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.659 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 27.0 ttp180 -133.57 141.78 47.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.56 ' HB2' ' HG1' ' A' ' 246' ' ' THR . 9.7 m-20 -83.93 112.42 40.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.712 177.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.97 -36.79 81.19 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.211 2.607 . . . . 0.0 113.305 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.9 t -93.99 13.39 23.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.768 0.318 . . . . 0.0 111.663 -172.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.56 ' HG1' ' HB2' ' A' ' 243' ' ' ASP . 80.3 p -125.2 -39.89 2.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.802 176.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 98.01 9.83 53.27 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.232 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -118.37 146.8 44.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.659 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 4.1 p80 -95.07 143.63 26.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -64.21 -65.36 0.69 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -168.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 177.99 -3.4 0.03 OUTLIER Glycine 0 CA--C 1.519 0.304 0 C-N-CA 119.871 -1.156 . . . . 0.0 113.751 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -140.26 172.37 12.84 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.342 -0.505 . . . . 0.0 110.472 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.56 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -160.22 174.98 37.04 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.919 ' HE2' ' HG3' ' A' ' 164' ' ' GLU . 85.1 m-85 -129.19 143.25 50.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.664 0.268 . . . . 0.0 110.874 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.494 HD11 HG22 ' A' ' 225' ' ' ILE . 92.3 mt -137.56 140.73 41.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.222 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 237' ' ' SER . 43.3 mt-10 -122.88 148.18 45.73 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 20.9 m-85 -116.98 158.05 24.76 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.007 0.432 . . . . 0.0 110.487 176.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.11 -3.91 58.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.757 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -135.67 134.03 38.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.095 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.74 -32.82 74.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.581 -171.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -70.48 -39.13 74.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.931 0.395 . . . . 0.0 110.437 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.8 m -64.97 -37.59 88.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.736 -174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 43.5 p -68.49 -45.13 73.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.167 0.508 . . . . 0.0 110.649 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -72.19 -22.16 61.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.944 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.52 -40.03 62.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 110.549 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.31 -33.4 75.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.474 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 263' ' ' SER . 97.7 t -56.16 -26.91 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.994 0.426 . . . . 0.0 111.137 173.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.2 t -85.72 -46.8 10.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.018 -0.427 . . . . 0.0 110.639 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.4 m -69.83 -38.2 76.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.54 ' HE1' ' CD1' ' A' ' 229' ' ' PHE . 89.5 mmm -91.81 -2.61 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.76 0.314 . . . . 0.0 111.543 -173.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.437 ' HA ' HG12 ' A' ' 282' ' ' VAL . 39.7 t30 -72.12 124.53 25.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.306 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.2 mt 63.48 25.9 14.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.326 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -83.11 118.04 23.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.774 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.82 121.45 21.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.2 tp -141.62 91.82 2.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.025 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 95.28 25.7 13.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.935 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 89.25 1.22 79.15 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.784 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -126.14 148.53 49.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.642 0.258 . . . . 0.0 110.541 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -89.83 117.67 28.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.404 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.21 120.56 14.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.791 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -93.8 115.75 28.18 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 174.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.601 HG22 HG12 ' A' ' 213' ' ' VAL . 14.2 p -121.08 143.76 32.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.053 0.454 . . . . 0.0 110.851 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -156.61 -179.69 31.78 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.684 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -80.25 133.74 36.02 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -76.3 146.26 39.01 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.625 HG12 ' HG3' ' A' ' 167' ' ' GLN . 30.8 m -112.66 -3.65 10.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.717 0.294 . . . . 0.0 111.516 -174.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 41.5 p -123.07 139.37 31.42 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.902 0.382 . . . . 0.0 111.015 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.41 138.03 37.93 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.834 2.356 . . . . 0.0 111.196 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.848 ' HD3' ' HD2' ' A' ' 210' ' ' ARG . 18.6 Cg_endo -59.47 -40.69 64.43 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.202 2.601 . . . . 0.0 112.73 -175.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 53.6 ttp 49.7 79.36 0.35 Allowed Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 123.912 0.757 . . . . 0.0 111.796 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.88 124.87 14.28 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.345 2.03 . . . . 0.0 111.91 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.6 pp -148.81 161.88 40.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.945 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 93.1 mt -134.36 90.8 2.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.243 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 39.1 p 46.44 67.81 4.03 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.34 117.86 4.48 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.099 1.866 . . . . 0.0 111.705 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -115.86 -8.0 11.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.988 0.423 . . . . 0.0 111.439 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.297 -177.437 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.56 104.52 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.889 0.376 . . . . 0.0 110.649 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 25.1 mmt -85.56 129.56 34.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.517 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 65.57 179.37 0.2 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.015 0.822 . . . . 0.0 111.417 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 54.08 42.28 31.66 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 111.343 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.586 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.7 tpm_? -84.49 102.39 12.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.492 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.407 ' HB2' HD12 ' A' ' 108' ' ' LEU . 16.0 mm-40 -96.3 100.41 12.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.195 176.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -64.67 -28.43 69.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.18 -30.09 70.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.546 ' HA ' ' HB2' ' A' ' 111' ' ' MET . 26.0 mt -70.81 -30.84 67.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.23 -25.24 66.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.362 0.601 . . . . 0.0 110.094 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.0 mt -84.08 -40.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.786 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.546 ' HB2' ' HA ' ' A' ' 108' ' ' LEU . 60.2 mmm -61.12 -29.97 70.09 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.543 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.687 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 73.5 m -73.87 -13.64 60.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.441 0.162 . . . . 0.0 111.237 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.652 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 29.8 mtp85 -108.96 139.89 43.21 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.25 135.51 63.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.165 0.507 . . . . 0.0 110.349 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -77.91 119.26 21.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.817 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 13.5 m -121.15 116.05 48.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.221 0.534 . . . . 0.0 110.348 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.438 ' HA2' ' HA ' ' A' ' 155' ' ' PHE . . . -117.8 170.17 13.51 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.193 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 20.9 t 72.09 51.18 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.608 0.718 . . . . 0.0 110.391 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.0 mt -103.06 127.43 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.651 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -72.11 147.15 46.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.876 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -72.37 75.59 1.02 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.855 0.836 . . . . 0.0 111.005 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -154.63 -45.55 0.09 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.845 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.418 HD11 ' HG3' ' A' ' 177' ' ' MET . 22.0 mt -77.29 91.37 3.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.03 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.25 -179.85 44.57 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.979 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -55.51 -46.4 76.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.117 0.484 . . . . 0.0 111.227 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.5 -46.57 89.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.103 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.3 m -67.27 -42.16 84.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.988 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.522 HG13 ' HE1' ' A' ' 143' ' ' MET . 18.1 mm -61.41 -45.27 98.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.084 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.508 ' HG3' HD11 ' A' ' 138' ' ' ILE . 59.0 ttt180 -62.4 -37.39 85.6 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.509 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -69.81 -33.4 72.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.068 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.47 -33.33 54.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.612 ' HB2' HD12 ' A' ' 138' ' ' ILE . 52.2 m-85 -90.1 -13.65 35.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.818 0.342 . . . . 0.0 111.068 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.417 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.89 -41.28 84.19 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 44.9 Cg_exo -40.97 -40.36 3.71 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.035 2.49 . . . . 0.0 114.26 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.493 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 43.6 m-85 -79.25 -47.93 15.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.685 0.279 . . . . 0.0 111.21 -176.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.31 170.04 41.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.702 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.2 122.69 9.76 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.755 2.303 . . . . 0.0 111.629 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 132' ' ' PHE . 75.1 mt -81.84 132.09 32.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.132 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -89.84 -43.6 10.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.307 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 97.4 p -157.7 155.24 29.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.139 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.435 HG23 ' HG2' ' A' ' 143' ' ' MET . 62.7 mt -133.52 127.01 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.65 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.745 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 28.9 m-20 -91.85 106.16 18.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.072 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.522 ' HE1' HG13 ' A' ' 128' ' ' ILE . 17.4 mmt -111.5 118.24 35.2 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.734 0.302 . . . . 0.0 111.062 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.0 m -79.27 73.08 5.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.795 0.807 . . . . 0.0 110.495 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 60.3 t-105 -79.77 83.02 5.78 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.602 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -119.55 71.08 0.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.567 -170.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 91.3 p -169.99 139.82 1.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.537 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.1 m -73.13 -19.69 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.706 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 p -85.91 4.67 36.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.001 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 48.5 mtm 66.57 64.71 0.48 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.444 175.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -150.98 164.03 37.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -132.53 122.43 24.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.229 0.538 . . . . 0.0 110.363 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -126.46 123.29 37.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.907 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 142.23 -97.78 0.21 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.666 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.438 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 52.0 p90 -147.15 175.44 10.72 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.174 0.511 . . . . 0.0 111.334 -175.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.37 163.56 39.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.673 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.745 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 96.2 m-85 -123.06 120.33 32.98 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.1 t -104.71 112.19 37.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.644 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.652 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 40.5 tt0 -102.88 131.07 50.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.5 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 81.3 m-85 -104.93 179.48 4.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.625 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -67.31 -38.53 85.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.165 0.507 . . . . 0.0 110.092 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.63 149.78 69.13 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.37 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 56.9 Cg_endo -70.02 -14.01 34.73 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.356 2.704 . . . . 0.0 112.237 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.584 ' HG3' ' CE1' ' A' ' 254' ' ' PHE . 75.5 mm-40 -60.82 -53.03 62.38 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.544 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -63.38 -14.34 49.16 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.973 0.416 . . . . 0.0 111.898 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.5 -54.2 5.37 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.564 ' HG3' HG23 ' A' ' 286' ' ' VAL . 15.9 mm100 -65.57 -34.0 77.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.968 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.493 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 25.6 tp -65.41 -43.58 90.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.238 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.76 -28.26 69.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.037 0.446 . . . . 0.0 110.08 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.66 -50.9 31.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.406 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -54.35 -35.36 62.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.37 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -100.61 -52.3 3.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 34.5 ttp -106.56 31.26 5.36 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -163.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -77.1 17.01 0.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.338 -0.226 . . . . 0.0 111.567 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.1 m -110.04 -73.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.57 0.224 . . . . 0.0 111.483 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.4 m -135.54 159.53 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.535 0.207 . . . . 0.0 110.938 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.97 ' HB2' HD12 ' A' ' 183' ' ' ILE . 3.5 tpt -123.88 96.61 5.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.892 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 24.0 tp 50.61 61.53 3.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.671 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.56 -179.28 18.94 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.306 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.76 57.71 5.04 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.093 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -134.21 119.0 18.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -75.55 136.38 40.56 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.902 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.97 HD12 ' HB2' ' A' ' 177' ' ' MET . 42.0 pt -124.32 158.42 31.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.678 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 22.7 tptm -111.3 106.41 15.36 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.37 110.1 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.938 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 103.28 176.95 26.38 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.212 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -127.28 136.47 28.95 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.42 126.54 22.83 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.995 2.464 . . . . 0.0 111.934 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.2 m -74.53 62.37 1.01 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.551 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.02 -63.33 1.28 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.095 0.474 . . . . 0.0 109.824 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.1 tp -132.99 146.14 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.836 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 160.01 147.33 4.87 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.779 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.443 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 22.0 tp60 -78.83 -29.14 44.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.821 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.543 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -75.87 -19.49 58.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.603 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 27.9 mm-40 -58.83 -51.45 81.75 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.288 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.603 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 64.2 Cg_exo -53.63 -38.36 84.18 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.208 1.939 . . . . 0.0 112.764 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.82 -39.31 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.511 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 194' ' ' ALA . 72.3 mt -60.32 -45.98 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 175.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.585 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 26.0 t70 -61.54 -41.97 98.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.431 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.26 -51.38 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.256 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 44.8 mt -68.29 -32.77 73.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.85 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.47 -41.78 77.1 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.585 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 32.5 mt-10 -67.67 -33.91 75.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.544 174.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -63.68 -37.36 87.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.937 0.399 . . . . 0.0 110.653 175.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.57 -37.33 73.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.505 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.522 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 29.5 mtp180 -59.29 -26.02 64.61 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.357 176.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -76.91 -11.29 59.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -111.37 179.28 4.07 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 62.0 m-20 -126.25 38.76 4.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.952 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 10.3 ptp180 -108.28 158.06 17.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.646 0.736 . . . . 0.0 112.603 -170.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.599 HG22 ' HB2' ' A' ' 263' ' ' SER . 41.3 pt -135.39 166.63 27.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.623 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.445 ' CD2' HD23 ' A' ' 168' ' ' LEU . 57.1 t80 -112.62 124.03 51.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.377 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.433 HG13 ' CZ ' ' A' ' 229' ' ' PHE . 26.8 m -115.01 131.3 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.382 0.61 . . . . 0.0 110.453 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 281' ' ' ARG . . . -122.66 172.0 8.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.873 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 24.3 m 63.79 22.23 12.98 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.506 0.67 . . . . 0.0 110.461 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 38.2 t -79.7 109.02 13.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.806 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -56.04 142.8 34.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.285 0.564 . . . . 0.0 111.033 -171.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -59.13 -22.5 60.98 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -168.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -92.51 -13.28 30.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 93.6 mt -81.84 133.81 35.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 19.0 m -96.69 171.71 8.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.604 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.519 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 9.8 p-10 -61.02 -42.17 97.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.581 0.229 . . . . 0.0 111.552 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.25 -27.1 69.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.366 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.58 -48.28 33.97 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.896 0.379 . . . . 0.0 110.086 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.521 HG22 HD11 ' A' ' 255' ' ' ILE . 34.2 mm -61.93 -38.54 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.475 ' HG3' HG21 ' A' ' 235' ' ' ILE . 63.0 tttm -56.26 -52.57 63.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.114 175.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 88.3 p -58.55 -34.43 71.01 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.83 -50.01 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 121.129 -0.229 . . . . 0.0 111.279 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.695 ' HB2' HD13 ' A' ' 235' ' ' ILE . 20.8 m-85 -64.31 -34.18 77.55 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.207 0.527 . . . . 0.0 111.074 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -63.63 -23.6 67.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.429 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.23 -11.57 60.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.76 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -112.04 -37.95 4.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.724 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.504 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -140.29 167.63 25.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.499 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -78.64 99.72 6.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.845 0.355 . . . . 0.0 111.053 -178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.695 HD13 ' HB2' ' A' ' 229' ' ' PHE . 8.3 mt -77.05 146.19 9.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.615 0.721 . . . . 0.0 111.453 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -110.49 -37.19 5.56 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.664 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 25.8 m -154.5 151.36 28.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -172.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 255' ' ' ILE . 52.9 t -153.7 116.14 4.4 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 61.9 m -141.23 111.28 6.67 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.676 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.553 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 34.8 mt -81.8 137.75 35.25 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -62.05 113.51 2.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 70.3 ttt180 -137.74 141.34 40.98 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.68 -167.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -105.02 117.64 58.12 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.179 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.77 -28.41 81.94 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 123.573 2.848 . . . . 0.0 112.952 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.2 t -79.82 -13.27 59.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.072 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 37.0 p -106.01 -36.93 6.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.956 0.408 . . . . 0.0 111.241 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.76 -35.12 4.19 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.822 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 63.5 pttt -87.43 -179.77 6.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 241' ' ' ALA . 6.2 p80 -120.35 163.77 17.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.883 0.373 . . . . 0.0 110.174 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -71.09 -3.93 22.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.389 -167.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 111.71 -11.02 27.81 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.176 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.421 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 51.5 p90 -135.23 173.54 11.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.707 0.289 . . . . 0.0 111.062 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.553 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -165.36 175.03 41.22 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.065 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.584 ' CE1' ' HG3' ' A' ' 164' ' ' GLU . 94.0 m-85 -128.88 142.9 50.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.766 0.317 . . . . 0.0 110.767 -178.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.521 HD11 HG22 ' A' ' 225' ' ' ILE . 83.9 mt -136.3 132.21 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.451 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.952 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 18.6 mt-10 -109.24 147.95 31.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.504 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 12.5 m-85 -112.18 150.26 31.09 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 123.164 0.29 . . . . 0.0 110.66 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.22 -55.35 29.31 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -73.65 117.13 15.06 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.536 171.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -52.99 -38.41 62.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.211 -175.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -75.08 -30.63 61.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.64 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.54 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 69.0 m -64.52 -19.76 65.8 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.599 ' HB2' HG22 ' A' ' 211' ' ' ILE . 78.1 p -57.69 -46.08 84.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.206 0.527 . . . . 0.0 109.929 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -76.68 -13.87 60.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.107 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.54 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 2.6 m-20 -64.69 -47.92 76.61 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 173.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.431 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . . . -64.96 -35.75 82.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.214 176.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 263' ' ' SER . 89.0 t -56.82 -31.89 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.273 0.559 . . . . 0.0 110.787 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 20.2 m -80.64 -38.38 29.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.499 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 24.7 t -93.91 -34.02 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.477 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 91.1 mmm -84.74 -4.64 59.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 -174.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.479 ' HA ' HG12 ' A' ' 282' ' ' VAL . 50.8 t30 -68.9 117.03 10.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.864 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 95.4 mt 67.95 40.13 2.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.316 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -96.73 121.78 38.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.683 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.18 111.37 10.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.586 0.708 . . . . 0.0 111.17 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.4 tp -140.69 110.35 6.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.432 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 91.77 25.28 23.19 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.435 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 74.97 10.69 84.02 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.517 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -138.26 144.51 40.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -76.44 116.32 17.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.648 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.95 128.84 38.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.908 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.446 ' HB2' ' HB1' ' A' ' 214' ' ' ALA . 9.4 mmt85 -98.5 115.31 28.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 271' ' ' ASN . 14.3 p -116.25 144.0 24.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.788 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.63 178.47 32.21 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.608 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -77.09 132.73 39.03 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.35 114.42 7.58 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.564 HG23 ' HG3' ' A' ' 167' ' ' GLN . 28.6 m -87.29 -27.6 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.808 -171.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.591 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 22.2 p -136.35 162.74 54.6 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.442 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -94.86 102.42 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.489 2.126 . . . . 0.0 112.162 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.591 ' HD3' ' O ' ' A' ' 287' ' ' THR . 23.6 Cg_exo -65.39 -29.34 54.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.478 2.119 . . . . 0.0 110.941 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 67.7 mtm -120.98 92.73 48.62 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.237 175.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -75.78 62.42 6.47 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 123.435 2.757 . . . . 0.0 112.222 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 292' ' ' LEU . 0.9 OUTLIER -170.62 103.13 0.25 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.316 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.1 tp -115.2 103.06 10.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.929 0.395 . . . . 0.0 110.408 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 7.1 t -122.22 121.25 27.9 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.289 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 4.0 Cg_exo -76.7 77.02 3.81 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.825 2.35 . . . . 0.0 111.528 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -85.66 -10.15 56.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.479 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.308 -179.513 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.44 96.8 4.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.894 0.378 . . . . 0.0 110.592 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -138.77 -22.74 0.96 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.771 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -162.12 98.38 1.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.352 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -139.1 -80.61 0.31 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.782 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 63.62 90.7 0.08 Allowed 'General case' 0 C--N 1.333 -0.122 0 O-C-N 123.876 0.735 . . . . 0.0 110.817 -175.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -61.9 106.93 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.989 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 106' ' ' ARG . 9.9 mmt180 -60.44 -37.46 81.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.509 -174.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.07 -32.18 72.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.258 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.492 HD23 ' SD ' ' A' ' 111' ' ' MET . 25.1 mt -67.75 -32.47 73.1 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.962 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.31 -29.64 70.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.262 0.553 . . . . 0.0 109.907 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.7 mt -82.34 -38.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.28 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.492 ' SD ' HD23 ' A' ' 108' ' ' LEU . 91.4 mtp -67.41 -30.07 69.73 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.727 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.6 m -74.18 -21.63 59.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.852 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.607 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 96.6 mtt180 -97.32 139.68 32.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 p -126.15 132.02 70.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.16 0.505 . . . . 0.0 110.319 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.5 ' HB2' ' HD3' ' A' ' 187' ' ' ARG . 91.3 t80 -76.58 117.1 17.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.426 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 41.2 t -115.89 114.96 47.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.811 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.7 169.13 18.68 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.026 -176.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.733 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 12.2 t 68.64 33.98 3.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.359 0.599 . . . . 0.0 110.871 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.9 mt -80.56 -13.19 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.049 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 65.9 t80 72.69 147.18 0.08 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.901 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 152' ' ' HIS . 12.8 p90 -77.34 76.22 3.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.38 0.609 . . . . 0.0 111.372 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.87 -65.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.23 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.8 mt -54.86 108.38 0.39 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.577 0.548 . . . . 0.0 111.503 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.21 -173.0 40.97 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.892 -174.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.14 -46.72 88.7 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.295 -0.452 . . . . 0.0 111.781 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 1.1 m-20 -60.41 -45.0 95.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.627 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.6 m -59.73 -43.7 94.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.874 0.368 . . . . 0.0 110.836 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.8 mm -63.98 -45.65 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.408 0.623 . . . . 0.0 110.226 177.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -56.58 -45.78 81.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.269 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 58.9 mt-30 -63.82 -34.12 77.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.526 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.56 -29.4 30.35 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -93.15 -20.18 20.74 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.442 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -50.2 -42.3 71.57 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 73.6 Cg_exo -42.3 -42.79 7.75 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 123.168 2.579 . . . . 0.0 114.786 174.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -78.38 -36.64 45.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -169.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.483 ' HA3' ' HB3' ' A' ' 165' ' ' ALA . . . -177.87 -172.67 42.59 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.132 175.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.548 ' HG3' ' CE1' ' A' ' 252' ' ' TYR . 73.0 Cg_endo -76.28 129.15 10.99 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.955 2.436 . . . . 0.0 112.123 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.2 mt -90.11 128.6 41.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.29 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.544 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 24.5 ttmm -91.98 -37.23 12.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.711 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.3 p -169.71 157.04 6.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.381 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.6 mt -126.64 108.3 18.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.46 99.53 11.72 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.766 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 57.4 ttm -119.7 127.47 52.9 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.089 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 m -67.29 80.24 0.15 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.573 0.546 . . . . 0.0 110.426 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -90.58 111.82 23.27 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.734 -174.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -67.94 114.85 6.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.907 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 p -68.83 -12.1 61.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.927 0.394 . . . . 0.0 111.548 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.88 -55.79 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.434 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.7 p -95.91 -12.29 25.36 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 31.9 mtm 60.93 47.28 7.71 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.505 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -135.13 176.4 8.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.262 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.41 ' O ' ' HA ' ' A' ' 121' ' ' TYR . 5.8 p80 -137.82 112.96 9.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 171.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -94.88 100.5 12.36 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.91 0.386 . . . . 0.0 110.174 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 135.46 -93.83 0.24 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.672 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -141.24 178.64 7.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.416 0.627 . . . . 0.0 112.468 -166.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.72 156.25 31.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.269 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.493 ' CE2' ' HD1' ' A' ' 115' ' ' TYR . 76.8 m-85 -113.04 126.18 55.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.12 114.01 41.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.607 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 38.6 tt0 -101.47 122.27 43.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.577 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -97.56 172.61 7.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.024 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 23.6 mt-10 -93.5 -7.43 44.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.963 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.1 m -140.22 135.43 16.18 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.809 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.26 -25.75 36.34 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.195 2.597 . . . . 0.0 113.036 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.469 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 18.4 mp0 -55.81 -45.06 78.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.483 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . . . -55.62 -40.28 71.9 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.937 0.398 . . . . 0.0 111.352 175.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.5 -35.02 78.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.904 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.748 ' HG3' HG11 ' A' ' 286' ' ' VAL . 16.6 mm-40 -68.38 -48.13 65.54 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.671 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.574 HD13 ' HD2' ' A' ' 212' ' ' TYR . 64.0 mt -60.38 -43.68 96.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.177 0.513 . . . . 0.0 111.113 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.61 -37.24 80.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.563 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.586 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 8.2 tt -72.41 -48.51 40.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.092 174.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -53.36 -43.24 67.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.264 -177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -100.23 -49.22 4.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.589 ' HG2' ' O ' ' A' ' 176' ' ' VAL . 16.1 ttp -107.91 29.97 6.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.685 -166.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.586 ' HB2' ' O ' ' A' ' 170' ' ' LEU . 27.4 t-20 -54.63 -51.13 66.36 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -174.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.528 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 19.2 m -113.61 16.48 18.67 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -169.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.589 ' O ' ' HG2' ' A' ' 173' ' ' MET . 10.7 m -140.02 135.89 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.832 0.287 . . . . 0.0 110.98 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.975 ' HB2' HD13 ' A' ' 183' ' ' ILE . 27.7 tpp -126.68 102.09 6.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.911 0.386 . . . . 0.0 110.932 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 21.0 tp 71.13 -68.41 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.149 172.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -114.15 -143.34 8.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.094 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.56 65.73 3.91 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.204 -0.522 . . . . 0.0 111.875 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -131.73 120.09 22.24 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 175' ' ' SER . 6.2 p30 -77.84 128.64 34.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.975 HD13 ' HB2' ' A' ' 177' ' ' MET . 37.0 pt -135.78 -175.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.245 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 68.2 mmtt -134.15 106.67 7.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.037 174.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.419 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 54.9 t -99.49 101.53 12.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 130.16 166.66 11.87 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.5 ' HD3' ' HB2' ' A' ' 115' ' ' TYR . 23.6 ptt180 -147.49 134.07 9.9 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.989 0.394 . . . . 0.0 111.309 -177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 7.6 Cg_exo -72.96 75.17 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.056 2.504 . . . . 0.0 110.611 173.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 p -59.74 126.52 27.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.266 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -63.36 139.04 58.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.028 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.5 mm -58.5 123.23 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.694 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -149.56 -141.35 3.41 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.952 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.43 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 27.0 tt0 -82.8 -33.37 27.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.982 0.42 . . . . 0.0 111.014 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -69.36 -34.99 75.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.855 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.647 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 15.6 tm0? -57.97 -53.33 66.94 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.222 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.647 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 74.7 Cg_exo -53.46 -36.04 78.21 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.588 2.192 . . . . 0.0 112.905 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.41 -42.0 73.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.777 0.322 . . . . 0.0 110.243 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 194' ' ' ALA . 81.5 mt -61.14 -47.88 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.287 0.565 . . . . 0.0 109.973 176.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.15 -37.47 87.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.836 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -58.95 -52.89 63.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.918 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.577 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 67.7 mt -68.04 -33.14 74.02 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.987 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.648 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.95 -46.03 71.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.4 -36.79 83.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.962 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 39.4 mt-10 -67.77 -27.39 66.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.975 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.13 -27.83 59.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.028 0.442 . . . . 0.0 110.326 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.648 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 72.4 mtp180 -74.39 -15.59 60.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.503 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.88 -11.01 60.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.511 0.672 . . . . 0.0 109.992 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -115.87 -178.74 3.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.388 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 9.6 m-80 -123.92 46.06 2.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -102.61 139.18 38.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.284 -166.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.446 HG21 ' HB2' ' A' ' 263' ' ' SER . 37.6 pt -125.17 166.55 20.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.798 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.624 ' HD1' ' HE1' ' A' ' 254' ' ' PHE . 49.0 t80 -117.65 130.07 56.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.697 -175.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.1 132.89 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.004 0.431 . . . . 0.0 110.256 176.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.02 176.46 7.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.6 t 64.41 22.71 12.81 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 123.93 0.768 . . . . 0.0 109.204 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 15.4 t -67.87 121.82 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.761 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -62.66 143.05 57.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.454 0.169 . . . . 0.0 110.687 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.599 ' HA ' ' CE1' ' A' ' 249' ' ' HIS . 28.6 pt20 -61.05 -16.82 48.01 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -166.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -105.4 -5.52 20.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.046 0.451 . . . . 0.0 110.846 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.537 HD21 ' HG ' ' A' ' 275' ' ' LEU . 2.9 tp -83.55 130.3 35.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' SER . . . . . 0.543 ' O ' HG12 ' A' ' 225' ' ' ILE . 29.7 p -102.37 167.84 9.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.377 -174.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.81 -37.98 83.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.282 0.563 . . . . 0.0 109.958 174.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -54.65 -40.03 68.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.997 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.7 -47.24 41.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.68 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.646 HG23 HD11 ' A' ' 255' ' ' ILE . 34.0 mm -60.41 -42.5 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.486 ' HG3' HG21 ' A' ' 235' ' ' ILE . 86.2 tttt -57.36 -48.78 78.12 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.04 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 88.0 p -60.83 -35.34 76.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -173.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.58 -43.67 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.633 0.254 . . . . 0.0 111.232 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.578 ' CB ' HD11 ' A' ' 235' ' ' ILE . 10.3 m-85 -68.26 -29.41 68.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.297 0.57 . . . . 0.0 110.802 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.87 -24.77 67.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.054 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.0 -17.84 62.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.889 -175.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.21 -44.73 3.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.02 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.627 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -124.55 170.17 16.61 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.098 -175.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -86.4 99.07 11.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.578 HD11 ' CB ' ' A' ' 229' ' ' PHE . 12.8 mt -84.59 150.82 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.332 0.587 . . . . 0.0 111.458 -175.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -117.04 -27.86 6.41 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.471 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.0 t -167.94 149.41 5.32 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.726 -173.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.57 ' SG ' HG12 ' A' ' 255' ' ' ILE . 50.3 t -148.2 126.3 12.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.257 175.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 99.0 m -142.52 121.33 12.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.787 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.438 ' CD2' ' HA3' ' A' ' 253' ' ' GLY . 31.1 mt -82.7 141.04 32.74 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.31 114.86 6.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.448 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 80.3 mtm180 -127.79 163.16 24.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.328 0.585 . . . . 0.0 112.365 -172.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.415 ' HA ' ' HD2' ' A' ' 244' ' ' PRO . 9.6 m-20 -104.69 104.95 48.47 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.458 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 9.6 Cg_endo -50.03 -45.74 31.45 Favored 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 123.86 3.04 . . . . 0.0 114.934 -167.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.8 p -93.21 9.58 35.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.428 ' OG1' ' HG2' ' A' ' 248' ' ' LYS . 72.3 p -114.5 -38.7 3.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.971 0.415 . . . . 0.0 110.469 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.15 2.54 56.89 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.34 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.428 ' HG2' ' OG1' ' A' ' 246' ' ' THR . 19.8 ptmt -99.27 158.33 15.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.887 0.375 . . . . 0.0 110.532 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.599 ' CE1' ' HA ' ' A' ' 218' ' ' GLN . 22.4 p80 -105.63 152.32 23.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -80.18 -1.29 39.8 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.832 -170.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 113.05 -6.98 25.38 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.375 172.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.548 ' CE1' ' HG3' ' A' ' 137' ' ' PRO . 24.3 p90 -138.2 161.86 35.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.664 0.269 . . . . 0.0 110.541 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.438 ' HA3' ' CD2' ' A' ' 240' ' ' LEU . . . -154.12 172.49 32.74 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.889 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.624 ' HE1' ' HD1' ' A' ' 212' ' ' TYR . 29.9 m-85 -129.0 144.07 51.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.811 0.339 . . . . 0.0 110.464 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.646 HD11 HG23 ' A' ' 225' ' ' ILE . 77.5 mt -136.09 133.2 50.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.297 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.5 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 33.4 mt-10 -113.78 143.72 44.17 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.627 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 6.6 m-85 -110.6 170.12 8.3 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.095 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.579 ' HB2' ' HD2' ' A' ' 259' ' ' LYS . 34.4 mt-10 -72.78 -43.56 62.66 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.709 0.766 . . . . 0.0 109.008 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . 0.579 ' HD2' ' HB2' ' A' ' 258' ' ' GLU . 11.0 mptt -105.81 130.09 53.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.058 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.79 -25.72 68.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.32 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -75.43 -31.92 60.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.776 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 46.7 m -70.12 -34.91 73.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.355 -176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.446 ' HB2' HG21 ' A' ' 211' ' ' ILE . 55.2 p -66.29 -34.61 78.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.339 0.59 . . . . 0.0 109.751 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -71.63 -25.93 62.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.556 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -68.45 -42.41 78.85 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.367 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.74 88.09 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.498 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.432 HG12 ' HA2' ' A' ' 283' ' ' GLY . 80.3 t -52.79 -48.71 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.985 0.422 . . . . 0.0 111.406 175.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.3 m -71.36 -23.47 61.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.1 m -94.34 -43.44 8.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' MET . . . . . . . . . . . . . 84.8 mmm -89.84 -4.4 57.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.022 -169.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -76.96 122.51 24.98 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.992 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.585 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 96.7 mt 70.79 27.97 3.46 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.182 -175.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -89.71 124.36 34.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.094 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -77.56 107.45 10.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.974 0.416 . . . . 0.0 110.961 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.537 ' HG ' HD21 ' A' ' 220' ' ' LEU . 31.2 tp -134.13 98.85 4.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.059 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 101.56 2.67 53.27 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.151 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.13 -0.15 41.12 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.319 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -131.68 142.44 49.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.804 0.335 . . . . 0.0 110.557 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.585 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 21.7 m-85 -74.0 111.22 8.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.592 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.44 128.16 35.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.884 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -98.95 116.23 30.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 212' ' ' TYR . 10.2 p -125.7 141.92 44.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.838 -176.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.432 ' HA2' HG12 ' A' ' 267' ' ' VAL . . . -160.8 173.41 37.29 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.397 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -71.1 125.99 28.37 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.85 124.05 21.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.748 HG11 ' HG3' ' A' ' 167' ' ' GLN . 34.0 m -88.79 -19.23 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 111.385 -172.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.566 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 5.4 t -147.36 147.98 30.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 173.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.413 ' HD2' ' OG1' ' A' ' 287' ' ' THR . 60.7 Cg_endo -73.21 103.74 1.66 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.78 2.32 . . . . 0.0 112.717 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.566 ' HD3' ' O ' ' A' ' 287' ' ' THR . 18.1 Cg_endo -97.4 150.22 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.592 2.861 . . . . 0.0 112.056 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 67.4 mtm -133.74 122.86 16.89 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.423 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.43 -9.49 24.24 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.478 2.118 . . . . 0.0 112.12 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 21.7 tp 60.96 44.27 10.67 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.725 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 49.3 tp -78.1 -74.4 0.27 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.091 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 17.9 m -117.74 95.25 47.59 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.307 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.79 76.69 3.62 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.116 2.544 . . . . 0.0 111.862 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -92.82 128.61 38.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.608 -0.71 . . . . 0.0 110.212 176.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 112.239 -0.344 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.83 41.41 14.63 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.795 0.438 . . . . 0.0 111.512 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 67.6 mtt -125.09 150.79 46.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.828 0.347 . . . . 0.0 110.676 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -129.11 117.62 21.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.389 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.795 ' HG3' ' H ' ' A' ' 104' ' ' ARG . 6.2 tp60 -168.87 -173.0 1.72 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.795 ' H ' ' HG3' ' A' ' 103' ' ' GLN . 14.1 ttp180 -59.22 -19.34 44.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.154 0.502 . . . . 0.0 111.019 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.484 ' HG2' ' HB3' ' A' ' 103' ' ' GLN . 13.5 pt20 -69.58 4.48 1.84 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.569 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -57.25 -37.34 72.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.139 0.495 . . . . 0.0 109.931 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.22 88.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.236 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.434 HD22 ' SD ' ' A' ' 111' ' ' MET . 66.7 mt -61.87 -35.26 77.78 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.999 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.66 -26.51 68.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.346 0.593 . . . . 0.0 110.818 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.77 -37.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.778 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.493 ' SD ' HG12 ' A' ' 198' ' ' ILE . 88.1 mtp -70.57 -29.68 66.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.741 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.1 m -70.64 -17.71 62.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 110.875 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -98.5 140.81 32.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.855 0.36 . . . . 0.0 110.146 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.761 HG13 ' HB ' ' A' ' 158' ' ' VAL . 3.7 p -120.47 126.88 75.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.672 0.749 . . . . 0.0 109.994 176.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -83.69 101.25 11.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.053 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.726 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 25.1 m -108.35 143.15 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.033 0.445 . . . . 0.0 111.243 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.772 ' HA3' ' HD1' ' A' ' 155' ' ' PHE . . . -152.4 177.68 30.02 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.36 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.522 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 23.2 t 65.01 50.09 1.95 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.672 0.749 . . . . 0.0 109.294 -175.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 77.1 mt -103.14 116.45 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.936 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -61.21 147.89 42.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.638 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -74.07 76.29 1.73 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.027 0.918 . . . . 0.0 111.047 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -163.55 -38.24 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 26.8 mt -76.53 92.6 3.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.453 174.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.56 -169.49 44.93 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.583 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 129' ' ' ARG . 20.8 tt0 -54.33 -46.51 72.89 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -64.11 -44.93 90.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.564 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -63.89 -45.17 90.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.945 HG13 ' HE2' ' A' ' 143' ' ' MET . 26.8 mm -69.17 -35.46 68.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.122 0.487 . . . . 0.0 110.427 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 27.9 ttt180 -59.37 -45.48 91.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.802 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.2 -33.45 71.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.838 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.19 -38.73 30.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.483 ' CD1' HG23 ' A' ' 128' ' ' ILE . 24.6 m-85 -89.33 -22.43 22.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.38 -42.97 90.16 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -44.96 -31.95 5.93 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.991 2.46 . . . . 0.0 114.53 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.684 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 74.6 m-85 -82.06 -37.2 26.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.48 -175.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.502 ' HA3' ' HB1' ' A' ' 165' ' ' ALA . . . -178.49 173.62 45.97 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.798 174.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.1 126.19 15.38 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.985 2.457 . . . . 0.0 111.956 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.611 HD11 HD12 ' A' ' 141' ' ' ILE . 61.9 mt -89.06 139.27 17.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.635 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.587 ' HD2' ' OE2' ' A' ' 159' ' ' GLU . 22.1 ttmm -98.84 -43.86 6.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.099 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.8 t -159.63 142.53 13.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.096 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.611 HD12 HD11 ' A' ' 138' ' ' ILE . 70.0 mt -126.17 110.42 23.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.87 0.366 . . . . 0.0 110.089 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 25.9 t70 -91.45 100.82 13.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.185 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.945 ' HE2' HG13 ' A' ' 128' ' ' ILE . 51.3 ttm -138.86 111.3 7.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.023 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 59.4 m -74.48 75.64 1.94 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.128 0.489 . . . . 0.0 111.377 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.442 ' HZ3' ' HA ' ' A' ' 147' ' ' SER . 3.9 t90 -104.28 92.81 4.5 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.81 115.21 12.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.588 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.442 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 17.8 m -68.83 -19.76 64.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.909 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 66.2 t -75.27 -55.66 10.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.917 0.389 . . . . 0.0 110.832 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.6 p -89.92 -15.28 32.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.864 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.9 mtm 64.19 43.06 5.12 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.79 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -121.21 164.42 16.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.538 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -154.2 -81.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.022 -177.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm 58.32 -169.04 0.13 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.027 0.441 . . . . 0.0 111.183 -174.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 63.62 -142.27 46.61 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.601 -0.727 . . . . 0.0 114.245 171.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.772 ' HD1' ' HA3' ' A' ' 117' ' ' GLY . 67.8 m-85 -130.43 178.31 6.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.224 -172.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.96 153.8 41.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.81 0.338 . . . . 0.0 110.755 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.479 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 88.9 m-85 -114.85 110.82 20.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.588 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.761 ' HB ' HG13 ' A' ' 114' ' ' VAL . 58.2 t -97.49 108.72 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.902 177.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.587 ' OE2' ' HD2' ' A' ' 139' ' ' LYS . 33.3 tt0 -102.35 119.8 39.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.124 -178.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.45 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 90.2 m-85 -97.4 -177.72 3.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.001 0.429 . . . . 0.0 111.342 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -80.18 -58.79 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.646 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.7 m -103.7 143.16 26.09 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.626 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 40.9 Cg_endo -67.52 -18.8 49.08 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.147 2.565 . . . . 0.0 112.798 -176.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.698 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 15.7 mp0 -55.81 -57.17 13.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.459 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.502 ' HB1' ' HA3' ' A' ' 136' ' ' GLY . . . -52.98 -26.85 16.54 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 177.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.18 -47.26 13.68 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.404 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.568 ' HG2' HG11 ' A' ' 286' ' ' VAL . 2.6 pp0? -66.72 -31.57 72.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.684 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 10.7 tp -73.23 -45.81 53.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.53 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.86 71.92 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.595 HD11 ' HA3' ' A' ' 186' ' ' GLY . 8.5 tt -66.63 -50.28 63.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.473 172.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -54.19 -49.72 68.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.351 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -86.48 -38.92 16.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -173.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 30.9 mtm -106.8 21.93 16.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -171.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.451 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 32.1 p30 -72.14 0.16 10.37 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.324 0.583 . . . . 0.0 110.23 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.9 m -95.5 -73.72 0.58 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.506 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.5 m -139.16 161.82 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.729 0.299 . . . . 0.0 111.167 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.648 ' HA ' ' HE3' ' A' ' 177' ' ' MET . 1.6 tpt -150.63 72.47 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.494 ' HG ' ' HE1' ' A' ' 177' ' ' MET . 74.1 mt 57.16 -166.43 0.14 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.765 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.19 -17.76 1.73 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.798 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 178' ' ' LEU . . . 85.45 21.67 53.48 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.443 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -143.78 176.63 9.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.058 0.456 . . . . 0.0 111.332 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -95.04 144.08 25.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.692 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.522 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 22.3 pt -116.71 171.26 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.834 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.726 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 34.8 mmtp -103.8 131.6 50.85 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 6.1 t -129.94 110.22 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.8 0.333 . . . . 0.0 110.487 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.595 ' HA3' HD11 ' A' ' 170' ' ' LEU . . . 90.16 -147.36 19.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.565 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.412 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 71.1 mtp180 54.88 62.85 7.56 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 122.685 0.394 . . . . 0.0 111.112 -177.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.412 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 15.1 Cg_exo -67.66 -38.53 13.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.535 2.157 . . . . 0.0 111.499 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 31.4 m -152.47 140.92 20.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.456 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -89.62 -14.3 35.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.127 0.489 . . . . 0.0 110.255 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.3 tp -153.39 148.73 13.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.307 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 160.99 -175.14 37.67 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.938 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -78.78 -21.27 48.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.752 0.31 . . . . 0.0 111.194 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -82.1 -28.49 32.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.483 -178.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.575 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 11.5 mm100 -55.57 -49.81 90.51 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 75.7 Cg_exo -53.23 -33.89 67.1 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.249 1.966 . . . . 0.0 112.846 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 63.4 mt -75.25 -48.14 32.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.877 0.37 . . . . 0.0 110.227 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.493 HG12 ' SD ' ' A' ' 111' ' ' MET . 68.7 mt -57.5 -48.08 83.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.924 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -69.43 -34.12 73.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.115 -176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -71.58 -37.94 70.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.671 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 60.8 mt -67.74 -33.22 74.44 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.198 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -58.72 -37.27 75.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 109.772 173.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -72.49 -30.35 64.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.356 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -68.42 -33.8 74.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.993 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.9 -24.62 62.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.262 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.575 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 65.6 mtp180 -72.62 -24.23 61.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.17 173.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.67 -39.63 19.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.277 0.56 . . . . 0.0 110.047 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -109.36 80.19 1.29 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.77 85.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.773 0.67 . . . . 0.0 110.916 -175.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 256' ' ' GLU . 9.1 ttt180 -128.09 143.31 51.06 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.537 -171.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.418 HG22 ' HB2' ' A' ' 263' ' ' SER . 39.7 pt -118.21 166.76 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.564 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.517 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 73.9 t80 -121.91 126.36 48.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.388 -173.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.508 HG12 ' CZ ' ' A' ' 229' ' ' PHE . 27.7 m -121.32 131.27 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.985 0.422 . . . . 0.0 110.358 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.87 175.27 7.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.451 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.6 t 59.96 31.53 20.72 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.867 0.841 . . . . 0.0 109.206 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 44.9 t -73.02 123.06 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.224 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -50.3 128.91 20.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.391 0.615 . . . . 0.0 110.968 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -55.74 -33.1 63.96 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.159 -173.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -99.07 37.0 1.6 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.477 0.656 . . . . 0.0 110.386 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.4 HD11 ' HA ' ' A' ' 220' ' ' LEU . 11.2 tp -124.69 133.01 53.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.7 m -95.84 170.09 9.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.849 -174.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -67.46 -36.33 80.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.756 0.312 . . . . 0.0 110.819 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.9 -30.78 70.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.642 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.5 -45.26 47.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.361 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.729 HG13 HD21 ' A' ' 240' ' ' LEU . 27.1 mm -59.85 -42.42 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.692 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.444 ' HB2' ' CB ' ' A' ' 238' ' ' CYS . 86.8 tttt -56.46 -52.52 64.38 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.868 176.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 79.6 p -56.31 -37.83 70.46 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -173.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.4 -45.48 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.677 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.554 ' HB2' HD12 ' A' ' 235' ' ' ILE . 26.3 m-85 -67.95 -27.75 66.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.292 0.568 . . . . 0.0 110.394 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.09 -26.51 67.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.142 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.19 -18.73 61.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.236 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -107.07 -31.33 8.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -153.28 159.37 28.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.875 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -75.45 111.2 10.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.505 0.669 . . . . 0.0 111.645 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.554 HD12 ' HB2' ' A' ' 229' ' ' PHE . 40.0 mt -84.03 148.98 4.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.4 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.618 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 77.8 tttt -108.35 -35.85 6.41 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.861 176.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 256' ' ' GLU . 17.0 m -153.44 136.05 15.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -170.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.444 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 52.4 t -138.68 114.75 10.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.883 0.373 . . . . 0.0 110.103 175.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 31.3 m -141.99 116.01 9.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.57 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.729 HD21 HG13 ' A' ' 225' ' ' ILE . 66.3 mt -77.98 138.58 38.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.63 3.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.484 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 34.6 mtm180 -122.41 143.17 49.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.775 -176.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -83.96 109.92 22.16 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.47 -16.47 55.32 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.477 2.118 . . . . 0.0 111.992 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.7 p -73.29 -29.18 62.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.595 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.536 HG23 ' HG2' ' A' ' 248' ' ' LYS . 4.1 t -120.55 -26.68 5.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.796 0.331 . . . . 0.0 111.762 -178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.56 37.06 8.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.201 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.536 ' HG2' HG23 ' A' ' 246' ' ' THR . 19.2 ptpt -140.43 150.05 43.35 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 18.1 p80 -80.59 132.36 35.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.332 0.586 . . . . 0.0 110.465 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -64.06 -21.04 66.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.112 -171.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 133.73 -15.3 4.64 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.273 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.517 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 33.8 p90 -128.36 169.86 13.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.692 0.282 . . . . 0.0 110.592 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.424 ' HA3' HD22 ' A' ' 240' ' ' LEU . . . -158.38 170.82 35.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.051 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.698 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 97.4 m-85 -130.86 138.92 50.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.068 0.461 . . . . 0.0 111.309 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.709 HD12 HG23 ' A' ' 225' ' ' ILE . 89.2 mt -133.95 128.53 53.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.699 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 210' ' ' ARG . 57.2 tt0 -109.85 145.89 36.02 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.495 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 16.8 m-85 -116.2 148.01 40.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.002 0.429 . . . . 0.0 111.262 -175.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.618 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 26.3 mt-10 -72.54 -21.95 61.09 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.081 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -116.91 126.33 52.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.725 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -50.73 -58.11 6.69 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -171.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -62.44 -29.07 70.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.226 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' SER . . . . . 0.409 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 49.9 m -64.97 -29.22 70.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 111.556 -175.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.46 ' HA ' ' CD1' ' A' ' 257' ' ' TYR . 87.5 p -63.19 -39.93 96.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.323 0.582 . . . . 0.0 109.712 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -78.28 -19.32 53.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.136 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . 0.409 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 85.9 m-20 -63.03 -43.05 99.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.65 84.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.683 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 263' ' ' SER . 97.4 t -56.06 -37.23 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 111.226 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.7 t -77.75 -35.69 51.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.0 m -94.83 -36.55 11.62 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -171.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.439 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.4 mmm -83.4 -0.52 50.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -169.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -73.53 125.99 29.22 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.487 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.522 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 91.1 mt 66.04 25.17 10.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.53 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -88.13 118.27 27.59 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 172.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.515 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 6.7 p-10 -74.69 115.71 14.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.458 0.647 . . . . 0.0 110.439 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 31.6 tp -123.75 97.83 5.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.14 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.5 26.63 35.2 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -175.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.5 -43.74 1.85 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.697 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -88.25 142.46 27.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.044 0.449 . . . . 0.0 111.203 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.522 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 68.2 m-85 -81.63 123.59 28.82 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.916 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.68 123.01 21.62 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.711 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -93.6 115.23 27.7 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 14.3 p -118.06 142.68 31.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.244 0.545 . . . . 0.0 111.428 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.483 ' HA3' HD13 ' A' ' 168' ' ' LEU . . . -157.95 -176.94 30.58 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.8 mppt? -85.98 147.73 26.08 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.323 0.561 . . . . 0.0 110.43 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.589 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -86.52 130.96 34.31 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.568 HG11 ' HG2' ' A' ' 167' ' ' GLN . 12.0 m -93.54 -19.46 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.834 0.349 . . . . 0.0 110.877 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 42.9 p -130.43 129.01 22.73 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.29 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -64.98 119.31 6.31 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.425 2.084 . . . . 0.0 111.045 173.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -71.83 78.37 1.75 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.154 2.57 . . . . 0.0 112.992 -174.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 56.6 ttp -128.92 85.47 60.07 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -83.88 124.26 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.295 2.663 . . . . 0.0 111.928 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 56.3 tp 72.67 135.26 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.935 0.772 . . . . 0.0 111.513 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 58.0 tp -73.56 88.44 1.66 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.666 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 3.2 t -107.56 104.65 53.59 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 121.402 0.62 . . . . 0.0 110.13 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -96.92 31.78 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.233 2.622 . . . . 0.0 112.363 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -133.81 15.52 3.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.309 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 22.8 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.233 -179.437 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.29 125.83 45.01 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 43.1 tpp -93.05 67.64 4.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.054 0.454 . . . . 0.0 110.735 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 66.76 -3.95 0.84 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.4 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 7.1 tp60 -70.94 -52.23 21.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.663 0.268 . . . . 0.0 111.267 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -70.41 -35.8 73.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.126 0.489 . . . . 0.0 110.451 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -91.55 78.71 5.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -50.86 -28.4 9.43 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.422 -173.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.06 71.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 111.363 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.53 HD21 ' SD ' ' A' ' 111' ' ' MET . 58.4 mt -68.55 -31.97 71.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.064 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.04 -27.87 68.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.213 0.53 . . . . 0.0 110.425 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.0 mt -85.86 -34.64 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.096 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.536 ' SD ' HG12 ' A' ' 198' ' ' ILE . 91.7 mtp -70.84 -16.43 62.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.042 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 71.2 m -84.39 -6.29 59.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.716 0.293 . . . . 0.0 111.188 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.504 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 51.8 mtt180 -116.78 141.88 47.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.757 0.313 . . . . 0.0 110.548 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.589 HG12 ' HB ' ' A' ' 158' ' ' VAL . 4.0 p -120.63 128.47 76.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.408 0.623 . . . . 0.0 109.752 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -83.11 115.56 21.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.016 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 17.2 m -108.33 124.87 65.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.518 0.675 . . . . 0.0 111.124 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.61 174.83 18.01 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.375 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 71.8 m 61.0 38.33 17.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.272 0.558 . . . . 0.0 110.517 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.423 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 57.5 mt -74.34 -21.81 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.563 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.423 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 84.0 t80 70.01 163.94 0.25 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.37 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.648 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 20.2 p90 -89.83 76.77 7.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.589 0.709 . . . . 0.0 110.704 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -164.1 -50.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.342 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.695 HD13 ' HG3' ' A' ' 177' ' ' MET . 73.3 mt -65.23 112.74 3.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.919 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.451 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -80.14 159.11 42.97 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.751 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -65.22 -37.32 86.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.207 0.527 . . . . 0.0 109.93 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.12 -41.12 97.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.606 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.4 m -64.76 -41.4 95.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.954 0.407 . . . . 0.0 110.292 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.722 HG13 ' HE1' ' A' ' 143' ' ' MET . 33.4 mm -59.2 -44.94 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.876 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.423 ' HA ' HD12 ' A' ' 138' ' ' ILE . 25.1 ttt180 -59.24 -40.48 86.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.223 0.535 . . . . 0.0 110.338 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -71.56 -33.89 69.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.583 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.95 -24.19 28.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.476 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 34.8 m-85 -95.15 -16.68 22.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.72 -42.03 92.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -44.73 -32.29 5.86 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 123.092 2.528 . . . . 0.0 114.888 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.758 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 78.5 m-85 -85.4 -42.78 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.769 0.319 . . . . 0.0 110.752 -177.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.61 157.22 29.46 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.969 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.45 117.92 4.65 Favored 'Trans proline' 0 C--O 1.241 0.649 0 C-N-CA 122.71 2.273 . . . . 0.0 111.722 175.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.431 HD13 ' HB2' ' A' ' 132' ' ' PHE . 54.9 mt -72.53 132.55 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.242 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -96.7 -43.05 7.72 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.228 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.7 m -152.76 140.41 19.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.3 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.8 mt -122.76 124.86 71.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.951 0.405 . . . . 0.0 110.139 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.555 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 8.0 m-20 -112.71 98.8 7.46 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 174.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.722 ' HE1' HG13 ' A' ' 128' ' ' ILE . 54.4 ttm -124.26 137.72 54.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.6 m -94.49 108.39 20.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.899 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -97.43 84.69 3.48 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 172.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -79.8 16.81 1.05 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.678 -1.146 . . . . 0.0 114.072 -163.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.555 ' CB ' ' HB2' ' A' ' 151' ' ' LYS . 22.9 t -151.09 163.86 37.82 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.15 -174.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.0 t -110.21 -21.36 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.248 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -88.2 28.51 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.766 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 20.0 mmt 66.49 30.39 8.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.523 176.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.555 ' HB2' ' CB ' ' A' ' 147' ' ' SER . 34.8 mmtp -95.77 146.14 24.77 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.648 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 37.8 t-80 -161.77 97.51 1.06 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.982 -174.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.43 6.52 8.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.194 0.521 . . . . 0.0 110.345 174.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.68 177.46 34.01 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.761 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -109.04 177.85 4.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.436 0.16 . . . . 0.0 110.741 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 142' ' ' ASP . . . -148.84 140.93 23.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.913 0.387 . . . . 0.0 111.613 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -110.45 116.57 31.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.92 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.589 ' HB ' HG12 ' A' ' 114' ' ' VAL . 88.3 t -95.71 108.27 20.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.045 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.504 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 38.5 tt0 -96.41 128.89 43.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.217 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -103.57 165.97 10.71 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.77 -13.94 60.31 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.66 173.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.7 m -138.65 139.64 25.03 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 45.0 Cg_endo -67.83 -19.28 47.0 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.314 2.676 . . . . 0.0 112.486 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.691 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 7.5 mp0 -59.44 -48.21 82.5 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.966 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.24 -22.23 66.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.871 0.367 . . . . 0.0 111.853 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.08 -49.61 10.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.927 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 164' ' ' GLU . 5.0 pp0? -64.3 -30.78 71.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.758 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.8 tp -71.22 -50.54 31.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.431 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.31 -33.39 75.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.392 . . . . 0.0 110.296 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.553 HD11 ' HA3' ' A' ' 186' ' ' GLY . 8.8 tt -71.74 -38.06 70.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.2 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.64 -52.12 64.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.183 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -100.04 -30.43 11.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -172.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 27.8 ttp -106.87 28.19 8.21 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.483 -170.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -74.62 -8.62 56.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.089 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.6 m -72.7 -73.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.17 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.543 HG13 ' HA ' ' A' ' 182' ' ' ASN . 27.1 m -144.69 167.59 10.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.949 0.404 . . . . 0.0 111.42 -173.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.718 ' HB2' HD11 ' A' ' 183' ' ' ILE . 11.7 tpp -132.4 74.47 1.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 172.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 60.6 mt 59.5 -174.3 0.1 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.28 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.2 -63.63 3.57 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.889 173.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 129.56 34.99 0.47 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -144.04 136.59 26.92 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.543 ' HA ' HG13 ' A' ' 176' ' ' VAL . 2.1 p-10 -71.59 141.49 50.01 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.983 0.42 . . . . 0.0 109.998 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.718 HD11 ' HB2' ' A' ' 177' ' ' MET . 45.3 pt -112.55 178.89 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.859 -176.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.628 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 18.6 tptm -112.87 112.64 24.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.603 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.0 t -109.7 109.45 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.049 0.452 . . . . 0.0 110.792 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.553 ' HA3' HD11 ' A' ' 170' ' ' LEU . . . 78.72 -163.08 49.51 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.744 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 58.93 78.77 0.33 Allowed Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 122.798 0.439 . . . . 0.0 111.436 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.37 97.33 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.679 2.253 . . . . 0.0 111.015 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.7 t 64.33 -79.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 O-C-N 124.0 0.812 . . . . 0.0 109.616 -169.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -176.51 -67.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.5 tp -86.08 140.51 15.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.096 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -170.37 154.53 23.3 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -67.08 -20.2 65.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.274 0.559 . . . . 0.0 111.097 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.528 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -76.76 -22.49 53.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.369 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.472 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 31.7 mm-40 -60.59 -53.46 64.23 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.2 Cg_endo -53.24 -34.56 70.26 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.489 2.126 . . . . 0.0 112.995 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 65.9 mt -74.63 -38.85 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.543 0.211 . . . . 0.0 110.691 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.536 HG12 ' SD ' ' A' ' 111' ' ' MET . 70.2 mt -58.07 -49.07 82.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.225 0.536 . . . . 0.0 109.732 174.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.9 -37.49 87.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.888 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . 0.473 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 24.7 tp60 -60.2 -51.66 68.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.877 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 31.6 mt -67.52 -33.27 74.74 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.936 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.486 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.87 -37.71 66.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.48 -36.66 63.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.922 174.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 200' ' ' GLN . 26.7 mt-10 -71.72 -24.0 61.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.819 0.342 . . . . 0.0 111.778 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.19 -26.55 61.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.394 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 37.2 mtm180 -69.71 -17.95 63.5 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.451 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.01 -15.25 62.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.097 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -119.89 -172.76 2.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.601 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.611 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 68.4 m-20 -130.29 41.72 3.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.453 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.507 ' HD3' ' HG3' ' A' ' 289' ' ' PRO . 32.1 ttp180 -101.13 138.01 38.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.3 0.571 . . . . 0.0 112.044 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.435 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.5 pt -124.71 167.76 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.233 175.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.436 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 77.6 t80 -121.47 129.07 52.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.707 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.453 HG13 ' CZ ' ' A' ' 229' ' ' PHE . 33.7 m -124.28 134.9 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.014 0.435 . . . . 0.0 110.445 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -130.8 178.27 6.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.944 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 28.5 t 59.44 36.16 23.08 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.626 0.727 . . . . 0.0 109.413 -173.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.594 HG12 HD13 ' A' ' 225' ' ' ILE . 10.5 t -73.61 120.47 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.687 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.465 ' HD2' ' NE2' ' A' ' 278' ' ' GLN . 25.9 t-80 -54.11 146.89 13.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.297 -174.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -48.58 -53.37 18.63 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -93.03 37.4 1.03 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.155 0.502 . . . . 0.0 111.368 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.431 HD21 HD23 ' A' ' 275' ' ' LEU . 12.2 tp -117.69 109.49 16.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 96.8 p -93.91 -179.36 4.95 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.065 -175.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.46 -32.18 73.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.658 0.266 . . . . 0.0 110.571 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.84 -35.75 79.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.026 0.441 . . . . 0.0 110.173 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.26 -48.52 72.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.294 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 255' ' ' ILE . 33.4 mm -62.89 -46.73 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.43 ' HG3' HG21 ' A' ' 235' ' ' ILE . 54.2 tttm -54.33 -52.42 61.61 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.26 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 62.0 p -55.99 -39.6 72.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -174.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.1 t -76.48 -45.97 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.456 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.73 ' HB2' HD13 ' A' ' 235' ' ' ILE . 9.0 m-85 -64.72 -32.51 74.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.521 0.677 . . . . 0.0 110.557 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.63 -25.32 68.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.523 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.26 -25.81 63.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.765 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -101.59 -33.61 9.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.553 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -145.11 164.56 27.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.607 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -77.51 99.41 5.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.853 0.359 . . . . 0.0 110.746 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.73 HD13 ' HB2' ' A' ' 229' ' ' PHE . 13.3 mt -74.6 146.57 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.353 0.596 . . . . 0.0 111.393 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -110.31 -34.41 6.36 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.882 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 50.7 m -162.2 131.07 4.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.372 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.43 ' SG ' HG12 ' A' ' 255' ' ' ILE . 52.5 t -131.59 117.06 18.21 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 26.2 m -138.6 113.76 9.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.845 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.568 HD23 ' HA3' ' A' ' 253' ' ' GLY . 33.3 mt -82.46 139.93 33.68 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.39 115.56 7.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -128.62 136.75 51.11 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.172 -172.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -69.42 109.35 4.36 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.65 -45.35 41.7 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.199 3.266 . . . . 0.0 114.611 -168.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.51 HG22 HG22 ' A' ' 246' ' ' THR . 8.7 t -82.71 -11.86 58.01 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -170.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.51 HG22 HG22 ' A' ' 245' ' ' THR . 23.0 p -114.94 -21.51 10.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.114 0.483 . . . . 0.0 112.237 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 77.57 39.3 25.96 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.464 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -126.04 130.7 51.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.897 0.38 . . . . 0.0 110.36 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.43 ' HE1' ' O ' ' A' ' 216' ' ' VAL . 23.9 p80 -76.85 128.86 35.36 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 173.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -62.21 -20.64 64.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.274 -173.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 130.78 -5.02 5.79 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.274 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.436 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 46.3 p90 -140.65 167.96 20.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.745 0.307 . . . . 0.0 110.607 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.568 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -158.56 172.09 35.42 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.084 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.691 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 97.9 m-85 -128.05 142.52 51.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.894 0.378 . . . . 0.0 110.852 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.598 HD11 HG23 ' A' ' 225' ' ' ILE . 77.8 mt -136.8 131.79 47.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.767 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.611 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 16.5 mt-10 -112.44 146.57 38.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.875 175.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.553 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 9.2 m-85 -108.89 161.2 15.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.807 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.54 -22.33 59.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.509 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.8 141.58 48.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.035 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . 0.577 ' HA ' ' OD1' ' A' ' 209' ' ' ASN . . . -57.99 -60.21 4.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -169.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -74.51 -20.61 59.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 -171.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.9 m -62.1 -25.8 67.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.431 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.435 ' HB2' HG23 ' A' ' 211' ' ' ILE . 87.8 p -68.94 -39.61 79.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.372 0.606 . . . . 0.0 109.697 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -75.08 -23.16 57.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.897 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.28 -41.27 98.98 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.71 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.497 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -65.54 -42.22 92.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.37 175.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.556 ' HA ' HG21 ' A' ' 282' ' ' VAL . 96.4 t -54.14 -34.32 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.193 0.52 . . . . 0.0 110.822 177.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 26.1 t -73.11 -35.29 66.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.29 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.6 t -92.74 -35.08 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 111.832 -173.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.497 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 73.2 mmm -88.64 5.65 42.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.785 0.326 . . . . 0.0 111.245 -171.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.476 ' HA ' HG11 ' A' ' 282' ' ' VAL . 25.1 t-20 -66.5 109.77 2.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.348 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.4 mt 63.47 40.91 7.89 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.549 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . 0.474 ' HD2' ' HB2' ' A' ' 275' ' ' LEU . 49.4 t80 -79.69 126.84 31.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.137 174.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -80.17 71.34 6.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.629 0.728 . . . . 0.0 111.444 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.474 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 30.8 tp -95.37 103.48 15.34 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.109 0.48 . . . . 0.0 110.245 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 90.14 21.45 38.65 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.494 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 88.91 -9.27 77.26 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.695 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.465 ' NE2' ' HD2' ' A' ' 217' ' ' HIS . 79.2 mt-30 -116.66 144.17 44.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.866 0.365 . . . . 0.0 110.697 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -80.2 115.45 19.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.577 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 64.6 mt -64.53 126.64 28.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.437 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 281' ' ' ARG . 2.5 mmt180 -93.57 115.1 27.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 176.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 267' ' ' VAL . 8.3 p -112.83 147.16 16.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.155 -173.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.93 169.92 38.27 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -84.15 134.26 34.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.07 107.78 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.018 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 15.9 m -68.19 -27.6 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.541 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 69.9 p -98.52 124.5 46.29 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-O 121.246 0.546 . . . . 0.0 110.845 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.28 152.17 81.69 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.755 2.303 . . . . 0.0 111.23 172.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.507 ' HG3' ' HD3' ' A' ' 210' ' ' ARG . 18.3 Cg_exo -66.56 76.94 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.713 2.275 . . . . 0.0 112.209 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 66.0 mtm 68.05 87.72 0.11 Allowed Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.214 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.57 119.67 6.65 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.569 2.179 . . . . 0.0 111.222 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.66 -79.91 0.21 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.039 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 56.43 -159.6 0.22 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 24.4 p -118.86 86.2 30.18 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.239 174.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.94 -13.62 21.5 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.228 2.619 . . . . 0.0 112.652 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -80.5 74.55 7.38 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.222 0.534 . . . . 0.0 110.42 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.339 -178.959 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.876 -0.489 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.29 -79.06 0.17 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.827 0.346 . . . . 0.0 111.265 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 14.9 tpt -110.24 110.29 21.07 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -122.29 8.19 9.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -171.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -52.59 -58.91 5.27 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.265 0.555 . . . . 0.0 109.943 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -135.04 144.05 47.07 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -70.98 90.62 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.784 -171.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.0 mtp-105 -56.57 -40.12 74.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.279 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.86 -30.81 71.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.697 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.714 HD22 HG21 ' A' ' 287' ' ' THR . 24.2 mt -69.37 -41.25 76.78 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.495 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.73 70.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 110.516 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 194' ' ' ALA . 69.4 mt -79.84 -46.25 22.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.872 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 30.9 mtm -65.22 -37.07 86.14 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.6 m -63.2 -19.21 64.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.738 0.304 . . . . 0.0 111.223 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -104.68 140.54 37.9 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.623 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.0 p -129.24 128.09 66.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.66 0.743 . . . . 0.0 110.371 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -85.13 113.59 21.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.332 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 29.6 m -111.41 116.44 52.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.306 0.574 . . . . 0.0 110.314 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -113.78 106.33 1.73 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.76 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.849 ' HB3' HG21 ' A' ' 183' ' ' ILE . 27.7 t 154.6 -90.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.894 1.278 . . . . 0.0 109.106 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.732 ' H ' HG21 ' A' ' 183' ' ' ILE . 13.6 mt 60.01 31.31 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.371 0.668 . . . . 0.0 111.497 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.646 ' HA ' ' HD3' ' A' ' 181' ' ' ARG . 27.8 t80 60.3 -164.06 0.23 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -124.14 75.44 1.38 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.792 1.282 . . . . 0.0 109.426 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 123' ' ' LEU . 5.8 tt0 -178.42 -144.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.81 -1.995 . . . . 0.0 106.64 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.538 HD22 HG21 ' A' ' 127' ' ' THR . 92.1 mt 57.6 -174.36 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.784 0.678 . . . . 0.0 112.187 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.79 -179.63 36.58 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.5 -45.72 90.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.821 0.343 . . . . 0.0 110.42 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.428 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 4.4 m-20 -56.87 -49.39 75.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.444 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.538 HG21 HD22 ' A' ' 123' ' ' LEU . 5.0 m -61.7 -43.1 99.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.034 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 21.5 mm -66.55 -39.84 84.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.54 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.445 ' O ' ' HB1' ' A' ' 133' ' ' ALA . 43.2 ttp180 -60.7 -38.65 85.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.999 177.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 78.0 mt-30 -71.53 -33.26 69.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.211 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.05 -33.76 50.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -92.73 -16.19 25.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.601 0.238 . . . . 0.0 111.495 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.605 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -51.01 -44.66 87.37 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 5.1 Cg_exo -43.24 -49.07 7.61 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.981 2.454 . . . . 0.0 113.976 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.504 ' HD2' ' HG ' ' A' ' 168' ' ' LEU . 72.7 m-85 -65.28 -48.49 72.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -170.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.3 -171.66 29.82 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.449 -1.358 . . . . 0.0 113.271 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 161' ' ' GLU . 71.7 Cg_endo -78.79 121.61 5.11 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.752 2.302 . . . . 0.0 111.737 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.48 HD11 HD13 ' A' ' 141' ' ' ILE . 57.6 mt -80.8 119.69 30.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.367 0.603 . . . . 0.0 110.662 -177.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.656 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 28.1 tptp -89.26 -34.13 16.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.847 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.9 t -174.53 162.14 3.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.857 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.48 HD13 HD11 ' A' ' 138' ' ' ILE . 70.1 mt -141.22 122.37 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.745 0.307 . . . . 0.0 110.307 175.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.672 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 12.0 m-20 -95.01 104.01 15.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.387 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 3.9 mmt -94.98 126.18 40.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.737 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.4 m -81.01 47.81 1.04 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.417 0.627 . . . . 0.0 109.75 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -81.16 123.01 28.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.232 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.35 104.14 4.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.621 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.2 t -84.85 1.53 46.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.219 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.42 -55.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.445 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.543 ' OG1' ' HE2' ' A' ' 151' ' ' LYS . 2.2 p -122.53 12.89 10.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.297 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.4 mtm 66.08 57.25 0.79 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.213 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.543 ' HE2' ' OG1' ' A' ' 149' ' ' THR . 49.2 mtmt -116.53 167.4 11.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.62 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -138.76 45.2 2.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.579 0.704 . . . . 0.0 110.562 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -95.07 85.2 4.27 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.39 -146.62 5.44 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.809 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -124.34 177.9 5.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.837 0.351 . . . . 0.0 110.058 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.96 140.95 28.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.154 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.672 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 92.7 m-85 -109.99 109.17 19.67 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.623 ' HB ' HG12 ' A' ' 114' ' ' VAL . 43.3 t -92.04 115.02 30.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.23 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.656 ' HG2' ' HB3' ' A' ' 139' ' ' LYS . 36.6 tt0 -105.26 125.46 51.01 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.414 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.18 174.44 5.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.373 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.488 ' HB2' ' HG2' ' A' ' 137' ' ' PRO . 46.3 mt-10 -89.46 -16.32 31.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.086 172.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.428 HG21 ' HD2' ' A' ' 137' ' ' PRO . 28.1 m -130.67 137.64 31.25 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.109 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.434 ' HG3' HD21 ' A' ' 108' ' ' LEU . 60.1 Cg_endo -73.1 -20.76 21.29 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.785 2.323 . . . . 0.0 112.647 -176.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.562 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 13.6 mp0 -54.24 -59.08 5.14 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.132 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.16 -26.66 17.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.17 -51.83 8.01 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.216 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.439 ' HG3' HG12 ' A' ' 286' ' ' VAL . 10.6 mm100 -67.52 -27.43 66.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.984 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.504 ' HG ' ' HD2' ' A' ' 135' ' ' PHE . 14.2 tp -72.13 -47.61 49.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.105 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.28 73.48 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 185' ' ' VAL . 6.6 tt -65.06 -51.95 58.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.656 172.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -56.09 -33.68 65.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.833 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -100.68 -48.85 4.37 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.9 mtm -95.73 28.83 2.87 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -167.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -85.5 30.69 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.996 0.903 . . . . 0.0 109.847 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.429 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 16.6 m -113.93 -74.32 0.63 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.323 176.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.4 m -145.59 170.86 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.467 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.609 ' HB2' HD11 ' A' ' 183' ' ' ILE . 22.5 tpp -143.4 91.33 2.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.604 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.511 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 75.7 mt 54.49 45.34 27.21 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.035 172.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 170.85 163.06 24.25 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.962 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.13 53.25 4.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.152 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . 0.646 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 25.4 mtp180 -143.46 125.78 15.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.096 0.474 . . . . 0.0 110.49 174.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 175' ' ' SER . 14.1 m120 -71.81 128.43 35.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.954 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.849 HG21 ' HB3' ' A' ' 118' ' ' SER . 43.9 pt -103.21 143.51 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.781 -177.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 50.4 mttp -103.0 118.29 36.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.463 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.7 t -110.67 111.77 37.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 123.591 0.557 . . . . 0.0 111.479 -172.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.409 ' O ' ' HD3' ' A' ' 188' ' ' PRO . . . 57.43 51.22 59.04 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.552 170.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -86.72 109.04 20.93 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 186' ' ' GLY . 95.0 Cg_endo -85.21 54.02 3.73 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.011 2.474 . . . . 0.0 112.796 -175.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.5 m -56.36 -50.14 72.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.587 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -101.53 12.9 36.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.144 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 49.5 mm -104.85 95.64 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.03 0.443 . . . . 0.0 110.434 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.51 -19.17 5.49 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.215 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -68.42 -37.79 80.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.012 0.434 . . . . 0.0 111.144 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.448 ' HB2' HD12 ' A' ' 110' ' ' ILE . . . -87.34 -17.64 31.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.738 -175.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.549 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 11.8 tm0? -57.7 -50.58 87.34 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.886 -174.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.0 Cg_endo -53.16 -37.3 79.73 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.604 2.203 . . . . 0.0 113.1 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.5 mt -74.59 -41.33 48.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.297 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.6 mt -59.73 -48.85 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.096 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.535 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 14.7 t70 -59.19 -43.27 92.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.46 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -59.38 -50.93 72.05 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.471 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.6 -33.0 73.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.681 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.41 -39.49 73.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.663 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 44.3 mt-10 -66.75 -33.82 76.46 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.755 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -66.51 -37.02 84.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.349 . . . . 0.0 110.568 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.35 -33.76 76.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.095 0.474 . . . . 0.0 110.27 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.663 ' HD3' ' HA ' ' A' ' 203' ' ' GLU . 66.9 mtp180 -70.36 -13.77 62.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.158 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.73 -38.37 19.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.052 0.453 . . . . 0.0 110.783 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.47 -19.88 23.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.114 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 61.64 46.92 6.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.16 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.414 ' HE ' ' HB3' ' A' ' 254' ' ' PHE . 22.5 ttt180 -103.32 137.14 41.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.72 -171.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 263' ' ' SER . 42.2 pt -118.96 167.25 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.346 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 81.3 t80 -119.53 128.04 53.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.619 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.98 135.04 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.217 0.532 . . . . 0.0 110.105 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 281' ' ' ARG . . . -121.92 173.86 7.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.642 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.426 ' OG ' ' HG2' ' A' ' 281' ' ' ARG . 2.0 p 43.7 42.35 4.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.946 0.879 . . . . 0.0 111.202 -174.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 24.1 t -84.77 108.64 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.27 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -54.88 135.72 47.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.559 0.695 . . . . 0.0 111.369 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -51.72 -27.29 11.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.701 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -85.59 -9.84 56.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.918 0.389 . . . . 0.0 111.113 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 72.1 mt -86.52 136.39 33.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.214 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 49.3 m -97.26 169.44 9.77 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.496 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -62.29 -29.64 70.57 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.304 -0.247 . . . . 0.0 111.073 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -66.24 -35.18 79.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.172 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -61.04 -54.21 47.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.979 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.522 HG13 HD21 ' A' ' 240' ' ' LEU . 24.9 mm -63.52 -43.52 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.995 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.672 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 54.6 tttm -58.29 -49.63 76.46 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.318 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 97.8 p -56.04 -43.92 78.3 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 17.4 t -75.03 -41.62 45.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.609 0.242 . . . . 0.0 111.109 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.561 ' CB ' HD12 ' A' ' 235' ' ' ILE . 4.6 m-85 -65.75 -34.31 77.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.179 0.514 . . . . 0.0 110.912 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.3 tm-20 -66.33 -24.84 66.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.746 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.25 -16.45 61.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.648 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -111.74 -44.5 3.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.628 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . 0.564 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -124.57 173.49 16.99 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.525 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -94.96 99.28 11.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.393 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.561 HD12 ' CB ' ' A' ' 229' ' ' PHE . 17.9 mt -79.12 146.09 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.424 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.5 tttm -111.22 -33.14 6.53 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.126 176.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 18.8 m -152.84 125.55 8.33 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.485 -170.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 26.8 p -108.05 114.22 27.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.042 0.449 . . . . 0.0 109.907 170.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 27.5 m -141.71 102.06 4.09 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.286 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.522 HD21 HG13 ' A' ' 225' ' ' ILE . 64.6 mt -83.8 131.82 34.87 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.426 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -62.92 110.99 1.95 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.52 ' HD2' ' O ' ' A' ' 247' ' ' GLY . 16.1 ttp180 -123.98 144.88 49.55 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.798 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -80.54 113.66 41.4 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 172.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.19 -25.71 47.72 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.707 2.938 . . . . 0.0 115.162 -167.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.7 t -110.09 3.75 20.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 8.2 t -103.83 -13.57 16.36 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.934 177.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.52 ' O ' ' HD2' ' A' ' 242' ' ' ARG . . . 91.83 -48.13 2.76 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.977 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.403 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 16.2 pttp -94.85 156.17 16.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.756 0.278 . . . . 0.0 110.451 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 4.4 p80 -80.07 161.88 25.11 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.743 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.15 -58.72 6.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.161 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 163.32 -17.18 0.13 Allowed Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.178 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.421 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 9.5 p90 -120.61 173.75 6.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.426 ' HA2' ' H ' ' A' ' 241' ' ' ALA . . . -163.84 172.89 39.82 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.959 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.562 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 76.4 m-85 -135.3 143.01 45.97 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 122.598 0.359 . . . . 0.0 110.072 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.2 mt -139.78 133.23 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.976 0.417 . . . . 0.0 110.705 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -105.68 147.79 28.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 13.2 m-85 -117.45 151.57 36.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.915 0.388 . . . . 0.0 110.269 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -72.4 -16.28 61.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.844 -176.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -131.41 132.33 44.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.904 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -56.35 -33.95 66.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.332 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.37 -33.39 61.04 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.032 0.444 . . . . 0.0 110.864 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 4.7 t -66.56 -36.11 81.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.186 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.687 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 71.9 p -65.94 -36.69 84.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.207 0.527 . . . . 0.0 109.963 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -72.79 -24.12 60.88 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.82 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.63 -44.91 76.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.0 0.428 . . . . 0.0 110.398 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -64.28 -38.17 90.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.49 HG12 ' HA2' ' A' ' 283' ' ' GLY . 72.0 t -53.85 -38.94 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 120.966 0.413 . . . . 0.0 111.457 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 m -82.02 -19.8 39.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.81 0.338 . . . . 0.0 111.596 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 17.8 m -95.24 -49.26 5.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.44 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 58.4 mmm -81.57 -9.19 59.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -168.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -69.24 128.43 36.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.359 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 93.2 mt 66.99 31.69 6.83 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.852 0.72 . . . . 0.0 110.508 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -100.63 116.4 32.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.982 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.65 116.37 6.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.006 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 31.7 tp -143.02 118.67 10.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.766 173.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.57 6.48 87.34 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.028 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.44 -0.17 46.64 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.282 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -134.1 151.15 51.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -84.35 116.2 22.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.714 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.97 115.02 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.603 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . 0.554 ' HB2' ' HB2' ' A' ' 214' ' ' ALA . 14.1 mmt180 -93.89 114.95 27.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.33 140.82 40.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 119.711 -0.795 . . . . 0.0 111.202 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . 0.49 ' HA2' HG12 ' A' ' 267' ' ' VAL . . . -153.97 -169.98 19.46 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -89.95 137.94 31.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 117.334 0.567 . . . . 0.0 109.59 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.41 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -71.06 121.9 19.07 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.439 HG12 ' HG3' ' A' ' 167' ' ' GLN . 28.2 m -79.48 -25.66 12.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.794 0.33 . . . . 0.0 110.987 -175.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.714 HG21 HD22 ' A' ' 108' ' ' LEU . 73.2 p -133.18 145.54 57.24 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.96 110.83 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.492 2.128 . . . . 0.0 111.185 173.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.13 89.27 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.91 2.407 . . . . 0.0 112.56 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 70.7 mtm -75.57 133.22 74.11 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.214 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.52 71.81 2.45 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 123.032 2.488 . . . . 0.0 112.859 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.0 tp 55.7 58.13 4.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.968 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 94.0 mt -117.88 96.27 5.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.036 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 8.9 t -86.61 132.26 43.11 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.09 0.471 . . . . 0.0 110.977 -176.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.21 -14.17 18.69 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.707 2.271 . . . . 0.0 112.25 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -133.04 134.21 44.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.461 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.773 -179.158 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.64 79.25 1.38 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.0 mtt -85.22 118.18 24.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.638 -175.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 60.31 24.49 13.95 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.791 0.682 . . . . 0.0 111.975 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -98.87 117.8 34.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.043 0.449 . . . . 0.0 110.58 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -116.2 139.98 49.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.473 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -82.1 51.14 1.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.498 0.666 . . . . 0.0 110.663 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 -67.99 -27.77 66.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.367 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.484 ' HB1' HD11 ' A' ' 197' ' ' ILE . . . -65.89 -30.53 71.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.343 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.454 HD21 HG22 ' A' ' 287' ' ' THR . 42.9 mt -60.93 -31.52 71.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.361 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.7 -24.96 67.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.132 0.491 . . . . 0.0 110.757 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.1 mt -87.83 -34.46 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.142 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.511 ' SD ' HG12 ' A' ' 198' ' ' ILE . 88.0 mtp -74.99 -15.5 60.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.093 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 97.7 m -79.61 -1.26 37.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.538 0.209 . . . . 0.0 111.378 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.885 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 32.7 mtt180 -110.81 142.43 42.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.765 0.317 . . . . 0.0 111.235 -174.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.545 HG23 HD11 ' A' ' 170' ' ' LEU . 8.9 p -128.4 129.79 69.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.408 0.623 . . . . 0.0 109.817 169.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -85.01 118.32 24.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.819 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.603 HG11 HG13 ' A' ' 185' ' ' VAL . 15.5 m -112.59 126.68 70.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.286 0.565 . . . . 0.0 111.372 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -131.31 175.36 19.61 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.543 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.7 m 62.1 31.87 17.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 122.934 0.493 . . . . 0.0 111.455 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.5 mt -77.22 112.83 15.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.067 0.46 . . . . 0.0 110.513 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -61.38 153.55 26.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.628 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.6 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 24.0 p90 -78.01 76.29 4.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.086 0.946 . . . . 0.0 110.949 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -165.21 -39.95 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.095 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.405 ' HB3' HD13 ' A' ' 128' ' ' ILE . 66.3 mt -74.93 85.96 2.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.969 174.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.48 172.33 55.22 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.924 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -55.1 -40.03 69.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 0.0 110.942 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -62.28 -53.49 54.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.58 178.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 m -59.0 -43.07 91.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.978 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.813 HG13 ' HE1' ' A' ' 143' ' ' MET . 28.4 mm -63.19 -45.32 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.738 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -57.39 -43.85 84.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.43 . . . . 0.0 110.248 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -68.73 -33.79 74.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.939 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.61 -27.03 25.73 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.502 ' HB2' HD12 ' A' ' 138' ' ' ILE . 4.9 m-85 -87.52 -26.01 23.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.78 0.324 . . . . 0.0 111.06 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.437 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -50.76 -42.19 76.09 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 26.1 Cg_exo -39.12 -45.96 2.88 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.168 2.579 . . . . 0.0 114.559 173.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.496 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 54.2 m-85 -76.1 -37.12 58.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.877 0.37 . . . . 0.0 110.597 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -176.04 153.49 14.81 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.45 124.31 15.94 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.718 2.279 . . . . 0.0 111.755 175.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.502 HD12 ' HB2' ' A' ' 132' ' ' PHE . 21.0 mt -83.13 136.51 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.073 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -110.96 -20.32 12.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.175 0.512 . . . . 0.0 110.751 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.873 ' HB3' ' HB2' ' A' ' 159' ' ' GLU . 29.5 t -151.84 131.16 12.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.444 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 64.8 mt -130.28 129.67 65.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -117.48 99.45 7.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.813 ' HE1' HG13 ' A' ' 128' ' ' ILE . 52.1 ttm -141.33 112.0 7.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.828 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.3 m -74.35 72.36 1.81 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.768 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 77.6 t-105 -88.22 82.36 7.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.527 0.68 . . . . 0.0 109.851 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -155.64 116.78 3.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.95 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.9 t -166.31 141.51 4.56 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.631 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 85.4 t -48.45 -53.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 123.512 0.507 . . . . 0.0 111.535 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 16.6 p -98.63 21.53 11.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.346 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.1 mtm 58.03 33.55 23.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.237 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.3 131.72 34.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.238 0.542 . . . . 0.0 109.986 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.6 ' H ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 t-160 -86.78 -79.03 0.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.308 -175.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.424 ' HB3' ' HE2' ' A' ' 153' ' ' LYS . 48.2 mtpt 52.33 38.44 24.97 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.941 0.4 . . . . 0.0 111.915 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -151.29 175.77 30.04 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.064 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.69 172.67 6.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.12 167.62 27.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.995 0.426 . . . . 0.0 111.299 -178.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -126.84 134.66 50.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.393 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.428 ' HB ' HG12 ' A' ' 114' ' ' VAL . 89.4 t -121.07 113.0 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.644 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.885 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 4.8 mp0 -105.54 119.62 39.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.554 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.14 179.87 5.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.793 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.36 -63.15 1.17 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.832 169.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.3 m -99.08 144.79 28.86 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.951 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 22.9 Cg_exo -65.71 -19.82 59.45 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.469 2.779 . . . . 0.0 112.535 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.479 ' OE2' ' HB3' ' A' ' 212' ' ' TYR . 0.6 OUTLIER -58.53 -54.91 41.75 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.836 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.16 -25.82 14.9 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.5 -53.01 7.29 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.384 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.403 ' HG3' HG23 ' A' ' 286' ' ' VAL . 83.7 mm-40 -64.47 -43.33 94.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.751 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.496 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 10.5 tp -59.64 -46.44 89.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.436 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.673 ' HB3' ' SD ' ' A' ' 173' ' ' MET . . . -61.68 -53.09 60.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.55 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.2 tt -54.45 -36.13 63.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.467 0.651 . . . . 0.0 110.234 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.01 -46.48 71.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.73 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -100.87 -21.13 15.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -173.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.673 ' SD ' ' HB3' ' A' ' 169' ' ' ALA . 4.6 ptm -99.74 18.55 17.88 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.925 -0.484 . . . . 0.0 110.792 -176.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -72.78 -2.92 22.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 24.1 m -101.56 -74.22 0.63 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.472 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.88 157.17 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.232 0.539 . . . . 0.0 111.675 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.537 ' HB2' HD12 ' A' ' 183' ' ' ILE . 23.9 tpp -121.78 97.27 5.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.693 175.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 75.3 mt 61.49 35.91 17.35 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.249 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.34 -130.37 9.73 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.112 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 67.1 -94.26 0.25 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.574 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -144.33 153.69 42.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -68.89 100.43 1.19 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 177' ' ' MET . 47.9 pt -74.84 149.6 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.369 -175.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.682 ' HE2' ' HA ' ' A' ' 184' ' ' LYS . 9.3 mmpt? -103.45 107.3 18.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.161 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.603 HG13 HG11 ' A' ' 116' ' ' VAL . 5.9 m -104.62 109.41 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.222 0.534 . . . . 0.0 111.135 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.55 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 84.77 86.54 0.92 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.486 174.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -108.48 113.35 60.23 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.33 104.99 0.55 Allowed 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.021 2.481 . . . . 0.0 112.211 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 m -55.44 -56.39 20.77 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.405 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -109.58 -65.9 1.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tp -168.63 -43.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.886 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 132.1 110.41 1.26 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.083 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -65.23 -31.54 72.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.302 0.572 . . . . 0.0 110.224 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -87.96 10.18 19.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.476 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.697 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 25.3 tp60 -49.25 -53.13 42.45 Favored Pre-proline 0 N--CA 1.469 0.488 0 O-C-N 123.296 0.373 . . . . 0.0 111.89 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.697 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 40.0 Cg_exo -59.06 -37.47 92.71 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.198 1.932 . . . . 0.0 112.701 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.484 HD11 ' HB1' ' A' ' 107' ' ' ALA . 74.8 mt -75.3 -43.26 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.065 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.511 HG12 ' SD ' ' A' ' 111' ' ' MET . 73.7 mt -58.16 -45.9 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.149 0.5 . . . . 0.0 110.158 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 36.0 t70 -66.8 -39.01 87.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.765 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.43 -48.4 75.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.869 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.578 ' HA ' ' HG3' ' A' ' 204' ' ' GLU . 54.3 mt -68.14 -33.12 73.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.649 0.261 . . . . 0.0 111.032 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.569 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.15 -42.96 77.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 51.5 mt-10 -64.7 -36.36 84.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.901 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 201' ' ' LEU . 5.8 mm-40 -53.66 -46.03 70.44 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.059 0.457 . . . . 0.0 110.891 175.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 285' ' ' ALA . . . -63.73 -37.01 85.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.784 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.569 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 76.3 mtp180 -72.47 -16.75 61.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.164 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -99.38 -38.21 8.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.458 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -86.72 -12.46 48.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.126 0.489 . . . . 0.0 111.1 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 61.02 48.48 6.47 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.18 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.863 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 12.8 ptm180 -122.11 158.02 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.989 0.424 . . . . 0.0 111.718 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 pt -136.36 168.59 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.578 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.518 ' HB2' ' CE2' ' A' ' 254' ' ' PHE . 14.1 t80 -122.89 138.63 54.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.611 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.572 HG12 ' CZ ' ' A' ' 229' ' ' PHE . 35.5 m -127.42 133.83 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 110.757 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.78 -178.52 4.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.309 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.4 t 61.27 30.24 19.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.902 0.858 . . . . 0.0 109.082 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.0 119.17 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.236 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -57.45 142.27 44.6 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.974 0.416 . . . . 0.0 111.062 -173.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -49.04 -36.18 17.49 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -168.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -91.03 -5.83 54.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -171.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.81 131.87 36.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.117 0.484 . . . . 0.0 111.14 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.2 p -100.6 173.58 6.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.192 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.467 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 6.1 p-10 -61.62 -35.46 77.94 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.722 0.296 . . . . 0.0 110.415 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.48 -39.08 82.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.258 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.36 -44.23 68.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.597 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.589 HG22 HD11 ' A' ' 255' ' ' ILE . 29.6 mm -66.37 -40.73 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.459 ' HB2' ' CB ' ' A' ' 238' ' ' CYS . 88.2 tttt -60.82 -43.33 98.35 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.479 176.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 51.1 m -59.36 -39.09 82.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.76 -45.5 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.625 0.25 . . . . 0.0 111.304 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.599 ' CB ' HD12 ' A' ' 235' ' ' ILE . 15.5 m-85 -65.91 -30.39 70.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.225 0.536 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 7.6 tp10 -61.0 -24.21 65.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.946 176.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.65 -13.16 59.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.883 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -111.06 -34.39 6.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.692 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.97 166.74 29.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.332 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -78.56 103.19 8.34 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.253 0.549 . . . . 0.0 111.336 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.599 HD12 ' CB ' ' A' ' 229' ' ' PHE . 22.3 mt -78.6 150.94 5.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.103 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.04 -28.66 8.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.794 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 256' ' ' GLU . 3.3 p -172.04 153.1 3.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.671 0.272 . . . . 0.0 111.136 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . 0.459 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 41.6 t -143.5 127.79 17.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.16 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.2 t -141.53 108.48 5.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.067 0.461 . . . . 0.0 111.311 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.525 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 36.5 mt -79.32 130.58 35.58 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.571 ' HB3' ' CD1' ' A' ' 252' ' ' TYR . . . -75.03 118.68 18.26 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.522 ' CB ' ' HA ' ' A' ' 249' ' ' HIS . 35.9 ptt180 -139.56 169.04 18.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.95 -170.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -106.17 108.48 61.79 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 173.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.41 -37.61 94.1 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.305 2.67 . . . . 0.0 113.161 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -35.04 79.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.949 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 41.0 p -97.78 -18.67 18.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 111.537 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 73.77 44.82 30.14 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.05 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -150.95 139.64 20.7 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . 0.522 ' HA ' ' CB ' ' A' ' 242' ' ' ARG . 6.2 p80 -83.68 140.23 32.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -81.26 30.06 0.34 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -169.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 92.97 -6.06 76.27 Favored Glycine 0 CA--C 1.505 -0.578 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.429 171.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.571 ' CD1' ' HB3' ' A' ' 241' ' ' ALA . 0.2 OUTLIER -140.42 173.87 11.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -176.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -169.77 174.7 44.02 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.413 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 212' ' ' TYR . 59.7 m-85 -129.51 146.92 51.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.169 0.484 . . . . 0.0 110.512 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.589 HD11 HG22 ' A' ' 225' ' ' ILE . 84.9 mt -136.03 147.76 28.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.008 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.863 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 34.7 mt-10 -127.65 146.81 50.43 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.639 ' HB2' ' OG ' ' A' ' 263' ' ' SER . 18.7 m-85 -119.66 159.18 24.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.825 0.345 . . . . 0.0 110.915 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.16 -36.42 69.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.211 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -107.1 131.67 53.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -58.23 -34.26 70.23 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.655 -173.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . 0.428 HE21 ' HB2' ' A' ' 261' ' ' GLN . 0.0 OUTLIER -64.81 -44.48 89.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.2 176.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.0 m -65.02 -30.58 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.296 -169.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.639 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 1.6 m -60.96 -47.6 85.69 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.389 0.614 . . . . 0.0 109.646 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -73.69 -26.84 60.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.325 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -74.29 -32.99 63.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.418 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -66.78 -40.07 88.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.418 HG23 HG22 ' A' ' 282' ' ' VAL . 64.5 t -55.13 -45.56 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.433 0.635 . . . . 0.0 109.882 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 53.0 m -63.26 -30.01 71.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.699 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.9 m -95.61 -37.26 10.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.475 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 90.5 mmm -92.77 -3.52 54.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -166.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 272' ' ' LEU . 15.9 t30 -72.95 124.77 26.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.22 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . 0.455 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 99.1 mt 72.37 26.17 2.67 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.901 0.75 . . . . 0.0 110.643 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -87.33 120.75 28.94 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.538 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 10.2 p-10 -78.21 101.23 6.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.467 0.651 . . . . 0.0 110.871 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.536 HD11 HD12 ' A' ' 280' ' ' LEU . 0.9 OUTLIER -113.37 107.7 16.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.03 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 73.58 22.32 78.56 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.838 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.27 -38.5 3.26 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.775 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -87.87 148.68 24.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.857 0.328 . . . . 0.0 110.979 -176.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.538 ' CE1' ' HB3' ' A' ' 274' ' ' ASP . 81.4 m-85 -90.55 113.33 25.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.088 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.536 HD12 HD11 ' A' ' 275' ' ' LEU . 69.9 mt -60.18 133.27 55.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.479 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -107.1 116.35 31.77 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 172.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.418 HG22 HG23 ' A' ' 267' ' ' VAL . 7.8 p -118.1 140.55 41.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.184 0.516 . . . . 0.0 111.36 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -132.47 174.78 20.24 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.018 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -100.33 45.43 0.98 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.597 0.713 . . . . 0.0 110.957 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.517 ' O ' ' HB1' ' A' ' 205' ' ' ALA . . . 33.09 69.89 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 112.9 -1.955 . . . . 0.0 113.709 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.403 HG23 ' HG3' ' A' ' 167' ' ' GLN . 35.1 m -54.8 -26.29 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.926 0.393 . . . . 0.0 111.159 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.466 ' HA ' ' HD2' ' A' ' 288' ' ' PRO . 25.7 p -134.04 107.14 11.44 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.611 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . 0.466 ' HD2' ' HA ' ' A' ' 287' ' ' THR . 21.8 Cg_endo -62.04 121.51 9.59 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.857 2.372 . . . . 0.0 111.363 172.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.25 56.45 5.48 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.864 2.376 . . . . 0.0 112.316 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' MET . . . . . 0.429 ' HG2' ' HB2' ' A' ' 288' ' ' PRO . 88.8 mmm -76.62 130.91 75.26 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.019 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.81 81.21 0.61 Allowed 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.802 2.334 . . . . 0.0 112.3 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 95.1 mt -95.87 60.9 2.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.503 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . 0.483 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 44.1 tp -94.47 104.38 16.34 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 5.9 p -108.44 96.52 19.27 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.026 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 293' ' ' LEU . 16.6 Cg_exo -68.18 -54.66 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.803 2.335 . . . . 0.0 111.393 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 48.92 54.55 10.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.41 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.21 -179.021 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.319 -0.312 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.66 96.95 5.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.828 0.347 . . . . 0.0 110.231 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -120.13 -31.77 4.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.473 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . . . -93.04 36.99 1.03 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 110.401 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -96.96 125.04 41.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.108 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 60.49 50.13 6.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.68 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.473 ' NE2' ' HA ' ' A' ' 102' ' ' ALA . 16.8 mt-30 -112.67 8.84 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.378 175.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -53.64 -49.26 68.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.494 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.7 -48.02 61.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.08 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.99 -34.66 78.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.947 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.96 -32.49 72.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.145 0.498 . . . . 0.0 110.584 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.8 mt -80.67 -34.59 14.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.158 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.455 ' SD ' HG12 ' A' ' 198' ' ' ILE . 84.8 mtp -71.42 -23.48 61.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.83 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.7 m -84.11 -1.74 55.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.842 0.353 . . . . 0.0 110.77 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.609 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 98.5 mtt180 -122.03 141.09 51.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.129 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.25 133.12 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.159 0.505 . . . . 0.0 110.022 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.44 ' HB3' ' HA ' ' A' ' 187' ' ' ARG . 71.5 t80 -83.5 121.1 26.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.617 HG12 ' HZ ' ' A' ' 132' ' ' PHE . 15.7 m -117.46 116.56 52.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.066 0.46 . . . . 0.0 110.097 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.462 ' O ' ' HB ' ' A' ' 183' ' ' ILE . . . -122.23 171.39 15.32 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.03 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 m 67.38 25.98 8.52 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.785 0.434 . . . . 0.0 111.196 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.3 mt -66.81 115.56 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -53.32 143.26 19.16 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.924 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -69.5 80.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.447 0.642 . . . . 0.0 110.206 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -164.3 -44.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.974 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.421 ' CD1' ' HG3' ' A' ' 177' ' ' MET . 48.1 mt -83.33 124.27 30.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.187 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -97.74 -169.86 32.63 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.4 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -65.28 -33.04 75.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.019 0.438 . . . . 0.0 110.225 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.506 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 9.8 m-20 -71.91 -50.59 27.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.535 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -41.86 86.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.503 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.905 HG13 ' HE3' ' A' ' 143' ' ' MET . 17.1 mm -63.95 -42.91 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.812 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.2 ttt85 -59.15 -38.74 80.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.982 0.42 . . . . 0.0 110.307 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 23.4 mt-30 -66.37 -33.78 76.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.338 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.62 -23.69 29.45 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.617 ' HZ ' HG12 ' A' ' 116' ' ' VAL . 28.3 m-85 -94.25 -21.8 18.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.765 0.317 . . . . 0.0 111.479 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.611 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.21 -42.58 87.16 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 1.1 Cg_endo -47.54 -39.12 29.12 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.86 2.374 . . . . 0.0 114.325 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.599 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 62.9 m-85 -78.39 -38.04 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -172.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.69 172.61 45.11 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.197 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.56 117.56 5.21 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.638 2.226 . . . . 0.0 111.469 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.736 HD12 HD12 ' A' ' 141' ' ' ILE . 80.9 mt -72.63 131.95 34.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.705 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -111.09 -21.02 12.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.352 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 t -165.36 142.28 5.68 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.963 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.736 HD12 HD12 ' A' ' 138' ' ' ILE . 54.0 mt -142.0 114.44 3.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.277 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.442 ' OD1' ' HB2' ' A' ' 157' ' ' PHE . 7.9 p-10 -110.28 108.15 18.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.496 0.665 . . . . 0.0 109.426 172.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.905 ' HE3' HG13 ' A' ' 128' ' ' ILE . 45.5 ttm -109.68 146.37 34.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.265 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.417 ' CB ' ' HB2' ' A' ' 153' ' ' LYS . 7.9 p -73.66 54.9 0.49 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.742 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.512 ' HA ' ' O ' ' A' ' 151' ' ' LYS . 43.9 t-105 -117.82 96.04 5.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -81.32 121.53 26.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.668 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.4 m -83.46 -9.74 58.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.713 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.9 -56.27 7.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.4 p -100.38 -6.23 26.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.968 0.413 . . . . 0.0 111.51 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.433 ' HE1' ' HB2' ' A' ' 150' ' ' MET . 41.5 mtm 66.13 56.9 0.8 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.304 178.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 145' ' ' TRP . 65.1 mttm -110.07 131.34 55.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.156 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -121.37 85.27 2.37 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 144' ' ' SER . 31.3 mmmt -61.52 -52.34 64.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.095 -174.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 123.4 15.91 3.59 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.746 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PHE . . . . . 0.488 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 51.6 p90 -128.11 156.33 43.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.239 0.519 . . . . 0.0 110.558 175.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.62 159.04 29.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.442 ' HB2' ' OD1' ' A' ' 142' ' ' ASP . 51.8 m-85 -112.33 112.74 24.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.846 172.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.445 HG12 ' CD2' ' A' ' 132' ' ' PHE . 59.3 t -98.7 117.46 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.177 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.609 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 37.0 tt0 -109.33 138.85 45.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -115.32 -175.97 2.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.229 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.36 -34.35 61.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.815 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.5 m -125.98 150.78 70.19 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.043 0.449 . . . . 0.0 111.365 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 58.0 Cg_endo -70.1 -14.1 34.62 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.369 2.713 . . . . 0.0 111.938 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.447 ' HG3' ' HE1' ' A' ' 254' ' ' PHE . 70.5 mm-40 -59.12 -59.59 5.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.985 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.73 -19.21 10.23 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.52 -53.32 6.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.798 0.332 . . . . 0.0 110.111 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.57 -36.78 84.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.828 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.599 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 18.5 tp -66.23 -46.96 75.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.29 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.54 -44.17 96.39 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.585 ' HG ' HG12 ' A' ' 185' ' ' VAL . 6.1 tt -55.43 -44.34 76.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.247 0.546 . . . . 0.0 109.789 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.16 -39.84 79.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.127 -0.942 . . . . 0.0 113.204 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -100.59 -7.34 24.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' MET . . . . . 0.871 ' HE2' ' HE2' ' A' ' 177' ' ' MET . 32.5 ttm -97.46 -16.46 20.15 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -78.59 27.39 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 111.414 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.473 ' O ' HG11 ' A' ' 176' ' ' VAL . 41.5 t -113.6 -58.77 2.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.359 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -164.3 167.47 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 124.042 0.839 . . . . 0.0 109.167 177.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' MET . . . . . 0.871 ' HE2' ' HE2' ' A' ' 173' ' ' MET . 15.1 tpp -134.05 88.16 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.423 0.63 . . . . 0.0 110.805 172.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.439 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 90.1 mt 58.96 -79.83 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.597 174.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -79.02 54.93 4.27 Favored Glycine 0 CA--C 1.518 0.219 0 N-CA-C 114.278 0.471 . . . . 0.0 114.278 -168.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.87 -52.42 3.6 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 114.078 0.391 . . . . 0.0 114.078 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -76.27 133.96 39.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.091 0.472 . . . . 0.0 111.631 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 43.8 t30 -80.12 134.59 36.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.096 171.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ILE . . . . . 0.641 HD12 ' SD ' ' A' ' 173' ' ' MET . 40.8 pt -105.0 173.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.951 0.405 . . . . 0.0 110.624 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 87.7 mttt -102.62 106.1 16.71 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.585 HG12 ' HG ' ' A' ' 170' ' ' LEU . 12.0 p -102.78 120.39 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.605 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 132.34 128.65 2.94 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.766 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 68.7 ttt180 -74.76 -50.71 4.17 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 119.408 -0.329 . . . . 0.0 111.551 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 187' ' ' ARG . 37.9 Cg_endo -65.9 84.55 0.24 Allowed 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.009 1.806 . . . . 0.0 112.819 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.4 t -97.0 -9.02 29.05 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . 0.557 ' ND2' HG22 ' A' ' 191' ' ' ILE . 15.9 t30 -116.69 -59.77 1.93 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.425 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.557 HG22 ' ND2' ' A' ' 190' ' ' ASN . 9.0 tp -172.36 -52.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 174.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.414 ' N ' HG21 ' A' ' 191' ' ' ILE . . . 89.65 136.51 6.14 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.244 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -76.42 -14.0 60.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.322 . . . . 0.0 111.361 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.436 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -103.89 5.62 35.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.023 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.583 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 19.3 tm0? -53.36 -46.64 97.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.146 -177.213 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 6.8 Cg_endo -51.85 -44.6 43.88 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.298 1.999 . . . . 0.0 112.75 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.427 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 70.5 mt -69.43 -41.43 80.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 0.0 110.386 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.455 HG12 ' SD ' ' A' ' 111' ' ' MET . 74.2 mt -57.8 -48.3 84.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.461 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.52 -38.75 90.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.078 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -63.84 -48.36 77.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.13 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 42.3 mt -67.48 -33.5 75.23 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.559 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.665 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.31 -47.87 68.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.55 -31.63 70.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.131 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.21 -37.95 89.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.008 0.432 . . . . 0.0 110.741 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -77.13 -26.19 52.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.181 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.665 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 81.1 mtp180 -70.95 -24.67 62.48 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.018 176.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.97 -24.15 63.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.293 0.568 . . . . 0.0 110.405 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.89 169.24 8.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.674 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 46.1 m-20 -105.31 38.59 1.92 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ARG . . . . . 0.446 ' CA ' ' HG2' ' A' ' 256' ' ' GLU . 20.7 ttm180 -95.36 138.25 33.31 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.033 -170.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.685 HG22 ' HD2' ' A' ' 284' ' ' LYS . 44.9 pt -122.75 167.02 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.074 175.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' TYR . . . . . 0.48 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 66.0 t80 -119.18 129.36 54.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.199 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . 0.554 HG13 ' CZ ' ' A' ' 229' ' ' PHE . 35.1 m -123.53 134.92 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -126.06 175.66 7.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.846 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.12 27.17 10.54 Favored 'General case' 0 CA--C 1.527 0.059 0 O-C-N 124.158 0.911 . . . . 0.0 109.629 -176.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' VAL . . . . . 0.434 HG12 HD11 ' A' ' 225' ' ' ILE . 22.2 t -77.13 112.46 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' HIS . . . . . 0.503 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 42.6 t-80 -53.3 136.95 36.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.058 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -55.08 -34.77 63.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.186 -173.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.13 7.13 47.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.727 0.775 . . . . 0.0 110.639 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.54 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.3 tp -92.0 124.5 36.15 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.7 t -89.65 168.43 12.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.986 0.422 . . . . 0.0 111.219 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.17 -22.85 63.89 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -65.48 -33.91 77.04 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.923 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -72.16 -46.44 56.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.423 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.71 HG13 HD21 ' A' ' 240' ' ' LEU . 21.8 mm -63.11 -50.82 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.67 -44.39 81.35 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.967 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 30.3 t -58.09 -43.68 87.19 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 19.1 t -76.82 -44.02 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.5 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PHE . . . . . 0.622 ' HB2' HD12 ' A' ' 235' ' ' ILE . 55.3 m-85 -64.1 -33.41 75.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.098 0.475 . . . . 0.0 110.71 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -61.01 -24.96 66.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.457 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.48 -11.93 60.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.153 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.87 -33.89 6.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -156.85 158.39 28.76 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.904 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -69.44 116.05 9.42 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.268 0.556 . . . . 0.0 111.101 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.622 HD12 ' HB2' ' A' ' 229' ' ' PHE . 47.0 mt -86.19 151.58 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.733 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -119.32 -15.41 9.13 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.418 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 256' ' ' GLU . 47.6 t -165.77 143.88 5.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -174.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 54.1 t -153.87 117.78 4.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 10.5 t -140.26 139.39 35.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.234 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LEU . . . . . 0.71 HD21 HG13 ' A' ' 225' ' ' ILE . 77.8 mt -105.43 130.94 53.41 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.81 121.28 15.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.033 0.444 . . . . 0.0 110.376 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 51.6 ttp180 -134.65 152.02 51.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.111 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 5.7 m-20 -74.11 148.47 86.6 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -45.94 -45.12 17.91 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.04 2.493 . . . . 0.0 113.377 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.2 t -154.66 75.11 0.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.707 0.765 . . . . 0.0 110.881 -176.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 18.1 p -125.01 -11.19 7.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.138 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 72.45 20.3 79.33 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.389 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 21.6 ptmt -156.69 141.78 17.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -94.14 140.99 29.06 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.093 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -44.1 -55.97 4.37 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.235 0.959 . . . . 0.0 113.046 -172.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 145.95 11.04 0.24 Allowed Glycine 0 CA--C 1.511 -0.19 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.054 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' TYR . . . . . 0.48 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 44.4 p90 -144.37 167.23 22.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.08 173.81 32.62 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.26 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.447 ' HE1' ' HG3' ' A' ' 164' ' ' GLU . 81.0 m-85 -133.59 143.99 49.01 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.533 HD12 HG21 ' A' ' 225' ' ' ILE . 67.6 mt -140.12 135.74 37.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.501 -176.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLU . . . . . 0.554 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 25.4 mt-10 -112.83 142.23 45.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 7.0 m-85 -102.18 167.35 10.06 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -73.3 -13.99 61.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.96 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -134.76 124.93 25.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.551 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -58.97 -44.14 91.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.203 -176.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -62.89 -33.98 76.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.826 0.346 . . . . 0.0 110.802 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 53.3 m -70.48 -27.87 64.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.55 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.42 ' O ' HG22 ' A' ' 267' ' ' VAL . 83.9 p -72.81 -31.3 64.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -72.68 -30.62 64.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.946 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.05 -38.68 92.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.248 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ALA . . . . . 0.415 ' HB2' ' CD2' ' A' ' 229' ' ' PHE . . . -66.05 -42.37 89.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.131 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 263' ' ' SER . 82.4 t -53.03 -45.82 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.863 0.363 . . . . 0.0 111.345 176.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.6 m -65.54 -32.13 73.56 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 32.0 t -94.12 -33.64 13.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' MET . . . . . 0.514 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.3 mmm -91.75 0.55 57.48 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -169.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -74.29 118.39 17.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.7 mt 68.62 31.35 4.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.451 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -89.75 123.18 33.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.28 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.1 t70 -69.78 120.21 15.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.875 0.369 . . . . 0.0 110.892 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.54 ' HG ' HD21 ' A' ' 220' ' ' LEU . 38.8 tp -138.41 94.41 2.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.614 173.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.39 25.49 39.39 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.902 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 84.9 3.87 87.57 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.811 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLN . . . . . 0.436 ' HG3' ' HB2' ' A' ' 217' ' ' HIS . 16.8 mm100 -109.64 139.67 44.38 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.55 -178.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.6 103.27 15.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.886 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.6 124.5 21.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.635 -175.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -93.92 116.61 29.07 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 171.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.403 HG23 HG12 ' A' ' 213' ' ' VAL . 14.5 p -124.44 148.37 28.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.103 0.478 . . . . 0.0 111.346 -171.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.19 177.76 41.64 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LYS . . . . . 0.685 ' HD2' HG22 ' A' ' 211' ' ' ILE . 4.6 mmmp? -80.32 123.26 27.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.286 0.543 . . . . 0.0 109.942 175.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . 0.472 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -52.47 127.48 22.69 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.96 0.787 . . . . 0.0 110.347 177.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.56 -25.6 5.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 123.466 0.479 . . . . 0.0 111.052 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' THR . . . . . 0.647 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 21.7 p -127.5 153.33 77.41 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -91.51 101.84 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.793 2.329 . . . . 0.0 112.031 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' PRO . . . . . 0.647 ' HD3' ' O ' ' A' ' 287' ' ' THR . 11.6 Cg_endo -93.67 99.7 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.564 2.843 . . . . 0.0 111.348 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 25.5 mmt -86.65 116.86 67.47 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.53 116.5 3.95 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.579 2.186 . . . . 0.0 110.67 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.9 mt -79.67 54.07 1.73 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 110.989 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 88.9 mt -123.17 125.63 45.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.205 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 36.5 p 49.05 68.14 3.82 Favored Pre-proline 0 CA--C 1.534 0.336 0 O-C-N 123.777 0.673 . . . . 0.0 111.388 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.4 154.39 60.84 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.116 2.544 . . . . 0.0 112.243 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 72.06 136.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.099 0.874 . . . . 0.0 111.702 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.372 177.619 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 C--O 1.231 0.108 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -61.48 -41.75 97.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.787 0.327 . . . . 0.0 110.791 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.51 -32.82 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.977 0.418 . . . . 0.0 110.075 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.551 HD23 ' SD ' ' A' ' 111' ' ' MET . 83.8 mt -63.25 -34.29 77.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.642 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.47 66.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.167 0.508 . . . . 0.0 110.813 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.0 mt -83.39 -36.83 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.883 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.639 ' SD ' HG12 ' A' ' 198' ' ' ILE . 87.2 mtp -72.22 -22.37 61.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.626 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 76.1 m -74.75 -9.78 58.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.88 0.371 . . . . 0.0 111.021 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -105.46 142.25 35.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.589 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.502 HG12 ' HB ' ' A' ' 158' ' ' VAL . 8.7 p -123.93 127.71 73.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.446 0.641 . . . . 0.0 109.826 170.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -80.54 106.8 12.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.829 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.481 HG11 ' CZ ' ' A' ' 132' ' ' PHE . 19.0 m -99.09 115.31 39.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.423 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.38 149.92 17.53 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.719 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.9 m 76.35 -66.69 0.25 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.872 0.869 . . . . 0.0 111.436 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 120' ' ' TYR . 78.6 mt 61.88 -91.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 O-C-N 123.383 0.427 . . . . 0.0 110.697 -176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 119' ' ' ILE . 23.3 t80 165.94 140.01 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -175.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -79.07 75.35 5.59 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.378 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -174.53 -51.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.991 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 178' ' ' LEU . 78.8 mt -58.81 128.21 36.07 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.717 -173.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.99 -177.6 37.82 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.605 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -67.96 -43.59 78.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.412 . . . . 0.0 111.024 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 16.9 t70 -68.28 -42.42 79.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.087 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.0 m -67.0 -37.96 85.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.125 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 128' ' ' ILE . 17.2 mm -61.98 -40.86 88.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.62 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.546 ' HA ' HD12 ' A' ' 138' ' ' ILE . 38.0 ttp-105 -59.06 -39.76 83.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 110.178 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 72.6 mt-30 -68.59 -34.2 75.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.337 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.09 -21.32 36.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.633 ' HB2' HD11 ' A' ' 138' ' ' ILE . 31.6 m-85 -100.93 -15.29 17.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.956 0.408 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.635 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -54.13 -40.56 82.89 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 177.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 5.9 Cg_exo -42.76 -38.18 6.41 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.289 2.66 . . . . 0.0 114.013 174.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.541 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 60.3 m-85 -81.49 -46.89 13.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.881 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.73 165.57 38.51 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.073 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.461 ' HG2' ' CE1' ' A' ' 252' ' ' TYR . 24.9 Cg_exo -65.05 120.16 7.33 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.722 2.282 . . . . 0.0 111.408 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' A' ' 132' ' ' PHE . 41.2 mt -79.62 129.54 37.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.356 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -96.62 -29.82 13.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.832 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.0 t -158.65 141.5 14.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.593 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.437 ' CG1' HG21 ' A' ' 138' ' ' ILE . 72.1 mt -131.5 122.65 50.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.657 0.265 . . . . 0.0 110.943 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 33.1 t70 -98.14 100.06 11.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.436 ' CE ' HG13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -104.93 139.62 39.38 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.833 -171.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.339 177.257 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 48.3 p90 . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.54 0.209 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.9 152.78 33.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.319 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 46.8 m-85 -109.56 109.95 20.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.785 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.502 ' HB ' HG12 ' A' ' 114' ' ' VAL . 97.4 t -95.33 108.81 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.801 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -106.42 115.7 30.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.354 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -89.21 178.83 6.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.218 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.49 -45.64 30.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.082 0.468 . . . . 0.0 109.796 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.64 141.86 24.21 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.452 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.9 Cg_endo -69.5 -21.33 34.87 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.256 2.637 . . . . 0.0 112.518 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.601 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 6.5 mp0 -55.2 -51.43 66.57 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.883 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.12 -23.85 66.79 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 120.954 0.407 . . . . 0.0 111.921 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.22 -48.53 12.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.753 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.6 ' HG3' HG11 ' A' ' 286' ' ' VAL . 32.2 mm-40 -64.6 -36.53 84.52 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.699 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.541 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 11.8 tp -66.51 -46.81 75.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.734 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.148 0.499 . . . . 0.0 109.931 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.536 ' HA ' HG21 ' A' ' 185' ' ' VAL . 6.7 tt -69.79 -46.1 66.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.574 173.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 16.4 mm-40 -56.75 -56.83 16.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.25 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -86.51 -39.42 16.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 27.2 ttp -104.63 30.17 5.61 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.588 -165.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -89.11 44.38 1.21 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.884 0.849 . . . . 0.0 109.673 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 19.6 m -115.59 -73.87 0.63 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.416 173.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.24 169.34 5.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.712 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.623 ' HB2' HD13 ' A' ' 183' ' ' ILE . 25.0 tpp -145.45 78.98 1.56 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.951 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.604 ' HB2' HD11 ' A' ' 123' ' ' LEU . 75.6 mt 63.84 162.15 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.527 174.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.29 -65.07 1.65 Allowed Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.008 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.6 62.81 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.203 -0.522 . . . . 0.0 111.861 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -143.53 129.54 19.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.772 0.32 . . . . 0.0 111.242 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 175' ' ' SER . 8.9 t30 -71.5 103.69 3.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.373 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.623 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.5 pt -85.62 159.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.211 0.529 . . . . 0.0 111.884 -173.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -110.51 114.95 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.804 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 170' ' ' LEU . 5.3 m -103.64 108.33 24.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.422 0.63 . . . . 0.0 110.787 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.88 177.37 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.441 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 43.8 tt0 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 121.081 0.467 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -75.05 -28.8 60.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.067 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.718 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 27.2 mm-40 -54.32 -53.76 55.66 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.812 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.718 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 52.6 Cg_exo -55.08 -36.12 92.11 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.196 1.931 . . . . 0.0 112.851 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 72.6 mt -70.98 -46.09 69.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.339 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.639 HG12 ' SD ' ' A' ' 111' ' ' MET . 73.9 mt -57.15 -45.76 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.924 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.7 -39.9 95.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.244 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -63.08 -49.94 72.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.868 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 68.1 mt -67.88 -31.91 72.04 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.604 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.34 -47.86 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.65 -36.57 81.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.826 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 208' ' ' PHE . 39.2 mt-10 -68.37 -37.14 80.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.255 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -67.96 -32.24 72.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.83 0.348 . . . . 0.0 110.423 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.9 mtp180 -63.02 -37.98 89.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.317 175.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.58 -27.86 67.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.507 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.435 ' HD2' ' O ' ' A' ' 204' ' ' GLU . 75.0 m-85 -94.73 -16.48 23.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.45 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 60.71 41.65 14.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.987 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.496 ' HD2' ' OE1' ' A' ' 256' ' ' GLU . 16.5 ttt180 -101.42 145.15 29.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.279 0.561 . . . . 0.0 112.285 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 47.9 pt -129.05 167.56 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.4 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.508 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 27.0 t80 -117.65 138.03 52.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.482 HG12 HG22 ' A' ' 282' ' ' VAL . 28.9 m -128.21 131.63 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.395 0.617 . . . . 0.0 110.915 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.38 173.05 7.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.588 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.8 t 58.51 31.5 21.09 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.742 0.782 . . . . 0.0 109.619 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.51 114.23 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.828 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.629 ' HA ' ' OE1' ' A' ' 278' ' ' GLN . 71.9 t60 -54.05 130.39 37.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.442 0.639 . . . . 0.0 111.726 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -48.58 -33.13 9.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.186 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -85.09 -23.1 28.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.964 0.411 . . . . 0.0 111.835 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.406 HD11 ' HG ' ' A' ' 275' ' ' LEU . 69.5 mt -77.74 128.55 34.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.421 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 21.6 m -92.24 173.29 7.9 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.468 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -49.29 -50.28 39.83 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.842 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.24 -33.87 75.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.506 -174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.84 -38.1 73.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.629 0.252 . . . . 0.0 110.586 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.829 HG22 HD11 ' A' ' 255' ' ' ILE . 29.2 mm -67.01 -41.84 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.454 ' HG3' HG21 ' A' ' 235' ' ' ILE . 83.9 tttt -57.67 -45.45 85.53 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.389 173.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 39.6 t -54.19 -47.75 71.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.45 -39.58 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.347 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.533 ' HB2' HD11 ' A' ' 235' ' ' ILE . 24.0 m-85 -68.31 -29.78 68.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.019 0.438 . . . . 0.0 110.603 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.12 -26.24 68.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.946 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.66 -16.31 62.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.407 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -111.56 -40.12 4.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.427 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -138.31 161.8 25.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.325 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -81.02 104.23 11.37 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.181 0.515 . . . . 0.0 110.694 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 229' ' ' PHE . 27.3 mt -82.83 151.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.702 0.763 . . . . 0.0 111.759 -175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.627 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 45.4 tttm -107.26 -40.13 5.49 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.044 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 53.1 m -158.62 152.92 24.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.816 0.341 . . . . 0.0 110.545 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 9.3 p -133.37 125.67 29.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.746 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 12.0 m -140.37 100.9 4.0 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.717 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.521 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 44.4 mt -84.23 148.04 26.93 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.3 91.75 1.35 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 16.4 ttp85 -109.06 138.08 45.96 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.428 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 9.4 t70 -118.95 126.59 27.01 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.643 -172.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 11.6 Cg_exo -67.37 -21.03 47.88 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.994 2.462 . . . . 0.0 113.258 -176.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 35.2 p -100.97 13.57 34.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 0.0 111.238 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.408 HG23 ' OD1' ' A' ' 243' ' ' ASP . 63.8 p -115.23 -29.65 6.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.251 0.548 . . . . 0.0 110.078 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 93.59 1.44 66.09 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.015 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -154.56 -165.87 2.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 7.9 p80 -98.6 154.0 18.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.301 0.572 . . . . 0.0 109.764 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -71.22 -15.34 62.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.864 -168.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 120.39 -6.19 11.78 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.281 -0.962 . . . . 0.0 113.035 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.461 ' CE1' ' HG2' ' A' ' 137' ' ' PRO . 0.5 OUTLIER -134.61 158.62 43.57 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -162.79 177.62 38.82 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.407 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.601 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 52.9 m-85 -132.28 149.19 52.42 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.829 HD11 HG22 ' A' ' 225' ' ' ILE . 82.5 mt -134.08 142.59 40.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.496 ' OE1' ' HD2' ' A' ' 210' ' ' ARG . 30.7 tt0 -128.16 134.54 49.09 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -170.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 10.4 m-85 -111.0 165.52 11.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.142 0.496 . . . . 0.0 111.534 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.627 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 13.6 mt-10 -88.22 -12.0 45.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.156 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -134.93 124.78 25.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.886 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -65.44 -22.09 66.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.45 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -75.17 -47.08 30.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.4 m -65.09 -33.35 75.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.831 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.593 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 90.2 p -67.74 -31.88 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 75.4 mt-30 -75.25 -24.65 57.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -63.98 -49.19 73.46 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 229' ' ' PHE . . . -58.5 -40.16 82.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.259 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.56 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 97.5 t -57.1 -39.33 65.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.976 0.417 . . . . 0.0 111.045 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.6 t -81.66 -40.52 22.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.285 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.5 m -80.48 -40.35 26.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.44 ' HB2' HG21 ' A' ' 282' ' ' VAL . 89.5 mmm -89.69 -5.01 57.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.856 -170.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 267' ' ' VAL . 63.5 t30 -71.09 122.05 19.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 98.3 mt 70.09 23.06 5.42 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.886 0.741 . . . . 0.0 111.015 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.35 125.77 30.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.09 101.57 9.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.063 0.459 . . . . 0.0 110.185 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.406 ' HG ' HD11 ' A' ' 220' ' ' LEU . 36.5 tp -121.25 99.55 6.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.983 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.73 25.8 37.25 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.285 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 77.19 33.78 43.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.206 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.629 ' OE1' ' HA ' ' A' ' 217' ' ' HIS . 2.1 tt0 -152.43 139.99 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -91.45 103.15 15.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.665 0.269 . . . . 0.0 111.079 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 34.8 mt -58.36 116.97 3.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.806 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 281' ' ' ARG . 14.3 mmm-85 -93.46 114.6 27.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.56 ' CG1' ' HA ' ' A' ' 267' ' ' VAL . 17.1 t -112.35 140.05 34.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.858 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -153.92 170.58 32.56 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.625 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -75.9 128.98 36.23 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -74.05 128.76 36.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.6 HG11 ' HG3' ' A' ' 167' ' ' GLN . 20.1 m -93.77 -19.67 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.478 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.525 HG21 HD22 ' A' ' 108' ' ' LEU . 4.3 t -147.82 138.86 13.31 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.144 175.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 CA--C 1.531 0.342 0 C-N-CA 123.346 2.697 . . . . 0.0 112.924 -179.093 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.442 ' HB3' HD12 ' A' ' 108' ' ' LEU . 69.1 mt-30 . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -65.62 -42.09 91.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.821 -172.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' A' ' 197' ' ' ILE . . . -66.85 -33.07 74.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.035 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.487 HD23 ' SD ' ' A' ' 111' ' ' MET . 57.3 mt -63.47 -32.13 73.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.467 -176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.13 -28.63 69.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.189 0.519 . . . . 0.0 110.575 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.5 mt -88.52 -35.92 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.207 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.531 ' SD ' HG12 ' A' ' 198' ' ' ILE . 94.0 mtp -67.06 -18.94 65.57 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.083 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 85.3 m -81.94 -10.68 59.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 110.592 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 98.4 mtt180 -109.7 143.4 39.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.229 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.4 p -120.37 121.7 66.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 168.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -76.09 129.16 36.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.721 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 15.0 m -123.83 122.16 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.497 0.665 . . . . 0.0 111.128 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.63 174.97 19.22 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.416 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.404 ' HB3' HH21 ' A' ' 181' ' ' ARG . 66.0 m 64.46 36.9 8.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.295 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.3 mt -85.0 105.84 14.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.42 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -52.85 146.49 10.59 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.341 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -71.4 76.13 0.76 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 122.029 0.919 . . . . 0.0 111.314 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -165.67 -43.34 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.196 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.522 HD22 HD12 ' A' ' 178' ' ' LEU . 36.2 mt -75.11 103.34 5.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.114 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.64 174.32 54.1 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.208 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.32 -39.97 94.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.69 -42.03 92.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.208 0.528 . . . . 0.0 110.371 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.3 m -68.9 -39.93 79.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.46 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.521 HG13 ' HE1' ' A' ' 143' ' ' MET . 35.5 mm -64.09 -44.2 97.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.512 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -57.28 -46.68 82.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.543 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.34 -33.25 74.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.582 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.634 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -78.28 -31.98 49.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.452 ' HD1' ' O ' ' A' ' 128' ' ' ILE . 50.1 m-85 -93.43 -17.08 23.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.776 0.322 . . . . 0.0 111.454 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.03 -44.11 91.22 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -47.52 -33.17 17.09 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.783 2.322 . . . . 0.0 114.389 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.564 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 70.1 m-85 -79.69 -53.47 6.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.4 -171.04 25.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 119.637 -1.268 . . . . 0.0 113.361 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.46 112.82 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.921 2.414 . . . . 0.0 111.736 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.646 HD13 HD11 ' A' ' 141' ' ' ILE . 68.7 mt -76.6 127.27 37.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.428 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -84.81 -45.81 11.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.568 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -166.22 131.65 2.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.803 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.646 HD11 HD13 ' A' ' 138' ' ' ILE . 67.6 mt -109.36 114.11 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 171.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -94.09 100.46 12.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.044 0.45 . . . . 0.0 110.554 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.521 ' HE1' HG13 ' A' ' 128' ' ' ILE . 36.5 ttm -143.14 124.65 14.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.929 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.581 177.723 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.66 164.74 37.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.965 0.412 . . . . 0.0 111.305 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.83 111.86 18.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.422 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 78.7 t -97.45 106.49 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.98 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.431 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 39.4 tt0 -107.57 128.57 54.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.76 0.314 . . . . 0.0 110.615 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -95.17 179.82 5.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.976 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.94 -14.9 28.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.851 0.358 . . . . 0.0 110.16 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.53 135.09 26.86 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.234 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 46.0 Cg_endo -67.57 -21.11 46.45 Favored 'Trans proline' 0 N--CA 1.474 0.35 0 C-N-CA 123.311 2.674 . . . . 0.0 112.585 -176.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.948 ' HG3' ' HE1' ' A' ' 254' ' ' PHE . 5.7 mm-40 -61.01 -52.08 66.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.872 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.645 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -66.86 -17.88 65.11 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.02 -47.21 18.94 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.432 ' HG3' HG11 ' A' ' 286' ' ' VAL . 29.6 mm-40 -69.49 -34.88 74.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.461 174.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 13.6 tp -61.77 -48.1 82.18 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.581 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.98 72.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.97 0.414 . . . . 0.0 110.229 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.65 -52.13 41.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.589 173.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.54 -38.85 60.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.669 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLN . . . . . 0.459 HE21 ' HE1' ' A' ' 135' ' ' PHE . 22.7 mt-30 -99.76 -49.22 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 34.4 ttp -104.87 29.63 6.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -165.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.96 -20.78 60.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.929 0.395 . . . . 0.0 110.708 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.9 p -72.32 -73.58 0.19 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.6 m -134.07 151.98 33.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.033 0.444 . . . . 0.0 111.422 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.797 ' HE2' ' HG ' ' A' ' 178' ' ' LEU . 1.7 tpt -125.55 97.14 5.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.809 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.797 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 85.9 mt 67.56 127.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.93 0.769 . . . . 0.0 112.377 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 72.17 -80.17 0.61 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.385 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.43 36.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.07 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.404 HH21 ' HB3' ' A' ' 118' ' ' SER . 7.7 tpt180 -100.4 122.42 43.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.687 0.279 . . . . 0.0 110.808 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.6 126.44 30.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.546 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.8 pt -120.26 176.91 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.396 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 74.0 mmtt -103.24 107.27 18.03 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 27.6 t -113.36 106.87 21.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.13 0.269 . . . . 0.0 110.696 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 C-N-CA 119.855 -1.164 . . . . 0.0 114.24 172.947 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 120.849 0.357 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.473 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -88.45 -12.37 43.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.653 0.263 . . . . 0.0 111.362 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.569 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 33.8 mm-40 -59.08 -49.88 90.79 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 75.4 Cg_exo -52.97 -35.29 70.76 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.288 1.992 . . . . 0.0 112.847 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 107' ' ' ALA . 60.6 mt -69.94 -46.64 72.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.129 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.531 HG12 ' SD ' ' A' ' 111' ' ' MET . 57.6 mt -57.41 -43.27 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.239 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.19 -44.38 88.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.043 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -68.8 -45.44 71.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.911 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.436 HD23 ' OE2' ' A' ' 204' ' ' GLU . 19.4 mt -64.73 -33.53 76.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.783 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.656 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.02 -51.77 60.61 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -60.18 -38.29 82.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.272 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.436 ' OE2' HD23 ' A' ' 201' ' ' LEU . 52.5 mt-10 -60.54 -45.98 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.106 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.02 87.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.882 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.656 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 53.3 mtp180 -64.89 -33.93 77.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.791 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.42 -30.03 66.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.814 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.69 -4.47 47.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.035 0.445 . . . . 0.0 110.68 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.2 m120 62.89 44.03 6.48 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.055 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -99.93 142.78 30.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.188 0.518 . . . . 0.0 111.382 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.5 pt -127.76 166.35 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.175 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.559 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 86.3 t80 -119.18 128.79 54.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.156 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.627 HG12 HG23 ' A' ' 282' ' ' VAL . 32.2 m -121.77 131.28 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.183 0.516 . . . . 0.0 110.641 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -124.8 174.19 8.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.17 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.2 t 60.78 30.94 20.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.887 0.851 . . . . 0.0 109.223 -174.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 36.1 t -79.91 116.06 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.581 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.58 ' HD2' ' HG3' ' A' ' 278' ' ' GLN . 7.6 t-80 -56.4 135.25 54.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.471 0.653 . . . . 0.0 111.677 -169.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -49.29 -38.19 26.48 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -171.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -89.94 -10.02 46.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.754 0.311 . . . . 0.0 111.145 -174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.473 ' HA ' HD12 ' A' ' 220' ' ' LEU . 10.7 tp -83.44 124.59 30.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.257 -174.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.9 t -87.59 169.17 12.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.817 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.08 -36.8 71.0 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.791 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.41 -45.56 72.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.706 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -74.01 -40.95 62.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.059 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.671 HG22 HD11 ' A' ' 255' ' ' ILE . 31.4 mm -63.38 -47.73 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 238' ' ' CYS . 66.1 tttm -58.16 -46.57 85.46 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.052 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.5 t -54.5 -43.57 71.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.07 -41.98 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.41 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.524 ' CB ' HD11 ' A' ' 235' ' ' ILE . 20.6 m-85 -67.44 -28.22 67.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.207 0.527 . . . . 0.0 110.537 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.7 -24.54 64.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.151 0.981 . . . . 0.0 110.467 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.95 -15.84 60.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.205 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -111.3 -23.23 10.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.99 0.424 . . . . 0.0 110.658 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.542 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -165.66 156.31 28.17 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.81 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 23.4 mmtp -74.08 122.52 22.81 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.546 0.688 . . . . 0.0 110.861 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.524 HD11 ' CB ' ' A' ' 229' ' ' PHE . 57.1 mt -92.91 150.43 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.144 -172.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.437 ' HE2' ' CB ' ' A' ' 256' ' ' GLU . 31.8 ttpt -110.5 -28.57 8.46 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.221 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 16.8 m -152.43 146.58 25.42 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.458 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 226' ' ' LYS . 47.2 t -152.78 107.33 3.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.521 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.7 m -140.52 109.27 5.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.133 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.56 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 51.4 mt -77.31 143.61 38.69 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.479 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.08 113.12 4.25 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 29.3 ttp180 -149.89 139.49 21.62 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.147 -169.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.29 128.45 86.04 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -44.49 -46.0 12.41 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.897 3.065 . . . . 0.0 114.394 -163.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 3.7 t -133.89 76.58 1.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.705 0.764 . . . . 0.0 110.579 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 6.6 p -125.75 1.33 7.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.289 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.18 12.75 69.31 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.043 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 22.5 pttp -163.35 179.66 7.2 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -131.0 152.02 50.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -48.32 -61.53 1.95 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.976 0.798 . . . . 0.0 112.573 -172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 160.97 12.33 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.616 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -152.05 -179.69 7.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.56 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -170.61 177.76 43.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.357 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.948 ' HE1' ' HG3' ' A' ' 164' ' ' GLU . 83.3 m-85 -128.96 143.57 50.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.971 0.415 . . . . 0.0 110.917 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.671 HD11 HG22 ' A' ' 225' ' ' ILE . 89.7 mt -140.45 140.75 33.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.004 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.437 ' CB ' ' HE2' ' A' ' 236' ' ' LYS . 45.2 mt-10 -120.67 147.6 45.04 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 20.2 m-85 -111.75 164.2 13.32 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.654 0.264 . . . . 0.0 110.312 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.84 -5.23 59.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.323 0.582 . . . . 0.0 109.433 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -127.87 128.63 45.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.848 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.51 68.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.206 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -74.86 -52.69 10.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.519 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.542 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 28.3 m -60.14 -31.49 70.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.456 -172.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.624 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 48.7 p -64.63 -48.62 74.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.997 0.427 . . . . 0.0 109.988 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -72.53 -18.92 61.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.189 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -69.15 -40.9 77.92 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.045 0.45 . . . . 0.0 110.044 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.62 75.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.949 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 271' ' ' ASN . 88.2 t -59.25 -31.58 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.164 0.507 . . . . 0.0 110.64 174.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.5 t -83.93 -46.6 11.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.898 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.7 m -78.31 -43.24 28.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.487 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 80.0 mmm -83.87 1.21 44.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.161 0.505 . . . . 0.0 110.752 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.636 ' HA ' HG12 ' A' ' 282' ' ' VAL . 18.7 t-20 -71.81 114.22 9.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.157 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 86.0 mt 67.31 36.86 3.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.195 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.42 121.78 33.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.326 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.55 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 26.7 t70 -75.76 106.35 7.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.72 0.295 . . . . 0.0 110.271 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 41.1 tp -131.04 110.03 10.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.028 0.442 . . . . 0.0 110.506 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.82 5.02 74.73 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.185 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.12 -5.16 31.89 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.337 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.58 ' HG3' ' HD2' ' A' ' 217' ' ' HIS . 28.5 mt-30 -125.19 143.52 50.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.828 0.346 . . . . 0.0 110.526 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 57.4 m-85 -78.07 113.22 15.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.089 173.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.37 130.37 44.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.05 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -98.35 114.58 26.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 271' ' ' ASN . 7.5 p -118.39 143.91 27.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.878 -174.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -157.59 173.81 35.0 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.394 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -75.83 135.01 40.22 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -71.99 144.93 48.67 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.432 HG11 ' HG3' ' A' ' 167' ' ' GLN . 20.3 m -109.3 -4.77 10.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.329 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.9 p -129.58 146.75 62.43 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.49 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.462 -0.351 0 C-N-CA 122.553 2.169 . . . . 0.0 111.013 173.247 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.466 0.65 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -64.03 -30.2 71.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.753 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.1 -44.05 60.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.39 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.499 HD23 ' SD ' ' A' ' 111' ' ' MET . 60.3 mt -61.02 -36.07 78.54 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.47 -36.74 71.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.5 mt -78.73 -40.86 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.215 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.56 ' SD ' HG12 ' A' ' 198' ' ' ILE . 90.6 mtp -62.09 -28.2 69.45 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.588 -176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 67.0 m -74.97 -14.69 60.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.815 0.341 . . . . 0.0 111.109 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.587 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 42.8 mtp180 -101.53 140.31 35.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.852 HG12 ' HB ' ' A' ' 158' ' ' VAL . 9.6 p -110.0 121.82 63.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -82.23 100.98 10.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.008 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 35.3 m -108.21 141.32 23.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.145 0.498 . . . . 0.0 110.969 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.826 ' HA3' ' HD1' ' A' ' 155' ' ' PHE . . . -155.59 170.97 33.59 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.277 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.4 t 62.49 37.83 13.08 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.795 0.807 . . . . 0.0 109.683 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.5 mt -73.29 -14.99 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.543 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.9 t80 74.55 140.88 0.06 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.822 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -72.11 78.25 0.95 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.427 0.632 . . . . 0.0 110.995 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -159.58 -54.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.256 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.8 mt -68.54 119.58 13.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.753 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.63 -173.48 44.34 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.073 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.59 -39.32 94.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.632 0.373 . . . . 0.0 111.316 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.403 ' HA ' ' NE ' ' A' ' 129' ' ' ARG . 22.2 t70 -62.85 -41.19 99.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.38 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.2 m -68.7 -40.13 80.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.453 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.43 HG13 ' CE ' ' A' ' 143' ' ' MET . 31.2 mm -62.73 -50.82 78.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.061 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 126' ' ' ASP . 38.7 ptt180 -60.05 -42.28 94.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.169 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -67.63 -33.29 74.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.39 -33.5 28.69 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.562 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 51.2 m-85 -87.89 -20.54 25.85 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.86 -43.93 97.28 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -41.68 -40.93 5.67 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.069 2.512 . . . . 0.0 114.221 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.685 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 57.0 m-85 -75.45 -46.64 31.42 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.544 0.211 . . . . 0.0 111.295 -174.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -165.25 173.21 41.02 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.612 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.49 119.89 6.79 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.672 2.248 . . . . 0.0 111.688 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.6 mt -83.39 121.97 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.623 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -80.78 -52.49 7.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.695 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.5 t -152.17 152.12 31.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.097 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -124.69 108.98 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.066 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.749 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 18.4 m-20 -81.46 98.76 8.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.43 ' CE ' HG13 ' A' ' 128' ' ' ILE . 51.5 ttm -136.76 137.65 40.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.025 0.441 . . . . 0.0 111.014 -176.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.792 175.289 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.826 ' HD1' ' HA3' ' A' ' 117' ' ' GLY . 41.4 m-85 . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 120.88 0.372 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.25 151.53 37.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.886 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.749 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 81.7 m-85 -114.87 109.44 18.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.952 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.852 ' HB ' HG12 ' A' ' 114' ' ' VAL . 87.8 t -91.71 105.63 16.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.587 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 50.5 tt0 -99.53 115.6 29.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.717 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -91.55 178.46 5.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.93 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -77.54 -37.18 51.35 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.258 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.77 146.14 37.04 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.078 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.9 Cg_endo -70.17 -18.99 34.75 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.358 2.705 . . . . 0.0 112.056 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.61 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 9.1 mp0 -55.92 -53.84 51.91 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.807 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.08 -21.37 64.9 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.09 -45.46 15.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.75 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.629 ' HG3' HG11 ' A' ' 286' ' ' VAL . 16.0 mm100 -69.0 -31.83 70.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.787 173.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.685 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 14.2 tp -70.23 -47.19 62.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.522 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.34 71.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.091 0.472 . . . . 0.0 109.85 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.648 HD12 ' HA3' ' A' ' 186' ' ' GLY . 4.0 tt -67.64 -51.81 45.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 172.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -52.53 -43.47 65.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.853 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -95.6 -46.41 6.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.7 ttp -104.28 31.08 4.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.089 0.471 . . . . 0.0 112.123 -166.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 9.0 p30 -76.59 7.06 4.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.582 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 15.3 m -102.49 -73.49 0.66 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.554 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 24.5 m -133.04 156.11 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 0.0 111.365 -173.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.976 ' HB2' HD13 ' A' ' 183' ' ' ILE . 2.1 tpt -122.95 104.06 9.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.376 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.99 61.04 2.48 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.181 172.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 122.75 -153.56 16.94 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.489 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.58 72.33 0.79 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.253 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 176' ' ' VAL . 21.8 tpt180 -143.57 118.95 10.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 175' ' ' SER . 42.2 m-80 -78.47 119.28 21.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.209 176.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.976 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.4 pt -111.81 166.72 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.237 -176.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.733 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 27.4 mtpp -103.48 134.65 46.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 172.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 116' ' ' VAL . 26.4 m -134.18 152.73 34.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.937 0.399 . . . . 0.0 110.305 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.648 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.83 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.003 173.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 N--CA 1.46 0.055 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -79.27 -32.46 43.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.493 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 51.4 tp60 -54.08 -53.31 59.99 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.0 Cg_endo -53.2 -39.38 80.73 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.542 2.162 . . . . 0.0 112.674 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.97 -45.21 55.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.56 HG12 ' SD ' ' A' ' 111' ' ' MET . 51.8 mt -59.33 -47.48 90.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.162 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.46 -39.5 94.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.777 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -63.35 -47.42 82.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.008 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 39.8 mt -67.18 -32.94 74.35 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.629 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.64 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.74 -45.23 74.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.991 0.424 . . . . 0.0 109.914 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -68.47 -34.95 76.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.066 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 35.5 mt-10 -66.69 -31.57 72.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.275 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.98 -29.24 64.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.164 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 74.9 mtp180 -72.36 -15.29 61.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.602 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -90.73 -2.53 57.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.92 169.06 16.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.987 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 36.3 m-20 -108.7 35.13 3.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.382 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.456 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 24.2 ttm180 -95.11 137.42 34.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.121 0.486 . . . . 0.0 111.595 -173.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 34.0 pt -128.95 167.07 25.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.987 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.486 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 73.5 t80 -122.34 126.81 48.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.618 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.523 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 35.7 m -122.4 132.96 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.998 0.428 . . . . 0.0 110.461 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.15 174.54 7.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.685 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 54.5 m 60.8 31.13 20.05 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.499 0.666 . . . . 0.0 109.955 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.55 127.64 36.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.031 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -56.91 135.16 55.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.593 0.235 . . . . 0.0 111.191 -173.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -47.5 -53.75 13.45 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.26 22.61 5.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.411 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.1 tp -101.5 131.36 47.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.7 p -93.94 171.61 8.75 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.287 0.476 . . . . 0.0 112.287 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.62 -32.13 73.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.856 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.33 -34.5 76.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.475 0.655 . . . . 0.0 109.844 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 228' ' ' VAL . 62.7 m-20 -73.56 -43.68 59.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.702 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.7 HG22 HD11 ' A' ' 255' ' ' ILE . 32.6 mm -64.38 -44.12 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 65.5 tttm -57.16 -49.8 74.83 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.607 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 67.3 m -56.84 -37.7 71.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 224' ' ' ASP . 25.1 t -75.95 -44.23 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 122.122 -0.361 . . . . 0.0 111.559 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 235' ' ' ILE . 32.6 m-85 -69.77 -28.79 66.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.455 0.645 . . . . 0.0 110.188 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 8.7 tp10 -59.51 -25.12 64.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.796 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.42 -9.93 59.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.182 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -109.61 -45.29 3.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.666 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -144.55 165.19 27.59 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.096 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -70.96 115.83 10.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.233 0.539 . . . . 0.0 110.783 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.578 HD11 ' HB2' ' A' ' 229' ' ' PHE . 27.6 mt -87.8 150.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.756 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -112.49 -23.08 10.49 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.26 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 22.6 t -172.24 145.37 1.72 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.321 . . . . 0.0 110.859 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.5 t -141.69 128.26 20.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.8 m -142.38 110.78 6.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.985 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.614 HD21 HG13 ' A' ' 225' ' ' ILE . 46.0 mt -83.98 133.55 34.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.18 119.31 14.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.839 0.352 . . . . 0.0 110.544 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.557 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 18.0 mtm180 -122.94 145.9 48.07 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.706 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.609 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 10.6 m-20 -79.55 140.11 55.4 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.441 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.46 -25.6 14.53 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 124.04 3.16 . . . . 0.0 114.769 -171.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.1 t -157.78 48.16 0.39 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.517 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.609 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 17.2 p -102.89 -28.81 11.82 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.73 -0.606 . . . . 0.0 111.879 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.54 59.09 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.702 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.27 174.23 14.56 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.557 ' HB3' ' HG2' ' A' ' 242' ' ' ARG . 28.0 p80 -109.24 146.72 33.76 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.586 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -48.2 -50.48 29.05 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.812 0.695 . . . . 0.0 111.718 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 152.6 -11.73 0.63 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.821 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.486 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 46.2 p90 -124.95 171.03 10.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.818 0.342 . . . . 0.0 110.605 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -162.32 167.76 37.03 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.499 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.61 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 98.6 m-85 -123.66 146.66 48.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.004 0.43 . . . . 0.0 110.983 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.7 HD11 HG22 ' A' ' 225' ' ' ILE . 87.4 mt -139.8 136.1 38.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.209 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 46.1 mt-10 -119.17 136.33 54.23 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.529 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 6.8 m-85 -98.63 176.04 5.79 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -80.5 -21.79 41.6 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.341 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -131.19 137.48 48.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.063 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -69.5 -31.78 70.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.661 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -66.47 -35.6 80.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.976 0.417 . . . . 0.0 110.369 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.8 m -70.82 -42.38 70.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.327 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 40.7 p -66.89 -40.02 87.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.443 . . . . 0.0 110.694 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -70.92 -22.67 62.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.077 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.5 -37.24 71.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.63 84.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.71 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.48 ' HA ' ' CG2' ' A' ' 282' ' ' VAL . 61.9 t -61.77 -27.32 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.498 0.666 . . . . 0.0 110.568 174.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.0 t -87.21 -34.12 19.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.788 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.9 m -94.07 -31.35 14.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.53 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 91.1 mmm -92.32 7.1 44.34 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -170.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.479 ' HA ' HG12 ' A' ' 282' ' ' VAL . 52.9 t30 -72.69 121.66 20.18 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.377 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 86.8 mt 65.95 27.71 10.75 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.06 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -81.92 122.76 28.16 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.92 114.24 15.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.009 0.433 . . . . 0.0 110.06 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.411 ' HG ' HD21 ' A' ' 220' ' ' LEU . 26.4 tp -127.03 91.94 3.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.373 0.606 . . . . 0.0 110.09 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 94.07 11.36 57.65 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.547 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.9 6.66 39.83 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.688 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -133.59 144.45 49.3 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -89.31 114.81 26.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.783 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 62.8 mt -63.49 124.37 21.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.271 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -94.0 115.12 27.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 267' ' ' VAL . 13.9 p -114.6 140.1 37.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.33 0.586 . . . . 0.0 111.139 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.28 174.69 33.4 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.578 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -84.86 122.94 29.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -61.27 127.38 31.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.172 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.629 HG11 ' HG3' ' A' ' 167' ' ' GLN . 35.5 m -91.45 -12.91 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.811 0.338 . . . . 0.0 111.443 -173.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.441 ' HA ' ' HD2' ' A' ' 288' ' ' PRO . 36.4 p -111.97 119.52 44.12 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-O 121.264 0.554 . . . . 0.0 111.058 175.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.516 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 43.9 Cg_endo . . . . . 0 CA--C 1.53 0.29 0 C-N-CA 123.102 2.535 . . . . 0.0 111.909 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.62 ' HB2' HD12 ' A' ' 108' ' ' LEU . 29.8 pt20 . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 121.066 0.46 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -60.58 -28.4 68.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.911 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 110' ' ' ILE . . . -74.86 -22.0 58.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.737 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 105' ' ' GLN . 57.2 mt -62.56 -33.3 74.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.693 0.282 . . . . 0.0 110.594 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.02 -25.67 65.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.794 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 107' ' ' ALA . 3.6 mp -87.75 -36.82 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.619 ' SD ' HG23 ' A' ' 198' ' ' ILE . 42.5 mtm -74.7 -22.28 58.94 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.44 -11.74 60.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.958 0.408 . . . . 0.0 110.46 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -106.55 140.95 38.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.713 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.542 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.9 p -121.59 128.79 75.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.404 0.621 . . . . 0.0 110.225 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -81.25 109.89 16.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.778 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.455 HG12 HD11 ' A' ' 119' ' ' ILE . 39.3 t -108.02 120.05 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.104 0.478 . . . . 0.0 111.253 -174.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -135.21 174.07 21.36 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.442 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.783 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 25.9 m 66.59 35.35 5.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.069 0.547 . . . . 0.0 111.37 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.455 HD11 HG12 ' A' ' 116' ' ' VAL . 46.0 mt -85.22 114.72 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.558 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -52.29 134.41 33.79 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.435 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -71.42 76.66 0.76 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 122.162 0.982 . . . . 0.0 111.474 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.46 -37.75 0.06 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.931 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.465 ' CD1' ' HG3' ' A' ' 177' ' ' MET . 59.8 mt -75.16 110.64 9.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.825 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.55 169.58 49.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.869 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.09 -36.91 84.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.935 0.397 . . . . 0.0 110.275 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.53 -35.01 76.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.547 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.6 m -64.54 -42.81 95.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 110.142 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.626 HG13 ' HE1' ' A' ' 143' ' ' MET . 33.7 mm -63.2 -41.58 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.488 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 43.3 ttp-105 -59.04 -41.36 87.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.548 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.24 -34.13 77.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.525 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.68 -32.21 28.22 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -88.35 -21.42 24.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.773 0.32 . . . . 0.0 111.383 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.62 98.32 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.66 -32.4 5.84 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 122.998 2.465 . . . . 0.0 114.252 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.588 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 74.0 m-85 -83.01 -44.14 15.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.485 0.183 . . . . 0.0 111.367 -176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.41 167.41 40.24 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.367 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.35 134.41 35.99 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.697 2.265 . . . . 0.0 111.338 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.445 HG21 ' CG1' ' A' ' 141' ' ' ILE . 50.3 mt -100.14 132.84 44.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.409 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.592 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 21.4 ttmm -98.7 -29.58 12.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.551 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.7 t -156.82 135.17 11.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.83 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.445 ' CG1' HG21 ' A' ' 138' ' ' ILE . 63.4 mt -128.69 116.57 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -114.22 99.53 7.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.973 0.416 . . . . 0.0 110.327 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.626 ' HE1' HG13 ' A' ' 128' ' ' ILE . 49.2 ttm -103.05 140.72 36.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.694 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 121.39 0.614 . . . . 0.0 110.119 176.283 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.231 0.08 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 143' ' ' MET . . . -127.09 139.53 52.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.006 0.431 . . . . 0.0 110.716 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -114.52 118.72 34.55 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.091 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' A' ' 114' ' ' VAL . 96.5 t -104.87 112.1 37.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -105.02 115.42 30.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -88.29 165.19 15.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.592 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 23.0 mt-10 -83.04 -12.02 57.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.222 175.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.9 m -136.66 134.43 19.5 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.969 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.08 -22.37 47.63 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.896 2.397 . . . . 0.0 112.475 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.74 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 13.7 mp0 -55.26 -54.2 46.48 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.389 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.03 -19.59 63.04 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.49 -52.1 9.65 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.647 ' HG3' HG11 ' A' ' 286' ' ' VAL . 14.9 mm100 -69.94 -27.17 64.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 175.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.588 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 12.9 tp -70.02 -50.57 40.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.415 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.63 -33.87 76.58 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.508 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.2 tt -61.25 -46.5 90.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.993 173.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -65.64 -44.2 87.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.675 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -86.93 -37.92 17.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.4 mtm -101.6 30.25 4.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.958 0.409 . . . . 0.0 111.324 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -68.33 -11.08 58.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.128 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 20.3 m -101.31 -72.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.2 m -138.21 166.06 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.08 0.467 . . . . 0.0 111.855 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.465 ' HG3' ' CD1' ' A' ' 123' ' ' LEU . 18.3 tpp -134.87 99.21 4.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.877 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.446 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 89.7 mt 53.49 41.28 32.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.607 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.62 -144.52 16.45 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.993 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.64 -123.02 15.2 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.255 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -143.95 179.0 7.46 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 175' ' ' SER . 9.2 t30 -51.27 111.56 0.59 Allowed 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.628 0.58 . . . . 0.0 110.694 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.783 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 47.6 pt -89.29 160.8 2.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.474 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 52.2 tttp -107.25 116.22 31.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.5 t -120.31 106.2 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.508 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.422 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.25 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 . . . . . 0 C--O 1.23 0.027 0 CA-C-O 120.796 0.332 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.88 -38.52 27.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.456 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.522 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 56.4 tp60 -58.22 -49.77 91.75 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.9 Cg_endo -52.9 -39.08 79.47 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.332 2.021 . . . . 0.0 112.458 177.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 56.9 mt -72.61 -39.39 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.819 0.342 . . . . 0.0 110.438 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.619 HG23 ' SD ' ' A' ' 111' ' ' MET . 69.9 mt -59.35 -50.07 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.602 176.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.64 -30.96 68.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.55 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.68 -52.09 62.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.453 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 27.5 mt -67.56 -33.55 75.26 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.921 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.693 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.28 -51.12 60.32 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 173.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -65.71 -30.91 71.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.308 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 40.3 mt-10 -67.2 -34.75 78.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.068 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.79 -36.69 65.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.712 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.693 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 71.5 mtp180 -66.48 -24.24 66.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.125 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.17 -13.92 60.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.241 0.543 . . . . 0.0 110.66 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -113.74 -179.28 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.365 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 46.2 m-20 -116.46 40.87 2.79 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -93.95 135.62 35.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.704 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.1 pt -135.18 167.18 26.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.566 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.58 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 27.0 t80 -121.65 130.57 53.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.776 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.531 HG21 HG21 ' A' ' 225' ' ' ILE . 28.1 m -121.42 131.92 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.099 0.476 . . . . 0.0 110.145 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.07 176.58 6.59 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.915 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.6 m 62.27 32.52 17.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.906 0.86 . . . . 0.0 109.339 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.445 HG13 HD11 ' A' ' 225' ' ' ILE . 16.4 t -77.76 112.74 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.505 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -60.13 139.57 57.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.232 0.539 . . . . 0.0 111.341 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -51.05 -35.99 37.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.78 -17.72 30.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.134 0.492 . . . . 0.0 111.051 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.727 HD21 ' HG ' ' A' ' 275' ' ' LEU . 0.9 OUTLIER -74.1 132.55 42.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.061 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.2 m -103.25 179.71 4.19 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.303 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -55.63 -46.46 77.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.602 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -67.47 -27.34 66.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.613 -173.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -66.91 -54.05 25.92 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.467 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.728 HG22 HD11 ' A' ' 255' ' ' ILE . 42.7 mm -63.5 -43.2 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.73 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.453 ' HG3' HG21 ' A' ' 235' ' ' ILE . 83.9 tttt -56.85 -49.44 75.46 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.577 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 35.3 t -55.51 -41.09 72.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.1 t -74.75 -40.93 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.235 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.712 ' HB2' HD11 ' A' ' 235' ' ' ILE . 24.4 m-85 -69.12 -35.74 76.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.467 0.651 . . . . 0.0 110.35 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 34.9 tp10 -59.2 -24.89 63.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.695 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.47 -19.76 64.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.002 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -111.51 -34.36 6.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -145.15 153.93 25.59 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.561 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 66.0 mmtt -73.76 113.3 10.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 111.941 -177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.712 HD11 ' HB2' ' A' ' 229' ' ' PHE . 51.4 mt -92.47 151.09 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.878 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -109.66 -36.31 5.97 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.562 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 19.0 m -147.94 146.04 28.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.705 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.44 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 53.3 t -153.9 118.26 4.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.758 174.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.9 t -141.26 119.22 11.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.205 0.526 . . . . 0.0 111.51 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.646 HD23 ' HA3' ' A' ' 253' ' ' GLY . 40.8 mt -91.94 132.61 36.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.033 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.64 124.44 23.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.55 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.593 ' HB3' ' CB ' ' A' ' 249' ' ' HIS . 14.7 ptt-85 -144.59 169.89 17.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.478 -173.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -104.56 100.92 25.04 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.728 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.25 -22.24 64.01 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.513 2.142 . . . . 0.0 112.368 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.8 p -75.65 -17.94 59.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.48 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 49.3 p -108.84 -42.22 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.997 0.427 . . . . 0.0 110.369 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 114.54 -16.92 18.96 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.748 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -107.19 160.69 15.39 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.608 -0.348 . . . . 0.0 110.493 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.593 ' CB ' ' HB3' ' A' ' 242' ' ' ARG . 26.9 p80 -100.76 162.56 12.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.539 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -75.03 -69.93 0.44 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.213 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 170.19 25.99 0.02 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.095 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.482 ' HB2' ' CE1' ' A' ' 212' ' ' TYR . 3.1 p90 -153.77 154.07 33.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.646 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -157.78 173.22 35.1 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.137 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.74 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 81.4 m-85 -127.09 146.06 50.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.981 0.419 . . . . 0.0 110.626 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.728 HD11 HG22 ' A' ' 225' ' ' ILE . 74.5 mt -135.02 138.78 48.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.284 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 45.6 mt-10 -121.63 142.46 50.1 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 6.3 m-85 -105.85 163.69 12.53 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.05 0.452 . . . . 0.0 111.458 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.31 -36.75 20.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.526 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -100.41 114.94 28.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.571 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -50.83 -59.46 4.09 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.547 0.53 . . . . 0.0 112.375 -168.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.43 -36.54 64.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.257 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.2 t -67.94 -21.14 65.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 89.6 p -66.55 -49.93 64.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.218 0.533 . . . . 0.0 110.4 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -75.56 -15.9 60.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.67 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.48 -40.84 73.4 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.29 83.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 95.9 t -57.44 -30.58 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.236 0.541 . . . . 0.0 111.177 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.8 m -87.34 -29.45 21.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.342 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 13.3 m -93.54 -40.47 10.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.989 0.423 . . . . 0.0 112.03 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.451 ' HG3' ' CD2' ' A' ' 229' ' ' PHE . 87.6 mmm -85.08 -2.88 58.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.951 -171.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.42 ' HA ' HG12 ' A' ' 282' ' ' VAL . 60.2 t30 -69.1 129.66 40.52 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.371 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.7 mt 66.31 27.69 10.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.808 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -90.34 117.96 29.47 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.661 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 4.0 p-10 -76.03 122.38 24.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.371 0.605 . . . . 0.0 110.289 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.727 ' HG ' HD21 ' A' ' 220' ' ' LEU . 26.5 tp -134.24 95.21 3.36 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.635 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 93.36 18.65 38.17 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.699 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.89 -36.75 4.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.68 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -93.82 147.95 22.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.767 0.317 . . . . 0.0 110.746 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.661 ' CE1' ' HB3' ' A' ' 274' ' ' ASP . 54.2 m-85 -87.44 115.9 25.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.743 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.4 mt -57.13 116.6 3.35 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.797 0.685 . . . . 0.0 111.122 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -93.69 115.0 27.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 271' ' ' ASN . 13.7 p -121.41 147.63 25.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.173 0.511 . . . . 0.0 111.12 -173.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.38 179.7 37.53 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -84.74 134.96 34.32 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.613 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -68.85 137.15 53.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.647 HG11 ' HG3' ' A' ' 167' ' ' GLN . 33.1 m -97.96 -11.96 8.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.479 . . . . 0.0 110.917 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 38.3 p -108.6 135.06 20.08 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.004 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 CA--C 1.53 0.312 0 C-N-CA 122.847 2.364 . . . . 0.0 111.478 174.273 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 120.988 0.423 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 106' ' ' ARG . 10.9 ptp180 -55.51 -28.2 53.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.281 -174.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 197' ' ' ILE . . . -68.37 -35.04 77.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.036 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.494 HD21 HG21 ' A' ' 287' ' ' THR . 40.8 mt -66.71 -31.8 72.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.041 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.42 69.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.339 0.59 . . . . 0.0 110.36 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.4 mt -88.05 -36.96 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.348 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.483 ' SD ' HG12 ' A' ' 198' ' ' ILE . 90.4 mtp -69.88 -19.27 63.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.44 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 86.3 m -85.71 -1.89 57.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.1 0.476 . . . . 0.0 110.99 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -118.33 142.13 47.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.211 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.664 HG12 ' HB ' ' A' ' 158' ' ' VAL . 8.8 p -115.24 119.79 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.631 0.729 . . . . 0.0 109.761 172.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 41.7 t80 -67.87 119.99 13.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.192 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.579 HG23 ' HB3' ' A' ' 156' ' ' ALA . 17.0 m -119.48 117.51 54.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.59 0.709 . . . . 0.0 111.69 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.46 170.86 23.15 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.056 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.667 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 10.5 t 64.15 36.76 9.37 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.645 0.735 . . . . 0.0 109.604 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 84.7 mt -78.76 -15.51 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.854 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 75.5 t80 76.04 139.28 0.06 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.664 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -74.89 77.64 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.581 0.705 . . . . 0.0 110.892 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -163.59 -35.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.396 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 178' ' ' LEU . 72.8 mt -85.64 128.92 34.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.206 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.27 176.85 39.08 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.893 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.72 -39.9 93.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 0.0 110.549 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 16.1 t70 -65.03 -41.96 94.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.279 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 m -61.15 -40.56 94.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.938 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.09 -38.69 82.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.789 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 129' ' ' ARG . 33.2 ttp-105 -61.52 -39.02 89.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.993 0.425 . . . . 0.0 109.946 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 78.0 mt-30 -63.94 -37.78 88.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.335 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.56 -36.66 37.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.264 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.545 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 56.9 m-85 -92.29 -7.85 46.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.978 0.418 . . . . 0.0 111.777 -177.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.604 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -53.4 -45.58 98.42 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 6.8 Cg_endo -51.21 -27.66 23.47 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.854 2.369 . . . . 0.0 114.534 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.62 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 58.5 m-85 -83.88 -42.95 15.82 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.408 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.8 -179.49 40.49 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.849 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.93 110.92 3.13 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.763 2.309 . . . . 0.0 111.799 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 63.1 mt -79.57 113.02 18.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.353 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -78.58 -41.48 31.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.845 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -162.1 156.75 22.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.523 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.1 mt -134.76 116.18 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.732 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 12.8 m-20 -88.31 98.92 11.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.1 ttm -120.61 133.37 55.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.885 0.374 . . . . 0.0 111.228 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.44 172.639 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 37.9 p90 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.579 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -138.15 158.46 44.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.064 0.459 . . . . 0.0 111.662 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -117.84 115.8 25.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.338 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.664 ' HB ' HG12 ' A' ' 114' ' ' VAL . 99.4 t -91.52 109.93 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.936 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -98.03 116.22 29.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.431 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.545 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 95.9 m-85 -92.86 176.47 6.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.657 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -95.76 -1.52 49.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.045 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.9 m -145.76 137.31 12.92 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.22 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 43.5 Cg_endo -68.54 -20.34 41.39 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.039 2.493 . . . . 0.0 112.164 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 79.6 mm-40 -58.09 -56.34 23.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.79 -20.35 34.83 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.27 -51.82 7.54 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -63.31 -34.68 78.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.769 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.62 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.6 tp -68.67 -48.92 62.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.601 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.49 83.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 110.155 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 174' ' ' ASN . 6.7 tt -63.06 -51.16 67.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.532 174.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -57.72 -47.93 81.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.014 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -85.7 -33.37 21.53 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.9 mtm -108.15 30.09 6.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 24.2 p-10 -79.81 23.26 0.44 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.828 0.347 . . . . 0.0 111.584 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.8 t -114.59 -73.35 0.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.853 0.358 . . . . 0.0 110.625 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.586 HG12 ' H ' ' A' ' 182' ' ' ASN . 20.8 m -139.73 169.04 17.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.217 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.846 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.1 tpt -141.59 94.36 2.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 123' ' ' LEU . 89.0 mt 60.13 -83.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.579 0.752 . . . . 0.0 112.279 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -108.99 -12.8 19.67 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.336 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.32 115.03 4.32 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.246 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -82.94 127.06 33.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.586 ' H ' HG12 ' A' ' 176' ' ' VAL . 20.4 t-20 61.54 76.43 0.37 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.773 0.671 . . . . 0.0 110.258 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.846 HD13 ' HB2' ' A' ' 177' ' ' MET . 49.6 pt -88.36 160.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.724 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 67.0 mttm -105.65 106.91 17.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.528 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 6.2 m -109.27 116.4 51.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.317 0.58 . . . . 0.0 110.217 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.448 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.443 -0.853 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.595 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.014 0.435 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -70.52 -32.04 69.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.441 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 29.1 mm-40 -57.36 -56.19 36.52 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -173.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.2 Cg_endo -53.68 -37.51 83.9 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.219 1.946 . . . . 0.0 112.748 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 107' ' ' ALA . 54.7 mt -75.96 -43.09 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.774 0.321 . . . . 0.0 111.15 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.483 HG12 ' SD ' ' A' ' 111' ' ' MET . 72.8 mt -61.72 -46.49 96.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.05 0.452 . . . . 0.0 109.975 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.57 -36.98 85.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.352 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -58.32 -53.95 52.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.118 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 58.1 mt -68.8 -33.7 74.31 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.904 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.699 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.03 -48.96 69.95 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.615 ' OE1' ' HD3' ' A' ' 206' ' ' ARG . 6.6 mm-40 -62.89 -35.99 81.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.084 176.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 40.7 mt-10 -63.92 -36.25 83.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.356 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.09 -34.01 63.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.83 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.699 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 72.2 mtp180 -69.09 -20.63 64.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.937 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.53 -18.13 59.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.149 0.5 . . . . 0.0 110.554 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -109.14 -169.96 1.58 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.052 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.482 ' CB ' ' HA ' ' A' ' 260' ' ' ALA . 27.2 p-10 -139.5 58.75 1.61 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.835 0.826 . . . . 0.0 109.656 178.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.53 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 18.6 ttm180 -111.05 139.13 46.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.173 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.1 pt -119.57 163.15 17.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.668 0.271 . . . . 0.0 110.597 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -113.9 127.0 55.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.152 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 28.3 m -114.8 128.01 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.359 0.599 . . . . 0.0 110.154 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -120.27 167.53 12.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.097 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.3 t 59.67 40.03 20.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.975 0.893 . . . . 0.0 109.095 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.531 HG13 HD11 ' A' ' 225' ' ' ILE . 39.4 t -77.4 120.99 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.473 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 40.2 t-80 -52.57 133.01 36.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.257 0.551 . . . . 0.0 111.05 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -49.27 -37.68 24.42 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -171.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -96.41 -6.1 38.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.126 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 275' ' ' LEU . 10.7 tp -88.7 112.41 23.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.5 t -96.93 -178.67 4.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.854 0.359 . . . . 0.0 111.734 -170.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -53.36 -38.51 63.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.544 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.45 -37.55 87.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.391 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.427 ' HB2' ' HG ' ' A' ' 220' ' ' LEU . 15.7 m-20 -73.86 -42.68 60.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.992 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.546 HG22 HD11 ' A' ' 255' ' ' ILE . 34.6 mm -64.21 -42.14 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.403 ' HG3' HG21 ' A' ' 235' ' ' ILE . 83.9 tttt -61.09 -48.77 80.14 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.001 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 13.2 p -60.16 -38.17 82.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.458 HG21 HD21 ' A' ' 275' ' ' LEU . 49.1 t -76.56 -40.29 33.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.766 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.57 ' CB ' HD11 ' A' ' 235' ' ' ILE . 6.1 m-85 -69.19 -32.49 71.81 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.133 0.492 . . . . 0.0 110.993 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 7.2 tm-20 -63.35 -24.39 67.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.051 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.2 -23.82 64.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.731 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -101.41 -34.21 9.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.341 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -152.16 149.25 20.9 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.539 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 29.6 mmtp -71.19 120.52 16.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.567 0.698 . . . . 0.0 111.105 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.57 HD11 ' CB ' ' A' ' 229' ' ' PHE . 28.2 mt -91.38 151.2 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.919 -172.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 257' ' ' TYR . 17.0 ttmt -103.7 -30.28 10.53 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.202 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 28.2 t -170.34 141.91 2.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.325 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 40.4 t -142.61 127.1 17.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.744 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.9 t -141.31 133.48 27.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.823 0.344 . . . . 0.0 110.304 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 27.7 mt -109.84 136.18 49.56 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.86 126.44 29.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.221 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.421 ' HG2' ' CB ' ' A' ' 249' ' ' HIS . 73.5 mtp180 -122.83 152.45 40.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.831 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.583 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 17.9 m-20 -70.5 145.85 93.29 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.74 -19.98 56.37 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 123.197 2.598 . . . . 0.0 114.159 -171.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.3 t -162.93 62.2 0.19 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.295 0.569 . . . . 0.0 111.996 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 58.7 p -127.93 -18.46 4.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.095 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.07 -46.3 1.72 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.101 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.34 177.89 6.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.848 0.356 . . . . 0.0 110.711 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.421 ' CB ' ' HG2' ' A' ' 242' ' ' ARG . 30.8 p80 -96.15 170.7 9.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.293 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -77.06 -80.6 0.1 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.938 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -179.8 18.12 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.029 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -154.89 163.9 39.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -168.66 -179.24 40.77 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.228 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.491 ' CZ ' ' HG3' ' A' ' 164' ' ' GLU . 91.1 m-85 -134.44 145.37 48.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.625 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.546 HD11 HG22 ' A' ' 225' ' ' ILE . 88.5 mt -138.04 132.06 42.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.036 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.53 ' HG2' ' HB2' ' A' ' 210' ' ' ARG . 81.6 mt-10 -110.02 146.16 35.79 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.525 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 8.2 m-85 -106.94 179.24 4.32 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.164 176.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -70.24 -50.63 37.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.924 0.868 . . . . 0.0 108.905 171.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -103.48 139.56 38.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.968 -1.469 . . . . 0.0 109.227 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.482 ' HA ' ' CB ' ' A' ' 209' ' ' ASN . . . -65.56 -28.79 69.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.705 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -72.82 -33.45 66.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.844 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.8 m -67.07 -37.18 83.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.053 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.536 ' HB2' HG23 ' A' ' 211' ' ' ILE . 21.6 p -68.23 -38.63 82.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 0.0 110.04 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -71.6 -25.96 62.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.33 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -65.39 -41.94 93.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.028 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -63.83 -41.68 97.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.468 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.17 -32.98 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.231 0.539 . . . . 0.0 111.001 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.9 t -75.37 -33.83 61.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.132 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.8 t -94.29 -40.17 10.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 112.041 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 75.2 mmm -83.33 -4.41 58.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -168.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.486 ' HA ' HG12 ' A' ' 282' ' ' VAL . 57.8 t30 -69.2 112.81 6.03 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.159 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.452 HD21 ' CZ ' ' A' ' 281' ' ' ARG . 94.1 mt 67.77 36.36 3.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.778 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -91.17 132.97 35.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.244 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -82.04 109.57 16.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.305 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.659 HD12 HD11 ' A' ' 280' ' ' LEU . 0.6 OUTLIER -117.38 91.38 3.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.137 0.494 . . . . 0.0 109.851 176.225 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.9 34.1 28.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.756 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 91.03 -0.29 75.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.969 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.482 ' OE1' ' HA ' ' A' ' 217' ' ' HIS . 34.6 tt0 -126.57 141.17 51.95 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 120.773 0.32 . . . . 0.0 110.342 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -92.58 123.25 35.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.87 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.659 HD11 HD12 ' A' ' 275' ' ' LEU . 48.2 mt -77.73 127.6 32.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.135 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.452 ' CZ ' HD21 ' A' ' 272' ' ' LEU . 37.4 mmt180 -95.1 114.78 26.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 271' ' ' ASN . 10.7 p -117.34 147.65 20.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.157 -173.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -159.47 175.47 36.36 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.382 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -82.06 126.41 31.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -61.68 126.81 28.68 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.309 0.381 . . . . 0.0 110.585 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.59 -24.94 5.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.359 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.494 HG21 HD21 ' A' ' 108' ' ' LEU . 16.1 p -132.57 133.16 23.21 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.732 0.301 . . . . 0.0 111.269 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.534 0.495 0 C-N-CA 122.616 2.211 . . . . 0.0 112.077 175.317 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.192 0.52 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -52.8 -48.23 67.05 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.908 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.0 -35.83 69.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.704 0.288 . . . . 0.0 111.081 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 108' ' ' LEU . 34.7 mt -66.59 -32.35 73.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.203 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.8 85.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.192 0.52 . . . . 0.0 110.136 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.97 -36.48 57.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.219 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.429 ' SD ' HG12 ' A' ' 198' ' ' ILE . 89.9 mtp -72.14 -17.01 62.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.915 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 80.2 m -89.01 -17.78 28.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.91 0.386 . . . . 0.0 110.597 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -99.08 141.53 31.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.144 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.69 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.5 p -128.05 131.58 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 121.773 0.796 . . . . 0.0 110.145 174.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.48 ' H ' ' HA2' ' A' ' 186' ' ' GLY . 39.1 t80 -94.71 104.48 16.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.222 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 17.4 m -99.38 116.52 42.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.607 0.717 . . . . 0.0 111.352 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.501 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -116.36 165.32 12.27 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.638 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.7 m 63.45 44.42 5.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.347 0.594 . . . . 0.0 110.861 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -72.91 142.93 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.234 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.447 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 37.8 t80 -54.81 127.26 27.65 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.598 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -74.47 76.71 1.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.024 0.44 . . . . 0.0 110.135 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 178.54 -36.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.111 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 178' ' ' LEU . 93.8 mt -61.44 132.41 53.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.965 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -98.59 168.23 22.65 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.791 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -55.41 -39.51 70.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.935 0.397 . . . . 0.0 111.183 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -64.55 -39.51 93.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.076 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -71.57 -38.25 70.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.41 -40.24 88.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.145 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -59.16 -43.35 92.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.58 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.37 -34.45 73.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.297 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.11 -33.44 26.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.504 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 40.7 m-85 -91.77 -16.81 26.3 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.442 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -54.88 -43.72 98.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 42.0 Cg_exo -40.58 -38.95 2.74 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.245 2.63 . . . . 0.0 115.062 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.709 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 61.5 m-85 -77.48 -37.17 51.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -173.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -179.01 -177.71 47.76 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.867 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HB2' ' OE1' ' A' ' 161' ' ' GLU . 73.4 Cg_endo -75.06 135.43 18.97 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.772 2.314 . . . . 0.0 112.258 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.515 HD13 HD11 ' A' ' 141' ' ' ILE . 68.9 mt -102.1 130.97 51.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.564 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 29.5 ttpp -94.48 -31.75 13.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -168.79 145.91 3.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.6 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.515 HD11 HD13 ' A' ' 138' ' ' ILE . 69.5 mt -130.81 131.16 64.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -122.29 101.49 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.416 ' HE3' ' HB2' ' A' ' 143' ' ' MET . 43.5 ttm -111.97 138.28 48.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.747 0.308 . . . . 0.0 110.931 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.8 m . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.295 173.609 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.501 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 29.5 m-85 . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.2 139.52 51.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.954 0.407 . . . . 0.0 110.647 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -105.34 109.33 21.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.824 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 114' ' ' VAL . 62.9 t -94.57 105.72 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -102.87 115.15 30.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.409 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 85.0 m-85 -88.94 172.38 9.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.628 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 47.8 mt-10 -89.95 -24.29 21.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.845 172.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.82 137.35 29.37 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.303 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.3 Cg_endo -69.43 -17.46 39.05 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.169 2.579 . . . . 0.0 112.362 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.599 ' HG3' ' HZ ' ' A' ' 254' ' ' PHE . 71.3 mm-40 -57.99 -54.91 41.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.011 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -59.33 -21.5 59.86 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.68 -52.39 8.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -63.95 -32.33 73.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.841 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.709 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.1 tp -68.52 -50.04 55.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.584 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.42 74.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.756 0.313 . . . . 0.0 110.374 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 185' ' ' VAL . 24.4 tp -68.76 -40.77 79.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.125 0.488 . . . . 0.0 110.651 173.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.84 -33.95 75.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.253 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -100.13 -51.19 3.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 13.6 mtm -103.11 29.3 5.59 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -165.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.419 ' HB2' HD12 ' A' ' 170' ' ' LEU . 64.4 t30 -83.61 32.5 0.46 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.575 0.702 . . . . 0.0 109.941 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 48.6 m -114.87 -74.08 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.369 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.07 163.84 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.395 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.885 ' HB2' HD13 ' A' ' 183' ' ' ILE . 0.8 OUTLIER -134.03 103.25 5.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.568 177.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.556 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 84.0 mt 54.7 77.75 0.19 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.931 0.77 . . . . 0.0 111.995 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 131.72 -139.56 11.05 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.167 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -133.7 62.67 0.63 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.322 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -142.22 124.19 15.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 175' ' ' SER . 95.3 m-20 -68.27 124.12 22.62 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 123.307 0.38 . . . . 0.0 110.439 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.885 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.3 pt -106.49 155.56 7.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.043 0.449 . . . . 0.0 110.77 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.1 tppp? -105.42 116.01 31.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.591 ' O ' HD13 ' A' ' 170' ' ' LEU . 21.7 t -100.06 102.19 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.405 0.621 . . . . 0.0 109.806 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.48 ' HA2' ' H ' ' A' ' 115' ' ' TYR . . . . . . . . 0 N--CA 1.445 -0.711 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.805 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.26 -13.2 50.52 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 12.0 tm0? -64.04 -52.87 52.89 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.82 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 77.7 Cg_exo -53.23 -38.52 81.65 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.485 2.123 . . . . 0.0 113.094 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 52.4 mt -67.36 -46.47 83.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.318 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.429 HG12 ' SD ' ' A' ' 111' ' ' MET . 66.5 mt -60.95 -45.56 98.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.317 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.32 -39.95 95.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.534 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -65.38 -47.31 76.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.557 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 49.9 mt -67.43 -33.11 74.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.092 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.608 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.6 -45.19 66.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.379 0.609 . . . . 0.0 109.53 173.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -70.44 -33.02 70.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.29 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 32.3 mt-10 -68.38 -25.6 65.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.812 0.339 . . . . 0.0 111.534 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.22 58.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 78.6 mtp180 -70.65 -10.69 59.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.193 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.34 -27.17 67.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.196 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -128.37 124.27 35.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.144 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -74.87 70.35 1.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.855 0.836 . . . . 0.0 110.277 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.892 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 3.3 ptp180 -113.46 155.37 25.44 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.725 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.6 pt -122.84 164.4 20.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.745 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -112.45 129.14 56.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.315 0.384 . . . . 0.0 110.204 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.586 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.7 m -124.08 132.91 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.192 0.52 . . . . 0.0 110.506 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -126.23 177.42 6.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.649 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.9 m 61.38 30.24 18.89 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.718 0.771 . . . . 0.0 109.792 -173.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.499 ' O ' ' HA2' ' A' ' 251' ' ' GLY . 30.8 t -85.42 115.48 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.432 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.695 ' HB3' HD23 ' A' ' 220' ' ' LEU . 23.3 t-80 -57.66 139.96 52.4 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.057 0.456 . . . . 0.0 110.661 -176.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.567 ' HB2' ' HD2' ' A' ' 248' ' ' LYS . 6.0 pt20 -46.38 -41.74 14.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ASP . . . . . 0.428 ' N ' ' HG3' ' A' ' 218' ' ' GLN . 0.7 OUTLIER -98.16 13.91 29.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -167.199 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 217' ' ' HIS . 3.6 mm? -86.72 121.89 29.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 25.0 m -78.11 171.61 14.77 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.609 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.49 -41.25 76.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.078 0.466 . . . . 0.0 110.101 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -69.49 -24.24 63.74 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.02 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 220' ' ' LEU . 7.6 m-20 -69.75 -45.64 67.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 110.258 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.729 HG22 HD11 ' A' ' 255' ' ' ILE . 14.5 mm -68.58 -38.08 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.419 ' HG3' HG21 ' A' ' 235' ' ' ILE . 85.3 tttt -60.53 -53.68 54.59 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.946 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 11.2 p -55.12 -38.63 68.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 224' ' ' ASP . 32.3 t -73.42 -46.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.541 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.653 ' HB2' HD11 ' A' ' 235' ' ' ILE . 17.3 m-85 -67.24 -29.99 69.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.39 0.614 . . . . 0.0 110.63 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.53 -24.15 63.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.902 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.53 -13.27 60.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.771 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -111.43 -30.92 7.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.799 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -157.34 166.8 33.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.974 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -80.18 110.69 15.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.509 0.671 . . . . 0.0 111.036 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.653 HD11 ' HB2' ' A' ' 229' ' ' PHE . 37.5 mt -83.17 151.21 4.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.604 -176.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -106.02 -34.94 7.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.448 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.4 p -173.37 156.24 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 255' ' ' ILE . 74.1 m -142.46 138.88 31.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.252 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 31.9 m -141.14 103.0 4.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.696 HD21 HG13 ' A' ' 225' ' ' ILE . 81.2 mt -83.94 149.53 26.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.705 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -84.85 104.37 14.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.756 0.313 . . . . 0.0 110.356 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.736 ' HG3' ' HB3' ' A' ' 249' ' ' HIS . 0.2 OUTLIER -97.53 152.67 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.53 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.612 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 8.8 m-20 -77.84 148.72 76.26 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.95 -8.13 13.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.972 2.448 . . . . 0.0 114.422 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -166.62 38.82 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.612 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 25.4 p -108.21 -16.45 14.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.347 -0.846 . . . . 0.0 112.02 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.4 77.17 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.696 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.567 ' HD2' ' HB2' ' A' ' 218' ' ' GLN . 46.4 pttt -168.22 -168.56 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.736 ' HB3' ' HG3' ' A' ' 242' ' ' ARG . 33.9 p80 -118.79 165.16 14.37 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.239 -177.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.409 ' HE2' ' OD2' ' A' ' 243' ' ' ASP . 77.4 mttt -64.76 -68.98 0.32 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.211 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 216' ' ' VAL . . . 170.5 24.91 0.02 OUTLIER Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.431 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -152.4 160.51 43.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.565 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.21 178.83 45.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.532 -176.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.599 ' HZ ' ' HG3' ' A' ' 164' ' ' GLU . 81.2 m-85 -131.92 153.05 50.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.774 0.321 . . . . 0.0 111.119 -176.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.729 HD11 HG22 ' A' ' 225' ' ' ILE . 84.1 mt -142.19 131.29 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.074 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.892 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 45.6 mt-10 -105.7 146.65 29.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 9.7 m-85 -110.77 160.61 16.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.723 0.297 . . . . 0.0 110.795 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.28 -23.77 51.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.372 0.606 . . . . 0.0 110.066 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -130.53 124.61 32.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.018 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.79 68.79 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.543 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 262' ' ' SER . 7.8 pt20 -59.6 -42.88 93.59 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.102 0.251 . . . . 0.0 111.03 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.434 ' N ' ' HG3' ' A' ' 261' ' ' GLN . 20.1 m -71.14 -32.83 69.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.826 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -43.06 97.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.017 0.437 . . . . 0.0 111.039 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -74.73 -23.12 58.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.49 -35.75 65.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.053 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.61 84.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.923 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.447 ' HA ' ' CG2' ' A' ' 282' ' ' VAL . 77.3 t -58.76 -27.01 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.225 0.535 . . . . 0.0 110.646 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.8 t -86.15 -30.6 22.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.9 m -93.95 -41.15 9.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.588 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 88.3 mmm -84.11 4.9 28.22 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -169.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.449 ' HA ' HG12 ' A' ' 282' ' ' VAL . 11.0 t30 -71.58 118.11 13.98 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.382 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 93.1 mt 66.83 34.13 5.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.601 -178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -88.33 122.85 32.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.438 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 16.3 t70 -73.28 119.24 17.25 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.727 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 44.8 tp -137.01 91.91 2.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.292 0.568 . . . . 0.0 110.111 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 96.65 22.77 17.6 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.464 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.91 -1.93 68.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.623 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -127.2 147.26 50.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.506 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 84.6 m-85 -89.39 116.1 27.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.217 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 69.6 mt -58.04 127.85 34.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.857 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 17.1 mmt180 -93.45 115.39 27.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 271' ' ' ASN . 13.9 p -115.82 135.98 54.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.178 0.513 . . . . 0.0 111.143 -173.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -154.94 -179.53 30.2 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.537 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 284' ' ' LYS . 39.3 mtpt -84.16 130.2 34.86 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.56 120.63 12.11 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.528 0.518 . . . . 0.0 109.821 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.68 -26.89 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 28.3 p -134.86 145.11 53.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.654 0.264 . . . . 0.0 110.783 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.459 -0.523 0 C-N-CA 122.366 2.044 . . . . 0.0 112.199 177.022 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -65.54 -32.2 73.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.835 0.35 . . . . 0.0 111.283 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.22 -30.84 66.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.153 0.502 . . . . 0.0 110.438 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.704 HD21 HD13 ' A' ' 201' ' ' LEU . 56.9 mt -71.71 -33.08 68.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.325 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.9 73.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.265 0.555 . . . . 0.0 110.028 175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.7 mt -73.31 -38.49 53.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.116 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.437 ' SD ' HG23 ' A' ' 198' ' ' ILE . 31.7 mtm -74.29 -2.22 24.11 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.541 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 73.8 m -82.68 -8.58 59.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.098 0.475 . . . . 0.0 110.018 175.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.931 ' HG2' ' HG2' ' A' ' 159' ' ' GLU . 58.3 mtt180 -113.33 141.87 46.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.15 -177.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.567 HG12 ' HB ' ' A' ' 158' ' ' VAL . 9.9 p -121.51 130.32 74.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.273 0.558 . . . . 0.0 109.749 171.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -83.64 114.91 21.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.079 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 21.4 m -112.24 121.23 64.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.616 0.722 . . . . 0.0 110.935 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.501 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -127.47 173.09 18.69 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.981 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 58.7 m 60.75 31.47 20.11 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.408 0.283 . . . . 0.0 111.176 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.561 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 71.1 mt -61.39 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.485 -176.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 119' ' ' ILE . 2.3 t80 164.6 149.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -174.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -88.26 73.14 8.94 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -176.84 -58.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.226 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.8 mt -58.84 99.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.273 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.32 171.32 54.76 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.032 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -57.05 -39.9 75.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.874 0.368 . . . . 0.0 110.656 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.35 -49.46 77.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.79 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.7 m -63.3 -44.18 95.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.087 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.418 HG13 ' HE1' ' A' ' 143' ' ' MET . 33.8 mm -60.74 -40.46 85.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.532 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -61.2 -38.67 87.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.337 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -70.88 -34.04 71.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.495 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.431 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -82.07 -29.02 32.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.231 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.512 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 46.3 m-85 -94.33 -14.86 24.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.829 0.347 . . . . 0.0 111.569 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.433 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.99 -41.97 88.3 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 55.1 Cg_exo -42.48 -35.72 4.04 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.016 2.477 . . . . 0.0 114.488 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.521 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 51.3 m-85 -82.49 -49.34 10.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 121.141 -0.223 . . . . 0.0 111.202 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.01 172.39 39.84 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.918 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.94 121.64 8.29 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.617 2.211 . . . . 0.0 111.705 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.2 mt -84.53 116.7 28.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.945 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -74.76 -43.75 53.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.917 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.3 t -161.96 152.78 17.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.358 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -130.45 126.12 60.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.63 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 13.3 t70 -96.28 99.77 11.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.418 ' HE1' HG13 ' A' ' 128' ' ' ILE . 46.9 ttm -136.21 126.88 27.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.204 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 C--N 1.322 -0.613 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.008 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.501 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 67.2 m-85 . . . . . 0 C--O 1.233 0.237 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 142' ' ' ASP . . . -137.29 140.95 41.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.089 0.471 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -109.98 109.75 20.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.597 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.567 ' HB ' HG12 ' A' ' 114' ' ' VAL . 47.7 t -91.06 110.36 22.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.337 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.931 ' HG2' ' HG2' ' A' ' 113' ' ' ARG . 47.3 mt-10 -99.72 123.08 43.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.532 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.44 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 95.8 m-85 -100.98 171.67 7.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.033 0.444 . . . . 0.0 110.085 176.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -86.1 -5.36 59.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.271 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 5.2 m -142.23 143.98 29.59 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.191 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 12.6 Cg_exo -69.69 -26.54 27.82 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.384 2.723 . . . . 0.0 112.038 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.685 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 8.1 mp0 -55.73 -57.05 13.62 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.954 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -59.81 -19.73 52.51 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.85 -51.15 8.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -68.07 -31.55 71.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.757 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.521 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 18.2 tp -67.03 -46.47 74.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.673 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.81 -34.73 73.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.072 0.463 . . . . 0.0 110.168 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 185' ' ' VAL . 2.9 tp -67.6 -51.98 43.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.556 172.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -54.83 -34.44 62.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.745 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -100.56 -51.54 3.58 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.1 ttp -107.78 29.33 7.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -165.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 31.9 p-10 -78.72 25.21 0.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.911 0.386 . . . . 0.0 111.302 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.1 m -113.33 -72.91 0.68 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.867 0.365 . . . . 0.0 111.069 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 30.9 m -134.29 164.04 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.002 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.627 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.9 tpt -139.51 91.9 2.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.793 0.33 . . . . 0.0 110.734 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.544 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 94.6 mt 61.56 -177.79 0.12 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.429 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.69 -113.14 1.06 Allowed Glycine 0 C--N 1.337 0.587 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.185 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.6 45.84 0.59 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 119' ' ' ILE . 12.5 tpt180 -127.2 135.84 51.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.899 -173.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 4.1 p-10 -91.85 142.53 27.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.627 HD13 ' HB2' ' A' ' 177' ' ' MET . 42.8 pt -129.66 168.19 23.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.792 0.33 . . . . 0.0 110.568 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 55.5 tptt -109.25 106.01 15.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.772 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.501 ' O ' HD13 ' A' ' 170' ' ' LEU . 43.3 t -103.03 104.29 16.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.698 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.1 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.458 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 59.5 tt0 . . . . . 0 C--O 1.236 0.368 0 CA-C-O 120.855 0.36 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.434 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -74.43 -23.2 58.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.203 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.695 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 23.1 tm0? -58.93 -52.92 71.38 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.497 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 54.2 Cg_exo -56.61 -35.17 96.97 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.286 1.99 . . . . 0.0 112.65 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.3 mt -67.99 -43.73 85.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 109.92 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.437 HG23 ' SD ' ' A' ' 111' ' ' MET . 84.9 mt -59.6 -48.71 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.052 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.25 -45.53 90.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.91 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -62.02 -53.03 61.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.704 HD13 HD21 ' A' ' 108' ' ' LEU . 30.8 mt -65.83 -33.11 75.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.262 -178.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.662 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.28 -42.84 70.48 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -71.44 -34.47 70.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.907 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 31.3 mt-10 -65.09 -36.51 84.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.67 -26.73 64.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.686 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.5 mtp180 -72.29 -14.12 61.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.59 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -88.39 0.8 55.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.351 0.596 . . . . 0.0 110.273 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -131.42 177.18 7.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.926 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 3.1 m-80 -118.95 43.35 2.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.13 -174.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 210' ' ' ARG . 36.7 ttt180 -99.8 137.24 38.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.98 -173.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.1 pt -133.08 166.57 29.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.559 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.625 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 84.6 t80 -120.81 131.89 54.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.363 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.443 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 33.6 m -125.91 137.42 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.156 0.503 . . . . 0.0 110.677 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -133.29 -178.55 5.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.715 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 28.2 t 62.73 26.58 15.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.756 0.789 . . . . 0.0 109.444 -171.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.452 HG13 HD11 ' A' ' 225' ' ' ILE . 9.4 t -79.68 115.86 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.093 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -60.88 145.5 49.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.551 -171.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -48.42 -54.54 13.7 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -85.68 36.91 0.67 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.992 0.425 . . . . 0.0 111.537 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 220' ' ' LEU . 9.1 tp -121.01 118.01 28.74 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 19.7 m -99.3 177.45 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.388 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -64.42 -26.75 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 110.412 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.46 -40.25 92.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.348 0.594 . . . . 0.0 109.909 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.64 -50.0 68.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.799 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.624 HG22 HD11 ' A' ' 255' ' ' ILE . 26.0 mm -68.17 -44.81 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.435 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 64.0 tttm -57.61 -46.56 83.93 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.44 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.2 t -52.76 -48.47 66.75 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.68 -43.32 61.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.343 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.579 ' CB ' HD11 ' A' ' 235' ' ' ILE . 11.2 m-85 -67.39 -30.01 69.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.232 0.539 . . . . 0.0 110.744 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.565 ' OE1' ' HB ' ' A' ' 235' ' ' ILE . 9.0 tp10 -63.16 -24.45 67.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.843 177.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.56 -11.63 59.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.874 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -111.2 -40.2 4.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.515 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -142.81 166.51 26.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.767 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -77.97 106.84 10.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.078 0.466 . . . . 0.0 110.521 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.579 HD11 ' CB ' ' A' ' 229' ' ' PHE . 21.5 mt -83.29 148.37 5.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.636 0.731 . . . . 0.0 111.579 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -106.9 -36.15 6.72 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.097 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.1 m -154.7 146.5 23.4 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -171.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 49.7 t -141.83 119.45 11.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.6 m -140.48 103.13 4.48 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.301 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.617 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 48.1 mt -75.96 129.23 36.59 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.47 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.21 116.5 6.64 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.475 0.485 . . . . 0.0 110.195 -175.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 31.0 ttp180 -136.43 142.21 43.63 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.783 -174.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.496 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 9.2 m-20 -75.97 115.18 44.21 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.69 -27.33 25.92 Favored 'Trans proline' 0 CA--C 1.527 0.175 0 C-N-CA 123.679 2.919 . . . . 0.0 114.138 -171.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 t -97.44 -14.21 21.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 71.0 p -92.37 -39.32 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.843 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.77 -0.47 70.14 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.3 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 62.6 pttt -117.56 138.18 52.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -82.63 144.55 30.22 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 252' ' ' TYR . 23.8 mtpp -78.29 10.96 2.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -167.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.64 38.43 Favored Glycine 0 CA--C 1.508 -0.388 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.264 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 250' ' ' LYS . 28.9 p90 -142.15 177.78 8.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.687 0.28 . . . . 0.0 110.488 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -167.63 174.41 42.68 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.158 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.685 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 86.1 m-85 -126.38 149.67 49.08 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.624 HD11 HG22 ' A' ' 225' ' ' ILE . 74.9 mt -140.29 142.73 30.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.454 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 51.0 mt-10 -117.75 147.52 42.9 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.551 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 11.6 m-85 -114.38 171.0 7.89 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 171.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -86.99 -9.75 54.85 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.46 0.648 . . . . 0.0 109.569 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -136.12 122.63 20.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.273 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.71 72.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.141 0.496 . . . . 0.0 111.079 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -63.44 -36.47 83.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.882 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.5 m -71.64 -40.82 69.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.33 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 43.1 p -67.17 -36.79 82.55 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -67.68 -30.86 70.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.3 -35.49 76.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.115 0.483 . . . . 0.0 110.256 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.24 85.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.086 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.441 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 95.7 t -58.25 -34.12 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 121.443 0.639 . . . . 0.0 110.126 173.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 43.1 t -73.06 -44.59 60.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.362 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.8 m -90.37 -35.36 15.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.45 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 82.7 mmm -87.17 -7.79 57.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -170.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -73.24 122.09 21.39 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.165 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 97.4 mt 64.25 31.27 13.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.437 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -86.59 133.85 33.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.022 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -80.09 105.6 11.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.951 0.405 . . . . 0.0 110.607 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 56.1 tp -126.11 95.65 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.244 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.12 21.99 47.07 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.502 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 90.05 9.26 65.89 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.607 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -129.92 155.3 46.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.57 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 73.5 m-85 -100.39 109.35 21.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 74.9 mt -59.55 133.95 56.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.639 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.414 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 14.8 mmt180 -99.58 116.18 31.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 267' ' ' VAL . 12.4 p -123.68 144.41 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.65 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.45 173.06 38.68 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.691 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -71.95 128.1 34.66 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.23 113.25 6.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.25 -24.14 23.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.867 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 50.2 p -100.67 133.09 21.43 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.983 0.42 . . . . 0.0 110.403 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 N--CA 1.463 -0.292 0 C-N-CA 122.594 2.196 . . . . 0.0 111.603 176.271 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.751 0.31 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.28 -48.85 80.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.474 ' HB2' HD12 ' A' ' 197' ' ' ILE . . . -69.75 -22.8 63.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.489 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.91 -32.12 73.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.092 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.71 -28.37 68.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.341 0.591 . . . . 0.0 110.401 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.0 mt -87.91 -40.44 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.343 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.539 ' SD ' HG12 ' A' ' 198' ' ' ILE . 92.2 mtp -69.08 -29.9 68.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.018 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 92.9 m -73.94 -12.02 60.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.593 0.235 . . . . 0.0 111.01 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 159' ' ' GLU . 47.1 mtt180 -106.51 141.39 37.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.08 0.467 . . . . 0.0 110.894 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.54 122.43 69.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.461 0.648 . . . . 0.0 109.407 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -74.86 119.88 19.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.108 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 15.3 m -114.22 114.74 47.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.405 0.621 . . . . 0.0 109.959 175.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.06 171.36 13.78 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.249 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.9 m 58.67 35.08 24.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 111.102 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.544 HD11 HG23 ' A' ' 116' ' ' VAL . 58.3 mt -68.99 126.36 28.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.213 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.62 140.28 58.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.165 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.37 77.3 1.02 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 122.133 0.968 . . . . 0.0 111.19 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -170.93 -26.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.732 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.401 HD22 HD12 ' A' ' 178' ' ' LEU . 40.1 mt -93.4 110.02 21.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.253 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.26 -174.99 45.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.962 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.65 -40.55 97.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 110.117 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.545 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 36.0 t70 -62.89 -48.77 77.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.688 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -61.12 -43.65 98.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.177 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.1 mm -63.66 -43.18 98.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -57.91 -41.37 82.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.486 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 97.8 mt-30 -60.29 -46.31 90.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.495 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.583 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -80.87 -26.98 36.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -171.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.527 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 32.1 m-85 -90.17 -16.4 29.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.705 0.288 . . . . 0.0 111.542 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.621 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -56.9 -42.48 96.57 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 6.9 Cg_endo -51.31 -27.92 25.09 Favored 'Trans proline' 0 C--N 1.361 1.184 0 C-N-CA 122.507 2.138 . . . . 0.0 114.197 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.752 ' HD2' ' HG ' ' A' ' 168' ' ' LEU . 64.6 m-85 -80.99 -46.04 15.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.635 0.255 . . . . 0.0 110.988 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.31 -178.53 39.09 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.476 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 62.3 Cg_endo -75.43 117.45 4.82 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.559 2.173 . . . . 0.0 111.65 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.8 mt -83.49 114.24 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.897 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.616 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 74.3 tttt -88.38 -33.17 18.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.78 -173.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.7 t -157.94 147.91 20.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.389 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.9 mt -133.67 113.24 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -96.63 100.02 11.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.514 ' HG3' ' HB2' ' A' ' 156' ' ' ALA . 52.4 ttm -126.92 137.85 53.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 177.933 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 38.5 p90 . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.172 0.511 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.514 ' HB2' ' HG3' ' A' ' 143' ' ' MET . . . -152.08 154.5 36.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.377 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -111.93 109.85 19.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.185 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 62.1 t -91.91 112.16 25.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.756 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.47 ' HA ' ' HG2' ' A' ' 113' ' ' ARG . 39.0 tt0 -100.08 120.49 39.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.972 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -98.23 170.0 9.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.685 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.616 ' HG2' ' HD2' ' A' ' 139' ' ' LYS . 35.6 mt-10 -80.34 -38.67 30.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 171.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.2 m -109.64 135.81 20.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.365 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 56.2 Cg_endo -69.44 -21.15 35.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.127 2.551 . . . . 0.0 112.597 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.696 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 10.7 mp0 -57.59 -50.65 72.41 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.129 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.407 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.04 -21.76 65.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.46 -51.72 8.99 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.022 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 164' ' ' GLU . 5.0 pp0? -63.85 -30.23 71.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.556 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.752 ' HG ' ' HD2' ' A' ' 135' ' ' PHE . 14.2 tp -73.79 -45.83 49.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.6 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.4 72.17 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.531 ' O ' ' HB3' ' A' ' 174' ' ' ASN . 6.8 tt -66.44 -50.0 64.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.27 172.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 10.6 mm-40 -52.72 -50.87 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.554 -178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -89.72 -32.98 16.76 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 22.8 mtm -106.71 30.79 5.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.479 . . . . 0.0 111.744 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 33.4 p-10 -74.92 -3.59 33.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.412 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.6 m -95.13 -73.38 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 110.841 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.9 m -140.69 164.73 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.082 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.635 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.4 tpt -124.43 95.03 4.38 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.549 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.401 HD12 HD22 ' A' ' 123' ' ' LEU . 91.7 mt 71.95 -50.53 0.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.971 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 161.1 -177.29 37.52 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.638 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 94.72 -87.78 1.1 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.604 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -127.55 142.54 51.35 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -70.68 108.4 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.635 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.3 pt -72.47 156.35 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.776 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 83.2 tttt -106.2 116.77 32.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.258 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 116' ' ' VAL . 5.4 m -100.27 114.39 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 172.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.478 179.004 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 . . . . . 0 N--CA 1.464 0.271 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.428 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -78.04 -22.2 49.53 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.545 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 71.9 mm-40 -52.32 -54.02 46.4 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -175.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 53.2 Cg_exo -56.21 -34.54 93.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.021 1.814 . . . . 0.0 112.684 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 107' ' ' ALA . 51.3 mt -75.98 -45.98 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.327 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.539 HG12 ' SD ' ' A' ' 111' ' ' MET . 69.1 mt -60.85 -43.34 95.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.292 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.08 -38.73 89.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.857 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -61.63 -52.47 64.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.855 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.532 HD13 HG22 ' A' ' 287' ' ' THR . 25.5 mt -67.54 -32.69 73.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.608 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.671 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.63 -47.84 66.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 171.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.515 ' OE1' ' HD3' ' A' ' 206' ' ' ARG . 5.8 mm-40 -63.24 -35.24 79.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.213 175.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.663 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 47.6 mt-10 -66.41 -33.45 75.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -77.64 -29.28 51.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.969 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.671 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 59.4 mtp180 -72.62 -25.35 61.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 110.408 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.65 -39.93 18.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.342 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -105.57 79.53 1.46 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 0.0 OUTLIER -52.4 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.427 1.079 . . . . 0.0 111.403 -173.198 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.471 ' HB2' ' HG3' ' A' ' 256' ' ' GLU . 44.8 ttm105 -134.09 146.12 50.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.995 0.426 . . . . 0.0 111.59 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.613 HG23 ' HB2' ' A' ' 263' ' ' SER . 49.3 pt -123.78 166.46 18.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.17 174.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.487 ' CG ' ' HB3' ' A' ' 164' ' ' GLU . 85.4 t80 -118.14 129.51 55.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.46 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 29.3 m -121.1 128.56 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.335 0.588 . . . . 0.0 110.237 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -119.57 176.2 5.48 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.464 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.4 m 60.26 32.59 20.83 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.415 0.626 . . . . 0.0 109.972 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.49 114.67 20.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.353 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 32.4 t-80 -55.57 137.65 48.44 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.456 0.472 . . . . 0.0 111.744 -172.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -49.99 -52.37 34.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -82.23 20.38 1.05 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.91 0.386 . . . . 0.0 111.722 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.654 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.0 tp -105.41 126.53 52.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.0 m -90.85 163.96 14.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.832 0.349 . . . . 0.0 111.746 -173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.452 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 6.0 p-10 -65.11 -27.29 68.65 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.27 0.557 . . . . 0.0 110.313 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.34 -31.61 71.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.751 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -74.33 -39.85 62.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.694 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.795 HG13 HD21 ' A' ' 240' ' ' LEU . 24.8 mm -65.74 -46.7 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -58.61 -51.56 69.41 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.955 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.4 p -58.94 -38.92 80.11 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 51.1 t -76.53 -41.99 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.196 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.543 ' CB ' HD11 ' A' ' 235' ' ' ILE . 25.0 m-85 -65.43 -28.67 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.217 -0.302 . . . . 0.0 110.736 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.18 -25.02 67.54 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.522 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.88 -17.49 55.51 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.064 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -111.52 -31.36 7.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.924 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.542 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -146.93 160.25 28.21 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.377 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 234' ' ' LYS . 0.7 OUTLIER -84.71 107.63 17.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.492 0.663 . . . . 0.0 110.993 -177.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.543 HD11 ' CB ' ' A' ' 229' ' ' PHE . 37.3 mt -86.03 151.4 3.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.928 -173.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -106.23 -27.49 11.01 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.921 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 235' ' ' ILE . 3.0 p -176.87 152.1 0.92 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.575 0.226 . . . . 0.0 110.677 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 36.5 t -137.59 129.5 28.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.282 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.1 t -141.05 104.16 4.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.411 0.624 . . . . 0.0 111.599 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.795 HD21 HG13 ' A' ' 225' ' ' ILE . 30.9 mt -75.95 133.57 40.43 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.433 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.44 114.35 4.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.162 0.506 . . . . 0.0 110.257 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.585 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 13.7 mtp180 -112.21 164.89 12.68 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.438 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.28 141.4 57.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -43.75 -45.04 11.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.518 2.812 . . . . 0.0 113.905 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.9 t -155.61 86.21 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.722 0.773 . . . . 0.0 111.21 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 20.3 p -135.28 -42.84 0.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.728 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 121.92 -24.04 7.19 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.463 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -107.65 166.5 10.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.969 0.414 . . . . 0.0 110.471 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 9.7 p80 -96.63 165.35 12.19 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -73.39 -82.15 0.06 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.402 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -167.4 7.52 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.615 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.421 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 28.7 p90 -150.49 175.76 11.57 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -165.16 174.98 41.09 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.44 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.696 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 78.8 m-85 -129.54 150.95 50.66 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 225' ' ' ILE . 81.9 mt -142.49 133.04 23.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.473 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 4.8 mp0 -106.51 146.97 29.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.648 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 8.8 m-85 -118.68 165.15 14.33 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.83 -37.57 86.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.755 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -118.22 140.12 50.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.434 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.76 -25.73 68.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.224 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -74.21 -43.45 57.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.234 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.6 m -66.32 -33.0 74.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.982 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.648 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 79.9 p -66.29 -37.82 86.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -71.39 -27.94 63.67 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.473 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.44 -44.08 92.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.077 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.05 92.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.386 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.65 -40.31 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.573 . . . . 0.0 110.665 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 20.7 m -70.35 -30.98 68.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.533 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.0 m -94.37 -42.99 8.6 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.477 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.3 mmm -82.66 6.45 17.81 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -169.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.483 ' HA ' HG12 ' A' ' 282' ' ' VAL . 65.2 t30 -72.13 120.57 17.92 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.277 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 93.4 mt 64.21 31.25 13.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.418 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -78.91 128.93 33.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.386 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.422 ' HB2' ' HE1' ' A' ' 279' ' ' TYR . 36.6 t70 -74.47 102.92 4.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.654 ' HG ' HD21 ' A' ' 220' ' ' LEU . 34.2 tp -136.8 109.93 7.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.752 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.07 56.69 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.408 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 83.11 4.46 89.83 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.654 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -130.47 156.15 45.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.435 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 45.7 m-85 -97.18 111.76 23.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.506 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 45.6 mt -59.68 127.17 30.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.5 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 30.6 mmt180 -92.71 114.37 26.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 171.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 271' ' ' ASN . 11.0 p -118.5 151.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.487 -171.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -169.58 174.86 43.9 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -72.68 141.96 48.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.404 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -82.36 129.35 34.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.418 ' CG1' ' HG2' ' A' ' 167' ' ' GLN . 19.9 m -92.05 -23.05 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.723 0.297 . . . . 0.0 110.739 -175.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.532 HG22 HD13 ' A' ' 201' ' ' LEU . 38.0 p -128.81 156.5 77.63 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 121.136 0.493 . . . . 0.0 111.373 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.663 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 66.4 Cg_endo . . . . . 0 N--CA 1.447 -1.242 0 C-N-CA 123.252 2.635 . . . . 0.0 112.662 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.516 0.198 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -57.12 -42.47 80.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.08 0.467 . . . . 0.0 110.991 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.63 -31.4 65.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.769 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 201' ' ' LEU . 45.7 mt -70.7 -32.93 70.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.14 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.36 -33.86 73.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.347 0.594 . . . . 0.0 109.801 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.4 mt -75.71 -37.07 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.381 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.562 ' CG ' HD12 ' A' ' 198' ' ' ILE . 86.6 mtp -69.26 -20.78 63.93 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.021 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 82.1 m -74.5 -11.72 60.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -99.5 142.38 31.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.805 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.6 p -123.52 122.74 65.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 89.5 t80 -65.56 126.62 28.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.741 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.99 115.41 48.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -124.3 163.2 18.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.139 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.0 m 60.76 47.12 8.27 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 122.661 0.385 . . . . 0.0 111.233 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.496 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 49.2 mt -74.05 -28.28 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.353 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 35.7 t80 72.43 135.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.619 0.575 . . . . 0.0 109.528 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -77.16 77.22 3.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.193 0.997 . . . . 0.0 111.047 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -151.67 -49.45 0.11 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.566 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.459 HD22 HD12 ' A' ' 178' ' ' LEU . 57.0 mt -68.04 137.64 55.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.59 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -98.72 173.67 27.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.409 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.82 -51.25 70.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 110.88 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.98 -27.83 63.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.876 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -64.55 -43.53 93.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.188 0.518 . . . . 0.0 109.762 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.556 HG13 ' HE1' ' A' ' 143' ' ' MET . 36.5 mm -64.44 -41.35 92.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.151 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 129' ' ' ARG . 20.7 ttt180 -55.73 -49.18 73.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.777 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.87 -33.29 73.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.759 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.611 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -83.17 -35.51 25.45 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.23 -17.2 33.14 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.55 96.38 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -44.35 -36.2 9.15 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.714 2.276 . . . . 0.0 114.277 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 169' ' ' ALA . 60.7 m-85 -77.9 -39.01 44.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.666 0.269 . . . . 0.0 110.717 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . -173.8 167.6 40.2 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.738 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.46 114.52 2.56 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.578 2.186 . . . . 0.0 111.865 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.577 HD13 HD11 ' A' ' 141' ' ' ILE . 65.2 mt -74.05 130.71 35.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.635 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 139' ' ' LYS . 36.8 ttpt -93.06 -33.99 13.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.393 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 t -174.05 128.38 0.38 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.949 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.577 HD11 HD13 ' A' ' 138' ' ' ILE . 68.9 mt -104.42 119.12 52.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -88.23 100.67 13.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.556 ' HE1' HG13 ' A' ' 128' ' ' ILE . 43.7 ttm -143.41 101.28 3.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.93 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 C--N 1.324 -0.529 0 CA-C-O 120.841 0.353 . . . . 0.0 110.924 -178.061 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.9 p90 . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.93 169.33 24.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.316 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.467 ' CE2' ' HD1' ' A' ' 115' ' ' TYR . 95.6 m-85 -124.18 112.82 17.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.164 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.1 t -91.85 108.5 20.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -105.06 118.99 37.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.11 0.481 . . . . 0.0 110.036 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -88.66 -176.11 5.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.966 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -83.35 -35.52 25.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.4 m -117.41 140.91 27.94 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.405 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 51.0 Cg_endo -66.84 -19.7 52.54 Favored 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 123.52 2.814 . . . . 0.0 112.609 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.654 ' HG3' ' CE1' ' A' ' 254' ' ' PHE . 80.6 mm-40 -58.33 -55.04 40.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.752 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.68 -21.03 62.4 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.984 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.92 -48.68 15.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.692 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.472 ' HG3' HG11 ' A' ' 286' ' ' VAL . 30.5 mm-40 -69.19 -33.18 72.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.503 174.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.509 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 13.7 tp -65.65 -47.07 76.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.656 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . . . -59.79 -37.71 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.08 0.467 . . . . 0.0 110.13 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.588 ' HG ' HG23 ' A' ' 185' ' ' VAL . 6.8 tt -65.38 -43.52 90.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.806 174.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.34 -34.44 76.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.99 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -100.61 -47.25 4.92 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.7 ttp -102.91 31.04 4.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.363 0.602 . . . . 0.0 111.708 -166.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 4.8 p-10 -74.68 16.66 0.26 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.551 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.4 m -106.35 -74.01 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.675 0.274 . . . . 0.0 111.47 -175.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 18.6 m -144.34 169.56 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.744 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.9 tpt -129.62 101.1 5.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 110.673 177.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.742 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 94.6 mt 63.66 32.45 13.82 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.016 173.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.63 -31.63 1.92 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.087 -0.578 . . . . 0.0 114.32 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.75 -64.71 3.99 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.647 -0.311 . . . . 0.0 113.293 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -144.41 150.91 38.49 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.563 -0.375 . . . . 0.0 110.679 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 8.4 p30 -72.44 118.8 15.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 177' ' ' MET . 43.6 pt -96.46 157.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.497 -174.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -105.14 110.99 23.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.408 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.588 HG23 ' HG ' ' A' ' 170' ' ' LEU . 9.7 m -99.76 122.82 52.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.067 0.461 . . . . 0.0 109.922 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.955 -178.022 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 . . . . . 0 N--CA 1.46 0.052 0 CA-C-O 121.058 0.456 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.472 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -97.52 11.81 35.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.777 -175.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.567 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 25.2 tm0? -53.57 -47.16 97.42 Favored Pre-proline 0 N--CA 1.47 0.551 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 6.9 Cg_endo -52.76 -36.19 72.21 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.355 2.036 . . . . 0.0 112.884 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 78.2 mt -74.18 -38.58 48.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.19 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.562 HD12 ' CG ' ' A' ' 111' ' ' MET . 12.7 mm -57.66 -50.19 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.179 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 30.5 t70 -69.98 -32.56 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.854 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.37 -50.64 72.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.03 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.458 HD13 HD21 ' A' ' 108' ' ' LEU . 44.6 mt -68.86 -33.47 73.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.645 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -55.54 -42.55 74.77 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 52.3 mt-10 -63.26 -33.73 76.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.732 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.72 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 26.4 mt-10 -65.37 -36.23 83.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.915 0.388 . . . . 0.0 110.84 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.5 -39.13 62.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.705 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.572 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 60.0 mtp180 -61.02 -22.3 64.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.485 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.96 -27.36 65.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.039 0.447 . . . . 0.0 110.71 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -105.8 169.73 8.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.224 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 0.9 OUTLIER -103.75 51.27 0.79 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.471 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 39.3 ttm180 -105.18 139.13 40.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.023 -167.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.457 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.4 pt -127.97 166.22 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.879 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.481 ' HE1' ' HB2' ' A' ' 252' ' ' TYR . 25.0 t80 -118.24 135.81 54.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.019 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.507 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.5 m -130.01 136.45 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 110.991 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -131.3 -179.17 5.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.553 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 69.6 m 62.44 27.37 16.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.869 0.842 . . . . 0.0 109.72 -171.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.496 HG13 HD11 ' A' ' 225' ' ' ILE . 21.7 t -79.22 116.56 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.538 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -56.0 140.7 42.46 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.253 0.549 . . . . 0.0 111.476 -174.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -58.52 -29.31 66.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.972 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.45 6.14 42.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.868 0.842 . . . . 0.0 110.067 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.566 HD21 ' HG ' ' A' ' 275' ' ' LEU . 7.3 tp -112.59 122.77 48.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.079 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.4 t -107.25 -178.69 3.71 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.074 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -60.63 -37.52 81.73 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.99 -24.62 64.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 0.0 110.452 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -72.6 -52.74 14.2 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.865 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.496 HD11 HG13 ' A' ' 216' ' ' VAL . 31.4 mm -61.76 -42.04 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.063 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 85.5 tttt -56.31 -50.23 72.02 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.708 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 m -56.09 -37.78 69.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 20.8 t -76.65 -44.28 33.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.574 ' HB2' HD11 ' A' ' 235' ' ' ILE . 7.4 m-85 -67.94 -31.34 71.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.591 0.71 . . . . 0.0 110.522 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -60.62 -24.46 65.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.94 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.29 -15.45 62.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.922 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.49 -33.76 6.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.348 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -152.03 163.7 30.21 Favored Glycine 0 CA--C 1.517 0.159 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.704 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.93 110.62 6.55 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.147 0.498 . . . . 0.0 111.581 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 229' ' ' PHE . 23.3 mt -88.33 150.44 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.017 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -106.16 -31.9 8.47 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.191 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 20.4 p -166.45 156.46 11.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.012 0.434 . . . . 0.0 111.423 -172.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 9.2 p -141.15 124.52 16.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.831 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.0 t -141.49 115.07 8.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.255 0.55 . . . . 0.0 110.973 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.503 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 28.9 mt -91.99 137.13 32.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.43 98.47 0.85 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.978 0.418 . . . . 0.0 110.08 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.655 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 25.5 ttt180 -104.68 131.69 51.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.523 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.555 ' HB2' ' HD2' ' A' ' 250' ' ' LYS . 4.7 t70 -97.28 126.52 41.58 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.317 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 10.5 Cg_exo -69.54 -20.45 35.85 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.457 2.772 . . . . 0.0 113.799 -173.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 43.3 p -87.24 -30.31 21.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.883 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.408 HG23 ' HG2' ' A' ' 248' ' ' LYS . 8.8 t -97.04 -22.84 16.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.295 0.569 . . . . 0.0 110.301 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 77.12 25.67 63.57 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.423 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.513 ' C ' ' HG3' ' A' ' 242' ' ' ARG . 64.2 pttt -142.72 154.65 44.48 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.6 OUTLIER -76.3 131.42 39.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.069 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LYS . . . . . 0.555 ' HD2' ' HB2' ' A' ' 243' ' ' ASP . 50.0 mtpt -74.55 3.41 7.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -164.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 102.5 2.67 50.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.368 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.481 ' HB2' ' HE1' ' A' ' 212' ' ' TYR . 32.9 p90 -141.88 165.21 28.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -169.25 178.46 42.41 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.021 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.654 ' CE1' ' HG3' ' A' ' 164' ' ' GLU . 88.2 m-85 -129.78 148.85 51.7 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.018 0.437 . . . . 0.0 110.594 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 225' ' ' ILE . 95.2 mt -136.08 133.21 50.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.255 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 49.0 mt-10 -113.21 135.14 54.15 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 6.2 m-85 -95.4 179.61 5.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -82.3 -17.97 43.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.467 0.651 . . . . 0.0 109.378 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -129.32 130.14 45.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.535 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 209' ' ' ASN . . . -68.87 -25.01 64.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.164 0.507 . . . . 0.0 111.232 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -75.09 -42.06 57.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.244 176.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.5 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 19.9 m -67.76 -29.44 68.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.733 -175.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.457 ' HB2' HG23 ' A' ' 211' ' ' ILE . 48.3 p -69.05 -32.58 72.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.195 0.521 . . . . 0.0 109.687 177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -74.67 -25.89 59.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.469 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 61.1 m-20 -64.02 -41.12 97.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.262 0.553 . . . . 0.0 109.836 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -61.96 -41.27 97.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.409 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.2 -40.13 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.187 0.517 . . . . 0.0 110.71 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 48.0 t -69.31 -30.9 69.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.5 m -94.53 -43.87 8.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 78.5 mmm -84.48 1.73 44.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.914 -169.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.51 ' HA ' HG12 ' A' ' 282' ' ' VAL . 45.7 t30 -69.45 117.07 10.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.603 0.24 . . . . 0.0 110.423 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 91.6 mt 63.68 36.78 10.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.38 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -90.25 124.55 34.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.254 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.474 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 18.2 t70 -74.81 108.96 7.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.65 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.566 ' HG ' HD21 ' A' ' 220' ' ' LEU . 46.3 tp -141.31 106.77 5.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.969 0.414 . . . . 0.0 109.997 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 94.08 24.64 19.11 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.552 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 78.52 11.85 84.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.654 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -142.68 150.47 40.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.682 0.277 . . . . 0.0 110.432 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 83.0 m-85 -87.16 114.18 23.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.392 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.4 131.68 51.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.636 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 213' ' ' VAL . 16.8 mmt180 -96.39 116.44 29.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 271' ' ' ASN . 9.4 p -120.66 144.68 28.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.617 -175.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.15 174.22 38.56 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.615 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -75.76 126.28 30.7 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.77 126.22 27.79 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.433 0.458 . . . . 0.0 109.862 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.472 HG11 ' HG3' ' A' ' 167' ' ' GLN . 34.4 m -94.29 -26.75 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -172.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.45 HG21 ' CD2' ' A' ' 108' ' ' LEU . 19.0 p -132.51 156.23 80.33 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.018 0.437 . . . . 0.0 111.687 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.72 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 86.6 Cg_endo . . . . . 0 N--CA 1.45 -1.04 0 C-N-CA 122.898 2.399 . . . . 0.0 112.572 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 . . . . . 0 C--O 1.227 -0.129 0 CA-C-O 120.97 0.414 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -61.86 -32.77 73.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.043 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -45.75 87.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.219 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.511 HD23 ' SD ' ' A' ' 111' ' ' MET . 87.0 mt -63.9 -31.84 73.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.807 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.76 67.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.835 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.6 mt -84.94 -33.61 8.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.21 0.528 . . . . 0.0 109.719 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.511 ' SD ' HD23 ' A' ' 108' ' ' LEU . 89.4 mtp -72.98 -21.68 60.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.016 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.955 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 31.6 p -82.59 3.55 28.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.095 0.474 . . . . 0.0 110.7 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.534 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 15.0 mtm180 -113.84 141.7 47.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 186' ' ' GLY . 4.2 p -124.98 122.67 63.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.551 0.691 . . . . 0.0 109.684 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -77.66 128.88 34.81 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 14.0 m -123.79 116.29 47.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.506 0.669 . . . . 0.0 110.241 175.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -125.11 174.84 17.33 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.582 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.5 m 61.77 34.35 17.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.961 0.41 . . . . 0.0 110.817 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 123' ' ' LEU . 63.9 mt -78.17 119.27 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.047 0.451 . . . . 0.0 110.889 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -53.25 144.86 15.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.442 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -70.8 80.61 0.62 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.771 0.796 . . . . 0.0 111.114 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -169.24 -29.69 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.552 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.402 HD12 HG23 ' A' ' 119' ' ' ILE . 35.0 mt -97.6 105.45 17.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.787 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.88 173.36 54.67 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.219 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.8 -35.42 74.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.257 0.551 . . . . 0.0 109.638 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.3 -51.38 67.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.878 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -61.99 -39.92 93.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.161 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.531 HG13 ' CE ' ' A' ' 143' ' ' MET . 22.2 mm -64.46 -39.73 86.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -56.6 -41.43 76.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.079 0.466 . . . . 0.0 110.116 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -72.24 -33.78 67.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.731 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.498 ' HB1' ' SD ' ' A' ' 177' ' ' MET . . . -85.6 -29.4 24.13 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.456 ' CD1' HG23 ' A' ' 128' ' ' ILE . 28.0 m-85 -94.98 -20.74 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -51.53 -41.9 79.65 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 29.2 Cg_exo -38.08 -41.98 1.4 Allowed 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 123.235 2.623 . . . . 0.0 114.625 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.488 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 67.0 m-85 -76.13 -44.59 37.7 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 121.299 -0.161 . . . . 0.0 111.156 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -170.22 166.83 40.02 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.571 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HG2' ' CE1' ' A' ' 252' ' ' TYR . 35.1 Cg_exo -62.16 117.98 4.85 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.846 2.364 . . . . 0.0 111.773 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.84 HD13 HD11 ' A' ' 141' ' ' ILE . 57.2 mt -77.84 130.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.565 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -99.83 -27.36 13.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.44 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.2 t -165.16 131.46 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.043 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.84 HD11 HD13 ' A' ' 138' ' ' ILE . 59.9 mt -130.54 128.81 63.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -120.98 106.77 11.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.965 0.412 . . . . 0.0 110.173 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.531 ' CE ' HG13 ' A' ' 128' ' ' ILE . 46.3 ttm -114.69 138.27 50.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.634 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.285 177.202 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 46.9 p90 . . . . . 0 C--O 1.235 0.317 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.456 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -155.63 148.09 23.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.702 176.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 81.0 m-85 -110.6 113.02 25.31 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.181 175.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.449 ' HB ' HG12 ' A' ' 114' ' ' VAL . 58.9 t -102.74 105.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.534 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 46.6 tt0 -108.44 126.8 53.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.58 177.56 5.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -76.86 -35.15 57.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.059 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.72 142.2 31.29 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.794 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.955 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 37.8 Cg_endo -66.52 -18.28 54.17 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.3 2.667 . . . . 0.0 112.584 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.54 ' HG3' ' HE2' ' A' ' 254' ' ' PHE . 17.0 mm-40 -56.56 -57.36 12.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.827 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.55 -21.92 65.94 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.26 -49.13 15.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.237 0.541 . . . . 0.0 109.672 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.657 ' HB2' HG11 ' A' ' 286' ' ' VAL . 31.8 mm-40 -67.29 -38.79 85.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.505 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.488 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 11.9 tp -60.61 -46.56 89.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.98 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.48 74.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 110.291 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.61 HD13 ' HA3' ' A' ' 186' ' ' GLY . 7.0 tp -70.11 -41.99 73.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.856 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 8.1 mm-40 -59.21 -39.03 81.4 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.311 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -101.02 -50.67 3.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 28.4 ttp -102.86 31.37 4.21 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -162.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.43 13.98 1.76 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.1 m -105.28 -73.52 0.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.573 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.6 m -144.79 144.14 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.199 0.524 . . . . 0.0 111.42 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.498 ' SD ' ' HB1' ' A' ' 131' ' ' ALA . 3.1 tpt -113.4 108.22 16.92 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 177' ' ' MET . 4.3 mm? 72.1 -55.38 0.67 Allowed 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.878 0.736 . . . . 0.0 110.658 -173.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 145.26 -167.11 27.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.393 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 92.3 -51.58 2.76 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.174 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -143.75 139.56 29.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.574 0.187 . . . . 0.0 110.858 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -64.87 112.24 3.18 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.862 172.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.492 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.6 pt -88.49 152.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.503 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 71.5 mmtt -103.66 105.19 15.35 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.478 HG22 HG12 ' A' ' 116' ' ' VAL . 43.1 t -111.23 135.93 48.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.227 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.61 ' HA3' HD13 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.597 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.717 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -76.82 -23.48 52.79 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.012 -0.43 . . . . 0.0 112.079 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.553 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 29.3 mm-40 -63.98 -49.61 73.91 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -172.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 8.9 Cg_endo -52.86 -38.43 78.55 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.665 2.243 . . . . 0.0 113.098 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.6 mt -71.83 -45.25 66.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.773 0.32 . . . . 0.0 110.485 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 194' ' ' ALA . 56.2 mt -60.78 -48.34 89.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.14 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.75 -42.3 95.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.344 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 6.4 tp-100 -60.44 -51.94 67.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.735 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 64.5 mt -67.5 -33.51 75.24 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.576 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.615 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -55.92 -42.96 76.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.304 0.573 . . . . 0.0 109.664 175.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 10.8 mm-40 -73.94 -32.71 63.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.943 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.631 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 29.5 mt-10 -69.69 -30.47 68.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.697 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.54 -29.04 65.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.993 0.425 . . . . 0.0 110.069 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 71.6 mtp180 -71.16 -21.76 62.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.361 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -81.41 6.16 15.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.47 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -132.58 -175.62 3.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.92 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -126.08 46.28 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.904 -174.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -105.58 137.66 43.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.15 -176.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.501 HG23 ' HB2' ' A' ' 263' ' ' SER . 49.2 pt -129.15 166.82 25.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.01 0.433 . . . . 0.0 110.735 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.611 ' HD1' ' CE2' ' A' ' 254' ' ' PHE . 85.2 t80 -122.47 129.72 52.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.421 -174.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.565 HG12 HG23 ' A' ' 282' ' ' VAL . 35.1 m -126.63 135.84 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.046 0.45 . . . . 0.0 110.307 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -132.95 -179.49 5.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.861 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.7 t 63.43 27.56 15.23 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.894 0.854 . . . . 0.0 109.056 -172.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.93 121.31 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.256 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 40.8 t-80 -55.21 133.88 49.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.173 0.511 . . . . 0.0 111.283 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -57.79 -28.63 64.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.291 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.72 3.71 50.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.724 0.297 . . . . 0.0 111.304 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 217' ' ' HIS . 14.1 tp -87.06 134.32 33.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 63.2 p -86.41 156.35 20.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.054 -171.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.94 -42.45 68.85 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.577 0.703 . . . . 0.0 109.474 172.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.46 -40.38 74.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.833 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -71.7 -38.58 70.54 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.1 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.615 HG22 HD11 ' A' ' 255' ' ' ILE . 27.0 mm -65.77 -46.24 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 86.8 tttt -57.7 -42.4 83.65 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.439 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.6 t -55.52 -47.75 75.77 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.641 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.33 -40.91 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 111.444 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.485 ' CB ' HD11 ' A' ' 235' ' ' ILE . 26.4 m-85 -66.74 -29.07 68.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.884 0.373 . . . . 0.0 110.992 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.4 mm-40 -63.9 -24.66 67.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.419 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.85 -20.14 60.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.27 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.64 -37.2 6.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.917 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.41 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -147.18 168.92 28.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.801 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 35.2 mmtt -88.01 116.03 25.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.761 0.791 . . . . 0.0 111.231 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.485 HD11 ' CB ' ' A' ' 229' ' ' PHE . 52.6 mt -86.8 150.95 3.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.641 -173.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -110.8 -22.38 11.59 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.759 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.1 t -172.56 143.28 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.707 0.289 . . . . 0.0 110.379 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.0 t -140.49 105.13 4.9 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.8 m -129.21 110.13 11.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.256 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.56 HD21 HG13 ' A' ' 225' ' ' ILE . 60.9 mt -78.71 131.55 36.65 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.539 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -70.53 122.52 19.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.09 0.471 . . . . 0.0 109.834 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.747 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 76.4 mtt180 -111.05 166.49 11.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.29 -171.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.06 135.24 33.58 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.38 -46.25 11.94 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.861 3.041 . . . . 0.0 114.707 -166.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.3 t -159.73 65.42 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.844 0.831 . . . . 0.0 111.607 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 21.8 p -133.15 6.56 3.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.919 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.01 71.74 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.945 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 248' ' ' LYS . 41.3 mtmt -147.33 159.37 43.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.747 ' HB3' ' HG2' ' A' ' 242' ' ' ARG . 19.8 p80 -107.32 147.36 30.39 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.506 170.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -63.44 -7.5 6.87 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -164.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 108.61 5.43 31.67 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.443 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.421 ' CE1' ' HG2' ' A' ' 137' ' ' PRO . 12.8 p90 -141.43 174.09 10.88 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.539 ' HA2' ' H ' ' A' ' 241' ' ' ALA . . . -164.49 172.34 40.23 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.767 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.611 ' CE2' ' HD1' ' A' ' 212' ' ' TYR . 92.4 m-85 -127.31 143.51 51.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.011 0.434 . . . . 0.0 110.687 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 225' ' ' ILE . 83.5 mt -136.61 136.89 48.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.094 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -116.72 146.73 42.59 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 8.6 m-85 -111.28 175.27 5.49 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -83.79 -13.45 53.79 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.222 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -135.48 133.46 38.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.979 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.4 -24.93 67.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.017 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -73.43 -35.4 65.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.873 175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.45 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 8.2 t -70.69 -37.64 73.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.678 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.501 ' HB2' HG23 ' A' ' 211' ' ' ILE . 62.3 p -66.41 -32.79 74.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.068 0.461 . . . . 0.0 110.115 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.49 -27.02 62.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.83 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.45 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 53.5 m-20 -62.92 -45.3 93.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.208 0.528 . . . . 0.0 109.626 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -62.33 -43.53 98.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.018 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 263' ' ' SER . 86.5 t -55.38 -37.16 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.297 0.57 . . . . 0.0 111.206 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.6 m -75.83 -24.19 55.81 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.246 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 18.3 m -95.08 -41.83 8.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 78.5 mmm -88.07 1.95 53.06 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -167.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.505 ' HA ' HG12 ' A' ' 282' ' ' VAL . 66.7 t30 -72.36 115.42 11.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.213 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.2 mt 65.18 38.35 6.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.346 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -94.39 123.56 37.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.105 174.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.529 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 32.2 t70 -71.94 108.4 5.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 25.5 tp -141.8 111.19 6.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 90.94 16.34 54.57 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.051 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 97.35 -6.31 63.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.593 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.7 152.08 51.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 74.7 m-85 -81.06 113.13 19.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.215 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.94 134.63 57.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.388 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -100.49 115.7 30.71 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.565 HG23 HG12 ' A' ' 213' ' ' VAL . 10.0 p -115.53 151.01 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.506 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.14 175.17 42.36 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.962 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -76.88 126.85 31.66 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.67 129.24 39.07 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.657 HG11 ' HB2' ' A' ' 167' ' ' GLN . 29.1 m -89.26 -11.43 10.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.783 0.325 . . . . 0.0 111.578 -170.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.533 HG23 HG23 ' A' ' 286' ' ' VAL . 68.3 p -120.87 133.39 24.1 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.27 0.557 . . . . 0.0 111.094 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 C--O 1.232 0.206 0 C-N-CA 123.099 2.533 . . . . 0.0 111.995 176.805 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -57.57 -47.85 80.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.75 92.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.118 0.485 . . . . 0.0 111.04 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.544 HD21 HD13 ' A' ' 201' ' ' LEU . 60.0 mt -71.95 -35.57 69.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.43 -37.11 77.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.412 . . . . 0.0 110.505 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.3 mt -67.02 -42.8 89.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.308 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 1.8 ttm -68.53 -14.65 63.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.831 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.3 m -77.13 -15.78 59.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.454 177.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.496 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 18.4 mtp180 -101.09 141.7 33.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.694 HG22 ' H ' ' A' ' 186' ' ' GLY . 1.0 OUTLIER -123.33 127.76 74.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 78.6 t80 -82.93 115.37 21.76 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 8.6 m -115.87 116.46 52.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.59 0.71 . . . . 0.0 110.787 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 155' ' ' PHE . . . -119.95 -175.0 15.6 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.898 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.863 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 20.9 m 67.12 21.46 10.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.928 0.491 . . . . 0.0 111.279 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.6 mt -84.88 102.81 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.388 . . . . 0.0 110.619 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 122' ' ' GLU . 79.3 t80 -53.75 144.25 18.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.633 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -72.3 76.62 1.0 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.172 0.987 . . . . 0.0 111.196 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 120' ' ' TYR . 31.0 tt0 -148.35 -47.47 0.16 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.756 174.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.3 mt -66.95 128.28 35.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.501 176.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.48 174.98 35.52 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.007 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.31 -36.51 71.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.339 0.59 . . . . 0.0 109.874 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -68.8 -43.44 75.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.132 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 m -59.59 -46.2 89.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.125 0.488 . . . . 0.0 110.454 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.511 HG13 ' HE1' ' A' ' 143' ' ' MET . 41.8 mm -62.22 -47.65 92.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.617 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -60.26 -41.1 92.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.863 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -63.14 -34.4 77.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.492 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.79 -34.48 22.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.442 ' HD1' ' O ' ' A' ' 128' ' ' ILE . 69.8 m-85 -91.47 -18.41 24.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.464 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -55.41 -42.02 93.81 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 42.5 Cg_exo -40.39 -43.03 3.96 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 123.017 2.478 . . . . 0.0 113.925 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.67 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 50.1 m-85 -74.91 -51.78 12.94 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.645 0.26 . . . . 0.0 111.142 -175.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.37 170.54 36.41 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.023 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.3 118.71 5.74 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.87 2.38 . . . . 0.0 110.896 175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.446 HG21 ' CG1' ' A' ' 141' ' ' ILE . 53.3 mt -82.78 120.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.374 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -88.88 -33.6 17.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.341 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.3 t -153.58 136.79 15.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.968 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.446 ' CG1' HG21 ' A' ' 138' ' ' ILE . 71.7 mt -120.49 107.46 20.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 169.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.719 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -84.75 98.66 10.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.355 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.511 ' HE1' HG13 ' A' ' 128' ' ' ILE . 57.0 ttm -149.45 134.34 17.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.784 0.325 . . . . 0.0 110.377 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.633 177.912 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.436 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 47.9 p90 . . . . . 0 C--O 1.237 0.401 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.465 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -146.2 156.15 43.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.719 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 93.8 m-85 -113.75 109.55 18.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.775 175.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.636 ' HB ' HG12 ' A' ' 114' ' ' VAL . 59.8 t -97.31 106.34 18.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.496 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 72.8 tt0 -108.46 122.84 47.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.539 -177.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -96.37 178.89 5.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -82.43 -17.87 43.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.555 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 m -133.38 143.66 49.05 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.673 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 57.9 Cg_endo -71.95 -22.85 22.65 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.199 2.599 . . . . 0.0 112.785 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.593 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 16.3 mp0 -55.16 -58.72 6.52 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.684 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.67 -22.47 23.27 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.75 -48.13 12.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.968 0.413 . . . . 0.0 110.316 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -73.34 -26.66 61.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.302 0.572 . . . . 0.0 109.699 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.67 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 16.3 tp -70.47 -47.27 61.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.233 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.0 -34.72 78.15 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 18.6 tp -65.24 -46.08 82.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.714 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.37 -47.71 72.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.673 -174.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -90.45 -43.84 10.01 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.4 mtm -94.46 30.3 2.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -170.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 170' ' ' LEU . 66.5 t30 -75.98 12.97 0.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.168 0.508 . . . . 0.0 110.806 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 22.2 m -113.72 -73.38 0.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.523 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.9 m -142.28 162.04 19.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 111.373 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.672 ' HB2' HD13 ' A' ' 183' ' ' ILE . 17.2 tpp -128.53 84.39 2.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.494 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.457 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 89.0 mt 70.16 -56.25 0.59 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.305 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -73.59 168.87 53.79 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.461 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.63 53.75 4.07 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.722 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 118' ' ' SER . 43.3 ttm180 -143.77 137.64 28.21 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 175' ' ' SER . 5.5 m-20 -72.09 112.07 7.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.192 0.52 . . . . 0.0 110.382 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.863 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 45.3 pt -81.38 158.41 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.139 -176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.717 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 24.8 ttmm -103.4 116.4 32.34 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.051 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.3 t -122.7 148.84 26.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.694 ' H ' HG22 ' A' ' 114' ' ' VAL . . . . . . . . 0 N--CA 1.446 -0.68 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.005 175.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 N--CA 1.46 0.064 0 CA-C-O 120.857 0.36 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -84.84 -19.6 32.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 25.3 tp60 -57.36 -47.47 98.96 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -176.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 73.1 Cg_exo -52.5 -38.88 75.46 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.08 1.853 . . . . 0.0 112.678 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.0 mt -75.67 -43.9 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.438 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 194' ' ' ALA . 79.9 mt -58.23 -46.88 88.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.784 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.04 -39.74 93.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.705 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -59.54 -52.81 63.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.98 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.544 HD13 HD21 ' A' ' 108' ' ' LEU . 42.0 mt -68.14 -32.91 73.51 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.191 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.604 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.59 -48.24 72.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -65.53 -33.7 76.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.855 175.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 30.7 mt-10 -66.11 -33.71 76.39 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.17 0.51 . . . . 0.0 111.155 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -72.75 -24.85 61.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.656 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 68.6 mtp180 -79.87 -28.12 39.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.372 174.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.8 -38.41 76.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.151 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -88.72 173.6 8.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.481 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 77.7 m-20 -116.58 34.71 4.91 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.797 -174.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -98.73 138.13 36.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.373 0.606 . . . . 0.0 111.507 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.47 ' HA ' ' H ' ' A' ' 285' ' ' ALA . 47.7 pt -124.0 167.11 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.954 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 83.5 t80 -117.06 128.04 54.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.53 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.471 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 34.6 m -117.7 132.56 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.251 0.548 . . . . 0.0 110.112 177.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -126.95 169.68 13.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.894 -174.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.3 t 62.37 32.29 16.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.87 0.843 . . . . 0.0 109.312 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.45 108.28 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.091 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -54.98 133.38 48.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.911 0.386 . . . . 0.0 110.725 -174.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -55.8 -24.22 34.76 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.24 -21.1 29.23 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.23 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.62 124.39 22.23 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.3 t -81.38 164.12 22.35 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.199 0.523 . . . . 0.0 111.329 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -53.47 -38.88 64.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.126 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.55 -35.56 77.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.661 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.33 -44.59 94.47 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.671 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.742 HG22 HD11 ' A' ' 255' ' ' ILE . 38.0 mm -67.04 -41.17 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.021 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.664 ' HD2' ' SG ' ' A' ' 238' ' ' CYS . 87.4 tttt -59.8 -45.07 93.48 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.633 174.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.1 m -54.96 -44.96 74.85 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.0 t -76.32 -38.22 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.719 0.295 . . . . 0.0 111.485 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.563 ' HB3' ' OH ' ' A' ' 257' ' ' TYR . 15.7 m-85 -72.51 -33.43 66.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 110.996 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -61.17 -24.61 66.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.027 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.56 -12.78 61.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.245 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -111.43 -45.51 3.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.896 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -134.02 177.12 19.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.044 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 234' ' ' LYS . 39.4 tptt -91.74 106.44 18.48 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.11 0.481 . . . . 0.0 110.424 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 229' ' ' PHE . 22.5 mt -75.94 142.71 14.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.843 0.83 . . . . 0.0 112.325 -175.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.468 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 54.4 tttt -101.69 -37.3 8.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.42 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 20.4 m -156.04 142.0 18.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.318 -172.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.664 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 26.6 p -130.05 121.58 26.72 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 168.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 29.0 m -142.05 102.31 4.1 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.943 0.401 . . . . 0.0 110.536 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.516 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 70.3 mt -76.4 131.0 38.85 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.484 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.21 115.32 5.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 14.7 ptt-85 -139.78 168.83 18.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -171.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 16.6 m-20 -112.71 123.64 33.46 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.972 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 11.9 Cg_endo -58.51 -22.92 61.89 Favored 'Trans proline' 0 CA--C 1.526 0.117 0 C-N-CA 123.077 2.518 . . . . 0.0 111.999 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 p -91.32 -4.81 55.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.662 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 47.8 p -114.22 -34.48 5.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.493 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.7 6.33 80.25 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.267 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -138.31 160.0 40.6 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 6.5 p80 -87.19 151.22 23.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.563 . . . . 0.0 110.448 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.01 -25.34 68.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.384 -170.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 135.99 -12.12 4.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.874 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.417 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 44.3 p90 -130.87 174.52 9.89 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -165.86 175.53 41.45 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.329 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.593 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 96.6 m-85 -129.52 142.37 50.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.971 0.415 . . . . 0.0 110.448 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.742 HD11 HG22 ' A' ' 225' ' ' ILE . 90.4 mt -136.07 142.66 38.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.132 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 41.7 mt-10 -120.76 148.76 43.54 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.643 ' HB2' ' OG ' ' A' ' 263' ' ' SER . 25.5 m-85 -118.97 153.5 34.55 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 123.396 0.435 . . . . 0.0 109.888 175.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 25.0 mt-10 -75.95 -9.05 58.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.49 0.662 . . . . 0.0 110.036 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -130.66 122.56 27.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.392 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -59.36 -32.24 69.94 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.872 -171.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -67.86 -39.17 83.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.027 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.7 m -67.54 -33.34 74.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.747 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.643 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 3.3 m -58.38 -50.66 72.88 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.573 0.701 . . . . 0.0 109.701 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' GLN . . . . . 0.419 ' HG2' ' HD3' ' A' ' 284' ' ' LYS . 77.0 mt-30 -76.75 -14.66 59.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.146 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.84 -45.96 63.57 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.74 78.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.875 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.508 HG13 ' HA2' ' A' ' 283' ' ' GLY . 88.6 t -56.12 -31.62 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.195 0.521 . . . . 0.0 111.073 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.5 t -87.37 -39.18 15.53 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.079 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.6 m -80.99 -41.49 22.66 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.543 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 77.4 mmm -83.16 -0.23 48.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 111.059 -172.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.528 ' HA ' HG12 ' A' ' 282' ' ' VAL . 26.7 t-20 -71.37 111.18 6.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.308 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.9 mt 70.36 34.66 2.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.37 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -88.23 129.76 35.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.761 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.32 113.43 13.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.387 0.613 . . . . 0.0 111.242 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 33.9 tp -142.05 121.24 13.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.09 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 68.72 28.76 72.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.198 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 86.34 -13.5 57.53 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.97 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -114.81 150.75 34.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.634 -0.333 . . . . 0.0 110.257 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -89.28 116.68 27.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.802 0.334 . . . . 0.0 110.139 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.39 126.09 26.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.109 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 5.5 mmt180 -99.69 114.75 28.05 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 271' ' ' ASN . 8.4 p -121.62 150.85 24.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.528 -170.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.508 ' HA2' HG13 ' A' ' 267' ' ' VAL . . . -169.88 174.59 44.08 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.419 ' HD3' ' HG2' ' A' ' 264' ' ' GLN . 4.2 mmmp? -73.21 125.69 28.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.153 0.477 . . . . 0.0 110.287 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -58.4 130.95 49.15 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.9 m -85.08 -17.56 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.926 0.393 . . . . 0.0 110.769 -173.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 66.4 p -109.73 142.88 26.72 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.101 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.531 0.348 0 C-N-CA 122.682 2.255 . . . . 0.0 111.343 172.625 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.698 ' HG3' HD12 ' A' ' 108' ' ' LEU . 35.2 tt0 . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 121.171 0.51 . . . . 0.0 111.677 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -65.97 -34.18 77.52 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.93 -24.78 58.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.698 HD12 ' HG3' ' A' ' 105' ' ' GLN . 39.4 mt -67.64 -33.9 75.88 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.957 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.29 -24.06 40.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.095 0.474 . . . . 0.0 111.006 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.3 -52.49 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.731 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.9 -22.47 65.96 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -175.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 72.3 m -74.06 -10.5 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.206 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 78.0 mtt180 -102.71 139.96 37.61 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.174 175.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.28 119.89 60.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 170.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 84.8 t80 -80.65 129.54 34.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.758 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.527 HG12 HG12 ' A' ' 185' ' ' VAL . 9.6 m -108.65 115.97 50.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.316 0.579 . . . . 0.0 110.198 175.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.11 135.31 12.07 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.819 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.9 t 60.35 79.28 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.327 0.651 . . . . 0.0 111.442 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.49 HD11 ' CG2' ' A' ' 116' ' ' VAL . 59.5 mt -93.82 127.12 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.434 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 181' ' ' ARG . 29.0 t80 -60.16 127.71 33.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -65.37 77.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.149 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -169.66 -37.93 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.061 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.2 mt -74.73 114.36 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.089 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.68 165.32 54.75 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.481 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -60.98 -40.65 94.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -60.6 -38.72 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.99 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.0 m -66.24 -42.92 87.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.563 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 mm -65.86 -40.91 88.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.496 0.665 . . . . 0.0 109.9 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -55.88 -44.17 77.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.829 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -72.21 -33.59 67.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.948 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.14 -37.35 46.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -91.16 -15.48 29.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.412 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -53.24 -45.63 98.26 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 34.3 Cg_exo -40.83 -40.79 3.72 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 123.247 2.631 . . . . 0.0 114.986 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.645 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 68.4 m-85 -72.66 -46.74 52.37 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -170.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.2 -164.93 20.53 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.561 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 161' ' ' GLU . 87.0 Cg_endo -79.83 107.73 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.071 2.514 . . . . 0.0 111.854 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.592 HD13 HD11 ' A' ' 141' ' ' ILE . 56.9 mt -66.71 113.74 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.316 0.579 . . . . 0.0 110.577 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 60.0 tttm -93.31 -40.58 10.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.047 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.2 t -155.54 128.62 8.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.466 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 138' ' ' ILE . 67.0 mt -111.06 108.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 171.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -100.43 98.65 9.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.805 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 52.7 ttm -131.34 127.51 37.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.948 0.404 . . . . 0.0 110.446 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.892 178.927 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 39.6 p90 . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.61 0.243 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 116' ' ' VAL . . . -161.41 153.7 19.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.489 176.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -123.66 123.03 39.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.236 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.6 t -104.65 105.97 19.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.526 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 35.5 tt0 -97.21 131.71 43.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.001 -176.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -109.52 162.35 14.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.489 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 137' ' ' PRO . 44.4 mt-10 -79.13 -9.15 59.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 0.0 110.668 174.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.69 133.58 19.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.878 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 43.1 Cg_endo -66.79 -20.41 52.21 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.135 2.556 . . . . 0.0 112.358 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.657 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 17.6 mp0 -55.74 -52.86 62.47 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.956 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -63.55 -20.61 65.77 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.18 -48.58 12.92 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.617 ' HG3' HG11 ' A' ' 286' ' ' VAL . 15.6 mm100 -66.77 -34.11 77.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.044 174.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.645 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 13.0 tp -68.87 -46.61 68.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.672 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.442 ' HA ' ' CE1' ' A' ' 135' ' ' PHE . . . -60.46 -31.21 70.23 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.652 HD12 ' HA3' ' A' ' 186' ' ' GLY . 5.3 tt -67.43 -55.9 11.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.014 172.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 167' ' ' GLN . 23.1 mt-10 -53.94 -30.14 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.058 -175.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -98.07 -51.22 4.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.9 mtm -106.62 29.33 7.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -167.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.561 ' HA ' HG22 ' A' ' 185' ' ' VAL . 65.1 t30 -86.09 26.08 1.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.632 0.729 . . . . 0.0 110.308 177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.2 t -114.23 -70.29 0.81 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.97 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 m -140.1 155.46 24.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.617 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.579 ' HE2' ' HG ' ' A' ' 178' ' ' LEU . 0.9 OUTLIER -126.81 100.99 6.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.414 175.927 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.579 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 94.9 mt 66.2 26.91 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.679 172.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 123.84 -112.26 1.81 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.954 -1.117 . . . . 0.0 114.594 171.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.81 38.51 3.04 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 114.451 0.541 . . . . 0.0 114.451 -165.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 120' ' ' TYR . 8.5 tpp180 -145.53 120.09 9.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 117.209 0.505 . . . . 0.0 111.09 173.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -87.49 83.18 7.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.432 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.6 pt -70.22 147.69 11.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.086 0.47 . . . . 0.0 110.938 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -103.55 107.02 17.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.36 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 174' ' ' ASN . 2.5 m -99.69 137.41 27.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.359 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.652 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.679 0 C-N-CA 120.655 -0.784 . . . . 0.0 111.447 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.006 0.431 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.69 -19.17 26.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.433 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.509 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 84.0 mm-40 -56.94 -48.87 96.68 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 54.5 Cg_exo -53.93 -39.29 85.36 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.152 1.902 . . . . 0.0 112.539 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.476 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 41.7 mm -67.61 -46.89 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 110.084 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 87.1 mt -57.9 -48.45 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.531 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 29.7 t70 -67.53 -40.99 85.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.164 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -62.7 -44.99 94.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.115 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 76.0 mt -67.58 -32.84 73.87 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.55 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.494 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -58.21 -38.31 76.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.188 0.518 . . . . 0.0 109.72 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 40.1 mt-10 -73.73 -31.53 63.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.945 175.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 57.7 mt-10 -67.26 -24.16 65.77 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.184 0.516 . . . . 0.0 110.984 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.403 ' HA ' HH11 ' A' ' 210' ' ' ARG . . . -74.85 -33.39 62.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.137 174.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 18.0 mtm180 -73.35 -13.78 61.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.786 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.32 -22.2 60.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.329 0.585 . . . . 0.0 110.171 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.99 166.99 18.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.305 -0.862 . . . . 0.0 108.997 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 65.2 m-20 -95.26 48.67 1.17 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.638 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 7.8 ptp180 -91.44 149.5 21.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.398 0.618 . . . . 0.0 111.206 -173.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.406 HG23 ' HB2' ' A' ' 263' ' ' SER . 44.1 pt -134.55 166.91 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.254 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -113.14 122.19 46.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.606 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.48 HG12 HG23 ' A' ' 282' ' ' VAL . 34.3 m -117.59 131.92 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.004 0.431 . . . . 0.0 110.227 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -126.13 172.12 10.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.159 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.7 m 62.68 27.56 16.19 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.922 0.868 . . . . 0.0 109.863 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.61 112.27 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.83 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -58.58 138.86 56.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.253 -171.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -52.67 -30.95 34.64 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -88.6 -22.81 23.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.497 0.189 . . . . 0.0 111.489 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.29 120.72 12.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.548 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.6 m -82.04 166.6 19.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.274 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -53.91 -45.4 71.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.511 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.98 -32.38 73.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.652 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 228' ' ' VAL . 8.3 t70 -68.7 -45.81 70.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.676 HG22 HD11 ' A' ' 255' ' ' ILE . 39.8 mm -66.29 -36.78 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.58 -52.72 63.96 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.28 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 89.7 p -55.74 -34.4 65.15 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 224' ' ' ASP . 24.5 t -73.55 -47.66 44.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.314 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.732 ' HB2' HD11 ' A' ' 235' ' ' ILE . 16.2 m-85 -68.39 -31.64 71.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.411 0.624 . . . . 0.0 110.526 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 29.5 tp10 -60.08 -24.35 64.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.367 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.91 -8.33 58.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.644 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -112.79 -45.21 3.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.562 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -140.82 171.71 23.96 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 64.8 mmtt -90.03 111.7 22.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.894 0.854 . . . . 0.0 111.697 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 229' ' ' PHE . 52.9 mt -87.16 151.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.682 -174.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -103.52 -40.33 6.38 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.786 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 50.8 m -156.88 151.01 24.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.411 -170.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.1 t -143.76 104.66 4.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.764 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.5 m -121.09 103.13 8.79 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.353 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.606 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 69.0 mt -80.46 144.52 32.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.818 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -66.55 105.05 1.4 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.526 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 41.0 ttt180 -129.16 142.09 50.97 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.065 -170.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 246' ' ' THR . 30.1 m-20 -93.61 115.16 64.7 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.032 176.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.42 -37.13 98.35 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.529 2.82 . . . . 0.0 113.769 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 82.8 p -92.75 10.22 31.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 243' ' ' ASP . 11.6 t -123.06 -9.78 8.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.045 -0.41 . . . . 0.0 111.196 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.09 -49.77 4.29 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.426 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 20.1 ptmt -77.32 172.97 12.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.174 0.511 . . . . 0.0 110.685 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 20.2 p80 -116.1 167.67 10.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.508 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -65.26 -80.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 O-C-N 123.485 0.49 . . . . 0.0 111.69 -173.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -175.99 17.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.232 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.432 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 31.3 p90 -157.03 176.71 12.39 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.0 178.06 45.17 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.041 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.657 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 89.4 m-85 -125.67 143.85 50.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.917 0.389 . . . . 0.0 110.19 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.676 HD11 HG22 ' A' ' 225' ' ' ILE . 87.0 mt -134.68 128.44 50.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.462 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.638 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 47.8 mt-10 -109.98 131.95 54.59 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.628 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 6.8 m-85 -97.07 176.97 5.75 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 123.155 0.285 . . . . 0.0 110.294 176.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.12 -22.85 35.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -121.15 121.94 38.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.361 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.67 -22.56 67.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.075 0.464 . . . . 0.0 110.939 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -72.0 -49.33 37.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.719 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 265' ' ' ASP . 44.9 m -66.67 -32.43 73.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.012 -176.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.628 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 59.8 p -66.56 -42.54 86.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 110.057 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -74.51 -21.62 59.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.522 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 262' ' ' SER . 0.5 OUTLIER -70.98 -37.19 72.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.405 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -63.78 -39.98 95.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 172.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.11 -33.67 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 121.33 0.586 . . . . 0.0 110.628 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.5 m -73.71 -39.61 64.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.133 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.5 m -89.37 -39.17 13.61 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.562 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 85.9 mmm -81.66 -1.56 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -171.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.545 ' HA ' HG12 ' A' ' 282' ' ' VAL . 22.9 t-20 -71.5 117.51 13.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 97.7 mt 70.01 32.75 2.95 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.44 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -91.23 121.19 32.78 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.454 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 12.4 t70 -74.38 118.55 17.47 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.333 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.7 tp -131.94 91.83 3.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.901 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 92.4 26.81 16.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 92.7 2.36 67.32 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.632 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -131.8 140.81 49.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.454 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 72.4 m-85 -85.37 112.61 20.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.6 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 71.7 mt -58.03 121.27 10.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 8.2 mmm180 -93.53 114.75 27.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 174.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 271' ' ' ASN . 11.4 p -119.87 143.85 30.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.745 -173.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -158.56 -171.84 24.93 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.505 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.62 128.92 36.76 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.773 0.32 . . . . 0.0 110.344 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -66.52 128.17 35.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 167' ' ' GLN . 29.4 m -97.32 -25.02 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -171.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 35.5 p -131.39 168.13 18.76 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 120.844 0.354 . . . . 0.0 111.569 -178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.458 -0.56 0 C-N-CA 123.191 2.594 . . . . 0.0 110.989 169.31 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.211 0.529 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -62.03 -33.81 75.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.7 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.55 80.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 0.0 110.884 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.51 HD21 HD13 ' A' ' 201' ' ' LEU . 61.7 mt -68.91 -31.28 70.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.598 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.68 -28.41 69.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.256 0.551 . . . . 0.0 110.384 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.84 -36.47 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.858 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.519 ' SD ' HG12 ' A' ' 198' ' ' ILE . 87.9 mtp -73.31 -21.81 60.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.2 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.818 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 30.4 p -79.72 -3.71 48.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -110.7 141.09 44.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.678 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.596 HG12 ' HB ' ' A' ' 158' ' ' VAL . 6.0 p -121.56 131.93 71.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.177 0.513 . . . . 0.0 110.051 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -79.11 121.03 24.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.07 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 25.7 m -118.18 129.26 74.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.5 0.667 . . . . 0.0 111.383 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.46 176.26 21.51 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.62 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 22.7 m 60.29 39.11 19.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.236 0.541 . . . . 0.0 110.576 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 57.5 mt -81.02 -15.74 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.373 -176.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 44.7 t80 71.21 153.62 0.13 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.204 -176.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -83.54 76.24 9.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.453 0.644 . . . . 0.0 111.052 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -163.43 -50.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.021 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.82 104.55 1.71 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.081 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.87 172.77 55.33 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.935 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.47 ' OE2' ' HB ' ' A' ' 141' ' ' ILE . 61.2 tt0 -64.17 -32.31 73.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.849 0.324 . . . . 0.0 110.67 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -54.85 -48.87 72.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.355 0.598 . . . . 0.0 109.958 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.2 m -70.69 -41.67 71.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.961 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.0 mm -61.41 -46.34 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.479 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -63.71 -37.31 86.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.034 0.445 . . . . 0.0 110.196 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -65.63 -32.38 73.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.969 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -79.44 -35.82 39.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.548 ' HB2' HD11 ' A' ' 138' ' ' ILE . 71.3 m-85 -90.66 -13.86 33.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 0.0 111.531 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.17 -43.18 89.71 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -43.83 -41.51 11.84 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.95 2.433 . . . . 0.0 114.564 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.451 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 51.4 m-85 -77.08 -50.94 11.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.536 0.208 . . . . 0.0 111.386 -174.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -158.36 171.0 35.14 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.884 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.64 117.63 5.01 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 111.218 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 132' ' ' PHE . 58.5 mt -78.82 116.31 22.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.105 0.479 . . . . 0.0 110.535 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.507 ' HE3' ' OE1' ' A' ' 159' ' ' GLU . 34.9 ttpt -88.42 -27.42 21.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.542 -177.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.2 t -163.83 145.48 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.753 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.495 HD11 HD13 ' A' ' 138' ' ' ILE . 61.7 mt -133.02 121.43 43.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.85 100.66 10.46 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.799 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 46.8 ttm -128.48 131.95 48.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 120.962 0.411 . . . . 0.0 109.942 175.95 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.1 p90 . . . . . 0 C--O 1.237 0.407 0 CA-C-O 120.821 0.344 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.97 167.14 31.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.305 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -125.46 121.38 33.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.664 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.596 ' HB ' HG12 ' A' ' 114' ' ' VAL . 90.2 t -100.15 116.65 43.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.102 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.507 ' OE1' ' HE3' ' A' ' 139' ' ' LYS . 41.5 tt0 -107.48 126.97 53.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.615 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.98 175.48 5.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.858 0.361 . . . . 0.0 110.964 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.462 ' OE1' ' HD3' ' A' ' 139' ' ' LYS . 5.5 mm-40 -71.98 -37.26 69.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.199 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.04 143.39 45.38 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.466 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.818 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 38.1 Cg_endo -66.26 -14.57 44.84 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.416 2.744 . . . . 0.0 112.219 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.924 ' HG3' ' HE2' ' A' ' 254' ' ' PHE . 15.4 mm-40 -62.33 -53.19 58.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.335 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.551 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.97 -18.98 60.37 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.66 -54.11 6.76 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.622 ' HG3' HG11 ' A' ' 286' ' ' VAL . 19.1 mm-40 -64.05 -36.29 83.51 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.967 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.551 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 12.9 tp -61.05 -48.41 81.88 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.643 177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.6 -31.91 69.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.837 0.351 . . . . 0.0 110.079 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 185' ' ' VAL . 16.3 tp -72.58 -46.76 52.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 172.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 14.3 mm-40 -52.47 -41.84 63.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.321 0.648 . . . . 0.0 111.701 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -100.72 -51.35 3.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.0 ttp -95.65 30.16 2.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -164.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.477 ' HB3' HD12 ' A' ' 170' ' ' LEU . 10.0 p30 -79.36 21.08 0.5 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.16 -0.337 . . . . 0.0 111.151 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 4.5 m -100.79 -74.11 0.62 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.071 0.462 . . . . 0.0 110.822 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.3 m -144.02 170.33 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.025 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.999 ' HB2' HD13 ' A' ' 183' ' ' ILE . 2.4 tpt -118.64 94.08 4.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.254 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.965 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 73.7 mt 56.13 45.36 23.58 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.788 0.68 . . . . 0.0 110.221 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.18 -135.39 12.96 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -172.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 66.98 -112.09 4.61 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.687 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -144.01 177.86 8.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.391 0.138 . . . . 0.0 110.796 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 175' ' ' SER . 49.2 t-20 -63.9 112.62 3.0 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.2 pt -97.54 168.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.292 0.568 . . . . 0.0 111.58 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 93.4 mttt -103.12 115.21 30.15 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.195 175.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.64 ' O ' HD13 ' A' ' 170' ' ' LEU . 18.3 t -113.01 102.85 14.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 171.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.883 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -175.506 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.155 0.502 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -90.24 -5.41 56.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.452 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.557 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 15.6 mm100 -54.01 -47.11 98.12 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.1 Cg_endo -52.76 -40.74 73.43 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.987 1.791 . . . . 0.0 112.354 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 70.7 mt -73.27 -45.69 52.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.534 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 194' ' ' ALA . 57.7 mt -58.26 -47.17 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.805 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.82 -39.78 91.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.915 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -67.11 -46.34 74.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.626 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 69.0 mt -66.95 -32.84 74.36 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.02 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.64 -46.03 70.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 18.2 mt-10 -68.5 -31.75 71.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.883 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 47.1 mt-10 -67.49 -30.27 69.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.4 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -76.98 -39.22 51.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.968 0.414 . . . . 0.0 110.046 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.566 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 58.5 mtp180 -57.76 -30.11 65.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.891 176.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.22 -19.9 62.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.994 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -110.94 0.12 16.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.799 0.333 . . . . 0.0 111.404 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 56.66 38.12 29.32 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.583 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -87.9 138.38 31.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.937 -173.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.526 ' HA ' ' H ' ' A' ' 285' ' ' ALA . 48.7 pt -129.99 166.19 28.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.088 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.504 ' HD1' ' CE2' ' A' ' 254' ' ' PHE . 84.4 t80 -120.97 129.58 53.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.339 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.626 HG12 HG23 ' A' ' 282' ' ' VAL . 31.5 m -121.23 133.35 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.231 0.538 . . . . 0.0 110.33 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.97 175.09 9.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.193 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 61.1 m 60.71 35.14 19.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.213 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.03 124.24 36.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.293 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 78.3 t60 -54.31 134.31 45.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.575 0.702 . . . . 0.0 111.245 -175.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.425 ' HG2' ' H ' ' A' ' 218' ' ' GLN . 5.8 pt20 -49.12 -35.48 16.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.268 -1.333 . . . . 0.0 114.181 -174.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -105.63 24.55 12.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.835 0.826 . . . . 0.0 110.789 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 217' ' ' HIS . 15.6 tp -105.3 133.46 50.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 21.0 t -98.76 167.17 10.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.044 0.45 . . . . 0.0 111.18 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -66.23 -22.56 66.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.02 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.54 -39.2 93.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.156 177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 228' ' ' VAL . 33.6 m-20 -71.04 -47.2 59.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.837 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.694 HG13 HD21 ' A' ' 240' ' ' LEU . 8.3 mm -63.16 -47.2 93.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 47.8 tttm -56.77 -45.51 82.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.226 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 77.6 p -60.87 -37.59 82.67 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -174.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 224' ' ' ASP . 4.8 t -76.35 -45.45 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.676 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.6 ' CB ' HD11 ' A' ' 235' ' ' ILE . 38.0 m-85 -62.74 -34.9 78.16 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.1 mm-40 -62.0 -24.37 67.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.731 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.05 -10.25 59.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.275 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.96 -43.65 4.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.083 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -145.73 -175.94 19.22 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.331 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -87.01 111.47 20.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.895 0.379 . . . . 0.0 110.346 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.6 HD11 ' CB ' ' A' ' 229' ' ' PHE . 14.3 mt -81.25 146.52 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.861 0.839 . . . . 0.0 111.962 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -109.58 -32.83 6.98 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.799 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 55.4 m -157.52 146.24 19.54 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -173.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 226' ' ' LYS . 43.2 t -153.9 99.53 2.28 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.488 0.493 . . . . 0.0 109.766 174.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.9 m -130.0 115.95 17.87 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.646 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.694 HD21 HG13 ' A' ' 225' ' ' ILE . 57.6 mt -84.59 135.82 34.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.63 112.95 1.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.668 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 27.0 ttp180 -133.57 141.78 47.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -83.93 112.42 40.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.712 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.97 -36.79 81.19 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.211 2.607 . . . . 0.0 113.305 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.9 t -93.99 13.39 23.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.768 0.318 . . . . 0.0 111.663 -172.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 80.3 p -125.2 -39.89 2.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.802 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 98.01 9.83 53.27 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.232 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -118.37 146.8 44.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 4.1 p80 -95.07 143.63 26.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -64.21 -65.36 0.69 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -168.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 177.99 -3.4 0.03 OUTLIER Glycine 0 CA--C 1.519 0.304 0 C-N-CA 119.871 -1.156 . . . . 0.0 113.751 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -140.26 172.37 12.84 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.342 -0.505 . . . . 0.0 110.472 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.598 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -160.22 174.98 37.04 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.924 ' HE2' ' HG3' ' A' ' 164' ' ' GLU . 85.1 m-85 -129.19 143.25 50.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.664 0.268 . . . . 0.0 110.874 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.515 HD11 HG22 ' A' ' 225' ' ' ILE . 92.3 mt -137.56 140.73 41.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.222 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 237' ' ' SER . 43.3 mt-10 -122.88 148.18 45.73 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.645 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 20.9 m-85 -116.98 158.05 24.76 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.007 0.432 . . . . 0.0 110.487 176.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.11 -3.91 58.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.757 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -135.67 134.03 38.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.095 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.74 -32.82 74.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.581 -171.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -70.48 -39.13 74.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.931 0.395 . . . . 0.0 110.437 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.8 m -64.97 -37.59 88.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.736 -174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 43.5 p -68.49 -45.13 73.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.167 0.508 . . . . 0.0 110.649 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -72.19 -22.16 61.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.944 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.52 -40.03 62.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 110.549 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.31 -33.4 75.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.474 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 263' ' ' SER . 97.7 t -56.16 -26.91 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.994 0.426 . . . . 0.0 111.137 173.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.2 t -85.72 -46.8 10.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.018 -0.427 . . . . 0.0 110.639 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.4 m -69.83 -38.2 76.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.422 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 89.5 mmm -91.81 -2.61 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.76 0.314 . . . . 0.0 111.543 -173.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 282' ' ' VAL . 39.7 t30 -72.12 124.53 25.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.306 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.2 mt 63.48 25.9 14.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.326 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -83.11 118.04 23.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.774 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.82 121.45 21.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.2 tp -141.62 91.82 2.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.025 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 95.28 25.7 13.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.935 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 89.25 1.22 79.15 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.784 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -126.14 148.53 49.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.642 0.258 . . . . 0.0 110.541 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -89.83 117.67 28.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.404 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.21 120.56 14.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.791 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -93.8 115.75 28.18 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 174.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.626 HG23 HG12 ' A' ' 213' ' ' VAL . 14.2 p -121.08 143.76 32.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.053 0.454 . . . . 0.0 110.851 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -156.61 -179.69 31.78 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.684 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -80.25 133.74 36.02 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.526 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -76.3 146.26 39.01 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.622 HG11 ' HG3' ' A' ' 167' ' ' GLN . 30.8 m -112.66 -3.65 10.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.717 0.294 . . . . 0.0 111.516 -174.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 41.5 p -123.07 139.37 31.42 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.902 0.382 . . . . 0.0 111.015 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.463 -0.285 0 C-N-CA 122.834 2.356 . . . . 0.0 111.196 173.872 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.43 ' HB2' HD12 ' A' ' 108' ' ' LEU . 16.0 mm-40 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -64.67 -28.43 69.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.18 -30.09 70.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 111' ' ' MET . 26.0 mt -70.81 -30.84 67.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.23 -25.24 66.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.362 0.601 . . . . 0.0 110.094 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.0 mt -84.08 -40.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.786 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 108' ' ' LEU . 60.2 mmm -61.12 -29.97 70.09 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.543 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 73.5 m -73.87 -13.64 60.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.441 0.162 . . . . 0.0 111.237 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.632 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 29.8 mtp85 -108.96 139.89 43.21 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.25 135.51 63.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.165 0.507 . . . . 0.0 110.349 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -77.91 119.26 21.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.817 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 13.5 m -121.15 116.05 48.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.221 0.534 . . . . 0.0 110.348 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 155' ' ' PHE . . . -117.8 170.17 13.51 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.193 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.437 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 20.9 t 72.09 51.18 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.608 0.718 . . . . 0.0 110.391 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.0 mt -103.06 127.43 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.651 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -72.11 147.15 46.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.876 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -72.37 75.59 1.02 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.855 0.836 . . . . 0.0 111.005 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -154.63 -45.55 0.09 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.845 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.442 HD13 ' HG3' ' A' ' 177' ' ' MET . 22.0 mt -77.29 91.37 3.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.03 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.25 -179.85 44.57 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.979 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -55.51 -46.4 76.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.117 0.484 . . . . 0.0 111.227 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.5 -46.57 89.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.103 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.3 m -67.27 -42.16 84.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.988 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.1 mm -61.41 -45.27 98.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.084 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.531 ' HG3' HD12 ' A' ' 138' ' ' ILE . 59.0 ttt180 -62.4 -37.39 85.6 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.509 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -69.81 -33.4 72.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.068 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.47 -33.33 54.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.642 ' HB2' HD11 ' A' ' 138' ' ' ILE . 52.2 m-85 -90.1 -13.65 35.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.818 0.342 . . . . 0.0 111.068 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.89 -41.28 84.19 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 44.9 Cg_exo -40.97 -40.36 3.71 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.035 2.49 . . . . 0.0 114.26 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.496 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 43.6 m-85 -79.25 -47.93 15.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.685 0.279 . . . . 0.0 111.21 -176.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.31 170.04 41.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.702 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.2 122.69 9.76 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.755 2.303 . . . . 0.0 111.629 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' A' ' 132' ' ' PHE . 75.1 mt -81.84 132.09 32.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.132 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -89.84 -43.6 10.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.307 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 97.4 p -157.7 155.24 29.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.139 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.429 HG22 ' HG2' ' A' ' 143' ' ' MET . 62.7 mt -133.52 127.01 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.65 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 28.9 m-20 -91.85 106.16 18.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.072 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.429 ' HG2' HG22 ' A' ' 141' ' ' ILE . 17.4 mmt -111.5 118.24 35.2 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.734 0.302 . . . . 0.0 111.062 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.795 0.807 . . . . 0.0 110.495 174.752 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.448 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 52.0 p90 . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 111.334 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.37 163.56 39.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.673 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.731 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 96.2 m-85 -123.06 120.33 32.98 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.1 t -104.71 112.19 37.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.644 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.632 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 40.5 tt0 -102.88 131.07 50.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.5 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 81.3 m-85 -104.93 179.48 4.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.625 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -67.31 -38.53 85.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.165 0.507 . . . . 0.0 110.092 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.63 149.78 69.13 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.37 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 56.9 Cg_endo -70.02 -14.01 34.73 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.356 2.704 . . . . 0.0 112.237 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.591 ' HG3' ' CE1' ' A' ' 254' ' ' PHE . 75.5 mm-40 -60.82 -53.03 62.38 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.544 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -63.38 -14.34 49.16 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.973 0.416 . . . . 0.0 111.898 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.5 -54.2 5.37 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.597 ' HG3' HG21 ' A' ' 286' ' ' VAL . 15.9 mm100 -65.57 -34.0 77.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.968 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.496 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 25.6 tp -65.41 -43.58 90.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.238 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.76 -28.26 69.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.037 0.446 . . . . 0.0 110.08 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.66 -50.9 31.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.406 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -54.35 -35.36 62.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.37 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -100.61 -52.3 3.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 34.5 ttp -106.56 31.26 5.36 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -163.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -77.1 17.01 0.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.338 -0.226 . . . . 0.0 111.567 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.1 m -110.04 -73.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.57 0.224 . . . . 0.0 111.483 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.4 m -135.54 159.53 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.535 0.207 . . . . 0.0 110.938 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.998 ' HB2' HD13 ' A' ' 183' ' ' ILE . 3.5 tpt -123.88 96.61 5.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.892 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 24.0 tp 50.61 61.53 3.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.671 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.56 -179.28 18.94 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.306 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.76 57.71 5.04 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.093 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -134.21 119.0 18.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -75.55 136.38 40.56 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.902 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.998 HD13 ' HB2' ' A' ' 177' ' ' MET . 42.0 pt -124.32 158.42 31.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.678 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 22.7 tptm -111.3 106.41 15.36 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.37 110.1 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.938 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.722 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.212 178.326 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.451 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 22.0 tp60 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.12 0.486 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -75.87 -19.49 58.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.625 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 27.9 mm-40 -58.83 -51.45 81.75 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.288 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 64.2 Cg_exo -53.63 -38.36 84.18 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.208 1.939 . . . . 0.0 112.764 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.82 -39.31 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.511 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 194' ' ' ALA . 72.3 mt -60.32 -45.98 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 175.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.597 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 26.0 t70 -61.54 -41.97 98.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.431 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.26 -51.38 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.256 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 44.8 mt -68.29 -32.77 73.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.85 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.47 -41.78 77.1 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 32.5 mt-10 -67.67 -33.91 75.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.544 174.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -63.68 -37.36 87.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.937 0.399 . . . . 0.0 110.653 175.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.57 -37.33 73.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.505 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' A' ' 203' ' ' GLU . 29.5 mtp180 -59.29 -26.02 64.61 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.357 176.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -76.91 -11.29 59.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -111.37 179.28 4.07 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 62.0 m-20 -126.25 38.76 4.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.977 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 10.3 ptp180 -108.28 158.06 17.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.646 0.736 . . . . 0.0 112.603 -170.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.616 HG23 ' HB2' ' A' ' 263' ' ' SER . 41.3 pt -135.39 166.63 27.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.623 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.424 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 57.1 t80 -112.62 124.03 51.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.377 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 26.8 m -115.01 131.3 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.382 0.61 . . . . 0.0 110.453 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -122.66 172.0 8.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.873 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 24.3 m 63.79 22.23 12.98 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.506 0.67 . . . . 0.0 110.461 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 38.2 t -79.7 109.02 13.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.806 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -56.04 142.8 34.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.285 0.564 . . . . 0.0 111.033 -171.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -59.13 -22.5 60.98 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -168.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -92.51 -13.28 30.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 93.6 mt -81.84 133.81 35.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 19.0 m -96.69 171.71 8.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.604 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.5 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 9.8 p-10 -61.02 -42.17 97.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.581 0.229 . . . . 0.0 111.552 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.25 -27.1 69.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.366 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.58 -48.28 33.97 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.896 0.379 . . . . 0.0 110.086 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.56 HG22 HD11 ' A' ' 255' ' ' ILE . 34.2 mm -61.93 -38.54 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.527 ' HG3' HG21 ' A' ' 235' ' ' ILE . 63.0 tttm -56.26 -52.57 63.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.114 175.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 88.3 p -58.55 -34.43 71.01 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.83 -50.01 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 121.129 -0.229 . . . . 0.0 111.279 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.732 ' HB2' HD11 ' A' ' 235' ' ' ILE . 20.8 m-85 -64.31 -34.18 77.55 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.207 0.527 . . . . 0.0 111.074 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -63.63 -23.6 67.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.429 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.23 -11.57 60.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.76 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -112.04 -37.95 4.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.724 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.498 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -140.29 167.63 25.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.499 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 67.0 mmtt -78.64 99.72 6.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.845 0.355 . . . . 0.0 111.053 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 229' ' ' PHE . 8.3 mt -77.05 146.19 9.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.615 0.721 . . . . 0.0 111.453 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -110.49 -37.19 5.56 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.664 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 25.8 m -154.5 151.36 28.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -172.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 255' ' ' ILE . 52.9 t -153.7 116.14 4.4 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 61.9 m -141.23 111.28 6.67 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.676 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.57 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 34.8 mt -81.8 137.75 35.25 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -62.05 113.51 2.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 70.3 ttt180 -137.74 141.34 40.98 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.68 -167.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 244' ' ' PRO . 28.7 m-20 -105.02 117.64 58.12 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.179 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 18.4 Cg_endo -57.77 -28.41 81.94 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 123.573 2.848 . . . . 0.0 112.952 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.2 t -79.82 -13.27 59.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.072 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 37.0 p -106.01 -36.93 6.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.956 0.408 . . . . 0.0 111.241 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.76 -35.12 4.19 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.822 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 63.5 pttt -87.43 -179.77 6.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 241' ' ' ALA . 6.2 p80 -120.35 163.77 17.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.883 0.373 . . . . 0.0 110.174 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -71.09 -3.93 22.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.389 -167.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 111.71 -11.02 27.81 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.176 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.424 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 51.5 p90 -135.23 173.54 11.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.707 0.289 . . . . 0.0 111.062 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -165.36 175.03 41.22 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.065 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.591 ' CE1' ' HG3' ' A' ' 164' ' ' GLU . 94.0 m-85 -128.88 142.9 50.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.766 0.317 . . . . 0.0 110.767 -178.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.56 HD11 HG22 ' A' ' 225' ' ' ILE . 83.9 mt -136.3 132.21 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.451 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.977 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 18.6 mt-10 -109.24 147.95 31.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.498 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 12.5 m-85 -112.18 150.26 31.09 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 123.164 0.29 . . . . 0.0 110.66 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.22 -55.35 29.31 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -73.65 117.13 15.06 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.536 171.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -52.99 -38.41 62.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.211 -175.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -75.08 -30.63 61.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.64 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.553 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 69.0 m -64.52 -19.76 65.8 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.616 ' HB2' HG23 ' A' ' 211' ' ' ILE . 78.1 p -57.69 -46.08 84.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.206 0.527 . . . . 0.0 109.929 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -76.68 -13.87 60.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.107 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.553 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 2.6 m-20 -64.69 -47.92 76.61 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 173.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.43 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . . . -64.96 -35.75 82.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.214 176.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 263' ' ' SER . 89.0 t -56.82 -31.89 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.273 0.559 . . . . 0.0 110.787 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 20.2 m -80.64 -38.38 29.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.499 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 24.7 t -93.91 -34.02 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.477 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 91.1 mmm -84.74 -4.64 59.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 -174.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.489 ' HA ' HG12 ' A' ' 282' ' ' VAL . 50.8 t30 -68.9 117.03 10.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.864 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 95.4 mt 67.95 40.13 2.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.316 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -96.73 121.78 38.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.683 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.18 111.37 10.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.586 0.708 . . . . 0.0 111.17 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.4 tp -140.69 110.35 6.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.432 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 91.77 25.28 23.19 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.435 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 74.97 10.69 84.02 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.517 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -138.26 144.51 40.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -76.44 116.32 17.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.648 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.95 128.84 38.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.908 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 9.4 mmt85 -98.5 115.31 28.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 271' ' ' ASN . 14.3 p -116.25 144.0 24.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.788 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.63 178.47 32.21 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.608 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -77.09 132.73 39.03 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.35 114.42 7.58 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.597 HG21 ' HG3' ' A' ' 167' ' ' GLN . 28.6 m -87.29 -27.6 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.808 -171.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 22.2 p -136.35 162.74 54.6 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.442 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.444 -1.432 0 C-N-CA 122.489 2.126 . . . . 0.0 112.162 175.317 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -60.44 -37.46 81.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.509 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.07 -32.18 72.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.258 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.494 HD23 ' SD ' ' A' ' 111' ' ' MET . 25.1 mt -67.75 -32.47 73.1 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.962 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.31 -29.64 70.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.262 0.553 . . . . 0.0 109.907 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.7 mt -82.34 -38.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.28 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.494 ' SD ' HD23 ' A' ' 108' ' ' LEU . 91.4 mtp -67.41 -30.07 69.73 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.727 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.6 m -74.18 -21.63 59.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.852 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 96.6 mtt180 -97.32 139.68 32.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 p -126.15 132.02 70.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.16 0.505 . . . . 0.0 110.319 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.494 ' HD1' ' CE2' ' A' ' 157' ' ' PHE . 91.3 t80 -76.58 117.1 17.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.426 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 41.2 t -115.89 114.96 47.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.811 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.7 169.13 18.68 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.026 -176.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.746 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 12.2 t 68.64 33.98 3.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.359 0.599 . . . . 0.0 110.871 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.9 mt -80.56 -13.19 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.049 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 65.9 t80 72.69 147.18 0.08 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.901 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -77.34 76.22 3.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.38 0.609 . . . . 0.0 111.372 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.87 -65.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.23 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.8 mt -54.86 108.38 0.39 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.577 0.548 . . . . 0.0 111.503 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.21 -173.0 40.97 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.892 -174.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.14 -46.72 88.7 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.295 -0.452 . . . . 0.0 111.781 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 1.1 m-20 -60.41 -45.0 95.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.627 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.6 m -59.73 -43.7 94.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.874 0.368 . . . . 0.0 110.836 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.8 mm -63.98 -45.65 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.408 0.623 . . . . 0.0 110.226 177.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -56.58 -45.78 81.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.269 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 58.9 mt-30 -63.82 -34.12 77.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.526 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.56 -29.4 30.35 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -93.15 -20.18 20.74 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.457 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -50.2 -42.3 71.57 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 73.6 Cg_exo -42.3 -42.79 7.75 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 123.168 2.579 . . . . 0.0 114.786 174.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -78.38 -36.64 45.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -169.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 165' ' ' ALA . . . -177.87 -172.67 42.59 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.132 175.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.547 ' HG3' ' CE1' ' A' ' 252' ' ' TYR . 73.0 Cg_endo -76.28 129.15 10.99 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.955 2.436 . . . . 0.0 112.123 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.2 mt -90.11 128.6 41.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.29 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.571 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 24.5 ttmm -91.98 -37.23 12.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.711 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.3 p -169.71 157.04 6.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.381 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.6 mt -126.64 108.3 18.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.46 99.53 11.72 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.766 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 57.4 ttm -119.7 127.47 52.9 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.089 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.233 0.197 0 O-C-N 123.573 0.546 . . . . 0.0 110.426 178.445 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 36.3 p90 . . . . . 0 C--O 1.236 0.369 0 CA-C-O 121.416 0.627 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.72 156.25 31.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.269 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' CE2' ' HD1' ' A' ' 115' ' ' TYR . 76.8 m-85 -113.04 126.18 55.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.12 114.01 41.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 38.6 tt0 -101.47 122.27 43.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.577 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -97.56 172.61 7.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.024 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.571 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 23.6 mt-10 -93.5 -7.43 44.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.963 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.1 m -140.22 135.43 16.18 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.809 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.26 -25.75 36.34 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.195 2.597 . . . . 0.0 113.036 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.478 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 18.4 mp0 -55.81 -45.06 78.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.546 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . . . -55.62 -40.28 71.9 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.937 0.398 . . . . 0.0 111.352 175.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.5 -35.02 78.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.904 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.68 ' HG3' HG11 ' A' ' 286' ' ' VAL . 16.6 mm-40 -68.38 -48.13 65.54 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.671 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.589 HD11 ' HD2' ' A' ' 212' ' ' TYR . 64.0 mt -60.38 -43.68 96.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.177 0.513 . . . . 0.0 111.113 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.61 -37.24 80.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.563 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 8.2 tt -72.41 -48.51 40.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.092 174.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -53.36 -43.24 67.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.264 -177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -100.23 -49.22 4.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 176' ' ' VAL . 16.1 ttp -107.91 29.97 6.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.685 -166.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.599 ' HB2' ' O ' ' A' ' 170' ' ' LEU . 7.1 t30 -54.63 -51.13 66.36 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -174.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 19.2 m -113.61 16.48 18.67 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -169.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' A' ' 173' ' ' MET . 10.7 m -140.02 135.89 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.832 0.287 . . . . 0.0 110.98 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.999 ' HB2' HD13 ' A' ' 183' ' ' ILE . 27.7 tpp -126.68 102.09 6.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.911 0.386 . . . . 0.0 110.932 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 21.0 tp 71.13 -68.41 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.149 172.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -114.15 -143.34 8.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.094 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.56 65.73 3.91 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.204 -0.522 . . . . 0.0 111.875 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -131.73 120.09 22.24 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 175' ' ' SER . 6.2 p30 -77.84 128.64 34.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 177' ' ' MET . 37.0 pt -135.78 -175.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.245 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 68.2 mmtt -134.15 106.67 7.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.037 174.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 174' ' ' ASN . 54.9 t -99.49 101.53 12.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.921 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -174.956 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLN . . . . . 0.422 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 27.0 tt0 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.982 0.42 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -69.36 -34.99 75.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.855 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.662 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 15.6 tm0? -57.97 -53.33 66.94 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.222 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 74.7 Cg_exo -53.46 -36.04 78.21 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.588 2.192 . . . . 0.0 112.905 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.41 -42.0 73.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.777 0.322 . . . . 0.0 110.243 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 194' ' ' ALA . 81.5 mt -61.14 -47.88 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.287 0.565 . . . . 0.0 109.973 176.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.15 -37.47 87.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.836 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -58.95 -52.89 63.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.918 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 67.7 mt -68.04 -33.14 74.02 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.987 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.659 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.95 -46.03 71.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.4 -36.79 83.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.962 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.566 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 39.4 mt-10 -67.77 -27.39 66.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.975 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.13 -27.83 59.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.028 0.442 . . . . 0.0 110.326 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.659 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 72.4 mtp180 -74.39 -15.59 60.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.503 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.88 -11.01 60.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.511 0.672 . . . . 0.0 109.992 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -115.87 -178.74 3.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.388 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 9.6 m-80 -123.92 46.06 2.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -102.61 139.18 38.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.284 -166.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.475 HG23 ' HB2' ' A' ' 263' ' ' SER . 37.6 pt -125.17 166.55 20.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.798 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.623 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 49.0 t80 -117.65 130.07 56.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.697 -175.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.1 132.89 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.004 0.431 . . . . 0.0 110.256 176.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.02 176.46 7.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.6 t 64.41 22.71 12.81 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 123.93 0.768 . . . . 0.0 109.204 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.404 HG13 HD11 ' A' ' 225' ' ' ILE . 15.4 t -67.87 121.82 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.761 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -62.66 143.05 57.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.454 0.169 . . . . 0.0 110.687 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLN . . . . . 0.63 ' HA ' ' CE1' ' A' ' 249' ' ' HIS . 28.6 pt20 -61.05 -16.82 48.01 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -166.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -105.4 -5.52 20.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.046 0.451 . . . . 0.0 110.846 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.541 HD21 ' HG ' ' A' ' 275' ' ' LEU . 2.9 tp -83.55 130.3 35.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' SER . . . . . 0.559 ' O ' HG12 ' A' ' 225' ' ' ILE . 29.7 p -102.37 167.84 9.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.377 -174.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.42 ' HB3' ' HG ' ' A' ' 240' ' ' LEU . 0.5 OUTLIER -60.81 -37.98 83.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.282 0.563 . . . . 0.0 109.958 174.725 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -54.65 -40.03 68.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.997 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.7 -47.24 41.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.68 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.671 HG22 HD11 ' A' ' 255' ' ' ILE . 34.0 mm -60.41 -42.5 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.55 ' HG3' HG21 ' A' ' 235' ' ' ILE . 86.2 tttt -57.36 -48.78 78.12 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.04 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 88.0 p -60.83 -35.34 76.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -173.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.58 -43.67 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.633 0.254 . . . . 0.0 111.232 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.588 ' CB ' HD11 ' A' ' 235' ' ' ILE . 10.3 m-85 -68.26 -29.41 68.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.297 0.57 . . . . 0.0 110.802 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.87 -24.77 67.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.054 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.0 -17.84 62.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.889 -175.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.21 -44.73 3.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.02 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.62 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -124.55 170.17 16.61 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.098 -175.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -86.4 99.07 11.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.588 HD11 ' CB ' ' A' ' 229' ' ' PHE . 12.8 mt -84.59 150.82 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.332 0.587 . . . . 0.0 111.458 -175.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -117.04 -27.86 6.41 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.471 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.0 t -167.94 149.41 5.32 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.726 -173.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.571 ' SG ' HG12 ' A' ' 255' ' ' ILE . 50.3 t -148.2 126.3 12.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.257 175.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 99.0 m -142.52 121.33 12.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.787 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.448 ' CD2' ' HA3' ' A' ' 253' ' ' GLY . 31.1 mt -82.7 141.04 32.74 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.31 114.86 6.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.463 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 80.3 mtm180 -127.79 163.16 24.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.328 0.585 . . . . 0.0 112.365 -172.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 244' ' ' PRO . 9.6 m-20 -104.69 104.95 48.47 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.458 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 9.6 Cg_endo -50.03 -45.74 31.45 Favored 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 123.86 3.04 . . . . 0.0 114.934 -167.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.8 p -93.21 9.58 35.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.447 ' OG1' ' HG2' ' A' ' 248' ' ' LYS . 72.3 p -114.5 -38.7 3.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.971 0.415 . . . . 0.0 110.469 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.15 2.54 56.89 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.34 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.447 ' HG2' ' OG1' ' A' ' 246' ' ' THR . 19.8 ptmt -99.27 158.33 15.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.887 0.375 . . . . 0.0 110.532 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.63 ' CE1' ' HA ' ' A' ' 218' ' ' GLN . 22.4 p80 -105.63 152.32 23.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -80.18 -1.29 39.8 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.832 -170.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 113.05 -6.98 25.38 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.375 172.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.547 ' CE1' ' HG3' ' A' ' 137' ' ' PRO . 24.3 p90 -138.2 161.86 35.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.664 0.269 . . . . 0.0 110.541 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' A' ' 240' ' ' LEU . . . -154.12 172.49 32.74 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.889 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.623 ' CE1' ' HD1' ' A' ' 212' ' ' TYR . 29.9 m-85 -129.0 144.07 51.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.811 0.339 . . . . 0.0 110.464 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.671 HD11 HG22 ' A' ' 225' ' ' ILE . 77.5 mt -136.09 133.2 50.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.297 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 33.4 mt-10 -113.78 143.72 44.17 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.62 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 6.6 m-85 -110.6 170.12 8.3 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.095 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.623 ' HB2' ' HD2' ' A' ' 259' ' ' LYS . 34.4 mt-10 -72.78 -43.56 62.66 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.709 0.766 . . . . 0.0 109.008 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LYS . . . . . 0.623 ' HD2' ' HB2' ' A' ' 258' ' ' GLU . 11.0 mptt -105.81 130.09 53.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.058 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.79 -25.72 68.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.32 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -75.43 -31.92 60.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.776 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.4 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 46.7 m -70.12 -34.91 73.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.355 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.475 ' HB2' HG23 ' A' ' 211' ' ' ILE . 55.2 p -66.29 -34.61 78.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.339 0.59 . . . . 0.0 109.751 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -71.63 -25.93 62.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.556 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -68.45 -42.41 78.85 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.367 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.74 88.09 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.498 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.436 HG13 ' HA2' ' A' ' 283' ' ' GLY . 80.3 t -52.79 -48.71 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.985 0.422 . . . . 0.0 111.406 175.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.3 m -71.36 -23.47 61.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.1 m -94.34 -43.44 8.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' MET . . . . . . . . . . . . . 84.8 mmm -89.84 -4.4 57.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.022 -169.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -76.96 122.51 24.98 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.992 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.608 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 96.7 mt 70.79 27.97 3.46 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.182 -175.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -89.71 124.36 34.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.094 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -77.56 107.45 10.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.974 0.416 . . . . 0.0 110.961 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.541 ' HG ' HD21 ' A' ' 220' ' ' LEU . 31.2 tp -134.13 98.85 4.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.059 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 101.56 2.67 53.27 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.151 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.13 -0.15 41.12 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.319 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -131.68 142.44 49.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.804 0.335 . . . . 0.0 110.557 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.608 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 21.7 m-85 -74.0 111.22 8.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.592 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.44 128.16 35.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.884 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -98.95 116.23 30.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 212' ' ' TYR . 10.2 p -125.7 141.92 44.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.838 -176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.436 ' HA2' HG13 ' A' ' 267' ' ' VAL . . . -160.8 173.41 37.29 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.397 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -71.1 125.99 28.37 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.85 124.05 21.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.68 HG11 ' HG3' ' A' ' 167' ' ' GLN . 34.0 m -88.79 -19.23 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 111.385 -172.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.412 ' OG1' ' HD2' ' A' ' 288' ' ' PRO . 5.4 t -147.36 147.98 30.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 173.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.412 ' HD2' ' OG1' ' A' ' 287' ' ' THR . 60.7 Cg_endo . . . . . 0 CA--C 1.533 0.469 0 C-N-CA 122.78 2.32 . . . . 0.0 112.717 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 CA--C 1.532 0.28 0 CA-C-O 120.761 0.315 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -57.25 -37.34 72.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.139 0.495 . . . . 0.0 109.931 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.22 88.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.236 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.442 HD23 ' SD ' ' A' ' 111' ' ' MET . 66.7 mt -61.87 -35.26 77.78 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.999 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.66 -26.51 68.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.346 0.593 . . . . 0.0 110.818 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.77 -37.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.778 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.508 ' SD ' HG12 ' A' ' 198' ' ' ILE . 88.1 mtp -70.57 -29.68 66.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.741 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.1 m -70.64 -17.71 62.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 110.875 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -98.5 140.81 32.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.855 0.36 . . . . 0.0 110.146 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.778 HG12 ' HB ' ' A' ' 158' ' ' VAL . 3.7 p -120.47 126.88 75.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.672 0.749 . . . . 0.0 109.994 176.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -83.69 101.25 11.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.053 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 25.1 m -108.35 143.15 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.033 0.445 . . . . 0.0 111.243 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.795 ' HA3' ' HD1' ' A' ' 155' ' ' PHE . . . -152.4 177.68 30.02 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.36 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 23.2 t 65.01 50.09 1.95 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.672 0.749 . . . . 0.0 109.294 -175.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 123' ' ' LEU . 77.1 mt -103.14 116.45 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.936 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -61.21 147.89 42.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.638 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -74.07 76.29 1.73 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.027 0.918 . . . . 0.0 111.047 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -163.55 -38.24 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 119' ' ' ILE . 26.8 mt -76.53 92.6 3.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.453 174.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.56 -169.49 44.93 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.583 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 129' ' ' ARG . 20.8 tt0 -54.33 -46.51 72.89 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -64.11 -44.93 90.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.564 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -63.89 -45.17 90.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.562 HG13 ' HE1' ' A' ' 143' ' ' MET . 26.8 mm -69.17 -35.46 68.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.122 0.487 . . . . 0.0 110.427 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 27.9 ttt180 -59.37 -45.48 91.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.802 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.2 -33.45 71.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.838 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.19 -38.73 30.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.502 ' CD1' HG23 ' A' ' 128' ' ' ILE . 24.6 m-85 -89.33 -22.43 22.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.38 -42.97 90.16 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -44.96 -31.95 5.93 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.991 2.46 . . . . 0.0 114.53 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.689 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 74.6 m-85 -82.06 -37.2 26.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.48 -175.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 165' ' ' ALA . . . -178.49 173.62 45.97 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.798 174.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.1 126.19 15.38 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.985 2.457 . . . . 0.0 111.956 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.622 HD13 HD11 ' A' ' 141' ' ' ILE . 61.9 mt -89.06 139.27 17.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.635 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.599 ' HD2' ' OE2' ' A' ' 159' ' ' GLU . 22.1 ttmm -98.84 -43.86 6.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.099 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.8 t -159.63 142.53 13.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.096 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.622 HD11 HD13 ' A' ' 138' ' ' ILE . 70.0 mt -126.17 110.42 23.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.87 0.366 . . . . 0.0 110.089 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 25.9 t70 -91.45 100.82 13.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.185 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.562 ' HE1' HG13 ' A' ' 128' ' ' ILE . 51.3 ttm -138.86 111.3 7.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.023 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 59.4 m . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.128 0.489 . . . . 0.0 111.377 178.904 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.795 ' HD1' ' HA3' ' A' ' 117' ' ' GLY . 67.8 m-85 . . . . . 0 C--O 1.236 0.381 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.96 153.8 41.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.81 0.338 . . . . 0.0 110.755 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.498 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 88.9 m-85 -114.85 110.82 20.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.588 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.778 ' HB ' HG12 ' A' ' 114' ' ' VAL . 58.2 t -97.49 108.72 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.902 177.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.599 ' OE2' ' HD2' ' A' ' 139' ' ' LYS . 33.3 tt0 -102.35 119.8 39.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.124 -178.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.446 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 90.2 m-85 -97.4 -177.72 3.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.001 0.429 . . . . 0.0 111.342 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -80.18 -58.79 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.646 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.7 m -103.7 143.16 26.09 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.626 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 40.9 Cg_endo -67.52 -18.8 49.08 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.147 2.565 . . . . 0.0 112.798 -176.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.701 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 15.7 mp0 -55.81 -57.17 13.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.459 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.534 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . . . -52.98 -26.85 16.54 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 177.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.18 -47.26 13.68 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.404 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.7 ' HG2' HG13 ' A' ' 286' ' ' VAL . 2.6 pp0? -66.72 -31.57 72.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.689 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 10.7 tp -73.23 -45.81 53.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.53 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.86 71.92 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.602 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.5 tt -66.63 -50.28 63.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.473 172.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -54.19 -49.72 68.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.351 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -86.48 -38.92 16.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -173.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 30.9 mtm -106.8 21.93 16.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -171.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 32.1 p30 -72.14 0.16 10.37 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.324 0.583 . . . . 0.0 110.23 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.9 m -95.5 -73.72 0.58 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.506 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.5 m -139.16 161.82 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.729 0.299 . . . . 0.0 111.167 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.548 ' HE2' ' HG ' ' A' ' 178' ' ' LEU . 1.6 tpt -150.63 72.47 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.548 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 74.1 mt 57.16 -166.43 0.14 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.765 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.19 -17.76 1.73 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.798 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.45 21.67 53.48 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.443 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -143.78 176.63 9.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.058 0.456 . . . . 0.0 111.332 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -95.04 144.08 25.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.692 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 22.3 pt -116.71 171.26 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.834 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.729 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 34.8 mmtp -103.8 131.6 50.85 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 6.1 t -129.94 110.22 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.8 0.333 . . . . 0.0 110.487 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.602 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.788 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.565 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.752 0.31 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.414 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -82.1 -28.49 32.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.483 -178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.585 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 11.5 mm100 -55.57 -49.81 90.51 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 75.7 Cg_exo -53.23 -33.89 67.1 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.249 1.966 . . . . 0.0 112.846 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 63.4 mt -75.25 -48.14 32.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.877 0.37 . . . . 0.0 110.227 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.508 HG12 ' SD ' ' A' ' 111' ' ' MET . 68.7 mt -57.5 -48.08 83.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.924 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 33.5 t70 -69.43 -34.12 73.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.115 -176.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -71.58 -37.94 70.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.671 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 60.8 mt -67.74 -33.22 74.44 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.198 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -58.72 -37.27 75.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 109.772 173.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 37.7 mt-10 -72.49 -30.35 64.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.356 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -68.42 -33.8 74.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.993 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.9 -24.62 62.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.262 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 65.6 mtp180 -72.62 -24.23 61.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.17 173.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.67 -39.63 19.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.277 0.56 . . . . 0.0 110.047 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -109.36 80.19 1.29 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.77 85.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.773 0.67 . . . . 0.0 110.916 -175.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 256' ' ' GLU . 9.1 ttt180 -128.09 143.31 51.06 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.537 -171.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 263' ' ' SER . 39.7 pt -118.21 166.76 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.564 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.524 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 73.9 t80 -121.91 126.36 48.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.388 -173.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.522 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.7 m -121.32 131.27 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.985 0.422 . . . . 0.0 110.358 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.87 175.27 7.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.451 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.6 t 59.96 31.53 20.72 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.867 0.841 . . . . 0.0 109.206 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 44.9 t -73.02 123.06 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.224 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -50.3 128.91 20.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.391 0.615 . . . . 0.0 110.968 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -55.74 -33.1 63.96 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.159 -173.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -99.07 37.0 1.6 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.477 0.656 . . . . 0.0 110.386 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 220' ' ' LEU . 11.2 tp -124.69 133.01 53.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.7 m -95.84 170.09 9.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.849 -174.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -67.46 -36.33 80.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.756 0.312 . . . . 0.0 110.819 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.9 -30.78 70.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.642 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.5 -45.26 47.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.361 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.77 HG13 HD21 ' A' ' 240' ' ' LEU . 27.1 mm -59.85 -42.42 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.692 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.44 ' HB2' ' CB ' ' A' ' 238' ' ' CYS . 86.8 tttt -56.46 -52.52 64.38 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.868 176.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 79.6 p -56.31 -37.83 70.46 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -173.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.4 -45.48 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.677 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.577 ' HB2' HD11 ' A' ' 235' ' ' ILE . 26.3 m-85 -67.95 -27.75 66.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.292 0.568 . . . . 0.0 110.394 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.09 -26.51 67.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.142 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.19 -18.73 61.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.236 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -107.07 -31.33 8.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -153.28 159.37 28.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.875 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -75.45 111.2 10.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.505 0.669 . . . . 0.0 111.645 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 229' ' ' PHE . 40.0 mt -84.03 148.98 4.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.4 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.635 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 77.8 tttt -108.35 -35.85 6.41 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.861 176.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 256' ' ' GLU . 17.0 m -153.44 136.05 15.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -170.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.44 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 52.4 t -138.68 114.75 10.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.883 0.373 . . . . 0.0 110.103 175.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 31.3 m -141.99 116.01 9.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.57 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.77 HD21 HG13 ' A' ' 225' ' ' ILE . 66.3 mt -77.98 138.58 38.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.63 3.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.499 ' HG2' ' CA ' ' A' ' 249' ' ' HIS . 34.6 mtm180 -122.41 143.17 49.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.775 -176.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -83.96 109.92 22.16 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.47 -16.47 55.32 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.477 2.118 . . . . 0.0 111.992 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.7 p -73.29 -29.18 62.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.595 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.551 HG23 ' HG2' ' A' ' 248' ' ' LYS . 4.1 t -120.55 -26.68 5.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.796 0.331 . . . . 0.0 111.762 -178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.56 37.06 8.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.201 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.551 ' HG2' HG23 ' A' ' 246' ' ' THR . 19.2 ptpt -140.43 150.05 43.35 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.499 ' CA ' ' HG2' ' A' ' 242' ' ' ARG . 18.1 p80 -80.59 132.36 35.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.332 0.586 . . . . 0.0 110.465 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -64.06 -21.04 66.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.112 -171.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 133.73 -15.3 4.64 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.273 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.524 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 33.8 p90 -128.36 169.86 13.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.692 0.282 . . . . 0.0 110.592 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -158.38 170.82 35.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.051 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.701 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 97.4 m-85 -130.86 138.92 50.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.068 0.461 . . . . 0.0 111.309 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 225' ' ' ILE . 89.2 mt -133.95 128.53 53.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.699 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 210' ' ' ARG . 57.2 tt0 -109.85 145.89 36.02 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.505 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 16.8 m-85 -116.2 148.01 40.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.002 0.429 . . . . 0.0 111.262 -175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.635 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 26.3 mt-10 -72.54 -21.95 61.09 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.081 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -116.91 126.33 52.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.725 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -50.73 -58.11 6.69 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -171.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -62.44 -29.07 70.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.226 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' SER . . . . . 0.418 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 49.9 m -64.97 -29.22 70.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 111.556 -175.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.47 ' HA ' ' CD1' ' A' ' 257' ' ' TYR . 87.5 p -63.19 -39.93 96.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.323 0.582 . . . . 0.0 109.712 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -78.28 -19.32 53.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.136 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 85.9 m-20 -63.03 -43.05 99.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.65 84.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.683 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 263' ' ' SER . 97.4 t -56.06 -37.23 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 111.226 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.7 t -77.75 -35.69 51.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.0 m -94.83 -36.55 11.62 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -171.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.438 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.4 mmm -83.4 -0.52 50.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -169.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -73.53 125.99 29.22 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.487 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 91.1 mt 66.04 25.17 10.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.53 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -88.13 118.27 27.59 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 172.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.522 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 6.7 p-10 -74.69 115.71 14.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.458 0.647 . . . . 0.0 110.439 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 31.6 tp -123.75 97.83 5.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.14 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.5 26.63 35.2 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -175.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.5 -43.74 1.85 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.697 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -88.25 142.46 27.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.044 0.449 . . . . 0.0 111.203 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 68.2 m-85 -81.63 123.59 28.82 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.916 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.68 123.01 21.62 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.711 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -93.6 115.23 27.7 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 14.3 p -118.06 142.68 31.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.244 0.545 . . . . 0.0 111.428 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.5 ' HA3' HD13 ' A' ' 168' ' ' LEU . . . -157.95 -176.94 30.58 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.8 mppt? -85.98 147.73 26.08 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.323 0.561 . . . . 0.0 110.43 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -86.52 130.96 34.31 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 167' ' ' GLN . 12.0 m -93.54 -19.46 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.834 0.349 . . . . 0.0 110.877 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 42.9 p -130.43 129.01 22.73 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.29 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 CA--C 1.531 0.364 0 C-N-CA 122.425 2.084 . . . . 0.0 111.045 173.368 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -50.86 -28.4 9.43 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.422 -173.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.06 71.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 111.363 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.539 HD23 ' SD ' ' A' ' 111' ' ' MET . 58.4 mt -68.55 -31.97 71.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.064 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.04 -27.87 68.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.213 0.53 . . . . 0.0 110.425 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.0 mt -85.86 -34.64 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.096 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.552 ' SD ' HG12 ' A' ' 198' ' ' ILE . 91.7 mtp -70.84 -16.43 62.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.042 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 71.2 m -84.39 -6.29 59.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.716 0.293 . . . . 0.0 111.188 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 51.8 mtt180 -116.78 141.88 47.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.757 0.313 . . . . 0.0 110.548 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 158' ' ' VAL . 4.0 p -120.63 128.47 76.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.408 0.623 . . . . 0.0 109.752 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -83.11 115.56 21.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.016 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 17.2 m -108.33 124.87 65.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.518 0.675 . . . . 0.0 111.124 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.61 174.83 18.01 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.375 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.459 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 71.8 m 61.0 38.33 17.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.272 0.558 . . . . 0.0 110.517 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 57.5 mt -74.34 -21.81 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.563 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 84.0 t80 70.01 163.94 0.25 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.37 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -89.83 76.77 7.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.589 0.709 . . . . 0.0 110.704 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -164.1 -50.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.342 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.715 HD13 ' HG3' ' A' ' 177' ' ' MET . 73.3 mt -65.23 112.74 3.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.919 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -80.14 159.11 42.97 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.751 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -65.22 -37.32 86.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.207 0.527 . . . . 0.0 109.93 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.12 -41.12 97.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.606 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.4 m -64.76 -41.4 95.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.954 0.407 . . . . 0.0 110.292 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 124' ' ' GLY . 33.4 mm -59.2 -44.94 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.876 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.44 ' HA ' HD12 ' A' ' 138' ' ' ILE . 25.1 ttt180 -59.24 -40.48 86.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.223 0.535 . . . . 0.0 110.338 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -71.56 -33.89 69.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.583 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.95 -24.19 28.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.488 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 34.8 m-85 -95.15 -16.68 22.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.72 -42.03 92.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -44.73 -32.29 5.86 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 123.092 2.528 . . . . 0.0 114.888 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.76 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 78.5 m-85 -85.4 -42.78 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.769 0.319 . . . . 0.0 110.752 -177.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.61 157.22 29.46 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.969 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.45 117.92 4.65 Favored 'Trans proline' 0 C--O 1.241 0.649 0 C-N-CA 122.71 2.273 . . . . 0.0 111.722 175.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' A' ' 132' ' ' PHE . 54.9 mt -72.53 132.55 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.242 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -96.7 -43.05 7.72 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.228 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.7 m -152.76 140.41 19.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.3 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.8 mt -122.76 124.86 71.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.951 0.405 . . . . 0.0 110.139 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 8.0 m-20 -112.71 98.8 7.46 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 174.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.408 ' CE ' HG13 ' A' ' 128' ' ' ILE . 54.4 ttm -124.26 137.72 54.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.899 178.146 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 47.4 p90 . . . . . 0 C--O 1.236 0.343 0 CA-C-O 120.436 0.16 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 142' ' ' ASP . . . -148.84 140.93 23.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.913 0.387 . . . . 0.0 111.613 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -110.45 116.57 31.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.92 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.574 ' HB ' HG12 ' A' ' 114' ' ' VAL . 88.3 t -95.71 108.27 20.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.045 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 38.5 tt0 -96.41 128.89 43.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.217 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -103.57 165.97 10.71 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.77 -13.94 60.31 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.66 173.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.7 m -138.65 139.64 25.03 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 45.0 Cg_endo -67.83 -19.28 47.0 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.314 2.676 . . . . 0.0 112.486 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.7 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 7.5 mp0 -59.44 -48.21 82.5 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.966 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.24 -22.23 66.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.871 0.367 . . . . 0.0 111.853 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.08 -49.61 10.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.927 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 164' ' ' GLU . 5.0 pp0? -64.3 -30.78 71.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.76 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.8 tp -71.22 -50.54 31.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.431 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.31 -33.39 75.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.392 . . . . 0.0 110.296 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.567 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.8 tt -71.74 -38.06 70.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.2 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.64 -52.12 64.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.183 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -100.04 -30.43 11.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -172.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 27.8 ttp -106.87 28.19 8.21 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.483 -170.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -74.62 -8.62 56.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.089 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.6 m -72.7 -73.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.17 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 182' ' ' ASN . 27.1 m -144.69 167.59 10.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.949 0.404 . . . . 0.0 111.42 -173.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.744 ' HB2' HD13 ' A' ' 183' ' ' ILE . 11.7 tpp -132.4 74.47 1.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 172.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 60.6 mt 59.5 -174.3 0.1 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.28 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.2 -63.63 3.57 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.889 173.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 129.56 34.99 0.47 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -144.04 136.59 26.92 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.521 ' HA ' HG12 ' A' ' 176' ' ' VAL . 2.1 p-10 -71.59 141.49 50.01 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.983 0.42 . . . . 0.0 109.998 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.3 pt -112.55 178.89 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.859 -176.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 18.6 tptm -112.87 112.64 24.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.603 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.0 t -109.7 109.45 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.049 0.452 . . . . 0.0 110.792 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.476 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.744 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 121.274 0.559 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.529 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -76.76 -22.49 53.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.369 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.474 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 31.7 mm-40 -60.59 -53.46 64.23 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.2 Cg_endo -53.24 -34.56 70.26 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.489 2.126 . . . . 0.0 112.995 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 65.9 mt -74.63 -38.85 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.543 0.211 . . . . 0.0 110.691 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.552 HG12 ' SD ' ' A' ' 111' ' ' MET . 70.2 mt -58.07 -49.07 82.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.225 0.536 . . . . 0.0 109.732 174.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.9 -37.49 87.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.888 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLN . . . . . 0.485 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 24.7 tp60 -60.2 -51.66 68.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.877 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 31.6 mt -67.52 -33.27 74.74 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.936 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.87 -37.71 66.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.48 -36.66 63.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.922 174.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 200' ' ' GLN . 26.7 mt-10 -71.72 -24.0 61.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.819 0.342 . . . . 0.0 111.778 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.19 -26.55 61.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.394 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 37.2 mtm180 -69.71 -17.95 63.5 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.451 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.01 -15.25 62.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.097 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -119.89 -172.76 2.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.601 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.619 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 68.4 m-20 -130.29 41.72 3.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.453 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.401 ' CA ' ' HG2' ' A' ' 256' ' ' GLU . 32.1 ttp180 -101.13 138.01 38.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.3 0.571 . . . . 0.0 112.044 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.5 pt -124.71 167.76 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.233 175.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 77.6 t80 -121.47 129.07 52.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.707 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.475 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 33.7 m -124.28 134.9 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.014 0.435 . . . . 0.0 110.445 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -130.8 178.27 6.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.944 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.402 ' CB ' ' HG2' ' A' ' 281' ' ' ARG . 28.5 t 59.44 36.16 23.08 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.626 0.727 . . . . 0.0 109.413 -173.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.613 HG13 HD11 ' A' ' 225' ' ' ILE . 10.5 t -73.61 120.47 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.687 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 79.5 t60 -54.11 146.89 13.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.297 -174.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -48.58 -53.37 18.63 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -93.03 37.4 1.03 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.155 0.502 . . . . 0.0 111.368 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.458 HD21 HD23 ' A' ' 275' ' ' LEU . 12.2 tp -117.69 109.49 16.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 96.8 p -93.91 -179.36 4.95 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.065 -175.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.46 -32.18 73.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.658 0.266 . . . . 0.0 110.571 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.84 -35.75 79.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.026 0.441 . . . . 0.0 110.173 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.26 -48.52 72.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.294 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.635 HG22 HD11 ' A' ' 255' ' ' ILE . 33.4 mm -62.89 -46.73 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.457 ' HG3' HG21 ' A' ' 235' ' ' ILE . 54.2 tttm -54.33 -52.42 61.61 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.26 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 62.0 p -55.99 -39.6 72.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -174.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.1 t -76.48 -45.97 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.456 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.767 ' HB2' HD11 ' A' ' 235' ' ' ILE . 9.0 m-85 -64.72 -32.51 74.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.521 0.677 . . . . 0.0 110.557 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.63 -25.32 68.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.523 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.26 -25.81 63.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.765 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -101.59 -33.61 9.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.541 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -145.11 164.56 27.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.607 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -77.51 99.41 5.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.853 0.359 . . . . 0.0 110.746 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.767 HD11 ' HB2' ' A' ' 229' ' ' PHE . 13.3 mt -74.6 146.57 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.353 0.596 . . . . 0.0 111.393 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -110.31 -34.41 6.36 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.882 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 50.7 m -162.2 131.07 4.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.372 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.428 ' SG ' HG12 ' A' ' 255' ' ' ILE . 52.5 t -131.59 117.06 18.21 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 26.2 m -138.6 113.76 9.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.845 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.577 ' CD2' ' HA3' ' A' ' 253' ' ' GLY . 33.3 mt -82.46 139.93 33.68 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.39 115.56 7.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -128.62 136.75 51.11 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.172 -172.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -69.42 109.35 4.36 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.65 -45.35 41.7 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.199 3.266 . . . . 0.0 114.611 -168.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.526 HG23 HG23 ' A' ' 246' ' ' THR . 8.7 t -82.71 -11.86 58.01 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -170.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.526 HG23 HG23 ' A' ' 245' ' ' THR . 23.0 p -114.94 -21.51 10.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.114 0.483 . . . . 0.0 112.237 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 77.57 39.3 25.96 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.464 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -126.04 130.7 51.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.897 0.38 . . . . 0.0 110.36 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.425 ' HE1' ' O ' ' A' ' 216' ' ' VAL . 23.9 p80 -76.85 128.86 35.36 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 173.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -62.21 -20.64 64.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.274 -173.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 130.78 -5.02 5.79 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.274 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.437 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 46.3 p90 -140.65 167.96 20.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.745 0.307 . . . . 0.0 110.607 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.577 ' HA3' ' CD2' ' A' ' 240' ' ' LEU . . . -158.56 172.09 35.42 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.084 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.7 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 97.9 m-85 -128.05 142.52 51.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.894 0.378 . . . . 0.0 110.852 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.635 HD11 HG22 ' A' ' 225' ' ' ILE . 77.8 mt -136.8 131.79 47.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.767 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 16.5 mt-10 -112.44 146.57 38.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.875 175.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.546 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 9.2 m-85 -108.89 161.2 15.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.807 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.54 -22.33 59.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.509 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.8 141.58 48.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.035 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.559 ' HA ' ' OD1' ' A' ' 209' ' ' ASN . . . -57.99 -60.21 4.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -169.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -74.51 -20.61 59.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 -171.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.9 m -62.1 -25.8 67.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.431 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 211' ' ' ILE . 87.8 p -68.94 -39.61 79.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.372 0.606 . . . . 0.0 109.697 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -75.08 -23.16 57.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.897 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.28 -41.27 98.98 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.71 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -65.54 -42.22 92.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.37 175.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.551 ' HA ' HG21 ' A' ' 282' ' ' VAL . 96.4 t -54.14 -34.32 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.193 0.52 . . . . 0.0 110.822 177.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 26.1 t -73.11 -35.29 66.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.29 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.6 t -92.74 -35.08 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 111.832 -173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 73.2 mmm -88.64 5.65 42.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.785 0.326 . . . . 0.0 111.245 -171.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.519 ' HA ' HG12 ' A' ' 282' ' ' VAL . 25.1 t-20 -66.5 109.77 2.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.348 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.4 mt 63.47 40.91 7.89 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.549 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' PHE . . . . . 0.485 ' HD2' ' HB2' ' A' ' 275' ' ' LEU . 49.4 t80 -79.69 126.84 31.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.137 174.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -80.17 71.34 6.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.629 0.728 . . . . 0.0 111.444 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.485 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 30.8 tp -95.37 103.48 15.34 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.109 0.48 . . . . 0.0 110.245 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 90.14 21.45 38.65 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.494 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 88.91 -9.27 77.26 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.695 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -116.66 144.17 44.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.866 0.365 . . . . 0.0 110.697 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -80.2 115.45 19.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.577 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 273' ' ' PHE . 64.6 mt -64.53 126.64 28.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.437 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 281' ' ' ARG . 2.5 mmt180 -93.57 115.1 27.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 176.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 267' ' ' VAL . 8.3 p -112.83 147.16 16.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.155 -173.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.93 169.92 38.27 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -84.15 134.26 34.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.07 107.78 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.018 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 15.9 m -68.19 -27.6 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.541 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 69.9 p -98.52 124.5 46.29 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-O 121.246 0.546 . . . . 0.0 110.845 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 N--CA 1.46 -0.454 0 C-N-CA 122.755 2.303 . . . . 0.0 111.23 172.885 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.421 ' HB3' ' HG ' ' A' ' 108' ' ' LEU . 31.5 mm-40 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.936 0.398 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.0 mtp-105 -56.57 -40.12 74.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.279 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.86 -30.81 71.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.697 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 287' ' ' THR . 24.2 mt -69.37 -41.25 76.78 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.495 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.73 70.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 110.516 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 194' ' ' ALA . 69.4 mt -79.84 -46.25 22.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.872 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 30.9 mtm -65.22 -37.07 86.14 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.6 m -63.2 -19.21 64.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.738 0.304 . . . . 0.0 111.223 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -104.68 140.54 37.9 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.635 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.0 p -129.24 128.09 66.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.66 0.743 . . . . 0.0 110.371 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -85.13 113.59 21.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.332 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 29.6 m -111.41 116.44 52.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.306 0.574 . . . . 0.0 110.314 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -113.78 106.33 1.73 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.76 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' SER . . . . . 0.867 ' HB3' HG22 ' A' ' 183' ' ' ILE . 27.7 t 154.6 -90.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.894 1.278 . . . . 0.0 109.106 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.792 ' H ' HG22 ' A' ' 183' ' ' ILE . 13.6 mt 60.01 31.31 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.371 0.668 . . . . 0.0 111.497 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.667 ' HA ' ' HD3' ' A' ' 181' ' ' ARG . 27.8 t80 60.3 -164.06 0.23 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -124.14 75.44 1.38 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.792 1.282 . . . . 0.0 109.426 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 123' ' ' LEU . 5.8 tt0 -178.42 -144.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.81 -1.995 . . . . 0.0 106.64 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.538 HD22 HG21 ' A' ' 127' ' ' THR . 92.1 mt 57.6 -174.36 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.784 0.678 . . . . 0.0 112.187 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.79 -179.63 36.58 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.5 -45.72 90.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.821 0.343 . . . . 0.0 110.42 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 4.4 m-20 -56.87 -49.39 75.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.444 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.538 HG21 HD22 ' A' ' 123' ' ' LEU . 5.0 m -61.7 -43.1 99.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.034 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 119' ' ' ILE . 21.5 mm -66.55 -39.84 84.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.54 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 129' ' ' ARG . 43.2 ttp180 -60.7 -38.65 85.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.999 177.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 78.0 mt-30 -71.53 -33.26 69.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.211 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.05 -33.76 50.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -92.73 -16.19 25.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.601 0.238 . . . . 0.0 111.495 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -51.01 -44.66 87.37 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 5.1 Cg_exo -43.24 -49.07 7.61 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.981 2.454 . . . . 0.0 113.976 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.505 ' HD2' ' HG ' ' A' ' 168' ' ' LEU . 72.7 m-85 -65.28 -48.49 72.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -170.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.3 -171.66 29.82 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.449 -1.358 . . . . 0.0 113.271 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 161' ' ' GLU . 71.7 Cg_endo -78.79 121.61 5.11 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.752 2.302 . . . . 0.0 111.737 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 141' ' ' ILE . 57.6 mt -80.8 119.69 30.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.367 0.603 . . . . 0.0 110.662 -177.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.667 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 28.1 tptp -89.26 -34.13 16.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.847 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.9 t -174.53 162.14 3.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.857 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 138' ' ' ILE . 70.1 mt -141.22 122.37 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.745 0.307 . . . . 0.0 110.307 175.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.669 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 12.0 m-20 -95.01 104.01 15.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.387 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 3.9 mmt -94.98 126.18 40.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.737 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.417 0.627 . . . . 0.0 109.75 174.495 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.96 140.95 28.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.154 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.669 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 92.7 m-85 -109.99 109.17 19.67 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.635 ' HB ' HG12 ' A' ' 114' ' ' VAL . 43.3 t -92.04 115.02 30.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.23 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.667 ' HG2' ' HB3' ' A' ' 139' ' ' LYS . 36.6 tt0 -105.26 125.46 51.01 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.414 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.18 174.44 5.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.373 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.508 ' HB2' ' HG2' ' A' ' 137' ' ' PRO . 46.3 mt-10 -89.46 -16.32 31.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.086 172.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.451 HG22 ' HD2' ' A' ' 137' ' ' PRO . 28.1 m -130.67 137.64 31.25 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.109 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.453 ' HG3' HD22 ' A' ' 108' ' ' LEU . 60.1 Cg_endo -73.1 -20.76 21.29 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.785 2.323 . . . . 0.0 112.647 -176.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.571 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 13.6 mp0 -54.24 -59.08 5.14 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.132 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.16 -26.66 17.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.17 -51.83 8.01 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.216 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.45 ' HG3' HG11 ' A' ' 286' ' ' VAL . 10.6 mm100 -67.52 -27.43 66.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.984 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.505 ' HG ' ' HD2' ' A' ' 135' ' ' PHE . 14.2 tp -72.13 -47.61 49.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.105 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.28 73.48 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 185' ' ' VAL . 6.6 tt -65.06 -51.95 58.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.656 172.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -56.09 -33.68 65.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.833 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -100.68 -48.85 4.37 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.9 mtm -95.73 28.83 2.87 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -167.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -85.5 30.69 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.996 0.903 . . . . 0.0 109.847 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 16.6 m -113.93 -74.32 0.63 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.323 176.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.4 m -145.59 170.86 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.467 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.625 ' HB2' HD13 ' A' ' 183' ' ' ILE . 22.5 tpp -143.4 91.33 2.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.604 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.518 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 75.7 mt 54.49 45.34 27.21 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.035 172.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 170.85 163.06 24.25 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.962 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.13 53.25 4.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.152 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ARG . . . . . 0.667 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 25.4 mtp180 -143.46 125.78 15.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.096 0.474 . . . . 0.0 110.49 174.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 175' ' ' SER . 14.1 m120 -71.81 128.43 35.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.954 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.867 HG22 ' HB3' ' A' ' 118' ' ' SER . 43.9 pt -103.21 143.51 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.781 -177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 50.4 mttp -103.0 118.29 36.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.439 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.7 t -110.67 111.77 37.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 123.591 0.557 . . . . 0.0 111.479 -172.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.262 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.552 170.059 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 121.012 0.434 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' A' ' 110' ' ' ILE . . . -87.34 -17.64 31.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.738 -175.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.554 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 11.8 tm0? -57.7 -50.58 87.34 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.886 -174.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.0 Cg_endo -53.16 -37.3 79.73 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.604 2.203 . . . . 0.0 113.1 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.5 mt -74.59 -41.33 48.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.297 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.6 mt -59.73 -48.85 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.096 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 14.7 t70 -59.19 -43.27 92.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.46 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -59.38 -50.93 72.05 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.471 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.6 -33.0 73.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.681 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.577 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.41 -39.49 73.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.68 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 44.3 mt-10 -66.75 -33.82 76.46 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.755 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.415 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 37.3 mt-10 -66.51 -37.02 84.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.349 . . . . 0.0 110.568 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.35 -33.76 76.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.095 0.474 . . . . 0.0 110.27 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.68 ' HD3' ' HA ' ' A' ' 203' ' ' GLU . 66.9 mtp180 -70.36 -13.77 62.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.158 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.73 -38.37 19.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.052 0.453 . . . . 0.0 110.783 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.47 -19.88 23.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.114 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 61.64 46.92 6.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.16 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.478 ' HE ' ' HB3' ' A' ' 254' ' ' PHE . 22.5 ttt180 -103.32 137.14 41.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.72 -171.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 263' ' ' SER . 42.2 pt -118.96 167.25 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.346 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 81.3 t80 -119.53 128.04 53.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.619 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.42 HG23 HG21 ' A' ' 216' ' ' VAL . 27.4 m -116.98 135.04 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.217 0.532 . . . . 0.0 110.105 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -121.92 173.86 7.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.642 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.447 ' OG ' ' HG2' ' A' ' 281' ' ' ARG . 2.0 p 43.7 42.35 4.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.946 0.879 . . . . 0.0 111.202 -174.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.42 HG21 HG23 ' A' ' 213' ' ' VAL . 24.1 t -84.77 108.64 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.27 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -54.88 135.72 47.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.559 0.695 . . . . 0.0 111.369 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -51.72 -27.29 11.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.701 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -85.59 -9.84 56.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.918 0.389 . . . . 0.0 111.113 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 72.1 mt -86.52 136.39 33.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.214 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 49.3 m -97.26 169.44 9.77 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.496 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -62.29 -29.64 70.57 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.304 -0.247 . . . . 0.0 111.073 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -66.24 -35.18 79.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.172 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -61.04 -54.21 47.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.979 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.535 HG13 HD21 ' A' ' 240' ' ' LEU . 24.9 mm -63.52 -43.52 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.995 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 54.6 tttm -58.29 -49.63 76.46 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.318 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 97.8 p -56.04 -43.92 78.3 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 17.4 t -75.03 -41.62 45.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.609 0.242 . . . . 0.0 111.109 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.57 ' CB ' HD11 ' A' ' 235' ' ' ILE . 4.6 m-85 -65.75 -34.31 77.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.179 0.514 . . . . 0.0 110.912 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.3 tm-20 -66.33 -24.84 66.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.746 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.25 -16.45 61.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.648 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -111.74 -44.5 3.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.628 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' GLY . . . . . 0.554 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -124.57 173.49 16.99 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.525 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -94.96 99.28 11.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.393 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.57 HD11 ' CB ' ' A' ' 229' ' ' PHE . 17.9 mt -79.12 146.09 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.424 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 44.5 tttm -111.22 -33.14 6.53 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.126 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 18.8 m -152.84 125.55 8.33 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.485 -170.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.686 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 26.8 p -108.05 114.22 27.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.042 0.449 . . . . 0.0 109.907 170.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 27.5 m -141.71 102.06 4.09 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.286 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.535 HD21 HG13 ' A' ' 225' ' ' ILE . 64.6 mt -83.8 131.82 34.87 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.459 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -62.92 110.99 1.95 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.537 ' HD2' ' O ' ' A' ' 247' ' ' GLY . 16.1 ttp180 -123.98 144.88 49.55 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.798 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.433 ' HB3' HG22 ' A' ' 246' ' ' THR . 17.8 t70 -80.54 113.66 41.4 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 172.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.19 -25.71 47.72 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.707 2.938 . . . . 0.0 115.162 -167.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.7 t -110.09 3.75 20.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 243' ' ' ASP . 8.2 t -103.83 -13.57 16.36 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.934 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . 0.537 ' O ' ' HD2' ' A' ' 242' ' ' ARG . . . 91.83 -48.13 2.76 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.977 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 16.2 pttp -94.85 156.17 16.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.756 0.278 . . . . 0.0 110.451 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 4.4 p80 -80.07 161.88 25.11 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.743 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.15 -58.72 6.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.161 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 163.32 -17.18 0.13 Allowed Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.178 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.411 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 9.5 p90 -120.61 173.75 6.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.459 ' HA2' ' H ' ' A' ' 241' ' ' ALA . . . -163.84 172.89 39.82 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.959 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.571 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 76.4 m-85 -135.3 143.01 45.97 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 122.598 0.359 . . . . 0.0 110.072 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.2 mt -139.78 133.23 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.976 0.417 . . . . 0.0 110.705 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -105.68 147.79 28.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 13.2 m-85 -117.45 151.57 36.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.915 0.388 . . . . 0.0 110.269 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 34.7 mt-10 -72.4 -16.28 61.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.844 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -131.41 132.33 44.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.904 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -56.35 -33.95 66.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.332 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.37 -33.39 61.04 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.032 0.444 . . . . 0.0 110.864 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 4.7 t -66.56 -36.11 81.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.186 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.687 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 71.9 p -65.94 -36.69 84.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.207 0.527 . . . . 0.0 109.963 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -72.79 -24.12 60.88 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.82 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.63 -44.91 76.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.0 0.428 . . . . 0.0 110.398 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -64.28 -38.17 90.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.467 HG13 ' HA2' ' A' ' 283' ' ' GLY . 72.0 t -53.85 -38.94 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 120.966 0.413 . . . . 0.0 111.457 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 m -82.02 -19.8 39.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.81 0.338 . . . . 0.0 111.596 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 17.8 m -95.24 -49.26 5.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 58.4 mmm -81.57 -9.19 59.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -168.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -69.24 128.43 36.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.359 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 93.2 mt 66.99 31.69 6.83 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.852 0.72 . . . . 0.0 110.508 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -100.63 116.4 32.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.982 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.65 116.37 6.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.006 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 31.7 tp -143.02 118.67 10.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.766 173.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.57 6.48 87.34 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.028 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.44 -0.17 46.64 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.282 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -134.1 151.15 51.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -84.35 116.2 22.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.714 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.97 115.02 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.603 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 14.1 mmt180 -93.89 114.95 27.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.33 140.82 40.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 119.711 -0.795 . . . . 0.0 111.202 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' GLY . . . . . 0.467 ' HA2' HG13 ' A' ' 267' ' ' VAL . . . -153.97 -169.98 19.46 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -89.95 137.94 31.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 117.334 0.567 . . . . 0.0 109.59 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.45 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -71.06 121.9 19.07 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.45 HG11 ' HG3' ' A' ' 167' ' ' GLN . 28.2 m -79.48 -25.66 12.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.794 0.33 . . . . 0.0 110.987 -175.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.727 HG21 HD21 ' A' ' 108' ' ' LEU . 73.2 p -133.18 145.54 57.24 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.415 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 52.6 Cg_endo . . . . . 0 N--CA 1.462 -0.345 0 C-N-CA 122.492 2.128 . . . . 0.0 111.185 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 121.498 0.666 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 106' ' ' ARG . 28.1 ptt180 -67.99 -27.77 66.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.367 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HB2' HD12 ' A' ' 197' ' ' ILE . . . -65.89 -30.53 71.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.343 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 287' ' ' THR . 42.9 mt -60.93 -31.52 71.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.361 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.7 -24.96 67.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.132 0.491 . . . . 0.0 110.757 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.1 mt -87.83 -34.46 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.142 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.529 ' SD ' HG12 ' A' ' 198' ' ' ILE . 88.0 mtp -74.99 -15.5 60.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.093 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 97.7 m -79.61 -1.26 37.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.538 0.209 . . . . 0.0 111.378 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.896 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 32.7 mtt180 -110.81 142.43 42.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.765 0.317 . . . . 0.0 111.235 -174.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.558 HG23 HD12 ' A' ' 170' ' ' LEU . 8.9 p -128.4 129.79 69.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.408 0.623 . . . . 0.0 109.817 169.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -85.01 118.32 24.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.819 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.64 HG12 HG12 ' A' ' 185' ' ' VAL . 15.5 m -112.59 126.68 70.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.286 0.565 . . . . 0.0 111.372 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -131.31 175.36 19.61 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.543 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.7 m 62.1 31.87 17.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 122.934 0.493 . . . . 0.0 111.455 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.5 mt -77.22 112.83 15.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.067 0.46 . . . . 0.0 110.513 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -61.38 153.55 26.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.628 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -78.01 76.29 4.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.086 0.946 . . . . 0.0 110.949 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -165.21 -39.95 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.095 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.458 ' HB3' HD11 ' A' ' 128' ' ' ILE . 66.3 mt -74.93 85.96 2.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.969 174.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.48 172.33 55.22 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.924 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -55.1 -40.03 69.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 0.0 110.942 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 130' ' ' GLN . 20.5 t70 -62.28 -53.49 54.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.58 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 m -59.0 -43.07 91.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.978 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 123' ' ' LEU . 28.4 mm -63.19 -45.32 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.738 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -57.39 -43.85 84.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.43 . . . . 0.0 110.248 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 15.3 mm100 -68.73 -33.79 74.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.939 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.61 -27.03 25.73 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.528 ' HB2' HD11 ' A' ' 138' ' ' ILE . 4.9 m-85 -87.52 -26.01 23.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.78 0.324 . . . . 0.0 111.06 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.452 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -50.76 -42.19 76.09 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 26.1 Cg_exo -39.12 -45.96 2.88 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.168 2.579 . . . . 0.0 114.559 173.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.497 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 54.2 m-85 -76.1 -37.12 58.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.877 0.37 . . . . 0.0 110.597 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -176.04 153.49 14.81 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.45 124.31 15.94 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.718 2.279 . . . . 0.0 111.755 175.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 132' ' ' PHE . 21.0 mt -83.13 136.51 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.073 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -110.96 -20.32 12.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.175 0.512 . . . . 0.0 110.751 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.883 ' HB3' ' HB2' ' A' ' 159' ' ' GLU . 29.5 t -151.84 131.16 12.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.444 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.406 ' CG1' HG21 ' A' ' 138' ' ' ILE . 64.8 mt -130.28 129.67 65.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -117.48 99.45 7.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 52.1 ttm -141.33 112.0 7.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.828 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.768 178.731 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -151.12 167.62 27.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.995 0.426 . . . . 0.0 111.299 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -126.84 134.66 50.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.393 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 114' ' ' VAL . 89.4 t -121.07 113.0 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.644 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.896 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 4.8 mp0 -105.54 119.62 39.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.554 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.14 179.87 5.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.793 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.36 -63.15 1.17 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.832 169.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.3 m -99.08 144.79 28.86 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.951 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 22.9 Cg_exo -65.71 -19.82 59.45 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.469 2.779 . . . . 0.0 112.535 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.482 ' OE2' ' HB3' ' A' ' 212' ' ' TYR . 0.6 OUTLIER -58.53 -54.91 41.75 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.836 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.16 -25.82 14.9 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.5 -53.01 7.29 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.384 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.425 ' HG3' HG21 ' A' ' 286' ' ' VAL . 83.7 mm-40 -64.47 -43.33 94.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.751 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.497 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 10.5 tp -59.64 -46.44 89.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.436 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.664 ' HB1' ' SD ' ' A' ' 173' ' ' MET . . . -61.68 -53.09 60.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.558 HD12 HG23 ' A' ' 114' ' ' VAL . 8.2 tt -54.45 -36.13 63.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.467 0.651 . . . . 0.0 110.234 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.01 -46.48 71.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.73 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -100.87 -21.13 15.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -173.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.664 ' SD ' ' HB1' ' A' ' 169' ' ' ALA . 4.6 ptm -99.74 18.55 17.88 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.925 -0.484 . . . . 0.0 110.792 -176.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -72.78 -2.92 22.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 24.1 m -101.56 -74.22 0.63 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.472 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.88 157.17 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.232 0.539 . . . . 0.0 111.675 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.574 ' HB2' HD13 ' A' ' 183' ' ' ILE . 23.9 tpp -121.78 97.27 5.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.693 175.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 75.3 mt 61.49 35.91 17.35 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.249 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.34 -130.37 9.73 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.112 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 67.1 -94.26 0.25 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.574 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -144.33 153.69 42.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 175' ' ' SER . 23.6 t-20 -68.89 100.43 1.19 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.574 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.9 pt -74.84 149.6 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.369 -175.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 184' ' ' LYS . 9.3 mmpt? -103.45 107.3 18.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.161 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.64 HG12 HG12 ' A' ' 116' ' ' VAL . 5.9 m -104.62 109.41 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.222 0.534 . . . . 0.0 111.135 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.409 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.486 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 CA--C 1.524 -0.036 0 CA-C-O 121.302 0.572 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.441 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -87.96 10.18 19.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.476 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.7 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 25.3 tp60 -49.25 -53.13 42.45 Favored Pre-proline 0 N--CA 1.469 0.488 0 O-C-N 123.296 0.373 . . . . 0.0 111.89 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 40.0 Cg_exo -59.06 -37.47 92.71 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.198 1.932 . . . . 0.0 112.701 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' A' ' 107' ' ' ALA . 74.8 mt -75.3 -43.26 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.065 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.529 HG12 ' SD ' ' A' ' 111' ' ' MET . 73.7 mt -58.16 -45.9 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.149 0.5 . . . . 0.0 110.158 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 36.0 t70 -66.8 -39.01 87.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.765 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.43 -48.4 75.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.869 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.592 ' HA ' ' HG3' ' A' ' 204' ' ' GLU . 54.3 mt -68.14 -33.12 73.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.649 0.261 . . . . 0.0 111.032 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.568 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.15 -42.96 77.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 51.5 mt-10 -64.7 -36.36 84.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.901 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 201' ' ' LEU . 5.8 mm-40 -53.66 -46.03 70.44 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.059 0.457 . . . . 0.0 110.891 175.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 285' ' ' ALA . . . -63.73 -37.01 85.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.784 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 76.3 mtp180 -72.47 -16.75 61.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.164 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -99.38 -38.21 8.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.458 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -86.72 -12.46 48.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.126 0.489 . . . . 0.0 111.1 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 61.02 48.48 6.47 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.18 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.89 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 12.8 ptm180 -122.11 158.02 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.989 0.424 . . . . 0.0 111.718 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 pt -136.36 168.59 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.578 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.524 ' HB2' ' CE2' ' A' ' 254' ' ' PHE . 14.1 t80 -122.89 138.63 54.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.611 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.589 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 35.5 m -127.42 133.83 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 110.757 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.78 -178.52 4.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.309 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.4 t 61.27 30.24 19.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.902 0.858 . . . . 0.0 109.082 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.0 119.17 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.236 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -57.45 142.27 44.6 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.974 0.416 . . . . 0.0 111.062 -173.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -49.04 -36.18 17.49 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -168.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -91.03 -5.83 54.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -171.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.81 131.87 36.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.117 0.484 . . . . 0.0 111.14 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.2 p -100.6 173.58 6.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.192 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.472 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 6.1 p-10 -61.62 -35.46 77.94 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.722 0.296 . . . . 0.0 110.415 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.48 -39.08 82.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.258 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.36 -44.23 68.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.597 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.604 HG22 HD11 ' A' ' 255' ' ' ILE . 29.6 mm -66.37 -40.73 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 88.2 tttt -60.82 -43.33 98.35 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.479 176.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 51.1 m -59.36 -39.09 82.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.76 -45.5 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.625 0.25 . . . . 0.0 111.304 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.603 ' CB ' HD11 ' A' ' 235' ' ' ILE . 15.5 m-85 -65.91 -30.39 70.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.225 0.536 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 7.6 tp10 -61.0 -24.21 65.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.946 176.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.65 -13.16 59.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.883 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -111.06 -34.39 6.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.692 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.97 166.74 29.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.332 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -78.56 103.19 8.34 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.253 0.549 . . . . 0.0 111.336 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.603 HD11 ' CB ' ' A' ' 229' ' ' PHE . 22.3 mt -78.6 150.94 5.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.103 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.04 -28.66 8.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.794 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.467 ' OG ' ' HB2' ' A' ' 256' ' ' GLU . 3.3 p -172.04 153.1 3.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.671 0.272 . . . . 0.0 111.136 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' CYS . . . . . 0.455 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 41.6 t -143.5 127.79 17.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.16 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 239' ' ' THR . 5.2 t -141.53 108.48 5.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.067 0.461 . . . . 0.0 111.311 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.569 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 36.5 mt -79.32 130.58 35.58 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ALA . . . . . 0.578 ' HB3' ' CD1' ' A' ' 252' ' ' TYR . . . -75.03 118.68 18.26 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.536 ' CB ' ' HA ' ' A' ' 249' ' ' HIS . 35.9 ptt180 -139.56 169.04 18.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.95 -170.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -106.17 108.48 61.79 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 173.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.41 -37.61 94.1 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.305 2.67 . . . . 0.0 113.161 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -35.04 79.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.949 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 41.0 p -97.78 -18.67 18.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 111.537 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 73.77 44.82 30.14 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.05 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -150.95 139.64 20.7 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' HIS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 242' ' ' ARG . 6.2 p80 -83.68 140.23 32.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -81.26 30.06 0.34 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -169.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 92.97 -6.06 76.27 Favored Glycine 0 CA--C 1.505 -0.578 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.429 171.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.578 ' CD1' ' HB3' ' A' ' 241' ' ' ALA . 0.2 OUTLIER -140.42 173.87 11.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -176.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -169.77 174.7 44.02 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.413 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 212' ' ' TYR . 59.7 m-85 -129.51 146.92 51.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.169 0.484 . . . . 0.0 110.512 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.604 HD11 HG22 ' A' ' 225' ' ' ILE . 84.9 mt -136.03 147.76 28.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.008 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.89 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 34.7 mt-10 -127.65 146.81 50.43 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.644 ' HB2' ' OG ' ' A' ' 263' ' ' SER . 18.7 m-85 -119.66 159.18 24.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.825 0.345 . . . . 0.0 110.915 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.16 -36.42 69.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.211 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -107.1 131.67 53.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -58.23 -34.26 70.23 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.655 -173.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLN . . . . . 0.426 HE21 ' HB2' ' A' ' 261' ' ' GLN . 0.0 OUTLIER -64.81 -44.48 89.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.2 176.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.0 m -65.02 -30.58 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.296 -169.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.644 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 1.6 m -60.96 -47.6 85.69 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.389 0.614 . . . . 0.0 109.646 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -73.69 -26.84 60.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.325 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -74.29 -32.99 63.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.418 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -66.78 -40.07 88.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 282' ' ' VAL . 64.5 t -55.13 -45.56 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.433 0.635 . . . . 0.0 109.882 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 53.0 m -63.26 -30.01 71.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.699 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.9 m -95.61 -37.26 10.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.484 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 90.5 mmm -92.77 -3.52 54.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -166.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 272' ' ' LEU . 15.9 t30 -72.95 124.77 26.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.22 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' LEU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 99.1 mt 72.37 26.17 2.67 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.901 0.75 . . . . 0.0 110.643 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -87.33 120.75 28.94 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.546 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 10.2 p-10 -78.21 101.23 6.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.467 0.651 . . . . 0.0 110.871 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.546 HD12 HD11 ' A' ' 280' ' ' LEU . 0.9 OUTLIER -113.37 107.7 16.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.03 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 73.58 22.32 78.56 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.838 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.27 -38.5 3.26 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.775 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -87.87 148.68 24.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.857 0.328 . . . . 0.0 110.979 -176.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.546 ' CE1' ' HB3' ' A' ' 274' ' ' ASP . 81.4 m-85 -90.55 113.33 25.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.088 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.546 HD11 HD12 ' A' ' 275' ' ' LEU . 69.9 mt -60.18 133.27 55.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.479 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -107.1 116.35 31.77 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 172.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 267' ' ' VAL . 7.8 p -118.1 140.55 41.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.184 0.516 . . . . 0.0 111.36 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -132.47 174.78 20.24 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.018 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -100.33 45.43 0.98 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.597 0.713 . . . . 0.0 110.957 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 205' ' ' ALA . . . 33.09 69.89 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 112.9 -1.955 . . . . 0.0 113.709 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.425 HG21 ' HG3' ' A' ' 167' ' ' GLN . 35.1 m -54.8 -26.29 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.926 0.393 . . . . 0.0 111.159 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' THR . . . . . 0.483 ' HA ' ' HD2' ' A' ' 288' ' ' PRO . 25.7 p -134.04 107.14 11.44 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.611 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' PRO . . . . . 0.506 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 21.8 Cg_endo . . . . . 0 N--CA 1.462 -0.38 0 C-N-CA 122.857 2.372 . . . . 0.0 111.363 172.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.042 0.448 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -53.64 -49.26 68.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.494 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.7 -48.02 61.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.08 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.99 -34.66 78.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.947 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.96 -32.49 72.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.145 0.498 . . . . 0.0 110.584 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.8 mt -80.67 -34.59 14.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.158 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.466 ' SD ' HG12 ' A' ' 198' ' ' ILE . 84.8 mtp -71.42 -23.48 61.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.83 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.7 m -84.11 -1.74 55.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.842 0.353 . . . . 0.0 110.77 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 98.5 mtt180 -122.03 141.09 51.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.129 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.25 133.12 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.159 0.505 . . . . 0.0 110.022 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -83.5 121.1 26.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.627 HG11 ' HZ ' ' A' ' 132' ' ' PHE . 15.7 m -117.46 116.56 52.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.066 0.46 . . . . 0.0 110.097 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 183' ' ' ILE . . . -122.23 171.39 15.32 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.03 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 m 67.38 25.98 8.52 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.785 0.434 . . . . 0.0 111.196 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.3 mt -66.81 115.56 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -53.32 143.26 19.16 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.924 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -69.5 80.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.447 0.642 . . . . 0.0 110.206 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -164.3 -44.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.974 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.435 ' CD1' ' HG3' ' A' ' 177' ' ' MET . 48.1 mt -83.33 124.27 30.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.187 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -97.74 -169.86 32.63 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.4 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -65.28 -33.04 75.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.019 0.438 . . . . 0.0 110.225 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 9.8 m-20 -71.91 -50.59 27.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.535 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -41.86 86.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.503 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.548 HG23 ' CE1' ' A' ' 132' ' ' PHE . 17.1 mm -63.95 -42.91 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.812 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.2 ttt85 -59.15 -38.74 80.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.982 0.42 . . . . 0.0 110.307 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 90.1 mt-30 -66.37 -33.78 76.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.338 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.62 -23.69 29.45 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.627 ' HZ ' HG11 ' A' ' 116' ' ' VAL . 28.3 m-85 -94.25 -21.8 18.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.765 0.317 . . . . 0.0 111.479 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.615 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.21 -42.58 87.16 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 1.1 Cg_endo -47.54 -39.12 29.12 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.86 2.374 . . . . 0.0 114.325 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.598 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 62.9 m-85 -78.39 -38.04 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -172.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.69 172.61 45.11 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.197 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.56 117.56 5.21 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.638 2.226 . . . . 0.0 111.469 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.762 HD13 HD11 ' A' ' 141' ' ' ILE . 80.9 mt -72.63 131.95 34.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.705 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -111.09 -21.02 12.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.352 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 42.4 t -165.36 142.28 5.68 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.963 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.762 HD11 HD13 ' A' ' 138' ' ' ILE . 54.0 mt -142.0 114.44 3.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.277 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 157' ' ' PHE . 7.9 p-10 -110.28 108.15 18.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.496 0.665 . . . . 0.0 109.426 172.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.546 ' HE1' HG13 ' A' ' 128' ' ' ILE . 45.5 ttm -109.68 146.37 34.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.265 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.742 178.193 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 51.6 p90 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.611 0.244 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.62 159.04 29.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.463 ' HB2' ' OD1' ' A' ' 142' ' ' ASP . 51.8 m-85 -112.33 112.74 24.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.846 172.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.452 HG11 ' CD2' ' A' ' 132' ' ' PHE . 59.3 t -98.7 117.46 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.177 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 37.0 tt0 -109.33 138.85 45.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -115.32 -175.97 2.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.229 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.36 -34.35 61.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.815 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.5 m -125.98 150.78 70.19 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.043 0.449 . . . . 0.0 111.365 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 58.0 Cg_endo -70.1 -14.1 34.62 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.369 2.713 . . . . 0.0 111.938 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.447 ' HG3' ' HE1' ' A' ' 254' ' ' PHE . 70.5 mm-40 -59.12 -59.59 5.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.985 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.73 -19.21 10.23 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.52 -53.32 6.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.798 0.332 . . . . 0.0 110.111 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -63.57 -36.78 84.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.828 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.598 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 18.5 tp -66.23 -46.96 75.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.29 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.54 -44.17 96.39 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.594 ' HG ' HG13 ' A' ' 185' ' ' VAL . 6.1 tt -55.43 -44.34 76.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.247 0.546 . . . . 0.0 109.789 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.16 -39.84 79.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.127 -0.942 . . . . 0.0 113.204 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -100.59 -7.34 24.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' MET . . . . . 0.648 ' SD ' HD11 ' A' ' 183' ' ' ILE . 32.5 ttm -97.46 -16.46 20.15 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -78.59 27.39 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 111.414 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.468 ' O ' HG13 ' A' ' 176' ' ' VAL . 41.5 t -113.6 -58.77 2.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.359 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -164.3 167.47 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 124.042 0.839 . . . . 0.0 109.167 177.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 177' ' ' MET . . . . . 0.449 ' SD ' ' HG ' ' A' ' 178' ' ' LEU . 15.1 tpp -134.05 88.16 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.423 0.63 . . . . 0.0 110.805 172.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.449 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 90.1 mt 58.96 -79.83 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.597 174.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -79.02 54.93 4.27 Favored Glycine 0 CA--C 1.518 0.219 0 N-CA-C 114.278 0.471 . . . . 0.0 114.278 -168.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.87 -52.42 3.6 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 114.078 0.391 . . . . 0.0 114.078 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -76.27 133.96 39.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.091 0.472 . . . . 0.0 111.631 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 43.8 t30 -80.12 134.59 36.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.096 171.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ILE . . . . . 0.648 HD11 ' SD ' ' A' ' 173' ' ' MET . 40.8 pt -105.0 173.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.951 0.405 . . . . 0.0 110.624 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 87.7 mttt -102.62 106.1 16.71 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.594 HG13 ' HG ' ' A' ' 170' ' ' LEU . 12.0 p -102.78 120.39 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.605 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.766 178.164 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.775 0.322 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -103.89 5.62 35.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.023 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLN . . . . . 0.589 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 19.3 tm0? -53.36 -46.64 97.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.146 -177.213 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 6.8 Cg_endo -51.85 -44.6 43.88 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.298 1.999 . . . . 0.0 112.75 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.438 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 70.5 mt -69.43 -41.43 80.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 0.0 110.386 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.466 HG12 ' SD ' ' A' ' 111' ' ' MET . 74.2 mt -57.8 -48.3 84.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.461 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.52 -38.75 90.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.078 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -63.84 -48.36 77.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.13 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 42.3 mt -67.48 -33.5 75.23 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.559 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.661 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.31 -47.87 68.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.55 -31.63 70.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.131 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.21 -37.95 89.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.008 0.432 . . . . 0.0 110.741 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -77.13 -26.19 52.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.181 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 81.1 mtp180 -70.95 -24.67 62.48 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.018 176.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.97 -24.15 63.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.293 0.568 . . . . 0.0 110.405 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.89 169.24 8.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.674 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 46.1 m-20 -105.31 38.59 1.92 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ARG . . . . . 0.468 ' CA ' ' HG2' ' A' ' 256' ' ' GLU . 20.7 ttm180 -95.36 138.25 33.31 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.033 -170.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.703 HG22 ' HD2' ' A' ' 284' ' ' LYS . 44.9 pt -122.75 167.02 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.074 175.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' TYR . . . . . 0.48 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 66.0 t80 -119.18 129.36 54.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.199 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' VAL . . . . . 0.559 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 35.1 m -123.53 134.92 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -126.06 175.66 7.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.846 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.12 27.17 10.54 Favored 'General case' 0 CA--C 1.527 0.059 0 O-C-N 124.158 0.911 . . . . 0.0 109.629 -176.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' VAL . . . . . 0.42 HG13 HD11 ' A' ' 225' ' ' ILE . 22.2 t -77.13 112.46 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' HIS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 42.6 t-80 -53.3 136.95 36.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.058 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -55.08 -34.77 63.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.186 -173.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.13 7.13 47.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.727 0.775 . . . . 0.0 110.639 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.567 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.3 tp -92.0 124.5 36.15 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.7 t -89.65 168.43 12.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.986 0.422 . . . . 0.0 111.219 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.17 -22.85 63.89 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -65.48 -33.91 77.04 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.923 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -72.16 -46.44 56.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.423 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.735 HG13 HD21 ' A' ' 240' ' ' LEU . 21.8 mm -63.11 -50.82 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.67 -44.39 81.35 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.967 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 30.3 t -58.09 -43.68 87.19 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 19.1 t -76.82 -44.02 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.5 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' PHE . . . . . 0.641 ' HB2' HD11 ' A' ' 235' ' ' ILE . 55.3 m-85 -64.1 -33.41 75.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.098 0.475 . . . . 0.0 110.71 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -61.01 -24.96 66.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.457 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.48 -11.93 60.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.153 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.87 -33.89 6.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -156.85 158.39 28.76 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.904 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -69.44 116.05 9.42 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.268 0.556 . . . . 0.0 111.101 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 229' ' ' PHE . 47.0 mt -86.19 151.58 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.733 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -119.32 -15.41 9.13 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.418 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 256' ' ' GLU . 47.6 t -165.77 143.88 5.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -174.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 54.1 t -153.87 117.78 4.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 10.5 t -140.26 139.39 35.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.234 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' LEU . . . . . 0.735 HD21 HG13 ' A' ' 225' ' ' ILE . 77.8 mt -105.43 130.94 53.41 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.81 121.28 15.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.033 0.444 . . . . 0.0 110.376 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 51.6 ttp180 -134.65 152.02 51.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.111 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.485 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 5.7 m-20 -74.11 148.47 86.6 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -45.94 -45.12 17.91 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.04 2.493 . . . . 0.0 113.377 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.2 t -154.66 75.11 0.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.707 0.765 . . . . 0.0 110.881 -176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 18.1 p -125.01 -11.19 7.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.138 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 72.45 20.3 79.33 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.389 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 21.6 ptmt -156.69 141.78 17.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -94.14 140.99 29.06 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.093 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -44.1 -55.97 4.37 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.235 0.959 . . . . 0.0 113.046 -172.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 145.95 11.04 0.24 Allowed Glycine 0 CA--C 1.511 -0.19 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.054 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' TYR . . . . . 0.48 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 44.4 p90 -144.37 167.23 22.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.08 173.81 32.62 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.26 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.447 ' HE1' ' HG3' ' A' ' 164' ' ' GLU . 81.0 m-85 -133.59 143.99 49.01 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 225' ' ' ILE . 67.6 mt -140.12 135.74 37.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.501 -176.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 25.4 mt-10 -112.83 142.23 45.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 7.0 m-85 -102.18 167.35 10.06 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -73.3 -13.99 61.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.96 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -134.76 124.93 25.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.551 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ALA . . . . . 0.412 ' HB2' ' OD1' ' A' ' 209' ' ' ASN . . . -58.97 -44.14 91.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.203 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -62.89 -33.98 76.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.826 0.346 . . . . 0.0 110.802 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 53.3 m -70.48 -27.87 64.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.55 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 267' ' ' VAL . 83.9 p -72.81 -31.3 64.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -72.68 -30.62 64.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.946 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.05 -38.68 92.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.248 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 229' ' ' PHE . . . -66.05 -42.37 89.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.131 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 263' ' ' SER . 82.4 t -53.03 -45.82 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.863 0.363 . . . . 0.0 111.345 176.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.6 m -65.54 -32.13 73.56 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 32.0 t -94.12 -33.64 13.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' MET . . . . . 0.517 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.3 mmm -91.75 0.55 57.48 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -169.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -74.29 118.39 17.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.7 mt 68.62 31.35 4.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.451 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -89.75 123.18 33.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.28 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.1 t70 -69.78 120.21 15.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.875 0.369 . . . . 0.0 110.892 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.567 ' HG ' HD21 ' A' ' 220' ' ' LEU . 38.8 tp -138.41 94.41 2.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.614 173.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.39 25.49 39.39 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.902 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 84.9 3.87 87.57 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.811 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLN . . . . . 0.463 ' HG3' ' HB2' ' A' ' 217' ' ' HIS . 16.8 mm100 -109.64 139.67 44.38 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.55 -178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.6 103.27 15.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.886 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.6 124.5 21.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.635 -175.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -93.92 116.61 29.07 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 171.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 213' ' ' VAL . 14.5 p -124.44 148.37 28.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.103 0.478 . . . . 0.0 111.346 -171.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.19 177.76 41.64 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LYS . . . . . 0.703 ' HD2' HG22 ' A' ' 211' ' ' ILE . 4.6 mmmp? -80.32 123.26 27.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.286 0.543 . . . . 0.0 109.942 175.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' ALA . . . . . 0.487 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -52.47 127.48 22.69 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.96 0.787 . . . . 0.0 110.347 177.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.56 -25.6 5.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 123.466 0.479 . . . . 0.0 111.052 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 21.7 p -127.5 153.33 77.41 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 C-N-CA 122.793 2.329 . . . . 0.0 112.031 178.836 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.87 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 73.37 -62.82 0.45 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.534 0.734 . . . . 0.0 111.953 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 58.15 48.7 12.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.276 0.56 . . . . 0.0 110.73 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.44 108.69 21.47 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -78.45 114.25 17.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.417 0.627 . . . . 0.0 112.224 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -111.66 -6.2 14.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.25 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -66.67 -25.0 66.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.656 -171.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -61.48 -41.75 97.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.787 0.327 . . . . 0.0 110.791 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.51 -32.82 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.977 0.418 . . . . 0.0 110.075 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.551 HD23 ' SD ' ' A' ' 111' ' ' MET . 83.8 mt -63.25 -34.29 77.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.642 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.47 66.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.167 0.508 . . . . 0.0 110.813 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.0 mt -83.39 -36.83 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.883 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.639 ' SD ' HG12 ' A' ' 198' ' ' ILE . 87.2 mtp -72.22 -22.37 61.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.626 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 76.1 m -74.75 -9.78 58.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.88 0.371 . . . . 0.0 111.021 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -105.46 142.25 35.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.589 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.502 HG12 ' HB ' ' A' ' 158' ' ' VAL . 8.7 p -123.93 127.71 73.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.446 0.641 . . . . 0.0 109.826 170.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -80.54 106.8 12.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.829 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.481 HG11 ' CZ ' ' A' ' 132' ' ' PHE . 19.0 m -99.09 115.31 39.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.423 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.38 149.92 17.53 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.719 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.9 m 76.35 -66.69 0.25 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.872 0.869 . . . . 0.0 111.436 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 120' ' ' TYR . 78.6 mt 61.88 -91.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 O-C-N 123.383 0.427 . . . . 0.0 110.697 -176.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 119' ' ' ILE . 23.3 t80 165.94 140.01 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -175.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -79.07 75.35 5.59 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.378 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -174.53 -51.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.991 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 178' ' ' LEU . 78.8 mt -58.81 128.21 36.07 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.717 -173.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.99 -177.6 37.82 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.605 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -67.96 -43.59 78.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.412 . . . . 0.0 111.024 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 16.9 t70 -68.28 -42.42 79.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.087 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.0 m -67.0 -37.96 85.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.125 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 128' ' ' ILE . 17.2 mm -61.98 -40.86 88.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.62 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.546 ' HA ' HD12 ' A' ' 138' ' ' ILE . 38.0 ttp-105 -59.06 -39.76 83.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 110.178 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 72.6 mt-30 -68.59 -34.2 75.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.337 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.09 -21.32 36.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.633 ' HB2' HD11 ' A' ' 138' ' ' ILE . 31.6 m-85 -100.93 -15.29 17.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.956 0.408 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.635 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -54.13 -40.56 82.89 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 177.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 5.9 Cg_exo -42.76 -38.18 6.41 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.289 2.66 . . . . 0.0 114.013 174.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.541 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 60.3 m-85 -81.49 -46.89 13.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.881 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.73 165.57 38.51 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.073 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.461 ' HG2' ' CE1' ' A' ' 252' ' ' TYR . 24.9 Cg_exo -65.05 120.16 7.33 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.722 2.282 . . . . 0.0 111.408 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' A' ' 132' ' ' PHE . 41.2 mt -79.62 129.54 37.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.356 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -96.62 -29.82 13.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.832 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.0 t -158.65 141.5 14.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.593 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.437 ' CG1' HG21 ' A' ' 138' ' ' ILE . 72.1 mt -131.5 122.65 50.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.657 0.265 . . . . 0.0 110.943 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 33.1 t70 -98.14 100.06 11.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.436 ' CE ' HG13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -104.93 139.62 39.38 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.833 -171.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 p -80.43 122.37 26.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.339 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -142.33 122.66 13.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.827 0.346 . . . . 0.0 110.359 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.28 120.74 40.38 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.9 m -83.64 -11.63 57.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -170.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.414 HG23 HG23 ' A' ' 149' ' ' THR . 22.3 m -95.61 -25.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.304 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 148' ' ' VAL . 58.3 p -106.09 -19.27 13.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.786 0.327 . . . . 0.0 111.434 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 47.6 mtm 66.63 27.91 9.34 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.245 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -148.6 174.88 11.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -156.17 130.23 8.62 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.79 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -125.22 86.2 2.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.15 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -156.06 -114.44 0.47 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.509 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -151.58 176.45 11.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.54 0.209 . . . . 0.0 110.552 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.9 152.78 33.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.319 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 46.8 m-85 -109.56 109.95 20.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.785 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.502 ' HB ' HG12 ' A' ' 114' ' ' VAL . 97.4 t -95.33 108.81 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.801 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -106.42 115.7 30.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.354 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -89.21 178.83 6.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.218 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.49 -45.64 30.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.082 0.468 . . . . 0.0 109.796 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.64 141.86 24.21 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.452 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.9 Cg_endo -69.5 -21.33 34.87 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.256 2.637 . . . . 0.0 112.518 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.601 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 6.5 mp0 -55.2 -51.43 66.57 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.883 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.12 -23.85 66.79 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 120.954 0.407 . . . . 0.0 111.921 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.22 -48.53 12.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.753 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.6 ' HG3' HG11 ' A' ' 286' ' ' VAL . 32.2 mm-40 -64.6 -36.53 84.52 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.699 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.541 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 11.8 tp -66.51 -46.81 75.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.734 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.148 0.499 . . . . 0.0 109.931 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.536 ' HA ' HG21 ' A' ' 185' ' ' VAL . 6.7 tt -69.79 -46.1 66.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.574 173.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 16.4 mm-40 -56.75 -56.83 16.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.25 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -86.51 -39.42 16.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 27.2 ttp -104.63 30.17 5.61 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.588 -165.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -89.11 44.38 1.21 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.884 0.849 . . . . 0.0 109.673 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 19.6 m -115.59 -73.87 0.63 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.416 173.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.24 169.34 5.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.712 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.623 ' HB2' HD13 ' A' ' 183' ' ' ILE . 25.0 tpp -145.45 78.98 1.56 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.951 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.604 ' HB2' HD11 ' A' ' 123' ' ' LEU . 75.6 mt 63.84 162.15 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.527 174.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.29 -65.07 1.65 Allowed Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.008 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.6 62.81 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.203 -0.522 . . . . 0.0 111.861 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -143.53 129.54 19.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.772 0.32 . . . . 0.0 111.242 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 175' ' ' SER . 8.9 t30 -71.5 103.69 3.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.373 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.623 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.5 pt -85.62 159.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.211 0.529 . . . . 0.0 111.884 -173.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -110.51 114.95 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.804 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 170' ' ' LEU . 5.3 m -103.64 108.33 24.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.422 0.63 . . . . 0.0 110.787 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.71 158.39 24.46 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.88 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 77.7 mtm180 -136.41 60.27 31.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.736 0.303 . . . . 0.0 110.189 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 9.3 Cg_endo -90.45 71.05 1.41 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.1 2.534 . . . . 0.0 111.493 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 191' ' ' ILE . 16.5 m -77.2 39.82 0.25 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.02 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 45.2 28.09 0.39 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.507 1.123 . . . . 0.0 113.364 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 189' ' ' SER . 46.8 mm -126.95 118.44 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 148.66 176.67 22.25 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.052 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.441 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 43.8 tt0 -81.32 -28.07 34.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.081 0.467 . . . . 0.0 110.629 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -75.05 -28.8 60.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.067 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.718 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 27.2 mm-40 -54.32 -53.76 55.66 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.812 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.718 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 52.6 Cg_exo -55.08 -36.12 92.11 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.196 1.931 . . . . 0.0 112.851 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 72.6 mt -70.98 -46.09 69.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.339 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.639 HG12 ' SD ' ' A' ' 111' ' ' MET . 73.9 mt -57.15 -45.76 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.924 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.7 -39.9 95.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.244 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -63.08 -49.94 72.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.868 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 68.1 mt -67.88 -31.91 72.04 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.604 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.34 -47.86 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.65 -36.57 81.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.826 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 208' ' ' PHE . 39.2 mt-10 -68.37 -37.14 80.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.255 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -67.96 -32.24 72.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.83 0.348 . . . . 0.0 110.423 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.9 mtp180 -63.02 -37.98 89.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.317 175.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.58 -27.86 67.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.507 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.435 ' HD2' ' O ' ' A' ' 204' ' ' GLU . 75.0 m-85 -94.73 -16.48 23.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.45 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 60.71 41.65 14.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.987 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.496 ' HD2' ' OE1' ' A' ' 256' ' ' GLU . 16.5 ttt180 -101.42 145.15 29.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.279 0.561 . . . . 0.0 112.285 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 47.9 pt -129.05 167.56 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.4 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.508 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 27.0 t80 -117.65 138.03 52.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.482 HG12 HG22 ' A' ' 282' ' ' VAL . 28.9 m -128.21 131.63 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.395 0.617 . . . . 0.0 110.915 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.38 173.05 7.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.588 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.8 t 58.51 31.5 21.09 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.742 0.782 . . . . 0.0 109.619 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.51 114.23 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.828 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.629 ' HA ' ' OE1' ' A' ' 278' ' ' GLN . 71.9 t60 -54.05 130.39 37.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.442 0.639 . . . . 0.0 111.726 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -48.58 -33.13 9.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.186 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -85.09 -23.1 28.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.964 0.411 . . . . 0.0 111.835 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.406 HD11 ' HG ' ' A' ' 275' ' ' LEU . 69.5 mt -77.74 128.55 34.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.421 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 21.6 m -92.24 173.29 7.9 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.468 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -49.29 -50.28 39.83 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.842 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.24 -33.87 75.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.506 -174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.84 -38.1 73.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.629 0.252 . . . . 0.0 110.586 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.829 HG22 HD11 ' A' ' 255' ' ' ILE . 29.2 mm -67.01 -41.84 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.454 ' HG3' HG21 ' A' ' 235' ' ' ILE . 83.9 tttt -57.67 -45.45 85.53 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.389 173.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 39.6 t -54.19 -47.75 71.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.45 -39.58 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.347 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.533 ' HB2' HD11 ' A' ' 235' ' ' ILE . 24.0 m-85 -68.31 -29.78 68.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.019 0.438 . . . . 0.0 110.603 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.12 -26.24 68.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.946 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.66 -16.31 62.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.407 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -111.56 -40.12 4.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.427 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -138.31 161.8 25.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.325 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -81.02 104.23 11.37 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.181 0.515 . . . . 0.0 110.694 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 229' ' ' PHE . 27.3 mt -82.83 151.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.702 0.763 . . . . 0.0 111.759 -175.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.627 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 45.4 tttm -107.26 -40.13 5.49 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.044 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 53.1 m -158.62 152.92 24.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.816 0.341 . . . . 0.0 110.545 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 9.3 p -133.37 125.67 29.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.746 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 12.0 m -140.37 100.9 4.0 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.717 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.521 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 44.4 mt -84.23 148.04 26.93 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.3 91.75 1.35 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 16.4 ttp85 -109.06 138.08 45.96 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.428 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 9.4 t70 -118.95 126.59 27.01 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.643 -172.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 11.6 Cg_exo -67.37 -21.03 47.88 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.994 2.462 . . . . 0.0 113.258 -176.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 35.2 p -100.97 13.57 34.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 0.0 111.238 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.408 HG23 ' OD1' ' A' ' 243' ' ' ASP . 63.8 p -115.23 -29.65 6.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.251 0.548 . . . . 0.0 110.078 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 93.59 1.44 66.09 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.015 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -154.56 -165.87 2.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 7.9 p80 -98.6 154.0 18.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.301 0.572 . . . . 0.0 109.764 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -71.22 -15.34 62.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.864 -168.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 120.39 -6.19 11.78 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.281 -0.962 . . . . 0.0 113.035 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.461 ' CE1' ' HG2' ' A' ' 137' ' ' PRO . 0.5 OUTLIER -134.61 158.62 43.57 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -162.79 177.62 38.82 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.407 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.601 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 52.9 m-85 -132.28 149.19 52.42 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.829 HD11 HG22 ' A' ' 225' ' ' ILE . 82.5 mt -134.08 142.59 40.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.496 ' OE1' ' HD2' ' A' ' 210' ' ' ARG . 30.7 tt0 -128.16 134.54 49.09 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -170.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 10.4 m-85 -111.0 165.52 11.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.142 0.496 . . . . 0.0 111.534 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.627 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 13.6 mt-10 -88.22 -12.0 45.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.156 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -134.93 124.78 25.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.886 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -65.44 -22.09 66.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.45 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -75.17 -47.08 30.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.4 m -65.09 -33.35 75.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.831 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.593 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 90.2 p -67.74 -31.88 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 75.4 mt-30 -75.25 -24.65 57.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -63.98 -49.19 73.46 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 229' ' ' PHE . . . -58.5 -40.16 82.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.259 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.56 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 97.5 t -57.1 -39.33 65.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.976 0.417 . . . . 0.0 111.045 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.6 t -81.66 -40.52 22.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.285 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.5 m -80.48 -40.35 26.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.44 ' HB2' HG21 ' A' ' 282' ' ' VAL . 89.5 mmm -89.69 -5.01 57.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.856 -170.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 267' ' ' VAL . 63.5 t30 -71.09 122.05 19.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 98.3 mt 70.09 23.06 5.42 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.886 0.741 . . . . 0.0 111.015 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.35 125.77 30.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.09 101.57 9.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.063 0.459 . . . . 0.0 110.185 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.406 ' HG ' HD11 ' A' ' 220' ' ' LEU . 36.5 tp -121.25 99.55 6.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.983 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.73 25.8 37.25 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.285 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 77.19 33.78 43.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.206 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.629 ' OE1' ' HA ' ' A' ' 217' ' ' HIS . 2.1 tt0 -152.43 139.99 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -91.45 103.15 15.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.665 0.269 . . . . 0.0 111.079 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 34.8 mt -58.36 116.97 3.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.806 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 281' ' ' ARG . 14.3 mmm-85 -93.46 114.6 27.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.56 ' CG1' ' HA ' ' A' ' 267' ' ' VAL . 17.1 t -112.35 140.05 34.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.858 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -153.92 170.58 32.56 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.625 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -75.9 128.98 36.23 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -74.05 128.76 36.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.6 HG11 ' HG3' ' A' ' 167' ' ' GLN . 20.1 m -93.77 -19.67 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.478 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.525 HG21 HD22 ' A' ' 108' ' ' LEU . 4.3 t -147.82 138.86 13.31 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.144 175.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.85 109.22 1.04 Allowed 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 123.346 2.697 . . . . 0.0 112.924 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.447 ' HD2' ' HD3' ' A' ' 210' ' ' ARG . 3.8 Cg_exo -76.2 99.67 1.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.097 2.531 . . . . 0.0 110.977 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 59.7 mtt -79.78 110.99 17.87 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.8 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.574 ' HB2' HD22 ' A' ' 292' ' ' LEU . 6.2 Cg_exo -74.43 -38.25 2.04 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.887 2.391 . . . . 0.0 111.98 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.574 HD22 ' HB2' ' A' ' 291' ' ' PRO . 3.2 mm? -119.2 95.79 4.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.252 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 34.3 tp -88.21 60.79 5.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.491 0.662 . . . . 0.0 109.667 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 19.8 p -115.52 92.73 34.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.542 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.04 24.31 0.75 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.109 2.539 . . . . 0.0 113.316 -174.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -141.81 24.12 2.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.57 . . . . 0.0 110.504 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.07 -179.424 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.996 -0.441 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.17 -37.28 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.725 0.298 . . . . 0.0 110.81 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 25.5 mmt -89.91 -47.25 7.99 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.51 85.56 6.48 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -81.14 60.52 4.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.575 0.703 . . . . 0.0 112.169 -171.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.433 ' HG2' ' HG3' ' A' ' 105' ' ' GLN . 40.2 ttm180 -130.6 150.59 51.73 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 171.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.442 ' HB3' HD12 ' A' ' 108' ' ' LEU . 69.1 mt-30 63.67 35.96 11.12 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -65.62 -42.09 91.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.821 -172.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' A' ' 197' ' ' ILE . . . -66.85 -33.07 74.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.035 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.487 HD23 ' SD ' ' A' ' 111' ' ' MET . 57.3 mt -63.47 -32.13 73.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.467 -176.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.13 -28.63 69.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.189 0.519 . . . . 0.0 110.575 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.5 mt -88.52 -35.92 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.207 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.531 ' SD ' HG12 ' A' ' 198' ' ' ILE . 94.0 mtp -67.06 -18.94 65.57 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.083 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 85.3 m -81.94 -10.68 59.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 110.592 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 98.4 mtt180 -109.7 143.4 39.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.229 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.4 p -120.37 121.7 66.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 168.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -76.09 129.16 36.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.721 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 15.0 m -123.83 122.16 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.497 0.665 . . . . 0.0 111.128 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.63 174.97 19.22 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.416 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.404 ' HB3' HH21 ' A' ' 181' ' ' ARG . 66.0 m 64.46 36.9 8.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.295 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.3 mt -85.0 105.84 14.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.42 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -52.85 146.49 10.59 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.341 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.42 ' HA ' ' CE1' ' A' ' 152' ' ' HIS . 14.1 p90 -71.4 76.13 0.76 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 122.029 0.919 . . . . 0.0 111.314 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -165.67 -43.34 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.196 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.522 HD22 HD12 ' A' ' 178' ' ' LEU . 36.2 mt -75.11 103.34 5.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.114 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.64 174.32 54.1 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.208 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.32 -39.97 94.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.69 -42.03 92.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.208 0.528 . . . . 0.0 110.371 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.3 m -68.9 -39.93 79.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.46 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.521 HG13 ' HE1' ' A' ' 143' ' ' MET . 35.5 mm -64.09 -44.2 97.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.512 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -57.28 -46.68 82.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.543 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.34 -33.25 74.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.582 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.634 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -78.28 -31.98 49.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.452 ' HD1' ' O ' ' A' ' 128' ' ' ILE . 50.1 m-85 -93.43 -17.08 23.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.776 0.322 . . . . 0.0 111.454 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.03 -44.11 91.22 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -47.52 -33.17 17.09 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.783 2.322 . . . . 0.0 114.389 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.564 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 70.1 m-85 -79.69 -53.47 6.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.4 -171.04 25.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 119.637 -1.268 . . . . 0.0 113.361 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.46 112.82 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.921 2.414 . . . . 0.0 111.736 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.646 HD13 HD11 ' A' ' 141' ' ' ILE . 68.7 mt -76.6 127.27 37.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.428 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -84.81 -45.81 11.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.568 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -166.22 131.65 2.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.803 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.646 HD11 HD13 ' A' ' 138' ' ' ILE . 67.6 mt -109.36 114.11 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 171.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -94.09 100.46 12.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.044 0.45 . . . . 0.0 110.554 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.521 ' HE1' HG13 ' A' ' 128' ' ' ILE . 36.5 ttm -143.14 124.65 14.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.929 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.5 m -87.41 107.63 18.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.581 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -84.18 83.53 7.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.552 0.691 . . . . 0.0 109.192 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.95 103.27 11.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.84 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.1 t -90.93 28.25 1.62 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.89 -174.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.0 t -71.71 -44.63 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.089 0.471 . . . . 0.0 109.894 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 150' ' ' MET . 33.0 p -119.62 12.78 12.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.629 175.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.498 ' HB2' ' O ' ' A' ' 149' ' ' THR . 42.2 mtp 74.19 -22.86 0.24 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.852 0.72 . . . . 0.0 110.984 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 149' ' ' THR . 49.7 mtmt -84.86 131.32 34.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 121' ' ' TYR . 22.9 p-80 -96.91 -170.85 2.11 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.544 -174.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -54.36 -44.99 72.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.895 0.379 . . . . 0.0 111.039 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.418 ' H ' ' HD2' ' A' ' 152' ' ' HIS . . . 108.99 -31.37 7.77 Favored Glycine 0 CA--C 1.508 -0.349 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.87 176.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -116.39 153.86 31.29 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.66 164.74 37.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.965 0.412 . . . . 0.0 111.305 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.83 111.86 18.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.422 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 78.7 t -97.45 106.49 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.98 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.431 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 39.4 tt0 -107.57 128.57 54.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.76 0.314 . . . . 0.0 110.615 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -95.17 179.82 5.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.976 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.94 -14.9 28.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.851 0.358 . . . . 0.0 110.16 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.53 135.09 26.86 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.234 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 46.0 Cg_endo -67.57 -21.11 46.45 Favored 'Trans proline' 0 N--CA 1.474 0.35 0 C-N-CA 123.311 2.674 . . . . 0.0 112.585 -176.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.948 ' HG3' ' HE1' ' A' ' 254' ' ' PHE . 5.7 mm-40 -61.01 -52.08 66.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.872 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.645 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -66.86 -17.88 65.11 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.02 -47.21 18.94 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.432 ' HG3' HG11 ' A' ' 286' ' ' VAL . 29.6 mm-40 -69.49 -34.88 74.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.461 174.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 13.6 tp -61.77 -48.1 82.18 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.581 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.98 72.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.97 0.414 . . . . 0.0 110.229 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.65 -52.13 41.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.589 173.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.54 -38.85 60.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.669 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLN . . . . . 0.459 HE21 ' HE1' ' A' ' 135' ' ' PHE . 22.7 mt-30 -99.76 -49.22 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 34.4 ttp -104.87 29.63 6.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -165.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.96 -20.78 60.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.929 0.395 . . . . 0.0 110.708 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.9 p -72.32 -73.58 0.19 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.6 m -134.07 151.98 33.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.033 0.444 . . . . 0.0 111.422 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.797 ' HE2' ' HG ' ' A' ' 178' ' ' LEU . 1.7 tpt -125.55 97.14 5.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.809 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.797 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 85.9 mt 67.56 127.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.93 0.769 . . . . 0.0 112.377 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 72.17 -80.17 0.61 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.385 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.43 36.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.07 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.404 HH21 ' HB3' ' A' ' 118' ' ' SER . 7.7 tpt180 -100.4 122.42 43.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.687 0.279 . . . . 0.0 110.808 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.6 126.44 30.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.546 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.8 pt -120.26 176.91 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.396 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 74.0 mmtt -103.24 107.27 18.03 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 27.6 t -113.36 106.87 21.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.13 0.269 . . . . 0.0 110.696 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 141.96 -97.87 0.21 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 119.855 -1.164 . . . . 0.0 114.24 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 189' ' ' SER . 87.5 mtt180 -78.25 127.16 82.0 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.665 0.269 . . . . 0.0 111.702 -170.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 3.6 Cg_exo -77.91 -9.46 16.84 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.967 2.445 . . . . 0.0 111.178 172.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 187' ' ' ARG . 35.3 p -157.29 156.68 32.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.449 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -48.55 -61.45 2.01 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.619 0.574 . . . . 0.0 112.214 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.525 HD12 ' HG3' ' A' ' 195' ' ' GLN . 10.6 tp -138.22 152.02 25.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -144.31 166.02 27.3 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.202 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -71.25 -15.77 62.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.849 0.357 . . . . 0.0 111.795 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.473 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -88.45 -12.37 43.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.653 0.263 . . . . 0.0 111.362 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.569 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 33.8 mm-40 -59.08 -49.88 90.79 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 75.4 Cg_exo -52.97 -35.29 70.76 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.288 1.992 . . . . 0.0 112.847 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 107' ' ' ALA . 60.6 mt -69.94 -46.64 72.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.129 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.531 HG12 ' SD ' ' A' ' 111' ' ' MET . 57.6 mt -57.41 -43.27 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.239 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.19 -44.38 88.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.043 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -68.8 -45.44 71.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.911 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.436 HD23 ' OE2' ' A' ' 204' ' ' GLU . 19.4 mt -64.73 -33.53 76.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.783 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.656 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.02 -51.77 60.61 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -60.18 -38.29 82.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.272 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.436 ' OE2' HD23 ' A' ' 201' ' ' LEU . 52.5 mt-10 -60.54 -45.98 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.106 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.02 87.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.882 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.656 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 53.3 mtp180 -64.89 -33.93 77.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.791 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.42 -30.03 66.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.814 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.69 -4.47 47.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.035 0.445 . . . . 0.0 110.68 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.2 m120 62.89 44.03 6.48 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.055 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -99.93 142.78 30.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.188 0.518 . . . . 0.0 111.382 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.5 pt -127.76 166.35 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.175 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.559 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 86.3 t80 -119.18 128.79 54.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.156 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.627 HG12 HG23 ' A' ' 282' ' ' VAL . 32.2 m -121.77 131.28 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.183 0.516 . . . . 0.0 110.641 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -124.8 174.19 8.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.17 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.2 t 60.78 30.94 20.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.887 0.851 . . . . 0.0 109.223 -174.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 36.1 t -79.91 116.06 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.581 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.58 ' HD2' ' HG3' ' A' ' 278' ' ' GLN . 7.6 t-80 -56.4 135.25 54.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.471 0.653 . . . . 0.0 111.677 -169.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -49.29 -38.19 26.48 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -171.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -89.94 -10.02 46.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.754 0.311 . . . . 0.0 111.145 -174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.473 ' HA ' HD12 ' A' ' 220' ' ' LEU . 10.7 tp -83.44 124.59 30.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.257 -174.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.9 t -87.59 169.17 12.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.817 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.08 -36.8 71.0 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.791 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.41 -45.56 72.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.706 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -74.01 -40.95 62.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.059 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.671 HG22 HD11 ' A' ' 255' ' ' ILE . 31.4 mm -63.38 -47.73 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 238' ' ' CYS . 66.1 tttm -58.16 -46.57 85.46 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.052 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.5 t -54.5 -43.57 71.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.07 -41.98 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.41 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.524 ' CB ' HD11 ' A' ' 235' ' ' ILE . 20.6 m-85 -67.44 -28.22 67.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.207 0.527 . . . . 0.0 110.537 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.7 -24.54 64.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.151 0.981 . . . . 0.0 110.467 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.95 -15.84 60.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.205 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -111.3 -23.23 10.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.99 0.424 . . . . 0.0 110.658 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.542 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -165.66 156.31 28.17 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.81 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 23.4 mmtp -74.08 122.52 22.81 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.546 0.688 . . . . 0.0 110.861 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.524 HD11 ' CB ' ' A' ' 229' ' ' PHE . 57.1 mt -92.91 150.43 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.144 -172.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.437 ' HE2' ' CB ' ' A' ' 256' ' ' GLU . 31.8 ttpt -110.5 -28.57 8.46 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.221 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 16.8 m -152.43 146.58 25.42 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.458 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 226' ' ' LYS . 47.2 t -152.78 107.33 3.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.521 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.7 m -140.52 109.27 5.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.133 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.56 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 51.4 mt -77.31 143.61 38.69 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.479 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.08 113.12 4.25 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 29.3 ttp180 -149.89 139.49 21.62 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.147 -169.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.29 128.45 86.04 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -44.49 -46.0 12.41 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.897 3.065 . . . . 0.0 114.394 -163.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 3.7 t -133.89 76.58 1.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.705 0.764 . . . . 0.0 110.579 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 6.6 p -125.75 1.33 7.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.289 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.18 12.75 69.31 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.043 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 22.5 pttp -163.35 179.66 7.2 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -131.0 152.02 50.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -48.32 -61.53 1.95 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.976 0.798 . . . . 0.0 112.573 -172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 160.97 12.33 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.616 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -152.05 -179.69 7.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.56 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -170.61 177.76 43.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.357 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.948 ' HE1' ' HG3' ' A' ' 164' ' ' GLU . 83.3 m-85 -128.96 143.57 50.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.971 0.415 . . . . 0.0 110.917 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.671 HD11 HG22 ' A' ' 225' ' ' ILE . 89.7 mt -140.45 140.75 33.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.004 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.437 ' CB ' ' HE2' ' A' ' 236' ' ' LYS . 45.2 mt-10 -120.67 147.6 45.04 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 20.2 m-85 -111.75 164.2 13.32 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.654 0.264 . . . . 0.0 110.312 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.84 -5.23 59.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.323 0.582 . . . . 0.0 109.433 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -127.87 128.63 45.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.848 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.51 68.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.206 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -74.86 -52.69 10.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.519 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.542 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 28.3 m -60.14 -31.49 70.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.456 -172.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.624 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 48.7 p -64.63 -48.62 74.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.997 0.427 . . . . 0.0 109.988 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -72.53 -18.92 61.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.189 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -69.15 -40.9 77.92 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.045 0.45 . . . . 0.0 110.044 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.62 75.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.949 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 271' ' ' ASN . 88.2 t -59.25 -31.58 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.164 0.507 . . . . 0.0 110.64 174.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.5 t -83.93 -46.6 11.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.898 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.7 m -78.31 -43.24 28.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.487 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 80.0 mmm -83.87 1.21 44.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.161 0.505 . . . . 0.0 110.752 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.636 ' HA ' HG12 ' A' ' 282' ' ' VAL . 18.7 t-20 -71.81 114.22 9.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.157 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 86.0 mt 67.31 36.86 3.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.195 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.42 121.78 33.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.326 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.55 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 26.7 t70 -75.76 106.35 7.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.72 0.295 . . . . 0.0 110.271 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 41.1 tp -131.04 110.03 10.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.028 0.442 . . . . 0.0 110.506 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.82 5.02 74.73 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.185 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.12 -5.16 31.89 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.337 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.58 ' HG3' ' HD2' ' A' ' 217' ' ' HIS . 28.5 mt-30 -125.19 143.52 50.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.828 0.346 . . . . 0.0 110.526 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 57.4 m-85 -78.07 113.22 15.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.089 173.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.37 130.37 44.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.05 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -98.35 114.58 26.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 271' ' ' ASN . 7.5 p -118.39 143.91 27.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.878 -174.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -157.59 173.81 35.0 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.394 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -75.83 135.01 40.22 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -71.99 144.93 48.67 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.432 HG11 ' HG3' ' A' ' 167' ' ' GLN . 20.3 m -109.3 -4.77 10.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.329 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.9 p -129.58 146.75 62.43 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.49 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.65 170.84 19.13 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.553 2.169 . . . . 0.0 111.013 173.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -44.89 -49.81 9.28 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.666 2.244 . . . . 0.0 112.11 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.455 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 24.4 mmt -133.58 111.92 12.69 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.394 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 9.2 Cg_exo -72.51 61.52 3.54 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.584 2.856 . . . . 0.0 112.554 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.7 pp -169.42 13.09 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.945 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 38.0 tp -97.54 64.53 1.83 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.425 0.631 . . . . 0.0 110.497 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 3.0 p -123.78 108.55 30.65 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.504 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.52 -37.52 97.2 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.816 2.344 . . . . 0.0 111.219 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -147.23 -69.83 0.24 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.123 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 84.0 m . . . . . 0 C--O 1.245 0.84 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.539 171.693 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.365 -0.294 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.98 -62.27 1.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.945 0.402 . . . . 0.0 111.422 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.9 mtm -86.81 -4.32 59.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 110.206 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.18 -37.09 54.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.851 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -82.75 64.17 7.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.263 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -99.18 20.15 14.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.816 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -86.44 28.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.466 0.65 . . . . 0.0 109.657 176.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -64.03 -30.2 71.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.753 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.1 -44.05 60.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.39 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.499 HD23 ' SD ' ' A' ' 111' ' ' MET . 60.3 mt -61.02 -36.07 78.54 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.47 -36.74 71.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.5 mt -78.73 -40.86 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.215 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.56 ' SD ' HG12 ' A' ' 198' ' ' ILE . 90.6 mtp -62.09 -28.2 69.45 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.588 -176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 67.0 m -74.97 -14.69 60.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.815 0.341 . . . . 0.0 111.109 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.587 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 42.8 mtp180 -101.53 140.31 35.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.852 HG12 ' HB ' ' A' ' 158' ' ' VAL . 9.6 p -110.0 121.82 63.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -82.23 100.98 10.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.008 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 35.3 m -108.21 141.32 23.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.145 0.498 . . . . 0.0 110.969 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.826 ' HA3' ' HD1' ' A' ' 155' ' ' PHE . . . -155.59 170.97 33.59 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.277 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.4 t 62.49 37.83 13.08 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.795 0.807 . . . . 0.0 109.683 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.5 mt -73.29 -14.99 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.543 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.9 t80 74.55 140.88 0.06 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.822 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.731 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 6.6 p90 -72.11 78.25 0.95 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.427 0.632 . . . . 0.0 110.995 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -159.58 -54.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.256 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.8 mt -68.54 119.58 13.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.753 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.63 -173.48 44.34 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.073 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.59 -39.32 94.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.632 0.373 . . . . 0.0 111.316 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.403 ' HA ' ' NE ' ' A' ' 129' ' ' ARG . 22.2 t70 -62.85 -41.19 99.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.38 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.2 m -68.7 -40.13 80.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.453 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.43 HG13 ' CE ' ' A' ' 143' ' ' MET . 31.2 mm -62.73 -50.82 78.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.061 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 126' ' ' ASP . 38.7 ptt180 -60.05 -42.28 94.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.169 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -67.63 -33.29 74.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.39 -33.5 28.69 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.562 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 51.2 m-85 -87.89 -20.54 25.85 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.86 -43.93 97.28 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -41.68 -40.93 5.67 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.069 2.512 . . . . 0.0 114.221 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.685 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 57.0 m-85 -75.45 -46.64 31.42 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.544 0.211 . . . . 0.0 111.295 -174.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -165.25 173.21 41.02 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.612 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.49 119.89 6.79 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.672 2.248 . . . . 0.0 111.688 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.6 mt -83.39 121.97 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.623 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -80.78 -52.49 7.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.695 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.5 t -152.17 152.12 31.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.097 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -124.69 108.98 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.066 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.749 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 18.4 m-20 -81.46 98.76 8.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.43 ' CE ' HG13 ' A' ' 128' ' ' ILE . 51.5 ttm -136.76 137.65 40.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.025 0.441 . . . . 0.0 111.014 -176.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 m -79.02 137.84 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.792 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.595 ' CZ2' ' HB2' ' A' ' 150' ' ' MET . 36.7 t-105 -119.02 124.01 45.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 46.6 m-20 -125.38 135.23 52.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.1 m 68.17 166.37 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 163.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 86.0 t -67.8 -31.4 52.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.896 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.429 ' O ' ' HG2' ' A' ' 150' ' ' MET . 3.3 p -71.92 2.52 5.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.736 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.595 ' HB2' ' CZ2' ' A' ' 145' ' ' TRP . 21.3 ptp 51.41 25.83 2.81 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.436 1.094 . . . . 0.0 111.869 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.731 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 99.8 mttt -100.8 130.28 46.8 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 146' ' ' ASP . 24.4 p80 -124.88 151.99 44.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.873 0.368 . . . . 0.0 111.419 -169.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -101.18 171.98 7.28 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.944 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 89.21 -142.82 17.03 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.278 168.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.826 ' HD1' ' HA3' ' A' ' 117' ' ' GLY . 41.4 m-85 -128.36 177.96 6.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.069 -0.566 . . . . 0.0 110.394 -171.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.25 151.53 37.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.886 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.749 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 81.7 m-85 -114.87 109.44 18.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.952 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.852 ' HB ' HG12 ' A' ' 114' ' ' VAL . 87.8 t -91.71 105.63 16.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.587 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 50.5 tt0 -99.53 115.6 29.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.717 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -91.55 178.46 5.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.93 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -77.54 -37.18 51.35 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.258 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.77 146.14 37.04 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.078 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.9 Cg_endo -70.17 -18.99 34.75 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.358 2.705 . . . . 0.0 112.056 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.61 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 9.1 mp0 -55.92 -53.84 51.91 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.807 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.08 -21.37 64.9 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.09 -45.46 15.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.75 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.629 ' HG3' HG11 ' A' ' 286' ' ' VAL . 16.0 mm100 -69.0 -31.83 70.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.787 173.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.685 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 14.2 tp -70.23 -47.19 62.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.522 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.34 71.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.091 0.472 . . . . 0.0 109.85 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.648 HD12 ' HA3' ' A' ' 186' ' ' GLY . 4.0 tt -67.64 -51.81 45.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 172.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -52.53 -43.47 65.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.853 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -95.6 -46.41 6.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.7 ttp -104.28 31.08 4.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.089 0.471 . . . . 0.0 112.123 -166.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 9.0 p30 -76.59 7.06 4.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.582 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 15.3 m -102.49 -73.49 0.66 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.554 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 24.5 m -133.04 156.11 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 0.0 111.365 -173.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.976 ' HB2' HD13 ' A' ' 183' ' ' ILE . 2.1 tpt -122.95 104.06 9.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.376 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.99 61.04 2.48 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.181 172.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 122.75 -153.56 16.94 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.489 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.58 72.33 0.79 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.253 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 176' ' ' VAL . 21.8 tpt180 -143.57 118.95 10.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 175' ' ' SER . 42.2 m-80 -78.47 119.28 21.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.209 176.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.976 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.4 pt -111.81 166.72 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.237 -176.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.733 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 27.4 mtpp -103.48 134.65 46.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 172.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 116' ' ' VAL . 26.4 m -134.18 152.73 34.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.937 0.399 . . . . 0.0 110.305 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.648 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 86.72 -95.2 2.03 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.003 173.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 4.4 ptp85 -178.07 134.6 0.34 Allowed Pre-proline 0 C--N 1.328 -0.355 0 O-C-N 123.753 0.325 . . . . 0.0 110.562 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 37.5 Cg_exo -61.75 131.95 37.8 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.684 2.256 . . . . 0.0 111.137 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.2 m -62.9 109.14 1.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.961 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -149.44 155.38 40.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.1 tp -89.15 135.84 24.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.865 0.364 . . . . 0.0 110.159 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -168.38 -150.44 6.62 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.869 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -80.71 -39.75 26.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -79.27 -32.46 43.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.493 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 51.4 tp60 -54.08 -53.31 59.99 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.0 Cg_endo -53.2 -39.38 80.73 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.542 2.162 . . . . 0.0 112.674 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.97 -45.21 55.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.56 HG12 ' SD ' ' A' ' 111' ' ' MET . 51.8 mt -59.33 -47.48 90.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.162 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.46 -39.5 94.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.777 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -63.35 -47.42 82.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.008 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 39.8 mt -67.18 -32.94 74.35 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.629 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.64 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.74 -45.23 74.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.991 0.424 . . . . 0.0 109.914 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -68.47 -34.95 76.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.066 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 35.5 mt-10 -66.69 -31.57 72.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.275 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.98 -29.24 64.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.164 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 74.9 mtp180 -72.36 -15.29 61.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.602 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -90.73 -2.53 57.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.92 169.06 16.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.987 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 36.3 m-20 -108.7 35.13 3.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.382 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.456 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 24.2 ttm180 -95.11 137.42 34.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.121 0.486 . . . . 0.0 111.595 -173.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 34.0 pt -128.95 167.07 25.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.987 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.486 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 73.5 t80 -122.34 126.81 48.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.618 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.523 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 35.7 m -122.4 132.96 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.998 0.428 . . . . 0.0 110.461 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.15 174.54 7.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.685 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 54.5 m 60.8 31.13 20.05 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.499 0.666 . . . . 0.0 109.955 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.55 127.64 36.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.031 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -56.91 135.16 55.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.593 0.235 . . . . 0.0 111.191 -173.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -47.5 -53.75 13.45 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.26 22.61 5.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.411 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.1 tp -101.5 131.36 47.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.7 p -93.94 171.61 8.75 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.287 0.476 . . . . 0.0 112.287 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.62 -32.13 73.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.856 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.33 -34.5 76.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.475 0.655 . . . . 0.0 109.844 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 228' ' ' VAL . 62.7 m-20 -73.56 -43.68 59.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.702 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.7 HG22 HD11 ' A' ' 255' ' ' ILE . 32.6 mm -64.38 -44.12 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 65.5 tttm -57.16 -49.8 74.83 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.607 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 67.3 m -56.84 -37.7 71.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 224' ' ' ASP . 25.1 t -75.95 -44.23 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 122.122 -0.361 . . . . 0.0 111.559 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 235' ' ' ILE . 32.6 m-85 -69.77 -28.79 66.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.455 0.645 . . . . 0.0 110.188 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 8.7 tp10 -59.51 -25.12 64.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.796 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.42 -9.93 59.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.182 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -109.61 -45.29 3.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.666 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -144.55 165.19 27.59 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.096 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -70.96 115.83 10.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.233 0.539 . . . . 0.0 110.783 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.578 HD11 ' HB2' ' A' ' 229' ' ' PHE . 27.6 mt -87.8 150.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.756 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -112.49 -23.08 10.49 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.26 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 22.6 t -172.24 145.37 1.72 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.321 . . . . 0.0 110.859 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.5 t -141.69 128.26 20.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.8 m -142.38 110.78 6.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.985 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.614 HD21 HG13 ' A' ' 225' ' ' ILE . 46.0 mt -83.98 133.55 34.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.18 119.31 14.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.839 0.352 . . . . 0.0 110.544 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.557 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 18.0 mtm180 -122.94 145.9 48.07 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.706 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.609 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 10.6 m-20 -79.55 140.11 55.4 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.441 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.46 -25.6 14.53 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 124.04 3.16 . . . . 0.0 114.769 -171.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.1 t -157.78 48.16 0.39 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.517 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.609 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 17.2 p -102.89 -28.81 11.82 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.73 -0.606 . . . . 0.0 111.879 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.54 59.09 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.702 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.27 174.23 14.56 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.557 ' HB3' ' HG2' ' A' ' 242' ' ' ARG . 28.0 p80 -109.24 146.72 33.76 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.586 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -48.2 -50.48 29.05 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.812 0.695 . . . . 0.0 111.718 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 152.6 -11.73 0.63 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.821 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.486 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 46.2 p90 -124.95 171.03 10.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.818 0.342 . . . . 0.0 110.605 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -162.32 167.76 37.03 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.499 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.61 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 98.6 m-85 -123.66 146.66 48.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.004 0.43 . . . . 0.0 110.983 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.7 HD11 HG22 ' A' ' 225' ' ' ILE . 87.4 mt -139.8 136.1 38.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.209 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 46.1 mt-10 -119.17 136.33 54.23 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.529 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 6.8 m-85 -98.63 176.04 5.79 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -80.5 -21.79 41.6 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.341 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -131.19 137.48 48.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.063 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -69.5 -31.78 70.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.661 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -66.47 -35.6 80.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.976 0.417 . . . . 0.0 110.369 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.8 m -70.82 -42.38 70.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.327 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 40.7 p -66.89 -40.02 87.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.443 . . . . 0.0 110.694 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -70.92 -22.67 62.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.077 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.5 -37.24 71.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.63 84.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.71 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.48 ' HA ' ' CG2' ' A' ' 282' ' ' VAL . 61.9 t -61.77 -27.32 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.498 0.666 . . . . 0.0 110.568 174.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.0 t -87.21 -34.12 19.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.788 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.9 m -94.07 -31.35 14.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.53 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 91.1 mmm -92.32 7.1 44.34 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -170.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.479 ' HA ' HG12 ' A' ' 282' ' ' VAL . 52.9 t30 -72.69 121.66 20.18 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.377 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 86.8 mt 65.95 27.71 10.75 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.06 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -81.92 122.76 28.16 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.92 114.24 15.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.009 0.433 . . . . 0.0 110.06 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.411 ' HG ' HD21 ' A' ' 220' ' ' LEU . 26.4 tp -127.03 91.94 3.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.373 0.606 . . . . 0.0 110.09 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 94.07 11.36 57.65 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.547 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.9 6.66 39.83 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.688 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -133.59 144.45 49.3 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -89.31 114.81 26.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.783 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 62.8 mt -63.49 124.37 21.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.271 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -94.0 115.12 27.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 267' ' ' VAL . 13.9 p -114.6 140.1 37.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.33 0.586 . . . . 0.0 111.139 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.28 174.69 33.4 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.578 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -84.86 122.94 29.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -61.27 127.38 31.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.172 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.629 HG11 ' HG3' ' A' ' 167' ' ' GLN . 35.5 m -91.45 -12.91 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.811 0.338 . . . . 0.0 111.443 -173.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.441 ' HA ' ' HD2' ' A' ' 288' ' ' PRO . 36.4 p -111.97 119.52 44.12 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-O 121.264 0.554 . . . . 0.0 111.058 175.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.516 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 43.9 Cg_endo -66.84 162.07 39.35 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.102 2.535 . . . . 0.0 111.909 176.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 288' ' ' PRO . 16.4 Cg_exo -68.39 76.05 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.297 2.665 . . . . 0.0 112.934 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.455 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 49.1 ttm -81.04 118.01 70.55 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 175.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 6.6 Cg_exo -74.73 59.48 4.98 Favored 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 123.235 2.623 . . . . 0.0 112.69 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.8 tp -118.2 37.08 4.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.423 0.63 . . . . 0.0 109.998 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.14 131.32 46.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 91.8 m 61.85 76.88 0.37 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 121.411 0.624 . . . . 0.0 109.609 -170.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.87 143.12 90.96 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.806 2.337 . . . . 0.0 112.171 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 59.64 42.48 17.1 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.444 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 C--O 1.251 1.15 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.535 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 112.266 -0.333 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.31 102.46 7.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.3 mtm -82.03 65.83 7.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.164 0.507 . . . . 0.0 110.688 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -89.8 124.05 34.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -99.21 77.4 2.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.404 0.621 . . . . 0.0 110.127 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -101.66 -0.99 33.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.044 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.62 ' HB2' HD12 ' A' ' 108' ' ' LEU . 29.8 pt20 -78.82 28.94 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.096 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -60.58 -28.4 68.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.911 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 110' ' ' ILE . . . -74.86 -22.0 58.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.737 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 105' ' ' GLN . 57.2 mt -62.56 -33.3 74.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.693 0.282 . . . . 0.0 110.594 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.02 -25.67 65.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.794 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 107' ' ' ALA . 3.6 mp -87.75 -36.82 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.619 ' SD ' HG23 ' A' ' 198' ' ' ILE . 42.5 mtm -74.7 -22.28 58.94 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.44 -11.74 60.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.958 0.408 . . . . 0.0 110.46 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -106.55 140.95 38.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.713 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.542 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.9 p -121.59 128.79 75.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.404 0.621 . . . . 0.0 110.225 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -81.25 109.89 16.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.778 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.455 HG12 HD11 ' A' ' 119' ' ' ILE . 39.3 t -108.02 120.05 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.104 0.478 . . . . 0.0 111.253 -174.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -135.21 174.07 21.36 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.442 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.783 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 25.9 m 66.59 35.35 5.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.069 0.547 . . . . 0.0 111.37 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.455 HD11 HG12 ' A' ' 116' ' ' VAL . 46.0 mt -85.22 114.72 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.558 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -52.29 134.41 33.79 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.435 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -71.42 76.66 0.76 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 122.162 0.982 . . . . 0.0 111.474 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.46 -37.75 0.06 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.931 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.465 ' CD1' ' HG3' ' A' ' 177' ' ' MET . 59.8 mt -75.16 110.64 9.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.825 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.55 169.58 49.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.869 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.09 -36.91 84.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.935 0.397 . . . . 0.0 110.275 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.53 -35.01 76.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.547 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.6 m -64.54 -42.81 95.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 110.142 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.626 HG13 ' HE1' ' A' ' 143' ' ' MET . 33.7 mm -63.2 -41.58 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.488 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 43.3 ttp-105 -59.04 -41.36 87.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.548 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.24 -34.13 77.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.525 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.68 -32.21 28.22 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -88.35 -21.42 24.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.773 0.32 . . . . 0.0 111.383 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.62 98.32 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.66 -32.4 5.84 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 122.998 2.465 . . . . 0.0 114.252 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.588 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 74.0 m-85 -83.01 -44.14 15.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.485 0.183 . . . . 0.0 111.367 -176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.41 167.41 40.24 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.367 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.35 134.41 35.99 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.697 2.265 . . . . 0.0 111.338 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.445 HG21 ' CG1' ' A' ' 141' ' ' ILE . 50.3 mt -100.14 132.84 44.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.409 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.592 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 21.4 ttmm -98.7 -29.58 12.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.551 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.7 t -156.82 135.17 11.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.83 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.445 ' CG1' HG21 ' A' ' 138' ' ' ILE . 63.4 mt -128.69 116.57 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -114.22 99.53 7.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.973 0.416 . . . . 0.0 110.327 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.626 ' HE1' HG13 ' A' ' 128' ' ' ILE . 49.2 ttm -103.05 140.72 36.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.694 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.2 m -76.18 69.81 2.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.39 0.614 . . . . 0.0 110.119 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -97.81 90.59 5.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.399 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.425 ' HB3' ' HD3' ' A' ' 153' ' ' LYS . 37.8 t70 -138.02 77.91 1.66 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.498 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 88.7 p -172.71 156.13 3.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.967 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.4 m -89.62 -19.27 7.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.325 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.9 p -91.12 8.85 33.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.759 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.8 mtm 66.27 31.8 8.26 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.962 0.505 . . . . 0.0 111.643 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -92.76 144.39 25.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.14 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -86.13 100.02 11.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.436 0.636 . . . . 0.0 110.273 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' A' ' 146' ' ' ASP . 83.8 tttt -82.57 54.6 2.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.313 -176.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 143.14 -133.49 5.5 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.078 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -132.64 178.59 6.73 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 143' ' ' MET . . . -127.09 139.53 52.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.006 0.431 . . . . 0.0 110.716 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -114.52 118.72 34.55 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.091 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' A' ' 114' ' ' VAL . 96.5 t -104.87 112.1 37.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -105.02 115.42 30.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -88.29 165.19 15.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.592 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 23.0 mt-10 -83.04 -12.02 57.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.222 175.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.9 m -136.66 134.43 19.5 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.969 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.08 -22.37 47.63 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.896 2.397 . . . . 0.0 112.475 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.74 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 13.7 mp0 -55.26 -54.2 46.48 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.389 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.03 -19.59 63.04 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.49 -52.1 9.65 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.647 ' HG3' HG11 ' A' ' 286' ' ' VAL . 14.9 mm100 -69.94 -27.17 64.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 175.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.588 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 12.9 tp -70.02 -50.57 40.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.415 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.63 -33.87 76.58 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.508 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.2 tt -61.25 -46.5 90.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.993 173.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -65.64 -44.2 87.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.675 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -86.93 -37.92 17.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.4 mtm -101.6 30.25 4.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.958 0.409 . . . . 0.0 111.324 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -68.33 -11.08 58.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.128 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 20.3 m -101.31 -72.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.2 m -138.21 166.06 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.08 0.467 . . . . 0.0 111.855 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.465 ' HG3' ' CD1' ' A' ' 123' ' ' LEU . 18.3 tpp -134.87 99.21 4.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.877 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.446 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 89.7 mt 53.49 41.28 32.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.607 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.62 -144.52 16.45 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.993 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.64 -123.02 15.2 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.255 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -143.95 179.0 7.46 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 175' ' ' SER . 9.2 t30 -51.27 111.56 0.59 Allowed 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.628 0.58 . . . . 0.0 110.694 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.783 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 47.6 pt -89.29 160.8 2.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.474 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 52.2 tttp -107.25 116.22 31.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.5 t -120.31 106.2 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.508 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 101.61 163.53 27.15 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.25 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.494 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 30.1 ptt180 -139.14 58.6 13.09 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.872 0.367 . . . . 0.0 111.709 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 9.3 Cg_endo -88.33 11.47 3.08 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.795 2.33 . . . . 0.0 111.89 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 42.2 m -104.52 9.83 35.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.355 0.597 . . . . 0.0 110.633 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -94.31 155.08 17.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.907 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.5 tp -115.81 140.5 37.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.086 0.47 . . . . 0.0 110.436 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 175.5 -160.76 29.42 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -82.12 -11.44 58.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.584 0.692 . . . . 0.0 110.806 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.88 -38.52 27.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.456 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.522 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 56.4 tp60 -58.22 -49.77 91.75 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.9 Cg_endo -52.9 -39.08 79.47 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.332 2.021 . . . . 0.0 112.458 177.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 56.9 mt -72.61 -39.39 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.819 0.342 . . . . 0.0 110.438 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.619 HG23 ' SD ' ' A' ' 111' ' ' MET . 69.9 mt -59.35 -50.07 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.602 176.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.64 -30.96 68.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.55 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.68 -52.09 62.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.453 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 27.5 mt -67.56 -33.55 75.26 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.921 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.693 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.28 -51.12 60.32 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 173.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -65.71 -30.91 71.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.308 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 40.3 mt-10 -67.2 -34.75 78.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.068 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.79 -36.69 65.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.712 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.693 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 71.5 mtp180 -66.48 -24.24 66.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.125 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.17 -13.92 60.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.241 0.543 . . . . 0.0 110.66 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -113.74 -179.28 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.365 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 46.2 m-20 -116.46 40.87 2.79 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.428 ' HD2' ' HG3' ' A' ' 289' ' ' PRO . 28.1 ttt180 -93.95 135.62 35.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.704 -173.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.1 pt -135.18 167.18 26.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.566 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.58 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 27.0 t80 -121.65 130.57 53.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.776 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.531 HG21 HG21 ' A' ' 225' ' ' ILE . 28.1 m -121.42 131.92 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.099 0.476 . . . . 0.0 110.145 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.07 176.58 6.59 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.915 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.6 m 62.27 32.52 17.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.906 0.86 . . . . 0.0 109.339 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.445 HG13 HD11 ' A' ' 225' ' ' ILE . 16.4 t -77.76 112.74 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.505 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -60.13 139.57 57.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.232 0.539 . . . . 0.0 111.341 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -51.05 -35.99 37.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.78 -17.72 30.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.134 0.492 . . . . 0.0 111.051 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.727 HD21 ' HG ' ' A' ' 275' ' ' LEU . 0.9 OUTLIER -74.1 132.55 42.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.061 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.2 m -103.25 179.71 4.19 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.303 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -55.63 -46.46 77.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.602 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -67.47 -27.34 66.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.613 -173.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -66.91 -54.05 25.92 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.467 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.728 HG22 HD11 ' A' ' 255' ' ' ILE . 42.7 mm -63.5 -43.2 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.73 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.453 ' HG3' HG21 ' A' ' 235' ' ' ILE . 83.9 tttt -56.85 -49.44 75.46 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.577 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 35.3 t -55.51 -41.09 72.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.1 t -74.75 -40.93 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.235 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.712 ' HB2' HD11 ' A' ' 235' ' ' ILE . 24.4 m-85 -69.12 -35.74 76.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.467 0.651 . . . . 0.0 110.35 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 34.9 tp10 -59.2 -24.89 63.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.695 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.47 -19.76 64.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.002 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -111.51 -34.36 6.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -145.15 153.93 25.59 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.561 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 66.0 mmtt -73.76 113.3 10.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 111.941 -177.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.712 HD11 ' HB2' ' A' ' 229' ' ' PHE . 51.4 mt -92.47 151.09 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.878 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -109.66 -36.31 5.97 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.562 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 19.0 m -147.94 146.04 28.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.705 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.44 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 53.3 t -153.9 118.26 4.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.758 174.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.9 t -141.26 119.22 11.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.205 0.526 . . . . 0.0 111.51 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.646 HD23 ' HA3' ' A' ' 253' ' ' GLY . 40.8 mt -91.94 132.61 36.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.033 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.64 124.44 23.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.55 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.593 ' HB3' ' CB ' ' A' ' 249' ' ' HIS . 14.7 ptt-85 -144.59 169.89 17.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.478 -173.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -104.56 100.92 25.04 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.728 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.25 -22.24 64.01 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.513 2.142 . . . . 0.0 112.368 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.8 p -75.65 -17.94 59.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.48 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 49.3 p -108.84 -42.22 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.997 0.427 . . . . 0.0 110.369 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 114.54 -16.92 18.96 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.748 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -107.19 160.69 15.39 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.608 -0.348 . . . . 0.0 110.493 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.593 ' CB ' ' HB3' ' A' ' 242' ' ' ARG . 26.9 p80 -100.76 162.56 12.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.539 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -75.03 -69.93 0.44 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.213 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 170.19 25.99 0.02 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.095 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.482 ' HB2' ' CE1' ' A' ' 212' ' ' TYR . 3.1 p90 -153.77 154.07 33.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.646 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -157.78 173.22 35.1 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.137 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.74 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 81.4 m-85 -127.09 146.06 50.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.981 0.419 . . . . 0.0 110.626 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.728 HD11 HG22 ' A' ' 225' ' ' ILE . 74.5 mt -135.02 138.78 48.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.284 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 45.6 mt-10 -121.63 142.46 50.1 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 6.3 m-85 -105.85 163.69 12.53 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.05 0.452 . . . . 0.0 111.458 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.31 -36.75 20.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.526 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -100.41 114.94 28.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.571 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -50.83 -59.46 4.09 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.547 0.53 . . . . 0.0 112.375 -168.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.43 -36.54 64.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.257 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.2 t -67.94 -21.14 65.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 89.6 p -66.55 -49.93 64.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.218 0.533 . . . . 0.0 110.4 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -75.56 -15.9 60.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.67 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.48 -40.84 73.4 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.29 83.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 95.9 t -57.44 -30.58 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.236 0.541 . . . . 0.0 111.177 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.8 m -87.34 -29.45 21.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.342 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 13.3 m -93.54 -40.47 10.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.989 0.423 . . . . 0.0 112.03 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.451 ' HG3' ' CD2' ' A' ' 229' ' ' PHE . 87.6 mmm -85.08 -2.88 58.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.951 -171.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.42 ' HA ' HG12 ' A' ' 282' ' ' VAL . 60.2 t30 -69.1 129.66 40.52 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.371 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.7 mt 66.31 27.69 10.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.808 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -90.34 117.96 29.47 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.661 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 4.0 p-10 -76.03 122.38 24.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.371 0.605 . . . . 0.0 110.289 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.727 ' HG ' HD21 ' A' ' 220' ' ' LEU . 26.5 tp -134.24 95.21 3.36 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.635 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 93.36 18.65 38.17 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.699 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.89 -36.75 4.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.68 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -93.82 147.95 22.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.767 0.317 . . . . 0.0 110.746 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.661 ' CE1' ' HB3' ' A' ' 274' ' ' ASP . 54.2 m-85 -87.44 115.9 25.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.743 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.4 mt -57.13 116.6 3.35 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.797 0.685 . . . . 0.0 111.122 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -93.69 115.0 27.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 271' ' ' ASN . 13.7 p -121.41 147.63 25.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.173 0.511 . . . . 0.0 111.12 -173.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.38 179.7 37.53 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -84.74 134.96 34.32 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.613 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -68.85 137.15 53.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.647 HG11 ' HG3' ' A' ' 167' ' ' GLN . 33.1 m -97.96 -11.96 8.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.479 . . . . 0.0 110.917 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 38.3 p -108.6 135.06 20.08 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.004 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 58.9 Cg_endo -73.29 147.82 42.6 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.847 2.364 . . . . 0.0 111.478 174.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.428 ' HG3' ' HD2' ' A' ' 210' ' ' ARG . 52.4 Cg_exo -54.18 143.19 64.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.866 2.377 . . . . 0.0 112.035 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 49.3 ttp -111.81 93.64 21.34 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.555 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.457 ' HD2' HD22 ' A' ' 292' ' ' LEU . 96.6 Cg_endo -84.92 -5.32 9.72 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.447 2.098 . . . . 0.0 111.267 171.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.457 HD22 ' HD2' ' A' ' 291' ' ' PRO . 3.3 mm? -63.29 107.38 1.06 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.932 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 92.8 mt 64.58 9.51 5.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.406 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 18.5 m -145.01 86.21 7.81 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.426 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.92 58.83 6.67 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.612 2.208 . . . . 0.0 111.351 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 60.12 -99.04 0.09 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.633 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 59.5 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.213 176.554 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 121.43 30.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.724 0.297 . . . . 0.0 110.518 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 49.5 tpp -131.1 -32.41 1.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.018 0.437 . . . . 0.0 110.718 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -120.71 163.55 17.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.369 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 56.77 58.66 3.95 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.403 0.621 . . . . 0.0 110.659 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -114.73 76.16 0.98 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.04 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 54.35 82.39 0.09 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.711 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 106' ' ' ARG . 10.9 ptp180 -55.51 -28.2 53.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.281 -174.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 197' ' ' ILE . . . -68.37 -35.04 77.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.036 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.494 HD21 HG21 ' A' ' 287' ' ' THR . 40.8 mt -66.71 -31.8 72.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.041 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.42 69.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.339 0.59 . . . . 0.0 110.36 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.4 mt -88.05 -36.96 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.348 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.483 ' SD ' HG12 ' A' ' 198' ' ' ILE . 90.4 mtp -69.88 -19.27 63.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.44 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 86.3 m -85.71 -1.89 57.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.1 0.476 . . . . 0.0 110.99 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -118.33 142.13 47.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.211 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.664 HG12 ' HB ' ' A' ' 158' ' ' VAL . 8.8 p -115.24 119.79 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.631 0.729 . . . . 0.0 109.761 172.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 41.7 t80 -67.87 119.99 13.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.192 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.579 HG23 ' HB3' ' A' ' 156' ' ' ALA . 17.0 m -119.48 117.51 54.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.59 0.709 . . . . 0.0 111.69 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.46 170.86 23.15 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.056 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.667 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 10.5 t 64.15 36.76 9.37 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.645 0.735 . . . . 0.0 109.604 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 84.7 mt -78.76 -15.51 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.854 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 75.5 t80 76.04 139.28 0.06 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.664 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.596 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 26.0 p90 -74.89 77.64 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.581 0.705 . . . . 0.0 110.892 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -163.59 -35.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.396 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 178' ' ' LEU . 72.8 mt -85.64 128.92 34.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.206 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.27 176.85 39.08 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.893 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.72 -39.9 93.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 0.0 110.549 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 16.1 t70 -65.03 -41.96 94.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.279 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 m -61.15 -40.56 94.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.938 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.09 -38.69 82.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.789 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 129' ' ' ARG . 33.2 ttp-105 -61.52 -39.02 89.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.993 0.425 . . . . 0.0 109.946 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 78.0 mt-30 -63.94 -37.78 88.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.335 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.56 -36.66 37.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.264 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.545 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 56.9 m-85 -92.29 -7.85 46.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.978 0.418 . . . . 0.0 111.777 -177.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.604 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -53.4 -45.58 98.42 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 6.8 Cg_endo -51.21 -27.66 23.47 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.854 2.369 . . . . 0.0 114.534 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.62 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 58.5 m-85 -83.88 -42.95 15.82 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.408 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.8 -179.49 40.49 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.849 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.93 110.92 3.13 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.763 2.309 . . . . 0.0 111.799 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 63.1 mt -79.57 113.02 18.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.353 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -78.58 -41.48 31.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.845 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -162.1 156.75 22.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.523 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.1 mt -134.76 116.18 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.732 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 12.8 m-20 -88.31 98.92 11.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.1 ttm -120.61 133.37 55.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.885 0.374 . . . . 0.0 111.228 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.626 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 16.3 m -77.67 99.05 5.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.44 172.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.618 ' HA ' ' HB2' ' A' ' 152' ' ' HIS . 12.7 t-105 -124.63 112.22 16.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.502 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -172.16 104.56 0.18 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.21 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.5 m -157.62 140.36 14.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 32.0 m -62.33 -21.03 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.144 -173.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.513 ' OG1' ' HD2' ' A' ' 151' ' ' LYS . 15.3 p -99.67 27.7 5.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.312 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 2.4 mpp? 55.12 60.16 3.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.45 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 40.2 mttp -143.12 176.51 9.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.685 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.626 ' HB2' ' O ' ' A' ' 144' ' ' SER . 14.6 p80 -153.35 158.22 41.21 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.127 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -112.62 -169.14 1.42 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.381 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 66.84 -147.05 49.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.496 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -140.86 178.44 7.35 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.579 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -138.15 158.46 44.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.064 0.459 . . . . 0.0 111.662 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -117.84 115.8 25.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.338 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.664 ' HB ' HG12 ' A' ' 114' ' ' VAL . 99.4 t -91.52 109.93 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.936 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -98.03 116.22 29.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.431 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.545 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 95.9 m-85 -92.86 176.47 6.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.657 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -95.76 -1.52 49.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.045 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.9 m -145.76 137.31 12.92 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.22 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 43.5 Cg_endo -68.54 -20.34 41.39 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.039 2.493 . . . . 0.0 112.164 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 79.6 mm-40 -58.09 -56.34 23.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.79 -20.35 34.83 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.27 -51.82 7.54 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -63.31 -34.68 78.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.769 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.62 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.6 tp -68.67 -48.92 62.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.601 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.49 83.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 110.155 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 174' ' ' ASN . 6.7 tt -63.06 -51.16 67.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.532 174.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -57.72 -47.93 81.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.014 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -85.7 -33.37 21.53 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.9 mtm -108.15 30.09 6.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 24.2 p-10 -79.81 23.26 0.44 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.828 0.347 . . . . 0.0 111.584 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.8 t -114.59 -73.35 0.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.853 0.358 . . . . 0.0 110.625 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.586 HG12 ' H ' ' A' ' 182' ' ' ASN . 20.8 m -139.73 169.04 17.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.217 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.846 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.1 tpt -141.59 94.36 2.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 123' ' ' LEU . 89.0 mt 60.13 -83.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.579 0.752 . . . . 0.0 112.279 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -108.99 -12.8 19.67 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.336 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.32 115.03 4.32 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.246 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -82.94 127.06 33.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.586 ' H ' HG12 ' A' ' 176' ' ' VAL . 20.4 t-20 61.54 76.43 0.37 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.773 0.671 . . . . 0.0 110.258 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.846 HD13 ' HB2' ' A' ' 177' ' ' MET . 49.6 pt -88.36 160.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.724 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 67.0 mttm -105.65 106.91 17.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.528 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 6.2 m -109.27 116.4 51.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.317 0.58 . . . . 0.0 110.217 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.448 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 72.87 -171.73 50.09 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.595 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.734 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 19.9 mmt180 -132.69 81.24 59.54 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 174.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.15 -37.61 96.22 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.124 2.549 . . . . 0.0 113.284 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.4 m -115.37 40.45 2.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.198 0.523 . . . . 0.0 111.461 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.734 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 29.4 t-20 -81.0 83.03 6.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.443 0.64 . . . . 0.0 109.295 173.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.575 ' HA ' ' HG3' ' A' ' 195' ' ' GLN . 10.0 tp -65.88 140.18 20.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.718 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 160.82 -161.28 32.67 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -64.32 -28.01 69.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.014 0.435 . . . . 0.0 111.454 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -70.52 -32.04 69.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.575 ' HG3' ' HA ' ' A' ' 191' ' ' ILE . 29.1 mm-40 -57.36 -56.19 36.52 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -173.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.2 Cg_endo -53.68 -37.51 83.9 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.219 1.946 . . . . 0.0 112.748 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 107' ' ' ALA . 54.7 mt -75.96 -43.09 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.774 0.321 . . . . 0.0 111.15 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.483 HG12 ' SD ' ' A' ' 111' ' ' MET . 72.8 mt -61.72 -46.49 96.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.05 0.452 . . . . 0.0 109.975 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.57 -36.98 85.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.352 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -58.32 -53.95 52.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.118 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 58.1 mt -68.8 -33.7 74.31 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.904 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.699 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.03 -48.96 69.95 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.615 ' OE1' ' HD3' ' A' ' 206' ' ' ARG . 6.6 mm-40 -62.89 -35.99 81.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.084 176.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 40.7 mt-10 -63.92 -36.25 83.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.356 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.09 -34.01 63.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.83 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.699 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 72.2 mtp180 -69.09 -20.63 64.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.937 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.53 -18.13 59.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.149 0.5 . . . . 0.0 110.554 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -109.14 -169.96 1.58 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.052 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.482 ' CB ' ' HA ' ' A' ' 260' ' ' ALA . 27.2 p-10 -139.5 58.75 1.61 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.835 0.826 . . . . 0.0 109.656 178.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.53 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 18.6 ttm180 -111.05 139.13 46.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.173 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.1 pt -119.57 163.15 17.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.668 0.271 . . . . 0.0 110.597 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -113.9 127.0 55.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.152 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 28.3 m -114.8 128.01 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.359 0.599 . . . . 0.0 110.154 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -120.27 167.53 12.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.097 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.3 t 59.67 40.03 20.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.975 0.893 . . . . 0.0 109.095 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.531 HG13 HD11 ' A' ' 225' ' ' ILE . 39.4 t -77.4 120.99 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.473 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 40.2 t-80 -52.57 133.01 36.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.257 0.551 . . . . 0.0 111.05 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -49.27 -37.68 24.42 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -171.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -96.41 -6.1 38.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.126 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 275' ' ' LEU . 10.7 tp -88.7 112.41 23.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.5 t -96.93 -178.67 4.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.854 0.359 . . . . 0.0 111.734 -170.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -53.36 -38.51 63.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.544 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.45 -37.55 87.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.391 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.427 ' HB2' ' HG ' ' A' ' 220' ' ' LEU . 15.7 m-20 -73.86 -42.68 60.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.992 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.546 HG22 HD11 ' A' ' 255' ' ' ILE . 34.6 mm -64.21 -42.14 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.403 ' HG3' HG21 ' A' ' 235' ' ' ILE . 83.9 tttt -61.09 -48.77 80.14 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.001 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 13.2 p -60.16 -38.17 82.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.458 HG21 HD21 ' A' ' 275' ' ' LEU . 49.1 t -76.56 -40.29 33.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.766 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.57 ' CB ' HD11 ' A' ' 235' ' ' ILE . 6.1 m-85 -69.19 -32.49 71.81 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.133 0.492 . . . . 0.0 110.993 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 7.2 tm-20 -63.35 -24.39 67.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.051 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.2 -23.82 64.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.731 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -101.41 -34.21 9.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.341 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -152.16 149.25 20.9 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.539 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 29.6 mmtp -71.19 120.52 16.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.567 0.698 . . . . 0.0 111.105 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.57 HD11 ' CB ' ' A' ' 229' ' ' PHE . 28.2 mt -91.38 151.2 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.919 -172.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 257' ' ' TYR . 17.0 ttmt -103.7 -30.28 10.53 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.202 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 28.2 t -170.34 141.91 2.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.325 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 40.4 t -142.61 127.1 17.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.744 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.9 t -141.31 133.48 27.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.823 0.344 . . . . 0.0 110.304 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 27.7 mt -109.84 136.18 49.56 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.86 126.44 29.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.221 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.421 ' HG2' ' CB ' ' A' ' 249' ' ' HIS . 73.5 mtp180 -122.83 152.45 40.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.831 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.583 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 17.9 m-20 -70.5 145.85 93.29 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.74 -19.98 56.37 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 123.197 2.598 . . . . 0.0 114.159 -171.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.3 t -162.93 62.2 0.19 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.295 0.569 . . . . 0.0 111.996 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 58.7 p -127.93 -18.46 4.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.095 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.07 -46.3 1.72 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.101 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.34 177.89 6.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.848 0.356 . . . . 0.0 110.711 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.421 ' CB ' ' HG2' ' A' ' 242' ' ' ARG . 30.8 p80 -96.15 170.7 9.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.293 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -77.06 -80.6 0.1 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.938 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -179.8 18.12 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.029 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -154.89 163.9 39.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -168.66 -179.24 40.77 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.228 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.491 ' CZ ' ' HG3' ' A' ' 164' ' ' GLU . 91.1 m-85 -134.44 145.37 48.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.625 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.546 HD11 HG22 ' A' ' 225' ' ' ILE . 88.5 mt -138.04 132.06 42.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.036 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.53 ' HG2' ' HB2' ' A' ' 210' ' ' ARG . 81.6 mt-10 -110.02 146.16 35.79 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.525 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 8.2 m-85 -106.94 179.24 4.32 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.164 176.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -70.24 -50.63 37.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.924 0.868 . . . . 0.0 108.905 171.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -103.48 139.56 38.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.968 -1.469 . . . . 0.0 109.227 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.482 ' HA ' ' CB ' ' A' ' 209' ' ' ASN . . . -65.56 -28.79 69.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.705 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -72.82 -33.45 66.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.844 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.8 m -67.07 -37.18 83.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.053 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.536 ' HB2' HG23 ' A' ' 211' ' ' ILE . 21.6 p -68.23 -38.63 82.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 0.0 110.04 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -71.6 -25.96 62.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.33 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -65.39 -41.94 93.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.028 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -63.83 -41.68 97.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.468 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.17 -32.98 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.231 0.539 . . . . 0.0 111.001 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.9 t -75.37 -33.83 61.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.132 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.8 t -94.29 -40.17 10.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 112.041 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 75.2 mmm -83.33 -4.41 58.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -168.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.486 ' HA ' HG12 ' A' ' 282' ' ' VAL . 57.8 t30 -69.2 112.81 6.03 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.159 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.452 HD21 ' CZ ' ' A' ' 281' ' ' ARG . 94.1 mt 67.77 36.36 3.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.778 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -91.17 132.97 35.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.244 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -82.04 109.57 16.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.305 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.659 HD12 HD11 ' A' ' 280' ' ' LEU . 0.6 OUTLIER -117.38 91.38 3.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.137 0.494 . . . . 0.0 109.851 176.225 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.9 34.1 28.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.756 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 91.03 -0.29 75.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.969 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.482 ' OE1' ' HA ' ' A' ' 217' ' ' HIS . 34.6 tt0 -126.57 141.17 51.95 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 120.773 0.32 . . . . 0.0 110.342 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -92.58 123.25 35.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.87 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.659 HD11 HD12 ' A' ' 275' ' ' LEU . 48.2 mt -77.73 127.6 32.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.135 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.452 ' CZ ' HD21 ' A' ' 272' ' ' LEU . 37.4 mmt180 -95.1 114.78 26.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 271' ' ' ASN . 10.7 p -117.34 147.65 20.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.157 -173.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -159.47 175.47 36.36 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.382 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -82.06 126.41 31.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -61.68 126.81 28.68 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.309 0.381 . . . . 0.0 110.585 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.59 -24.94 5.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.359 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.605 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 16.1 p -132.57 133.16 23.21 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.732 0.301 . . . . 0.0 111.269 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.32 103.71 1.44 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.616 2.211 . . . . 0.0 112.077 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' A' ' 287' ' ' THR . 90.9 Cg_endo -89.38 139.16 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.688 2.259 . . . . 0.0 113.187 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 64.1 mtt -108.11 109.51 61.91 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.803 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.33 113.19 3.63 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.488 2.125 . . . . 0.0 112.562 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 94.3 mt -83.23 51.77 2.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.352 0.596 . . . . 0.0 110.35 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 87.8 mt -89.92 105.53 17.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.092 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 2.7 p -90.14 114.43 60.9 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.508 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.35 76.01 2.79 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.101 2.534 . . . . 0.0 112.238 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -85.15 64.24 8.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.332 0.587 . . . . 0.0 110.294 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 28.8 m . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.776 179.632 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.285 -0.326 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 59.49 39.98 21.14 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 174.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 55.7 ttp -108.35 -38.54 5.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.948 0.404 . . . . 0.0 110.637 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.68 -71.24 0.75 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.734 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.471 ' HB3' ' H ' ' A' ' 104' ' ' ARG . 47.8 mt-30 -137.91 -161.15 1.14 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.713 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.471 ' H ' ' HB3' ' A' ' 103' ' ' GLN . 24.8 ttt180 64.75 -84.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.846 0.716 . . . . 0.0 111.353 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -86.71 -7.58 58.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.192 0.52 . . . . 0.0 110.157 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -52.8 -48.23 67.05 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.908 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.0 -35.83 69.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.704 0.288 . . . . 0.0 111.081 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 108' ' ' LEU . 34.7 mt -66.59 -32.35 73.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.203 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.8 85.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.192 0.52 . . . . 0.0 110.136 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.97 -36.48 57.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.219 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.429 ' SD ' HG12 ' A' ' 198' ' ' ILE . 89.9 mtp -72.14 -17.01 62.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.915 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 80.2 m -89.01 -17.78 28.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.91 0.386 . . . . 0.0 110.597 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -99.08 141.53 31.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.144 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.69 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.5 p -128.05 131.58 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 121.773 0.796 . . . . 0.0 110.145 174.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.48 ' H ' ' HA2' ' A' ' 186' ' ' GLY . 39.1 t80 -94.71 104.48 16.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.222 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 17.4 m -99.38 116.52 42.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.607 0.717 . . . . 0.0 111.352 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.501 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -116.36 165.32 12.27 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.638 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.7 m 63.45 44.42 5.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.347 0.594 . . . . 0.0 110.861 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -72.91 142.93 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.234 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.447 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 37.8 t80 -54.81 127.26 27.65 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.598 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.511 ' OH ' ' HA ' ' A' ' 151' ' ' LYS . 36.4 t80 -74.47 76.71 1.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.024 0.44 . . . . 0.0 110.135 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 178.54 -36.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.111 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 178' ' ' LEU . 93.8 mt -61.44 132.41 53.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.965 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -98.59 168.23 22.65 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.791 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -55.41 -39.51 70.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.935 0.397 . . . . 0.0 111.183 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -64.55 -39.51 93.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.076 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -71.57 -38.25 70.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.41 -40.24 88.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.145 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -59.16 -43.35 92.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.58 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.37 -34.45 73.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.297 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.11 -33.44 26.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.504 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 40.7 m-85 -91.77 -16.81 26.3 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.442 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -54.88 -43.72 98.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 42.0 Cg_exo -40.58 -38.95 2.74 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.245 2.63 . . . . 0.0 115.062 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.709 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 61.5 m-85 -77.48 -37.17 51.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -173.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -179.01 -177.71 47.76 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.867 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HB2' ' OE1' ' A' ' 161' ' ' GLU . 73.4 Cg_endo -75.06 135.43 18.97 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.772 2.314 . . . . 0.0 112.258 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.515 HD13 HD11 ' A' ' 141' ' ' ILE . 68.9 mt -102.1 130.97 51.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.564 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 29.5 ttpp -94.48 -31.75 13.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -168.79 145.91 3.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.6 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.515 HD11 HD13 ' A' ' 138' ' ' ILE . 69.5 mt -130.81 131.16 64.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -122.29 101.49 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.416 ' HE3' ' HB2' ' A' ' 143' ' ' MET . 43.5 ttm -111.97 138.28 48.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.747 0.308 . . . . 0.0 110.931 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.402 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 27.8 m -75.25 116.39 15.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.295 173.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.421 ' CD1' ' HD2' ' A' ' 152' ' ' HIS . 0.9 OUTLIER -149.23 98.27 2.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.28 114.2 4.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.034 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.8 m -87.14 3.73 45.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.536 HG13 HG23 ' A' ' 149' ' ' THR . 8.8 p -110.06 -40.51 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.368 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.536 HG23 HG13 ' A' ' 148' ' ' VAL . 36.8 p -104.71 -0.34 27.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.889 0.376 . . . . 0.0 111.521 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 53.8 mtm 63.28 33.63 13.94 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.309 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.511 ' HA ' ' OH ' ' A' ' 121' ' ' TYR . 28.3 mmmt -97.91 131.92 43.95 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.421 ' HD2' ' CD1' ' A' ' 145' ' ' TRP . 14.4 t-80 -78.0 -61.37 2.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.0 tttm 36.98 62.12 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.502 1.126 . . . . 0.0 112.33 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 144' ' ' SER . . . 165.26 -173.95 41.08 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.658 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.501 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 29.5 m-85 -118.96 179.13 4.25 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.2 139.52 51.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.954 0.407 . . . . 0.0 110.647 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -105.34 109.33 21.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.824 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 114' ' ' VAL . 62.9 t -94.57 105.72 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -102.87 115.15 30.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.409 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 85.0 m-85 -88.94 172.38 9.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.628 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 47.8 mt-10 -89.95 -24.29 21.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.845 172.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.82 137.35 29.37 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.303 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.3 Cg_endo -69.43 -17.46 39.05 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.169 2.579 . . . . 0.0 112.362 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.599 ' HG3' ' HZ ' ' A' ' 254' ' ' PHE . 71.3 mm-40 -57.99 -54.91 41.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.011 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -59.33 -21.5 59.86 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.68 -52.39 8.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -63.95 -32.33 73.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.841 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.709 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.1 tp -68.52 -50.04 55.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.584 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.42 74.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.756 0.313 . . . . 0.0 110.374 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 185' ' ' VAL . 24.4 tp -68.76 -40.77 79.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.125 0.488 . . . . 0.0 110.651 173.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.84 -33.95 75.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.253 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -100.13 -51.19 3.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 13.6 mtm -103.11 29.3 5.59 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -165.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.419 ' HB2' HD12 ' A' ' 170' ' ' LEU . 64.4 t30 -83.61 32.5 0.46 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.575 0.702 . . . . 0.0 109.941 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 48.6 m -114.87 -74.08 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.369 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.07 163.84 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.395 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.885 ' HB2' HD13 ' A' ' 183' ' ' ILE . 0.8 OUTLIER -134.03 103.25 5.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.568 177.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.556 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 84.0 mt 54.7 77.75 0.19 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.931 0.77 . . . . 0.0 111.995 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 131.72 -139.56 11.05 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.167 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -133.7 62.67 0.63 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.322 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -142.22 124.19 15.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 175' ' ' SER . 95.3 m-20 -68.27 124.12 22.62 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 123.307 0.38 . . . . 0.0 110.439 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.885 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.3 pt -106.49 155.56 7.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.043 0.449 . . . . 0.0 110.77 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.1 tppp? -105.42 116.01 31.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.591 ' O ' HD13 ' A' ' 170' ' ' LEU . 21.7 t -100.06 102.19 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.405 0.621 . . . . 0.0 109.806 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.48 ' HA2' ' H ' ' A' ' 115' ' ' TYR . . . 92.15 -174.41 37.05 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.805 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -116.52 86.09 17.7 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 186' ' ' GLY . 6.4 Cg_exo -73.93 66.59 5.0 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.511 2.807 . . . . 0.0 112.372 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.3 t -137.54 170.82 15.43 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.304 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -76.88 91.04 3.52 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.6 tp -64.06 -21.35 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.453 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.98 -100.09 2.28 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.044 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -54.24 -40.33 67.62 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.26 -13.2 50.52 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 12.0 tm0? -64.04 -52.87 52.89 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.82 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 77.7 Cg_exo -53.23 -38.52 81.65 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.485 2.123 . . . . 0.0 113.094 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 52.4 mt -67.36 -46.47 83.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.318 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.429 HG12 ' SD ' ' A' ' 111' ' ' MET . 66.5 mt -60.95 -45.56 98.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.317 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.32 -39.95 95.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.534 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -65.38 -47.31 76.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.557 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 49.9 mt -67.43 -33.11 74.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.092 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.608 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.6 -45.19 66.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.379 0.609 . . . . 0.0 109.53 173.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -70.44 -33.02 70.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.29 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 32.3 mt-10 -68.38 -25.6 65.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.812 0.339 . . . . 0.0 111.534 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.22 58.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 78.6 mtp180 -70.65 -10.69 59.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.193 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.34 -27.17 67.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.196 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -128.37 124.27 35.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.144 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -74.87 70.35 1.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.855 0.836 . . . . 0.0 110.277 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.892 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 3.3 ptp180 -113.46 155.37 25.44 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.725 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.6 pt -122.84 164.4 20.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.745 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -112.45 129.14 56.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.315 0.384 . . . . 0.0 110.204 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.586 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.7 m -124.08 132.91 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.192 0.52 . . . . 0.0 110.506 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -126.23 177.42 6.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.649 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.9 m 61.38 30.24 18.89 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.718 0.771 . . . . 0.0 109.792 -173.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.499 ' O ' ' HA2' ' A' ' 251' ' ' GLY . 30.8 t -85.42 115.48 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.432 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.695 ' HB3' HD23 ' A' ' 220' ' ' LEU . 23.3 t-80 -57.66 139.96 52.4 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.057 0.456 . . . . 0.0 110.661 -176.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.567 ' HB2' ' HD2' ' A' ' 248' ' ' LYS . 6.0 pt20 -46.38 -41.74 14.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ASP . . . . . 0.428 ' N ' ' HG3' ' A' ' 218' ' ' GLN . 0.7 OUTLIER -98.16 13.91 29.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -167.199 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 217' ' ' HIS . 3.6 mm? -86.72 121.89 29.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 25.0 m -78.11 171.61 14.77 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.609 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.49 -41.25 76.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.078 0.466 . . . . 0.0 110.101 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -69.49 -24.24 63.74 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.02 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 220' ' ' LEU . 7.6 m-20 -69.75 -45.64 67.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 110.258 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.729 HG22 HD11 ' A' ' 255' ' ' ILE . 14.5 mm -68.58 -38.08 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.419 ' HG3' HG21 ' A' ' 235' ' ' ILE . 85.3 tttt -60.53 -53.68 54.59 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.946 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 11.2 p -55.12 -38.63 68.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 224' ' ' ASP . 32.3 t -73.42 -46.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.541 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.653 ' HB2' HD11 ' A' ' 235' ' ' ILE . 17.3 m-85 -67.24 -29.99 69.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.39 0.614 . . . . 0.0 110.63 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.53 -24.15 63.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.902 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.53 -13.27 60.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.771 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -111.43 -30.92 7.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.799 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -157.34 166.8 33.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.974 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -80.18 110.69 15.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.509 0.671 . . . . 0.0 111.036 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.653 HD11 ' HB2' ' A' ' 229' ' ' PHE . 37.5 mt -83.17 151.21 4.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.604 -176.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.445 ' HG3' ' CG2' ' A' ' 297' ' ' THR . 29.2 ttpp -106.02 -34.94 7.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.448 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.4 p -173.37 156.24 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 255' ' ' ILE . 74.1 m -142.46 138.88 31.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.252 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 31.9 m -141.14 103.0 4.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.696 HD21 HG13 ' A' ' 225' ' ' ILE . 81.2 mt -83.94 149.53 26.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.705 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -84.85 104.37 14.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.756 0.313 . . . . 0.0 110.356 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.736 ' HG3' ' HB3' ' A' ' 249' ' ' HIS . 0.2 OUTLIER -97.53 152.67 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.53 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.612 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 8.8 m-20 -77.84 148.72 76.26 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.95 -8.13 13.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.972 2.448 . . . . 0.0 114.422 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -166.62 38.82 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.612 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 25.4 p -108.21 -16.45 14.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.347 -0.846 . . . . 0.0 112.02 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.4 77.17 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.696 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.567 ' HD2' ' HB2' ' A' ' 218' ' ' GLN . 46.4 pttt -168.22 -168.56 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.736 ' HB3' ' HG3' ' A' ' 242' ' ' ARG . 33.9 p80 -118.79 165.16 14.37 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.239 -177.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.409 ' HE2' ' OD2' ' A' ' 243' ' ' ASP . 77.4 mttt -64.76 -68.98 0.32 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.211 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 216' ' ' VAL . . . 170.5 24.91 0.02 OUTLIER Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.431 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -152.4 160.51 43.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.565 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.21 178.83 45.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.532 -176.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.599 ' HZ ' ' HG3' ' A' ' 164' ' ' GLU . 81.2 m-85 -131.92 153.05 50.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.774 0.321 . . . . 0.0 111.119 -176.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.729 HD11 HG22 ' A' ' 225' ' ' ILE . 84.1 mt -142.19 131.29 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.074 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.892 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 45.6 mt-10 -105.7 146.65 29.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 9.7 m-85 -110.77 160.61 16.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.723 0.297 . . . . 0.0 110.795 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.28 -23.77 51.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.372 0.606 . . . . 0.0 110.066 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -130.53 124.61 32.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.018 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.79 68.79 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.543 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 262' ' ' SER . 7.8 pt20 -59.6 -42.88 93.59 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.102 0.251 . . . . 0.0 111.03 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.434 ' N ' ' HG3' ' A' ' 261' ' ' GLN . 20.1 m -71.14 -32.83 69.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.826 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -43.06 97.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.017 0.437 . . . . 0.0 111.039 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -74.73 -23.12 58.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.49 -35.75 65.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.053 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.61 84.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.923 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.447 ' HA ' ' CG2' ' A' ' 282' ' ' VAL . 77.3 t -58.76 -27.01 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.225 0.535 . . . . 0.0 110.646 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.8 t -86.15 -30.6 22.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.9 m -93.95 -41.15 9.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.588 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 88.3 mmm -84.11 4.9 28.22 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -169.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.449 ' HA ' HG12 ' A' ' 282' ' ' VAL . 11.0 t30 -71.58 118.11 13.98 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.382 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 93.1 mt 66.83 34.13 5.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.601 -178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -88.33 122.85 32.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.438 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 16.3 t70 -73.28 119.24 17.25 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.727 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 44.8 tp -137.01 91.91 2.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.292 0.568 . . . . 0.0 110.111 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 96.65 22.77 17.6 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.464 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.91 -1.93 68.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.623 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -127.2 147.26 50.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.506 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 84.6 m-85 -89.39 116.1 27.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.217 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 69.6 mt -58.04 127.85 34.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.857 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 17.1 mmt180 -93.45 115.39 27.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 271' ' ' ASN . 13.9 p -115.82 135.98 54.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.178 0.513 . . . . 0.0 111.143 -173.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -154.94 -179.53 30.2 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.537 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 284' ' ' LYS . 39.3 mtpt -84.16 130.2 34.86 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.56 120.63 12.11 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.528 0.518 . . . . 0.0 109.821 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.68 -26.89 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -173.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.498 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 28.3 p -134.86 145.11 53.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.654 0.264 . . . . 0.0 110.783 177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.2 108.05 2.59 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.366 2.044 . . . . 0.0 112.199 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 287' ' ' THR . 25.0 Cg_exo -63.17 -38.72 43.16 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.845 2.363 . . . . 0.0 111.444 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.443 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 27.9 ttt -138.45 108.64 7.97 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.796 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 12.1 Cg_exo -71.57 -21.85 25.21 Favored 'Trans proline' 0 CA--C 1.526 0.124 0 C-N-CA 123.303 2.669 . . . . 0.0 113.227 -176.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 49.6 tp -116.11 88.58 2.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.991 0.424 . . . . 0.0 111.374 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.531 HD12 ' NH2' ' A' ' 210' ' ' ARG . 43.7 mt -110.74 139.15 46.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.952 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 1.8 t -59.13 109.99 2.33 Favored Pre-proline 0 C--O 1.237 0.408 0 O-C-N 123.868 0.73 . . . . 0.0 111.729 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 8.3 Cg_endo -87.67 111.33 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.665 2.91 . . . . 0.0 112.546 -176.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.72 -29.14 4.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.361 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' THR . . . . . 0.445 ' CG2' ' HG3' ' A' ' 236' ' ' LYS . 93.8 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.06 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.811 -0.515 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.449 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . . . -122.85 -52.39 1.89 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.668 0.271 . . . . 0.0 111.041 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.0 mtm -83.25 -40.83 19.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.986 0.422 . . . . 0.0 110.827 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.9 40.26 1.05 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.483 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.494 ' HG3' ' HB3' ' A' ' 105' ' ' GLN . 6.4 tp-100 -163.75 134.54 4.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.455 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -100.88 67.62 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.767 0.794 . . . . 0.0 109.121 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.518 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -95.3 -7.03 39.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.164 -168.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -65.54 -32.2 73.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.835 0.35 . . . . 0.0 111.283 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.22 -30.84 66.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.153 0.502 . . . . 0.0 110.438 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.704 HD21 HD13 ' A' ' 201' ' ' LEU . 56.9 mt -71.71 -33.08 68.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.325 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.9 73.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.265 0.555 . . . . 0.0 110.028 175.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.7 mt -73.31 -38.49 53.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.116 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.437 ' SD ' HG23 ' A' ' 198' ' ' ILE . 31.7 mtm -74.29 -2.22 24.11 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.541 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 73.8 m -82.68 -8.58 59.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.098 0.475 . . . . 0.0 110.018 175.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.931 ' HG2' ' HG2' ' A' ' 159' ' ' GLU . 58.3 mtt180 -113.33 141.87 46.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.15 -177.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.567 HG12 ' HB ' ' A' ' 158' ' ' VAL . 9.9 p -121.51 130.32 74.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.273 0.558 . . . . 0.0 109.749 171.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -83.64 114.91 21.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.079 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 21.4 m -112.24 121.23 64.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.616 0.722 . . . . 0.0 110.935 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.501 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -127.47 173.09 18.69 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.981 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 58.7 m 60.75 31.47 20.11 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.408 0.283 . . . . 0.0 111.176 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.561 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 71.1 mt -61.39 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.485 -176.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 119' ' ' ILE . 2.3 t80 164.6 149.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -174.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 5.0 p90 -88.26 73.14 8.94 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -176.84 -58.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.226 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.8 mt -58.84 99.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.273 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.32 171.32 54.76 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.032 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -57.05 -39.9 75.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.874 0.368 . . . . 0.0 110.656 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.35 -49.46 77.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.79 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.7 m -63.3 -44.18 95.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.087 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.418 HG13 ' HE1' ' A' ' 143' ' ' MET . 33.8 mm -60.74 -40.46 85.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.532 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -61.2 -38.67 87.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.337 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -70.88 -34.04 71.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.495 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.431 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -82.07 -29.02 32.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.231 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.512 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 46.3 m-85 -94.33 -14.86 24.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.829 0.347 . . . . 0.0 111.569 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.433 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.99 -41.97 88.3 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 55.1 Cg_exo -42.48 -35.72 4.04 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.016 2.477 . . . . 0.0 114.488 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.521 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 51.3 m-85 -82.49 -49.34 10.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 121.141 -0.223 . . . . 0.0 111.202 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.01 172.39 39.84 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.918 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.94 121.64 8.29 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.617 2.211 . . . . 0.0 111.705 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.2 mt -84.53 116.7 28.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.945 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -74.76 -43.75 53.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.917 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.3 t -161.96 152.78 17.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.358 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -130.45 126.12 60.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.63 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 13.3 t70 -96.28 99.77 11.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.418 ' HE1' HG13 ' A' ' 128' ' ' ILE . 46.9 ttm -136.21 126.88 27.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.204 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 11.2 m -69.44 99.87 1.3 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -110.7 136.4 49.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -174.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 150' ' ' MET . 7.6 t70 -107.97 141.27 39.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.686 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.2 m -115.21 -1.95 12.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.331 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.0 t -77.12 -50.86 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.136 0.493 . . . . 0.0 109.859 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.6 p -113.35 -15.64 12.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.21 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' A' ' 146' ' ' ASP . 60.8 mtm 70.98 14.09 6.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.841 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 59.0 mtmt -110.95 130.9 55.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 144' ' ' SER . 56.8 p-80 -127.13 140.0 52.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.064 0.459 . . . . 0.0 111.542 -169.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -110.53 117.34 33.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.809 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 153.85 -164.74 31.37 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.99 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.501 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 67.2 m-85 -125.12 177.81 5.89 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 142' ' ' ASP . . . -137.29 140.95 41.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.089 0.471 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -109.98 109.75 20.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.597 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.567 ' HB ' HG12 ' A' ' 114' ' ' VAL . 47.7 t -91.06 110.36 22.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.337 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.931 ' HG2' ' HG2' ' A' ' 113' ' ' ARG . 47.3 mt-10 -99.72 123.08 43.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.532 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.44 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 95.8 m-85 -100.98 171.67 7.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.033 0.444 . . . . 0.0 110.085 176.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -86.1 -5.36 59.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.271 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 5.2 m -142.23 143.98 29.59 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.191 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 12.6 Cg_exo -69.69 -26.54 27.82 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.384 2.723 . . . . 0.0 112.038 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.685 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 8.1 mp0 -55.73 -57.05 13.62 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.954 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -59.81 -19.73 52.51 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.85 -51.15 8.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -68.07 -31.55 71.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.757 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.521 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 18.2 tp -67.03 -46.47 74.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.673 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.81 -34.73 73.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.072 0.463 . . . . 0.0 110.168 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 185' ' ' VAL . 2.9 tp -67.6 -51.98 43.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.556 172.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -54.83 -34.44 62.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.745 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -100.56 -51.54 3.58 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.1 ttp -107.78 29.33 7.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -165.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 31.9 p-10 -78.72 25.21 0.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.911 0.386 . . . . 0.0 111.302 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.1 m -113.33 -72.91 0.68 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.867 0.365 . . . . 0.0 111.069 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 30.9 m -134.29 164.04 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.002 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.627 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.9 tpt -139.51 91.9 2.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.793 0.33 . . . . 0.0 110.734 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.544 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 94.6 mt 61.56 -177.79 0.12 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.429 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.69 -113.14 1.06 Allowed Glycine 0 C--N 1.337 0.587 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.185 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.6 45.84 0.59 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 119' ' ' ILE . 12.5 tpt180 -127.2 135.84 51.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.899 -173.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 4.1 p-10 -91.85 142.53 27.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.627 HD13 ' HB2' ' A' ' 177' ' ' MET . 42.8 pt -129.66 168.19 23.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.792 0.33 . . . . 0.0 110.568 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 55.5 tptt -109.25 106.01 15.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.772 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.501 ' O ' HD13 ' A' ' 170' ' ' LEU . 43.3 t -103.03 104.29 16.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.431 ' O ' ' HD3' ' A' ' 188' ' ' PRO . . . 94.74 125.8 4.53 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.1 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -105.15 101.62 31.56 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 186' ' ' GLY . 18.4 Cg_exo -66.94 -21.1 50.46 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.813 2.342 . . . . 0.0 112.056 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 42.8 m -79.64 46.27 0.75 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.39 0.614 . . . . 0.0 111.367 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -76.6 -66.47 0.81 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.216 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.3 mm 52.01 41.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.651 0.739 . . . . 0.0 111.217 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.27 -155.21 19.73 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.484 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.458 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 59.5 tt0 -73.98 -30.8 62.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.855 0.36 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.434 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -74.43 -23.2 58.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.203 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.695 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 23.1 tm0? -58.93 -52.92 71.38 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.497 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 54.2 Cg_exo -56.61 -35.17 96.97 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.286 1.99 . . . . 0.0 112.65 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.3 mt -67.99 -43.73 85.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 109.92 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.437 HG23 ' SD ' ' A' ' 111' ' ' MET . 84.9 mt -59.6 -48.71 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.052 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.25 -45.53 90.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.91 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -62.02 -53.03 61.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.704 HD13 HD21 ' A' ' 108' ' ' LEU . 30.8 mt -65.83 -33.11 75.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.262 -178.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.662 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.28 -42.84 70.48 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -71.44 -34.47 70.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.907 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 31.3 mt-10 -65.09 -36.51 84.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.67 -26.73 64.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.686 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.5 mtp180 -72.29 -14.12 61.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.59 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -88.39 0.8 55.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.351 0.596 . . . . 0.0 110.273 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -131.42 177.18 7.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.926 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 3.1 m-80 -118.95 43.35 2.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.13 -174.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 210' ' ' ARG . 36.7 ttt180 -99.8 137.24 38.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.98 -173.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.1 pt -133.08 166.57 29.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.559 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.625 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 84.6 t80 -120.81 131.89 54.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.363 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.443 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 33.6 m -125.91 137.42 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.156 0.503 . . . . 0.0 110.677 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -133.29 -178.55 5.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.715 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 28.2 t 62.73 26.58 15.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.756 0.789 . . . . 0.0 109.444 -171.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.452 HG13 HD11 ' A' ' 225' ' ' ILE . 9.4 t -79.68 115.86 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.093 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -60.88 145.5 49.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.551 -171.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -48.42 -54.54 13.7 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -85.68 36.91 0.67 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.992 0.425 . . . . 0.0 111.537 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 220' ' ' LEU . 9.1 tp -121.01 118.01 28.74 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 19.7 m -99.3 177.45 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.388 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -64.42 -26.75 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 110.412 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.46 -40.25 92.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.348 0.594 . . . . 0.0 109.909 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.64 -50.0 68.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.799 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.624 HG22 HD11 ' A' ' 255' ' ' ILE . 26.0 mm -68.17 -44.81 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.435 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 64.0 tttm -57.61 -46.56 83.93 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.44 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.2 t -52.76 -48.47 66.75 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.68 -43.32 61.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.343 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.579 ' CB ' HD11 ' A' ' 235' ' ' ILE . 11.2 m-85 -67.39 -30.01 69.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.232 0.539 . . . . 0.0 110.744 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.565 ' OE1' ' HB ' ' A' ' 235' ' ' ILE . 9.0 tp10 -63.16 -24.45 67.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.843 177.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.56 -11.63 59.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.874 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -111.2 -40.2 4.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.515 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -142.81 166.51 26.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.767 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -77.97 106.84 10.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.078 0.466 . . . . 0.0 110.521 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.579 HD11 ' CB ' ' A' ' 229' ' ' PHE . 21.5 mt -83.29 148.37 5.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.636 0.731 . . . . 0.0 111.579 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -106.9 -36.15 6.72 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.097 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.1 m -154.7 146.5 23.4 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -171.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 49.7 t -141.83 119.45 11.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.6 m -140.48 103.13 4.48 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.301 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.617 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 48.1 mt -75.96 129.23 36.59 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.47 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.21 116.5 6.64 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.475 0.485 . . . . 0.0 110.195 -175.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 31.0 ttp180 -136.43 142.21 43.63 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.783 -174.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.496 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 9.2 m-20 -75.97 115.18 44.21 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.69 -27.33 25.92 Favored 'Trans proline' 0 CA--C 1.527 0.175 0 C-N-CA 123.679 2.919 . . . . 0.0 114.138 -171.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 t -97.44 -14.21 21.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 71.0 p -92.37 -39.32 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.843 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.77 -0.47 70.14 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.3 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 62.6 pttt -117.56 138.18 52.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -82.63 144.55 30.22 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 252' ' ' TYR . 23.8 mtpp -78.29 10.96 2.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -167.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.64 38.43 Favored Glycine 0 CA--C 1.508 -0.388 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.264 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 250' ' ' LYS . 28.9 p90 -142.15 177.78 8.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.687 0.28 . . . . 0.0 110.488 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -167.63 174.41 42.68 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.158 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.685 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 86.1 m-85 -126.38 149.67 49.08 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.624 HD11 HG22 ' A' ' 225' ' ' ILE . 74.9 mt -140.29 142.73 30.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.454 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 51.0 mt-10 -117.75 147.52 42.9 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.551 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 11.6 m-85 -114.38 171.0 7.89 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 171.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -86.99 -9.75 54.85 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.46 0.648 . . . . 0.0 109.569 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -136.12 122.63 20.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.273 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.71 72.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.141 0.496 . . . . 0.0 111.079 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -63.44 -36.47 83.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.882 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.5 m -71.64 -40.82 69.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.33 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 43.1 p -67.17 -36.79 82.55 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -67.68 -30.86 70.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.3 -35.49 76.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.115 0.483 . . . . 0.0 110.256 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.24 85.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.086 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.441 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 95.7 t -58.25 -34.12 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 121.443 0.639 . . . . 0.0 110.126 173.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 43.1 t -73.06 -44.59 60.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.362 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.8 m -90.37 -35.36 15.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.45 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 82.7 mmm -87.17 -7.79 57.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -170.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -73.24 122.09 21.39 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.165 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 97.4 mt 64.25 31.27 13.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.437 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -86.59 133.85 33.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.022 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -80.09 105.6 11.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.951 0.405 . . . . 0.0 110.607 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 56.1 tp -126.11 95.65 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.244 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.12 21.99 47.07 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.502 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 90.05 9.26 65.89 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.607 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -129.92 155.3 46.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.57 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 73.5 m-85 -100.39 109.35 21.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 74.9 mt -59.55 133.95 56.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.639 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.414 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 14.8 mmt180 -99.58 116.18 31.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 267' ' ' VAL . 12.4 p -123.68 144.41 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.65 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.45 173.06 38.68 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.691 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -71.95 128.1 34.66 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.23 113.25 6.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.25 -24.14 23.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.867 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 50.2 p -100.67 133.09 21.43 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.983 0.42 . . . . 0.0 110.403 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.01 143.71 73.34 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.594 2.196 . . . . 0.0 111.603 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.76 93.94 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.6 2.2 . . . . 0.0 111.926 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 65.1 mtt -78.13 121.98 84.69 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.205 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.39 101.88 1.41 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.486 2.124 . . . . 0.0 111.529 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.34 20.83 3.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.283 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 92.9 mt 72.85 124.47 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.227 0.955 . . . . 0.0 112.105 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 1.3 p -98.54 103.8 20.59 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.302 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.82 122.36 8.11 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.09 2.527 . . . . 0.0 112.443 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -110.76 133.45 53.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.488 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 62.8 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.422 -177.936 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 112.366 -0.293 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.91 41.59 2.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.079 0.466 . . . . 0.0 110.128 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.648 ' HB3' HH21 ' A' ' 106' ' ' ARG . 2.0 tmt? -75.78 82.7 2.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.718 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.628 ' O ' ' HG3' ' A' ' 106' ' ' ARG . . . 49.92 48.19 22.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.294 174.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -36.16 79.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.426 -175.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -81.65 -17.41 48.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 110.951 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.563 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 62.5 tt0 -91.06 -21.93 21.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.236 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.648 HH21 ' HB3' ' A' ' 101' ' ' MET . 82.6 mtt180 -59.28 -48.85 80.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.474 ' HB2' HD12 ' A' ' 197' ' ' ILE . . . -69.75 -22.8 63.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.489 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.91 -32.12 73.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.092 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.71 -28.37 68.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.341 0.591 . . . . 0.0 110.401 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.0 mt -87.91 -40.44 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.343 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.539 ' SD ' HG12 ' A' ' 198' ' ' ILE . 92.2 mtp -69.08 -29.9 68.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.018 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 92.9 m -73.94 -12.02 60.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.593 0.235 . . . . 0.0 111.01 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 159' ' ' GLU . 47.1 mtt180 -106.51 141.39 37.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.08 0.467 . . . . 0.0 110.894 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.54 122.43 69.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.461 0.648 . . . . 0.0 109.407 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -74.86 119.88 19.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.108 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 15.3 m -114.22 114.74 47.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.405 0.621 . . . . 0.0 109.959 175.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.06 171.36 13.78 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.249 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.9 m 58.67 35.08 24.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 111.102 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.544 HD11 HG23 ' A' ' 116' ' ' VAL . 58.3 mt -68.99 126.36 28.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.213 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.62 140.28 58.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.165 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.657 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 0.0 OUTLIER -72.37 77.3 1.02 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 122.133 0.968 . . . . 0.0 111.19 -179.249 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -170.93 -26.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.732 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.401 HD22 HD12 ' A' ' 178' ' ' LEU . 40.1 mt -93.4 110.02 21.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.253 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.26 -174.99 45.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.962 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.65 -40.55 97.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 110.117 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.545 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 36.0 t70 -62.89 -48.77 77.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.688 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -61.12 -43.65 98.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.177 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.1 mm -63.66 -43.18 98.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -57.91 -41.37 82.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.486 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 97.8 mt-30 -60.29 -46.31 90.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.495 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.583 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -80.87 -26.98 36.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -171.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.527 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 32.1 m-85 -90.17 -16.4 29.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.705 0.288 . . . . 0.0 111.542 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.621 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -56.9 -42.48 96.57 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 6.9 Cg_endo -51.31 -27.92 25.09 Favored 'Trans proline' 0 C--N 1.361 1.184 0 C-N-CA 122.507 2.138 . . . . 0.0 114.197 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.752 ' HD2' ' HG ' ' A' ' 168' ' ' LEU . 64.6 m-85 -80.99 -46.04 15.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.635 0.255 . . . . 0.0 110.988 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.31 -178.53 39.09 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.476 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 62.3 Cg_endo -75.43 117.45 4.82 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.559 2.173 . . . . 0.0 111.65 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.8 mt -83.49 114.24 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.897 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.616 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 74.3 tttt -88.38 -33.17 18.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.78 -173.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.7 t -157.94 147.91 20.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.389 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.9 mt -133.67 113.24 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -96.63 100.02 11.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.514 ' HG3' ' HB2' ' A' ' 156' ' ' ALA . 52.4 ttm -126.92 137.85 53.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.6 m -93.42 123.56 36.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.633 ' HD1' ' HD2' ' A' ' 152' ' ' HIS . 22.2 t90 -113.85 130.02 56.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.54 74.28 3.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.666 -176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.573 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 69.0 m -60.49 -23.57 64.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.877 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.512 HG23 HG23 ' A' ' 149' ' ' THR . 28.0 m -74.54 -25.08 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.706 -178.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.512 HG23 HG23 ' A' ' 148' ' ' VAL . 34.4 p -125.73 3.36 7.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.991 0.424 . . . . 0.0 111.426 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.464 ' HA ' ' CH2' ' A' ' 145' ' ' TRP . 48.3 mtm 56.3 42.1 28.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.359 -177.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -127.21 176.51 7.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.557 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.657 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 63.8 t-80 -135.98 82.41 1.94 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.851 0.357 . . . . 0.0 110.795 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.467 ' HG2' ' N ' ' A' ' 154' ' ' GLY . 67.1 tttt -109.78 151.65 26.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.467 ' N ' ' HG2' ' A' ' 153' ' ' LYS . . . 112.97 -135.53 12.73 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.332 172.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -140.04 177.93 7.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.172 0.511 . . . . 0.0 111.642 -171.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.514 ' HB2' ' HG3' ' A' ' 143' ' ' MET . . . -152.08 154.5 36.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.377 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -111.93 109.85 19.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.185 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 62.1 t -91.91 112.16 25.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.756 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.47 ' HA ' ' HG2' ' A' ' 113' ' ' ARG . 39.0 tt0 -100.08 120.49 39.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.972 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -98.23 170.0 9.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.685 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.616 ' HG2' ' HD2' ' A' ' 139' ' ' LYS . 35.6 mt-10 -80.34 -38.67 30.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 171.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.2 m -109.64 135.81 20.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.365 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 56.2 Cg_endo -69.44 -21.15 35.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.127 2.551 . . . . 0.0 112.597 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.696 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 10.7 mp0 -57.59 -50.65 72.41 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.129 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.407 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.04 -21.76 65.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.46 -51.72 8.99 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.022 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 164' ' ' GLU . 5.0 pp0? -63.85 -30.23 71.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.556 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.752 ' HG ' ' HD2' ' A' ' 135' ' ' PHE . 14.2 tp -73.79 -45.83 49.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.6 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.4 72.17 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.531 ' O ' ' HB3' ' A' ' 174' ' ' ASN . 6.8 tt -66.44 -50.0 64.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.27 172.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 10.6 mm-40 -52.72 -50.87 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.554 -178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -89.72 -32.98 16.76 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 22.8 mtm -106.71 30.79 5.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.479 . . . . 0.0 111.744 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 33.4 p-10 -74.92 -3.59 33.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.412 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.6 m -95.13 -73.38 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 110.841 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.9 m -140.69 164.73 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.082 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.635 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.4 tpt -124.43 95.03 4.38 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.549 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.401 HD12 HD22 ' A' ' 123' ' ' LEU . 91.7 mt 71.95 -50.53 0.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.971 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 161.1 -177.29 37.52 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.638 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 94.72 -87.78 1.1 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.604 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -127.55 142.54 51.35 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -70.68 108.4 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.635 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.3 pt -72.47 156.35 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.776 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 83.2 tttt -106.2 116.77 32.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.258 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 116' ' ' VAL . 5.4 m -100.27 114.39 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 172.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 147.02 129.73 2.0 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.478 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.577 ' H ' ' HD2' ' A' ' 188' ' ' PRO . 26.7 tpt180 -104.58 -48.19 0.14 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 187' ' ' ARG . 59.2 Cg_endo -72.49 59.32 3.24 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.838 1.692 . . . . 0.0 113.106 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 m -78.77 -52.07 8.89 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -85.93 161.33 19.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.364 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.5 tp -61.21 115.44 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.36 0.6 . . . . 0.0 111.704 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -120.66 157.7 15.79 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.826 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -68.29 -7.95 35.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.428 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -78.04 -22.2 49.53 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.545 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 71.9 mm-40 -52.32 -54.02 46.4 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -175.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 53.2 Cg_exo -56.21 -34.54 93.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.021 1.814 . . . . 0.0 112.684 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 107' ' ' ALA . 51.3 mt -75.98 -45.98 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.327 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.539 HG12 ' SD ' ' A' ' 111' ' ' MET . 69.1 mt -60.85 -43.34 95.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.292 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.08 -38.73 89.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.857 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -61.63 -52.47 64.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.855 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.532 HD13 HG22 ' A' ' 287' ' ' THR . 25.5 mt -67.54 -32.69 73.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.608 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.671 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.63 -47.84 66.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 171.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.515 ' OE1' ' HD3' ' A' ' 206' ' ' ARG . 5.8 mm-40 -63.24 -35.24 79.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.213 175.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.663 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 47.6 mt-10 -66.41 -33.45 75.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -77.64 -29.28 51.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.969 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.671 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 59.4 mtp180 -72.62 -25.35 61.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 110.408 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.65 -39.93 18.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.342 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -105.57 79.53 1.46 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 0.0 OUTLIER -52.4 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.427 1.079 . . . . 0.0 111.403 -173.198 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.471 ' HB2' ' HG3' ' A' ' 256' ' ' GLU . 44.8 ttm105 -134.09 146.12 50.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.995 0.426 . . . . 0.0 111.59 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.613 HG23 ' HB2' ' A' ' 263' ' ' SER . 49.3 pt -123.78 166.46 18.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.17 174.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.487 ' CG ' ' HB3' ' A' ' 164' ' ' GLU . 85.4 t80 -118.14 129.51 55.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.46 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 29.3 m -121.1 128.56 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.335 0.588 . . . . 0.0 110.237 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -119.57 176.2 5.48 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.464 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.4 m 60.26 32.59 20.83 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.415 0.626 . . . . 0.0 109.972 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.49 114.67 20.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.353 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 32.4 t-80 -55.57 137.65 48.44 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.456 0.472 . . . . 0.0 111.744 -172.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -49.99 -52.37 34.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -82.23 20.38 1.05 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.91 0.386 . . . . 0.0 111.722 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.654 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.0 tp -105.41 126.53 52.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.0 m -90.85 163.96 14.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.832 0.349 . . . . 0.0 111.746 -173.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.452 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 6.0 p-10 -65.11 -27.29 68.65 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.27 0.557 . . . . 0.0 110.313 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.34 -31.61 71.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.751 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -74.33 -39.85 62.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.694 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.795 HG13 HD21 ' A' ' 240' ' ' LEU . 24.8 mm -65.74 -46.7 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -58.61 -51.56 69.41 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.955 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.4 p -58.94 -38.92 80.11 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 51.1 t -76.53 -41.99 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.196 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.543 ' CB ' HD11 ' A' ' 235' ' ' ILE . 25.0 m-85 -65.43 -28.67 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.217 -0.302 . . . . 0.0 110.736 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.18 -25.02 67.54 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.522 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.88 -17.49 55.51 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.064 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -111.52 -31.36 7.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.924 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.542 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -146.93 160.25 28.21 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.377 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 234' ' ' LYS . 0.7 OUTLIER -84.71 107.63 17.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.492 0.663 . . . . 0.0 110.993 -177.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.543 HD11 ' CB ' ' A' ' 229' ' ' PHE . 37.3 mt -86.03 151.4 3.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.928 -173.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -106.23 -27.49 11.01 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.921 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 235' ' ' ILE . 3.0 p -176.87 152.1 0.92 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.575 0.226 . . . . 0.0 110.677 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 36.5 t -137.59 129.5 28.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.282 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.1 t -141.05 104.16 4.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.411 0.624 . . . . 0.0 111.599 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.795 HD21 HG13 ' A' ' 225' ' ' ILE . 30.9 mt -75.95 133.57 40.43 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.433 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.44 114.35 4.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.162 0.506 . . . . 0.0 110.257 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.585 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 13.7 mtp180 -112.21 164.89 12.68 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.438 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.28 141.4 57.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -43.75 -45.04 11.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.518 2.812 . . . . 0.0 113.905 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.9 t -155.61 86.21 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.722 0.773 . . . . 0.0 111.21 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 20.3 p -135.28 -42.84 0.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.728 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 121.92 -24.04 7.19 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.463 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -107.65 166.5 10.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.969 0.414 . . . . 0.0 110.471 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 9.7 p80 -96.63 165.35 12.19 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -73.39 -82.15 0.06 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.402 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -167.4 7.52 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.615 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.421 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 28.7 p90 -150.49 175.76 11.57 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -165.16 174.98 41.09 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.44 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.696 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 78.8 m-85 -129.54 150.95 50.66 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 225' ' ' ILE . 81.9 mt -142.49 133.04 23.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.473 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 4.8 mp0 -106.51 146.97 29.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.648 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 8.8 m-85 -118.68 165.15 14.33 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.83 -37.57 86.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.755 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -118.22 140.12 50.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.434 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.76 -25.73 68.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.224 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -74.21 -43.45 57.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.234 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.6 m -66.32 -33.0 74.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.982 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.648 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 79.9 p -66.29 -37.82 86.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -71.39 -27.94 63.67 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.473 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.44 -44.08 92.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.077 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.05 92.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.386 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.65 -40.31 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.573 . . . . 0.0 110.665 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 20.7 m -70.35 -30.98 68.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.533 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.0 m -94.37 -42.99 8.6 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.477 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.3 mmm -82.66 6.45 17.81 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -169.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.483 ' HA ' HG12 ' A' ' 282' ' ' VAL . 65.2 t30 -72.13 120.57 17.92 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.277 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 93.4 mt 64.21 31.25 13.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.418 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -78.91 128.93 33.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.386 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.422 ' HB2' ' HE1' ' A' ' 279' ' ' TYR . 36.6 t70 -74.47 102.92 4.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.654 ' HG ' HD21 ' A' ' 220' ' ' LEU . 34.2 tp -136.8 109.93 7.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.752 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.07 56.69 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.408 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 83.11 4.46 89.83 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.654 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -130.47 156.15 45.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.435 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 45.7 m-85 -97.18 111.76 23.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.506 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 45.6 mt -59.68 127.17 30.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.5 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 30.6 mmt180 -92.71 114.37 26.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 171.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 271' ' ' ASN . 11.0 p -118.5 151.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.487 -171.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -169.58 174.86 43.9 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -72.68 141.96 48.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.404 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -82.36 129.35 34.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.418 ' CG1' ' HG2' ' A' ' 167' ' ' GLN . 19.9 m -92.05 -23.05 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.723 0.297 . . . . 0.0 110.739 -175.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.532 HG22 HD13 ' A' ' 201' ' ' LEU . 38.0 p -128.81 156.5 77.63 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 121.136 0.493 . . . . 0.0 111.373 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.663 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 66.4 Cg_endo -97.05 103.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 123.252 2.635 . . . . 0.0 112.662 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.495 ' HD2' ' HA ' ' A' ' 288' ' ' PRO . 27.5 Cg_endo -64.4 135.07 44.5 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.273 1.982 . . . . 0.0 111.186 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 26.4 mmt -83.67 119.15 73.24 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.916 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 97.07 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.64 2.226 . . . . 0.0 111.975 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 292' ' ' LEU . 2.5 pt? -65.8 -26.87 67.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.053 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 89.7 mt -137.12 119.02 15.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.617 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 3.0 p -82.75 141.69 44.73 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.613 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 12.1 Cg_exo -70.32 97.53 0.69 Allowed 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.646 2.231 . . . . 0.0 111.111 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 62.4 -161.73 0.29 Allowed 'General case' 0 C--O 1.234 0.262 0 O-C-N 123.73 0.644 . . . . 0.0 110.724 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.752 179.263 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 55.38 55.46 7.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.266 0.555 . . . . 0.0 111.3 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.3 tpt -136.31 74.43 1.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -103.73 -171.75 1.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.891 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 59.12 40.33 22.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -92.14 -1.16 57.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.203 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -75.53 3.65 9.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.424 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -57.12 -42.47 80.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.08 0.467 . . . . 0.0 110.991 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.63 -31.4 65.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.769 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 201' ' ' LEU . 45.7 mt -70.7 -32.93 70.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.14 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.36 -33.86 73.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.347 0.594 . . . . 0.0 109.801 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.4 mt -75.71 -37.07 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.381 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.562 ' CG ' HD12 ' A' ' 198' ' ' ILE . 86.6 mtp -69.26 -20.78 63.93 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.021 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 82.1 m -74.5 -11.72 60.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -99.5 142.38 31.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.805 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.6 p -123.52 122.74 65.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 89.5 t80 -65.56 126.62 28.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.741 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.99 115.41 48.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -124.3 163.2 18.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.139 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.0 m 60.76 47.12 8.27 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 122.661 0.385 . . . . 0.0 111.233 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.496 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 49.2 mt -74.05 -28.28 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.353 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 35.7 t80 72.43 135.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.619 0.575 . . . . 0.0 109.528 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -77.16 77.22 3.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.193 0.997 . . . . 0.0 111.047 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -151.67 -49.45 0.11 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.566 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.459 HD22 HD12 ' A' ' 178' ' ' LEU . 57.0 mt -68.04 137.64 55.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.59 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -98.72 173.67 27.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.409 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.82 -51.25 70.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 110.88 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.98 -27.83 63.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.876 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -64.55 -43.53 93.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.188 0.518 . . . . 0.0 109.762 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.556 HG13 ' HE1' ' A' ' 143' ' ' MET . 36.5 mm -64.44 -41.35 92.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.151 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 129' ' ' ARG . 20.7 ttt180 -55.73 -49.18 73.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.777 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.87 -33.29 73.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.759 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.611 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -83.17 -35.51 25.45 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.23 -17.2 33.14 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.55 96.38 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -44.35 -36.2 9.15 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.714 2.276 . . . . 0.0 114.277 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 169' ' ' ALA . 60.7 m-85 -77.9 -39.01 44.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.666 0.269 . . . . 0.0 110.717 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . -173.8 167.6 40.2 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.738 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.46 114.52 2.56 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.578 2.186 . . . . 0.0 111.865 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.577 HD13 HD11 ' A' ' 141' ' ' ILE . 65.2 mt -74.05 130.71 35.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.635 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 139' ' ' LYS . 36.8 ttpt -93.06 -33.99 13.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.393 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 t -174.05 128.38 0.38 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.949 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.577 HD11 HD13 ' A' ' 138' ' ' ILE . 68.9 mt -104.42 119.12 52.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -88.23 100.67 13.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.556 ' HE1' HG13 ' A' ' 128' ' ' ILE . 43.7 ttm -143.41 101.28 3.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.93 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.732 ' HB2' ' HE2' ' A' ' 153' ' ' LYS . 18.4 m -74.59 104.68 5.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.841 0.353 . . . . 0.0 110.924 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -76.79 111.88 12.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.108 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.862 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 25.3 m-20 -76.81 83.02 3.4 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.4 m -52.09 -34.6 44.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.9 m -63.17 -27.59 43.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -130.09 12.07 5.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 111.515 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 47.1 mtm 55.83 32.4 19.52 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.656 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.862 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 91.9 mttt -89.21 175.6 7.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.082 0.468 . . . . 0.0 109.925 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.402 ' HB2' ' HG2' ' A' ' 143' ' ' MET . 22.6 p80 -153.03 46.11 0.68 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 170.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.732 ' HE2' ' HB2' ' A' ' 144' ' ' SER . 64.6 mmtt 65.45 -71.95 0.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.03 -174.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.34 -25.2 1.55 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -123.99 165.2 17.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.748 -0.726 . . . . 0.0 109.401 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.93 169.33 24.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.316 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.467 ' CE2' ' HD1' ' A' ' 115' ' ' TYR . 95.6 m-85 -124.18 112.82 17.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.164 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.1 t -91.85 108.5 20.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -105.06 118.99 37.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.11 0.481 . . . . 0.0 110.036 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -88.66 -176.11 5.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.966 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -83.35 -35.52 25.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.4 m -117.41 140.91 27.94 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.405 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 51.0 Cg_endo -66.84 -19.7 52.54 Favored 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 123.52 2.814 . . . . 0.0 112.609 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.654 ' HG3' ' CE1' ' A' ' 254' ' ' PHE . 80.6 mm-40 -58.33 -55.04 40.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.752 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.68 -21.03 62.4 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.984 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.92 -48.68 15.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.692 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.472 ' HG3' HG11 ' A' ' 286' ' ' VAL . 30.5 mm-40 -69.19 -33.18 72.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.503 174.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.509 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 13.7 tp -65.65 -47.07 76.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.656 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . . . -59.79 -37.71 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.08 0.467 . . . . 0.0 110.13 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.588 ' HG ' HG23 ' A' ' 185' ' ' VAL . 6.8 tt -65.38 -43.52 90.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.806 174.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.34 -34.44 76.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.99 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -100.61 -47.25 4.92 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.7 ttp -102.91 31.04 4.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.363 0.602 . . . . 0.0 111.708 -166.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 4.8 p-10 -74.68 16.66 0.26 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.551 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.4 m -106.35 -74.01 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.675 0.274 . . . . 0.0 111.47 -175.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 18.6 m -144.34 169.56 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.744 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.9 tpt -129.62 101.1 5.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 110.673 177.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.742 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 94.6 mt 63.66 32.45 13.82 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.016 173.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.63 -31.63 1.92 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.087 -0.578 . . . . 0.0 114.32 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.75 -64.71 3.99 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.647 -0.311 . . . . 0.0 113.293 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -144.41 150.91 38.49 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.563 -0.375 . . . . 0.0 110.679 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 8.4 p30 -72.44 118.8 15.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 177' ' ' MET . 43.6 pt -96.46 157.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.497 -174.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -105.14 110.99 23.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.408 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.588 HG23 ' HG ' ' A' ' 170' ' ' LEU . 9.7 m -99.76 122.82 52.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.067 0.461 . . . . 0.0 109.922 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 87.05 143.8 8.19 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.955 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -142.43 73.09 20.96 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.0 57.23 6.4 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.175 2.583 . . . . 0.0 113.31 -171.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.8 t -154.88 -54.19 0.09 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -69.79 109.86 4.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.569 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 34.4 mm 61.64 69.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.464 0.65 . . . . 0.0 110.886 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -103.73 47.4 1.1 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -61.93 -37.59 85.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.058 0.456 . . . . 0.0 111.365 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.472 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -97.52 11.81 35.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.777 -175.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.567 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 25.2 tm0? -53.57 -47.16 97.42 Favored Pre-proline 0 N--CA 1.47 0.551 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 6.9 Cg_endo -52.76 -36.19 72.21 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.355 2.036 . . . . 0.0 112.884 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 78.2 mt -74.18 -38.58 48.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.19 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.562 HD12 ' CG ' ' A' ' 111' ' ' MET . 12.7 mm -57.66 -50.19 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.179 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 30.5 t70 -69.98 -32.56 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.854 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.37 -50.64 72.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.03 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.458 HD13 HD21 ' A' ' 108' ' ' LEU . 44.6 mt -68.86 -33.47 73.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.645 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -55.54 -42.55 74.77 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 52.3 mt-10 -63.26 -33.73 76.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.732 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.72 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 26.4 mt-10 -65.37 -36.23 83.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.915 0.388 . . . . 0.0 110.84 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.5 -39.13 62.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.705 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.572 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 60.0 mtp180 -61.02 -22.3 64.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.485 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.96 -27.36 65.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.039 0.447 . . . . 0.0 110.71 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -105.8 169.73 8.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.224 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 0.9 OUTLIER -103.75 51.27 0.79 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.471 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 39.3 ttm180 -105.18 139.13 40.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.023 -167.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.457 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.4 pt -127.97 166.22 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.879 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.481 ' HE1' ' HB2' ' A' ' 252' ' ' TYR . 25.0 t80 -118.24 135.81 54.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.019 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.507 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.5 m -130.01 136.45 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 110.991 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -131.3 -179.17 5.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.553 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 69.6 m 62.44 27.37 16.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.869 0.842 . . . . 0.0 109.72 -171.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.496 HG13 HD11 ' A' ' 225' ' ' ILE . 21.7 t -79.22 116.56 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.538 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -56.0 140.7 42.46 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.253 0.549 . . . . 0.0 111.476 -174.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -58.52 -29.31 66.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.972 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.45 6.14 42.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.868 0.842 . . . . 0.0 110.067 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.566 HD21 ' HG ' ' A' ' 275' ' ' LEU . 7.3 tp -112.59 122.77 48.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.079 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.4 t -107.25 -178.69 3.71 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.074 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -60.63 -37.52 81.73 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.99 -24.62 64.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 0.0 110.452 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -72.6 -52.74 14.2 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.865 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.496 HD11 HG13 ' A' ' 216' ' ' VAL . 31.4 mm -61.76 -42.04 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.063 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 85.5 tttt -56.31 -50.23 72.02 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.708 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 m -56.09 -37.78 69.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 20.8 t -76.65 -44.28 33.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.574 ' HB2' HD11 ' A' ' 235' ' ' ILE . 7.4 m-85 -67.94 -31.34 71.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.591 0.71 . . . . 0.0 110.522 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -60.62 -24.46 65.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.94 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.29 -15.45 62.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.922 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.49 -33.76 6.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.348 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -152.03 163.7 30.21 Favored Glycine 0 CA--C 1.517 0.159 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.704 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.93 110.62 6.55 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.147 0.498 . . . . 0.0 111.581 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 229' ' ' PHE . 23.3 mt -88.33 150.44 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.017 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -106.16 -31.9 8.47 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.191 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 20.4 p -166.45 156.46 11.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.012 0.434 . . . . 0.0 111.423 -172.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 9.2 p -141.15 124.52 16.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.831 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.0 t -141.49 115.07 8.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.255 0.55 . . . . 0.0 110.973 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.503 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 28.9 mt -91.99 137.13 32.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.43 98.47 0.85 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.978 0.418 . . . . 0.0 110.08 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.655 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 25.5 ttt180 -104.68 131.69 51.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.523 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.555 ' HB2' ' HD2' ' A' ' 250' ' ' LYS . 4.7 t70 -97.28 126.52 41.58 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.317 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 10.5 Cg_exo -69.54 -20.45 35.85 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.457 2.772 . . . . 0.0 113.799 -173.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 43.3 p -87.24 -30.31 21.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.883 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.408 HG23 ' HG2' ' A' ' 248' ' ' LYS . 8.8 t -97.04 -22.84 16.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.295 0.569 . . . . 0.0 110.301 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 77.12 25.67 63.57 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.423 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.513 ' C ' ' HG3' ' A' ' 242' ' ' ARG . 64.2 pttt -142.72 154.65 44.48 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.6 OUTLIER -76.3 131.42 39.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.555 ' HD2' ' HB2' ' A' ' 243' ' ' ASP . 50.0 mtpt -74.55 3.41 7.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -164.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 102.5 2.67 50.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.368 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.481 ' HB2' ' HE1' ' A' ' 212' ' ' TYR . 32.9 p90 -141.88 165.21 28.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -169.25 178.46 42.41 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.021 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.654 ' CE1' ' HG3' ' A' ' 164' ' ' GLU . 88.2 m-85 -129.78 148.85 51.7 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.018 0.437 . . . . 0.0 110.594 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 225' ' ' ILE . 95.2 mt -136.08 133.21 50.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.255 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 49.0 mt-10 -113.21 135.14 54.15 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 6.2 m-85 -95.4 179.61 5.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -82.3 -17.97 43.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.467 0.651 . . . . 0.0 109.378 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -129.32 130.14 45.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.535 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 209' ' ' ASN . . . -68.87 -25.01 64.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.164 0.507 . . . . 0.0 111.232 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -75.09 -42.06 57.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.244 176.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.5 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 19.9 m -67.76 -29.44 68.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.733 -175.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.457 ' HB2' HG23 ' A' ' 211' ' ' ILE . 48.3 p -69.05 -32.58 72.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.195 0.521 . . . . 0.0 109.687 177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -74.67 -25.89 59.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.469 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 61.1 m-20 -64.02 -41.12 97.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.262 0.553 . . . . 0.0 109.836 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -61.96 -41.27 97.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.409 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.2 -40.13 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.187 0.517 . . . . 0.0 110.71 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 48.0 t -69.31 -30.9 69.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.5 m -94.53 -43.87 8.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 78.5 mmm -84.48 1.73 44.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.914 -169.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.51 ' HA ' HG12 ' A' ' 282' ' ' VAL . 45.7 t30 -69.45 117.07 10.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.603 0.24 . . . . 0.0 110.423 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 91.6 mt 63.68 36.78 10.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.38 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -90.25 124.55 34.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.254 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.474 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 18.2 t70 -74.81 108.96 7.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.65 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.566 ' HG ' HD21 ' A' ' 220' ' ' LEU . 46.3 tp -141.31 106.77 5.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.969 0.414 . . . . 0.0 109.997 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 94.08 24.64 19.11 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.552 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 78.52 11.85 84.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.654 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -142.68 150.47 40.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.682 0.277 . . . . 0.0 110.432 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 83.0 m-85 -87.16 114.18 23.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.392 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.4 131.68 51.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.636 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 213' ' ' VAL . 16.8 mmt180 -96.39 116.44 29.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 271' ' ' ASN . 9.4 p -120.66 144.68 28.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.617 -175.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.15 174.22 38.56 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.615 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -75.76 126.28 30.7 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.77 126.22 27.79 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.433 0.458 . . . . 0.0 109.862 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.472 HG11 ' HG3' ' A' ' 167' ' ' GLN . 34.4 m -94.29 -26.75 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -172.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.45 HG21 ' CD2' ' A' ' 108' ' ' LEU . 19.0 p -132.51 156.23 80.33 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.018 0.437 . . . . 0.0 111.687 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.72 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 86.6 Cg_endo -92.9 103.4 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.898 2.399 . . . . 0.0 112.572 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 287' ' ' THR . 74.3 Cg_endo -78.3 149.76 25.05 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.2 1.933 . . . . 0.0 111.159 175.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.755 ' HG3' ' HG ' ' A' ' 292' ' ' LEU . 46.9 tpp -91.62 108.4 29.12 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.39 55.19 5.32 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.844 2.363 . . . . 0.0 113.302 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.755 ' HG ' ' HG3' ' A' ' 290' ' ' MET . 96.4 mt -78.97 -74.59 0.27 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 93.2 mt 54.17 51.3 14.73 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.346 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 26.2 m -90.77 112.89 55.82 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.886 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.62 145.34 91.41 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.029 2.486 . . . . 0.0 112.108 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -93.11 58.88 3.0 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.246 0.546 . . . . 0.0 110.782 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.564 178.508 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.67 61.44 4.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.136 0.493 . . . . 0.0 110.346 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.3 mtm -112.29 83.17 1.76 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.033 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.18 -48.06 83.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.626 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -165.49 -60.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.977 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 64.56 54.87 1.39 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.597 0.561 . . . . 0.0 110.929 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -134.44 -53.37 0.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.893 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -61.86 -32.77 73.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.043 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -45.75 87.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.219 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.511 HD23 ' SD ' ' A' ' 111' ' ' MET . 87.0 mt -63.9 -31.84 73.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.807 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.76 67.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.835 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.6 mt -84.94 -33.61 8.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.21 0.528 . . . . 0.0 109.719 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.511 ' SD ' HD23 ' A' ' 108' ' ' LEU . 89.4 mtp -72.98 -21.68 60.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.016 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.955 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 31.6 p -82.59 3.55 28.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.095 0.474 . . . . 0.0 110.7 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.534 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 15.0 mtm180 -113.84 141.7 47.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 186' ' ' GLY . 4.2 p -124.98 122.67 63.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.551 0.691 . . . . 0.0 109.684 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' A' ' 187' ' ' ARG . 48.7 t80 -77.66 128.88 34.81 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 14.0 m -123.79 116.29 47.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.506 0.669 . . . . 0.0 110.241 175.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -125.11 174.84 17.33 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.582 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.5 m 61.77 34.35 17.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.961 0.41 . . . . 0.0 110.817 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 123' ' ' LEU . 63.9 mt -78.17 119.27 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.047 0.451 . . . . 0.0 110.889 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -53.25 144.86 15.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.442 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.967 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 10.4 p90 -70.8 80.61 0.62 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.771 0.796 . . . . 0.0 111.114 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -169.24 -29.69 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.552 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.402 HD12 HG23 ' A' ' 119' ' ' ILE . 35.0 mt -97.6 105.45 17.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.787 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.88 173.36 54.67 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.219 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.8 -35.42 74.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.257 0.551 . . . . 0.0 109.638 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.3 -51.38 67.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.878 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -61.99 -39.92 93.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.161 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.531 HG13 ' CE ' ' A' ' 143' ' ' MET . 22.2 mm -64.46 -39.73 86.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -56.6 -41.43 76.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.079 0.466 . . . . 0.0 110.116 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -72.24 -33.78 67.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.731 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.498 ' HB1' ' SD ' ' A' ' 177' ' ' MET . . . -85.6 -29.4 24.13 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.456 ' CD1' HG23 ' A' ' 128' ' ' ILE . 28.0 m-85 -94.98 -20.74 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -51.53 -41.9 79.65 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 29.2 Cg_exo -38.08 -41.98 1.4 Allowed 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 123.235 2.623 . . . . 0.0 114.625 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.488 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 67.0 m-85 -76.13 -44.59 37.7 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 121.299 -0.161 . . . . 0.0 111.156 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -170.22 166.83 40.02 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.571 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HG2' ' CE1' ' A' ' 252' ' ' TYR . 35.1 Cg_exo -62.16 117.98 4.85 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.846 2.364 . . . . 0.0 111.773 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.84 HD13 HD11 ' A' ' 141' ' ' ILE . 57.2 mt -77.84 130.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.565 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -99.83 -27.36 13.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.44 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.2 t -165.16 131.46 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.043 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.84 HD11 HD13 ' A' ' 138' ' ' ILE . 59.9 mt -130.54 128.81 63.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -120.98 106.77 11.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.965 0.412 . . . . 0.0 110.173 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.531 ' CE ' HG13 ' A' ' 128' ' ' ILE . 46.3 ttm -114.69 138.27 50.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.634 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.6 m -80.33 89.2 5.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.285 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -106.57 119.28 38.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.944 0.402 . . . . 0.0 110.651 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -92.46 85.68 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.092 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.9 m -60.66 -25.67 66.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.043 -173.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.408 HG23 HG23 ' A' ' 149' ' ' THR . 29.2 m -77.63 -25.57 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -173.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.408 HG23 HG23 ' A' ' 148' ' ' VAL . 69.5 p -111.94 -18.09 12.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.035 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 42.5 mtm 67.08 16.23 10.25 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.078 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -85.17 143.72 28.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.967 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 50.7 t-80 -129.92 88.76 2.71 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.333 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -135.86 96.71 3.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.302 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.06 -154.58 11.74 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.359 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -124.93 175.76 7.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.456 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -155.63 148.09 23.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.702 176.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 81.0 m-85 -110.6 113.02 25.31 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.181 175.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.449 ' HB ' HG12 ' A' ' 114' ' ' VAL . 58.9 t -102.74 105.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.534 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 46.6 tt0 -108.44 126.8 53.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.58 177.56 5.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -76.86 -35.15 57.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.059 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.72 142.2 31.29 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.794 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.955 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 37.8 Cg_endo -66.52 -18.28 54.17 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.3 2.667 . . . . 0.0 112.584 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.54 ' HG3' ' HE2' ' A' ' 254' ' ' PHE . 17.0 mm-40 -56.56 -57.36 12.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.827 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.55 -21.92 65.94 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.26 -49.13 15.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.237 0.541 . . . . 0.0 109.672 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.657 ' HB2' HG11 ' A' ' 286' ' ' VAL . 31.8 mm-40 -67.29 -38.79 85.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.505 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.488 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 11.9 tp -60.61 -46.56 89.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.98 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.48 74.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 110.291 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.61 HD13 ' HA3' ' A' ' 186' ' ' GLY . 7.0 tp -70.11 -41.99 73.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.856 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 8.1 mm-40 -59.21 -39.03 81.4 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.311 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -101.02 -50.67 3.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 28.4 ttp -102.86 31.37 4.21 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -162.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.43 13.98 1.76 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.1 m -105.28 -73.52 0.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.573 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.6 m -144.79 144.14 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.199 0.524 . . . . 0.0 111.42 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.498 ' SD ' ' HB1' ' A' ' 131' ' ' ALA . 3.1 tpt -113.4 108.22 16.92 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 177' ' ' MET . 4.3 mm? 72.1 -55.38 0.67 Allowed 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.878 0.736 . . . . 0.0 110.658 -173.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 145.26 -167.11 27.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.393 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 92.3 -51.58 2.76 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.174 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -143.75 139.56 29.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.574 0.187 . . . . 0.0 110.858 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -64.87 112.24 3.18 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.862 172.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.492 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.6 pt -88.49 152.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.503 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 71.5 mmtt -103.66 105.19 15.35 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.478 HG22 HG12 ' A' ' 116' ' ' VAL . 43.1 t -111.23 135.93 48.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.227 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.61 ' HA3' HD13 ' A' ' 170' ' ' LEU . . . 87.04 48.49 4.36 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.717 173.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.447 ' HB3' ' CD2' ' A' ' 115' ' ' TYR . 8.4 tpt180 -118.34 79.81 15.5 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.39 -54.19 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.437 2.092 . . . . 0.0 111.774 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.2 p -179.27 159.52 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.013 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -132.24 32.41 3.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.565 0.697 . . . . 0.0 109.684 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.4 mm -95.01 27.83 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.359 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.4 ' O ' ' HD2' ' A' ' 196' ' ' PRO . . . 77.16 -72.54 2.09 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 115.64 -0.709 . . . . 0.0 114.286 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -53.74 -39.47 65.34 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -164.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -76.82 -23.48 52.79 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.012 -0.43 . . . . 0.0 112.079 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.553 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 29.3 mm-40 -63.98 -49.61 73.91 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -172.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 8.9 Cg_endo -52.86 -38.43 78.55 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.665 2.243 . . . . 0.0 113.098 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.6 mt -71.83 -45.25 66.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.773 0.32 . . . . 0.0 110.485 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 194' ' ' ALA . 56.2 mt -60.78 -48.34 89.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.14 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.75 -42.3 95.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.344 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 6.4 tp-100 -60.44 -51.94 67.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.735 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 64.5 mt -67.5 -33.51 75.24 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.576 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.615 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -55.92 -42.96 76.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.304 0.573 . . . . 0.0 109.664 175.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 10.8 mm-40 -73.94 -32.71 63.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.943 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.631 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 29.5 mt-10 -69.69 -30.47 68.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.697 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.54 -29.04 65.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.993 0.425 . . . . 0.0 110.069 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 71.6 mtp180 -71.16 -21.76 62.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.361 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -81.41 6.16 15.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.47 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -132.58 -175.62 3.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.92 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -126.08 46.28 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.904 -174.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.787 ' HD2' ' HG3' ' A' ' 289' ' ' PRO . 39.7 ttt180 -105.58 137.66 43.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.15 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.501 HG23 ' HB2' ' A' ' 263' ' ' SER . 49.2 pt -129.15 166.82 25.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.01 0.433 . . . . 0.0 110.735 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.611 ' HD1' ' CE2' ' A' ' 254' ' ' PHE . 85.2 t80 -122.47 129.72 52.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.421 -174.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.565 HG12 HG23 ' A' ' 282' ' ' VAL . 35.1 m -126.63 135.84 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.046 0.45 . . . . 0.0 110.307 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -132.95 -179.49 5.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.861 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.7 t 63.43 27.56 15.23 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.894 0.854 . . . . 0.0 109.056 -172.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.93 121.31 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.256 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 40.8 t-80 -55.21 133.88 49.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.173 0.511 . . . . 0.0 111.283 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -57.79 -28.63 64.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.291 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.72 3.71 50.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.724 0.297 . . . . 0.0 111.304 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 217' ' ' HIS . 14.1 tp -87.06 134.32 33.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 63.2 p -86.41 156.35 20.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.054 -171.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.94 -42.45 68.85 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.577 0.703 . . . . 0.0 109.474 172.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.46 -40.38 74.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.833 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -71.7 -38.58 70.54 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.1 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.615 HG22 HD11 ' A' ' 255' ' ' ILE . 27.0 mm -65.77 -46.24 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 86.8 tttt -57.7 -42.4 83.65 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.439 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.6 t -55.52 -47.75 75.77 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.641 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.33 -40.91 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 111.444 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.485 ' CB ' HD11 ' A' ' 235' ' ' ILE . 26.4 m-85 -66.74 -29.07 68.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.884 0.373 . . . . 0.0 110.992 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.4 mm-40 -63.9 -24.66 67.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.419 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.85 -20.14 60.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.27 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.64 -37.2 6.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.917 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.41 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -147.18 168.92 28.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.801 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 35.2 mmtt -88.01 116.03 25.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.761 0.791 . . . . 0.0 111.231 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.485 HD11 ' CB ' ' A' ' 229' ' ' PHE . 52.6 mt -86.8 150.95 3.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.641 -173.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -110.8 -22.38 11.59 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.759 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.1 t -172.56 143.28 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.707 0.289 . . . . 0.0 110.379 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.0 t -140.49 105.13 4.9 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.8 m -129.21 110.13 11.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.256 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.56 HD21 HG13 ' A' ' 225' ' ' ILE . 60.9 mt -78.71 131.55 36.65 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.539 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -70.53 122.52 19.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.09 0.471 . . . . 0.0 109.834 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.747 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 76.4 mtt180 -111.05 166.49 11.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.29 -171.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.06 135.24 33.58 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.38 -46.25 11.94 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.861 3.041 . . . . 0.0 114.707 -166.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.3 t -159.73 65.42 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.844 0.831 . . . . 0.0 111.607 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 21.8 p -133.15 6.56 3.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.919 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.01 71.74 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.945 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 248' ' ' LYS . 41.3 mtmt -147.33 159.37 43.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.747 ' HB3' ' HG2' ' A' ' 242' ' ' ARG . 19.8 p80 -107.32 147.36 30.39 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.506 170.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -63.44 -7.5 6.87 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -164.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 108.61 5.43 31.67 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.443 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.421 ' CE1' ' HG2' ' A' ' 137' ' ' PRO . 12.8 p90 -141.43 174.09 10.88 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.539 ' HA2' ' H ' ' A' ' 241' ' ' ALA . . . -164.49 172.34 40.23 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.767 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.611 ' CE2' ' HD1' ' A' ' 212' ' ' TYR . 92.4 m-85 -127.31 143.51 51.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.011 0.434 . . . . 0.0 110.687 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 225' ' ' ILE . 83.5 mt -136.61 136.89 48.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.094 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -116.72 146.73 42.59 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 8.6 m-85 -111.28 175.27 5.49 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -83.79 -13.45 53.79 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.222 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -135.48 133.46 38.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.979 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.4 -24.93 67.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.017 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -73.43 -35.4 65.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.873 175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.45 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 8.2 t -70.69 -37.64 73.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.678 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.501 ' HB2' HG23 ' A' ' 211' ' ' ILE . 62.3 p -66.41 -32.79 74.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.068 0.461 . . . . 0.0 110.115 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.49 -27.02 62.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.83 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.45 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 53.5 m-20 -62.92 -45.3 93.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.208 0.528 . . . . 0.0 109.626 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -62.33 -43.53 98.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.018 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 263' ' ' SER . 86.5 t -55.38 -37.16 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.297 0.57 . . . . 0.0 111.206 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.6 m -75.83 -24.19 55.81 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.246 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 18.3 m -95.08 -41.83 8.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 78.5 mmm -88.07 1.95 53.06 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -167.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.505 ' HA ' HG12 ' A' ' 282' ' ' VAL . 66.7 t30 -72.36 115.42 11.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.213 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.2 mt 65.18 38.35 6.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.346 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -94.39 123.56 37.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.105 174.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.529 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 32.2 t70 -71.94 108.4 5.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 25.5 tp -141.8 111.19 6.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 90.94 16.34 54.57 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.051 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 97.35 -6.31 63.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.593 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.7 152.08 51.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 74.7 m-85 -81.06 113.13 19.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.215 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.94 134.63 57.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.388 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -100.49 115.7 30.71 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.565 HG23 HG12 ' A' ' 213' ' ' VAL . 10.0 p -115.53 151.01 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.506 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.14 175.17 42.36 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.962 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -76.88 126.85 31.66 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.67 129.24 39.07 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.657 HG11 ' HB2' ' A' ' 167' ' ' GLN . 29.1 m -89.26 -11.43 10.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.783 0.325 . . . . 0.0 111.578 -170.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.533 HG23 HG23 ' A' ' 286' ' ' VAL . 68.3 p -120.87 133.39 24.1 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.27 0.557 . . . . 0.0 111.094 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.48 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 38.8 Cg_endo -67.09 146.34 76.41 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.099 2.533 . . . . 0.0 111.995 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.787 ' HG3' ' HD2' ' A' ' 210' ' ' ARG . 14.3 Cg_exo -69.55 -16.7 38.57 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.04 2.493 . . . . 0.0 112.632 -177.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 54.2 ttp -148.05 92.03 4.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.3 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.72 72.08 6.24 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.977 2.452 . . . . 0.0 112.05 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 6.7 mp 52.16 57.61 6.29 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.284 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 45.4 tp -66.5 109.63 2.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.07 0.462 . . . . 0.0 110.16 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.777 ' HB ' ' HD3' ' A' ' 295' ' ' PRO . 39.7 m -105.87 -56.29 0.07 OUTLIER Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.847 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.777 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 39.5 Cg_exo -61.96 111.4 1.21 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.105 1.87 . . . . 0.0 112.427 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -158.58 -69.91 0.09 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.912 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 37.1 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.228 178.159 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.91 89.59 2.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.197 0.522 . . . . 0.0 110.737 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -94.07 62.76 3.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.356 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 59.79 30.12 19.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.013 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.445 ' O ' ' HB3' ' A' ' 104' ' ' ARG . 10.8 pt20 -95.99 165.15 12.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.968 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' A' ' 103' ' ' GLN . 25.4 tpt180 72.1 138.61 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.11 0.881 . . . . 0.0 111.352 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 75.0 2.91 4.08 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.757 172.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -57.57 -47.85 80.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.75 92.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.118 0.485 . . . . 0.0 111.04 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.544 HD21 HD13 ' A' ' 201' ' ' LEU . 60.0 mt -71.95 -35.57 69.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.43 -37.11 77.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.412 . . . . 0.0 110.505 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.3 mt -67.02 -42.8 89.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.308 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 1.8 ttm -68.53 -14.65 63.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.831 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.3 m -77.13 -15.78 59.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.454 177.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.496 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 18.4 mtp180 -101.09 141.7 33.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.694 HG22 ' H ' ' A' ' 186' ' ' GLY . 1.0 OUTLIER -123.33 127.76 74.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 78.6 t80 -82.93 115.37 21.76 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 8.6 m -115.87 116.46 52.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.59 0.71 . . . . 0.0 110.787 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 155' ' ' PHE . . . -119.95 -175.0 15.6 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.898 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.863 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 20.9 m 67.12 21.46 10.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.928 0.491 . . . . 0.0 111.279 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.6 mt -84.88 102.81 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.388 . . . . 0.0 110.619 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 122' ' ' GLU . 79.3 t80 -53.75 144.25 18.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.633 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.504 ' HA ' ' CE1' ' A' ' 152' ' ' HIS . 20.1 p90 -72.3 76.62 1.0 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.172 0.987 . . . . 0.0 111.196 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 120' ' ' TYR . 31.0 tt0 -148.35 -47.47 0.16 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.756 174.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.3 mt -66.95 128.28 35.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.501 176.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.48 174.98 35.52 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.007 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.31 -36.51 71.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.339 0.59 . . . . 0.0 109.874 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -68.8 -43.44 75.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.132 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 m -59.59 -46.2 89.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.125 0.488 . . . . 0.0 110.454 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.511 HG13 ' HE1' ' A' ' 143' ' ' MET . 41.8 mm -62.22 -47.65 92.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.617 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -60.26 -41.1 92.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.863 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -63.14 -34.4 77.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.492 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.79 -34.48 22.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.442 ' HD1' ' O ' ' A' ' 128' ' ' ILE . 69.8 m-85 -91.47 -18.41 24.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.464 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -55.41 -42.02 93.81 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 42.5 Cg_exo -40.39 -43.03 3.96 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 123.017 2.478 . . . . 0.0 113.925 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.67 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 50.1 m-85 -74.91 -51.78 12.94 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.645 0.26 . . . . 0.0 111.142 -175.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.37 170.54 36.41 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.023 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.3 118.71 5.74 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.87 2.38 . . . . 0.0 110.896 175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.446 HG21 ' CG1' ' A' ' 141' ' ' ILE . 53.3 mt -82.78 120.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.374 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -88.88 -33.6 17.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.341 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.3 t -153.58 136.79 15.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.968 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.446 ' CG1' HG21 ' A' ' 138' ' ' ILE . 71.7 mt -120.49 107.46 20.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 169.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.719 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -84.75 98.66 10.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.355 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.511 ' HE1' HG13 ' A' ' 128' ' ' ILE . 57.0 ttm -149.45 134.34 17.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.784 0.325 . . . . 0.0 110.377 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 p -74.2 56.98 0.65 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.633 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -99.7 93.2 5.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.002 0.43 . . . . 0.0 111.259 -177.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -173.05 88.35 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.597 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.2 p -163.54 140.55 7.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.594 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 50.5 t -65.38 -21.77 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.309 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.2 p -88.03 1.16 54.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.949 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 62.5 mtm 59.66 40.19 20.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -108.04 140.76 40.74 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.265 0.555 . . . . 0.0 111.83 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.504 ' CE1' ' HA ' ' A' ' 121' ' ' TYR . 2.4 p-80 -145.95 162.03 38.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 170.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -54.62 -64.85 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.699 0.285 . . . . 0.0 111.476 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.78 -22.3 1.16 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.9 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.436 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 47.9 p90 -108.78 151.38 26.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.465 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -146.2 156.15 43.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.719 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 93.8 m-85 -113.75 109.55 18.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.775 175.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.636 ' HB ' HG12 ' A' ' 114' ' ' VAL . 59.8 t -97.31 106.34 18.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.496 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 72.8 tt0 -108.46 122.84 47.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.539 -177.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -96.37 178.89 5.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -82.43 -17.87 43.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.555 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 m -133.38 143.66 49.05 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.673 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 57.9 Cg_endo -71.95 -22.85 22.65 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.199 2.599 . . . . 0.0 112.785 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.593 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 16.3 mp0 -55.16 -58.72 6.52 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.684 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.67 -22.47 23.27 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.75 -48.13 12.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.968 0.413 . . . . 0.0 110.316 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -73.34 -26.66 61.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.302 0.572 . . . . 0.0 109.699 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.67 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 16.3 tp -70.47 -47.27 61.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.233 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.0 -34.72 78.15 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 18.6 tp -65.24 -46.08 82.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.714 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.37 -47.71 72.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.673 -174.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -90.45 -43.84 10.01 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.4 mtm -94.46 30.3 2.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -170.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 170' ' ' LEU . 66.5 t30 -75.98 12.97 0.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.168 0.508 . . . . 0.0 110.806 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 22.2 m -113.72 -73.38 0.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.523 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.9 m -142.28 162.04 19.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 111.373 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.672 ' HB2' HD13 ' A' ' 183' ' ' ILE . 17.2 tpp -128.53 84.39 2.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.494 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.457 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 89.0 mt 70.16 -56.25 0.59 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.305 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -73.59 168.87 53.79 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.461 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.63 53.75 4.07 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.722 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 118' ' ' SER . 43.3 ttm180 -143.77 137.64 28.21 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 175' ' ' SER . 5.5 m-20 -72.09 112.07 7.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.192 0.52 . . . . 0.0 110.382 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.863 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 45.3 pt -81.38 158.41 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.139 -176.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.717 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 24.8 ttmm -103.4 116.4 32.34 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.051 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.3 t -122.7 148.84 26.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.694 ' H ' HG22 ' A' ' 114' ' ' VAL . . . 107.24 -118.74 5.65 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.005 175.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 187' ' ' ARG . 0.0 OUTLIER -145.11 121.46 6.05 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.9 -35.89 53.16 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.498 2.132 . . . . 0.0 110.855 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.4 m -83.24 76.07 9.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.272 173.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -63.67 -57.16 10.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.106 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.08 72.52 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.608 0.718 . . . . 0.0 109.989 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -101.94 -178.09 27.95 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.978 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -70.35 -16.99 63.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.133 0.466 . . . . 0.0 111.091 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -84.84 -19.6 32.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 25.3 tp60 -57.36 -47.47 98.96 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -176.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 73.1 Cg_exo -52.5 -38.88 75.46 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.08 1.853 . . . . 0.0 112.678 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.0 mt -75.67 -43.9 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.438 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 194' ' ' ALA . 79.9 mt -58.23 -46.88 88.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.784 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.04 -39.74 93.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.705 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -59.54 -52.81 63.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.98 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.544 HD13 HD21 ' A' ' 108' ' ' LEU . 42.0 mt -68.14 -32.91 73.51 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.191 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.604 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.59 -48.24 72.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -65.53 -33.7 76.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.855 175.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 30.7 mt-10 -66.11 -33.71 76.39 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.17 0.51 . . . . 0.0 111.155 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -72.75 -24.85 61.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.656 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 68.6 mtp180 -79.87 -28.12 39.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.372 174.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.8 -38.41 76.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.151 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -88.72 173.6 8.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.481 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 77.7 m-20 -116.58 34.71 4.91 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.797 -174.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.68 ' HD3' ' HG3' ' A' ' 289' ' ' PRO . 17.0 ttp180 -98.73 138.13 36.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.373 0.606 . . . . 0.0 111.507 -174.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.47 ' HA ' ' H ' ' A' ' 285' ' ' ALA . 47.7 pt -124.0 167.11 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.954 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 83.5 t80 -117.06 128.04 54.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.53 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.471 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 34.6 m -117.7 132.56 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.251 0.548 . . . . 0.0 110.112 177.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -126.95 169.68 13.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.894 -174.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.3 t 62.37 32.29 16.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.87 0.843 . . . . 0.0 109.312 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.45 108.28 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.091 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -54.98 133.38 48.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.911 0.386 . . . . 0.0 110.725 -174.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -55.8 -24.22 34.76 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.24 -21.1 29.23 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.23 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.62 124.39 22.23 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.3 t -81.38 164.12 22.35 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.199 0.523 . . . . 0.0 111.329 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -53.47 -38.88 64.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.126 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.55 -35.56 77.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.661 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.33 -44.59 94.47 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.671 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.742 HG22 HD11 ' A' ' 255' ' ' ILE . 38.0 mm -67.04 -41.17 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.021 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.664 ' HD2' ' SG ' ' A' ' 238' ' ' CYS . 87.4 tttt -59.8 -45.07 93.48 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.633 174.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.1 m -54.96 -44.96 74.85 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.0 t -76.32 -38.22 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.719 0.295 . . . . 0.0 111.485 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.563 ' HB3' ' OH ' ' A' ' 257' ' ' TYR . 15.7 m-85 -72.51 -33.43 66.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 110.996 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -61.17 -24.61 66.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.027 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.56 -12.78 61.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.245 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -111.43 -45.51 3.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.896 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -134.02 177.12 19.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.044 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 234' ' ' LYS . 39.4 tptt -91.74 106.44 18.48 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.11 0.481 . . . . 0.0 110.424 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 229' ' ' PHE . 22.5 mt -75.94 142.71 14.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.843 0.83 . . . . 0.0 112.325 -175.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.468 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 54.4 tttt -101.69 -37.3 8.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.42 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 20.4 m -156.04 142.0 18.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.318 -172.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.664 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 26.6 p -130.05 121.58 26.72 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 168.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 29.0 m -142.05 102.31 4.1 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.943 0.401 . . . . 0.0 110.536 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.516 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 70.3 mt -76.4 131.0 38.85 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.484 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.21 115.32 5.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 14.7 ptt-85 -139.78 168.83 18.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -171.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 16.6 m-20 -112.71 123.64 33.46 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.972 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 11.9 Cg_endo -58.51 -22.92 61.89 Favored 'Trans proline' 0 CA--C 1.526 0.117 0 C-N-CA 123.077 2.518 . . . . 0.0 111.999 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 p -91.32 -4.81 55.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.662 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 47.8 p -114.22 -34.48 5.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.493 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.7 6.33 80.25 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.267 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -138.31 160.0 40.6 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 6.5 p80 -87.19 151.22 23.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.563 . . . . 0.0 110.448 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.01 -25.34 68.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.384 -170.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 135.99 -12.12 4.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.874 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.417 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 44.3 p90 -130.87 174.52 9.89 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -165.86 175.53 41.45 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.329 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.593 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 96.6 m-85 -129.52 142.37 50.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.971 0.415 . . . . 0.0 110.448 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.742 HD11 HG22 ' A' ' 225' ' ' ILE . 90.4 mt -136.07 142.66 38.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.132 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 41.7 mt-10 -120.76 148.76 43.54 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.643 ' HB2' ' OG ' ' A' ' 263' ' ' SER . 25.5 m-85 -118.97 153.5 34.55 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 123.396 0.435 . . . . 0.0 109.888 175.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 25.0 mt-10 -75.95 -9.05 58.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.49 0.662 . . . . 0.0 110.036 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -130.66 122.56 27.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.392 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -59.36 -32.24 69.94 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.872 -171.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -67.86 -39.17 83.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.027 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.7 m -67.54 -33.34 74.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.747 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.643 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 3.3 m -58.38 -50.66 72.88 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.573 0.701 . . . . 0.0 109.701 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' GLN . . . . . 0.419 ' HG2' ' HD3' ' A' ' 284' ' ' LYS . 77.0 mt-30 -76.75 -14.66 59.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.146 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.84 -45.96 63.57 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.74 78.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.875 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.508 HG13 ' HA2' ' A' ' 283' ' ' GLY . 88.6 t -56.12 -31.62 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.195 0.521 . . . . 0.0 111.073 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.5 t -87.37 -39.18 15.53 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.079 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.6 m -80.99 -41.49 22.66 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.543 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 77.4 mmm -83.16 -0.23 48.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 111.059 -172.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.528 ' HA ' HG12 ' A' ' 282' ' ' VAL . 26.7 t-20 -71.37 111.18 6.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.308 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.9 mt 70.36 34.66 2.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.37 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -88.23 129.76 35.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.761 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.32 113.43 13.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.387 0.613 . . . . 0.0 111.242 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 33.9 tp -142.05 121.24 13.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.09 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 68.72 28.76 72.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.198 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 86.34 -13.5 57.53 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.97 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -114.81 150.75 34.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.634 -0.333 . . . . 0.0 110.257 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -89.28 116.68 27.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.802 0.334 . . . . 0.0 110.139 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.39 126.09 26.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.109 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 5.5 mmt180 -99.69 114.75 28.05 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 271' ' ' ASN . 8.4 p -121.62 150.85 24.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.528 -170.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.508 ' HA2' HG13 ' A' ' 267' ' ' VAL . . . -169.88 174.59 44.08 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.419 ' HD3' ' HG2' ' A' ' 264' ' ' GLN . 4.2 mmmp? -73.21 125.69 28.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.153 0.477 . . . . 0.0 110.287 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -58.4 130.95 49.15 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.9 m -85.08 -17.56 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.926 0.393 . . . . 0.0 110.769 -173.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 66.4 p -109.73 142.88 26.72 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.101 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 61.2 Cg_endo -73.05 156.65 51.75 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.682 2.255 . . . . 0.0 111.343 172.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.68 ' HG3' ' HD3' ' A' ' 210' ' ' ARG . 34.7 Cg_exo -58.36 92.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.909 2.406 . . . . 0.0 112.777 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 49.8 ttm -103.08 128.82 26.82 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.488 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.453 ' HB3' ' HB ' ' A' ' 294' ' ' THR . 69.1 Cg_exo -51.32 115.77 2.27 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.159 2.573 . . . . 0.0 113.084 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 93.1 mt -91.12 94.74 9.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.917 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 90.6 mt 56.13 56.19 6.1 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.644 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 291' ' ' PRO . 9.7 t -63.12 140.18 97.63 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.6 -178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 16.5 Cg_exo -68.08 73.98 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.232 2.621 . . . . 0.0 112.621 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -97.99 104.23 16.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.343 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.572 179.159 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 62.82 176.84 0.15 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.403 0.62 . . . . 0.0 112.297 176.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 68.0 mtt -122.03 116.35 24.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.009 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 103' ' ' GLN . . . -129.31 174.34 9.7 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.828 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 102' ' ' ALA . 34.6 tt0 74.79 -38.77 0.39 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.324 0.65 . . . . 0.0 111.328 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -53.35 109.77 0.48 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.29 0.636 . . . . 0.0 111.35 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.698 ' HG3' HD12 ' A' ' 108' ' ' LEU . 35.2 tt0 68.62 11.88 8.5 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.576 0.547 . . . . 0.0 111.677 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -65.97 -34.18 77.52 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.93 -24.78 58.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.698 HD12 ' HG3' ' A' ' 105' ' ' GLN . 39.4 mt -67.64 -33.9 75.88 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.957 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.29 -24.06 40.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.095 0.474 . . . . 0.0 111.006 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.3 -52.49 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.731 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.9 -22.47 65.96 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -175.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 72.3 m -74.06 -10.5 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.206 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 78.0 mtt180 -102.71 139.96 37.61 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.174 175.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.28 119.89 60.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 170.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 84.8 t80 -80.65 129.54 34.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.758 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.527 HG12 HG12 ' A' ' 185' ' ' VAL . 9.6 m -108.65 115.97 50.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.316 0.579 . . . . 0.0 110.198 175.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.11 135.31 12.07 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.819 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.9 t 60.35 79.28 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.327 0.651 . . . . 0.0 111.442 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.49 HD11 ' CG2' ' A' ' 116' ' ' VAL . 59.5 mt -93.82 127.12 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.434 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 181' ' ' ARG . 29.0 t80 -60.16 127.71 33.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -65.37 77.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.149 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -169.66 -37.93 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.061 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.2 mt -74.73 114.36 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.089 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.424 ' HA2' ' HZ3' ' A' ' 145' ' ' TRP . . . -74.68 165.32 54.75 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.481 176.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -60.98 -40.65 94.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -60.6 -38.72 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.99 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.0 m -66.24 -42.92 87.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.563 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 mm -65.86 -40.91 88.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.496 0.665 . . . . 0.0 109.9 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -55.88 -44.17 77.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.829 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -72.21 -33.59 67.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.948 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.14 -37.35 46.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -91.16 -15.48 29.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.412 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -53.24 -45.63 98.26 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 34.3 Cg_exo -40.83 -40.79 3.72 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 123.247 2.631 . . . . 0.0 114.986 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.645 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 68.4 m-85 -72.66 -46.74 52.37 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -170.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.2 -164.93 20.53 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.561 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 161' ' ' GLU . 87.0 Cg_endo -79.83 107.73 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.071 2.514 . . . . 0.0 111.854 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.592 HD13 HD11 ' A' ' 141' ' ' ILE . 56.9 mt -66.71 113.74 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.316 0.579 . . . . 0.0 110.577 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 60.0 tttm -93.31 -40.58 10.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.047 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.2 t -155.54 128.62 8.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.466 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 138' ' ' ILE . 67.0 mt -111.06 108.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 171.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -100.43 98.65 9.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.805 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 52.7 ttm -131.34 127.51 37.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.948 0.404 . . . . 0.0 110.446 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.6 p -80.53 124.69 29.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.892 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.424 ' HZ3' ' HA2' ' A' ' 124' ' ' GLY . 46.3 t-105 -103.95 122.58 45.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -132.11 173.37 11.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.626 0.25 . . . . 0.0 110.947 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.9 m 70.61 141.37 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 O-C-N 124.313 1.008 . . . . 0.0 112.434 171.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.43 -20.4 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.677 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.5 p -91.69 10.56 27.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.542 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 68.1 mtm 69.39 11.3 8.05 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.941 0.496 . . . . 0.0 112.21 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -87.33 130.3 34.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.958 0.409 . . . . 0.0 110.626 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -123.92 121.85 36.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.955 0.407 . . . . 0.0 110.371 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -116.8 73.44 0.86 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.839 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -154.08 -146.99 4.53 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.563 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -111.9 177.5 4.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.61 0.243 . . . . 0.0 110.605 -175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 116' ' ' VAL . . . -161.41 153.7 19.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.489 176.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -123.66 123.03 39.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.236 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.6 t -104.65 105.97 19.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.526 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 35.5 tt0 -97.21 131.71 43.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.001 -176.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -109.52 162.35 14.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.489 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 137' ' ' PRO . 44.4 mt-10 -79.13 -9.15 59.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 0.0 110.668 174.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.69 133.58 19.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.878 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 43.1 Cg_endo -66.79 -20.41 52.21 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.135 2.556 . . . . 0.0 112.358 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.657 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 17.6 mp0 -55.74 -52.86 62.47 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.956 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -63.55 -20.61 65.77 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.18 -48.58 12.92 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.617 ' HG3' HG11 ' A' ' 286' ' ' VAL . 15.6 mm100 -66.77 -34.11 77.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.044 174.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.645 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 13.0 tp -68.87 -46.61 68.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.672 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.442 ' HA ' ' CE1' ' A' ' 135' ' ' PHE . . . -60.46 -31.21 70.23 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.652 HD12 ' HA3' ' A' ' 186' ' ' GLY . 5.3 tt -67.43 -55.9 11.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.014 172.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 167' ' ' GLN . 23.1 mt-10 -53.94 -30.14 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.058 -175.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -98.07 -51.22 4.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.9 mtm -106.62 29.33 7.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -167.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.561 ' HA ' HG22 ' A' ' 185' ' ' VAL . 65.1 t30 -86.09 26.08 1.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.632 0.729 . . . . 0.0 110.308 177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.2 t -114.23 -70.29 0.81 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.97 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 m -140.1 155.46 24.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.617 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.579 ' HE2' ' HG ' ' A' ' 178' ' ' LEU . 0.9 OUTLIER -126.81 100.99 6.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.414 175.927 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.579 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 94.9 mt 66.2 26.91 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.679 172.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 123.84 -112.26 1.81 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.954 -1.117 . . . . 0.0 114.594 171.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.81 38.51 3.04 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 114.451 0.541 . . . . 0.0 114.451 -165.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 120' ' ' TYR . 8.5 tpp180 -145.53 120.09 9.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 117.209 0.505 . . . . 0.0 111.09 173.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -87.49 83.18 7.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.432 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.6 pt -70.22 147.69 11.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.086 0.47 . . . . 0.0 110.938 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -103.55 107.02 17.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.36 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 174' ' ' ASN . 2.5 m -99.69 137.41 27.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.359 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.652 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 82.52 90.71 0.64 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.655 -0.784 . . . . 0.0 111.447 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.497 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 68.5 ttt180 -65.43 123.25 83.86 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.752 0.311 . . . . 0.0 110.76 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 3.5 Cg_exo -75.42 50.59 2.69 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 123.366 2.711 . . . . 0.0 112.217 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.6 p -87.92 62.9 7.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.434 0.635 . . . . 0.0 110.425 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -82.5 65.93 7.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.96 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 48.9 mm -63.72 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.396 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 118.32 -4.03 15.77 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.708 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -83.06 -56.89 3.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.006 0.431 . . . . 0.0 111.059 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.69 -19.17 26.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.433 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.509 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 84.0 mm-40 -56.94 -48.87 96.68 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 54.5 Cg_exo -53.93 -39.29 85.36 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.152 1.902 . . . . 0.0 112.539 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.476 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 41.7 mm -67.61 -46.89 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 110.084 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 87.1 mt -57.9 -48.45 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.531 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 29.7 t70 -67.53 -40.99 85.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.164 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -62.7 -44.99 94.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.115 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 76.0 mt -67.58 -32.84 73.87 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.55 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.494 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -58.21 -38.31 76.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.188 0.518 . . . . 0.0 109.72 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 40.1 mt-10 -73.73 -31.53 63.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.945 175.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 57.7 mt-10 -67.26 -24.16 65.77 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.184 0.516 . . . . 0.0 110.984 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.403 ' HA ' HH11 ' A' ' 210' ' ' ARG . . . -74.85 -33.39 62.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.137 174.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 18.0 mtm180 -73.35 -13.78 61.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.786 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.32 -22.2 60.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.329 0.585 . . . . 0.0 110.171 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.99 166.99 18.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.305 -0.862 . . . . 0.0 108.997 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 65.2 m-20 -95.26 48.67 1.17 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.638 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 7.8 ptp180 -91.44 149.5 21.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.398 0.618 . . . . 0.0 111.206 -173.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.406 HG23 ' HB2' ' A' ' 263' ' ' SER . 44.1 pt -134.55 166.91 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.254 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -113.14 122.19 46.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.606 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.48 HG12 HG23 ' A' ' 282' ' ' VAL . 34.3 m -117.59 131.92 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.004 0.431 . . . . 0.0 110.227 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -126.13 172.12 10.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.159 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.7 m 62.68 27.56 16.19 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.922 0.868 . . . . 0.0 109.863 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.61 112.27 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.83 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -58.58 138.86 56.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.253 -171.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -52.67 -30.95 34.64 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -88.6 -22.81 23.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.497 0.189 . . . . 0.0 111.489 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.29 120.72 12.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.548 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.6 m -82.04 166.6 19.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.274 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -53.91 -45.4 71.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.511 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.98 -32.38 73.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.652 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 228' ' ' VAL . 8.3 t70 -68.7 -45.81 70.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.676 HG22 HD11 ' A' ' 255' ' ' ILE . 39.8 mm -66.29 -36.78 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.58 -52.72 63.96 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.28 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 89.7 p -55.74 -34.4 65.15 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 224' ' ' ASP . 24.5 t -73.55 -47.66 44.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.314 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.732 ' HB2' HD11 ' A' ' 235' ' ' ILE . 16.2 m-85 -68.39 -31.64 71.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.411 0.624 . . . . 0.0 110.526 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 29.5 tp10 -60.08 -24.35 64.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.367 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.91 -8.33 58.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.644 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -112.79 -45.21 3.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.562 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -140.82 171.71 23.96 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 64.8 mmtt -90.03 111.7 22.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.894 0.854 . . . . 0.0 111.697 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 229' ' ' PHE . 52.9 mt -87.16 151.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.682 -174.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -103.52 -40.33 6.38 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.786 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 50.8 m -156.88 151.01 24.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.411 -170.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.1 t -143.76 104.66 4.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.764 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.5 m -121.09 103.13 8.79 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.353 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.606 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 69.0 mt -80.46 144.52 32.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.818 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -66.55 105.05 1.4 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.526 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 41.0 ttt180 -129.16 142.09 50.97 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.065 -170.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 246' ' ' THR . 30.1 m-20 -93.61 115.16 64.7 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.032 176.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.42 -37.13 98.35 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.529 2.82 . . . . 0.0 113.769 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 82.8 p -92.75 10.22 31.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 243' ' ' ASP . 11.6 t -123.06 -9.78 8.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.045 -0.41 . . . . 0.0 111.196 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.09 -49.77 4.29 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.426 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 20.1 ptmt -77.32 172.97 12.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.174 0.511 . . . . 0.0 110.685 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 20.2 p80 -116.1 167.67 10.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.508 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -65.26 -80.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 O-C-N 123.485 0.49 . . . . 0.0 111.69 -173.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -175.99 17.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.232 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.432 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 31.3 p90 -157.03 176.71 12.39 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.0 178.06 45.17 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.041 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.657 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 89.4 m-85 -125.67 143.85 50.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.917 0.389 . . . . 0.0 110.19 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.676 HD11 HG22 ' A' ' 225' ' ' ILE . 87.0 mt -134.68 128.44 50.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.462 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.638 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 47.8 mt-10 -109.98 131.95 54.59 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.628 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 6.8 m-85 -97.07 176.97 5.75 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 123.155 0.285 . . . . 0.0 110.294 176.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.12 -22.85 35.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -121.15 121.94 38.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.361 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.67 -22.56 67.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.075 0.464 . . . . 0.0 110.939 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -72.0 -49.33 37.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.719 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 265' ' ' ASP . 44.9 m -66.67 -32.43 73.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.012 -176.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.628 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 59.8 p -66.56 -42.54 86.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 110.057 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -74.51 -21.62 59.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.522 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 262' ' ' SER . 0.5 OUTLIER -70.98 -37.19 72.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.405 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -63.78 -39.98 95.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 172.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.11 -33.67 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 121.33 0.586 . . . . 0.0 110.628 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.5 m -73.71 -39.61 64.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.133 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.5 m -89.37 -39.17 13.61 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.562 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 85.9 mmm -81.66 -1.56 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -171.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.545 ' HA ' HG12 ' A' ' 282' ' ' VAL . 22.9 t-20 -71.5 117.51 13.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 97.7 mt 70.01 32.75 2.95 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.44 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -91.23 121.19 32.78 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.454 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 12.4 t70 -74.38 118.55 17.47 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.333 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.7 tp -131.94 91.83 3.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.901 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 92.4 26.81 16.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 92.7 2.36 67.32 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.632 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -131.8 140.81 49.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.454 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 72.4 m-85 -85.37 112.61 20.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.6 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 71.7 mt -58.03 121.27 10.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 8.2 mmm180 -93.53 114.75 27.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 174.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 271' ' ' ASN . 11.4 p -119.87 143.85 30.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.745 -173.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -158.56 -171.84 24.93 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.505 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.62 128.92 36.76 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.773 0.32 . . . . 0.0 110.344 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -66.52 128.17 35.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 167' ' ' GLN . 29.4 m -97.32 -25.02 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -171.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.448 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 35.5 p -131.39 168.13 18.76 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 120.844 0.354 . . . . 0.0 111.569 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.05 103.52 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.191 2.594 . . . . 0.0 110.989 169.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 287' ' ' THR . 20.4 Cg_exo -64.99 146.63 87.98 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.006 2.471 . . . . 0.0 112.682 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.431 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 88.3 mtp -100.15 110.29 59.21 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.121 177.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 1.5 Cg_endo -83.89 93.89 0.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.082 2.522 . . . . 0.0 111.596 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.14 63.17 1.8 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.212 0.529 . . . . 0.0 111.158 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.42 -2.52 58.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.925 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 11.0 m -53.97 126.41 51.2 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.048 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 7.7 Cg_exo -73.7 61.18 4.48 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.337 2.691 . . . . 0.0 112.503 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -107.2 16.66 23.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.24 0.543 . . . . 0.0 109.865 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.375 -178.224 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.039 0 N-CA-C 112.645 -0.182 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.0 81.0 8.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.901 0.381 . . . . 0.0 110.79 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 94.1 mmm -81.18 60.6 4.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.522 0.677 . . . . 0.0 110.624 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -122.81 74.67 1.22 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.95 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -97.71 156.48 16.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.709 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.42 72.37 1.38 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.637 0.732 . . . . 0.0 110.629 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -88.96 9.82 23.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.824 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -62.03 -33.81 75.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.7 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.55 80.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 0.0 110.884 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.51 HD21 HD13 ' A' ' 201' ' ' LEU . 61.7 mt -68.91 -31.28 70.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.598 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.68 -28.41 69.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.256 0.551 . . . . 0.0 110.384 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.84 -36.47 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.858 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.519 ' SD ' HG12 ' A' ' 198' ' ' ILE . 87.9 mtp -73.31 -21.81 60.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.2 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.818 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 30.4 p -79.72 -3.71 48.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -110.7 141.09 44.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.678 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.596 HG12 ' HB ' ' A' ' 158' ' ' VAL . 6.0 p -121.56 131.93 71.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.177 0.513 . . . . 0.0 110.051 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -79.11 121.03 24.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.07 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 25.7 m -118.18 129.26 74.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.5 0.667 . . . . 0.0 111.383 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.46 176.26 21.51 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.62 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 22.7 m 60.29 39.11 19.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.236 0.541 . . . . 0.0 110.576 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 57.5 mt -81.02 -15.74 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.373 -176.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 44.7 t80 71.21 153.62 0.13 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.204 -176.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -83.54 76.24 9.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.453 0.644 . . . . 0.0 111.052 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -163.43 -50.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.021 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.82 104.55 1.71 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.081 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.87 172.77 55.33 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.935 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.47 ' OE2' ' HB ' ' A' ' 141' ' ' ILE . 61.2 tt0 -64.17 -32.31 73.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.849 0.324 . . . . 0.0 110.67 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -54.85 -48.87 72.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.355 0.598 . . . . 0.0 109.958 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.2 m -70.69 -41.67 71.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.961 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.0 mm -61.41 -46.34 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.479 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -63.71 -37.31 86.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.034 0.445 . . . . 0.0 110.196 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -65.63 -32.38 73.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.969 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -79.44 -35.82 39.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.548 ' HB2' HD11 ' A' ' 138' ' ' ILE . 71.3 m-85 -90.66 -13.86 33.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 0.0 111.531 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.17 -43.18 89.71 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -43.83 -41.51 11.84 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.95 2.433 . . . . 0.0 114.564 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.451 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 51.4 m-85 -77.08 -50.94 11.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.536 0.208 . . . . 0.0 111.386 -174.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -158.36 171.0 35.14 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.884 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.64 117.63 5.01 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 111.218 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 132' ' ' PHE . 58.5 mt -78.82 116.31 22.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.105 0.479 . . . . 0.0 110.535 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.507 ' HE3' ' OE1' ' A' ' 159' ' ' GLU . 34.9 ttpt -88.42 -27.42 21.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.542 -177.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.2 t -163.83 145.48 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.753 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.495 HD11 HD13 ' A' ' 138' ' ' ILE . 61.7 mt -133.02 121.43 43.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.85 100.66 10.46 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.799 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 46.8 ttm -128.48 131.95 48.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.6 t -78.56 76.49 5.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.962 0.411 . . . . 0.0 109.942 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 38.1 t90 -89.23 95.14 10.18 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 175.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.63 110.39 4.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.667 -176.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.429 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 5.5 p -71.47 -25.52 62.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.149 -174.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.86 -50.44 80.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.386 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.406 ' HB ' ' HE2' ' A' ' 151' ' ' LYS . 13.0 p -91.46 -5.25 54.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.222 0.534 . . . . 0.0 111.324 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 57.6 mtm 57.56 42.88 23.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.69 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.406 ' HE2' ' HB ' ' A' ' 149' ' ' THR . 57.2 pttt -162.24 175.1 12.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.597 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.601 ' HB3' ' HA ' ' A' ' 145' ' ' TRP . 9.9 p80 -142.13 135.62 29.24 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.991 0.425 . . . . 0.0 110.211 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -129.98 88.73 2.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.714 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 168.12 -130.46 2.1 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.635 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -124.54 177.86 5.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.821 0.344 . . . . 0.0 111.395 -172.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.97 167.14 31.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.305 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -125.46 121.38 33.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.664 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.596 ' HB ' HG12 ' A' ' 114' ' ' VAL . 90.2 t -100.15 116.65 43.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.102 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.507 ' OE1' ' HE3' ' A' ' 139' ' ' LYS . 41.5 tt0 -107.48 126.97 53.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.615 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.98 175.48 5.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.858 0.361 . . . . 0.0 110.964 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.462 ' OE1' ' HD3' ' A' ' 139' ' ' LYS . 5.5 mm-40 -71.98 -37.26 69.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.199 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.04 143.39 45.38 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.466 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.818 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 38.1 Cg_endo -66.26 -14.57 44.84 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.416 2.744 . . . . 0.0 112.219 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.924 ' HG3' ' HE2' ' A' ' 254' ' ' PHE . 15.4 mm-40 -62.33 -53.19 58.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.335 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.551 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.97 -18.98 60.37 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.66 -54.11 6.76 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.622 ' HG3' HG11 ' A' ' 286' ' ' VAL . 19.1 mm-40 -64.05 -36.29 83.51 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.967 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.551 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 12.9 tp -61.05 -48.41 81.88 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.643 177.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.6 -31.91 69.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.837 0.351 . . . . 0.0 110.079 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 185' ' ' VAL . 16.3 tp -72.58 -46.76 52.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 172.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 14.3 mm-40 -52.47 -41.84 63.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.321 0.648 . . . . 0.0 111.701 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -100.72 -51.35 3.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.0 ttp -95.65 30.16 2.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -164.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.477 ' HB3' HD12 ' A' ' 170' ' ' LEU . 10.0 p30 -79.36 21.08 0.5 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.16 -0.337 . . . . 0.0 111.151 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 4.5 m -100.79 -74.11 0.62 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.071 0.462 . . . . 0.0 110.822 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.3 m -144.02 170.33 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.025 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.999 ' HB2' HD13 ' A' ' 183' ' ' ILE . 2.4 tpt -118.64 94.08 4.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.254 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.965 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 73.7 mt 56.13 45.36 23.58 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.788 0.68 . . . . 0.0 110.221 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.18 -135.39 12.96 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -172.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 66.98 -112.09 4.61 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.687 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -144.01 177.86 8.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.391 0.138 . . . . 0.0 110.796 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 175' ' ' SER . 49.2 t-20 -63.9 112.62 3.0 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.2 pt -97.54 168.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.292 0.568 . . . . 0.0 111.58 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 93.4 mttt -103.12 115.21 30.15 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.195 175.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.64 ' O ' HD13 ' A' ' 170' ' ' LEU . 18.3 t -113.01 102.85 14.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 171.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.02 -130.74 10.67 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 48.7 64.48 8.58 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-O 120.763 0.316 . . . . 0.0 111.493 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 190' ' ' ASN . 22.0 Cg_exo -64.57 -49.02 3.6 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.464 2.109 . . . . 0.0 112.251 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.4 t 70.65 -30.97 0.21 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.599 0.76 . . . . 0.0 112.034 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.461 ' H ' ' C ' ' A' ' 188' ' ' PRO . 6.5 t30 -72.61 93.97 1.67 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.631 0.372 . . . . 0.0 110.741 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 50.4 mm 71.5 -69.11 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.502 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 74.58 60.14 3.56 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.119 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -72.8 -26.74 61.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.155 0.502 . . . . 0.0 110.693 -176.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -90.24 -5.41 56.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.452 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.557 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 15.6 mm100 -54.01 -47.11 98.12 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.1 Cg_endo -52.76 -40.74 73.43 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.987 1.791 . . . . 0.0 112.354 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 70.7 mt -73.27 -45.69 52.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.534 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 194' ' ' ALA . 57.7 mt -58.26 -47.17 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.805 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.82 -39.78 91.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.915 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -67.11 -46.34 74.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.626 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 69.0 mt -66.95 -32.84 74.36 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.02 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.64 -46.03 70.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 18.2 mt-10 -68.5 -31.75 71.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.883 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 47.1 mt-10 -67.49 -30.27 69.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.4 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -76.98 -39.22 51.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.968 0.414 . . . . 0.0 110.046 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.566 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 58.5 mtp180 -57.76 -30.11 65.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.891 176.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.22 -19.9 62.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.994 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -110.94 0.12 16.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.799 0.333 . . . . 0.0 111.404 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 56.66 38.12 29.32 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.583 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.86 ' HD2' ' HD3' ' A' ' 289' ' ' PRO . 43.9 ttt180 -87.9 138.38 31.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.937 -173.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.526 ' HA ' ' H ' ' A' ' 285' ' ' ALA . 48.7 pt -129.99 166.19 28.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.088 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.504 ' HD1' ' CE2' ' A' ' 254' ' ' PHE . 84.4 t80 -120.97 129.58 53.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.339 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.626 HG12 HG23 ' A' ' 282' ' ' VAL . 31.5 m -121.23 133.35 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.231 0.538 . . . . 0.0 110.33 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.97 175.09 9.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.193 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 61.1 m 60.71 35.14 19.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.213 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.03 124.24 36.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.293 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 78.3 t60 -54.31 134.31 45.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.575 0.702 . . . . 0.0 111.245 -175.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.425 ' HG2' ' H ' ' A' ' 218' ' ' GLN . 5.8 pt20 -49.12 -35.48 16.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.268 -1.333 . . . . 0.0 114.181 -174.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -105.63 24.55 12.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.835 0.826 . . . . 0.0 110.789 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 217' ' ' HIS . 15.6 tp -105.3 133.46 50.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 21.0 t -98.76 167.17 10.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.044 0.45 . . . . 0.0 111.18 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -66.23 -22.56 66.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.02 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.54 -39.2 93.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.156 177.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 228' ' ' VAL . 33.6 m-20 -71.04 -47.2 59.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.837 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.694 HG13 HD21 ' A' ' 240' ' ' LEU . 8.3 mm -63.16 -47.2 93.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 47.8 tttm -56.77 -45.51 82.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.226 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 77.6 p -60.87 -37.59 82.67 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -174.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 224' ' ' ASP . 4.8 t -76.35 -45.45 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.676 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.6 ' CB ' HD11 ' A' ' 235' ' ' ILE . 38.0 m-85 -62.74 -34.9 78.16 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.1 mm-40 -62.0 -24.37 67.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.731 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.05 -10.25 59.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.275 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.96 -43.65 4.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.083 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -145.73 -175.94 19.22 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.331 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -87.01 111.47 20.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.895 0.379 . . . . 0.0 110.346 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.6 HD11 ' CB ' ' A' ' 229' ' ' PHE . 14.3 mt -81.25 146.52 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.861 0.839 . . . . 0.0 111.962 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -109.58 -32.83 6.98 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.799 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 55.4 m -157.52 146.24 19.54 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -173.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 226' ' ' LYS . 43.2 t -153.9 99.53 2.28 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.488 0.493 . . . . 0.0 109.766 174.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.9 m -130.0 115.95 17.87 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.646 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.694 HD21 HG13 ' A' ' 225' ' ' ILE . 57.6 mt -84.59 135.82 34.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.63 112.95 1.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.668 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 27.0 ttp180 -133.57 141.78 47.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -83.93 112.42 40.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.712 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.97 -36.79 81.19 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.211 2.607 . . . . 0.0 113.305 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.9 t -93.99 13.39 23.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.768 0.318 . . . . 0.0 111.663 -172.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 80.3 p -125.2 -39.89 2.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.802 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 98.01 9.83 53.27 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.232 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -118.37 146.8 44.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 4.1 p80 -95.07 143.63 26.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -64.21 -65.36 0.69 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -168.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 177.99 -3.4 0.03 OUTLIER Glycine 0 CA--C 1.519 0.304 0 C-N-CA 119.871 -1.156 . . . . 0.0 113.751 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -140.26 172.37 12.84 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.342 -0.505 . . . . 0.0 110.472 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.598 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -160.22 174.98 37.04 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.924 ' HE2' ' HG3' ' A' ' 164' ' ' GLU . 85.1 m-85 -129.19 143.25 50.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.664 0.268 . . . . 0.0 110.874 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.515 HD11 HG22 ' A' ' 225' ' ' ILE . 92.3 mt -137.56 140.73 41.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.222 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 237' ' ' SER . 43.3 mt-10 -122.88 148.18 45.73 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.645 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 20.9 m-85 -116.98 158.05 24.76 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.007 0.432 . . . . 0.0 110.487 176.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.11 -3.91 58.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.757 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -135.67 134.03 38.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.095 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.74 -32.82 74.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.581 -171.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -70.48 -39.13 74.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.931 0.395 . . . . 0.0 110.437 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.8 m -64.97 -37.59 88.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.736 -174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 43.5 p -68.49 -45.13 73.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.167 0.508 . . . . 0.0 110.649 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -72.19 -22.16 61.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.944 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.52 -40.03 62.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 110.549 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.31 -33.4 75.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.474 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 263' ' ' SER . 97.7 t -56.16 -26.91 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.994 0.426 . . . . 0.0 111.137 173.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.2 t -85.72 -46.8 10.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.018 -0.427 . . . . 0.0 110.639 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.4 m -69.83 -38.2 76.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.422 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 89.5 mmm -91.81 -2.61 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.76 0.314 . . . . 0.0 111.543 -173.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 282' ' ' VAL . 39.7 t30 -72.12 124.53 25.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.306 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.2 mt 63.48 25.9 14.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.326 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -83.11 118.04 23.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.774 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.82 121.45 21.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.2 tp -141.62 91.82 2.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.025 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 95.28 25.7 13.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.935 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 89.25 1.22 79.15 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.784 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -126.14 148.53 49.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.642 0.258 . . . . 0.0 110.541 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -89.83 117.67 28.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.404 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.21 120.56 14.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.791 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -93.8 115.75 28.18 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 174.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.626 HG23 HG12 ' A' ' 213' ' ' VAL . 14.2 p -121.08 143.76 32.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.053 0.454 . . . . 0.0 110.851 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -156.61 -179.69 31.78 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.684 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -80.25 133.74 36.02 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.526 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -76.3 146.26 39.01 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.622 HG11 ' HG3' ' A' ' 167' ' ' GLN . 30.8 m -112.66 -3.65 10.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.717 0.294 . . . . 0.0 111.516 -174.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 41.5 p -123.07 139.37 31.42 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.902 0.382 . . . . 0.0 111.015 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.41 138.03 37.93 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.834 2.356 . . . . 0.0 111.196 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.86 ' HD3' ' HD2' ' A' ' 210' ' ' ARG . 18.6 Cg_endo -59.47 -40.69 64.43 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.202 2.601 . . . . 0.0 112.73 -175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 53.6 ttp 49.7 79.36 0.35 Allowed Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 123.912 0.757 . . . . 0.0 111.796 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.88 124.87 14.28 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.345 2.03 . . . . 0.0 111.91 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.6 pp -148.81 161.88 40.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.945 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 93.1 mt -134.36 90.8 2.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.243 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 39.1 p 46.44 67.81 4.03 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.34 117.86 4.48 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.099 1.866 . . . . 0.0 111.705 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -115.86 -8.0 11.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.988 0.423 . . . . 0.0 111.439 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.297 -177.437 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.56 104.52 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.889 0.376 . . . . 0.0 110.649 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 25.1 mmt -85.56 129.56 34.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.517 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 65.57 179.37 0.2 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.015 0.822 . . . . 0.0 111.417 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 54.08 42.28 31.66 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 111.343 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.621 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.7 tpm_? -84.49 102.39 12.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.492 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.43 ' HB2' HD12 ' A' ' 108' ' ' LEU . 16.0 mm-40 -96.3 100.41 12.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.195 176.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -64.67 -28.43 69.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.18 -30.09 70.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 111' ' ' MET . 26.0 mt -70.81 -30.84 67.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.23 -25.24 66.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.362 0.601 . . . . 0.0 110.094 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.0 mt -84.08 -40.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.786 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 108' ' ' LEU . 60.2 mmm -61.12 -29.97 70.09 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.543 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 73.5 m -73.87 -13.64 60.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.441 0.162 . . . . 0.0 111.237 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.632 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 29.8 mtp85 -108.96 139.89 43.21 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.25 135.51 63.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.165 0.507 . . . . 0.0 110.349 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -77.91 119.26 21.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.817 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 13.5 m -121.15 116.05 48.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.221 0.534 . . . . 0.0 110.348 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 155' ' ' PHE . . . -117.8 170.17 13.51 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.193 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.437 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 20.9 t 72.09 51.18 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.608 0.718 . . . . 0.0 110.391 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.0 mt -103.06 127.43 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.651 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -72.11 147.15 46.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.876 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -72.37 75.59 1.02 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.855 0.836 . . . . 0.0 111.005 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -154.63 -45.55 0.09 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.845 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.442 HD13 ' HG3' ' A' ' 177' ' ' MET . 22.0 mt -77.29 91.37 3.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.03 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.25 -179.85 44.57 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.979 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -55.51 -46.4 76.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.117 0.484 . . . . 0.0 111.227 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.5 -46.57 89.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.103 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.3 m -67.27 -42.16 84.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.988 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.1 mm -61.41 -45.27 98.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.084 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.531 ' HG3' HD12 ' A' ' 138' ' ' ILE . 59.0 ttt180 -62.4 -37.39 85.6 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.509 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -69.81 -33.4 72.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.068 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.47 -33.33 54.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.642 ' HB2' HD11 ' A' ' 138' ' ' ILE . 52.2 m-85 -90.1 -13.65 35.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.818 0.342 . . . . 0.0 111.068 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.89 -41.28 84.19 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 44.9 Cg_exo -40.97 -40.36 3.71 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.035 2.49 . . . . 0.0 114.26 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.496 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 43.6 m-85 -79.25 -47.93 15.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.685 0.279 . . . . 0.0 111.21 -176.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.31 170.04 41.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.702 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.2 122.69 9.76 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.755 2.303 . . . . 0.0 111.629 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' A' ' 132' ' ' PHE . 75.1 mt -81.84 132.09 32.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.132 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -89.84 -43.6 10.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.307 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 97.4 p -157.7 155.24 29.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.139 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.429 HG22 ' HG2' ' A' ' 143' ' ' MET . 62.7 mt -133.52 127.01 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.65 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 28.9 m-20 -91.85 106.16 18.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.072 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.429 ' HG2' HG22 ' A' ' 141' ' ' ILE . 17.4 mmt -111.5 118.24 35.2 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.734 0.302 . . . . 0.0 111.062 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.0 m -79.27 73.08 5.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.795 0.807 . . . . 0.0 110.495 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 60.3 t-105 -79.77 83.02 5.78 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.602 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -119.55 71.08 0.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.567 -170.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 91.3 p -169.99 139.82 1.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.537 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.1 m -73.13 -19.69 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.706 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 p -85.91 4.67 36.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.001 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 48.5 mtm 66.57 64.71 0.48 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.444 175.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -150.98 164.03 37.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -132.53 122.43 24.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.229 0.538 . . . . 0.0 110.363 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -126.46 123.29 37.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.907 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 142.23 -97.78 0.21 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.666 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.448 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 52.0 p90 -147.15 175.44 10.72 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.174 0.511 . . . . 0.0 111.334 -175.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.37 163.56 39.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.673 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.731 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 96.2 m-85 -123.06 120.33 32.98 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.1 t -104.71 112.19 37.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.644 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.632 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 40.5 tt0 -102.88 131.07 50.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.5 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 81.3 m-85 -104.93 179.48 4.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.625 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -67.31 -38.53 85.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.165 0.507 . . . . 0.0 110.092 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.63 149.78 69.13 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.37 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 56.9 Cg_endo -70.02 -14.01 34.73 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.356 2.704 . . . . 0.0 112.237 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.591 ' HG3' ' CE1' ' A' ' 254' ' ' PHE . 75.5 mm-40 -60.82 -53.03 62.38 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.544 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -63.38 -14.34 49.16 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.973 0.416 . . . . 0.0 111.898 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.5 -54.2 5.37 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.597 ' HG3' HG21 ' A' ' 286' ' ' VAL . 15.9 mm100 -65.57 -34.0 77.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.968 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.496 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 25.6 tp -65.41 -43.58 90.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.238 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.76 -28.26 69.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.037 0.446 . . . . 0.0 110.08 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.66 -50.9 31.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.406 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -54.35 -35.36 62.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.37 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -100.61 -52.3 3.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 34.5 ttp -106.56 31.26 5.36 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -163.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -77.1 17.01 0.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.338 -0.226 . . . . 0.0 111.567 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.1 m -110.04 -73.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.57 0.224 . . . . 0.0 111.483 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.4 m -135.54 159.53 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.535 0.207 . . . . 0.0 110.938 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.998 ' HB2' HD13 ' A' ' 183' ' ' ILE . 3.5 tpt -123.88 96.61 5.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.892 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 24.0 tp 50.61 61.53 3.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.671 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.56 -179.28 18.94 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.306 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.76 57.71 5.04 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.093 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -134.21 119.0 18.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -75.55 136.38 40.56 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.902 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.998 HD13 ' HB2' ' A' ' 177' ' ' MET . 42.0 pt -124.32 158.42 31.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.678 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 22.7 tptm -111.3 106.41 15.36 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.37 110.1 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.938 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 103.28 176.95 26.38 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.212 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -127.28 136.47 28.95 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.42 126.54 22.83 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.995 2.464 . . . . 0.0 111.934 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.2 m -74.53 62.37 1.01 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.551 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.02 -63.33 1.28 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.095 0.474 . . . . 0.0 109.824 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.1 tp -132.99 146.14 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.836 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 160.01 147.33 4.87 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.779 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.451 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 22.0 tp60 -78.83 -29.14 44.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.821 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -75.87 -19.49 58.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.625 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 27.9 mm-40 -58.83 -51.45 81.75 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.288 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 64.2 Cg_exo -53.63 -38.36 84.18 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.208 1.939 . . . . 0.0 112.764 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.82 -39.31 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.511 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 194' ' ' ALA . 72.3 mt -60.32 -45.98 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 175.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.597 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 26.0 t70 -61.54 -41.97 98.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.431 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.26 -51.38 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.256 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 44.8 mt -68.29 -32.77 73.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.85 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.47 -41.78 77.1 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 32.5 mt-10 -67.67 -33.91 75.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.544 174.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -63.68 -37.36 87.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.937 0.399 . . . . 0.0 110.653 175.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.57 -37.33 73.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.505 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' A' ' 203' ' ' GLU . 29.5 mtp180 -59.29 -26.02 64.61 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.357 176.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -76.91 -11.29 59.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -111.37 179.28 4.07 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 62.0 m-20 -126.25 38.76 4.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.977 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 10.3 ptp180 -108.28 158.06 17.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.646 0.736 . . . . 0.0 112.603 -170.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.616 HG23 ' HB2' ' A' ' 263' ' ' SER . 41.3 pt -135.39 166.63 27.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.623 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.424 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 57.1 t80 -112.62 124.03 51.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.377 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 26.8 m -115.01 131.3 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.382 0.61 . . . . 0.0 110.453 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -122.66 172.0 8.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.873 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 24.3 m 63.79 22.23 12.98 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.506 0.67 . . . . 0.0 110.461 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 38.2 t -79.7 109.02 13.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.806 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -56.04 142.8 34.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.285 0.564 . . . . 0.0 111.033 -171.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -59.13 -22.5 60.98 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -168.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -92.51 -13.28 30.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 93.6 mt -81.84 133.81 35.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 19.0 m -96.69 171.71 8.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.604 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.5 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 9.8 p-10 -61.02 -42.17 97.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.581 0.229 . . . . 0.0 111.552 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.25 -27.1 69.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.366 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.58 -48.28 33.97 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.896 0.379 . . . . 0.0 110.086 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.56 HG22 HD11 ' A' ' 255' ' ' ILE . 34.2 mm -61.93 -38.54 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.527 ' HG3' HG21 ' A' ' 235' ' ' ILE . 63.0 tttm -56.26 -52.57 63.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.114 175.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 88.3 p -58.55 -34.43 71.01 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.83 -50.01 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 121.129 -0.229 . . . . 0.0 111.279 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.732 ' HB2' HD11 ' A' ' 235' ' ' ILE . 20.8 m-85 -64.31 -34.18 77.55 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.207 0.527 . . . . 0.0 111.074 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -63.63 -23.6 67.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.429 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.23 -11.57 60.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.76 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -112.04 -37.95 4.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.724 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.498 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -140.29 167.63 25.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.499 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 67.0 mmtt -78.64 99.72 6.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.845 0.355 . . . . 0.0 111.053 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 229' ' ' PHE . 8.3 mt -77.05 146.19 9.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.615 0.721 . . . . 0.0 111.453 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -110.49 -37.19 5.56 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.664 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 25.8 m -154.5 151.36 28.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -172.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 255' ' ' ILE . 52.9 t -153.7 116.14 4.4 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 61.9 m -141.23 111.28 6.67 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.676 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.57 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 34.8 mt -81.8 137.75 35.25 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -62.05 113.51 2.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 70.3 ttt180 -137.74 141.34 40.98 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.68 -167.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 244' ' ' PRO . 28.7 m-20 -105.02 117.64 58.12 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.179 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 18.4 Cg_endo -57.77 -28.41 81.94 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 123.573 2.848 . . . . 0.0 112.952 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.2 t -79.82 -13.27 59.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.072 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 37.0 p -106.01 -36.93 6.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.956 0.408 . . . . 0.0 111.241 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.76 -35.12 4.19 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.822 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 63.5 pttt -87.43 -179.77 6.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 241' ' ' ALA . 6.2 p80 -120.35 163.77 17.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.883 0.373 . . . . 0.0 110.174 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -71.09 -3.93 22.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.389 -167.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 111.71 -11.02 27.81 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.176 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.424 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 51.5 p90 -135.23 173.54 11.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.707 0.289 . . . . 0.0 111.062 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -165.36 175.03 41.22 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.065 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.591 ' CE1' ' HG3' ' A' ' 164' ' ' GLU . 94.0 m-85 -128.88 142.9 50.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.766 0.317 . . . . 0.0 110.767 -178.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.56 HD11 HG22 ' A' ' 225' ' ' ILE . 83.9 mt -136.3 132.21 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.451 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.977 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 18.6 mt-10 -109.24 147.95 31.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.498 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 12.5 m-85 -112.18 150.26 31.09 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 123.164 0.29 . . . . 0.0 110.66 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.22 -55.35 29.31 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -73.65 117.13 15.06 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.536 171.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -52.99 -38.41 62.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.211 -175.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -75.08 -30.63 61.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.64 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.553 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 69.0 m -64.52 -19.76 65.8 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.616 ' HB2' HG23 ' A' ' 211' ' ' ILE . 78.1 p -57.69 -46.08 84.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.206 0.527 . . . . 0.0 109.929 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -76.68 -13.87 60.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.107 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.553 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 2.6 m-20 -64.69 -47.92 76.61 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 173.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.43 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . . . -64.96 -35.75 82.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.214 176.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 263' ' ' SER . 89.0 t -56.82 -31.89 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.273 0.559 . . . . 0.0 110.787 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 20.2 m -80.64 -38.38 29.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.499 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 24.7 t -93.91 -34.02 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.477 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 91.1 mmm -84.74 -4.64 59.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 -174.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.489 ' HA ' HG12 ' A' ' 282' ' ' VAL . 50.8 t30 -68.9 117.03 10.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.864 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 95.4 mt 67.95 40.13 2.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.316 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -96.73 121.78 38.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.683 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.18 111.37 10.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.586 0.708 . . . . 0.0 111.17 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.4 tp -140.69 110.35 6.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.432 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 91.77 25.28 23.19 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.435 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 74.97 10.69 84.02 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.517 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -138.26 144.51 40.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -76.44 116.32 17.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.648 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.95 128.84 38.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.908 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 9.4 mmt85 -98.5 115.31 28.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 271' ' ' ASN . 14.3 p -116.25 144.0 24.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.788 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.63 178.47 32.21 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.608 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -77.09 132.73 39.03 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.35 114.42 7.58 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.597 HG21 ' HG3' ' A' ' 167' ' ' GLN . 28.6 m -87.29 -27.6 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.808 -171.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.602 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 22.2 p -136.35 162.74 54.6 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.442 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -94.86 102.42 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.489 2.126 . . . . 0.0 112.162 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 287' ' ' THR . 23.6 Cg_exo -65.39 -29.34 54.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.478 2.119 . . . . 0.0 110.941 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 67.7 mtm -120.98 92.73 48.62 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.237 175.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -75.78 62.42 6.47 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 123.435 2.757 . . . . 0.0 112.222 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 292' ' ' LEU . 0.9 OUTLIER -170.62 103.13 0.25 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.316 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.1 tp -115.2 103.06 10.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.929 0.395 . . . . 0.0 110.408 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 7.1 t -122.22 121.25 27.9 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.289 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 4.0 Cg_exo -76.7 77.02 3.81 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.825 2.35 . . . . 0.0 111.528 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -85.66 -10.15 56.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.479 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.308 -179.513 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.44 96.8 4.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.894 0.378 . . . . 0.0 110.592 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -138.77 -22.74 0.96 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.771 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -162.12 98.38 1.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.352 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -139.1 -80.61 0.31 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.782 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 28.5 tpt180 63.62 90.7 0.08 Allowed 'General case' 0 C--N 1.333 -0.122 0 O-C-N 123.876 0.735 . . . . 0.0 110.817 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -61.9 106.93 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.989 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -60.44 -37.46 81.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.509 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.07 -32.18 72.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.258 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.494 HD23 ' SD ' ' A' ' 111' ' ' MET . 25.1 mt -67.75 -32.47 73.1 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.962 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.31 -29.64 70.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.262 0.553 . . . . 0.0 109.907 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.7 mt -82.34 -38.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.28 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.494 ' SD ' HD23 ' A' ' 108' ' ' LEU . 91.4 mtp -67.41 -30.07 69.73 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.727 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.6 m -74.18 -21.63 59.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.852 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 96.6 mtt180 -97.32 139.68 32.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 p -126.15 132.02 70.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.16 0.505 . . . . 0.0 110.319 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.52 ' HB2' ' HD3' ' A' ' 187' ' ' ARG . 91.3 t80 -76.58 117.1 17.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.426 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 41.2 t -115.89 114.96 47.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.811 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.7 169.13 18.68 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.026 -176.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.746 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 12.2 t 68.64 33.98 3.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.359 0.599 . . . . 0.0 110.871 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.9 mt -80.56 -13.19 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.049 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 65.9 t80 72.69 147.18 0.08 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.901 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 152' ' ' HIS . 12.8 p90 -77.34 76.22 3.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.38 0.609 . . . . 0.0 111.372 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.87 -65.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.23 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.8 mt -54.86 108.38 0.39 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.577 0.548 . . . . 0.0 111.503 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.21 -173.0 40.97 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.892 -174.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.14 -46.72 88.7 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.295 -0.452 . . . . 0.0 111.781 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 1.1 m-20 -60.41 -45.0 95.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.627 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.6 m -59.73 -43.7 94.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.874 0.368 . . . . 0.0 110.836 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.8 mm -63.98 -45.65 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.408 0.623 . . . . 0.0 110.226 177.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -56.58 -45.78 81.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.269 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 58.9 mt-30 -63.82 -34.12 77.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.526 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.56 -29.4 30.35 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -93.15 -20.18 20.74 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.457 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -50.2 -42.3 71.57 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 73.6 Cg_exo -42.3 -42.79 7.75 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 123.168 2.579 . . . . 0.0 114.786 174.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -78.38 -36.64 45.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -169.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 165' ' ' ALA . . . -177.87 -172.67 42.59 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.132 175.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.547 ' HG3' ' CE1' ' A' ' 252' ' ' TYR . 73.0 Cg_endo -76.28 129.15 10.99 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.955 2.436 . . . . 0.0 112.123 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.2 mt -90.11 128.6 41.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.29 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.571 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 24.5 ttmm -91.98 -37.23 12.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.711 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.3 p -169.71 157.04 6.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.381 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.6 mt -126.64 108.3 18.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.46 99.53 11.72 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.766 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 57.4 ttm -119.7 127.47 52.9 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.089 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 m -67.29 80.24 0.15 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.573 0.546 . . . . 0.0 110.426 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -90.58 111.82 23.27 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.734 -174.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -67.94 114.85 6.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.907 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 p -68.83 -12.1 61.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.927 0.394 . . . . 0.0 111.548 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.88 -55.79 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.434 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.7 p -95.91 -12.29 25.36 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 31.9 mtm 60.93 47.28 7.71 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.505 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -135.13 176.4 8.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.262 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 121' ' ' TYR . 5.8 p80 -137.82 112.96 9.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 171.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 41.0 ttmt -94.88 100.5 12.36 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.91 0.386 . . . . 0.0 110.174 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 135.46 -93.83 0.24 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.672 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -141.24 178.64 7.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.416 0.627 . . . . 0.0 112.468 -166.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.72 156.25 31.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.269 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' CE2' ' HD1' ' A' ' 115' ' ' TYR . 76.8 m-85 -113.04 126.18 55.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.12 114.01 41.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 38.6 tt0 -101.47 122.27 43.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.577 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -97.56 172.61 7.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.024 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.571 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 23.6 mt-10 -93.5 -7.43 44.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.963 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.1 m -140.22 135.43 16.18 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.809 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.26 -25.75 36.34 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.195 2.597 . . . . 0.0 113.036 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.478 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 18.4 mp0 -55.81 -45.06 78.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.546 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . . . -55.62 -40.28 71.9 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.937 0.398 . . . . 0.0 111.352 175.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.5 -35.02 78.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.904 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.68 ' HG3' HG11 ' A' ' 286' ' ' VAL . 16.6 mm-40 -68.38 -48.13 65.54 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.671 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.589 HD11 ' HD2' ' A' ' 212' ' ' TYR . 64.0 mt -60.38 -43.68 96.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.177 0.513 . . . . 0.0 111.113 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.61 -37.24 80.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.563 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 8.2 tt -72.41 -48.51 40.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.092 174.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -53.36 -43.24 67.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.264 -177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -100.23 -49.22 4.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 176' ' ' VAL . 16.1 ttp -107.91 29.97 6.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.685 -166.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.599 ' HB2' ' O ' ' A' ' 170' ' ' LEU . 7.1 t30 -54.63 -51.13 66.36 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -174.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 19.2 m -113.61 16.48 18.67 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -169.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' A' ' 173' ' ' MET . 10.7 m -140.02 135.89 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.832 0.287 . . . . 0.0 110.98 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.999 ' HB2' HD13 ' A' ' 183' ' ' ILE . 27.7 tpp -126.68 102.09 6.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.911 0.386 . . . . 0.0 110.932 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 21.0 tp 71.13 -68.41 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.149 172.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -114.15 -143.34 8.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.094 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.56 65.73 3.91 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.204 -0.522 . . . . 0.0 111.875 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -131.73 120.09 22.24 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 175' ' ' SER . 6.2 p30 -77.84 128.64 34.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 177' ' ' MET . 37.0 pt -135.78 -175.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.245 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 68.2 mmtt -134.15 106.67 7.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.037 174.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 174' ' ' ASN . 54.9 t -99.49 101.53 12.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 130.16 166.66 11.87 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.52 ' HD3' ' HB2' ' A' ' 115' ' ' TYR . 23.6 ptt180 -147.49 134.07 9.9 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.989 0.394 . . . . 0.0 111.309 -177.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 7.6 Cg_exo -72.96 75.17 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.056 2.504 . . . . 0.0 110.611 173.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 p -59.74 126.52 27.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.266 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -63.36 139.04 58.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.028 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.5 mm -58.5 123.23 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.694 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -149.56 -141.35 3.41 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.952 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.422 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 27.0 tt0 -82.8 -33.37 27.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.982 0.42 . . . . 0.0 111.014 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -69.36 -34.99 75.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.855 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.662 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 15.6 tm0? -57.97 -53.33 66.94 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.222 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 74.7 Cg_exo -53.46 -36.04 78.21 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.588 2.192 . . . . 0.0 112.905 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.41 -42.0 73.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.777 0.322 . . . . 0.0 110.243 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 194' ' ' ALA . 81.5 mt -61.14 -47.88 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.287 0.565 . . . . 0.0 109.973 176.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.15 -37.47 87.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.836 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -58.95 -52.89 63.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.918 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 67.7 mt -68.04 -33.14 74.02 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.987 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.659 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.95 -46.03 71.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.4 -36.79 83.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.962 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.566 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 39.4 mt-10 -67.77 -27.39 66.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.975 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.13 -27.83 59.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.028 0.442 . . . . 0.0 110.326 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.659 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 72.4 mtp180 -74.39 -15.59 60.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.503 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.88 -11.01 60.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.511 0.672 . . . . 0.0 109.992 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -115.87 -178.74 3.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.388 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 9.6 m-80 -123.92 46.06 2.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -102.61 139.18 38.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.284 -166.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.475 HG23 ' HB2' ' A' ' 263' ' ' SER . 37.6 pt -125.17 166.55 20.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.798 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.623 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 49.0 t80 -117.65 130.07 56.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.697 -175.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.1 132.89 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.004 0.431 . . . . 0.0 110.256 176.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.02 176.46 7.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.6 t 64.41 22.71 12.81 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 123.93 0.768 . . . . 0.0 109.204 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.404 HG13 HD11 ' A' ' 225' ' ' ILE . 15.4 t -67.87 121.82 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.761 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -62.66 143.05 57.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.454 0.169 . . . . 0.0 110.687 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.63 ' HA ' ' CE1' ' A' ' 249' ' ' HIS . 28.6 pt20 -61.05 -16.82 48.01 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -166.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -105.4 -5.52 20.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.046 0.451 . . . . 0.0 110.846 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.541 HD21 ' HG ' ' A' ' 275' ' ' LEU . 2.9 tp -83.55 130.3 35.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' SER . . . . . 0.559 ' O ' HG12 ' A' ' 225' ' ' ILE . 29.7 p -102.37 167.84 9.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.377 -174.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.42 ' HB3' ' HG ' ' A' ' 240' ' ' LEU . 0.5 OUTLIER -60.81 -37.98 83.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.282 0.563 . . . . 0.0 109.958 174.725 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -54.65 -40.03 68.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.997 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.7 -47.24 41.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.68 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.671 HG22 HD11 ' A' ' 255' ' ' ILE . 34.0 mm -60.41 -42.5 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.55 ' HG3' HG21 ' A' ' 235' ' ' ILE . 86.2 tttt -57.36 -48.78 78.12 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.04 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 88.0 p -60.83 -35.34 76.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -173.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.58 -43.67 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.633 0.254 . . . . 0.0 111.232 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.588 ' CB ' HD11 ' A' ' 235' ' ' ILE . 10.3 m-85 -68.26 -29.41 68.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.297 0.57 . . . . 0.0 110.802 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.87 -24.77 67.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.054 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.0 -17.84 62.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.889 -175.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.21 -44.73 3.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.02 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.62 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -124.55 170.17 16.61 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.098 -175.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -86.4 99.07 11.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.588 HD11 ' CB ' ' A' ' 229' ' ' PHE . 12.8 mt -84.59 150.82 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.332 0.587 . . . . 0.0 111.458 -175.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -117.04 -27.86 6.41 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.471 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.0 t -167.94 149.41 5.32 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.726 -173.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.571 ' SG ' HG12 ' A' ' 255' ' ' ILE . 50.3 t -148.2 126.3 12.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.257 175.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 99.0 m -142.52 121.33 12.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.787 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.448 ' CD2' ' HA3' ' A' ' 253' ' ' GLY . 31.1 mt -82.7 141.04 32.74 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.31 114.86 6.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.463 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 80.3 mtm180 -127.79 163.16 24.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.328 0.585 . . . . 0.0 112.365 -172.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 244' ' ' PRO . 9.6 m-20 -104.69 104.95 48.47 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.458 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 9.6 Cg_endo -50.03 -45.74 31.45 Favored 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 123.86 3.04 . . . . 0.0 114.934 -167.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.8 p -93.21 9.58 35.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.447 ' OG1' ' HG2' ' A' ' 248' ' ' LYS . 72.3 p -114.5 -38.7 3.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.971 0.415 . . . . 0.0 110.469 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.15 2.54 56.89 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.34 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.447 ' HG2' ' OG1' ' A' ' 246' ' ' THR . 19.8 ptmt -99.27 158.33 15.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.887 0.375 . . . . 0.0 110.532 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.63 ' CE1' ' HA ' ' A' ' 218' ' ' GLN . 22.4 p80 -105.63 152.32 23.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -80.18 -1.29 39.8 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.832 -170.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 113.05 -6.98 25.38 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.375 172.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.547 ' CE1' ' HG3' ' A' ' 137' ' ' PRO . 24.3 p90 -138.2 161.86 35.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.664 0.269 . . . . 0.0 110.541 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' A' ' 240' ' ' LEU . . . -154.12 172.49 32.74 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.889 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.623 ' CE1' ' HD1' ' A' ' 212' ' ' TYR . 29.9 m-85 -129.0 144.07 51.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.811 0.339 . . . . 0.0 110.464 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.671 HD11 HG22 ' A' ' 225' ' ' ILE . 77.5 mt -136.09 133.2 50.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.297 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 33.4 mt-10 -113.78 143.72 44.17 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.62 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 6.6 m-85 -110.6 170.12 8.3 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.095 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.623 ' HB2' ' HD2' ' A' ' 259' ' ' LYS . 34.4 mt-10 -72.78 -43.56 62.66 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.709 0.766 . . . . 0.0 109.008 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LYS . . . . . 0.623 ' HD2' ' HB2' ' A' ' 258' ' ' GLU . 11.0 mptt -105.81 130.09 53.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.058 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.79 -25.72 68.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.32 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -75.43 -31.92 60.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.776 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.4 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 46.7 m -70.12 -34.91 73.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.355 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.475 ' HB2' HG23 ' A' ' 211' ' ' ILE . 55.2 p -66.29 -34.61 78.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.339 0.59 . . . . 0.0 109.751 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -71.63 -25.93 62.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.556 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -68.45 -42.41 78.85 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.367 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.74 88.09 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.498 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.436 HG13 ' HA2' ' A' ' 283' ' ' GLY . 80.3 t -52.79 -48.71 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.985 0.422 . . . . 0.0 111.406 175.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.3 m -71.36 -23.47 61.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.1 m -94.34 -43.44 8.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' MET . . . . . . . . . . . . . 84.8 mmm -89.84 -4.4 57.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.022 -169.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -76.96 122.51 24.98 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.992 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.608 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 96.7 mt 70.79 27.97 3.46 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.182 -175.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -89.71 124.36 34.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.094 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -77.56 107.45 10.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.974 0.416 . . . . 0.0 110.961 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.541 ' HG ' HD21 ' A' ' 220' ' ' LEU . 31.2 tp -134.13 98.85 4.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.059 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 101.56 2.67 53.27 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.151 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.13 -0.15 41.12 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.319 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -131.68 142.44 49.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.804 0.335 . . . . 0.0 110.557 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.608 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 21.7 m-85 -74.0 111.22 8.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.592 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.44 128.16 35.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.884 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -98.95 116.23 30.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 212' ' ' TYR . 10.2 p -125.7 141.92 44.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.838 -176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.436 ' HA2' HG13 ' A' ' 267' ' ' VAL . . . -160.8 173.41 37.29 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.397 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -71.1 125.99 28.37 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.85 124.05 21.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.68 HG11 ' HG3' ' A' ' 167' ' ' GLN . 34.0 m -88.79 -19.23 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 111.385 -172.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.547 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 5.4 t -147.36 147.98 30.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 173.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 60.7 Cg_endo -73.21 103.74 1.66 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.78 2.32 . . . . 0.0 112.717 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 287' ' ' THR . 18.1 Cg_endo -97.4 150.22 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.592 2.861 . . . . 0.0 112.056 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 67.4 mtm -133.74 122.86 16.89 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.423 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.43 -9.49 24.24 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.478 2.118 . . . . 0.0 112.12 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 21.7 tp 60.96 44.27 10.67 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.725 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 49.3 tp -78.1 -74.4 0.27 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.091 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 17.9 m -117.74 95.25 47.59 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.307 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.79 76.69 3.62 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.116 2.544 . . . . 0.0 111.862 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -92.82 128.61 38.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.608 -0.71 . . . . 0.0 110.212 176.972 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 112.239 -0.344 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.83 41.41 14.63 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.795 0.438 . . . . 0.0 111.512 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 67.6 mtt -125.09 150.79 46.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.828 0.347 . . . . 0.0 110.676 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -129.11 117.62 21.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.389 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.776 ' HG3' ' H ' ' A' ' 104' ' ' ARG . 6.2 tp60 -168.87 -173.0 1.72 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.776 ' H ' ' HG3' ' A' ' 103' ' ' GLN . 14.1 ttp180 -59.22 -19.34 44.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.154 0.502 . . . . 0.0 111.019 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.496 ' HG2' ' HB3' ' A' ' 103' ' ' GLN . 13.5 pt20 -69.58 4.48 1.84 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.569 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -57.25 -37.34 72.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.139 0.495 . . . . 0.0 109.931 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.22 88.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.236 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.442 HD23 ' SD ' ' A' ' 111' ' ' MET . 66.7 mt -61.87 -35.26 77.78 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.999 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.66 -26.51 68.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.346 0.593 . . . . 0.0 110.818 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.77 -37.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.778 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.508 ' SD ' HG12 ' A' ' 198' ' ' ILE . 88.1 mtp -70.57 -29.68 66.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.741 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.1 m -70.64 -17.71 62.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 110.875 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -98.5 140.81 32.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.855 0.36 . . . . 0.0 110.146 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.778 HG12 ' HB ' ' A' ' 158' ' ' VAL . 3.7 p -120.47 126.88 75.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.672 0.749 . . . . 0.0 109.994 176.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -83.69 101.25 11.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.053 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 25.1 m -108.35 143.15 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.033 0.445 . . . . 0.0 111.243 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.795 ' HA3' ' HD1' ' A' ' 155' ' ' PHE . . . -152.4 177.68 30.02 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.36 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 23.2 t 65.01 50.09 1.95 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.672 0.749 . . . . 0.0 109.294 -175.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 123' ' ' LEU . 77.1 mt -103.14 116.45 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.936 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -61.21 147.89 42.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.638 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -74.07 76.29 1.73 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.027 0.918 . . . . 0.0 111.047 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -163.55 -38.24 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 119' ' ' ILE . 26.8 mt -76.53 92.6 3.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.453 174.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.56 -169.49 44.93 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.583 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 129' ' ' ARG . 20.8 tt0 -54.33 -46.51 72.89 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -64.11 -44.93 90.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.564 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -63.89 -45.17 90.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.562 HG13 ' HE1' ' A' ' 143' ' ' MET . 26.8 mm -69.17 -35.46 68.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.122 0.487 . . . . 0.0 110.427 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 27.9 ttt180 -59.37 -45.48 91.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.802 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.2 -33.45 71.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.838 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.19 -38.73 30.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.502 ' CD1' HG23 ' A' ' 128' ' ' ILE . 24.6 m-85 -89.33 -22.43 22.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.38 -42.97 90.16 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -44.96 -31.95 5.93 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.991 2.46 . . . . 0.0 114.53 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.689 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 74.6 m-85 -82.06 -37.2 26.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.48 -175.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 165' ' ' ALA . . . -178.49 173.62 45.97 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.798 174.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.1 126.19 15.38 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.985 2.457 . . . . 0.0 111.956 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.622 HD13 HD11 ' A' ' 141' ' ' ILE . 61.9 mt -89.06 139.27 17.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.635 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.599 ' HD2' ' OE2' ' A' ' 159' ' ' GLU . 22.1 ttmm -98.84 -43.86 6.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.099 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.8 t -159.63 142.53 13.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.096 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.622 HD11 HD13 ' A' ' 138' ' ' ILE . 70.0 mt -126.17 110.42 23.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.87 0.366 . . . . 0.0 110.089 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 25.9 t70 -91.45 100.82 13.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.185 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.562 ' HE1' HG13 ' A' ' 128' ' ' ILE . 51.3 ttm -138.86 111.3 7.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.023 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 59.4 m -74.48 75.64 1.94 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.128 0.489 . . . . 0.0 111.377 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.455 ' HZ3' ' HA ' ' A' ' 147' ' ' SER . 3.9 t90 -104.28 92.81 4.5 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.81 115.21 12.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.588 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.455 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 17.8 m -68.83 -19.76 64.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.909 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 66.2 t -75.27 -55.66 10.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.917 0.389 . . . . 0.0 110.832 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.6 p -89.92 -15.28 32.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.864 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.9 mtm 64.19 43.06 5.12 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.79 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -121.21 164.42 16.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.538 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -154.2 -81.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.022 -177.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm 58.32 -169.04 0.13 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.027 0.441 . . . . 0.0 111.183 -174.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 63.62 -142.27 46.61 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.601 -0.727 . . . . 0.0 114.245 171.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.795 ' HD1' ' HA3' ' A' ' 117' ' ' GLY . 67.8 m-85 -130.43 178.31 6.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.224 -172.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.96 153.8 41.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.81 0.338 . . . . 0.0 110.755 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.498 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 88.9 m-85 -114.85 110.82 20.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.588 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.778 ' HB ' HG12 ' A' ' 114' ' ' VAL . 58.2 t -97.49 108.72 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.902 177.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.599 ' OE2' ' HD2' ' A' ' 139' ' ' LYS . 33.3 tt0 -102.35 119.8 39.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.124 -178.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.446 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 90.2 m-85 -97.4 -177.72 3.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.001 0.429 . . . . 0.0 111.342 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -80.18 -58.79 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.646 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.7 m -103.7 143.16 26.09 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.626 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 40.9 Cg_endo -67.52 -18.8 49.08 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.147 2.565 . . . . 0.0 112.798 -176.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.701 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 15.7 mp0 -55.81 -57.17 13.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.459 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.534 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . . . -52.98 -26.85 16.54 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 177.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.18 -47.26 13.68 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.404 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.7 ' HG2' HG13 ' A' ' 286' ' ' VAL . 2.6 pp0? -66.72 -31.57 72.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.689 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 10.7 tp -73.23 -45.81 53.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.53 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.86 71.92 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.602 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.5 tt -66.63 -50.28 63.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.473 172.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -54.19 -49.72 68.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.351 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -86.48 -38.92 16.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -173.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 30.9 mtm -106.8 21.93 16.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -171.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 32.1 p30 -72.14 0.16 10.37 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.324 0.583 . . . . 0.0 110.23 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.9 m -95.5 -73.72 0.58 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.506 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.5 m -139.16 161.82 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.729 0.299 . . . . 0.0 111.167 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.548 ' HE2' ' HG ' ' A' ' 178' ' ' LEU . 1.6 tpt -150.63 72.47 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.548 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 74.1 mt 57.16 -166.43 0.14 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.765 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.19 -17.76 1.73 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.798 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.45 21.67 53.48 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.443 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -143.78 176.63 9.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.058 0.456 . . . . 0.0 111.332 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -95.04 144.08 25.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.692 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 22.3 pt -116.71 171.26 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.834 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.729 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 34.8 mmtp -103.8 131.6 50.85 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 6.1 t -129.94 110.22 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.8 0.333 . . . . 0.0 110.487 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.602 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 90.16 -147.36 19.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.565 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.41 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 71.1 mtp180 54.88 62.85 7.56 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 122.685 0.394 . . . . 0.0 111.112 -177.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 15.1 Cg_exo -67.66 -38.53 13.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.535 2.157 . . . . 0.0 111.499 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 31.4 m -152.47 140.92 20.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.456 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -89.62 -14.3 35.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.127 0.489 . . . . 0.0 110.255 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.3 tp -153.39 148.73 13.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.307 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 160.99 -175.14 37.67 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.938 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -78.78 -21.27 48.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.752 0.31 . . . . 0.0 111.194 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.414 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -82.1 -28.49 32.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.483 -178.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.585 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 11.5 mm100 -55.57 -49.81 90.51 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 75.7 Cg_exo -53.23 -33.89 67.1 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.249 1.966 . . . . 0.0 112.846 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 63.4 mt -75.25 -48.14 32.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.877 0.37 . . . . 0.0 110.227 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.508 HG12 ' SD ' ' A' ' 111' ' ' MET . 68.7 mt -57.5 -48.08 83.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.924 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 33.5 t70 -69.43 -34.12 73.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.115 -176.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -71.58 -37.94 70.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.671 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 60.8 mt -67.74 -33.22 74.44 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.198 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -58.72 -37.27 75.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 109.772 173.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 37.7 mt-10 -72.49 -30.35 64.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.356 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -68.42 -33.8 74.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.993 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.9 -24.62 62.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.262 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 65.6 mtp180 -72.62 -24.23 61.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.17 173.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.67 -39.63 19.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.277 0.56 . . . . 0.0 110.047 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -109.36 80.19 1.29 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.77 85.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.773 0.67 . . . . 0.0 110.916 -175.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 256' ' ' GLU . 9.1 ttt180 -128.09 143.31 51.06 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.537 -171.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 263' ' ' SER . 39.7 pt -118.21 166.76 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.564 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.524 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 73.9 t80 -121.91 126.36 48.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.388 -173.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.522 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.7 m -121.32 131.27 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.985 0.422 . . . . 0.0 110.358 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.87 175.27 7.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.451 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.6 t 59.96 31.53 20.72 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.867 0.841 . . . . 0.0 109.206 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 44.9 t -73.02 123.06 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.224 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -50.3 128.91 20.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.391 0.615 . . . . 0.0 110.968 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -55.74 -33.1 63.96 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.159 -173.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -99.07 37.0 1.6 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.477 0.656 . . . . 0.0 110.386 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 220' ' ' LEU . 11.2 tp -124.69 133.01 53.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.7 m -95.84 170.09 9.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.849 -174.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -67.46 -36.33 80.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.756 0.312 . . . . 0.0 110.819 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.9 -30.78 70.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.642 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.5 -45.26 47.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.361 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.77 HG13 HD21 ' A' ' 240' ' ' LEU . 27.1 mm -59.85 -42.42 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.692 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.44 ' HB2' ' CB ' ' A' ' 238' ' ' CYS . 86.8 tttt -56.46 -52.52 64.38 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.868 176.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 79.6 p -56.31 -37.83 70.46 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -173.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.4 -45.48 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.677 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.577 ' HB2' HD11 ' A' ' 235' ' ' ILE . 26.3 m-85 -67.95 -27.75 66.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.292 0.568 . . . . 0.0 110.394 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.09 -26.51 67.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.142 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.19 -18.73 61.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.236 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -107.07 -31.33 8.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -153.28 159.37 28.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.875 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -75.45 111.2 10.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.505 0.669 . . . . 0.0 111.645 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 229' ' ' PHE . 40.0 mt -84.03 148.98 4.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.4 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.635 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 77.8 tttt -108.35 -35.85 6.41 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.861 176.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 256' ' ' GLU . 17.0 m -153.44 136.05 15.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -170.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.44 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 52.4 t -138.68 114.75 10.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.883 0.373 . . . . 0.0 110.103 175.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 31.3 m -141.99 116.01 9.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.57 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.77 HD21 HG13 ' A' ' 225' ' ' ILE . 66.3 mt -77.98 138.58 38.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.63 3.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.499 ' HG2' ' CA ' ' A' ' 249' ' ' HIS . 34.6 mtm180 -122.41 143.17 49.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.775 -176.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -83.96 109.92 22.16 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.47 -16.47 55.32 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.477 2.118 . . . . 0.0 111.992 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.7 p -73.29 -29.18 62.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.595 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.551 HG23 ' HG2' ' A' ' 248' ' ' LYS . 4.1 t -120.55 -26.68 5.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.796 0.331 . . . . 0.0 111.762 -178.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.56 37.06 8.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.201 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.551 ' HG2' HG23 ' A' ' 246' ' ' THR . 19.2 ptpt -140.43 150.05 43.35 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.499 ' CA ' ' HG2' ' A' ' 242' ' ' ARG . 18.1 p80 -80.59 132.36 35.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.332 0.586 . . . . 0.0 110.465 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -64.06 -21.04 66.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.112 -171.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 133.73 -15.3 4.64 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.273 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.524 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 33.8 p90 -128.36 169.86 13.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.692 0.282 . . . . 0.0 110.592 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -158.38 170.82 35.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.051 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.701 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 97.4 m-85 -130.86 138.92 50.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.068 0.461 . . . . 0.0 111.309 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 225' ' ' ILE . 89.2 mt -133.95 128.53 53.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.699 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 210' ' ' ARG . 57.2 tt0 -109.85 145.89 36.02 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.505 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 16.8 m-85 -116.2 148.01 40.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.002 0.429 . . . . 0.0 111.262 -175.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.635 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 26.3 mt-10 -72.54 -21.95 61.09 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.081 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -116.91 126.33 52.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.725 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -50.73 -58.11 6.69 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -171.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -62.44 -29.07 70.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.226 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' SER . . . . . 0.418 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 49.9 m -64.97 -29.22 70.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 111.556 -175.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.47 ' HA ' ' CD1' ' A' ' 257' ' ' TYR . 87.5 p -63.19 -39.93 96.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.323 0.582 . . . . 0.0 109.712 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -78.28 -19.32 53.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.136 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 85.9 m-20 -63.03 -43.05 99.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.65 84.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.683 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 263' ' ' SER . 97.4 t -56.06 -37.23 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 111.226 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.7 t -77.75 -35.69 51.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.0 m -94.83 -36.55 11.62 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -171.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.438 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.4 mmm -83.4 -0.52 50.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -169.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -73.53 125.99 29.22 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.487 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 91.1 mt 66.04 25.17 10.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.53 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -88.13 118.27 27.59 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 172.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.522 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 6.7 p-10 -74.69 115.71 14.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.458 0.647 . . . . 0.0 110.439 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 31.6 tp -123.75 97.83 5.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.14 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.5 26.63 35.2 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -175.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.5 -43.74 1.85 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.697 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -88.25 142.46 27.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.044 0.449 . . . . 0.0 111.203 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 68.2 m-85 -81.63 123.59 28.82 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.916 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.68 123.01 21.62 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.711 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -93.6 115.23 27.7 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 14.3 p -118.06 142.68 31.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.244 0.545 . . . . 0.0 111.428 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.5 ' HA3' HD13 ' A' ' 168' ' ' LEU . . . -157.95 -176.94 30.58 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.8 mppt? -85.98 147.73 26.08 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.323 0.561 . . . . 0.0 110.43 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -86.52 130.96 34.31 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 167' ' ' GLN . 12.0 m -93.54 -19.46 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.834 0.349 . . . . 0.0 110.877 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 42.9 p -130.43 129.01 22.73 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.29 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 28.0 Cg_endo -64.98 119.31 6.31 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.425 2.084 . . . . 0.0 111.045 173.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 288' ' ' PRO . 8.6 Cg_exo -71.83 78.37 1.75 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.154 2.57 . . . . 0.0 112.992 -174.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 56.6 ttp -128.92 85.47 60.07 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -83.88 124.26 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.295 2.663 . . . . 0.0 111.928 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 56.3 tp 72.67 135.26 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.935 0.772 . . . . 0.0 111.513 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 58.0 tp -73.56 88.44 1.66 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.666 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 3.2 t -107.56 104.65 53.59 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 121.402 0.62 . . . . 0.0 110.13 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -96.92 31.78 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.233 2.622 . . . . 0.0 112.363 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -133.81 15.52 3.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.309 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 22.8 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.233 -179.437 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.29 125.83 45.01 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 43.1 tpp -93.05 67.64 4.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.054 0.454 . . . . 0.0 110.735 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 66.76 -3.95 0.84 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 7.1 tp60 -70.94 -52.23 21.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.663 0.268 . . . . 0.0 111.267 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 7.6 tpt180 -70.41 -35.8 73.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.126 0.489 . . . . 0.0 110.451 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -91.55 78.71 5.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -50.86 -28.4 9.43 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.422 -173.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.06 71.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 111.363 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.539 HD23 ' SD ' ' A' ' 111' ' ' MET . 58.4 mt -68.55 -31.97 71.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.064 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.04 -27.87 68.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.213 0.53 . . . . 0.0 110.425 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.0 mt -85.86 -34.64 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.096 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.552 ' SD ' HG12 ' A' ' 198' ' ' ILE . 91.7 mtp -70.84 -16.43 62.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.042 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 71.2 m -84.39 -6.29 59.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.716 0.293 . . . . 0.0 111.188 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 51.8 mtt180 -116.78 141.88 47.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.757 0.313 . . . . 0.0 110.548 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 158' ' ' VAL . 4.0 p -120.63 128.47 76.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.408 0.623 . . . . 0.0 109.752 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -83.11 115.56 21.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.016 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 17.2 m -108.33 124.87 65.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.518 0.675 . . . . 0.0 111.124 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.61 174.83 18.01 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.375 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.459 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 71.8 m 61.0 38.33 17.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.272 0.558 . . . . 0.0 110.517 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 57.5 mt -74.34 -21.81 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.563 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 84.0 t80 70.01 163.94 0.25 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.37 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.671 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 20.2 p90 -89.83 76.77 7.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.589 0.709 . . . . 0.0 110.704 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -164.1 -50.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.342 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.715 HD13 ' HG3' ' A' ' 177' ' ' MET . 73.3 mt -65.23 112.74 3.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.919 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -80.14 159.11 42.97 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.751 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -65.22 -37.32 86.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.207 0.527 . . . . 0.0 109.93 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.12 -41.12 97.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.606 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.4 m -64.76 -41.4 95.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.954 0.407 . . . . 0.0 110.292 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 124' ' ' GLY . 33.4 mm -59.2 -44.94 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.876 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.44 ' HA ' HD12 ' A' ' 138' ' ' ILE . 25.1 ttt180 -59.24 -40.48 86.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.223 0.535 . . . . 0.0 110.338 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -71.56 -33.89 69.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.583 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.95 -24.19 28.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.488 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 34.8 m-85 -95.15 -16.68 22.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.72 -42.03 92.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -44.73 -32.29 5.86 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 123.092 2.528 . . . . 0.0 114.888 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.76 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 78.5 m-85 -85.4 -42.78 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.769 0.319 . . . . 0.0 110.752 -177.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.61 157.22 29.46 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.969 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.45 117.92 4.65 Favored 'Trans proline' 0 C--O 1.241 0.649 0 C-N-CA 122.71 2.273 . . . . 0.0 111.722 175.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' A' ' 132' ' ' PHE . 54.9 mt -72.53 132.55 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.242 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -96.7 -43.05 7.72 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.228 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.7 m -152.76 140.41 19.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.3 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.8 mt -122.76 124.86 71.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.951 0.405 . . . . 0.0 110.139 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 8.0 m-20 -112.71 98.8 7.46 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 174.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.408 ' CE ' HG13 ' A' ' 128' ' ' ILE . 54.4 ttm -124.26 137.72 54.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.6 m -94.49 108.39 20.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.899 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.407 ' CH2' ' HA ' ' A' ' 150' ' ' MET . 0.0 OUTLIER -97.43 84.69 3.48 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 172.198 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -79.8 16.81 1.05 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.678 -1.146 . . . . 0.0 114.072 -163.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.558 ' CB ' ' HB2' ' A' ' 151' ' ' LYS . 22.9 t -151.09 163.86 37.82 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.15 -174.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.0 t -110.21 -21.36 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.248 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -88.2 28.51 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.766 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.407 ' HA ' ' CH2' ' A' ' 145' ' ' TRP . 20.0 mmt 66.49 30.39 8.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.523 176.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.558 ' HB2' ' CB ' ' A' ' 147' ' ' SER . 34.8 mmtp -95.77 146.14 24.77 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.671 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 37.8 t-80 -161.77 97.51 1.06 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.982 -174.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.43 6.52 8.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.194 0.521 . . . . 0.0 110.345 174.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.68 177.46 34.01 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.761 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -109.04 177.85 4.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.436 0.16 . . . . 0.0 110.741 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 142' ' ' ASP . . . -148.84 140.93 23.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.913 0.387 . . . . 0.0 111.613 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -110.45 116.57 31.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.92 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.574 ' HB ' HG12 ' A' ' 114' ' ' VAL . 88.3 t -95.71 108.27 20.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.045 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 38.5 tt0 -96.41 128.89 43.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.217 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -103.57 165.97 10.71 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.77 -13.94 60.31 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.66 173.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.7 m -138.65 139.64 25.03 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 45.0 Cg_endo -67.83 -19.28 47.0 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.314 2.676 . . . . 0.0 112.486 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.7 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 7.5 mp0 -59.44 -48.21 82.5 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.966 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.24 -22.23 66.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.871 0.367 . . . . 0.0 111.853 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.08 -49.61 10.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.927 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 164' ' ' GLU . 5.0 pp0? -64.3 -30.78 71.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.76 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.8 tp -71.22 -50.54 31.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.431 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.31 -33.39 75.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.392 . . . . 0.0 110.296 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.567 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.8 tt -71.74 -38.06 70.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.2 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.64 -52.12 64.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.183 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -100.04 -30.43 11.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -172.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 27.8 ttp -106.87 28.19 8.21 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.483 -170.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -74.62 -8.62 56.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.089 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.6 m -72.7 -73.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.17 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 182' ' ' ASN . 27.1 m -144.69 167.59 10.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.949 0.404 . . . . 0.0 111.42 -173.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.744 ' HB2' HD13 ' A' ' 183' ' ' ILE . 11.7 tpp -132.4 74.47 1.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 172.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 60.6 mt 59.5 -174.3 0.1 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.28 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.2 -63.63 3.57 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.889 173.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 129.56 34.99 0.47 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -144.04 136.59 26.92 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.521 ' HA ' HG12 ' A' ' 176' ' ' VAL . 2.1 p-10 -71.59 141.49 50.01 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.983 0.42 . . . . 0.0 109.998 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.3 pt -112.55 178.89 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.859 -176.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 18.6 tptm -112.87 112.64 24.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.603 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.0 t -109.7 109.45 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.049 0.452 . . . . 0.0 110.792 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 78.72 -163.08 49.51 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.744 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 58.93 78.77 0.33 Allowed Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 122.798 0.439 . . . . 0.0 111.436 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.37 97.33 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.679 2.253 . . . . 0.0 111.015 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.7 t 64.33 -79.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 O-C-N 124.0 0.812 . . . . 0.0 109.616 -169.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -176.51 -67.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.5 tp -86.08 140.51 15.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.096 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -170.37 154.53 23.3 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -67.08 -20.2 65.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.274 0.559 . . . . 0.0 111.097 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.529 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -76.76 -22.49 53.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.369 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.474 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 31.7 mm-40 -60.59 -53.46 64.23 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.2 Cg_endo -53.24 -34.56 70.26 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.489 2.126 . . . . 0.0 112.995 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 65.9 mt -74.63 -38.85 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.543 0.211 . . . . 0.0 110.691 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.552 HG12 ' SD ' ' A' ' 111' ' ' MET . 70.2 mt -58.07 -49.07 82.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.225 0.536 . . . . 0.0 109.732 174.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.9 -37.49 87.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.888 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLN . . . . . 0.485 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 24.7 tp60 -60.2 -51.66 68.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.877 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 31.6 mt -67.52 -33.27 74.74 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.936 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.87 -37.71 66.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.48 -36.66 63.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.922 174.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 200' ' ' GLN . 26.7 mt-10 -71.72 -24.0 61.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.819 0.342 . . . . 0.0 111.778 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.19 -26.55 61.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.394 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 37.2 mtm180 -69.71 -17.95 63.5 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.451 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.01 -15.25 62.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.097 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -119.89 -172.76 2.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.601 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.619 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 68.4 m-20 -130.29 41.72 3.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.453 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.523 ' HD3' ' HG3' ' A' ' 289' ' ' PRO . 32.1 ttp180 -101.13 138.01 38.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.3 0.571 . . . . 0.0 112.044 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.5 pt -124.71 167.76 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.233 175.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 77.6 t80 -121.47 129.07 52.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.707 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.475 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 33.7 m -124.28 134.9 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.014 0.435 . . . . 0.0 110.445 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -130.8 178.27 6.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.944 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.402 ' CB ' ' HG2' ' A' ' 281' ' ' ARG . 28.5 t 59.44 36.16 23.08 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.626 0.727 . . . . 0.0 109.413 -173.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.613 HG13 HD11 ' A' ' 225' ' ' ILE . 10.5 t -73.61 120.47 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.687 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 79.5 t60 -54.11 146.89 13.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.297 -174.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -48.58 -53.37 18.63 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -93.03 37.4 1.03 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.155 0.502 . . . . 0.0 111.368 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.458 HD21 HD23 ' A' ' 275' ' ' LEU . 12.2 tp -117.69 109.49 16.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 96.8 p -93.91 -179.36 4.95 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.065 -175.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.46 -32.18 73.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.658 0.266 . . . . 0.0 110.571 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.84 -35.75 79.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.026 0.441 . . . . 0.0 110.173 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.26 -48.52 72.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.294 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.635 HG22 HD11 ' A' ' 255' ' ' ILE . 33.4 mm -62.89 -46.73 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.457 ' HG3' HG21 ' A' ' 235' ' ' ILE . 54.2 tttm -54.33 -52.42 61.61 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.26 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 62.0 p -55.99 -39.6 72.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -174.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.1 t -76.48 -45.97 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.456 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.767 ' HB2' HD11 ' A' ' 235' ' ' ILE . 9.0 m-85 -64.72 -32.51 74.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.521 0.677 . . . . 0.0 110.557 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.63 -25.32 68.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.523 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.26 -25.81 63.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.765 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -101.59 -33.61 9.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.541 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -145.11 164.56 27.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.607 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -77.51 99.41 5.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.853 0.359 . . . . 0.0 110.746 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.767 HD11 ' HB2' ' A' ' 229' ' ' PHE . 13.3 mt -74.6 146.57 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.353 0.596 . . . . 0.0 111.393 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -110.31 -34.41 6.36 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.882 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 50.7 m -162.2 131.07 4.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.372 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.428 ' SG ' HG12 ' A' ' 255' ' ' ILE . 52.5 t -131.59 117.06 18.21 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 26.2 m -138.6 113.76 9.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.845 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.577 ' CD2' ' HA3' ' A' ' 253' ' ' GLY . 33.3 mt -82.46 139.93 33.68 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.39 115.56 7.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -128.62 136.75 51.11 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.172 -172.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -69.42 109.35 4.36 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.65 -45.35 41.7 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.199 3.266 . . . . 0.0 114.611 -168.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.526 HG23 HG23 ' A' ' 246' ' ' THR . 8.7 t -82.71 -11.86 58.01 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -170.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.526 HG23 HG23 ' A' ' 245' ' ' THR . 23.0 p -114.94 -21.51 10.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.114 0.483 . . . . 0.0 112.237 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 77.57 39.3 25.96 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.464 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -126.04 130.7 51.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.897 0.38 . . . . 0.0 110.36 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.425 ' HE1' ' O ' ' A' ' 216' ' ' VAL . 23.9 p80 -76.85 128.86 35.36 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 173.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -62.21 -20.64 64.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.274 -173.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 130.78 -5.02 5.79 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.274 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.437 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 46.3 p90 -140.65 167.96 20.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.745 0.307 . . . . 0.0 110.607 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.577 ' HA3' ' CD2' ' A' ' 240' ' ' LEU . . . -158.56 172.09 35.42 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.084 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.7 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 97.9 m-85 -128.05 142.52 51.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.894 0.378 . . . . 0.0 110.852 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.635 HD11 HG22 ' A' ' 225' ' ' ILE . 77.8 mt -136.8 131.79 47.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.767 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 16.5 mt-10 -112.44 146.57 38.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.875 175.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.546 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 9.2 m-85 -108.89 161.2 15.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.807 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.54 -22.33 59.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.509 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.8 141.58 48.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.035 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.559 ' HA ' ' OD1' ' A' ' 209' ' ' ASN . . . -57.99 -60.21 4.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -169.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -74.51 -20.61 59.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 -171.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.9 m -62.1 -25.8 67.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.431 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 211' ' ' ILE . 87.8 p -68.94 -39.61 79.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.372 0.606 . . . . 0.0 109.697 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -75.08 -23.16 57.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.897 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.28 -41.27 98.98 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.71 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -65.54 -42.22 92.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.37 175.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.551 ' HA ' HG21 ' A' ' 282' ' ' VAL . 96.4 t -54.14 -34.32 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.193 0.52 . . . . 0.0 110.822 177.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 26.1 t -73.11 -35.29 66.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.29 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.6 t -92.74 -35.08 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 111.832 -173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 73.2 mmm -88.64 5.65 42.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.785 0.326 . . . . 0.0 111.245 -171.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.519 ' HA ' HG12 ' A' ' 282' ' ' VAL . 25.1 t-20 -66.5 109.77 2.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.348 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.4 mt 63.47 40.91 7.89 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.549 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' PHE . . . . . 0.485 ' HD2' ' HB2' ' A' ' 275' ' ' LEU . 49.4 t80 -79.69 126.84 31.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.137 174.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -80.17 71.34 6.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.629 0.728 . . . . 0.0 111.444 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.485 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 30.8 tp -95.37 103.48 15.34 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.109 0.48 . . . . 0.0 110.245 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 90.14 21.45 38.65 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.494 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 88.91 -9.27 77.26 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.695 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -116.66 144.17 44.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.866 0.365 . . . . 0.0 110.697 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -80.2 115.45 19.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.577 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 273' ' ' PHE . 64.6 mt -64.53 126.64 28.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.437 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 281' ' ' ARG . 2.5 mmt180 -93.57 115.1 27.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 176.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 267' ' ' VAL . 8.3 p -112.83 147.16 16.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.155 -173.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.93 169.92 38.27 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -84.15 134.26 34.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.07 107.78 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.018 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 15.9 m -68.19 -27.6 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.541 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 69.9 p -98.52 124.5 46.29 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-O 121.246 0.546 . . . . 0.0 110.845 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 36.0 Cg_endo -66.28 152.17 81.69 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.755 2.303 . . . . 0.0 111.23 172.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.523 ' HG3' ' HD3' ' A' ' 210' ' ' ARG . 18.3 Cg_exo -66.56 76.94 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.713 2.275 . . . . 0.0 112.209 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 66.0 mtm 68.05 87.72 0.11 Allowed Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.214 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.57 119.67 6.65 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.569 2.179 . . . . 0.0 111.222 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.66 -79.91 0.21 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.039 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 56.43 -159.6 0.22 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 24.4 p -118.86 86.2 30.18 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.239 174.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.94 -13.62 21.5 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.228 2.619 . . . . 0.0 112.652 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -80.5 74.55 7.38 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.222 0.534 . . . . 0.0 110.42 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.339 -178.959 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.876 -0.489 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.29 -79.06 0.17 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.827 0.346 . . . . 0.0 111.265 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 14.9 tpt -110.24 110.29 21.07 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -122.29 8.19 9.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -171.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -52.59 -58.91 5.27 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.265 0.555 . . . . 0.0 109.943 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -135.04 144.05 47.07 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.421 ' HB3' ' HG ' ' A' ' 108' ' ' LEU . 31.5 mm-40 -70.98 90.62 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.784 -171.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.0 mtp-105 -56.57 -40.12 74.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.279 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.86 -30.81 71.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.697 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 287' ' ' THR . 24.2 mt -69.37 -41.25 76.78 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.495 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.73 70.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 110.516 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 194' ' ' ALA . 69.4 mt -79.84 -46.25 22.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.872 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 30.9 mtm -65.22 -37.07 86.14 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.6 m -63.2 -19.21 64.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.738 0.304 . . . . 0.0 111.223 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -104.68 140.54 37.9 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.635 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.0 p -129.24 128.09 66.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.66 0.743 . . . . 0.0 110.371 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -85.13 113.59 21.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.332 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 29.6 m -111.41 116.44 52.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.306 0.574 . . . . 0.0 110.314 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -113.78 106.33 1.73 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.76 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.867 ' HB3' HG22 ' A' ' 183' ' ' ILE . 27.7 t 154.6 -90.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.894 1.278 . . . . 0.0 109.106 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.792 ' H ' HG22 ' A' ' 183' ' ' ILE . 13.6 mt 60.01 31.31 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.371 0.668 . . . . 0.0 111.497 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.667 ' HA ' ' HD3' ' A' ' 181' ' ' ARG . 27.8 t80 60.3 -164.06 0.23 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -124.14 75.44 1.38 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.792 1.282 . . . . 0.0 109.426 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 123' ' ' LEU . 5.8 tt0 -178.42 -144.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.81 -1.995 . . . . 0.0 106.64 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.538 HD22 HG21 ' A' ' 127' ' ' THR . 92.1 mt 57.6 -174.36 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.784 0.678 . . . . 0.0 112.187 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.79 -179.63 36.58 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.5 -45.72 90.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.821 0.343 . . . . 0.0 110.42 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 4.4 m-20 -56.87 -49.39 75.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.444 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.538 HG21 HD22 ' A' ' 123' ' ' LEU . 5.0 m -61.7 -43.1 99.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.034 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 119' ' ' ILE . 21.5 mm -66.55 -39.84 84.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.54 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 129' ' ' ARG . 43.2 ttp180 -60.7 -38.65 85.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.999 177.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 78.0 mt-30 -71.53 -33.26 69.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.211 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.05 -33.76 50.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -92.73 -16.19 25.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.601 0.238 . . . . 0.0 111.495 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -51.01 -44.66 87.37 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 5.1 Cg_exo -43.24 -49.07 7.61 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.981 2.454 . . . . 0.0 113.976 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.505 ' HD2' ' HG ' ' A' ' 168' ' ' LEU . 72.7 m-85 -65.28 -48.49 72.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -170.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.3 -171.66 29.82 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.449 -1.358 . . . . 0.0 113.271 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 161' ' ' GLU . 71.7 Cg_endo -78.79 121.61 5.11 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.752 2.302 . . . . 0.0 111.737 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 141' ' ' ILE . 57.6 mt -80.8 119.69 30.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.367 0.603 . . . . 0.0 110.662 -177.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.667 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 28.1 tptp -89.26 -34.13 16.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.847 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.9 t -174.53 162.14 3.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.857 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 138' ' ' ILE . 70.1 mt -141.22 122.37 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.745 0.307 . . . . 0.0 110.307 175.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.669 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 12.0 m-20 -95.01 104.01 15.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.387 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 3.9 mmt -94.98 126.18 40.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.737 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.4 m -81.01 47.81 1.04 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.417 0.627 . . . . 0.0 109.75 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -81.16 123.01 28.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.232 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.35 104.14 4.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.621 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.2 t -84.85 1.53 46.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.219 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.42 -55.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.445 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.541 ' OG1' ' HE2' ' A' ' 151' ' ' LYS . 2.2 p -122.53 12.89 10.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.297 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.4 mtm 66.08 57.25 0.79 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.213 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.541 ' HE2' ' OG1' ' A' ' 149' ' ' THR . 49.2 mtmt -116.53 167.4 11.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.62 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -138.76 45.2 2.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.579 0.704 . . . . 0.0 110.562 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -95.07 85.2 4.27 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.39 -146.62 5.44 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.809 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -124.34 177.9 5.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.837 0.351 . . . . 0.0 110.058 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.96 140.95 28.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.154 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.669 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 92.7 m-85 -109.99 109.17 19.67 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.635 ' HB ' HG12 ' A' ' 114' ' ' VAL . 43.3 t -92.04 115.02 30.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.23 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.667 ' HG2' ' HB3' ' A' ' 139' ' ' LYS . 36.6 tt0 -105.26 125.46 51.01 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.414 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.18 174.44 5.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.373 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.508 ' HB2' ' HG2' ' A' ' 137' ' ' PRO . 46.3 mt-10 -89.46 -16.32 31.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.086 172.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.451 HG22 ' HD2' ' A' ' 137' ' ' PRO . 28.1 m -130.67 137.64 31.25 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.109 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.453 ' HG3' HD22 ' A' ' 108' ' ' LEU . 60.1 Cg_endo -73.1 -20.76 21.29 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.785 2.323 . . . . 0.0 112.647 -176.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.571 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 13.6 mp0 -54.24 -59.08 5.14 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.132 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.16 -26.66 17.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.17 -51.83 8.01 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.216 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.45 ' HG3' HG11 ' A' ' 286' ' ' VAL . 10.6 mm100 -67.52 -27.43 66.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.984 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.505 ' HG ' ' HD2' ' A' ' 135' ' ' PHE . 14.2 tp -72.13 -47.61 49.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.105 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.28 73.48 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 185' ' ' VAL . 6.6 tt -65.06 -51.95 58.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.656 172.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -56.09 -33.68 65.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.833 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -100.68 -48.85 4.37 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.9 mtm -95.73 28.83 2.87 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -167.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -85.5 30.69 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.996 0.903 . . . . 0.0 109.847 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 16.6 m -113.93 -74.32 0.63 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.323 176.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.4 m -145.59 170.86 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.467 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.625 ' HB2' HD13 ' A' ' 183' ' ' ILE . 22.5 tpp -143.4 91.33 2.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.604 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.518 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 75.7 mt 54.49 45.34 27.21 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.035 172.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 170.85 163.06 24.25 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.962 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.13 53.25 4.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.152 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ARG . . . . . 0.667 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 25.4 mtp180 -143.46 125.78 15.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.096 0.474 . . . . 0.0 110.49 174.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 175' ' ' SER . 14.1 m120 -71.81 128.43 35.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.954 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.867 HG22 ' HB3' ' A' ' 118' ' ' SER . 43.9 pt -103.21 143.51 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.781 -177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 50.4 mttp -103.0 118.29 36.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.439 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.7 t -110.67 111.77 37.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 123.591 0.557 . . . . 0.0 111.479 -172.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 188' ' ' PRO . . . 57.43 51.22 59.04 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.552 170.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -86.72 109.04 20.93 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 186' ' ' GLY . 95.0 Cg_endo -85.21 54.02 3.73 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.011 2.474 . . . . 0.0 112.796 -175.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.5 m -56.36 -50.14 72.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.587 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -101.53 12.9 36.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.144 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 49.5 mm -104.85 95.64 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.03 0.443 . . . . 0.0 110.434 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.51 -19.17 5.49 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.215 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -68.42 -37.79 80.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.012 0.434 . . . . 0.0 111.144 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' A' ' 110' ' ' ILE . . . -87.34 -17.64 31.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.738 -175.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.554 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 11.8 tm0? -57.7 -50.58 87.34 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.886 -174.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.0 Cg_endo -53.16 -37.3 79.73 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.604 2.203 . . . . 0.0 113.1 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.5 mt -74.59 -41.33 48.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.297 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.6 mt -59.73 -48.85 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.096 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 14.7 t70 -59.19 -43.27 92.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.46 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -59.38 -50.93 72.05 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.471 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.6 -33.0 73.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.681 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.577 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.41 -39.49 73.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.68 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 44.3 mt-10 -66.75 -33.82 76.46 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.755 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.415 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 37.3 mt-10 -66.51 -37.02 84.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.349 . . . . 0.0 110.568 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.35 -33.76 76.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.095 0.474 . . . . 0.0 110.27 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.68 ' HD3' ' HA ' ' A' ' 203' ' ' GLU . 66.9 mtp180 -70.36 -13.77 62.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.158 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.73 -38.37 19.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.052 0.453 . . . . 0.0 110.783 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.47 -19.88 23.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.114 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 61.64 46.92 6.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.16 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.478 ' HE ' ' HB3' ' A' ' 254' ' ' PHE . 22.5 ttt180 -103.32 137.14 41.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.72 -171.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 263' ' ' SER . 42.2 pt -118.96 167.25 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.346 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 81.3 t80 -119.53 128.04 53.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.619 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.42 HG23 HG21 ' A' ' 216' ' ' VAL . 27.4 m -116.98 135.04 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.217 0.532 . . . . 0.0 110.105 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -121.92 173.86 7.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.642 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.447 ' OG ' ' HG2' ' A' ' 281' ' ' ARG . 2.0 p 43.7 42.35 4.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.946 0.879 . . . . 0.0 111.202 -174.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.42 HG21 HG23 ' A' ' 213' ' ' VAL . 24.1 t -84.77 108.64 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.27 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -54.88 135.72 47.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.559 0.695 . . . . 0.0 111.369 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -51.72 -27.29 11.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.701 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -85.59 -9.84 56.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.918 0.389 . . . . 0.0 111.113 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 72.1 mt -86.52 136.39 33.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.214 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 49.3 m -97.26 169.44 9.77 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.496 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -62.29 -29.64 70.57 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.304 -0.247 . . . . 0.0 111.073 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -66.24 -35.18 79.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.172 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -61.04 -54.21 47.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.979 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.535 HG13 HD21 ' A' ' 240' ' ' LEU . 24.9 mm -63.52 -43.52 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.995 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 54.6 tttm -58.29 -49.63 76.46 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.318 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 97.8 p -56.04 -43.92 78.3 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 17.4 t -75.03 -41.62 45.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.609 0.242 . . . . 0.0 111.109 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.57 ' CB ' HD11 ' A' ' 235' ' ' ILE . 4.6 m-85 -65.75 -34.31 77.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.179 0.514 . . . . 0.0 110.912 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.3 tm-20 -66.33 -24.84 66.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.746 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.25 -16.45 61.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.648 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -111.74 -44.5 3.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.628 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' GLY . . . . . 0.554 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -124.57 173.49 16.99 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.525 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -94.96 99.28 11.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.393 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.57 HD11 ' CB ' ' A' ' 229' ' ' PHE . 17.9 mt -79.12 146.09 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.424 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 44.5 tttm -111.22 -33.14 6.53 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.126 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 18.8 m -152.84 125.55 8.33 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.485 -170.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.686 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 26.8 p -108.05 114.22 27.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.042 0.449 . . . . 0.0 109.907 170.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 27.5 m -141.71 102.06 4.09 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.286 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.535 HD21 HG13 ' A' ' 225' ' ' ILE . 64.6 mt -83.8 131.82 34.87 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.459 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -62.92 110.99 1.95 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.537 ' HD2' ' O ' ' A' ' 247' ' ' GLY . 16.1 ttp180 -123.98 144.88 49.55 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.798 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.433 ' HB3' HG22 ' A' ' 246' ' ' THR . 17.8 t70 -80.54 113.66 41.4 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 172.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.19 -25.71 47.72 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.707 2.938 . . . . 0.0 115.162 -167.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.7 t -110.09 3.75 20.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 243' ' ' ASP . 8.2 t -103.83 -13.57 16.36 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.934 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.537 ' O ' ' HD2' ' A' ' 242' ' ' ARG . . . 91.83 -48.13 2.76 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.977 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 16.2 pttp -94.85 156.17 16.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.756 0.278 . . . . 0.0 110.451 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 4.4 p80 -80.07 161.88 25.11 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.743 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.15 -58.72 6.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.161 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 163.32 -17.18 0.13 Allowed Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.178 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.411 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 9.5 p90 -120.61 173.75 6.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.459 ' HA2' ' H ' ' A' ' 241' ' ' ALA . . . -163.84 172.89 39.82 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.959 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.571 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 76.4 m-85 -135.3 143.01 45.97 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 122.598 0.359 . . . . 0.0 110.072 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.2 mt -139.78 133.23 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.976 0.417 . . . . 0.0 110.705 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -105.68 147.79 28.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 13.2 m-85 -117.45 151.57 36.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.915 0.388 . . . . 0.0 110.269 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 34.7 mt-10 -72.4 -16.28 61.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.844 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -131.41 132.33 44.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.904 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -56.35 -33.95 66.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.332 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.37 -33.39 61.04 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.032 0.444 . . . . 0.0 110.864 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 4.7 t -66.56 -36.11 81.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.186 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.687 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 71.9 p -65.94 -36.69 84.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.207 0.527 . . . . 0.0 109.963 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -72.79 -24.12 60.88 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.82 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.63 -44.91 76.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.0 0.428 . . . . 0.0 110.398 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -64.28 -38.17 90.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.467 HG13 ' HA2' ' A' ' 283' ' ' GLY . 72.0 t -53.85 -38.94 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 120.966 0.413 . . . . 0.0 111.457 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 m -82.02 -19.8 39.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.81 0.338 . . . . 0.0 111.596 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 17.8 m -95.24 -49.26 5.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 58.4 mmm -81.57 -9.19 59.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -168.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -69.24 128.43 36.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.359 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 93.2 mt 66.99 31.69 6.83 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.852 0.72 . . . . 0.0 110.508 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -100.63 116.4 32.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.982 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.65 116.37 6.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.006 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 31.7 tp -143.02 118.67 10.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.766 173.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.57 6.48 87.34 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.028 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.44 -0.17 46.64 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.282 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -134.1 151.15 51.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -84.35 116.2 22.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.714 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.97 115.02 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.603 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 14.1 mmt180 -93.89 114.95 27.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.33 140.82 40.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 119.711 -0.795 . . . . 0.0 111.202 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLY . . . . . 0.467 ' HA2' HG13 ' A' ' 267' ' ' VAL . . . -153.97 -169.98 19.46 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -89.95 137.94 31.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 117.334 0.567 . . . . 0.0 109.59 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.45 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -71.06 121.9 19.07 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.45 HG11 ' HG3' ' A' ' 167' ' ' GLN . 28.2 m -79.48 -25.66 12.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.794 0.33 . . . . 0.0 110.987 -175.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.727 HG21 HD21 ' A' ' 108' ' ' LEU . 73.2 p -133.18 145.54 57.24 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.415 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 52.6 Cg_endo -70.96 110.83 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.492 2.128 . . . . 0.0 111.185 173.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.13 89.27 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.91 2.407 . . . . 0.0 112.56 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 70.7 mtm -75.57 133.22 74.11 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.214 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.52 71.81 2.45 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 123.032 2.488 . . . . 0.0 112.859 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.0 tp 55.7 58.13 4.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.968 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 94.0 mt -117.88 96.27 5.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.036 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 8.9 t -86.61 132.26 43.11 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.09 0.471 . . . . 0.0 110.977 -176.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.21 -14.17 18.69 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.707 2.271 . . . . 0.0 112.25 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -133.04 134.21 44.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.461 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.773 -179.158 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.64 79.25 1.38 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.0 mtt -85.22 118.18 24.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.638 -175.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 60.31 24.49 13.95 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.791 0.682 . . . . 0.0 111.975 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -98.87 117.8 34.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.043 0.449 . . . . 0.0 110.58 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -116.2 139.98 49.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.473 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -82.1 51.14 1.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.498 0.666 . . . . 0.0 110.663 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 106' ' ' ARG . 28.1 ptt180 -67.99 -27.77 66.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.367 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HB2' HD12 ' A' ' 197' ' ' ILE . . . -65.89 -30.53 71.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.343 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 287' ' ' THR . 42.9 mt -60.93 -31.52 71.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.361 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.7 -24.96 67.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.132 0.491 . . . . 0.0 110.757 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.1 mt -87.83 -34.46 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.142 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.529 ' SD ' HG12 ' A' ' 198' ' ' ILE . 88.0 mtp -74.99 -15.5 60.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.093 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 97.7 m -79.61 -1.26 37.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.538 0.209 . . . . 0.0 111.378 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.896 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 32.7 mtt180 -110.81 142.43 42.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.765 0.317 . . . . 0.0 111.235 -174.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.558 HG23 HD12 ' A' ' 170' ' ' LEU . 8.9 p -128.4 129.79 69.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.408 0.623 . . . . 0.0 109.817 169.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -85.01 118.32 24.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.819 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.64 HG12 HG12 ' A' ' 185' ' ' VAL . 15.5 m -112.59 126.68 70.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.286 0.565 . . . . 0.0 111.372 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -131.31 175.36 19.61 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.543 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.7 m 62.1 31.87 17.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 122.934 0.493 . . . . 0.0 111.455 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.5 mt -77.22 112.83 15.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.067 0.46 . . . . 0.0 110.513 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -61.38 153.55 26.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.628 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.649 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 24.0 p90 -78.01 76.29 4.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.086 0.946 . . . . 0.0 110.949 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -165.21 -39.95 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.095 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.458 ' HB3' HD11 ' A' ' 128' ' ' ILE . 66.3 mt -74.93 85.96 2.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.969 174.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.48 172.33 55.22 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.924 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -55.1 -40.03 69.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 0.0 110.942 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 130' ' ' GLN . 20.5 t70 -62.28 -53.49 54.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.58 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 m -59.0 -43.07 91.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.978 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 123' ' ' LEU . 28.4 mm -63.19 -45.32 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.738 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -57.39 -43.85 84.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.43 . . . . 0.0 110.248 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 15.3 mm100 -68.73 -33.79 74.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.939 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.61 -27.03 25.73 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.528 ' HB2' HD11 ' A' ' 138' ' ' ILE . 4.9 m-85 -87.52 -26.01 23.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.78 0.324 . . . . 0.0 111.06 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.452 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -50.76 -42.19 76.09 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 26.1 Cg_exo -39.12 -45.96 2.88 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.168 2.579 . . . . 0.0 114.559 173.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.497 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 54.2 m-85 -76.1 -37.12 58.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.877 0.37 . . . . 0.0 110.597 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -176.04 153.49 14.81 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.45 124.31 15.94 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.718 2.279 . . . . 0.0 111.755 175.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 132' ' ' PHE . 21.0 mt -83.13 136.51 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.073 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -110.96 -20.32 12.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.175 0.512 . . . . 0.0 110.751 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.883 ' HB3' ' HB2' ' A' ' 159' ' ' GLU . 29.5 t -151.84 131.16 12.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.444 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.406 ' CG1' HG21 ' A' ' 138' ' ' ILE . 64.8 mt -130.28 129.67 65.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -117.48 99.45 7.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 52.1 ttm -141.33 112.0 7.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.828 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.3 m -74.35 72.36 1.81 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.768 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 77.6 t-105 -88.22 82.36 7.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.527 0.68 . . . . 0.0 109.851 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -155.64 116.78 3.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.95 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.9 t -166.31 141.51 4.56 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.631 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 85.4 t -48.45 -53.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 123.512 0.507 . . . . 0.0 111.535 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 16.6 p -98.63 21.53 11.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.346 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.1 mtm 58.03 33.55 23.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.237 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.3 131.72 34.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.238 0.542 . . . . 0.0 109.986 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.649 ' H ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 t-160 -86.78 -79.03 0.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.308 -175.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 153' ' ' LYS . 48.2 mtpt 52.33 38.44 24.97 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.941 0.4 . . . . 0.0 111.915 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -151.29 175.77 30.04 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.064 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.69 172.67 6.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -151.12 167.62 27.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.995 0.426 . . . . 0.0 111.299 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -126.84 134.66 50.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.393 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 114' ' ' VAL . 89.4 t -121.07 113.0 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.644 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.896 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 4.8 mp0 -105.54 119.62 39.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.554 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.14 179.87 5.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.793 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.36 -63.15 1.17 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.832 169.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.3 m -99.08 144.79 28.86 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.951 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 22.9 Cg_exo -65.71 -19.82 59.45 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.469 2.779 . . . . 0.0 112.535 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.482 ' OE2' ' HB3' ' A' ' 212' ' ' TYR . 0.6 OUTLIER -58.53 -54.91 41.75 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.836 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.16 -25.82 14.9 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.5 -53.01 7.29 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.384 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.425 ' HG3' HG21 ' A' ' 286' ' ' VAL . 83.7 mm-40 -64.47 -43.33 94.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.751 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.497 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 10.5 tp -59.64 -46.44 89.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.436 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.664 ' HB1' ' SD ' ' A' ' 173' ' ' MET . . . -61.68 -53.09 60.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.558 HD12 HG23 ' A' ' 114' ' ' VAL . 8.2 tt -54.45 -36.13 63.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.467 0.651 . . . . 0.0 110.234 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.01 -46.48 71.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.73 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -100.87 -21.13 15.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -173.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.664 ' SD ' ' HB1' ' A' ' 169' ' ' ALA . 4.6 ptm -99.74 18.55 17.88 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.925 -0.484 . . . . 0.0 110.792 -176.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -72.78 -2.92 22.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 24.1 m -101.56 -74.22 0.63 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.472 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.88 157.17 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.232 0.539 . . . . 0.0 111.675 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.574 ' HB2' HD13 ' A' ' 183' ' ' ILE . 23.9 tpp -121.78 97.27 5.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.693 175.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 75.3 mt 61.49 35.91 17.35 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.249 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.34 -130.37 9.73 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.112 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 67.1 -94.26 0.25 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.574 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -144.33 153.69 42.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 175' ' ' SER . 23.6 t-20 -68.89 100.43 1.19 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.574 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.9 pt -74.84 149.6 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.369 -175.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 184' ' ' LYS . 9.3 mmpt? -103.45 107.3 18.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.161 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.64 HG12 HG12 ' A' ' 116' ' ' VAL . 5.9 m -104.62 109.41 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.222 0.534 . . . . 0.0 111.135 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 170' ' ' LEU . . . 84.77 86.54 0.92 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.486 174.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -108.48 113.35 60.23 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.33 104.99 0.55 Allowed 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.021 2.481 . . . . 0.0 112.211 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 m -55.44 -56.39 20.77 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.405 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -109.58 -65.9 1.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tp -168.63 -43.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.886 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 132.1 110.41 1.26 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.083 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -65.23 -31.54 72.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.302 0.572 . . . . 0.0 110.224 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.441 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -87.96 10.18 19.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.476 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.7 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 25.3 tp60 -49.25 -53.13 42.45 Favored Pre-proline 0 N--CA 1.469 0.488 0 O-C-N 123.296 0.373 . . . . 0.0 111.89 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 40.0 Cg_exo -59.06 -37.47 92.71 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.198 1.932 . . . . 0.0 112.701 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' A' ' 107' ' ' ALA . 74.8 mt -75.3 -43.26 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.065 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.529 HG12 ' SD ' ' A' ' 111' ' ' MET . 73.7 mt -58.16 -45.9 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.149 0.5 . . . . 0.0 110.158 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 36.0 t70 -66.8 -39.01 87.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.765 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.43 -48.4 75.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.869 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.592 ' HA ' ' HG3' ' A' ' 204' ' ' GLU . 54.3 mt -68.14 -33.12 73.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.649 0.261 . . . . 0.0 111.032 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.568 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.15 -42.96 77.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 51.5 mt-10 -64.7 -36.36 84.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.901 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 201' ' ' LEU . 5.8 mm-40 -53.66 -46.03 70.44 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.059 0.457 . . . . 0.0 110.891 175.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 285' ' ' ALA . . . -63.73 -37.01 85.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.784 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 76.3 mtp180 -72.47 -16.75 61.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.164 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -99.38 -38.21 8.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.458 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -86.72 -12.46 48.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.126 0.489 . . . . 0.0 111.1 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 61.02 48.48 6.47 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.18 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.89 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 12.8 ptm180 -122.11 158.02 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.989 0.424 . . . . 0.0 111.718 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 pt -136.36 168.59 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.578 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.524 ' HB2' ' CE2' ' A' ' 254' ' ' PHE . 14.1 t80 -122.89 138.63 54.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.611 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.589 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 35.5 m -127.42 133.83 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 110.757 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.78 -178.52 4.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.309 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.4 t 61.27 30.24 19.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.902 0.858 . . . . 0.0 109.082 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.0 119.17 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.236 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -57.45 142.27 44.6 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.974 0.416 . . . . 0.0 111.062 -173.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -49.04 -36.18 17.49 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -168.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -91.03 -5.83 54.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -171.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.81 131.87 36.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.117 0.484 . . . . 0.0 111.14 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.2 p -100.6 173.58 6.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.192 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.472 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 6.1 p-10 -61.62 -35.46 77.94 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.722 0.296 . . . . 0.0 110.415 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.48 -39.08 82.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.258 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.36 -44.23 68.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.597 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.604 HG22 HD11 ' A' ' 255' ' ' ILE . 29.6 mm -66.37 -40.73 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 88.2 tttt -60.82 -43.33 98.35 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.479 176.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 51.1 m -59.36 -39.09 82.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.76 -45.5 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.625 0.25 . . . . 0.0 111.304 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.603 ' CB ' HD11 ' A' ' 235' ' ' ILE . 15.5 m-85 -65.91 -30.39 70.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.225 0.536 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 7.6 tp10 -61.0 -24.21 65.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.946 176.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.65 -13.16 59.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.883 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -111.06 -34.39 6.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.692 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.97 166.74 29.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.332 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -78.56 103.19 8.34 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.253 0.549 . . . . 0.0 111.336 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.603 HD11 ' CB ' ' A' ' 229' ' ' PHE . 22.3 mt -78.6 150.94 5.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.103 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.04 -28.66 8.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.794 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.467 ' OG ' ' HB2' ' A' ' 256' ' ' GLU . 3.3 p -172.04 153.1 3.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.671 0.272 . . . . 0.0 111.136 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' CYS . . . . . 0.455 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 41.6 t -143.5 127.79 17.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.16 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 239' ' ' THR . 5.2 t -141.53 108.48 5.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.067 0.461 . . . . 0.0 111.311 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.569 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 36.5 mt -79.32 130.58 35.58 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.578 ' HB3' ' CD1' ' A' ' 252' ' ' TYR . . . -75.03 118.68 18.26 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.536 ' CB ' ' HA ' ' A' ' 249' ' ' HIS . 35.9 ptt180 -139.56 169.04 18.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.95 -170.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -106.17 108.48 61.79 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 173.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.41 -37.61 94.1 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.305 2.67 . . . . 0.0 113.161 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -35.04 79.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.949 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 41.0 p -97.78 -18.67 18.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 111.537 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 73.77 44.82 30.14 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.05 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -150.95 139.64 20.7 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' HIS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 242' ' ' ARG . 6.2 p80 -83.68 140.23 32.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -81.26 30.06 0.34 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -169.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 92.97 -6.06 76.27 Favored Glycine 0 CA--C 1.505 -0.578 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.429 171.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.578 ' CD1' ' HB3' ' A' ' 241' ' ' ALA . 0.2 OUTLIER -140.42 173.87 11.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -176.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -169.77 174.7 44.02 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.413 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 212' ' ' TYR . 59.7 m-85 -129.51 146.92 51.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.169 0.484 . . . . 0.0 110.512 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.604 HD11 HG22 ' A' ' 225' ' ' ILE . 84.9 mt -136.03 147.76 28.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.008 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.89 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 34.7 mt-10 -127.65 146.81 50.43 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.644 ' HB2' ' OG ' ' A' ' 263' ' ' SER . 18.7 m-85 -119.66 159.18 24.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.825 0.345 . . . . 0.0 110.915 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.16 -36.42 69.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.211 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -107.1 131.67 53.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -58.23 -34.26 70.23 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.655 -173.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLN . . . . . 0.426 HE21 ' HB2' ' A' ' 261' ' ' GLN . 0.0 OUTLIER -64.81 -44.48 89.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.2 176.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.0 m -65.02 -30.58 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.296 -169.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.644 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 1.6 m -60.96 -47.6 85.69 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.389 0.614 . . . . 0.0 109.646 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -73.69 -26.84 60.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.325 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -74.29 -32.99 63.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.418 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -66.78 -40.07 88.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 282' ' ' VAL . 64.5 t -55.13 -45.56 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.433 0.635 . . . . 0.0 109.882 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 53.0 m -63.26 -30.01 71.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.699 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.9 m -95.61 -37.26 10.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.484 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 90.5 mmm -92.77 -3.52 54.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -166.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 272' ' ' LEU . 15.9 t30 -72.95 124.77 26.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.22 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' LEU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 99.1 mt 72.37 26.17 2.67 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.901 0.75 . . . . 0.0 110.643 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -87.33 120.75 28.94 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.546 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 10.2 p-10 -78.21 101.23 6.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.467 0.651 . . . . 0.0 110.871 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.546 HD12 HD11 ' A' ' 280' ' ' LEU . 0.9 OUTLIER -113.37 107.7 16.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.03 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 73.58 22.32 78.56 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.838 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.27 -38.5 3.26 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.775 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -87.87 148.68 24.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.857 0.328 . . . . 0.0 110.979 -176.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.546 ' CE1' ' HB3' ' A' ' 274' ' ' ASP . 81.4 m-85 -90.55 113.33 25.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.088 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.546 HD11 HD12 ' A' ' 275' ' ' LEU . 69.9 mt -60.18 133.27 55.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.479 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -107.1 116.35 31.77 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 172.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 267' ' ' VAL . 7.8 p -118.1 140.55 41.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.184 0.516 . . . . 0.0 111.36 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -132.47 174.78 20.24 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.018 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -100.33 45.43 0.98 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.597 0.713 . . . . 0.0 110.957 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 205' ' ' ALA . . . 33.09 69.89 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 112.9 -1.955 . . . . 0.0 113.709 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.425 HG21 ' HG3' ' A' ' 167' ' ' GLN . 35.1 m -54.8 -26.29 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.926 0.393 . . . . 0.0 111.159 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.483 ' HA ' ' HD2' ' A' ' 288' ' ' PRO . 25.7 p -134.04 107.14 11.44 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.611 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' PRO . . . . . 0.506 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 21.8 Cg_endo -62.04 121.51 9.59 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.857 2.372 . . . . 0.0 111.363 172.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.25 56.45 5.48 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.864 2.376 . . . . 0.0 112.316 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' MET . . . . . 0.441 ' HG2' ' HB2' ' A' ' 288' ' ' PRO . 88.8 mmm -76.62 130.91 75.26 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.019 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.81 81.21 0.61 Allowed 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.802 2.334 . . . . 0.0 112.3 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 95.1 mt -95.87 60.9 2.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.503 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' LEU . . . . . 0.498 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 44.1 tp -94.47 104.38 16.34 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 5.9 p -108.44 96.52 19.27 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.026 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 293' ' ' LEU . 16.6 Cg_exo -68.18 -54.66 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.803 2.335 . . . . 0.0 111.393 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 48.92 54.55 10.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.41 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.21 -179.021 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.319 -0.312 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.66 96.95 5.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.828 0.347 . . . . 0.0 110.231 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -120.13 -31.77 4.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -93.04 36.99 1.03 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 110.401 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -96.96 125.04 41.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.108 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 60.49 50.13 6.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.68 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 -112.67 8.84 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.378 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -53.64 -49.26 68.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.494 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.7 -48.02 61.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.08 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.99 -34.66 78.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.947 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.96 -32.49 72.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.145 0.498 . . . . 0.0 110.584 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.8 mt -80.67 -34.59 14.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.158 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.466 ' SD ' HG12 ' A' ' 198' ' ' ILE . 84.8 mtp -71.42 -23.48 61.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.83 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.7 m -84.11 -1.74 55.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.842 0.353 . . . . 0.0 110.77 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 98.5 mtt180 -122.03 141.09 51.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.129 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.25 133.12 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.159 0.505 . . . . 0.0 110.022 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.472 ' HB3' ' HA ' ' A' ' 187' ' ' ARG . 71.5 t80 -83.5 121.1 26.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.627 HG11 ' HZ ' ' A' ' 132' ' ' PHE . 15.7 m -117.46 116.56 52.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.066 0.46 . . . . 0.0 110.097 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 183' ' ' ILE . . . -122.23 171.39 15.32 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.03 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 m 67.38 25.98 8.52 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.785 0.434 . . . . 0.0 111.196 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.3 mt -66.81 115.56 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -53.32 143.26 19.16 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.924 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -69.5 80.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.447 0.642 . . . . 0.0 110.206 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -164.3 -44.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.974 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.435 ' CD1' ' HG3' ' A' ' 177' ' ' MET . 48.1 mt -83.33 124.27 30.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.187 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -97.74 -169.86 32.63 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.4 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -65.28 -33.04 75.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.019 0.438 . . . . 0.0 110.225 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 9.8 m-20 -71.91 -50.59 27.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.535 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -41.86 86.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.503 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.548 HG23 ' CE1' ' A' ' 132' ' ' PHE . 17.1 mm -63.95 -42.91 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.812 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.2 ttt85 -59.15 -38.74 80.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.982 0.42 . . . . 0.0 110.307 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 90.1 mt-30 -66.37 -33.78 76.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.338 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.62 -23.69 29.45 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.627 ' HZ ' HG11 ' A' ' 116' ' ' VAL . 28.3 m-85 -94.25 -21.8 18.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.765 0.317 . . . . 0.0 111.479 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.615 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.21 -42.58 87.16 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 1.1 Cg_endo -47.54 -39.12 29.12 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.86 2.374 . . . . 0.0 114.325 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.598 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 62.9 m-85 -78.39 -38.04 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -172.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.69 172.61 45.11 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.197 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.56 117.56 5.21 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.638 2.226 . . . . 0.0 111.469 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.762 HD13 HD11 ' A' ' 141' ' ' ILE . 80.9 mt -72.63 131.95 34.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.705 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -111.09 -21.02 12.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.352 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 42.4 t -165.36 142.28 5.68 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.963 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.762 HD11 HD13 ' A' ' 138' ' ' ILE . 54.0 mt -142.0 114.44 3.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.277 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 157' ' ' PHE . 7.9 p-10 -110.28 108.15 18.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.496 0.665 . . . . 0.0 109.426 172.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.546 ' HE1' HG13 ' A' ' 128' ' ' ILE . 45.5 ttm -109.68 146.37 34.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.265 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.415 ' CB ' ' HB2' ' A' ' 153' ' ' LYS . 7.9 p -73.66 54.9 0.49 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.742 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.504 ' HA ' ' O ' ' A' ' 151' ' ' LYS . 43.9 t-105 -117.82 96.04 5.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -81.32 121.53 26.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.668 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.4 m -83.46 -9.74 58.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.713 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.9 -56.27 7.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.4 p -100.38 -6.23 26.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.968 0.413 . . . . 0.0 111.51 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 41.5 mtm 66.13 56.9 0.8 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.304 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 145' ' ' TRP . 65.1 mttm -110.07 131.34 55.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.156 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -121.37 85.27 2.37 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.415 ' HB2' ' CB ' ' A' ' 144' ' ' SER . 31.3 mmmt -61.52 -52.34 64.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.095 -174.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 123.4 15.91 3.59 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.746 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 51.6 p90 -128.11 156.33 43.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.239 0.519 . . . . 0.0 110.558 175.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.62 159.04 29.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.463 ' HB2' ' OD1' ' A' ' 142' ' ' ASP . 51.8 m-85 -112.33 112.74 24.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.846 172.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.452 HG11 ' CD2' ' A' ' 132' ' ' PHE . 59.3 t -98.7 117.46 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.177 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 37.0 tt0 -109.33 138.85 45.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -115.32 -175.97 2.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.229 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.36 -34.35 61.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.815 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.5 m -125.98 150.78 70.19 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.043 0.449 . . . . 0.0 111.365 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 58.0 Cg_endo -70.1 -14.1 34.62 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.369 2.713 . . . . 0.0 111.938 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.447 ' HG3' ' HE1' ' A' ' 254' ' ' PHE . 70.5 mm-40 -59.12 -59.59 5.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.985 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.73 -19.21 10.23 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.52 -53.32 6.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.798 0.332 . . . . 0.0 110.111 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -63.57 -36.78 84.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.828 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.598 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 18.5 tp -66.23 -46.96 75.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.29 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.54 -44.17 96.39 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.594 ' HG ' HG13 ' A' ' 185' ' ' VAL . 6.1 tt -55.43 -44.34 76.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.247 0.546 . . . . 0.0 109.789 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.16 -39.84 79.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.127 -0.942 . . . . 0.0 113.204 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -100.59 -7.34 24.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' MET . . . . . 0.648 ' SD ' HD11 ' A' ' 183' ' ' ILE . 32.5 ttm -97.46 -16.46 20.15 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -78.59 27.39 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 111.414 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.468 ' O ' HG13 ' A' ' 176' ' ' VAL . 41.5 t -113.6 -58.77 2.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.359 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -164.3 167.47 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 124.042 0.839 . . . . 0.0 109.167 177.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.449 ' SD ' ' HG ' ' A' ' 178' ' ' LEU . 15.1 tpp -134.05 88.16 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.423 0.63 . . . . 0.0 110.805 172.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.449 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 90.1 mt 58.96 -79.83 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.597 174.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -79.02 54.93 4.27 Favored Glycine 0 CA--C 1.518 0.219 0 N-CA-C 114.278 0.471 . . . . 0.0 114.278 -168.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.87 -52.42 3.6 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 114.078 0.391 . . . . 0.0 114.078 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -76.27 133.96 39.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.091 0.472 . . . . 0.0 111.631 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 43.8 t30 -80.12 134.59 36.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.096 171.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ILE . . . . . 0.648 HD11 ' SD ' ' A' ' 173' ' ' MET . 40.8 pt -105.0 173.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.951 0.405 . . . . 0.0 110.624 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 87.7 mttt -102.62 106.1 16.71 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.594 HG13 ' HG ' ' A' ' 170' ' ' LEU . 12.0 p -102.78 120.39 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.605 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 132.34 128.65 2.94 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.766 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 68.7 ttt180 -74.76 -50.71 4.17 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 119.408 -0.329 . . . . 0.0 111.551 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 187' ' ' ARG . 37.9 Cg_endo -65.9 84.55 0.24 Allowed 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.009 1.806 . . . . 0.0 112.819 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.4 t -97.0 -9.02 29.05 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASN . . . . . 0.416 ' OD1' HG22 ' A' ' 191' ' ' ILE . 28.6 t-20 -116.69 -59.77 1.93 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.425 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.416 HG22 ' OD1' ' A' ' 190' ' ' ASN . 9.0 tp -172.36 -52.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 174.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 191' ' ' ILE . . . 89.65 136.51 6.14 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.244 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -76.42 -14.0 60.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.322 . . . . 0.0 111.361 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -103.89 5.62 35.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.023 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.589 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 19.3 tm0? -53.36 -46.64 97.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.146 -177.213 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 6.8 Cg_endo -51.85 -44.6 43.88 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.298 1.999 . . . . 0.0 112.75 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.438 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 70.5 mt -69.43 -41.43 80.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 0.0 110.386 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.466 HG12 ' SD ' ' A' ' 111' ' ' MET . 74.2 mt -57.8 -48.3 84.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.461 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.52 -38.75 90.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.078 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -63.84 -48.36 77.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.13 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 42.3 mt -67.48 -33.5 75.23 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.559 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.661 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.31 -47.87 68.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.55 -31.63 70.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.131 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.21 -37.95 89.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.008 0.432 . . . . 0.0 110.741 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -77.13 -26.19 52.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.181 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 81.1 mtp180 -70.95 -24.67 62.48 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.018 176.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.97 -24.15 63.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.293 0.568 . . . . 0.0 110.405 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.89 169.24 8.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.674 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 46.1 m-20 -105.31 38.59 1.92 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ARG . . . . . 0.468 ' CA ' ' HG2' ' A' ' 256' ' ' GLU . 20.7 ttm180 -95.36 138.25 33.31 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.033 -170.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.703 HG22 ' HD2' ' A' ' 284' ' ' LYS . 44.9 pt -122.75 167.02 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.074 175.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' TYR . . . . . 0.48 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 66.0 t80 -119.18 129.36 54.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.199 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' VAL . . . . . 0.559 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 35.1 m -123.53 134.92 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -126.06 175.66 7.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.846 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.12 27.17 10.54 Favored 'General case' 0 CA--C 1.527 0.059 0 O-C-N 124.158 0.911 . . . . 0.0 109.629 -176.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' VAL . . . . . 0.42 HG13 HD11 ' A' ' 225' ' ' ILE . 22.2 t -77.13 112.46 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' HIS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 42.6 t-80 -53.3 136.95 36.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.058 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -55.08 -34.77 63.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.186 -173.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.13 7.13 47.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.727 0.775 . . . . 0.0 110.639 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.567 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.3 tp -92.0 124.5 36.15 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.7 t -89.65 168.43 12.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.986 0.422 . . . . 0.0 111.219 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.17 -22.85 63.89 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -65.48 -33.91 77.04 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.923 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -72.16 -46.44 56.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.423 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.735 HG13 HD21 ' A' ' 240' ' ' LEU . 21.8 mm -63.11 -50.82 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.67 -44.39 81.35 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.967 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 30.3 t -58.09 -43.68 87.19 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 19.1 t -76.82 -44.02 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.5 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PHE . . . . . 0.641 ' HB2' HD11 ' A' ' 235' ' ' ILE . 55.3 m-85 -64.1 -33.41 75.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.098 0.475 . . . . 0.0 110.71 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -61.01 -24.96 66.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.457 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.48 -11.93 60.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.153 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.87 -33.89 6.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -156.85 158.39 28.76 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.904 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -69.44 116.05 9.42 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.268 0.556 . . . . 0.0 111.101 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 229' ' ' PHE . 47.0 mt -86.19 151.58 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.733 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -119.32 -15.41 9.13 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.418 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 256' ' ' GLU . 47.6 t -165.77 143.88 5.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -174.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 54.1 t -153.87 117.78 4.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 10.5 t -140.26 139.39 35.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.234 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LEU . . . . . 0.735 HD21 HG13 ' A' ' 225' ' ' ILE . 77.8 mt -105.43 130.94 53.41 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.81 121.28 15.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.033 0.444 . . . . 0.0 110.376 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 51.6 ttp180 -134.65 152.02 51.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.111 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.485 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 5.7 m-20 -74.11 148.47 86.6 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -45.94 -45.12 17.91 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.04 2.493 . . . . 0.0 113.377 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.2 t -154.66 75.11 0.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.707 0.765 . . . . 0.0 110.881 -176.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 18.1 p -125.01 -11.19 7.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.138 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 72.45 20.3 79.33 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.389 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 21.6 ptmt -156.69 141.78 17.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -94.14 140.99 29.06 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.093 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -44.1 -55.97 4.37 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.235 0.959 . . . . 0.0 113.046 -172.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 145.95 11.04 0.24 Allowed Glycine 0 CA--C 1.511 -0.19 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.054 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' TYR . . . . . 0.48 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 44.4 p90 -144.37 167.23 22.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.08 173.81 32.62 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.26 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.447 ' HE1' ' HG3' ' A' ' 164' ' ' GLU . 81.0 m-85 -133.59 143.99 49.01 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 225' ' ' ILE . 67.6 mt -140.12 135.74 37.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.501 -176.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 25.4 mt-10 -112.83 142.23 45.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 7.0 m-85 -102.18 167.35 10.06 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -73.3 -13.99 61.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.96 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -134.76 124.93 25.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.551 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ALA . . . . . 0.412 ' HB2' ' OD1' ' A' ' 209' ' ' ASN . . . -58.97 -44.14 91.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.203 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -62.89 -33.98 76.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.826 0.346 . . . . 0.0 110.802 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 53.3 m -70.48 -27.87 64.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.55 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 267' ' ' VAL . 83.9 p -72.81 -31.3 64.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -72.68 -30.62 64.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.946 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.05 -38.68 92.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.248 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 229' ' ' PHE . . . -66.05 -42.37 89.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.131 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 263' ' ' SER . 82.4 t -53.03 -45.82 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.863 0.363 . . . . 0.0 111.345 176.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.6 m -65.54 -32.13 73.56 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 32.0 t -94.12 -33.64 13.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' MET . . . . . 0.517 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.3 mmm -91.75 0.55 57.48 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -169.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -74.29 118.39 17.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.7 mt 68.62 31.35 4.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.451 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -89.75 123.18 33.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.28 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.1 t70 -69.78 120.21 15.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.875 0.369 . . . . 0.0 110.892 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.567 ' HG ' HD21 ' A' ' 220' ' ' LEU . 38.8 tp -138.41 94.41 2.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.614 173.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.39 25.49 39.39 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.902 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 84.9 3.87 87.57 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.811 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLN . . . . . 0.463 ' HG3' ' HB2' ' A' ' 217' ' ' HIS . 16.8 mm100 -109.64 139.67 44.38 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.55 -178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.6 103.27 15.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.886 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.6 124.5 21.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.635 -175.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -93.92 116.61 29.07 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 171.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 213' ' ' VAL . 14.5 p -124.44 148.37 28.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.103 0.478 . . . . 0.0 111.346 -171.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.19 177.76 41.64 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LYS . . . . . 0.703 ' HD2' HG22 ' A' ' 211' ' ' ILE . 4.6 mmmp? -80.32 123.26 27.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.286 0.543 . . . . 0.0 109.942 175.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' ALA . . . . . 0.487 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -52.47 127.48 22.69 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.96 0.787 . . . . 0.0 110.347 177.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.56 -25.6 5.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 123.466 0.479 . . . . 0.0 111.052 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' THR . . . . . 0.641 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 21.7 p -127.5 153.33 77.41 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -91.51 101.84 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.793 2.329 . . . . 0.0 112.031 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' PRO . . . . . 0.641 ' HD3' ' O ' ' A' ' 287' ' ' THR . 11.6 Cg_endo -93.67 99.7 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.564 2.843 . . . . 0.0 111.348 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 25.5 mmt -86.65 116.86 67.47 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.53 116.5 3.95 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.579 2.186 . . . . 0.0 110.67 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.9 mt -79.67 54.07 1.73 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 110.989 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 88.9 mt -123.17 125.63 45.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.205 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 36.5 p 49.05 68.14 3.82 Favored Pre-proline 0 CA--C 1.534 0.336 0 O-C-N 123.777 0.673 . . . . 0.0 111.388 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.4 154.39 60.84 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.116 2.544 . . . . 0.0 112.243 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 72.06 136.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.099 0.874 . . . . 0.0 111.702 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.372 177.619 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 C--O 1.231 0.108 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -61.48 -41.75 97.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.787 0.327 . . . . 0.0 110.791 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.51 -32.82 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.977 0.418 . . . . 0.0 110.075 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.551 HD23 ' SD ' ' A' ' 111' ' ' MET . 83.8 mt -63.25 -34.29 77.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.642 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.47 66.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.167 0.508 . . . . 0.0 110.813 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.0 mt -83.39 -36.83 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.883 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.639 ' SD ' HG12 ' A' ' 198' ' ' ILE . 87.2 mtp -72.22 -22.37 61.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.626 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 76.1 m -74.75 -9.78 58.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.88 0.371 . . . . 0.0 111.021 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -105.46 142.25 35.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.589 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.502 HG12 ' HB ' ' A' ' 158' ' ' VAL . 8.7 p -123.93 127.71 73.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.446 0.641 . . . . 0.0 109.826 170.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -80.54 106.8 12.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.829 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.481 HG11 ' CZ ' ' A' ' 132' ' ' PHE . 19.0 m -99.09 115.31 39.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.423 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.38 149.92 17.53 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.719 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.9 m 76.35 -66.69 0.25 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.872 0.869 . . . . 0.0 111.436 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 120' ' ' TYR . 78.6 mt 61.88 -91.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 O-C-N 123.383 0.427 . . . . 0.0 110.697 -176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 119' ' ' ILE . 23.3 t80 165.94 140.01 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -175.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -79.07 75.35 5.59 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.378 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -174.53 -51.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.991 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 178' ' ' LEU . 78.8 mt -58.81 128.21 36.07 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.717 -173.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.99 -177.6 37.82 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.605 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -67.96 -43.59 78.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.412 . . . . 0.0 111.024 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 16.9 t70 -68.28 -42.42 79.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.087 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.0 m -67.0 -37.96 85.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.125 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 128' ' ' ILE . 17.2 mm -61.98 -40.86 88.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.62 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.546 ' HA ' HD12 ' A' ' 138' ' ' ILE . 38.0 ttp-105 -59.06 -39.76 83.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 110.178 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 72.6 mt-30 -68.59 -34.2 75.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.337 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.09 -21.32 36.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.633 ' HB2' HD11 ' A' ' 138' ' ' ILE . 31.6 m-85 -100.93 -15.29 17.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.956 0.408 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.635 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -54.13 -40.56 82.89 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 177.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 5.9 Cg_exo -42.76 -38.18 6.41 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.289 2.66 . . . . 0.0 114.013 174.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.541 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 60.3 m-85 -81.49 -46.89 13.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.881 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.73 165.57 38.51 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.073 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.461 ' HG2' ' CE1' ' A' ' 252' ' ' TYR . 24.9 Cg_exo -65.05 120.16 7.33 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.722 2.282 . . . . 0.0 111.408 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' A' ' 132' ' ' PHE . 41.2 mt -79.62 129.54 37.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.356 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -96.62 -29.82 13.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.832 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.0 t -158.65 141.5 14.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.593 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.437 ' CG1' HG21 ' A' ' 138' ' ' ILE . 72.1 mt -131.5 122.65 50.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.657 0.265 . . . . 0.0 110.943 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 33.1 t70 -98.14 100.06 11.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.436 ' CE ' HG13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -104.93 139.62 39.38 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.833 -171.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 p . . . . . 0 C--N 1.323 -0.585 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.339 177.257 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 48.3 p90 . . . . . 0 N--CA 1.453 -0.304 0 CA-C-O 120.54 0.209 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.9 152.78 33.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.319 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 46.8 m-85 -109.56 109.95 20.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.785 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.502 ' HB ' HG12 ' A' ' 114' ' ' VAL . 97.4 t -95.33 108.81 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.801 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -106.42 115.7 30.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.354 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -89.21 178.83 6.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.218 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.49 -45.64 30.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.082 0.468 . . . . 0.0 109.796 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.64 141.86 24.21 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.452 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.9 Cg_endo -69.5 -21.33 34.87 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.256 2.637 . . . . 0.0 112.518 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.601 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 6.5 mp0 -55.2 -51.43 66.57 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.883 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.12 -23.85 66.79 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 120.954 0.407 . . . . 0.0 111.921 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.22 -48.53 12.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.753 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.6 ' HG3' HG11 ' A' ' 286' ' ' VAL . 32.2 mm-40 -64.6 -36.53 84.52 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.699 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.541 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 11.8 tp -66.51 -46.81 75.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.734 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.148 0.499 . . . . 0.0 109.931 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.536 ' HA ' HG21 ' A' ' 185' ' ' VAL . 6.7 tt -69.79 -46.1 66.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.574 173.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 16.4 mm-40 -56.75 -56.83 16.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.25 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -86.51 -39.42 16.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 27.2 ttp -104.63 30.17 5.61 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.588 -165.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -89.11 44.38 1.21 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.884 0.849 . . . . 0.0 109.673 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 19.6 m -115.59 -73.87 0.63 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.416 173.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.24 169.34 5.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.712 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.623 ' HB2' HD13 ' A' ' 183' ' ' ILE . 25.0 tpp -145.45 78.98 1.56 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.951 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.604 ' HB2' HD11 ' A' ' 123' ' ' LEU . 75.6 mt 63.84 162.15 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.527 174.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.29 -65.07 1.65 Allowed Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.008 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.6 62.81 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.203 -0.522 . . . . 0.0 111.861 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -143.53 129.54 19.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.772 0.32 . . . . 0.0 111.242 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 175' ' ' SER . 8.9 t30 -71.5 103.69 3.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.373 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.623 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.5 pt -85.62 159.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.211 0.529 . . . . 0.0 111.884 -173.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -110.51 114.95 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.804 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 170' ' ' LEU . 5.3 m -103.64 108.33 24.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.422 0.63 . . . . 0.0 110.787 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.88 177.37 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.441 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 43.8 tt0 . . . . . 0 N--CA 1.456 -0.149 0 CA-C-O 121.081 0.467 . . . . 0.0 110.629 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -75.05 -28.8 60.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.067 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.718 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 27.2 mm-40 -54.32 -53.76 55.66 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.812 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.718 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 52.6 Cg_exo -55.08 -36.12 92.11 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.196 1.931 . . . . 0.0 112.851 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 72.6 mt -70.98 -46.09 69.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.339 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.639 HG12 ' SD ' ' A' ' 111' ' ' MET . 73.9 mt -57.15 -45.76 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.924 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.7 -39.9 95.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.244 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -63.08 -49.94 72.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.868 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 68.1 mt -67.88 -31.91 72.04 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.604 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.34 -47.86 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.65 -36.57 81.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.826 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 208' ' ' PHE . 39.2 mt-10 -68.37 -37.14 80.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.255 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -67.96 -32.24 72.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.83 0.348 . . . . 0.0 110.423 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.9 mtp180 -63.02 -37.98 89.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.317 175.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.58 -27.86 67.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.507 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.435 ' HD2' ' O ' ' A' ' 204' ' ' GLU . 75.0 m-85 -94.73 -16.48 23.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.45 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 60.71 41.65 14.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.987 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.496 ' HD2' ' OE1' ' A' ' 256' ' ' GLU . 16.5 ttt180 -101.42 145.15 29.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.279 0.561 . . . . 0.0 112.285 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 47.9 pt -129.05 167.56 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.4 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.508 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 27.0 t80 -117.65 138.03 52.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.482 HG12 HG22 ' A' ' 282' ' ' VAL . 28.9 m -128.21 131.63 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.395 0.617 . . . . 0.0 110.915 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.38 173.05 7.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.588 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.8 t 58.51 31.5 21.09 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.742 0.782 . . . . 0.0 109.619 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.51 114.23 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.828 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.629 ' HA ' ' OE1' ' A' ' 278' ' ' GLN . 25.0 t-80 -54.05 130.39 37.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.442 0.639 . . . . 0.0 111.726 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -48.58 -33.13 9.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.186 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -85.09 -23.1 28.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.964 0.411 . . . . 0.0 111.835 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.406 HD11 ' HG ' ' A' ' 275' ' ' LEU . 69.5 mt -77.74 128.55 34.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.421 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 21.6 m -92.24 173.29 7.9 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.468 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -49.29 -50.28 39.83 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.842 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.24 -33.87 75.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.506 -174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.84 -38.1 73.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.629 0.252 . . . . 0.0 110.586 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.829 HG22 HD11 ' A' ' 255' ' ' ILE . 29.2 mm -67.01 -41.84 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.454 ' HG3' HG21 ' A' ' 235' ' ' ILE . 83.9 tttt -57.67 -45.45 85.53 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.389 173.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 39.6 t -54.19 -47.75 71.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.45 -39.58 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.347 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.533 ' HB2' HD11 ' A' ' 235' ' ' ILE . 24.0 m-85 -68.31 -29.78 68.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.019 0.438 . . . . 0.0 110.603 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.12 -26.24 68.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.946 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.66 -16.31 62.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.407 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -111.56 -40.12 4.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.427 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -138.31 161.8 25.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.325 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -81.02 104.23 11.37 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.181 0.515 . . . . 0.0 110.694 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 229' ' ' PHE . 27.3 mt -82.83 151.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.702 0.763 . . . . 0.0 111.759 -175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.627 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 45.4 tttm -107.26 -40.13 5.49 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.044 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 53.1 m -158.62 152.92 24.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.816 0.341 . . . . 0.0 110.545 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 9.3 p -133.37 125.67 29.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.746 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 12.0 m -140.37 100.9 4.0 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.717 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.521 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 44.4 mt -84.23 148.04 26.93 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.3 91.75 1.35 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 16.4 ttp85 -109.06 138.08 45.96 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.428 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 9.4 t70 -118.95 126.59 27.01 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.643 -172.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 11.6 Cg_exo -67.37 -21.03 47.88 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.994 2.462 . . . . 0.0 113.258 -176.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 35.2 p -100.97 13.57 34.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 0.0 111.238 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.408 HG23 ' OD1' ' A' ' 243' ' ' ASP . 63.8 p -115.23 -29.65 6.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.251 0.548 . . . . 0.0 110.078 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 93.59 1.44 66.09 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.015 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -154.56 -165.87 2.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 7.9 p80 -98.6 154.0 18.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.301 0.572 . . . . 0.0 109.764 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -71.22 -15.34 62.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.864 -168.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 120.39 -6.19 11.78 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.281 -0.962 . . . . 0.0 113.035 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.461 ' CE1' ' HG2' ' A' ' 137' ' ' PRO . 0.5 OUTLIER -134.61 158.62 43.57 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -162.79 177.62 38.82 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.407 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.601 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 52.9 m-85 -132.28 149.19 52.42 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.829 HD11 HG22 ' A' ' 225' ' ' ILE . 82.5 mt -134.08 142.59 40.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.496 ' OE1' ' HD2' ' A' ' 210' ' ' ARG . 30.7 tt0 -128.16 134.54 49.09 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -170.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 10.4 m-85 -111.0 165.52 11.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.142 0.496 . . . . 0.0 111.534 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.627 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 13.6 mt-10 -88.22 -12.0 45.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.156 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -134.93 124.78 25.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.886 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -65.44 -22.09 66.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.45 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -75.17 -47.08 30.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.4 m -65.09 -33.35 75.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.831 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.593 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 90.2 p -67.74 -31.88 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 75.4 mt-30 -75.25 -24.65 57.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -63.98 -49.19 73.46 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 229' ' ' PHE . . . -58.5 -40.16 82.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.259 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.56 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 97.5 t -57.1 -39.33 65.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.976 0.417 . . . . 0.0 111.045 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.6 t -81.66 -40.52 22.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.285 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.5 m -80.48 -40.35 26.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.44 ' HB2' HG21 ' A' ' 282' ' ' VAL . 89.5 mmm -89.69 -5.01 57.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.856 -170.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 267' ' ' VAL . 63.5 t30 -71.09 122.05 19.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 98.3 mt 70.09 23.06 5.42 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.886 0.741 . . . . 0.0 111.015 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.35 125.77 30.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.09 101.57 9.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.063 0.459 . . . . 0.0 110.185 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.406 ' HG ' HD11 ' A' ' 220' ' ' LEU . 36.5 tp -121.25 99.55 6.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.983 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.73 25.8 37.25 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.285 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 77.19 33.78 43.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.206 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.629 ' OE1' ' HA ' ' A' ' 217' ' ' HIS . 2.1 tt0 -152.43 139.99 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -91.45 103.15 15.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.665 0.269 . . . . 0.0 111.079 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 34.8 mt -58.36 116.97 3.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.806 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 281' ' ' ARG . 14.3 mmm-85 -93.46 114.6 27.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.56 ' CG1' ' HA ' ' A' ' 267' ' ' VAL . 17.1 t -112.35 140.05 34.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.858 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -153.92 170.58 32.56 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.625 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -75.9 128.98 36.23 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -74.05 128.76 36.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.6 HG11 ' HG3' ' A' ' 167' ' ' GLN . 20.1 m -93.77 -19.67 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.478 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.525 HG21 HD22 ' A' ' 108' ' ' LEU . 4.3 t -147.82 138.86 13.31 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.144 175.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 CA--C 1.531 0.342 0 C-N-CA 123.346 2.697 . . . . 0.0 112.924 -179.093 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.442 ' HB3' HD12 ' A' ' 108' ' ' LEU . 69.1 mt-30 . . . . . 0 N--CA 1.464 0.228 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -65.62 -42.09 91.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.821 -172.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' A' ' 197' ' ' ILE . . . -66.85 -33.07 74.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.035 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.487 HD23 ' SD ' ' A' ' 111' ' ' MET . 57.3 mt -63.47 -32.13 73.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.467 -176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.13 -28.63 69.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.189 0.519 . . . . 0.0 110.575 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.5 mt -88.52 -35.92 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.207 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.531 ' SD ' HG12 ' A' ' 198' ' ' ILE . 94.0 mtp -67.06 -18.94 65.57 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.083 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 85.3 m -81.94 -10.68 59.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 110.592 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 98.4 mtt180 -109.7 143.4 39.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.229 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.4 p -120.37 121.7 66.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 168.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -76.09 129.16 36.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.721 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 15.0 m -123.83 122.16 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.497 0.665 . . . . 0.0 111.128 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.63 174.97 19.22 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.416 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.404 ' HB3' HH21 ' A' ' 181' ' ' ARG . 66.0 m 64.46 36.9 8.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.295 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.3 mt -85.0 105.84 14.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.42 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -52.85 146.49 10.59 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.341 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -71.4 76.13 0.76 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 122.029 0.919 . . . . 0.0 111.314 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -165.67 -43.34 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.196 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.522 HD22 HD12 ' A' ' 178' ' ' LEU . 36.2 mt -75.11 103.34 5.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.114 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.64 174.32 54.1 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.208 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.32 -39.97 94.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.69 -42.03 92.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.208 0.528 . . . . 0.0 110.371 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.3 m -68.9 -39.93 79.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.46 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.521 HG13 ' HE1' ' A' ' 143' ' ' MET . 35.5 mm -64.09 -44.2 97.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.512 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -57.28 -46.68 82.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.543 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.34 -33.25 74.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.582 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.634 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -78.28 -31.98 49.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.452 ' HD1' ' O ' ' A' ' 128' ' ' ILE . 50.1 m-85 -93.43 -17.08 23.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.776 0.322 . . . . 0.0 111.454 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.03 -44.11 91.22 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -47.52 -33.17 17.09 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.783 2.322 . . . . 0.0 114.389 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.564 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 70.1 m-85 -79.69 -53.47 6.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.4 -171.04 25.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 119.637 -1.268 . . . . 0.0 113.361 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.46 112.82 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.921 2.414 . . . . 0.0 111.736 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.646 HD13 HD11 ' A' ' 141' ' ' ILE . 68.7 mt -76.6 127.27 37.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.428 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -84.81 -45.81 11.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.568 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -166.22 131.65 2.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.803 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.646 HD11 HD13 ' A' ' 138' ' ' ILE . 67.6 mt -109.36 114.11 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 171.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -94.09 100.46 12.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.044 0.45 . . . . 0.0 110.554 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.521 ' HE1' HG13 ' A' ' 128' ' ' ILE . 36.5 ttm -143.14 124.65 14.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.929 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.5 m . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.581 177.723 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.66 164.74 37.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.965 0.412 . . . . 0.0 111.305 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.83 111.86 18.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.422 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 78.7 t -97.45 106.49 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.98 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.431 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 39.4 tt0 -107.57 128.57 54.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.76 0.314 . . . . 0.0 110.615 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -95.17 179.82 5.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.976 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.94 -14.9 28.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.851 0.358 . . . . 0.0 110.16 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.53 135.09 26.86 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.234 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 46.0 Cg_endo -67.57 -21.11 46.45 Favored 'Trans proline' 0 N--CA 1.474 0.35 0 C-N-CA 123.311 2.674 . . . . 0.0 112.585 -176.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.948 ' HG3' ' HE1' ' A' ' 254' ' ' PHE . 5.7 mm-40 -61.01 -52.08 66.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.872 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.645 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -66.86 -17.88 65.11 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.02 -47.21 18.94 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.432 ' HG3' HG11 ' A' ' 286' ' ' VAL . 29.6 mm-40 -69.49 -34.88 74.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.461 174.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 13.6 tp -61.77 -48.1 82.18 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.581 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.98 72.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.97 0.414 . . . . 0.0 110.229 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.65 -52.13 41.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.589 173.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.54 -38.85 60.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.669 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . 0.459 HE21 ' HE1' ' A' ' 135' ' ' PHE . 22.7 mt-30 -99.76 -49.22 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 34.4 ttp -104.87 29.63 6.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -165.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.96 -20.78 60.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.929 0.395 . . . . 0.0 110.708 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.9 p -72.32 -73.58 0.19 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.6 m -134.07 151.98 33.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.033 0.444 . . . . 0.0 111.422 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.797 ' HE2' ' HG ' ' A' ' 178' ' ' LEU . 1.7 tpt -125.55 97.14 5.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.809 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.797 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 85.9 mt 67.56 127.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.93 0.769 . . . . 0.0 112.377 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 72.17 -80.17 0.61 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.385 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.43 36.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.07 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.404 HH21 ' HB3' ' A' ' 118' ' ' SER . 7.7 tpt180 -100.4 122.42 43.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.687 0.279 . . . . 0.0 110.808 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.6 126.44 30.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.546 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.8 pt -120.26 176.91 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.396 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 74.0 mmtt -103.24 107.27 18.03 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 27.6 t -113.36 106.87 21.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.13 0.269 . . . . 0.0 110.696 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 C-N-CA 119.855 -1.164 . . . . 0.0 114.24 172.947 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 CA--C 1.529 0.151 0 CA-C-O 120.849 0.357 . . . . 0.0 111.795 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.473 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -88.45 -12.37 43.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.653 0.263 . . . . 0.0 111.362 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.569 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 33.8 mm-40 -59.08 -49.88 90.79 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 75.4 Cg_exo -52.97 -35.29 70.76 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.288 1.992 . . . . 0.0 112.847 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 107' ' ' ALA . 60.6 mt -69.94 -46.64 72.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.129 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.531 HG12 ' SD ' ' A' ' 111' ' ' MET . 57.6 mt -57.41 -43.27 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.239 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.19 -44.38 88.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.043 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -68.8 -45.44 71.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.911 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.436 HD23 ' OE2' ' A' ' 204' ' ' GLU . 19.4 mt -64.73 -33.53 76.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.783 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.656 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.02 -51.77 60.61 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -60.18 -38.29 82.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.272 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.436 ' OE2' HD23 ' A' ' 201' ' ' LEU . 52.5 mt-10 -60.54 -45.98 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.106 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.02 87.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.882 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.656 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 53.3 mtp180 -64.89 -33.93 77.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.791 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.42 -30.03 66.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.814 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.69 -4.47 47.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.035 0.445 . . . . 0.0 110.68 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.2 m120 62.89 44.03 6.48 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.055 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -99.93 142.78 30.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.188 0.518 . . . . 0.0 111.382 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.5 pt -127.76 166.35 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.175 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.559 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 86.3 t80 -119.18 128.79 54.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.156 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.627 HG12 HG23 ' A' ' 282' ' ' VAL . 32.2 m -121.77 131.28 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.183 0.516 . . . . 0.0 110.641 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -124.8 174.19 8.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.17 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.2 t 60.78 30.94 20.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.887 0.851 . . . . 0.0 109.223 -174.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 36.1 t -79.91 116.06 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.581 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.58 ' HD2' ' HG3' ' A' ' 278' ' ' GLN . 7.6 t-80 -56.4 135.25 54.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.471 0.653 . . . . 0.0 111.677 -169.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -49.29 -38.19 26.48 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -171.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -89.94 -10.02 46.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.754 0.311 . . . . 0.0 111.145 -174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.473 ' HA ' HD12 ' A' ' 220' ' ' LEU . 10.7 tp -83.44 124.59 30.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.257 -174.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.9 t -87.59 169.17 12.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.817 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.08 -36.8 71.0 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.791 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.41 -45.56 72.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.706 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -74.01 -40.95 62.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.059 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.671 HG22 HD11 ' A' ' 255' ' ' ILE . 31.4 mm -63.38 -47.73 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 238' ' ' CYS . 66.1 tttm -58.16 -46.57 85.46 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.052 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.5 t -54.5 -43.57 71.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.07 -41.98 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.41 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.524 ' CB ' HD11 ' A' ' 235' ' ' ILE . 20.6 m-85 -67.44 -28.22 67.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.207 0.527 . . . . 0.0 110.537 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.7 -24.54 64.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.151 0.981 . . . . 0.0 110.467 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.95 -15.84 60.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.205 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -111.3 -23.23 10.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.99 0.424 . . . . 0.0 110.658 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.542 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -165.66 156.31 28.17 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.81 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 23.4 mmtp -74.08 122.52 22.81 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.546 0.688 . . . . 0.0 110.861 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.524 HD11 ' CB ' ' A' ' 229' ' ' PHE . 57.1 mt -92.91 150.43 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.144 -172.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.437 ' HE2' ' CB ' ' A' ' 256' ' ' GLU . 31.8 ttpt -110.5 -28.57 8.46 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.221 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 16.8 m -152.43 146.58 25.42 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.458 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 226' ' ' LYS . 47.2 t -152.78 107.33 3.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.521 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.7 m -140.52 109.27 5.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.133 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.56 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 51.4 mt -77.31 143.61 38.69 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.479 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.08 113.12 4.25 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 29.3 ttp180 -149.89 139.49 21.62 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.147 -169.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.29 128.45 86.04 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -44.49 -46.0 12.41 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.897 3.065 . . . . 0.0 114.394 -163.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 3.7 t -133.89 76.58 1.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.705 0.764 . . . . 0.0 110.579 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 6.6 p -125.75 1.33 7.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.289 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.18 12.75 69.31 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.043 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 22.5 pttp -163.35 179.66 7.2 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -131.0 152.02 50.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -48.32 -61.53 1.95 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.976 0.798 . . . . 0.0 112.573 -172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 160.97 12.33 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.616 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -152.05 -179.69 7.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.56 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -170.61 177.76 43.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.357 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.948 ' HE1' ' HG3' ' A' ' 164' ' ' GLU . 83.3 m-85 -128.96 143.57 50.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.971 0.415 . . . . 0.0 110.917 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.671 HD11 HG22 ' A' ' 225' ' ' ILE . 89.7 mt -140.45 140.75 33.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.004 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.437 ' CB ' ' HE2' ' A' ' 236' ' ' LYS . 45.2 mt-10 -120.67 147.6 45.04 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 20.2 m-85 -111.75 164.2 13.32 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.654 0.264 . . . . 0.0 110.312 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.84 -5.23 59.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.323 0.582 . . . . 0.0 109.433 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -127.87 128.63 45.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.848 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.51 68.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.206 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -74.86 -52.69 10.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.519 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.542 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 28.3 m -60.14 -31.49 70.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.456 -172.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.624 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 48.7 p -64.63 -48.62 74.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.997 0.427 . . . . 0.0 109.988 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -72.53 -18.92 61.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.189 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -69.15 -40.9 77.92 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.045 0.45 . . . . 0.0 110.044 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.62 75.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.949 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 271' ' ' ASN . 88.2 t -59.25 -31.58 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.164 0.507 . . . . 0.0 110.64 174.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.5 t -83.93 -46.6 11.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.898 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.7 m -78.31 -43.24 28.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.487 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 80.0 mmm -83.87 1.21 44.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.161 0.505 . . . . 0.0 110.752 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.636 ' HA ' HG12 ' A' ' 282' ' ' VAL . 18.7 t-20 -71.81 114.22 9.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.157 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 86.0 mt 67.31 36.86 3.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.195 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.42 121.78 33.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.326 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.55 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 26.7 t70 -75.76 106.35 7.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.72 0.295 . . . . 0.0 110.271 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 41.1 tp -131.04 110.03 10.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.028 0.442 . . . . 0.0 110.506 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.82 5.02 74.73 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.185 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.12 -5.16 31.89 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.337 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.58 ' HG3' ' HD2' ' A' ' 217' ' ' HIS . 28.5 mt-30 -125.19 143.52 50.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.828 0.346 . . . . 0.0 110.526 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 57.4 m-85 -78.07 113.22 15.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.089 173.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.37 130.37 44.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.05 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -98.35 114.58 26.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 271' ' ' ASN . 7.5 p -118.39 143.91 27.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.878 -174.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -157.59 173.81 35.0 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.394 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -75.83 135.01 40.22 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -71.99 144.93 48.67 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.432 HG11 ' HG3' ' A' ' 167' ' ' GLN . 20.3 m -109.3 -4.77 10.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.329 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.9 p -129.58 146.75 62.43 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.49 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.462 -0.351 0 C-N-CA 122.553 2.169 . . . . 0.0 111.013 173.247 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.466 0.65 . . . . 0.0 109.657 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -64.03 -30.2 71.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.753 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.1 -44.05 60.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.39 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.499 HD23 ' SD ' ' A' ' 111' ' ' MET . 60.3 mt -61.02 -36.07 78.54 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.47 -36.74 71.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.5 mt -78.73 -40.86 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.215 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.56 ' SD ' HG12 ' A' ' 198' ' ' ILE . 90.6 mtp -62.09 -28.2 69.45 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.588 -176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 67.0 m -74.97 -14.69 60.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.815 0.341 . . . . 0.0 111.109 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.587 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 42.8 mtp180 -101.53 140.31 35.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.852 HG12 ' HB ' ' A' ' 158' ' ' VAL . 9.6 p -110.0 121.82 63.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -82.23 100.98 10.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.008 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 35.3 m -108.21 141.32 23.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.145 0.498 . . . . 0.0 110.969 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.826 ' HA3' ' HD1' ' A' ' 155' ' ' PHE . . . -155.59 170.97 33.59 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.277 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.4 t 62.49 37.83 13.08 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.795 0.807 . . . . 0.0 109.683 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.5 mt -73.29 -14.99 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.543 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.9 t80 74.55 140.88 0.06 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.822 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -72.11 78.25 0.95 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.427 0.632 . . . . 0.0 110.995 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -159.58 -54.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.256 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.8 mt -68.54 119.58 13.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.753 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.63 -173.48 44.34 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.073 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.59 -39.32 94.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.632 0.373 . . . . 0.0 111.316 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.403 ' HA ' ' NE ' ' A' ' 129' ' ' ARG . 22.2 t70 -62.85 -41.19 99.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.38 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.2 m -68.7 -40.13 80.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.453 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.43 HG13 ' CE ' ' A' ' 143' ' ' MET . 31.2 mm -62.73 -50.82 78.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.061 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 126' ' ' ASP . 38.7 ptt180 -60.05 -42.28 94.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.169 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -67.63 -33.29 74.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.39 -33.5 28.69 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.562 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 51.2 m-85 -87.89 -20.54 25.85 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.86 -43.93 97.28 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -41.68 -40.93 5.67 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.069 2.512 . . . . 0.0 114.221 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.685 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 57.0 m-85 -75.45 -46.64 31.42 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.544 0.211 . . . . 0.0 111.295 -174.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -165.25 173.21 41.02 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.612 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.49 119.89 6.79 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.672 2.248 . . . . 0.0 111.688 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.6 mt -83.39 121.97 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.623 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -80.78 -52.49 7.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.695 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.5 t -152.17 152.12 31.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.097 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -124.69 108.98 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.066 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.749 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 18.4 m-20 -81.46 98.76 8.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.43 ' CE ' HG13 ' A' ' 128' ' ' ILE . 51.5 ttm -136.76 137.65 40.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.025 0.441 . . . . 0.0 111.014 -176.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.792 175.289 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.826 ' HD1' ' HA3' ' A' ' 117' ' ' GLY . 41.4 m-85 . . . . . 0 N--CA 1.452 -0.348 0 CA-C-O 120.88 0.372 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.25 151.53 37.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.886 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.749 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 81.7 m-85 -114.87 109.44 18.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.952 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.852 ' HB ' HG12 ' A' ' 114' ' ' VAL . 87.8 t -91.71 105.63 16.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.587 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 50.5 tt0 -99.53 115.6 29.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.717 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -91.55 178.46 5.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.93 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -77.54 -37.18 51.35 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.258 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.77 146.14 37.04 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.078 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.9 Cg_endo -70.17 -18.99 34.75 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.358 2.705 . . . . 0.0 112.056 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.61 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 9.1 mp0 -55.92 -53.84 51.91 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.807 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.08 -21.37 64.9 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.09 -45.46 15.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.75 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.629 ' HG3' HG11 ' A' ' 286' ' ' VAL . 16.0 mm100 -69.0 -31.83 70.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.787 173.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.685 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 14.2 tp -70.23 -47.19 62.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.522 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.34 71.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.091 0.472 . . . . 0.0 109.85 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.648 HD12 ' HA3' ' A' ' 186' ' ' GLY . 4.0 tt -67.64 -51.81 45.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 172.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -52.53 -43.47 65.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.853 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -95.6 -46.41 6.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.7 ttp -104.28 31.08 4.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.089 0.471 . . . . 0.0 112.123 -166.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 9.0 p30 -76.59 7.06 4.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.582 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 15.3 m -102.49 -73.49 0.66 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.554 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 24.5 m -133.04 156.11 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 0.0 111.365 -173.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.976 ' HB2' HD13 ' A' ' 183' ' ' ILE . 2.1 tpt -122.95 104.06 9.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.376 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.99 61.04 2.48 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.181 172.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 122.75 -153.56 16.94 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.489 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.58 72.33 0.79 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.253 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 176' ' ' VAL . 21.8 tpt180 -143.57 118.95 10.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 175' ' ' SER . 42.2 m-80 -78.47 119.28 21.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.209 176.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.976 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.4 pt -111.81 166.72 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.237 -176.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.733 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 27.4 mtpp -103.48 134.65 46.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 172.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 116' ' ' VAL . 26.4 m -134.18 152.73 34.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.937 0.399 . . . . 0.0 110.305 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.648 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.83 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.003 173.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 N--CA 1.46 0.055 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -79.27 -32.46 43.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.493 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 51.4 tp60 -54.08 -53.31 59.99 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.0 Cg_endo -53.2 -39.38 80.73 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.542 2.162 . . . . 0.0 112.674 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.97 -45.21 55.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.56 HG12 ' SD ' ' A' ' 111' ' ' MET . 51.8 mt -59.33 -47.48 90.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.162 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.46 -39.5 94.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.777 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -63.35 -47.42 82.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.008 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 39.8 mt -67.18 -32.94 74.35 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.629 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.64 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.74 -45.23 74.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.991 0.424 . . . . 0.0 109.914 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -68.47 -34.95 76.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.066 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 35.5 mt-10 -66.69 -31.57 72.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.275 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.98 -29.24 64.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.164 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 74.9 mtp180 -72.36 -15.29 61.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.602 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -90.73 -2.53 57.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.92 169.06 16.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.987 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 36.3 m-20 -108.7 35.13 3.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.382 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.456 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 24.2 ttm180 -95.11 137.42 34.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.121 0.486 . . . . 0.0 111.595 -173.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 34.0 pt -128.95 167.07 25.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.987 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.486 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 73.5 t80 -122.34 126.81 48.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.618 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.523 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 35.7 m -122.4 132.96 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.998 0.428 . . . . 0.0 110.461 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.15 174.54 7.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.685 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 54.5 m 60.8 31.13 20.05 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.499 0.666 . . . . 0.0 109.955 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.55 127.64 36.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.031 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.521 ' HD2' ' HG3' ' A' ' 278' ' ' GLN . 19.0 t-80 -56.91 135.16 55.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.593 0.235 . . . . 0.0 111.191 -173.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -47.5 -53.75 13.45 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.26 22.61 5.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.411 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.1 tp -101.5 131.36 47.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.7 p -93.94 171.61 8.75 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.287 0.476 . . . . 0.0 112.287 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.62 -32.13 73.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.856 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.33 -34.5 76.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.475 0.655 . . . . 0.0 109.844 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 228' ' ' VAL . 62.7 m-20 -73.56 -43.68 59.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.702 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.7 HG22 HD11 ' A' ' 255' ' ' ILE . 32.6 mm -64.38 -44.12 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 65.5 tttm -57.16 -49.8 74.83 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.607 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 67.3 m -56.84 -37.7 71.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 224' ' ' ASP . 25.1 t -75.95 -44.23 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 122.122 -0.361 . . . . 0.0 111.559 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 235' ' ' ILE . 32.6 m-85 -69.77 -28.79 66.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.455 0.645 . . . . 0.0 110.188 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 8.7 tp10 -59.51 -25.12 64.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.796 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.42 -9.93 59.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.182 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -109.61 -45.29 3.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.666 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -144.55 165.19 27.59 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.096 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -70.96 115.83 10.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.233 0.539 . . . . 0.0 110.783 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.578 HD11 ' HB2' ' A' ' 229' ' ' PHE . 27.6 mt -87.8 150.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.756 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -112.49 -23.08 10.49 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.26 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 22.6 t -172.24 145.37 1.72 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.321 . . . . 0.0 110.859 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.5 t -141.69 128.26 20.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.8 m -142.38 110.78 6.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.985 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.614 HD21 HG13 ' A' ' 225' ' ' ILE . 46.0 mt -83.98 133.55 34.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.18 119.31 14.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.839 0.352 . . . . 0.0 110.544 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.557 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 18.0 mtm180 -122.94 145.9 48.07 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.706 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.609 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 10.6 m-20 -79.55 140.11 55.4 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.441 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.46 -25.6 14.53 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 124.04 3.16 . . . . 0.0 114.769 -171.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.1 t -157.78 48.16 0.39 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.517 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.609 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 17.2 p -102.89 -28.81 11.82 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.73 -0.606 . . . . 0.0 111.879 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.54 59.09 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.702 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.27 174.23 14.56 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.557 ' HB3' ' HG2' ' A' ' 242' ' ' ARG . 28.0 p80 -109.24 146.72 33.76 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.586 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -48.2 -50.48 29.05 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.812 0.695 . . . . 0.0 111.718 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 152.6 -11.73 0.63 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.821 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.486 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 46.2 p90 -124.95 171.03 10.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.818 0.342 . . . . 0.0 110.605 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -162.32 167.76 37.03 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.499 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.61 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 98.6 m-85 -123.66 146.66 48.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.004 0.43 . . . . 0.0 110.983 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.7 HD11 HG22 ' A' ' 225' ' ' ILE . 87.4 mt -139.8 136.1 38.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.209 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 46.1 mt-10 -119.17 136.33 54.23 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.529 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 6.8 m-85 -98.63 176.04 5.79 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -80.5 -21.79 41.6 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.341 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -131.19 137.48 48.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.063 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -69.5 -31.78 70.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.661 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -66.47 -35.6 80.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.976 0.417 . . . . 0.0 110.369 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.8 m -70.82 -42.38 70.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.327 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 40.7 p -66.89 -40.02 87.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.443 . . . . 0.0 110.694 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -70.92 -22.67 62.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.077 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.5 -37.24 71.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.63 84.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.71 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.48 ' HA ' ' CG2' ' A' ' 282' ' ' VAL . 61.9 t -61.77 -27.32 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.498 0.666 . . . . 0.0 110.568 174.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.0 t -87.21 -34.12 19.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.788 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.9 m -94.07 -31.35 14.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.53 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 91.1 mmm -92.32 7.1 44.34 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -170.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.479 ' HA ' HG12 ' A' ' 282' ' ' VAL . 52.9 t30 -72.69 121.66 20.18 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.377 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 86.8 mt 65.95 27.71 10.75 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.06 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -81.92 122.76 28.16 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.92 114.24 15.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.009 0.433 . . . . 0.0 110.06 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.411 ' HG ' HD21 ' A' ' 220' ' ' LEU . 26.4 tp -127.03 91.94 3.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.373 0.606 . . . . 0.0 110.09 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 94.07 11.36 57.65 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.547 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.9 6.66 39.83 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.688 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.521 ' HG3' ' HD2' ' A' ' 217' ' ' HIS . 29.2 mt-30 -133.59 144.45 49.3 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -89.31 114.81 26.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.783 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 62.8 mt -63.49 124.37 21.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.271 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -94.0 115.12 27.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 267' ' ' VAL . 13.9 p -114.6 140.1 37.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.33 0.586 . . . . 0.0 111.139 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.28 174.69 33.4 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.578 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -84.86 122.94 29.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -61.27 127.38 31.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.172 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.629 HG11 ' HG3' ' A' ' 167' ' ' GLN . 35.5 m -91.45 -12.91 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.811 0.338 . . . . 0.0 111.443 -173.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.441 ' HA ' ' HD2' ' A' ' 288' ' ' PRO . 36.4 p -111.97 119.52 44.12 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-O 121.264 0.554 . . . . 0.0 111.058 175.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.516 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 43.9 Cg_endo . . . . . 0 CA--C 1.53 0.29 0 C-N-CA 123.102 2.535 . . . . 0.0 111.909 176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.62 ' HB2' HD12 ' A' ' 108' ' ' LEU . 29.8 pt20 . . . . . 0 CA--C 1.532 0.266 0 CA-C-O 121.066 0.46 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -60.58 -28.4 68.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.911 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 110' ' ' ILE . . . -74.86 -22.0 58.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.737 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 105' ' ' GLN . 57.2 mt -62.56 -33.3 74.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.693 0.282 . . . . 0.0 110.594 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.02 -25.67 65.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.794 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 107' ' ' ALA . 3.6 mp -87.75 -36.82 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.619 ' SD ' HG23 ' A' ' 198' ' ' ILE . 42.5 mtm -74.7 -22.28 58.94 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.44 -11.74 60.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.958 0.408 . . . . 0.0 110.46 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -106.55 140.95 38.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.713 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.542 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.9 p -121.59 128.79 75.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.404 0.621 . . . . 0.0 110.225 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -81.25 109.89 16.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.778 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.455 HG12 HD11 ' A' ' 119' ' ' ILE . 39.3 t -108.02 120.05 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.104 0.478 . . . . 0.0 111.253 -174.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -135.21 174.07 21.36 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.442 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.783 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 25.9 m 66.59 35.35 5.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.069 0.547 . . . . 0.0 111.37 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.455 HD11 HG12 ' A' ' 116' ' ' VAL . 46.0 mt -85.22 114.72 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.558 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -52.29 134.41 33.79 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.435 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -71.42 76.66 0.76 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 122.162 0.982 . . . . 0.0 111.474 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.46 -37.75 0.06 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.931 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.465 ' CD1' ' HG3' ' A' ' 177' ' ' MET . 59.8 mt -75.16 110.64 9.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.825 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.55 169.58 49.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.869 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.09 -36.91 84.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.935 0.397 . . . . 0.0 110.275 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.53 -35.01 76.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.547 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.6 m -64.54 -42.81 95.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 110.142 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.626 HG13 ' HE1' ' A' ' 143' ' ' MET . 33.7 mm -63.2 -41.58 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.488 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 43.3 ttp-105 -59.04 -41.36 87.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.548 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.24 -34.13 77.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.525 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.68 -32.21 28.22 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -88.35 -21.42 24.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.773 0.32 . . . . 0.0 111.383 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.62 98.32 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.66 -32.4 5.84 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 122.998 2.465 . . . . 0.0 114.252 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.588 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 74.0 m-85 -83.01 -44.14 15.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.485 0.183 . . . . 0.0 111.367 -176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.41 167.41 40.24 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.367 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.35 134.41 35.99 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.697 2.265 . . . . 0.0 111.338 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.445 HG21 ' CG1' ' A' ' 141' ' ' ILE . 50.3 mt -100.14 132.84 44.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.409 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.592 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 21.4 ttmm -98.7 -29.58 12.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.551 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.7 t -156.82 135.17 11.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.83 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.445 ' CG1' HG21 ' A' ' 138' ' ' ILE . 63.4 mt -128.69 116.57 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -114.22 99.53 7.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.973 0.416 . . . . 0.0 110.327 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.626 ' HE1' HG13 ' A' ' 128' ' ' ILE . 49.2 ttm -103.05 140.72 36.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.694 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.2 m . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 121.39 0.614 . . . . 0.0 110.119 176.283 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.231 0.08 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 143' ' ' MET . . . -127.09 139.53 52.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.006 0.431 . . . . 0.0 110.716 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -114.52 118.72 34.55 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.091 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' A' ' 114' ' ' VAL . 96.5 t -104.87 112.1 37.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -105.02 115.42 30.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -88.29 165.19 15.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.592 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 23.0 mt-10 -83.04 -12.02 57.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.222 175.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.9 m -136.66 134.43 19.5 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.969 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.08 -22.37 47.63 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.896 2.397 . . . . 0.0 112.475 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.74 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 13.7 mp0 -55.26 -54.2 46.48 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.389 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.03 -19.59 63.04 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.49 -52.1 9.65 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.647 ' HG3' HG11 ' A' ' 286' ' ' VAL . 14.9 mm100 -69.94 -27.17 64.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 175.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.588 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 12.9 tp -70.02 -50.57 40.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.415 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.63 -33.87 76.58 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.508 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.2 tt -61.25 -46.5 90.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.993 173.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -65.64 -44.2 87.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.675 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -86.93 -37.92 17.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.4 mtm -101.6 30.25 4.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.958 0.409 . . . . 0.0 111.324 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -68.33 -11.08 58.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.128 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 20.3 m -101.31 -72.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.2 m -138.21 166.06 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.08 0.467 . . . . 0.0 111.855 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.465 ' HG3' ' CD1' ' A' ' 123' ' ' LEU . 18.3 tpp -134.87 99.21 4.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.877 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.446 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 89.7 mt 53.49 41.28 32.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.607 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.62 -144.52 16.45 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.993 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.64 -123.02 15.2 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.255 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -143.95 179.0 7.46 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 175' ' ' SER . 9.2 t30 -51.27 111.56 0.59 Allowed 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.628 0.58 . . . . 0.0 110.694 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.783 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 47.6 pt -89.29 160.8 2.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.474 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 52.2 tttp -107.25 116.22 31.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.5 t -120.31 106.2 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.508 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.422 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.25 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 . . . . . 0 C--O 1.23 0.027 0 CA-C-O 120.796 0.332 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.88 -38.52 27.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.456 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.522 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 56.4 tp60 -58.22 -49.77 91.75 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.9 Cg_endo -52.9 -39.08 79.47 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.332 2.021 . . . . 0.0 112.458 177.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 56.9 mt -72.61 -39.39 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.819 0.342 . . . . 0.0 110.438 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.619 HG23 ' SD ' ' A' ' 111' ' ' MET . 69.9 mt -59.35 -50.07 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.602 176.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.64 -30.96 68.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.55 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.68 -52.09 62.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.453 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 27.5 mt -67.56 -33.55 75.26 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.921 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.693 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.28 -51.12 60.32 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 173.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -65.71 -30.91 71.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.308 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 40.3 mt-10 -67.2 -34.75 78.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.068 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.79 -36.69 65.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.712 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.693 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 71.5 mtp180 -66.48 -24.24 66.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.125 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.17 -13.92 60.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.241 0.543 . . . . 0.0 110.66 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -113.74 -179.28 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.365 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 46.2 m-20 -116.46 40.87 2.79 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -93.95 135.62 35.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.704 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.1 pt -135.18 167.18 26.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.566 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.58 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 27.0 t80 -121.65 130.57 53.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.776 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.531 HG21 HG21 ' A' ' 225' ' ' ILE . 28.1 m -121.42 131.92 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.099 0.476 . . . . 0.0 110.145 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.07 176.58 6.59 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.915 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.6 m 62.27 32.52 17.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.906 0.86 . . . . 0.0 109.339 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.445 HG13 HD11 ' A' ' 225' ' ' ILE . 16.4 t -77.76 112.74 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.505 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -60.13 139.57 57.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.232 0.539 . . . . 0.0 111.341 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -51.05 -35.99 37.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.78 -17.72 30.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.134 0.492 . . . . 0.0 111.051 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.727 HD21 ' HG ' ' A' ' 275' ' ' LEU . 0.9 OUTLIER -74.1 132.55 42.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.061 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.2 m -103.25 179.71 4.19 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.303 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -55.63 -46.46 77.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.602 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -67.47 -27.34 66.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.613 -173.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -66.91 -54.05 25.92 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.467 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.728 HG22 HD11 ' A' ' 255' ' ' ILE . 42.7 mm -63.5 -43.2 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.73 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.453 ' HG3' HG21 ' A' ' 235' ' ' ILE . 83.9 tttt -56.85 -49.44 75.46 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.577 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 35.3 t -55.51 -41.09 72.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.1 t -74.75 -40.93 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.235 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.712 ' HB2' HD11 ' A' ' 235' ' ' ILE . 24.4 m-85 -69.12 -35.74 76.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.467 0.651 . . . . 0.0 110.35 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 34.9 tp10 -59.2 -24.89 63.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.695 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.47 -19.76 64.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.002 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -111.51 -34.36 6.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -145.15 153.93 25.59 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.561 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 66.0 mmtt -73.76 113.3 10.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 111.941 -177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.712 HD11 ' HB2' ' A' ' 229' ' ' PHE . 51.4 mt -92.47 151.09 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.878 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -109.66 -36.31 5.97 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.562 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 19.0 m -147.94 146.04 28.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.705 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.44 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 53.3 t -153.9 118.26 4.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.758 174.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.9 t -141.26 119.22 11.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.205 0.526 . . . . 0.0 111.51 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.646 HD23 ' HA3' ' A' ' 253' ' ' GLY . 40.8 mt -91.94 132.61 36.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.033 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.64 124.44 23.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.55 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.593 ' HB3' ' CB ' ' A' ' 249' ' ' HIS . 14.7 ptt-85 -144.59 169.89 17.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.478 -173.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -104.56 100.92 25.04 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.728 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.25 -22.24 64.01 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.513 2.142 . . . . 0.0 112.368 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.8 p -75.65 -17.94 59.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.48 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 49.3 p -108.84 -42.22 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.997 0.427 . . . . 0.0 110.369 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 114.54 -16.92 18.96 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.748 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -107.19 160.69 15.39 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.608 -0.348 . . . . 0.0 110.493 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.593 ' CB ' ' HB3' ' A' ' 242' ' ' ARG . 26.9 p80 -100.76 162.56 12.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.539 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -75.03 -69.93 0.44 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.213 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 170.19 25.99 0.02 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.095 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.482 ' HB2' ' CE1' ' A' ' 212' ' ' TYR . 3.1 p90 -153.77 154.07 33.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.646 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -157.78 173.22 35.1 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.137 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.74 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 81.4 m-85 -127.09 146.06 50.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.981 0.419 . . . . 0.0 110.626 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.728 HD11 HG22 ' A' ' 225' ' ' ILE . 74.5 mt -135.02 138.78 48.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.284 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 45.6 mt-10 -121.63 142.46 50.1 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 6.3 m-85 -105.85 163.69 12.53 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.05 0.452 . . . . 0.0 111.458 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.31 -36.75 20.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.526 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -100.41 114.94 28.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.571 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -50.83 -59.46 4.09 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.547 0.53 . . . . 0.0 112.375 -168.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.43 -36.54 64.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.257 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.2 t -67.94 -21.14 65.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 89.6 p -66.55 -49.93 64.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.218 0.533 . . . . 0.0 110.4 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -75.56 -15.9 60.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.67 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.48 -40.84 73.4 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.29 83.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 95.9 t -57.44 -30.58 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.236 0.541 . . . . 0.0 111.177 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.8 m -87.34 -29.45 21.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.342 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 13.3 m -93.54 -40.47 10.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.989 0.423 . . . . 0.0 112.03 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.451 ' HG3' ' CD2' ' A' ' 229' ' ' PHE . 87.6 mmm -85.08 -2.88 58.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.951 -171.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.42 ' HA ' HG12 ' A' ' 282' ' ' VAL . 60.2 t30 -69.1 129.66 40.52 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.371 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.7 mt 66.31 27.69 10.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.808 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -90.34 117.96 29.47 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.661 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 4.0 p-10 -76.03 122.38 24.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.371 0.605 . . . . 0.0 110.289 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.727 ' HG ' HD21 ' A' ' 220' ' ' LEU . 26.5 tp -134.24 95.21 3.36 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.635 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 93.36 18.65 38.17 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.699 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.89 -36.75 4.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.68 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -93.82 147.95 22.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.767 0.317 . . . . 0.0 110.746 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.661 ' CE1' ' HB3' ' A' ' 274' ' ' ASP . 54.2 m-85 -87.44 115.9 25.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.743 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.4 mt -57.13 116.6 3.35 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.797 0.685 . . . . 0.0 111.122 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -93.69 115.0 27.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 271' ' ' ASN . 13.7 p -121.41 147.63 25.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.173 0.511 . . . . 0.0 111.12 -173.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.38 179.7 37.53 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -84.74 134.96 34.32 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.613 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -68.85 137.15 53.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.647 HG11 ' HG3' ' A' ' 167' ' ' GLN . 33.1 m -97.96 -11.96 8.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.479 . . . . 0.0 110.917 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 38.3 p -108.6 135.06 20.08 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.004 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo . . . . . 0 CA--C 1.53 0.312 0 C-N-CA 122.847 2.364 . . . . 0.0 111.478 174.273 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 . . . . . 0 N--CA 1.463 0.203 0 CA-C-O 120.988 0.423 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 106' ' ' ARG . 10.9 ptp180 -55.51 -28.2 53.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.281 -174.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 197' ' ' ILE . . . -68.37 -35.04 77.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.036 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.494 HD21 HG21 ' A' ' 287' ' ' THR . 40.8 mt -66.71 -31.8 72.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.041 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.42 69.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.339 0.59 . . . . 0.0 110.36 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.4 mt -88.05 -36.96 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.348 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.483 ' SD ' HG12 ' A' ' 198' ' ' ILE . 90.4 mtp -69.88 -19.27 63.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.44 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 86.3 m -85.71 -1.89 57.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.1 0.476 . . . . 0.0 110.99 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -118.33 142.13 47.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.211 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.664 HG12 ' HB ' ' A' ' 158' ' ' VAL . 8.8 p -115.24 119.79 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.631 0.729 . . . . 0.0 109.761 172.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 41.7 t80 -67.87 119.99 13.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.192 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.579 HG23 ' HB3' ' A' ' 156' ' ' ALA . 17.0 m -119.48 117.51 54.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.59 0.709 . . . . 0.0 111.69 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.46 170.86 23.15 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.056 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.667 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 10.5 t 64.15 36.76 9.37 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.645 0.735 . . . . 0.0 109.604 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 84.7 mt -78.76 -15.51 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.854 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 75.5 t80 76.04 139.28 0.06 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.664 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -74.89 77.64 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.581 0.705 . . . . 0.0 110.892 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -163.59 -35.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.396 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 178' ' ' LEU . 72.8 mt -85.64 128.92 34.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.206 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.27 176.85 39.08 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.893 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.72 -39.9 93.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 0.0 110.549 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 16.1 t70 -65.03 -41.96 94.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.279 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 m -61.15 -40.56 94.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.938 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.09 -38.69 82.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.789 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 129' ' ' ARG . 33.2 ttp-105 -61.52 -39.02 89.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.993 0.425 . . . . 0.0 109.946 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 78.0 mt-30 -63.94 -37.78 88.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.335 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.56 -36.66 37.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.264 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.545 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 56.9 m-85 -92.29 -7.85 46.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.978 0.418 . . . . 0.0 111.777 -177.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.604 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -53.4 -45.58 98.42 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 6.8 Cg_endo -51.21 -27.66 23.47 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.854 2.369 . . . . 0.0 114.534 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.62 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 58.5 m-85 -83.88 -42.95 15.82 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.408 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.8 -179.49 40.49 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.849 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.93 110.92 3.13 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.763 2.309 . . . . 0.0 111.799 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 63.1 mt -79.57 113.02 18.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.353 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -78.58 -41.48 31.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.845 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -162.1 156.75 22.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.523 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.1 mt -134.76 116.18 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.732 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 12.8 m-20 -88.31 98.92 11.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.1 ttm -120.61 133.37 55.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.885 0.374 . . . . 0.0 111.228 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 C--N 1.324 -0.51 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.44 172.639 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 37.9 p90 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.579 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -138.15 158.46 44.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.064 0.459 . . . . 0.0 111.662 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -117.84 115.8 25.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.338 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.664 ' HB ' HG12 ' A' ' 114' ' ' VAL . 99.4 t -91.52 109.93 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.936 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -98.03 116.22 29.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.431 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.545 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 95.9 m-85 -92.86 176.47 6.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.657 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -95.76 -1.52 49.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.045 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.9 m -145.76 137.31 12.92 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.22 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 43.5 Cg_endo -68.54 -20.34 41.39 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.039 2.493 . . . . 0.0 112.164 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 79.6 mm-40 -58.09 -56.34 23.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.79 -20.35 34.83 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.27 -51.82 7.54 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -63.31 -34.68 78.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.769 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.62 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.6 tp -68.67 -48.92 62.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.601 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.49 83.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 110.155 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 174' ' ' ASN . 6.7 tt -63.06 -51.16 67.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.532 174.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -57.72 -47.93 81.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.014 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -85.7 -33.37 21.53 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.9 mtm -108.15 30.09 6.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 24.2 p-10 -79.81 23.26 0.44 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.828 0.347 . . . . 0.0 111.584 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.8 t -114.59 -73.35 0.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.853 0.358 . . . . 0.0 110.625 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.586 HG12 ' H ' ' A' ' 182' ' ' ASN . 20.8 m -139.73 169.04 17.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.217 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.846 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.1 tpt -141.59 94.36 2.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 123' ' ' LEU . 89.0 mt 60.13 -83.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.579 0.752 . . . . 0.0 112.279 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -108.99 -12.8 19.67 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.336 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.32 115.03 4.32 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.246 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -82.94 127.06 33.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.586 ' H ' HG12 ' A' ' 176' ' ' VAL . 20.4 t-20 61.54 76.43 0.37 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.773 0.671 . . . . 0.0 110.258 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.846 HD13 ' HB2' ' A' ' 177' ' ' MET . 49.6 pt -88.36 160.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.724 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 67.0 mttm -105.65 106.91 17.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.528 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 6.2 m -109.27 116.4 51.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.317 0.58 . . . . 0.0 110.217 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.448 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.443 -0.853 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.595 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 121.014 0.435 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -70.52 -32.04 69.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.441 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 29.1 mm-40 -57.36 -56.19 36.52 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -173.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.2 Cg_endo -53.68 -37.51 83.9 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.219 1.946 . . . . 0.0 112.748 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 107' ' ' ALA . 54.7 mt -75.96 -43.09 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.774 0.321 . . . . 0.0 111.15 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.483 HG12 ' SD ' ' A' ' 111' ' ' MET . 72.8 mt -61.72 -46.49 96.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.05 0.452 . . . . 0.0 109.975 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.57 -36.98 85.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.352 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -58.32 -53.95 52.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.118 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 58.1 mt -68.8 -33.7 74.31 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.904 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.699 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.03 -48.96 69.95 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.615 ' OE1' ' HD3' ' A' ' 206' ' ' ARG . 6.6 mm-40 -62.89 -35.99 81.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.084 176.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 40.7 mt-10 -63.92 -36.25 83.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.356 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.09 -34.01 63.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.83 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.699 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 72.2 mtp180 -69.09 -20.63 64.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.937 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.53 -18.13 59.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.149 0.5 . . . . 0.0 110.554 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -109.14 -169.96 1.58 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.052 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.482 ' CB ' ' HA ' ' A' ' 260' ' ' ALA . 27.2 p-10 -139.5 58.75 1.61 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.835 0.826 . . . . 0.0 109.656 178.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.53 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 18.6 ttm180 -111.05 139.13 46.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.173 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.1 pt -119.57 163.15 17.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.668 0.271 . . . . 0.0 110.597 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -113.9 127.0 55.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.152 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 28.3 m -114.8 128.01 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.359 0.599 . . . . 0.0 110.154 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -120.27 167.53 12.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.097 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.3 t 59.67 40.03 20.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.975 0.893 . . . . 0.0 109.095 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.531 HG13 HD11 ' A' ' 225' ' ' ILE . 39.4 t -77.4 120.99 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.473 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 40.2 t-80 -52.57 133.01 36.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.257 0.551 . . . . 0.0 111.05 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -49.27 -37.68 24.42 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -171.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -96.41 -6.1 38.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.126 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 275' ' ' LEU . 10.7 tp -88.7 112.41 23.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.5 t -96.93 -178.67 4.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.854 0.359 . . . . 0.0 111.734 -170.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -53.36 -38.51 63.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.544 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.45 -37.55 87.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.391 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.427 ' HB2' ' HG ' ' A' ' 220' ' ' LEU . 15.7 m-20 -73.86 -42.68 60.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.992 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.546 HG22 HD11 ' A' ' 255' ' ' ILE . 34.6 mm -64.21 -42.14 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.403 ' HG3' HG21 ' A' ' 235' ' ' ILE . 83.9 tttt -61.09 -48.77 80.14 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.001 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 13.2 p -60.16 -38.17 82.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.458 HG21 HD21 ' A' ' 275' ' ' LEU . 49.1 t -76.56 -40.29 33.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.766 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.57 ' CB ' HD11 ' A' ' 235' ' ' ILE . 6.1 m-85 -69.19 -32.49 71.81 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.133 0.492 . . . . 0.0 110.993 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 7.2 tm-20 -63.35 -24.39 67.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.051 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.2 -23.82 64.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.731 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -101.41 -34.21 9.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.341 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -152.16 149.25 20.9 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.539 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 29.6 mmtp -71.19 120.52 16.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.567 0.698 . . . . 0.0 111.105 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.57 HD11 ' CB ' ' A' ' 229' ' ' PHE . 28.2 mt -91.38 151.2 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.919 -172.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 257' ' ' TYR . 17.0 ttmt -103.7 -30.28 10.53 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.202 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 28.2 t -170.34 141.91 2.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.325 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 40.4 t -142.61 127.1 17.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.744 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.9 t -141.31 133.48 27.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.823 0.344 . . . . 0.0 110.304 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 27.7 mt -109.84 136.18 49.56 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.86 126.44 29.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.221 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.421 ' HG2' ' CB ' ' A' ' 249' ' ' HIS . 73.5 mtp180 -122.83 152.45 40.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.831 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.583 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 17.9 m-20 -70.5 145.85 93.29 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.74 -19.98 56.37 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 123.197 2.598 . . . . 0.0 114.159 -171.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.3 t -162.93 62.2 0.19 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.295 0.569 . . . . 0.0 111.996 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 58.7 p -127.93 -18.46 4.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.095 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.07 -46.3 1.72 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.101 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.34 177.89 6.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.848 0.356 . . . . 0.0 110.711 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.421 ' CB ' ' HG2' ' A' ' 242' ' ' ARG . 30.8 p80 -96.15 170.7 9.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.293 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -77.06 -80.6 0.1 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.938 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -179.8 18.12 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.029 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -154.89 163.9 39.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -168.66 -179.24 40.77 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.228 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.491 ' CZ ' ' HG3' ' A' ' 164' ' ' GLU . 91.1 m-85 -134.44 145.37 48.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.625 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.546 HD11 HG22 ' A' ' 225' ' ' ILE . 88.5 mt -138.04 132.06 42.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.036 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.53 ' HG2' ' HB2' ' A' ' 210' ' ' ARG . 81.6 mt-10 -110.02 146.16 35.79 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.525 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 8.2 m-85 -106.94 179.24 4.32 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.164 176.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -70.24 -50.63 37.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.924 0.868 . . . . 0.0 108.905 171.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -103.48 139.56 38.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.968 -1.469 . . . . 0.0 109.227 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.482 ' HA ' ' CB ' ' A' ' 209' ' ' ASN . . . -65.56 -28.79 69.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.705 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -72.82 -33.45 66.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.844 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.8 m -67.07 -37.18 83.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.053 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.536 ' HB2' HG23 ' A' ' 211' ' ' ILE . 21.6 p -68.23 -38.63 82.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 0.0 110.04 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -71.6 -25.96 62.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.33 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -65.39 -41.94 93.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.028 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -63.83 -41.68 97.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.468 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.17 -32.98 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.231 0.539 . . . . 0.0 111.001 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.9 t -75.37 -33.83 61.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.132 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.8 t -94.29 -40.17 10.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 112.041 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 75.2 mmm -83.33 -4.41 58.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -168.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.486 ' HA ' HG12 ' A' ' 282' ' ' VAL . 57.8 t30 -69.2 112.81 6.03 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.159 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.452 HD21 ' CZ ' ' A' ' 281' ' ' ARG . 94.1 mt 67.77 36.36 3.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.778 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -91.17 132.97 35.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.244 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -82.04 109.57 16.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.305 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.659 HD12 HD11 ' A' ' 280' ' ' LEU . 0.6 OUTLIER -117.38 91.38 3.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.137 0.494 . . . . 0.0 109.851 176.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.9 34.1 28.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.756 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 91.03 -0.29 75.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.969 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.482 ' OE1' ' HA ' ' A' ' 217' ' ' HIS . 34.6 tt0 -126.57 141.17 51.95 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 120.773 0.32 . . . . 0.0 110.342 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -92.58 123.25 35.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.87 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.659 HD11 HD12 ' A' ' 275' ' ' LEU . 48.2 mt -77.73 127.6 32.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.135 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.452 ' CZ ' HD21 ' A' ' 272' ' ' LEU . 37.4 mmt180 -95.1 114.78 26.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 271' ' ' ASN . 10.7 p -117.34 147.65 20.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.157 -173.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -159.47 175.47 36.36 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.382 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -82.06 126.41 31.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -61.68 126.81 28.68 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.309 0.381 . . . . 0.0 110.585 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.59 -24.94 5.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.359 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.494 HG21 HD21 ' A' ' 108' ' ' LEU . 16.1 p -132.57 133.16 23.21 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.732 0.301 . . . . 0.0 111.269 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.534 0.495 0 C-N-CA 122.616 2.211 . . . . 0.0 112.077 175.317 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.192 0.52 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -52.8 -48.23 67.05 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.908 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.0 -35.83 69.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.704 0.288 . . . . 0.0 111.081 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 108' ' ' LEU . 34.7 mt -66.59 -32.35 73.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.203 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.8 85.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.192 0.52 . . . . 0.0 110.136 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.97 -36.48 57.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.219 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.429 ' SD ' HG12 ' A' ' 198' ' ' ILE . 89.9 mtp -72.14 -17.01 62.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.915 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 80.2 m -89.01 -17.78 28.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.91 0.386 . . . . 0.0 110.597 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -99.08 141.53 31.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.144 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.69 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.5 p -128.05 131.58 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 121.773 0.796 . . . . 0.0 110.145 174.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.48 ' H ' ' HA2' ' A' ' 186' ' ' GLY . 39.1 t80 -94.71 104.48 16.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.222 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 17.4 m -99.38 116.52 42.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.607 0.717 . . . . 0.0 111.352 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.501 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -116.36 165.32 12.27 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.638 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.7 m 63.45 44.42 5.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.347 0.594 . . . . 0.0 110.861 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -72.91 142.93 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.234 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.447 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 37.8 t80 -54.81 127.26 27.65 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.598 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -74.47 76.71 1.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.024 0.44 . . . . 0.0 110.135 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 178.54 -36.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.111 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 178' ' ' LEU . 93.8 mt -61.44 132.41 53.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.965 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -98.59 168.23 22.65 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.791 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -55.41 -39.51 70.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.935 0.397 . . . . 0.0 111.183 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -64.55 -39.51 93.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.076 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -71.57 -38.25 70.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.41 -40.24 88.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.145 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -59.16 -43.35 92.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.58 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.37 -34.45 73.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.297 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.11 -33.44 26.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.504 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 40.7 m-85 -91.77 -16.81 26.3 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.442 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -54.88 -43.72 98.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 42.0 Cg_exo -40.58 -38.95 2.74 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.245 2.63 . . . . 0.0 115.062 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.709 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 61.5 m-85 -77.48 -37.17 51.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -173.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -179.01 -177.71 47.76 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.867 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HB2' ' OE1' ' A' ' 161' ' ' GLU . 73.4 Cg_endo -75.06 135.43 18.97 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.772 2.314 . . . . 0.0 112.258 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.515 HD13 HD11 ' A' ' 141' ' ' ILE . 68.9 mt -102.1 130.97 51.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.564 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 29.5 ttpp -94.48 -31.75 13.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -168.79 145.91 3.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.6 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.515 HD11 HD13 ' A' ' 138' ' ' ILE . 69.5 mt -130.81 131.16 64.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -122.29 101.49 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.416 ' HE3' ' HB2' ' A' ' 143' ' ' MET . 43.5 ttm -111.97 138.28 48.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.747 0.308 . . . . 0.0 110.931 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.8 m . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.295 173.609 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.501 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 29.5 m-85 . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.2 139.52 51.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.954 0.407 . . . . 0.0 110.647 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -105.34 109.33 21.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.824 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 114' ' ' VAL . 62.9 t -94.57 105.72 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -102.87 115.15 30.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.409 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 85.0 m-85 -88.94 172.38 9.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.628 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 47.8 mt-10 -89.95 -24.29 21.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.845 172.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.82 137.35 29.37 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.303 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.3 Cg_endo -69.43 -17.46 39.05 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.169 2.579 . . . . 0.0 112.362 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.599 ' HG3' ' HZ ' ' A' ' 254' ' ' PHE . 71.3 mm-40 -57.99 -54.91 41.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.011 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -59.33 -21.5 59.86 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.68 -52.39 8.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -63.95 -32.33 73.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.841 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.709 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.1 tp -68.52 -50.04 55.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.584 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.42 74.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.756 0.313 . . . . 0.0 110.374 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 185' ' ' VAL . 24.4 tp -68.76 -40.77 79.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.125 0.488 . . . . 0.0 110.651 173.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.84 -33.95 75.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.253 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -100.13 -51.19 3.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 13.6 mtm -103.11 29.3 5.59 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -165.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.419 ' HB2' HD12 ' A' ' 170' ' ' LEU . 64.4 t30 -83.61 32.5 0.46 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.575 0.702 . . . . 0.0 109.941 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 48.6 m -114.87 -74.08 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.369 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.07 163.84 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.395 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.885 ' HB2' HD13 ' A' ' 183' ' ' ILE . 0.8 OUTLIER -134.03 103.25 5.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.568 177.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.556 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 84.0 mt 54.7 77.75 0.19 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.931 0.77 . . . . 0.0 111.995 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 131.72 -139.56 11.05 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.167 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -133.7 62.67 0.63 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.322 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -142.22 124.19 15.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 175' ' ' SER . 95.3 m-20 -68.27 124.12 22.62 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 123.307 0.38 . . . . 0.0 110.439 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.885 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.3 pt -106.49 155.56 7.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.043 0.449 . . . . 0.0 110.77 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.1 tppp? -105.42 116.01 31.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.591 ' O ' HD13 ' A' ' 170' ' ' LEU . 21.7 t -100.06 102.19 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.405 0.621 . . . . 0.0 109.806 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.48 ' HA2' ' H ' ' A' ' 115' ' ' TYR . . . . . . . . 0 N--CA 1.445 -0.711 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.805 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.26 -13.2 50.52 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 12.0 tm0? -64.04 -52.87 52.89 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.82 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 77.7 Cg_exo -53.23 -38.52 81.65 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.485 2.123 . . . . 0.0 113.094 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 52.4 mt -67.36 -46.47 83.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.318 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.429 HG12 ' SD ' ' A' ' 111' ' ' MET . 66.5 mt -60.95 -45.56 98.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.317 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.32 -39.95 95.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.534 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -65.38 -47.31 76.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.557 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 49.9 mt -67.43 -33.11 74.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.092 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.608 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.6 -45.19 66.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.379 0.609 . . . . 0.0 109.53 173.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -70.44 -33.02 70.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.29 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 32.3 mt-10 -68.38 -25.6 65.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.812 0.339 . . . . 0.0 111.534 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.22 58.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 78.6 mtp180 -70.65 -10.69 59.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.193 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.34 -27.17 67.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.196 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -128.37 124.27 35.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.144 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -74.87 70.35 1.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.855 0.836 . . . . 0.0 110.277 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.892 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 3.3 ptp180 -113.46 155.37 25.44 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.725 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.6 pt -122.84 164.4 20.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.745 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -112.45 129.14 56.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.315 0.384 . . . . 0.0 110.204 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.586 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.7 m -124.08 132.91 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.192 0.52 . . . . 0.0 110.506 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -126.23 177.42 6.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.649 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.9 m 61.38 30.24 18.89 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.718 0.771 . . . . 0.0 109.792 -173.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.499 ' O ' ' HA2' ' A' ' 251' ' ' GLY . 30.8 t -85.42 115.48 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.432 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.695 ' HB3' HD23 ' A' ' 220' ' ' LEU . 23.3 t-80 -57.66 139.96 52.4 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.057 0.456 . . . . 0.0 110.661 -176.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.567 ' HB2' ' HD2' ' A' ' 248' ' ' LYS . 6.0 pt20 -46.38 -41.74 14.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . 0.428 ' N ' ' HG3' ' A' ' 218' ' ' GLN . 0.7 OUTLIER -98.16 13.91 29.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -167.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 217' ' ' HIS . 3.6 mm? -86.72 121.89 29.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 25.0 m -78.11 171.61 14.77 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.609 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.49 -41.25 76.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.078 0.466 . . . . 0.0 110.101 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -69.49 -24.24 63.74 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.02 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 220' ' ' LEU . 7.6 m-20 -69.75 -45.64 67.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 110.258 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.729 HG22 HD11 ' A' ' 255' ' ' ILE . 14.5 mm -68.58 -38.08 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.419 ' HG3' HG21 ' A' ' 235' ' ' ILE . 85.3 tttt -60.53 -53.68 54.59 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.946 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 11.2 p -55.12 -38.63 68.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 224' ' ' ASP . 32.3 t -73.42 -46.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.541 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.653 ' HB2' HD11 ' A' ' 235' ' ' ILE . 17.3 m-85 -67.24 -29.99 69.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.39 0.614 . . . . 0.0 110.63 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.53 -24.15 63.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.902 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.53 -13.27 60.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.771 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -111.43 -30.92 7.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.799 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -157.34 166.8 33.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.974 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -80.18 110.69 15.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.509 0.671 . . . . 0.0 111.036 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.653 HD11 ' HB2' ' A' ' 229' ' ' PHE . 37.5 mt -83.17 151.21 4.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.604 -176.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.2 ttpp -106.02 -34.94 7.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.448 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.4 p -173.37 156.24 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 255' ' ' ILE . 74.1 m -142.46 138.88 31.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.252 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 31.9 m -141.14 103.0 4.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.696 HD21 HG13 ' A' ' 225' ' ' ILE . 81.2 mt -83.94 149.53 26.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.705 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -84.85 104.37 14.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.756 0.313 . . . . 0.0 110.356 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.736 ' HG3' ' HB3' ' A' ' 249' ' ' HIS . 0.2 OUTLIER -97.53 152.67 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.53 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.612 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 8.8 m-20 -77.84 148.72 76.26 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.95 -8.13 13.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.972 2.448 . . . . 0.0 114.422 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -166.62 38.82 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.612 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 25.4 p -108.21 -16.45 14.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.347 -0.846 . . . . 0.0 112.02 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.4 77.17 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.696 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.567 ' HD2' ' HB2' ' A' ' 218' ' ' GLN . 46.4 pttt -168.22 -168.56 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.736 ' HB3' ' HG3' ' A' ' 242' ' ' ARG . 33.9 p80 -118.79 165.16 14.37 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.239 -177.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.409 ' HE2' ' OD2' ' A' ' 243' ' ' ASP . 77.4 mttt -64.76 -68.98 0.32 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.211 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 216' ' ' VAL . . . 170.5 24.91 0.02 OUTLIER Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.431 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -152.4 160.51 43.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.565 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.21 178.83 45.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.532 -176.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.599 ' HZ ' ' HG3' ' A' ' 164' ' ' GLU . 81.2 m-85 -131.92 153.05 50.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.774 0.321 . . . . 0.0 111.119 -176.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.729 HD11 HG22 ' A' ' 225' ' ' ILE . 84.1 mt -142.19 131.29 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.074 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.892 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 45.6 mt-10 -105.7 146.65 29.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 9.7 m-85 -110.77 160.61 16.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.723 0.297 . . . . 0.0 110.795 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.28 -23.77 51.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.372 0.606 . . . . 0.0 110.066 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -130.53 124.61 32.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.018 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.79 68.79 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.543 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 262' ' ' SER . 7.8 pt20 -59.6 -42.88 93.59 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.102 0.251 . . . . 0.0 111.03 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.434 ' N ' ' HG3' ' A' ' 261' ' ' GLN . 20.1 m -71.14 -32.83 69.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.826 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -43.06 97.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.017 0.437 . . . . 0.0 111.039 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -74.73 -23.12 58.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.49 -35.75 65.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.053 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.61 84.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.923 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.447 ' HA ' ' CG2' ' A' ' 282' ' ' VAL . 77.3 t -58.76 -27.01 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.225 0.535 . . . . 0.0 110.646 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.8 t -86.15 -30.6 22.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.9 m -93.95 -41.15 9.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.588 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 88.3 mmm -84.11 4.9 28.22 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -169.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.449 ' HA ' HG12 ' A' ' 282' ' ' VAL . 11.0 t30 -71.58 118.11 13.98 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.382 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 93.1 mt 66.83 34.13 5.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.601 -178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -88.33 122.85 32.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.438 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 16.3 t70 -73.28 119.24 17.25 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.727 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 44.8 tp -137.01 91.91 2.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.292 0.568 . . . . 0.0 110.111 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 96.65 22.77 17.6 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.464 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.91 -1.93 68.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.623 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -127.2 147.26 50.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.506 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 84.6 m-85 -89.39 116.1 27.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.217 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 69.6 mt -58.04 127.85 34.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.857 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 17.1 mmt180 -93.45 115.39 27.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 271' ' ' ASN . 13.9 p -115.82 135.98 54.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.178 0.513 . . . . 0.0 111.143 -173.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -154.94 -179.53 30.2 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.537 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 284' ' ' LYS . 39.3 mtpt -84.16 130.2 34.86 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.56 120.63 12.11 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.528 0.518 . . . . 0.0 109.821 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.68 -26.89 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 28.3 p -134.86 145.11 53.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.654 0.264 . . . . 0.0 110.783 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.459 -0.523 0 C-N-CA 122.366 2.044 . . . . 0.0 112.199 177.022 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.154 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -65.54 -32.2 73.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.835 0.35 . . . . 0.0 111.283 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.22 -30.84 66.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.153 0.502 . . . . 0.0 110.438 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.704 HD21 HD13 ' A' ' 201' ' ' LEU . 56.9 mt -71.71 -33.08 68.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.325 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.9 73.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.265 0.555 . . . . 0.0 110.028 175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.7 mt -73.31 -38.49 53.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.116 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.437 ' SD ' HG23 ' A' ' 198' ' ' ILE . 31.7 mtm -74.29 -2.22 24.11 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.541 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 73.8 m -82.68 -8.58 59.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.098 0.475 . . . . 0.0 110.018 175.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.931 ' HG2' ' HG2' ' A' ' 159' ' ' GLU . 58.3 mtt180 -113.33 141.87 46.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.15 -177.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.567 HG12 ' HB ' ' A' ' 158' ' ' VAL . 9.9 p -121.51 130.32 74.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.273 0.558 . . . . 0.0 109.749 171.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -83.64 114.91 21.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.079 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 21.4 m -112.24 121.23 64.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.616 0.722 . . . . 0.0 110.935 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.501 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -127.47 173.09 18.69 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.981 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 58.7 m 60.75 31.47 20.11 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.408 0.283 . . . . 0.0 111.176 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.561 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 71.1 mt -61.39 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.485 -176.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 119' ' ' ILE . 2.3 t80 164.6 149.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -174.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -88.26 73.14 8.94 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -176.84 -58.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.226 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.8 mt -58.84 99.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.273 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.32 171.32 54.76 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.032 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -57.05 -39.9 75.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.874 0.368 . . . . 0.0 110.656 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.35 -49.46 77.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.79 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.7 m -63.3 -44.18 95.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.087 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.418 HG13 ' HE1' ' A' ' 143' ' ' MET . 33.8 mm -60.74 -40.46 85.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.532 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -61.2 -38.67 87.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.337 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -70.88 -34.04 71.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.495 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.431 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -82.07 -29.02 32.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.231 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.512 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 46.3 m-85 -94.33 -14.86 24.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.829 0.347 . . . . 0.0 111.569 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.433 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.99 -41.97 88.3 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 55.1 Cg_exo -42.48 -35.72 4.04 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.016 2.477 . . . . 0.0 114.488 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.521 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 51.3 m-85 -82.49 -49.34 10.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 121.141 -0.223 . . . . 0.0 111.202 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.01 172.39 39.84 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.918 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.94 121.64 8.29 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.617 2.211 . . . . 0.0 111.705 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.2 mt -84.53 116.7 28.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.945 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -74.76 -43.75 53.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.917 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.3 t -161.96 152.78 17.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.358 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -130.45 126.12 60.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.63 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 13.3 t70 -96.28 99.77 11.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.418 ' HE1' HG13 ' A' ' 128' ' ' ILE . 46.9 ttm -136.21 126.88 27.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.204 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.2 m . . . . . 0 C--N 1.322 -0.613 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.008 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.501 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 67.2 m-85 . . . . . 0 C--O 1.233 0.237 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 142' ' ' ASP . . . -137.29 140.95 41.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.089 0.471 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -109.98 109.75 20.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.597 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.567 ' HB ' HG12 ' A' ' 114' ' ' VAL . 47.7 t -91.06 110.36 22.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.337 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.931 ' HG2' ' HG2' ' A' ' 113' ' ' ARG . 47.3 mt-10 -99.72 123.08 43.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.532 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.44 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 95.8 m-85 -100.98 171.67 7.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.033 0.444 . . . . 0.0 110.085 176.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -86.1 -5.36 59.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.271 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 5.2 m -142.23 143.98 29.59 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.191 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 12.6 Cg_exo -69.69 -26.54 27.82 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.384 2.723 . . . . 0.0 112.038 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.685 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 8.1 mp0 -55.73 -57.05 13.62 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.954 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -59.81 -19.73 52.51 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.85 -51.15 8.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -68.07 -31.55 71.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.757 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.521 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 18.2 tp -67.03 -46.47 74.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.673 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.81 -34.73 73.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.072 0.463 . . . . 0.0 110.168 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 185' ' ' VAL . 2.9 tp -67.6 -51.98 43.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.556 172.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -54.83 -34.44 62.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.745 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -100.56 -51.54 3.58 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.1 ttp -107.78 29.33 7.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -165.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 31.9 p-10 -78.72 25.21 0.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.911 0.386 . . . . 0.0 111.302 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.1 m -113.33 -72.91 0.68 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.867 0.365 . . . . 0.0 111.069 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 30.9 m -134.29 164.04 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.002 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.627 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.9 tpt -139.51 91.9 2.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.793 0.33 . . . . 0.0 110.734 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.544 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 94.6 mt 61.56 -177.79 0.12 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.429 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.69 -113.14 1.06 Allowed Glycine 0 C--N 1.337 0.587 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.185 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.6 45.84 0.59 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 119' ' ' ILE . 12.5 tpt180 -127.2 135.84 51.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.899 -173.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 4.1 p-10 -91.85 142.53 27.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.627 HD13 ' HB2' ' A' ' 177' ' ' MET . 42.8 pt -129.66 168.19 23.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.792 0.33 . . . . 0.0 110.568 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 55.5 tptt -109.25 106.01 15.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.772 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.501 ' O ' HD13 ' A' ' 170' ' ' LEU . 43.3 t -103.03 104.29 16.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.698 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.1 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.458 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 59.5 tt0 . . . . . 0 C--O 1.236 0.368 0 CA-C-O 120.855 0.36 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.434 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -74.43 -23.2 58.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.203 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.695 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 23.1 tm0? -58.93 -52.92 71.38 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.497 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 54.2 Cg_exo -56.61 -35.17 96.97 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.286 1.99 . . . . 0.0 112.65 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.3 mt -67.99 -43.73 85.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 109.92 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.437 HG23 ' SD ' ' A' ' 111' ' ' MET . 84.9 mt -59.6 -48.71 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.052 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.25 -45.53 90.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.91 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -62.02 -53.03 61.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.704 HD13 HD21 ' A' ' 108' ' ' LEU . 30.8 mt -65.83 -33.11 75.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.262 -178.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.662 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.28 -42.84 70.48 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -71.44 -34.47 70.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.907 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 31.3 mt-10 -65.09 -36.51 84.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.67 -26.73 64.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.686 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.5 mtp180 -72.29 -14.12 61.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.59 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -88.39 0.8 55.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.351 0.596 . . . . 0.0 110.273 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -131.42 177.18 7.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.926 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 3.1 m-80 -118.95 43.35 2.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.13 -174.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 210' ' ' ARG . 36.7 ttt180 -99.8 137.24 38.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.98 -173.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.1 pt -133.08 166.57 29.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.559 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.625 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 84.6 t80 -120.81 131.89 54.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.363 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.443 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 33.6 m -125.91 137.42 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.156 0.503 . . . . 0.0 110.677 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -133.29 -178.55 5.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.715 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 28.2 t 62.73 26.58 15.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.756 0.789 . . . . 0.0 109.444 -171.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.452 HG13 HD11 ' A' ' 225' ' ' ILE . 9.4 t -79.68 115.86 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.093 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -60.88 145.5 49.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.551 -171.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -48.42 -54.54 13.7 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -85.68 36.91 0.67 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.992 0.425 . . . . 0.0 111.537 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 220' ' ' LEU . 9.1 tp -121.01 118.01 28.74 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 19.7 m -99.3 177.45 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.388 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -64.42 -26.75 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 110.412 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.46 -40.25 92.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.348 0.594 . . . . 0.0 109.909 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.64 -50.0 68.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.799 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.624 HG22 HD11 ' A' ' 255' ' ' ILE . 26.0 mm -68.17 -44.81 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.435 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 64.0 tttm -57.61 -46.56 83.93 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.44 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.2 t -52.76 -48.47 66.75 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.68 -43.32 61.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.343 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.579 ' CB ' HD11 ' A' ' 235' ' ' ILE . 11.2 m-85 -67.39 -30.01 69.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.232 0.539 . . . . 0.0 110.744 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.565 ' OE1' ' HB ' ' A' ' 235' ' ' ILE . 9.0 tp10 -63.16 -24.45 67.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.843 177.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.56 -11.63 59.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.874 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -111.2 -40.2 4.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.515 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -142.81 166.51 26.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.767 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -77.97 106.84 10.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.078 0.466 . . . . 0.0 110.521 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.579 HD11 ' CB ' ' A' ' 229' ' ' PHE . 21.5 mt -83.29 148.37 5.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.636 0.731 . . . . 0.0 111.579 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -106.9 -36.15 6.72 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.097 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.1 m -154.7 146.5 23.4 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -171.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 49.7 t -141.83 119.45 11.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.6 m -140.48 103.13 4.48 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.301 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.617 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 48.1 mt -75.96 129.23 36.59 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.47 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.21 116.5 6.64 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.475 0.485 . . . . 0.0 110.195 -175.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 31.0 ttp180 -136.43 142.21 43.63 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.783 -174.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.496 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 9.2 m-20 -75.97 115.18 44.21 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.69 -27.33 25.92 Favored 'Trans proline' 0 CA--C 1.527 0.175 0 C-N-CA 123.679 2.919 . . . . 0.0 114.138 -171.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 t -97.44 -14.21 21.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 71.0 p -92.37 -39.32 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.843 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.77 -0.47 70.14 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.3 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 62.6 pttt -117.56 138.18 52.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -82.63 144.55 30.22 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 252' ' ' TYR . 23.8 mtpp -78.29 10.96 2.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -167.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.64 38.43 Favored Glycine 0 CA--C 1.508 -0.388 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.264 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 250' ' ' LYS . 28.9 p90 -142.15 177.78 8.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.687 0.28 . . . . 0.0 110.488 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -167.63 174.41 42.68 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.158 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.685 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 86.1 m-85 -126.38 149.67 49.08 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.624 HD11 HG22 ' A' ' 225' ' ' ILE . 74.9 mt -140.29 142.73 30.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.454 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 51.0 mt-10 -117.75 147.52 42.9 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.551 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 11.6 m-85 -114.38 171.0 7.89 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 171.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -86.99 -9.75 54.85 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.46 0.648 . . . . 0.0 109.569 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -136.12 122.63 20.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.273 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.71 72.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.141 0.496 . . . . 0.0 111.079 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -63.44 -36.47 83.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.882 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.5 m -71.64 -40.82 69.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.33 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 43.1 p -67.17 -36.79 82.55 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -67.68 -30.86 70.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.3 -35.49 76.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.115 0.483 . . . . 0.0 110.256 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.24 85.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.086 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.441 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 95.7 t -58.25 -34.12 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 121.443 0.639 . . . . 0.0 110.126 173.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 43.1 t -73.06 -44.59 60.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.362 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.8 m -90.37 -35.36 15.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.45 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 82.7 mmm -87.17 -7.79 57.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -170.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -73.24 122.09 21.39 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.165 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 97.4 mt 64.25 31.27 13.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.437 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -86.59 133.85 33.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.022 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -80.09 105.6 11.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.951 0.405 . . . . 0.0 110.607 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 56.1 tp -126.11 95.65 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.244 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.12 21.99 47.07 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.502 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 90.05 9.26 65.89 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.607 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -129.92 155.3 46.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.57 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 73.5 m-85 -100.39 109.35 21.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 74.9 mt -59.55 133.95 56.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.639 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.414 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 14.8 mmt180 -99.58 116.18 31.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 267' ' ' VAL . 12.4 p -123.68 144.41 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.65 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.45 173.06 38.68 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.691 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -71.95 128.1 34.66 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.23 113.25 6.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.25 -24.14 23.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.867 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 50.2 p -100.67 133.09 21.43 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.983 0.42 . . . . 0.0 110.403 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 N--CA 1.463 -0.292 0 C-N-CA 122.594 2.196 . . . . 0.0 111.603 176.271 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.751 0.31 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -59.28 -48.85 80.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.474 ' HB2' HD12 ' A' ' 197' ' ' ILE . . . -69.75 -22.8 63.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.489 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.91 -32.12 73.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.092 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.71 -28.37 68.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.341 0.591 . . . . 0.0 110.401 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.0 mt -87.91 -40.44 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.343 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.539 ' SD ' HG12 ' A' ' 198' ' ' ILE . 92.2 mtp -69.08 -29.9 68.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.018 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 92.9 m -73.94 -12.02 60.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.593 0.235 . . . . 0.0 111.01 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 159' ' ' GLU . 47.1 mtt180 -106.51 141.39 37.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.08 0.467 . . . . 0.0 110.894 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.54 122.43 69.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.461 0.648 . . . . 0.0 109.407 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -74.86 119.88 19.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.108 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 15.3 m -114.22 114.74 47.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.405 0.621 . . . . 0.0 109.959 175.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.06 171.36 13.78 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.249 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.9 m 58.67 35.08 24.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 111.102 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.544 HD11 HG23 ' A' ' 116' ' ' VAL . 58.3 mt -68.99 126.36 28.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.213 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.62 140.28 58.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.165 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -72.37 77.3 1.02 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 122.133 0.968 . . . . 0.0 111.19 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -170.93 -26.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.732 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.401 HD22 HD12 ' A' ' 178' ' ' LEU . 40.1 mt -93.4 110.02 21.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.253 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.26 -174.99 45.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.962 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.65 -40.55 97.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 110.117 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.545 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 36.0 t70 -62.89 -48.77 77.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.688 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -61.12 -43.65 98.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.177 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.1 mm -63.66 -43.18 98.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -57.91 -41.37 82.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.486 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 97.8 mt-30 -60.29 -46.31 90.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.495 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.583 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -80.87 -26.98 36.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -171.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.527 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 32.1 m-85 -90.17 -16.4 29.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.705 0.288 . . . . 0.0 111.542 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.621 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -56.9 -42.48 96.57 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 6.9 Cg_endo -51.31 -27.92 25.09 Favored 'Trans proline' 0 C--N 1.361 1.184 0 C-N-CA 122.507 2.138 . . . . 0.0 114.197 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.752 ' HD2' ' HG ' ' A' ' 168' ' ' LEU . 64.6 m-85 -80.99 -46.04 15.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.635 0.255 . . . . 0.0 110.988 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.31 -178.53 39.09 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.476 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 62.3 Cg_endo -75.43 117.45 4.82 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.559 2.173 . . . . 0.0 111.65 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.8 mt -83.49 114.24 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.897 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.616 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 74.3 tttt -88.38 -33.17 18.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.78 -173.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.7 t -157.94 147.91 20.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.389 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.9 mt -133.67 113.24 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -96.63 100.02 11.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.514 ' HG3' ' HB2' ' A' ' 156' ' ' ALA . 52.4 ttm -126.92 137.85 53.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 177.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 38.5 p90 . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.172 0.511 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.514 ' HB2' ' HG3' ' A' ' 143' ' ' MET . . . -152.08 154.5 36.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.377 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -111.93 109.85 19.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.185 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 62.1 t -91.91 112.16 25.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.756 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.47 ' HA ' ' HG2' ' A' ' 113' ' ' ARG . 39.0 tt0 -100.08 120.49 39.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.972 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -98.23 170.0 9.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.685 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.616 ' HG2' ' HD2' ' A' ' 139' ' ' LYS . 35.6 mt-10 -80.34 -38.67 30.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 171.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.2 m -109.64 135.81 20.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.365 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 56.2 Cg_endo -69.44 -21.15 35.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.127 2.551 . . . . 0.0 112.597 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.696 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 10.7 mp0 -57.59 -50.65 72.41 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.129 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.407 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.04 -21.76 65.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.46 -51.72 8.99 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.022 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 164' ' ' GLU . 5.0 pp0? -63.85 -30.23 71.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.556 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.752 ' HG ' ' HD2' ' A' ' 135' ' ' PHE . 14.2 tp -73.79 -45.83 49.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.6 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.4 72.17 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.531 ' O ' ' HB3' ' A' ' 174' ' ' ASN . 6.8 tt -66.44 -50.0 64.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.27 172.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 10.6 mm-40 -52.72 -50.87 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.554 -178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -89.72 -32.98 16.76 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 22.8 mtm -106.71 30.79 5.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.479 . . . . 0.0 111.744 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 33.4 p-10 -74.92 -3.59 33.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.412 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.6 m -95.13 -73.38 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 110.841 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.9 m -140.69 164.73 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.082 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.635 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.4 tpt -124.43 95.03 4.38 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.549 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.401 HD12 HD22 ' A' ' 123' ' ' LEU . 91.7 mt 71.95 -50.53 0.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.971 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 161.1 -177.29 37.52 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.638 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 94.72 -87.78 1.1 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.604 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -127.55 142.54 51.35 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -70.68 108.4 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.635 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.3 pt -72.47 156.35 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.776 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 83.2 tttt -106.2 116.77 32.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.258 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 116' ' ' VAL . 5.4 m -100.27 114.39 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 172.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.436 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.478 179.004 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 . . . . . 0 N--CA 1.464 0.271 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.428 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -78.04 -22.2 49.53 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.545 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 71.9 mm-40 -52.32 -54.02 46.4 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -175.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 53.2 Cg_exo -56.21 -34.54 93.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.021 1.814 . . . . 0.0 112.684 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 107' ' ' ALA . 51.3 mt -75.98 -45.98 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.327 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.539 HG12 ' SD ' ' A' ' 111' ' ' MET . 69.1 mt -60.85 -43.34 95.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.292 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.08 -38.73 89.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.857 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -61.63 -52.47 64.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.855 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.532 HD13 HG22 ' A' ' 287' ' ' THR . 25.5 mt -67.54 -32.69 73.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.608 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.671 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.63 -47.84 66.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 171.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.515 ' OE1' ' HD3' ' A' ' 206' ' ' ARG . 5.8 mm-40 -63.24 -35.24 79.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.213 175.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.663 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 47.6 mt-10 -66.41 -33.45 75.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -77.64 -29.28 51.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.969 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.671 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 59.4 mtp180 -72.62 -25.35 61.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 110.408 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.65 -39.93 18.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.342 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -105.57 79.53 1.46 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 0.1 OUTLIER -52.4 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.427 1.079 . . . . 0.0 111.403 -173.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.471 ' HB2' ' HG3' ' A' ' 256' ' ' GLU . 44.8 ttm105 -134.09 146.12 50.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.995 0.426 . . . . 0.0 111.59 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.613 HG23 ' HB2' ' A' ' 263' ' ' SER . 49.3 pt -123.78 166.46 18.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.17 174.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.487 ' CG ' ' HB3' ' A' ' 164' ' ' GLU . 85.4 t80 -118.14 129.51 55.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.46 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 29.3 m -121.1 128.56 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.335 0.588 . . . . 0.0 110.237 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -119.57 176.2 5.48 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.464 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.4 m 60.26 32.59 20.83 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.415 0.626 . . . . 0.0 109.972 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.49 114.67 20.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.353 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 32.4 t-80 -55.57 137.65 48.44 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.456 0.472 . . . . 0.0 111.744 -172.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -49.99 -52.37 34.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -82.23 20.38 1.05 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.91 0.386 . . . . 0.0 111.722 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.654 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.0 tp -105.41 126.53 52.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.0 m -90.85 163.96 14.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.832 0.349 . . . . 0.0 111.746 -173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.452 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 6.0 p-10 -65.11 -27.29 68.65 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.27 0.557 . . . . 0.0 110.313 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.34 -31.61 71.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.751 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -74.33 -39.85 62.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.694 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.795 HG13 HD21 ' A' ' 240' ' ' LEU . 24.8 mm -65.74 -46.7 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -58.61 -51.56 69.41 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.955 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.4 p -58.94 -38.92 80.11 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 51.1 t -76.53 -41.99 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.196 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.543 ' CB ' HD11 ' A' ' 235' ' ' ILE . 25.0 m-85 -65.43 -28.67 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.217 -0.302 . . . . 0.0 110.736 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.18 -25.02 67.54 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.522 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.88 -17.49 55.51 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.064 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -111.52 -31.36 7.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.924 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.542 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -146.93 160.25 28.21 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.377 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 234' ' ' LYS . 0.7 OUTLIER -84.71 107.63 17.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.492 0.663 . . . . 0.0 110.993 -177.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.543 HD11 ' CB ' ' A' ' 229' ' ' PHE . 37.3 mt -86.03 151.4 3.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.928 -173.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -106.23 -27.49 11.01 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.921 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 235' ' ' ILE . 3.0 p -176.87 152.1 0.92 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.575 0.226 . . . . 0.0 110.677 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 36.5 t -137.59 129.5 28.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.282 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.1 t -141.05 104.16 4.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.411 0.624 . . . . 0.0 111.599 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.795 HD21 HG13 ' A' ' 225' ' ' ILE . 30.9 mt -75.95 133.57 40.43 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.433 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.44 114.35 4.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.162 0.506 . . . . 0.0 110.257 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.585 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 13.7 mtp180 -112.21 164.89 12.68 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.438 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.28 141.4 57.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -43.75 -45.04 11.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.518 2.812 . . . . 0.0 113.905 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.9 t -155.61 86.21 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.722 0.773 . . . . 0.0 111.21 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 20.3 p -135.28 -42.84 0.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.728 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 121.92 -24.04 7.19 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.463 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -107.65 166.5 10.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.969 0.414 . . . . 0.0 110.471 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 9.7 p80 -96.63 165.35 12.19 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -73.39 -82.15 0.06 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.402 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -167.4 7.52 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.615 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.421 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 28.7 p90 -150.49 175.76 11.57 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -165.16 174.98 41.09 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.44 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.696 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 78.8 m-85 -129.54 150.95 50.66 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 225' ' ' ILE . 81.9 mt -142.49 133.04 23.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.473 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 4.8 mp0 -106.51 146.97 29.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.648 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 8.8 m-85 -118.68 165.15 14.33 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.83 -37.57 86.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.755 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -118.22 140.12 50.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.434 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.76 -25.73 68.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.224 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -74.21 -43.45 57.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.234 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.6 m -66.32 -33.0 74.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.982 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.648 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 79.9 p -66.29 -37.82 86.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -71.39 -27.94 63.67 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.473 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.44 -44.08 92.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.077 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.05 92.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.386 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.65 -40.31 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.573 . . . . 0.0 110.665 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 20.7 m -70.35 -30.98 68.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.533 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.0 m -94.37 -42.99 8.6 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.477 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.3 mmm -82.66 6.45 17.81 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -169.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.483 ' HA ' HG12 ' A' ' 282' ' ' VAL . 65.2 t30 -72.13 120.57 17.92 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.277 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 93.4 mt 64.21 31.25 13.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.418 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -78.91 128.93 33.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.386 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.422 ' HB2' ' HE1' ' A' ' 279' ' ' TYR . 36.6 t70 -74.47 102.92 4.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.654 ' HG ' HD21 ' A' ' 220' ' ' LEU . 34.2 tp -136.8 109.93 7.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.752 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.07 56.69 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.408 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 83.11 4.46 89.83 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.654 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -130.47 156.15 45.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.435 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 45.7 m-85 -97.18 111.76 23.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.506 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 45.6 mt -59.68 127.17 30.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.5 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 30.6 mmt180 -92.71 114.37 26.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 171.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 271' ' ' ASN . 11.0 p -118.5 151.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.487 -171.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -169.58 174.86 43.9 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -72.68 141.96 48.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.404 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -82.36 129.35 34.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.418 ' CG1' ' HG2' ' A' ' 167' ' ' GLN . 19.9 m -92.05 -23.05 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.723 0.297 . . . . 0.0 110.739 -175.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.532 HG22 HD13 ' A' ' 201' ' ' LEU . 38.0 p -128.81 156.5 77.63 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 121.136 0.493 . . . . 0.0 111.373 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.663 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 66.4 Cg_endo . . . . . 0 N--CA 1.447 -1.242 0 C-N-CA 123.252 2.635 . . . . 0.0 112.662 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 . . . . . 0 CA--C 1.529 0.157 0 CA-C-O 120.516 0.198 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -57.12 -42.47 80.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.08 0.467 . . . . 0.0 110.991 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.63 -31.4 65.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.769 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 201' ' ' LEU . 45.7 mt -70.7 -32.93 70.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.14 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.36 -33.86 73.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.347 0.594 . . . . 0.0 109.801 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.4 mt -75.71 -37.07 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.381 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.562 ' CG ' HD12 ' A' ' 198' ' ' ILE . 86.6 mtp -69.26 -20.78 63.93 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.021 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 82.1 m -74.5 -11.72 60.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -99.5 142.38 31.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.805 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.6 p -123.52 122.74 65.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 89.5 t80 -65.56 126.62 28.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.741 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.99 115.41 48.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -124.3 163.2 18.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.139 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.0 m 60.76 47.12 8.27 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 122.661 0.385 . . . . 0.0 111.233 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.496 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 49.2 mt -74.05 -28.28 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.353 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 35.7 t80 72.43 135.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.619 0.575 . . . . 0.0 109.528 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -77.16 77.22 3.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.193 0.997 . . . . 0.0 111.047 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -151.67 -49.45 0.11 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.566 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.459 HD22 HD12 ' A' ' 178' ' ' LEU . 57.0 mt -68.04 137.64 55.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.59 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -98.72 173.67 27.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.409 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.82 -51.25 70.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 110.88 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.98 -27.83 63.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.876 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -64.55 -43.53 93.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.188 0.518 . . . . 0.0 109.762 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.556 HG13 ' HE1' ' A' ' 143' ' ' MET . 36.5 mm -64.44 -41.35 92.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.151 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 129' ' ' ARG . 20.7 ttt180 -55.73 -49.18 73.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.777 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.87 -33.29 73.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.759 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.611 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -83.17 -35.51 25.45 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.23 -17.2 33.14 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.55 96.38 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -44.35 -36.2 9.15 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.714 2.276 . . . . 0.0 114.277 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 169' ' ' ALA . 60.7 m-85 -77.9 -39.01 44.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.666 0.269 . . . . 0.0 110.717 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . -173.8 167.6 40.2 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.738 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.46 114.52 2.56 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.578 2.186 . . . . 0.0 111.865 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.577 HD13 HD11 ' A' ' 141' ' ' ILE . 65.2 mt -74.05 130.71 35.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.635 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 139' ' ' LYS . 36.8 ttpt -93.06 -33.99 13.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.393 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 t -174.05 128.38 0.38 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.949 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.577 HD11 HD13 ' A' ' 138' ' ' ILE . 68.9 mt -104.42 119.12 52.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -88.23 100.67 13.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.556 ' HE1' HG13 ' A' ' 128' ' ' ILE . 43.7 ttm -143.41 101.28 3.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.93 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.4 m . . . . . 0 C--N 1.324 -0.529 0 CA-C-O 120.841 0.353 . . . . 0.0 110.924 -178.061 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.9 p90 . . . . . 0 N--CA 1.45 -0.425 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.93 169.33 24.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.316 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.467 ' CE2' ' HD1' ' A' ' 115' ' ' TYR . 95.6 m-85 -124.18 112.82 17.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.164 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.1 t -91.85 108.5 20.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -105.06 118.99 37.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.11 0.481 . . . . 0.0 110.036 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -88.66 -176.11 5.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.966 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -83.35 -35.52 25.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.4 m -117.41 140.91 27.94 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.405 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 51.0 Cg_endo -66.84 -19.7 52.54 Favored 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 123.52 2.814 . . . . 0.0 112.609 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.654 ' HG3' ' CE1' ' A' ' 254' ' ' PHE . 80.6 mm-40 -58.33 -55.04 40.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.752 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.68 -21.03 62.4 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.984 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.92 -48.68 15.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.692 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.472 ' HG3' HG11 ' A' ' 286' ' ' VAL . 30.5 mm-40 -69.19 -33.18 72.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.503 174.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.509 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 13.7 tp -65.65 -47.07 76.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.656 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . . . -59.79 -37.71 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.08 0.467 . . . . 0.0 110.13 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.588 ' HG ' HG23 ' A' ' 185' ' ' VAL . 6.8 tt -65.38 -43.52 90.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.806 174.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.34 -34.44 76.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.99 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -100.61 -47.25 4.92 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.7 ttp -102.91 31.04 4.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.363 0.602 . . . . 0.0 111.708 -166.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 4.8 p-10 -74.68 16.66 0.26 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.551 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.4 m -106.35 -74.01 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.675 0.274 . . . . 0.0 111.47 -175.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 18.6 m -144.34 169.56 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.744 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.9 tpt -129.62 101.1 5.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 110.673 177.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.742 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 94.6 mt 63.66 32.45 13.82 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.016 173.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.63 -31.63 1.92 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.087 -0.578 . . . . 0.0 114.32 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.75 -64.71 3.99 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.647 -0.311 . . . . 0.0 113.293 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -144.41 150.91 38.49 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.563 -0.375 . . . . 0.0 110.679 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 8.4 p30 -72.44 118.8 15.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 177' ' ' MET . 43.6 pt -96.46 157.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.497 -174.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -105.14 110.99 23.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.408 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.588 HG23 ' HG ' ' A' ' 170' ' ' LEU . 9.7 m -99.76 122.82 52.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.067 0.461 . . . . 0.0 109.922 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.489 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.955 -178.022 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 . . . . . 0 N--CA 1.46 0.052 0 CA-C-O 121.058 0.456 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.472 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -97.52 11.81 35.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.777 -175.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.567 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 25.2 tm0? -53.57 -47.16 97.42 Favored Pre-proline 0 N--CA 1.47 0.551 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 6.9 Cg_endo -52.76 -36.19 72.21 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.355 2.036 . . . . 0.0 112.884 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 78.2 mt -74.18 -38.58 48.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.19 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.562 HD12 ' CG ' ' A' ' 111' ' ' MET . 12.7 mm -57.66 -50.19 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.179 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 30.5 t70 -69.98 -32.56 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.854 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.37 -50.64 72.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.03 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.458 HD13 HD21 ' A' ' 108' ' ' LEU . 44.6 mt -68.86 -33.47 73.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.645 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -55.54 -42.55 74.77 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 52.3 mt-10 -63.26 -33.73 76.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.732 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.72 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 26.4 mt-10 -65.37 -36.23 83.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.915 0.388 . . . . 0.0 110.84 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.5 -39.13 62.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.705 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.572 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 60.0 mtp180 -61.02 -22.3 64.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.485 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.96 -27.36 65.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.039 0.447 . . . . 0.0 110.71 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -105.8 169.73 8.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.224 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 0.9 OUTLIER -103.75 51.27 0.79 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.471 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 39.3 ttm180 -105.18 139.13 40.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.023 -167.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.457 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.4 pt -127.97 166.22 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.879 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.481 ' HE1' ' HB2' ' A' ' 252' ' ' TYR . 25.0 t80 -118.24 135.81 54.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.019 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.507 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.5 m -130.01 136.45 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 110.991 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -131.3 -179.17 5.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.553 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 69.6 m 62.44 27.37 16.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.869 0.842 . . . . 0.0 109.72 -171.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.496 HG13 HD11 ' A' ' 225' ' ' ILE . 21.7 t -79.22 116.56 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.538 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -56.0 140.7 42.46 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.253 0.549 . . . . 0.0 111.476 -174.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -58.52 -29.31 66.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.972 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.45 6.14 42.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.868 0.842 . . . . 0.0 110.067 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.566 HD21 ' HG ' ' A' ' 275' ' ' LEU . 7.3 tp -112.59 122.77 48.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.079 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.4 t -107.25 -178.69 3.71 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.074 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -60.63 -37.52 81.73 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.99 -24.62 64.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 0.0 110.452 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -72.6 -52.74 14.2 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.865 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.496 HD11 HG13 ' A' ' 216' ' ' VAL . 31.4 mm -61.76 -42.04 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.063 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 85.5 tttt -56.31 -50.23 72.02 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.708 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 m -56.09 -37.78 69.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 20.8 t -76.65 -44.28 33.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.574 ' HB2' HD11 ' A' ' 235' ' ' ILE . 7.4 m-85 -67.94 -31.34 71.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.591 0.71 . . . . 0.0 110.522 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -60.62 -24.46 65.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.94 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.29 -15.45 62.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.922 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.49 -33.76 6.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.348 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -152.03 163.7 30.21 Favored Glycine 0 CA--C 1.517 0.159 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.704 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.93 110.62 6.55 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.147 0.498 . . . . 0.0 111.581 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 229' ' ' PHE . 23.3 mt -88.33 150.44 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.017 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -106.16 -31.9 8.47 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.191 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 20.4 p -166.45 156.46 11.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.012 0.434 . . . . 0.0 111.423 -172.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 9.2 p -141.15 124.52 16.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.831 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.0 t -141.49 115.07 8.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.255 0.55 . . . . 0.0 110.973 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.503 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 28.9 mt -91.99 137.13 32.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.43 98.47 0.85 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.978 0.418 . . . . 0.0 110.08 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.655 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 25.5 ttt180 -104.68 131.69 51.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.523 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.555 ' HB2' ' HD2' ' A' ' 250' ' ' LYS . 4.7 t70 -97.28 126.52 41.58 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.317 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 10.5 Cg_exo -69.54 -20.45 35.85 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.457 2.772 . . . . 0.0 113.799 -173.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 43.3 p -87.24 -30.31 21.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.883 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.408 HG23 ' HG2' ' A' ' 248' ' ' LYS . 8.8 t -97.04 -22.84 16.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.295 0.569 . . . . 0.0 110.301 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 77.12 25.67 63.57 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.423 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.513 ' C ' ' HG3' ' A' ' 242' ' ' ARG . 64.2 pttt -142.72 154.65 44.48 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.6 OUTLIER -76.3 131.42 39.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . 0.555 ' HD2' ' HB2' ' A' ' 243' ' ' ASP . 50.0 mtpt -74.55 3.41 7.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -164.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 102.5 2.67 50.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.368 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.481 ' HB2' ' HE1' ' A' ' 212' ' ' TYR . 32.9 p90 -141.88 165.21 28.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -169.25 178.46 42.41 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.021 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.654 ' CE1' ' HG3' ' A' ' 164' ' ' GLU . 88.2 m-85 -129.78 148.85 51.7 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.018 0.437 . . . . 0.0 110.594 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 225' ' ' ILE . 95.2 mt -136.08 133.21 50.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.255 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 49.0 mt-10 -113.21 135.14 54.15 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 6.2 m-85 -95.4 179.61 5.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -82.3 -17.97 43.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.467 0.651 . . . . 0.0 109.378 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -129.32 130.14 45.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.535 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 209' ' ' ASN . . . -68.87 -25.01 64.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.164 0.507 . . . . 0.0 111.232 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -75.09 -42.06 57.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.244 176.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.5 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 19.9 m -67.76 -29.44 68.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.733 -175.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.457 ' HB2' HG23 ' A' ' 211' ' ' ILE . 48.3 p -69.05 -32.58 72.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.195 0.521 . . . . 0.0 109.687 177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -74.67 -25.89 59.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.469 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 61.1 m-20 -64.02 -41.12 97.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.262 0.553 . . . . 0.0 109.836 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -61.96 -41.27 97.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.409 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.2 -40.13 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.187 0.517 . . . . 0.0 110.71 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 48.0 t -69.31 -30.9 69.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.5 m -94.53 -43.87 8.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 78.5 mmm -84.48 1.73 44.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.914 -169.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.51 ' HA ' HG12 ' A' ' 282' ' ' VAL . 45.7 t30 -69.45 117.07 10.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.603 0.24 . . . . 0.0 110.423 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 91.6 mt 63.68 36.78 10.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.38 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -90.25 124.55 34.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.254 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.474 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 18.2 t70 -74.81 108.96 7.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.65 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.566 ' HG ' HD21 ' A' ' 220' ' ' LEU . 46.3 tp -141.31 106.77 5.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.969 0.414 . . . . 0.0 109.997 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 94.08 24.64 19.11 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.552 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 78.52 11.85 84.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.654 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -142.68 150.47 40.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.682 0.277 . . . . 0.0 110.432 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 83.0 m-85 -87.16 114.18 23.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.392 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.4 131.68 51.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.636 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 213' ' ' VAL . 16.8 mmt180 -96.39 116.44 29.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 271' ' ' ASN . 9.4 p -120.66 144.68 28.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.617 -175.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.15 174.22 38.56 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.615 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -75.76 126.28 30.7 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.77 126.22 27.79 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.433 0.458 . . . . 0.0 109.862 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.472 HG11 ' HG3' ' A' ' 167' ' ' GLN . 34.4 m -94.29 -26.75 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -172.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.45 HG21 ' CD2' ' A' ' 108' ' ' LEU . 19.0 p -132.51 156.23 80.33 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.018 0.437 . . . . 0.0 111.687 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.72 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 86.6 Cg_endo . . . . . 0 N--CA 1.45 -1.04 0 C-N-CA 122.898 2.399 . . . . 0.0 112.572 175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 . . . . . 0 C--O 1.227 -0.129 0 CA-C-O 120.97 0.414 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -61.86 -32.77 73.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.043 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -45.75 87.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.219 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.511 HD23 ' SD ' ' A' ' 111' ' ' MET . 87.0 mt -63.9 -31.84 73.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.807 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.76 67.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.835 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.6 mt -84.94 -33.61 8.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.21 0.528 . . . . 0.0 109.719 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.511 ' SD ' HD23 ' A' ' 108' ' ' LEU . 89.4 mtp -72.98 -21.68 60.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.016 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.955 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 31.6 p -82.59 3.55 28.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.095 0.474 . . . . 0.0 110.7 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.534 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 15.0 mtm180 -113.84 141.7 47.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 186' ' ' GLY . 4.2 p -124.98 122.67 63.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.551 0.691 . . . . 0.0 109.684 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -77.66 128.88 34.81 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 14.0 m -123.79 116.29 47.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.506 0.669 . . . . 0.0 110.241 175.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -125.11 174.84 17.33 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.582 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.5 m 61.77 34.35 17.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.961 0.41 . . . . 0.0 110.817 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 123' ' ' LEU . 63.9 mt -78.17 119.27 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.047 0.451 . . . . 0.0 110.889 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -53.25 144.86 15.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.442 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -70.8 80.61 0.62 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.771 0.796 . . . . 0.0 111.114 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -169.24 -29.69 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.552 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.402 HD12 HG23 ' A' ' 119' ' ' ILE . 35.0 mt -97.6 105.45 17.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.787 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.88 173.36 54.67 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.219 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.8 -35.42 74.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.257 0.551 . . . . 0.0 109.638 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.3 -51.38 67.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.878 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -61.99 -39.92 93.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.161 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.531 HG13 ' CE ' ' A' ' 143' ' ' MET . 22.2 mm -64.46 -39.73 86.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -56.6 -41.43 76.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.079 0.466 . . . . 0.0 110.116 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -72.24 -33.78 67.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.731 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.498 ' HB1' ' SD ' ' A' ' 177' ' ' MET . . . -85.6 -29.4 24.13 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.456 ' CD1' HG23 ' A' ' 128' ' ' ILE . 28.0 m-85 -94.98 -20.74 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -51.53 -41.9 79.65 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 29.2 Cg_exo -38.08 -41.98 1.4 Allowed 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 123.235 2.623 . . . . 0.0 114.625 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.488 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 67.0 m-85 -76.13 -44.59 37.7 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 121.299 -0.161 . . . . 0.0 111.156 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -170.22 166.83 40.02 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.571 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HG2' ' CE1' ' A' ' 252' ' ' TYR . 35.1 Cg_exo -62.16 117.98 4.85 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.846 2.364 . . . . 0.0 111.773 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.84 HD13 HD11 ' A' ' 141' ' ' ILE . 57.2 mt -77.84 130.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.565 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -99.83 -27.36 13.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.44 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.2 t -165.16 131.46 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.043 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.84 HD11 HD13 ' A' ' 138' ' ' ILE . 59.9 mt -130.54 128.81 63.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -120.98 106.77 11.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.965 0.412 . . . . 0.0 110.173 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.531 ' CE ' HG13 ' A' ' 128' ' ' ILE . 46.3 ttm -114.69 138.27 50.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.634 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 C--N 1.321 -0.635 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.285 177.202 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 46.9 p90 . . . . . 0 C--O 1.235 0.317 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.456 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -155.63 148.09 23.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.702 176.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 81.0 m-85 -110.6 113.02 25.31 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.181 175.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.449 ' HB ' HG12 ' A' ' 114' ' ' VAL . 58.9 t -102.74 105.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.534 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 46.6 tt0 -108.44 126.8 53.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.58 177.56 5.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -76.86 -35.15 57.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.059 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.72 142.2 31.29 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.794 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.955 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 37.8 Cg_endo -66.52 -18.28 54.17 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.3 2.667 . . . . 0.0 112.584 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.54 ' HG3' ' HE2' ' A' ' 254' ' ' PHE . 17.0 mm-40 -56.56 -57.36 12.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.827 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.55 -21.92 65.94 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.26 -49.13 15.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.237 0.541 . . . . 0.0 109.672 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.657 ' HB2' HG11 ' A' ' 286' ' ' VAL . 31.8 mm-40 -67.29 -38.79 85.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.505 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.488 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 11.9 tp -60.61 -46.56 89.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.98 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.48 74.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 110.291 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.61 HD13 ' HA3' ' A' ' 186' ' ' GLY . 7.0 tp -70.11 -41.99 73.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.856 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 8.1 mm-40 -59.21 -39.03 81.4 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.311 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -101.02 -50.67 3.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 28.4 ttp -102.86 31.37 4.21 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -162.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.43 13.98 1.76 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.1 m -105.28 -73.52 0.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.573 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.6 m -144.79 144.14 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.199 0.524 . . . . 0.0 111.42 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.498 ' SD ' ' HB1' ' A' ' 131' ' ' ALA . 3.1 tpt -113.4 108.22 16.92 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 177' ' ' MET . 4.3 mm? 72.1 -55.38 0.67 Allowed 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.878 0.736 . . . . 0.0 110.658 -173.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 145.26 -167.11 27.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.393 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 92.3 -51.58 2.76 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.174 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -143.75 139.56 29.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.574 0.187 . . . . 0.0 110.858 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -64.87 112.24 3.18 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.862 172.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.492 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.6 pt -88.49 152.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.503 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 71.5 mmtt -103.66 105.19 15.35 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.478 HG22 HG12 ' A' ' 116' ' ' VAL . 43.1 t -111.23 135.93 48.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.227 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.61 ' HA3' HD13 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.447 -0.597 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.717 173.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -76.82 -23.48 52.79 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.012 -0.43 . . . . 0.0 112.079 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.553 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 29.3 mm-40 -63.98 -49.61 73.91 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -172.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 8.9 Cg_endo -52.86 -38.43 78.55 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.665 2.243 . . . . 0.0 113.098 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.6 mt -71.83 -45.25 66.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.773 0.32 . . . . 0.0 110.485 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 194' ' ' ALA . 56.2 mt -60.78 -48.34 89.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.14 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.75 -42.3 95.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.344 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 6.4 tp-100 -60.44 -51.94 67.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.735 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 64.5 mt -67.5 -33.51 75.24 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.576 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.615 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -55.92 -42.96 76.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.304 0.573 . . . . 0.0 109.664 175.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 10.8 mm-40 -73.94 -32.71 63.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.943 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.631 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 29.5 mt-10 -69.69 -30.47 68.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.697 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.54 -29.04 65.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.993 0.425 . . . . 0.0 110.069 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 71.6 mtp180 -71.16 -21.76 62.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.361 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -81.41 6.16 15.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.47 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -132.58 -175.62 3.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.92 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -126.08 46.28 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.904 -174.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -105.58 137.66 43.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.15 -176.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.501 HG23 ' HB2' ' A' ' 263' ' ' SER . 49.2 pt -129.15 166.82 25.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.01 0.433 . . . . 0.0 110.735 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.611 ' HD1' ' CE2' ' A' ' 254' ' ' PHE . 85.2 t80 -122.47 129.72 52.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.421 -174.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.565 HG12 HG23 ' A' ' 282' ' ' VAL . 35.1 m -126.63 135.84 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.046 0.45 . . . . 0.0 110.307 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -132.95 -179.49 5.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.861 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.7 t 63.43 27.56 15.23 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.894 0.854 . . . . 0.0 109.056 -172.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.93 121.31 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.256 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 40.8 t-80 -55.21 133.88 49.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.173 0.511 . . . . 0.0 111.283 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -57.79 -28.63 64.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.291 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.72 3.71 50.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.724 0.297 . . . . 0.0 111.304 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 217' ' ' HIS . 14.1 tp -87.06 134.32 33.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 63.2 p -86.41 156.35 20.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.054 -171.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.94 -42.45 68.85 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.577 0.703 . . . . 0.0 109.474 172.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.46 -40.38 74.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.833 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -71.7 -38.58 70.54 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.1 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.615 HG22 HD11 ' A' ' 255' ' ' ILE . 27.0 mm -65.77 -46.24 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 86.8 tttt -57.7 -42.4 83.65 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.439 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.6 t -55.52 -47.75 75.77 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.641 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.33 -40.91 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 111.444 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.485 ' CB ' HD11 ' A' ' 235' ' ' ILE . 26.4 m-85 -66.74 -29.07 68.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.884 0.373 . . . . 0.0 110.992 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.4 mm-40 -63.9 -24.66 67.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.419 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.85 -20.14 60.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.27 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.64 -37.2 6.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.917 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.41 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -147.18 168.92 28.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.801 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 35.2 mmtt -88.01 116.03 25.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.761 0.791 . . . . 0.0 111.231 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.485 HD11 ' CB ' ' A' ' 229' ' ' PHE . 52.6 mt -86.8 150.95 3.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.641 -173.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -110.8 -22.38 11.59 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.759 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.1 t -172.56 143.28 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.707 0.289 . . . . 0.0 110.379 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.0 t -140.49 105.13 4.9 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.8 m -129.21 110.13 11.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.256 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.56 HD21 HG13 ' A' ' 225' ' ' ILE . 60.9 mt -78.71 131.55 36.65 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.539 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -70.53 122.52 19.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.09 0.471 . . . . 0.0 109.834 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.747 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 76.4 mtt180 -111.05 166.49 11.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.29 -171.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.06 135.24 33.58 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.38 -46.25 11.94 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.861 3.041 . . . . 0.0 114.707 -166.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.3 t -159.73 65.42 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.844 0.831 . . . . 0.0 111.607 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 21.8 p -133.15 6.56 3.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.919 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.01 71.74 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.945 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 248' ' ' LYS . 41.3 mtmt -147.33 159.37 43.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.747 ' HB3' ' HG2' ' A' ' 242' ' ' ARG . 19.8 p80 -107.32 147.36 30.39 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.506 170.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -63.44 -7.5 6.87 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -164.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 108.61 5.43 31.67 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.443 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.421 ' CE1' ' HG2' ' A' ' 137' ' ' PRO . 12.8 p90 -141.43 174.09 10.88 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.539 ' HA2' ' H ' ' A' ' 241' ' ' ALA . . . -164.49 172.34 40.23 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.767 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.611 ' CE2' ' HD1' ' A' ' 212' ' ' TYR . 92.4 m-85 -127.31 143.51 51.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.011 0.434 . . . . 0.0 110.687 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 225' ' ' ILE . 83.5 mt -136.61 136.89 48.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.094 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -116.72 146.73 42.59 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 8.6 m-85 -111.28 175.27 5.49 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -83.79 -13.45 53.79 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.222 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -135.48 133.46 38.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.979 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.4 -24.93 67.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.017 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -73.43 -35.4 65.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.873 175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.45 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 8.2 t -70.69 -37.64 73.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.678 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.501 ' HB2' HG23 ' A' ' 211' ' ' ILE . 62.3 p -66.41 -32.79 74.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.068 0.461 . . . . 0.0 110.115 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.49 -27.02 62.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.83 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.45 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 53.5 m-20 -62.92 -45.3 93.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.208 0.528 . . . . 0.0 109.626 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -62.33 -43.53 98.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.018 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 263' ' ' SER . 86.5 t -55.38 -37.16 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.297 0.57 . . . . 0.0 111.206 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.6 m -75.83 -24.19 55.81 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.246 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 18.3 m -95.08 -41.83 8.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 78.5 mmm -88.07 1.95 53.06 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -167.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.505 ' HA ' HG12 ' A' ' 282' ' ' VAL . 66.7 t30 -72.36 115.42 11.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.213 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.2 mt 65.18 38.35 6.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.346 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -94.39 123.56 37.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.105 174.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.529 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 32.2 t70 -71.94 108.4 5.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 25.5 tp -141.8 111.19 6.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 90.94 16.34 54.57 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.051 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 97.35 -6.31 63.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.593 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.7 152.08 51.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 74.7 m-85 -81.06 113.13 19.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.215 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.94 134.63 57.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.388 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -100.49 115.7 30.71 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.565 HG23 HG12 ' A' ' 213' ' ' VAL . 10.0 p -115.53 151.01 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.506 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.14 175.17 42.36 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.962 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -76.88 126.85 31.66 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.67 129.24 39.07 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.657 HG11 ' HB2' ' A' ' 167' ' ' GLN . 29.1 m -89.26 -11.43 10.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.783 0.325 . . . . 0.0 111.578 -170.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.533 HG23 HG23 ' A' ' 286' ' ' VAL . 68.3 p -120.87 133.39 24.1 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.27 0.557 . . . . 0.0 111.094 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 C--O 1.232 0.206 0 C-N-CA 123.099 2.533 . . . . 0.0 111.995 176.805 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -57.57 -47.85 80.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.75 92.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.118 0.485 . . . . 0.0 111.04 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.544 HD21 HD13 ' A' ' 201' ' ' LEU . 60.0 mt -71.95 -35.57 69.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.43 -37.11 77.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.412 . . . . 0.0 110.505 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.3 mt -67.02 -42.8 89.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.308 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 1.8 ttm -68.53 -14.65 63.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.831 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.3 m -77.13 -15.78 59.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.454 177.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.496 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 18.4 mtp180 -101.09 141.7 33.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.694 HG22 ' H ' ' A' ' 186' ' ' GLY . 1.0 OUTLIER -123.33 127.76 74.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 78.6 t80 -82.93 115.37 21.76 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 8.6 m -115.87 116.46 52.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.59 0.71 . . . . 0.0 110.787 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 155' ' ' PHE . . . -119.95 -175.0 15.6 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.898 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.863 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 20.9 m 67.12 21.46 10.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.928 0.491 . . . . 0.0 111.279 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.6 mt -84.88 102.81 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.388 . . . . 0.0 110.619 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 122' ' ' GLU . 79.3 t80 -53.75 144.25 18.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.633 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -72.3 76.62 1.0 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.172 0.987 . . . . 0.0 111.196 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 120' ' ' TYR . 31.0 tt0 -148.35 -47.47 0.16 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.756 174.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.3 mt -66.95 128.28 35.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.501 176.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.48 174.98 35.52 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.007 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.31 -36.51 71.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.339 0.59 . . . . 0.0 109.874 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -68.8 -43.44 75.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.132 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 m -59.59 -46.2 89.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.125 0.488 . . . . 0.0 110.454 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.511 HG13 ' HE1' ' A' ' 143' ' ' MET . 41.8 mm -62.22 -47.65 92.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.617 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -60.26 -41.1 92.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.863 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -63.14 -34.4 77.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.492 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.79 -34.48 22.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.442 ' HD1' ' O ' ' A' ' 128' ' ' ILE . 69.8 m-85 -91.47 -18.41 24.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.464 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -55.41 -42.02 93.81 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 42.5 Cg_exo -40.39 -43.03 3.96 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 123.017 2.478 . . . . 0.0 113.925 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.67 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 50.1 m-85 -74.91 -51.78 12.94 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.645 0.26 . . . . 0.0 111.142 -175.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.37 170.54 36.41 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.023 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.3 118.71 5.74 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.87 2.38 . . . . 0.0 110.896 175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.446 HG21 ' CG1' ' A' ' 141' ' ' ILE . 53.3 mt -82.78 120.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.374 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -88.88 -33.6 17.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.341 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.3 t -153.58 136.79 15.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.968 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.446 ' CG1' HG21 ' A' ' 138' ' ' ILE . 71.7 mt -120.49 107.46 20.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 169.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.719 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -84.75 98.66 10.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.355 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.511 ' HE1' HG13 ' A' ' 128' ' ' ILE . 57.0 ttm -149.45 134.34 17.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.784 0.325 . . . . 0.0 110.377 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.633 177.912 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.436 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 47.9 p90 . . . . . 0 C--O 1.237 0.401 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.465 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -146.2 156.15 43.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.719 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 93.8 m-85 -113.75 109.55 18.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.775 175.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.636 ' HB ' HG12 ' A' ' 114' ' ' VAL . 59.8 t -97.31 106.34 18.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.496 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 72.8 tt0 -108.46 122.84 47.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.539 -177.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -96.37 178.89 5.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -82.43 -17.87 43.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.555 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 m -133.38 143.66 49.05 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.673 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 57.9 Cg_endo -71.95 -22.85 22.65 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.199 2.599 . . . . 0.0 112.785 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.593 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 16.3 mp0 -55.16 -58.72 6.52 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.684 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.67 -22.47 23.27 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.75 -48.13 12.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.968 0.413 . . . . 0.0 110.316 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -73.34 -26.66 61.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.302 0.572 . . . . 0.0 109.699 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.67 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 16.3 tp -70.47 -47.27 61.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.233 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.0 -34.72 78.15 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 18.6 tp -65.24 -46.08 82.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.714 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.37 -47.71 72.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.673 -174.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -90.45 -43.84 10.01 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.4 mtm -94.46 30.3 2.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -170.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 170' ' ' LEU . 3.5 t-20 -75.98 12.97 0.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.168 0.508 . . . . 0.0 110.806 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 22.2 m -113.72 -73.38 0.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.523 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.9 m -142.28 162.04 19.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 111.373 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.672 ' HB2' HD13 ' A' ' 183' ' ' ILE . 17.2 tpp -128.53 84.39 2.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.494 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.457 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 89.0 mt 70.16 -56.25 0.59 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.305 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -73.59 168.87 53.79 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.461 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.63 53.75 4.07 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.722 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 118' ' ' SER . 43.3 ttm180 -143.77 137.64 28.21 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 175' ' ' SER . 0.9 OUTLIER -72.09 112.07 7.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.192 0.52 . . . . 0.0 110.382 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.863 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 45.3 pt -81.38 158.41 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.139 -176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.717 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 24.8 ttmm -103.4 116.4 32.34 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.051 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.3 t -122.7 148.84 26.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.694 ' H ' HG22 ' A' ' 114' ' ' VAL . . . . . . . . 0 N--CA 1.446 -0.68 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.005 175.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 . . . . . 0 N--CA 1.46 0.064 0 CA-C-O 120.857 0.36 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -84.84 -19.6 32.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 25.3 tp60 -57.36 -47.47 98.96 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -176.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 73.1 Cg_exo -52.5 -38.88 75.46 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.08 1.853 . . . . 0.0 112.678 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.0 mt -75.67 -43.9 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.438 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 194' ' ' ALA . 79.9 mt -58.23 -46.88 88.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.784 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.04 -39.74 93.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.705 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -59.54 -52.81 63.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.98 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.544 HD13 HD21 ' A' ' 108' ' ' LEU . 42.0 mt -68.14 -32.91 73.51 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.191 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.604 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.59 -48.24 72.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -65.53 -33.7 76.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.855 175.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 30.7 mt-10 -66.11 -33.71 76.39 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.17 0.51 . . . . 0.0 111.155 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -72.75 -24.85 61.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.656 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 68.6 mtp180 -79.87 -28.12 39.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.372 174.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.8 -38.41 76.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.151 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -88.72 173.6 8.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.481 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 14.1 m120 -116.58 34.71 4.91 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.797 -174.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 17.0 ttp180 -98.73 138.13 36.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.373 0.606 . . . . 0.0 111.507 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.47 ' HA ' ' H ' ' A' ' 285' ' ' ALA . 47.7 pt -124.0 167.11 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.954 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 83.5 t80 -117.06 128.04 54.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.53 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.471 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 34.6 m -117.7 132.56 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.251 0.548 . . . . 0.0 110.112 177.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -126.95 169.68 13.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.894 -174.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.3 t 62.37 32.29 16.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.87 0.843 . . . . 0.0 109.312 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.45 108.28 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.091 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -54.98 133.38 48.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.911 0.386 . . . . 0.0 110.725 -174.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -55.8 -24.22 34.76 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.24 -21.1 29.23 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.23 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.62 124.39 22.23 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.3 t -81.38 164.12 22.35 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.199 0.523 . . . . 0.0 111.329 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -53.47 -38.88 64.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.126 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.55 -35.56 77.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.661 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.33 -44.59 94.47 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.671 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.742 HG22 HD11 ' A' ' 255' ' ' ILE . 38.0 mm -67.04 -41.17 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.021 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.664 ' HD2' ' SG ' ' A' ' 238' ' ' CYS . 87.4 tttt -59.8 -45.07 93.48 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.633 174.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.1 m -54.96 -44.96 74.85 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.0 t -76.32 -38.22 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.719 0.295 . . . . 0.0 111.485 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.563 ' HB3' ' OH ' ' A' ' 257' ' ' TYR . 15.7 m-85 -72.51 -33.43 66.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 110.996 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -61.17 -24.61 66.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.027 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.56 -12.78 61.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.245 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -111.43 -45.51 3.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.896 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -134.02 177.12 19.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.044 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 234' ' ' LYS . 39.4 tptt -91.74 106.44 18.48 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.11 0.481 . . . . 0.0 110.424 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 229' ' ' PHE . 22.5 mt -75.94 142.71 14.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.843 0.83 . . . . 0.0 112.325 -175.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.468 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 54.4 tttt -101.69 -37.3 8.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.42 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 20.4 m -156.04 142.0 18.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.318 -172.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.664 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 26.6 p -130.05 121.58 26.72 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 168.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 29.0 m -142.05 102.31 4.1 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.943 0.401 . . . . 0.0 110.536 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.516 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 70.3 mt -76.4 131.0 38.85 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.484 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.21 115.32 5.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 14.7 ptt-85 -139.78 168.83 18.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -171.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 16.6 m-20 -112.71 123.64 33.46 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.972 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 11.9 Cg_endo -58.51 -22.92 61.89 Favored 'Trans proline' 0 CA--C 1.526 0.117 0 C-N-CA 123.077 2.518 . . . . 0.0 111.999 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 p -91.32 -4.81 55.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.662 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 47.8 p -114.22 -34.48 5.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.493 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.7 6.33 80.25 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.267 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -138.31 160.0 40.6 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 6.5 p80 -87.19 151.22 23.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.563 . . . . 0.0 110.448 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.01 -25.34 68.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.384 -170.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 135.99 -12.12 4.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.874 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.417 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 44.3 p90 -130.87 174.52 9.89 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -165.86 175.53 41.45 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.329 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.593 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 96.6 m-85 -129.52 142.37 50.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.971 0.415 . . . . 0.0 110.448 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.742 HD11 HG22 ' A' ' 225' ' ' ILE . 90.4 mt -136.07 142.66 38.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.132 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 41.7 mt-10 -120.76 148.76 43.54 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.643 ' HB2' ' OG ' ' A' ' 263' ' ' SER . 25.5 m-85 -118.97 153.5 34.55 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 123.396 0.435 . . . . 0.0 109.888 175.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 25.0 mt-10 -75.95 -9.05 58.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.49 0.662 . . . . 0.0 110.036 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -130.66 122.56 27.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.392 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -59.36 -32.24 69.94 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.872 -171.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -67.86 -39.17 83.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.027 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.7 m -67.54 -33.34 74.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.747 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.643 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 3.3 m -58.38 -50.66 72.88 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.573 0.701 . . . . 0.0 109.701 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . 0.419 ' HG2' ' HD3' ' A' ' 284' ' ' LYS . 24.6 mt-30 -76.75 -14.66 59.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.146 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.84 -45.96 63.57 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.74 78.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.875 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.508 HG13 ' HA2' ' A' ' 283' ' ' GLY . 88.6 t -56.12 -31.62 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.195 0.521 . . . . 0.0 111.073 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.5 t -87.37 -39.18 15.53 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.079 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.6 m -80.99 -41.49 22.66 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.543 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 77.4 mmm -83.16 -0.23 48.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 111.059 -172.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.528 ' HA ' HG12 ' A' ' 282' ' ' VAL . 26.7 t-20 -71.37 111.18 6.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.308 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.9 mt 70.36 34.66 2.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.37 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -88.23 129.76 35.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.761 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.32 113.43 13.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.387 0.613 . . . . 0.0 111.242 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 33.9 tp -142.05 121.24 13.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.09 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 68.72 28.76 72.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.198 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 86.34 -13.5 57.53 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.97 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -114.81 150.75 34.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.634 -0.333 . . . . 0.0 110.257 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -89.28 116.68 27.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.802 0.334 . . . . 0.0 110.139 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.39 126.09 26.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.109 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 5.5 mmt180 -99.69 114.75 28.05 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 271' ' ' ASN . 8.4 p -121.62 150.85 24.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.528 -170.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.508 ' HA2' HG13 ' A' ' 267' ' ' VAL . . . -169.88 174.59 44.08 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.419 ' HD3' ' HG2' ' A' ' 264' ' ' GLN . 4.2 mmmp? -73.21 125.69 28.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.153 0.477 . . . . 0.0 110.287 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -58.4 130.95 49.15 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.9 m -85.08 -17.56 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.926 0.393 . . . . 0.0 110.769 -173.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 66.4 p -109.73 142.88 26.72 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.101 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.531 0.348 0 C-N-CA 122.682 2.255 . . . . 0.0 111.343 172.625 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.698 ' HG3' HD12 ' A' ' 108' ' ' LEU . 35.2 tt0 . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 121.171 0.51 . . . . 0.0 111.677 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -65.97 -34.18 77.52 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.93 -24.78 58.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.698 HD12 ' HG3' ' A' ' 105' ' ' GLN . 39.4 mt -67.64 -33.9 75.88 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.957 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.29 -24.06 40.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.095 0.474 . . . . 0.0 111.006 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.3 -52.49 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.731 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.9 -22.47 65.96 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -175.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 72.3 m -74.06 -10.5 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.206 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 78.0 mtt180 -102.71 139.96 37.61 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.174 175.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.28 119.89 60.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 170.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 84.8 t80 -80.65 129.54 34.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.758 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.527 HG12 HG12 ' A' ' 185' ' ' VAL . 9.6 m -108.65 115.97 50.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.316 0.579 . . . . 0.0 110.198 175.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.11 135.31 12.07 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.819 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.9 t 60.35 79.28 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.327 0.651 . . . . 0.0 111.442 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.49 HD11 ' CG2' ' A' ' 116' ' ' VAL . 59.5 mt -93.82 127.12 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.434 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 181' ' ' ARG . 29.0 t80 -60.16 127.71 33.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -65.37 77.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.149 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -169.66 -37.93 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.061 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.2 mt -74.73 114.36 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.089 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -74.68 165.32 54.75 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.481 176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -60.98 -40.65 94.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -60.6 -38.72 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.99 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.0 m -66.24 -42.92 87.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.563 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 mm -65.86 -40.91 88.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.496 0.665 . . . . 0.0 109.9 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -55.88 -44.17 77.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.829 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -72.21 -33.59 67.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.948 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.14 -37.35 46.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -91.16 -15.48 29.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.412 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -53.24 -45.63 98.26 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 34.3 Cg_exo -40.83 -40.79 3.72 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 123.247 2.631 . . . . 0.0 114.986 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.645 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 68.4 m-85 -72.66 -46.74 52.37 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -170.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.2 -164.93 20.53 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.561 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 161' ' ' GLU . 87.0 Cg_endo -79.83 107.73 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.071 2.514 . . . . 0.0 111.854 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.592 HD13 HD11 ' A' ' 141' ' ' ILE . 56.9 mt -66.71 113.74 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.316 0.579 . . . . 0.0 110.577 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 60.0 tttm -93.31 -40.58 10.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.047 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.2 t -155.54 128.62 8.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.466 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 138' ' ' ILE . 67.0 mt -111.06 108.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 171.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -100.43 98.65 9.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.805 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 52.7 ttm -131.34 127.51 37.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.948 0.404 . . . . 0.0 110.446 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.6 p . . . . . 0 C--N 1.32 -0.711 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.892 178.927 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 39.6 p90 . . . . . 0 C--O 1.234 0.285 0 CA-C-O 120.61 0.243 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 116' ' ' VAL . . . -161.41 153.7 19.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.489 176.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -123.66 123.03 39.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.236 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.6 t -104.65 105.97 19.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.526 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 35.5 tt0 -97.21 131.71 43.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.001 -176.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -109.52 162.35 14.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.489 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 137' ' ' PRO . 44.4 mt-10 -79.13 -9.15 59.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 0.0 110.668 174.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.69 133.58 19.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.878 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 43.1 Cg_endo -66.79 -20.41 52.21 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.135 2.556 . . . . 0.0 112.358 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.657 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 17.6 mp0 -55.74 -52.86 62.47 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.956 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -63.55 -20.61 65.77 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.18 -48.58 12.92 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.617 ' HG3' HG11 ' A' ' 286' ' ' VAL . 15.6 mm100 -66.77 -34.11 77.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.044 174.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.645 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 13.0 tp -68.87 -46.61 68.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.672 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.442 ' HA ' ' CE1' ' A' ' 135' ' ' PHE . . . -60.46 -31.21 70.23 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.652 HD12 ' HA3' ' A' ' 186' ' ' GLY . 5.3 tt -67.43 -55.9 11.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.014 172.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 167' ' ' GLN . 23.1 mt-10 -53.94 -30.14 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.058 -175.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -98.07 -51.22 4.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.9 mtm -106.62 29.33 7.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -167.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.561 ' HA ' HG22 ' A' ' 185' ' ' VAL . 65.1 t30 -86.09 26.08 1.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.632 0.729 . . . . 0.0 110.308 177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.2 t -114.23 -70.29 0.81 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.97 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 m -140.1 155.46 24.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.617 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.579 ' HE2' ' HG ' ' A' ' 178' ' ' LEU . 0.9 OUTLIER -126.81 100.99 6.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.414 175.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.579 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 94.9 mt 66.2 26.91 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.679 172.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 123.84 -112.26 1.81 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.954 -1.117 . . . . 0.0 114.594 171.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.81 38.51 3.04 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 114.451 0.541 . . . . 0.0 114.451 -165.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 120' ' ' TYR . 8.5 tpp180 -145.53 120.09 9.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 117.209 0.505 . . . . 0.0 111.09 173.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -87.49 83.18 7.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.432 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.6 pt -70.22 147.69 11.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.086 0.47 . . . . 0.0 110.938 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -103.55 107.02 17.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.36 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 174' ' ' ASN . 2.5 m -99.69 137.41 27.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.359 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.652 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.446 -0.679 0 C-N-CA 120.655 -0.784 . . . . 0.0 111.447 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 121.006 0.431 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.69 -19.17 26.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.433 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.509 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 84.0 mm-40 -56.94 -48.87 96.68 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 54.5 Cg_exo -53.93 -39.29 85.36 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.152 1.902 . . . . 0.0 112.539 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.476 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 41.7 mm -67.61 -46.89 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 110.084 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 87.1 mt -57.9 -48.45 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.531 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 29.7 t70 -67.53 -40.99 85.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.164 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -62.7 -44.99 94.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.115 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 76.0 mt -67.58 -32.84 73.87 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.55 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.494 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -58.21 -38.31 76.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.188 0.518 . . . . 0.0 109.72 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 40.1 mt-10 -73.73 -31.53 63.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.945 175.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 57.7 mt-10 -67.26 -24.16 65.77 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.184 0.516 . . . . 0.0 110.984 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.403 ' HA ' HH11 ' A' ' 210' ' ' ARG . . . -74.85 -33.39 62.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.137 174.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 18.0 mtm180 -73.35 -13.78 61.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.786 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.32 -22.2 60.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.329 0.585 . . . . 0.0 110.171 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.99 166.99 18.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.305 -0.862 . . . . 0.0 108.997 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 65.2 m-20 -95.26 48.67 1.17 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.638 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 7.8 ptp180 -91.44 149.5 21.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.398 0.618 . . . . 0.0 111.206 -173.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.406 HG23 ' HB2' ' A' ' 263' ' ' SER . 44.1 pt -134.55 166.91 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.254 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -113.14 122.19 46.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.606 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.48 HG12 HG23 ' A' ' 282' ' ' VAL . 34.3 m -117.59 131.92 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.004 0.431 . . . . 0.0 110.227 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -126.13 172.12 10.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.159 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.7 m 62.68 27.56 16.19 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.922 0.868 . . . . 0.0 109.863 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.61 112.27 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.83 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -58.58 138.86 56.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.253 -171.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -52.67 -30.95 34.64 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -88.6 -22.81 23.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.497 0.189 . . . . 0.0 111.489 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.29 120.72 12.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.548 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.6 m -82.04 166.6 19.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.274 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -53.91 -45.4 71.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.511 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.98 -32.38 73.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.652 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 228' ' ' VAL . 8.3 t70 -68.7 -45.81 70.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.676 HG22 HD11 ' A' ' 255' ' ' ILE . 39.8 mm -66.29 -36.78 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.58 -52.72 63.96 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.28 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 89.7 p -55.74 -34.4 65.15 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 224' ' ' ASP . 24.5 t -73.55 -47.66 44.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.314 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.732 ' HB2' HD11 ' A' ' 235' ' ' ILE . 16.2 m-85 -68.39 -31.64 71.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.411 0.624 . . . . 0.0 110.526 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 29.5 tp10 -60.08 -24.35 64.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.367 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.91 -8.33 58.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.644 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -112.79 -45.21 3.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.562 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -140.82 171.71 23.96 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 64.8 mmtt -90.03 111.7 22.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.894 0.854 . . . . 0.0 111.697 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 229' ' ' PHE . 52.9 mt -87.16 151.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.682 -174.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -103.52 -40.33 6.38 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.786 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 50.8 m -156.88 151.01 24.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.411 -170.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.1 t -143.76 104.66 4.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.764 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.5 m -121.09 103.13 8.79 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.353 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.606 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 69.0 mt -80.46 144.52 32.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.818 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -66.55 105.05 1.4 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.526 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 41.0 ttt180 -129.16 142.09 50.97 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.065 -170.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 246' ' ' THR . 30.1 m-20 -93.61 115.16 64.7 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.032 176.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.42 -37.13 98.35 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.529 2.82 . . . . 0.0 113.769 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 82.8 p -92.75 10.22 31.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 243' ' ' ASP . 11.6 t -123.06 -9.78 8.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.045 -0.41 . . . . 0.0 111.196 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.09 -49.77 4.29 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.426 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 20.1 ptmt -77.32 172.97 12.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.174 0.511 . . . . 0.0 110.685 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 20.2 p80 -116.1 167.67 10.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.508 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -65.26 -80.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 O-C-N 123.485 0.49 . . . . 0.0 111.69 -173.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -175.99 17.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.232 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.432 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 31.3 p90 -157.03 176.71 12.39 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.0 178.06 45.17 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.041 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.657 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 89.4 m-85 -125.67 143.85 50.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.917 0.389 . . . . 0.0 110.19 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.676 HD11 HG22 ' A' ' 225' ' ' ILE . 87.0 mt -134.68 128.44 50.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.462 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.638 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 47.8 mt-10 -109.98 131.95 54.59 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.628 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 6.8 m-85 -97.07 176.97 5.75 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 123.155 0.285 . . . . 0.0 110.294 176.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.12 -22.85 35.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -121.15 121.94 38.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.361 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.67 -22.56 67.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.075 0.464 . . . . 0.0 110.939 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -72.0 -49.33 37.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.719 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 265' ' ' ASP . 44.9 m -66.67 -32.43 73.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.012 -176.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.628 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 59.8 p -66.56 -42.54 86.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 110.057 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -74.51 -21.62 59.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.522 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 262' ' ' SER . 0.5 OUTLIER -70.98 -37.19 72.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -63.78 -39.98 95.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 172.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.11 -33.67 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 121.33 0.586 . . . . 0.0 110.628 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.5 m -73.71 -39.61 64.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.133 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.5 m -89.37 -39.17 13.61 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.562 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 85.9 mmm -81.66 -1.56 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -171.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.545 ' HA ' HG12 ' A' ' 282' ' ' VAL . 22.9 t-20 -71.5 117.51 13.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 97.7 mt 70.01 32.75 2.95 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.44 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -91.23 121.19 32.78 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.454 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 12.4 t70 -74.38 118.55 17.47 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.333 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.7 tp -131.94 91.83 3.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.901 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 92.4 26.81 16.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 92.7 2.36 67.32 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.632 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -131.8 140.81 49.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.454 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 72.4 m-85 -85.37 112.61 20.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.6 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 71.7 mt -58.03 121.27 10.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 8.2 mmm180 -93.53 114.75 27.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 174.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 271' ' ' ASN . 11.4 p -119.87 143.85 30.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.745 -173.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -158.56 -171.84 24.93 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.505 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.62 128.92 36.76 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.773 0.32 . . . . 0.0 110.344 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -66.52 128.17 35.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 167' ' ' GLN . 29.4 m -97.32 -25.02 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -171.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 35.5 p -131.39 168.13 18.76 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 120.844 0.354 . . . . 0.0 111.569 -178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.458 -0.56 0 C-N-CA 123.191 2.594 . . . . 0.0 110.989 169.31 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 . . . . . 0 C--O 1.233 0.219 0 CA-C-O 121.211 0.529 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -62.03 -33.81 75.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.7 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.55 80.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 0.0 110.884 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.51 HD21 HD13 ' A' ' 201' ' ' LEU . 61.7 mt -68.91 -31.28 70.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.598 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.68 -28.41 69.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.256 0.551 . . . . 0.0 110.384 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.84 -36.47 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.858 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.519 ' SD ' HG12 ' A' ' 198' ' ' ILE . 87.9 mtp -73.31 -21.81 60.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.2 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.818 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 30.4 p -79.72 -3.71 48.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -110.7 141.09 44.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.678 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.596 HG12 ' HB ' ' A' ' 158' ' ' VAL . 6.0 p -121.56 131.93 71.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.177 0.513 . . . . 0.0 110.051 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -79.11 121.03 24.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.07 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 25.7 m -118.18 129.26 74.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.5 0.667 . . . . 0.0 111.383 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.46 176.26 21.51 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.62 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 22.7 m 60.29 39.11 19.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.236 0.541 . . . . 0.0 110.576 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 57.5 mt -81.02 -15.74 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.373 -176.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 44.7 t80 71.21 153.62 0.13 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.204 -176.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -83.54 76.24 9.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.453 0.644 . . . . 0.0 111.052 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -163.43 -50.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.021 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.82 104.55 1.71 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.081 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.87 172.77 55.33 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.935 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.47 ' OE2' ' HB ' ' A' ' 141' ' ' ILE . 61.2 tt0 -64.17 -32.31 73.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.849 0.324 . . . . 0.0 110.67 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -54.85 -48.87 72.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.355 0.598 . . . . 0.0 109.958 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.2 m -70.69 -41.67 71.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.961 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.0 mm -61.41 -46.34 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.479 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -63.71 -37.31 86.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.034 0.445 . . . . 0.0 110.196 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -65.63 -32.38 73.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.969 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.558 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -79.44 -35.82 39.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.548 ' HB2' HD11 ' A' ' 138' ' ' ILE . 71.3 m-85 -90.66 -13.86 33.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 0.0 111.531 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.17 -43.18 89.71 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -43.83 -41.51 11.84 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.95 2.433 . . . . 0.0 114.564 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.451 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 51.4 m-85 -77.08 -50.94 11.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.536 0.208 . . . . 0.0 111.386 -174.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -158.36 171.0 35.14 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.884 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.64 117.63 5.01 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 111.218 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 132' ' ' PHE . 58.5 mt -78.82 116.31 22.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.105 0.479 . . . . 0.0 110.535 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.507 ' HE3' ' OE1' ' A' ' 159' ' ' GLU . 34.9 ttpt -88.42 -27.42 21.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.542 -177.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.2 t -163.83 145.48 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.753 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.495 HD11 HD13 ' A' ' 138' ' ' ILE . 61.7 mt -133.02 121.43 43.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.85 100.66 10.46 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.799 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 46.8 ttm -128.48 131.95 48.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--N 1.324 -0.53 0 CA-C-O 120.962 0.411 . . . . 0.0 109.942 175.95 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.1 p90 . . . . . 0 C--O 1.237 0.407 0 CA-C-O 120.821 0.344 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.97 167.14 31.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.305 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -125.46 121.38 33.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.664 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.596 ' HB ' HG12 ' A' ' 114' ' ' VAL . 90.2 t -100.15 116.65 43.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.102 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.507 ' OE1' ' HE3' ' A' ' 139' ' ' LYS . 41.5 tt0 -107.48 126.97 53.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.615 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.98 175.48 5.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.858 0.361 . . . . 0.0 110.964 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.462 ' OE1' ' HD3' ' A' ' 139' ' ' LYS . 5.5 mm-40 -71.98 -37.26 69.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.199 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.04 143.39 45.38 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.466 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.818 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 38.1 Cg_endo -66.26 -14.57 44.84 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.416 2.744 . . . . 0.0 112.219 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.924 ' HG3' ' HE2' ' A' ' 254' ' ' PHE . 15.4 mm-40 -62.33 -53.19 58.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.335 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.551 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.97 -18.98 60.37 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.66 -54.11 6.76 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.622 ' HG3' HG11 ' A' ' 286' ' ' VAL . 19.1 mm-40 -64.05 -36.29 83.51 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.967 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.551 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 12.9 tp -61.05 -48.41 81.88 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.643 177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.6 -31.91 69.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.837 0.351 . . . . 0.0 110.079 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 185' ' ' VAL . 16.3 tp -72.58 -46.76 52.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 172.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 14.3 mm-40 -52.47 -41.84 63.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.321 0.648 . . . . 0.0 111.701 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -100.72 -51.35 3.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.0 ttp -95.65 30.16 2.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -164.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.477 ' HB3' HD12 ' A' ' 170' ' ' LEU . 10.0 p30 -79.36 21.08 0.5 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.16 -0.337 . . . . 0.0 111.151 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 4.5 m -100.79 -74.11 0.62 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.071 0.462 . . . . 0.0 110.822 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.3 m -144.02 170.33 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.025 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.999 ' HB2' HD13 ' A' ' 183' ' ' ILE . 2.4 tpt -118.64 94.08 4.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.254 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.965 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 73.7 mt 56.13 45.36 23.58 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.788 0.68 . . . . 0.0 110.221 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.18 -135.39 12.96 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -172.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 66.98 -112.09 4.61 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.687 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -144.01 177.86 8.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.391 0.138 . . . . 0.0 110.796 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 175' ' ' SER . 49.2 t-20 -63.9 112.62 3.0 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.2 pt -97.54 168.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.292 0.568 . . . . 0.0 111.58 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 93.4 mttt -103.12 115.21 30.15 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.195 175.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.64 ' O ' HD13 ' A' ' 170' ' ' LEU . 18.3 t -113.01 102.85 14.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 171.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.883 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -175.506 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 121.155 0.502 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -90.24 -5.41 56.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.452 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.557 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 15.6 mm100 -54.01 -47.11 98.12 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.1 Cg_endo -52.76 -40.74 73.43 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.987 1.791 . . . . 0.0 112.354 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 70.7 mt -73.27 -45.69 52.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.534 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 194' ' ' ALA . 57.7 mt -58.26 -47.17 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.805 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.82 -39.78 91.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.915 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -67.11 -46.34 74.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.626 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 69.0 mt -66.95 -32.84 74.36 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.02 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.64 -46.03 70.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 18.2 mt-10 -68.5 -31.75 71.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.883 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 47.1 mt-10 -67.49 -30.27 69.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.4 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -76.98 -39.22 51.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.968 0.414 . . . . 0.0 110.046 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.566 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 58.5 mtp180 -57.76 -30.11 65.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.891 176.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.22 -19.9 62.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.994 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -110.94 0.12 16.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.799 0.333 . . . . 0.0 111.404 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 56.66 38.12 29.32 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.583 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -87.9 138.38 31.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.937 -173.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.526 ' HA ' ' H ' ' A' ' 285' ' ' ALA . 48.7 pt -129.99 166.19 28.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.088 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.504 ' HD1' ' CE2' ' A' ' 254' ' ' PHE . 84.4 t80 -120.97 129.58 53.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.339 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.626 HG12 HG23 ' A' ' 282' ' ' VAL . 31.5 m -121.23 133.35 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.231 0.538 . . . . 0.0 110.33 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.97 175.09 9.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.193 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 61.1 m 60.71 35.14 19.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.213 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.03 124.24 36.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.293 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 25.9 t-80 -54.31 134.31 45.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.575 0.702 . . . . 0.0 111.245 -175.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.425 ' HG2' ' H ' ' A' ' 218' ' ' GLN . 2.2 pt20 -49.12 -35.48 16.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.268 -1.333 . . . . 0.0 114.181 -174.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -105.63 24.55 12.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.835 0.826 . . . . 0.0 110.789 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 217' ' ' HIS . 15.6 tp -105.3 133.46 50.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 21.0 t -98.76 167.17 10.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.044 0.45 . . . . 0.0 111.18 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -66.23 -22.56 66.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.02 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.54 -39.2 93.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.156 177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 228' ' ' VAL . 33.6 m-20 -71.04 -47.2 59.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.837 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.694 HG13 HD21 ' A' ' 240' ' ' LEU . 8.3 mm -63.16 -47.2 93.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 47.8 tttm -56.77 -45.51 82.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.226 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 77.6 p -60.87 -37.59 82.67 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -174.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 224' ' ' ASP . 4.8 t -76.35 -45.45 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.676 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.6 ' CB ' HD11 ' A' ' 235' ' ' ILE . 38.0 m-85 -62.74 -34.9 78.16 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.1 mm-40 -62.0 -24.37 67.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.731 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.05 -10.25 59.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.275 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.96 -43.65 4.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.083 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -145.73 -175.94 19.22 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.331 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -87.01 111.47 20.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.895 0.379 . . . . 0.0 110.346 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.6 HD11 ' CB ' ' A' ' 229' ' ' PHE . 14.3 mt -81.25 146.52 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.861 0.839 . . . . 0.0 111.962 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -109.58 -32.83 6.98 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.799 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 55.4 m -157.52 146.24 19.54 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -173.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 226' ' ' LYS . 43.2 t -153.9 99.53 2.28 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.488 0.493 . . . . 0.0 109.766 174.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.9 m -130.0 115.95 17.87 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.646 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.694 HD21 HG13 ' A' ' 225' ' ' ILE . 57.6 mt -84.59 135.82 34.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.63 112.95 1.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.668 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 27.0 ttp180 -133.57 141.78 47.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -83.93 112.42 40.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.712 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.97 -36.79 81.19 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.211 2.607 . . . . 0.0 113.305 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.9 t -93.99 13.39 23.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.768 0.318 . . . . 0.0 111.663 -172.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 80.3 p -125.2 -39.89 2.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.802 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 98.01 9.83 53.27 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.232 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -118.37 146.8 44.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 4.1 p80 -95.07 143.63 26.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -64.21 -65.36 0.69 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -168.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 177.99 -3.4 0.03 OUTLIER Glycine 0 CA--C 1.519 0.304 0 C-N-CA 119.871 -1.156 . . . . 0.0 113.751 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -140.26 172.37 12.84 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.342 -0.505 . . . . 0.0 110.472 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.598 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -160.22 174.98 37.04 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.924 ' HE2' ' HG3' ' A' ' 164' ' ' GLU . 85.1 m-85 -129.19 143.25 50.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.664 0.268 . . . . 0.0 110.874 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.515 HD11 HG22 ' A' ' 225' ' ' ILE . 92.3 mt -137.56 140.73 41.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.222 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 237' ' ' SER . 43.3 mt-10 -122.88 148.18 45.73 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.645 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 20.9 m-85 -116.98 158.05 24.76 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.007 0.432 . . . . 0.0 110.487 176.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.11 -3.91 58.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.757 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -135.67 134.03 38.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.095 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.74 -32.82 74.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.581 -171.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -70.48 -39.13 74.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.931 0.395 . . . . 0.0 110.437 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.8 m -64.97 -37.59 88.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.736 -174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 43.5 p -68.49 -45.13 73.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.167 0.508 . . . . 0.0 110.649 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -72.19 -22.16 61.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.944 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.52 -40.03 62.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 110.549 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.31 -33.4 75.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.474 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 263' ' ' SER . 97.7 t -56.16 -26.91 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.994 0.426 . . . . 0.0 111.137 173.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.2 t -85.72 -46.8 10.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.018 -0.427 . . . . 0.0 110.639 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.4 m -69.83 -38.2 76.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.422 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 89.5 mmm -91.81 -2.61 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.76 0.314 . . . . 0.0 111.543 -173.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 282' ' ' VAL . 39.7 t30 -72.12 124.53 25.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.306 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.2 mt 63.48 25.9 14.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.326 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -83.11 118.04 23.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.774 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.82 121.45 21.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.2 tp -141.62 91.82 2.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.025 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 95.28 25.7 13.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.935 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 89.25 1.22 79.15 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.784 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -126.14 148.53 49.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.642 0.258 . . . . 0.0 110.541 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -89.83 117.67 28.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.404 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.21 120.56 14.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.791 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -93.8 115.75 28.18 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 174.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.626 HG23 HG12 ' A' ' 213' ' ' VAL . 14.2 p -121.08 143.76 32.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.053 0.454 . . . . 0.0 110.851 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -156.61 -179.69 31.78 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.684 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -80.25 133.74 36.02 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.526 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -76.3 146.26 39.01 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.622 HG11 ' HG3' ' A' ' 167' ' ' GLN . 30.8 m -112.66 -3.65 10.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.717 0.294 . . . . 0.0 111.516 -174.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 41.5 p -123.07 139.37 31.42 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.902 0.382 . . . . 0.0 111.015 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.463 -0.285 0 C-N-CA 122.834 2.356 . . . . 0.0 111.196 173.872 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.43 ' HB2' HD12 ' A' ' 108' ' ' LEU . 16.0 mm-40 . . . . . 0 N--CA 1.453 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -64.67 -28.43 69.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.18 -30.09 70.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 111' ' ' MET . 26.0 mt -70.81 -30.84 67.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.23 -25.24 66.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.362 0.601 . . . . 0.0 110.094 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.0 mt -84.08 -40.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.786 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 108' ' ' LEU . 60.2 mmm -61.12 -29.97 70.09 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.543 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 73.5 m -73.87 -13.64 60.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.441 0.162 . . . . 0.0 111.237 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.632 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 29.8 mtp85 -108.96 139.89 43.21 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.25 135.51 63.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.165 0.507 . . . . 0.0 110.349 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -77.91 119.26 21.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.817 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 13.5 m -121.15 116.05 48.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.221 0.534 . . . . 0.0 110.348 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 155' ' ' PHE . . . -117.8 170.17 13.51 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.193 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.437 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 20.9 t 72.09 51.18 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.608 0.718 . . . . 0.0 110.391 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.0 mt -103.06 127.43 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.651 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -72.11 147.15 46.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.876 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -72.37 75.59 1.02 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.855 0.836 . . . . 0.0 111.005 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -154.63 -45.55 0.09 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.845 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.442 HD13 ' HG3' ' A' ' 177' ' ' MET . 22.0 mt -77.29 91.37 3.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.03 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.25 -179.85 44.57 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.979 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -55.51 -46.4 76.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.117 0.484 . . . . 0.0 111.227 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.5 -46.57 89.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.103 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.3 m -67.27 -42.16 84.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.988 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.1 mm -61.41 -45.27 98.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.084 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.531 ' HG3' HD12 ' A' ' 138' ' ' ILE . 59.0 ttt180 -62.4 -37.39 85.6 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.509 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -69.81 -33.4 72.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.068 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.47 -33.33 54.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.642 ' HB2' HD11 ' A' ' 138' ' ' ILE . 52.2 m-85 -90.1 -13.65 35.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.818 0.342 . . . . 0.0 111.068 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.89 -41.28 84.19 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 44.9 Cg_exo -40.97 -40.36 3.71 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.035 2.49 . . . . 0.0 114.26 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.496 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 43.6 m-85 -79.25 -47.93 15.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.685 0.279 . . . . 0.0 111.21 -176.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.31 170.04 41.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.702 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.2 122.69 9.76 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.755 2.303 . . . . 0.0 111.629 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' A' ' 132' ' ' PHE . 75.1 mt -81.84 132.09 32.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.132 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -89.84 -43.6 10.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.307 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 97.4 p -157.7 155.24 29.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.139 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.429 HG22 ' HG2' ' A' ' 143' ' ' MET . 62.7 mt -133.52 127.01 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.65 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 28.9 m-20 -91.85 106.16 18.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.072 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.429 ' HG2' HG22 ' A' ' 141' ' ' ILE . 17.4 mmt -111.5 118.24 35.2 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.734 0.302 . . . . 0.0 111.062 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.795 0.807 . . . . 0.0 110.495 174.752 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.448 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 52.0 p90 . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 111.334 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.37 163.56 39.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.673 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.731 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 96.2 m-85 -123.06 120.33 32.98 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.1 t -104.71 112.19 37.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.644 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.632 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 40.5 tt0 -102.88 131.07 50.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.5 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 81.3 m-85 -104.93 179.48 4.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.625 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -67.31 -38.53 85.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.165 0.507 . . . . 0.0 110.092 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.63 149.78 69.13 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.37 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 56.9 Cg_endo -70.02 -14.01 34.73 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.356 2.704 . . . . 0.0 112.237 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.591 ' HG3' ' CE1' ' A' ' 254' ' ' PHE . 75.5 mm-40 -60.82 -53.03 62.38 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.544 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -63.38 -14.34 49.16 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.973 0.416 . . . . 0.0 111.898 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.5 -54.2 5.37 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.597 ' HG3' HG21 ' A' ' 286' ' ' VAL . 15.9 mm100 -65.57 -34.0 77.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.968 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.496 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 25.6 tp -65.41 -43.58 90.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.238 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.76 -28.26 69.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.037 0.446 . . . . 0.0 110.08 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.66 -50.9 31.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.406 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -54.35 -35.36 62.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.37 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -100.61 -52.3 3.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 34.5 ttp -106.56 31.26 5.36 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -163.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -77.1 17.01 0.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.338 -0.226 . . . . 0.0 111.567 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.1 m -110.04 -73.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.57 0.224 . . . . 0.0 111.483 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.4 m -135.54 159.53 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.535 0.207 . . . . 0.0 110.938 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.998 ' HB2' HD13 ' A' ' 183' ' ' ILE . 3.5 tpt -123.88 96.61 5.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.892 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 24.0 tp 50.61 61.53 3.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.671 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.56 -179.28 18.94 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.306 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.76 57.71 5.04 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.093 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -134.21 119.0 18.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -75.55 136.38 40.56 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.902 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.998 HD13 ' HB2' ' A' ' 177' ' ' MET . 42.0 pt -124.32 158.42 31.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.678 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 22.7 tptm -111.3 106.41 15.36 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.37 110.1 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.938 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.722 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.212 178.326 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.451 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 22.0 tp60 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.12 0.486 . . . . 0.0 110.821 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -75.87 -19.49 58.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.625 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 27.9 mm-40 -58.83 -51.45 81.75 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.288 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 64.2 Cg_exo -53.63 -38.36 84.18 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.208 1.939 . . . . 0.0 112.764 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.82 -39.31 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.511 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 194' ' ' ALA . 72.3 mt -60.32 -45.98 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 175.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.597 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 26.0 t70 -61.54 -41.97 98.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.431 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.26 -51.38 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.256 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 44.8 mt -68.29 -32.77 73.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.85 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.47 -41.78 77.1 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 32.5 mt-10 -67.67 -33.91 75.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.544 174.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -63.68 -37.36 87.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.937 0.399 . . . . 0.0 110.653 175.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.57 -37.33 73.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.505 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' A' ' 203' ' ' GLU . 29.5 mtp180 -59.29 -26.02 64.61 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.357 176.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -76.91 -11.29 59.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -111.37 179.28 4.07 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 62.0 m-20 -126.25 38.76 4.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.977 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 10.3 ptp180 -108.28 158.06 17.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.646 0.736 . . . . 0.0 112.603 -170.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.616 HG23 ' HB2' ' A' ' 263' ' ' SER . 41.3 pt -135.39 166.63 27.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.623 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.424 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 57.1 t80 -112.62 124.03 51.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.377 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 26.8 m -115.01 131.3 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.382 0.61 . . . . 0.0 110.453 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -122.66 172.0 8.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.873 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 24.3 m 63.79 22.23 12.98 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.506 0.67 . . . . 0.0 110.461 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 38.2 t -79.7 109.02 13.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.806 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -56.04 142.8 34.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.285 0.564 . . . . 0.0 111.033 -171.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -59.13 -22.5 60.98 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -168.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -92.51 -13.28 30.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 93.6 mt -81.84 133.81 35.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 19.0 m -96.69 171.71 8.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.604 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.5 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 9.8 p-10 -61.02 -42.17 97.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.581 0.229 . . . . 0.0 111.552 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.25 -27.1 69.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.366 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.58 -48.28 33.97 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.896 0.379 . . . . 0.0 110.086 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.56 HG22 HD11 ' A' ' 255' ' ' ILE . 34.2 mm -61.93 -38.54 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.527 ' HG3' HG21 ' A' ' 235' ' ' ILE . 63.0 tttm -56.26 -52.57 63.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.114 175.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 88.3 p -58.55 -34.43 71.01 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.83 -50.01 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 121.129 -0.229 . . . . 0.0 111.279 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.732 ' HB2' HD11 ' A' ' 235' ' ' ILE . 20.8 m-85 -64.31 -34.18 77.55 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.207 0.527 . . . . 0.0 111.074 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -63.63 -23.6 67.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.429 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.23 -11.57 60.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.76 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -112.04 -37.95 4.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.724 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.498 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -140.29 167.63 25.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.499 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 67.0 mmtt -78.64 99.72 6.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.845 0.355 . . . . 0.0 111.053 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 229' ' ' PHE . 8.3 mt -77.05 146.19 9.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.615 0.721 . . . . 0.0 111.453 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -110.49 -37.19 5.56 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.664 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 25.8 m -154.5 151.36 28.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -172.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 255' ' ' ILE . 52.9 t -153.7 116.14 4.4 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 61.9 m -141.23 111.28 6.67 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.676 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.57 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 34.8 mt -81.8 137.75 35.25 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -62.05 113.51 2.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 70.3 ttt180 -137.74 141.34 40.98 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.68 -167.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 244' ' ' PRO . 28.7 m-20 -105.02 117.64 58.12 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.179 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 18.4 Cg_endo -57.77 -28.41 81.94 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 123.573 2.848 . . . . 0.0 112.952 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.2 t -79.82 -13.27 59.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.072 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 37.0 p -106.01 -36.93 6.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.956 0.408 . . . . 0.0 111.241 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.76 -35.12 4.19 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.822 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 63.5 pttt -87.43 -179.77 6.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 241' ' ' ALA . 6.2 p80 -120.35 163.77 17.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.883 0.373 . . . . 0.0 110.174 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -71.09 -3.93 22.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.389 -167.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 111.71 -11.02 27.81 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.176 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.424 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 51.5 p90 -135.23 173.54 11.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.707 0.289 . . . . 0.0 111.062 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -165.36 175.03 41.22 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.065 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.591 ' CE1' ' HG3' ' A' ' 164' ' ' GLU . 94.0 m-85 -128.88 142.9 50.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.766 0.317 . . . . 0.0 110.767 -178.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.56 HD11 HG22 ' A' ' 225' ' ' ILE . 83.9 mt -136.3 132.21 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.451 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.977 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 18.6 mt-10 -109.24 147.95 31.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.498 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 12.5 m-85 -112.18 150.26 31.09 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 123.164 0.29 . . . . 0.0 110.66 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.22 -55.35 29.31 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -73.65 117.13 15.06 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.536 171.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -52.99 -38.41 62.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.211 -175.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -75.08 -30.63 61.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.64 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.553 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 69.0 m -64.52 -19.76 65.8 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.616 ' HB2' HG23 ' A' ' 211' ' ' ILE . 78.1 p -57.69 -46.08 84.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.206 0.527 . . . . 0.0 109.929 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -76.68 -13.87 60.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.107 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.553 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 2.6 m-20 -64.69 -47.92 76.61 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 173.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.43 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . . . -64.96 -35.75 82.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.214 176.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 263' ' ' SER . 89.0 t -56.82 -31.89 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.273 0.559 . . . . 0.0 110.787 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 20.2 m -80.64 -38.38 29.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.499 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 24.7 t -93.91 -34.02 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.477 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 91.1 mmm -84.74 -4.64 59.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 -174.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.489 ' HA ' HG12 ' A' ' 282' ' ' VAL . 50.8 t30 -68.9 117.03 10.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.864 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 95.4 mt 67.95 40.13 2.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.316 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -96.73 121.78 38.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.683 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.18 111.37 10.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.586 0.708 . . . . 0.0 111.17 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.4 tp -140.69 110.35 6.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.432 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 91.77 25.28 23.19 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.435 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 74.97 10.69 84.02 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.517 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -138.26 144.51 40.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -76.44 116.32 17.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.648 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.95 128.84 38.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.908 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 9.4 mmt85 -98.5 115.31 28.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 271' ' ' ASN . 14.3 p -116.25 144.0 24.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.788 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.63 178.47 32.21 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.608 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -77.09 132.73 39.03 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.35 114.42 7.58 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.597 HG21 ' HG3' ' A' ' 167' ' ' GLN . 28.6 m -87.29 -27.6 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.808 -171.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 22.2 p -136.35 162.74 54.6 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.442 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.444 -1.432 0 C-N-CA 122.489 2.126 . . . . 0.0 112.162 175.317 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 . . . . . 0 C--O 1.231 0.116 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -60.44 -37.46 81.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.509 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.07 -32.18 72.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.258 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.494 HD23 ' SD ' ' A' ' 111' ' ' MET . 25.1 mt -67.75 -32.47 73.1 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.962 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.31 -29.64 70.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.262 0.553 . . . . 0.0 109.907 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.7 mt -82.34 -38.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.28 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.494 ' SD ' HD23 ' A' ' 108' ' ' LEU . 91.4 mtp -67.41 -30.07 69.73 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.727 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.6 m -74.18 -21.63 59.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.852 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 96.6 mtt180 -97.32 139.68 32.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 p -126.15 132.02 70.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.16 0.505 . . . . 0.0 110.319 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.494 ' HD1' ' CE2' ' A' ' 157' ' ' PHE . 91.3 t80 -76.58 117.1 17.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.426 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 41.2 t -115.89 114.96 47.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.811 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.7 169.13 18.68 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.026 -176.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.746 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 12.2 t 68.64 33.98 3.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.359 0.599 . . . . 0.0 110.871 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.9 mt -80.56 -13.19 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.049 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 65.9 t80 72.69 147.18 0.08 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.901 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -77.34 76.22 3.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.38 0.609 . . . . 0.0 111.372 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.87 -65.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.23 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.8 mt -54.86 108.38 0.39 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.577 0.548 . . . . 0.0 111.503 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.21 -173.0 40.97 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.892 -174.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.14 -46.72 88.7 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.295 -0.452 . . . . 0.0 111.781 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 1.1 m-20 -60.41 -45.0 95.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.627 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.6 m -59.73 -43.7 94.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.874 0.368 . . . . 0.0 110.836 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.8 mm -63.98 -45.65 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.408 0.623 . . . . 0.0 110.226 177.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -56.58 -45.78 81.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.269 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 58.9 mt-30 -63.82 -34.12 77.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.526 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.56 -29.4 30.35 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -93.15 -20.18 20.74 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.457 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -50.2 -42.3 71.57 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 73.6 Cg_exo -42.3 -42.79 7.75 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 123.168 2.579 . . . . 0.0 114.786 174.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -78.38 -36.64 45.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -169.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 165' ' ' ALA . . . -177.87 -172.67 42.59 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.132 175.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.547 ' HG3' ' CE1' ' A' ' 252' ' ' TYR . 73.0 Cg_endo -76.28 129.15 10.99 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.955 2.436 . . . . 0.0 112.123 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.2 mt -90.11 128.6 41.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.29 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.571 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 24.5 ttmm -91.98 -37.23 12.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.711 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.3 p -169.71 157.04 6.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.381 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.6 mt -126.64 108.3 18.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.46 99.53 11.72 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.766 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 57.4 ttm -119.7 127.47 52.9 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.089 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 m . . . . . 0 C--O 1.233 0.197 0 O-C-N 123.573 0.546 . . . . 0.0 110.426 178.445 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 36.3 p90 . . . . . 0 C--O 1.236 0.369 0 CA-C-O 121.416 0.627 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.72 156.25 31.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.269 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.494 ' CE2' ' HD1' ' A' ' 115' ' ' TYR . 76.8 m-85 -113.04 126.18 55.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.12 114.01 41.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 38.6 tt0 -101.47 122.27 43.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.577 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -97.56 172.61 7.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.024 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.571 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 23.6 mt-10 -93.5 -7.43 44.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.963 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.1 m -140.22 135.43 16.18 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.809 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.26 -25.75 36.34 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.195 2.597 . . . . 0.0 113.036 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.478 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 18.4 mp0 -55.81 -45.06 78.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.546 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . . . -55.62 -40.28 71.9 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.937 0.398 . . . . 0.0 111.352 175.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.5 -35.02 78.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.904 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.68 ' HG3' HG11 ' A' ' 286' ' ' VAL . 16.6 mm-40 -68.38 -48.13 65.54 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.671 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.589 HD11 ' HD2' ' A' ' 212' ' ' TYR . 64.0 mt -60.38 -43.68 96.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.177 0.513 . . . . 0.0 111.113 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.61 -37.24 80.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.563 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 8.2 tt -72.41 -48.51 40.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.092 174.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -53.36 -43.24 67.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.264 -177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -100.23 -49.22 4.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 176' ' ' VAL . 16.1 ttp -107.91 29.97 6.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.685 -166.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.599 ' HB2' ' O ' ' A' ' 170' ' ' LEU . 27.4 t-20 -54.63 -51.13 66.36 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -174.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 19.2 m -113.61 16.48 18.67 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -169.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' A' ' 173' ' ' MET . 10.7 m -140.02 135.89 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.832 0.287 . . . . 0.0 110.98 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.999 ' HB2' HD13 ' A' ' 183' ' ' ILE . 27.7 tpp -126.68 102.09 6.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.911 0.386 . . . . 0.0 110.932 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 21.0 tp 71.13 -68.41 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.149 172.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -114.15 -143.34 8.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.094 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.56 65.73 3.91 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.204 -0.522 . . . . 0.0 111.875 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -131.73 120.09 22.24 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 175' ' ' SER . 6.2 p30 -77.84 128.64 34.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 177' ' ' MET . 37.0 pt -135.78 -175.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.245 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 68.2 mmtt -134.15 106.67 7.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.037 174.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 174' ' ' ASN . 54.9 t -99.49 101.53 12.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.921 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -174.956 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . 0.422 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 27.0 tt0 . . . . . 0 CA--C 1.529 0.155 0 CA-C-O 120.982 0.42 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -69.36 -34.99 75.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.855 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.662 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 15.6 tm0? -57.97 -53.33 66.94 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.222 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 74.7 Cg_exo -53.46 -36.04 78.21 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.588 2.192 . . . . 0.0 112.905 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.41 -42.0 73.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.777 0.322 . . . . 0.0 110.243 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 194' ' ' ALA . 81.5 mt -61.14 -47.88 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.287 0.565 . . . . 0.0 109.973 176.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.15 -37.47 87.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.836 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -58.95 -52.89 63.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.918 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 67.7 mt -68.04 -33.14 74.02 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.987 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.659 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.95 -46.03 71.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.4 -36.79 83.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.962 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.566 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 39.4 mt-10 -67.77 -27.39 66.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.975 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.13 -27.83 59.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.028 0.442 . . . . 0.0 110.326 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.659 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 72.4 mtp180 -74.39 -15.59 60.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.503 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.88 -11.01 60.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.511 0.672 . . . . 0.0 109.992 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -115.87 -178.74 3.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.388 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 9.6 m-80 -123.92 46.06 2.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -102.61 139.18 38.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.284 -166.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.475 HG23 ' HB2' ' A' ' 263' ' ' SER . 37.6 pt -125.17 166.55 20.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.798 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.623 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 49.0 t80 -117.65 130.07 56.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.697 -175.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.1 132.89 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.004 0.431 . . . . 0.0 110.256 176.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.02 176.46 7.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.6 t 64.41 22.71 12.81 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 123.93 0.768 . . . . 0.0 109.204 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.404 HG13 HD11 ' A' ' 225' ' ' ILE . 15.4 t -67.87 121.82 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.761 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -62.66 143.05 57.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.454 0.169 . . . . 0.0 110.687 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . 0.63 ' HA ' ' CE1' ' A' ' 249' ' ' HIS . 28.6 pt20 -61.05 -16.82 48.01 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -166.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -105.4 -5.52 20.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.046 0.451 . . . . 0.0 110.846 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.541 HD21 ' HG ' ' A' ' 275' ' ' LEU . 2.9 tp -83.55 130.3 35.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . 0.559 ' O ' HG12 ' A' ' 225' ' ' ILE . 29.7 p -102.37 167.84 9.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.377 -174.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.42 ' HB3' ' HG ' ' A' ' 240' ' ' LEU . 0.5 OUTLIER -60.81 -37.98 83.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.282 0.563 . . . . 0.0 109.958 174.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -54.65 -40.03 68.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.997 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.7 -47.24 41.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.68 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.671 HG22 HD11 ' A' ' 255' ' ' ILE . 34.0 mm -60.41 -42.5 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.55 ' HG3' HG21 ' A' ' 235' ' ' ILE . 86.2 tttt -57.36 -48.78 78.12 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.04 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 88.0 p -60.83 -35.34 76.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -173.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.58 -43.67 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.633 0.254 . . . . 0.0 111.232 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.588 ' CB ' HD11 ' A' ' 235' ' ' ILE . 10.3 m-85 -68.26 -29.41 68.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.297 0.57 . . . . 0.0 110.802 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.87 -24.77 67.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.054 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.0 -17.84 62.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.889 -175.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.21 -44.73 3.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.02 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.62 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -124.55 170.17 16.61 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.098 -175.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -86.4 99.07 11.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.588 HD11 ' CB ' ' A' ' 229' ' ' PHE . 12.8 mt -84.59 150.82 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.332 0.587 . . . . 0.0 111.458 -175.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -117.04 -27.86 6.41 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.471 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.0 t -167.94 149.41 5.32 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.726 -173.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.571 ' SG ' HG12 ' A' ' 255' ' ' ILE . 50.3 t -148.2 126.3 12.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.257 175.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 99.0 m -142.52 121.33 12.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.787 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.448 ' CD2' ' HA3' ' A' ' 253' ' ' GLY . 31.1 mt -82.7 141.04 32.74 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.31 114.86 6.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.463 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 80.3 mtm180 -127.79 163.16 24.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.328 0.585 . . . . 0.0 112.365 -172.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 244' ' ' PRO . 9.6 m-20 -104.69 104.95 48.47 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.458 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 9.6 Cg_endo -50.03 -45.74 31.45 Favored 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 123.86 3.04 . . . . 0.0 114.934 -167.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.8 p -93.21 9.58 35.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.447 ' OG1' ' HG2' ' A' ' 248' ' ' LYS . 72.3 p -114.5 -38.7 3.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.971 0.415 . . . . 0.0 110.469 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.15 2.54 56.89 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.34 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.447 ' HG2' ' OG1' ' A' ' 246' ' ' THR . 19.8 ptmt -99.27 158.33 15.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.887 0.375 . . . . 0.0 110.532 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.63 ' CE1' ' HA ' ' A' ' 218' ' ' GLN . 22.4 p80 -105.63 152.32 23.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -80.18 -1.29 39.8 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.832 -170.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 113.05 -6.98 25.38 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.375 172.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.547 ' CE1' ' HG3' ' A' ' 137' ' ' PRO . 24.3 p90 -138.2 161.86 35.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.664 0.269 . . . . 0.0 110.541 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' A' ' 240' ' ' LEU . . . -154.12 172.49 32.74 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.889 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.623 ' CE1' ' HD1' ' A' ' 212' ' ' TYR . 29.9 m-85 -129.0 144.07 51.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.811 0.339 . . . . 0.0 110.464 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.671 HD11 HG22 ' A' ' 225' ' ' ILE . 77.5 mt -136.09 133.2 50.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.297 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 33.4 mt-10 -113.78 143.72 44.17 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.62 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 6.6 m-85 -110.6 170.12 8.3 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.095 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.623 ' HB2' ' HD2' ' A' ' 259' ' ' LYS . 34.4 mt-10 -72.78 -43.56 62.66 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.709 0.766 . . . . 0.0 109.008 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . 0.623 ' HD2' ' HB2' ' A' ' 258' ' ' GLU . 11.0 mptt -105.81 130.09 53.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.058 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.79 -25.72 68.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.32 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -75.43 -31.92 60.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.776 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.4 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 46.7 m -70.12 -34.91 73.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.355 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.475 ' HB2' HG23 ' A' ' 211' ' ' ILE . 55.2 p -66.29 -34.61 78.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.339 0.59 . . . . 0.0 109.751 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -71.63 -25.93 62.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.556 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -68.45 -42.41 78.85 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.367 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.74 88.09 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.498 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.436 HG13 ' HA2' ' A' ' 283' ' ' GLY . 80.3 t -52.79 -48.71 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.985 0.422 . . . . 0.0 111.406 175.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.3 m -71.36 -23.47 61.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.1 m -94.34 -43.44 8.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . . . . . . . . . 84.8 mmm -89.84 -4.4 57.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.022 -169.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -76.96 122.51 24.98 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.992 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.608 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 96.7 mt 70.79 27.97 3.46 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.182 -175.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -89.71 124.36 34.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.094 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -77.56 107.45 10.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.974 0.416 . . . . 0.0 110.961 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.541 ' HG ' HD21 ' A' ' 220' ' ' LEU . 31.2 tp -134.13 98.85 4.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.059 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 101.56 2.67 53.27 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.151 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.13 -0.15 41.12 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.319 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -131.68 142.44 49.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.804 0.335 . . . . 0.0 110.557 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.608 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 21.7 m-85 -74.0 111.22 8.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.592 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.44 128.16 35.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.884 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -98.95 116.23 30.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 212' ' ' TYR . 10.2 p -125.7 141.92 44.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.838 -176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.436 ' HA2' HG13 ' A' ' 267' ' ' VAL . . . -160.8 173.41 37.29 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.397 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -71.1 125.99 28.37 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.85 124.05 21.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.68 HG11 ' HG3' ' A' ' 167' ' ' GLN . 34.0 m -88.79 -19.23 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 111.385 -172.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.412 ' OG1' ' HD2' ' A' ' 288' ' ' PRO . 5.4 t -147.36 147.98 30.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 173.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.412 ' HD2' ' OG1' ' A' ' 287' ' ' THR . 60.7 Cg_endo . . . . . 0 CA--C 1.533 0.469 0 C-N-CA 122.78 2.32 . . . . 0.0 112.717 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 . . . . . 0 CA--C 1.532 0.28 0 CA-C-O 120.761 0.315 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -57.25 -37.34 72.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.139 0.495 . . . . 0.0 109.931 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.22 88.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.236 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.442 HD23 ' SD ' ' A' ' 111' ' ' MET . 66.7 mt -61.87 -35.26 77.78 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.999 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.66 -26.51 68.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.346 0.593 . . . . 0.0 110.818 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.77 -37.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.778 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.508 ' SD ' HG12 ' A' ' 198' ' ' ILE . 88.1 mtp -70.57 -29.68 66.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.741 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.1 m -70.64 -17.71 62.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 110.875 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -98.5 140.81 32.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.855 0.36 . . . . 0.0 110.146 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.778 HG12 ' HB ' ' A' ' 158' ' ' VAL . 3.7 p -120.47 126.88 75.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.672 0.749 . . . . 0.0 109.994 176.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -83.69 101.25 11.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.053 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 25.1 m -108.35 143.15 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.033 0.445 . . . . 0.0 111.243 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.795 ' HA3' ' HD1' ' A' ' 155' ' ' PHE . . . -152.4 177.68 30.02 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.36 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 23.2 t 65.01 50.09 1.95 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.672 0.749 . . . . 0.0 109.294 -175.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 123' ' ' LEU . 77.1 mt -103.14 116.45 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.936 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -61.21 147.89 42.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.638 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -74.07 76.29 1.73 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.027 0.918 . . . . 0.0 111.047 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -163.55 -38.24 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 119' ' ' ILE . 26.8 mt -76.53 92.6 3.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.453 174.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.56 -169.49 44.93 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.583 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 129' ' ' ARG . 20.8 tt0 -54.33 -46.51 72.89 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -64.11 -44.93 90.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.564 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -63.89 -45.17 90.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.562 HG13 ' HE1' ' A' ' 143' ' ' MET . 26.8 mm -69.17 -35.46 68.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.122 0.487 . . . . 0.0 110.427 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 27.9 ttt180 -59.37 -45.48 91.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.802 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.2 -33.45 71.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.838 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.19 -38.73 30.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.502 ' CD1' HG23 ' A' ' 128' ' ' ILE . 24.6 m-85 -89.33 -22.43 22.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.38 -42.97 90.16 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -44.96 -31.95 5.93 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.991 2.46 . . . . 0.0 114.53 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.689 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 74.6 m-85 -82.06 -37.2 26.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.48 -175.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 165' ' ' ALA . . . -178.49 173.62 45.97 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.798 174.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.1 126.19 15.38 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.985 2.457 . . . . 0.0 111.956 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.622 HD13 HD11 ' A' ' 141' ' ' ILE . 61.9 mt -89.06 139.27 17.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.635 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.599 ' HD2' ' OE2' ' A' ' 159' ' ' GLU . 22.1 ttmm -98.84 -43.86 6.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.099 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.8 t -159.63 142.53 13.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.096 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.622 HD11 HD13 ' A' ' 138' ' ' ILE . 70.0 mt -126.17 110.42 23.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.87 0.366 . . . . 0.0 110.089 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 25.9 t70 -91.45 100.82 13.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.185 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.562 ' HE1' HG13 ' A' ' 128' ' ' ILE . 51.3 ttm -138.86 111.3 7.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.023 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 59.4 m . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.128 0.489 . . . . 0.0 111.377 178.904 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.795 ' HD1' ' HA3' ' A' ' 117' ' ' GLY . 67.8 m-85 . . . . . 0 C--O 1.236 0.381 0 N-CA-C 110.224 -0.288 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.96 153.8 41.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.81 0.338 . . . . 0.0 110.755 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.498 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 88.9 m-85 -114.85 110.82 20.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.588 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.778 ' HB ' HG12 ' A' ' 114' ' ' VAL . 58.2 t -97.49 108.72 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.902 177.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.599 ' OE2' ' HD2' ' A' ' 139' ' ' LYS . 33.3 tt0 -102.35 119.8 39.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.124 -178.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.446 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 90.2 m-85 -97.4 -177.72 3.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.001 0.429 . . . . 0.0 111.342 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -80.18 -58.79 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.646 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.7 m -103.7 143.16 26.09 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.626 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 40.9 Cg_endo -67.52 -18.8 49.08 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.147 2.565 . . . . 0.0 112.798 -176.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.701 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 15.7 mp0 -55.81 -57.17 13.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.459 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.534 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . . . -52.98 -26.85 16.54 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 177.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.18 -47.26 13.68 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.404 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.7 ' HG2' HG13 ' A' ' 286' ' ' VAL . 2.6 pp0? -66.72 -31.57 72.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.689 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 10.7 tp -73.23 -45.81 53.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.53 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.86 71.92 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.602 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.5 tt -66.63 -50.28 63.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.473 172.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -54.19 -49.72 68.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.351 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -86.48 -38.92 16.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -173.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 30.9 mtm -106.8 21.93 16.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -171.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 32.1 p30 -72.14 0.16 10.37 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.324 0.583 . . . . 0.0 110.23 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.9 m -95.5 -73.72 0.58 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.506 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.5 m -139.16 161.82 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.729 0.299 . . . . 0.0 111.167 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.548 ' HE2' ' HG ' ' A' ' 178' ' ' LEU . 1.6 tpt -150.63 72.47 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.548 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 74.1 mt 57.16 -166.43 0.14 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.765 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.19 -17.76 1.73 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.798 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.45 21.67 53.48 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.443 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -143.78 176.63 9.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.058 0.456 . . . . 0.0 111.332 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -95.04 144.08 25.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.692 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 22.3 pt -116.71 171.26 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.834 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.729 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 34.8 mmtp -103.8 131.6 50.85 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 6.1 t -129.94 110.22 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.8 0.333 . . . . 0.0 110.487 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.602 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.444 -0.788 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.565 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.752 0.31 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.414 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -82.1 -28.49 32.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.483 -178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.585 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 11.5 mm100 -55.57 -49.81 90.51 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 75.7 Cg_exo -53.23 -33.89 67.1 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.249 1.966 . . . . 0.0 112.846 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 63.4 mt -75.25 -48.14 32.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.877 0.37 . . . . 0.0 110.227 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.508 HG12 ' SD ' ' A' ' 111' ' ' MET . 68.7 mt -57.5 -48.08 83.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.924 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 33.5 t70 -69.43 -34.12 73.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.115 -176.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -71.58 -37.94 70.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.671 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 60.8 mt -67.74 -33.22 74.44 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.198 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -58.72 -37.27 75.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 109.772 173.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 37.7 mt-10 -72.49 -30.35 64.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.356 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -68.42 -33.8 74.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.993 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.9 -24.62 62.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.262 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 65.6 mtp180 -72.62 -24.23 61.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.17 173.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.67 -39.63 19.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.277 0.56 . . . . 0.0 110.047 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -109.36 80.19 1.29 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.77 85.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.773 0.67 . . . . 0.0 110.916 -175.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 256' ' ' GLU . 9.1 ttt180 -128.09 143.31 51.06 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.537 -171.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 263' ' ' SER . 39.7 pt -118.21 166.76 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.564 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.524 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 73.9 t80 -121.91 126.36 48.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.388 -173.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.522 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.7 m -121.32 131.27 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.985 0.422 . . . . 0.0 110.358 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.87 175.27 7.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.451 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.6 t 59.96 31.53 20.72 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.867 0.841 . . . . 0.0 109.206 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 44.9 t -73.02 123.06 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.224 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -50.3 128.91 20.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.391 0.615 . . . . 0.0 110.968 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -55.74 -33.1 63.96 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.159 -173.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -99.07 37.0 1.6 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.477 0.656 . . . . 0.0 110.386 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 220' ' ' LEU . 11.2 tp -124.69 133.01 53.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.7 m -95.84 170.09 9.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.849 -174.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -67.46 -36.33 80.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.756 0.312 . . . . 0.0 110.819 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.9 -30.78 70.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.642 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.5 -45.26 47.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.361 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.77 HG13 HD21 ' A' ' 240' ' ' LEU . 27.1 mm -59.85 -42.42 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.692 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.44 ' HB2' ' CB ' ' A' ' 238' ' ' CYS . 86.8 tttt -56.46 -52.52 64.38 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.868 176.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 79.6 p -56.31 -37.83 70.46 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -173.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.4 -45.48 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.677 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.577 ' HB2' HD11 ' A' ' 235' ' ' ILE . 26.3 m-85 -67.95 -27.75 66.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.292 0.568 . . . . 0.0 110.394 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.09 -26.51 67.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.142 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.19 -18.73 61.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.236 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -107.07 -31.33 8.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -153.28 159.37 28.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.875 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -75.45 111.2 10.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.505 0.669 . . . . 0.0 111.645 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 229' ' ' PHE . 40.0 mt -84.03 148.98 4.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.4 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.635 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 77.8 tttt -108.35 -35.85 6.41 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.861 176.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 256' ' ' GLU . 17.0 m -153.44 136.05 15.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -170.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.44 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 52.4 t -138.68 114.75 10.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.883 0.373 . . . . 0.0 110.103 175.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 31.3 m -141.99 116.01 9.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.57 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.77 HD21 HG13 ' A' ' 225' ' ' ILE . 66.3 mt -77.98 138.58 38.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.63 3.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.499 ' HG2' ' CA ' ' A' ' 249' ' ' HIS . 34.6 mtm180 -122.41 143.17 49.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.775 -176.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -83.96 109.92 22.16 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.47 -16.47 55.32 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.477 2.118 . . . . 0.0 111.992 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.7 p -73.29 -29.18 62.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.595 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.551 HG23 ' HG2' ' A' ' 248' ' ' LYS . 4.1 t -120.55 -26.68 5.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.796 0.331 . . . . 0.0 111.762 -178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.56 37.06 8.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.201 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.551 ' HG2' HG23 ' A' ' 246' ' ' THR . 19.2 ptpt -140.43 150.05 43.35 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.499 ' CA ' ' HG2' ' A' ' 242' ' ' ARG . 18.1 p80 -80.59 132.36 35.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.332 0.586 . . . . 0.0 110.465 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -64.06 -21.04 66.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.112 -171.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 133.73 -15.3 4.64 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.273 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.524 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 33.8 p90 -128.36 169.86 13.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.692 0.282 . . . . 0.0 110.592 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -158.38 170.82 35.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.051 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.701 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 97.4 m-85 -130.86 138.92 50.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.068 0.461 . . . . 0.0 111.309 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 225' ' ' ILE . 89.2 mt -133.95 128.53 53.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.699 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 210' ' ' ARG . 57.2 tt0 -109.85 145.89 36.02 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.505 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 16.8 m-85 -116.2 148.01 40.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.002 0.429 . . . . 0.0 111.262 -175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.635 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 26.3 mt-10 -72.54 -21.95 61.09 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.081 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -116.91 126.33 52.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.725 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -50.73 -58.11 6.69 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -171.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -62.44 -29.07 70.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.226 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . 0.418 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 49.9 m -64.97 -29.22 70.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 111.556 -175.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.47 ' HA ' ' CD1' ' A' ' 257' ' ' TYR . 87.5 p -63.19 -39.93 96.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.323 0.582 . . . . 0.0 109.712 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -78.28 -19.32 53.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.136 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 85.9 m-20 -63.03 -43.05 99.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.65 84.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.683 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 263' ' ' SER . 97.4 t -56.06 -37.23 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 111.226 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.7 t -77.75 -35.69 51.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.0 m -94.83 -36.55 11.62 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -171.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.438 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.4 mmm -83.4 -0.52 50.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -169.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -73.53 125.99 29.22 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.487 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 91.1 mt 66.04 25.17 10.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.53 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -88.13 118.27 27.59 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 172.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.522 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 6.7 p-10 -74.69 115.71 14.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.458 0.647 . . . . 0.0 110.439 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 31.6 tp -123.75 97.83 5.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.14 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.5 26.63 35.2 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -175.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.5 -43.74 1.85 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.697 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -88.25 142.46 27.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.044 0.449 . . . . 0.0 111.203 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 68.2 m-85 -81.63 123.59 28.82 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.916 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.68 123.01 21.62 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.711 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -93.6 115.23 27.7 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 14.3 p -118.06 142.68 31.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.244 0.545 . . . . 0.0 111.428 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.5 ' HA3' HD13 ' A' ' 168' ' ' LEU . . . -157.95 -176.94 30.58 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.8 mppt? -85.98 147.73 26.08 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.323 0.561 . . . . 0.0 110.43 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -86.52 130.96 34.31 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 167' ' ' GLN . 12.0 m -93.54 -19.46 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.834 0.349 . . . . 0.0 110.877 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 42.9 p -130.43 129.01 22.73 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.29 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo . . . . . 0 CA--C 1.531 0.364 0 C-N-CA 122.425 2.084 . . . . 0.0 111.045 173.368 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -50.86 -28.4 9.43 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.422 -173.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.06 71.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 111.363 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.539 HD23 ' SD ' ' A' ' 111' ' ' MET . 58.4 mt -68.55 -31.97 71.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.064 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.04 -27.87 68.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.213 0.53 . . . . 0.0 110.425 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.0 mt -85.86 -34.64 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.096 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.552 ' SD ' HG12 ' A' ' 198' ' ' ILE . 91.7 mtp -70.84 -16.43 62.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.042 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 71.2 m -84.39 -6.29 59.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.716 0.293 . . . . 0.0 111.188 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 51.8 mtt180 -116.78 141.88 47.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.757 0.313 . . . . 0.0 110.548 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 158' ' ' VAL . 4.0 p -120.63 128.47 76.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.408 0.623 . . . . 0.0 109.752 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -83.11 115.56 21.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.016 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 17.2 m -108.33 124.87 65.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.518 0.675 . . . . 0.0 111.124 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.61 174.83 18.01 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.375 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.459 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 71.8 m 61.0 38.33 17.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.272 0.558 . . . . 0.0 110.517 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 57.5 mt -74.34 -21.81 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.563 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 84.0 t80 70.01 163.94 0.25 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.37 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -89.83 76.77 7.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.589 0.709 . . . . 0.0 110.704 178.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -164.1 -50.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.342 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.715 HD13 ' HG3' ' A' ' 177' ' ' MET . 73.3 mt -65.23 112.74 3.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.919 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -80.14 159.11 42.97 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.751 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -65.22 -37.32 86.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.207 0.527 . . . . 0.0 109.93 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.12 -41.12 97.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.606 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.4 m -64.76 -41.4 95.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.954 0.407 . . . . 0.0 110.292 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 124' ' ' GLY . 33.4 mm -59.2 -44.94 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.876 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.44 ' HA ' HD12 ' A' ' 138' ' ' ILE . 25.1 ttt180 -59.24 -40.48 86.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.223 0.535 . . . . 0.0 110.338 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -71.56 -33.89 69.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.583 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.95 -24.19 28.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.488 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 34.8 m-85 -95.15 -16.68 22.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.72 -42.03 92.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -44.73 -32.29 5.86 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 123.092 2.528 . . . . 0.0 114.888 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.76 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 78.5 m-85 -85.4 -42.78 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.769 0.319 . . . . 0.0 110.752 -177.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.61 157.22 29.46 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.969 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.45 117.92 4.65 Favored 'Trans proline' 0 C--O 1.241 0.649 0 C-N-CA 122.71 2.273 . . . . 0.0 111.722 175.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' A' ' 132' ' ' PHE . 54.9 mt -72.53 132.55 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.242 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -96.7 -43.05 7.72 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.228 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.7 m -152.76 140.41 19.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.3 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.8 mt -122.76 124.86 71.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.951 0.405 . . . . 0.0 110.139 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 8.0 m-20 -112.71 98.8 7.46 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 174.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.408 ' CE ' HG13 ' A' ' 128' ' ' ILE . 54.4 ttm -124.26 137.72 54.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.322 -0.6 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.899 178.146 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 47.4 p90 . . . . . 0 C--O 1.236 0.343 0 CA-C-O 120.436 0.16 . . . . 0.0 110.741 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 142' ' ' ASP . . . -148.84 140.93 23.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.913 0.387 . . . . 0.0 111.613 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -110.45 116.57 31.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.92 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.574 ' HB ' HG12 ' A' ' 114' ' ' VAL . 88.3 t -95.71 108.27 20.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.045 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 38.5 tt0 -96.41 128.89 43.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.217 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -103.57 165.97 10.71 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.77 -13.94 60.31 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.66 173.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.7 m -138.65 139.64 25.03 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 45.0 Cg_endo -67.83 -19.28 47.0 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.314 2.676 . . . . 0.0 112.486 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.7 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 7.5 mp0 -59.44 -48.21 82.5 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.966 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.24 -22.23 66.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.871 0.367 . . . . 0.0 111.853 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.08 -49.61 10.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.927 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 164' ' ' GLU . 5.0 pp0? -64.3 -30.78 71.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.76 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.8 tp -71.22 -50.54 31.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.431 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.31 -33.39 75.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.392 . . . . 0.0 110.296 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.567 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.8 tt -71.74 -38.06 70.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.2 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.64 -52.12 64.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.183 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -100.04 -30.43 11.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -172.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 27.8 ttp -106.87 28.19 8.21 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.483 -170.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -74.62 -8.62 56.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.089 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.6 m -72.7 -73.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.17 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 182' ' ' ASN . 27.1 m -144.69 167.59 10.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.949 0.404 . . . . 0.0 111.42 -173.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.744 ' HB2' HD13 ' A' ' 183' ' ' ILE . 11.7 tpp -132.4 74.47 1.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 172.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 60.6 mt 59.5 -174.3 0.1 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.28 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.2 -63.63 3.57 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.889 173.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 129.56 34.99 0.47 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -144.04 136.59 26.92 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.521 ' HA ' HG12 ' A' ' 176' ' ' VAL . 2.1 p-10 -71.59 141.49 50.01 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.983 0.42 . . . . 0.0 109.998 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.3 pt -112.55 178.89 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.859 -176.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 18.6 tptm -112.87 112.64 24.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.603 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.0 t -109.7 109.45 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.049 0.452 . . . . 0.0 110.792 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.449 -0.476 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.744 174.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 . . . . . 0 CA--C 1.531 0.238 0 CA-C-O 121.274 0.559 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.529 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -76.76 -22.49 53.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.369 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.474 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 31.7 mm-40 -60.59 -53.46 64.23 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.2 Cg_endo -53.24 -34.56 70.26 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.489 2.126 . . . . 0.0 112.995 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 65.9 mt -74.63 -38.85 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.543 0.211 . . . . 0.0 110.691 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.552 HG12 ' SD ' ' A' ' 111' ' ' MET . 70.2 mt -58.07 -49.07 82.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.225 0.536 . . . . 0.0 109.732 174.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.9 -37.49 87.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.888 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . 0.485 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 24.7 tp60 -60.2 -51.66 68.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.877 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 31.6 mt -67.52 -33.27 74.74 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.936 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.87 -37.71 66.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.48 -36.66 63.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.922 174.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 200' ' ' GLN . 26.7 mt-10 -71.72 -24.0 61.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.819 0.342 . . . . 0.0 111.778 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.19 -26.55 61.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.394 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 37.2 mtm180 -69.71 -17.95 63.5 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.451 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.01 -15.25 62.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.097 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -119.89 -172.76 2.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.601 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.619 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 68.4 m-20 -130.29 41.72 3.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.453 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.401 ' CA ' ' HG2' ' A' ' 256' ' ' GLU . 32.1 ttp180 -101.13 138.01 38.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.3 0.571 . . . . 0.0 112.044 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.5 pt -124.71 167.76 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.233 175.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 77.6 t80 -121.47 129.07 52.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.707 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.475 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 33.7 m -124.28 134.9 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.014 0.435 . . . . 0.0 110.445 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -130.8 178.27 6.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.944 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.402 ' CB ' ' HG2' ' A' ' 281' ' ' ARG . 28.5 t 59.44 36.16 23.08 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.626 0.727 . . . . 0.0 109.413 -173.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.613 HG13 HD11 ' A' ' 225' ' ' ILE . 10.5 t -73.61 120.47 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.687 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.463 ' HD2' ' NE2' ' A' ' 278' ' ' GLN . 25.9 t-80 -54.11 146.89 13.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.297 -174.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -48.58 -53.37 18.63 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -93.03 37.4 1.03 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.155 0.502 . . . . 0.0 111.368 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.458 HD21 HD23 ' A' ' 275' ' ' LEU . 12.2 tp -117.69 109.49 16.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 96.8 p -93.91 -179.36 4.95 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.065 -175.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.46 -32.18 73.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.658 0.266 . . . . 0.0 110.571 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.84 -35.75 79.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.026 0.441 . . . . 0.0 110.173 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.26 -48.52 72.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.294 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.635 HG22 HD11 ' A' ' 255' ' ' ILE . 33.4 mm -62.89 -46.73 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.457 ' HG3' HG21 ' A' ' 235' ' ' ILE . 54.2 tttm -54.33 -52.42 61.61 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.26 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 62.0 p -55.99 -39.6 72.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -174.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.1 t -76.48 -45.97 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.456 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.767 ' HB2' HD11 ' A' ' 235' ' ' ILE . 9.0 m-85 -64.72 -32.51 74.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.521 0.677 . . . . 0.0 110.557 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.63 -25.32 68.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.523 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.26 -25.81 63.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.765 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -101.59 -33.61 9.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.541 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -145.11 164.56 27.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.607 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -77.51 99.41 5.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.853 0.359 . . . . 0.0 110.746 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.767 HD11 ' HB2' ' A' ' 229' ' ' PHE . 13.3 mt -74.6 146.57 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.353 0.596 . . . . 0.0 111.393 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -110.31 -34.41 6.36 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.882 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 50.7 m -162.2 131.07 4.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.372 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.428 ' SG ' HG12 ' A' ' 255' ' ' ILE . 52.5 t -131.59 117.06 18.21 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 26.2 m -138.6 113.76 9.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.845 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.577 ' CD2' ' HA3' ' A' ' 253' ' ' GLY . 33.3 mt -82.46 139.93 33.68 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.39 115.56 7.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -128.62 136.75 51.11 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.172 -172.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -69.42 109.35 4.36 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.65 -45.35 41.7 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.199 3.266 . . . . 0.0 114.611 -168.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.526 HG23 HG23 ' A' ' 246' ' ' THR . 8.7 t -82.71 -11.86 58.01 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -170.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.526 HG23 HG23 ' A' ' 245' ' ' THR . 23.0 p -114.94 -21.51 10.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.114 0.483 . . . . 0.0 112.237 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 77.57 39.3 25.96 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.464 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -126.04 130.7 51.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.897 0.38 . . . . 0.0 110.36 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.425 ' HE1' ' O ' ' A' ' 216' ' ' VAL . 23.9 p80 -76.85 128.86 35.36 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 173.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -62.21 -20.64 64.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.274 -173.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 130.78 -5.02 5.79 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.274 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.437 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 46.3 p90 -140.65 167.96 20.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.745 0.307 . . . . 0.0 110.607 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.577 ' HA3' ' CD2' ' A' ' 240' ' ' LEU . . . -158.56 172.09 35.42 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.084 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.7 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 97.9 m-85 -128.05 142.52 51.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.894 0.378 . . . . 0.0 110.852 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.635 HD11 HG22 ' A' ' 225' ' ' ILE . 77.8 mt -136.8 131.79 47.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.767 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 16.5 mt-10 -112.44 146.57 38.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.875 175.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.546 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 9.2 m-85 -108.89 161.2 15.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.807 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.54 -22.33 59.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.509 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.8 141.58 48.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.035 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.559 ' HA ' ' OD1' ' A' ' 209' ' ' ASN . . . -57.99 -60.21 4.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -169.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -74.51 -20.61 59.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 -171.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.9 m -62.1 -25.8 67.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.431 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 211' ' ' ILE . 87.8 p -68.94 -39.61 79.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.372 0.606 . . . . 0.0 109.697 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -75.08 -23.16 57.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.897 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.28 -41.27 98.98 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.71 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -65.54 -42.22 92.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.37 175.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.551 ' HA ' HG21 ' A' ' 282' ' ' VAL . 96.4 t -54.14 -34.32 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.193 0.52 . . . . 0.0 110.822 177.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 26.1 t -73.11 -35.29 66.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.29 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.6 t -92.74 -35.08 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 111.832 -173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 73.2 mmm -88.64 5.65 42.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.785 0.326 . . . . 0.0 111.245 -171.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.519 ' HA ' HG12 ' A' ' 282' ' ' VAL . 25.1 t-20 -66.5 109.77 2.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.348 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.4 mt 63.47 40.91 7.89 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.549 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . 0.485 ' HD2' ' HB2' ' A' ' 275' ' ' LEU . 49.4 t80 -79.69 126.84 31.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.137 174.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -80.17 71.34 6.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.629 0.728 . . . . 0.0 111.444 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.485 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 30.8 tp -95.37 103.48 15.34 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.109 0.48 . . . . 0.0 110.245 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 90.14 21.45 38.65 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.494 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 88.91 -9.27 77.26 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.695 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.463 ' NE2' ' HD2' ' A' ' 217' ' ' HIS . 79.2 mt-30 -116.66 144.17 44.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.866 0.365 . . . . 0.0 110.697 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -80.2 115.45 19.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.577 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 273' ' ' PHE . 64.6 mt -64.53 126.64 28.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.437 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 281' ' ' ARG . 2.5 mmt180 -93.57 115.1 27.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 176.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 267' ' ' VAL . 8.3 p -112.83 147.16 16.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.155 -173.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.93 169.92 38.27 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -84.15 134.26 34.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.07 107.78 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.018 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 15.9 m -68.19 -27.6 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.541 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 69.9 p -98.52 124.5 46.29 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-O 121.246 0.546 . . . . 0.0 110.845 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 N--CA 1.46 -0.454 0 C-N-CA 122.755 2.303 . . . . 0.0 111.23 172.885 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.421 ' HB3' ' HG ' ' A' ' 108' ' ' LEU . 31.5 mm-40 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.936 0.398 . . . . 0.0 111.784 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.0 mtp-105 -56.57 -40.12 74.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.279 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.86 -30.81 71.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.697 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 287' ' ' THR . 24.2 mt -69.37 -41.25 76.78 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.495 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.73 70.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 110.516 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 194' ' ' ALA . 69.4 mt -79.84 -46.25 22.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.872 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 30.9 mtm -65.22 -37.07 86.14 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.6 m -63.2 -19.21 64.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.738 0.304 . . . . 0.0 111.223 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -104.68 140.54 37.9 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.635 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.0 p -129.24 128.09 66.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.66 0.743 . . . . 0.0 110.371 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -85.13 113.59 21.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.332 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 29.6 m -111.41 116.44 52.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.306 0.574 . . . . 0.0 110.314 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -113.78 106.33 1.73 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.76 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . 0.867 ' HB3' HG22 ' A' ' 183' ' ' ILE . 27.7 t 154.6 -90.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.894 1.278 . . . . 0.0 109.106 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.792 ' H ' HG22 ' A' ' 183' ' ' ILE . 13.6 mt 60.01 31.31 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.371 0.668 . . . . 0.0 111.497 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.667 ' HA ' ' HD3' ' A' ' 181' ' ' ARG . 27.8 t80 60.3 -164.06 0.23 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -124.14 75.44 1.38 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.792 1.282 . . . . 0.0 109.426 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 123' ' ' LEU . 5.8 tt0 -178.42 -144.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.81 -1.995 . . . . 0.0 106.64 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.538 HD22 HG21 ' A' ' 127' ' ' THR . 92.1 mt 57.6 -174.36 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.784 0.678 . . . . 0.0 112.187 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.79 -179.63 36.58 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.5 -45.72 90.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.821 0.343 . . . . 0.0 110.42 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 4.4 m-20 -56.87 -49.39 75.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.444 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.538 HG21 HD22 ' A' ' 123' ' ' LEU . 5.0 m -61.7 -43.1 99.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.034 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 119' ' ' ILE . 21.5 mm -66.55 -39.84 84.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.54 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 129' ' ' ARG . 43.2 ttp180 -60.7 -38.65 85.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.999 177.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 78.0 mt-30 -71.53 -33.26 69.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.211 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.05 -33.76 50.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -92.73 -16.19 25.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.601 0.238 . . . . 0.0 111.495 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -51.01 -44.66 87.37 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 5.1 Cg_exo -43.24 -49.07 7.61 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.981 2.454 . . . . 0.0 113.976 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.505 ' HD2' ' HG ' ' A' ' 168' ' ' LEU . 72.7 m-85 -65.28 -48.49 72.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -170.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.3 -171.66 29.82 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.449 -1.358 . . . . 0.0 113.271 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 161' ' ' GLU . 71.7 Cg_endo -78.79 121.61 5.11 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.752 2.302 . . . . 0.0 111.737 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 141' ' ' ILE . 57.6 mt -80.8 119.69 30.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.367 0.603 . . . . 0.0 110.662 -177.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.667 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 28.1 tptp -89.26 -34.13 16.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.847 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.9 t -174.53 162.14 3.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.857 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 138' ' ' ILE . 70.1 mt -141.22 122.37 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.745 0.307 . . . . 0.0 110.307 175.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.669 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 12.0 m-20 -95.01 104.01 15.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.387 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 3.9 mmt -94.98 126.18 40.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.737 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.417 0.627 . . . . 0.0 109.75 174.495 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 . . . . . 0 C--O 1.236 0.39 0 CA-C-O 120.837 0.351 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.96 140.95 28.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.154 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.669 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 92.7 m-85 -109.99 109.17 19.67 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.635 ' HB ' HG12 ' A' ' 114' ' ' VAL . 43.3 t -92.04 115.02 30.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.23 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.667 ' HG2' ' HB3' ' A' ' 139' ' ' LYS . 36.6 tt0 -105.26 125.46 51.01 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.414 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.18 174.44 5.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.373 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.508 ' HB2' ' HG2' ' A' ' 137' ' ' PRO . 46.3 mt-10 -89.46 -16.32 31.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.086 172.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.451 HG22 ' HD2' ' A' ' 137' ' ' PRO . 28.1 m -130.67 137.64 31.25 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.109 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.453 ' HG3' HD22 ' A' ' 108' ' ' LEU . 60.1 Cg_endo -73.1 -20.76 21.29 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.785 2.323 . . . . 0.0 112.647 -176.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.571 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 13.6 mp0 -54.24 -59.08 5.14 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.132 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.16 -26.66 17.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.17 -51.83 8.01 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.216 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.45 ' HG3' HG11 ' A' ' 286' ' ' VAL . 10.6 mm100 -67.52 -27.43 66.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.984 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.505 ' HG ' ' HD2' ' A' ' 135' ' ' PHE . 14.2 tp -72.13 -47.61 49.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.105 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.28 73.48 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 185' ' ' VAL . 6.6 tt -65.06 -51.95 58.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.656 172.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -56.09 -33.68 65.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.833 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -100.68 -48.85 4.37 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.9 mtm -95.73 28.83 2.87 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -167.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -85.5 30.69 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.996 0.903 . . . . 0.0 109.847 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 16.6 m -113.93 -74.32 0.63 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.323 176.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.4 m -145.59 170.86 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.467 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.625 ' HB2' HD13 ' A' ' 183' ' ' ILE . 22.5 tpp -143.4 91.33 2.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.604 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.518 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 75.7 mt 54.49 45.34 27.21 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.035 172.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 170.85 163.06 24.25 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.962 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.13 53.25 4.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.152 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . 0.667 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 25.4 mtp180 -143.46 125.78 15.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.096 0.474 . . . . 0.0 110.49 174.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 175' ' ' SER . 14.1 m120 -71.81 128.43 35.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.954 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.867 HG22 ' HB3' ' A' ' 118' ' ' SER . 43.9 pt -103.21 143.51 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.781 -177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 50.4 mttp -103.0 118.29 36.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.439 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.7 t -110.67 111.77 37.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 123.591 0.557 . . . . 0.0 111.479 -172.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.262 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.552 170.059 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 . . . . . 0 CA--C 1.529 0.136 0 CA-C-O 121.012 0.434 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' A' ' 110' ' ' ILE . . . -87.34 -17.64 31.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.738 -175.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.554 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 11.8 tm0? -57.7 -50.58 87.34 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.886 -174.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.0 Cg_endo -53.16 -37.3 79.73 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.604 2.203 . . . . 0.0 113.1 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.5 mt -74.59 -41.33 48.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.297 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.6 mt -59.73 -48.85 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.096 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 14.7 t70 -59.19 -43.27 92.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.46 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -59.38 -50.93 72.05 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.471 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.6 -33.0 73.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.681 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.577 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.41 -39.49 73.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.68 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 44.3 mt-10 -66.75 -33.82 76.46 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.755 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.415 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 37.3 mt-10 -66.51 -37.02 84.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.349 . . . . 0.0 110.568 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.35 -33.76 76.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.095 0.474 . . . . 0.0 110.27 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.68 ' HD3' ' HA ' ' A' ' 203' ' ' GLU . 66.9 mtp180 -70.36 -13.77 62.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.158 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.73 -38.37 19.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.052 0.453 . . . . 0.0 110.783 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.47 -19.88 23.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.114 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 61.64 46.92 6.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.16 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.478 ' HE ' ' HB3' ' A' ' 254' ' ' PHE . 22.5 ttt180 -103.32 137.14 41.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.72 -171.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 263' ' ' SER . 42.2 pt -118.96 167.25 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.346 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 81.3 t80 -119.53 128.04 53.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.619 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.42 HG23 HG21 ' A' ' 216' ' ' VAL . 27.4 m -116.98 135.04 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.217 0.532 . . . . 0.0 110.105 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -121.92 173.86 7.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.642 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.447 ' OG ' ' HG2' ' A' ' 281' ' ' ARG . 2.0 p 43.7 42.35 4.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.946 0.879 . . . . 0.0 111.202 -174.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.42 HG21 HG23 ' A' ' 213' ' ' VAL . 24.1 t -84.77 108.64 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.27 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -54.88 135.72 47.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.559 0.695 . . . . 0.0 111.369 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -51.72 -27.29 11.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.701 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -85.59 -9.84 56.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.918 0.389 . . . . 0.0 111.113 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 72.1 mt -86.52 136.39 33.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.214 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 49.3 m -97.26 169.44 9.77 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.496 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -62.29 -29.64 70.57 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.304 -0.247 . . . . 0.0 111.073 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -66.24 -35.18 79.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.172 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -61.04 -54.21 47.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.979 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.535 HG13 HD21 ' A' ' 240' ' ' LEU . 24.9 mm -63.52 -43.52 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.995 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 54.6 tttm -58.29 -49.63 76.46 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.318 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 97.8 p -56.04 -43.92 78.3 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 17.4 t -75.03 -41.62 45.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.609 0.242 . . . . 0.0 111.109 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.57 ' CB ' HD11 ' A' ' 235' ' ' ILE . 4.6 m-85 -65.75 -34.31 77.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.179 0.514 . . . . 0.0 110.912 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.3 tm-20 -66.33 -24.84 66.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.746 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.25 -16.45 61.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.648 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -111.74 -44.5 3.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.628 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . 0.554 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -124.57 173.49 16.99 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.525 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -94.96 99.28 11.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.393 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.57 HD11 ' CB ' ' A' ' 229' ' ' PHE . 17.9 mt -79.12 146.09 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.424 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 44.5 tttm -111.22 -33.14 6.53 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.126 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 18.8 m -152.84 125.55 8.33 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.485 -170.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.686 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 26.8 p -108.05 114.22 27.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.042 0.449 . . . . 0.0 109.907 170.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 27.5 m -141.71 102.06 4.09 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.286 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.535 HD21 HG13 ' A' ' 225' ' ' ILE . 64.6 mt -83.8 131.82 34.87 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.459 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -62.92 110.99 1.95 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.537 ' HD2' ' O ' ' A' ' 247' ' ' GLY . 16.1 ttp180 -123.98 144.88 49.55 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.798 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.433 ' HB3' HG22 ' A' ' 246' ' ' THR . 17.8 t70 -80.54 113.66 41.4 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 172.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.19 -25.71 47.72 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.707 2.938 . . . . 0.0 115.162 -167.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.7 t -110.09 3.75 20.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 243' ' ' ASP . 8.2 t -103.83 -13.57 16.36 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.934 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . 0.537 ' O ' ' HD2' ' A' ' 242' ' ' ARG . . . 91.83 -48.13 2.76 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.977 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 16.2 pttp -94.85 156.17 16.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.756 0.278 . . . . 0.0 110.451 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 4.4 p80 -80.07 161.88 25.11 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.743 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.15 -58.72 6.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.161 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 163.32 -17.18 0.13 Allowed Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.178 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.411 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 9.5 p90 -120.61 173.75 6.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.459 ' HA2' ' H ' ' A' ' 241' ' ' ALA . . . -163.84 172.89 39.82 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.959 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.571 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 76.4 m-85 -135.3 143.01 45.97 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 122.598 0.359 . . . . 0.0 110.072 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.2 mt -139.78 133.23 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.976 0.417 . . . . 0.0 110.705 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -105.68 147.79 28.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 13.2 m-85 -117.45 151.57 36.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.915 0.388 . . . . 0.0 110.269 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 34.7 mt-10 -72.4 -16.28 61.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.844 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -131.41 132.33 44.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.904 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -56.35 -33.95 66.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.332 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.37 -33.39 61.04 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.032 0.444 . . . . 0.0 110.864 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 4.7 t -66.56 -36.11 81.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.186 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.687 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 71.9 p -65.94 -36.69 84.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.207 0.527 . . . . 0.0 109.963 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -72.79 -24.12 60.88 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.82 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.63 -44.91 76.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.0 0.428 . . . . 0.0 110.398 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -64.28 -38.17 90.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.467 HG13 ' HA2' ' A' ' 283' ' ' GLY . 72.0 t -53.85 -38.94 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 120.966 0.413 . . . . 0.0 111.457 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 m -82.02 -19.8 39.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.81 0.338 . . . . 0.0 111.596 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 17.8 m -95.24 -49.26 5.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 58.4 mmm -81.57 -9.19 59.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -168.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -69.24 128.43 36.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.359 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 93.2 mt 66.99 31.69 6.83 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.852 0.72 . . . . 0.0 110.508 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -100.63 116.4 32.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.982 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.65 116.37 6.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.006 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 31.7 tp -143.02 118.67 10.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.766 173.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.57 6.48 87.34 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.028 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.44 -0.17 46.64 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.282 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -134.1 151.15 51.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -84.35 116.2 22.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.714 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.97 115.02 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.603 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 14.1 mmt180 -93.89 114.95 27.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.33 140.82 40.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 119.711 -0.795 . . . . 0.0 111.202 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . 0.467 ' HA2' HG13 ' A' ' 267' ' ' VAL . . . -153.97 -169.98 19.46 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -89.95 137.94 31.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 117.334 0.567 . . . . 0.0 109.59 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.45 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -71.06 121.9 19.07 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.45 HG11 ' HG3' ' A' ' 167' ' ' GLN . 28.2 m -79.48 -25.66 12.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.794 0.33 . . . . 0.0 110.987 -175.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.727 HG21 HD21 ' A' ' 108' ' ' LEU . 73.2 p -133.18 145.54 57.24 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.415 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 52.6 Cg_endo . . . . . 0 N--CA 1.462 -0.345 0 C-N-CA 122.492 2.128 . . . . 0.0 111.185 173.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 . . . . . 0 CA--C 1.53 0.185 0 CA-C-O 121.498 0.666 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 106' ' ' ARG . 28.1 ptt180 -67.99 -27.77 66.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.367 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HB2' HD12 ' A' ' 197' ' ' ILE . . . -65.89 -30.53 71.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.343 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 287' ' ' THR . 42.9 mt -60.93 -31.52 71.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.361 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.7 -24.96 67.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.132 0.491 . . . . 0.0 110.757 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.1 mt -87.83 -34.46 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.142 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.529 ' SD ' HG12 ' A' ' 198' ' ' ILE . 88.0 mtp -74.99 -15.5 60.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.093 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 97.7 m -79.61 -1.26 37.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.538 0.209 . . . . 0.0 111.378 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.896 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 32.7 mtt180 -110.81 142.43 42.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.765 0.317 . . . . 0.0 111.235 -174.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.558 HG23 HD12 ' A' ' 170' ' ' LEU . 8.9 p -128.4 129.79 69.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.408 0.623 . . . . 0.0 109.817 169.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -85.01 118.32 24.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.819 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.64 HG12 HG12 ' A' ' 185' ' ' VAL . 15.5 m -112.59 126.68 70.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.286 0.565 . . . . 0.0 111.372 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -131.31 175.36 19.61 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.543 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.7 m 62.1 31.87 17.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 122.934 0.493 . . . . 0.0 111.455 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.5 mt -77.22 112.83 15.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.067 0.46 . . . . 0.0 110.513 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -61.38 153.55 26.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.628 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -78.01 76.29 4.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.086 0.946 . . . . 0.0 110.949 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -165.21 -39.95 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.095 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.458 ' HB3' HD11 ' A' ' 128' ' ' ILE . 66.3 mt -74.93 85.96 2.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.969 174.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.48 172.33 55.22 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.924 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -55.1 -40.03 69.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 0.0 110.942 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 130' ' ' GLN . 20.5 t70 -62.28 -53.49 54.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.58 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 m -59.0 -43.07 91.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.978 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 123' ' ' LEU . 28.4 mm -63.19 -45.32 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.738 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -57.39 -43.85 84.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.43 . . . . 0.0 110.248 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 15.3 mm100 -68.73 -33.79 74.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.939 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.61 -27.03 25.73 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.528 ' HB2' HD11 ' A' ' 138' ' ' ILE . 4.9 m-85 -87.52 -26.01 23.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.78 0.324 . . . . 0.0 111.06 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.452 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -50.76 -42.19 76.09 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 26.1 Cg_exo -39.12 -45.96 2.88 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.168 2.579 . . . . 0.0 114.559 173.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.497 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 54.2 m-85 -76.1 -37.12 58.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.877 0.37 . . . . 0.0 110.597 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -176.04 153.49 14.81 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.45 124.31 15.94 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.718 2.279 . . . . 0.0 111.755 175.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 132' ' ' PHE . 21.0 mt -83.13 136.51 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.073 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -110.96 -20.32 12.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.175 0.512 . . . . 0.0 110.751 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.883 ' HB3' ' HB2' ' A' ' 159' ' ' GLU . 29.5 t -151.84 131.16 12.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.444 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.406 ' CG1' HG21 ' A' ' 138' ' ' ILE . 64.8 mt -130.28 129.67 65.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -117.48 99.45 7.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 52.1 ttm -141.33 112.0 7.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.828 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.3 m . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.768 178.731 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -151.12 167.62 27.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.995 0.426 . . . . 0.0 111.299 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -126.84 134.66 50.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.393 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 114' ' ' VAL . 89.4 t -121.07 113.0 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.644 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.896 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 4.8 mp0 -105.54 119.62 39.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.554 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.14 179.87 5.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.793 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.36 -63.15 1.17 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.832 169.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.3 m -99.08 144.79 28.86 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.951 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 22.9 Cg_exo -65.71 -19.82 59.45 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.469 2.779 . . . . 0.0 112.535 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.482 ' OE2' ' HB3' ' A' ' 212' ' ' TYR . 0.6 OUTLIER -58.53 -54.91 41.75 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.836 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.16 -25.82 14.9 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.5 -53.01 7.29 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.384 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.425 ' HG3' HG21 ' A' ' 286' ' ' VAL . 83.7 mm-40 -64.47 -43.33 94.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.751 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.497 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 10.5 tp -59.64 -46.44 89.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.436 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.664 ' HB1' ' SD ' ' A' ' 173' ' ' MET . . . -61.68 -53.09 60.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.558 HD12 HG23 ' A' ' 114' ' ' VAL . 8.2 tt -54.45 -36.13 63.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.467 0.651 . . . . 0.0 110.234 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.01 -46.48 71.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.73 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -100.87 -21.13 15.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -173.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.664 ' SD ' ' HB1' ' A' ' 169' ' ' ALA . 4.6 ptm -99.74 18.55 17.88 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.925 -0.484 . . . . 0.0 110.792 -176.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -72.78 -2.92 22.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 24.1 m -101.56 -74.22 0.63 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.472 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.88 157.17 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.232 0.539 . . . . 0.0 111.675 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.574 ' HB2' HD13 ' A' ' 183' ' ' ILE . 23.9 tpp -121.78 97.27 5.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.693 175.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 75.3 mt 61.49 35.91 17.35 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.249 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.34 -130.37 9.73 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.112 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 67.1 -94.26 0.25 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.574 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -144.33 153.69 42.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 175' ' ' SER . 23.6 t-20 -68.89 100.43 1.19 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.574 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.9 pt -74.84 149.6 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.369 -175.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 184' ' ' LYS . 9.3 mmpt? -103.45 107.3 18.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.161 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.64 HG12 HG12 ' A' ' 116' ' ' VAL . 5.9 m -104.62 109.41 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.222 0.534 . . . . 0.0 111.135 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 170' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.409 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.486 174.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 . . . . . 0 CA--C 1.524 -0.036 0 CA-C-O 121.302 0.572 . . . . 0.0 110.224 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.441 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -87.96 10.18 19.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.476 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.7 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 25.3 tp60 -49.25 -53.13 42.45 Favored Pre-proline 0 N--CA 1.469 0.488 0 O-C-N 123.296 0.373 . . . . 0.0 111.89 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 40.0 Cg_exo -59.06 -37.47 92.71 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.198 1.932 . . . . 0.0 112.701 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' A' ' 107' ' ' ALA . 74.8 mt -75.3 -43.26 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.065 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.529 HG12 ' SD ' ' A' ' 111' ' ' MET . 73.7 mt -58.16 -45.9 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.149 0.5 . . . . 0.0 110.158 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 36.0 t70 -66.8 -39.01 87.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.765 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.43 -48.4 75.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.869 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.592 ' HA ' ' HG3' ' A' ' 204' ' ' GLU . 54.3 mt -68.14 -33.12 73.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.649 0.261 . . . . 0.0 111.032 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.568 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.15 -42.96 77.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 51.5 mt-10 -64.7 -36.36 84.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.901 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 201' ' ' LEU . 5.8 mm-40 -53.66 -46.03 70.44 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.059 0.457 . . . . 0.0 110.891 175.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 285' ' ' ALA . . . -63.73 -37.01 85.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.784 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 76.3 mtp180 -72.47 -16.75 61.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.164 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -99.38 -38.21 8.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.458 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -86.72 -12.46 48.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.126 0.489 . . . . 0.0 111.1 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 61.02 48.48 6.47 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.18 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.89 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 12.8 ptm180 -122.11 158.02 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.989 0.424 . . . . 0.0 111.718 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 pt -136.36 168.59 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.578 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.524 ' HB2' ' CE2' ' A' ' 254' ' ' PHE . 14.1 t80 -122.89 138.63 54.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.611 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.589 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 35.5 m -127.42 133.83 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 110.757 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.78 -178.52 4.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.309 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.4 t 61.27 30.24 19.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.902 0.858 . . . . 0.0 109.082 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.0 119.17 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.236 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -57.45 142.27 44.6 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.974 0.416 . . . . 0.0 111.062 -173.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -49.04 -36.18 17.49 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -168.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -91.03 -5.83 54.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -171.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.81 131.87 36.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.117 0.484 . . . . 0.0 111.14 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.2 p -100.6 173.58 6.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.192 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.472 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 6.1 p-10 -61.62 -35.46 77.94 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.722 0.296 . . . . 0.0 110.415 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.48 -39.08 82.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.258 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.36 -44.23 68.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.597 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.604 HG22 HD11 ' A' ' 255' ' ' ILE . 29.6 mm -66.37 -40.73 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 88.2 tttt -60.82 -43.33 98.35 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.479 176.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 51.1 m -59.36 -39.09 82.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.76 -45.5 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.625 0.25 . . . . 0.0 111.304 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.603 ' CB ' HD11 ' A' ' 235' ' ' ILE . 15.5 m-85 -65.91 -30.39 70.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.225 0.536 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 7.6 tp10 -61.0 -24.21 65.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.946 176.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.65 -13.16 59.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.883 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -111.06 -34.39 6.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.692 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.97 166.74 29.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.332 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -78.56 103.19 8.34 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.253 0.549 . . . . 0.0 111.336 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.603 HD11 ' CB ' ' A' ' 229' ' ' PHE . 22.3 mt -78.6 150.94 5.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.103 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.04 -28.66 8.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.794 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.467 ' OG ' ' HB2' ' A' ' 256' ' ' GLU . 3.3 p -172.04 153.1 3.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.671 0.272 . . . . 0.0 111.136 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . 0.455 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 41.6 t -143.5 127.79 17.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.16 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 239' ' ' THR . 5.2 t -141.53 108.48 5.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.067 0.461 . . . . 0.0 111.311 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.569 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 36.5 mt -79.32 130.58 35.58 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . 0.578 ' HB3' ' CD1' ' A' ' 252' ' ' TYR . . . -75.03 118.68 18.26 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.536 ' CB ' ' HA ' ' A' ' 249' ' ' HIS . 35.9 ptt180 -139.56 169.04 18.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.95 -170.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -106.17 108.48 61.79 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 173.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.41 -37.61 94.1 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.305 2.67 . . . . 0.0 113.161 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -35.04 79.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.949 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 41.0 p -97.78 -18.67 18.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 111.537 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 73.77 44.82 30.14 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.05 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -150.95 139.64 20.7 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 242' ' ' ARG . 6.2 p80 -83.68 140.23 32.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -81.26 30.06 0.34 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -169.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 92.97 -6.06 76.27 Favored Glycine 0 CA--C 1.505 -0.578 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.429 171.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.578 ' CD1' ' HB3' ' A' ' 241' ' ' ALA . 0.2 OUTLIER -140.42 173.87 11.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -176.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -169.77 174.7 44.02 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.413 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 212' ' ' TYR . 59.7 m-85 -129.51 146.92 51.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.169 0.484 . . . . 0.0 110.512 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.604 HD11 HG22 ' A' ' 225' ' ' ILE . 84.9 mt -136.03 147.76 28.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.008 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.89 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 34.7 mt-10 -127.65 146.81 50.43 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.644 ' HB2' ' OG ' ' A' ' 263' ' ' SER . 18.7 m-85 -119.66 159.18 24.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.825 0.345 . . . . 0.0 110.915 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.16 -36.42 69.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.211 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -107.1 131.67 53.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -58.23 -34.26 70.23 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.655 -173.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . 0.426 HE21 ' HB2' ' A' ' 261' ' ' GLN . 0.0 OUTLIER -64.81 -44.48 89.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.2 176.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.0 m -65.02 -30.58 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.296 -169.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.644 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 1.6 m -60.96 -47.6 85.69 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.389 0.614 . . . . 0.0 109.646 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -73.69 -26.84 60.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.325 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -74.29 -32.99 63.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.418 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -66.78 -40.07 88.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 282' ' ' VAL . 64.5 t -55.13 -45.56 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.433 0.635 . . . . 0.0 109.882 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 53.0 m -63.26 -30.01 71.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.699 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.9 m -95.61 -37.26 10.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.484 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 90.5 mmm -92.77 -3.52 54.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -166.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 272' ' ' LEU . 15.9 t30 -72.95 124.77 26.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.22 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 99.1 mt 72.37 26.17 2.67 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.901 0.75 . . . . 0.0 110.643 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -87.33 120.75 28.94 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.546 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 10.2 p-10 -78.21 101.23 6.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.467 0.651 . . . . 0.0 110.871 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.546 HD12 HD11 ' A' ' 280' ' ' LEU . 0.9 OUTLIER -113.37 107.7 16.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.03 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 73.58 22.32 78.56 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.838 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.27 -38.5 3.26 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.775 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -87.87 148.68 24.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.857 0.328 . . . . 0.0 110.979 -176.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.546 ' CE1' ' HB3' ' A' ' 274' ' ' ASP . 81.4 m-85 -90.55 113.33 25.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.088 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.546 HD11 HD12 ' A' ' 275' ' ' LEU . 69.9 mt -60.18 133.27 55.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.479 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -107.1 116.35 31.77 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 172.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 267' ' ' VAL . 7.8 p -118.1 140.55 41.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.184 0.516 . . . . 0.0 111.36 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -132.47 174.78 20.24 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.018 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -100.33 45.43 0.98 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.597 0.713 . . . . 0.0 110.957 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 205' ' ' ALA . . . 33.09 69.89 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 112.9 -1.955 . . . . 0.0 113.709 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.425 HG21 ' HG3' ' A' ' 167' ' ' GLN . 35.1 m -54.8 -26.29 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.926 0.393 . . . . 0.0 111.159 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . 0.483 ' HA ' ' HD2' ' A' ' 288' ' ' PRO . 25.7 p -134.04 107.14 11.44 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.611 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . 0.506 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 21.8 Cg_endo . . . . . 0 N--CA 1.462 -0.38 0 C-N-CA 122.857 2.372 . . . . 0.0 111.363 172.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 121.042 0.448 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -53.64 -49.26 68.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.494 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.7 -48.02 61.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.08 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.99 -34.66 78.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.947 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.96 -32.49 72.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.145 0.498 . . . . 0.0 110.584 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.8 mt -80.67 -34.59 14.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.158 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.466 ' SD ' HG12 ' A' ' 198' ' ' ILE . 84.8 mtp -71.42 -23.48 61.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.83 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.7 m -84.11 -1.74 55.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.842 0.353 . . . . 0.0 110.77 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 98.5 mtt180 -122.03 141.09 51.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.129 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.25 133.12 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.159 0.505 . . . . 0.0 110.022 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -83.5 121.1 26.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.627 HG11 ' HZ ' ' A' ' 132' ' ' PHE . 15.7 m -117.46 116.56 52.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.066 0.46 . . . . 0.0 110.097 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 183' ' ' ILE . . . -122.23 171.39 15.32 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.03 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 m 67.38 25.98 8.52 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.785 0.434 . . . . 0.0 111.196 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.3 mt -66.81 115.56 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -53.32 143.26 19.16 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.924 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -69.5 80.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.447 0.642 . . . . 0.0 110.206 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -164.3 -44.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.974 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.435 ' CD1' ' HG3' ' A' ' 177' ' ' MET . 48.1 mt -83.33 124.27 30.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.187 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -97.74 -169.86 32.63 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.4 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -65.28 -33.04 75.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.019 0.438 . . . . 0.0 110.225 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 9.8 m-20 -71.91 -50.59 27.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.535 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -41.86 86.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.503 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.548 HG23 ' CE1' ' A' ' 132' ' ' PHE . 17.1 mm -63.95 -42.91 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.812 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.2 ttt85 -59.15 -38.74 80.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.982 0.42 . . . . 0.0 110.307 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 23.4 mt-30 -66.37 -33.78 76.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.338 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.62 -23.69 29.45 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.627 ' HZ ' HG11 ' A' ' 116' ' ' VAL . 28.3 m-85 -94.25 -21.8 18.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.765 0.317 . . . . 0.0 111.479 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.615 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.21 -42.58 87.16 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 1.1 Cg_endo -47.54 -39.12 29.12 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.86 2.374 . . . . 0.0 114.325 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.598 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 62.9 m-85 -78.39 -38.04 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -172.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.69 172.61 45.11 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.197 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.56 117.56 5.21 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.638 2.226 . . . . 0.0 111.469 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.762 HD13 HD11 ' A' ' 141' ' ' ILE . 80.9 mt -72.63 131.95 34.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.705 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -111.09 -21.02 12.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.352 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 42.4 t -165.36 142.28 5.68 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.963 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.762 HD11 HD13 ' A' ' 138' ' ' ILE . 54.0 mt -142.0 114.44 3.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.277 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 157' ' ' PHE . 7.9 p-10 -110.28 108.15 18.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.496 0.665 . . . . 0.0 109.426 172.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.546 ' HE1' HG13 ' A' ' 128' ' ' ILE . 45.5 ttm -109.68 146.37 34.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.265 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.742 178.193 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 51.6 p90 . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.611 0.244 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.62 159.04 29.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.463 ' HB2' ' OD1' ' A' ' 142' ' ' ASP . 51.8 m-85 -112.33 112.74 24.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.846 172.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.452 HG11 ' CD2' ' A' ' 132' ' ' PHE . 59.3 t -98.7 117.46 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.177 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 37.0 tt0 -109.33 138.85 45.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -115.32 -175.97 2.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.229 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.36 -34.35 61.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.815 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.5 m -125.98 150.78 70.19 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.043 0.449 . . . . 0.0 111.365 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 58.0 Cg_endo -70.1 -14.1 34.62 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.369 2.713 . . . . 0.0 111.938 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.447 ' HG3' ' HE1' ' A' ' 254' ' ' PHE . 70.5 mm-40 -59.12 -59.59 5.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.985 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.73 -19.21 10.23 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.52 -53.32 6.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.798 0.332 . . . . 0.0 110.111 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.57 -36.78 84.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.828 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.598 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 18.5 tp -66.23 -46.96 75.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.29 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.54 -44.17 96.39 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.594 ' HG ' HG13 ' A' ' 185' ' ' VAL . 6.1 tt -55.43 -44.34 76.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.247 0.546 . . . . 0.0 109.789 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.16 -39.84 79.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.127 -0.942 . . . . 0.0 113.204 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -100.59 -7.34 24.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' MET . . . . . 0.648 ' SD ' HD11 ' A' ' 183' ' ' ILE . 32.5 ttm -97.46 -16.46 20.15 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -78.59 27.39 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 111.414 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.468 ' O ' HG13 ' A' ' 176' ' ' VAL . 41.5 t -113.6 -58.77 2.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.359 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -164.3 167.47 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 124.042 0.839 . . . . 0.0 109.167 177.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' MET . . . . . 0.449 ' SD ' ' HG ' ' A' ' 178' ' ' LEU . 15.1 tpp -134.05 88.16 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.423 0.63 . . . . 0.0 110.805 172.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.449 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 90.1 mt 58.96 -79.83 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.597 174.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -79.02 54.93 4.27 Favored Glycine 0 CA--C 1.518 0.219 0 N-CA-C 114.278 0.471 . . . . 0.0 114.278 -168.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.87 -52.42 3.6 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 114.078 0.391 . . . . 0.0 114.078 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -76.27 133.96 39.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.091 0.472 . . . . 0.0 111.631 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 43.8 t30 -80.12 134.59 36.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.096 171.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ILE . . . . . 0.648 HD11 ' SD ' ' A' ' 173' ' ' MET . 40.8 pt -105.0 173.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.951 0.405 . . . . 0.0 110.624 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 87.7 mttt -102.62 106.1 16.71 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.594 HG13 ' HG ' ' A' ' 170' ' ' LEU . 12.0 p -102.78 120.39 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.605 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.766 178.164 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.775 0.322 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -103.89 5.62 35.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.023 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLN . . . . . 0.589 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 19.3 tm0? -53.36 -46.64 97.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.146 -177.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 6.8 Cg_endo -51.85 -44.6 43.88 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.298 1.999 . . . . 0.0 112.75 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.438 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 70.5 mt -69.43 -41.43 80.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 0.0 110.386 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.466 HG12 ' SD ' ' A' ' 111' ' ' MET . 74.2 mt -57.8 -48.3 84.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.461 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.52 -38.75 90.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.078 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -63.84 -48.36 77.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.13 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 42.3 mt -67.48 -33.5 75.23 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.559 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.661 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.31 -47.87 68.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.55 -31.63 70.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.131 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.21 -37.95 89.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.008 0.432 . . . . 0.0 110.741 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -77.13 -26.19 52.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.181 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 81.1 mtp180 -70.95 -24.67 62.48 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.018 176.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.97 -24.15 63.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.293 0.568 . . . . 0.0 110.405 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.89 169.24 8.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.674 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 46.1 m-20 -105.31 38.59 1.92 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ARG . . . . . 0.468 ' CA ' ' HG2' ' A' ' 256' ' ' GLU . 20.7 ttm180 -95.36 138.25 33.31 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.033 -170.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.703 HG22 ' HD2' ' A' ' 284' ' ' LYS . 44.9 pt -122.75 167.02 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.074 175.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' TYR . . . . . 0.48 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 66.0 t80 -119.18 129.36 54.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.199 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . 0.559 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 35.1 m -123.53 134.92 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -126.06 175.66 7.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.846 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.12 27.17 10.54 Favored 'General case' 0 CA--C 1.527 0.059 0 O-C-N 124.158 0.911 . . . . 0.0 109.629 -176.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' VAL . . . . . 0.42 HG13 HD11 ' A' ' 225' ' ' ILE . 22.2 t -77.13 112.46 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' HIS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 42.6 t-80 -53.3 136.95 36.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.058 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -55.08 -34.77 63.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.186 -173.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.13 7.13 47.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.727 0.775 . . . . 0.0 110.639 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.567 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.3 tp -92.0 124.5 36.15 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.7 t -89.65 168.43 12.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.986 0.422 . . . . 0.0 111.219 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.17 -22.85 63.89 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -65.48 -33.91 77.04 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.923 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -72.16 -46.44 56.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.423 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.735 HG13 HD21 ' A' ' 240' ' ' LEU . 21.8 mm -63.11 -50.82 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.67 -44.39 81.35 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.967 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 30.3 t -58.09 -43.68 87.19 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 19.1 t -76.82 -44.02 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.5 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' PHE . . . . . 0.641 ' HB2' HD11 ' A' ' 235' ' ' ILE . 55.3 m-85 -64.1 -33.41 75.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.098 0.475 . . . . 0.0 110.71 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -61.01 -24.96 66.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.457 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.48 -11.93 60.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.153 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.87 -33.89 6.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -156.85 158.39 28.76 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.904 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -69.44 116.05 9.42 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.268 0.556 . . . . 0.0 111.101 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 229' ' ' PHE . 47.0 mt -86.19 151.58 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.733 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -119.32 -15.41 9.13 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.418 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 256' ' ' GLU . 47.6 t -165.77 143.88 5.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -174.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 54.1 t -153.87 117.78 4.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 10.5 t -140.26 139.39 35.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.234 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' LEU . . . . . 0.735 HD21 HG13 ' A' ' 225' ' ' ILE . 77.8 mt -105.43 130.94 53.41 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.81 121.28 15.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.033 0.444 . . . . 0.0 110.376 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 51.6 ttp180 -134.65 152.02 51.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.111 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.485 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 5.7 m-20 -74.11 148.47 86.6 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -45.94 -45.12 17.91 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.04 2.493 . . . . 0.0 113.377 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.2 t -154.66 75.11 0.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.707 0.765 . . . . 0.0 110.881 -176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 18.1 p -125.01 -11.19 7.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.138 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 72.45 20.3 79.33 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.389 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 21.6 ptmt -156.69 141.78 17.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -94.14 140.99 29.06 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.093 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -44.1 -55.97 4.37 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.235 0.959 . . . . 0.0 113.046 -172.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 145.95 11.04 0.24 Allowed Glycine 0 CA--C 1.511 -0.19 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.054 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' TYR . . . . . 0.48 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 44.4 p90 -144.37 167.23 22.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.08 173.81 32.62 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.26 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.447 ' HE1' ' HG3' ' A' ' 164' ' ' GLU . 81.0 m-85 -133.59 143.99 49.01 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 225' ' ' ILE . 67.6 mt -140.12 135.74 37.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.501 -176.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 25.4 mt-10 -112.83 142.23 45.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 7.0 m-85 -102.18 167.35 10.06 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -73.3 -13.99 61.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.96 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -134.76 124.93 25.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.551 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ALA . . . . . 0.412 ' HB2' ' OD1' ' A' ' 209' ' ' ASN . . . -58.97 -44.14 91.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.203 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -62.89 -33.98 76.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.826 0.346 . . . . 0.0 110.802 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 53.3 m -70.48 -27.87 64.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.55 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 267' ' ' VAL . 83.9 p -72.81 -31.3 64.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -72.68 -30.62 64.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.946 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.05 -38.68 92.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.248 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 229' ' ' PHE . . . -66.05 -42.37 89.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.131 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 263' ' ' SER . 82.4 t -53.03 -45.82 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.863 0.363 . . . . 0.0 111.345 176.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.6 m -65.54 -32.13 73.56 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 32.0 t -94.12 -33.64 13.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' MET . . . . . 0.517 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.3 mmm -91.75 0.55 57.48 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -169.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -74.29 118.39 17.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.7 mt 68.62 31.35 4.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.451 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -89.75 123.18 33.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.28 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.1 t70 -69.78 120.21 15.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.875 0.369 . . . . 0.0 110.892 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.567 ' HG ' HD21 ' A' ' 220' ' ' LEU . 38.8 tp -138.41 94.41 2.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.614 173.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.39 25.49 39.39 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.902 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 84.9 3.87 87.57 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.811 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLN . . . . . 0.463 ' HG3' ' HB2' ' A' ' 217' ' ' HIS . 16.8 mm100 -109.64 139.67 44.38 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.55 -178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.6 103.27 15.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.886 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.6 124.5 21.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.635 -175.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -93.92 116.61 29.07 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 171.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 213' ' ' VAL . 14.5 p -124.44 148.37 28.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.103 0.478 . . . . 0.0 111.346 -171.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.19 177.76 41.64 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LYS . . . . . 0.703 ' HD2' HG22 ' A' ' 211' ' ' ILE . 4.6 mmmp? -80.32 123.26 27.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.286 0.543 . . . . 0.0 109.942 175.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' ALA . . . . . 0.487 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -52.47 127.48 22.69 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.96 0.787 . . . . 0.0 110.347 177.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.56 -25.6 5.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 123.466 0.479 . . . . 0.0 111.052 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 21.7 p -127.5 153.33 77.41 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 C-N-CA 122.793 2.329 . . . . 0.0 112.031 178.836 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.87 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 73.37 -62.82 0.45 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.534 0.734 . . . . 0.0 111.953 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.3 mpp? 58.15 48.7 12.49 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.276 0.56 . . . . 0.0 110.73 -177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -97.44 108.69 21.47 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -78.45 114.25 17.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.417 0.627 . . . . 0.0 112.224 -172.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -111.66 -6.2 14.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.25 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -66.67 -25.0 66.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.656 -171.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -61.48 -41.75 97.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.787 0.327 . . . . 0.0 110.791 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.51 -32.82 64.47 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.977 0.418 . . . . 0.0 110.075 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.551 HD23 ' SD ' ' A' ' 111' ' ' MET . 83.8 mt -63.25 -34.29 77.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.642 177.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.47 66.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.167 0.508 . . . . 0.0 110.813 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.0 mt -83.39 -36.83 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.883 175.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.639 ' SD ' HG12 ' A' ' 198' ' ' ILE . 87.2 mtp -72.22 -22.37 61.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.626 -176.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.648 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 76.1 m -74.75 -9.78 58.89 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.88 0.371 . . . . 0.0 111.021 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -105.46 142.25 35.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.589 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.502 HG12 ' HB ' ' A' ' 158' ' ' VAL . 8.7 p -123.93 127.71 73.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.446 0.641 . . . . 0.0 109.826 170.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -80.54 106.8 12.83 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.829 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.481 HG11 ' CZ ' ' A' ' 132' ' ' PHE . 19.0 m -99.09 115.31 39.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.423 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -103.38 149.92 17.53 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.719 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.9 m 76.35 -66.69 0.25 Allowed 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.872 0.869 . . . . 0.0 111.436 178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.513 ' O ' ' HB2' ' A' ' 120' ' ' TYR . 78.6 mt 61.88 -91.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 O-C-N 123.383 0.427 . . . . 0.0 110.697 -176.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 119' ' ' ILE . 23.3 t80 165.94 140.01 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -175.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -79.07 75.35 5.59 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.378 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -174.53 -51.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.991 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 178' ' ' LEU . 78.8 mt -58.81 128.21 36.07 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.717 -173.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -94.99 -177.6 37.82 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.605 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -67.96 -43.59 78.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.412 . . . . 0.0 111.024 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 16.9 t70 -68.28 -42.42 79.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.087 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 24.0 m -67.0 -37.96 85.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.125 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.456 HD13 ' HA ' ' A' ' 128' ' ' ILE . 17.2 mm -61.98 -40.86 88.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.62 177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.546 ' HA ' HD12 ' A' ' 138' ' ' ILE . 38.0 ttp-105 -59.06 -39.76 83.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.886 0.374 . . . . 0.0 110.178 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 72.6 mt-30 -68.59 -34.2 75.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.337 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.09 -21.32 36.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.633 ' HB2' HD11 ' A' ' 138' ' ' ILE . 31.6 m-85 -100.93 -15.29 17.58 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.956 0.408 . . . . 0.0 111.12 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.635 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -54.13 -40.56 82.89 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 177.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.635 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 5.9 Cg_exo -42.76 -38.18 6.41 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.289 2.66 . . . . 0.0 114.013 174.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.541 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 60.3 m-85 -81.49 -46.89 13.87 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 121.049 -0.26 . . . . 0.0 110.881 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.73 165.57 38.51 Favored Glycine 0 N--CA 1.443 -0.872 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.073 172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.461 ' HG2' ' CE1' ' A' ' 252' ' ' TYR . 24.9 Cg_exo -65.05 120.16 7.33 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.722 2.282 . . . . 0.0 111.408 174.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.633 HD11 ' HB2' ' A' ' 132' ' ' PHE . 41.2 mt -79.62 129.54 37.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.356 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -96.62 -29.82 13.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.832 -175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.0 t -158.65 141.5 14.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.593 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.437 ' CG1' HG21 ' A' ' 138' ' ' ILE . 72.1 mt -131.5 122.65 50.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.657 0.265 . . . . 0.0 110.943 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 33.1 t70 -98.14 100.06 11.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 170.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.436 ' CE ' HG13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -104.93 139.62 39.38 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.833 -171.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 p -80.43 122.37 26.89 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.339 177.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -142.33 122.66 13.93 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 120.827 0.346 . . . . 0.0 110.359 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.28 120.74 40.38 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 25.9 m -83.64 -11.63 57.02 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -170.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.414 HG23 HG23 ' A' ' 149' ' ' THR . 22.3 m -95.61 -25.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.304 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.414 HG23 HG23 ' A' ' 148' ' ' VAL . 58.3 p -106.09 -19.27 13.77 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.786 0.327 . . . . 0.0 111.434 177.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 47.6 mtm 66.63 27.91 9.34 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.245 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 46.2 pttt -148.6 174.88 11.68 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -156.17 130.23 8.62 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.79 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -125.22 86.2 2.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.15 172.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -156.06 -114.44 0.47 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.509 -177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -151.58 176.45 11.33 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.54 0.209 . . . . 0.0 110.552 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -151.9 152.78 33.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.319 176.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 46.8 m-85 -109.56 109.95 20.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.785 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.502 ' HB ' HG12 ' A' ' 114' ' ' VAL . 97.4 t -95.33 108.81 21.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.801 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -106.42 115.7 30.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.354 -178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -89.21 178.83 6.26 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.218 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.49 -45.64 30.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.082 0.468 . . . . 0.0 109.796 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 28.7 m -108.64 141.86 24.21 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.452 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.9 Cg_endo -69.5 -21.33 34.87 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.256 2.637 . . . . 0.0 112.518 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.601 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 6.5 mp0 -55.2 -51.43 66.57 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.883 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.12 -23.85 66.79 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 120.954 0.407 . . . . 0.0 111.921 -178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.22 -48.53 12.95 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.112 -0.494 . . . . 0.0 109.753 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.6 ' HG3' HG11 ' A' ' 286' ' ' VAL . 32.2 mm-40 -64.6 -36.53 84.52 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.699 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.541 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 11.8 tp -66.51 -46.81 75.01 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.734 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.06 72.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.148 0.499 . . . . 0.0 109.931 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.536 ' HA ' HG21 ' A' ' 185' ' ' VAL . 6.7 tt -69.79 -46.1 66.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.574 173.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 16.4 mm-40 -56.75 -56.83 16.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.144 -0.935 . . . . 0.0 112.25 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -86.51 -39.42 16.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 27.2 ttp -104.63 30.17 5.61 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.198 -0.601 . . . . 0.0 112.588 -165.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -89.11 44.38 1.21 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.884 0.849 . . . . 0.0 109.673 173.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 19.6 m -115.59 -73.87 0.63 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.416 173.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 18.9 m -146.24 169.34 5.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.712 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.623 ' HB2' HD13 ' A' ' 183' ' ' ILE . 25.0 tpp -145.45 78.98 1.56 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.951 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.604 ' HB2' HD11 ' A' ' 123' ' ' LEU . 75.6 mt 63.84 162.15 0.11 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.527 174.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.29 -65.07 1.65 Allowed Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.736 -0.665 . . . . 0.0 113.008 178.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 140.6 62.81 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 121.203 -0.522 . . . . 0.0 111.861 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.3 tpt180 -143.53 129.54 19.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.772 0.32 . . . . 0.0 111.242 178.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 175' ' ' SER . 8.9 t30 -71.5 103.69 3.04 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.373 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.623 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.5 pt -85.62 159.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.211 0.529 . . . . 0.0 111.884 -173.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -110.51 114.95 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.804 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 170' ' ' LEU . 5.3 m -103.64 108.33 24.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.422 0.63 . . . . 0.0 110.787 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 82.71 158.39 24.46 Favored Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.589 -0.732 . . . . 0.0 112.88 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 77.7 mtm180 -136.41 60.27 31.23 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.736 0.303 . . . . 0.0 110.189 172.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 9.3 Cg_endo -90.45 71.05 1.41 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.1 2.534 . . . . 0.0 111.493 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.474 ' O ' HG12 ' A' ' 191' ' ' ILE . 16.5 m -77.2 39.82 0.25 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.02 -176.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 45.2 28.09 0.39 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.507 1.123 . . . . 0.0 113.364 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 189' ' ' SER . 46.8 mm -126.95 118.44 50.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 148.66 176.67 22.25 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.052 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.441 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 43.8 tt0 -81.32 -28.07 34.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.081 0.467 . . . . 0.0 110.629 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -75.05 -28.8 60.55 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.067 -177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.718 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 27.2 mm-40 -54.32 -53.76 55.66 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.812 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.718 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 52.6 Cg_exo -55.08 -36.12 92.11 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.196 1.931 . . . . 0.0 112.851 176.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 72.6 mt -70.98 -46.09 69.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.783 0.325 . . . . 0.0 110.339 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.639 HG12 ' SD ' ' A' ' 111' ' ' MET . 73.9 mt -57.15 -45.76 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.924 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.7 -39.9 95.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.244 -178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -63.08 -49.94 72.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.868 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 68.1 mt -67.88 -31.91 72.04 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.729 -179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.604 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.34 -47.86 69.0 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -61.65 -36.57 81.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.826 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 208' ' ' PHE . 39.2 mt-10 -68.37 -37.14 80.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.255 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -67.96 -32.24 72.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.83 0.348 . . . . 0.0 110.423 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.9 mtp180 -63.02 -37.98 89.36 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.317 175.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.58 -27.86 67.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.507 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.435 ' HD2' ' O ' ' A' ' 204' ' ' GLU . 75.0 m-85 -94.73 -16.48 23.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.45 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 60.71 41.65 14.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.987 -178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.496 ' HD2' ' OE1' ' A' ' 256' ' ' GLU . 16.5 ttt180 -101.42 145.15 29.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.279 0.561 . . . . 0.0 112.285 -169.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 47.9 pt -129.05 167.56 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.4 178.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.508 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 27.0 t80 -117.65 138.03 52.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.906 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.482 HG12 HG22 ' A' ' 282' ' ' VAL . 28.9 m -128.21 131.63 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.395 0.617 . . . . 0.0 110.915 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -122.38 173.05 7.88 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.588 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.8 t 58.51 31.5 21.09 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.742 0.782 . . . . 0.0 109.619 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.51 114.23 12.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.797 -1.092 . . . . 0.0 108.828 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.629 ' HA ' ' OE1' ' A' ' 278' ' ' GLN . 25.0 t-80 -54.05 130.39 37.78 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.442 0.639 . . . . 0.0 111.726 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -48.58 -33.13 9.16 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 114.23 -1.35 . . . . 0.0 114.186 -173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -85.09 -23.1 28.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.964 0.411 . . . . 0.0 111.835 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.406 HD11 ' HG ' ' A' ' 275' ' ' LEU . 69.5 mt -77.74 128.55 34.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.421 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 21.6 m -92.24 173.29 7.9 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.468 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -49.29 -50.28 39.83 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.842 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -62.24 -33.87 75.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.506 -174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -70.84 -38.1 73.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.629 0.252 . . . . 0.0 110.586 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.829 HG22 HD11 ' A' ' 255' ' ' ILE . 29.2 mm -67.01 -41.84 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.454 ' HG3' HG21 ' A' ' 235' ' ' ILE . 83.9 tttt -57.67 -45.45 85.53 Favored 'General case' 0 C--O 1.218 -0.57 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.389 173.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 39.6 t -54.19 -47.75 71.73 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.45 -39.58 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 121.15 -0.22 . . . . 0.0 111.347 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.533 ' HB2' HD11 ' A' ' 235' ' ' ILE . 24.0 m-85 -68.31 -29.78 68.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.019 0.438 . . . . 0.0 110.603 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -62.12 -26.24 68.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.946 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.66 -16.31 62.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.407 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -111.56 -40.12 4.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.082 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.427 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -138.31 161.8 25.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.52 -0.847 . . . . 0.0 112.325 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -81.02 104.23 11.37 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.181 0.515 . . . . 0.0 110.694 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.533 HD11 ' HB2' ' A' ' 229' ' ' PHE . 27.3 mt -82.83 151.15 4.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.702 0.763 . . . . 0.0 111.759 -175.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.627 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 45.4 tttm -107.26 -40.13 5.49 Favored 'General case' 0 N--CA 1.437 -1.092 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.044 176.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 53.1 m -158.62 152.92 24.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.816 0.341 . . . . 0.0 110.545 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 9.3 p -133.37 125.67 29.65 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.746 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 12.0 m -140.37 100.9 4.0 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.717 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.521 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 44.4 mt -84.23 148.04 26.93 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 174.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -72.3 91.75 1.35 Allowed 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.692 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 16.4 ttp85 -109.06 138.08 45.96 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.428 -175.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' A' ' 244' ' ' PRO . 9.4 t70 -118.95 126.59 27.01 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.643 -172.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 11.6 Cg_exo -67.37 -21.03 47.88 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.994 2.462 . . . . 0.0 113.258 -176.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 35.2 p -100.97 13.57 34.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.133 0.492 . . . . 0.0 111.238 -175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.408 HG23 ' OD1' ' A' ' 243' ' ' ASP . 63.8 p -115.23 -29.65 6.54 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.251 0.548 . . . . 0.0 110.078 173.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 93.59 1.44 66.09 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.015 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -154.56 -165.87 2.18 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.692 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 7.9 p80 -98.6 154.0 18.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.301 0.572 . . . . 0.0 109.764 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -71.22 -15.34 62.45 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.782 -1.099 . . . . 0.0 112.864 -168.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 120.39 -6.19 11.78 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 120.281 -0.962 . . . . 0.0 113.035 175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.461 ' CE1' ' HG2' ' A' ' 137' ' ' PRO . 0.5 OUTLIER -134.61 158.62 43.57 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -162.79 177.62 38.82 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.407 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.601 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 52.9 m-85 -132.28 149.19 52.42 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.829 HD11 HG22 ' A' ' 225' ' ' ILE . 82.5 mt -134.08 142.59 40.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.496 ' OE1' ' HD2' ' A' ' 210' ' ' ARG . 30.7 tt0 -128.16 134.54 49.09 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -170.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.593 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 10.4 m-85 -111.0 165.52 11.81 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.142 0.496 . . . . 0.0 111.534 -173.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.627 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 13.6 mt-10 -88.22 -12.0 45.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.156 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -134.93 124.78 25.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.886 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 264' ' ' GLN . . . -65.44 -22.09 66.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.45 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -75.17 -47.08 30.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 23.4 m -65.09 -33.35 75.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.831 -175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.593 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 90.2 p -67.74 -31.88 72.1 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 260' ' ' ALA . 75.4 mt-30 -75.25 -24.65 57.68 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.06 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -63.98 -49.19 73.46 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 175.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 229' ' ' PHE . . . -58.5 -40.16 82.06 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.131 -0.94 . . . . 0.0 111.259 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.56 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 97.5 t -57.1 -39.33 65.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.976 0.417 . . . . 0.0 111.045 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.6 t -81.66 -40.52 22.75 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.285 -176.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.5 m -80.48 -40.35 26.35 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.44 ' HB2' HG21 ' A' ' 282' ' ' VAL . 89.5 mmm -89.69 -5.01 57.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.856 -170.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 267' ' ' VAL . 63.5 t30 -71.09 122.05 19.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 98.3 mt 70.09 23.06 5.42 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 123.886 0.741 . . . . 0.0 111.015 -178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.35 125.77 30.32 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -81.09 101.57 9.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.063 0.459 . . . . 0.0 110.185 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.406 ' HG ' HD11 ' A' ' 220' ' ' LEU . 36.5 tp -121.25 99.55 6.55 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.983 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.73 25.8 37.25 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.285 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 77.19 33.78 43.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.206 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.629 ' OE1' ' HA ' ' A' ' 217' ' ' HIS . 2.1 tt0 -152.43 139.99 19.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -91.45 103.15 15.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.665 0.269 . . . . 0.0 111.079 -176.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 34.8 mt -58.36 116.97 3.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.806 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 281' ' ' ARG . 14.3 mmm-85 -93.46 114.6 27.02 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.56 ' CG1' ' HA ' ' A' ' 267' ' ' VAL . 17.1 t -112.35 140.05 34.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.858 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -153.92 170.58 32.56 Favored Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.625 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -75.9 128.98 36.23 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -74.05 128.76 36.36 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.6 HG11 ' HG3' ' A' ' 167' ' ' GLN . 20.1 m -93.77 -19.67 6.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.778 0.323 . . . . 0.0 111.478 -172.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.525 HG21 HD22 ' A' ' 108' ' ' LEU . 4.3 t -147.82 138.86 13.31 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.144 175.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.85 109.22 1.04 Allowed 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 123.346 2.697 . . . . 0.0 112.924 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.447 ' HD2' ' HD3' ' A' ' 210' ' ' ARG . 3.8 Cg_exo -76.2 99.67 1.31 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.097 2.531 . . . . 0.0 110.977 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 59.7 mtt -79.78 110.99 17.87 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.8 -176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.574 ' HB2' HD22 ' A' ' 292' ' ' LEU . 6.2 Cg_exo -74.43 -38.25 2.04 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.887 2.391 . . . . 0.0 111.98 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.574 HD22 ' HB2' ' A' ' 291' ' ' PRO . 3.2 mm? -119.2 95.79 4.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.252 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 34.3 tp -88.21 60.79 5.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.491 0.662 . . . . 0.0 109.667 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 19.8 p -115.52 92.73 34.1 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.542 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -83.04 24.31 0.75 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 123.109 2.539 . . . . 0.0 113.316 -174.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -141.81 24.12 2.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.296 0.57 . . . . 0.0 110.504 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 35.8 m . . . . . 0 C--O 1.249 1.059 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.07 -179.424 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.996 -0.441 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -86.17 -37.28 18.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.725 0.298 . . . . 0.0 110.81 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 25.5 mmt -89.91 -47.25 7.99 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.51 85.56 6.48 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 171.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -81.14 60.52 4.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.575 0.703 . . . . 0.0 112.169 -171.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.433 ' HG2' ' HG3' ' A' ' 105' ' ' GLN . 40.2 ttm180 -130.6 150.59 51.73 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 171.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.442 ' HB3' HD12 ' A' ' 108' ' ' LEU . 69.1 mt-30 63.67 35.96 11.12 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -173.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -65.62 -42.09 91.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.821 -172.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.415 ' HB2' ' HB ' ' A' ' 197' ' ' ILE . . . -66.85 -33.07 74.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.035 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.487 HD23 ' SD ' ' A' ' 111' ' ' MET . 57.3 mt -63.47 -32.13 73.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.467 -176.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.13 -28.63 69.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.189 0.519 . . . . 0.0 110.575 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.5 mt -88.52 -35.92 8.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.207 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.531 ' SD ' HG12 ' A' ' 198' ' ' ILE . 94.0 mtp -67.06 -18.94 65.57 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.083 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 85.3 m -81.94 -10.68 59.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 110.592 177.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.431 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 98.4 mtt180 -109.7 143.4 39.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.229 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.4 p -120.37 121.7 66.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 168.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -76.09 129.16 36.39 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.721 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.671 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 15.0 m -123.83 122.16 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.497 0.665 . . . . 0.0 111.128 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -129.63 174.97 19.22 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.416 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.404 ' HB3' HH21 ' A' ' 181' ' ' ARG . 66.0 m 64.46 36.9 8.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 111.295 -179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 63.3 mt -85.0 105.84 14.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.42 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -52.85 146.49 10.59 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.341 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.42 ' HA ' ' CE1' ' A' ' 152' ' ' HIS . 14.1 p90 -71.4 76.13 0.76 Allowed 'General case' 0 CA--C 1.527 0.089 0 CA-C-O 122.029 0.919 . . . . 0.0 111.314 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -165.67 -43.34 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.196 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.522 HD22 HD12 ' A' ' 178' ' ' LEU . 36.2 mt -75.11 103.34 5.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.638 -1.165 . . . . 0.0 110.114 177.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -81.64 174.32 54.1 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.208 178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -62.32 -39.97 94.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.887 0.375 . . . . 0.0 110.205 -178.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -59.69 -42.03 92.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.208 0.528 . . . . 0.0 110.371 178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 2.3 m -68.9 -39.93 79.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.46 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.521 HG13 ' HE1' ' A' ' 143' ' ' MET . 35.5 mm -64.09 -44.2 97.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.512 177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -57.28 -46.68 82.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.543 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -62.34 -33.25 74.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.582 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.634 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -78.28 -31.98 49.27 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.452 ' HD1' ' O ' ' A' ' 128' ' ' ILE . 50.1 m-85 -93.43 -17.08 23.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.776 0.322 . . . . 0.0 111.454 -178.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.03 -44.11 91.22 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -47.52 -33.17 17.09 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.783 2.322 . . . . 0.0 114.389 177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.564 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 70.1 m-85 -79.69 -53.47 6.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.4 -171.04 25.79 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 119.637 -1.268 . . . . 0.0 113.361 177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.46 112.82 2.79 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.921 2.414 . . . . 0.0 111.736 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.646 HD13 HD11 ' A' ' 141' ' ' ILE . 68.7 mt -76.6 127.27 37.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.428 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -84.81 -45.81 11.98 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.568 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -166.22 131.65 2.35 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.803 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.646 HD11 HD13 ' A' ' 138' ' ' ILE . 67.6 mt -109.36 114.11 46.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 171.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -94.09 100.46 12.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.044 0.45 . . . . 0.0 110.554 -178.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.521 ' HE1' HG13 ' A' ' 128' ' ' ILE . 36.5 ttm -143.14 124.65 14.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.929 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.5 m -87.41 107.63 18.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.581 177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -84.18 83.53 7.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.552 0.691 . . . . 0.0 109.192 174.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -81.95 103.27 11.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.84 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 21.1 t -90.93 28.25 1.62 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.89 -174.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 87.0 t -71.71 -44.63 68.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.089 0.471 . . . . 0.0 109.894 175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 150' ' ' MET . 33.0 p -119.62 12.78 12.37 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.629 175.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.498 ' HB2' ' O ' ' A' ' 149' ' ' THR . 42.2 mtp 74.19 -22.86 0.24 Allowed 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.852 0.72 . . . . 0.0 110.984 -174.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 149' ' ' THR . 49.7 mtmt -84.86 131.32 34.53 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 121' ' ' TYR . 22.9 p-80 -96.91 -170.85 2.11 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.544 -174.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -54.36 -44.99 72.67 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.895 0.379 . . . . 0.0 111.039 -178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.418 ' H ' ' HD2' ' A' ' 152' ' ' HIS . . . 108.99 -31.37 7.77 Favored Glycine 0 CA--C 1.508 -0.349 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.87 176.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -116.39 153.86 31.29 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -153.66 164.74 37.77 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.965 0.412 . . . . 0.0 111.305 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -120.83 111.86 18.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.422 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 78.7 t -97.45 106.49 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.98 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.431 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 39.4 tt0 -107.57 128.57 54.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.76 0.314 . . . . 0.0 110.615 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -95.17 179.82 5.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.976 176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -91.94 -14.9 28.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.851 0.358 . . . . 0.0 110.16 172.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 18.9 m -130.53 135.09 26.86 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.234 175.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.642 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 46.0 Cg_endo -67.57 -21.11 46.45 Favored 'Trans proline' 0 N--CA 1.474 0.35 0 C-N-CA 123.311 2.674 . . . . 0.0 112.585 -176.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.948 ' HG3' ' HE1' ' A' ' 254' ' ' PHE . 5.7 mm-40 -61.01 -52.08 66.53 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.872 -174.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.645 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -66.86 -17.88 65.11 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.02 -47.21 18.94 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.432 ' HG3' HG11 ' A' ' 286' ' ' VAL . 29.6 mm-40 -69.49 -34.88 74.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.461 174.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.645 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 13.6 tp -61.77 -48.1 82.18 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.581 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.04 -32.98 72.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.97 0.414 . . . . 0.0 110.229 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.65 -52.13 41.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.589 173.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -52.54 -38.85 60.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.669 -176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . 0.459 HE21 ' HE1' ' A' ' 135' ' ' PHE . 22.7 mt-30 -99.76 -49.22 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 34.4 ttp -104.87 29.63 6.13 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -165.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -72.96 -20.78 60.98 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.929 0.395 . . . . 0.0 110.708 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 3.9 p -72.32 -73.58 0.19 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 17.6 m -134.07 151.98 33.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.033 0.444 . . . . 0.0 111.422 -175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.797 ' HE2' ' HG ' ' A' ' 178' ' ' LEU . 1.7 tpt -125.55 97.14 5.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.809 177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.797 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 85.9 mt 67.56 127.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 O-C-N 123.93 0.769 . . . . 0.0 112.377 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 72.17 -80.17 0.61 Allowed Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.385 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 178.43 36.89 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.07 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.404 HH21 ' HB3' ' A' ' 118' ' ' SER . 7.7 tpt180 -100.4 122.42 43.12 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.687 0.279 . . . . 0.0 110.808 178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.6 126.44 30.99 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.546 173.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.8 pt -120.26 176.91 3.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.396 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.671 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 74.0 mmtt -103.24 107.27 18.03 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 27.6 t -113.36 106.87 21.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.13 0.269 . . . . 0.0 110.696 -178.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 141.96 -97.87 0.21 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 119.855 -1.164 . . . . 0.0 114.24 172.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 189' ' ' SER . 87.5 mtt180 -78.25 127.16 82.0 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-O 120.665 0.269 . . . . 0.0 111.702 -170.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 3.6 Cg_exo -77.91 -9.46 16.84 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.967 2.445 . . . . 0.0 111.178 172.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 187' ' ' ARG . 35.3 p -157.29 156.68 32.84 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.449 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -48.55 -61.45 2.01 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 123.619 0.574 . . . . 0.0 112.214 -175.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.525 HD12 ' HG3' ' A' ' 195' ' ' GLN . 10.6 tp -138.22 152.02 25.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -144.31 166.02 27.3 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.202 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -71.25 -15.77 62.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.849 0.357 . . . . 0.0 111.795 -177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.473 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -88.45 -12.37 43.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.653 0.263 . . . . 0.0 111.362 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.569 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 33.8 mm-40 -59.08 -49.88 90.79 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 75.4 Cg_exo -52.97 -35.29 70.76 Favored 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 122.288 1.992 . . . . 0.0 112.847 177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 107' ' ' ALA . 60.6 mt -69.94 -46.64 72.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.129 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.531 HG12 ' SD ' ' A' ' 111' ' ' MET . 57.6 mt -57.41 -43.27 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.239 178.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -58.19 -44.38 88.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.043 178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -68.8 -45.44 71.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.911 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.436 HD23 ' OE2' ' A' ' 204' ' ' GLU . 19.4 mt -64.73 -33.53 76.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.784 -0.189 . . . . 0.0 110.783 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.656 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.02 -51.77 60.61 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -60.18 -38.29 82.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.272 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.436 ' OE2' HD23 ' A' ' 201' ' ' LEU . 52.5 mt-10 -60.54 -45.98 91.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.106 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -65.98 -38.02 87.46 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.882 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.656 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 53.3 mtp180 -64.89 -33.93 77.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.791 178.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -70.42 -30.03 66.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.814 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -94.69 -4.47 47.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.035 0.445 . . . . 0.0 110.68 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 7.2 m120 62.89 44.03 6.48 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.055 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 18.7 ttp180 -99.93 142.78 30.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.188 0.518 . . . . 0.0 111.382 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.5 pt -127.76 166.35 24.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.175 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.559 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 86.3 t80 -119.18 128.79 54.57 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.156 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.627 HG12 HG23 ' A' ' 282' ' ' VAL . 32.2 m -121.77 131.28 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-O 121.183 0.516 . . . . 0.0 110.641 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -124.8 174.19 8.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.17 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 18.2 t 60.78 30.94 20.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.887 0.851 . . . . 0.0 109.223 -174.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 36.1 t -79.91 116.06 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.581 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.58 ' HD2' ' HG3' ' A' ' 278' ' ' GLN . 7.6 t-80 -56.4 135.25 54.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.471 0.653 . . . . 0.0 111.677 -169.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -49.29 -38.19 26.48 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -171.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -89.94 -10.02 46.64 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.754 0.311 . . . . 0.0 111.145 -174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.473 ' HA ' HD12 ' A' ' 220' ' ' LEU . 10.7 tp -83.44 124.59 30.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.257 -174.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 27.9 t -87.59 169.17 12.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.817 -173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -57.08 -36.8 71.0 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.791 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.41 -45.56 72.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.706 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -74.01 -40.95 62.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.059 -175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.671 HG22 HD11 ' A' ' 255' ' ' ILE . 31.4 mm -63.38 -47.73 90.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 238' ' ' CYS . 66.1 tttm -58.16 -46.57 85.46 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.052 176.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.5 t -54.5 -43.57 71.95 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.07 -41.98 38.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.093 -0.243 . . . . 0.0 111.41 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.524 ' CB ' HD11 ' A' ' 235' ' ' ILE . 20.6 m-85 -67.44 -28.22 67.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.207 0.527 . . . . 0.0 110.537 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -59.7 -24.54 64.05 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 124.151 0.981 . . . . 0.0 110.467 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -74.95 -15.84 60.66 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.205 -173.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -111.3 -23.23 10.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.99 0.424 . . . . 0.0 110.658 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.542 ' HA3' ' HB3' ' A' ' 262' ' ' SER . . . -165.66 156.31 28.17 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.81 177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.458 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 23.4 mmtp -74.08 122.52 22.81 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.546 0.688 . . . . 0.0 110.861 -179.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.524 HD11 ' CB ' ' A' ' 229' ' ' PHE . 57.1 mt -92.91 150.43 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.589 -1.187 . . . . 0.0 112.144 -172.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.437 ' HE2' ' CB ' ' A' ' 256' ' ' GLU . 31.8 ttpt -110.5 -28.57 8.46 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.221 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 16.8 m -152.43 146.58 25.42 Favored 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.458 -173.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 226' ' ' LYS . 47.2 t -152.78 107.33 3.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.521 174.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 58.7 m -140.52 109.27 5.98 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.133 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.56 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 51.4 mt -77.31 143.61 38.69 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.879 -0.601 . . . . 0.0 109.479 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -66.08 113.12 4.25 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 177.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 29.3 ttp180 -149.89 139.49 21.62 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.147 -169.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -74.29 128.45 86.04 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -44.49 -46.0 12.41 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 123.897 3.065 . . . . 0.0 114.394 -163.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 3.7 t -133.89 76.58 1.66 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.705 0.764 . . . . 0.0 110.579 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 6.6 p -125.75 1.33 7.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.289 176.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 70.18 12.75 69.31 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 121.081 -0.58 . . . . 0.0 113.043 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 22.5 pttp -163.35 179.66 7.2 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -131.0 152.02 50.76 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -48.32 -61.53 1.95 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 123.976 0.798 . . . . 0.0 112.573 -172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 160.97 12.33 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.245 -0.978 . . . . 0.0 112.616 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 18.0 p90 -152.05 -179.69 7.72 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.56 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -170.61 177.76 43.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.357 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.948 ' HE1' ' HG3' ' A' ' 164' ' ' GLU . 83.3 m-85 -128.96 143.57 50.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.971 0.415 . . . . 0.0 110.917 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.671 HD11 HG22 ' A' ' 225' ' ' ILE . 89.7 mt -140.45 140.75 33.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.004 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.437 ' CB ' ' HE2' ' A' ' 236' ' ' LYS . 45.2 mt-10 -120.67 147.6 45.04 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.624 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 20.2 m-85 -111.75 164.2 13.32 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 120.654 0.264 . . . . 0.0 110.312 177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -86.84 -5.23 59.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.323 0.582 . . . . 0.0 109.433 174.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -127.87 128.63 45.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.848 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.99 -26.51 68.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.206 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -74.86 -52.69 10.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.519 176.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.542 ' HB3' ' HA3' ' A' ' 233' ' ' GLY . 28.3 m -60.14 -31.49 70.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.456 -172.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.624 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 48.7 p -64.63 -48.62 74.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.997 0.427 . . . . 0.0 109.988 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -72.53 -18.92 61.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.189 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -69.15 -40.9 77.92 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.045 0.45 . . . . 0.0 110.044 176.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.35 -33.62 75.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.949 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.442 ' O ' ' HB2' ' A' ' 271' ' ' ASN . 88.2 t -59.25 -31.58 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 121.164 0.507 . . . . 0.0 110.64 174.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.5 t -83.93 -46.6 11.92 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.898 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.7 m -78.31 -43.24 28.49 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -172.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.487 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 80.0 mmm -83.87 1.21 44.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.161 0.505 . . . . 0.0 110.752 -173.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.636 ' HA ' HG12 ' A' ' 282' ' ' VAL . 18.7 t-20 -71.81 114.22 9.67 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.157 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 86.0 mt 67.31 36.86 3.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.195 -177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -91.42 121.78 33.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.326 175.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.55 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 26.7 t70 -75.76 106.35 7.29 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.72 0.295 . . . . 0.0 110.271 -178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 41.1 tp -131.04 110.03 10.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.028 0.442 . . . . 0.0 110.506 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 88.82 5.02 74.73 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.185 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.12 -5.16 31.89 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.337 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.58 ' HG3' ' HD2' ' A' ' 217' ' ' HIS . 28.5 mt-30 -125.19 143.52 50.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.828 0.346 . . . . 0.0 110.526 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 57.4 m-85 -78.07 113.22 15.8 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.089 173.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 83.0 mt -62.37 130.37 44.97 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.05 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -98.35 114.58 26.95 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 173.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 271' ' ' ASN . 7.5 p -118.39 143.91 27.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.878 -174.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -157.59 173.81 35.0 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.394 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 8.6 mtpt -75.83 135.01 40.22 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -71.99 144.93 48.67 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.432 HG11 ' HG3' ' A' ' 167' ' ' GLN . 20.3 m -109.3 -4.77 10.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 C-N-CA 120.816 -0.354 . . . . 0.0 111.329 -175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 46.9 p -129.58 146.75 62.43 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.49 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.65 170.84 19.13 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.553 2.169 . . . . 0.0 111.013 173.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -44.89 -49.81 9.28 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.666 2.244 . . . . 0.0 112.11 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.455 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 24.4 mmt -133.58 111.92 12.69 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.394 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 9.2 Cg_exo -72.51 61.52 3.54 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 123.584 2.856 . . . . 0.0 112.554 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.7 pp -169.42 13.09 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.945 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 38.0 tp -97.54 64.53 1.83 Allowed 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 121.425 0.631 . . . . 0.0 110.497 -173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 3.0 p -123.78 108.55 30.65 Favored Pre-proline 0 C--N 1.318 -0.798 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.504 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -56.52 -37.52 97.2 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.816 2.344 . . . . 0.0 111.219 177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -147.23 -69.83 0.24 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.123 172.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 84.0 m . . . . . 0 C--O 1.245 0.84 0 CA-C-N 115.116 -0.947 . . . . 0.0 108.539 171.693 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.755 0 N-CA-C 112.365 -0.294 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -61.98 -62.27 1.9 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.945 0.402 . . . . 0.0 111.422 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 71.9 mtm -86.81 -4.32 59.16 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.099 0.476 . . . . 0.0 110.206 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.18 -37.09 54.39 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.851 175.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -82.75 64.17 7.24 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.263 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -99.18 20.15 14.02 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.816 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -86.44 28.3 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.466 0.65 . . . . 0.0 109.657 176.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -64.03 -30.2 71.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.753 -176.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -73.1 -44.05 60.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.39 175.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.499 HD23 ' SD ' ' A' ' 111' ' ' MET . 60.3 mt -61.02 -36.07 78.54 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.274 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.47 -36.74 71.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.114 0.483 . . . . 0.0 110.437 177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.5 mt -78.73 -40.86 23.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.215 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.56 ' SD ' HG12 ' A' ' 198' ' ' ILE . 90.6 mtp -62.09 -28.2 69.45 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.588 -176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 67.0 m -74.97 -14.69 60.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.815 0.341 . . . . 0.0 111.109 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.587 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 42.8 mtp180 -101.53 140.31 35.99 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.852 HG12 ' HB ' ' A' ' 158' ' ' VAL . 9.6 p -110.0 121.82 63.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -82.23 100.98 10.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.008 -178.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.733 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 35.3 m -108.21 141.32 23.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.145 0.498 . . . . 0.0 110.969 -179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.826 ' HA3' ' HD1' ' A' ' 155' ' ' PHE . . . -155.59 170.97 33.59 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.277 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 9.4 t 62.49 37.83 13.08 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.795 0.807 . . . . 0.0 109.683 -176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 73.5 mt -73.29 -14.99 16.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.543 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.9 t80 74.55 140.88 0.06 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.822 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.731 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 6.6 p90 -72.11 78.25 0.95 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.427 0.632 . . . . 0.0 110.995 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -159.58 -54.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.426 -0.807 . . . . 0.0 110.256 175.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.8 mt -68.54 119.58 13.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.753 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.63 -173.48 44.34 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.073 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -63.59 -39.32 94.08 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 122.632 0.373 . . . . 0.0 111.316 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.403 ' HA ' ' NE ' ' A' ' 129' ' ' ARG . 22.2 t70 -62.85 -41.19 99.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.38 -176.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.2 m -68.7 -40.13 80.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.453 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.43 HG13 ' CE ' ' A' ' 143' ' ' MET . 31.2 mm -62.73 -50.82 78.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.061 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.403 ' NE ' ' HA ' ' A' ' 126' ' ' ASP . 38.7 ptt180 -60.05 -42.28 94.12 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.169 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -67.63 -33.29 74.68 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.39 -33.5 28.69 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.265 0.468 . . . . 0.0 112.265 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.562 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 51.2 m-85 -87.89 -20.54 25.85 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 -177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.86 -43.93 97.28 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -41.68 -40.93 5.67 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.069 2.512 . . . . 0.0 114.221 176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.685 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 57.0 m-85 -75.45 -46.64 31.42 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.544 0.211 . . . . 0.0 111.295 -174.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -165.25 173.21 41.02 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.612 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.49 119.89 6.79 Favored 'Trans proline' 0 C--O 1.24 0.578 0 C-N-CA 122.672 2.248 . . . . 0.0 111.688 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.6 mt -83.39 121.97 36.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.623 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -80.78 -52.49 7.46 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.695 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 12.5 t -152.17 152.12 31.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.097 -177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -124.69 108.98 21.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.066 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.749 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 18.4 m-20 -81.46 98.76 8.4 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.43 ' CE ' HG13 ' A' ' 128' ' ' ILE . 51.5 ttm -136.76 137.65 40.09 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.025 0.441 . . . . 0.0 111.014 -176.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.3 m -79.02 137.84 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.792 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.595 ' CZ2' ' HB2' ' A' ' 150' ' ' MET . 36.7 t-105 -119.02 124.01 45.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.532 ' HB2' ' HA ' ' A' ' 152' ' ' HIS . 46.6 m-20 -125.38 135.23 52.2 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.1 m 68.17 166.37 0.25 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 163.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 86.0 t -67.8 -31.4 52.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.896 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.429 ' O ' ' HG2' ' A' ' 150' ' ' MET . 3.3 p -71.92 2.52 5.44 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.736 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.595 ' HB2' ' CZ2' ' A' ' 145' ' ' TRP . 21.3 ptp 51.41 25.83 2.81 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.436 1.094 . . . . 0.0 111.869 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.731 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 99.8 mttt -100.8 130.28 46.8 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 175.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.532 ' HA ' ' HB2' ' A' ' 146' ' ' ASP . 24.4 p80 -124.88 151.99 44.61 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.873 0.368 . . . . 0.0 111.419 -169.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -101.18 171.98 7.28 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.944 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 89.21 -142.82 17.03 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.83 -0.7 . . . . 0.0 114.278 168.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.826 ' HD1' ' HA3' ' A' ' 117' ' ' GLY . 41.4 m-85 -128.36 177.96 6.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.069 -0.566 . . . . 0.0 110.394 -171.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.25 151.53 37.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.886 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.749 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 81.7 m-85 -114.87 109.44 18.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.952 176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.852 ' HB ' HG12 ' A' ' 114' ' ' VAL . 87.8 t -91.71 105.63 16.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.587 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 50.5 tt0 -99.53 115.6 29.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.717 -176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -91.55 178.46 5.93 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.057 -0.52 . . . . 0.0 109.93 178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -77.54 -37.18 51.35 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.258 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.7 m -116.77 146.14 37.04 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.078 -178.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.9 Cg_endo -70.17 -18.99 34.75 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.358 2.705 . . . . 0.0 112.056 -179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.61 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 9.1 mp0 -55.92 -53.84 51.91 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.807 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.442 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.08 -21.37 64.9 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.09 -45.46 15.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.75 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.629 ' HG3' HG11 ' A' ' 286' ' ' VAL . 16.0 mm100 -69.0 -31.83 70.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.787 173.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.685 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 14.2 tp -70.23 -47.19 62.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.522 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -61.62 -31.34 71.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.091 0.472 . . . . 0.0 109.85 177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.648 HD12 ' HA3' ' A' ' 186' ' ' GLY . 4.0 tt -67.64 -51.81 45.55 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 172.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.0 mm-40 -52.53 -43.47 65.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.853 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -95.6 -46.41 6.65 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -175.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.7 ttp -104.28 31.08 4.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.089 0.471 . . . . 0.0 112.123 -166.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.412 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 9.0 p30 -76.59 7.06 4.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.582 178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 15.3 m -102.49 -73.49 0.66 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.554 -177.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 181' ' ' ARG . 24.5 m -133.04 156.11 41.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.819 0.342 . . . . 0.0 111.365 -173.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.976 ' HB2' HD13 ' A' ' 183' ' ' ILE . 2.1 tpt -122.95 104.06 9.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.376 177.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.99 61.04 2.48 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.181 172.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 122.75 -153.56 16.94 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.397 -0.906 . . . . 0.0 112.489 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -96.58 72.33 0.79 Allowed Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.253 -177.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 176' ' ' VAL . 21.8 tpt180 -143.57 118.95 10.26 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 175' ' ' SER . 42.2 m-80 -78.47 119.28 21.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.852 0.358 . . . . 0.0 110.209 176.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.976 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.4 pt -111.81 166.72 5.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.237 -176.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.733 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 27.4 mtpp -103.48 134.65 46.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 172.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.675 HG12 HG12 ' A' ' 116' ' ' VAL . 26.4 m -134.18 152.73 34.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.937 0.399 . . . . 0.0 110.305 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.648 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 86.72 -95.2 2.03 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.003 173.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 4.4 ptp85 -178.07 134.6 0.34 Allowed Pre-proline 0 C--N 1.328 -0.355 0 O-C-N 123.753 0.325 . . . . 0.0 110.562 -174.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 37.5 Cg_exo -61.75 131.95 37.8 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.684 2.256 . . . . 0.0 111.137 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 16.2 m -62.9 109.14 1.36 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.961 -177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -149.44 155.38 40.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.1 tp -89.15 135.84 24.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.865 0.364 . . . . 0.0 110.159 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -168.38 -150.44 6.62 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.869 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -80.71 -39.75 26.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.553 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -79.27 -32.46 43.68 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.689 0.255 . . . . 0.0 111.689 -175.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.493 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 51.4 tp60 -54.08 -53.31 59.99 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.0 Cg_endo -53.2 -39.38 80.73 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.542 2.162 . . . . 0.0 112.674 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.97 -45.21 55.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 -177.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.56 HG12 ' SD ' ' A' ' 111' ' ' MET . 51.8 mt -59.33 -47.48 90.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-O 121.15 0.5 . . . . 0.0 110.162 176.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.46 -39.5 94.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.777 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 23.5 tp60 -63.35 -47.42 82.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.008 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.551 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 39.8 mt -67.18 -32.94 74.35 Favored 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 121.172 -0.211 . . . . 0.0 110.629 -179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.64 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.74 -45.23 74.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.991 0.424 . . . . 0.0 109.914 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -68.47 -34.95 76.83 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.066 174.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 35.5 mt-10 -66.69 -31.57 72.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.275 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -71.98 -29.24 64.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.164 174.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 74.9 mtp180 -72.36 -15.29 61.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.602 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -90.73 -2.53 57.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -130.92 169.06 16.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.987 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.584 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 36.3 m-20 -108.7 35.13 3.32 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.382 -175.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.456 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 24.2 ttm180 -95.11 137.42 34.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.121 0.486 . . . . 0.0 111.595 -173.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 34.0 pt -128.95 167.07 25.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.987 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.486 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 73.5 t80 -122.34 126.81 48.85 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.618 -176.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.523 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 35.7 m -122.4 132.96 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 CA-C-O 120.998 0.428 . . . . 0.0 110.461 177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.15 174.54 7.99 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.685 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 54.5 m 60.8 31.13 20.05 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.499 0.666 . . . . 0.0 109.955 -175.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.55 127.64 36.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.031 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.521 ' HD2' ' HG3' ' A' ' 278' ' ' GLN . 19.0 t-80 -56.91 135.16 55.97 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.593 0.235 . . . . 0.0 111.191 -173.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -47.5 -53.75 13.45 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -169.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.26 22.61 5.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.411 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.1 tp -101.5 131.36 47.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 77.7 p -93.94 171.61 8.75 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.287 0.476 . . . . 0.0 112.287 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -63.62 -32.13 73.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.856 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.33 -34.5 76.76 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.475 0.655 . . . . 0.0 109.844 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 228' ' ' VAL . 62.7 m-20 -73.56 -43.68 59.27 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.074 -0.967 . . . . 0.0 110.702 -178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.7 HG22 HD11 ' A' ' 255' ' ' ILE . 32.6 mm -64.38 -44.12 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 65.5 tttm -57.16 -49.8 74.83 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.607 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 67.3 m -56.84 -37.7 71.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.779 0.659 . . . . 0.0 112.779 -175.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 224' ' ' ASP . 25.1 t -75.95 -44.23 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 122.122 -0.361 . . . . 0.0 111.559 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.578 ' HB2' HD11 ' A' ' 235' ' ' ILE . 32.6 m-85 -69.77 -28.79 66.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.455 0.645 . . . . 0.0 110.188 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 8.7 tp10 -59.51 -25.12 64.21 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.796 175.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.42 -9.93 59.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.182 -174.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -109.61 -45.29 3.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.666 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -144.55 165.19 27.59 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.096 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -70.96 115.83 10.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.233 0.539 . . . . 0.0 110.783 178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.578 HD11 ' HB2' ' A' ' 229' ' ' PHE . 27.6 mt -87.8 150.56 3.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.756 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -112.49 -23.08 10.49 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.26 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 22.6 t -172.24 145.37 1.72 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.773 0.321 . . . . 0.0 110.859 -175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.5 t -141.69 128.26 20.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 175.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.8 m -142.38 110.78 6.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.985 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.614 HD21 HG13 ' A' ' 225' ' ' ILE . 46.0 mt -83.98 133.55 34.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 174.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -70.18 119.31 14.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.839 0.352 . . . . 0.0 110.544 -178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.557 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 18.0 mtm180 -122.94 145.9 48.07 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.706 -176.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.609 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 10.6 m-20 -79.55 140.11 55.4 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.441 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -50.46 -25.6 14.53 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 124.04 3.16 . . . . 0.0 114.769 -171.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.1 t -157.78 48.16 0.39 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.517 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.609 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 17.2 p -102.89 -28.81 11.82 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.73 -0.606 . . . . 0.0 111.879 176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.04 20.54 59.09 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.702 -175.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.27 174.23 14.56 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.557 ' HB3' ' HG2' ' A' ' 242' ' ' ARG . 28.0 p80 -109.24 146.72 33.76 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.586 173.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -48.2 -50.48 29.05 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.812 0.695 . . . . 0.0 111.718 -173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 152.6 -11.73 0.63 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.821 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.486 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 46.2 p90 -124.95 171.03 10.53 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.818 0.342 . . . . 0.0 110.605 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -162.32 167.76 37.03 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.499 178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.61 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 98.6 m-85 -123.66 146.66 48.05 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.004 0.43 . . . . 0.0 110.983 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.7 HD11 HG22 ' A' ' 225' ' ' ILE . 87.4 mt -139.8 136.1 38.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.209 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.584 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 46.1 mt-10 -119.17 136.33 54.23 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 177.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.529 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 6.8 m-85 -98.63 176.04 5.79 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -80.5 -21.79 41.6 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.341 173.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -131.19 137.48 48.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.063 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -69.5 -31.78 70.24 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.661 -173.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 88.3 mm-40 -66.47 -35.6 80.67 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.976 0.417 . . . . 0.0 110.369 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 9.8 m -70.82 -42.38 70.3 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.327 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 40.7 p -66.89 -40.02 87.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.029 0.443 . . . . 0.0 110.694 -178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -70.92 -22.67 62.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.077 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.5 -37.24 71.26 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.63 84.04 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.71 174.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.48 ' HA ' ' CG2' ' A' ' 282' ' ' VAL . 61.9 t -61.77 -27.32 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 121.498 0.666 . . . . 0.0 110.568 174.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.0 t -87.21 -34.12 19.09 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.788 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.9 m -94.07 -31.35 14.24 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -172.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.53 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 91.1 mmm -92.32 7.1 44.34 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -170.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.479 ' HA ' HG12 ' A' ' 282' ' ' VAL . 52.9 t30 -72.69 121.66 20.18 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.377 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 86.8 mt 65.95 27.71 10.75 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.06 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -81.92 122.76 28.16 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.92 114.24 15.49 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.009 0.433 . . . . 0.0 110.06 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.411 ' HG ' HD21 ' A' ' 220' ' ' LEU . 26.4 tp -127.03 91.94 3.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.373 0.606 . . . . 0.0 110.09 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 94.07 11.36 57.65 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.547 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.9 6.66 39.83 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.688 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.521 ' HG3' ' HD2' ' A' ' 217' ' ' HIS . 29.2 mt-30 -133.59 144.45 49.3 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -89.31 114.81 26.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.783 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 62.8 mt -63.49 124.37 21.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.271 -178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -94.0 115.12 27.43 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 172.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.48 ' CG2' ' HA ' ' A' ' 267' ' ' VAL . 13.9 p -114.6 140.1 37.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.33 0.586 . . . . 0.0 111.139 -173.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.28 174.69 33.4 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.578 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -84.86 122.94 29.88 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -61.27 127.38 31.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.172 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.629 HG11 ' HG3' ' A' ' 167' ' ' GLN . 35.5 m -91.45 -12.91 9.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.811 0.338 . . . . 0.0 111.443 -173.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.441 ' HA ' ' HD2' ' A' ' 288' ' ' PRO . 36.4 p -111.97 119.52 44.12 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-O 121.264 0.554 . . . . 0.0 111.058 175.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.516 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 43.9 Cg_endo -66.84 162.07 39.35 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.102 2.535 . . . . 0.0 111.909 176.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 288' ' ' PRO . 16.4 Cg_exo -68.39 76.05 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.297 2.665 . . . . 0.0 112.934 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.455 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 49.1 ttm -81.04 118.01 70.55 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 175.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 6.6 Cg_exo -74.73 59.48 4.98 Favored 'Trans proline' 0 CA--C 1.529 0.263 0 C-N-CA 123.235 2.623 . . . . 0.0 112.69 -176.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 27.8 tp -118.2 37.08 4.11 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.423 0.63 . . . . 0.0 109.998 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -65.14 131.32 46.22 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 91.8 m 61.85 76.88 0.37 Allowed Pre-proline 0 CA--C 1.534 0.331 0 CA-C-O 121.411 0.624 . . . . 0.0 109.609 -170.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.87 143.12 90.96 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.806 2.337 . . . . 0.0 112.171 -177.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 59.64 42.48 17.1 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.444 -178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 C--O 1.251 1.15 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.535 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 112.266 -0.333 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.31 102.46 7.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 69.3 mtm -82.03 65.83 7.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.164 0.507 . . . . 0.0 110.688 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -89.8 124.05 34.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -99.21 77.4 2.14 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.404 0.621 . . . . 0.0 110.127 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -101.66 -0.99 33.69 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.044 -178.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.62 ' HB2' HD12 ' A' ' 108' ' ' LEU . 29.8 pt20 -78.82 28.94 0.2 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.096 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 90.2 mtm180 -60.58 -28.4 68.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.911 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 110' ' ' ILE . . . -74.86 -22.0 58.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.737 -178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.62 HD12 ' HB2' ' A' ' 105' ' ' GLN . 57.2 mt -62.56 -33.3 74.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.693 0.282 . . . . 0.0 110.594 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.02 -25.67 65.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.794 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.452 ' CD1' ' HA ' ' A' ' 107' ' ' ALA . 3.6 mp -87.75 -36.82 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.489 179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.619 ' SD ' HG23 ' A' ' 198' ' ' ILE . 42.5 mtm -74.7 -22.28 58.94 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.4 m -75.44 -11.74 60.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.958 0.408 . . . . 0.0 110.46 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -106.55 140.95 38.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.713 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.542 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.9 p -121.59 128.79 75.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-O 121.404 0.621 . . . . 0.0 110.225 176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 76.8 t80 -81.25 109.89 16.2 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.778 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.455 HG12 HD11 ' A' ' 119' ' ' ILE . 39.3 t -108.02 120.05 58.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.104 0.478 . . . . 0.0 111.253 -174.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -135.21 174.07 21.36 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.442 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.783 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 25.9 m 66.59 35.35 5.42 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 123.069 0.547 . . . . 0.0 111.37 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.455 HD11 HG12 ' A' ' 116' ' ' VAL . 46.0 mt -85.22 114.72 25.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.558 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -52.29 134.41 33.79 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.435 177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 23.1 p90 -71.42 76.66 0.76 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 122.162 0.982 . . . . 0.0 111.474 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.46 -37.75 0.06 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.931 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.465 ' CD1' ' HG3' ' A' ' 177' ' ' MET . 59.8 mt -75.16 110.64 9.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.825 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -71.55 169.58 49.79 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.869 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -66.09 -36.91 84.46 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.935 0.397 . . . . 0.0 110.275 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -68.53 -35.01 76.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.547 177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.6 m -64.54 -42.81 95.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.989 0.423 . . . . 0.0 110.142 176.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.626 HG13 ' HE1' ' A' ' 143' ' ' MET . 33.7 mm -63.2 -41.58 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.488 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 43.3 ttp-105 -59.04 -41.36 87.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.548 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -65.24 -34.13 77.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.525 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.68 -32.21 28.22 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -88.35 -21.42 24.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.773 0.32 . . . . 0.0 111.383 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.6 -43.62 98.32 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.66 -32.4 5.84 Favored 'Trans proline' 0 C--N 1.363 1.309 0 C-N-CA 122.998 2.465 . . . . 0.0 114.252 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.588 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 74.0 m-85 -83.01 -44.14 15.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.485 0.183 . . . . 0.0 111.367 -176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.41 167.41 40.24 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.367 173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.35 134.41 35.99 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.697 2.265 . . . . 0.0 111.338 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.445 HG21 ' CG1' ' A' ' 141' ' ' ILE . 50.3 mt -100.14 132.84 44.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.409 -175.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.592 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 21.4 ttmm -98.7 -29.58 12.94 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.551 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.7 t -156.82 135.17 11.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.83 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.445 ' CG1' HG21 ' A' ' 138' ' ' ILE . 63.4 mt -128.69 116.57 41.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -114.22 99.53 7.68 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.973 0.416 . . . . 0.0 110.327 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.626 ' HE1' HG13 ' A' ' 128' ' ' ILE . 49.2 ttm -103.05 140.72 36.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.694 176.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.2 m -76.18 69.81 2.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.39 0.614 . . . . 0.0 110.119 176.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 41.8 t-105 -97.81 90.59 5.01 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.399 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.425 ' HB3' ' HD3' ' A' ' 153' ' ' LYS . 37.8 t70 -138.02 77.91 1.66 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.498 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 88.7 p -172.71 156.13 3.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.967 177.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.4 m -89.62 -19.27 7.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.325 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.9 p -91.12 8.85 33.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.759 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.8 mtm 66.27 31.8 8.26 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 122.962 0.505 . . . . 0.0 111.643 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -92.76 144.39 25.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.14 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -86.13 100.02 11.91 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.436 0.636 . . . . 0.0 110.273 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.425 ' HD3' ' HB3' ' A' ' 146' ' ' ASP . 83.8 tttt -82.57 54.6 2.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.313 -176.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 143.14 -133.49 5.5 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.078 -178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -132.64 178.59 6.73 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 143' ' ' MET . . . -127.09 139.53 52.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.006 0.431 . . . . 0.0 110.716 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -114.52 118.72 34.55 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.091 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' A' ' 114' ' ' VAL . 96.5 t -104.87 112.1 37.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -105.02 115.42 30.24 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.509 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -88.29 165.19 15.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.409 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.592 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 23.0 mt-10 -83.04 -12.02 57.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.222 175.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.9 m -136.66 134.43 19.5 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.969 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.08 -22.37 47.63 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.896 2.397 . . . . 0.0 112.475 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.74 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 13.7 mp0 -55.26 -54.2 46.48 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.389 177.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.536 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.03 -19.59 63.04 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.49 -52.1 9.65 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.647 ' HG3' HG11 ' A' ' 286' ' ' VAL . 14.9 mm100 -69.94 -27.17 64.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.222 175.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.588 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 12.9 tp -70.02 -50.57 40.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.415 177.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.63 -33.87 76.58 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.508 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.2 tt -61.25 -46.5 90.15 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.993 173.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -65.64 -44.2 87.15 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.343 -0.844 . . . . 0.0 112.675 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -86.93 -37.92 17.16 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.4 mtm -101.6 30.25 4.41 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.958 0.409 . . . . 0.0 111.324 -173.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.5 p30 -68.33 -11.08 58.94 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.128 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 20.3 m -101.31 -72.81 0.67 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -175.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 26.2 m -138.21 166.06 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.08 0.467 . . . . 0.0 111.855 -174.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.465 ' HG3' ' CD1' ' A' ' 123' ' ' LEU . 18.3 tpp -134.87 99.21 4.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.877 177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.446 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 89.7 mt 53.49 41.28 32.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.607 178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 101.62 -144.52 16.45 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.993 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 68.64 -123.02 15.2 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.255 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -143.95 179.0 7.46 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 175' ' ' SER . 9.2 t30 -51.27 111.56 0.59 Allowed 'General case' 0 C--O 1.236 0.37 0 O-C-N 123.628 0.58 . . . . 0.0 110.694 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.783 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 47.6 pt -89.29 160.8 2.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.474 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 52.2 tttp -107.25 116.22 31.55 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 17.5 t -120.31 106.2 18.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.508 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 101.61 163.53 27.15 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.25 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.494 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 30.1 ptt180 -139.14 58.6 13.09 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-O 120.872 0.367 . . . . 0.0 111.709 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 9.3 Cg_endo -88.33 11.47 3.08 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.795 2.33 . . . . 0.0 111.89 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 42.2 m -104.52 9.83 35.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.355 0.597 . . . . 0.0 110.633 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -94.31 155.08 17.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.907 175.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.5 tp -115.81 140.5 37.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.086 0.47 . . . . 0.0 110.436 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 175.5 -160.76 29.42 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -82.12 -11.44 58.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.584 0.692 . . . . 0.0 110.806 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -80.88 -38.52 27.95 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.456 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.522 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 56.4 tp60 -58.22 -49.77 91.75 Favored Pre-proline 0 CA--C 1.54 0.56 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.9 Cg_endo -52.9 -39.08 79.47 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 122.332 2.021 . . . . 0.0 112.458 177.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 56.9 mt -72.61 -39.39 61.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.819 0.342 . . . . 0.0 110.438 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.619 HG23 ' SD ' ' A' ' 111' ' ' MET . 69.9 mt -59.35 -50.07 81.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.602 176.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.64 -30.96 68.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.55 -179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -63.68 -52.09 62.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.453 177.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 27.5 mt -67.56 -33.55 75.26 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.921 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.693 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.28 -51.12 60.32 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 173.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -65.71 -30.91 71.65 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.308 176.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 40.3 mt-10 -67.2 -34.75 78.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.068 177.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.79 -36.69 65.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.712 176.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.693 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 71.5 mtp180 -66.48 -24.24 66.38 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.125 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -74.17 -13.92 60.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.241 0.543 . . . . 0.0 110.66 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -113.74 -179.28 3.59 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.365 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 46.2 m-20 -116.46 40.87 2.79 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.428 ' HD2' ' HG3' ' A' ' 289' ' ' PRO . 28.1 ttt180 -93.95 135.62 35.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.704 -173.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 41.1 pt -135.18 167.18 26.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.566 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.58 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 27.0 t80 -121.65 130.57 53.56 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.776 -175.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.531 HG21 HG21 ' A' ' 225' ' ' ILE . 28.1 m -121.42 131.92 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.099 0.476 . . . . 0.0 110.145 176.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.07 176.58 6.59 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.915 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.6 m 62.27 32.52 17.07 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.906 0.86 . . . . 0.0 109.339 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.445 HG13 HD11 ' A' ' 225' ' ' ILE . 16.4 t -77.76 112.74 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.505 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -60.13 139.57 57.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.232 0.539 . . . . 0.0 111.341 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -51.05 -35.99 37.47 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -170.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -87.78 -17.72 30.98 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.134 0.492 . . . . 0.0 111.051 -174.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.727 HD21 ' HG ' ' A' ' 275' ' ' LEU . 0.9 OUTLIER -74.1 132.55 42.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.061 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.2 m -103.25 179.71 4.19 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.303 -174.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -55.63 -46.46 77.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.01 0.433 . . . . 0.0 110.602 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -67.47 -27.34 66.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.613 -173.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -66.91 -54.05 25.92 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.467 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.728 HG22 HD11 ' A' ' 255' ' ' ILE . 42.7 mm -63.5 -43.2 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.73 -177.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.453 ' HG3' HG21 ' A' ' 235' ' ' ILE . 83.9 tttt -56.85 -49.44 75.46 Favored 'General case' 0 C--O 1.218 -0.595 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.577 175.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 35.3 t -55.51 -41.09 72.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -174.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 14.1 t -74.75 -40.93 47.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 C-N-CA 120.738 -0.385 . . . . 0.0 111.235 -176.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.712 ' HB2' HD11 ' A' ' 235' ' ' ILE . 24.4 m-85 -69.12 -35.74 76.74 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.467 0.651 . . . . 0.0 110.35 177.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 34.9 tp10 -59.2 -24.89 63.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.695 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.47 -19.76 64.57 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.002 -176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -111.51 -34.36 6.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -145.15 153.93 25.59 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.561 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 66.0 mmtt -73.76 113.3 10.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 111.941 -177.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.712 HD11 ' HB2' ' A' ' 229' ' ' PHE . 51.4 mt -92.47 151.09 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.878 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -109.66 -36.31 5.97 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.034 -0.984 . . . . 0.0 111.562 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 19.0 m -147.94 146.04 28.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.705 -170.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.44 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 53.3 t -153.9 118.26 4.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.758 174.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.9 t -141.26 119.22 11.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.205 0.526 . . . . 0.0 111.51 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.646 HD23 ' HA3' ' A' ' 253' ' ' GLY . 40.8 mt -91.94 132.61 36.38 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.033 177.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.64 124.44 23.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.55 -178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.593 ' HB3' ' CB ' ' A' ' 249' ' ' HIS . 14.7 ptt-85 -144.59 169.89 17.11 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.478 -173.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -104.56 100.92 25.04 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.728 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -59.25 -22.24 64.01 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.513 2.142 . . . . 0.0 112.368 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.8 p -75.65 -17.94 59.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.48 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 49.3 p -108.84 -42.22 4.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.997 0.427 . . . . 0.0 110.369 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 114.54 -16.92 18.96 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.748 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -107.19 160.69 15.39 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.608 -0.348 . . . . 0.0 110.493 -177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.593 ' CB ' ' HB3' ' A' ' 242' ' ' ARG . 26.9 p80 -100.76 162.56 12.83 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.539 177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -75.03 -69.93 0.44 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.213 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 170.19 25.99 0.02 OUTLIER Glycine 0 C--N 1.331 0.291 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.095 176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.482 ' HB2' ' CE1' ' A' ' 212' ' ' TYR . 3.1 p90 -153.77 154.07 33.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.646 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -157.78 173.22 35.1 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.137 -178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.74 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 81.4 m-85 -127.09 146.06 50.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.981 0.419 . . . . 0.0 110.626 -177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.728 HD11 HG22 ' A' ' 225' ' ' ILE . 74.5 mt -135.02 138.78 48.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.284 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.56 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 45.6 mt-10 -121.63 142.46 50.1 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.643 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 6.3 m-85 -105.85 163.69 12.53 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.05 0.452 . . . . 0.0 111.458 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -85.31 -36.75 20.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.526 174.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -100.41 114.94 28.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.571 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -50.83 -59.46 4.09 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 123.547 0.53 . . . . 0.0 112.375 -168.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -54.43 -36.54 64.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.257 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.2 t -67.94 -21.14 65.12 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.643 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 89.6 p -66.55 -49.93 64.81 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.218 0.533 . . . . 0.0 110.4 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -75.56 -15.9 60.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.67 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.48 -40.84 73.4 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 174.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -64.56 -36.29 83.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 95.9 t -57.44 -30.58 36.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.236 0.541 . . . . 0.0 111.177 174.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.8 m -87.34 -29.45 21.55 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.342 -177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 13.3 m -93.54 -40.47 10.29 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.989 0.423 . . . . 0.0 112.03 -174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.451 ' HG3' ' CD2' ' A' ' 229' ' ' PHE . 87.6 mmm -85.08 -2.88 58.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.951 -171.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.42 ' HA ' HG12 ' A' ' 282' ' ' VAL . 60.2 t30 -69.1 129.66 40.52 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.371 -178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.7 mt 66.31 27.69 10.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.808 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -90.34 117.96 29.47 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 172.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.661 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 4.0 p-10 -76.03 122.38 24.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.371 0.605 . . . . 0.0 110.289 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.727 ' HG ' HD21 ' A' ' 220' ' ' LEU . 26.5 tp -134.24 95.21 3.36 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.635 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 93.36 18.65 38.17 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.835 -0.697 . . . . 0.0 111.699 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.89 -36.75 4.19 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.68 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -93.82 147.95 22.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.767 0.317 . . . . 0.0 110.746 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.661 ' CE1' ' HB3' ' A' ' 274' ' ' ASP . 54.2 m-85 -87.44 115.9 25.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.743 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 93.4 mt -57.13 116.6 3.35 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.797 0.685 . . . . 0.0 111.122 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -93.69 115.0 27.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 173.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 271' ' ' ASN . 13.7 p -121.41 147.63 25.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.173 0.511 . . . . 0.0 111.12 -173.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.38 179.7 37.53 Favored Glycine 0 N--CA 1.443 -0.882 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -84.74 134.96 34.32 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.613 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -68.85 137.15 53.68 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.647 HG11 ' HG3' ' A' ' 167' ' ' GLN . 33.1 m -97.96 -11.96 8.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.479 . . . . 0.0 110.917 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 38.3 p -108.6 135.06 20.08 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.004 175.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 58.9 Cg_endo -73.29 147.82 42.6 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.847 2.364 . . . . 0.0 111.478 174.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.428 ' HG3' ' HD2' ' A' ' 210' ' ' ARG . 52.4 Cg_exo -54.18 143.19 64.65 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.866 2.377 . . . . 0.0 112.035 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 49.3 ttp -111.81 93.64 21.34 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.555 -176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.457 ' HD2' HD22 ' A' ' 292' ' ' LEU . 96.6 Cg_endo -84.92 -5.32 9.72 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.447 2.098 . . . . 0.0 111.267 171.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.457 HD22 ' HD2' ' A' ' 291' ' ' PRO . 3.3 mm? -63.29 107.38 1.06 Allowed 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.932 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 92.8 mt 64.58 9.51 5.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.406 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 18.5 m -145.01 86.21 7.81 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.426 -178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -77.92 58.83 6.67 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.612 2.208 . . . . 0.0 111.351 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 60.12 -99.04 0.09 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.633 -174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 59.5 m . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.509 -0.758 . . . . 0.0 109.213 176.554 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 112.253 -0.339 . . . . 0.0 112.253 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -88.58 121.43 30.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.724 0.297 . . . . 0.0 110.518 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 49.5 tpp -131.1 -32.41 1.61 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.018 0.437 . . . . 0.0 110.718 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -120.71 163.55 17.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.369 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 56.77 58.66 3.95 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.403 0.621 . . . . 0.0 110.659 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -114.73 76.16 0.98 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.04 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 86.2 mm-40 54.35 82.39 0.09 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.711 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 106' ' ' ARG . 10.9 ptp180 -55.51 -28.2 53.2 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.281 -174.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 197' ' ' ILE . . . -68.37 -35.04 77.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.036 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.494 HD21 HG21 ' A' ' 287' ' ' THR . 40.8 mt -66.71 -31.8 72.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.041 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.9 -28.42 69.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.339 0.59 . . . . 0.0 110.36 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 67.4 mt -88.05 -36.96 10.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.348 177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.483 ' SD ' HG12 ' A' ' 198' ' ' ILE . 90.4 mtp -69.88 -19.27 63.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.44 -176.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 86.3 m -85.71 -1.89 57.65 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.1 0.476 . . . . 0.0 110.99 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -118.33 142.13 47.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.211 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.664 HG12 ' HB ' ' A' ' 158' ' ' VAL . 8.8 p -115.24 119.79 62.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.631 0.729 . . . . 0.0 109.761 172.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.401 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 41.7 t80 -67.87 119.99 13.45 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.192 175.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.579 HG23 ' HB3' ' A' ' 156' ' ' ALA . 17.0 m -119.48 117.51 54.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.59 0.709 . . . . 0.0 111.69 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -136.46 170.86 23.15 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.056 177.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.667 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 10.5 t 64.15 36.76 9.37 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.645 0.735 . . . . 0.0 109.604 -177.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 84.7 mt -78.76 -15.51 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.854 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 75.5 t80 76.04 139.28 0.06 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.968 -1.015 . . . . 0.0 109.664 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.596 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 26.0 p90 -74.89 77.64 2.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.581 0.705 . . . . 0.0 110.892 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -163.59 -35.04 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.396 177.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.576 HD11 ' HB2' ' A' ' 178' ' ' LEU . 72.8 mt -85.64 128.92 34.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.206 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.27 176.85 39.08 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.893 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.72 -39.9 93.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.032 0.444 . . . . 0.0 110.549 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 16.1 t70 -65.03 -41.96 94.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.279 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.3 m -61.15 -40.56 94.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.938 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 29.3 mm -66.09 -38.69 82.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.789 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 129' ' ' ARG . 33.2 ttp-105 -61.52 -39.02 89.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.993 0.425 . . . . 0.0 109.946 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 78.0 mt-30 -63.94 -37.78 88.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.335 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.56 -36.66 37.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.264 -173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.545 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . 56.9 m-85 -92.29 -7.85 46.85 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.978 0.418 . . . . 0.0 111.777 -177.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.604 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -53.4 -45.58 98.42 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 6.8 Cg_endo -51.21 -27.66 23.47 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.854 2.369 . . . . 0.0 114.534 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.62 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 58.5 m-85 -83.88 -42.95 15.82 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.989 -0.284 . . . . 0.0 111.408 -174.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.8 -179.49 40.49 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.849 176.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.93 110.92 3.13 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.763 2.309 . . . . 0.0 111.799 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 63.1 mt -79.57 113.02 18.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.353 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -78.58 -41.48 31.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.845 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.2 t -162.1 156.75 22.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.523 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.1 mt -134.76 116.18 20.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.732 176.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 12.8 m-20 -88.31 98.92 11.86 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.1 ttm -120.61 133.37 55.38 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.885 0.374 . . . . 0.0 111.228 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.626 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 16.3 m -77.67 99.05 5.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.44 172.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.618 ' HA ' ' HB2' ' A' ' 152' ' ' HIS . 12.7 t-105 -124.63 112.22 16.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.502 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -172.16 104.56 0.18 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.21 173.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.5 m -157.62 140.36 14.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 32.0 m -62.33 -21.03 25.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.144 -173.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.513 ' OG1' ' HD2' ' A' ' 151' ' ' LYS . 15.3 p -99.67 27.7 5.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.312 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 2.4 mpp? 55.12 60.16 3.59 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.45 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.596 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 40.2 mttp -143.12 176.51 9.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.685 -176.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.626 ' HB2' ' O ' ' A' ' 144' ' ' SER . 14.6 p80 -153.35 158.22 41.21 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.127 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -112.62 -169.14 1.42 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.381 174.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 66.84 -147.05 49.17 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.496 174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -140.86 178.44 7.35 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.579 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -138.15 158.46 44.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.064 0.459 . . . . 0.0 111.662 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -117.84 115.8 25.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.338 173.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.664 ' HB ' HG12 ' A' ' 114' ' ' VAL . 99.4 t -91.52 109.93 21.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.322 -0.399 . . . . 0.0 109.936 176.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -98.03 116.22 29.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.973 0.416 . . . . 0.0 110.431 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.545 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 95.9 m-85 -92.86 176.47 6.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.657 176.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -95.76 -1.52 49.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.045 173.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.9 m -145.76 137.31 12.92 Favored Pre-proline 0 C--O 1.233 0.228 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.22 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 43.5 Cg_endo -68.54 -20.34 41.39 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.039 2.493 . . . . 0.0 112.164 -178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 254' ' ' PHE . 79.6 mm-40 -58.09 -56.34 23.35 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.079 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -57.79 -20.35 34.83 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.27 -51.82 7.54 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -176.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -63.31 -34.68 78.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.769 173.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.62 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.6 tp -68.67 -48.92 62.72 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.601 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.49 83.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.939 0.4 . . . . 0.0 110.155 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 174' ' ' ASN . 6.7 tt -63.06 -51.16 67.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.532 174.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -57.72 -47.93 81.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.014 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -85.7 -33.37 21.53 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -174.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.9 mtm -108.15 30.09 6.72 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -174.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 24.2 p-10 -79.81 23.26 0.44 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.828 0.347 . . . . 0.0 111.584 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.8 t -114.59 -73.35 0.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.853 0.358 . . . . 0.0 110.625 178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.586 HG12 ' H ' ' A' ' 182' ' ' ASN . 20.8 m -139.73 169.04 17.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.631 -0.259 . . . . 0.0 111.217 -175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.846 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.1 tpt -141.59 94.36 2.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 123' ' ' LEU . 89.0 mt 60.13 -83.99 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.579 0.752 . . . . 0.0 112.279 176.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -108.99 -12.8 19.67 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.336 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.32 115.03 4.32 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.246 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -82.94 127.06 33.18 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.586 ' H ' HG12 ' A' ' 176' ' ' VAL . 20.4 t-20 61.54 76.43 0.37 Allowed 'General case' 0 C--O 1.235 0.301 0 O-C-N 123.773 0.671 . . . . 0.0 110.258 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.846 HD13 ' HB2' ' A' ' 177' ' ' MET . 49.6 pt -88.36 160.16 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.724 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 67.0 mttm -105.65 106.91 17.64 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.528 176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 6.2 m -109.27 116.4 51.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.317 0.58 . . . . 0.0 110.217 175.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.448 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 72.87 -171.73 50.09 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.595 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.734 ' HB3' ' HB2' ' A' ' 190' ' ' ASN . 19.9 mmt180 -132.69 81.24 59.54 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 174.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.15 -37.61 96.22 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.124 2.549 . . . . 0.0 113.284 -173.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 50.4 m -115.37 40.45 2.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.198 0.523 . . . . 0.0 111.461 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.734 ' HB2' ' HB3' ' A' ' 187' ' ' ARG . 29.4 t-20 -81.0 83.03 6.8 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.443 0.64 . . . . 0.0 109.295 173.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.575 ' HA ' ' HG3' ' A' ' 195' ' ' GLN . 10.0 tp -65.88 140.18 20.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.718 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 160.82 -161.28 32.67 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.521 -0.632 . . . . 0.0 111.521 -178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -64.32 -28.01 69.41 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.014 0.435 . . . . 0.0 111.454 -176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.433 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -70.52 -32.04 69.35 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.765 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.575 ' HG3' ' HA ' ' A' ' 191' ' ' ILE . 29.1 mm-40 -57.36 -56.19 36.52 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -173.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.2 Cg_endo -53.68 -37.51 83.9 Favored 'Trans proline' 0 C--N 1.352 0.741 0 C-N-CA 122.219 1.946 . . . . 0.0 112.748 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.401 ' HB ' ' HB2' ' A' ' 107' ' ' ALA . 54.7 mt -75.96 -43.09 39.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.774 0.321 . . . . 0.0 111.15 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.483 HG12 ' SD ' ' A' ' 111' ' ' MET . 72.8 mt -61.72 -46.49 96.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.05 0.452 . . . . 0.0 109.975 176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -63.57 -36.98 85.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.352 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 46.8 tp60 -58.32 -53.95 52.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.118 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 58.1 mt -68.8 -33.7 74.31 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.904 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.699 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.03 -48.96 69.95 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 173.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.615 ' OE1' ' HD3' ' A' ' 206' ' ' ARG . 6.6 mm-40 -62.89 -35.99 81.85 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.084 176.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 40.7 mt-10 -63.92 -36.25 83.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.356 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.09 -34.01 63.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.83 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.699 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 72.2 mtp180 -69.09 -20.63 64.08 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.937 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -75.53 -18.13 59.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.149 0.5 . . . . 0.0 110.554 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -109.14 -169.96 1.58 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.052 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.482 ' CB ' ' HA ' ' A' ' 260' ' ' ALA . 27.2 p-10 -139.5 58.75 1.61 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.835 0.826 . . . . 0.0 109.656 178.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.53 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 18.6 ttm180 -111.05 139.13 46.66 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.173 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.536 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.1 pt -119.57 163.15 17.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.668 0.271 . . . . 0.0 110.597 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -113.9 127.0 55.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.152 -178.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 28.3 m -114.8 128.01 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 121.359 0.599 . . . . 0.0 110.154 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -120.27 167.53 12.19 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.097 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 23.3 t 59.67 40.03 20.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.975 0.893 . . . . 0.0 109.095 -175.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.531 HG13 HD11 ' A' ' 225' ' ' ILE . 39.4 t -77.4 120.99 28.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.473 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.543 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 40.2 t-80 -52.57 133.01 36.18 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.257 0.551 . . . . 0.0 111.05 -175.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -49.27 -37.68 24.42 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -171.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -96.41 -6.1 38.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.072 0.463 . . . . 0.0 111.126 -176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 275' ' ' LEU . 10.7 tp -88.7 112.41 23.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.5 t -96.93 -178.67 4.29 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.854 0.359 . . . . 0.0 111.734 -170.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -53.36 -38.51 63.38 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.544 -177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.45 -37.55 87.2 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.391 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.427 ' HB2' ' HG ' ' A' ' 220' ' ' LEU . 15.7 m-20 -73.86 -42.68 60.44 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.992 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.546 HG22 HD11 ' A' ' 255' ' ' ILE . 34.6 mm -64.21 -42.14 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.403 ' HG3' HG21 ' A' ' 235' ' ' ILE . 83.9 tttt -61.09 -48.77 80.14 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.001 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 13.2 p -60.16 -38.17 82.34 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.458 HG21 HD21 ' A' ' 275' ' ' LEU . 49.1 t -76.56 -40.29 33.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.866 0.365 . . . . 0.0 110.766 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.57 ' CB ' HD11 ' A' ' 235' ' ' ILE . 6.1 m-85 -69.19 -32.49 71.81 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.133 0.492 . . . . 0.0 110.993 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 7.2 tm-20 -63.35 -24.39 67.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.051 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -68.2 -23.82 64.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.731 -176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -101.41 -34.21 9.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.341 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.617 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -152.16 149.25 20.9 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.539 178.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 29.6 mmtp -71.19 120.52 16.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.567 0.698 . . . . 0.0 111.105 -178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.57 HD11 ' CB ' ' A' ' 229' ' ' PHE . 28.2 mt -91.38 151.2 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.919 -172.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.499 ' HE3' ' O ' ' A' ' 257' ' ' TYR . 17.0 ttmt -103.7 -30.28 10.53 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.202 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 28.2 t -170.34 141.91 2.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 121.003 -0.279 . . . . 0.0 110.325 -172.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 40.4 t -142.61 127.1 17.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.744 178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.9 t -141.31 133.48 27.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.823 0.344 . . . . 0.0 110.304 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . . . . . . . . . 27.7 mt -109.84 136.18 49.56 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.86 126.44 29.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.221 179.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.421 ' HG2' ' CB ' ' A' ' 249' ' ' HIS . 73.5 mtp180 -122.83 152.45 40.7 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.831 -177.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.583 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 17.9 m-20 -70.5 145.85 93.29 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 175.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.74 -19.98 56.37 Favored 'Trans proline' 0 CA--C 1.528 0.201 0 C-N-CA 123.197 2.598 . . . . 0.0 114.159 -171.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.3 t -162.93 62.2 0.19 Allowed 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.295 0.569 . . . . 0.0 111.996 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 58.7 p -127.93 -18.46 4.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.095 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 97.07 -46.3 1.72 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.101 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.34 177.89 6.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.848 0.356 . . . . 0.0 110.711 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.421 ' CB ' ' HG2' ' A' ' 242' ' ' ARG . 30.8 p80 -96.15 170.7 9.08 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.293 176.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -77.06 -80.6 0.1 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.938 -177.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -179.8 18.12 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 120.036 -1.078 . . . . 0.0 113.029 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -154.89 163.9 39.62 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -168.66 -179.24 40.77 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.228 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.491 ' CZ ' ' HG3' ' A' ' 164' ' ' GLU . 91.1 m-85 -134.44 145.37 48.8 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 120.822 0.344 . . . . 0.0 110.625 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.546 HD11 HG22 ' A' ' 225' ' ' ILE . 88.5 mt -138.04 132.06 42.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.036 -178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.53 ' HG2' ' HB2' ' A' ' 210' ' ' ARG . 81.6 mt-10 -110.02 146.16 35.79 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 174.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.525 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 8.2 m-85 -106.94 179.24 4.32 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.164 176.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -70.24 -50.63 37.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.924 0.868 . . . . 0.0 108.905 171.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 7.8 mttm -103.48 139.56 38.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 113.968 -1.469 . . . . 0.0 109.227 -173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.482 ' HA ' ' CB ' ' A' ' 209' ' ' ASN . . . -65.56 -28.79 69.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.705 -174.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -72.82 -33.45 66.2 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.844 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.8 m -67.07 -37.18 83.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.053 -172.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.536 ' HB2' HG23 ' A' ' 211' ' ' ILE . 21.6 p -68.23 -38.63 82.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 0.0 110.04 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -71.6 -25.96 62.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.33 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -65.39 -41.94 93.16 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.028 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -63.83 -41.68 97.79 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.468 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 83.2 t -55.17 -32.98 29.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.231 0.539 . . . . 0.0 111.001 176.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.9 t -75.37 -33.83 61.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.132 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.8 t -94.29 -40.17 10.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 112.041 -174.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.494 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 75.2 mmm -83.33 -4.41 58.42 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -168.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.486 ' HA ' HG12 ' A' ' 282' ' ' VAL . 57.8 t30 -69.2 112.81 6.03 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.159 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.452 HD21 ' CZ ' ' A' ' 281' ' ' ARG . 94.1 mt 67.77 36.36 3.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.778 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -91.17 132.97 35.74 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.244 173.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -82.04 109.57 16.49 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.305 -178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.659 HD12 HD11 ' A' ' 280' ' ' LEU . 0.6 OUTLIER -117.38 91.38 3.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.137 0.494 . . . . 0.0 109.851 176.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 80.9 34.1 28.21 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.756 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 91.03 -0.29 75.68 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.969 175.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.482 ' OE1' ' HA ' ' A' ' 217' ' ' HIS . 34.6 tt0 -126.57 141.17 51.95 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 120.773 0.32 . . . . 0.0 110.342 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -92.58 123.25 35.74 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.87 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.659 HD11 HD12 ' A' ' 275' ' ' LEU . 48.2 mt -77.73 127.6 32.69 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.135 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.452 ' CZ ' HD21 ' A' ' 272' ' ' LEU . 37.4 mmt180 -95.1 114.78 26.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 171.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 271' ' ' ASN . 10.7 p -117.34 147.65 20.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.157 -173.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -159.47 175.47 36.36 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.382 177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -82.06 126.41 31.97 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -61.68 126.81 28.68 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 123.309 0.381 . . . . 0.0 110.585 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 27.8 m -88.59 -24.94 5.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.359 -175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.605 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 16.1 p -132.57 133.16 23.21 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.732 0.301 . . . . 0.0 111.269 177.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -81.32 103.71 1.44 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.616 2.211 . . . . 0.0 112.077 175.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' A' ' 287' ' ' THR . 90.9 Cg_endo -89.38 139.16 3.42 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.688 2.259 . . . . 0.0 113.187 -177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 64.1 mtt -108.11 109.51 61.91 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.02 -0.537 . . . . 0.0 109.803 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -76.33 113.19 3.63 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.488 2.125 . . . . 0.0 112.562 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 94.3 mt -83.23 51.77 2.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.352 0.596 . . . . 0.0 110.35 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 87.8 mt -89.92 105.53 17.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.092 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 2.7 p -90.14 114.43 60.9 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.508 176.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.35 76.01 2.79 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 123.101 2.534 . . . . 0.0 112.238 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -85.15 64.24 8.56 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.332 0.587 . . . . 0.0 110.294 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 28.8 m . . . . . 0 C--O 1.247 0.941 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.776 179.632 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.706 0 N-CA-C 112.285 -0.326 . . . . 0.0 112.285 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 59.49 39.98 21.14 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 174.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 55.7 ttp -108.35 -38.54 5.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.948 0.404 . . . . 0.0 110.637 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -115.68 -71.24 0.75 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.734 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.471 ' HB3' ' H ' ' A' ' 104' ' ' ARG . 47.8 mt-30 -137.91 -161.15 1.14 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.713 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.471 ' H ' ' HB3' ' A' ' 103' ' ' GLN . 24.8 ttt180 64.75 -84.58 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.846 0.716 . . . . 0.0 111.353 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -86.71 -7.58 58.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.192 0.52 . . . . 0.0 110.157 -176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -52.8 -48.23 67.05 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.908 -176.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.0 -35.83 69.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.704 0.288 . . . . 0.0 111.081 -177.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 108' ' ' LEU . 34.7 mt -66.59 -32.35 73.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.203 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.8 85.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.192 0.52 . . . . 0.0 110.136 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.3 mt -71.97 -36.48 57.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.219 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.429 ' SD ' HG12 ' A' ' 198' ' ' ILE . 89.9 mtp -72.14 -17.01 62.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.915 -178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 80.2 m -89.01 -17.78 28.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.91 0.386 . . . . 0.0 110.597 178.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -99.08 141.53 31.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.144 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.69 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.5 p -128.05 131.58 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 CA-C-O 121.773 0.796 . . . . 0.0 110.145 174.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.48 ' H ' ' HA2' ' A' ' 186' ' ' GLY . 39.1 t80 -94.71 104.48 16.4 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.222 -176.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 17.4 m -99.38 116.52 42.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.607 0.717 . . . . 0.0 111.352 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.501 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -116.36 165.32 12.27 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.638 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 53.7 m 63.45 44.42 5.39 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.347 0.594 . . . . 0.0 110.861 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 53.2 mt -72.91 142.93 14.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.234 178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.447 ' HB3' ' HG ' ' A' ' 123' ' ' LEU . 37.8 t80 -54.81 127.26 27.65 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.598 176.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.511 ' OH ' ' HA ' ' A' ' 151' ' ' LYS . 36.4 t80 -74.47 76.71 1.94 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.024 0.44 . . . . 0.0 110.135 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 178.54 -36.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.111 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 178' ' ' LEU . 93.8 mt -61.44 132.41 53.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.965 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -98.59 168.23 22.65 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.791 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -55.41 -39.51 70.3 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.935 0.397 . . . . 0.0 111.183 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -64.55 -39.51 93.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.076 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.1 m -71.57 -38.25 70.96 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.486 -177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 34.4 mm -64.41 -40.24 88.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.145 176.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -59.16 -43.35 92.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.58 176.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.37 -34.45 73.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.297 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -83.11 -33.44 26.32 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.504 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 40.7 m-85 -91.77 -16.81 26.3 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.292 0.479 . . . . 0.0 112.292 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.442 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -54.88 -43.72 98.97 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 177.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 42.0 Cg_exo -40.58 -38.95 2.74 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 123.245 2.63 . . . . 0.0 115.062 176.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.709 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 61.5 m-85 -77.48 -37.17 51.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -173.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -179.01 -177.71 47.76 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.867 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.418 ' HB2' ' OE1' ' A' ' 161' ' ' GLU . 73.4 Cg_endo -75.06 135.43 18.97 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.772 2.314 . . . . 0.0 112.258 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.515 HD13 HD11 ' A' ' 141' ' ' ILE . 68.9 mt -102.1 130.97 51.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.564 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 29.5 ttpp -94.48 -31.75 13.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.812 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -168.79 145.91 3.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.6 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.515 HD11 HD13 ' A' ' 138' ' ' ILE . 69.5 mt -130.81 131.16 64.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 174.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -122.29 101.49 7.54 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.416 ' HE3' ' HB2' ' A' ' 143' ' ' MET . 43.5 ttm -111.97 138.28 48.81 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.747 0.308 . . . . 0.0 110.931 178.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.402 ' HB2' ' HA3' ' A' ' 154' ' ' GLY . 27.8 m -75.25 116.39 15.92 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.295 173.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.421 ' CD1' ' HD2' ' A' ' 152' ' ' HIS . 0.9 OUTLIER -149.23 98.27 2.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 178.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -65.28 114.2 4.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.034 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.8 m -87.14 3.73 45.12 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -167.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.536 HG13 HG23 ' A' ' 149' ' ' THR . 8.8 p -110.06 -40.51 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.368 178.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.536 HG23 HG13 ' A' ' 148' ' ' VAL . 36.8 p -104.71 -0.34 27.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.889 0.376 . . . . 0.0 111.521 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 53.8 mtm 63.28 33.63 13.94 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.309 176.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.511 ' HA ' ' OH ' ' A' ' 121' ' ' TYR . 28.3 mmmt -97.91 131.92 43.95 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.421 ' HD2' ' CD1' ' A' ' 145' ' ' TRP . 14.4 t-80 -78.0 -61.37 2.02 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 62.0 tttm 36.98 62.12 0.82 Allowed 'General case' 0 N--CA 1.468 0.446 0 O-C-N 124.502 1.126 . . . . 0.0 112.33 171.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 144' ' ' SER . . . 165.26 -173.95 41.08 Favored Glycine 0 N--CA 1.441 -0.992 0 C-N-CA 120.224 -0.988 . . . . 0.0 112.658 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.501 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 29.5 m-85 -118.96 179.13 4.25 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -129.2 139.52 51.84 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.954 0.407 . . . . 0.0 110.647 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -105.34 109.33 21.27 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.824 176.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 114' ' ' VAL . 62.9 t -94.57 105.72 17.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -102.87 115.15 30.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.409 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 85.0 m-85 -88.94 172.38 9.19 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.628 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 47.8 mt-10 -89.95 -24.29 21.33 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.845 172.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.82 137.35 29.37 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.303 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 55.3 Cg_endo -69.43 -17.46 39.05 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.169 2.579 . . . . 0.0 112.362 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.599 ' HG3' ' HZ ' ' A' ' 254' ' ' PHE . 71.3 mm-40 -57.99 -54.91 41.62 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.011 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -59.33 -21.5 59.86 Favored 'General case' 0 C--O 1.226 -0.181 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -78.68 -52.39 8.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 19.7 mm-40 -63.95 -32.33 73.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.841 174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.709 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.1 tp -68.52 -50.04 55.1 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.584 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.55 -33.42 74.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.756 0.313 . . . . 0.0 110.374 178.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 185' ' ' VAL . 24.4 tp -68.76 -40.77 79.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.125 0.488 . . . . 0.0 110.651 173.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.84 -33.95 75.09 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.253 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -100.13 -51.19 3.74 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 13.6 mtm -103.11 29.3 5.59 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -165.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.419 ' HB2' HD12 ' A' ' 170' ' ' LEU . 64.4 t30 -83.61 32.5 0.46 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.575 0.702 . . . . 0.0 109.941 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 48.6 m -114.87 -74.08 0.63 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.369 176.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 30.8 m -142.07 163.84 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.395 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.885 ' HB2' HD13 ' A' ' 183' ' ' ILE . 0.8 OUTLIER -134.03 103.25 5.72 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.568 177.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.556 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 84.0 mt 54.7 77.75 0.19 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.931 0.77 . . . . 0.0 111.995 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 131.72 -139.56 11.05 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.167 178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -133.7 62.67 0.63 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.322 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -142.22 124.19 15.31 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 175' ' ' SER . 95.3 m-20 -68.27 124.12 22.62 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 123.307 0.38 . . . . 0.0 110.439 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.885 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.3 pt -106.49 155.56 7.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.043 0.449 . . . . 0.0 110.77 -179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 4.1 tppp? -105.42 116.01 31.22 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.591 ' O ' HD13 ' A' ' 170' ' ' LEU . 21.7 t -100.06 102.19 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.405 0.621 . . . . 0.0 109.806 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.48 ' HA2' ' H ' ' A' ' 115' ' ' TYR . . . 92.15 -174.41 37.05 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.805 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -116.52 86.09 17.7 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 186' ' ' GLY . 6.4 Cg_exo -73.93 66.59 5.0 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.511 2.807 . . . . 0.0 112.372 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 17.3 t -137.54 170.82 15.43 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.304 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -76.88 91.04 3.52 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.6 tp -64.06 -21.35 28.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.453 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 83.98 -100.09 2.28 Favored Glycine 0 C--O 1.224 -0.506 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.044 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -54.24 -40.33 67.62 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -85.26 -13.2 50.52 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.491 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 12.0 tm0? -64.04 -52.87 52.89 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.82 -173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.491 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 77.7 Cg_exo -53.23 -38.52 81.65 Favored 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.485 2.123 . . . . 0.0 113.094 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 52.4 mt -67.36 -46.47 83.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.318 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.429 HG12 ' SD ' ' A' ' 111' ' ' MET . 66.5 mt -60.95 -45.56 98.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.317 177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -63.32 -39.95 95.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.534 -178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -65.38 -47.31 76.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.557 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.506 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 49.9 mt -67.43 -33.11 74.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.092 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.608 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.6 -45.19 66.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.379 0.609 . . . . 0.0 109.53 173.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -70.44 -33.02 70.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.29 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 32.3 mt-10 -68.38 -25.6 65.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.812 0.339 . . . . 0.0 111.534 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -76.15 -30.22 58.07 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 174.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.608 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 78.6 mtp180 -70.65 -10.69 59.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.193 -178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.34 -27.17 67.15 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.302 0.573 . . . . 0.0 110.196 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -128.37 124.27 35.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.144 176.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -74.87 70.35 1.94 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.855 0.836 . . . . 0.0 110.277 178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.892 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 3.3 ptp180 -113.46 155.37 25.44 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.725 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 32.6 pt -122.84 164.4 20.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.745 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -112.45 129.14 56.44 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 123.315 0.384 . . . . 0.0 110.204 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.586 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.7 m -124.08 132.91 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-O 121.192 0.52 . . . . 0.0 110.506 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -126.23 177.42 6.42 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.649 -177.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.9 m 61.38 30.24 18.89 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.718 0.771 . . . . 0.0 109.792 -173.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.499 ' O ' ' HA2' ' A' ' 251' ' ' GLY . 30.8 t -85.42 115.48 27.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.432 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.695 ' HB3' HD23 ' A' ' 220' ' ' LEU . 23.3 t-80 -57.66 139.96 52.4 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 121.057 0.456 . . . . 0.0 110.661 -176.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.567 ' HB2' ' HD2' ' A' ' 248' ' ' LYS . 6.0 pt20 -46.38 -41.74 14.02 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -169.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . 0.428 ' N ' ' HG3' ' A' ' 218' ' ' GLN . 0.7 OUTLIER -98.16 13.91 29.5 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -167.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 217' ' ' HIS . 3.6 mm? -86.72 121.89 29.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 171.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 25.0 m -78.11 171.61 14.77 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.609 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -56.49 -41.25 76.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.078 0.466 . . . . 0.0 110.101 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -69.49 -24.24 63.74 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.02 -179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.456 ' HB3' HD12 ' A' ' 220' ' ' LEU . 7.6 m-20 -69.75 -45.64 67.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 110.258 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.729 HG22 HD11 ' A' ' 255' ' ' ILE . 14.5 mm -68.58 -38.08 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 177.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.419 ' HG3' HG21 ' A' ' 235' ' ' ILE . 85.3 tttt -60.53 -53.68 54.59 Favored 'General case' 0 C--O 1.215 -0.761 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.946 175.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 11.2 p -55.12 -38.63 68.44 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 224' ' ' ASP . 32.3 t -73.42 -46.61 48.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.541 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.653 ' HB2' HD11 ' A' ' 235' ' ' ILE . 17.3 m-85 -67.24 -29.99 69.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.39 0.614 . . . . 0.0 110.63 179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -59.53 -24.15 63.42 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.902 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.53 -13.27 60.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.771 -174.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -111.43 -30.92 7.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.799 -178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -157.34 166.8 33.81 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.974 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -80.18 110.69 15.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.509 0.671 . . . . 0.0 111.036 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.653 HD11 ' HB2' ' A' ' 229' ' ' PHE . 37.5 mt -83.17 151.21 4.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.604 -176.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.445 ' HG3' ' CG2' ' A' ' 297' ' ' THR . 29.2 ttpp -106.02 -34.94 7.42 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.448 179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.4 p -173.37 156.24 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 110.386 -0.227 . . . . 0.0 110.386 -173.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 255' ' ' ILE . 74.1 m -142.46 138.88 31.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.252 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 31.9 m -141.14 103.0 4.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.696 HD21 HG13 ' A' ' 225' ' ' ILE . 81.2 mt -83.94 149.53 26.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.705 173.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -84.85 104.37 14.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.756 0.313 . . . . 0.0 110.356 177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.736 ' HG3' ' HB3' ' A' ' 249' ' ' HIS . 0.2 OUTLIER -97.53 152.67 18.78 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.53 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.612 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 8.8 m-20 -77.84 148.72 76.26 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.95 -8.13 13.13 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.972 2.448 . . . . 0.0 114.422 -173.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -166.62 38.82 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.612 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 25.4 p -108.21 -16.45 14.26 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.347 -0.846 . . . . 0.0 112.02 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.4 77.17 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.696 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.567 ' HD2' ' HB2' ' A' ' 218' ' ' GLN . 46.4 pttt -168.22 -168.56 0.96 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.736 ' HB3' ' HG3' ' A' ' 242' ' ' ARG . 33.9 p80 -118.79 165.16 14.37 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.239 -177.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.409 ' HE2' ' OD2' ' A' ' 243' ' ' ASP . 77.4 mttt -64.76 -68.98 0.32 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.211 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . 0.499 ' HA2' ' O ' ' A' ' 216' ' ' VAL . . . 170.5 24.91 0.02 OUTLIER Glycine 0 C--N 1.331 0.25 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.431 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -152.4 160.51 43.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.565 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -174.21 178.83 45.91 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.532 -176.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.599 ' HZ ' ' HG3' ' A' ' 164' ' ' GLU . 81.2 m-85 -131.92 153.05 50.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.774 0.321 . . . . 0.0 111.119 -176.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.729 HD11 HG22 ' A' ' 225' ' ' ILE . 84.1 mt -142.19 131.29 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.074 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.892 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 45.6 mt-10 -105.7 146.65 29.49 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 176.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 9.7 m-85 -110.77 160.61 16.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 120.723 0.297 . . . . 0.0 110.795 178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -77.28 -23.77 51.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.372 0.606 . . . . 0.0 110.066 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -130.53 124.61 32.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.018 178.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -57.16 -34.79 68.79 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.543 -172.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.434 ' HG3' ' N ' ' A' ' 262' ' ' SER . 7.8 pt20 -59.6 -42.88 93.59 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 123.102 0.251 . . . . 0.0 111.03 178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.434 ' N ' ' HG3' ' A' ' 261' ' ' GLN . 20.1 m -71.14 -32.83 69.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.826 -176.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -43.06 97.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.017 0.437 . . . . 0.0 111.039 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -74.73 -23.12 58.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -73.49 -35.75 65.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.053 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -66.96 -37.61 84.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.923 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.447 ' HA ' ' CG2' ' A' ' 282' ' ' VAL . 77.3 t -58.76 -27.01 33.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.225 0.535 . . . . 0.0 110.646 173.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 36.8 t -86.15 -30.6 22.36 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.142 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.9 m -93.95 -41.15 9.74 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.588 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 88.3 mmm -84.11 4.9 28.22 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -169.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.449 ' HA ' HG12 ' A' ' 282' ' ' VAL . 11.0 t30 -71.58 118.11 13.98 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.382 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.506 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 93.1 mt 66.83 34.13 5.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.601 -178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -88.33 122.85 32.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.839 -0.801 . . . . 0.0 108.839 173.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.438 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 16.3 t70 -73.28 119.24 17.25 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.934 -0.307 . . . . 0.0 110.727 -177.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 44.8 tp -137.01 91.91 2.67 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.292 0.568 . . . . 0.0 110.111 175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 96.65 22.77 17.6 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.464 179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 93.91 -1.93 68.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.623 177.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -127.2 147.26 50.21 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.506 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 84.6 m-85 -89.39 116.1 27.33 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.217 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 69.6 mt -58.04 127.85 34.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.857 -176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 17.1 mmt180 -93.45 115.39 27.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 271' ' ' ASN . 13.9 p -115.82 135.98 54.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.178 0.513 . . . . 0.0 111.143 -173.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -154.94 -179.53 30.2 Favored Glycine 0 N--CA 1.441 -1.027 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.537 177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 284' ' ' LYS . 39.3 mtpt -84.16 130.2 34.86 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -63.56 120.63 12.11 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.528 0.518 . . . . 0.0 109.821 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.3 m -91.68 -26.89 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -173.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.498 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 28.3 p -134.86 145.11 53.31 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 120.654 0.264 . . . . 0.0 110.783 177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -76.2 108.05 2.59 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.366 2.044 . . . . 0.0 112.199 177.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 287' ' ' THR . 25.0 Cg_exo -63.17 -38.72 43.16 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.845 2.363 . . . . 0.0 111.444 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.443 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 27.9 ttt -138.45 108.64 7.97 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.317 -0.856 . . . . 0.0 108.796 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 12.1 Cg_exo -71.57 -21.85 25.21 Favored 'Trans proline' 0 CA--C 1.526 0.124 0 C-N-CA 123.303 2.669 . . . . 0.0 113.227 -176.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 49.6 tp -116.11 88.58 2.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.991 0.424 . . . . 0.0 111.374 -176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.531 HD12 ' NH2' ' A' ' 210' ' ' ARG . 43.7 mt -110.74 139.15 46.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.952 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 1.8 t -59.13 109.99 2.33 Favored Pre-proline 0 C--O 1.237 0.408 0 O-C-N 123.868 0.73 . . . . 0.0 111.729 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 8.3 Cg_endo -87.67 111.33 0.76 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.665 2.91 . . . . 0.0 112.546 -176.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -121.72 -29.14 4.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.361 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . 0.445 ' CG2' ' HG3' ' A' ' 236' ' ' LYS . 93.8 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.06 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 N-CA-C 111.811 -0.515 . . . . 0.0 111.811 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.449 ' HA ' ' NE2' ' A' ' 105' ' ' GLN . . . -122.85 -52.39 1.89 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.668 0.271 . . . . 0.0 111.041 -176.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.0 mtm -83.25 -40.83 19.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.986 0.422 . . . . 0.0 110.827 -177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -92.9 40.26 1.05 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.483 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.494 ' HG3' ' HB3' ' A' ' 105' ' ' GLN . 6.4 tp-100 -163.75 134.54 4.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.455 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 43.7 ttp180 -100.88 67.62 1.24 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.767 0.794 . . . . 0.0 109.121 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.518 ' CD ' ' H ' ' A' ' 105' ' ' GLN . 0.0 OUTLIER -95.3 -7.03 39.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.164 -168.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -65.54 -32.2 73.67 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.835 0.35 . . . . 0.0 111.283 -176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -71.22 -30.84 66.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.153 0.502 . . . . 0.0 110.438 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.704 HD21 HD13 ' A' ' 201' ' ' LEU . 56.9 mt -71.71 -33.08 68.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.325 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.9 73.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.265 0.555 . . . . 0.0 110.028 175.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.7 mt -73.31 -38.49 53.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.116 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.437 ' SD ' HG23 ' A' ' 198' ' ' ILE . 31.7 mtm -74.29 -2.22 24.11 Favored 'General case' 0 C--O 1.224 -0.285 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.541 178.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 73.8 m -82.68 -8.58 59.59 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.098 0.475 . . . . 0.0 110.018 175.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.931 ' HG2' ' HG2' ' A' ' 159' ' ' GLU . 58.3 mtt180 -113.33 141.87 46.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.15 -177.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.567 HG12 ' HB ' ' A' ' 158' ' ' VAL . 9.9 p -121.51 130.32 74.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.273 0.558 . . . . 0.0 109.749 171.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -83.64 114.91 21.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.079 178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 21.4 m -112.24 121.23 64.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.616 0.722 . . . . 0.0 110.935 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.501 ' HA2' ' HD1' ' A' ' 155' ' ' PHE . . . -127.47 173.09 18.69 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.981 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 58.7 m 60.75 31.47 20.11 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.408 0.283 . . . . 0.0 111.176 -178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.561 ' O ' ' HG2' ' A' ' 181' ' ' ARG . 71.1 mt -61.39 -84.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.485 -176.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.519 ' HB2' ' O ' ' A' ' 119' ' ' ILE . 2.3 t80 164.6 149.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -174.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 151' ' ' LYS . 5.0 p90 -88.26 73.14 8.94 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 168.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -176.84 -58.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.226 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.8 mt -58.84 99.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.273 178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -76.32 171.32 54.76 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 121.106 -0.569 . . . . 0.0 113.032 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -57.05 -39.9 75.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.874 0.368 . . . . 0.0 110.656 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -58.35 -49.46 77.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.79 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 22.7 m -63.3 -44.18 95.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.087 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.418 HG13 ' HE1' ' A' ' 143' ' ' MET . 33.8 mm -60.74 -40.46 85.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.532 177.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -61.2 -38.67 87.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.337 178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -70.88 -34.04 71.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.495 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.431 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -82.07 -29.02 32.05 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.231 -174.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.512 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 46.3 m-85 -94.33 -14.86 24.95 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.829 0.347 . . . . 0.0 111.569 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.433 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.99 -41.97 88.3 Favored Pre-proline 0 CA--C 1.541 0.605 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 175.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 55.1 Cg_exo -42.48 -35.72 4.04 Favored 'Trans proline' 0 C--N 1.362 1.288 0 C-N-CA 123.016 2.477 . . . . 0.0 114.488 174.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.521 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 51.3 m-85 -82.49 -49.34 10.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 121.141 -0.223 . . . . 0.0 111.202 -176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.01 172.39 39.84 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.238 -0.982 . . . . 0.0 112.918 175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.94 121.64 8.29 Favored 'Trans proline' 0 C--O 1.238 0.493 0 C-N-CA 122.617 2.211 . . . . 0.0 111.705 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 61.2 mt -84.53 116.7 28.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.945 -178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -74.76 -43.75 53.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.09 -0.959 . . . . 0.0 109.917 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.3 t -161.96 152.78 17.71 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.358 -176.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -130.45 126.12 60.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 174.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.63 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 13.3 t70 -96.28 99.77 11.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 173.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.418 ' HE1' HG13 ' A' ' 128' ' ' ILE . 46.9 ttm -136.21 126.88 27.18 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.204 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 11.2 m -69.44 99.87 1.3 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 175.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -110.7 136.4 49.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.109 -174.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 150' ' ' MET . 7.6 t70 -107.97 141.27 39.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.686 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.2 m -115.21 -1.95 12.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.331 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 61.0 t -77.12 -50.86 19.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.136 0.493 . . . . 0.0 109.859 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 54.6 p -113.35 -15.64 12.62 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.21 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' A' ' 146' ' ' ASP . 60.8 mtm 70.98 14.09 6.89 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.841 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 121' ' ' TYR . 59.0 mtmt -110.95 130.9 55.45 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 172.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 144' ' ' SER . 56.8 p-80 -127.13 140.0 52.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.064 0.459 . . . . 0.0 111.542 -169.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.9 ptmm? -110.53 117.34 33.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.809 176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 153.85 -164.74 31.37 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.99 -178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.501 ' HD1' ' HA2' ' A' ' 117' ' ' GLY . 67.2 m-85 -125.12 177.81 5.89 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -176.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.63 ' HA ' ' O ' ' A' ' 142' ' ' ASP . . . -137.29 140.95 41.9 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.089 0.471 . . . . 0.0 111.775 -179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -109.98 109.75 20.44 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.597 173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.567 ' HB ' HG12 ' A' ' 114' ' ' VAL . 47.7 t -91.06 110.36 22.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.337 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.931 ' HG2' ' HG2' ' A' ' 113' ' ' ARG . 47.3 mt-10 -99.72 123.08 43.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.532 -179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.44 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 95.8 m-85 -100.98 171.67 7.49 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.033 0.444 . . . . 0.0 110.085 176.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -86.1 -5.36 59.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.271 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 5.2 m -142.23 143.98 29.59 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.191 177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 12.6 Cg_exo -69.69 -26.54 27.82 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.384 2.723 . . . . 0.0 112.038 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.685 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 8.1 mp0 -55.73 -57.05 13.62 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.954 -178.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -59.81 -19.73 52.51 Favored 'General case' 0 N--CA 1.461 0.115 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.85 -51.15 8.92 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -68.07 -31.55 71.26 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.757 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.521 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 18.2 tp -67.03 -46.47 74.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.673 177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.81 -34.73 73.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.072 0.463 . . . . 0.0 110.168 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.501 HD13 ' O ' ' A' ' 185' ' ' VAL . 2.9 tp -67.6 -51.98 43.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.556 172.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -54.83 -34.44 62.82 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.745 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -100.56 -51.54 3.58 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -176.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.1 ttp -107.78 29.33 7.34 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -165.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 31.9 p-10 -78.72 25.21 0.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.911 0.386 . . . . 0.0 111.302 179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.1 m -113.33 -72.91 0.68 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.867 0.365 . . . . 0.0 111.069 -176.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 30.9 m -134.29 164.04 35.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.002 -175.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.627 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.9 tpt -139.51 91.9 2.53 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.793 0.33 . . . . 0.0 110.734 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.544 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 94.6 mt 61.56 -177.79 0.12 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.429 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 46.69 -113.14 1.06 Allowed Glycine 0 C--N 1.337 0.587 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.185 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -152.6 45.84 0.59 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 176.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.561 ' HG2' ' O ' ' A' ' 119' ' ' ILE . 12.5 tpt180 -127.2 135.84 51.22 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.899 -173.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 4.1 p-10 -91.85 142.53 27.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.627 HD13 ' HB2' ' A' ' 177' ' ' MET . 42.8 pt -129.66 168.19 23.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.792 0.33 . . . . 0.0 110.568 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 55.5 tptt -109.25 106.01 15.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.772 178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.501 ' O ' HD13 ' A' ' 170' ' ' LEU . 43.3 t -103.03 104.29 16.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.431 ' O ' ' HD3' ' A' ' 188' ' ' PRO . . . 94.74 125.8 4.53 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.1 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -105.15 101.62 31.56 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 186' ' ' GLY . 18.4 Cg_exo -66.94 -21.1 50.46 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.813 2.342 . . . . 0.0 112.056 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 42.8 m -79.64 46.27 0.75 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.39 0.614 . . . . 0.0 111.367 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -76.6 -66.47 0.81 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.216 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 11.3 mm 52.01 41.48 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-O 121.651 0.739 . . . . 0.0 111.217 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -107.27 -155.21 19.73 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.484 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.458 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 59.5 tt0 -73.98 -30.8 62.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.855 0.36 . . . . 0.0 110.86 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.434 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -74.43 -23.2 58.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.203 -178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.695 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 23.1 tm0? -58.93 -52.92 71.38 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.497 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 54.2 Cg_exo -56.61 -35.17 96.97 Favored 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.286 1.99 . . . . 0.0 112.65 176.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 59.3 mt -67.99 -43.73 85.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.075 0.464 . . . . 0.0 109.92 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.437 HG23 ' SD ' ' A' ' 111' ' ' MET . 84.9 mt -59.6 -48.71 86.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.052 174.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -59.25 -45.53 90.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.91 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -62.02 -53.03 61.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.14 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.704 HD13 HD21 ' A' ' 108' ' ' LEU . 30.8 mt -65.83 -33.11 75.09 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.85 -0.159 . . . . 0.0 111.262 -178.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.662 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.28 -42.84 70.48 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 173.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -71.44 -34.47 70.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.907 175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.512 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 31.3 mt-10 -65.09 -36.51 84.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.67 -26.73 64.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.686 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 80.5 mtp180 -72.29 -14.12 61.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.59 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -88.39 0.8 55.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.351 0.596 . . . . 0.0 110.273 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -131.42 177.18 7.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.926 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 3.1 m-80 -118.95 43.35 2.58 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.13 -174.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 210' ' ' ARG . 36.7 ttt180 -99.8 137.24 38.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.98 -173.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 48.1 pt -133.08 166.57 29.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.559 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.625 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 84.6 t80 -120.81 131.89 54.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.363 -176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.443 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 33.6 m -125.91 137.42 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.156 0.503 . . . . 0.0 110.677 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -133.29 -178.55 5.03 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.715 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 28.2 t 62.73 26.58 15.7 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.756 0.789 . . . . 0.0 109.444 -171.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.452 HG13 HD11 ' A' ' 225' ' ' ILE . 9.4 t -79.68 115.86 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.093 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -60.88 145.5 49.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.551 -171.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -48.42 -54.54 13.7 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -175.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -85.68 36.91 0.67 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.992 0.425 . . . . 0.0 111.537 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.414 ' HA ' HD12 ' A' ' 220' ' ' LEU . 9.1 tp -121.01 118.01 28.74 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 19.7 m -99.3 177.45 5.19 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.388 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -64.42 -26.75 68.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.95 0.405 . . . . 0.0 110.412 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.46 -40.25 92.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.348 0.594 . . . . 0.0 109.909 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -64.64 -50.0 68.83 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.799 179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.624 HG22 HD11 ' A' ' 255' ' ' ILE . 26.0 mm -68.17 -44.81 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.435 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 64.0 tttm -57.61 -46.56 83.93 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.44 176.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.2 t -52.76 -48.47 66.75 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.68 -43.32 61.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 121.039 -0.264 . . . . 0.0 111.343 -176.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.579 ' CB ' HD11 ' A' ' 235' ' ' ILE . 11.2 m-85 -67.39 -30.01 69.68 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.232 0.539 . . . . 0.0 110.744 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.565 ' OE1' ' HB ' ' A' ' 235' ' ' ILE . 9.0 tp10 -63.16 -24.45 67.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.843 177.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -76.56 -11.63 59.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.874 -173.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -111.2 -40.2 4.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.515 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -142.81 166.51 26.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.767 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -77.97 106.84 10.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.078 0.466 . . . . 0.0 110.521 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.579 HD11 ' CB ' ' A' ' 229' ' ' PHE . 21.5 mt -83.29 148.37 5.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.636 0.731 . . . . 0.0 111.579 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -106.9 -36.15 6.72 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.097 176.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.1 m -154.7 146.5 23.4 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 -171.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 49.7 t -141.83 119.45 11.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 8.6 m -140.48 103.13 4.48 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.301 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.617 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 48.1 mt -75.96 129.23 36.59 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.47 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.21 116.5 6.64 Favored 'General case' 0 C--N 1.321 -0.64 0 O-C-N 123.475 0.485 . . . . 0.0 110.195 -175.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 31.0 ttp180 -136.43 142.21 43.63 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.783 -174.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.496 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 9.2 m-20 -75.97 115.18 44.21 Favored Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -51.69 -27.33 25.92 Favored 'Trans proline' 0 CA--C 1.527 0.175 0 C-N-CA 123.679 2.919 . . . . 0.0 114.138 -171.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 t -97.44 -14.21 21.3 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.219 0.452 . . . . 0.0 112.219 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 71.0 p -92.37 -39.32 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.843 -176.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.77 -0.47 70.14 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.3 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 62.6 pttt -117.56 138.18 52.09 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -82.63 144.55 30.22 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 252' ' ' TYR . 23.8 mtpp -78.29 10.96 2.62 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -167.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 106.02 -3.64 38.43 Favored Glycine 0 CA--C 1.508 -0.388 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.264 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.519 ' CE1' ' HB2' ' A' ' 250' ' ' LYS . 28.9 p90 -142.15 177.78 8.0 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.687 0.28 . . . . 0.0 110.488 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -167.63 174.41 42.68 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 121.228 -0.511 . . . . 0.0 112.158 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.685 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 86.1 m-85 -126.38 149.67 49.08 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.624 HD11 HG22 ' A' ' 225' ' ' ILE . 74.9 mt -140.29 142.73 30.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.454 -177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 51.0 mt-10 -117.75 147.52 42.9 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.551 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 11.6 m-85 -114.38 171.0 7.89 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 171.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -86.99 -9.75 54.85 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.46 0.648 . . . . 0.0 109.569 174.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -136.12 122.63 20.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.273 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -60.0 -33.71 72.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.141 0.496 . . . . 0.0 111.079 -178.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -63.44 -36.47 83.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.882 177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 24.5 m -71.64 -40.82 69.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.33 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 43.1 p -67.17 -36.79 82.55 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -67.68 -30.86 70.49 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 173.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.3 -35.49 76.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.115 0.483 . . . . 0.0 110.256 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.24 85.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.086 174.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.441 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 95.7 t -58.25 -34.12 49.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-O 121.443 0.639 . . . . 0.0 110.126 173.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 43.1 t -73.06 -44.59 60.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.362 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 7.8 m -90.37 -35.36 15.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -171.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.45 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 82.7 mmm -87.17 -7.79 57.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -170.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -73.24 122.09 21.39 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.165 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.57 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 97.4 mt 64.25 31.27 13.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.437 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -86.59 133.85 33.68 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.022 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -80.09 105.6 11.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.951 0.405 . . . . 0.0 110.607 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 56.1 tp -126.11 95.65 4.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.244 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 87.12 21.99 47.07 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.502 177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 90.05 9.26 65.89 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.607 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -129.92 155.3 46.28 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 176.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.57 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 73.5 m-85 -100.39 109.35 21.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.28 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 74.9 mt -59.55 133.95 56.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.639 -176.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.414 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 14.8 mmt180 -99.58 116.18 31.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 173.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 267' ' ' VAL . 12.4 p -123.68 144.41 33.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.65 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.45 173.06 38.68 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.691 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -71.95 128.1 34.66 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.23 113.25 6.4 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.25 -24.14 23.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.867 -173.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 50.2 p -100.67 133.09 21.43 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.983 0.42 . . . . 0.0 110.403 175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -66.01 143.71 73.34 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.594 2.196 . . . . 0.0 111.603 176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -65.76 93.94 0.27 Allowed 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.6 2.2 . . . . 0.0 111.926 178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 65.1 mtt -78.13 121.98 84.69 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.205 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -73.39 101.88 1.41 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.486 2.124 . . . . 0.0 111.529 177.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 1.7 pp -88.34 20.83 3.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.283 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 92.9 mt 72.85 124.47 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.227 0.955 . . . . 0.0 112.105 175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 1.3 p -98.54 103.8 20.59 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.302 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.82 122.36 8.11 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.09 2.527 . . . . 0.0 112.443 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -110.76 133.45 53.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.488 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 62.8 m . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.422 -177.936 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.651 0 N-CA-C 112.366 -0.293 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.91 41.59 2.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.079 0.466 . . . . 0.0 110.128 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.648 ' HB3' HH21 ' A' ' 106' ' ' ARG . 2.0 tmt? -75.78 82.7 2.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.718 -177.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.628 ' O ' ' HG3' ' A' ' 106' ' ' ARG . . . 49.92 48.19 22.16 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.294 174.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.17 -36.16 79.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.426 -175.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.3 mtp180 -81.65 -17.41 48.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 110.951 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.563 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 62.5 tt0 -91.06 -21.93 21.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.236 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.648 HH21 ' HB3' ' A' ' 101' ' ' MET . 82.6 mtt180 -59.28 -48.85 80.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.311 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.474 ' HB2' HD12 ' A' ' 197' ' ' ILE . . . -69.75 -22.8 63.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.489 -176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 63.9 mt -62.91 -32.12 73.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.092 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.71 -28.37 68.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.341 0.591 . . . . 0.0 110.401 176.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.0 mt -87.91 -40.44 13.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.343 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.539 ' SD ' HG12 ' A' ' 198' ' ' ILE . 92.2 mtp -69.08 -29.9 68.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.018 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.682 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 92.9 m -73.94 -12.02 60.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.593 0.235 . . . . 0.0 111.01 178.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.47 ' HG2' ' HA ' ' A' ' 159' ' ' GLU . 47.1 mtt180 -106.51 141.39 37.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.08 0.467 . . . . 0.0 110.894 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.8 p -115.54 122.43 69.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.461 0.648 . . . . 0.0 109.407 171.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -74.86 119.88 19.65 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.108 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 15.3 m -114.22 114.74 47.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.405 0.621 . . . . 0.0 109.959 175.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -117.06 171.36 13.78 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.249 -177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.9 m 58.67 35.08 24.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 111.102 -178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.544 HD11 HG23 ' A' ' 116' ' ' VAL . 58.3 mt -68.99 126.36 28.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.213 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -61.62 140.28 58.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.165 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.657 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 0.0 OUTLIER -72.37 77.3 1.02 Allowed 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 122.133 0.968 . . . . 0.0 111.19 -179.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -170.93 -26.94 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.444 -1.253 . . . . 0.0 108.732 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.401 HD22 HD12 ' A' ' 178' ' ' LEU . 40.1 mt -93.4 110.02 21.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.253 179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -90.26 -174.99 45.02 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.962 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.65 -40.55 97.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.928 0.394 . . . . 0.0 110.117 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.545 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 36.0 t70 -62.89 -48.77 77.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.688 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 5.9 m -61.12 -43.65 98.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.177 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 28.1 mm -63.66 -43.18 98.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.343 177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -57.91 -41.37 82.51 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.486 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 97.8 mt-30 -60.29 -46.31 90.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.495 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.583 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -80.87 -26.98 36.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -171.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.527 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 32.1 m-85 -90.17 -16.4 29.59 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.705 0.288 . . . . 0.0 111.542 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.621 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -56.9 -42.48 96.57 Favored Pre-proline 0 CA--C 1.542 0.657 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 6.9 Cg_endo -51.31 -27.92 25.09 Favored 'Trans proline' 0 C--N 1.361 1.184 0 C-N-CA 122.507 2.138 . . . . 0.0 114.197 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.752 ' HD2' ' HG ' ' A' ' 168' ' ' LEU . 64.6 m-85 -80.99 -46.04 15.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.635 0.255 . . . . 0.0 110.988 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -166.31 -178.53 39.09 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.476 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HD3' ' CE1' ' A' ' 252' ' ' TYR . 62.3 Cg_endo -75.43 117.45 4.82 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.559 2.173 . . . . 0.0 111.65 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.8 mt -83.49 114.24 23.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.897 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.616 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 74.3 tttt -88.38 -33.17 18.01 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.78 -173.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 26.7 t -157.94 147.91 20.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.389 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.9 mt -133.67 113.24 18.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 175.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -96.63 100.02 11.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 174.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.514 ' HG3' ' HB2' ' A' ' 156' ' ' ALA . 52.4 ttm -126.92 137.85 53.2 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.907 -175.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 50.6 m -93.42 123.56 36.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 177.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.633 ' HD1' ' HD2' ' A' ' 152' ' ' HIS . 22.2 t90 -113.85 130.02 56.52 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -76.54 74.28 3.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.666 -176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.573 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 69.0 m -60.49 -23.57 64.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.877 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.512 HG23 HG23 ' A' ' 149' ' ' THR . 28.0 m -74.54 -25.08 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.706 -178.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.512 HG23 HG23 ' A' ' 148' ' ' VAL . 34.4 p -125.73 3.36 7.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.991 0.424 . . . . 0.0 111.426 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.464 ' HA ' ' CH2' ' A' ' 145' ' ' TRP . 48.3 mtm 56.3 42.1 28.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.359 -177.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -127.21 176.51 7.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.557 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.657 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 63.8 t-80 -135.98 82.41 1.94 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.851 0.357 . . . . 0.0 110.795 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.467 ' HG2' ' N ' ' A' ' 154' ' ' GLY . 67.1 tttt -109.78 151.65 26.7 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.467 ' N ' ' HG2' ' A' ' 153' ' ' LYS . . . 112.97 -135.53 12.73 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.332 172.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -140.04 177.93 7.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.172 0.511 . . . . 0.0 111.642 -171.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.514 ' HB2' ' HG3' ' A' ' 143' ' ' MET . . . -152.08 154.5 36.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.377 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -111.93 109.85 19.86 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.185 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 113' ' ' ARG . 62.1 t -91.91 112.16 25.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.756 178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.47 ' HA ' ' HG2' ' A' ' 113' ' ' ARG . 39.0 tt0 -100.08 120.49 39.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.972 -177.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -98.23 170.0 9.19 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.685 173.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.616 ' HG2' ' HD2' ' A' ' 139' ' ' LYS . 35.6 mt-10 -80.34 -38.67 30.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 171.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 19.2 m -109.64 135.81 20.35 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.365 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 56.2 Cg_endo -69.44 -21.15 35.42 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.127 2.551 . . . . 0.0 112.597 -175.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.696 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 10.7 mp0 -57.59 -50.65 72.41 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.129 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.407 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.04 -21.76 65.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.46 -51.72 8.99 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.022 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 164' ' ' GLU . 5.0 pp0? -63.85 -30.23 71.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.556 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.752 ' HG ' ' HD2' ' A' ' 135' ' ' PHE . 14.2 tp -73.79 -45.83 49.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.6 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.4 72.17 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 176.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.531 ' O ' ' HB3' ' A' ' 174' ' ' ASN . 6.8 tt -66.44 -50.0 64.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.27 172.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 10.6 mm-40 -52.72 -50.87 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.554 -178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -89.72 -32.98 16.76 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 22.8 mtm -106.71 30.79 5.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.105 0.479 . . . . 0.0 111.744 -174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.531 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 33.4 p-10 -74.92 -3.59 33.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.412 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.6 m -95.13 -73.38 0.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.81 0.338 . . . . 0.0 110.841 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.9 m -140.69 164.73 21.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.082 -175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.635 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.4 tpt -124.43 95.03 4.38 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.549 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.401 HD12 HD22 ' A' ' 123' ' ' LEU . 91.7 mt 71.95 -50.53 0.69 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.971 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 161.1 -177.29 37.52 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.638 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 94.72 -87.78 1.1 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.604 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -127.55 142.54 51.35 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -70.68 108.4 4.38 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.635 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.3 pt -72.47 156.35 6.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.776 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 83.2 tttt -106.2 116.77 32.51 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.258 173.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.553 HG12 HG12 ' A' ' 116' ' ' VAL . 5.4 m -100.27 114.39 38.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 172.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 147.02 129.73 2.0 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.478 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.577 ' H ' ' HD2' ' A' ' 188' ' ' PRO . 26.7 tpt180 -104.58 -48.19 0.14 Allowed Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.577 ' HD2' ' H ' ' A' ' 187' ' ' ARG . 59.2 Cg_endo -72.49 59.32 3.24 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 121.838 1.692 . . . . 0.0 113.106 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 6.0 m -78.77 -52.07 8.89 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -85.93 161.33 19.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.364 175.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 5.5 tp -61.21 115.44 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.36 0.6 . . . . 0.0 111.704 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -120.66 157.7 15.79 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.826 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -68.29 -7.95 35.35 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.428 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -78.04 -22.2 49.53 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.545 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 71.9 mm-40 -52.32 -54.02 46.4 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 113.175 0.805 . . . . 0.0 113.175 -175.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 53.2 Cg_exo -56.21 -34.54 93.67 Favored 'Trans proline' 0 C--N 1.354 0.864 0 C-N-CA 122.021 1.814 . . . . 0.0 112.684 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.474 HD12 ' HB2' ' A' ' 107' ' ' ALA . 51.3 mt -75.98 -45.98 35.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.327 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.539 HG12 ' SD ' ' A' ' 111' ' ' MET . 69.1 mt -60.85 -43.34 95.38 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.156 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.292 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.08 -38.73 89.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.857 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -61.63 -52.47 64.25 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.855 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.532 HD13 HG22 ' A' ' 287' ' ' THR . 25.5 mt -67.54 -32.69 73.64 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.608 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.671 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -52.63 -47.84 66.78 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 171.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.515 ' OE1' ' HD3' ' A' ' 206' ' ' ARG . 5.8 mm-40 -63.24 -35.24 79.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.213 175.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.663 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 47.6 mt-10 -66.41 -33.45 75.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.943 177.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -77.64 -29.28 51.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.969 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.671 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 59.4 mtp180 -72.62 -25.35 61.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 0.0 110.408 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.65 -39.93 18.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.342 177.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -105.57 79.53 1.46 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 174.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 0.1 OUTLIER -52.4 96.09 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.427 1.079 . . . . 0.0 111.403 -173.198 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.471 ' HB2' ' HG3' ' A' ' 256' ' ' GLU . 44.8 ttm105 -134.09 146.12 50.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.995 0.426 . . . . 0.0 111.59 -171.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.613 HG23 ' HB2' ' A' ' 263' ' ' SER . 49.3 pt -123.78 166.46 18.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.17 174.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.487 ' CG ' ' HB3' ' A' ' 164' ' ' GLU . 85.4 t80 -118.14 129.51 55.57 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.46 -175.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 29.3 m -121.1 128.56 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 121.335 0.588 . . . . 0.0 110.237 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -119.57 176.2 5.48 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.464 -178.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.4 m 60.26 32.59 20.83 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.415 0.626 . . . . 0.0 109.972 -175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.49 114.67 20.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.353 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 32.4 t-80 -55.57 137.65 48.44 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.456 0.472 . . . . 0.0 111.744 -172.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -49.99 -52.37 34.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -82.23 20.38 1.05 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.91 0.386 . . . . 0.0 111.722 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.654 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.0 tp -105.41 126.53 52.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 176.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 18.0 m -90.85 163.96 14.22 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.832 0.349 . . . . 0.0 111.746 -173.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.452 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 6.0 p-10 -65.11 -27.29 68.65 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.27 0.557 . . . . 0.0 110.313 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.34 -31.61 71.14 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.751 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -74.33 -39.85 62.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.694 -178.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.795 HG13 HD21 ' A' ' 240' ' ' LEU . 24.8 mm -65.74 -46.7 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -58.61 -51.56 69.41 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.955 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 14.4 p -58.94 -38.92 80.11 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -175.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 51.1 t -76.53 -41.99 35.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 121.009 -0.277 . . . . 0.0 111.196 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.543 ' CB ' HD11 ' A' ' 235' ' ' ILE . 25.0 m-85 -65.43 -28.67 69.4 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.217 -0.302 . . . . 0.0 110.736 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -62.18 -25.02 67.54 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.654 0.74 . . . . 0.0 110.522 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.88 -17.49 55.51 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.064 -174.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -111.52 -31.36 7.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.924 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.542 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -146.93 160.25 28.21 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.377 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 234' ' ' LYS . 0.7 OUTLIER -84.71 107.63 17.0 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.492 0.663 . . . . 0.0 110.993 -177.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.543 HD11 ' CB ' ' A' ' 229' ' ' PHE . 37.3 mt -86.03 151.4 3.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.928 -173.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -106.23 -27.49 11.01 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.921 175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.458 ' N ' HG22 ' A' ' 235' ' ' ILE . 3.0 p -176.87 152.1 0.92 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 120.575 0.226 . . . . 0.0 110.677 -175.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 36.5 t -137.59 129.5 28.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.282 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 5.1 t -141.05 104.16 4.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.411 0.624 . . . . 0.0 111.599 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.795 HD21 HG13 ' A' ' 225' ' ' ILE . 30.9 mt -75.95 133.57 40.43 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.433 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.44 114.35 4.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.162 0.506 . . . . 0.0 110.257 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.585 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 13.7 mtp180 -112.21 164.89 12.68 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.438 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.28 141.4 57.48 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 175.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -43.75 -45.04 11.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.518 2.812 . . . . 0.0 113.905 -171.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 4.9 t -155.61 86.21 1.06 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.722 0.773 . . . . 0.0 111.21 176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 20.3 p -135.28 -42.84 0.71 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.728 176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 121.92 -24.04 7.19 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.463 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -107.65 166.5 10.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.969 0.414 . . . . 0.0 110.471 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.585 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 9.7 p80 -96.63 165.35 12.19 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -73.39 -82.15 0.06 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.402 -175.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -167.4 7.52 0.05 OUTLIER Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.192 -1.004 . . . . 0.0 112.615 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.421 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 28.7 p90 -150.49 175.76 11.57 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -178.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -165.16 174.98 41.09 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.44 -179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.696 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 78.8 m-85 -129.54 150.95 50.66 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.715 HD11 HG22 ' A' ' 225' ' ' ILE . 81.9 mt -142.49 133.04 23.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.473 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 4.8 mp0 -106.51 146.97 29.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.648 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 8.8 m-85 -118.68 165.15 14.33 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -65.83 -37.57 86.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.081 0.467 . . . . 0.0 110.755 176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -118.22 140.12 50.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.434 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.76 -25.73 68.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.224 -179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -74.21 -43.45 57.09 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.234 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 19.6 m -66.32 -33.0 74.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.982 -173.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.648 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 79.9 p -66.29 -37.82 86.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -71.39 -27.94 63.67 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.473 177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.44 -44.08 92.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.077 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.72 -39.05 92.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.386 176.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 88.8 t -56.65 -40.31 68.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.304 0.573 . . . . 0.0 110.665 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 20.7 m -70.35 -30.98 68.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.533 -176.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.0 m -94.37 -42.99 8.6 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -176.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.477 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.3 mmm -82.66 6.45 17.81 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -169.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.483 ' HA ' HG12 ' A' ' 282' ' ' VAL . 65.2 t30 -72.13 120.57 17.92 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.277 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.435 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 93.4 mt 64.21 31.25 13.28 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.418 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -78.91 128.93 33.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.386 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.422 ' HB2' ' HE1' ' A' ' 279' ' ' TYR . 36.6 t70 -74.47 102.92 4.63 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.466 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.654 ' HG ' HD21 ' A' ' 220' ' ' LEU . 34.2 tp -136.8 109.93 7.76 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.752 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 84.88 21.07 56.69 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.408 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 83.11 4.46 89.83 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 121.146 -0.549 . . . . 0.0 112.654 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -130.47 156.15 45.25 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.435 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 45.7 m-85 -97.18 111.76 23.86 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.506 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 45.6 mt -59.68 127.17 30.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.5 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 30.6 mmt180 -92.71 114.37 26.91 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 171.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 271' ' ' ASN . 11.0 p -118.5 151.92 20.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 120.472 -0.491 . . . . 0.0 111.487 -171.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -169.58 174.86 43.9 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -72.68 141.96 48.25 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.404 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -82.36 129.35 34.86 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 175.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.418 ' CG1' ' HG2' ' A' ' 167' ' ' GLN . 19.9 m -92.05 -23.05 5.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.723 0.297 . . . . 0.0 110.739 -175.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.532 HG22 HD13 ' A' ' 201' ' ' LEU . 38.0 p -128.81 156.5 77.63 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 121.136 0.493 . . . . 0.0 111.373 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.663 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 66.4 Cg_endo -97.05 103.01 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 123.252 2.635 . . . . 0.0 112.662 176.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.495 ' HD2' ' HA ' ' A' ' 288' ' ' PRO . 27.5 Cg_endo -64.4 135.07 44.5 Favored 'Trans proline' 0 N--CA 1.464 -0.258 0 C-N-CA 122.273 1.982 . . . . 0.0 111.186 174.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 26.4 mmt -83.67 119.15 73.24 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.916 -177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -68.72 97.07 0.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.64 2.226 . . . . 0.0 111.975 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 292' ' ' LEU . 2.5 pt? -65.8 -26.87 67.88 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.053 177.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 89.7 mt -137.12 119.02 15.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.617 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 3.0 p -82.75 141.69 44.73 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.613 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 12.1 Cg_exo -70.32 97.53 0.69 Allowed 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.646 2.231 . . . . 0.0 111.111 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 62.4 -161.73 0.29 Allowed 'General case' 0 C--O 1.234 0.262 0 O-C-N 123.73 0.644 . . . . 0.0 110.724 -177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.378 -0.82 . . . . 0.0 109.752 179.263 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 55.38 55.46 7.38 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.266 0.555 . . . . 0.0 111.3 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 13.3 tpt -136.31 74.43 1.5 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -103.73 -171.75 1.99 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.891 -175.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 59.12 40.33 22.0 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.24 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 49.7 mtm180 -92.14 -1.16 57.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.203 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -75.53 3.65 9.0 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.424 -176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -57.12 -42.47 80.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.08 0.467 . . . . 0.0 110.991 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -72.63 -31.4 65.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.769 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.458 HD21 HD13 ' A' ' 201' ' ' LEU . 45.7 mt -70.7 -32.93 70.32 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.14 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.36 -33.86 73.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.347 0.594 . . . . 0.0 109.801 174.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 70.4 mt -75.71 -37.07 35.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.381 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.562 ' CG ' HD12 ' A' ' 198' ' ' ILE . 86.6 mtp -69.26 -20.78 63.93 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.021 -178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 82.1 m -74.5 -11.72 60.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -99.5 142.38 31.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.805 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.6 p -123.52 122.74 65.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 89.5 t80 -65.56 126.62 28.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.741 178.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -116.99 115.41 48.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -124.3 163.2 18.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.139 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 74.0 m 60.76 47.12 8.27 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 122.661 0.385 . . . . 0.0 111.233 -178.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.496 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 49.2 mt -74.05 -28.28 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.353 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 35.7 t80 72.43 135.69 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.619 0.575 . . . . 0.0 109.528 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.498 ' HA ' ' CE1' ' A' ' 152' ' ' HIS . 21.2 p90 -77.16 77.22 3.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 122.193 0.997 . . . . 0.0 111.047 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -151.67 -49.45 0.11 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 114.264 -1.335 . . . . 0.0 108.566 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.459 HD22 HD12 ' A' ' 178' ' ' LEU . 57.0 mt -68.04 137.64 55.2 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.59 177.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -98.72 173.67 27.21 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.409 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.82 -51.25 70.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.297 0.57 . . . . 0.0 110.88 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -70.98 -27.83 63.99 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.876 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.5 m -64.55 -43.53 93.65 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.188 0.518 . . . . 0.0 109.762 175.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.556 HG13 ' HE1' ' A' ' 143' ' ' MET . 36.5 mm -64.44 -41.35 92.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.151 175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 129' ' ' ARG . 20.7 ttt180 -55.73 -49.18 73.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.777 176.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.87 -33.29 73.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.759 -178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.611 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -83.17 -35.51 25.45 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -87.23 -17.2 33.14 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -178.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.51 -42.55 96.38 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -44.35 -36.2 9.15 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 122.714 2.276 . . . . 0.0 114.277 176.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 169' ' ' ALA . 60.7 m-85 -77.9 -39.01 44.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.666 0.269 . . . . 0.0 110.717 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.415 ' HA3' ' CB ' ' A' ' 165' ' ' ALA . . . -173.8 167.6 40.2 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 121.111 -0.566 . . . . 0.0 111.738 171.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -63.46 114.52 2.56 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.578 2.186 . . . . 0.0 111.865 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.577 HD13 HD11 ' A' ' 141' ' ' ILE . 65.2 mt -74.05 130.71 35.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.635 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 139' ' ' LYS . 36.8 ttpt -93.06 -33.99 13.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.393 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.1 t -174.05 128.38 0.38 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.949 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.577 HD11 HD13 ' A' ' 138' ' ' ILE . 68.9 mt -104.42 119.12 52.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 172.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -88.23 100.67 13.16 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.556 ' HE1' HG13 ' A' ' 128' ' ' ILE . 43.7 ttm -143.41 101.28 3.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.93 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.732 ' HB2' ' HE2' ' A' ' 153' ' ' LYS . 18.4 m -74.59 104.68 5.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.841 0.353 . . . . 0.0 110.924 -178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -76.79 111.88 12.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.108 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.862 ' HB2' ' HB2' ' A' ' 151' ' ' LYS . 25.3 m-20 -76.81 83.02 3.4 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 6.4 m -52.09 -34.6 44.7 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -172.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 29.9 m -63.17 -27.59 43.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 p -130.09 12.07 5.59 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.87 0.367 . . . . 0.0 111.515 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 47.1 mtm 55.83 32.4 19.52 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.656 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.862 ' HB2' ' HB2' ' A' ' 146' ' ' ASP . 91.9 mttt -89.21 175.6 7.29 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.082 0.468 . . . . 0.0 109.925 177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.498 ' CE1' ' HA ' ' A' ' 121' ' ' TYR . 17.3 p-80 -153.03 46.11 0.68 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 170.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.732 ' HE2' ' HB2' ' A' ' 144' ' ' SER . 64.6 mmtt 65.45 -71.95 0.08 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.217 -1.356 . . . . 0.0 111.03 -174.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 147.34 -25.2 1.55 Allowed Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 -176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -123.99 165.2 17.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.748 -0.726 . . . . 0.0 109.401 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -155.93 169.33 24.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.316 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.467 ' CE2' ' HD1' ' A' ' 115' ' ' TYR . 95.6 m-85 -124.18 112.82 17.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.164 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 96.1 t -91.85 108.5 20.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 177.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -105.06 118.99 37.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.11 0.481 . . . . 0.0 110.036 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -88.66 -176.11 5.15 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.966 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -83.35 -35.52 25.1 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 172.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.4 m -117.41 140.91 27.94 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.405 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.62 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 51.0 Cg_endo -66.84 -19.7 52.54 Favored 'Trans proline' 0 N--CA 1.474 0.363 0 C-N-CA 123.52 2.814 . . . . 0.0 112.609 -176.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.654 ' HG3' ' CE1' ' A' ' 254' ' ' PHE . 80.6 mm-40 -58.33 -55.04 40.1 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.752 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.68 -21.03 62.4 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 120.929 0.395 . . . . 0.0 111.984 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.92 -48.68 15.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.692 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.472 ' HG3' HG11 ' A' ' 286' ' ' VAL . 30.5 mm-40 -69.19 -33.18 72.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.503 174.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.509 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 13.7 tp -65.65 -47.07 76.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.656 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 135' ' ' PHE . . . -59.79 -37.71 79.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.08 0.467 . . . . 0.0 110.13 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.588 ' HG ' HG23 ' A' ' 185' ' ' VAL . 6.8 tt -65.38 -43.52 90.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.806 174.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.34 -34.44 76.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.99 -176.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -100.61 -47.25 4.92 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 29.7 ttp -102.91 31.04 4.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.363 0.602 . . . . 0.0 111.708 -166.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 4.8 p-10 -74.68 16.66 0.26 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.551 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 5.4 m -106.35 -74.01 0.67 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.675 0.274 . . . . 0.0 111.47 -175.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.534 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 18.6 m -144.34 169.56 9.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.744 ' HB2' HD13 ' A' ' 183' ' ' ILE . 1.9 tpt -129.62 101.1 5.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.97 0.414 . . . . 0.0 110.673 177.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.742 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 94.6 mt 63.66 32.45 13.82 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.016 173.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.63 -31.63 1.92 Allowed Glycine 0 CA--C 1.522 0.469 0 C-N-CA 121.087 -0.578 . . . . 0.0 114.32 173.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -53.75 -64.71 3.99 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.647 -0.311 . . . . 0.0 113.293 -175.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -144.41 150.91 38.49 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.563 -0.375 . . . . 0.0 110.679 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.534 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 8.4 p30 -72.44 118.8 15.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 173.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 177' ' ' MET . 43.6 pt -96.46 157.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.497 -174.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -105.14 110.99 23.59 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.408 173.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.588 HG23 ' HG ' ' A' ' 170' ' ' LEU . 9.7 m -99.76 122.82 52.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.067 0.461 . . . . 0.0 109.922 176.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 87.05 143.8 8.19 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.955 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 35.1 ttp180 -142.43 73.09 20.96 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.0 57.23 6.4 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.175 2.583 . . . . 0.0 113.31 -171.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.8 t -154.88 -54.19 0.09 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -69.79 109.86 4.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.569 177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 34.4 mm 61.64 69.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.464 0.65 . . . . 0.0 110.886 178.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -103.73 47.4 1.1 Allowed Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 30.2 tp60 -61.93 -37.59 85.24 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.058 0.456 . . . . 0.0 111.365 -173.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.472 ' O ' HG12 ' A' ' 198' ' ' ILE . . . -97.52 11.81 35.58 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.777 -175.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.567 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 25.2 tm0? -53.57 -47.16 97.42 Favored Pre-proline 0 N--CA 1.47 0.551 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 6.9 Cg_endo -52.76 -36.19 72.21 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.355 2.036 . . . . 0.0 112.884 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 78.2 mt -74.18 -38.58 48.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.19 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.562 HD12 ' CG ' ' A' ' 111' ' ' MET . 12.7 mm -57.66 -50.19 78.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.179 179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 30.5 t70 -69.98 -32.56 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.854 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -60.37 -50.64 72.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.03 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.458 HD13 HD21 ' A' ' 108' ' ' LEU . 44.6 mt -68.86 -33.47 73.86 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.645 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -55.54 -42.55 74.77 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 174.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 52.3 mt-10 -63.26 -33.73 76.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.732 174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.72 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 26.4 mt-10 -65.37 -36.23 83.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.915 0.388 . . . . 0.0 110.84 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.5 -39.13 62.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.705 176.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.572 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 60.0 mtp180 -61.02 -22.3 64.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.485 178.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.96 -27.36 65.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.039 0.447 . . . . 0.0 110.71 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -105.8 169.73 8.31 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.224 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 0.9 OUTLIER -103.75 51.27 0.79 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.471 ' HB2' ' HG2' ' A' ' 256' ' ' GLU . 39.3 ttm180 -105.18 139.13 40.31 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.023 -167.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.457 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.4 pt -127.97 166.22 25.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.879 173.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.481 ' HE1' ' HB2' ' A' ' 252' ' ' TYR . 25.0 t80 -118.24 135.81 54.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.019 -176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.507 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.5 m -130.01 136.45 58.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 110.991 177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -131.3 -179.17 5.19 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.553 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 69.6 m 62.44 27.37 16.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.869 0.842 . . . . 0.0 109.72 -171.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.496 HG13 HD11 ' A' ' 225' ' ' ILE . 21.7 t -79.22 116.56 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.538 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 23.0 t-80 -56.0 140.7 42.46 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.253 0.549 . . . . 0.0 111.476 -174.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -58.52 -29.31 66.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.972 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -89.45 6.14 42.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.868 0.842 . . . . 0.0 110.067 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.566 HD21 ' HG ' ' A' ' 275' ' ' LEU . 7.3 tp -112.59 122.77 48.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.079 -177.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 8.4 t -107.25 -178.69 3.71 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.28 -0.168 . . . . 0.0 111.074 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -60.63 -37.52 81.73 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 111.626 0.232 . . . . 0.0 111.626 -174.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -68.99 -24.62 64.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.913 0.387 . . . . 0.0 110.452 -177.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -72.6 -52.74 14.2 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.865 176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.496 HD11 HG13 ' A' ' 216' ' ' VAL . 31.4 mm -61.76 -42.04 92.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.063 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 85.5 tttt -56.31 -50.23 72.02 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.708 176.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 70.4 m -56.09 -37.78 69.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 20.8 t -76.65 -44.28 33.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 111.499 0.185 . . . . 0.0 111.499 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.574 ' HB2' HD11 ' A' ' 235' ' ' ILE . 7.4 m-85 -67.94 -31.34 71.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.591 0.71 . . . . 0.0 110.522 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -60.62 -24.46 65.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.94 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.29 -15.45 62.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.922 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -111.49 -33.76 6.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.348 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -152.03 163.7 30.21 Favored Glycine 0 CA--C 1.517 0.159 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.704 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.93 110.62 6.55 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.147 0.498 . . . . 0.0 111.581 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 229' ' ' PHE . 23.3 mt -88.33 150.44 3.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.017 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -106.16 -31.9 8.47 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.191 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 20.4 p -166.45 156.46 11.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.012 0.434 . . . . 0.0 111.423 -172.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.484 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 9.2 p -141.15 124.52 16.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.831 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 9.0 t -141.49 115.07 8.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.255 0.55 . . . . 0.0 110.973 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.503 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 28.9 mt -91.99 137.13 32.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.43 98.47 0.85 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.978 0.418 . . . . 0.0 110.08 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.655 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 25.5 ttt180 -104.68 131.69 51.81 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.523 178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.555 ' HB2' ' HD2' ' A' ' 250' ' ' LYS . 4.7 t70 -97.28 126.52 41.58 Favored Pre-proline 0 C--N 1.311 -1.083 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.317 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 243' ' ' ASP . 10.5 Cg_exo -69.54 -20.45 35.85 Favored 'Trans proline' 0 CA--C 1.528 0.194 0 C-N-CA 123.457 2.772 . . . . 0.0 113.799 -173.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 43.3 p -87.24 -30.31 21.02 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.883 -173.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.408 HG23 ' HG2' ' A' ' 248' ' ' LYS . 8.8 t -97.04 -22.84 16.57 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.295 0.569 . . . . 0.0 110.301 175.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 77.12 25.67 63.57 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.423 173.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.513 ' C ' ' HG3' ' A' ' 242' ' ' ARG . 64.2 pttt -142.72 154.65 44.48 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 0.6 OUTLIER -76.3 131.42 39.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.555 ' HD2' ' HB2' ' A' ' 243' ' ' ASP . 50.0 mtpt -74.55 3.41 7.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -164.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 102.5 2.67 50.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.174 -1.012 . . . . 0.0 112.368 174.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.481 ' HB2' ' HE1' ' A' ' 212' ' ' TYR . 32.9 p90 -141.88 165.21 28.08 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 178.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -169.25 178.46 42.41 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.021 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.654 ' CE1' ' HG3' ' A' ' 164' ' ' GLU . 88.2 m-85 -129.78 148.85 51.7 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.018 0.437 . . . . 0.0 110.594 -177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.492 HD11 HG22 ' A' ' 225' ' ' ILE . 95.2 mt -136.08 133.21 50.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.255 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 49.0 mt-10 -113.21 135.14 54.15 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.496 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 6.2 m-85 -95.4 179.61 5.11 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -82.3 -17.97 43.94 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.467 0.651 . . . . 0.0 109.378 172.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -129.32 130.14 45.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.535 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 209' ' ' ASN . . . -68.87 -25.01 64.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.164 0.507 . . . . 0.0 111.232 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -75.09 -42.06 57.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.244 176.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.5 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 19.9 m -67.76 -29.44 68.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.733 -175.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.457 ' HB2' HG23 ' A' ' 211' ' ' ILE . 48.3 p -69.05 -32.58 72.17 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.195 0.521 . . . . 0.0 109.687 177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -74.67 -25.89 59.48 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.469 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.5 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 61.1 m-20 -64.02 -41.12 97.55 Favored 'General case' 0 CA--C 1.518 -0.278 0 CA-C-O 121.262 0.553 . . . . 0.0 109.836 175.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.446 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -61.96 -41.27 97.8 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.409 174.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 91.3 t -56.2 -40.13 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 121.187 0.517 . . . . 0.0 110.71 176.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 48.0 t -69.31 -30.9 69.07 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.442 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 8.5 m -94.53 -43.87 8.13 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.446 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 78.5 mmm -84.48 1.73 44.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.914 -169.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.51 ' HA ' HG12 ' A' ' 282' ' ' VAL . 45.7 t30 -69.45 117.07 10.61 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.603 0.24 . . . . 0.0 110.423 -179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 91.6 mt 63.68 36.78 10.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.38 -177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -90.25 124.55 34.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.254 175.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.474 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 18.2 t70 -74.81 108.96 7.88 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.65 -177.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.566 ' HG ' HD21 ' A' ' 220' ' ' LEU . 46.3 tp -141.31 106.77 5.04 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.969 0.414 . . . . 0.0 109.997 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 94.08 24.64 19.11 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.552 -178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 78.52 11.85 84.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.654 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -142.68 150.47 40.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.682 0.277 . . . . 0.0 110.432 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 83.0 m-85 -87.16 114.18 23.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.392 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 43.9 mt -60.4 131.68 51.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.636 -177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 213' ' ' VAL . 16.8 mmt180 -96.39 116.44 29.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 271' ' ' ASN . 9.4 p -120.66 144.68 28.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.617 -175.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.15 174.22 38.56 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.615 178.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -75.76 126.28 30.7 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.77 126.22 27.79 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.433 0.458 . . . . 0.0 109.862 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.472 HG11 ' HG3' ' A' ' 167' ' ' GLN . 34.4 m -94.29 -26.75 4.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -172.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.45 HG21 ' CD2' ' A' ' 108' ' ' LEU . 19.0 p -132.51 156.23 80.33 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.018 0.437 . . . . 0.0 111.687 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.72 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 86.6 Cg_endo -92.9 103.4 0.17 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.898 2.399 . . . . 0.0 112.572 175.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 287' ' ' THR . 74.3 Cg_endo -78.3 149.76 25.05 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.2 1.933 . . . . 0.0 111.159 175.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.755 ' HG3' ' HG ' ' A' ' 292' ' ' LEU . 46.9 tpp -91.62 108.4 29.12 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.39 55.19 5.32 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.844 2.363 . . . . 0.0 113.302 -173.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.755 ' HG ' ' HG3' ' A' ' 290' ' ' MET . 96.4 mt -78.97 -74.59 0.27 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 176.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 93.2 mt 54.17 51.3 14.73 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.346 175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 26.2 m -90.77 112.89 55.82 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.886 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.62 145.34 91.41 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 123.029 2.486 . . . . 0.0 112.108 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -93.11 58.88 3.0 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.246 0.546 . . . . 0.0 110.782 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.522 -0.752 . . . . 0.0 109.564 178.508 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.731 0 N-CA-C 111.691 -0.564 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -91.67 61.44 4.23 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.136 0.493 . . . . 0.0 110.346 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.3 mtm -112.29 83.17 1.76 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.033 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.18 -48.06 83.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.626 -176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -165.49 -60.84 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.977 -176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 79.3 mtt180 64.56 54.87 1.39 Allowed 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.597 0.561 . . . . 0.0 110.929 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -134.44 -53.37 0.83 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.893 177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -61.86 -32.77 73.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.043 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.13 -45.75 87.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.219 176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.511 HD23 ' SD ' ' A' ' 111' ' ' MET . 87.0 mt -63.9 -31.84 73.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.807 176.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.07 -24.76 67.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.835 176.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.6 mt -84.94 -33.61 8.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.21 0.528 . . . . 0.0 109.719 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.511 ' SD ' HD23 ' A' ' 108' ' ' LEU . 89.4 mtp -72.98 -21.68 60.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.016 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.955 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 31.6 p -82.59 3.55 28.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.095 0.474 . . . . 0.0 110.7 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.534 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 15.0 mtm180 -113.84 141.7 47.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 186' ' ' GLY . 4.2 p -124.98 122.67 63.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.551 0.691 . . . . 0.0 109.684 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.447 ' CD2' ' HB3' ' A' ' 187' ' ' ARG . 48.7 t80 -77.66 128.88 34.81 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 174.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 14.0 m -123.79 116.29 47.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.506 0.669 . . . . 0.0 110.241 175.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -125.11 174.84 17.33 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.582 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 19.5 m 61.77 34.35 17.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.961 0.41 . . . . 0.0 110.817 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 123' ' ' LEU . 63.9 mt -78.17 119.27 26.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.047 0.451 . . . . 0.0 110.889 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -53.25 144.86 15.04 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.442 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.967 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 10.4 p90 -70.8 80.61 0.62 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.771 0.796 . . . . 0.0 111.114 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -169.24 -29.69 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.552 -177.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.402 HD12 HG23 ' A' ' 119' ' ' ILE . 35.0 mt -97.6 105.45 17.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.787 -177.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -80.88 173.36 54.67 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.412 -0.899 . . . . 0.0 111.219 175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -59.8 -35.42 74.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.257 0.551 . . . . 0.0 109.638 179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -62.3 -51.38 67.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.878 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.6 m -61.99 -39.92 93.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.161 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.531 HG13 ' CE ' ' A' ' 143' ' ' MET . 22.2 mm -64.46 -39.73 86.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -56.6 -41.43 76.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.079 0.466 . . . . 0.0 110.116 174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -72.24 -33.78 67.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.731 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.498 ' HB1' ' SD ' ' A' ' 177' ' ' MET . . . -85.6 -29.4 24.13 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.456 ' CD1' HG23 ' A' ' 128' ' ' ILE . 28.0 m-85 -94.98 -20.74 19.11 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -51.53 -41.9 79.65 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 29.2 Cg_exo -38.08 -41.98 1.4 Allowed 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 123.235 2.623 . . . . 0.0 114.625 173.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.488 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 67.0 m-85 -76.13 -44.59 37.7 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 121.299 -0.161 . . . . 0.0 111.156 -175.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -170.22 166.83 40.02 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.571 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.421 ' HG2' ' CE1' ' A' ' 252' ' ' TYR . 35.1 Cg_exo -62.16 117.98 4.85 Favored 'Trans proline' 0 C--O 1.237 0.456 0 C-N-CA 122.846 2.364 . . . . 0.0 111.773 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.84 HD13 HD11 ' A' ' 141' ' ' ILE . 57.2 mt -77.84 130.74 35.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.565 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -99.83 -27.36 13.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.44 -177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.2 t -165.16 131.46 2.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.043 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.84 HD11 HD13 ' A' ' 138' ' ' ILE . 59.9 mt -130.54 128.81 63.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 172.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -120.98 106.77 11.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.965 0.412 . . . . 0.0 110.173 172.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.531 ' CE ' HG13 ' A' ' 128' ' ' ILE . 46.3 ttm -114.69 138.27 50.91 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.634 178.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.6 m -80.33 89.2 5.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.285 177.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 40.4 t-105 -106.57 119.28 38.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.944 0.402 . . . . 0.0 110.651 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -92.46 85.68 5.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.092 -177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 26.9 m -60.66 -25.67 66.51 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.527 -0.761 . . . . 0.0 113.043 -173.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.408 HG23 HG23 ' A' ' 149' ' ' THR . 29.2 m -77.63 -25.57 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -173.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.408 HG23 HG23 ' A' ' 148' ' ' VAL . 69.5 p -111.94 -18.09 12.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.035 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 42.5 mtm 67.08 16.23 10.25 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.078 -177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -85.17 143.72 28.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.967 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 50.7 t-80 -129.92 88.76 2.71 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.333 -175.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -135.86 96.71 3.47 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.302 175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -176.06 -154.58 11.74 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.359 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -124.93 175.76 7.09 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.237 -0.282 . . . . 0.0 110.237 -176.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.456 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -155.63 148.09 23.87 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.702 176.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 141' ' ' ILE . 81.0 m-85 -110.6 113.02 25.31 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.181 175.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.449 ' HB ' HG12 ' A' ' 114' ' ' VAL . 58.9 t -102.74 105.9 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.534 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 46.6 tt0 -108.44 126.8 53.3 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.245 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -99.58 177.56 5.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -76.86 -35.15 57.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.057 0.456 . . . . 0.0 110.059 173.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 14.4 m -118.72 142.2 31.29 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.794 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.955 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 37.8 Cg_endo -66.52 -18.28 54.17 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.3 2.667 . . . . 0.0 112.584 -178.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.54 ' HG3' ' HE2' ' A' ' 254' ' ' PHE . 17.0 mm-40 -56.56 -57.36 12.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.827 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -62.55 -21.92 65.94 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.26 -49.13 15.74 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.237 0.541 . . . . 0.0 109.672 -177.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.657 ' HB2' HG11 ' A' ' 286' ' ' VAL . 31.8 mm-40 -67.29 -38.79 85.61 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.505 174.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.488 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 11.9 tp -60.61 -46.56 89.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.98 178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.48 74.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.961 0.41 . . . . 0.0 110.291 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.61 HD13 ' HA3' ' A' ' 186' ' ' GLY . 7.0 tp -70.11 -41.99 73.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.856 172.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 8.1 mm-40 -59.21 -39.03 81.4 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.311 -176.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -101.02 -50.67 3.74 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 28.4 ttp -102.86 31.37 4.21 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -162.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -79.43 13.98 1.76 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 42.1 m -105.28 -73.52 0.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.929 -0.309 . . . . 0.0 111.573 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 15.6 m -144.79 144.14 22.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.199 0.524 . . . . 0.0 111.42 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.498 ' SD ' ' HB1' ' A' ' 131' ' ' ALA . 3.1 tpt -113.4 108.22 16.92 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 174.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 177' ' ' MET . 4.3 mm? 72.1 -55.38 0.67 Allowed 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.878 0.736 . . . . 0.0 110.658 -173.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 145.26 -167.11 27.47 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.393 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 92.3 -51.58 2.76 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.095 -0.574 . . . . 0.0 113.174 176.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -143.75 139.56 29.49 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.574 0.187 . . . . 0.0 110.858 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -64.87 112.24 3.18 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.862 172.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.492 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.6 pt -88.49 152.3 3.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.503 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.651 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 71.5 mmtt -103.66 105.19 15.35 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.478 HG22 HG12 ' A' ' 116' ' ' VAL . 43.1 t -111.23 135.93 48.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.227 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.61 ' HA3' HD13 ' A' ' 170' ' ' LEU . . . 87.04 48.49 4.36 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.717 173.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.447 ' HB3' ' CD2' ' A' ' 115' ' ' TYR . 8.4 tpt180 -118.34 79.81 15.5 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 175.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -71.39 -54.19 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.437 2.092 . . . . 0.0 111.774 -178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.2 p -179.27 159.52 0.95 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.013 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -132.24 32.41 3.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.565 0.697 . . . . 0.0 109.684 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.4 mm -95.01 27.83 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.359 -176.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.4 ' O ' ' HD2' ' A' ' 196' ' ' PRO . . . 77.16 -72.54 2.09 Favored Glycine 0 C--O 1.22 -0.731 0 CA-C-N 115.64 -0.709 . . . . 0.0 114.286 172.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -53.74 -39.47 65.34 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -164.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.429 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -76.82 -23.48 52.79 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.012 -0.43 . . . . 0.0 112.079 -176.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.553 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 29.3 mm-40 -63.98 -49.61 73.91 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -172.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 8.9 Cg_endo -52.86 -38.43 78.55 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 122.665 2.243 . . . . 0.0 113.098 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 58.6 mt -71.83 -45.25 66.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.773 0.32 . . . . 0.0 110.485 -177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 194' ' ' ALA . 56.2 mt -60.78 -48.34 89.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.14 177.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -64.75 -42.3 95.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.344 -177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.413 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 6.4 tp-100 -60.44 -51.94 67.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.735 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 64.5 mt -67.5 -33.51 75.24 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.576 -178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.615 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -55.92 -42.96 76.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.304 0.573 . . . . 0.0 109.664 175.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 10.8 mm-40 -73.94 -32.71 63.62 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.943 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.631 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 29.5 mt-10 -69.69 -30.47 68.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.697 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.54 -29.04 65.41 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.993 0.425 . . . . 0.0 110.069 175.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.615 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 71.6 mtp180 -71.16 -21.76 62.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.361 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -81.41 6.16 15.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.47 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -132.58 -175.62 3.82 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.92 177.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -126.08 46.28 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.904 -174.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.787 ' HD2' ' HG3' ' A' ' 289' ' ' PRO . 39.7 ttt180 -105.58 137.66 43.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.15 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.501 HG23 ' HB2' ' A' ' 263' ' ' SER . 49.2 pt -129.15 166.82 25.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.01 0.433 . . . . 0.0 110.735 175.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.611 ' HD1' ' CE2' ' A' ' 254' ' ' PHE . 85.2 t80 -122.47 129.72 52.31 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.421 -174.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.565 HG12 HG23 ' A' ' 282' ' ' VAL . 35.1 m -126.63 135.84 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.046 0.45 . . . . 0.0 110.307 176.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -132.95 -179.49 5.51 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.861 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 9.7 t 63.43 27.56 15.23 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 121.894 0.854 . . . . 0.0 109.056 -172.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.93 121.31 35.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.516 -1.22 . . . . 0.0 109.256 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 40.8 t-80 -55.21 133.88 49.41 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.173 0.511 . . . . 0.0 111.283 -175.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -57.79 -28.63 64.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.963 -1.017 . . . . 0.0 113.291 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -97.72 3.71 50.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.724 0.297 . . . . 0.0 111.304 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 217' ' ' HIS . 14.1 tp -87.06 134.32 33.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -177.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 63.2 p -86.41 156.35 20.2 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.339 -0.391 . . . . 0.0 112.054 -171.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.94 -42.45 68.85 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.577 0.703 . . . . 0.0 109.474 172.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.46 -40.38 74.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.548 -1.205 . . . . 0.0 111.833 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -71.7 -38.58 70.54 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.1 -176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.615 HG22 HD11 ' A' ' 255' ' ' ILE . 27.0 mm -65.77 -46.24 89.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 86.8 tttt -57.7 -42.4 83.65 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.439 176.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.6 t -55.52 -47.75 75.77 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.641 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.33 -40.91 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.646 0.26 . . . . 0.0 111.444 -177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.485 ' CB ' HD11 ' A' ' 235' ' ' ILE . 26.4 m-85 -66.74 -29.07 68.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.884 0.373 . . . . 0.0 110.992 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.4 mm-40 -63.9 -24.66 67.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.419 176.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.85 -20.14 60.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.27 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -105.64 -37.2 6.84 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.917 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.41 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -147.18 168.92 28.26 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.801 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 35.2 mmtt -88.01 116.03 25.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.761 0.791 . . . . 0.0 111.231 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.485 HD11 ' CB ' ' A' ' 229' ' ' PHE . 52.6 mt -86.8 150.95 3.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.641 -173.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -110.8 -22.38 11.59 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.759 177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.1 t -172.56 143.28 1.32 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.707 0.289 . . . . 0.0 110.379 -175.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.0 t -140.49 105.13 4.9 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 176.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 15.8 m -129.21 110.13 11.73 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.256 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.56 HD21 HG13 ' A' ' 225' ' ' ILE . 60.9 mt -78.71 131.55 36.65 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.539 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -70.53 122.52 19.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.09 0.471 . . . . 0.0 109.834 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.747 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 76.4 mtt180 -111.05 166.49 11.02 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.29 -171.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -88.06 135.24 33.58 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -44.38 -46.25 11.94 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.861 3.041 . . . . 0.0 114.707 -166.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 8.3 t -159.73 65.42 0.37 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.844 0.831 . . . . 0.0 111.607 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 21.8 p -133.15 6.56 3.9 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.919 174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.01 71.74 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.945 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 248' ' ' LYS . 41.3 mtmt -147.33 159.37 43.75 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -176.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.747 ' HB3' ' HG2' ' A' ' 242' ' ' ARG . 19.8 p80 -107.32 147.36 30.39 Favored 'General case' 0 C--N 1.318 -0.762 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.506 170.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -63.44 -7.5 6.87 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -164.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 108.61 5.43 31.67 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.443 177.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.421 ' CE1' ' HG2' ' A' ' 137' ' ' PRO . 12.8 p90 -141.43 174.09 10.88 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 176.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.539 ' HA2' ' H ' ' A' ' 241' ' ' ALA . . . -164.49 172.34 40.23 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.767 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.611 ' CE2' ' HD1' ' A' ' 212' ' ' TYR . 92.4 m-85 -127.31 143.51 51.22 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.011 0.434 . . . . 0.0 110.687 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 225' ' ' ILE . 83.5 mt -136.61 136.89 48.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.094 -178.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -116.72 146.73 42.59 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 8.6 m-85 -111.28 175.27 5.49 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -83.79 -13.45 53.79 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.222 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -135.48 133.46 38.52 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.979 175.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -65.4 -24.93 67.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.017 -178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -73.43 -35.4 65.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.873 175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.45 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 8.2 t -70.69 -37.64 73.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.678 -176.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.501 ' HB2' HG23 ' A' ' 211' ' ' ILE . 62.3 p -66.41 -32.79 74.38 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.068 0.461 . . . . 0.0 110.115 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -71.49 -27.02 62.94 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.83 176.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.45 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 53.5 m-20 -62.92 -45.3 93.14 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.208 0.528 . . . . 0.0 109.626 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -62.33 -43.53 98.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.018 177.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 263' ' ' SER . 86.5 t -55.38 -37.16 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.297 0.57 . . . . 0.0 111.206 178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 17.6 m -75.83 -24.19 55.81 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.246 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 18.3 m -95.08 -41.83 8.92 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 78.5 mmm -88.07 1.95 53.06 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -167.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.505 ' HA ' HG12 ' A' ' 282' ' ' VAL . 66.7 t30 -72.36 115.42 11.59 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.839 -0.344 . . . . 0.0 110.213 -178.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.2 mt 65.18 38.35 6.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.346 -176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -94.39 123.56 37.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.105 174.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.529 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 32.2 t70 -71.94 108.4 5.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.772 0.32 . . . . 0.0 110.856 -177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 25.5 tp -141.8 111.19 6.45 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 90.94 16.34 54.57 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.051 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 97.35 -6.31 63.32 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.593 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -132.7 152.08 51.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.529 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 74.7 m-85 -81.06 113.13 19.05 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.215 175.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 69.3 mt -60.94 134.63 57.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.388 -177.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 14.7 mmt180 -100.49 115.7 30.71 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 172.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.565 HG23 HG12 ' A' ' 213' ' ' VAL . 10.0 p -115.53 151.01 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.506 -175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.14 175.17 42.36 Favored Glycine 0 N--CA 1.436 -1.322 0 C-N-CA 120.697 -0.763 . . . . 0.0 111.962 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -76.88 126.85 31.66 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.67 129.24 39.07 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.657 HG11 ' HB2' ' A' ' 167' ' ' GLN . 29.1 m -89.26 -11.43 10.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.783 0.325 . . . . 0.0 111.578 -170.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.533 HG23 HG23 ' A' ' 286' ' ' VAL . 68.3 p -120.87 133.39 24.1 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-O 121.27 0.557 . . . . 0.0 111.094 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.48 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 38.8 Cg_endo -67.09 146.34 76.41 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 123.099 2.533 . . . . 0.0 111.995 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.787 ' HG3' ' HD2' ' A' ' 210' ' ' ARG . 14.3 Cg_exo -69.55 -16.7 38.57 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.04 2.493 . . . . 0.0 112.632 -177.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 54.2 ttp -148.05 92.03 4.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.3 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -77.72 72.08 6.24 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.977 2.452 . . . . 0.0 112.05 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 6.7 mp 52.16 57.61 6.29 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.284 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 45.4 tp -66.5 109.63 2.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.07 0.462 . . . . 0.0 110.16 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.777 ' HB ' ' HD3' ' A' ' 295' ' ' PRO . 39.7 m -105.87 -56.29 0.07 OUTLIER Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.847 -177.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.777 ' HD3' ' HB ' ' A' ' 294' ' ' THR . 39.5 Cg_exo -61.96 111.4 1.21 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.105 1.87 . . . . 0.0 112.427 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -158.58 -69.91 0.09 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.912 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 37.1 m . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.647 -0.692 . . . . 0.0 110.228 178.159 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 112.06 -0.416 . . . . 0.0 112.06 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -130.91 89.59 2.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.197 0.522 . . . . 0.0 110.737 178.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -94.07 62.76 3.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.356 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 59.79 30.12 19.69 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.013 -178.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.445 ' O ' ' HB3' ' A' ' 104' ' ' ARG . 10.8 pt20 -95.99 165.15 12.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.968 -176.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' A' ' 103' ' ' GLN . 25.4 tpt180 72.1 138.61 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.11 0.881 . . . . 0.0 111.352 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 75.0 2.91 4.08 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.757 172.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -57.57 -47.85 80.94 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -177.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.51 -39.75 92.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.118 0.485 . . . . 0.0 111.04 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.544 HD21 HD13 ' A' ' 201' ' ' LEU . 60.0 mt -71.95 -35.57 69.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.913 179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.43 -37.11 77.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.964 0.412 . . . . 0.0 110.505 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.3 mt -67.02 -42.8 89.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.308 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 1.8 ttm -68.53 -14.65 63.15 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.831 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.3 m -77.13 -15.78 59.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.454 177.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.496 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 18.4 mtp180 -101.09 141.7 33.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.694 HG22 ' H ' ' A' ' 186' ' ' GLY . 1.0 OUTLIER -123.33 127.76 74.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 78.6 t80 -82.93 115.37 21.76 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.717 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 8.6 m -115.87 116.46 52.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.59 0.71 . . . . 0.0 110.787 178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 155' ' ' PHE . . . -119.95 -175.0 15.6 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.898 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.863 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 20.9 m 67.12 21.46 10.1 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 122.928 0.491 . . . . 0.0 111.279 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 61.6 mt -84.88 102.81 11.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.916 0.388 . . . . 0.0 110.619 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.454 ' CE2' ' HB2' ' A' ' 122' ' ' GLU . 79.3 t80 -53.75 144.25 18.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.633 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.504 ' HA ' ' CE1' ' A' ' 152' ' ' HIS . 20.1 p90 -72.3 76.62 1.0 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 122.172 0.987 . . . . 0.0 111.196 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 120' ' ' TYR . 31.0 tt0 -148.35 -47.47 0.16 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.715 -1.13 . . . . 0.0 108.756 174.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 32.3 mt -66.95 128.28 35.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.501 176.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.48 174.98 35.52 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.007 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -57.31 -36.51 71.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.339 0.59 . . . . 0.0 109.874 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -68.8 -43.44 75.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.132 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.2 m -59.59 -46.2 89.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.125 0.488 . . . . 0.0 110.454 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.511 HG13 ' HE1' ' A' ' 143' ' ' MET . 41.8 mm -62.22 -47.65 92.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.617 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -60.26 -41.1 92.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.863 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -63.14 -34.4 77.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.492 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.79 -34.48 22.76 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -174.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.442 ' HD1' ' O ' ' A' ' 128' ' ' ILE . 69.8 m-85 -91.47 -18.41 24.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.464 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -55.41 -42.02 93.81 Favored Pre-proline 0 CA--C 1.539 0.532 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 178.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 42.5 Cg_exo -40.39 -43.03 3.96 Favored 'Trans proline' 0 C--N 1.363 1.29 0 C-N-CA 123.017 2.478 . . . . 0.0 113.925 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.67 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 50.1 m-85 -74.91 -51.78 12.94 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.645 0.26 . . . . 0.0 111.142 -175.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.37 170.54 36.41 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 119.929 -1.129 . . . . 0.0 113.023 177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -66.3 118.71 5.74 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.87 2.38 . . . . 0.0 110.896 175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.446 HG21 ' CG1' ' A' ' 141' ' ' ILE . 53.3 mt -82.78 120.96 35.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.374 -177.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -88.88 -33.6 17.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.341 -178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.3 t -153.58 136.79 15.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.968 179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.446 ' CG1' HG21 ' A' ' 138' ' ' ILE . 71.7 mt -120.49 107.46 20.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 169.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.719 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 1.0 OUTLIER -84.75 98.66 10.38 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.355 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.511 ' HE1' HG13 ' A' ' 128' ' ' ILE . 57.0 ttm -149.45 134.34 17.92 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.784 0.325 . . . . 0.0 110.377 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 1.9 p -74.2 56.98 0.65 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.633 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 74.4 t-105 -99.7 93.2 5.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.002 0.43 . . . . 0.0 111.259 -177.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -173.05 88.35 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.597 172.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 29.2 p -163.54 140.55 7.2 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.594 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 50.5 t -65.38 -21.77 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.309 177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.2 p -88.03 1.16 54.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.949 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 62.5 mtm 59.66 40.19 20.29 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.953 -179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -108.04 140.76 40.74 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.265 0.555 . . . . 0.0 111.83 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.504 ' CE1' ' HA ' ' A' ' 121' ' ' TYR . 2.4 p-80 -145.95 162.03 38.73 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 170.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -54.62 -64.85 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.699 0.285 . . . . 0.0 111.476 -176.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 149.78 -22.3 1.16 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.9 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.436 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 47.9 p90 -108.78 151.38 26.3 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.465 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -146.2 156.15 43.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.625 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.719 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 93.8 m-85 -113.75 109.55 18.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.775 175.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.636 ' HB ' HG12 ' A' ' 114' ' ' VAL . 59.8 t -97.31 106.34 18.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.496 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 72.8 tt0 -108.46 122.84 47.87 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.539 -177.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -96.37 178.89 5.21 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.296 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -82.43 -17.87 43.85 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.555 173.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.4 m -133.38 143.66 49.05 Favored Pre-proline 0 C--N 1.333 -0.145 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.673 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 57.9 Cg_endo -71.95 -22.85 22.65 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.199 2.599 . . . . 0.0 112.785 -176.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.593 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 16.3 mp0 -55.16 -58.72 6.52 Favored 'General case' 0 C--O 1.222 -0.386 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.684 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.67 -22.47 23.27 Favored 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.75 -48.13 12.96 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.968 0.413 . . . . 0.0 110.316 -176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -73.34 -26.66 61.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.302 0.572 . . . . 0.0 109.699 176.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.67 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 16.3 tp -70.47 -47.27 61.43 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.233 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.0 -34.72 78.15 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 176.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 18.6 tp -65.24 -46.08 82.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.714 173.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -54.37 -47.71 72.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.673 -174.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -90.45 -43.84 10.01 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 12.4 mtm -94.46 30.3 2.02 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -170.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 170' ' ' LEU . 3.5 t-20 -75.98 12.97 0.96 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.168 0.508 . . . . 0.0 110.806 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 22.2 m -113.72 -73.38 0.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.523 -178.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.9 m -142.28 162.04 19.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.858 0.361 . . . . 0.0 111.373 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.672 ' HB2' HD13 ' A' ' 183' ' ' ILE . 17.2 tpp -128.53 84.39 2.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.494 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.457 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 89.0 mt 70.16 -56.25 0.59 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.106 -0.952 . . . . 0.0 112.305 176.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -73.59 168.87 53.79 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.461 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -88.63 53.75 4.07 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.722 -178.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.447 ' HD2' ' O ' ' A' ' 118' ' ' SER . 43.3 ttm180 -143.77 137.64 28.21 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 175' ' ' SER . 0.9 OUTLIER -72.09 112.07 7.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.192 0.52 . . . . 0.0 110.382 178.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.863 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 45.3 pt -81.38 158.41 4.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.139 -176.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.717 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 24.8 ttmm -103.4 116.4 32.34 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.051 176.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.3 t -122.7 148.84 26.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -177.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.694 ' H ' HG22 ' A' ' 114' ' ' VAL . . . 107.24 -118.74 5.65 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.005 175.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 187' ' ' ARG . 0.0 OUTLIER -145.11 121.46 6.05 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.9 -35.89 53.16 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.498 2.132 . . . . 0.0 110.855 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.4 m -83.24 76.07 9.91 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.272 173.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -63.67 -57.16 10.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.106 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 41.9 mm -88.08 72.52 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.608 0.718 . . . . 0.0 109.989 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -101.94 -178.09 27.95 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.978 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -70.35 -16.99 63.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.133 0.466 . . . . 0.0 111.091 -178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -84.84 -19.6 32.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.499 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 25.3 tp60 -57.36 -47.47 98.96 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -176.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 73.1 Cg_exo -52.5 -38.88 75.46 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.08 1.853 . . . . 0.0 112.678 176.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 68.0 mt -75.67 -43.9 40.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.438 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 194' ' ' ALA . 79.9 mt -58.23 -46.88 88.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.784 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -65.04 -39.74 93.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.705 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -59.54 -52.81 63.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.98 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.544 HD13 HD21 ' A' ' 108' ' ' LEU . 42.0 mt -68.14 -32.91 73.51 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.191 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.604 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.59 -48.24 72.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -65.53 -33.7 76.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.855 175.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 30.7 mt-10 -66.11 -33.71 76.39 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.17 0.51 . . . . 0.0 111.155 176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -72.75 -24.85 61.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.656 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.604 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 68.6 mtp180 -79.87 -28.12 39.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.372 174.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.8 -38.41 76.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.151 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -88.72 173.6 8.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.481 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 14.1 m120 -116.58 34.71 4.91 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 120.954 -0.298 . . . . 0.0 110.797 -174.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.68 ' HD3' ' HG3' ' A' ' 289' ' ' PRO . 17.0 ttp180 -98.73 138.13 36.33 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.373 0.606 . . . . 0.0 111.507 -174.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.47 ' HA ' ' H ' ' A' ' 285' ' ' ALA . 47.7 pt -124.0 167.11 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.954 177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 83.5 t80 -117.06 128.04 54.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.53 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.471 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 34.6 m -117.7 132.56 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-O 121.251 0.548 . . . . 0.0 110.112 177.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -126.95 169.68 13.06 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.894 -174.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 14.3 t 62.37 32.29 16.95 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.87 0.843 . . . . 0.0 109.312 -176.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.45 108.28 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.091 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -54.98 133.38 48.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.911 0.386 . . . . 0.0 110.725 -174.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -55.8 -24.22 34.76 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -171.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -85.24 -21.1 29.23 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.952 -0.299 . . . . 0.0 111.23 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 83.0 mt -65.62 124.39 22.23 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 174.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 23.3 t -81.38 164.12 22.35 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.199 0.523 . . . . 0.0 111.329 -174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -53.47 -38.88 64.02 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.126 176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.55 -35.56 77.58 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.661 -177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.33 -44.59 94.47 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.671 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.742 HG22 HD11 ' A' ' 255' ' ' ILE . 38.0 mm -67.04 -41.17 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.021 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.664 ' HD2' ' SG ' ' A' ' 238' ' ' CYS . 87.4 tttt -59.8 -45.07 93.48 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.633 174.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.1 m -54.96 -44.96 74.85 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.0 t -76.32 -38.22 32.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.719 0.295 . . . . 0.0 111.485 -176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.563 ' HB3' ' OH ' ' A' ' 257' ' ' TYR . 15.7 m-85 -72.51 -33.43 66.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.152 0.501 . . . . 0.0 110.996 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -61.17 -24.61 66.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.027 175.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.56 -12.78 61.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.245 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -111.43 -45.51 3.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.89 0.376 . . . . 0.0 110.896 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -134.02 177.12 19.36 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.044 -179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 234' ' ' LYS . 39.4 tptt -91.74 106.44 18.48 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.11 0.481 . . . . 0.0 110.424 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.559 HD11 ' HB2' ' A' ' 229' ' ' PHE . 22.5 mt -75.94 142.71 14.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.843 0.83 . . . . 0.0 112.325 -175.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.468 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 54.4 tttt -101.69 -37.3 8.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.42 175.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.443 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 20.4 m -156.04 142.0 18.11 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.318 -172.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.664 ' SG ' ' HD2' ' A' ' 226' ' ' LYS . 26.6 p -130.05 121.58 26.72 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 168.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 29.0 m -142.05 102.31 4.1 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.943 0.401 . . . . 0.0 110.536 175.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.516 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 70.3 mt -76.4 131.0 38.85 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 174.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.484 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -65.21 115.32 5.42 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 14.7 ptt-85 -139.78 168.83 18.92 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.143 -171.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.49 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 16.6 m-20 -112.71 123.64 33.46 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.972 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 11.9 Cg_endo -58.51 -22.92 61.89 Favored 'Trans proline' 0 CA--C 1.526 0.117 0 C-N-CA 123.077 2.518 . . . . 0.0 111.999 177.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.2 p -91.32 -4.81 55.46 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.662 -177.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.49 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 47.8 p -114.22 -34.48 5.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.734 -0.386 . . . . 0.0 111.493 -177.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 86.7 6.33 80.25 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.267 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -138.31 160.0 40.6 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 6.5 p80 -87.19 151.22 23.36 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.281 0.563 . . . . 0.0 110.448 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -64.01 -25.34 68.08 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.384 -170.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 135.99 -12.12 4.18 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.874 -177.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.417 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 44.3 p90 -130.87 174.52 9.89 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 177.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.516 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -165.86 175.53 41.45 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.329 -179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.593 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 96.6 m-85 -129.52 142.37 50.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.971 0.415 . . . . 0.0 110.448 -179.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.742 HD11 HG22 ' A' ' 225' ' ' ILE . 90.4 mt -136.07 142.66 38.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.132 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.6 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 41.7 mt-10 -120.76 148.76 43.54 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -177.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.643 ' HB2' ' OG ' ' A' ' 263' ' ' SER . 25.5 m-85 -118.97 153.5 34.55 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 123.396 0.435 . . . . 0.0 109.888 175.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 25.0 mt-10 -75.95 -9.05 58.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.49 0.662 . . . . 0.0 110.036 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -130.66 122.56 27.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.392 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -59.36 -32.24 69.94 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.872 -171.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -67.86 -39.17 83.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.027 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 35.7 m -67.54 -33.34 74.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.747 -176.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.643 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 3.3 m -58.38 -50.66 72.88 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.573 0.701 . . . . 0.0 109.701 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . 0.419 ' HG2' ' HD3' ' A' ' 284' ' ' LYS . 24.6 mt-30 -76.75 -14.66 59.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.146 -178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -70.84 -45.96 63.57 Favored 'General case' 0 CA--C 1.513 -0.474 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.97 -34.74 78.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.875 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.508 HG13 ' HA2' ' A' ' 283' ' ' GLY . 88.6 t -56.12 -31.62 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.195 0.521 . . . . 0.0 111.073 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.5 t -87.37 -39.18 15.53 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.079 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.6 m -80.99 -41.49 22.66 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -175.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.543 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 77.4 mmm -83.16 -0.23 48.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.952 0.406 . . . . 0.0 111.059 -172.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.528 ' HA ' HG12 ' A' ' 282' ' ' VAL . 26.7 t-20 -71.37 111.18 6.49 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.308 -179.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.9 mt 70.36 34.66 2.21 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.37 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -88.23 129.76 35.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.761 176.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -76.32 113.43 13.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.387 0.613 . . . . 0.0 111.242 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 33.9 tp -142.05 121.24 13.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.09 177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 68.72 28.76 72.89 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.198 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 86.34 -13.5 57.53 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.97 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -114.81 150.75 34.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 122.634 -0.333 . . . . 0.0 110.257 -177.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -89.28 116.68 27.68 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.802 0.334 . . . . 0.0 110.139 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 60.4 mt -62.39 126.09 26.16 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.109 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 5.5 mmt180 -99.69 114.75 28.05 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 174.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 271' ' ' ASN . 8.4 p -121.62 150.85 24.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.528 -170.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.508 ' HA2' HG13 ' A' ' 267' ' ' VAL . . . -169.88 174.59 44.08 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 177.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.419 ' HD3' ' HG2' ' A' ' 264' ' ' GLN . 4.2 mmmp? -73.21 125.69 28.33 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 117.153 0.477 . . . . 0.0 110.287 176.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.474 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -58.4 130.95 49.15 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 173.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 34.9 m -85.08 -17.56 9.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.926 0.393 . . . . 0.0 110.769 -173.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 66.4 p -109.73 142.88 26.72 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.101 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 61.2 Cg_endo -73.05 156.65 51.75 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 122.682 2.255 . . . . 0.0 111.343 172.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.68 ' HG3' ' HD3' ' A' ' 210' ' ' ARG . 34.7 Cg_exo -58.36 92.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.909 2.406 . . . . 0.0 112.777 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 49.8 ttm -103.08 128.82 26.82 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.488 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.453 ' HB3' ' HB ' ' A' ' 294' ' ' THR . 69.1 Cg_exo -51.32 115.77 2.27 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 123.159 2.573 . . . . 0.0 113.084 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 93.1 mt -91.12 94.74 9.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.917 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 90.6 mt 56.13 56.19 6.1 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.644 -178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 291' ' ' PRO . 9.7 t -63.12 140.18 97.63 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.6 -178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 16.5 Cg_exo -68.08 73.98 0.74 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.232 2.621 . . . . 0.0 112.621 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -97.99 104.23 16.25 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.343 177.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.722 -0.656 . . . . 0.0 109.572 179.159 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 112.235 -0.346 . . . . 0.0 112.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 62.82 176.84 0.15 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 121.403 0.62 . . . . 0.0 112.297 176.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 68.0 mtt -122.03 116.35 24.12 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.009 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 103' ' ' GLN . . . -129.31 174.34 9.7 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.828 178.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.412 ' HB3' ' O ' ' A' ' 102' ' ' ALA . 34.6 tt0 74.79 -38.77 0.39 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.324 0.65 . . . . 0.0 111.328 177.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -53.35 109.77 0.48 Allowed 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.29 0.636 . . . . 0.0 111.35 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.698 ' HG3' HD12 ' A' ' 108' ' ' LEU . 35.2 tt0 68.62 11.88 8.5 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.576 0.547 . . . . 0.0 111.677 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 -65.97 -34.18 77.52 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -175.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -74.93 -24.78 58.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -177.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.698 HD12 ' HG3' ' A' ' 105' ' ' GLN . 39.4 mt -67.64 -33.9 75.88 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.957 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.29 -24.06 40.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.095 0.474 . . . . 0.0 111.006 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 79.1 mt -84.3 -52.49 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.731 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -66.9 -22.47 65.96 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -175.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 72.3 m -74.06 -10.5 59.69 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.206 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 78.0 mtt180 -102.71 139.96 37.61 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.174 175.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.28 119.89 60.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 170.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.55 ' O ' ' HA ' ' A' ' 185' ' ' VAL . 84.8 t80 -80.65 129.54 34.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.758 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.527 HG12 HG12 ' A' ' 185' ' ' VAL . 9.6 m -108.65 115.97 50.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.316 0.579 . . . . 0.0 110.198 175.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.11 135.31 12.07 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.819 -177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 4.9 t 60.35 79.28 0.25 Allowed 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 123.327 0.651 . . . . 0.0 111.442 178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.49 HD11 ' CG2' ' A' ' 116' ' ' VAL . 59.5 mt -93.82 127.12 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.434 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.5 ' HB2' ' HB2' ' A' ' 181' ' ' ARG . 29.0 t80 -60.16 127.71 33.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -65.37 77.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.149 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -169.66 -37.93 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.061 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 73.2 mt -74.73 114.36 13.08 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.089 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.424 ' HA2' ' HZ3' ' A' ' 145' ' ' TRP . . . -74.68 165.32 54.75 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.481 176.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -60.98 -40.65 94.25 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -60.6 -38.72 85.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.99 178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 16.0 m -66.24 -42.92 87.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.563 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 37.5 mm -65.86 -40.91 88.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.496 0.665 . . . . 0.0 109.9 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -55.88 -44.17 77.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.829 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -72.21 -33.59 67.71 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.948 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.14 -37.35 46.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -91.16 -15.48 29.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -177.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.412 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -53.24 -45.63 98.26 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 176.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 34.3 Cg_exo -40.83 -40.79 3.72 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 123.247 2.631 . . . . 0.0 114.986 177.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.645 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 68.4 m-85 -72.66 -46.74 52.37 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -170.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -164.2 -164.93 20.53 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.561 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.475 ' HG2' ' HB2' ' A' ' 161' ' ' GLU . 87.0 Cg_endo -79.83 107.73 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.071 2.514 . . . . 0.0 111.854 -178.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.592 HD13 HD11 ' A' ' 141' ' ' ILE . 56.9 mt -66.71 113.74 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.316 0.579 . . . . 0.0 110.577 178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.409 ' HD2' ' HG2' ' A' ' 161' ' ' GLU . 60.0 tttm -93.31 -40.58 10.33 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.047 -177.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 25.2 t -155.54 128.62 8.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.466 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.592 HD11 HD13 ' A' ' 138' ' ' ILE . 67.0 mt -111.06 108.14 24.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 171.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -100.43 98.65 9.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.805 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 52.7 ttm -131.34 127.51 37.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.948 0.404 . . . . 0.0 110.446 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.6 p -80.53 124.69 29.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.892 178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.424 ' HZ3' ' HA2' ' A' ' 124' ' ' GLY . 46.3 t-105 -103.95 122.58 45.5 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -132.11 173.37 11.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.626 0.25 . . . . 0.0 110.947 -174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.9 m 70.61 141.37 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 O-C-N 124.313 1.008 . . . . 0.0 112.434 171.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.43 -20.4 26.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.677 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.5 p -91.69 10.56 27.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.542 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 68.1 mtm 69.39 11.3 8.05 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.941 0.496 . . . . 0.0 112.21 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -87.33 130.3 34.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.958 0.409 . . . . 0.0 110.626 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -123.92 121.85 36.42 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.955 0.407 . . . . 0.0 110.371 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -116.8 73.44 0.86 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.839 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -154.08 -146.99 4.53 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.427 -0.892 . . . . 0.0 112.563 -178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -111.9 177.5 4.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.61 0.243 . . . . 0.0 110.605 -175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 116' ' ' VAL . . . -161.41 153.7 19.98 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.489 176.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -123.66 123.03 39.64 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.236 177.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 51.6 t -104.65 105.97 19.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.526 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 35.5 tt0 -97.21 131.71 43.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.001 -176.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -109.52 162.35 14.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.489 176.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.475 ' HB2' ' HG2' ' A' ' 137' ' ' PRO . 44.4 mt-10 -79.13 -9.15 59.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.757 0.313 . . . . 0.0 110.668 174.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.69 133.58 19.04 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.878 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.55 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 43.1 Cg_endo -66.79 -20.41 52.21 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 123.135 2.556 . . . . 0.0 112.358 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.657 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 17.6 mp0 -55.74 -52.86 62.47 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.956 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -63.55 -20.61 65.77 Favored 'General case' 0 C--O 1.224 -0.264 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -80.18 -48.58 12.92 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.617 ' HG3' HG11 ' A' ' 286' ' ' VAL . 15.6 mm100 -66.77 -34.11 77.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.044 174.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.645 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 13.0 tp -68.87 -46.61 68.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.672 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.442 ' HA ' ' CE1' ' A' ' 135' ' ' PHE . . . -60.46 -31.21 70.23 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.652 HD12 ' HA3' ' A' ' 186' ' ' GLY . 5.3 tt -67.43 -55.9 11.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.014 172.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' ' 167' ' ' GLN . 23.1 mt-10 -53.94 -30.14 45.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.058 -175.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -98.07 -51.22 4.1 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 18.9 mtm -106.62 29.33 7.03 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -167.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.561 ' HA ' HG22 ' A' ' 185' ' ' VAL . 65.1 t30 -86.09 26.08 1.07 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.632 0.729 . . . . 0.0 110.308 177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 22.2 t -114.23 -70.29 0.81 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.97 176.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 21.5 m -140.1 155.46 24.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.617 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.579 ' HE2' ' HG ' ' A' ' 178' ' ' LEU . 0.9 OUTLIER -126.81 100.99 6.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.414 175.927 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.579 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 94.9 mt 66.2 26.91 10.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.679 172.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 123.84 -112.26 1.81 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.954 -1.117 . . . . 0.0 114.594 171.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.81 38.51 3.04 Favored Glycine 0 N--CA 1.452 -0.255 0 N-CA-C 114.451 0.541 . . . . 0.0 114.451 -165.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.5 ' HB2' ' HB2' ' A' ' 120' ' ' TYR . 8.5 tpp180 -145.53 120.09 9.75 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 117.209 0.505 . . . . 0.0 111.09 173.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -87.49 83.18 7.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.432 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . . . . . . . . . 45.6 pt -70.22 147.69 11.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.086 0.47 . . . . 0.0 110.938 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -103.55 107.02 17.69 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.36 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 174' ' ' ASN . 2.5 m -99.69 137.41 27.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.359 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.652 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 82.52 90.71 0.64 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.655 -0.784 . . . . 0.0 111.447 -178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.497 ' HA ' ' HD3' ' A' ' 188' ' ' PRO . 68.5 ttt180 -65.43 123.25 83.86 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.752 0.311 . . . . 0.0 110.76 -176.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 3.5 Cg_exo -75.42 50.59 2.69 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 123.366 2.711 . . . . 0.0 112.217 179.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 9.6 p -87.92 62.9 7.12 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.434 0.635 . . . . 0.0 110.425 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.5 65.93 7.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.96 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 48.9 mm -63.72 -40.28 88.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.396 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 118.32 -4.03 15.77 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.708 176.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -83.06 -56.89 3.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.006 0.431 . . . . 0.0 111.059 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -88.69 -19.17 26.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.433 -176.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.509 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 84.0 mm-40 -56.94 -48.87 96.68 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 54.5 Cg_exo -53.93 -39.29 85.36 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.152 1.902 . . . . 0.0 112.539 178.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.476 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 41.7 mm -67.61 -46.89 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 110.084 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 87.1 mt -57.9 -48.45 83.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.531 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 29.7 t70 -67.53 -40.99 85.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.164 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -62.7 -44.99 94.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.115 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 76.0 mt -67.58 -32.84 73.87 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.55 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.494 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -58.21 -38.31 76.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.188 0.518 . . . . 0.0 109.72 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 40.1 mt-10 -73.73 -31.53 63.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.945 175.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 57.7 mt-10 -67.26 -24.16 65.77 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 121.184 0.516 . . . . 0.0 110.984 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.403 ' HA ' HH11 ' A' ' 210' ' ' ARG . . . -74.85 -33.39 62.12 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.137 174.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 18.0 mtm180 -73.35 -13.78 61.16 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.786 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.32 -22.2 60.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.329 0.585 . . . . 0.0 110.171 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.99 166.99 18.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.305 -0.862 . . . . 0.0 108.997 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.577 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 65.2 m-20 -95.26 48.67 1.17 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.638 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 7.8 ptp180 -91.44 149.5 21.67 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.398 0.618 . . . . 0.0 111.206 -173.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.406 HG23 ' HB2' ' A' ' 263' ' ' SER . 44.1 pt -134.55 166.91 27.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.254 175.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -113.14 122.19 46.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.606 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.48 HG12 HG23 ' A' ' 282' ' ' VAL . 34.3 m -117.59 131.92 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-O 121.004 0.431 . . . . 0.0 110.227 177.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -126.13 172.12 10.29 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.159 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 43.7 m 62.68 27.56 16.19 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.922 0.868 . . . . 0.0 109.863 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 42.2 t -77.61 112.27 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.83 178.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 -58.58 138.86 56.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.253 -171.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -52.67 -30.95 34.64 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -169.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -88.6 -22.81 23.31 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.497 0.189 . . . . 0.0 111.489 -173.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 97.7 mt -63.29 120.72 12.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.898 0.38 . . . . 0.0 110.548 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 14.6 m -82.04 166.6 19.63 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.274 -176.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -53.91 -45.4 71.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.511 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.98 -32.38 73.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.652 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 228' ' ' VAL . 8.3 t70 -68.7 -45.81 70.65 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -176.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.676 HG22 HD11 ' A' ' 255' ' ' ILE . 39.8 mm -66.29 -36.78 78.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -60.58 -52.72 63.96 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.28 174.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 89.7 p -55.74 -34.4 65.15 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -174.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 224' ' ' ASP . 24.5 t -73.55 -47.66 44.15 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.314 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.732 ' HB2' HD11 ' A' ' 235' ' ' ILE . 16.2 m-85 -68.39 -31.64 71.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.411 0.624 . . . . 0.0 110.526 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 233' ' ' GLY . 29.5 tp10 -60.08 -24.35 64.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.367 174.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -78.91 -8.33 58.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.644 -177.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -112.79 -45.21 3.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.562 177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 230' ' ' GLU . . . -140.82 171.71 23.96 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 64.8 mmtt -90.03 111.7 22.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.894 0.854 . . . . 0.0 111.697 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 229' ' ' PHE . 52.9 mt -87.16 151.58 3.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.205 -1.361 . . . . 0.0 111.682 -174.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 24.5 ttpp -103.52 -40.33 6.38 Favored 'General case' 0 N--CA 1.436 -1.174 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.786 174.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 50.8 m -156.88 151.01 24.99 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.411 -170.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 52.1 t -143.76 104.66 4.21 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.764 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.5 m -121.09 103.13 8.79 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.353 -177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.606 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 69.0 mt -80.46 144.52 32.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.818 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -66.55 105.05 1.4 Allowed 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.526 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 41.0 ttt180 -129.16 142.09 50.97 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.065 -170.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 246' ' ' THR . 30.1 m-20 -93.61 115.16 64.7 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.032 176.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -57.42 -37.13 98.35 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.529 2.82 . . . . 0.0 113.769 -168.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 82.8 p -92.75 10.22 31.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -170.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 243' ' ' ASP . 11.6 t -123.06 -9.78 8.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.045 -0.41 . . . . 0.0 111.196 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 84.09 -49.77 4.29 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.426 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.404 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 20.1 ptmt -77.32 172.97 12.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.174 0.511 . . . . 0.0 110.685 -178.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 20.2 p80 -116.1 167.67 10.78 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.508 176.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -65.26 -80.51 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 O-C-N 123.485 0.49 . . . . 0.0 111.69 -173.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . -175.99 17.57 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.232 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.432 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 31.3 p90 -157.03 176.71 12.39 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -173.0 178.06 45.17 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.041 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.657 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 89.4 m-85 -125.67 143.85 50.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.917 0.389 . . . . 0.0 110.19 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.676 HD11 HG22 ' A' ' 225' ' ' ILE . 87.0 mt -134.68 128.44 50.76 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.462 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.638 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 47.8 mt-10 -109.98 131.95 54.59 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.628 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 6.8 m-85 -97.07 176.97 5.75 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 123.155 0.285 . . . . 0.0 110.294 176.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -82.12 -22.85 35.98 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -121.15 121.94 38.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.361 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.67 -22.56 67.01 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.075 0.464 . . . . 0.0 110.939 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -72.0 -49.33 37.99 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.719 174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 265' ' ' ASP . 44.9 m -66.67 -32.43 73.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.855 -0.611 . . . . 0.0 112.012 -176.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.628 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 59.8 p -66.56 -42.54 86.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.14 0.495 . . . . 0.0 110.057 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -74.51 -21.62 59.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.522 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.411 ' HB2' ' HA ' ' A' ' 262' ' ' SER . 0.5 OUTLIER -70.98 -37.19 72.73 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 175.405 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -63.78 -39.98 95.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 172.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 85.4 t -57.11 -33.67 43.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 CA-C-O 121.33 0.586 . . . . 0.0 110.628 175.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.5 m -73.71 -39.61 64.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.133 -179.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.5 m -89.37 -39.17 13.61 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -173.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.562 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 85.9 mmm -81.66 -1.56 47.21 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -171.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.545 ' HA ' HG12 ' A' ' 282' ' ' VAL . 22.9 t-20 -71.5 117.51 13.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 97.7 mt 70.01 32.75 2.95 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.44 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -91.23 121.19 32.78 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.454 ' HB2' ' CE1' ' A' ' 279' ' ' TYR . 12.4 t70 -74.38 118.55 17.47 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.779 -0.369 . . . . 0.0 110.333 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.7 tp -131.94 91.83 3.03 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.901 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 92.4 26.81 16.93 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.547 178.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 92.7 2.36 67.32 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.632 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -131.8 140.81 49.29 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.454 ' CE1' ' HB2' ' A' ' 274' ' ' ASP . 72.4 m-85 -85.37 112.61 20.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.6 179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 71.7 mt -58.03 121.27 10.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.925 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.504 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 8.2 mmm180 -93.53 114.75 27.18 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 174.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 271' ' ' ASN . 11.4 p -119.87 143.85 30.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.745 -173.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -158.56 -171.84 24.93 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.505 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -90.62 128.92 36.76 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.773 0.32 . . . . 0.0 110.344 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.444 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -66.52 128.17 35.16 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.617 HG11 ' HG3' ' A' ' 167' ' ' GLN . 29.4 m -97.32 -25.02 4.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -171.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.448 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 35.5 p -131.39 168.13 18.76 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-O 120.844 0.354 . . . . 0.0 111.569 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -81.05 103.52 1.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.191 2.594 . . . . 0.0 110.989 169.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 287' ' ' THR . 20.4 Cg_exo -64.99 146.63 87.98 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 123.006 2.471 . . . . 0.0 112.682 -174.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.431 ' HA ' ' HD3' ' A' ' 291' ' ' PRO . 88.3 mtp -100.15 110.29 59.21 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.121 177.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 290' ' ' MET . 1.5 Cg_endo -83.89 93.89 0.77 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.082 2.522 . . . . 0.0 111.596 178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.14 63.17 1.8 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.212 0.529 . . . . 0.0 111.158 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.42 -2.52 58.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.925 177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 11.0 m -53.97 126.41 51.2 Favored Pre-proline 0 C--O 1.237 0.399 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.048 179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 7.7 Cg_exo -73.7 61.18 4.48 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.337 2.691 . . . . 0.0 112.503 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -107.2 16.66 23.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.24 0.543 . . . . 0.0 109.865 177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 C--O 1.248 1.005 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.375 -178.224 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.039 0 N-CA-C 112.645 -0.182 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -84.0 81.0 8.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.901 0.381 . . . . 0.0 110.79 -177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 94.1 mmm -81.18 60.6 4.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.522 0.677 . . . . 0.0 110.624 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -122.81 74.67 1.22 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.95 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -97.71 156.48 16.53 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.709 178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -127.42 72.37 1.38 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.637 0.732 . . . . 0.0 110.629 -177.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -88.96 9.82 23.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.824 177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -62.03 -33.81 75.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.7 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.65 -35.55 80.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 0.0 110.884 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.51 HD21 HD13 ' A' ' 201' ' ' LEU . 61.7 mt -68.91 -31.28 70.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.598 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.68 -28.41 69.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.256 0.551 . . . . 0.0 110.384 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 76.7 mt -79.84 -36.47 17.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.858 174.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.519 ' SD ' HG12 ' A' ' 198' ' ' ILE . 87.9 mtp -73.31 -21.81 60.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.2 -176.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.818 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 30.4 p -79.72 -3.71 48.63 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -110.7 141.09 44.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.678 174.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.596 HG12 ' HB ' ' A' ' 158' ' ' VAL . 6.0 p -121.56 131.93 71.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-O 121.177 0.513 . . . . 0.0 110.051 176.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -79.11 121.03 24.49 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.07 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.688 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 25.7 m -118.18 129.26 74.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.5 0.667 . . . . 0.0 111.383 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -140.46 176.26 21.51 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.62 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 22.7 m 60.29 39.11 19.35 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.236 0.541 . . . . 0.0 110.576 -177.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 57.5 mt -81.02 -15.74 12.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.373 -176.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 44.7 t80 71.21 153.62 0.13 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.204 -176.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -83.54 76.24 9.96 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.453 0.644 . . . . 0.0 111.052 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -163.43 -50.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.021 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.9 mt -67.82 104.55 1.71 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.081 -178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.87 172.77 55.33 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.935 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.47 ' OE2' ' HB ' ' A' ' 141' ' ' ILE . 61.2 tt0 -64.17 -32.31 73.84 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.849 0.324 . . . . 0.0 110.67 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -54.85 -48.87 72.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.355 0.598 . . . . 0.0 109.958 176.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.2 m -70.69 -41.67 71.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.961 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 32.0 mm -61.41 -46.34 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.479 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -63.71 -37.31 86.88 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.034 0.445 . . . . 0.0 110.196 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -65.63 -32.38 73.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.969 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.558 ' HB1' ' HE1' ' A' ' 177' ' ' MET . . . -79.44 -35.82 39.87 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -174.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.548 ' HB2' HD11 ' A' ' 138' ' ' ILE . 71.3 m-85 -90.66 -13.86 33.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.814 0.34 . . . . 0.0 111.531 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.17 -43.18 89.71 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -43.83 -41.51 11.84 Favored 'Trans proline' 0 C--N 1.362 1.268 0 C-N-CA 122.95 2.433 . . . . 0.0 114.564 176.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.451 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 51.4 m-85 -77.08 -50.94 11.93 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.536 0.208 . . . . 0.0 111.386 -174.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -158.36 171.0 35.14 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.884 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.64 117.63 5.01 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.66 2.24 . . . . 0.0 111.218 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 132' ' ' PHE . 58.5 mt -78.82 116.31 22.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.105 0.479 . . . . 0.0 110.535 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.507 ' HE3' ' OE1' ' A' ' 159' ' ' GLU . 34.9 ttpt -88.42 -27.42 21.57 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.542 -177.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.2 t -163.83 145.48 9.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.753 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.495 HD11 HD13 ' A' ' 138' ' ' ILE . 61.7 mt -133.02 121.43 43.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 172.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -103.85 100.66 10.46 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.799 177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 46.8 ttm -128.48 131.95 48.35 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.378 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.6 t -78.56 76.49 5.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.962 0.411 . . . . 0.0 109.942 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 38.1 t90 -89.23 95.14 10.18 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 175.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.63 110.39 4.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.667 -176.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.429 ' HA ' ' CZ3' ' A' ' 145' ' ' TRP . 5.5 p -71.47 -25.52 62.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.149 -174.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.86 -50.44 80.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.91 0.386 . . . . 0.0 110.875 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.406 ' HB ' ' HE2' ' A' ' 151' ' ' LYS . 13.0 p -91.46 -5.25 54.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.222 0.534 . . . . 0.0 111.324 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 57.6 mtm 57.56 42.88 23.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.69 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.406 ' HE2' ' HB ' ' A' ' 149' ' ' THR . 57.2 pttt -162.24 175.1 12.0 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.597 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.601 ' HB3' ' HA ' ' A' ' 145' ' ' TRP . 9.9 p80 -142.13 135.62 29.24 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.991 0.425 . . . . 0.0 110.211 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -129.98 88.73 2.7 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.714 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 168.12 -130.46 2.1 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.635 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -124.54 177.86 5.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.821 0.344 . . . . 0.0 111.395 -172.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.97 167.14 31.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.305 176.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -125.46 121.38 33.61 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.664 176.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.596 ' HB ' HG12 ' A' ' 114' ' ' VAL . 90.2 t -100.15 116.65 43.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.102 178.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.507 ' OE1' ' HE3' ' A' ' 139' ' ' LYS . 41.5 tt0 -107.48 126.97 53.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.615 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -104.98 175.48 5.48 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.858 0.361 . . . . 0.0 110.964 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.462 ' OE1' ' HD3' ' A' ' 139' ' ' LYS . 5.5 mm-40 -71.98 -37.26 69.9 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.199 171.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 22.0 m -126.04 143.39 45.38 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.466 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.818 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 38.1 Cg_endo -66.26 -14.57 44.84 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.416 2.744 . . . . 0.0 112.219 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.924 ' HG3' ' HE2' ' A' ' 254' ' ' PHE . 15.4 mm-40 -62.33 -53.19 58.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.335 -176.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.551 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -60.97 -18.98 60.37 Favored 'General case' 0 CA--C 1.523 -0.067 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -77.66 -54.11 6.76 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -177.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.622 ' HG3' HG11 ' A' ' 286' ' ' VAL . 19.1 mm-40 -64.05 -36.29 83.51 Favored 'General case' 0 C--O 1.218 -0.6 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.967 173.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.551 ' HB3' ' HA ' ' A' ' 165' ' ' ALA . 12.9 tp -61.05 -48.41 81.88 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.643 177.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -59.6 -31.91 69.91 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.837 0.351 . . . . 0.0 110.079 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 185' ' ' VAL . 16.3 tp -72.58 -46.76 52.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.9 172.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 14.3 mm-40 -52.47 -41.84 63.69 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.321 0.648 . . . . 0.0 111.701 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 81.8 mt-30 -100.72 -51.35 3.6 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 35.0 ttp -95.65 30.16 2.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -164.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.477 ' HB3' HD12 ' A' ' 170' ' ' LEU . 10.0 p30 -79.36 21.08 0.5 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 122.16 -0.337 . . . . 0.0 111.151 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 4.5 m -100.79 -74.11 0.62 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.071 0.462 . . . . 0.0 110.822 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 29.3 m -144.02 170.33 8.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.025 -175.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.999 ' HB2' HD13 ' A' ' 183' ' ' ILE . 2.4 tpt -118.64 94.08 4.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.254 178.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.965 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 73.7 mt 56.13 45.36 23.58 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 123.788 0.68 . . . . 0.0 110.221 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.18 -135.39 12.96 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -172.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 66.98 -112.09 4.61 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.687 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -144.01 177.86 8.27 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.391 0.138 . . . . 0.0 110.796 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 175' ' ' SER . 49.2 t-20 -63.9 112.62 3.0 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 175.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.2 pt -97.54 168.49 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.292 0.568 . . . . 0.0 111.58 -174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.688 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 93.4 mttt -103.12 115.21 30.15 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.195 175.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.64 ' O ' HD13 ' A' ' 170' ' ' LEU . 18.3 t -113.01 102.85 14.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 171.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.02 -130.74 10.67 Favored Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -175.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 58.5 mtp85 48.7 64.48 8.58 Favored Pre-proline 0 N--CA 1.467 0.387 0 CA-C-O 120.763 0.316 . . . . 0.0 111.493 178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 190' ' ' ASN . 22.0 Cg_exo -64.57 -49.02 3.6 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.464 2.109 . . . . 0.0 112.251 -175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 32.4 t 70.65 -30.97 0.21 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.599 0.76 . . . . 0.0 112.034 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.461 ' H ' ' C ' ' A' ' 188' ' ' PRO . 6.5 t30 -72.61 93.97 1.67 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 122.631 0.372 . . . . 0.0 110.741 -179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 50.4 mm 71.5 -69.11 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.502 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 74.58 60.14 3.56 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.535 -0.84 . . . . 0.0 111.119 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -72.8 -26.74 61.62 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.155 0.502 . . . . 0.0 110.693 -176.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -90.24 -5.41 56.38 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.452 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.557 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 15.6 mm100 -54.01 -47.11 98.12 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.1 Cg_endo -52.76 -40.74 73.43 Favored 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 121.987 1.791 . . . . 0.0 112.354 177.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 70.7 mt -73.27 -45.69 52.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.534 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.524 HG13 ' O ' ' A' ' 194' ' ' ALA . 57.7 mt -58.26 -47.17 88.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.805 179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -65.82 -39.78 91.18 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.915 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -67.11 -46.34 74.49 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.626 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.571 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 69.0 mt -66.95 -32.84 74.36 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.02 178.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.566 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.64 -46.03 70.4 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 173.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.483 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 18.2 mt-10 -68.5 -31.75 71.23 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.883 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 47.1 mt-10 -67.49 -30.27 69.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.4 177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -76.98 -39.22 51.27 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.968 0.414 . . . . 0.0 110.046 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.566 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 58.5 mtp180 -57.76 -30.11 65.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.891 176.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -71.22 -19.9 62.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.994 -177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -110.94 0.12 16.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.799 0.333 . . . . 0.0 111.404 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 56.66 38.12 29.32 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.583 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.86 ' HD2' ' HD3' ' A' ' 289' ' ' PRO . 43.9 ttt180 -87.9 138.38 31.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.937 -173.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.526 ' HA ' ' H ' ' A' ' 285' ' ' ALA . 48.7 pt -129.99 166.19 28.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.088 175.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.504 ' HD1' ' CE2' ' A' ' 254' ' ' PHE . 84.4 t80 -120.97 129.58 53.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.339 -175.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.626 HG12 HG23 ' A' ' 282' ' ' VAL . 31.5 m -121.23 133.35 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.231 0.538 . . . . 0.0 110.33 178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.97 175.09 9.15 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.193 -176.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 61.1 m 60.71 35.14 19.79 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.213 -175.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.03 124.24 36.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.293 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.496 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 25.9 t-80 -54.31 134.31 45.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.575 0.702 . . . . 0.0 111.245 -175.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.425 ' HG2' ' H ' ' A' ' 218' ' ' GLN . 2.2 pt20 -49.12 -35.48 16.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 114.268 -1.333 . . . . 0.0 114.181 -174.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -105.63 24.55 12.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.835 0.826 . . . . 0.0 110.789 -178.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 217' ' ' HIS . 15.6 tp -105.3 133.46 50.04 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 21.0 t -98.76 167.17 10.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.044 0.45 . . . . 0.0 111.18 -171.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -66.23 -22.56 66.33 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.02 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -63.54 -39.2 93.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.156 177.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 228' ' ' VAL . 33.6 m-20 -71.04 -47.2 59.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.837 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.694 HG13 HD21 ' A' ' 240' ' ' LEU . 8.3 mm -63.16 -47.2 93.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.453 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 47.8 tttm -56.77 -45.51 82.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.226 176.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 77.6 p -60.87 -37.59 82.67 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -174.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 224' ' ' ASP . 4.8 t -76.35 -45.45 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.676 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.6 ' CB ' HD11 ' A' ' 235' ' ' ILE . 38.0 m-85 -62.74 -34.9 78.16 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.134 0.492 . . . . 0.0 110.891 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.1 mm-40 -62.0 -24.37 67.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.731 177.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.05 -10.25 59.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.275 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -107.96 -43.65 4.38 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.083 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -145.73 -175.94 19.22 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.331 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -87.01 111.47 20.9 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.895 0.379 . . . . 0.0 110.346 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.6 HD11 ' CB ' ' A' ' 229' ' ' PHE . 14.3 mt -81.25 146.52 7.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.861 0.839 . . . . 0.0 111.962 -177.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -109.58 -32.83 6.98 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 114.244 -1.344 . . . . 0.0 110.799 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.425 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 55.4 m -157.52 146.24 19.54 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -173.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 226' ' ' LYS . 43.2 t -153.9 99.53 2.28 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 123.488 0.493 . . . . 0.0 109.766 174.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.9 m -130.0 115.95 17.87 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.646 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.694 HD21 HG13 ' A' ' 225' ' ' ILE . 57.6 mt -84.59 135.82 34.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.63 112.95 1.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.668 ' HA ' ' HA ' ' A' ' 249' ' ' HIS . 27.0 ttp180 -133.57 141.78 47.86 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -83.93 112.42 40.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.712 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.97 -36.79 81.19 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 123.211 2.607 . . . . 0.0 113.305 -173.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 13.9 t -93.99 13.39 23.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.768 0.318 . . . . 0.0 111.663 -172.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 80.3 p -125.2 -39.89 2.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.108 0.48 . . . . 0.0 110.802 176.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 98.01 9.83 53.27 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.232 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 14.1 ptmt -118.37 146.8 44.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.668 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 4.1 p80 -95.07 143.63 26.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 174.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -64.21 -65.36 0.69 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -168.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 177.99 -3.4 0.03 OUTLIER Glycine 0 CA--C 1.519 0.304 0 C-N-CA 119.871 -1.156 . . . . 0.0 113.751 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -140.26 172.37 12.84 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 122.342 -0.505 . . . . 0.0 110.472 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.598 ' HA3' HD23 ' A' ' 240' ' ' LEU . . . -160.22 174.98 37.04 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.13 -0.557 . . . . 0.0 111.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.924 ' HE2' ' HG3' ' A' ' 164' ' ' GLU . 85.1 m-85 -129.19 143.25 50.79 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.664 0.268 . . . . 0.0 110.874 -178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.515 HD11 HG22 ' A' ' 225' ' ' ILE . 92.3 mt -137.56 140.73 41.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.222 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 237' ' ' SER . 43.3 mt-10 -122.88 148.18 45.73 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.645 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 20.9 m-85 -116.98 158.05 24.76 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.007 0.432 . . . . 0.0 110.487 176.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -85.11 -3.91 58.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.757 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -135.67 134.03 38.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.095 174.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -66.74 -32.82 74.36 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.581 -171.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -70.48 -39.13 74.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.931 0.395 . . . . 0.0 110.437 178.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 13.8 m -64.97 -37.59 88.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.736 -174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.645 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 43.5 p -68.49 -45.13 73.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.167 0.508 . . . . 0.0 110.649 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -72.19 -22.16 61.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.944 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.52 -40.03 62.0 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 110.549 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -63.31 -33.4 75.43 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.474 177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 263' ' ' SER . 97.7 t -56.16 -26.91 22.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 120.994 0.426 . . . . 0.0 111.137 173.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 37.2 t -85.72 -46.8 10.36 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 122.018 -0.427 . . . . 0.0 110.639 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.4 m -69.83 -38.2 76.46 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -174.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.422 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 89.5 mmm -91.81 -2.61 56.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.76 0.314 . . . . 0.0 111.543 -173.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 282' ' ' VAL . 39.7 t30 -72.12 124.53 25.2 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.306 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 94.2 mt 63.48 25.9 14.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.326 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -83.11 118.04 23.29 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.381 -0.827 . . . . 0.0 108.774 174.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -74.82 121.45 21.82 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.2 tp -141.62 91.82 2.4 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.025 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 95.28 25.7 13.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.725 -0.75 . . . . 0.0 111.935 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 89.25 1.22 79.15 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.784 177.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -126.14 148.53 49.37 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.642 0.258 . . . . 0.0 110.541 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -89.83 117.67 28.84 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.404 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.21 120.56 14.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.791 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -93.8 115.75 28.18 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 174.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.626 HG23 HG12 ' A' ' 213' ' ' VAL . 14.2 p -121.08 143.76 32.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-O 121.053 0.454 . . . . 0.0 110.851 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -156.61 -179.69 31.78 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.684 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -80.25 133.74 36.02 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.526 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -76.3 146.26 39.01 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.622 HG11 ' HG3' ' A' ' 167' ' ' GLN . 30.8 m -112.66 -3.65 10.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.717 0.294 . . . . 0.0 111.516 -174.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 41.5 p -123.07 139.37 31.42 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-O 120.902 0.382 . . . . 0.0 111.015 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -69.41 138.03 37.93 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.834 2.356 . . . . 0.0 111.196 173.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.86 ' HD3' ' HD2' ' A' ' 210' ' ' ARG . 18.6 Cg_endo -59.47 -40.69 64.43 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.202 2.601 . . . . 0.0 112.73 -175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 53.6 ttp 49.7 79.36 0.35 Allowed Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 123.912 0.757 . . . . 0.0 111.796 177.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.88 124.87 14.28 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.345 2.03 . . . . 0.0 111.91 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 2.6 pp -148.81 161.88 40.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.945 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 93.1 mt -134.36 90.8 2.71 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.243 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 39.1 p 46.44 67.81 4.03 Favored Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -77.34 117.86 4.48 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.099 1.866 . . . . 0.0 111.705 177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -115.86 -8.0 11.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.988 0.423 . . . . 0.0 111.439 -178.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.539 -0.743 . . . . 0.0 111.297 -177.437 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.758 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.56 104.52 16.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.889 0.376 . . . . 0.0 110.649 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 25.1 mmt -85.56 129.56 34.79 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.517 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 65.57 179.37 0.2 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.015 0.822 . . . . 0.0 111.417 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 54.08 42.28 31.66 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.093 0.473 . . . . 0.0 111.343 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.621 ' HA ' ' HE ' ' A' ' 104' ' ' ARG . 3.7 tpm_? -84.49 102.39 12.79 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.492 -177.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.43 ' HB2' HD12 ' A' ' 108' ' ' LEU . 16.0 mm-40 -96.3 100.41 12.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.195 176.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -64.67 -28.43 69.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.854 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.18 -30.09 70.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.864 0.364 . . . . 0.0 110.865 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.55 ' HA ' ' HB2' ' A' ' 111' ' ' MET . 26.0 mt -70.81 -30.84 67.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.872 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.23 -25.24 66.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.362 0.601 . . . . 0.0 110.094 175.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.0 mt -84.08 -40.54 15.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.786 174.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.55 ' HB2' ' HA ' ' A' ' 108' ' ' LEU . 60.2 mmm -61.12 -29.97 70.09 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.543 -178.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 73.5 m -73.87 -13.64 60.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.441 0.162 . . . . 0.0 111.237 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.632 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 29.8 mtp85 -108.96 139.89 43.21 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.4 p -124.25 135.51 63.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.165 0.507 . . . . 0.0 110.349 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -77.91 119.26 21.12 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.817 176.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 13.5 m -121.15 116.05 48.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.221 0.534 . . . . 0.0 110.348 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 155' ' ' PHE . . . -117.8 170.17 13.51 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.193 -178.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.437 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 20.9 t 72.09 51.18 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 121.608 0.718 . . . . 0.0 110.391 178.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 62.0 mt -103.06 127.43 56.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.651 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -72.11 147.15 46.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.876 177.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -72.37 75.59 1.02 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.855 0.836 . . . . 0.0 111.005 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -154.63 -45.55 0.09 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.827 -1.079 . . . . 0.0 108.845 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.442 HD13 ' HG3' ' A' ' 177' ' ' MET . 22.0 mt -77.29 91.37 3.79 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.03 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.25 -179.85 44.57 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.979 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -55.51 -46.4 76.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.117 0.484 . . . . 0.0 111.227 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -60.5 -46.57 89.63 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.103 -178.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 27.3 m -67.27 -42.16 84.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.988 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.1 mm -61.41 -45.27 98.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.084 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.531 ' HG3' HD12 ' A' ' 138' ' ' ILE . 59.0 ttt180 -62.4 -37.39 85.6 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.509 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -69.81 -33.4 72.29 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.068 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -77.47 -33.33 54.67 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.106 0.409 . . . . 0.0 112.106 -176.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.642 ' HB2' HD11 ' A' ' 138' ' ' ILE . 52.2 m-85 -90.1 -13.65 35.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.818 0.342 . . . . 0.0 111.068 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.89 -41.28 84.19 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 178.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 44.9 Cg_exo -40.97 -40.36 3.71 Favored 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.035 2.49 . . . . 0.0 114.26 174.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.496 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 43.6 m-85 -79.25 -47.93 15.05 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 120.685 0.279 . . . . 0.0 111.21 -176.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -168.31 170.04 41.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.177 -1.011 . . . . 0.0 112.702 175.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -68.2 122.69 9.76 Favored 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.755 2.303 . . . . 0.0 111.629 175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.642 HD11 ' HB2' ' A' ' 132' ' ' PHE . 75.1 mt -81.84 132.09 32.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.132 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -89.84 -43.6 10.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.307 179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 97.4 p -157.7 155.24 29.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.139 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.429 HG22 ' HG2' ' A' ' 143' ' ' MET . 62.7 mt -133.52 127.01 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.65 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.731 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 28.9 m-20 -91.85 106.16 18.26 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.072 176.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.429 ' HG2' HG22 ' A' ' 141' ' ' ILE . 17.4 mmt -111.5 118.24 35.2 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.734 0.302 . . . . 0.0 111.062 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 53.0 m -79.27 73.08 5.89 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.795 0.807 . . . . 0.0 110.495 174.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 60.3 t-105 -79.77 83.02 5.78 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.602 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -119.55 71.08 0.86 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.567 -170.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 91.3 p -169.99 139.82 1.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.537 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 31.1 m -73.13 -19.69 18.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.706 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 14.7 p -85.91 4.67 36.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.001 -177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 48.5 mtm 66.57 64.71 0.48 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.444 175.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -150.98 164.03 37.35 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 173.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -132.53 122.43 24.82 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.229 0.538 . . . . 0.0 110.363 177.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -126.46 123.29 37.52 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.907 -178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 142.23 -97.78 0.21 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.321 -0.943 . . . . 0.0 112.666 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.448 ' HA ' ' HA2' ' A' ' 117' ' ' GLY . 52.0 p90 -147.15 175.44 10.72 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.174 0.511 . . . . 0.0 111.334 -175.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -154.37 163.56 39.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.673 176.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.731 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 96.2 m-85 -123.06 120.33 32.98 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 87.1 t -104.71 112.19 37.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.644 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.632 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 40.5 tt0 -102.88 131.07 50.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.5 178.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 138' ' ' ILE . 81.3 m-85 -104.93 179.48 4.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.625 178.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -67.31 -38.53 85.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.165 0.507 . . . . 0.0 110.092 171.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.4 m -126.63 149.78 69.13 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.37 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 56.9 Cg_endo -70.02 -14.01 34.73 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 123.356 2.704 . . . . 0.0 112.237 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.591 ' HG3' ' CE1' ' A' ' 254' ' ' PHE . 75.5 mm-40 -60.82 -53.03 62.38 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.544 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 168' ' ' LEU . . . -63.38 -14.34 49.16 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.973 0.416 . . . . 0.0 111.898 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.5 -54.2 5.37 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.597 ' HG3' HG21 ' A' ' 286' ' ' VAL . 15.9 mm100 -65.57 -34.0 77.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.968 174.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.496 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 25.6 tp -65.41 -43.58 90.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.238 177.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.76 -28.26 69.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.037 0.446 . . . . 0.0 110.08 178.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 7.2 tt -70.66 -50.9 31.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.406 172.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -54.35 -35.36 62.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.37 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -100.61 -52.3 3.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 34.5 ttp -106.56 31.26 5.36 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -163.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -77.1 17.01 0.49 Allowed 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.338 -0.226 . . . . 0.0 111.567 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 15.1 m -110.04 -73.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.57 0.224 . . . . 0.0 111.483 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 28.4 m -135.54 159.53 40.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.535 0.207 . . . . 0.0 110.938 -176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.998 ' HB2' HD13 ' A' ' 183' ' ' ILE . 3.5 tpt -123.88 96.61 5.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.892 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 24.0 tp 50.61 61.53 3.17 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.671 173.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 139.56 -179.28 18.94 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.306 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -82.76 57.71 5.04 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.093 179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 11.4 tpp180 -134.21 119.0 18.24 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -75.55 136.38 40.56 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.902 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.998 HD13 ' HB2' ' A' ' 177' ' ' MET . 42.0 pt -124.32 158.42 31.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.678 179.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 22.7 tptm -111.3 106.41 15.36 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 177.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.37 110.1 26.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.938 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 103.28 176.95 26.38 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.212 178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -127.28 136.47 28.95 Favored Pre-proline 0 C--N 1.323 -0.563 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -55.42 126.54 22.83 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.995 2.464 . . . . 0.0 111.934 176.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 20.2 m -74.53 62.37 1.01 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.551 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.02 -63.33 1.28 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.095 0.474 . . . . 0.0 109.824 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.1 tp -132.99 146.14 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.836 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 160.01 147.33 4.87 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.779 178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.451 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 22.0 tp60 -78.83 -29.14 44.56 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.821 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.547 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -75.87 -19.49 58.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.625 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 27.9 mm-40 -58.83 -51.45 81.75 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.288 -174.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 64.2 Cg_exo -53.63 -38.36 84.18 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.208 1.939 . . . . 0.0 112.764 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.82 -39.31 67.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 110.511 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 194' ' ' ALA . 72.3 mt -60.32 -45.98 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.987 175.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.597 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 26.0 t70 -61.54 -41.97 98.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.431 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.26 -51.38 70.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.256 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 44.8 mt -68.29 -32.77 73.15 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.85 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.47 -41.78 77.1 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 173.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.597 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 32.5 mt-10 -67.67 -33.91 75.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.544 174.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -63.68 -37.36 87.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.937 0.399 . . . . 0.0 110.653 175.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.57 -37.33 73.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.505 176.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.525 ' HD3' ' HA ' ' A' ' 203' ' ' GLU . 29.5 mtp180 -59.29 -26.02 64.61 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.357 176.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -76.91 -11.29 59.79 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -111.37 179.28 4.07 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 62.0 m-20 -126.25 38.76 4.07 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.977 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 10.3 ptp180 -108.28 158.06 17.8 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.646 0.736 . . . . 0.0 112.603 -170.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.616 HG23 ' HB2' ' A' ' 263' ' ' SER . 41.3 pt -135.39 166.63 27.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.623 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.424 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 57.1 t80 -112.62 124.03 51.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.377 -177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 26.8 m -115.01 131.3 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-O 121.382 0.61 . . . . 0.0 110.453 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -122.66 172.0 8.73 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.873 -176.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 24.3 m 63.79 22.23 12.98 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.506 0.67 . . . . 0.0 110.461 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 38.2 t -79.7 109.02 13.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.806 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -56.04 142.8 34.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.285 0.564 . . . . 0.0 111.033 -171.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -59.13 -22.5 60.98 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -168.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -92.51 -13.28 30.08 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 93.6 mt -81.84 133.81 35.36 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 19.0 m -96.69 171.71 8.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.604 -177.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.5 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 9.8 p-10 -61.02 -42.17 97.95 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.581 0.229 . . . . 0.0 111.552 -174.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -63.25 -27.1 69.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.366 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -73.58 -48.28 33.97 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 120.896 0.379 . . . . 0.0 110.086 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.56 HG22 HD11 ' A' ' 255' ' ' ILE . 34.2 mm -61.93 -38.54 80.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.527 ' HG3' HG21 ' A' ' 235' ' ' ILE . 63.0 tttm -56.26 -52.57 63.99 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.114 175.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 88.3 p -58.55 -34.43 71.01 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -174.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 28.4 t -74.83 -50.01 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 121.129 -0.229 . . . . 0.0 111.279 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.732 ' HB2' HD11 ' A' ' 235' ' ' ILE . 20.8 m-85 -64.31 -34.18 77.55 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.207 0.527 . . . . 0.0 111.074 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -63.63 -23.6 67.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.429 178.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -75.23 -11.57 60.1 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.76 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -112.04 -37.95 4.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.724 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.498 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -140.29 167.63 25.41 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.499 -178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 234' ' ' LYS . 67.0 mmtt -78.64 99.72 6.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.845 0.355 . . . . 0.0 111.053 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.732 HD11 ' HB2' ' A' ' 229' ' ' PHE . 8.3 mt -77.05 146.19 9.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.615 0.721 . . . . 0.0 111.453 -178.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -110.49 -37.19 5.56 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.262 -1.335 . . . . 0.0 110.664 177.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.486 ' HB2' ' HB2' ' A' ' 256' ' ' GLU . 25.8 m -154.5 151.36 28.83 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -172.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.471 ' SG ' HG12 ' A' ' 255' ' ' ILE . 52.9 t -153.7 116.14 4.4 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 61.9 m -141.23 111.28 6.67 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.676 178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.57 ' HA ' ' CA ' ' A' ' 253' ' ' GLY . 34.8 mt -81.8 137.75 35.25 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 249' ' ' HIS . . . -62.05 113.51 2.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 178.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 70.3 ttt180 -137.74 141.34 40.98 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.68 -167.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.413 ' HA ' ' HD2' ' A' ' 244' ' ' PRO . 28.7 m-20 -105.02 117.64 58.12 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.179 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 18.4 Cg_endo -57.77 -28.41 81.94 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 123.573 2.848 . . . . 0.0 112.952 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.2 t -79.82 -13.27 59.54 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.072 -178.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 37.0 p -106.01 -36.93 6.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.956 0.408 . . . . 0.0 111.241 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 92.76 -35.12 4.19 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.822 -177.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.492 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 63.5 pttt -87.43 -179.77 6.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 241' ' ' ALA . 6.2 p80 -120.35 163.77 17.34 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.883 0.373 . . . . 0.0 110.174 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -71.09 -3.93 22.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.102 -0.954 . . . . 0.0 113.389 -167.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 111.71 -11.02 27.81 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.176 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.424 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 51.5 p90 -135.23 173.54 11.61 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.707 0.289 . . . . 0.0 111.062 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -165.36 175.03 41.22 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.065 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.591 ' CE1' ' HG3' ' A' ' 164' ' ' GLU . 94.0 m-85 -128.88 142.9 50.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.766 0.317 . . . . 0.0 110.767 -178.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.56 HD11 HG22 ' A' ' 225' ' ' ILE . 83.9 mt -136.3 132.21 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.451 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.977 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 18.6 mt-10 -109.24 147.95 31.76 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.498 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 12.5 m-85 -112.18 150.26 31.09 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 123.164 0.29 . . . . 0.0 110.66 176.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -62.22 -55.35 29.31 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 56.3 mttm -73.65 117.13 15.06 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.536 171.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -52.99 -38.41 62.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.406 -0.815 . . . . 0.0 112.211 -175.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -75.08 -30.63 61.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.64 -176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.553 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 69.0 m -64.52 -19.76 65.8 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.616 ' HB2' HG23 ' A' ' 211' ' ' ILE . 78.1 p -57.69 -46.08 84.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.206 0.527 . . . . 0.0 109.929 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -76.68 -13.87 60.01 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.107 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.553 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 2.6 m-20 -64.69 -47.92 76.61 Favored 'General case' 0 CA--C 1.516 -0.346 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 173.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.43 ' HB2' ' OH ' ' A' ' 257' ' ' TYR . . . -64.96 -35.75 82.17 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.214 176.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 263' ' ' SER . 89.0 t -56.82 -31.89 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.273 0.559 . . . . 0.0 110.787 175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 20.2 m -80.64 -38.38 29.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.499 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 24.7 t -93.91 -34.02 13.27 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -173.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.477 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 91.1 mmm -84.74 -4.64 59.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.825 0.345 . . . . 0.0 111.146 -174.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.489 ' HA ' HG12 ' A' ' 282' ' ' VAL . 50.8 t30 -68.9 117.03 10.06 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.864 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 95.4 mt 67.95 40.13 2.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.316 -177.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -96.73 121.78 38.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.683 172.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -75.18 111.37 10.35 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.586 0.708 . . . . 0.0 111.17 -176.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 29.4 tp -140.69 110.35 6.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.432 178.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 91.77 25.28 23.19 Favored Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.435 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 74.97 10.69 84.02 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.251 -0.5 . . . . 0.0 112.517 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -138.26 144.51 40.56 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -76.44 116.32 17.01 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.648 175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.95 128.84 38.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.908 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.461 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 9.4 mmt85 -98.5 115.31 28.29 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 172.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' A' ' 271' ' ' ASN . 14.3 p -116.25 144.0 24.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.788 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -155.63 178.47 32.21 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.608 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -77.09 132.73 39.03 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -69.35 114.42 7.58 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.597 HG21 ' HG3' ' A' ' 167' ' ' GLN . 28.6 m -87.29 -27.6 5.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.808 -171.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.602 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 22.2 p -136.35 162.74 54.6 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.442 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -94.86 102.42 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.489 2.126 . . . . 0.0 112.162 175.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 287' ' ' THR . 23.6 Cg_exo -65.39 -29.34 54.05 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.478 2.119 . . . . 0.0 110.941 176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 67.7 mtm -120.98 92.73 48.62 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.237 175.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -75.78 62.42 6.47 Favored 'Trans proline' 0 CA--C 1.528 0.209 0 C-N-CA 123.435 2.757 . . . . 0.0 112.222 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 292' ' ' LEU . 0.9 OUTLIER -170.62 103.13 0.25 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.316 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 64.1 tp -115.2 103.06 10.47 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.929 0.395 . . . . 0.0 110.408 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 295' ' ' PRO . 7.1 t -122.22 121.25 27.9 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.289 177.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 294' ' ' THR . 4.0 Cg_exo -76.7 77.02 3.81 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.825 2.35 . . . . 0.0 111.528 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -85.66 -10.15 56.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.479 -178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.522 -0.751 . . . . 0.0 110.308 -179.513 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.44 96.8 4.81 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.894 0.378 . . . . 0.0 110.592 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -138.77 -22.74 0.96 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.771 176.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -162.12 98.38 1.05 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.352 179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -139.1 -80.61 0.31 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.782 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 104' ' ' ARG . 28.5 tpt180 63.62 90.7 0.08 Allowed 'General case' 0 C--N 1.333 -0.122 0 O-C-N 123.876 0.735 . . . . 0.0 110.817 -175.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -61.9 106.93 0.76 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.989 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 9.9 mmt180 -60.44 -37.46 81.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.509 -174.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -68.07 -32.18 72.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.258 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.494 HD23 ' SD ' ' A' ' 111' ' ' MET . 25.1 mt -67.75 -32.47 73.1 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.814 -0.175 . . . . 0.0 110.962 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.31 -29.64 70.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.262 0.553 . . . . 0.0 109.907 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 66.7 mt -82.34 -38.3 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.28 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.494 ' SD ' HD23 ' A' ' 108' ' ' LEU . 91.4 mtp -67.41 -30.07 69.73 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.727 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.6 m -74.18 -21.63 59.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.852 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 96.6 mtt180 -97.32 139.68 32.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.1 p -126.15 132.02 70.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.16 0.505 . . . . 0.0 110.319 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.52 ' HB2' ' HD3' ' A' ' 187' ' ' ARG . 91.3 t80 -76.58 117.1 17.88 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.426 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 41.2 t -115.89 114.96 47.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.811 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.7 169.13 18.68 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.026 -176.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.746 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 12.2 t 68.64 33.98 3.66 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 121.359 0.599 . . . . 0.0 110.871 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 56.9 mt -80.56 -13.19 12.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.049 -178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 65.9 t80 72.69 147.18 0.08 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.901 -173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 152' ' ' HIS . 12.8 p90 -77.34 76.22 3.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.38 0.609 . . . . 0.0 111.372 -179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -159.87 -65.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.23 176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.8 mt -54.86 108.38 0.39 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.577 0.548 . . . . 0.0 111.503 -175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.21 -173.0 40.97 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.904 -0.589 . . . . 0.0 113.892 -174.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -60.14 -46.72 88.7 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.295 -0.452 . . . . 0.0 111.781 -175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 1.1 m-20 -60.41 -45.0 95.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.627 -175.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.6 m -59.73 -43.7 94.09 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.874 0.368 . . . . 0.0 110.836 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 40.8 mm -63.98 -45.65 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.408 0.623 . . . . 0.0 110.226 177.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -56.58 -45.78 81.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.269 177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 58.9 mt-30 -63.82 -34.12 77.2 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.526 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.56 -29.4 30.35 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -93.15 -20.18 20.74 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.457 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -50.2 -42.3 71.57 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 73.6 Cg_exo -42.3 -42.79 7.75 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 123.168 2.579 . . . . 0.0 114.786 174.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -78.38 -36.64 45.7 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -169.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.546 ' HA3' ' HB2' ' A' ' 165' ' ' ALA . . . -177.87 -172.67 42.59 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.132 175.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.547 ' HG3' ' CE1' ' A' ' 252' ' ' TYR . 73.0 Cg_endo -76.28 129.15 10.99 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.955 2.436 . . . . 0.0 112.123 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 67.2 mt -90.11 128.6 41.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.29 -177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.571 ' HB2' ' HG2' ' A' ' 161' ' ' GLU . 24.5 ttmm -91.98 -37.23 12.96 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.711 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.3 p -169.71 157.04 6.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.381 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.6 mt -126.64 108.3 18.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 174.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -86.46 99.53 11.72 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.766 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 57.4 ttm -119.7 127.47 52.9 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.089 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 6.9 m -67.29 80.24 0.15 Allowed 'General case' 0 C--O 1.233 0.197 0 O-C-N 123.573 0.546 . . . . 0.0 110.426 178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -90.58 111.82 23.27 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.734 -174.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -67.94 114.85 6.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.907 177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 p -68.83 -12.1 61.18 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.927 0.394 . . . . 0.0 111.548 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 53.6 t -85.88 -55.79 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.434 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 6.7 p -95.91 -12.29 25.36 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 31.9 mtm 60.93 47.28 7.71 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.505 -175.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -135.13 176.4 8.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.262 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 121' ' ' TYR . 5.8 p80 -137.82 112.96 9.19 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 171.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 121' ' ' TYR . 41.0 ttmt -94.88 100.5 12.36 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.91 0.386 . . . . 0.0 110.174 -178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 135.46 -93.83 0.24 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.672 175.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -141.24 178.64 7.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.416 0.627 . . . . 0.0 112.468 -166.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -157.72 156.25 31.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.776 -1.102 . . . . 0.0 109.269 175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.494 ' CE2' ' HD1' ' A' ' 115' ' ' TYR . 76.8 m-85 -113.04 126.18 55.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 178.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.12 114.01 41.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 38.6 tt0 -101.47 122.27 43.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.577 179.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -97.56 172.61 7.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.024 174.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.571 ' HG2' ' HB2' ' A' ' 139' ' ' LYS . 23.6 mt-10 -93.5 -7.43 44.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.963 174.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.1 m -140.22 135.43 16.18 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.809 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.26 -25.75 36.34 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.195 2.597 . . . . 0.0 113.036 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.478 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 18.4 mp0 -55.81 -45.06 78.39 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.546 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . . . -55.62 -40.28 71.9 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.937 0.398 . . . . 0.0 111.352 175.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -67.5 -35.02 78.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.904 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.68 ' HG3' HG11 ' A' ' 286' ' ' VAL . 16.6 mm-40 -68.38 -48.13 65.54 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.671 176.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.589 HD11 ' HD2' ' A' ' 212' ' ' TYR . 64.0 mt -60.38 -43.68 96.35 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.177 0.513 . . . . 0.0 111.113 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.61 -37.24 80.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.208 -0.905 . . . . 0.0 110.563 -178.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.599 ' O ' ' HB2' ' A' ' 174' ' ' ASN . 8.2 tt -72.41 -48.51 40.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.092 174.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -53.36 -43.24 67.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.264 -177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -100.23 -49.22 4.34 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 176' ' ' VAL . 16.1 ttp -107.91 29.97 6.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.941 -0.304 . . . . 0.0 111.685 -166.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.599 ' HB2' ' O ' ' A' ' 170' ' ' LEU . 27.4 t-20 -54.63 -51.13 66.36 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -174.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 183' ' ' ILE . 19.2 m -113.61 16.48 18.67 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -169.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' A' ' 173' ' ' MET . 10.7 m -140.02 135.89 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 117.832 0.287 . . . . 0.0 110.98 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.999 ' HB2' HD13 ' A' ' 183' ' ' ILE . 27.7 tpp -126.68 102.09 6.92 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.911 0.386 . . . . 0.0 110.932 175.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 21.0 tp 71.13 -68.41 0.22 Allowed 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.149 172.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -114.15 -143.34 8.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.094 -177.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -85.56 65.73 3.91 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.204 -0.522 . . . . 0.0 111.875 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -131.73 120.09 22.24 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 175' ' ' SER . 6.2 p30 -77.84 128.64 34.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.999 HD13 ' HB2' ' A' ' 177' ' ' MET . 37.0 pt -135.78 -175.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.245 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 68.2 mmtt -134.15 106.67 7.29 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.037 174.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 174' ' ' ASN . 54.9 t -99.49 101.53 12.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 130.16 166.66 11.87 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -174.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.52 ' HD3' ' HB2' ' A' ' 115' ' ' TYR . 23.6 ptt180 -147.49 134.07 9.9 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 116.989 0.394 . . . . 0.0 111.309 -177.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 187' ' ' ARG . 7.6 Cg_exo -72.96 75.17 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.056 2.504 . . . . 0.0 110.611 173.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 18.1 p -59.74 126.52 27.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.266 -176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -63.36 139.04 58.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.028 176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 46.5 mm -58.5 123.23 10.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.694 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -149.56 -141.35 3.41 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 121.006 -0.616 . . . . 0.0 111.952 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.422 ' O ' ' HD2' ' A' ' 196' ' ' PRO . 27.0 tt0 -82.8 -33.37 27.27 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.982 0.42 . . . . 0.0 111.014 -179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -69.36 -34.99 75.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.855 -176.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.662 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 15.6 tm0? -57.97 -53.33 66.94 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.222 -176.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.662 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 74.7 Cg_exo -53.46 -36.04 78.21 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.588 2.192 . . . . 0.0 112.905 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 55.6 mt -71.41 -42.0 73.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.777 0.322 . . . . 0.0 110.243 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 194' ' ' ALA . 81.5 mt -61.14 -47.88 91.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.287 0.565 . . . . 0.0 109.973 176.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -64.15 -37.47 87.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.836 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 46.6 tp60 -58.95 -52.89 63.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.918 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.566 ' HA ' ' HB2' ' A' ' 204' ' ' GLU . 67.7 mt -68.04 -33.14 74.02 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.987 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.659 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.95 -46.03 71.47 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 173.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -66.4 -36.79 83.73 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.962 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.566 ' HB2' ' HA ' ' A' ' 201' ' ' LEU . 39.4 mt-10 -67.77 -27.39 66.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.975 -179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.13 -27.83 59.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.028 0.442 . . . . 0.0 110.326 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.659 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 72.4 mtp180 -74.39 -15.59 60.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.503 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -73.88 -11.01 60.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.511 0.672 . . . . 0.0 109.992 174.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -115.87 -178.74 3.47 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.388 175.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 9.6 m-80 -123.92 46.06 2.34 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -102.61 139.18 38.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.284 -166.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.475 HG23 ' HB2' ' A' ' 263' ' ' SER . 37.6 pt -125.17 166.55 20.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.798 174.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.623 ' HD1' ' CE1' ' A' ' 254' ' ' PHE . 49.0 t80 -117.65 130.07 56.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.697 -175.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 27.5 m -122.1 132.89 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 121.004 0.431 . . . . 0.0 110.256 176.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -129.02 176.46 7.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.64 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 8.6 t 64.41 22.71 12.81 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 123.93 0.768 . . . . 0.0 109.204 -173.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.404 HG13 HD11 ' A' ' 225' ' ' ILE . 15.4 t -67.87 121.82 17.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 114.823 -1.08 . . . . 0.0 108.761 178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -62.66 143.05 57.77 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.454 0.169 . . . . 0.0 110.687 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.63 ' HA ' ' CE1' ' A' ' 249' ' ' HIS . 28.6 pt20 -61.05 -16.82 48.01 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -166.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -105.4 -5.52 20.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.046 0.451 . . . . 0.0 110.846 179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.541 HD21 ' HG ' ' A' ' 275' ' ' LEU . 2.9 tp -83.55 130.3 35.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.732 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . 0.559 ' O ' HG12 ' A' ' 225' ' ' ILE . 29.7 p -102.37 167.84 9.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.377 -174.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.42 ' HB3' ' HG ' ' A' ' 240' ' ' LEU . 0.5 OUTLIER -60.81 -37.98 83.81 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.282 0.563 . . . . 0.0 109.958 174.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -54.65 -40.03 68.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.997 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.7 -47.24 41.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.68 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.671 HG22 HD11 ' A' ' 255' ' ' ILE . 34.0 mm -60.41 -42.5 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -177.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.55 ' HG3' HG21 ' A' ' 235' ' ' ILE . 86.2 tttt -57.36 -48.78 78.12 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.04 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 88.0 p -60.83 -35.34 76.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.86 0.319 . . . . 0.0 111.86 -173.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.58 -43.67 34.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.633 0.254 . . . . 0.0 111.232 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.588 ' CB ' HD11 ' A' ' 235' ' ' ILE . 10.3 m-85 -68.26 -29.41 68.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.297 0.57 . . . . 0.0 110.802 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.87 -24.77 67.87 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.054 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -71.0 -17.84 62.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.889 -175.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -112.21 -44.73 3.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.02 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.62 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -124.55 170.17 16.61 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.472 -0.87 . . . . 0.0 113.098 -175.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -86.4 99.07 11.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.588 HD11 ' CB ' ' A' ' 229' ' ' PHE . 12.8 mt -84.59 150.82 3.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.332 0.587 . . . . 0.0 111.458 -175.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -117.04 -27.86 6.41 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.471 178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.0 t -167.94 149.41 5.32 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.726 -173.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.571 ' SG ' HG12 ' A' ' 255' ' ' ILE . 50.3 t -148.2 126.3 12.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.257 175.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 99.0 m -142.52 121.33 12.7 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.787 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.448 ' CD2' ' HA3' ' A' ' 253' ' ' GLY . 31.1 mt -82.7 141.04 32.74 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 173.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.31 114.86 6.36 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.463 ' HG2' ' HB3' ' A' ' 249' ' ' HIS . 80.3 mtm180 -127.79 163.16 24.97 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.328 0.585 . . . . 0.0 112.365 -172.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.43 ' HA ' ' HD2' ' A' ' 244' ' ' PRO . 9.6 m-20 -104.69 104.95 48.47 Favored Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.458 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 243' ' ' ASP . 9.6 Cg_endo -50.03 -45.74 31.45 Favored 'Trans proline' 0 N--CA 1.475 0.439 0 C-N-CA 123.86 3.04 . . . . 0.0 114.934 -167.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 7.8 p -93.21 9.58 35.5 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -171.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.447 ' OG1' ' HG2' ' A' ' 248' ' ' LYS . 72.3 p -114.5 -38.7 3.97 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.971 0.415 . . . . 0.0 110.469 175.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 99.15 2.54 56.89 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.34 177.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.447 ' HG2' ' OG1' ' A' ' 246' ' ' THR . 19.8 ptmt -99.27 158.33 15.77 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.887 0.375 . . . . 0.0 110.532 -178.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.63 ' CE1' ' HA ' ' A' ' 218' ' ' GLN . 22.4 p80 -105.63 152.32 23.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 169.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -80.18 -1.29 39.8 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.832 -170.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 113.05 -6.98 25.38 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.375 172.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.547 ' CE1' ' HG3' ' A' ' 137' ' ' PRO . 24.3 p90 -138.2 161.86 35.74 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.664 0.269 . . . . 0.0 110.541 -178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.448 ' HA3' ' CD2' ' A' ' 240' ' ' LEU . . . -154.12 172.49 32.74 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.889 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.623 ' CE1' ' HD1' ' A' ' 212' ' ' TYR . 29.9 m-85 -129.0 144.07 51.07 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.811 0.339 . . . . 0.0 110.464 -176.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.671 HD11 HG22 ' A' ' 225' ' ' ILE . 77.5 mt -136.09 133.2 50.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.297 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.509 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 33.4 mt-10 -113.78 143.72 44.17 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.62 ' HE2' ' HA3' ' A' ' 233' ' ' GLY . 6.6 m-85 -110.6 170.12 8.3 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.095 178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.623 ' HB2' ' HD2' ' A' ' 259' ' ' LYS . 34.4 mt-10 -72.78 -43.56 62.66 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.709 0.766 . . . . 0.0 109.008 175.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . 0.623 ' HD2' ' HB2' ' A' ' 258' ' ' GLU . 11.0 mptt -105.81 130.09 53.86 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.058 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -64.79 -25.72 68.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.32 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -75.43 -31.92 60.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.776 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.4 ' OG ' ' HB2' ' A' ' 259' ' ' LYS . 46.7 m -70.12 -34.91 73.68 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.355 -176.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.475 ' HB2' HG23 ' A' ' 211' ' ' ILE . 55.2 p -66.29 -34.61 78.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.339 0.59 . . . . 0.0 109.751 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -71.63 -25.93 62.35 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.556 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -68.45 -42.41 78.85 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.367 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -62.87 -37.74 88.09 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.498 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.436 HG13 ' HA2' ' A' ' 283' ' ' GLY . 80.3 t -52.79 -48.71 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.985 0.422 . . . . 0.0 111.406 175.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 46.3 m -71.36 -23.47 61.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 11.1 m -94.34 -43.44 8.4 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . . . . . . . . . 84.8 mmm -89.84 -4.4 57.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.022 -169.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.9 t30 -76.96 122.51 24.98 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.992 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.608 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 96.7 mt 70.79 27.97 3.46 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.182 -175.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -89.71 124.36 34.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.094 173.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -77.56 107.45 10.03 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.974 0.416 . . . . 0.0 110.961 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.541 ' HG ' HD21 ' A' ' 220' ' ' LEU . 31.2 tp -134.13 98.85 4.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.059 177.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 101.56 2.67 53.27 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.151 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.13 -0.15 41.12 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.319 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -131.68 142.44 49.82 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.804 0.335 . . . . 0.0 110.557 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.608 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 21.7 m-85 -74.0 111.22 8.95 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.592 177.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.44 128.16 35.32 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.884 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 13.3 mmt180 -98.95 116.23 30.72 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 173.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 212' ' ' TYR . 10.2 p -125.7 141.92 44.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 C-N-CA 120.376 -0.53 . . . . 0.0 110.838 -176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.436 ' HA2' HG13 ' A' ' 267' ' ' VAL . . . -160.8 173.41 37.29 Favored Glycine 0 N--CA 1.439 -1.142 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.397 178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 38.2 mtpt -71.1 125.99 28.37 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -65.85 124.05 21.44 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.68 HG11 ' HG3' ' A' ' 167' ' ' GLN . 34.0 m -88.79 -19.23 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.923 0.392 . . . . 0.0 111.385 -172.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.547 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 5.4 t -147.36 147.98 30.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 173.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 60.7 Cg_endo -73.21 103.74 1.66 Allowed 'Trans proline' 0 CA--C 1.533 0.469 0 C-N-CA 122.78 2.32 . . . . 0.0 112.717 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 287' ' ' THR . 18.1 Cg_endo -97.4 150.22 0.92 Allowed 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.592 2.861 . . . . 0.0 112.056 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 67.4 mtm -133.74 122.86 16.89 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.423 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.43 -9.49 24.24 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.478 2.118 . . . . 0.0 112.12 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 21.7 tp 60.96 44.27 10.67 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.725 176.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 49.3 tp -78.1 -74.4 0.27 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.091 -178.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 17.9 m -117.74 95.25 47.59 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.307 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.79 76.69 3.62 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.116 2.544 . . . . 0.0 111.862 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -92.82 128.61 38.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.608 -0.71 . . . . 0.0 110.212 176.972 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.83 0 N-CA-C 112.239 -0.344 . . . . 0.0 112.239 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . 60.83 41.41 14.63 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.795 0.438 . . . . 0.0 111.512 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 67.6 mtt -125.09 150.79 46.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.828 0.347 . . . . 0.0 110.676 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -129.11 117.62 21.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.389 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.776 ' HG3' ' H ' ' A' ' 104' ' ' ARG . 6.2 tp60 -168.87 -173.0 1.72 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.776 ' H ' ' HG3' ' A' ' 103' ' ' GLN . 14.1 ttp180 -59.22 -19.34 44.72 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.154 0.502 . . . . 0.0 111.019 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.496 ' HG2' ' HB3' ' A' ' 103' ' ' GLN . 13.5 pt20 -69.58 4.48 1.84 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.569 179.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -57.25 -37.34 72.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.139 0.495 . . . . 0.0 109.931 171.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.22 88.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.236 176.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.442 HD23 ' SD ' ' A' ' 111' ' ' MET . 66.7 mt -61.87 -35.26 77.78 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.999 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.66 -26.51 68.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.346 0.593 . . . . 0.0 110.818 177.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.7 mt -81.77 -37.5 15.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.778 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.508 ' SD ' HG12 ' A' ' 198' ' ' ILE . 88.1 mtp -70.57 -29.68 66.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.741 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.1 m -70.64 -17.71 62.86 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.749 0.309 . . . . 0.0 110.875 177.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -98.5 140.81 32.19 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.855 0.36 . . . . 0.0 110.146 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.778 HG12 ' HB ' ' A' ' 158' ' ' VAL . 3.7 p -120.47 126.88 75.74 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.672 0.749 . . . . 0.0 109.994 176.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -83.69 101.25 11.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.053 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 25.1 m -108.35 143.15 19.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.033 0.445 . . . . 0.0 111.243 -178.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.795 ' HA3' ' HD1' ' A' ' 155' ' ' PHE . . . -152.4 177.68 30.02 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.36 -178.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 183' ' ' ILE . 23.2 t 65.01 50.09 1.95 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.672 0.749 . . . . 0.0 109.294 -175.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 123' ' ' LEU . 77.1 mt -103.14 116.45 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.936 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -61.21 147.89 42.75 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.638 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -74.07 76.29 1.73 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 122.027 0.918 . . . . 0.0 111.047 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -163.55 -38.24 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.409 HD12 HG23 ' A' ' 119' ' ' ILE . 26.8 mt -76.53 92.6 3.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 113.916 -1.493 . . . . 0.0 109.453 174.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -88.56 -169.49 44.93 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.583 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 129' ' ' ARG . 20.8 tt0 -54.33 -46.51 72.89 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 178.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -64.11 -44.93 90.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.564 -177.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.4 m -63.89 -45.17 90.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.837 0.351 . . . . 0.0 110.936 -177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.562 HG13 ' HE1' ' A' ' 143' ' ' MET . 26.8 mm -69.17 -35.46 68.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.122 0.487 . . . . 0.0 110.427 178.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 27.9 ttt180 -59.37 -45.48 91.33 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.802 175.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -70.2 -33.45 71.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.838 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.19 -38.73 30.62 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.502 ' CD1' HG23 ' A' ' 128' ' ' ILE . 24.6 m-85 -89.33 -22.43 22.64 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -175.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -52.38 -42.97 90.16 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_exo -44.96 -31.95 5.93 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 122.991 2.46 . . . . 0.0 114.53 176.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.689 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 74.6 m-85 -82.06 -37.2 26.78 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 121.127 -0.229 . . . . 0.0 111.48 -175.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 165' ' ' ALA . . . -178.49 173.62 45.97 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.798 174.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.1 126.19 15.38 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.985 2.457 . . . . 0.0 111.956 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.622 HD13 HD11 ' A' ' 141' ' ' ILE . 61.9 mt -89.06 139.27 17.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.635 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.599 ' HD2' ' OE2' ' A' ' 159' ' ' GLU . 22.1 ttmm -98.84 -43.86 6.59 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.099 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.8 t -159.63 142.53 13.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.096 -176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.622 HD11 HD13 ' A' ' 138' ' ' ILE . 70.0 mt -126.17 110.42 23.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.87 0.366 . . . . 0.0 110.089 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 157' ' ' PHE . 25.9 t70 -91.45 100.82 13.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.185 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.562 ' HE1' HG13 ' A' ' 128' ' ' ILE . 51.3 ttm -138.86 111.3 7.52 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.023 177.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 59.4 m -74.48 75.64 1.94 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.128 0.489 . . . . 0.0 111.377 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.455 ' HZ3' ' HA ' ' A' ' 147' ' ' SER . 3.9 t90 -104.28 92.81 4.5 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -73.81 115.21 12.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.588 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.455 ' HA ' ' HZ3' ' A' ' 145' ' ' TRP . 17.8 m -68.83 -19.76 64.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.909 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 66.2 t -75.27 -55.66 10.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.917 0.389 . . . . 0.0 110.832 -178.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 31.6 p -89.92 -15.28 32.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.864 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 64.9 mtm 64.19 43.06 5.12 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.79 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -121.21 164.42 16.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.538 -178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -154.2 -81.83 0.08 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.022 -177.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm 58.32 -169.04 0.13 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.027 0.441 . . . . 0.0 111.183 -174.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 63.62 -142.27 46.61 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.601 -0.727 . . . . 0.0 114.245 171.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.795 ' HD1' ' HA3' ' A' ' 117' ' ' GLY . 67.8 m-85 -130.43 178.31 6.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.264 -0.468 . . . . 0.0 110.224 -172.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.96 153.8 41.9 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.81 0.338 . . . . 0.0 110.755 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.498 ' HB2' ' HB3' ' A' ' 142' ' ' ASP . 88.9 m-85 -114.85 110.82 20.27 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.588 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.778 ' HB ' HG12 ' A' ' 114' ' ' VAL . 58.2 t -97.49 108.72 22.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.902 177.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.599 ' OE2' ' HD2' ' A' ' 139' ' ' LYS . 33.3 tt0 -102.35 119.8 39.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.124 -178.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.446 ' OH ' ' HB3' ' A' ' 132' ' ' PHE . 90.2 m-85 -97.4 -177.72 3.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.001 0.429 . . . . 0.0 111.342 179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -80.18 -58.79 2.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.646 169.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 20.7 m -103.7 143.16 26.09 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.626 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 40.9 Cg_endo -67.52 -18.8 49.08 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 123.147 2.565 . . . . 0.0 112.798 -176.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.701 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 15.7 mp0 -55.81 -57.17 13.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.459 178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.534 ' HB2' ' HA3' ' A' ' 136' ' ' GLY . . . -52.98 -26.85 16.54 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 177.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.18 -47.26 13.68 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.404 -176.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.7 ' HG2' HG13 ' A' ' 286' ' ' VAL . 2.6 pp0? -66.72 -31.57 72.31 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 175.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.689 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 10.7 tp -73.23 -45.81 53.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.53 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.43 -30.86 71.92 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.602 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.5 tt -66.63 -50.28 63.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.473 172.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -54.19 -49.72 68.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.351 -178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -86.48 -38.92 16.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -173.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 30.9 mtm -106.8 21.93 16.73 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -171.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.443 ' HB3' ' O ' ' A' ' 170' ' ' LEU . 32.1 p30 -72.14 0.16 10.37 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 121.324 0.583 . . . . 0.0 110.23 174.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.9 m -95.5 -73.72 0.58 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.506 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 22.5 m -139.16 161.82 28.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.729 0.299 . . . . 0.0 111.167 -175.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.548 ' HE2' ' HG ' ' A' ' 178' ' ' LEU . 1.6 tpt -150.63 72.47 1.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.548 ' HG ' ' HE2' ' A' ' 177' ' ' MET . 74.1 mt 57.16 -166.43 0.14 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.765 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 73.19 -17.76 1.73 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.798 176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 85.45 21.67 53.48 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.443 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 -143.78 176.63 9.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.058 0.456 . . . . 0.0 111.332 -178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -95.04 144.08 25.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.692 175.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.527 ' HA ' ' HB3' ' A' ' 118' ' ' SER . 22.3 pt -116.71 171.26 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 110.834 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.729 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 34.8 mmtp -103.8 131.6 50.85 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 173.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 6.1 t -129.94 110.22 19.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 120.8 0.333 . . . . 0.0 110.487 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.602 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 90.16 -147.36 19.17 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.565 174.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.41 ' N ' ' HD3' ' A' ' 188' ' ' PRO . 71.1 mtp180 54.88 62.85 7.56 Favored Pre-proline 0 C--N 1.329 -0.311 0 C-N-CA 122.685 0.394 . . . . 0.0 111.112 -177.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.41 ' HD3' ' N ' ' A' ' 187' ' ' ARG . 15.1 Cg_exo -67.66 -38.53 13.86 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.535 2.157 . . . . 0.0 111.499 -178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 31.4 m -152.47 140.92 20.67 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.456 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -89.62 -14.3 35.26 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.127 0.489 . . . . 0.0 110.255 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 9.3 tp -153.39 148.73 13.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.307 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 160.99 -175.14 37.67 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.938 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -78.78 -21.27 48.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.752 0.31 . . . . 0.0 111.194 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.414 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -82.1 -28.49 32.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.483 -178.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.585 ' HB2' ' HD3' ' A' ' 196' ' ' PRO . 11.5 mm100 -55.57 -49.81 90.51 Favored Pre-proline 0 CA--C 1.536 0.42 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -176.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 195' ' ' GLN . 75.7 Cg_exo -53.23 -33.89 67.1 Favored 'Trans proline' 0 C--N 1.357 1.013 0 C-N-CA 122.249 1.966 . . . . 0.0 112.846 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 63.4 mt -75.25 -48.14 32.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.877 0.37 . . . . 0.0 110.227 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.508 HG12 ' SD ' ' A' ' 111' ' ' MET . 68.7 mt -57.5 -48.08 83.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.924 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 33.5 t70 -69.43 -34.12 73.97 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.115 -176.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -71.58 -37.94 70.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.671 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 60.8 mt -67.74 -33.22 74.44 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.198 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -58.72 -37.27 75.78 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.122 0.487 . . . . 0.0 109.772 173.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 37.7 mt-10 -72.49 -30.35 64.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.356 174.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -68.42 -33.8 74.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.993 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -70.9 -24.62 62.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.262 174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.587 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 65.6 mtp180 -72.62 -24.23 61.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.17 173.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -83.67 -39.63 19.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.277 0.56 . . . . 0.0 110.047 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -109.36 80.19 1.29 Allowed 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -61.77 85.95 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.773 0.67 . . . . 0.0 110.916 -175.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 256' ' ' GLU . 9.1 ttt180 -128.09 143.31 51.06 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.537 -171.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 263' ' ' SER . 39.7 pt -118.21 166.76 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.564 -178.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.524 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 73.9 t80 -121.91 126.36 48.47 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.388 -173.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.522 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 27.7 m -121.32 131.27 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.985 0.422 . . . . 0.0 110.358 177.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.87 175.27 7.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.451 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 22.6 t 59.96 31.53 20.72 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.867 0.841 . . . . 0.0 109.206 -172.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 44.9 t -73.02 123.06 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.224 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -50.3 128.91 20.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.391 0.615 . . . . 0.0 110.968 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -55.74 -33.1 63.96 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 114.956 -1.02 . . . . 0.0 113.159 -173.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -99.07 37.0 1.6 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.477 0.656 . . . . 0.0 110.386 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 220' ' ' LEU . 11.2 tp -124.69 133.01 53.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 15.7 m -95.84 170.09 9.54 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.849 -174.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -67.46 -36.33 80.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.756 0.312 . . . . 0.0 110.819 -176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.9 -30.78 70.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.642 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -74.5 -45.26 47.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.361 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.77 HG13 HD21 ' A' ' 240' ' ' LEU . 27.1 mm -59.85 -42.42 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.692 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.44 ' HB2' ' CB ' ' A' ' 238' ' ' CYS . 86.8 tttt -56.46 -52.52 64.38 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.868 176.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 79.6 p -56.31 -37.83 70.46 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -173.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 38.6 t -76.4 -45.48 34.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.981 -0.288 . . . . 0.0 111.677 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.577 ' HB2' HD11 ' A' ' 235' ' ' ILE . 26.3 m-85 -67.95 -27.75 66.87 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.292 0.568 . . . . 0.0 110.394 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -61.09 -26.51 67.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.142 176.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.19 -18.73 61.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.236 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -107.07 -31.33 8.33 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 -177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -153.28 159.37 28.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.875 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -75.45 111.2 10.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.505 0.669 . . . . 0.0 111.645 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 229' ' ' PHE . 40.0 mt -84.03 148.98 4.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 114.717 -1.129 . . . . 0.0 111.4 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.635 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 77.8 tttt -108.35 -35.85 6.41 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.861 176.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' A' ' 256' ' ' GLU . 17.0 m -153.44 136.05 15.18 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -170.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.44 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 52.4 t -138.68 114.75 10.18 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.883 0.373 . . . . 0.0 110.103 175.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 31.3 m -141.99 116.01 9.35 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.57 178.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.77 HD21 HG13 ' A' ' 225' ' ' ILE . 66.3 mt -77.98 138.58 38.91 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 174.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.07 110.63 3.49 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.499 ' HG2' ' CA ' ' A' ' 249' ' ' HIS . 34.6 mtm180 -122.41 143.17 49.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.775 -176.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -83.96 109.92 22.16 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 174.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -64.47 -16.47 55.32 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.477 2.118 . . . . 0.0 111.992 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.7 p -73.29 -29.18 62.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.595 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.551 HG23 ' HG2' ' A' ' 248' ' ' LYS . 4.1 t -120.55 -26.68 5.29 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.796 0.331 . . . . 0.0 111.762 -178.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 87.56 37.06 8.26 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.201 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.551 ' HG2' HG23 ' A' ' 246' ' ' THR . 19.2 ptpt -140.43 150.05 43.35 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.499 ' CA ' ' HG2' ' A' ' 242' ' ' ARG . 18.1 p80 -80.59 132.36 35.62 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.332 0.586 . . . . 0.0 110.465 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -64.06 -21.04 66.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.112 -171.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 133.73 -15.3 4.64 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.336 -0.935 . . . . 0.0 112.273 177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.524 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 33.8 p90 -128.36 169.86 13.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.692 0.282 . . . . 0.0 110.592 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 240' ' ' LEU . . . -158.38 170.82 35.12 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.051 -178.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.701 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 97.4 m-85 -130.86 138.92 50.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.068 0.461 . . . . 0.0 111.309 -177.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.755 HD11 HG22 ' A' ' 225' ' ' ILE . 89.2 mt -133.95 128.53 53.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.699 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 210' ' ' ARG . 57.2 tt0 -109.85 145.89 36.02 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -176.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.505 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 16.8 m-85 -116.2 148.01 40.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.002 0.429 . . . . 0.0 111.262 -175.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.635 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 26.3 mt-10 -72.54 -21.95 61.09 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.081 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -116.91 126.33 52.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.725 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -50.73 -58.11 6.69 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -171.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -62.44 -29.07 70.25 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.068 -0.514 . . . . 0.0 112.226 -175.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . 0.418 ' HA ' ' OD2' ' A' ' 265' ' ' ASP . 49.9 m -64.97 -29.22 70.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.677 0.275 . . . . 0.0 111.556 -175.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.47 ' HA ' ' CD1' ' A' ' 257' ' ' TYR . 87.5 p -63.19 -39.93 96.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.323 0.582 . . . . 0.0 109.712 178.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -78.28 -19.32 53.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.136 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . 0.418 ' OD2' ' HA ' ' A' ' 262' ' ' SER . 85.9 m-20 -63.03 -43.05 99.78 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . . . . . . . . . . . -67.43 -41.65 84.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.683 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 263' ' ' SER . 97.4 t -56.06 -37.23 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 121.273 0.559 . . . . 0.0 111.226 177.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.7 t -77.75 -35.69 51.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.295 -177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 16.0 m -94.83 -36.55 11.62 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -171.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.438 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.4 mmm -83.4 -0.52 50.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.535 0.568 . . . . 0.0 112.535 -169.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -73.53 125.99 29.22 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.487 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.541 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 91.1 mt 66.04 25.17 10.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.53 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -88.13 118.27 27.59 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 172.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.522 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 6.7 p-10 -74.69 115.71 14.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.458 0.647 . . . . 0.0 110.439 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 31.6 tp -123.75 97.83 5.55 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.14 178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.5 26.63 35.2 Favored Glycine 0 N--CA 1.443 -0.833 0 N-CA-C 111.006 -0.837 . . . . 0.0 111.006 -175.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.5 -43.74 1.85 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.697 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -88.25 142.46 27.73 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.044 0.449 . . . . 0.0 111.203 -176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.541 ' HB3' ' HA ' ' A' ' 272' ' ' LEU . 68.2 m-85 -81.63 123.59 28.82 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.916 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 58.5 mt -71.68 123.01 21.62 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.711 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 31.9 mmt180 -93.6 115.23 27.7 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 170.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 14.3 p -118.06 142.68 31.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.244 0.545 . . . . 0.0 111.428 -172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.5 ' HA3' HD13 ' A' ' 168' ' ' LEU . . . -157.95 -176.94 30.58 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 5.8 mppt? -85.98 147.73 26.08 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 117.323 0.561 . . . . 0.0 110.43 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -86.52 130.96 34.31 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.7 HG13 ' HG2' ' A' ' 167' ' ' GLN . 12.0 m -93.54 -19.46 6.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 120.834 0.349 . . . . 0.0 110.877 -178.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 42.9 p -130.43 129.01 22.73 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.29 177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 28.0 Cg_endo -64.98 119.31 6.31 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.425 2.084 . . . . 0.0 111.045 173.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 288' ' ' PRO . 8.6 Cg_exo -71.83 78.37 1.75 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.154 2.57 . . . . 0.0 112.992 -174.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 56.6 ttp -128.92 85.47 60.07 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.309 176.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -83.88 124.26 3.4 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 123.295 2.663 . . . . 0.0 111.928 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 56.3 tp 72.67 135.26 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.935 0.772 . . . . 0.0 111.513 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 58.0 tp -73.56 88.44 1.66 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.666 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 3.2 t -107.56 104.65 53.59 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-O 121.402 0.62 . . . . 0.0 110.13 173.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -96.92 31.78 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.233 2.622 . . . . 0.0 112.363 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -133.81 15.52 3.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.309 -178.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 22.8 m . . . . . 0 C--O 1.252 1.191 0 CA-C-O 119.044 -0.503 . . . . 0.0 111.233 -179.437 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.661 0 N-CA-C 111.954 -0.458 . . . . 0.0 111.954 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.29 125.83 45.01 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 43.1 tpp -93.05 67.64 4.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.054 0.454 . . . . 0.0 110.735 -177.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 66.76 -3.95 0.84 Allowed 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.402 ' OE1' ' HA ' ' A' ' 103' ' ' GLN . 7.1 tp60 -70.94 -52.23 21.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.663 0.268 . . . . 0.0 111.267 -176.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.403 ' HA ' ' HD2' ' A' ' 104' ' ' ARG . 7.6 tpt180 -70.41 -35.8 73.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.126 0.489 . . . . 0.0 110.451 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.1 mt-30 -91.55 78.71 5.57 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 31.8 ptt180 -50.86 -28.4 9.43 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 114.912 -1.04 . . . . 0.0 113.422 -173.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.98 -31.06 71.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.7 0.286 . . . . 0.0 111.363 -178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.539 HD23 ' SD ' ' A' ' 111' ' ' MET . 58.4 mt -68.55 -31.97 71.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.064 -178.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.04 -27.87 68.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.213 0.53 . . . . 0.0 110.425 177.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 72.0 mt -85.86 -34.64 8.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.096 176.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.552 ' SD ' HG12 ' A' ' 198' ' ' ILE . 91.7 mtp -70.84 -16.43 62.71 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.042 -176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 71.2 m -84.39 -6.29 59.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.716 0.293 . . . . 0.0 111.188 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 51.8 mtt180 -116.78 141.88 47.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.757 0.313 . . . . 0.0 110.548 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.574 HG12 ' HB ' ' A' ' 158' ' ' VAL . 4.0 p -120.63 128.47 76.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.408 0.623 . . . . 0.0 109.752 174.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -83.11 115.56 21.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.016 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 17.2 m -108.33 124.87 65.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.518 0.675 . . . . 0.0 111.124 178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -126.61 174.83 18.01 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.375 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.459 ' HB2' ' HA ' ' A' ' 183' ' ' ILE . 71.8 m 61.0 38.33 17.43 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.272 0.558 . . . . 0.0 110.517 -176.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 120' ' ' TYR . 57.5 mt -74.34 -21.81 17.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.563 -176.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 119' ' ' ILE . 84.0 t80 70.01 163.94 0.25 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.37 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.671 ' HA ' ' HB3' ' A' ' 152' ' ' HIS . 20.2 p90 -89.83 76.77 7.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.589 0.709 . . . . 0.0 110.704 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -164.1 -50.87 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.342 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.715 HD13 ' HG3' ' A' ' 177' ' ' MET . 73.3 mt -65.23 112.74 3.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.919 -178.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 128' ' ' ILE . . . -80.14 159.11 42.97 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.751 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -65.22 -37.32 86.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.207 0.527 . . . . 0.0 109.93 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.12 -41.12 97.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.606 176.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.4 m -64.76 -41.4 95.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.954 0.407 . . . . 0.0 110.292 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 124' ' ' GLY . 33.4 mm -59.2 -44.94 93.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.876 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.44 ' HA ' HD12 ' A' ' 138' ' ' ILE . 25.1 ttt180 -59.24 -40.48 86.09 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.223 0.535 . . . . 0.0 110.338 179.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -71.56 -33.89 69.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.583 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.95 -24.19 28.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -175.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.488 ' CZ ' HG11 ' A' ' 116' ' ' VAL . 34.8 m-85 -95.15 -16.68 22.4 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -54.72 -42.03 92.99 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -44.73 -32.29 5.86 Favored 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 123.092 2.528 . . . . 0.0 114.888 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.76 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 78.5 m-85 -85.4 -42.78 14.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.769 0.319 . . . . 0.0 110.752 -177.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -167.61 157.22 29.46 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.969 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.45 117.92 4.65 Favored 'Trans proline' 0 C--O 1.241 0.649 0 C-N-CA 122.71 2.273 . . . . 0.0 111.722 175.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.466 HD11 ' HB2' ' A' ' 132' ' ' PHE . 54.9 mt -72.53 132.55 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.242 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -96.7 -43.05 7.72 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.228 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.7 m -152.76 140.41 19.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.3 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 63.8 mt -122.76 124.86 71.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.951 0.405 . . . . 0.0 110.139 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.565 ' O ' ' HA ' ' A' ' 156' ' ' ALA . 8.0 m-20 -112.71 98.8 7.46 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 174.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.408 ' CE ' HG13 ' A' ' 128' ' ' ILE . 54.4 ttm -124.26 137.72 54.48 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.6 m -94.49 108.39 20.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.899 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.407 ' CH2' ' HA ' ' A' ' 150' ' ' MET . 0.0 OUTLIER -97.43 84.69 3.48 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 172.198 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -79.8 16.81 1.05 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.678 -1.146 . . . . 0.0 114.072 -163.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.558 ' CB ' ' HB2' ' A' ' 151' ' ' LYS . 22.9 t -151.09 163.86 37.82 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.856 -0.737 . . . . 0.0 112.15 -174.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 47.0 t -110.21 -21.36 5.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.248 173.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.4 p -88.2 28.51 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.766 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.407 ' HA ' ' CH2' ' A' ' 145' ' ' TRP . 20.0 mmt 66.49 30.39 8.63 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.523 176.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.558 ' HB2' ' CB ' ' A' ' 147' ' ' SER . 34.8 mmtp -95.77 146.14 24.77 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 173.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.671 ' HB3' ' HA ' ' A' ' 121' ' ' TYR . 37.8 t-80 -161.77 97.51 1.06 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.982 -174.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.43 6.52 8.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.194 0.521 . . . . 0.0 110.345 174.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -70.68 177.46 34.01 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.761 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -109.04 177.85 4.64 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.436 0.16 . . . . 0.0 110.741 -176.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 142' ' ' ASP . . . -148.84 140.93 23.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.913 0.387 . . . . 0.0 111.613 178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -110.45 116.57 31.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.92 172.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.574 ' HB ' HG12 ' A' ' 114' ' ' VAL . 88.3 t -95.71 108.27 20.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.045 178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.495 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 38.5 tt0 -96.41 128.89 43.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.217 178.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -103.57 165.97 10.71 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 174.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.77 -13.94 60.31 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.66 173.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.7 m -138.65 139.64 25.03 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.657 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 45.0 Cg_endo -67.83 -19.28 47.0 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.314 2.676 . . . . 0.0 112.486 -178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.7 ' HG2' ' HE1' ' A' ' 254' ' ' PHE . 7.5 mp0 -59.44 -48.21 82.5 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.966 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.24 -22.23 66.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.871 0.367 . . . . 0.0 111.853 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.08 -49.61 10.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.927 -176.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 164' ' ' GLU . 5.0 pp0? -64.3 -30.78 71.82 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.76 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 17.8 tp -71.22 -50.54 31.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.431 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -63.31 -33.39 75.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.392 . . . . 0.0 110.296 178.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.567 HD12 ' HA3' ' A' ' 186' ' ' GLY . 8.8 tt -71.74 -38.06 70.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.2 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.64 -52.12 64.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.183 -177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -100.04 -30.43 11.98 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -172.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 27.8 ttp -106.87 28.19 8.21 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.483 -170.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -74.62 -8.62 56.95 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.387 0.613 . . . . 0.0 110.089 177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 10.6 m -72.7 -73.92 0.18 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.17 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 182' ' ' ASN . 27.1 m -144.69 167.59 10.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.949 0.404 . . . . 0.0 111.42 -173.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.744 ' HB2' HD13 ' A' ' 183' ' ' ILE . 11.7 tpp -132.4 74.47 1.58 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 172.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 60.6 mt 59.5 -174.3 0.1 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.28 -179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.2 -63.63 3.57 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.286 -0.483 . . . . 0.0 112.889 173.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 129.56 34.99 0.47 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -144.04 136.59 26.92 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.521 ' HA ' HG12 ' A' ' 176' ' ' VAL . 2.1 p-10 -71.59 141.49 50.01 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.983 0.42 . . . . 0.0 109.998 178.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.744 HD13 ' HB2' ' A' ' 177' ' ' MET . 45.3 pt -112.55 178.89 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.859 -176.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.631 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 18.6 tptm -112.87 112.64 24.27 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.603 175.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 16.0 t -109.7 109.45 28.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.049 0.452 . . . . 0.0 110.792 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.567 ' HA3' HD12 ' A' ' 170' ' ' LEU . . . 78.72 -163.08 49.51 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.744 174.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 67.6 mtt85 58.93 78.77 0.33 Allowed Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 122.798 0.439 . . . . 0.0 111.436 177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -61.37 97.33 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.679 2.253 . . . . 0.0 111.015 175.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 19.7 t 64.33 -79.41 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 O-C-N 124.0 0.812 . . . . 0.0 109.616 -169.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -176.51 -67.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.21 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 8.5 tp -86.08 140.51 15.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.096 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -170.37 154.53 23.3 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 111.156 -0.777 . . . . 0.0 111.156 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -67.08 -20.2 65.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.274 0.559 . . . . 0.0 111.097 -177.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.529 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -76.76 -22.49 53.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.369 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.474 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 31.7 mm-40 -60.59 -53.46 64.23 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 7.2 Cg_endo -53.24 -34.56 70.26 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.489 2.126 . . . . 0.0 112.995 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 65.9 mt -74.63 -38.85 46.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.543 0.211 . . . . 0.0 110.691 -178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.552 HG12 ' SD ' ' A' ' 111' ' ' MET . 70.2 mt -58.07 -49.07 82.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 121.225 0.536 . . . . 0.0 109.732 174.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.9 -37.49 87.81 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.888 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . 0.485 ' O ' ' HG3' ' A' ' 204' ' ' GLU . 24.7 tp60 -60.2 -51.66 68.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.877 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 31.6 mt -67.52 -33.27 74.74 Favored 'General case' 0 C--O 1.219 -0.552 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.936 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -54.87 -37.71 66.6 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -74.48 -36.66 63.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.922 174.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.485 ' HG3' ' O ' ' A' ' 200' ' ' GLN . 26.7 mt-10 -71.72 -24.0 61.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.819 0.342 . . . . 0.0 111.778 -177.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -73.19 -26.55 61.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.394 175.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 37.2 mtm180 -69.71 -17.95 63.5 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.451 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -72.01 -15.25 62.04 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.097 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -119.89 -172.76 2.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.601 176.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.619 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 68.4 m-20 -130.29 41.72 3.36 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.453 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.523 ' HD3' ' HG3' ' A' ' 289' ' ' PRO . 32.1 ttp180 -101.13 138.01 38.73 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.3 0.571 . . . . 0.0 112.044 -172.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 263' ' ' SER . 47.5 pt -124.71 167.76 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.233 175.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.443 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 77.6 t80 -121.47 129.07 52.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.707 -174.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.475 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 33.7 m -124.28 134.9 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 121.014 0.435 . . . . 0.0 110.445 178.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -130.8 178.27 6.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.944 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.402 ' CB ' ' HG2' ' A' ' 281' ' ' ARG . 28.5 t 59.44 36.16 23.08 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.626 0.727 . . . . 0.0 109.413 -173.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.613 HG13 HD11 ' A' ' 225' ' ' ILE . 10.5 t -73.61 120.47 22.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.687 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.463 ' HD2' ' NE2' ' A' ' 278' ' ' GLN . 25.9 t-80 -54.11 146.89 13.83 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.297 -174.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -48.58 -53.37 18.63 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -93.03 37.4 1.03 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.155 0.502 . . . . 0.0 111.368 -178.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.458 HD21 HD23 ' A' ' 275' ' ' LEU . 12.2 tp -117.69 109.49 16.7 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 96.8 p -93.91 -179.36 4.95 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.065 -175.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -63.46 -32.18 73.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.658 0.266 . . . . 0.0 110.571 -179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -67.84 -35.75 79.14 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.026 0.441 . . . . 0.0 110.173 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -65.26 -48.52 72.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.294 178.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.635 HG22 HD11 ' A' ' 255' ' ' ILE . 33.4 mm -62.89 -46.73 95.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.457 ' HG3' HG21 ' A' ' 235' ' ' ILE . 54.2 tttm -54.33 -52.42 61.61 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.26 176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 62.0 p -55.99 -39.6 72.08 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -174.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 21.1 t -76.48 -45.97 32.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.456 -179.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.767 ' HB2' HD11 ' A' ' 235' ' ' ILE . 9.0 m-85 -64.72 -32.51 74.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.521 0.677 . . . . 0.0 110.557 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.63 -25.32 68.05 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.523 177.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -70.26 -25.81 63.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.765 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -101.59 -33.61 9.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.079 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.541 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -145.11 164.56 27.91 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.607 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -77.51 99.41 5.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.853 0.359 . . . . 0.0 110.746 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.767 HD11 ' HB2' ' A' ' 229' ' ' PHE . 13.3 mt -74.6 146.57 9.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.353 0.596 . . . . 0.0 111.393 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -110.31 -34.41 6.36 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.882 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 50.7 m -162.2 131.07 4.26 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.372 -172.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.428 ' SG ' HG12 ' A' ' 255' ' ' ILE . 52.5 t -131.59 117.06 18.21 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 175.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 26.2 m -138.6 113.76 9.41 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.845 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.577 ' CD2' ' HA3' ' A' ' 253' ' ' GLY . 33.3 mt -82.46 139.93 33.68 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 174.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.39 115.56 7.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -128.62 136.75 51.11 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.172 -172.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -69.42 109.35 4.36 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 174.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -53.65 -45.35 41.7 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.199 3.266 . . . . 0.0 114.611 -168.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.526 HG23 HG23 ' A' ' 246' ' ' THR . 8.7 t -82.71 -11.86 58.01 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -170.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.526 HG23 HG23 ' A' ' 245' ' ' THR . 23.0 p -114.94 -21.51 10.05 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.114 0.483 . . . . 0.0 112.237 -176.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 77.57 39.3 25.96 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.464 175.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -126.04 130.7 51.65 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.897 0.38 . . . . 0.0 110.36 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.425 ' HE1' ' O ' ' A' ' 216' ' ' VAL . 23.9 p80 -76.85 128.86 35.36 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 173.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 30.1 mtpp -62.21 -20.64 64.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.274 -173.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 130.78 -5.02 5.79 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.274 177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.437 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 46.3 p90 -140.65 167.96 20.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.745 0.307 . . . . 0.0 110.607 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.577 ' HA3' ' CD2' ' A' ' 240' ' ' LEU . . . -158.56 172.09 35.42 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.084 178.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.7 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 97.9 m-85 -128.05 142.52 51.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.894 0.378 . . . . 0.0 110.852 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.635 HD11 HG22 ' A' ' 225' ' ' ILE . 77.8 mt -136.8 131.79 47.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.767 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.619 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 16.5 mt-10 -112.44 146.57 38.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.875 175.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.546 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 9.2 m-85 -108.89 161.2 15.36 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.807 179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.54 -22.33 59.08 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.509 178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.8 141.58 48.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.035 176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.559 ' HA ' ' OD1' ' A' ' 209' ' ' ASN . . . -57.99 -60.21 4.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -169.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -74.51 -20.61 59.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 -171.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 22.9 m -62.1 -25.8 67.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.431 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 211' ' ' ILE . 87.8 p -68.94 -39.61 79.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.372 0.606 . . . . 0.0 109.697 177.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -75.08 -23.16 57.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.897 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -63.28 -41.27 98.98 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.71 175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -65.54 -42.22 92.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.37 175.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.551 ' HA ' HG21 ' A' ' 282' ' ' VAL . 96.4 t -54.14 -34.32 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 121.193 0.52 . . . . 0.0 110.822 177.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 26.1 t -73.11 -35.29 66.53 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.29 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.6 t -92.74 -35.08 13.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.805 0.336 . . . . 0.0 111.832 -173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 73.2 mmm -88.64 5.65 42.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.785 0.326 . . . . 0.0 111.245 -171.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.519 ' HA ' HG12 ' A' ' 282' ' ' VAL . 25.1 t-20 -66.5 109.77 2.89 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.348 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.4 mt 63.47 40.91 7.89 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.549 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . 0.485 ' HD2' ' HB2' ' A' ' 275' ' ' LEU . 49.4 t80 -79.69 126.84 31.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.137 174.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -80.17 71.34 6.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.629 0.728 . . . . 0.0 111.444 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.485 ' HB2' ' HD2' ' A' ' 273' ' ' PHE . 30.8 tp -95.37 103.48 15.34 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.109 0.48 . . . . 0.0 110.245 -177.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 90.14 21.45 38.65 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.494 -178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 88.91 -9.27 77.26 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.695 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.463 ' NE2' ' HD2' ' A' ' 217' ' ' HIS . 79.2 mt-30 -116.66 144.17 44.74 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.866 0.365 . . . . 0.0 110.697 -177.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -80.2 115.45 19.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.577 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.412 HD12 ' HB3' ' A' ' 273' ' ' PHE . 64.6 mt -64.53 126.64 28.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.437 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 281' ' ' ARG . 2.5 mmt180 -93.57 115.1 27.58 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 176.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 267' ' ' VAL . 8.3 p -112.83 147.16 16.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 C-N-CA 120.566 -0.453 . . . . 0.0 111.155 -173.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -162.93 169.92 38.27 Favored Glycine 0 N--CA 1.44 -1.08 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 176.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt -84.15 134.26 34.58 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -70.07 107.78 3.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.018 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 15.9 m -68.19 -27.6 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.541 -176.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . . . . . . . . . 69.9 p -98.52 124.5 46.29 Favored Pre-proline 0 N--CA 1.447 -0.585 0 CA-C-O 121.246 0.546 . . . . 0.0 110.845 177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 289' ' ' PRO . 36.0 Cg_endo -66.28 152.17 81.69 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.755 2.303 . . . . 0.0 111.23 172.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.523 ' HG3' ' HD3' ' A' ' 210' ' ' ARG . 18.3 Cg_exo -66.56 76.94 0.37 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.713 2.275 . . . . 0.0 112.209 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 66.0 mtm 68.05 87.72 0.11 Allowed Pre-proline 0 C--O 1.234 0.285 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.214 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.57 119.67 6.65 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.569 2.179 . . . . 0.0 111.222 176.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 85.9 mt -84.66 -79.91 0.21 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.039 -176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 3.5 mm? 56.43 -159.6 0.22 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.999 0.428 . . . . 0.0 110.535 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 24.4 p -118.86 86.2 30.18 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.239 174.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -74.94 -13.62 21.5 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.228 2.619 . . . . 0.0 112.652 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -80.5 74.55 7.38 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.222 0.534 . . . . 0.0 110.42 179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.339 -178.959 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 111.876 -0.489 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.29 -79.06 0.17 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.827 0.346 . . . . 0.0 111.265 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 14.9 tpt -110.24 110.29 21.07 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -122.29 8.19 9.68 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -171.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -52.59 -58.91 5.27 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.265 0.555 . . . . 0.0 109.943 175.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -135.04 144.05 47.07 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 169.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.421 ' HB3' ' HG ' ' A' ' 108' ' ' LEU . 31.5 mm-40 -70.98 90.62 0.83 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.784 -171.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 28.0 mtp-105 -56.57 -40.12 74.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.279 177.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.86 -30.81 71.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.697 -177.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.727 HD21 HG21 ' A' ' 287' ' ' THR . 24.2 mt -69.37 -41.25 76.78 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.495 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.29 -28.73 70.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.177 0.513 . . . . 0.0 110.516 178.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.463 HD12 ' HB2' ' A' ' 194' ' ' ALA . 69.4 mt -79.84 -46.25 22.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.872 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 30.9 mtm -65.22 -37.07 86.14 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.6 m -63.2 -19.21 64.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.738 0.304 . . . . 0.0 111.223 -178.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 74.3 mtp85 -104.68 140.54 37.9 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.635 HG12 ' HB ' ' A' ' 158' ' ' VAL . 2.0 p -129.24 128.09 66.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.66 0.743 . . . . 0.0 110.371 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -85.13 113.59 21.63 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.332 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 184' ' ' LYS . 29.6 m -111.41 116.44 52.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.306 0.574 . . . . 0.0 110.314 175.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 118' ' ' SER . . . -113.78 106.33 1.73 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.76 -177.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.867 ' HB3' HG22 ' A' ' 183' ' ' ILE . 27.7 t 154.6 -90.34 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.894 1.278 . . . . 0.0 109.106 175.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.792 ' H ' HG22 ' A' ' 183' ' ' ILE . 13.6 mt 60.01 31.31 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.371 0.668 . . . . 0.0 111.497 176.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.667 ' HA ' ' HD3' ' A' ' 181' ' ' ARG . 27.8 t80 60.3 -164.06 0.23 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 174.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -124.14 75.44 1.38 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.792 1.282 . . . . 0.0 109.426 170.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 123' ' ' LEU . 5.8 tt0 -178.42 -144.75 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 112.81 -1.995 . . . . 0.0 106.64 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.538 HD22 HG21 ' A' ' 127' ' ' THR . 92.1 mt 57.6 -174.36 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.784 0.678 . . . . 0.0 112.187 176.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -161.79 -179.63 36.58 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -59.5 -45.72 90.87 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.821 0.343 . . . . 0.0 110.42 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.427 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 4.4 m-20 -56.87 -49.39 75.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.444 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.538 HG21 HD22 ' A' ' 123' ' ' LEU . 5.0 m -61.7 -43.1 99.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.034 -177.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.442 HD11 HG23 ' A' ' 119' ' ' ILE . 21.5 mm -66.55 -39.84 84.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.54 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 129' ' ' ARG . 43.2 ttp180 -60.7 -38.65 85.71 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.999 177.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 78.0 mt-30 -71.53 -33.26 69.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.211 177.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.05 -33.76 50.78 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -175.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -92.73 -16.19 25.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.601 0.238 . . . . 0.0 111.495 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -51.01 -44.66 87.37 Favored Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 5.1 Cg_exo -43.24 -49.07 7.61 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.981 2.454 . . . . 0.0 113.976 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.505 ' HD2' ' HG ' ' A' ' 168' ' ' LEU . 72.7 m-85 -65.28 -48.49 72.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -170.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -163.3 -171.66 29.82 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 119.449 -1.358 . . . . 0.0 113.271 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 161' ' ' GLU . 71.7 Cg_endo -78.79 121.61 5.11 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.752 2.302 . . . . 0.0 111.737 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.491 HD13 HD11 ' A' ' 141' ' ' ILE . 57.6 mt -80.8 119.69 30.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.367 0.603 . . . . 0.0 110.662 -177.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.667 ' HB3' ' HG2' ' A' ' 159' ' ' GLU . 28.1 tptp -89.26 -34.13 16.72 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.847 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.9 t -174.53 162.14 3.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.857 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.491 HD11 HD13 ' A' ' 138' ' ' ILE . 70.1 mt -141.22 122.37 13.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.745 0.307 . . . . 0.0 110.307 175.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.669 ' HB2' ' HB2' ' A' ' 157' ' ' PHE . 12.0 m-20 -95.01 104.01 15.87 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.387 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 3.9 mmt -94.98 126.18 40.15 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.737 178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 15.4 m -81.01 47.81 1.04 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.417 0.627 . . . . 0.0 109.75 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 16.7 t90 -81.16 123.01 28.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.232 -175.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -73.35 104.14 4.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.621 -176.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 10.2 t -84.85 1.53 46.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.219 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.1 t -78.42 -55.72 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.445 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.541 ' OG1' ' HE2' ' A' ' 151' ' ' LYS . 2.2 p -122.53 12.89 10.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.297 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 67.4 mtm 66.08 57.25 0.79 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.213 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.541 ' HE2' ' OG1' ' A' ' 149' ' ' THR . 49.2 mtmt -116.53 167.4 11.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.62 178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -138.76 45.2 2.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.579 0.704 . . . . 0.0 110.562 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -95.07 85.2 4.27 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -172.39 -146.62 5.44 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.809 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -124.34 177.9 5.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.837 0.351 . . . . 0.0 110.058 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -144.96 140.95 28.58 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.154 174.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.669 ' HB2' ' HB2' ' A' ' 142' ' ' ASP . 92.7 m-85 -109.99 109.17 19.67 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.635 ' HB ' HG12 ' A' ' 114' ' ' VAL . 43.3 t -92.04 115.02 30.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.23 -178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.667 ' HG2' ' HB3' ' A' ' 139' ' ' LYS . 36.6 tt0 -105.26 125.46 51.01 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.414 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -108.18 174.44 5.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.373 176.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.508 ' HB2' ' HG2' ' A' ' 137' ' ' PRO . 46.3 mt-10 -89.46 -16.32 31.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.086 172.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.451 HG22 ' HD2' ' A' ' 137' ' ' PRO . 28.1 m -130.67 137.64 31.25 Favored Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.109 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.453 ' HG3' HD22 ' A' ' 108' ' ' LEU . 60.1 Cg_endo -73.1 -20.76 21.29 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.785 2.323 . . . . 0.0 112.647 -176.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.571 ' HG2' ' HE2' ' A' ' 254' ' ' PHE . 13.6 mp0 -54.24 -59.08 5.14 Favored 'General case' 0 C--O 1.22 -0.472 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.132 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.16 -26.66 17.87 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -81.17 -51.83 8.01 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.216 -175.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.45 ' HG3' HG11 ' A' ' 286' ' ' VAL . 10.6 mm100 -67.52 -27.43 66.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.984 177.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.505 ' HG ' ' HD2' ' A' ' 135' ' ' PHE . 14.2 tp -72.13 -47.61 49.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.105 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.28 73.48 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 185' ' ' VAL . 6.6 tt -65.06 -51.95 58.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.656 172.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -56.09 -33.68 65.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.833 -176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -100.68 -48.85 4.37 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . . . . . . . . . 15.9 mtm -95.73 28.83 2.87 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -167.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -85.5 30.69 0.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.996 0.903 . . . . 0.0 109.847 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 16.6 m -113.93 -74.32 0.63 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.323 176.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.4 m -145.59 170.86 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.467 -178.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.625 ' HB2' HD13 ' A' ' 183' ' ' ILE . 22.5 tpp -143.4 91.33 2.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.93 0.395 . . . . 0.0 110.604 178.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.518 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 75.7 mt 54.49 45.34 27.21 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.035 172.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 170.85 163.06 24.25 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.962 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -79.13 53.25 4.14 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.09 -0.576 . . . . 0.0 113.152 -179.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . 0.667 ' HD3' ' HA ' ' A' ' 120' ' ' TYR . 25.4 mtp180 -143.46 125.78 15.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.096 0.474 . . . . 0.0 110.49 174.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 175' ' ' SER . 14.1 m120 -71.81 128.43 35.75 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.954 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.867 HG22 ' HB3' ' A' ' 118' ' ' SER . 43.9 pt -103.21 143.51 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.781 -177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.539 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 50.4 mttp -103.0 118.29 36.49 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 176.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.439 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.7 t -110.67 111.77 37.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 123.591 0.557 . . . . 0.0 111.479 -172.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.411 ' O ' ' HD3' ' A' ' 188' ' ' PRO . . . 57.43 51.22 59.04 Favored Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.434 -0.803 . . . . 0.0 114.552 170.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -86.72 109.04 20.93 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 186' ' ' GLY . 95.0 Cg_endo -85.21 54.02 3.73 Favored 'Trans proline' 0 N--CA 1.462 -0.341 0 C-N-CA 123.011 2.474 . . . . 0.0 112.796 -175.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 24.5 m -56.36 -50.14 72.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.587 -178.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -101.53 12.9 36.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.144 -176.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 49.5 mm -104.85 95.64 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.03 0.443 . . . . 0.0 110.434 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.51 -19.17 5.49 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.215 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -68.42 -37.79 80.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.012 0.434 . . . . 0.0 111.144 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.463 ' HB2' HD12 ' A' ' 110' ' ' ILE . . . -87.34 -17.64 31.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.738 -175.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.554 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 11.8 tm0? -57.7 -50.58 87.34 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.886 -174.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 10.0 Cg_endo -53.16 -37.3 79.73 Favored 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.604 2.203 . . . . 0.0 113.1 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 62.5 mt -74.59 -41.33 48.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.297 -178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 83.6 mt -59.73 -48.85 86.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.096 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.543 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 14.7 t70 -59.19 -43.27 92.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.46 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -59.38 -50.93 72.05 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.471 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 36.2 mt -68.6 -33.0 73.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.681 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.577 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.41 -39.49 73.12 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 172.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.68 ' HA ' ' HD3' ' A' ' 206' ' ' ARG . 44.3 mt-10 -66.75 -33.82 76.46 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.755 174.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.415 ' HB3' ' HG3' ' A' ' 288' ' ' PRO . 37.3 mt-10 -66.51 -37.02 84.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.349 . . . . 0.0 110.568 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -63.35 -33.76 76.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.095 0.474 . . . . 0.0 110.27 173.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.68 ' HD3' ' HA ' ' A' ' 203' ' ' GLU . 66.9 mtp180 -70.36 -13.77 62.29 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.158 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -84.73 -38.37 19.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.052 0.453 . . . . 0.0 110.783 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.47 -19.88 23.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.114 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 61.64 46.92 6.78 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.16 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.478 ' HE ' ' HB3' ' A' ' 254' ' ' PHE . 22.5 ttt180 -103.32 137.14 41.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.72 -171.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.503 HG23 ' HB2' ' A' ' 263' ' ' SER . 42.2 pt -118.96 167.25 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.346 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.42 ' CD2' ' HB3' ' A' ' 164' ' ' GLU . 81.3 t80 -119.53 128.04 53.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.619 -175.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.42 HG23 HG21 ' A' ' 216' ' ' VAL . 27.4 m -116.98 135.04 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-O 121.217 0.532 . . . . 0.0 110.105 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . 0.573 ' HB3' ' HB2' ' A' ' 281' ' ' ARG . . . -121.92 173.86 7.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.642 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.447 ' OG ' ' HG2' ' A' ' 281' ' ' ARG . 2.0 p 43.7 42.35 4.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.946 0.879 . . . . 0.0 111.202 -174.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.42 HG21 HG23 ' A' ' 213' ' ' VAL . 24.1 t -84.77 108.64 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.27 175.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 28.4 t-80 -54.88 135.72 47.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.559 0.695 . . . . 0.0 111.369 -172.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -51.72 -27.29 11.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 114.435 -1.257 . . . . 0.0 113.701 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -85.59 -9.84 56.73 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.918 0.389 . . . . 0.0 111.113 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 72.1 mt -86.52 136.39 33.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.214 177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 49.3 m -97.26 169.44 9.77 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 121.165 -0.214 . . . . 0.0 110.496 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -62.29 -29.64 70.57 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.304 -0.247 . . . . 0.0 111.073 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -66.24 -35.18 79.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.172 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -61.04 -54.21 47.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.979 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.535 HG13 HD21 ' A' ' 240' ' ' LEU . 24.9 mm -63.52 -43.52 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.995 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 238' ' ' CYS . 54.6 tttm -58.29 -49.63 76.46 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.318 177.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 97.8 p -56.04 -43.92 78.3 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -174.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 17.4 t -75.03 -41.62 45.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.609 0.242 . . . . 0.0 111.109 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.57 ' CB ' HD11 ' A' ' 235' ' ' ILE . 4.6 m-85 -65.75 -34.31 77.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.179 0.514 . . . . 0.0 110.912 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 3.3 tm-20 -66.33 -24.84 66.6 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.746 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -72.25 -16.45 61.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.648 -175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -111.74 -44.5 3.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.628 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . 0.554 ' HA3' ' HE2' ' A' ' 257' ' ' TYR . . . -124.57 173.49 16.99 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.525 -177.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -94.96 99.28 11.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.393 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.57 HD11 ' CB ' ' A' ' 229' ' ' PHE . 17.9 mt -79.12 146.09 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.424 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.42 ' HB2' ' HG2' ' A' ' 258' ' ' GLU . 44.5 tttm -111.22 -33.14 6.53 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.126 176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 18.8 m -152.84 125.55 8.33 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.899 -0.32 . . . . 0.0 111.485 -170.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.686 ' HB3' ' HB2' ' A' ' 226' ' ' LYS . 26.8 p -108.05 114.22 27.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.042 0.449 . . . . 0.0 109.907 170.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 27.5 m -141.71 102.06 4.09 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.286 176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.535 HD21 HG13 ' A' ' 225' ' ' ILE . 64.6 mt -83.8 131.82 34.87 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.459 ' H ' ' HA2' ' A' ' 253' ' ' GLY . . . -62.92 110.99 1.95 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.537 ' HD2' ' O ' ' A' ' 247' ' ' GLY . 16.1 ttp180 -123.98 144.88 49.55 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.798 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.433 ' HB3' HG22 ' A' ' 246' ' ' THR . 17.8 t70 -80.54 113.66 41.4 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 172.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.19 -25.71 47.72 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 123.707 2.938 . . . . 0.0 115.162 -167.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.7 t -110.09 3.75 20.55 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -171.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 243' ' ' ASP . 8.2 t -103.83 -13.57 16.36 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.934 177.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.537 ' O ' ' HD2' ' A' ' 242' ' ' ARG . . . 91.83 -48.13 2.76 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.977 177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 16.2 pttp -94.85 156.17 16.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.756 0.278 . . . . 0.0 110.451 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 242' ' ' ARG . 4.4 p80 -80.07 161.88 25.11 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.743 -176.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -63.15 -58.72 6.3 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.161 -173.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 163.32 -17.18 0.13 Allowed Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.178 -178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.411 ' CE1' ' HD3' ' A' ' 137' ' ' PRO . 9.5 p90 -120.61 173.75 6.99 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.459 ' HA2' ' H ' ' A' ' 241' ' ' ALA . . . -163.84 172.89 39.82 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.959 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.571 ' HE2' ' HG2' ' A' ' 164' ' ' GLU . 76.4 m-85 -135.3 143.01 45.97 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 122.598 0.359 . . . . 0.0 110.072 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.2 mt -139.78 133.23 36.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.976 0.417 . . . . 0.0 110.705 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -105.68 147.79 28.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.687 ' HB2' ' HB3' ' A' ' 263' ' ' SER . 13.2 m-85 -117.45 151.57 36.79 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 120.915 0.388 . . . . 0.0 110.269 176.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.42 ' HG2' ' HB2' ' A' ' 236' ' ' LYS . 34.7 mt-10 -72.4 -16.28 61.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.844 -176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -131.41 132.33 44.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.904 177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -56.35 -33.95 66.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.332 -172.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -75.37 -33.39 61.04 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.032 0.444 . . . . 0.0 110.864 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 4.7 t -66.56 -36.11 81.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.186 -172.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.687 ' HB3' ' HB2' ' A' ' 257' ' ' TYR . 71.9 p -65.94 -36.69 84.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.207 0.527 . . . . 0.0 109.963 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -72.79 -24.12 60.88 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.82 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.63 -44.91 76.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.0 0.428 . . . . 0.0 110.398 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -64.28 -38.17 90.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.564 178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.467 HG13 ' HA2' ' A' ' 283' ' ' GLY . 72.0 t -53.85 -38.94 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 120.966 0.413 . . . . 0.0 111.457 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.7 m -82.02 -19.8 39.69 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.81 0.338 . . . . 0.0 111.596 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 17.8 m -95.24 -49.26 5.56 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 266' ' ' ALA . 58.4 mmm -81.57 -9.19 59.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -168.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -69.24 128.43 36.6 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.359 -177.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 93.2 mt 66.99 31.69 6.83 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.852 0.72 . . . . 0.0 110.508 -179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -100.63 116.4 32.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.982 174.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -64.65 116.37 6.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.723 -0.672 . . . . 0.0 112.006 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 31.7 tp -143.02 118.67 10.43 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.766 173.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 83.57 6.48 87.34 Favored Glycine 0 N--CA 1.454 -0.152 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.028 178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.44 -0.17 46.64 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.282 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -134.1 151.15 51.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -84.35 116.2 22.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.714 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.97 115.02 3.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.603 177.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' A' ' 214' ' ' ALA . 14.1 mmt180 -93.89 114.95 27.28 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 11.0 p -118.33 140.82 40.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 C-N-CA 119.711 -0.795 . . . . 0.0 111.202 -176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . 0.467 ' HA2' HG13 ' A' ' 267' ' ' VAL . . . -153.97 -169.98 19.46 Favored Glycine 0 N--CA 1.439 -1.141 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -89.95 137.94 31.91 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 117.334 0.567 . . . . 0.0 109.59 178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.45 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . . . -71.06 121.9 19.07 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 173.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.45 HG11 ' HG3' ' A' ' 167' ' ' GLN . 28.2 m -79.48 -25.66 12.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.794 0.33 . . . . 0.0 110.987 -175.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.727 HG21 HD21 ' A' ' 108' ' ' LEU . 73.2 p -133.18 145.54 57.24 Favored Pre-proline 0 N--CA 1.448 -0.538 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.505 176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.415 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 52.6 Cg_endo -70.96 110.83 2.9 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.492 2.128 . . . . 0.0 111.185 173.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -64.13 89.27 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.91 2.407 . . . . 0.0 112.56 -177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 70.7 mtm -75.57 133.22 74.11 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.214 177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.52 71.81 2.45 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 123.032 2.488 . . . . 0.0 112.859 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 29.0 tp 55.7 58.13 4.74 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.968 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 94.0 mt -117.88 96.27 5.29 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.036 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 8.9 t -86.61 132.26 43.11 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.09 0.471 . . . . 0.0 110.977 -176.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -76.21 -14.17 18.69 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.707 2.271 . . . . 0.0 112.25 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . -133.04 134.21 44.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.461 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.544 -0.741 . . . . 0.0 110.773 -179.158 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.64 79.25 1.38 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 66.0 mtt -85.22 118.18 24.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.638 -175.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . 60.31 24.49 13.95 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.791 0.682 . . . . 0.0 111.975 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -98.87 117.8 34.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.043 0.449 . . . . 0.0 110.58 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -116.2 139.98 49.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.473 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -82.1 51.14 1.71 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.498 0.666 . . . . 0.0 110.663 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' A' ' 106' ' ' ARG . 28.1 ptt180 -67.99 -27.77 66.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.367 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.46 ' HB2' HD12 ' A' ' 197' ' ' ILE . . . -65.89 -30.53 71.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.343 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 287' ' ' THR . 42.9 mt -60.93 -31.52 71.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.361 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.7 -24.96 67.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.132 0.491 . . . . 0.0 110.757 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.1 mt -87.83 -34.46 7.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.142 176.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.529 ' SD ' HG12 ' A' ' 198' ' ' ILE . 88.0 mtp -74.99 -15.5 60.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.093 -174.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 97.7 m -79.61 -1.26 37.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.538 0.209 . . . . 0.0 111.378 178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.896 ' HG2' ' HG3' ' A' ' 159' ' ' GLU . 32.7 mtt180 -110.81 142.43 42.82 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.765 0.317 . . . . 0.0 111.235 -174.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.558 HG23 HD12 ' A' ' 170' ' ' LEU . 8.9 p -128.4 129.79 69.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.408 0.623 . . . . 0.0 109.817 169.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -85.01 118.32 24.51 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.819 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.64 HG12 HG12 ' A' ' 185' ' ' VAL . 15.5 m -112.59 126.68 70.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.286 0.565 . . . . 0.0 111.372 -178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -131.31 175.36 19.61 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.543 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.7 m 62.1 31.87 17.67 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 122.934 0.493 . . . . 0.0 111.455 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 43.5 mt -77.22 112.83 15.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.067 0.46 . . . . 0.0 110.513 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -61.38 153.55 26.53 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.628 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.649 ' HB3' ' H ' ' A' ' 152' ' ' HIS . 24.0 p90 -78.01 76.29 4.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 122.086 0.946 . . . . 0.0 110.949 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -165.21 -39.95 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.095 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.458 ' HB3' HD11 ' A' ' 128' ' ' ILE . 66.3 mt -74.93 85.96 2.27 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.969 174.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.48 172.33 55.22 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.924 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -55.1 -40.03 69.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.77 0.319 . . . . 0.0 110.942 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 130' ' ' GLN . 20.5 t70 -62.28 -53.49 54.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.58 178.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 4.3 m -59.0 -43.07 91.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.978 -178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 123' ' ' LEU . 28.4 mm -63.19 -45.32 98.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.738 178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -57.39 -43.85 84.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.43 . . . . 0.0 110.248 178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 126' ' ' ASP . 15.3 mm100 -68.73 -33.79 74.52 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.939 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.61 -27.03 25.73 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.528 ' HB2' HD11 ' A' ' 138' ' ' ILE . 4.9 m-85 -87.52 -26.01 23.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.78 0.324 . . . . 0.0 111.06 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.452 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -50.76 -42.19 76.09 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 26.1 Cg_exo -39.12 -45.96 2.88 Favored 'Trans proline' 0 C--N 1.36 1.144 0 C-N-CA 123.168 2.579 . . . . 0.0 114.559 173.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.497 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 54.2 m-85 -76.1 -37.12 58.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.877 0.37 . . . . 0.0 110.597 -175.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -176.04 153.49 14.81 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.45 124.31 15.94 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 122.718 2.279 . . . . 0.0 111.755 175.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.528 HD11 ' HB2' ' A' ' 132' ' ' PHE . 21.0 mt -83.13 136.51 22.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.073 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -110.96 -20.32 12.47 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.175 0.512 . . . . 0.0 110.751 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.883 ' HB3' ' HB2' ' A' ' 159' ' ' GLU . 29.5 t -151.84 131.16 12.85 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.444 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.406 ' CG1' HG21 ' A' ' 138' ' ' ILE . 64.8 mt -130.28 129.67 65.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -117.48 99.45 7.0 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 174.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 52.1 ttm -141.33 112.0 7.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.828 178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 18.3 m -74.35 72.36 1.81 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.768 178.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 77.6 t-105 -88.22 82.36 7.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.527 0.68 . . . . 0.0 109.851 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -155.64 116.78 3.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.95 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.9 t -166.31 141.51 4.56 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.631 -179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 85.4 t -48.45 -53.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 123.512 0.507 . . . . 0.0 111.535 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 16.6 p -98.63 21.53 11.18 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.346 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 58.1 mtm 58.03 33.55 23.3 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.237 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.3 131.72 34.37 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.238 0.542 . . . . 0.0 109.986 179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.649 ' H ' ' HB3' ' A' ' 121' ' ' TYR . 2.4 t-160 -86.78 -79.03 0.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.308 -175.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 153' ' ' LYS . 48.2 mtpt 52.33 38.44 24.97 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.941 0.4 . . . . 0.0 111.915 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -151.29 175.77 30.04 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.064 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -108.69 172.67 6.71 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 116' ' ' VAL . . . -151.12 167.62 27.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.995 0.426 . . . . 0.0 111.299 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -126.84 134.66 50.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.393 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 114' ' ' VAL . 89.4 t -121.07 113.0 38.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.644 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.896 ' HG3' ' HG2' ' A' ' 113' ' ' ARG . 4.8 mp0 -105.54 119.62 39.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.554 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -92.14 179.87 5.45 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.793 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -71.36 -63.15 1.17 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.832 169.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 24.3 m -99.08 144.79 28.86 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.951 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 22.9 Cg_exo -65.71 -19.82 59.45 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.469 2.779 . . . . 0.0 112.535 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.482 ' OE2' ' HB3' ' A' ' 212' ' ' TYR . 0.6 OUTLIER -58.53 -54.91 41.75 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.836 179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -53.16 -25.82 14.9 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -79.5 -53.01 7.29 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.384 -176.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.425 ' HG3' HG21 ' A' ' 286' ' ' VAL . 83.7 mm-40 -64.47 -43.33 94.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.751 176.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.497 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 10.5 tp -59.64 -46.44 89.0 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.436 177.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.664 ' HB1' ' SD ' ' A' ' 173' ' ' MET . . . -61.68 -53.09 60.8 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.558 HD12 HG23 ' A' ' 114' ' ' VAL . 8.2 tt -54.45 -36.13 63.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.467 0.651 . . . . 0.0 110.234 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.01 -46.48 71.12 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.73 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -100.87 -21.13 15.2 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -173.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.664 ' SD ' ' HB1' ' A' ' 169' ' ' ALA . 4.6 ptm -99.74 18.55 17.88 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 121.925 -0.484 . . . . 0.0 110.792 -176.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 34.7 p30 -72.78 -2.92 22.33 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -174.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 182' ' ' ASN . 24.1 m -101.56 -74.22 0.63 Allowed 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.472 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 16.0 m -140.88 157.17 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.232 0.539 . . . . 0.0 111.675 -176.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.574 ' HB2' HD13 ' A' ' 183' ' ' ILE . 23.9 tpp -121.78 97.27 5.41 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.693 175.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 75.3 mt 61.49 35.91 17.35 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.249 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 80.34 -130.37 9.73 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.112 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 67.1 -94.26 0.25 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 121.33 -0.462 . . . . 0.0 113.574 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -144.33 153.69 42.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -173.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 175' ' ' SER . 23.6 t-20 -68.89 100.43 1.19 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.574 HD13 ' HB2' ' A' ' 177' ' ' MET . 47.9 pt -74.84 149.6 7.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.369 -175.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.708 ' HE2' ' HA ' ' A' ' 184' ' ' LYS . 9.3 mmpt? -103.45 107.3 18.08 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.161 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.64 HG12 HG12 ' A' ' 116' ' ' VAL . 5.9 m -104.62 109.41 27.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.222 0.534 . . . . 0.0 111.135 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 170' ' ' LEU . . . 84.77 86.54 0.92 Allowed Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.486 174.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -108.48 113.35 60.23 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 175.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -64.33 104.99 0.55 Allowed 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.021 2.481 . . . . 0.0 112.211 178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 1.2 m -55.44 -56.39 20.77 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.405 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -109.58 -65.9 1.11 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 174.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 6.7 tp -168.63 -43.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.886 175.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 132.1 110.41 1.26 Allowed Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.083 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -65.23 -31.54 72.75 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.302 0.572 . . . . 0.0 110.224 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.441 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -87.96 10.18 19.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.476 -176.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.7 ' HB3' ' HD3' ' A' ' 196' ' ' PRO . 25.3 tp60 -49.25 -53.13 42.45 Favored Pre-proline 0 N--CA 1.469 0.488 0 O-C-N 123.296 0.373 . . . . 0.0 111.89 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 195' ' ' GLN . 40.0 Cg_exo -59.06 -37.47 92.71 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 122.198 1.932 . . . . 0.0 112.701 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.46 HD12 ' HB2' ' A' ' 107' ' ' ALA . 74.8 mt -75.3 -43.26 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.065 -177.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.529 HG12 ' SD ' ' A' ' 111' ' ' MET . 73.7 mt -58.16 -45.9 88.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.149 0.5 . . . . 0.0 110.158 177.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 203' ' ' GLU . 36.0 t70 -66.8 -39.01 87.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.765 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -64.43 -48.4 75.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.869 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.592 ' HA ' ' HG3' ' A' ' 204' ' ' GLU . 54.3 mt -68.14 -33.12 73.9 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.649 0.261 . . . . 0.0 111.032 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.568 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -56.15 -42.96 77.81 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 173.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 199' ' ' ASP . 51.5 mt-10 -64.7 -36.36 84.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.901 174.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.592 ' HG3' ' HA ' ' A' ' 201' ' ' LEU . 5.8 mm-40 -53.66 -46.03 70.44 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-O 121.059 0.457 . . . . 0.0 110.891 175.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 285' ' ' ALA . . . -63.73 -37.01 85.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.784 176.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.568 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 76.3 mtp180 -72.47 -16.75 61.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.164 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -99.38 -38.21 8.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.458 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -86.72 -12.46 48.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.126 0.489 . . . . 0.0 111.1 179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 61.02 48.48 6.47 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.18 175.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.89 ' HB3' ' HG2' ' A' ' 256' ' ' GLU . 12.8 ptm180 -122.11 158.02 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.989 0.424 . . . . 0.0 111.718 -174.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 46.2 pt -136.36 168.59 21.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.578 -177.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.524 ' HB2' ' CE2' ' A' ' 254' ' ' PHE . 14.1 t80 -122.89 138.63 54.61 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.611 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.589 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 35.5 m -127.42 133.83 67.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 121.096 0.474 . . . . 0.0 110.757 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -125.78 -178.52 4.3 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.309 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 11.4 t 61.27 30.24 19.07 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.902 0.858 . . . . 0.0 109.082 -172.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.0 119.17 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.236 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 -57.45 142.27 44.6 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.974 0.416 . . . . 0.0 111.062 -173.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -49.04 -36.18 17.49 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -168.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -91.03 -5.83 54.75 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -171.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 92.3 mt -79.81 131.87 36.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.117 0.484 . . . . 0.0 111.14 -175.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.2 p -100.6 173.58 6.48 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.192 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.472 ' HA ' ' HG ' ' A' ' 240' ' ' LEU . 6.1 p-10 -61.62 -35.46 77.94 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.722 0.296 . . . . 0.0 110.415 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -59.48 -39.08 82.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.258 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -70.36 -44.23 68.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.597 -176.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.604 HG22 HD11 ' A' ' 255' ' ' ILE . 29.6 mm -66.37 -40.73 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -178.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.456 ' O ' ' HB2' ' A' ' 230' ' ' GLU . 88.2 tttt -60.82 -43.33 98.35 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.479 176.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 51.1 m -59.36 -39.09 82.14 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 39.5 t -76.76 -45.5 31.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.625 0.25 . . . . 0.0 111.304 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.603 ' CB ' HD11 ' A' ' 235' ' ' ILE . 15.5 m-85 -65.91 -30.39 70.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.225 0.536 . . . . 0.0 110.987 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 226' ' ' LYS . 7.6 tp10 -61.0 -24.21 65.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.946 176.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.65 -13.16 59.98 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.883 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -111.06 -34.39 6.21 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.692 -178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -149.97 166.74 29.93 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.332 179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -78.56 103.19 8.34 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.253 0.549 . . . . 0.0 111.336 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.603 HD11 ' CB ' ' A' ' 229' ' ' PHE . 22.3 mt -78.6 150.94 5.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.103 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -109.04 -28.66 8.96 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.794 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.467 ' OG ' ' HB2' ' A' ' 256' ' ' GLU . 3.3 p -172.04 153.1 3.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.671 0.272 . . . . 0.0 111.136 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . 0.455 ' CB ' ' HB2' ' A' ' 226' ' ' LYS . 41.6 t -143.5 127.79 17.74 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.16 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.403 ' O ' HG23 ' A' ' 239' ' ' THR . 5.2 t -141.53 108.48 5.43 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.067 0.461 . . . . 0.0 111.311 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.569 ' HA ' ' HA3' ' A' ' 253' ' ' GLY . 36.5 mt -79.32 130.58 35.58 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 175.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.578 ' HB3' ' CD1' ' A' ' 252' ' ' TYR . . . -75.03 118.68 18.26 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -178.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.536 ' CB ' ' HA ' ' A' ' 249' ' ' HIS . 35.9 ptt180 -139.56 169.04 18.47 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.95 -170.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -106.17 108.48 61.79 Favored Pre-proline 0 C--N 1.318 -0.769 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 173.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -58.41 -37.61 94.1 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.305 2.67 . . . . 0.0 113.161 -175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.44 -35.04 79.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.949 -176.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . . . . . . . . . 41.0 p -97.78 -18.67 18.65 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 111.537 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 73.77 44.82 30.14 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.05 174.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -150.95 139.64 20.7 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . 0.536 ' HA ' ' CB ' ' A' ' 242' ' ' ARG . 6.2 p80 -83.68 140.23 32.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 48.8 mtpt -81.26 30.06 0.34 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -169.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 92.97 -6.06 76.27 Favored Glycine 0 CA--C 1.505 -0.578 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.429 171.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.578 ' CD1' ' HB3' ' A' ' 241' ' ' ALA . 0.2 OUTLIER -140.42 173.87 11.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -176.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 240' ' ' LEU . . . -169.77 174.7 44.02 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.413 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 212' ' ' TYR . 59.7 m-85 -129.51 146.92 51.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 117.169 0.484 . . . . 0.0 110.512 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.604 HD11 HG22 ' A' ' 225' ' ' ILE . 84.9 mt -136.03 147.76 28.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.008 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.89 ' HG2' ' HB3' ' A' ' 210' ' ' ARG . 34.7 mt-10 -127.65 146.81 50.43 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -175.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.644 ' HB2' ' OG ' ' A' ' 263' ' ' SER . 18.7 m-85 -119.66 159.18 24.94 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.825 0.345 . . . . 0.0 110.915 -178.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -72.16 -36.42 69.31 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.211 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -107.1 131.67 53.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . . . . . . . . . . . -58.23 -34.26 70.23 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.655 -173.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . 0.426 HE21 ' HB2' ' A' ' 261' ' ' GLN . 0.0 OUTLIER -64.81 -44.48 89.78 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.2 176.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 18.0 m -65.02 -30.58 71.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.296 -169.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.644 ' OG ' ' HB2' ' A' ' 257' ' ' TYR . 1.6 m -60.96 -47.6 85.69 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 121.389 0.614 . . . . 0.0 109.646 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -73.69 -26.84 60.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.325 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -74.29 -32.99 63.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.418 -178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.453 ' O ' ' HG2' ' A' ' 270' ' ' MET . . . -66.78 -40.07 88.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 173.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 282' ' ' VAL . 64.5 t -55.13 -45.56 77.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 121.433 0.635 . . . . 0.0 109.882 173.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 53.0 m -63.26 -30.01 71.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.699 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 15.9 m -95.61 -37.26 10.92 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.484 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 90.5 mmm -92.77 -3.52 54.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -166.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 272' ' ' LEU . 15.9 t30 -72.95 124.77 26.11 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.22 176.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . 0.464 ' HA ' ' HB3' ' A' ' 279' ' ' TYR . 99.1 mt 72.37 26.17 2.67 Favored 'General case' 0 N--CA 1.464 0.262 0 O-C-N 123.901 0.75 . . . . 0.0 110.643 -175.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -87.33 120.75 28.94 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 174.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.546 ' HB3' ' CE1' ' A' ' 279' ' ' TYR . 10.2 p-10 -78.21 101.23 6.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.467 0.651 . . . . 0.0 110.871 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.546 HD12 HD11 ' A' ' 280' ' ' LEU . 0.9 OUTLIER -113.37 107.7 16.21 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.03 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 73.58 22.32 78.56 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.741 -0.742 . . . . 0.0 111.838 -177.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 105.27 -38.5 3.26 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.775 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -87.87 148.68 24.53 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.857 0.328 . . . . 0.0 110.979 -176.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.546 ' CE1' ' HB3' ' A' ' 274' ' ' ASP . 81.4 m-85 -90.55 113.33 25.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.088 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.546 HD11 HD12 ' A' ' 275' ' ' LEU . 69.9 mt -60.18 133.27 55.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.479 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 24.6 mmt180 -107.1 116.35 31.77 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 172.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 267' ' ' VAL . 7.8 p -118.1 140.55 41.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-O 121.184 0.516 . . . . 0.0 111.36 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -132.47 174.78 20.24 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.018 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -100.33 45.43 0.98 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.597 0.713 . . . . 0.0 110.957 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 205' ' ' ALA . . . 33.09 69.89 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 112.9 -1.955 . . . . 0.0 113.709 174.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.425 HG21 ' HG3' ' A' ' 167' ' ' GLN . 35.1 m -54.8 -26.29 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.926 0.393 . . . . 0.0 111.159 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.483 ' HA ' ' HD2' ' A' ' 288' ' ' PRO . 25.7 p -134.04 107.14 11.44 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.611 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . 0.506 ' HG3' ' HB3' ' A' ' 204' ' ' GLU . 21.8 Cg_endo -62.04 121.51 9.59 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.857 2.372 . . . . 0.0 111.363 172.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.25 56.45 5.48 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.864 2.376 . . . . 0.0 112.316 -177.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . 0.441 ' HG2' ' HB2' ' A' ' 288' ' ' PRO . 88.8 mmm -76.62 130.91 75.26 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.019 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -68.81 81.21 0.61 Allowed 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.802 2.334 . . . . 0.0 112.3 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 95.1 mt -95.87 60.9 2.14 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.503 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . 0.498 ' O ' ' HD3' ' A' ' 295' ' ' PRO . 44.1 tp -94.47 104.38 16.34 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 177.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 5.9 p -108.44 96.52 19.27 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.026 -176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 293' ' ' LEU . 16.6 Cg_exo -68.18 -54.66 0.3 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.803 2.335 . . . . 0.0 111.393 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 48.92 54.55 10.65 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.41 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.502 -0.761 . . . . 0.0 110.21 -179.021 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.806 0 N-CA-C 112.319 -0.312 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.66 96.95 5.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.828 0.347 . . . . 0.0 110.231 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -120.13 -31.77 4.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.521 ' HA ' HE21 ' A' ' 105' ' ' GLN . . . -93.04 36.99 1.03 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.11 0.481 . . . . 0.0 110.401 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -96.96 125.04 41.11 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.108 -176.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 60.49 50.13 6.14 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.68 -179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.521 HE21 ' HA ' ' A' ' 102' ' ' ALA . 16.8 mt-30 -112.67 8.84 19.17 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.378 175.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 27.6 tpt180 -53.64 -49.26 68.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.494 176.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -69.7 -48.02 61.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.08 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.99 -34.66 78.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.947 -176.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.96 -32.49 72.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.145 0.498 . . . . 0.0 110.584 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.8 mt -80.67 -34.59 14.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.158 177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.466 ' SD ' HG12 ' A' ' 198' ' ' ILE . 84.8 mtp -71.42 -23.48 61.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.83 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 163' ' ' PRO . 84.7 m -84.11 -1.74 55.48 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.842 0.353 . . . . 0.0 110.77 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.6 ' HG2' ' HB2' ' A' ' 159' ' ' GLU . 98.5 mtt180 -122.03 141.09 51.71 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.129 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.25 133.12 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.159 0.505 . . . . 0.0 110.022 176.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.472 ' HB3' ' HA ' ' A' ' 187' ' ' ARG . 71.5 t80 -83.5 121.1 26.75 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.627 HG11 ' HZ ' ' A' ' 132' ' ' PHE . 15.7 m -117.46 116.56 52.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.066 0.46 . . . . 0.0 110.097 176.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 183' ' ' ILE . . . -122.23 171.39 15.32 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.03 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 35.8 m 67.38 25.98 8.52 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 122.785 0.434 . . . . 0.0 111.196 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 71.3 mt -66.81 115.56 4.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 178.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -53.32 143.26 19.16 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.924 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -69.5 80.53 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.447 0.642 . . . . 0.0 110.206 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -164.3 -44.79 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.974 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.435 ' CD1' ' HG3' ' A' ' 177' ' ' MET . 48.1 mt -83.33 124.27 30.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.187 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -97.74 -169.86 32.63 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.732 -0.747 . . . . 0.0 111.4 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -65.28 -33.04 75.04 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.019 0.438 . . . . 0.0 110.225 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 130' ' ' GLN . 9.8 m-20 -71.91 -50.59 27.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.535 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -41.86 86.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.503 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.548 HG23 ' CE1' ' A' ' 132' ' ' PHE . 17.1 mm -63.95 -42.91 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.812 177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 30.2 ttt85 -59.15 -38.74 80.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.982 0.42 . . . . 0.0 110.307 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 126' ' ' ASP . 23.4 mt-30 -66.37 -33.78 76.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.338 178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -84.62 -23.69 29.45 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -173.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.627 ' HZ ' HG11 ' A' ' 116' ' ' VAL . 28.3 m-85 -94.25 -21.8 18.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.765 0.317 . . . . 0.0 111.479 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.615 ' N ' ' HD2' ' A' ' 134' ' ' PRO . . . -52.21 -42.58 87.16 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.569 0.951 . . . . 0.0 113.569 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.615 ' HD2' ' N ' ' A' ' 133' ' ' ALA . 1.1 Cg_endo -47.54 -39.12 29.12 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.86 2.374 . . . . 0.0 114.325 176.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.598 ' HD1' ' HG ' ' A' ' 168' ' ' LEU . 62.9 m-85 -78.39 -38.04 42.63 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.744 0.276 . . . . 0.0 111.744 -172.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -172.69 172.61 45.11 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.197 175.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -71.56 117.56 5.21 Favored 'Trans proline' 0 C--O 1.24 0.576 0 C-N-CA 122.638 2.226 . . . . 0.0 111.469 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.762 HD13 HD11 ' A' ' 141' ' ' ILE . 80.9 mt -72.63 131.95 34.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.705 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -111.09 -21.02 12.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.352 -178.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' A' ' 159' ' ' GLU . 42.4 t -165.36 142.28 5.68 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.963 178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.762 HD11 HD13 ' A' ' 138' ' ' ILE . 54.0 mt -142.0 114.44 3.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.277 173.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 157' ' ' PHE . 7.9 p-10 -110.28 108.15 18.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.496 0.665 . . . . 0.0 109.426 172.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.546 ' HE1' HG13 ' A' ' 128' ' ' ILE . 45.5 ttm -109.68 146.37 34.95 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.265 -178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.415 ' CB ' ' HB2' ' A' ' 153' ' ' LYS . 7.9 p -73.66 54.9 0.49 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.742 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.504 ' HA ' ' O ' ' A' ' 151' ' ' LYS . 43.9 t-105 -117.82 96.04 5.19 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 172.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -81.32 121.53 26.32 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.668 178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 20.4 m -83.46 -9.74 58.81 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.713 -175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.9 -56.27 7.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.76 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.4 p -100.38 -6.23 26.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.968 0.413 . . . . 0.0 111.51 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 41.5 mtm 66.13 56.9 0.8 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.304 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 145' ' ' TRP . 65.1 mttm -110.07 131.34 55.14 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.156 177.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -121.37 85.27 2.37 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.415 ' HB2' ' CB ' ' A' ' 144' ' ' SER . 31.3 mmmt -61.52 -52.34 64.87 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.095 -174.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 123.4 15.91 3.59 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 119.948 -1.12 . . . . 0.0 113.746 174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 116' ' ' VAL . 51.6 p90 -128.11 156.33 43.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 117.239 0.519 . . . . 0.0 110.558 175.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.62 159.04 29.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.992 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.463 ' HB2' ' OD1' ' A' ' 142' ' ' ASP . 51.8 m-85 -112.33 112.74 24.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.846 172.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.452 HG11 ' CD2' ' A' ' 132' ' ' PHE . 59.3 t -98.7 117.46 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.177 -178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.6 ' HB2' ' HG2' ' A' ' 113' ' ' ARG . 37.0 tt0 -109.33 138.85 45.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.049 -178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -115.32 -175.97 2.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.229 175.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -75.36 -34.35 61.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 110.815 171.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.5 m -125.98 150.78 70.19 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 121.043 0.449 . . . . 0.0 111.365 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 58.0 Cg_endo -70.1 -14.1 34.62 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.369 2.713 . . . . 0.0 111.938 -179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.447 ' HG3' ' HE1' ' A' ' 254' ' ' PHE . 70.5 mm-40 -59.12 -59.59 5.23 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.985 -178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.73 -19.21 10.23 Favored 'General case' 0 C--O 1.224 -0.261 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -82.52 -53.32 6.06 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.798 0.332 . . . . 0.0 110.111 -176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -63.57 -36.78 84.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.828 174.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.598 ' HG ' ' HD1' ' A' ' 135' ' ' PHE . 18.5 tp -66.23 -46.96 75.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.29 177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -60.54 -44.17 96.39 Favored 'General case' 0 C--O 1.22 -0.453 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.594 ' HG ' HG13 ' A' ' 185' ' ' VAL . 6.1 tt -55.43 -44.34 76.18 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.247 0.546 . . . . 0.0 109.789 176.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -58.16 -39.84 79.86 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.127 -0.942 . . . . 0.0 113.204 -177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -100.59 -7.34 24.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' MET . . . . . 0.648 ' SD ' HD11 ' A' ' 183' ' ' ILE . 32.5 ttm -97.46 -16.46 20.15 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -173.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -78.59 27.39 0.21 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.196 0.522 . . . . 0.0 111.414 -176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.468 ' O ' HG13 ' A' ' 176' ' ' VAL . 41.5 t -113.6 -58.77 2.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.359 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 182' ' ' ASN . 1.0 OUTLIER -164.3 167.47 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 O-C-N 124.042 0.839 . . . . 0.0 109.167 177.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.449 ' SD ' ' HG ' ' A' ' 178' ' ' LEU . 15.1 tpp -134.05 88.16 2.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.423 0.63 . . . . 0.0 110.805 172.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.449 ' HG ' ' SD ' ' A' ' 177' ' ' MET . 90.1 mt 58.96 -79.83 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 114.12 -1.4 . . . . 0.0 113.597 174.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -79.02 54.93 4.27 Favored Glycine 0 CA--C 1.518 0.219 0 N-CA-C 114.278 0.471 . . . . 0.0 114.278 -168.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 77.87 -52.42 3.6 Favored Glycine 0 CA--C 1.519 0.329 0 N-CA-C 114.078 0.391 . . . . 0.0 114.078 172.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -76.27 133.96 39.92 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.091 0.472 . . . . 0.0 111.631 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 176' ' ' VAL . 43.8 t30 -80.12 134.59 36.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.096 171.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ILE . . . . . 0.648 HD11 ' SD ' ' A' ' 173' ' ' MET . 40.8 pt -105.0 173.24 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.951 0.405 . . . . 0.0 110.624 -177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 87.7 mttt -102.62 106.1 16.71 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.594 HG13 ' HG ' ' A' ' 170' ' ' LEU . 12.0 p -102.78 120.39 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.605 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 132.34 128.65 2.94 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.766 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 68.7 ttt180 -74.76 -50.71 4.17 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 119.408 -0.329 . . . . 0.0 111.551 179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 187' ' ' ARG . 37.9 Cg_endo -65.9 84.55 0.24 Allowed 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.009 1.806 . . . . 0.0 112.819 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.4 t -97.0 -9.02 29.05 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 174.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . 0.566 ' ND2' HG22 ' A' ' 191' ' ' ILE . 15.9 t30 -116.69 -59.77 1.93 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.425 177.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.566 HG22 ' ND2' ' A' ' 190' ' ' ASN . 9.0 tp -172.36 -52.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 111.51 0.189 . . . . 0.0 111.51 174.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 191' ' ' ILE . . . 89.65 136.51 6.14 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.244 -178.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -76.42 -14.0 60.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.775 0.322 . . . . 0.0 111.361 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.438 ' O ' HG13 ' A' ' 198' ' ' ILE . . . -103.89 5.62 35.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.023 -177.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.589 ' N ' ' HD2' ' A' ' 196' ' ' PRO . 19.3 tm0? -53.36 -46.64 97.88 Favored Pre-proline 0 CA--C 1.542 0.652 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.146 -177.213 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 195' ' ' GLN . 6.8 Cg_endo -51.85 -44.6 43.88 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.298 1.999 . . . . 0.0 112.75 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.438 ' O ' ' HG ' ' A' ' 201' ' ' LEU . 70.5 mt -69.43 -41.43 80.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 0.0 110.386 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.466 HG12 ' SD ' ' A' ' 111' ' ' MET . 74.2 mt -57.8 -48.3 84.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.461 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -65.52 -38.75 90.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.078 -178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -63.84 -48.36 77.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.13 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 197' ' ' ILE . 42.3 mt -67.48 -33.5 75.23 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 121.151 -0.22 . . . . 0.0 110.559 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.661 ' O ' ' HG3' ' A' ' 206' ' ' ARG . . . -53.31 -47.87 68.89 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -68.55 -31.63 70.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.131 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -63.21 -37.95 89.24 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.008 0.432 . . . . 0.0 110.741 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -77.13 -26.19 52.93 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.181 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 202' ' ' ALA . 81.1 mtp180 -70.95 -24.67 62.48 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.018 176.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -69.97 -24.15 63.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.293 0.568 . . . . 0.0 110.405 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -104.89 169.24 8.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.674 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 256' ' ' GLU . 46.1 m-20 -105.31 38.59 1.92 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ARG . . . . . 0.468 ' CA ' ' HG2' ' A' ' 256' ' ' GLU . 20.7 ttm180 -95.36 138.25 33.31 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.033 -170.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.703 HG22 ' HD2' ' A' ' 284' ' ' LYS . 44.9 pt -122.75 167.02 16.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.074 175.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' TYR . . . . . 0.48 ' HE1' ' CD2' ' A' ' 252' ' ' TYR . 66.0 t80 -119.18 129.36 54.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.199 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . 0.559 HG11 ' CZ ' ' A' ' 229' ' ' PHE . 35.1 m -123.53 134.92 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -126.06 175.66 7.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.846 -176.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 66.12 27.17 10.54 Favored 'General case' 0 CA--C 1.527 0.059 0 O-C-N 124.158 0.911 . . . . 0.0 109.629 -176.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' VAL . . . . . 0.42 HG13 HD11 ' A' ' 225' ' ' ILE . 22.2 t -77.13 112.46 15.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.114 -176.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' HIS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 220' ' ' LEU . 42.6 t-80 -53.3 136.95 36.08 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.058 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -55.08 -34.77 63.9 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.993 -1.003 . . . . 0.0 113.186 -173.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -95.13 7.13 47.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.727 0.775 . . . . 0.0 110.639 -177.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.567 HD21 ' HG ' ' A' ' 275' ' ' LEU . 15.3 tp -92.0 124.5 36.15 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 33.7 t -89.65 168.43 12.14 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.986 0.422 . . . . 0.0 111.219 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -69.17 -22.85 63.89 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -65.48 -33.91 77.04 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.923 175.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -72.16 -46.44 56.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.423 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.735 HG13 HD21 ' A' ' 240' ' ' LEU . 21.8 mm -63.11 -50.82 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -56.67 -44.39 81.35 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.967 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 30.3 t -58.09 -43.68 87.19 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -175.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' VAL . . . . . . . . . . . . . 19.1 t -76.82 -44.02 32.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.5 -176.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PHE . . . . . 0.641 ' HB2' HD11 ' A' ' 235' ' ' ILE . 55.3 m-85 -64.1 -33.41 75.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.098 0.475 . . . . 0.0 110.71 178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -61.01 -24.96 66.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.457 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -73.48 -11.93 60.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.153 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -111.87 -33.89 6.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.862 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' GLY . . . . . . . . . . . . . . . -156.85 158.39 28.76 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.904 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 14.7 tppt? -69.44 116.05 9.42 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.268 0.556 . . . . 0.0 111.101 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 229' ' ' PHE . 47.0 mt -86.19 151.58 3.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.733 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -119.32 -15.41 9.13 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.418 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.514 ' HB3' ' HB2' ' A' ' 256' ' ' GLU . 47.6 t -165.77 143.88 5.84 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 -174.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' CYS . . . . . . . . . . . . . 54.1 t -153.87 117.78 4.74 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 10.5 t -140.26 139.39 35.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.234 179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LEU . . . . . 0.735 HD21 HG13 ' A' ' 225' ' ' ILE . 77.8 mt -105.43 130.94 53.41 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -67.81 121.28 15.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.033 0.444 . . . . 0.0 110.376 -177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 248' ' ' LYS . 51.6 ttp180 -134.65 152.02 51.47 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.111 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.485 ' HB2' ' OG1' ' A' ' 246' ' ' THR . 5.7 m-20 -74.11 148.47 86.6 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 175.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -45.94 -45.12 17.91 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.04 2.493 . . . . 0.0 113.377 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 2.2 t -154.66 75.11 0.97 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.707 0.765 . . . . 0.0 110.881 -176.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 243' ' ' ASP . 18.1 p -125.01 -11.19 7.11 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.138 177.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 72.45 20.3 79.33 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.389 -178.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 242' ' ' ARG . 21.6 ptmt -156.69 141.78 17.22 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' HIS . . . . . . . . . . . . . 27.5 p80 -94.14 140.99 29.06 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.093 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -44.1 -55.97 4.37 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.235 0.959 . . . . 0.0 113.046 -172.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' GLY . . . . . . . . . . . . . . . 145.95 11.04 0.24 Allowed Glycine 0 CA--C 1.511 -0.19 0 C-N-CA 119.731 -1.223 . . . . 0.0 113.054 178.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' TYR . . . . . 0.48 ' CD2' ' HE1' ' A' ' 212' ' ' TYR . 44.4 p90 -144.37 167.23 22.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 176.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLY . . . . . . . . . . . . . . . -154.08 173.81 32.62 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.26 -177.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.447 ' HE1' ' HG3' ' A' ' 164' ' ' GLU . 81.0 m-85 -133.59 143.99 49.01 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 -178.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 225' ' ' ILE . 67.6 mt -140.12 135.74 37.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.501 -176.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLU . . . . . 0.564 ' HA ' ' O ' ' A' ' 209' ' ' ASN . 25.4 mt-10 -112.83 142.23 45.72 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 174.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 229' ' ' PHE . 7.0 m-85 -102.18 167.35 10.06 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 173.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -73.3 -13.99 61.22 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.96 173.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -134.76 124.93 25.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.551 178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ALA . . . . . 0.412 ' HB2' ' OD1' ' A' ' 209' ' ' ASN . . . -58.97 -44.14 91.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.203 -176.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -62.89 -33.98 76.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.826 0.346 . . . . 0.0 110.802 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' SER . . . . . . . . . . . . . 53.3 m -70.48 -27.87 64.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.55 -179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 267' ' ' VAL . 83.9 p -72.81 -31.3 64.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -72.68 -30.62 64.41 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.946 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -63.05 -38.68 92.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.248 175.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ALA . . . . . 0.422 ' HB1' ' CD2' ' A' ' 229' ' ' PHE . . . -66.05 -42.37 89.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.131 175.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 263' ' ' SER . 82.4 t -53.03 -45.82 53.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-O 120.863 0.363 . . . . 0.0 111.345 176.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 18.6 m -65.54 -32.13 73.56 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 32.0 t -94.12 -33.64 13.27 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -173.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' MET . . . . . 0.517 ' HG3' ' CE2' ' A' ' 229' ' ' PHE . 94.3 mmm -91.75 0.55 57.48 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -169.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -74.29 118.39 17.19 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' LEU . . . . . . . . . . . . . 96.7 mt 68.62 31.35 4.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.451 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -89.75 123.18 33.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.28 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 278' ' ' GLN . 10.1 t70 -69.78 120.21 15.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.875 0.369 . . . . 0.0 110.892 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.567 ' HG ' HD21 ' A' ' 220' ' ' LEU . 38.8 tp -138.41 94.41 2.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.614 173.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 85.39 25.49 39.39 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.902 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 84.9 3.87 87.57 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.923 -0.656 . . . . 0.0 111.811 -178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLN . . . . . 0.463 ' HG3' ' HB2' ' A' ' 217' ' ' HIS . 16.8 mm100 -109.64 139.67 44.38 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.55 -178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -96.6 103.27 15.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.886 175.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 35.7 mt -63.6 124.5 21.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.635 -175.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -93.92 116.61 29.07 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 171.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.414 HG23 HG12 ' A' ' 213' ' ' VAL . 14.5 p -124.44 148.37 28.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 121.103 0.478 . . . . 0.0 111.346 -171.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . -167.19 177.76 41.64 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LYS . . . . . 0.703 ' HD2' HG22 ' A' ' 211' ' ' ILE . 4.6 mmmp? -80.32 123.26 27.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 117.286 0.543 . . . . 0.0 109.942 175.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . 0.487 ' H ' ' HA ' ' A' ' 211' ' ' ILE . . . -52.47 127.48 22.69 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.96 0.787 . . . . 0.0 110.347 177.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 35.8 m -88.56 -25.6 5.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 123.466 0.479 . . . . 0.0 111.052 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' THR . . . . . 0.641 ' O ' ' HD3' ' A' ' 289' ' ' PRO . 21.7 p -127.5 153.33 77.41 Favored Pre-proline 0 C--N 1.323 -0.575 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 175.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -91.51 101.84 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.793 2.329 . . . . 0.0 112.031 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' PRO . . . . . 0.641 ' HD3' ' O ' ' A' ' 287' ' ' THR . 11.6 Cg_endo -93.67 99.7 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.564 2.843 . . . . 0.0 111.348 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' MET . . . . . . . . . . . . . 25.5 mmt -86.65 116.86 67.47 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.82 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.53 116.5 3.95 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.579 2.186 . . . . 0.0 110.67 174.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LEU . . . . . . . . . . . . . 82.9 mt -79.67 54.07 1.73 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.157 0.503 . . . . 0.0 110.989 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 88.9 mt -123.17 125.63 45.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.205 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' THR . . . . . . . . . . . . . 36.5 p 49.05 68.14 3.82 Favored Pre-proline 0 CA--C 1.534 0.336 0 O-C-N 123.777 0.673 . . . . 0.0 111.388 -175.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.4 154.39 60.84 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.116 2.544 . . . . 0.0 112.243 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ALA . . . . . . . . . . . . . . . 72.06 136.33 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 O-C-N 124.099 0.874 . . . . 0.0 111.702 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' THR . . . . . . . . . . . . . 22.4 p . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.4 -0.809 . . . . 0.0 110.372 177.619 . . . . . . . . 0 0 . 1 stop_ save_